PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA
J	Peifer, M; Fernandez-Cuesta, L; Sos, ML; George, J; Seidel, D; Kasper, LH; Plenker, D; Leenders, F; Sun, RP; Zander, T; Menon, R; Koker, M; Dahmen, I; Muller, C; Di Cerbo, V; Schildhaus, HU; Altmuller, J; Baessmann, I; Becker, C; de Wilde, B; Vandesompele, J; Bohm, D; Ansen, S; Gabler, F; Wilkening, I; Heynck, S; Heuckmann, JM; Lu, X; Carter, SL; Cibulskis, K; Banerji, S; Getz, G; Park, KS; Rauh, D; Grutter, C; Fischer, M; Pasqualucci, L; Wright, G; Wainer, Z; Russell, P; Petersen, I; Chen, Y; Stoelben, E; Ludwig, C; Schnabel, P; Hoffmann, H; Muley, T; Brockmann, M; Engel-Riedel, W; Muscarella, LA; Fazio, VM; Groen, H; Timens, W; Sietsma, H; Thunnissen, E; Smit, E; Heideman, DAM; Snijders, PJF; Cappuzzo, F; Ligorio, C; Damiani, S; Field, J; Solberg, S; Brustugun, OT; Lund-Iversen, M; Sanger, J; Clement, JH; Soltermann, A; Moch, H; Weder, W; Solomon, B; Soria, JC; Validire, P; Besse, B; Brambilla, E; Brambilla, C; Lantuejoul, S; Lorimier, P; Schneider, PM; Hallek, M; Pao, W; Meyerson, M; Sage, J; Shendure, J; Schneider, R; Buttner, R; Wolf, J; Nurnberg, P; Perner, S; Heukamp, LC; Brindle, PK; Haas, S; Thomas, RK				Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Kasper, Lawryn H.; Plenker, Dennis; Leenders, Frauke; Sun, Ruping; Zander, Thomas; Menon, Roopika; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Di Cerbo, Vincenzo; Schildhaus, Hans-Ulrich; Altmueller, Janine; Baessmann, Ingelore; Becker, Christian; de Wilde, Bram; Vandesompele, Jo; Boehm, Diana; Ansen, Sascha; Gabler, Franziska; Wilkening, Ines; Heynck, Stefanie; Heuckmann, Johannes M.; Lu, Xin; Carter, Scott L.; Cibulskis, Kristian; Banerji, Shantanu; Getz, Gad; Park, Kwon-Sik; Rauh, Daniel; Gruetter, Christian; Fischer, Matthias; Pasqualucci, Laura; Wright, Gavin; Wainer, Zoe; Russell, Prudence; Petersen, Iver; Chen, Yuan; Stoelben, Erich; Ludwig, Corinna; Schnabel, Philipp; Hoffmann, Hans; Muley, Thomas; Brockmann, Michael; Engel-Riedel, Walburga; Muscarella, Lucia A.; Fazio, Vito M.; Groen, Harry; Timens, Wim; Sietsma, Hannie; Thunnissen, Erik; Smit, Egbert; Heideman, Danielle A. M.; Snijders, Peter J. F.; Cappuzzo, Federico; Ligorio, Claudia; Damiani, Stefania; Field, John; Solberg, Steinar; Brustugun, Odd Terje; Lund-Iversen, Marius; Saenger, Joerg; Clement, Joachim H.; Soltermann, Alex; Moch, Holger; Weder, Walter; Solomon, Benjamin; Soria, Jean-Charles; Validire, Pierre; Besse, Benjamin; Brambilla, Elisabeth; Brambilla, Christian; Lantuejoul, Sylvie; Lorimier, Philippe; Schneider, Peter M.; Hallek, Michael; Pao, William; Meyerson, Matthew; Sage, Julien; Shendure, Jay; Schneider, Robert; Buettner, Reinhard; Wolf, Juergen; Nuernberg, Peter; Perner, Sven; Heukamp, Lukas C.; Brindle, Paul K.; Haas, Stefan; Thomas, Roman K.			Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer	NATURE GENETICS			English	Article							FREQUENT MUTATION; EGFR MUTATIONS; MOUSE MODEL; E-CADHERIN; GENE; P53; CBP; ACETYLATION; SIGNATURES; FUSIONS	Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis(1-3). We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an extremely high mutation rate of 7.4 +/- 1 protein-changing mutations per million base pairs. Therefore, we conducted integrated analyses of the various data sets to identify pathogenetically relevant mutated genes. In all cases, we found evidence for inactivation of TP53 and RB1 and identified recurrent mutations in the CREBBP, EP300 and MLL genes that encode histone modifiers. Furthermore, we observed mutations in PTEN, SLIT2 and EPHA7, as well as focal amplifications of the FGFR1 tyrosine kinase gene. Finally, we detected many of the alterations found in humans in SCLC tumors from Tp53 and Rb1 double knockout mice(4). Our study implicates histone modification as a major feature of SCLC, reveals potentially therapeutically tractable genomic alterations and provides a generalizable framework for the identification of biologically relevant genes in the context of high mutational background.	[Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Plenker, Dennis; Leenders, Frauke; Zander, Thomas; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Heuckmann, Johannes M.; Lu, Xin; Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Plenker, Dennis; Leenders, Frauke; Zander, Thomas; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Gabler, Franziska; Wilkening, Ines; Heynck, Stefanie; Heuckmann, Johannes M.; Lu, Xin; Thomas, Roman K.] Univ Cologne, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, Max Planck Soc, D-50931 Cologne, Germany; [Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Plenker, Dennis; Leenders, Frauke; Zander, Thomas; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Gabler, Franziska; Wilkening, Ines; Heynck, Stefanie; Heuckmann, Johannes M.; Lu, Xin; Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Sos, Martin L.; Zander, Thomas; Ansen, Sascha; Hallek, Michael; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Sos, Martin L.; Zander, Thomas; Ansen, Sascha; Hallek, Michael; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, D-50931 Cologne, Germany; [Seidel, Danila; Leenders, Frauke; Hallek, Michael; Buettner, Reinhard; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Lab Translat Canc Genom, Ctr Integrated Oncol Kolm Bonn, D-50931 Cologne, Germany; [Kasper, Lawryn H.; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Sun, Ruping; Haas, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Menon, Roopika; Boehm, Diana; Perner, Sven] Univ Hosp Bonn, Inst Prostate Canc Res, Inst Pathol, Bonn, Germany; [Di Cerbo, Vincenzo; Schneider, Robert] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Schildhaus, Hans-Ulrich; Buettner, Reinhard; Heukamp, Lukas C.; Thomas, Roman K.] Univ Cologne, Dept Pathol, Cologne, Germany; [Altmueller, Janine; Baessmann, Ingelore; Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [de Wilde, Bram; Vandesompele, Jo] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Carter, Scott L.; Cibulskis, Kristian; Banerji, Shantanu; Getz, Gad; Meyerson, Matthew] Broad Inst Harvard & MIT, Cambridge, MA USA; [Park, Kwon-Sik; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Park, Kwon-Sik; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Rauh, Daniel; Gruetter, Christian] Tech Univ Dortmund, Dept Chem Biol, Dortmund, Germany; [Fischer, Matthias] Univ Childrens Hosp Cologne, Dept Pediat Oncol & Hematol, Cologne, Germany; [Fischer, Matthias; Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY USA; [Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Wright, Gavin; Wainer, Zoe] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic, Australia; [Russell, Prudence] St Vincents Hosp, Dept Pathol, Melbourne, Vic, Australia; [Petersen, Iver; Chen, Yuan] Univ Jena, Jena Univ Hosp, Inst Pathol, Jena, Germany; [Stoelben, Erich; Ludwig, Corinna; Engel-Riedel, Walburga] Kliniken Stadt Koln, Lungenklin Merheim, Dept Thorac Surg, Cologne, Germany; [Schnabel, Philipp] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Hoffmann, Hans; Muley, Thomas] Thoraxklin Heidelberg, Dept Thorac Surg, Heidelberg, Germany; [Brockmann, Michael] Hosp Merheim, Dept Pathol, Kliniken Stadt Koln, Cologne, Germany; [Muscarella, Lucia A.; Fazio, Vito M.] Ist Ricovero & Cura Carattere Sci IRCCS Casa Soll, Lab Oncol, San Giovanni Rotondo, Italy; [Groen, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9713 AV Groningen, Netherlands; [Timens, Wim; Sietsma, Hannie] Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands; [Thunnissen, Erik; Heideman, Danielle A. M.; Snijders, Peter J. F.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Smit, Egbert] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands; [Cappuzzo, Federico] Osped Civile, Dept Med Oncol, Livorno, Italy; [Ligorio, Claudia; Damiani, Stefania] Univ Hosp Bologna, Dept Haematol & Oncol Sci, Bologna, Italy; [Field, John] Univ Liverpool, Roy Castle Lung Canc Res Programme, Canc Res Ctr, Liverpool L69 3BX, Merseyside, England; [Solberg, Steinar] Oslo Univ Hosp, Rikshosp, Dept Thorac Surg, Oslo, Norway; [Brustugun, Odd Terje] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Brustugun, Odd Terje] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Lund-Iversen, Marius] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Saenger, Joerg] Inst Pathol Bad Berka, Bad Berka, Germany; [Clement, Joachim H.] Univ Jena, Dept Internal Med 2, Jena Univ Hosp, Jena, Germany; [Soltermann, Alex; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Weder, Walter] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Solomon, Benjamin] Peter MacCallum Canc Ctr, Dept Haematol & Med Oncol, Melbourne, Vic, Australia; [Soria, Jean-Charles; Besse, Benjamin] Inst Gustave Roussy, Dept Med, Phase Unit 1, Villejuif, France; [Validire, Pierre] Inst Mutualiste Montsouris, France Serv Anat Pathol, Paris, France; [Brambilla, Elisabeth; Brambilla, Christian; Lantuejoul, Sylvie; Lorimier, Philippe] Univ Grenoble 1, Dept Pathol, Grenoble, France; [Brambilla, Elisabeth; Brambilla, Christian; Lantuejoul, Sylvie] Univ Grenoble 1, Inst Albert Bonniot, INSERM U823, Grenoble, France; [Schneider, Peter M.] Univ Cologne, Inst Legal Med, D-50931 Cologne, Germany; [Pao, William] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schneider, Robert] Univ Strasbourg, CNRS UMR 7104, INSERM U964, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany		Thomas, RK (corresponding author), Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany.	roman.thomas@uni-koeln.de	Seidel, Danila/Y-6795-2018; Brambilla, Elisabeth MP/L-8796-2013; Fernandez-Cuesta, Lynnette/Z-1875-2019; lantuejoul, sylvie/N-9315-2017; Fazio, Vito Michele VMF/H-3007-2016; Groen, Harry/AAP-2242-2021; Timens, Wim/K-5570-2013; Heukamp, Lukas C/A-8338-2013; Sos, Martin L/I-1852-2014; Shendure, Jay/AAU-3684-2021; Fernandez-Cuesta, Lynnette/O-2415-2017; Rauh, Daniel/G-1595-2013; Vandesompele, Jo/W-3411-2018; Besse, Benjamin/V-1523-2019; Lantuejoul, Sylvie/N-4671-2013; Schildhaus, Hans-Ulrich/J-3094-2012; Field, John K./AAD-5674-2020; Muscarella, Lucia Anna/K-5979-2016; Cappuzzo, federico/R-2827-2016; Soltermann, Alex/AAE-3012-2020; Cibulskis, Kristian/AAC-7380-2019; Hallek, Michael/Y-3191-2019; Muley, Thomas/AAY-9200-2020; Di Cerbo, Vincenzo/AAR-2818-2021; Heukamp, Lukas/G-9967-2012	Seidel, Danila/0000-0003-4388-3117; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; lantuejoul, sylvie/0000-0003-4310-6975; Fazio, Vito Michele VMF/0000-0002-7751-1867; Timens, Wim/0000-0002-4146-6363; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; Vandesompele, Jo/0000-0001-6274-0184; Besse, Benjamin/0000-0001-5090-8189; Field, John K./0000-0003-3951-6365; Muscarella, Lucia Anna/0000-0002-1866-8151; Cappuzzo, federico/0000-0002-6295-6767; Haas, Stefan/0000-0003-3418-3688; Peifer, Martin/0000-0002-5243-5503; Thunnissen, Erik/0000-0001-5355-8508; Clement, Joachim H./0000-0002-6601-2456; Brindle, Paul/0000-0001-7172-8478; Solomon, Benjamin/0000-0003-3059-5730; Heukamp, Lukas/0000-0002-3388-3482; Groen, Harry J.M./0000-0002-2978-5265; Wright, Gavin/0000-0002-7000-9305; Meyerson, Matthew/0000-0002-9133-8108; DAMIANI, STEFANIA/0000-0002-2757-5985; De Wilde, Bram/0000-0003-0213-1322; Shendure, Jay/0000-0002-1516-1865; Rauh, Daniel/0000-0002-1970-7642; Smit, Egbert/0000-0002-7329-6995; Schneider, Peter M./0000-0003-0744-2349; Di Cerbo, Vincenzo/0000-0002-2920-1274; Altmuller, Janine/0000-0003-4372-1521	German Ministry of Science and Education (BMBF) as part of the NGFNplus programFederal Ministry of Education & Research (BMBF) [01GS08100, 01GS08101]; Max Planck SocietyMax Planck SocietyFoundation CELLEX [M.I..F.A.NEUR8061]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB832, TP6, TP5, Z1, TH1386/3-1]; European Union's Framework Programme CURELUNG [HEALTH-F2-2010-258677]; Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant [SU2C-AACR-IR60109]; Behrens-Weise Foundation; US National Institutes of Health (NIH) Cancer CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA021765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research HospitalAmerican Lebanese Syrian Associated Charities (ALSAC); Associazione Italiana Ricerca sul Cancro (AIRC)Fondazione AIRC per la ricerca sul cancro [IG 9425]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA021765] Funding Source: NIH RePORTER	We are indebted to the individuals donating their tumor specimens as part of the Clinical Lung Cancer Genome Project initiative. Additional biospecimens for this study were obtained from the Victorian Cancer Biobank (Melbourne, Australia). The Institutional Review Board (IRB) of each participating institution approved collection and use of all specimens in this study. We also thank our colleagues at The Cancer Genome Atlas Research Network (TCGA) and A.L. Kung for invaluable discussion and many helpful comments. This work was supported by the German Ministry of Science and Education (BMBF) as part of the NGFNplus program (grant 01GS08100 to R.K.T. and 01GS08101 to J.W. and P.N.), by the Max Planck Society (M.I..F.A.NEUR8061 to R.K.T.), by the Deutsche Forschungsgemeinschaft (DFG) through SFB832 (TP6 to R.K.T. and TP5 and Z1 to L.C.H. and R.B.) and TH1386/3-1 (to R.K.T. and M.L.S.), by the European Union's Framework Programme CURELUNG (HEALTH-F2-2010-258677 to R.K.T., J.F., E.B., C. Brambilla, S.L., B.B. and J.W.), by Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2C-AACR-IR60109 to R.K.T. and W.P.), by the Behrens-Weise Foundation (to R.K.T.) and by an anonymous foundation to R.K.T. M.L.S. is a fellow of the International Association for the Study of Lung Cancer (IASLC). P.K.B. and L.H.K. thank the St. Jude Cell and Tissue Imaging facility and acknowledge support from the US National Institutes of Health (NIH) Cancer Center (grant P30 CA021765) and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. F.C. was supported by Associazione Italiana Ricerca sul Cancro (AIRC, grant IG 9425).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; GAZZERI S, 1991, CANCER RES, V51, P2566; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Han SY, 2000, CANCER RES, V60, P3147; Hassan MI, 2010, J CANCER RES CLIN, V136, P333, DOI 10.1007/s00432-009-0751-9; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Karro JE, 2008, MOL BIOL EVOL, V25, P362, DOI 10.1093/molbev/msm261; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; MORI N, 1990, ONCOGENE, V5, P1713; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Muraoka M, 1996, ONCOGENE, V12, P1565; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Querings S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019601; Rodin SN, 2005, SEMIN CANCER BIOL, V15, P103, DOI 10.1016/j.semcancer.2004.08.005; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Scheble VJ, 2010, MODERN PATHOL, V23, P1061, DOI 10.1038/modpathol.2010.87; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Tillinghast GW, 2003, GENE CHROMOSOME CANC, V37, P121, DOI 10.1002/gcc.10195; Tiseo M, 2007, J THORAC ONCOL, V2, P764, DOI 10.1097/JTO.0b013e3180986262; Travis W.D., 2004, PATHOLOGY GENETICS T, P344; Travis William D, 2009, Eur J Cancer, V45 Suppl 1, P251, DOI 10.1016/S0959-8049(09)70040-1; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Voortman J, 2010, P NATL ACAD SCI USA, V107, P13040, DOI 10.1073/pnas.1008132107; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	90	832	863	1	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1104	+		10.1038/ng.2396			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	WOS:000309550200009	22941188	Green Accepted, Green Published	Y	N	2022-01-24	
J	Morin, RD; O'Connor, MD; Griffith, M; Kuchenbauer, F; Delaney, A; Prabhu, AL; Zhao, Y; McDonald, H; Zeng, T; Hirst, M; Eaves, CJ; Marra, MA				Morin, Ryan D.; O'Connor, Michael D.; Griffith, Malachi; Kuchenbauer, Florian; Delaney, Allen; Prabhu, Anna-Liisa; Zhao, Yongjun; McDonald, Helen; Zeng, Thomas; Hirst, Martin; Eaves, Connie J.; Marra, Marco A.			Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells	GENOME RESEARCH			English	Article							GENE-EXPRESSION SIGNATURES; MOLECULAR SIGNATURE; MESSENGER-RNAS; DIFFERENTIATION; LINES; IDENTIFICATION; PRECURSORS; TARGETS; BODIES; MOUSE	MicroRNAs (miRNAs) are emerging as important, albeit poorly characterized, regulators of biological processes. Key to further elucidation of their roles is the generation of more complete lists of their numbers and expression changes in different cell states. Here, we report a new method for surveying the expression of small RNAs, including microRNAs, using Illumina sequencing technology. We also present a set of methods for annotating sequences deriving from known miRNAs, identifying variability in mature miRNA sequences, and identifying sequences belonging to previously unidentified miRNA genes. Application of this approach to RNA from human embryonic stem cells obtained before and after their differentiation into embryoid bodies revealed the sequences and expression levels of 334 known plus 104 novel miRNA genes. One hundred seventy-one known and 23 novel microRNA sequences exhibited significant expression differences between these two developmental states. Owing to the increased number of sequence reads, these libraries represent the deepest miRNA sampling to date, spanning nearly six orders of magnitude of expression. The predicted targets of those miRNAs enriched in either sample shared common features. Included among the high-ranked predicted gene targets are those implicated in differentiation, cell cycle control, programmed cell death, and transcriptional regulation.	[O'Connor, Michael D.; Kuchenbauer, Florian; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Morin, Ryan D.; Griffith, Malachi; Delaney, Allen; Prabhu, Anna-Liisa; Zhao, Yongjun; McDonald, Helen; Zeng, Thomas; Hirst, Martin; Marra, Marco A.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada		Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca; mmarra@bcgsc.ca	Hirst, Martin/C-3619-2009; Onestas, Ghislain/A-4081-2008; Marra, Marco A/B-5987-2008; Morin, Ryan/AAE-7824-2019; Hirst, Martin/B-7684-2016; Griffith, Malachi/P-1285-2014	Marra, Marco A/0000-0001-7146-7175; Morin, Ryan/0000-0003-2932-7800; Griffith, Malachi/0000-0002-6388-446X; Eaves, Connie/0000-0002-3452-1926; O'Connor, Michael/0000-0002-4883-1706			Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Davison TS, 2006, METHOD ENZYMOL, V411, P14, DOI 10.1016/S0076-6879(06)11002-2; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hirst M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r113; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Loong SNK, 2007, RNA, V13, P170, DOI 10.1261/rna.223807; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhao JJ, 2006, CHILD NERV SYST, V22, P1419, DOI 10.1007/s00381-006-0173-9	54	831	976	1	75	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2008	18	4					610	621		10.1101/gr.7179508			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	282IZ	WOS:000254562400010	18285502	Green Published, Bronze			2022-01-24	
J	KRUGLYAK, L; LANDER, ES				KRUGLYAK, L; LANDER, ES			COMPLETE MULTIPOINT SIB-PAIR ANALYSIS OF QUALITATIVE AND QUANTITATIVE TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFFECTED RELATIVE PAIRS; LINKAGE ANALYSIS; POWER; STRATEGIES; MAPS	Sib-pair analysis is an increasingly important tool for genetic dissection of complex traits. Current methods for sib-pair analysis are primarily based on studying individual genetic markers one at a time and thus fail to use the full inheritance information provided by multipoint linkage analysis. In this paper, we describe how to extract the complete multipoint inheritance information for each sib pair. We then describe methods that use this information to map loci affecting traits, thereby providing a unified approach to both qualitative and quantitative traits. Specifically, complete multipoint approaches are presented for (1) exclusion mapping of qualitative traits; (2) maximum-likelihood mapping of qualitative traits; (3) information-content mapping, showing the extent to which all inheritance information has been extracted at each location in the genome; and (4) quantitative-trait mapping, by two parametric methods and one nonparametric method. In addition, we explore the effects of marker density, marker polymorphism, and availability of parents on the information content of a study. We have implemented the analysis methods in a new computer package, MAPMAKER/SIBS. With this computer package, complete multipoint analysis with dozens of markers in hundreds of sib pairs can be carried out in minutes.	MIT,DEPT BIOL,CAMBRIDGE,MA		KRUGLYAK, L (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.						BISHOP DT, 1990, AM J HUM GENET, V46, P254; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FULKER DW, 1995, AM J HUM GENET, V56, P1224; FULKER DW, 1994, AM J HUM GENET, V54, P1092; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GUO SW, 1994, AM J HUM GENET, V54, P1104; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; KRUGLYAK L, 1995, GENETICS, V139, P1421; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; OLSON JM, 1995, AM J HUM GENET, V56, P788; Penrose LS, 1938, ANN EUGENIC, V8, P233, DOI 10.1111/j.1469-1809.1938.tb02176.x; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; SANDKUIJL LA, 1989, MULTIPOINT MAPPING L; TERWILLIGR JD, 1994, HDB HUMAN GENETIC LI; [No title captured]	26	830	836	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					439	454					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	WOS:A1995RL77100028	7668271				2022-01-24	
J	ANDREW, SE; GOLDBERG, YP; KREMER, B; TELENIUS, H; THEILMANN, J; ADAM, S; STARR, E; SQUITIERI, F; LIN, BY; KALCHMAN, MA; GRAHAM, RK; HAYDEN, MR				ANDREW, SE; GOLDBERG, YP; KREMER, B; TELENIUS, H; THEILMANN, J; ADAM, S; STARR, E; SQUITIERI, F; LIN, BY; KALCHMAN, MA; GRAHAM, RK; HAYDEN, MR			THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; CTG REPEAT; FRAGILE-X; AGE; ONSET; EXPANSION; DNA; INSTABILITY; MUTATIONS	Huntington's disease (HD) is associated with the expansion of a CAG trinucleotide repeat in a novel gene. We have assessed 360 HD individuals from 259 unrelated families and found a highly significant correlation (r = 0.70, p = 10(-7) between the age of onset and the repeat length, which accounts for approximately 50% of the variation in the age of onset. Significant associations were also found between repeat length and age of death and onset of other clinical features. Sib pair and parent-child analysis revealed that the CAG repeat demonstrates only mild instability. Affected HD siblings had significant correlations for trinucleotide expansion (r = 0.66, p < 0.001) which was not apparent for affected parent-child pairs.	UNIV BRITISH COLUMBIA, DEPT MED GENET, 416 2125 E MALL, Vancouver, BC V6T 1Z4, CANADA; UNIV BRITISH COLUMBIA, CTR NEURODEGENERAT DISORDERS, Vancouver, BC V6T 1Z4, CANADA				Squitieri, Ferdinando/N-1852-2019; Hayden, Michael R/D-8581-2011	Squitieri, Ferdinando/0000-0002-7397-1727; Hayden, Michael R/0000-0001-5159-1419; Adam, Shelin/0000-0002-4401-6157			ADAMS P, 1988, AM J HUM GENET, V43, P695; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DRAPER N. R., 1981, APPL REGRESSION ANAL; FARRER LA, 1985, AM J HUM GENET, V37, P350; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harper PS, 1991, HUNTINGTONS DIS; HAYDEN MR, 1985, CLIN GENET, V28, P100; HAYDEN MR, 1993, CLIN GENET, V43, P217; Hayden MR, 1981, HUNTINGTONS CHOREA; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1982, AM J HUM GENET, V34, P481; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; STEVENS DL, HUNTINGTONS CHOREA 1, P191; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192	27	830	840	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					398	403		10.1038/ng0893-398			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	WOS:A1993LQ17800019	8401589				2022-01-24	
J	Hung, T; Wang, YL; Lin, MF; Koegel, AK; Kotake, Y; Grant, GD; Horlings, HM; Shah, N; Umbricht, C; Wang, P; Wang, Y; Kong, B; Langerod, A; Borresen-Dale, AL; Kim, SK; van de Vijver, M; Sukumar, S; Whitfield, ML; Kellis, M; Xiong, Y; Wong, DJ; Chang, HY				Hung, Tiffany; Wang, Yulei; Lin, Michael F.; Koegel, Ashley K.; Kotake, Yojiro; Grant, Gavin D.; Horlings, Hugo M.; Shah, Nilay; Umbricht, Christopher; Wang, Pei; Wang, Yu; Kong, Benjamin; Langerod, Anita; Borresen-Dale, Anne-Lise; Kim, Seung K.; van de Vijver, Marc; Sukumar, Saraswati; Whitfield, Michael L.; Kellis, Manolis; Xiong, Yue; Wong, David J.; Chang, Howard Y.			Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters	NATURE GENETICS			English	Article							GENE-EXPRESSION; HUMAN FIBROBLASTS; CDK INHIBITORS; BREAST-CANCER; MODULE MAP; GENOME; IDENTIFICATION; DEMARCATION; CHECKPOINTS; INITIATION	Transcription of long noncoding RNAs (lncRNAs) within gene regulatory elements can modulate gene activity in response to external stimuli, but the scope and functions of such activity are not known. Here we use an ultrahigh-density array that tiles the promoters of 56 cell-cycle genes to interrogate 108 samples representing diverse perturbations. We identify 216 transcribed regions that encode putative lncRNAs, many with RT-PCR-validated periodic expression during the cell cycle, show altered expression in human cancers and are regulated in expression by specific oncogenic stimuli, stem cell differentiation or DNA damage. DNA damage induces five lncRNAs from the CDKN1A promoter, and one such lncRNA, named PANDA, is induced in a p53-dependent manner. PANDA interacts with the transcription factor NF-YA to limit expression of pro-apoptotic genes; PANDA depletion markedly sensitized human fibroblasts to apoptosis by doxorubicin. These findings suggest potentially widespread roles for promoter lncRNAs in cell-growth control.	[Hung, Tiffany; Koegel, Ashley K.; Wong, David J.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Hung, Tiffany; Koegel, Ashley K.; Kim, Seung K.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wang, Yulei; Wang, Yu; Kong, Benjamin] Life Technol, Foster City, CA USA; [Lin, Michael F.; Kellis, Manolis] Broad Inst, Cambridge, MA USA; [Lin, Michael F.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kotake, Yojiro; Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kotake, Yojiro] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Kotake, Yojiro] Hamamatsu Univ Sch Med, Dept Biochem 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Grant, Gavin D.; Whitfield, Michael L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Horlings, Hugo M.; van de Vijver, Marc] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Shah, Nilay; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Umbricht, Christopher] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Wang, Pei; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Langerod, Anita; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Dept Genet, Inst Canc Res, Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway		Wong, DJ (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	davewong@stanford.edu; howchang@stanford.edu	Kellis, Manolis/ABE-7385-2020; Shah, Nilay/H-9988-2013; Whitfield, Michael/AAC-5010-2020; Shah, Nilay/E-4925-2015	Kellis, Manolis/0000-0001-7113-9630; Wang, Yulei/0000-0002-9057-9786; van de Vijver, Marc/0000-0002-0385-4787; Shah, Nilay/0000-0002-8906-6844; Grant, Gavin/0000-0002-8958-2056	US National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08-AR054615]; NIH/National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01-CA118750, R01-CA130795]; Juvenile Diabetes Research FoundationJuvenile Diabetes Research Foundation; American Cancer SocietyAmerican Cancer Society; Stanford Graduate FellowshipStanford University; National Science Foundation (NSF)National Science Foundation (NSF); Department of Defense (DoD)United States Department of Defense; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22115508] Funding Source: KAKEN; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA130795, R01CA140311, R01CA118750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08AR054615] Funding Source: NIH RePORTER	We thank J. Rinn, M. Guttman and A. Regev for discussions, L. Attardi for careful reading of the manuscript and P. Khavari for reagents. Y.W., B.K. and Yu Wang are employees of Life Technologies. This work was supported by grants from the US National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (K08-AR054615 to D.J.W.), NIH/National Cancer Institute (NCI) (R01-CA118750 to H.Y.C. and R01-CA130795 to M.L.W.), the Juvenile Diabetes Research Foundation (S.K.K. and H.Y.C.) and the American Cancer Society (H.Y.C.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. T.H. is supported by the Stanford Graduate Fellowship, the National Science Foundation (NSF) Graduate Research Fellowship and the Department of Defense (DoD) National Defense Science & Engineering Graduate Fellowship (NDSEG).	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Geisler S, 2001, CANCER RES, V61, P2505; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; LIN M, 2010, NATURE PRECEDIN 0818, DOI DOI 10.1038/NPRE.2010.4784.1; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000067; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Michlewski G, 2010, RNA, V16, P1673, DOI 10.1261/rna.2136010; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	53	829	898	4	245	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2011	43	7					621	U196		10.1038/ng.848			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	WOS:000292184600005	21642992	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Rogaeva, E; Meng, Y; Lee, JH; Gu, Y; Kawarai, T; Zou, F; Katayama, T; Baldwin, CT; Cheng, R; Hasegawa, H; Chen, F; Shibata, N; Lunetta, KL; Pardossi-Piquard, R; Bohm, C; Wakutani, Y; Cupples, LA; Cuenco, KT; Green, RC; Pinessi, L; Rainero, I; Sorbi, S; Bruni, A; Duara, R; Friedland, RP; Inzelberg, R; Hampe, W; Bujo, H; Song, YQ; Andersen, OM; Willnow, TE; Graff-Radford, N; Petersen, RC; Dickson, D; Der, SD; Fraser, PE; Schmitt-Ulms, G; Younkin, S; Mayeux, R; Farrer, LA; St George-Hyslop, P				Rogaeva, Ekaterina; Meng, Yan; Lee, Joseph H.; Gu, Yongjun; Kawarai, Toshitaka; Zou, Fanggeng; Katayama, Taiichi; Baldwin, Clinton T.; Cheng, Rong; Hasegawa, Hiroshi; Chen, Fusheng; Shibata, Nobuto; Lunetta, Kathryn L.; Pardossi-Piquard, Raphaelle; Bohm, Christopher; Wakutani, Yosuke; Cupples, L. Adrienne; Cuenco, Karen T.; Green, Robert C.; Pinessi, Lorenzo; Rainero, Innocenzo; Sorbi, Sandro; Bruni, Amalia; Duara, Ranjan; Friedland, Robert P.; Inzelberg, Rivka; Hampe, Wolfgang; Bujo, Hideaki; Song, You-Qiang; Andersen, Olav M.; Willnow, Thomas E.; Graff-Radford, Neill; Petersen, Ronald C.; Dickson, Dennis; Der, Sandy D.; Fraser, Paul E.; Schmitt-Ulms, Gerold; Younkin, Steven; Mayeux, Richard; Farrer, Lindsay A.; St George-Hyslop, Peter			The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILY-BASED ASSOCIATION; APOLIPOPROTEIN-E GENOTYPE; MISSENSE MUTATIONS; BETA PRODUCTION; TESTS; GENE; COMPLEX; SUSCEPTIBILITY; INFORMATION	The recycling of the amyloid precursor protein ( APP) from the cell surface via the endocytic pathways plays a key role in the generation of amyloid beta peptide ( A beta) in Alzheimer disease. We report here that inherited variants in the SORL1 neuronal sorting receptor are associated with late- onset Alzheimer disease. These variants, which occur in at least two different clusters of intronic sequences within the SORL1 gene ( also known as LR11 or SORLA) may regulate tissue- specific expression of SORL1. We also show that SORL1 directs trafficking of APP into recycling pathways and that when SORL1 is underexpressed, APP is sorted into A beta- generating compartments. These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease.	Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY USA; Univ Toronto, Ctr Res Neurodegenerat Dis, Dept Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Toronto Western Hosp, Res Inst, Toronto, ON M5S 3H2, Canada; Boston Univ, Sch Med, Dept Epidemiol, Dept Med,Genet Program,Dept Neurol,Dept Genet & G, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA; Mayo Clin Rochester, Dept Neurol, Rochester, MN 55905 USA; Univ Turin, Dept Neurosci, I-10126 Turin, Italy; Univ Florence, Dept Neurol & Psychiat Sci, Ctr Res Transfer & High Educ Chron Inflammat Dege, I-50139 Florence, Italy; Reg Ctr Neurogenet, I-88046 Lamezia Terme, CZ, Italy; Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Mem Disorders, Miami Beach, FL 33140 USA; Univ Miami, Sch Med, Dept Psychiat, Miami Beach, FL 33140 USA; Univ Miami, Sch Med, Dept Behav Sci & Med, Miami Beach, FL 33140 USA; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; Meir Hosp, Kfar Saba & Rappaport Fac Med, IL-47441 Haifa, Israel; Univ Med Ctr Hamburg Eppendorf, Dept Mol Cell Biol, D-20246 Hamburg, Germany; Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat M6, Chuo Ku, Chiba 2608670, Japan; Univ Hong Kong, Dept Biochem, Dept Orthopaed Surg, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; Max Delbruck Ctr Mol Med, Dept Mol Cardiovasc Res, D-13125 Berlin, Germany		Mayeux, R (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA.	rpm2@columbia.edu; farrer@bu.edu; p.hyslop@utoronto.ca	Friedland, Robert/A-2834-2010; Song, You-Qiang/E-5207-2011; Mayeux, Richard/E-9788-2013; Song, You-qiang/C-4401-2009; Shibata, Nobuto/AAB-9366-2020; Inzelberg, Rivka/E-5861-2010; Pardossi-Piquard, Raphaelle/D-6263-2012; Pardossi-Piquard, Raphaelle/ABA-4472-2021; Kawarai, Toshitaka/C-2822-2013; Farrer, Lindsay/AAS-1035-2020; Lee, Joseph H/D-2441-2012; Andersen, Olav/N-2777-2017; Bruni, Amalia/K-5038-2016	Friedland, Robert/0000-0001-5721-1843; Mayeux, Richard/0000-0001-6519-9696; Inzelberg, Rivka/0000-0002-0720-0502; Pardossi-Piquard, Raphaelle/0000-0001-5292-4414; Kawarai, Toshitaka/0000-0003-4547-8131; Lee, Joseph H/0000-0002-2000-4821; Lunetta, Kathryn/0000-0002-9268-810X; Andersen, Olav/0000-0003-4226-3354; St George-Hyslop, Peter/0000-0003-0796-7209; Baldwin, Clinton/0000-0002-3275-9463; Willnow, Thomas/0000-0001-9515-7921; Farrer, Lindsay/0000-0001-5533-4225; Dickson, Dennis W/0000-0001-7189-7917; Bruni, Amalia/0000-0003-3471-3343; Song, You-Qiang/0000-0001-9407-2256; Cupples, L. Adrienne/0000-0003-0273-7965; sorbi, sandro/0000-0002-0380-6670	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG009029, U01AG006786, P30AG013846, P01AG007232, R37AG015473, P50AG016574, R01AG017173] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG016574, P01-AG07232, R37 AG015473-08, P30 AG013846, R37 AG015473-06, P01 AG007232, P50-AG16574, R37 AG015473, R37-AG15473, R01 AG017173, R01-AG017173, P30-AG13846, U01-AG06786, U01 AG006786, R37 AG015473-07, R37 AG015473-09, R01-HG/AG02213, R01-AG09029, R37 AG015473-10, R01 AG009029] Funding Source: Medline		Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Athan ES, 2001, JAMA-J AM MED ASSOC, V286, P2257, DOI 10.1001/jama.286.18.2257; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bayer TA, 2001, BRAIN PATHOL, V11, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bowirrat A, 2001, EUR J NEUROL, V8, P119, DOI 10.1046/j.1468-1331.2001.00183.x; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ertekin-Taner N, 2005, HUM MOL GENET, V14, P447, DOI 10.1093/hmg/ddi041; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lee JH, 2004, MOL PSYCHIATR, V9, P1042, DOI 10.1038/sj.mp.4001538; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Rogaeva EA, 1999, NAT GENET, V22, P19, DOI 10.1038/8729; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	49	829	854	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					168	177		10.1038/ng1943			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900014	17220890	Green Accepted			2022-01-24	
J	Meyers, EN; Lewandoski, M; Martin, GR				Meyers, EN; Lewandoski, M; Martin, GR			An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination	NATURE GENETICS			English	Article							TARGETED MUTATION; VERTEBRATE LIMB; NERVOUS-SYSTEM; GENE; MOUSE; DELETION; MICE; INITIATION; OUTGROWTH; EMBRYO	We describe a strategy for generating an allelic series of mutations at a given locus that requires the production of only one targetted mouse line. The 'allelogenic' mouse line we produced carries a hypomorphic allele of Fgf8, which can be converted to a null allele by mating to cre transgenic animals. The hypomorphic allele can also be reverted to wild-type by mating the allelogenic mice to flp transgenic animals, thereby generating a mouse line suitable for Cre-induced tissue-specific knockout experiments. Analysis of embryos carrying different combinations of these alleles revealed requirements for Fgf8 gene function during gastrulation, as well as cardiac, craniofacial, forebrain, midbrain and cerebellar development.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA		Martin, GR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.			Lewandoski, Mark/0000-0002-1066-3735			BALLYCUIF L, 1995, CURR OPIN GENET DEV, V5, P450, DOI 10.1016/0959-437X(95)90048-L; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; GRAZIADEI PPC, 1992, NEUROSCIENCE, V46, P617, DOI 10.1016/0306-4522(92)90149-V; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Lee SMK, 1997, DEVELOPMENT, V124, P959; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWANDOSKI M, IN PRESS COLD SPRING; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; MAGIN TM, 1992, NUCLEIC ACIDS RES, V14, P379; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; Nagy A., 1993, Gene targeting: a practical approach., P147; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PUELLES L, 1996, MAMMALIAN DEV, P173; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; SAVAGE MP, 1993, DEV DYNAM, V198, P159, DOI 10.1002/aja.1001980302; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Wurst W., 1993, Gene targeting: a practical approach., P33	39	829	844	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					136	141		10.1038/ng0298-136			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	WOS:000071779500020	9462741				2022-01-24	
J	Kong, A; Cox, NJ				Kong, A; Cox, NJ			Allele-sharing models: LOD scores and accurate linkage tests	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS	Starting with a test statistic for linkage analysis based on allele sharing, we propose an associated one-parameter model. Under general missing-data patterns, this model allows exact calculation of likelihood ratios and LOD scores and has been implemented by a simple modification of existing software. Most important, accurate linkage tests can be performed. Using an example, we show that some previously suggested approaches to handling less than perfectly informative data can be unacceptably conservative. Situations in which this model may not perform well are discussed, and an alternative model that requires additional computations is suggested.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; DECODE GENET,REYKJAVIK,ICELAND		Kong, A (corresponding author), UNIV CHICAGO,DEPT STAT,CHICAGO,IL 60637, USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Kong, Augustine/0000-0001-8193-5438	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK-47481, DK-20595] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM46800] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK047481, P60DK020595, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM046800] Funding Source: NIH RePORTER		COX DR, 1994, THEORETICAL STATISTI; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; RISCH N, 1990, AM J HUM GENET, V46, P222; *SAGE, 1994, STAT ANAL GEN EP REL; Teng J, 1997, AM J HUM GENET, V60, P979; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 1996, AM J HUM GENET, V59, P704	11	829	836	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1179	1188		10.1086/301592			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	WOS:A1997YH01700025	9345087	Green Published, Bronze			2022-01-24	
J	Yoshizawa, T; Handa, Y; Uematsu, Y; Takeda, S; Sekine, K; Yoshihara, Y; Kawakami, T; Arioka, K; Sato, H; Uchiyama, Y; Masushige, S; Fukamizu, A; Matsumoto, T; Kato, S				Yoshizawa, T; Handa, Y; Uematsu, Y; Takeda, S; Sekine, K; Yoshihara, Y; Kawakami, T; Arioka, K; Sato, H; Uchiyama, Y; Masushige, S; Fukamizu, A; Matsumoto, T; Kato, S			Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning	NATURE GENETICS			English	Article							D ENDOCRINE SYSTEM; GENE-EXPRESSION; SIGNALING PATHWAYS; NUCLEAR RECEPTORS; RESISTANT RICKETS; ESTROGEN-RECEPTOR; 1,25-DIHYDROXYVITAMIN-D3; BINDING; DIFFERENTIATION; RXR	1 alpha,25-Dihydroxyvitamin D-3[1 alpha,25(OH)(2)D-3], an active form of vitamin D, has roles in many biological phenomena such as calcium homeostasis and bone formation(1-3), which are thought to be mediated by the 1 alpha,25(OH)(2)D-3 receptor (VDR), a member of the nuclear hormone receptors superfamily(4-6). However, the molecular basis for the actions of 1 alpha,25(OH)(2)D-3 in bone formation, its role during development and VDR genetic polymorphisms for predicting bone mineral density(7) are uncertain. To investigate the functional role of VDR, we generated mice deficient in VDR by gene targeting. We report here that in VDR null mutant mice, no defects in development and growth were observed before weaning, irrespective of reduced expression of vitamin D target genes. After weaning, however, mutants failed to thrive, with appearance of alopoecia, hypocalcaemia and infertility, and bone formation was severely impaired as a typical feature of vitamin D-dependent rickets type II (refs 8,9). Unlike humans with this disease, most of the null mutant mice died within 15 weeks after birth, and uterine hypoplasia with impaired folliculogenesis was found in female reproductive organs. These defects, such as alopoecia and uterine hypoplasia, were not observed in vitamin D-deficient animals. The findings establish a critical role for VDR in growth, bone formation and female reproduction in the post-weaning stage.	UNIV TOKYO, INST MOL & CELLULAR BIOSCI, BUNKYO KU, TOKYO 113, JAPAN; TOKYO UNIV AGR, DEPT AGR CHEM, SETAGAYA KU, TOKYO 156, JAPAN; CHUGAI PHARMACEUT CO LTD, FUJI GOTENBA RES LABS, SHIZUOKA 412, JAPAN; UNIV TSUKUBA, INST APPL BIOCHEM, TSUKUBA, IBARAKI 305, JAPAN; UNIV TOKUSHIMA, DEPT INTERNAL MED 1, TOKUSHIMA 770, JAPAN				fukamizu, akiyoshi/J-5350-2012; takeda, shu/B-5195-2012	fukamizu, akiyoshi/0000-0002-8786-6020; Sekine, Keisuke/0000-0001-5133-0876			ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; BERESFORD JN, 1986, ENDOCRINOLOGY, V119, P1776, DOI 10.1210/endo-119-4-1776; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; DELVIN EE, 1987, EUR J BIOCHEM, V163, P659, DOI 10.1111/j.1432-1033.1987.tb10915.x; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; ERICKSON GF, 1986, SEMIN REPROD ENDOCR, V4, P233, DOI 10.1055/s-2007-1022504; Eriebacher Adrian, 1995, Cell, V80, P371; Felig P., 1995, ENDOCRINOLOGY METABO; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; Hawa NS, 1996, CLIN ENDOCRINOL, V45, P85; HENRY HL, 1984, ANNU REV NUTR, V4, P493, DOI 10.1146/annurev.nu.04.070184.002425; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KATO S, 1995, MOL CELL BIOL, V15, P5858; KAWASHIMA H, 1981, NATURE, V291, P327, DOI 10.1038/291327a0; KOJIMA R, 1994, J BIOL CHEM, V269, P3270; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MALLOY PJ, 1994, J CLIN ENDOCR METAB, V78, P313, DOI 10.1210/jc.78.2.313; MALLOY PJ, 1990, J CLIN INVEST, V86, P2071, DOI 10.1172/JCI114944; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; REEVE L, 1983, J BIOL CHEM, V258, P3615; Studzinski George P., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P279; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459	30	828	859	0	47	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					391	396		10.1038/ng0897-391			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	WOS:A1997XM90900025	9241280				2022-01-24	
J	DUYAO, M; AMBROSE, C; MYERS, R; NOVELLETTO, A; PERSICHETTI, F; FRONTALI, M; FOLSTEIN, S; ROSS, C; FRANZ, M; ABBOTT, M; GRAY, J; CONNEALLY, P; YOUNG, A; PENNEY, J; HOLLINGSWORTH, Z; SHOULSON, I; LAZZARINI, A; FALEK, A; KOROSHETZ, W; SAX, D; BIRD, E; VONSATTEL, J; BONILLA, E; ALVIR, J; CONDE, JB; CHA, JH; DURE, L; GOMEZ, F; RAMOS, M; SANCHEZRAMOS, J; SNODGRASS, S; DEYOUNG, M; WEXLER, N; MOSCOWITZ, C; PENCHASZADEH, G; MACFARLANE, H; ANDERSON, M; JENKINS, B; SRINIDHI, J; BARNES, G; GUSELLA, J; MACDONALD, M				DUYAO, M; AMBROSE, C; MYERS, R; NOVELLETTO, A; PERSICHETTI, F; FRONTALI, M; FOLSTEIN, S; ROSS, C; FRANZ, M; ABBOTT, M; GRAY, J; CONNEALLY, P; YOUNG, A; PENNEY, J; HOLLINGSWORTH, Z; SHOULSON, I; LAZZARINI, A; FALEK, A; KOROSHETZ, W; SAX, D; BIRD, E; VONSATTEL, J; BONILLA, E; ALVIR, J; CONDE, JB; CHA, JH; DURE, L; GOMEZ, F; RAMOS, M; SANCHEZRAMOS, J; SNODGRASS, S; DEYOUNG, M; WEXLER, N; MOSCOWITZ, C; PENCHASZADEH, G; MACFARLANE, H; ANDERSON, M; JENKINS, B; SRINIDHI, J; BARNES, G; GUSELLA, J; MACDONALD, M			TRINUCLEOTIDE REPEAT LENGTH INSTABILITY AND AGE-OF-ONSET IN HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; MYOTONIC-DYSTROPHY; FRAGILE-X; DNA MARKERS; CTG REPEAT; REGION; GENE; RECOMBINATION; DIAGNOSIS; EXPANSION	The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118; UNIV ROMA TOR VERGATA,DEPT BIOL,ROME,ITALY; CNR,INST MED SPERIMENTALE,ROME,ITALY; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; INDIANA UNIV,MED CTR,DEPT MED GENET,INDIANAPOLIS,IN 46202; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; UNIV ROCHESTER,MED CTR,DEPT NEUROL,ROCHESTER,NY 14642; UNIV MED & DENT NEW JERSEY,DEPT NEUROL,NEW BRUNSWICK,NJ 08903; EMORY UNIV,SCH MED,DEPT PSYCHIAT,ATLANTA,GA 30306; HARVARD UNIV,MCLEAN HOSP,CTR BRAIN TISSUE RESOURCE,BELMONT,MA 02178; HARVARD UNIV,SCH MED,DEPT NEUROPATHOL,BELMONT,MA 02178; UNIV ZULIA,MARACAIBO,VENEZUELA; LONG ISL JEWISH MED CTR,GLEN OAKS,NY 11004; BAYOR UNIV,COLL MED,HOUSTON,TX 77009; KENNEDY KREIGER INST,NEUROSCI LAB,BALTIMORE,MD 21205; HOSP VIRGEN CAMINO,SERV GENET,E-31008 PAMPLONA,SPAIN; UNIV MIAMI,DEPT NEUROL,MIAMI,FL 33136; UNIV MISSISSIPPI,MED CTR,JACKSON,MS 39216; COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL & PSYCHIAT,NEW YORK,NY 10032; HEREDITARY DIS FDN,SANTA MONICA,CA 90401; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114				Dure, Leon/B-3243-2008; Sanchez-Ramos, Juan/O-7870-2014; Sanchez-Ramos, Juan/A-1188-2009	Novelletto, Andrea/0000-0002-1146-7680; Persichetti, Francesca/0000-0002-9804-644X; Myers, Richard/0000-0002-8365-2674; Sanchez-Ramos, Juan/0000-0002-3391-7857	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS016375, R01NS017978, P01NS016375, P01NS016367, P50NS016367] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS16367, NS16375, NS17978] Funding Source: Medline		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; [Anonymous], 1989, SAS STAT USERS GUIDE, V2; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; FOLSTEIN SE, 1985, SCIENCE, V229, P776, DOI 10.1126/science.2992086; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PRITCHARD C, 1992, AM J HUM GENET, V50, P1218; SUTHERS GK, 1992, J MED GENET, V29, P761, DOI 10.1136/jmg.29.11.761; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VERKERK AJM, 1991, CELL, V65, P904; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; YU S, 1992, AM J HUM GENET, V50, P968	34	827	839	0	49	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					387	392		10.1038/ng0893-387			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	WOS:A1993LQ17800017	8401587				2022-01-24	
J	Satoh, S; Daigo, Y; Furukawa, Y; Kato, T; Miwa, N; Nishiwaki, T; Kawasoe, T; Ishiguro, H; Fujita, M; Tokino, T; Sasaki, Y; Imaoka, S; Murata, M; Shimano, T; Yamaoka, Y; Nakamura, Y				Satoh, S; Daigo, Y; Furukawa, Y; Kato, T; Miwa, N; Nishiwaki, T; Kawasoe, T; Ishiguro, H; Fujita, M; Tokino, T; Sasaki, Y; Imaoka, S; Murata, M; Shimano, T; Yamaoka, Y; Nakamura, Y			AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1	NATURE GENETICS			English	Article							BETA-CATENIN GENE; TUMOR-SUPPRESSOR; APC; ACTIVATION; ADENOVIRUS; APOPTOSIS; PATHWAY; EXON-3	The Wnt signalling pathway is essential for development and organogenesis(1-3). Wnt signalling stabilizes beta-catenin, which accumulates in the cytoplasm, binds to T-cell factor (TCF; also known as lymphocyte enhancer-binding factor, LEF) and then upregulates downstream genes(4-6). Mutations in CTNNB1 (encoding beta-catenin) or ape (adenomatous polyposis coli) have been reported in human neoplasms including colon cancers and hepatocellular carcinomas(7-13) (HCCs), Because HCCs tend to show accumulation of beta-catenin more often than mutations in CTNNB1, we looked for mutations in AXIN1, encoding a key factor for Wnt signalling, in 6 HCC cell lines and 100 primary HCCs. Among the 4 cell lines and 87 HCCs in which we did not detect CTNNB1 mutations, we identified AXIN1 mutations in 3 cell lines and 6 mutations in 5 of the primary HCCs. In cell lines containing mutations in either gene, we observed increased DNA binding of TCF associated with beta-catenin in nuclei. Adenovirus mediated gene transfer of wild-type AXIN1 induced apoptosis in hepatocellular and colorectal cancer cells that had accumulated beta-catenin as a consequence of either APC, CTNNB1 or AXIN1 mutation, suggesting that axin may be an effective therapeutic molecule for suppressing growth of hepatocellular and colorectal cancers.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; Sapporo Med Univ, Sch Med, Canc Res Inst, Dept Mol Biol, Sapporo, Hokkaido, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; Municipal Ikeda Hosp, Osaka, Japan; Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kyoto, Japan		Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.		Tokino, Takashi/AAI-9887-2021				Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DING SF, 1993, CANCER DETECT PREV, V17, P405; Fukuchi T, 1998, CANCER RES, V58, P3526; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ihara A, 1996, HEPATOLOGY, V23, P1441, DOI 10.1053/jhep.1996.v23.pm0008675162; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Iwao K, 1998, CANCER RES, V58, P1021; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee YJ, 1999, J BIOL CHEM, V274, P1566, DOI 10.1074/jbc.274.3.1566; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Miyoshi Y, 1998, CANCER RES, V58, P2524; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nagai H, 1997, ONCOGENE, V14, P2927, DOI 10.1038/sj.onc.1201136; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nakamura Y, 1997, NAT MED, V3, P499, DOI 10.1038/nm0597-499; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Takahashi M, 1996, J BIOL CHEM, V271, P26536, DOI 10.1074/jbc.271.43.26536; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Voeller HJ, 1998, CANCER RES, V58, P2520; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zurawel RH, 1998, CANCER RES, V58, P896	28	826	851	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					245	250		10.1038/73448			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	WOS:000085590600013	10700176				2022-01-24	
J	Schulze, K; Imbeaud, S; Letouze, E; Alexandrov, LB; Calderaro, J; Rebouissou, S; Couchy, G; Meiller, C; Shinde, J; Soysouvanh, F; Calatayud, AL; Pinyol, R; Pelletier, L; Balabaud, C; Laurent, A; Blanc, JF; Mazzaferro, V; Calvo, F; Villanueva, A; Nault, JC; Bioulac-Sage, P; Stratton, MR; Llovet, JM; Zucman-Rossi, J				Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Alexandrov, Ludmil B.; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pinyol, Roser; Pelletier, Laura; Balabaud, Charles; Laurent, Alexis; Blanc, Jean-Frederic; Mazzaferro, Vincenzo; Calvo, Fabien; Villanueva, Augusto; Nault, Jean-Charles; Bioulac-Sage, Paulette; Stratton, Michael R.; Llovet, Josep M.; Zucman-Rossi, Jessica			Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets	NATURE GENETICS			English	Article							GROWTH-FACTOR 19; SOMATIC MUTATIONS; MOLECULAR CLASSIFICATION; RECURRENT MUTATIONS; P53 GENE; CANCER; MECHANISMS; EXPRESSION; LANDSCAPE; PROGNOSIS	Genomic analyses promise to improve tumor characterization to optimize personalized treatment for patients with hepatocellular carcinoma (HCC). Exome sequencing analysis of 243 liver tumors identified mutational signatures associated with specific risk factors, mainly combined alcohol and tobacco consumption and exposure to aflatoxin B-1. We identified 161 putative driver genes associated with 11 recurrently altered pathways. Associations of mutations defined 3 groups of genes related to risk factors and centered on CTNNB1 (alcohol), TP53 (hepatitis B virus, HBV) and AXIN1. Analyses according to tumor stage progression identified TERT promoter mutation as an early event, whereas FGF3, FGF4, FGF19 or CCND1 amplification and TP53 and CDKN2A alterations appeared at more advanced stages in aggressive tumors. In 28% of the tumors, we identified genetic alterations potentially targetable by US Food and Drug Administration (FDA)-approved drugs. In conclusion, we identified risk factor-specific mutational signatures and defined the extensive landscape of altered genes and pathways in HCC, which will be useful to design clinical trials for targeted therapy.	[Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Inst Univ Hematol, Equipe Labellisee Ligue Canc, Genom Fonct Tumeurs Solides, INSERM,UMR 1162, Paris, France; [Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Univ Paris 05, Labex Immunooncol, Sorbonne Paris Cite, Fac Med, Paris, France; [Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Univ Paris 13, Sorbonne Paris Cite, Unite Format & Rech Sante, Med,Biol Humaine, Bobigny, France; [Schulze, Kornelius; Imbeaud, Sandrine; Letouze, Eric; Calderaro, Julien; Rebouissou, Sandra; Couchy, Gabrielle; Meiller, Clement; Shinde, Jayendra; Soysouvanh, Frederic; Calatayud, Anna-Line; Pelletier, Laura; Calvo, Fabien; Nault, Jean-Charles; Zucman-Rossi, Jessica] Univ Paris Diderot, Paris, France; [Alexandrov, Ludmil B.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Calderaro, Julien] Ctr Hosp Univ Henri Mondor, Assistance Publ Hop Paris, Dept Pathol, Creteil, France; [Pinyol, Roser; Villanueva, Augusto] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer,Liver Unit, Hepatocellular Carcinoma Translat Res Lab,Barcelo, Barcelona, Spain; [Balabaud, Charles; Blanc, Jean-Frederic; Bioulac-Sage, Paulette] Univ Bordeaux, INSERM, UMR 1053, Bordeaux, France; [Laurent, Alexis] Ctr Hosp Univ Henri Mondor, Assistance Publ Hop Paris, Dept Digest & Hepatobiliary Surg, Creteil, France; [Laurent, Alexis] Hop Henri Mondor, INSERM, UMR 955, F-94010 Creteil, France; [Blanc, Jean-Frederic] Hop St Andre, Ctr Hosp Univ Bordeaux, Dept Hepatol, Bordeaux, France; [Mazzaferro, Vincenzo] Fdn Ist Tumori, Dept Liver Surg & Transplant, Milan, Italy; [Villanueva, Augusto; Llovet, Josep M.] Mt Sinai Sch Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY USA; [Nault, Jean-Charles] Hop Univ Paris Seine St Denis, Assistance Publ Hop Paris, Pole Activite Cancerol Specialisee, Serv Hepatol, Bondy, France; [Bioulac-Sage, Paulette] Pellegrin Hosp, Ctr Hosp Univ Bordeaux, Dept Pathol, Bordeaux, France; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Zucman-Rossi, Jessica] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France		Zucman-Rossi, J (corresponding author), Inst Univ Hematol, Equipe Labellisee Ligue Canc, Genom Fonct Tumeurs Solides, INSERM,UMR 1162, Paris, France.	jessica.zucman-rossi@inserm.fr	j, zucman-rossi/AAV-3594-2021; Alexandrov, Ludmil/AAS-1454-2021; Llovet, Josep M/ABB-6264-2021; Llovet, Josep M/D-4340-2014; Pinyol, Roser/AAA-4404-2019; Mazzaferro, Vincenzo/C-2726-2017; Rebouissou, Sandra/O-5938-2017; Mazzaferro, Vincenzo/AAL-4707-2020; zucman-rossi, Jessica/B-5098-2009; Letouze, Eric/AAP-9924-2020; Laurent, Alexis/O-3657-2016; Imbeaud, Sandrine/P-8780-2017	j, zucman-rossi/0000-0002-5687-0334; Alexandrov, Ludmil/0000-0003-3596-4515; Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Mazzaferro, Vincenzo/0000-0002-4013-8085; Rebouissou, Sandra/0000-0003-0188-2271; zucman-rossi, Jessica/0000-0002-5687-0334; Letouze, Eric/0000-0002-6369-2839; Soysouvanh, Frederic/0000-0001-8197-1615; Pinyol, Roser/0000-0002-0288-6314; Laurent, Alexis/0000-0003-1372-0843; Shinde, Jayendra/0000-0002-9219-0483; Imbeaud, Sandrine/0000-0001-8439-6732; nault, jean charles/0000-0002-4875-9353; Villanueva, Augusto/0000-0003-3585-3727	Institut National du Cancer (INCa)Institut National du Cancer (INCA) France; ICGC project; PAIR-CHC project NoFLIC - (INCa and Association pour la Recherche contre le Cancer, ARC); HEPTROMIC (Framework Programme 7); Canceropole Ile de FranceRegion Ile-de-France; Centres de Ressources Biologiques (CRB) Liver Tumors; Tumorotheque Centre Hospitalier Universitaire Bordeaux; Centre Hospitalier Universitaire Henri Mondor; BioIntelligence (OSEO); INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; INCaInstitut National du Cancer (INCA) France; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SCHU 2893/2-1]; AIRC (Italian Association for Cancer Research)Fondazione AIRC per la ricerca sul cancro; European Comission Framework Programme 7 (HEPTROMIC); Samuel Waxman Cancer Research Foundation; Spanish National Health InstituteSpanish Government [SAF-2010-16055, SAF-2013-41027]; Asociacion Espanola Contra el Cancer (AECC); National Nuclear Security Administration of the US Department of EnergyNational Nuclear Security Administration; ICREAICREA Funding Source: Custom	We warmly thank A. Boulais, C. Guichard, I. Ben Maad and C. Pilati for helpful participation in this work. We thank L. de Koning, C. Baldeyron, A. Barbet and C. Lecerf from the Institut Curie for the reverse-phase protein array experiments. We also thank J. Saric, C. Laurent, L. Chiche, B. Le Bail and C. Castain (Centre Hospitalier Universitaire Bordeaux) and D. Cherqui and J. Tran Van Nhieu (Centre Hospitalier Universitaire Henri Mondor, Creteil) for contributing to the tissue collection. This work was supported by Institut National du Cancer (INCa) with the ICGC project, the PAIR-CHC project NoFLIC (funded by INCa and Association pour la Recherche contre le Cancer, ARC), HEPTROMIC (Framework Programme 7), Canceropole Ile de France, Centres de Ressources Biologiques (CRB) Liver Tumors, Tumorotheque Centre Hospitalier Universitaire Bordeaux and Centre Hospitalier Universitaire Henri Mondor, BioIntelligence (OSEO) and INSERM. J.-C.N. was supported by a fellowship from INCa. K.S. is supported by the Deutsche Forschungsgemeinschaft (DFG grant SCHU 2893/2-1). Research performed at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the US Department of Energy. V.M. is supported by a grant from AIRC (Italian Association for Cancer Research). J.M.L. is supported by grants from the European Comission Framework Programme 7 (HEPTROMIC, proposal 259744), The Samuel Waxman Cancer Research Foundation, the Spanish National Health Institute (SAF-2010-16055 and SAF-2013-41027) and the Asociacion Espanola Contra el Cancer (AECC).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Hyeon J, 2013, DIGEST DIS SCI, V58, P1916, DOI 10.1007/s10620-013-2609-x; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nault JC, 2013, GASTROENTEROLOGY, V144, P888, DOI 10.1053/j.gastro.2013.02.032; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005; Roncalli M, 2011, DIGEST LIVER DIS, V43, pS361, DOI 10.1016/S1590-8658(11)60592-6; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Totoki Y, 2014, GENOME RES, V24, P1411, DOI 10.1101/gr.160598.113; Troncale S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038686; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	40	825	850	10	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					505	U106		10.1038/ng.3252			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	WOS:000353635800013	25822088	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Kathiresan, S; Altschuler, D; Anand, S; Ardissino, D; Asselta, R; Ball, SG; Balmforth, AJ; Berger, K; Berglund, G; Bernardi, F; Bernardinelli, L; Berzuini, C; Braund, PS; Burnett, MS; Burtt, N; Cambien, F; Casari, G; Celli, P; Chen, Z; Corrocher, R; Daly, MJ; Deloukas, P; Devaney, J; Do, R; Duga, S; Elosua, R; Engert, JC; Epstein, SE; Erdmann, J; Ferrario, M; Fetiveau, R; Fischer, M; Friedlander, Y; Gabriel, SB; Galli, M; Gianniny, L; Girelli, D; Grosshennig, A; Guiducci, C; Hakonarson, HH; Hall, AS; Havulinna, AS; Hengstenberg, C; Hirschhorn, JN; Holm, H; Huge, A; Kent, KM; Konig, IR; Korn, JM; Li, M; Lieb, W; Lindsay, JM; Linsel-Nitschke, P; Lucas, G; MacRae, CA; Mannucci, PM; Marrugat, J; Martinelli, N; Marziliano, N; Matthai, W; McCarroll, SA; McKeown, PP; Meigs, JB; Melander, O; Merlini, PA; Mirel, D; Morgan, T; Musunuru, K; Nathan, DM; Nemesh, J; O'Donnell, CJ; Olivieri, O; Ouwehand, W; Parkin, M; Patterson, CC; Peltonen, L; Peyvandi, F; Piazza, A; Pichard, AD; Preuss, M; Purcell, S; Qasim, A; Rader, DJ; Ramos, R; Reilly, MP; Ribichini, F; Rossi, M; Sala, J; Salomaa, V; Samani, NJ; Satler, L; Scheffold, T; Scholz, M; Schreiber, S; Schunkert, H; Schwartz, SM; Siscovick, DS; Spertus, JA; Spreafico, M; Stark, K; Stefansson, K; Stoll, M; Subirana, I; Surti, A; Thompson, JR; Thorleifsson, G; Thorsteinsdottir, U; Tubaro, M; Voight, BF; Waksman, R; Wichmann, HE; Wilensky, R; Williams, G; Wright, BJ; Xie, C; Yee, J; Ziegler, A; Zonzin, P				Kathiresan, Sekar; Altschuler, David; Anand, Sonia; Ardissino, Diego; Asselta, Rosanna; Ball, Stephen G.; Balmforth, Anthony J.; Berger, Klaus; Berglund, Goran; Bernardi, Francesco; Bernardinelli, Luisa; Berzuini, Carlo; Braund, Peter S.; Burnett, Mary-Susan; Burtt, Noel; Cambien, Francois; Casari, Giorgio; Celli, Patrizia; Chen, Zhen; Corrocher, Roberto; Daly, Mark J.; Deloukas, Panos; Devaney, Joe; Do, Ron; Duga, Stefano; Elosua, Roberto; Engert, James C.; Epstein, Stephen E.; Erdmann, Jeanette; Ferrario, Maurizio; Fetiveau, Raffaela; Fischer, Marcus; Friedlander, Yechiel; Gabriel, Stacey B.; Galli, Michele; Gianniny, Lauren; Girelli, Domenico; Grosshennig, Anika; Guiducci, Candace; Hakonarson, Hakon H.; Hall, Alistair S.; Havulinna, Aki S.; Hengstenberg, Christian; Hirschhorn, Joel N.; Holm, Hilma; Huge, Andreas; Kent, Kenneth M.; Konig, Inke R.; Korn, Joshua M.; Li, Mingyao; Lieb, Wolfgang; Lindsay, Joseph M.; Linsel-Nitschke, Patrick; Lucas, Gavin; MacRae, Calum A.; Mannucci, Pier M.; Marrugat, Jaume; Martinelli, Nicola; Marziliano, Nicola; Matthai, William; McCarroll, Steven A.; McKeown, Pascal P.; Meigs, James B.; Melander, Olle; Merlini, Pier Angelica; Mirel, Daniel; Morgan, Thomas; Musunuru, Kiran; Nathan, David M.; Nemesh, James; O'Donnell, Christopher J.; Olivieri, Oliviero; Ouwehand, Willem; Parkin, Melissa; Patterson, Chris C.; Peltonen, Leena; Peyvandi, Flora; Piazza, Alberto; Pichard, Augusto D.; Preuss, Michael; Purcell, Shaun; Qasim, Atif; Rader, Daniel J.; Ramos, Rafael; Reilly, Muredach P.; Ribichini, Flavio; Rossi, Marco; Sala, Joan; Salomaa, Veikko; Samani, Nilesh J.; Satler, Lowell; Scheffold, Thomas; Scholz, Michael; Schreiber, Stefan; Schunkert, Heribert; Schwartz, Stephen M.; Siscovick, David S.; Spertus, John A.; Spreafico, Marta; Stark, Klaus; Stefansson, Kari; Stoll, Monika; Subirana, Isaac; Surti, Aarti; Thompson, John R.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Tubaro, Marco; Voight, Benjamin F.; Waksman, Ron; Wichmann, H-Erich; Wilensky, Robert; Williams, Gordon; Wright, Benjamin J.; Xie, Changchun; Yee, Jean; Ziegler, Andreas; Zonzin, Pietro		Myocardial Infarction Genetics Consortium	Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; LDL-RECEPTOR GENE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; RISK; CHOLESTEROL; LOCI; PCSK9; HYPERCHOLESTEROLEMIA	We conducted a genome-wide association study testing single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) for association with early-onset myocardial infarction in 2,967 cases ad 3,075 controls. We carried out replication in an independent sample with an effective sample size of up to 19,492. SNPs at nine loci reached genome-wide significance: three are newly identified (21q22 near MRPS6-SLC5A3-KCNE2, 6p24 in PHACTR1 and 2q33 in WDR12) and six replicated prior observations(1-4) (9p21, 1p13 near CERSL2-PSRC1-SORT1, 10q11 near CXCL12, 1q41 in MIA3, 19p13 near LDLR and 1p32 near PCSK9). We tested 554 common copy number polymorphisms (> 1% allele frequency) and none met the pre-specified threshold for replication (P < 10(-3)). We identified 8,065 rare CNVs but did not detect a greater CNV burden in cases compared to controls, in genes compared to the genome as a whole, or at any individual locus. SNPs at nine loci were reproducibly associated with myocardial infarction, but tests of common and rare CNVs failed to identify additional associations with myocardial infarction risk.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Hum Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Gen Med Div, Boston, MA 02114 USA; Broad Inst MIT & Harvard, Prgm Med Populat Genet, Cambridge, MA 02142 USA; Harvard Med Sch, Dept Med, Boston, MA 02115 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; Univ Parma, Azienda Osped, I-43100 Parma, Italy; Univ Milan, Dept Intern Med & Med Specialities, Fdn Ist Ricov & Cura Carattere Sci, Osped Maggiore Mangiagalle & Regina Elena, I-20122 Milan, Italy; Univ Milan, Dept Biol Genet Med Sci, I-20133 Milan, Italy; McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci, Dept Med, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci, Dept Clin Epidemiol, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Hamilton Hlth Sci, Dept Biostatist, Hamilton, ON L8L 2X2, Canada; McGill Univ, Dept Med, Quebec City, PQ H3A 1A1, Canada; McGill Univ, Dept Human Genet, Quebec City, PQ H3A 1A1, Canada; Azienda Osped Niguarda Ca Granda, Div Cardiol, I-20162 Milan, Italy; Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Cardiovasc Endocrinol Sect, Boston, MA 02115 USA; Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; Univ Kiel, Inst Klin Molekularbiol, D-24105 Kiel, Germany; CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; Ctr Mathemat Sci, Stat Lab, Cambridge CB3 0WA, England; deCODE Genet Inc, IS-101 Reykjavik, Iceland; Framingham Heart Study &, Natl Heart Lung Blood Inst, Framingham, MA 01702 USA; Hebrew Univ Hadassah Sch Publ Hlth, Epidemiol, IL-91120 Jerusalem, Israel; Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Hosp Girona Josep Trueta, Cardiol, Coronar, Girona 17007, Spain; Inst Catala Salut, IDIAP Jordi Gol, Barcelona 08007, Spain; Inst Invest Biomed Girona, Girona 17007, Spain; Inst Municip Invest Med, Cardiovasc Epidemiol & Genet, Barcelona 08003, Spain; Ist Clin Humanitas, Fdn Ist Ricov & Cura Carrattere Sci, Div Cardiol, I-20089 Milan, Italy; Ludwig Maximilians Univ Munchen, Inst Med Inform Sci Biometr & Epidemiol, D-81377 Munich, Germany; Lund Univ, Univ Hosp Malmo, Dept Clin Sci Hypertens & Cardiovasc Dis, S-20502 Malmo, Sweden; Lund Univ, Univ Hosp Malmo, Dept Clin Sci, Int Med, S-20502 Malmo, Sweden; MRC, Biostat Unit, Cambridge, England; Mid America Heart Inst & Univ Missouri, Kansas City, MO 64111 USA; Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Helsinki 00300, Finland; Osped Livorno, Div Cardiol, I-57100 Livorno, Italy; Osped San Camillo, Div Cardiol, I-00151 Rome, Italy; Osped San Filippo Neri, Div Cardiol, I-00135 Rome, Italy; Policlin San Matteo, Fdn Ist Ricov & Cura Carrattere Sci, I-27100 Pavia, Italy; Queens Univ Belfast, Ctr Publ Hlth, Inst Clin Sci, Belfast BT12 6BJ, North Ireland; Ist Sci San Raffaele, Milan, Italy; San Raffaele Univ, Vita Salute, I-20132 Milan, Italy; Trium Anal Online GmbH, D-81677 Munich, Germany; Univ Cambridge, Dept Hematol, Cambridge CB2 2PT, England; Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; Univ Helsinki, Inst Mol Med, Helsinki 00029, Finland; Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; Univ Leeds, LIGHT Res Inst, Fac Med & Hlth, Leeds LS1 3EX, England; Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, England; Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, England; Univ Lubeck, Med Klinik 2, D-23538 Lubeck, Germany; Univ Lubeck, Inst Med Biometr & Stat, D-23538 Lubeck, Germany; Univ Munster, Liebniz Inst Arterioscler Res, D-48149 Munster, Germany; Univ Munster, Inst Epidemiol & Social Med, D-48149 Munster, Germany; Univ Paris 06, INSERM UMR S 525, F-75634 Paris, France; Univ Pavia, Dept Appl Hlth Sci, I-27100 Pavia, Italy; Univ Pennsylvania, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; Univ Pennsylvania, Cardiovasc Inst, Philadelphia, PA 19104 USA; Univ Pennsylvania, Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany; Osped Rovigo, Div Cardiol, I-45100 Rovigo, Italy; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; Univ Verona, Dept Clin & Expt Med, I-37134 Verona, Italy; Univ Verona, Osped Borgo Trento, Div Cardiol, I-37126 Verona, Italy; Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Witten Herdecke, Inst Heart & Circulat Res, D-44227 Dortmund, Germany; Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA; Washington Hosp Ctr, MedStar Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England		Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	skathiresan1@partners.org	Hengstenberg, Christian/U-5485-2019; Peyvandi, Flora/AAK-7437-2020; Stefansson, Kari/AAE-7187-2019; Wichmann, Heinz Erich/AAA-5695-2022; Altshuler, David M/A-4476-2009; Wang, Weili/D-1546-2011; Ardissino, Diego/AAC-4041-2022; Lucas, Gavin/D-4346-2012; Ramos, Rafel/D-9627-2016; Bernardinelli, Luisa/AAL-5750-2021; Deloukas, Panos/B-2922-2013; Meigs, James/P-3927-2019; Voight, Benjamin/F-1775-2011; Ramos, Rafel/P-2083-2019; Casari, Giorgio/J-3070-2018; Erdmann, Jeanette/A-4417-2009; Martinelli, Nicola/J-5622-2016; Lieb, Wolfgang/C-1990-2012; Berzuini, Carlo/AAA-7023-2019; Konig, Inke R/A-4544-2009; Cambien, Francois/AAP-9751-2020; Stark, Klaus/D-3813-2009; Daly, Mark J/B-2453-2017; Havulinna, Aki/AAM-4769-2021; Asselta, Rosanna/AAC-2367-2019; Erdmann, Jeanette/P-7513-2014; Hall, Alistair/K-1953-2019; bernardi, francesco/F-5443-2013; Duga, Stefano/F-8173-2014; Morgan, Tom/C-3478-2012; Chen, Zhen/M-3936-2017; Stark, Klaus/L-7367-2013; Nicola, Marziliano/ABF-9518-2021; Ribichini, Flavio/AAB-7767-2022; Spertus, John/ABD-3075-2021; Olivieri, Oliviero/A-9126-2008; Girelli, Domenico/B-1183-2008; Spreafico, Marta/C-5945-2014; Ziegler, Andreas/G-4246-2012	Peyvandi, Flora/0000-0001-7423-9864; Altshuler, David M/0000-0002-7250-4107; Ramos, Rafel/0000-0001-7970-5537; Deloukas, Panos/0000-0001-9251-070X; Meigs, James/0000-0002-2439-2657; Ramos, Rafel/0000-0001-7970-5537; Casari, Giorgio/0000-0002-0115-8980; Martinelli, Nicola/0000-0001-6465-5119; Berzuini, Carlo/0000-0001-6056-0489; Konig, Inke R/0000-0003-0504-6465; Stark, Klaus/0000-0002-7832-1942; Daly, Mark J/0000-0002-0949-8752; Erdmann, Jeanette/0000-0002-4486-6231; Duga, Stefano/0000-0003-3457-1410; Chen, Zhen/0000-0002-9946-1362; Stark, Klaus/0000-0002-7832-1942; Olivieri, Oliviero/0000-0001-8209-9056; Girelli, Domenico/0000-0001-9684-1899; Melander, Olle/0000-0002-2581-484X; Preuss, Michael/0000-0001-5266-8465; Marrugat, Jaume/0000-0003-3320-554X; Engert, James/0000-0001-8411-4790; Asselta, Rosanna/0000-0001-5351-0619; Lucas, Gavin/0000-0003-4166-9416; Hall, Alistair/0000-0003-0306-7887; Ferrario, Marco M/0000-0003-2741-7124; Reilly, Muredach/0000-0002-3035-9386; Spreafico, Marta/0000-0003-3378-5513; solinas, emilia/0000-0003-3532-1317; Piazza, Alberto/0000-0002-2355-4183; Ziegler, Andreas/0000-0002-8386-5397	Canada Graduate Scholarship Doctoral Award from the Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); May Cohen Eli Lilly Endowed Chair in Womens Health Research, McMaster University; Michael G. DeGroote and Heart and Stroke Foundation of Ontario Chair in Population Health; Cardiovascular Institute of the University of Pennsylvania; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); European UnionEuropean Commission [LSHM-CT- 2006-037593]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); Heart Trust Fund (Royal Victoria Hospital); Northern Ireland Chest, Heart and Stroke Association; Royal Victoria Hospital Research Fellowship; Northern Ireland Research and Development Office; Cariverona Foundation, Verona, ItalyFondazione Cariverona; Veneto RegionRegione Veneto; Italian Ministry of University and ResearchMinistry of Education, Universities and Research (MIUR); MedStar Research Institute; GlaxoSmithKlineGlaxoSmithKline; British Heart FoundationBritish Heart Foundation; Wellcome TrustWellcome TrustEuropean Commission; Finnish Foundation for Cardiovascular Research; Nordic Center of Excellence in Disease Genetics; Center of Excellence in Complex Disease Genetics of the Academy of FinlandAcademy of Finland; Sigrid Juselius FoundationSigrid Juselius Foundation; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54 RR020278]; The Broad Institute Center for Genotyping and Analysis; Department of Medicine and Cardiovascular Research Center at Massachusetts General Hospital; Donovan Family Foundation; Fannie E. Rippel Foundation; Doris Duke Charitable Foundation Clinical Scientist Development AwardAmerican Heart AssociationDoris Duke Charitable Foundation (DDCF); National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); AGAUR Generalitat de CatalunyaAgencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya; FIS de Catalunya; CIBER Epidemiologia y Salud Publica; Ministerio de Sanidad y Consumo Instituto de Salud Carlos IIIInstituto de Salud Carlos III [Red HERACLES RD06/0009]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K24 DK080140, N01HD013107, P30ES007033, R01HL056931]; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802320] Funding Source: UKRI; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0802320] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [N01HD013107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL056931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K24DK080140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER	The HARPS study was supported by the grants (R01HL056931, P30ES007033) and a contract (N01HD013107) from US National Institutes of Health.; The REGICOR study was partially funded by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Red HERACLES RD06/0009), the CIBER Epidemiologia y Salud Publica, the FIS and AGAUR Generalitat de Catalunya.; Massachusetts General Hospital. The MIGen study was funded by the US National Institutes of Health (NIH) and National Heart, Lung, and Blood Institutes STAMPEED genomics research program through a grant to D.A. S.K. is supported by a Doris Duke Charitable Foundation Clinical Scientist Development Award, a charitable gift from the Fannie E. Rippel Foundation, the Donovan Family Foundation, a career development award from the NIH and the Department of Medicine and Cardiovascular Research Center at Massachusetts General Hospital. J.B.M. is supported by grant K24 DK080140 from the NIH.; Broad Institute. Genotyping was partially funded by The Broad Institute Center for Genotyping and Analysis, which is supported by grant U54 RR020278 from the National Center for Research Resources.; FINRISK. V.S. was supported by the Sigrid Juselius Foundation. L.P. was supported by the Center of Excellence in Complex Disease Genetics of the Academy of Finland, the Nordic Center of Excellence in Disease Genetics and the Finnish Foundation for Cardiovascular Research.; WTCCC Study. The study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. N.J.S. and S.G.B. hold chairs funded by the BHF.; PennCATH/MedStar. Recruitment of the PennCATH cohort was supported by the Cardiovascular Institute of the University of Pennsylvania. Recruitment of the MedStar cohort was supported by a research grant from GlaxoSmithKline and from the MedStar Research Institute. Genotyping was done at the Center for Applied Genomics at the Childrens Hospital of Philadelphia and supported by GlaxoSmithKline through an Alternate Drug Discovery Initiative research alliance award (to M.P.R. and D.J.R.) with the University of Pennsylvania School of Medicine. D.J.R. was supported by a Doris Duke Charitable Foundation Distinguished Clinical Scientist Award.; Verona Heart Study. The study was supported by a grant from the Italian Ministry of University and Research and grants from the Veneto Region and the Cariverona Foundation, Verona, Italy; Mid-America Heart Institute. T.M. is supported by a career development grant from the NIH.; Irish Family Study. We thank the clinical staff members for their valuable contribution to the collection of families for this study. The research was supported by the Northern Ireland Research and Development Office, a Royal Victoria Hospital Research Fellowship, the Northern Ireland Chest, Heart and Stroke Association, and the Heart Trust Fund (Royal Victoria Hospital).; GerMIFS I and II. The German Study was supported by the Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research in the context of the German National Genome Research Network. Cardiogenics. Cardiogenics is an EU-funded integrated project (LSHM-CT- 2006-037593).; INTERHEART. S.A. holds the Michael G. DeGroote and Heart and Stroke Foundation of Ontario Chair in Population Health and the May Cohen Eli Lilly Endowed Chair in Womens Health Research, McMaster University. We acknowledge the contribution of S. Yusuf who initiated and, together with the Steering Committee, supervised the conduct of the INTERHEART study. We thank members of the Project Office, S. Rangarajan (study coordinator) and K. Hall (laboratory manager), for their assistance in coordinating the genetics component of the INTERHEART project. R.D. is a recipient of a Canada Graduate Scholarship Doctoral Award from the Canadian Institutes for Health Research.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; *CTR DIS CTRL PREV, 2004, MMWR-MORBID MORTAL W, V56, P113; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; KWON HM, 1992, J BIOL CHEM, V267, P6297; Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	825	842	0	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					334	341		10.1038/ng.327			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	WOS:000263640200023	19198609	Green Accepted			2022-01-24	
J	Lee, CK; Weindruch, R; Prolla, TA				Lee, CK; Weindruch, R; Prolla, TA			Gene-expression profile of the ageing brain in mice	NATURE GENETICS			English	Article							DIETARY RESTRICTION; ALZHEIMERS-DISEASE; CALORIC RESTRICTION; NEURONS; INFLAMMATION; RESPONSES; LESIONS; ROLES; BETA; RAT	Ageing of the brain leads to impairments in cognitive and motor skills, and is the major risk factor for several common neurological disorders such as Alzheimer disease (AD) and Parkinson disease (PD). Recent studies suggest that normal brain ageing is associated with subtle morphological and functional alterations in specific neuronal circuits, as opposed to large-scale neuronal loss'. In fact, ageing of the central nervous system in diverse mammalian species shares many features, such as atrophy of pyramidal neurons, synaptic atrophy, decrease of striatal dopamine receptors. accumulation of fluorescent pigments, cytoskeletal abnormalities, and reactive astrocytes and microglia(2). To provide the first global analysis of brain ageing at the molecular level, we used oligonucleotide arrays representing 6,347 genes to determine the gene-expression profile of the ageing neocortex and cerebellum in mice. Ageing resulted in a gene-expression profile indicative of an inflammatory response, oxidative stress and reduced neurotrophic support in both brain regions. At the transcriptional level, brain ageing in mice displays parallels with human neurodegenerative disorders. Caloric restriction, which retards the ageing process in mammals, selectively attenuated the age-associated induction of genes encoding inflammatory and stress responses.	Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Ctr Environm Toxicol, Madison, WI 53706 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53706 USA; Vet Adm Hosp, Ctr Geriatr Res Educ & Clin, Madison, WI USA		Weindruch, R (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.		Dilger, Ryan N./E-7031-2010; Lee, Cheol-Koo/F-2103-2013	Dilger, Ryan N./0000-0003-2538-2845; Lee, Cheol-Koo/0000-0003-3927-9195	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA078723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG011915] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA78723] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG11915] Funding Source: Medline		Blumenthal HT, 1997, J GERONTOL A-BIOL, V52, pB1, DOI 10.1093/gerona/52A.1.B1; DISTERHOFT JF, 1994, CALCIUM HYPOTHESIS A; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Finch Caleb E., 1999, P613; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GAUBATZ JW, 1995, MOL BASIS AGING, P71; HALLGREN R, 1982, INFLAMMATION, V6, P291, DOI 10.1007/BF00916410; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hermann DM, 1999, NEUROSCIENCE, V88, P599, DOI 10.1016/S0306-4522(98)00249-8; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Kaltschmidt B, 1999, ANTIOXID REDOX SIGN, V1, P129, DOI 10.1089/ars.1999.1.2-129; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEMERE CA, 1995, AM J PATHOL, V146, P848; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; McEwen BS, 1999, FRONT NEUROENDOCRIN, V20, P49, DOI 10.1006/frne.1998.0173; MOROIFETTERS SE, 1989, NEUROBIOL AGING, V10, P317, DOI 10.1016/0197-4580(89)90042-0; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Pasinetti GM, 1999, SYNAPSE, V31, P278, DOI 10.1002/(SICI)1098-2396(19990315)31:4<278::AID-SYN5>3.0.CO;2-0; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Ryseck RP, 1996, BRAZ J MED BIOL RES, V29, P895; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X; WEINDRUCH R, 1988, RETARDATION AGING DI	26	825	853	1	60	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					294	297		10.1038/77046			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900016	10888876				2022-01-24	
J	Thomas, RK; Baker, AC; DeBiasi, RM; Winckler, W; LaFramboise, T; Lin, WM; Wang, M; Feng, W; Zander, T; MacConnaill, LE; Lee, JC; Nicoletti, R; Hatton, C; Goyette, M; Girard, L; Majmudar, K; Ziaugra, L; Wong, KK; Gabriel, S; Beroukhim, R; Peyton, M; Barretina, J; Dutt, A; Emery, C; Greulich, H; Shah, K; Sasaki, H; Gazdar, A; Minna, J; Armstrong, SA; Mellinghoff, IK; Hodi, FS; Dranoff, G; Mischel, PS; Cloughesy, TF; Nelson, SF; Liau, LM; Mertz, K; Rubin, MA; Moch, H; Loda, M; Catalona, W; Fletcher, J; Signoretti, S; Kaye, F; Anderson, KC; Demetri, GD; Dummer, R; Wagner, S; Herlyn, M; Sellers, WR; Meyerson, M; Garraway, LA				Thomas, Roman K.; Baker, Alissa C.; DeBiasi, Ralph M.; Winckler, Wendy; LaFramboise, Thomas; Lin, William M.; Wang, Meng; Feng, Whei; Zander, Thomas; MacConnaill, Laura E.; Lee, Jeffrey C.; Nicoletti, Rick; Hatton, Charlie; Goyette, Mary; Girard, Luc; Majmudar, Kuntal; Ziaugra, Liuda; Wong, Kwok-Kin; Gabriel, Stacey; Beroukhim, Rameen; Peyton, Michael; Barretina, Jordi; Dutt, Amit; Emery, Caroline; Greulich, Heidi; Shah, Kinjal; Sasaki, Hidefumi; Gazdar, Adi; Minna, John; Armstrong, Scott A.; Mellinghoff, Ingo K.; Hodi, F. Stephen; Dranoff, Glenn; Mischel, Paul S.; Cloughesy, Tim F.; Nelson, Stan F.; Liau, Linda M.; Mertz, Kirsten; Rubin, Mark A.; Moch, Holger; Loda, Massimo; Catalona, William; Fletcher, Jonathan; Signoretti, Sabina; Kaye, Frederic; Anderson, Kenneth C.; Demetri, George D.; Dummer, Reinhard; Wagner, Stephan; Herlyn, Meenhard; Sellers, William R.; Meyerson, Matthew; Garraway, Levi A.			High-throughput oncogene mutation profiling in human cancer	NATURE GENETICS			English	Article							GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE JAK2; OF-FUNCTION MUTATION; MYELOPROLIFERATIVE DISORDERS; ACTIVATING MUTATIONS; LUNG ADENOCARCINOMA; POLYCYTHEMIA-VERA; GENE; SENSITIVITY; GEFITINIB	Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression(1,2). However, widespread clinical application of this information is hampered by an inability to identify critical genetic events across the spectrum of human tumors with adequate sensitivity and scalability. Here, we have adapted high-throughput genotyping to query 238 known oncogene mutations across 1,000 human tumor samples. This approach established robust mutation distributions spanning 17 cancer types. Of 17 oncogenes analyzed, we found 14 to be mutated at least once, and 298 (30%) samples carried at least one mutation. Moreover, we identified previously unrecognized oncogene mutations in several tumor types and observed an unexpectedly high number of co-occurring mutations. These results offer a new dimension in tumor genetics, where mutations involving multiple cancer genes may be interrogated simultaneously and in 'real time' to guide cancer classification and rational therapeutic intervention.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol & Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60637 USA; NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; USN, Natl Med Ctr, Bethesda, MD 20084 USA; Dana Farber Canc Inst, Ludwig Ctr Canc Res, Boston, MA 02115 USA; Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; Med Univ Vienna, Austrian Acad Sci, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Novartis Inst BioMed Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Melanoma Program Med Oncol, Boston, MA 02115 USA; Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; Univ Cologne, Fac Med, D-50931 Cologne, Germany; Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany		Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	levi_garraway@dfci.harvard.edu	Peyton, Michael/A-8728-2008; Dutt, Amit/I-1911-2013; Nelson, Stanley F/D-4771-2009; Meyerson, Matthew L/E-7123-2012; kaye, frederic/E-2437-2011; Mertz, Kirsten/AAY-1660-2020; Barretina, Jordi/A-7192-2013	Dutt, Amit/0000-0002-1119-4774; Nelson, Stanley F/0000-0002-2082-3114; Mertz, Kirsten/0000-0002-3074-6925; wong, kwok kin/0000-0001-6323-235X; Rubin, Mark/0000-0002-8321-9950; Wagner, Stephan/0000-0003-4941-7029; Barretina, Jordi/0000-0002-3478-4080; Liau, Linda/0000-0002-4053-0052; Hatton, Charlie/0000-0001-9903-4291	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA070907, ZIASC007256, Z01SC007256] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA70907, P50 CA070907] Funding Source: Medline		Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; JIANG J, 2004, BLOOD; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nakahara M, 1998, GASTROENTEROLOGY, V115, P1090, DOI 10.1016/S0016-5085(98)70079-4; Naoki K, 2002, CANCER RES, V62, P7001; *NAT HUM GEN RES I, 2006, CANC SEQ; National Cancer Institute National Human Genome Research Institute, 2006, CANC GEN ATL; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Thomas RK, 2005, COLD SH Q B, V70, P73, DOI 10.1101/sqb.2005.70.056; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Werner M, 2002, HUM MUTAT, V20, P57, DOI 10.1002/humu.10094	27	824	844	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					347	351		10.1038/ng1975			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	WOS:000244480000016	17293865				2022-01-24	
J	Sachse, C; Brockmoller, J; Bauer, S; Roots, I				Sachse, C; Brockmoller, J; Bauer, S; Roots, I			Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POOR METABOLIZER PHENOTYPE; CYP2D6 ALLELE; DEBRISOQUINE; GENE; IDENTIFICATION; HYDROXYLATION; DELETION; SPARTEINE; LOCUS; DEXTROMETHORPHAN	Cytochrome P450 2DG (CYP2DG) metabolizes many important drugs. CYP2DG activity ranges from complete deficiency to ultrafast metabolism, depending on at least 16 different known alleles. Their frequencies were determined in 589 unrelated German volunteers and correlated with enzyme activity measured by phenotyping with dextromethorphan or debrisoquine. For genotyping, nested PCR-RFLP tests from a PCR amplificate of the entire CYP2D6 gene were developed. The frequency of the CYP2DG6*1 allele coding for extensive metabolizer (EM) phenotype was .364. The alleles coding for slightly (CYP2D6*2) or moderately (*9 and *10) reduced activity (intermediate metabolizer phenotype [IM]) showed frequencies of .324, .018, and .015, respectively. By use of novel PCR tests for discrimination, CYP2D6 gene duplication alleles were found with frequencies of .005 (*1x2), .013 (*2x2), and .001 (*4x2). Frequencies of alleles with complete deficiency (poor metabolizer phenotype [PM]) were .207 (*4), .020 (*3 and *5), .009 (*6), and .001 (*7, *15, and *16). The defective CYP2D6 alleles *8, *11, *12, *13, and *14 were not found. All 41 PMs (7.0%) in this sample were explained by five mutations detected by four PCR-RFLP tests, which may suffice, together with the gene duplication test, for clinical prediction of CYP2D6 capacity. Three novel variants of known CYP2D6 alleles were discovered: *1C(T1957C), *2B (additional C2558T), and *4E (additional C2938T) Analysis of variance showed significant differences in enzymatic activity measured by the dextromethorphan metabolic ratio (MR) between carriers of EM/PM (mean MR = .006) and IM/PM (mean MR = .014) alleles and between carriers of one (mean MR = .009) and two (mean MR = .003) functional alleles. The results of this study provide a solid basis for prediction of CYP2D6 capacity, as required in drug research and routine drug treatment.	HUMBOLDT UNIV BERLIN,UNIV KLIN CHARITE,INST KLIN PHARMAKOL,D-10098 BERLIN,GERMANY								AGUNDEZ JAG, 1995, CLIN PHARMACOL THER, V57, P265, DOI 10.1016/0009-9236(95)90151-5; Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; Appanna G, 1996, DRUG METAB DISPOS, V24, P303; Benet L.Z., 1996, GOODMAN GILMANS PHAR, V3, P27; BERTILSSON L, 1995, CLIN PHARMACOKINET, V29, P192, DOI 10.2165/00003088-199529030-00005; BROCKMOLLER J, 1994, CLIN PHARMACOKINET, V27, P216, DOI 10.2165/00003088-199427030-00005; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; CHEN ZR, 1990, THER DRUG MONIT, V12, P97, DOI 10.1097/00007691-199001000-00018; DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516; DALY AK, 1991, PHARMACOGENETICS, V1, P33, DOI 10.1097/00008571-199110000-00006; Daly AK, 1996, PHARMACOGENETICS, V6, P319, DOI 10.1097/00008571-199608000-00005; DALY AK, 1995, HUM GENET, V95, P337; Daly AK, 1996, PHARMACOGENETICS, V6, P193, DOI 10.1097/00008571-199606000-00001; DIXON WJ, 1992, BMDP STATISTICAL SOF; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; EVERT B, 1994, N-S ARCH PHARMACOL, V350, P434; EVERT B, 1994, PHARMACOGENETICS, V4, P271, DOI 10.1097/00008571-199410000-00005; GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; Johansson I, 1996, PHARMACOGENETICS, V6, P351, DOI 10.1097/00008571-199608000-00008; JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825; KIMURA S, 1989, AM J HUM GENET, V45, P889; LENNARD MS, 1977, J CHROMATOGR, V133, P161, DOI 10.1016/S0021-9673(00)89216-X; Lovlie R, 1996, FEBS LETT, V392, P30, DOI 10.1016/0014-5793(96)00779-X; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MASIMIREMBWA CM, 1993, PHARMACOGENETICS, V3, P275, DOI 10.1097/00008571-199312000-00001; PANSERAT S, 1995, BRIT J CLIN PHARMACO, V40, P361, DOI 10.1111/j.1365-2125.1995.tb04558.x; Sachse C, 1996, PHARMACOGENETICS, V6, P269, DOI 10.1097/00008571-199606000-00012; Sambrook J., 1989, MOL CLONING LAB MANU; SAXENA R, 1994, HUM MOL GENET, V3, P923, DOI 10.1093/hmg/3.6.923; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; STEEN VM, 1995, PHARMACOGENETICS, V5, P215, DOI 10.1097/00008571-199508000-00005; TEFRE T, 1994, PHARMACOGENETICS, V4, P47; TYNDALE R, 1991, PHARMACOGENETICS, V1, P26, DOI 10.1097/00008571-199110000-00005	35	822	859	0	31	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					284	295					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	WOS:A1997WE93100007	9012401				2022-01-24	
J	Cargill, M; Schrodi, SJ; Chang, M; Garcia, VE; Brandon, R; Callis, KP; Matsunami, N; Ardlie, KG; Civello, D; Catanese, JJ; Leong, DU; Panko, JM; McAllister, LB; Hansen, CB; Papenfuss, J; Prescott, SM; White, TJ; Leppert, MF; Krueger, GG; Begovich, AB				Cargill, Michele; Schrodi, Steven J.; Chang, Monica; Garcia, Veronica E.; Brandon, Rhonda; Callis, Kristina P.; Matsunami, Nori; Ardlie, Kristin G.; Civello, Daniel; Catanese, Joseph J.; Leong, Diane U.; Panko, Jackie M.; McAllister, Linda B.; Hansen, Christopher B.; Papenfuss, Jason; Prescott, Stephen M.; White, Thomas J.; Leppert, Mark F.; Krueger, Gerald G.; Begovich, Ann B.			A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; INHERITED INTERLEUKIN-12 DEFICIENCY; GENOME-WIDE ASSOCIATION; IL-12 P40 GENE; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; ALZHEIMERS-DISEASE; HLA-C; VARIANTS; IL-23	We performed a multitiered, case-control association study of psoriasis in three independent sample sets of white North American individuals (1,446 cases and 1,432 controls) with 25,215 genecentric single-nucleotide polymorphisms (SNPs) and found a highly significant association with an IL12B 3'-untranslated-region SNP (rs3212227), confirming the results of a small Japanese study. This SNP was significant in all three sample sets (odds ratio [OR](common) 0.64, combined P [P-comb] = 7.85 x 10(-10)). A Monte Carlo simulation to address multiple testing suggests that this association is not a type comb I error. The coding regions of IL12B were resequenced in 96 individuals with psoriasis, and 30 additional IL12B-region SNPs were genotyped. Haplotypes were estimated, and genotype-conditioned analyses identified a second risk allele (rs6887695) located similar to 60 kb upstream of the IL12B coding region that exhibited association with psoriasis after adjustment for rs3212227. Together, these two SNPs mark a common IL12B risk haplotype (ORcommon 1.40, P-comb = 8.11 x 10(-9)) and comb a less frequent protective haplotype (ORcommon 0.58, P-comb = 5.65 x 10(-12)), which were statistically significant in all three comb studies. Since IL12B encodes the common IL-12p40 subunit of IL-12 and IL-23, we individually genotyped 17 SNPs in the genes encoding the other chains of these cytokines (IL12A and IL23A) and their receptors (IL12RB1, IL12RB2, and IL23R). Haplotype analyses identified two IL23R missense SNPs that together mark a common psoriasis-associated haplotype in all three studies (ORcommon 1.44, P-comb = 3.13 x 10-(6)). Individuals homozygous for both the IL12B and the IL23R comb predisposing haplotypes have an increased risk of disease (ORcommon 1.66, P-comb = 1.33 x 10(-8)). These data, and the comb previous observation that administration of an antibody specific for the IL-12p40 subunit to patients with psoriasis is highly efficacious, suggest that these genes play a fundamental role in psoriasis pathogenesis.	Celera, Alameda, CA 94502 USA; Univ Utah, Dept Dermatol, Salt Lake City, UT USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; LineaGen Res Corp, Salt Lake City, UT USA; SeraCare Life Sci, Genom Collaborat Div, Cambridge, MA USA		Begovich, AB (corresponding author), Celera, 1401 Harbor Bay Pkwy, Alameda, CA 94502 USA.	ann.begovich@celera.com	Schrodi, Steven J./O-4288-2019	Schrodi, Steven J./0000-0003-2304-8528; Morelli, Maria Paula/0000-0001-7157-486X	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR000064] Funding Source: Medline		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Bowman EP, 2006, CURR OPIN INFECT DIS, V19, P245, DOI 10.1097/01.qco.0000224818.42729.67; Breslow N., 1980, STAT METHODS CANC RE, V1; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fisher R.A., 1954, STAT METHODS RES WOR, V20th ed; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Hall MA, 2000, GENES IMMUN, V1, P219, DOI 10.1038/sj.gene.6363661; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hewett D, 2002, GENOMICS, V79, P305, DOI 10.1006/geno.2002.6720; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hong K, 1999, J IMMUNOL, V162, P7480; Hu XL, 2004, HUM HERED, V57, P156, DOI 10.1159/000079246; Huang D, 2000, GENES IMMUN, V1, P515, DOI 10.1038/sj.gene.6363720; Huang HJ, 2006, GASTROENTEROLOGY, V130, P1679, DOI 10.1053/j.gastro.2006.02.032; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jeffreys H, 1935, P CAMB PHILOS SOC, V31, P203, DOI 10.1017/S030500410001330X; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li YH, 2004, NEUROSCI LETT, V366, P268, DOI 10.1016/j.neulet.2004.05.047; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Litjens NHR, 2004, J INVEST DERMATOL, V122, P923, DOI 10.1111/j.0022-202X.2004.22427.x; Long AD, 1999, GENOME RES, V9, P720; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Mueller T, 2004, J HEPATOL, V41, P652, DOI 10.1016/j.jhep.2004.06.021; Muller-Berghaus J, 2004, GENES IMMUN, V5, P431, DOI 10.1038/sj.gene.6364102; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nielsen DM, 2004, GENETICS, V168, P1029, DOI 10.1534/genetics.103.022335; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Orozco G, 2005, HUM IMMUNOL, V66, P711, DOI 10.1016/j.humimm.2005.02.004; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez E, 2005, RHEUMATOLOGY, V44, P1136, DOI 10.1093/rheumatology/keh697; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schlesselman JJ., 1982, CASE CONTROL STUDIES; Schrodi SJ, 2005, STAT APPL GENET MOL, V4; Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Sokal RR, 1995, BIOMETRY; Stanilova S, 2005, GENES IMMUN, V6, P364, DOI 10.1038/sj.gene.6364213; THOMSON G, 1988, AM J HUM GENET, V43, P799; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Valdes AM, 1997, AM J HUM GENET, V60, P703; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; WALTER SD, 1975, BIOMETRIKA, V62, P371, DOI 10.2307/2335374; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Weir BS, 1996, GENETIC DATA ANAL; Winterfield LS, 2005, ANN RHEUM DIS, V64, P87, DOI 10.1136/ard.2004.032276; Yilmaz V, 2005, CYTOKINE, V30, P188, DOI 10.1016/j.cyto.2005.01.006; YIP SY, 1984, J AM ACAD DERMATOL, V10, P965, DOI 10.1016/S0190-9622(84)80314-X; Yoo JH, 2005, NUCLEIC ACIDS RES, V33, pW483, DOI 10.1093/nar/gki428; Zwiers A, 2004, GENES IMMUN, V5, P675, DOI 10.1038/sj.gene.6364131	76	821	850	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					273	290		10.1086/511051			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	WOS:000243729500007	17236132	Green Published, Bronze			2022-01-24	
J	Herschkowitz, JI; Simin, K; Weigman, VJ; Mikaelian, I; Usary, J; Hu, ZY; Rasmussen, KE; Jones, LP; Assefnia, S; Chandrasekharan, S; Backlund, MG; Yin, YZ; Khramtsov, AI; Bastein, R; Quackenbush, J; Glazer, RI; Brown, PH; Green, JE; Kopelovich, L; Furth, PA; Palazzo, JP; Olopade, OI; Bernard, PS; Churchill, GA; Van Dyke, T; Perou, CM				Herschkowitz, Jason I.; Simin, Karl; Weigman, Victor J.; Mikaelian, Igor; Usary, Jerry; Hu, Zhiyuan; Rasmussen, Karen E.; Jones, Laundette P.; Assefnia, Shahin; Chandrasekharan, Subhashini; Backlund, Michael G.; Yin, Yuzhi; Khramtsov, Andrey I.; Bastein, Roy; Quackenbush, John; Glazer, Robert I.; Brown, Powel H.; Green, Jeffrey E.; Kopelovich, Levy; Furth, Priscilla A.; Palazzo, Juan P.; Olopade, Olufunmilayo I.; Bernard, Philip S.; Churchill, Gary A.; Van Dyke, Terry; Perou, Charles M.			Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors	GENOME BIOLOGY			English	Article							TAG TRANSGENIC MICE; MOLECULAR PORTRAITS; EPITHELIAL-CELLS; MICROARRAY DATA; BRCA1 MUTATIONS; MOUSE MODELS; KI-RAS; CANCER; PROFILES; PATTERNS	Background Although numerous mouse models of breast carcinomas have been developed, we do not know the extent to which any faithfully represent clinically significant human phenotypes. To address this need, we characterized mammary tumor gene expression profiles from thirteen different murine models using DNA microarrays and compared the resulting data to that of human breast tumors. Results Unsupervised hierarchical clustering analysis showed that six models ( TgWAP-Myc, TgMMTV-Neu, TgMMTV-PyMT, TgWAP-Int., TgWAP9 Tag, and TgC3( 1)9 Tag) yielded tumors with distinctive and homogeneous expression patterns within each strain. However, in each of four other models ( TgWAP-T-181, TgMMTV-Wnt1, Brca1(Co/Co); TgMMTV-Cre; p53(+/-) and DMBA-induced), tumors with a variety of histologies and expression profiles developed. In many models, similarities to human breast tumors were recognized including proliferation and human breast tumor subtype signatures. Significantly, tumors of several models displayed characteristics of human basal-like breast tumors including two models with induced Brca1 deficiencies. Tumors of other murine models shared features and trended towards significance of gene enrichment with human luminal tumors, however, these murine tumors lacked expression of ER and ER-regulated genes. TgMMTV-Neu tumors did not have a significant gene overlap with the human HER2+/ER-subtype and were more similar to human luminal tumors. Conclusions Many of the defining characteristics of human subtypes were conserved among mouse models. Although no single mouse model recapitulated all the expression features of a given human subtype, these shared expression features provide a common framework for an improved integration of murine mammary tumor models with human breast tumors.	Univ N Carolina, Ctr Canc, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; Baylor Coll Med, Houston, TX 77030 USA; NCI, Lab Cellular Regulat & Carcinogenesis, Bethesda, MD 20892 USA; NCI, Chemoprevent Agent Dev Res Grp, Bethesda, MD 20892 USA; Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; Univ Chicago, Dept Med, Hematol Oncol Sect, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Hematol Oncol Sect, Comm Canc Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA		Perou, CM (corresponding author), Univ N Carolina, Ctr Canc, Lineberger Comprehens Canc Ctr, Campus Box 7295, Chapel Hill, NC 27599 USA.	jih@unc.edu; Karl.Simin@umassmed.edu; weigman@gmail.com; igor.mikaelian@roche.com; usary@unc.edu; zhu@med.unc.edu; karen_rasmussen@med.unc.edu; ljone010@umaryland.edu; sa358@georgetown.edu; subhashini_chandrasekharan@med.unc.edu; michael.backlund@Vanderbilt.Edu; yiny@georgetown.edu; andrey1@uchicago.edu; roy.bastien@hci.utah.edu; john.quackenbush@hci.utah.edu; glazerr@georgetown.edu; pbrown@breastcenter.tmc.edu; jegreen@mail.nih.gov; kopelovich@nih.gov; paf3@georgetown.edu; Juan.Palazzo@jefferson.edu; folopade@medicine.bsd.uchicago.edu; phil.bernard@hci.utah.edu; gary.churchill@jax.org; tvdlab@med.unc.edu; cperou@med.unc.edu	Churchill, Gary/AAY-7496-2020; Perou, Charles M/H-9934-2014; Khramtsov, Andrey I/H-8701-2018	Churchill, Gary/0000-0001-9190-9284; Perou, Charles M/0000-0001-9827-2247; Khramtsov, Andrey I/0000-0001-6301-4619; Hu, Zhiyuan/0000-0002-2963-2453	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA046283, P50-CA58223-09A1, R01 CA101227, T32 CA009686, R01-CA046283-16, R01 CA112176-05, R01-CA101211, N01-CN15044, N01-CN-05024, R01-CA-101227-01, R01 CA112176, P50 CA058223, N01-CN43308, N01CN43308, R01 CA101211] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32 ES007017, T32 ES07017] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01BC005740] Funding Source: NIH RePORTER		ASSELINLABAT ML, 2006, NAT CELL BIOL; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Colnot DR, 2004, CLIN CANCER RES, V10, P7827, DOI 10.1158/1078-0432.CCR-04-1090; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Frech MS, 2005, CANCER RES, V65, P681; Gruvberger S, 2001, CANCER RES, V61, P5979; Hennighausen L, 2000, ONCOGENE, V19, P966, DOI 10.1038/sj.onc.1203346; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu ML, 2001, ONCOGENE, V20, P2044, DOI 10.1038/sj.onc.1204280; Liu ML, 1998, ONCOGENE, V17, P2403, DOI 10.1038/sj.onc.1202456; LIVASY CA, 2005, MOD PATHOL; Medina D, 2005, ENDOCR-RELAT CANCER, V12, P483, DOI 10.1677/erc.1.00804; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; MUNOZ B, 1989, MOL CELL ENDOCRINOL, V62, P23, DOI 10.1016/0303-7207(89)90109-3; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; OH DS, 2006, J CLIN ONCOL; PAIK S, 2006, J CLIN ONCOL; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Phillips KA, 1999, J NATL CANCER I, V91, P469, DOI 10.1093/jnci/91.5.469; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van Beers EH, 2005, CANCER RES, V65, P822; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wijnhoven SWP, 2005, CANCER RES, V65, P8166, DOI 10.1158/0008-5472.CAN-05-1650	55	818	834	1	46	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2007	8	5							r76	10.1186/gb-2007-8-5-r76			34	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	175AA	WOS:000246983100012	17493263	Green Published, hybrid			2022-01-24	
J	Aaltonen, J; Bjorses, P; Perheentupa, J; HorelliKuitunen, N; Palotie, A; Peltonen, L; Lee, YS; Francis, F; Hennig, S; Thiel, C; Lehrach, H; Yaspo, ML				Aaltonen, J; Bjorses, P; Perheentupa, J; HorelliKuitunen, N; Palotie, A; Peltonen, L; Lee, YS; Francis, F; Hennig, S; Thiel, C; Lehrach, H; Yaspo, ML			An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains	NATURE GENETICS			English	Article							HUMAN DNA; PHOSPHOFRUCTOKINASE GENE; CODING REGIONS; SEQUENCES; PROTEIN; IDENTIFICATION; CANDIDIASIS; AUTOANTIGEN; MODEL; EXON	Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is the only described systemic autoimmune disease with established monogenic background, and the first autoimmune disorder localized outside the major histocompatibility complex (MHC) region. The primary biochemical defect in APECED is unknown. We have isolated a novel gene, AIRE, encoding for a putative nuclear protein featuring two PHD-type zinc-finger motifs, suggesting its involvement in transcriptional regulation. Five mutations in AIRE are reported in individuals with this disorder. This is the first report of a single-gene defect causing a systemic human autoimmune disease, providing a tool for exploring the molecular basis of autoimmunity.	UNIV HELSINKI,INST BIOMED,DEPT HUMAN MOL GENET,FIN-00300 HELSINKI,FINLAND; UNIV HELSINKI,HOSP CHILDREN & ADOLESCENTS,HELSINKI,FINLAND; UNIV HELSINKI,DEPT CLIN CHEM,SF-00100 HELSINKI,FINLAND; UNIV HELSINKI,DEPT BIOMED,SF-00100 HELSINKI,FINLAND; MAX PLANCK INST MOL GENET,D-14195 BERLIN,GERMANY				Francis, Fiona/B-5854-2016				AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; Aaltonen J, 1997, GENOME RES, V7, P820, DOI 10.1101/gr.7.8.820; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; AHONEN P, 1988, J CLIN ENDOCR METAB, V66, P1152, DOI 10.1210/jcem-66-6-1152; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bjorses P, 1996, AM J HUM GENET, V59, P879; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CAMPBELL RD, 1993, CURR OPIN IMMUNOL, V5, P887, DOI 10.1016/0952-7915(93)90101-W; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ELSON A, 1990, GENOMICS, V7, P47, DOI 10.1016/0888-7543(90)90517-X; Fidel Paul L. Jr., 1994, Trends in Microbiology, V2, P202, DOI 10.1016/0966-842X(94)90112-I; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GE Q, 1995, J CLIN INVEST, V96, P1730, DOI 10.1172/JCI118218; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Heiskanen M, 1996, TRENDS GENET, V12, P379, DOI 10.1016/0168-9525(96)30083-8; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; KROHN K, 1992, LANCET, V339, P770, DOI 10.1016/0140-6736(92)91894-E; KULP D, 1996, ISMB, V4, P134; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEVANON D, 1995, BIOCHEM MOL BIOL INT, V35, P929; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; THOMAS A, 1994, IMA J MATH APPL MED, V11, P149; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	34	817	831	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					399	403		10.1038/ng1297-399			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	WOS:A1997YJ92400019	9398840				2022-01-24	
J	Abyzov, A; Urban, AE; Snyder, M; Gerstein, M				Abyzov, Alexej; Urban, Alexander E.; Snyder, Michael; Gerstein, Mark			CNVnator: An approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing	GENOME RESEARCH			English	Article							COPY NUMBER VARIATION; STRUCTURAL VARIATION; RESOLUTION; VARIANTS; REARRANGEMENTS; DISEASE; MAP	Copy number variation (CNV) in the genome is a complex phenomenon, and not completely understood. We have developed a method, CNVnator, for CNV discovery and genotyping from read-depth (RD) analysis of personal genome sequencing. Our method is based on combining the established mean-shift approach with additional refinements (multiple-bandwidth partitioning and GC correction) to broaden the range of discovered CNVs. We calibrated CNVnator using the extensive validation performed by the 1000 Genomes Project. Because of this, we could use CNVnator for CNV discovery and genotyping in a population and characterization of atypical CNVs, such as de novo and multi-allelic events. Overall, for CNVs accessible by RD, CNVnator has high sensitivity (86%-96%), low false-discovery rate (3%-20%), high genotyping accuracy (93%-95%), and high resolution in breakpoint discovery (<200 bp in 90% of cases with high sequencing coverage). Furthermore, CNVnator is complementary in a straightforward way to split-read and read-pair approaches: It misses CNVs created by retrotransposable elements, but more than half of the validated CNVs that it identifies are not detected by split-read or read-pair. By genotyping CNVs in the CEPH, Yoruba, and Chinese-Japanese populations, we estimated that at least 11% of all CNV loci involve complex, multi-allelic events, a considerably higher estimate than reported earlier. Moreover, among these events, we observed cases with allele distribution strongly deviating from Hardy-Weinberg equilibrium, possibly implying selection on certain complex loci. Finally, by combining discovery and genotyping, we identified six potential de novo CNVs in two family trios.	[Abyzov, Alexej; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Abyzov, Alexej; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Urban, Alexander E.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Urban, Alexander E.; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA		Abyzov, A (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.	abyzov@gersteinlab.org; mark.gerstein@yale.edu	Abyzov, Alexej/M-4284-2013; Abyzov, Alexej/AAT-4615-2020	Abyzov, Alexej/0000-0001-5405-6729	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR19895]; AL Williams Professorship funds; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR019895] Funding Source: NIH RePORTER	We acknowledge support from the NIH and from the AL Williams Professorship funds. We also acknowledge the Yale University Biomedical High Performance Computing Center, its support team (in particular, Robert Bjornson and Nicholas Carriero), and NIH grant RR19895, which funded the instrumentation. We thank Ekta Khurana, Xinmeng Jasmine Mu, and Declan Clarke for useful discussions during the course of the study and help in preparing the manuscript.	Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; HUANG W, 1993, BLOOD, V82, P1264, DOI 10.1182/blood.V82.4.1264.bloodjournal8241264; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Slade I, 2010, J MED GENET, V47, P342, DOI 10.1136/jmg.2009.072983; Wand MP, 1995, KERNEL SMOOTHING; Wang LY, 2009, GENOME RES, V19, P106, DOI 10.1101/gr.080069.108; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	31	816	841	7	73	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2011	21	6					974	984		10.1101/gr.114876.110			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	771JQ	WOS:000291153400017	21324876	Bronze, Green Published	Y	N	2022-01-24	
J	HOLT, IJ; HARDING, AE; PETTY, RKH; MORGANHUGHES, JA				HOLT, IJ; HARDING, AE; PETTY, RKH; MORGANHUGHES, JA			A NEW MITOCHONDRIAL DISEASE ASSOCIATED WITH MITOCHONDRIAL-DNA HETEROPLASMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND					holt, ian/0000-0001-5468-0193			ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anderson S, 1982, MITOCHONDRIAL GENES, P5; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CHOMYN A, 1985, ACHIEVEMENTS PERSPEC, V2, P259; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Hauswirth W, 1985, ACHIEVEMENTS PERSPEC, P49; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1988, HUM GENET, V79, P53, DOI 10.1007/BF00291710; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOLT IJ, 1988, LANCET, V1, P1462; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020; Old JM, 1986, HUMAN GENETIC DISEAS, P1; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; POULTON J, 1989, LANCET, V1, P236; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VANERVEN PMM, 1987, ARCH NEUROL-CHICAGO, V44, P775, DOI 10.1001/archneur.1987.00520190079019; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YATSCOFF RW, 1978, SOMAT CELL GENET, V4, P633, DOI 10.1007/BF01543155; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	34	816	828	0	21	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					428	433					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	WOS:A1990CT66800004	2137962				2022-01-24	
J	ALANI, E; CAO, L; KLECKNER, N				ALANI, E; CAO, L; KLECKNER, N			A METHOD FOR GENE DISRUPTION THAT ALLOWS REPEATED USE OF URA3 SELECTION IN THE CONSTRUCTION OF MULTIPLY DISRUPTED YEAST STRAINS	GENETICS			English	Article											ALANI, E (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138, USA.						BARNES WM, 1981, J BACTERIOL, V147, P124, DOI 10.1128/JB.147.1.124-134.1981; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; CHATTOO BB, 1979, GENETICS, V93, P51; FOSTER TJ, 1981, CELL, V23, P201, DOI 10.1016/0092-8674(81)90285-3; GUARENTE L, 1980, CELL, V20, P543, DOI 10.1016/0092-8674(80)90640-6; HALLING SM, 1982, P NATL ACAD SCI-BIOL, V79, P2608, DOI 10.1073/pnas.79.8.2608; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JINKSROBERTSON S, 1986, GENETICS, V114, P731; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; LICHTEN M, 1987, GENETICS, V115, P233; MANIATIS T, 1982, MOL CLONING LABORATO; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Miller J. H., 1972, EXPT MOL GENETICS; ORRWEAVER T, 1981, P NATL ACAD SCI USA, V78, P6364; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; Sherman F., 1983, METHODS YEAST GENETI; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WILLIAMSON DH, 1983, EXP CELL RES, V145, P209, DOI 10.1016/S0014-4827(83)80022-6; WINSTON F, 1983, METHOD ENZYMOL, V101, P211; 1986, NEW ENGLAND BIOLABS	23	816	825	0	22	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	AUG	1987	116	4					541	545		10.1534/genetics.112.541.test			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J5784	WOS:A1987J578400006	3305158	Bronze, Green Published			2022-01-24	
J	Wallace, RH; Wang, DW; Singh, R; Scheffer, IE; George, AL; Phillips, HA; Saar, K; Reis, A; Johnson, EW; Sutherland, GR; Berkovic, SF; Mulley, JC				Wallace, RH; Wang, DW; Singh, R; Scheffer, IE; George, AL; Phillips, HA; Saar, K; Reis, A; Johnson, EW; Sutherland, GR; Berkovic, SF; Mulley, JC			Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta 1 subunit gene SCN1B	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; SODIUM-CHANNEL; BRAIN; CONVULSIONS	Febrile seizures affect approximately 3% of all children under six years of age and are by far the most common seizure disorder(1). A small proportion of children with febrile seizures later develop ongoing epilepsy with afebrile seizures(2). Segregation analysis suggests the majority of cases have complex inheritance(3) but rare families show apparent autosomal dominant: inheritance. Two putative loci have been mapped (FEB1 and FEB2), but specific genes have not yet been identified(4,5). We recently described a clinical subset, termed generalized epilepsy with febrile seizures plus (GEFS(+)), in which many family members have seizures with fever that may persist beyond six years of age or be associated with afebrile generalized seizures(6). We now report linkage, in another large GEFS(+) family, to chromosome region 19q13.1 and identification of a mutation in the voltage-gated sodium (Na+)-channel beta 1 subunit gene (SCN1B). The mutation changes a conserved cysteine residue disrupting a putative disulfide bridge which normally maintains an extracellular immunoglobulin-like fold. Go-expression of the mutant pr subunit with a brain Na+-channel alpha subunit in Xenopus laevis oocytes demonstrates that the mutation interferes with the ability of the subunit to modulate channel-gating kinetics consistent with a loss-of-function allele. This observation develops the theme that idiopathic epilepsies are a family of channelopathies and raises the possibility of involvement of other Na+-channel subunit genes in febrile seizures and generalized epilepsies with complex inheritance patterns.	Womens & Childrens Hosp, Ctr Genet Med, Dept Cytogenet & Mol Genet, N Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Pharmacol, Nashville, TN 37232 USA; Univ Melbourne, Dept Med Neurol, Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; Monash Med Ctr, Melbourne, Vic, Australia; Max Delbruck Zentrum, Mikrosatellitenzentrum, D-14059 Berlin, Germany; Humboldt Univ, Inst Human Genet, Berlin, Germany; Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Univ Adelaide, Dept Genet, Adelaide, SA, Australia		Mulley, JC (corresponding author), Womens & Childrens Hosp, Ctr Genet Med, Dept Cytogenet & Mol Genet, N Adelaide, SA 5006, Australia.		Scheffer, Ingrid E/G-1668-2013; Sutherland, Grant Robert/D-2606-2012; Reis, Andre/D-2309-2009	Scheffer, Ingrid E/0000-0002-2311-2174; Reis, Andre/0000-0002-6301-6363; Wallace, Robyn/0000-0001-6141-3317; Saar, Kathrin/0000-0002-4483-1557	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS32387] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032387, R37NS032387] Funding Source: NIH RePORTER		BERKOVIC SF, 1997, EPILEPSY COMPREHENSI, P217; BLERVERT C, 1998, SCIENCE, V279, P403; Bulman DE, 1997, HUM MOL GENET, V6, P1679, DOI 10.1093/hmg/6.10.1679; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONOHUE NV, 1992, EPILEPTIC SYNDROMES, P45; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Johnson WG, 1996, AM J MED GENET, V61, P345; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MACDONALD RL, 1994, EPILEPSIA, V35, P541; MAKITA N, 1994, GENOMICS, V23, P628, DOI 10.1006/geno.1994.1551; Makita N, 1996, J NEUROSCI, V16, P7117; MAKITA N, 1994, J BIOL CHEM, V269, P7571; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; NELSON KB, 1981, FEBRILE SEIZURES, P360; RICH SS, 1987, AM J HUM GENET, V41, P249; RYAN SG, 1995, NAT GENET, V10, P4, DOI 10.1038/ng0595-4; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308	30	814	859	1	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					366	370		10.1038/1252			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	WOS:000075107600020	9697698				2022-01-24	
J	Pritchard, JK				Pritchard, JK			Are rare variants responsible for susceptibility to complex diseases?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; MUTATION-RATES; POPULATION-GENETICS; HEMOPHILIA-B; HUMANS; TRAITS; GENES; STRATEGIES; SELECTION	Little is known about the nature of genetic variation underlying complex diseases in humans. One popular view proposes that mapping efforts should focus on identification of susceptibility mutations that are relatively old and at high frequency. It is generally assumed-at least for modeling purposes-that selection against complex disease mutations is so weak that it can be ignored. In this article, I propose an explicit model for the evolution of complex disease loci, incorporating mutation, random genetic drift, and the possibility of purifying selection against susceptibility mutations. I show that, for the most plausible range of mutation rates, neutral susceptibility alleles are unlikely to be at intermediate frequencies and contribute little to the overall genetic variance for the disease. Instead, it seems likely that the bulk of genetic variance underlying diseases is due to loci where susceptibility mutations are mildly deleterious and where there is a high overall mutation rate to the susceptible class. At such loci, the total frequency of susceptibility mutations may be quite high, but there is likely to be extensive allelic heterogeneity at many of these loci. I discuss some practical implications of these results for gene mapping efforts.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England		Pritchard, JK (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.						Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Ewens W.J., 1979, MATH POPULATION GENE; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; FEARNHEAD P, 2001, IN PRESS THEOR POP B; Friedman JM, 1999, AM J MED GENET, V89, P1; Giannelli F, 1999, AM J HUM GENET, V65, P1580, DOI 10.1086/302652; Green PM, 1999, AM J HUM GENET, V65, P1572, DOI 10.1086/302651; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Levin BR, 2000, GENETICS, V154, P985; LI WH, 1991, GENETICS, V129, P513; Long AD, 1999, GENOME RES, V9, P720; Nachman MW, 2000, GENETICS, V156, P297; Neuhauser C, 1997, GENETICS, V145, P519; Peters AD, 2000, GENETICS, V156, P1635; Przeworski M, 1999, MOL BIOL EVOL, V16, P246, DOI 10.1093/oxfordjournals.molbev.a026106; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Richardson S, 1996, MARKOV CHAIN MONTE C; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Slatkin M, 1997, GENETICS, V147, P1855; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Tolarova MM, 1997, AM J MED GENET, V72, P394, DOI 10.1002/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R; Wall JD, 2000, GENETICS, V155, P1865; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; Wright S., 1949, P365; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766; Zwick ME, 2000, ANNU REV GENOM HUM G, V1, P387, DOI 10.1146/annurev.genom.1.1.387	39	813	840	0	33	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					124	137		10.1086/321272			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	WOS:000170108100013	11404818	Bronze, Green Published			2022-01-24	
J	Vulpe, CD; Kuo, YM; Murphy, TL; Cowley, L; Askwith, C; Libina, N; Gitschier, J; Anderson, GJ				Vulpe, CD; Kuo, YM; Murphy, TL; Cowley, L; Askwith, C; Libina, N; Gitschier, J; Anderson, GJ			Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; FET3 GENE; FERROXIDASE; EXPRESSION; YEAST	Iron is essential for many cellular functions; consequently, disturbances of iron homeostasis, leading to either iron deficiency or iron overload, can have significant clinical consequences. Despite the clinical prevalence of these disorders, the mechanism by which dietary iron is absorbed into the body is poorly understood. We have identified a key component in intestinal iron transport by study of the sex-linked anaemia (s/a) mouse, which has a block in intestinal iron transport(1). Mice carrying the sla mutation develop moderate to severe microcytic hypochromic anaemia(1). Although these mice take up iron from the intestinal lumen into mature epithelial cells normally(2), the subsequent exit of iron into the circulation is diminished(3). As a result, iron accumulates in enterocytes and is lost during turnover of the intestinal epithelium(4). Biochemical studies have failed to identify the underlying difference between s/a and normal mice, therefore, we used a genetic approach to identify the gene mutant in sla mice. We describe here a novel gene, Heph, encoding a transmembrane-bound ceruloplasmin homologue that is mutant in the sla mouse and highly expressed in intestine. We suggest that the hephaestin protein is a multicopper ferroxidase necessary for iron egress from intestinal enterocytes into the circulation and that it is an important link between copper and iron metabolism in mammals.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Queensland, Joint Clin Sci Program, Brisbane, Qld, Australia; Queensland Inst Med Res, Clin Sci Unit, Brisbane, Qld, Australia; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA		Gitschier, J (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Anderson, Gregory J/G-4148-2013	Anderson, Gregory J/0000-0002-8814-5866; Vulpe, Chris/0000-0001-5134-8929			Anderson GJ, 1998, GENOMICS, V48, P34, DOI 10.1006/geno.1997.5138; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; BANNERMAN RM, 1976, FED PROC, V35, P2281; Bothwell TH, 1998, SEMIN HEMATOL, V35, P55; BOTHWELL TH, 1979, IRON METABOLISM MAN, P256; BROCKDORFF N, 1991, MAMM GENOME, V1, P152, DOI 10.1007/BF00351061; Danks D.M., 1989, METABOLIC BASIS INHE, P1411; Davis LG, 1986, BASIC METHODS MOL BI, P42; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; EDWARDS JA, 1977, J LAB CLIN MED, V90, P68; FALCONER DS, 1962, GENET RES, V3, P248, DOI 10.1017/S0016672300035035; GREWAL MS, 1962, GENET RES, V3, P238, DOI 10.1017/S0016672300035023; HALLIDAY JW, 1992, IRON HUMAN DISEASE, P131; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kuo YM, 1997, HUM MOL GENET, V6, P1043, DOI 10.1093/hmg/6.7.1043; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; Logan JI, 1996, J NEUROL NEUROSUR PS, V61, P431, DOI 10.1136/jnnp.61.5.431; Lombard M, 1997, GUT, V40, P435, DOI 10.1136/gut.40.4.435; MANIS J, 1970, NATURE, V227, P385, DOI 10.1038/227385a0; Skikne B., 1994, IRON METABOLISM HLTH, P151; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552	23	812	837	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					195	199		10.1038/5979			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	WOS:000078399500022	9988272				2022-01-24	
J	Jenne, DE; Reimann, H; Nezu, J; Friedel, W; Loff, S; Jeschke, R; Muller, D; Back, W; Zimmer, M				Jenne, DE; Reimann, H; Nezu, J; Friedel, W; Loff, S; Jeschke, R; Muller, D; Back, W; Zimmer, M			Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase	NATURE GENETICS			English	Article							CANCER; GENES; CHROMOSOME-5Q21; IDENTIFICATION; LOCUS; MAP	Peutz-Jeghers (PJ) syndrome is an autosomal-dominant disorder characterized by melanocytic macules of the lips, multiple gastrointestinal hamartomatous polyps and an increased risk for various neoplasms, including gastrointestinal cancer. The PJ gene was recently mapped to chromosome 19p13.3 by linkage analysis, with the highest lod score at marker D19S886. In a distance of 190 kb proximal to D19S886, we identified and characterized a novel human gene encoding the serine threonine kinase STK11. In a three-generation PJ family, we found an STK11 allele with a deletion of exons 4 and 5 and an inversion of exons 6 and 7 segregating with the disease. Sequence analysis of STK11 exons in four unrelated PJ patients has identified three nonsense and one acceptor splice site mutations. All five germline mutations are predicted to disrupt the function of the kinase domain, We conclude that germline mutations in STK11, probably in conjunction with acquired genetic defects of the second allele in somatic cells, cause the manifestations of PJ syndrome.	Max Planck Inst Psychiat, Dept Neuroimmunol, D-82152 Martinsried, Germany; Chugai Res Inst Mol Med, Ibaraki, Osaka 30041, Japan; Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Heidelberg, Mannheim Clin, Dept Pediat Surg, D-68135 Mannheim, Germany; Univ Wurzburg, Childrens Clin & Polyclin, D-97080 Wurzburg, Germany; Max Planck Inst Mol Physiol, Dept Biol Struct, D-44139 Dortmund, Germany; Univ Heidelberg, Mannheim Clin, Dept Pathol, D-68135 Mannheim, Germany; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97078 Wurzburg, Germany		Jenne, DE (corresponding author), Max Planck Inst Psychiat, Dept Neuroimmunol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Jenne, Dieter Erich/AAP-1414-2020	Loff, Steffan/0000-0003-4788-3181			Amos CI, 1997, CANCER RES, V57, P3653; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LOFF S, 1995, LANGENBECK ARCH CHIR, V380, P43; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; PILAT D, 1994, GENOMICS, V24, P445, DOI 10.1006/geno.1994.1651; RACKWITZ HR, 1985, GENE, V40, P259, DOI 10.1016/0378-1119(85)90048-4; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SPIGELMAN AD, 1989, GUT, V30, P1588, DOI 10.1136/gut.30.11.1588; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	19	812	857	1	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					38	44		10.1038/ng0198-38			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600018	9425897				2022-01-24	
J	Song, WJ; Sullivan, MG; Legare, RD; Hutchings, S; Tan, XL; Kufrin, D; Ratajczak, J; Resende, IC; Haworth, C; Hock, R; Loh, M; Felix, C; Roy, DC; Busque, L; Kurnit, D; Willman, C; Gewirtz, AM; Speck, NA; Bushweller, JH; Li, FP; Gardiner, K; Poncz, M; Maris, JM; Gilliland, DG				Song, WJ; Sullivan, MG; Legare, RD; Hutchings, S; Tan, XL; Kufrin, D; Ratajczak, J; Resende, IC; Haworth, C; Hock, R; Loh, M; Felix, C; Roy, DC; Busque, L; Kurnit, D; Willman, C; Gewirtz, AM; Speck, NA; Bushweller, JH; Li, FP; Gardiner, K; Poncz, M; Maris, JM; Gilliland, DG			Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PLATELET DISORDER; TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL TRANSLOCATIONS; DEFINITIVE HEMATOPOIESIS; FUSION TRANSCRIPT; GENE; AML1; T(12-21)	Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML, MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukaemia (AML). Informative recombination events in 6 FPD/AML pedigrees with evidence of linkage to markers on chromosome 21q identified an 880-kb interval containing the disease gene. Mutational analysis of regional candidate genes showed nonsense mutations or intragenic deletion of one allele of the haematopoietic transcription factor CBFA2 (formerly AML1) that co-segregated with the disease in four FPD/AML pedigrees. We identified heterozygous CBFA2 missense mutations that co-segregated with the disease in the remaining two FPD/AML pedigrees at phylogenetically conserved amino acids R166 and R201, respectively. Analysis of bone marrow or peripheral blood cells from affected FPD/AML individuals showed a decrement in megakaryocyte colony formation, demonstrating that CBFA2 dosage affects megakaryopoiesis. Our findings support a model for FPD/AML in which haploinsufficiency of CBFA2 causes an autosomal dominant congenital platelet defect and predisposes to the acquisition of additional mutations that cause leukaemia.	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Brown Univ, Women & Infants Hosp, Program Womens Oncol, Providence, RI USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Leicester Royal Infirm, Leicester, Leics, England; St Vincent Hosp, Childrens Ctr Canc & Blood Dis, Indianapolis, IN USA; Univ Montreal, Maisonneuve Rosemont Hosp, Dept Hematol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H3C 3J7, Canada; Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Ctr Canc, Albuquerque, NM 87131 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03756 USA; Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA; Eleanor Roosevelt Inst, Denver, CO USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA		Gilliland, DG (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.			Roy, Denis-Claude/0000-0002-5921-1692; Bushweller, John/0000-0002-5386-1758	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA078545, R01CA081932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R29AI039536] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA78545, R01 CA81932] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R29 AI39536] Funding Source: Medline		Akamatsu Y, 1997, GENE, V185, P111, DOI 10.1016/S0378-1119(96)00644-0; Arepally G, 1998, BLOOD, V92, P2600, DOI 10.1182/blood.V92.7.2600; BAE SC, 1994, MOL CELL BIOL, V14, P3242, DOI 10.1128/MCB.14.5.3242; BERARDI MJ, IN PRESS STRUCTURE; BUSQUE L, 1993, BLOOD, V82, P337; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; Crute BE, 1996, J BIOL CHEM, V271, P26251, DOI 10.1074/jbc.271.42.26251; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DOWTON SB, 1985, BLOOD, V65, P557; ERICKSON P, 1992, BLOOD, V80, P1825; FEARON ER, 1986, NEW ENGL J MED, V315, P15, DOI 10.1056/NEJM198607033150103; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; GERRARD JM, 1991, BRIT J HAEMATOL, V79, P246, DOI 10.1111/j.1365-2141.1991.tb04529.x; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Ho CY, 1996, BLOOD, V87, P5218, DOI 10.1182/blood.V87.12.5218.bloodjournal87125218; Horwitz M, 1997, AM J HUM GENET, V61, P873, DOI 10.1086/514894; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Knudson AG, 1997, J CLIN ONCOL, V15, P3280, DOI 10.1200/JCO.1997.15.10.3280; Kowalska MA, 1999, BRIT J HAEMATOL, V104, P220, DOI 10.1046/j.1365-2141.1999.01169.x; Legare RD, 1997, LEUKEMIA, V11, P2111, DOI 10.1038/sj.leu.2400852; Levanon D, 1996, DNA CELL BIOL, V15, P175, DOI 10.1089/dna.1996.15.175; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Loh ML, 1998, BLOOD, V92, P4792, DOI 10.1182/blood.V92.12.4792.424k30_4792_4797; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; MORRISSEY J, 1993, BLOOD, V81, P1124; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Ratajczak MZ, 1998, BLOOD, V91, P353, DOI 10.1182/blood.V91.1.353.353_353_359; Ratajczak MZ, 1997, BRIT J HAEMATOL, V99, P228, DOI 10.1046/j.1365-2141.1997.3563170.x; ROMANA SP, 1995, BLOOD, V85, P3662, DOI 10.1182/blood.V85.12.3662.bloodjournal85123662; ROMANA SP, 1995, BLOOD, V86, P4263, DOI 10.1182/blood.V86.11.4263.bloodjournal86114263; Rowley JD, 1998, J LAB CLIN MED, V132, P244, DOI 10.1016/S0022-2143(98)90036-1; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Rubnitz JE, 1999, LEUKEMIA, V13, P19, DOI 10.1038/sj.leu.2401257; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Speck NA, 1999, CANCER RES, V59, p1789S; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WEINBERG RA, 1989, CANCER RES, V49, P3713; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303	49	810	828	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					166	175		10.1038/13793			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	WOS:000082827500015	10508512				2022-01-24	
J	KOENIG, M; BEGGS, AH; MOYER, M; SCHERPF, S; HEINDRICH, K; BETTECKEN, T; MENG, G; MULLER, CR; LINDLOF, M; KAARIAINEN, H; DELACHAPELLE, A; KIURU, A; SAVONTAUS, ML; GILGENKRANTZ, H; RECAN, D; CHELLY, J; KAPLAN, JC; COVONE, AE; ARCHIDIACONO, N; ROMEO, G; LIECHTIGALLATI, S; SCHNEIDER, V; BRAGA, S; MOSER, H; DARRAS, BT; MURPHY, P; FRANCKE, U; CHEN, JD; MORGAN, G; DENTON, M; GREENBERG, CR; WROGEMANN, K; BLONDEN, LAJ; VANPAASSEN, HMB; VANOMMEN, GJB; KUNKEL, LM				KOENIG, M; BEGGS, AH; MOYER, M; SCHERPF, S; HEINDRICH, K; BETTECKEN, T; MENG, G; MULLER, CR; LINDLOF, M; KAARIAINEN, H; DELACHAPELLE, A; KIURU, A; SAVONTAUS, ML; GILGENKRANTZ, H; RECAN, D; CHELLY, J; KAPLAN, JC; COVONE, AE; ARCHIDIACONO, N; ROMEO, G; LIECHTIGALLATI, S; SCHNEIDER, V; BRAGA, S; MOSER, H; DARRAS, BT; MURPHY, P; FRANCKE, U; CHEN, JD; MORGAN, G; DENTON, M; GREENBERG, CR; WROGEMANN, K; BLONDEN, LAJ; VANPAASSEN, HMB; VANOMMEN, GJB; KUNKEL, LM			THE MOLECULAR-BASIS FOR DUCHENNE VERSUS BECKER MUSCULAR-DYSTROPHY - CORRELATION OF SEVERITY WITH TYPE OF DELETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SYLVIUS LABS,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,DIV GENET,BOSTON,MA 02115; HOP COCHIN,INST PATHOL MOLEC,INSERM,F-75674 PARIS 14,FRANCE; IST GIANNINA GASLINI,MOLEC GENET LAB,I-16148 GENOA,ITALY; PRINCE WALES HOSP,DEPT PATHOL,SYDNEY,NSW,AUSTRALIA; UNIV WURZBURG,INST HUMAN GENET,D-8700 WURZBURG,FED REP GER; UNIV HELSINKI,DEPT MED GENET,SF-00100 HELSINKI 10,FINLAND; UNIV TURKU,DEPT MED GENET,SF-20500 TURKU 50,FINLAND; UNIV BERN,INSELSPITAL,DEPT PEDIAT,CH-3010 BERN,SWITZERLAND; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV MANITOBA,DEPT BIOCHEM,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT HUMAN GENET,WINNIPEG R3T 2N2,MANITOBA,CANADA				Covone, Angela/AAA-7859-2020; Gilgenkrantz, Helene/G-5534-2017	Covone, Angela/0000-0002-7669-5270; archidiacono, nicoletta/0000-0002-1439-9521; gilgenkrantz, helene/0000-0001-6770-4561; Beggs, Alan/0000-0001-8818-0568			BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1988, AM J HUM GENET, V43, P126; DARRAS BT, 1988, AM J HUM GENET, V43, P612; DENDUNNEN JT, IN PRESS TOPOGRAPHY; ENGEL AG, 1986, MYOLOGY BASIC CLIN, V2; FORREST SM, 1987, LANCET, V2, P1294; GILGENKRANTZ H, IN PRESS GENOMICS; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEMAIRE C, 1988, EMBO J, V7, P4157, DOI 10.1002/j.1460-2075.1988.tb03311.x; LIECHTIGALLATI S, 1989, HUM GENET, V81, P343, DOI 10.1007/BF00283688; LINDLOF M, 1989, AM J HUM GENET, V44, P496; MALHOTRA SB, 1988, SCIENCE, V242, P756; MCCABE ERB, 1989, J CLIN INVEST, V83, P95, DOI 10.1172/JCI113890; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0	24	810	829	1	49	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					498	506					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	WOS:A1989AW39500003	2491009				2022-01-24	
J	Dews, M; Homayouni, A; Yu, D; Murphy, D; Sevignani, C; Wentzel, E; Furth, EE; Lee, WM; Enders, GH; T Mendell, J; Thomas-Tikhonenko, A				Dews, Michael; Homayouni, Asal; Yu, Duonan; Murphy, Danielle; Sevignani, Cinzia; Wentzel, Erik; Furth, Emma E.; Lee, William M.; Enders, Greg H.; T Mendell, Joshua; Thomas-Tikhonenko, Andrei			Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster	NATURE GENETICS			English	Article							C-MYC; IN-VIVO; EPITHELIAL-CELLS; RAS; THROMBOSPONDIN-1; EXPRESSION; FIBROBLASTS; HYPOXIA; GENE	Human adenocarcinomas commonly harbor mutations in the KRAS and MYC proto-oncogenes and the TP53 tumor suppressor gene. All three genetic lesions are potentially pro-angiogenic, as they sustain production of vascular endothelial growth factor ( VEGF). Yet Kras-transformed mouse colonocytes lacking p53 formed indolent, poorly vascularized tumors, whereas additional transduction with a Myc-encoding retrovirus promoted vigorous vascularization and growth. In addition, VEGF levels were unaffected by Myc, but enhanced neovascularization correlated with downregulation of anti-angiogenic thrombospondin-1 ( Tsp1) and related proteins, such as connective tissue growth factor (CTGF). Both Tsp1 and CTGF are predicted targets for repression by the miR-17- 92 microRNA cluster, which was upregulated in colonocytes coexpressing K-Ras and c-Myc. Indeed, miR-17- 92 knockdown with antisense 2'-O-methyl oligoribonucleotides partly restored Tsp1 and CTGF expression; in addition, transduction of Ras-only cells with a miR-17- 2-encoding retrovirus reduced Tsp1 and CTGF levels. Notably, miR-17-92-transduced cells formed larger, better-perfused tumors. These findings establish a role for microRNAs in non - cell-autonomous Myc-induced tumor phenotypes.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA		Thomas-Tikhonenko, A (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	andreit@mail.vet.upenn.edu	Thomas-Tikhonenko, Andrei/E-5329-2011	Thomas-Tikhonenko, Andrei/0000-0002-2739-2206	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA097932, R29CA071881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK050306] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R29 CA071881-06, R29 CA071881-05, R21 CA097932-02, R21 CA097932, CA 097932, R29 CA071881-04, R21 CA097932-01] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30 DK050306, DK 050306] Funding Source: Medline		Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Janz A, 2000, NUCLEIC ACIDS RES, V28, P2268, DOI 10.1093/nar/28.11.2268; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Knies-Bamforth UE, 2004, CANCER RES, V64, P6563, DOI 10.1158/0008-5472.CAN-03-3176; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Rak J, 2002, CANCER RES, V62, P1931; Ravi R, 2000, GENE DEV, V14, P34; Ruddell A, 2003, AM J PATHOL, V163, P2233, DOI 10.1016/S0002-9440(10)63581-X; Sevignani C, 1998, J CLIN INVEST, V101, P1572, DOI 10.1172/JCI919; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Tikhonenko AT, 1996, J BIOL CHEM, V271, P30741, DOI 10.1074/jbc.271.48.30741; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8	30	808	864	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1060	1065		10.1038/ng1855			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	WOS:000240112100025	16878133	Green Accepted			2022-01-24	
J	Rountree, MR; Bachman, KE; Baylin, SB				Rountree, MR; Bachman, KE; Baylin, SB			DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci	NATURE GENETICS			English	Article							HISTONE DEACETYLASE COMPLEX; DNA METHYLTRANSFERASE; METHYLATION; CHROMATIN; CELLS; TRANSCRIPTION; ORGANIZATION; DOMAIN; MECP2; (CYTOSINE-5)-METHYLTRANSFERASE	DNA methylation can contribute to transcriptional silencing through several transcriptionally repressive complexes, which include methyl-CpG binding domain proteins (MBDs) and histone deacetylases (HDACs). We show here that the chief enzyme that maintains mammalian DNA methylation, DNMT1, can also establish a repressive transcription complex. The non-catalytic amino terminus of DNMT1 binds to HDAC2 and a new protein, DMAP1 (for DNMT1 associated protein), and can mediate transcriptional repression. DMAP1 has intrinsic transcription repressive activity, and binds to the transcriptional co-repressor TSG101. DMAP1 is targeted to replication foci through interaction with the far N terminus of DNMT1 throughout S phase, whereas HDAC2 joins DNMT1 and DMAP1 only during late S phase, providing a platform for how histones may become deacetylated in heterochromatin following replication. Thus, DNMT1 not only maintains DNA methylation, but also may directly target, in a heritable manner, transcriptionally repressive chromatin to the genome during DNA replication.	Johns Hopkins Univ, Sch Med, Ctr Oncol, Tumor Biol Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA		Rountree, MR (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Oncol, Tumor Biol Lab, Baltimore, MD 21205 USA.	rountree@jhmi.edu	Rountree, Michael R/C-6332-2018	Rountree, Michael R/0000-0003-2371-6389	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA043318, R01CA054396] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA43318, CA54396] Funding Source: Medline		ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gaudet F, 1998, J BIOL CHEM, V273, P32725, DOI 10.1074/jbc.273.49.32725; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; KASS SU, 1996, EPIGENETIC MECH GENE, P529; Krude T, 1999, CURR BIOL, V9, pR394, DOI 10.1016/S0960-9822(99)80251-6; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Leonhardt H., 1993, Experientia Supplementum (Basel), V64, P109; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Lewin B, 1998, CELL, V93, P301, DOI 10.1016/S0092-8674(00)81154-X; Li E, 1999, NAT GENET, V23, P5, DOI 10.1038/12595; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Mertineit C, 1998, DEVELOPMENT, V125, P889; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Rein T, 1999, J BIOL CHEM, V274, P25792, DOI 10.1074/jbc.274.36.25792; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Sun ZJ, 1999, CANCER-AM CANCER SOC, V86, P689, DOI 10.1002/(SICI)1097-0142(19990815)86:4<689::AID-CNCR19>3.0.CO;2-P; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wade PA, 1998, COLD SPRING HARB SYM, V63, P435, DOI 10.1101/sqb.1998.63.435; Watanabe M, 1998, BIOCHEM BIOPH RES CO, V245, P900, DOI 10.1006/bbrc.1998.8547; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287; Yoder JA, 1996, J BIOL CHEM, V271, P31092, DOI 10.1074/jbc.271.49.31092; Zhong Q, 1998, CANCER RES, V58, P2699	48	808	833	5	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2000	25	3					269	277		10.1038/77023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900012	10888872				2022-01-24	
J	Shalon, D; Smith, SJ; Brown, PO				Shalon, D; Smith, SJ; Brown, PO			A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization	GENOME RESEARCH			English	Article							AMPLIFICATION	Detecting and determining the relative abundance of diverse individual sequences in complex DNA samples is a recurring experimental challenge in analyzing genomes. We describe a general experimental approach to this problem, using microscopic arrays of DNA fragments on glass substrates for differential hybridization analysis of fluorescently labeled DNA samples. To test the system, 864 physically mapped lambda clones of yeast genomic DNA, together representing > 75% of the yeast genome, were arranged into 1.8-cm x 1.8-cm arrays, each containing a total of 1744 elements. The microarrays were characterized by simultaneous hybridization of two different sets of isolated yeast chromosomes labeled with two different fluorophores. A laser fluorescent scanner was used to detect the hybridization signals from the two fluorophores. The results demonstrate the utility of DNA microarrays in the analysis of complex DNA samples. This system should find numerous applications in genome-wide genetic mapping, physical mapping, and gene expression studies.	STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,DEPT BIOCHEM,STANFORD,CA 94305; STANFORD UNIV,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305					Shalon, Tidhar Dari/0000-0003-2646-6215	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00450] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R21HG000450, R01HG000450] Funding Source: NIH RePORTER		BILLINGS PR, 1991, FASEB J, V5, P28, DOI 10.1096/fasebj.5.1.1846833; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; GROTHUES D, 1993, NUCLEIC ACIDS RES, V21, P1321, DOI 10.1093/nar/21.5.1321; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; MASKOS U, 1992, NUCLEIC ACIDS RES, V20, P1675, DOI 10.1093/nar/20.7.1675; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; RILES L, 1993, GENETICS, V134, P81; Ross M. T., 1992, Techniques for the analysis of complex genomes., P137; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SHALON D, 1995, THESIS STANFORD U ST; ZEHETNER G, 1994, NATURE, V367, P489, DOI 10.1038/367489a0	15	808	859	2	58	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724	1054-9803			GENOME RES	Genome Res.	JUL	1996	6	7					639	645		10.1101/gr.6.7.639			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	UX136	WOS:A1996UX13600009	8796352	Bronze			2022-01-24	
J	Niederreither, K; Subbarayan, V; Dolle, P; Chambon, P				Niederreither, K; Subbarayan, V; Dolle, P; Chambon, P			Embryonic retinoic acid synthesis is essential for early mouse post-implantation development	NATURE GENETICS			English	Article							HEART DEVELOPMENT; NERVOUS-SYSTEM; HENSEN NODE; EXPRESSION; DEHYDROGENASE; GENE; IDENTIFICATION; RECEPTORS; PATTERNS	A number of studies have suggested that the active derivative of vitamin A, retinoic acid (RA), may be important for early development of mammalian embryos(1,2). Severe vitamin A deprivation in rodents results in maternal infertility(3), precluding a thorough investigation of the role of RA during embryogenesis, Here we show that production of RA by the retinaldehyde dehydrogenase-2 (Raldh2) enzyme(4,5) is required for mouse embryo survival and early morphogenesis. Raldh2 is an HAD-dependent aldehyde dehydrogenase with high substrate specificity for retinaldehyde(4,5). Its pattern of expression during mouse development has suggested that it may be responsible for embryonic RA synthesis(4,6). We generated a targeted disruption of the mouse Raldh2 gene and found that Raldh2(-/-) embryos, which die at midgestation without undergoing axial rotation (body turning), exhibit shortening along the anterioposterior axis and do not form limb buds. Their heart consists of a single, medial, dilated cavity. Their frontonasal region is truncated and their otocysts are severely reduced. These defects result from a block in embryonic RA synthesis, as shown by the lack of activity of RA-responsive transgenes, the altered expression of an RA-target homeobox gene and the near full rescue of the mutant phenotype by maternal RA administration, Our data establish that RA synthesized by the post-implantation mammalian embryo is an essential developmental hormone whose lack leads to early embryo death.	ULP, Coll France, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France		Chambon, P (corresponding author), ULP, Coll France, INSERM, CNRS,Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.		Dolle, Pascal/A-8037-2010	Dolle, Pascal/0000-0002-9294-9090			Ang HL, 1996, J BIOL CHEM, V271, P9526, DOI 10.1074/jbc.271.16.9526; Ang HL, 1997, DEV DYNAM, V208, P536; ANG SL, 1994, DEVELOPMENT, V120, P2979; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Blumberg B, 1997, SEMIN CELL DEV BIOL, V8, P417, DOI 10.1006/scdb.1997.0165; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10056, DOI 10.1073/pnas.89.21.10056; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; DECIMO D, 1995, GENE PROBES PRACTICA, V2, P183; Dickman ED, 1997, DEVELOPMENT, V124, P3111; Dierich A, 1997, METHODS IN DEVELOPMENTAL TOXICOLOGY AND BIOLOGY, P111; DUPE V, 1997, DEVELOPMENT, V124, P339; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; Maden M, 1998, DEVELOPMENT, V125, P4133; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MCCAFFERY P, 1993, DEV BIOL, V158, P390, DOI 10.1006/dbio.1993.1197; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Neela J, 1997, NATL MED J INDIA, V10, P15; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; REPRESA J, 1991, NATURE, V353, P561, DOI 10.1038/353561a0; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; SIMEONE A, 1995, MECH DEVELOP, V51, P83, DOI 10.1016/0925-4773(95)96241-M; TWAL W, 1995, DEV BIOL, V168, P225, DOI 10.1006/dbio.1995.1075; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	29	804	827	1	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					444	448		10.1038/7788			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	WOS:000079439700031	10192400				2022-01-24	
J	KACSER, H; BURNS, JA				KACSER, H; BURNS, JA			THE MOLECULAR-BASIS OF DOMINANCE	GENETICS			English	Article											KACSER, H (corresponding author), UNIV EDINBURGH,DEPT GENET,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND.						ABRAHAM I, 1978, P NATL ACAD SCI USA, V75, P4446, DOI 10.1073/pnas.75.9.4446; ANDREWS KM, 1974, THESIS EDINBURGH U; BULFIELD G, 1974, ARCH DIS CHILD, V49, P545, DOI 10.1136/adc.49.7.545; CALIGARI PDS, 1980, PROC R SOC SER B-BIO, V208, P163, DOI 10.1098/rspb.1980.0048; CHARLESWORTH B, 1979, NATURE, V278, P848, DOI 10.1038/278848a0; CHARLESWORTH B, 1979, GENET RES, V34, P281, DOI 10.1017/S0016672300019510; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CORNISHBOWDEN A, 1976, J MOL BIOL, V101, P1, DOI 10.1016/0022-2836(76)90062-0; CROSBY JL, 1963, J THEOR BIOL, V5, P35, DOI 10.1016/0022-5193(63)90035-3; Falconer D. S., 1960, INTRO QUANTITATIVE G; Fersht A, 1977, ENZYME STRUCTURE MEC; FINCHAM JRS, 1972, HEREDITY, V28, P387, DOI 10.1038/hdy.1972.49; FINCHAM JRS, 1966, GENETIC COMPLEMENTAT; Fisher RA, 1928, AM NAT, V62, P115, DOI 10.1086/280193; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FLINT HJ, 1980, BIOCHEM J, V190, P1; Ford EB, 1940, ANN EUGENIC, V10, P227, DOI 10.1111/j.1469-1809.1940.tb02249.x; GIANNELLI F, 1976, J CELL SCI, V20, P207; GRUNEBERG H, 1952, GENETICS MOUSE; HALDANE JBS, 1930, AM NATURALIST, V63, P87; HARRIS H, 1975, PRINCIPLES HUMAN BIO; HEINRICH R, 1975, BIOSYSTEMS, V7, P130, DOI 10.1016/0303-2647(75)90050-7; KACSER H, 1973, NATURE, V244, P77, DOI 10.1038/244077a0; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KACSER H, 1979, MODELS STUDY INBORN, P33; KNOX WE, 1958, AM J HUM GENET, V10, P53; LINDSLEY DL, 1972, GENETICS, V71, P157; MENDEL G., 1866, VERHAND NATURF VER B, VIV, P3, DOI DOI 10.5962/BHL.TITLE.61004; MIDDLETON RJ, 1980, THESIS EDINBURGH U; MUKAI T, 1972, GENETICS, V72, P335; OHH BK, 1970, GENETICS, V66, P517; PLUNKETT CR, 1933, AM NAT, V67, P84; REICHERT U, 1967, ZBL BAKT PARASIT, V205, P63; REICHERT U, 1968, THESIS FREIE U BERLI; Robertson A., 1967, Heritage from Mendel., P265; SHEPPARD PM, 1966, HEREDITY, V21, P139, DOI 10.1038/hdy.1966.8; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; SVED J. A., 1970, Biomathematics. Volume 1. Mathematical topics in population genetics., P289; TATESON RW, 1972, THESIS EDINBURGH U; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; WRIGHT SEWALL, 1960, GENETICS, V45, P1503	41	804	817	0	36	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1981	97	3-4					639	666					28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MD370	WOS:A1981MD37000009	7297851				2022-01-24	
J	Bodmer, W; Bonilla, C				Bodmer, Walter; Bonilla, Carolina			Common and rare variants in multifactorial susceptibility to common diseases	NATURE GENETICS			English	Article; Proceedings Paper	Meeting on the Genomics of Common Diseases	JUL 07-10, 2007	Wellcome Trust Sanger Inst, Cambridge, ENGLAND		Wellcome Trust Sanger Inst		GENOME-WIDE ASSOCIATION; DEPENDENT DIABETES-MELLITUS; COLORECTAL-CANCER; RISK LOCUS; HL-A; GENE; APC; RESISTANCE; ADENOMAS; FAMILY	Here, we give a historical overview of the search for genetic variants that influence the susceptibility of an individual to a chronic disease, from RA Fisher's seminal work to the current excitement of whole-genome association studies (WGAS). We then discuss the concepts behind the identification of common variants as disease causal factors and contrast them to the basic ideas that underlie the rare variant hypothesis. The identification of rare variants involves the careful selection of candidate genes to examine, the availability of highly efficient resequencing techniques and the appropriate assessment of the functional consequences of the implicated variant. We believe that this strategy can be successfully applied at present in order to unravel the contribution of rare variants to the multifactorial inheritance of common diseases, which could lead to the implementation of much needed preventative screening schemes.	[Bodmer, Walter; Bonilla, Carolina] Univ Oxford, Canc & Immunogenet Lab, John Radcliffe Hosp, Oxford OX3 9DS, England		Bodmer, W (corresponding author), Univ Oxford, Canc & Immunogenet Lab, John Radcliffe Hosp, Oxford OX3 9DS, England.	walter.bodmer@hertford.ox.ac.uk	Bonilla, Carolina/U-9263-2018	Bonilla, Carolina/0000-0002-9972-6383; Bodmer, Walter/0000-0001-6244-9792	Cancer Research UKCancer Research UK [A6426] Funding Source: Medline		AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Amiel J.L, 1967, HISTOCOMPAT TEST, V1967, P79; BODMER JG, 1989, LANCET, V1, P1455; Bodmer W, 1999, CYTOGENET CELL GENET, V86, P99, DOI 10.1159/000015360; BODMER W, 1981, BIOL MANIPULATION LI, P217; BODMER W, 1972, NATL CANC I MONOGR, V36, P127; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L.L., 1999, GENETICS HUMAN POPUL; CLARKE C, 1961, PROGR MED GENETICS, V1; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Fearnhead NS, 2005, CELL CYCLE, V4, P521, DOI 10.4161/cc.4.4.1591; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Felix R, 2006, MUTAT RES-FUND MOL M, V602, P175, DOI 10.1016/j.mrfmmm.2006.09.004; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher RA, 1932, GENETICS, V17, P0107; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Haldane JBS, 1949, RICERCA SCIENTIFIC S, V19, P3; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LILLY F, 1964, LANCET, V2, P1207; Lovelock PK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1826; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; MCDEVITT HO, 1974, LANCET, V1, P1269; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; THOMSEN M, 1975, TRANSPLANT REV-DENMA, V22, P125; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	34	803	828	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					695	701		10.1038/ng.f.136			7	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	WOS:000256212000007	18509313	Green Accepted, Bronze			2022-01-24	
J	Feng, JQ; Ward, LM; Liu, SG; Lu, YB; Xie, YX; Yuan, BZ; Yu, XJ; Rauch, F; Davis, SI; Zhang, SB; Rios, H; Drezner, MK; Quarles, LD; Bonewald, LF; White, KE				Feng, Jian Q.; Ward, Leanne M.; Liu, Shiguang; Lu, Yongbo; Xie, Yixia; Yuan, Baozhi; Yu, Xijie; Rauch, Frank; Davis, Siobhan I.; Zhang, Shubin; Rios, Hector; Drezner, Marc K.; Quarles, L. Darryl; Bonewald, Lynda F.; White, Kenneth E.			Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism	NATURE GENETICS			English	Article							DENTIN MATRIX PROTEIN-1; BONE MINERALIZATION; HYPOPHOSPHATEMIA; EXPRESSION; CARTILAGE; CHICKEN	The osteocyte, a terminally differentiated cell comprising 90%-95% of all bone cells(1,2), may have multiple functions, including acting as a mechanosensor in bone (re) modeling(3). Dentin matrix protein 1 (encoded by DMP1) is highly expressed in osteocytes(4) and, when deleted in mice, results in a hypomineralized bone phenotype(5). We investigated the potential for this gene not only to direct skeletal mineralization but also to regulate phosphate (Pi) homeostasis. Both Dmp1-null mice and individuals with a newly identified disorder, autosomal recessive hypophosphatemic rickets, manifest rickets and osteomalacia with isolated renal phosphate-wasting associated with elevated fibroblast growth factor 23 (FGF23) levels and normocalciuria. Mutational analyses showed that autosomal recessive hypophosphatemic rickets family carried a mutation affecting the DMP1 start codon, and a second family carried a 7-bp deletion disrupting the highly conserved DMP1 C terminus. Mechanistic studies using Dmp1-null mice demonstrated that absence of DMP1 results in defective osteocyte maturation and increased FGF23 expression, leading to pathological changes in bone mineralization. Our findings suggest a bone-renal axis that is central to guiding proper mineral metabolism.	Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Div Nephrol, Kansas City, KS 66160 USA; Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; Univ Missouri, Kansas City, MO 64108 USA; Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Univ Wisconsin, Dept Med, Madison, WI USA; McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada		Ward, LM (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	Lward@cheo.on.ca; dquarles@kumc.edu	Ward, Leanne Marie/AAF-8482-2020; Bonewald, Lynda/Q-3638-2019; Yu, Xijie/H-4124-2011; Rauch, Frank/D-1554-2009	Ward, Leanne Marie/0000-0003-1557-9185; Yu, Xijie/0000-0002-3504-7664; Rauch, Frank/0000-0002-6261-0360; Quarles, L. Darryl/0000-0002-5082-7896; Lu, Yongbo/0000-0003-3692-1736	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01 AR051587, AR-45955, R01 AR027032, R56 AR045955, R56 AR027032, P01 AR046798, R01 AR045955, AR051587, AR027032, AR046798] Funding Source: Medline; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [DE13480, R29 DE013480] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK063934, R01 DK063934] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R56AR045955, R01AR027032, R56AR027032, R01AR051587, P01AR046798, R01AR045955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R29DE013480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK063934] Funding Source: NIH RePORTER		Butler WT, 2002, CONNECT TISSUE RES, V43, P301, DOI 10.1080/03008200290000682; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; FROST HM, 1960, J BONE JOINT SURG AM, V42, P138, DOI 10.2106/00004623-196042010-00011; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; Ito N, 2005, J BONE MINER METAB, V23, P435, DOI 10.1007/s00774-005-0625-4; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P443, DOI 10.1007/BF02405074; MCKEE MD, 1992, ANAT REC, V234, P479, DOI 10.1002/ar.1092340404; PALUMBO C, 1990, ACTA ANAT, V137, P350; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; SMITH R, 1976, LANCET, V1, P40; Tenenhouse HS, 1999, NEPHROL DIAL TRANSPL, V14, P333, DOI 10.1093/ndt/14.2.333; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	24	803	855	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1310	1315		10.1038/ng1905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	WOS:000241592700020	17033621	Green Accepted			2022-01-24	
J	Chevreux, B; Pfisterer, T; Drescher, B; Driesel, AJ; Muller, WEG; Wetter, T; Suhai, S				Chevreux, B; Pfisterer, T; Drescher, B; Driesel, AJ; Muller, WEG; Wetter, T; Suhai, S			Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs	GENOME RESEARCH			English	Article							DNA; ALIGNMENT; PROGRAM	We present an EST sequence assembler that specializes in reconstruction of pristine mRNA transcripts, while at the same time detecting and classifying single nucleotide polymorphisms (SNPs) occuring in different variations thereof. The assembler Uses iterative multipass strategies centered on high-confidence regions within sequences and has a fallback strategy for using low-confidence regions when needed. It features special functions to assemble high numbers of highly similar sequences without prior masking, an automatic editor that edits and analyzes alignments by inspecting the Underlying traces, and detection and classification of sequence properties like SNPs with a high specificity and a sensitivity down to one mutation per sequence. In addition, it includes possibilities to Use incorrectly preprocessed sequences, routines to make Use of additional sequencing information such as base-error probabilities, template insert sizes, strain information, etc., and functions to detect and resolve possible misassemblies. The assembler is routinely used for such various tasks as mutation detection in different cell types, similarity analysis of transcripts between organisms, and pristine assembly Of sequences from various sources for oligo design in clinical microarray experiments.	German Canc Res Ctr, Dept Mol Biophys, D-69120 Heidelberg, Germany; Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany; Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Angew Mol Biol Abt, D-55099 Mainz, Germany; VitiGen AG, D-76833 Siebeldingen, Germany; RZPD German Resource Ctr Genome Res, D-14059 Berlin, Germany; MWG Biotech AG, D-85560 Ebersberg, Germany		Chevreux, B (corresponding author), German Canc Res Ctr, Dept Mol Biophys, D-69120 Heidelberg, Germany.	bastien@chevreux.org	Muller, W. E. G./AAR-8651-2020	Muller, W. E. G./0000-0002-8223-3689; Chevreux, Bastien/0000-0003-4419-8840			ALLEX CF, 1996, INTELL SYTEMS MOL BI, V4, P3; Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; BAEZAYATES R, 1992, COMMUN ACM, V35, P74, DOI 10.1145/135239.135243; Barker G, 2003, BIOINFORMATICS, V19, P421, DOI 10.1093/bioinformatics/btf881; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bonfield JK, 1996, DNA SEQUENCE, V6, P109, DOI 10.3109/10425179609010197; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; CHAN SC, 1992, B MATH BIOL, V54, P563, DOI 10.1007/BF02459635; Chevreux B, 2000, GENOMICS AND PROTEOMICS, P51; CHEVREUX B, 1999, P GERM C BIOINF GCB, P45; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Dear S, 1998, GENOME RES, V8, P260, DOI 10.1101/gr.8.3.260; Durbin R, 1998, GENOME RES, V8, P161, DOI 10.1101/gr.8.3.161; GIEGERICH R, 1996, PAIRWISE SEQUENCE AL; Grillo G, 1996, COMPUT APPL BIOSCI, V12, P1; Gusfield D., 1997, ACM SIGACT NEWS, V28, P41; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Huang XQ, 1996, GENOMICS, V33, P21, DOI 10.1006/geno.1996.0155; KECECIOGLU JD, 1992, 9237 TR; Kumar S, 1996, J MOL EVOL, V42, P183, DOI 10.1007/BF02198844; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Muller WEG, 2001, COMP BIOCHEM PHYS A, V129, P433, DOI 10.1016/S1095-6433(00)00360-3; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; NICKERSON DA, 2000, RES ABSTR DOE HUM GE; Notredame C, 1996, NUCLEIC ACIDS RES, V24, P1515, DOI 10.1093/nar/24.8.1515; *PAR INC, 2002, PAR TRANS ASS US MAN; *PAR INC, 2002, PAR FILT PACK US MAN; PARSONS R, 1993, P 1 INT C INT SYST M; Pearson WR, 1998, J MOL BIOL, V276, P71, DOI 10.1006/jmbi.1997.1525; PEARSON WR, 1995, PROTEIN SCI, V4, P1145, DOI 10.1002/pro.5560040613; PELTOLA H, 1984, NUCLEIC ACIDS RES, V12, P307, DOI 10.1093/nar/12.1Part1.307; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; PFISTERER T, 1999, LECT NOTES ARTIFICAL, P201; Shpaer EG, 1996, GENOMICS, V38, P179, DOI 10.1006/geno.1996.0614; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STADEN R, 1997, NEW STADEN PACKAGE M; Stoye J, 1998, GENE, V211, pGC45, DOI 10.1016/S0378-1119(98)00097-3; Tammi MT, 2002, BIOINFORMATICS, V18, P379, DOI 10.1093/bioinformatics/18.3.379; Walther D, 2001, GENOME RES, V11, P875, DOI 10.1101/gr.177901; WU S, 1992, COMMUN ACM, V35, P83, DOI 10.1145/135239.135244; Zhang C, 1997, COMPUT APPL BIOSCI, V13, P565	42	802	809	3	44	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2004	14	6					1147	1159		10.1101/gr.1917404			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	826TR	WOS:000221852400017	15140833	Green Published, Bronze			2022-01-24	
J	Liu, PT; Jenkins, NA; Copeland, NG				Liu, PT; Jenkins, NA; Copeland, NG			A highly efficient recombineering-based method for generating conditional knockout mutations	GENOME RESEARCH			English	Article							BACTERIAL ARTIFICIAL CHROMOSOMES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; GENE REPLACEMENT; CRE RECOMBINASE; DNA; SYSTEM; HOMOLOGY; CLONING; VECTOR	Phage-based Escherichia coli homologous recombination systems have recently been developed that now make it possible to subdone or modify DNA cloned into plasmids, BACs, or PACs without the need for restriction enzymes or DNA ligases. This new form of chromosome engineering, termed recombineering, has many different uses for functional genomic studies. Here we describe a new recombineering-based method for generating conditional mouse knockout (cko) mutations. This method uses homologous recombination mediated by the lambda phage Red proteins, to subdone DNA from BACs into high-copy plasmids by gap repair, and together with Cre or Flpe recombinases, to introduce IoxP or FRT sites into the subdoned DNA. Unlike other methods that use short 45-55-bp regions of homology for recombineering, our method uses much longer regions of homology. We also make use of several new E coli strains, in which the proteins required for recombination are expressed from a defective temperature-sensitive lambda prophage, and the Cre or Flpe recombinases from an arabinose-inducible promoter. We also describe two new Neo selection cassettes that work well in both E coli and mouse ES cells. Our method is fast, efficient, and reliable and makes it possible to generate cko-targeting vectors in less than 2 wk. This method should also facilitate the generation of knock-in mutations and transgene constructs, as well as expedite the analysis of regulatory elements and functional domains in or near genes.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA		Copeland, NG (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.		Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474			BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FEISS M, 1982, GENE, V17, P123, DOI 10.1016/0378-1119(82)90064-6; Gray M, 2001, NUCLEIC ACIDS RES, V29, P5156, DOI 10.1093/nar/29.24.5156; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Murphy KC, 2000, GENE, V246, P321, DOI 10.1016/S0378-1119(00)00071-8; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Poteete AR, 2001, FEMS MICROBIOL LETT, V201, P9, DOI 10.1016/S0378-1097(01)00242-7; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Stahl FW, 1998, GENE, V223, P95, DOI 10.1016/S0378-1119(98)00246-7; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	26	802	838	0	55	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	MAR	2003	13	3					476	484		10.1101/gr.749203			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	653CX	WOS:000181418600016	12618378	Green Published, Bronze			2022-01-24	
J	Weinrich, SL; Pruzan, R; Ma, LB; Ouellette, M; Tesmer, VM; Holt, SE; Bodnar, AG; Lichtsteiner, S; Kim, NW; Trager, JB; Taylor, RD; Carlos, R; Andrews, WH; Wright, WE; Shay, JW; Harley, CB; Morin, GB				Weinrich, SL; Pruzan, R; Ma, LB; Ouellette, M; Tesmer, VM; Holt, SE; Bodnar, AG; Lichtsteiner, S; Kim, NW; Trager, JB; Taylor, RD; Carlos, R; Andrews, WH; Wright, WE; Shay, JW; Harley, CB; Morin, GB			Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT	NATURE GENETICS			English	Article							EXPRESSION; DNA; POLYMERASES; MECHANISM; CANCER; ENZYME; VECTOR; CELLS; GENES	The maintenance of chromosome termini, or telomeres, requires the action of the enzyme telomerase, as conventional DNA polymerases cannot fully replicate the ends of linear molecules(1-4). Telomerase is expressed and telomere length is maintained in human germ cells and the great majority of primary human tumours(5,6). However, telomerase is not detectable in most normal somatic cells; this corresponds to the gradual telomere loss observed with each cell division(7-9). It has been proposed that telomere erosion eventually signals entry into senescence or cell crisis and that activation of telomerase is usually required for immortal cell proliferation(10). In addition to the human telomerase RNA component (hTR; ref, 11), TP1/TLP1 (refs 12,13), a protein that is homologous to the p80 protein associated with the Tetrahymena enzyme(14), has been identified in humans. More recently, the human telomerase reverse transcriptase (hTRT; refs 15, 16), which is homologous to the reverse transcriptase (RT)like proteins associated with the Euplotes aediculatus (Ea_p123), Saccharomyces cerevisiae (Est2p) and Schizosaccharomyces pombe (SpTrt1) telomerases(15,17), has been reported to be a telomerase protein subunit. A catalytic function has been demonstrated for Est2p in the RT-like class but not for p80 or its homologue(17,18). We now report that in vitro transcription and translation of hTRT when co-synthesized or mixed with hTR reconstitutes telomerase activity that exhibits enzymatic properties like those of the native enzyme, Single amino-acid changes in conserved telomerase-specific and RT motifs reduce or abolish activity, providing direct evidence that hTRT is the catalytic protein component of telomerase. Normal human diploid cells transiently expressing hTRT possessed telomerase activity, demonstrating that hTRT is the limiting component necessary for restoration of telomerase activity in these cells. The ability to reconstitute telomerase permits further analysis of its biochemical and biological roles in cell aging and carcinogenesis.	GERON CORP,MENLO PK,CA 94025; UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235				Morin, Gregg B/E-9123-2012; Shay, Jerry W/F-7878-2011	Morin, Gregg B/0000-0001-8949-4374; 	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG05747, AG07992] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG007992] Funding Source: NIH RePORTER		Autexier C, 1996, EMBO J, V15, P5928, DOI 10.1002/j.1460-2075.1996.tb00979.x; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; COLLINS K, 1995, CELL, V81, P677, DOI 10.1016/0092-8674(95)90529-4; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HARRINGTON I, 1997, SCIENCE, V274, P973; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.biochem.63.1.777; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; LIN JH, 1994, GENE, V147, P287, DOI 10.1016/0378-1119(94)90083-3; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Morin GB, 1997, EUR J CANCER, V33, P750, DOI 10.1016/S0959-8049(97)00061-0; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NAKAYAMA JI, 1997, CELL, V88, P1; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; PEREZ HD, 1994, J BIOL CHEM, V269, P22485; PRUZAN R, 1990, J BIOL CHEM, V265, P2804; SHAY JW, 1997, EUR J CANCER, V33, P777; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0	31	802	857	0	40	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					498	502		10.1038/ng1297-498			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	WOS:A1997YJ92400039	9398860				2022-01-24	
J	Zhang, ZF; Lee, JC; Lin, LP; Olivas, V; Au, V; LaFramboise, T; Abdel-Rahman, M; Wang, XQ; Levine, AD; Rho, JK; Choi, YJ; Choi, CM; Kim, SW; Jang, SJ; Park, YS; Kim, WS; Lee, DH; Lee, JS; Miller, VA; Arcila, M; Ladanyi, M; Moonsamy, P; Sawyers, C; Boggon, TJ; Ma, PC; Costa, C; Taron, M; Rosell, R; Halmos, B; Bivona, TG				Zhang, Zhenfeng; Lee, Jae Cheol; Lin, Luping; Olivas, Victor; Au, Valerie; LaFramboise, Thomas; Abdel-Rahman, Mohamed; Wang, Xiaoqi; Levine, Alan D.; Rho, Jin Kyung; Choi, Yun Jung; Choi, Chang-Min; Kim, Sang-We; Jang, Se Jin; Park, Young Soo; Kim, Woo Sung; Lee, Dae Ho; Lee, Jung-Shin; Miller, Vincent A.; Arcila, Maria; Ladanyi, Marc; Moonsamy, Philicia; Sawyers, Charles; Boggon, Titus J.; Ma, Patrick C.; Costa, Carlota; Taron, Miquel; Rosell, Rafael; Halmos, Balazs; Bivona, Trever G.			Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASES; NF-KAPPA-B; ACQUIRED-RESISTANCE; MET AMPLIFICATION; MUTANT EGFR; GEFITINIB; MUTATIONS; TUMORS; ERLOTINIB; GROWTH	Human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently respond to treatment with EGFRtargeted tyrosine kinase inhibitors (TKIs), such as erlotinib, but responses are not durable, as tumors acquire resistance. Secondary mutations in EGFR (such as T790M) or upregulation of the MET kinase are found in over 50% of resistant tumors. Here, we report increased activation of AXL and evidence for epithelial-to-mesenchymal transition (EMT) in multiple in vitro and in vivo EGFR-mutant lung cancer models with acquired resistance to erlotinib in the absence of the EGFR p.Thr790Met alteration or MET activation. Genetic or pharmacological inhibition of AXL restored sensitivity to erlotinib in these tumor models. Increased expression of AXL and, in some cases, of its ligand GAS6 was found in EGFR-mutant lung cancers obtained from individuals with acquired resistance to TKIs. These data identify AXL as a promising therapeutic target whose inhibition could prevent or overcome acquired resistance to EGFR TKIs in individuals with EGFR-mutant lung cancer.	[Lin, Luping; Olivas, Victor; Bivona, Trever G.] Univ Calif San Francisco, Div Hematol Oncol, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Zhang, Zhenfeng; Levine, Alan D.] Case Western Reserve Univ, Sch Med, Dept Pathol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Zhang, Zhenfeng; LaFramboise, Thomas; Abdel-Rahman, Mohamed; Levine, Alan D.] Case Comprehens Canc Ctr, Ireland Canc Ctr, Cleveland, OH USA; [Abdel-Rahman, Mohamed] Case Western Reserve Univ, Sch Med, Div Hematol Oncol, Univ Hosp Case Med Ctr, Cleveland, OH USA; [Zhang, Zhenfeng; Au, Valerie; Wang, Xiaoqi; Halmos, Balazs] Columbia Univ, Div Hematol Oncol, Med Ctr, New York, NY USA; [Lee, Jae Cheol; Choi, Chang-Min; Kim, Sang-We; Lee, Dae Ho; Lee, Jung-Shin] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea; [LaFramboise, Thomas] Case Western Reserve Univ, Sch Med, Dept Genet, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Levine, Alan D.] Case Western Reserve Univ, Sch Med, Div Gastroenterol & Liver Dis, Univ Hosp Case Med Ctr, Cleveland, OH USA; [Rho, Jin Kyung; Choi, Yun Jung; Choi, Chang-Min; Kim, Woo Sung] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pulm & Crit Care Med, Seoul, South Korea; [Jang, Se Jin; Park, Young Soo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pathol, Seoul, South Korea; [Arcila, Maria; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Ladanyi, Marc; Moonsamy, Philicia; Sawyers, Charles; Bivona, Trever G.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Ma, Patrick C.] Case Western Reserve Univ, Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Ma, Patrick C.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Costa, Carlota; Taron, Miquel; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain; [Costa, Carlota; Taron, Miquel; Rosell, Rafael] USP Dexeus Univ Inst, Pangaea Biotech, Barcelona, Spain		Bivona, TG (corresponding author), Univ Calif San Francisco, Div Hematol Oncol, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	bh2376@columbia.edu; tbivona@medicine.ucsf.edu	Ladanyi, Marc/AAG-8585-2019; Lee, Jae Cheol/AAA-2678-2021; Sawyers, Charles/G-5327-2016; Arcila, Maria/ABE-2235-2021		Korean Health Technology RD Project [A102059]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 1K08CA154787, P01 CA129243]; Uniting Against Lung Cancer Research Award; National Lung Cancer Partnership Young Investigator Award; La Caixa FoundationLa Caixa Foundation; American Cancer Society Research Scholar GrantAmerican Cancer Society [RSG-08-303-01]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K08CA154787, R01CA169338, P01CA129243, DP2CA174497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T35HL007616] Funding Source: NIH RePORTER	The authors thank K. Shokat for assistance with structural modeling of the AXL gatekeeper mutation, W. Polkinghorn, J. Wongvipat and E. Chan for advice and technical assistance and S. Edelheit of the Case Genomics Center for technical assistance. This work was supported by the Korean Health Technology R&D Project (grant A102059 to J.C.L.), the US National Institutes of Health (K08 1K08CA154787 to T.G.B. and P01 CA129243 to M.L.), a Uniting Against Lung Cancer Research Award, a National Lung Cancer Partnership Young Investigator Award (to T.G.B.), a grant from the La Caixa Foundation (to R.R.) and an American Cancer Society Research Scholar Grant (RSG-08-303-01 to B.H.).	Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; AZUMI N, 1987, AM J CLIN PATHOL, V88, P286, DOI 10.1093/ajcp/88.3.286; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Rosell R, 2009, CLIN LUNG CANCER, V10, P8, DOI 10.3816/CLC.2009.n.001; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	29	801	818	8	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					852	+		10.1038/ng.2330			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	WOS:000306854700008	22751098	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Ren, ZH; Gao, JP; Li, LG; Cai, XL; Huang, W; Chao, DY; Zhu, MZ; Wang, ZY; Luan, S; Lin, HX				Ren, ZH; Gao, JP; Li, LG; Cai, XL; Huang, W; Chao, DY; Zhu, MZ; Wang, ZY; Luan, S; Lin, HX			A rice quantitative trait locus for salt tolerance encodes a sodium transporter	NATURE GENETICS			English	Article							HIGH-AFFINITY POTASSIUM; HKT TRANSPORTERS; K+ NUTRITION; NA+; GENE; ATHKT1; ROOTS; ANTIPORTER; SEQUENCE; GENOME	Many important agronomic traits in crop plants, including stress tolerance, are complex traits controlled by quantitative trait loci (QTLs). Isolation of these QTLs holds great promise to improve world agriculture but is a challenging task. We previously mapped a rice QTL, SKC1, that maintained K+ homeostasis in the salt-tolerant variety under salt stress(1), consistent with the earlier finding that K+ homeostasis is important in salt tolerance(2,3). To understand the molecular basis of this QTL, we isolated the SKC1 gene by map-based cloning and found that it encoded a member of HKT-type transporters. SKC1 is preferentially expressed in the parenchyma cells surrounding the xylem vessels. Voltage-clamp analysis showed that SKC1 protein functions as a Na+-selective transporter. Physiological analysis suggested that SKC1 is involved in regulating K+/Na+ homeostasis under salt stress, providing a potential tool for improving salt tolerance in crops.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; UC Berkeley Ctr Mol Life Sci, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, SHARF Lab, Shanghai, Peoples R China		Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	sluan@nature.berkeley.edu; hxlin@sibs.ac.cn	Chao, Dai-Yin/H-1357-2012; Chao, Daiyin/A-5213-2013; Ren, Zhonghai/N-6944-2019	Ren, Zhonghai/0000-0002-0759-3668; ?, ??/0000-0003-2832-4800			Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; EPSTEIN E, 1961, PLANT PHYSIOL, V36, P437, DOI 10.1104/pp.36.4.437; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gassmann W, 1996, PLANT J, V10, P869, DOI 10.1046/j.1365-313X.1996.10050869.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; LANDER ES, 1989, GENETICS, V121, P185; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Liu K, 2001, PLANT CELL, V13, P1453, DOI 10.1105/tpc.13.6.1453; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; MOONS A, 1995, PLANT PHYSIOL, V107, P177, DOI 10.1104/pp.107.1.177; Ponnamperuma F.N., 1986, PROGR RAINFED LOWLAN; Qi Z, 2004, PLANT PHYSIOL, V136, P2548, DOI 10.1104/pp.104.049213; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Schachtman D, 1999, TRENDS PLANT SCI, V4, P281, DOI 10.1016/S1360-1385(99)01428-4; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Wang TB, 1998, PLANT PHYSIOL, V118, P651, DOI 10.1104/pp.118.2.651; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	801	961	12	285	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1141	1146		10.1038/ng1643			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	WOS:000232185600029	16155566				2022-01-24	
J	Shulaev, V; Sargent, DJ; Crowhurst, RN; Mockler, TC; Folkerts, O; Delcher, AL; Jaiswal, P; Mockaitis, K; Liston, A; Mane, SP; Burns, P; Davis, TM; Slovin, JP; Bassil, N; Hellens, RP; Evans, C; Harkins, T; Kodira, C; Desany, B; Crasta, OR; Jensen, RV; Allan, AC; Michael, TP; Setubal, JC; Celton, JM; Rees, DJG; Williams, KP; Holt, SH; Rojas, JJR; Chatterjee, M; Liu, B; Silva, H; Meisel, L; Adato, A; Filichkin, SA; Troggio, M; Viola, R; Ashman, TL; Wang, H; Dharmawardhana, P; Elser, J; Raja, R; Priest, HD; Bryant, DW; Fox, SE; Givan, SA; Wilhelm, LJ; Naithani, S; Christoffels, A; Salama, DY; Carter, J; Girona, EL; Zdepski, A; Wang, WQ; Kerstetter, RA; Schwab, W; Korban, SS; Davik, J; Monfort, A; Denoyes-Rothan, B; Arus, P; Mittler, R; Flinn, B; Aharoni, A; Bennetzen, JL; Salzberg, SL; Dickerman, AW; Velasco, R; Borodovsky, M; Veilleux, RE; Folta, KM				Shulaev, Vladimir; Sargent, Daniel J.; Crowhurst, Ross N.; Mockler, Todd C.; Folkerts, Otto; Delcher, Arthur L.; Jaiswal, Pankaj; Mockaitis, Keithanne; Liston, Aaron; Mane, Shrinivasrao P.; Burns, Paul; Davis, Thomas M.; Slovin, Janet P.; Bassil, Nahla; Hellens, Roger P.; Evans, Clive; Harkins, Tim; Kodira, Chinnappa; Desany, Brian; Crasta, Oswald R.; Jensen, Roderick V.; Allan, Andrew C.; Michael, Todd P.; Setubal, Joao Carlos; Celton, Jean-Marc; Rees, D. Jasper G.; Williams, Kelly P.; Holt, Sarah H.; Rojas, Juan Jairo Ruiz; Chatterjee, Mithu; Liu, Bo; Silva, Herman; Meisel, Lee; Adato, Avital; Filichkin, Sergei A.; Troggio, Michela; Viola, Roberto; Ashman, Tia-Lynn; Wang, Hao; Dharmawardhana, Palitha; Elser, Justin; Raja, Rajani; Priest, Henry D.; Bryant, Douglas W., Jr.; Fox, Samuel E.; Givan, Scott A.; Wilhelm, Larry J.; Naithani, Sushma; Christoffels, Alan; Salama, David Y.; Carter, Jade; Girona, Elena Lopez; Zdepski, Anna; Wang, Wenqin; Kerstetter, Randall A.; Schwab, Wilfried; Korban, Schuyler S.; Davik, Jahn; Monfort, Amparo; Denoyes-Rothan, Beatrice; Arus, Pere; Mittler, Ron; Flinn, Barry; Aharoni, Asaph; Bennetzen, Jeffrey L.; Salzberg, Steven L.; Dickerman, Allan W.; Velasco, Riccardo; Borodovsky, Mark; Veilleux, Richard E.; Folta, Kevin M.			The genome of woodland strawberry (Fragaria vesca)	NATURE GENETICS			English	Article							PHYLOGENETIC TREE SELECTION; DIPLOID STRAWBERRY; GENE-EXPRESSION; SEQUENCE; ALIGNMENT; PROTEINS; ROSACEAE; PLANTS; IDENTIFICATION; TRANSFORMATION	The woodland strawberry, Fragaria vesca (2n = 2x = 14), is a versatile experimental plant system. This diminutive herbaceous perennial has a small genome (240 Mb), is amenable to genetic transformation and shares substantial sequence identity with the cultivated strawberry (Fragaria x ananassa) and other economically important rosaceous plants. Here we report the draft F. vesca genome, which was sequenced to x39 coverage using second-generation technology, assembled de novo and then anchored to the genetic linkage map into seven pseudochromosomes. This diploid strawberry sequence lacks the large genome duplications seen in other rosids. Gene prediction modeling identified 34,809 genes, with most being supported by transcriptome mapping. Genes critical to valuable horticultural traits including flavor, nutritional value and flowering time were identified. Macrosyntenic relationships between Fragaria and Prunus predict a hypothetical ancestral Rosaceae genome that had nine chromosomes. New phylogenetic analysis of 154 protein-coding genes suggests that assignment of Populus to Malvidae, rather than Fabidae, is warranted.	[Chatterjee, Mithu; Salama, David Y.; Folta, Kevin M.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Shulaev, Vladimir; Mittler, Ron] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Crowhurst, Ross N.; Hellens, Roger P.; Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Mt Albert Res Ctr, Auckland, New Zealand; [Mockler, Todd C.; Jaiswal, Pankaj; Liston, Aaron; Filichkin, Sergei A.; Dharmawardhana, Palitha; Elser, Justin; Raja, Rajani; Priest, Henry D.; Bryant, Douglas W., Jr.; Fox, Samuel E.; Givan, Scott A.; Wilhelm, Larry J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Mockler, Todd C.; Filichkin, Sergei A.; Priest, Henry D.; Bryant, Douglas W., Jr.; Fox, Samuel E.; Givan, Scott A.; Wilhelm, Larry J.] Oregon State Univ, CGRB, Corvallis, OR 97331 USA; [Folkerts, Otto; Crasta, Oswald R.] Chromatin Inc, Champaign, IL USA; [Delcher, Arthur L.; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Mockaitis, Keithanne; Carter, Jade] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA; [Mane, Shrinivasrao P.; Evans, Clive; Setubal, Joao Carlos; Williams, Kelly P.; Dickerman, Allan W.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Burns, Paul; Borodovsky, Mark] Joint Georgia Tech & Emory Wallace H Coulter Dept, Atlanta, GA USA; [Davis, Thomas M.; Liu, Bo] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Slovin, Janet P.] ARS, USDA, Henry Wallace Beltsville Agr Res Ctr, Beltsville, MD USA; [Bassil, Nahla] ARS, USDA, Corvallis, OR USA; [Harkins, Tim; Kodira, Chinnappa; Desany, Brian] Roche Appl Sci, Roche Diagnost, Indianapolis, IN USA; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Allan, Andrew C.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Michael, Todd P.; Zdepski, Anna; Wang, Wenqin; Kerstetter, Randall A.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08855 USA; [Setubal, Joao Carlos] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Celton, Jean-Marc; Rees, D. Jasper G.] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Holt, Sarah H.; Rojas, Juan Jairo Ruiz; Veilleux, Richard E.] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA; [Holt, Sarah H.; Flinn, Barry] Inst Adv Learning & Res, Inst Sustainable & Renewable Resources, Danville, PA USA; [Chatterjee, Mithu; Folta, Kevin M.] Univ Florida, Grad Program Plant Mol & Cellular Biol, Gainesville, FL USA; [Silva, Herman] Univ Chile, Fac Agron, Santiago, Chile; [Meisel, Lee; Aharoni, Asaph] Univ Andres Bello, Fac Ciencias Biol, Ctr Biotecnol Vegetal, Santiago, Chile; [Adato, Avital] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Troggio, Michela; Viola, Roberto; Velasco, Riccardo] Fdn Edmund Mach, Res & Innovat Ctr, IASMA, San Michele All Adige, Trento, Italy; [Ashman, Tia-Lynn] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Wang, Hao; Bennetzen, Jeffrey L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Naithani, Sushma] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Christoffels, Alan] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Schwab, Wilfried] Tech Univ Munich, D-8000 Munich, Germany; [Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Davik, Jahn] Norwegian Inst Agr & Environm Res, Kvithamar, Stjordal, Norway; [Monfort, Amparo; Arus, Pere] IRTA, Barcelona, Spain; [Monfort, Amparo; Arus, Pere] Ctr Recerca Agrigenom CSIC IRTA UAB, Barcelona, Spain; [Denoyes-Rothan, Beatrice] INRA, UREF, Villenave Dornon, France; [Borodovsky, Mark] Georgia Tech, Sch Computat Sci & Engn, Atlanta, GA USA		Folta, KM (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	kfolta@ufl.edu	Viola, Roberto/D-2277-2010; Arus, Pere/F-6443-2015; Meisel, Lee/J-6755-2012; Sargent, Daniel James/A-2933-2014; Setubal, Joao C/C-7305-2012; Rees, Jasper/D-9672-2011; Allan, Andrew C/L-3253-2016; Crowhurst, Ross N/N-8892-2017; Naithani, Sushma/AAU-1450-2021; Silva, Herman P/C-7252-2012; Lopez-Girona, Elena/Q-4822-2016; Lopez-Girona, Elena/V-2790-2019; Christoffels, Alan/C-3269-2014; Meisel, Lee/C-3864-2008; Mittler, Ron/ABE-6496-2020; Flinn, Barry/AAE-6341-2020; Jaiswal, Pankaj/H-7599-2016; Rees, David Jasper Gilbert/AAZ-8073-2020; Velasco, Riccardo/G-8710-2011; Monfort, Amparo/K-1356-2015; Jaiswal, Pankaj/R-4214-2019; Salzberg, Steven/Q-6514-2019; aharoni, asaph/W-6670-2019; Mockler, Todd C/L-2609-2013; Salzberg, Steven L/F-6162-2011; Wang, Wenqin/AAR-2970-2021; Wang, Hao/C-7651-2009; Viola, Roberto/F-3657-2014	Arus, Pere/0000-0003-0939-8038; Meisel, Lee/0000-0002-4806-6864; Sargent, Daniel James/0000-0002-6686-7147; Setubal, Joao C/0000-0001-9174-2816; Rees, Jasper/0000-0003-3321-1325; Allan, Andrew C/0000-0003-1944-7067; Crowhurst, Ross N/0000-0003-0608-2134; Naithani, Sushma/0000-0001-7819-4552; Silva, Herman P/0000-0003-1007-7442; Lopez-Girona, Elena/0000-0003-0376-6135; Lopez-Girona, Elena/0000-0003-0376-6135; Christoffels, Alan/0000-0002-0420-2916; Flinn, Barry/0000-0002-3843-3990; Jaiswal, Pankaj/0000-0002-1005-8383; Rees, David Jasper Gilbert/0000-0003-3321-1325; Monfort, Amparo/0000-0001-7106-7745; Jaiswal, Pankaj/0000-0002-1005-8383; Salzberg, Steven/0000-0002-8859-7432; Mockler, Todd C/0000-0002-0462-5775; Salzberg, Steven L/0000-0002-8859-7432; Wang, Wenqin/0000-0001-6427-6338; Slovin, Janet/0000-0001-6609-7034; Carter, Jade/0000-0003-2792-1662; Mane, Shrinivasrao/0000-0003-4123-624X; Wang, Hao/0000-0002-9634-8778; Viola, Roberto/0000-0002-8202-8503; Celton, Jean-Marc/0000-0002-1452-4812; Givan, Scott/0000-0002-0630-8589; Hellens, Roger/0000-0003-2094-0887; Michael, Todd/0000-0001-6272-2875; Velasco, Riccardo/0000-0002-8760-5031; Denoyes, Beatrice/0000-0002-0369-9609	RocheRoche Holding; Virginia Bioinformatics Institute; University of Florida Institute of Food and Agricultural Sciences (IFAS) Dean for ResearchUniversity of Florida; University of Florida Strawberry Breeding Program; Province of Trento, ItalyAutonomous Province of Trento; Driscoll's Strawberry Associates; United States Department of Agriculture/Cooperative State Research, Education and Extension Service (USDA/CSREES)United States Department of Agriculture (USDA)National Institute of Food and Agriculture [VA-135816]; Rutgers Busch Biomedical Funding; East Malling Trust (EMT); Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Oregon State Agricultural Research Foundation [ARF4435]; Oregon State Computational and Genome Biology Initiative; Oregon State University; Center for Genomics and Bioinformatics; METACyt Initiative of Indiana University; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG00783]; USDA-CSREES National Research Initiative (NRI)United States Department of Agriculture (USDA)National Institute of Food and Agriculture [2008-35300-04411]; New Hampshire Agricultural Experiment Station Project [NH00535]; USDA/ARS CRISUnited States Department of Agriculture (USDA)USDA Agricultural Research Service [1275-21000-180-01R]; Division Of Integrative Organismal SystemsNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0822201] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG006677, R01HG000783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM006845] Funding Source: NIH RePORTER	This work was supported by Roche and 454 Sequencing; the Virginia Bioinformatics Institute; the University of Florida Institute of Food and Agricultural Sciences (IFAS) Dean for Research; the University of Florida Strawberry Breeding Program; The Province of Trento, Italy (to R. V.); Driscoll's Strawberry Associates; United States Department of Agriculture/Cooperative State Research, Education and Extension Service (USDA/CSREES) Hatch Project VA-135816 (to B. F.); Rutgers Busch Biomedical Funding (to T. P. M.); East Malling Trust (EMT) and Biotechnology and Biological Sciences Research Council (BBSRC) (to D.J.S. and E. L. G.); the Oregon State Agricultural Research Foundation #ARF4435 (to T. C. M.); the Oregon State Computational and Genome Biology Initiative (to T. C. M.); Oregon State University start-up fund (to P.J.); the Center for Genomics and Bioinformatics, supported in part by the METACyt Initiative of Indiana University (to K. M.); US National Institutes of Health (grant HG00783; to M. B.); USDA-CSREES National Research Initiative (NRI) Plant Genome Grant 2008-35300-04411 and New Hampshire Agricultural Experiment Station Project NH00535 (to T. M. D.); and USDA/ARS CRIS #1275-21000-180-01R (to J.P.S.).	Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Alsheikh MK, 2002, PLANT CELL REP, V20, P1173, DOI 10.1007/s00299-002-0453-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Darrow G.M., 1966, STRAWBERRY HIST BREE; Davis TM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-81; Davis TM, 1997, J HERED, V88, P215, DOI 10.1093/oxfordjournals.jhered.a023091; Dempsey DA, 1998, TRENDS MICROBIOL, V6, P54, DOI 10.1016/S0966-842X(97)01186-4; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Endress PK, 2006, PLANT SYST EVOL, V260, P223, DOI 10.1007/s00606-006-0444-7; Folta KM, 2010, PLANT GENOME-US, V3, P90, DOI 10.3835/plantgenome2010.02.0003; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim KY, 2004, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.2004.649.18; Liu B, 2006, INT J PLANT SCI, V167, P367, DOI 10.1086/499317; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Oosumi T, 2006, PLANTA, V223, P1219, DOI 10.1007/s00425-005-0170-3; Oosumi T, 2010, PHYSIOL PLANTARUM, V140, P1, DOI 10.1111/j.1399-3054.2010.01378.x; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pontaroli AC, 2009, PLANT GENOME-US, V2, P93, DOI 10.3835/plantgenome2008.09.0007; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; QUI YL, 2010, J SYST EVOL, V48, P391; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ruiz-Rojas JJ, 2010, THEOR APPL GENET, V121, P449, DOI 10.1007/s00122-010-1322-9; Sargent DJ, 2008, GENOME, V51, P120, DOI [10.1139/G07-107, 10.1139/g07-107]; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tian YY, 2007, NUCLEIC ACIDS RES, V35, pD328, DOI 10.1093/nar/gkl905; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wei YL, 2007, MOL BIOL REP, V34, P105, DOI 10.1007/s11033-006-9024-8; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Yoshida K, 2008, PLANT CELL PHYSIOL, V49, P157, DOI 10.1093/pcp/pcn009; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-217; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	61	800	855	12	245	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					109	116		10.1038/ng.740			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	WOS:000286623800007	21186353	Green Published, hybrid, Green Accepted	Y	N	2022-01-24	
J	O'Donovan, MC; Craddock, N; Norton, N; Williams, H; Peirce, T; Moskvina, V; Nikolov, I; Hamshere, M; Carroll, L; Georgieva, L; Dwyer, S; Holmans, P; Marchini, JL; Spencer, CCA; Howie, B; Leung, HT; Hartmann, AM; Moller, HJ; Morris, DW; Shi, YY; Feng, GY; Hoffmann, P; Propping, P; Vasilescu, C; Maier, W; Rietschel, M; Zammit, S; Schumacher, J; Quinn, EM; Schulze, TG; Williams, NM; Giegling, I; Iwata, N; Ikeda, M; Darvasi, A; Shifman, S; He, L; Duan, J; Sanders, AR; Levinson, DF; Gejman, PV; Cichon, S; Nothen, MM; Gill, M; Corvin, A; Rujescu, D; Kirov, G; Owen, MJ				O'Donovan, Michael C.; Craddock, Nicholas; Norton, Nadine; Williams, Hywel; Peirce, Timothy; Moskvina, Valentina; Nikolov, Ivan; Hamshere, Marian; Carroll, Liam; Georgieva, Lyudmila; Dwyer, Sarah; Holmans, Peter; Marchini, Jonathan L.; Spencer, Chris C. A.; Howie, Bryan; Leung, Hin-Tak; Hartmann, Annette M.; Moeller, Hans-Juergen; Morris, Derek W.; Shi, YongYong; Feng, GuoYin; Hoffmann, Per; Propping, Peter; Vasilescu, Catalina; Maier, Wolfgang; Rietschel, Marcella; Zammit, Stanley; Schumacher, Johannes; Quinn, Emma M.; Schulze, Thomas G.; Williams, Nigel M.; Giegling, Ina; Iwata, Nakao; Ikeda, Masashi; Darvasi, Ariel; Shifman, Sagiv; He, Lin; Duan, Jubao; Sanders, Alan R.; Levinson, Douglas F.; Gejman, Pablo V.; Cichon, Sven; Noethen, Markus M.; Gill, Michael; Corvin, Aiden; Rujescu, Dan; Kirov, George; Owen, Michael J.		Mol Genetics Of Schizophrenia Coll	Identification of loci associated with schizophrenia by genome-wide association and follow-up	NATURE GENETICS			English	Article								We carried out a genome-wide association study of schizophrenia (479 cases, 2,937 controls) and tested loci with P < 10(-5) in up to 16,726 additional subjects. Of 12 loci followed up, 3 had strong independent support (P < 5 x 10(-4)), and the overall pattern of replication was unlikely to occur by chance (P < 9 x 10(-8)). Meta-analysis provided strongest evidence for association around ZNF804A (P = 1.61 x 10(-7)) and this strengthened when the affected phenotype included bipolar disorder (P = 9.96 x 10(-9)).	[O'Donovan, Michael C.; Craddock, Nicholas; Norton, Nadine; Williams, Hywel; Peirce, Timothy; Moskvina, Valentina; Nikolov, Ivan; Hamshere, Marian; Carroll, Liam; Georgieva, Lyudmila; Dwyer, Sarah; Holmans, Peter; Zammit, Stanley; Williams, Nigel M.; Kirov, George; Owen, Michael J.] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, England; [Marchini, Jonathan L.; Spencer, Chris C. A.; Howie, Bryan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Leung, Hin-Tak] Univ Cambridge, Dept Med Genet, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Hartmann, Annette M.; Giegling, Ina; Rujescu, Dan] Univ Munich, Div Mol & Clin Neurbiol, D-80336 Munich, Germany; [Moeller, Hans-Juergen] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Morris, Derek W.; Quinn, Emma M.; Gill, Michael; Corvin, Aiden] Univ Dublin Trinity Coll, Sch Med, Neuropsychiat Genet Res Grp, Dublin 8, Ireland; [Shi, YongYong] Shanghai Jiao Tong Univ, BioX Ctr, Shanghai 200030, Peoples R China; [Feng, GuoYin] Shanghai Inst Mental Hlth, Shanghai 200030, Peoples R China; [Hoffmann, Per; Vasilescu, Catalina; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Gen, Life & Brain Ctr, D-53105 Bonn, Germany; [Propping, Peter; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; [Rietschel, Marcella] Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Schumacher, Johannes; Schulze, Thomas G.] US Natl Inst Mental Hlth, Natl Inst Hlth, Bethesda, MD 20892 USA; [Iwata, Nakao; Ikeda, Masashi] Fujita Hlth Univ, Sch Med, Dept Psychiat, Aichi 4701192, Japan; [Iwata, Nakao; Ikeda, Masashi] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; [Darvasi, Ariel; Shifman, Sagiv] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Northwestern Univ, Ctr Psychiat Genet, Evanston, IL 60201 USA; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60201 USA; [Levinson, Douglas F.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA		O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, England.	wpcmod@cf.ac.uk; wpcmjo@cf.ac.uk	Morris, Derek/AAW-8343-2021; Holmans, Peter/F-4518-2015; Hoffmann, Per/A-5149-2010; Giegling, Ina/ABA-3677-2021; Marchini, Jonathan/ABE-9024-2020; Cichon, Sven/H-8803-2013; Nothen, Markus/B-2027-2009; Schumacher, Johannes/F-4970-2015; Hartmann, Annette/AAS-6331-2021; Williams, Hywel/AAL-2440-2021; Schulze, Thomas G/H-2157-2013; Shifman, Sagiv/D-8749-2017; O'Donovan, Michael C/P-7005-2018; Cichon, Sven/B-9618-2014	Morris, Derek/0000-0002-3413-570X; Holmans, Peter/0000-0003-0870-9412; Hoffmann, Per/0000-0002-6573-983X; Marchini, Jonathan/0000-0003-0610-8322; Cichon, Sven/0000-0002-9475-086X; Nothen, Markus/0000-0002-8770-2464; Schumacher, Johannes/0000-0001-9217-6457; Williams, Hywel/0000-0001-7758-0312; Shifman, Sagiv/0000-0003-4071-5361; O'Donovan, Michael C/0000-0001-7073-2379; Cichon, Sven/0000-0002-9475-086X; Black, Donald/0000-0001-8038-1971; Zammit, Stanley/0000-0002-2647-9211; Ikeda, Masashi/0000-0001-6237-2449; Buccola, Nancy/0000-0003-1378-4636; Newton-Bishop, Julia/0000-0001-9147-6802; Shi, Yongyong/0000-0003-1710-1505; Escott-Price, Valentina/0000-0003-1784-5483; Walters, James/0000-0002-6980-4053; Corvin, Aiden/0000-0001-6717-4089; Kirov, George/0000-0002-3427-3950; Gill, Michael/0000-0003-0206-5337	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Wellcome TrustWellcome TrustEuropean Commission; Science Foundation IrelandScience Foundation IrelandEuropean Commission; Health Research Board (Ireland); National Genomic Network of the 'Bundesministerium fur Bildung und Forschung' (BMBF)Federal Ministry of Education & Research (BMBF); Alfried Krupp von Bohlen und Halbach-Stiftung; GlaxoSmithKline.GlaxoSmithKline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9810900] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9810900] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH046276, R01MH060879] Funding Source: NIH RePORTER	The UK research was supported by grants from the MRC and the Wellcome Trust. We are grateful to the Wellcome Trust Case Control Consortium for access to control genotypes (and to the individuals acknowledged in that respect in ref. 4) and their contribution to the genome-wide study, and to the Welsh e-Science Centre at Cardiff University for access to computing resources for some of this work. In Dublin, the research was supported by Science Foundation Ireland, the Health Research Board (Ireland) and the Wellcome Trust. We are grateful to J. Waddington for sample recruitment. Irish controls were supplied by J. McPartlin and the Trinity College Biobank. In Bonn and Mannheim, the work was supported by the National Genomic Network of the 'Bundesministerium fur Bildung und Forschung' (BMBF) and the Alfried Krupp von Bohlen und Halbach-Stiftung. We also thank the Department of Psychiatry, LMU Munich for clinical characterization of the Munich subjects and the processing of the samples. Recruitment in Munich was partially supported by GlaxoSmithKline. The Ashkenazi samples are part of the Hebrew University Genetic Resource.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; RISCH N, 1990, AM J HUM GENET, V46, P222; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	10	800	829	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1053	1055		10.1038/ng.201			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	WOS:000258761200014	18677311				2022-01-24	
J	Lynch, M; Ritland, K				Lynch, M; Ritland, K			Estimation of pairwise relatedness with molecular markers	GENETICS			English	Article							QUANTITATIVE INHERITANCE; POPULATION-STRUCTURE; NATURAL-POPULATIONS; INFERENCES	Applications of quantitative genetics and conservation genetics often require measures of pairwise relationships between individuals, which, in the absence of known pedigree structure, can be estimated only by use of molecular markers. Here we introduce methods for the joint estimation of the two-gene and four-gene coefficients of relationship from data on codominant molecular markers in randomly mating populations. In a comparison with other published estimators of pairwise relatedness, we find these new "regression" estimators to be computationally simpler and to yield similar or lower sampling variances, particularly when many loci are used or when loci are hypervariable. Two examples are given in which the new estimators are applied to natural populations, one that reveals isolation-by-distance in an annual plant and the other that suggests a genetic basis for a coat color polymorphism in bears.	Univ Oregon, Dept Biol, Eugene, OR 97408 USA; Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada		Lynch, M (corresponding author), Univ Oregon, Dept Biol, Eugene, OR 97408 USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-36827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM036827] Funding Source: NIH RePORTER		AVISE JC, 1995, MOL MARKERS NATURAL; COCKERHAM CC, 1971, GENETICS, V69, P235; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; Geyer Charles J., 1995, P245; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Jacquard A, 1974, GENETIC STRUCTURE PO; KEMPTHORNE O, 1954, PROC R SOC SER B-BIO, V143, P103, DOI 10.1098/rspb.1954.0056; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; LI CC, 1953, AM J HUM GENET, V5, P107; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Lynch M., 1998, GENETICS ANAL QUANTI; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; PAMILO P, 1982, THEOR POPUL BIOL, V21, P171, DOI 10.1016/0040-5809(82)90012-0; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Ritland K, 1996, EVOLUTION, V50, P1062, DOI 10.1111/j.1558-5646.1996.tb02347.x; RITLAND K, 1989, POPULATION GENETICS, P183; RITLAND K, 1999, IN PRESS ADAPTIVE GE; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; THOMPSON EA, 1976, ANN HUM GENET, V40, P201, DOI 10.1111/j.1469-1809.1976.tb00181.x; Weir BS, 1996, GENETIC DATA ANAL; [No title captured]	24	800	816	2	139	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	AUG	1999	152	4					1753	1766					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224GL	WOS:000081889600046	10430599				2022-01-24	
J	Lefebvre, S; Burlet, P; Liu, Q; Bertrandy, S; Clermont, O; Munnich, A; Dreyfuss, G; Melki, J				Lefebvre, S; Burlet, P; Liu, Q; Bertrandy, S; Clermont, O; Munnich, A; Dreyfuss, G; Melki, J			Correlation between severity and SMN protein level in spinal muscular atrophy	NATURE GENETICS			English	Article							MOTOR-NEURON GENE; DELETIONS; INDIVIDUALS; 5Q13		HOP NECKER ENFANTS MALAD,INST NECKER,IFREM,INSERM U393,UNITE RECH HANDICAPS GENET LENFANT,F-75743 PARIS,FRANCE; UNIV PENN,HOWARD HUGHES MED INST,SCH MED,PHILADELPHIA,PA 19104; UNIV PENN,DEPT BIOCHEM & BIOPHYS,SCH MED,PHILADELPHIA,PA 19104				Lefebvre, Suzie/D-5092-2017; Dreyfuss, Gideon/D-1218-2013	Dreyfuss, Gideon/0000-0001-8129-8774			ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Burglen L, 1997, AM J HUM GENET, V60, P72; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; CHANG JG, 1995, AM J HUM GENET, V57, P1503; COBBEN JM, 1995, AM J HUM GENET, V57, P805; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Munsat TL., 1991, NEUROMUSCULAR DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-T, DOI 10.1016/0960-8966(91)90052-T]; POWERS MM, 1955, STAIN TECHNOL, V30, P83, DOI 10.3109/10520295509113749; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7	17	800	810	3	41	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					265	269		10.1038/ng0797-265			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	WOS:A1997XG60900022	9207792				2022-01-24	
J	DITTMER, D; PATI, S; ZAMBETTI, G; CHU, S; TERESKY, AK; MOORE, M; FINLAY, C; LEVINE, AJ				DITTMER, D; PATI, S; ZAMBETTI, G; CHU, S; TERESKY, AK; MOORE, M; FINLAY, C; LEVINE, AJ			GAIN OF FUNCTION MUTATIONS IN P53	NATURE GENETICS			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; CELLULAR TUMOR-ANTIGEN; WILD-TYPE P53; GROWTH-REGULATION; PROTEINS BIND; CELLS; GENE; TRANSFORMATION; DNA; CARCINOMAS	We report that the expression of murine or human mutant p53 proteins in cells with no endogenous p53 proteins confers new or additional phenotypes upon these cells. Mutant p53 proteins expressed in cell lines lacking p53 resulted in either enhanced tumorigenic potential in nude mice ((10)3 cells) or enhanced plating efficiency in agar cell culture (human SAOS-2 cells). Also, mutant human p53 alleles, unlike the wild-type p53 protein, could also enhance the expression of a test gene regulated by the multi-drug resistance enhancer-promoter element. These data demonstrate a gain of function associated with p53 mutations in addition to the loss of function shown previously to be associated with mutations in this tumour suppressor gene.	PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544				Zambetti, Gerard/N-8093-2018; Dittmer, Dirk/AAH-3535-2021	Zambetti, Gerard/0000-0002-0929-5007; Dittmer, Dirk/0000-0003-4968-5656	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA055036, P01CA041086] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA55036, P01 CA 41086] Funding Source: Medline		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; BARNONETTI J, 1992, GENE DEV, V6, P1886; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JOHNSON P, 1991, MOL CELL BIOL, V11, P1; JOHNSON P, 1992, CANCER SURV, V12, P137; KERN SE, 1991, ONCOGENE, V6, P131; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MARTIN HM, 1992, INT J CANCER, V50, P859, DOI 10.1002/ijc.2910500604; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MIETZ JA, 1992, EMBO J, V11, P5013, DOI 10.1002/j.1460-2075.1992.tb05608.x; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; RIOU G, 1990, LANCET, V335, P1171; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SHAULSKY G, 1991, CANCER RES, V51, P5232; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; THOR AD, 1992, JNCI-J NATL CANCER I, V84, P845, DOI 10.1093/jnci/84.11.845; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WOLF D, 1984, MOL CELL BIOL, V4, P552, DOI 10.1128/MCB.4.3.552; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143; ZAMBETTI GP, 1992, P NATL ACAD SCI USA, V89, P3952, DOI 10.1073/pnas.89.9.3952	41	800	812	1	31	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					42	46		10.1038/ng0593-42			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	WOS:A1993LA33700010	8099841				2022-01-24	
J	Liang, Y; Ridzon, D; Wong, L; Chen, CF				Liang, Yu; Ridzon, Dana; Wong, Linda; Chen, Caifu			Characterization of microRNA expression profiles in normal human tissues	BMC GENOMICS			English	Article							GENE-EXPRESSION; HOST GENES; MOUSE; MIRNAS; CELL; DIFFERENTIATION; IDENTIFICATION; RESOURCE; GENOMICS; CANCERS	Background: Measuring the quantity of miRNAs in tissues of different physiological and pathological conditions is an important first step to investigate the functions of miRNAs. Matched samples from normal state can provide essential baseline references to analyze the variation of miRNA abundance. Results: We provided expression data of 345 miRNAs in 40 normal human tissues, which identified universally expressed miRNAs, and several groups of miRNAs expressed exclusively or preferentially in certain tissue types. Many miRNAs with co-regulated expression patterns are located within the same genomic clusters, and candidate transcriptional factors that control the pattern of their expression may be identified by a comparative genomic strategy. Hierarchical clustering of normal tissues by their miRNA expression profiles basically followed the structure, anatomical locations, and physiological functions of the organs, suggesting that functions of a miRNA could be appreciated by linking to the biologies of the tissues in which it is uniquely expressed. Many predicted target genes of miRNAs that had specific reduced expression in brain and peripheral blood mononuclear cells are required for embryonic development of the nervous and hematopoietic systems based on database search. Conclusion: We presented a global view of tissue distribution of miRNAs in relation to their chromosomal locations and genomic structures. We also described evidence from the cis-regulatory elements and the predicted target genes of miRNAs to support their tissue- specific functional roles to regulate the physiologies of the normal tissues in which they are expressed.	Appl Biosyst Inc, Mol & Cell Biol R&D, Foster City, CA 94404 USA		Liang, Y (corresponding author), Appl Biosyst Inc, Mol & Cell Biol R&D, 850 Lincoln Ctr Dr, Foster City, CA 94404 USA.	Yu.Liang@appliedbiosystems.com; ridzonda@appliedbiosystems.com; Linda.Wong@appliedbiosystems.com; ChenCX@appliedbiosystems.com					Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; GAUR AB, 2007, IN PRESS CANC RES; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; KIM YK, 2007, EMBO J; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mersey BD, 2005, HUM MOL GENET, V14, P3371, DOI 10.1093/hmg/ddi368; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; ROLDO C, 2006, J CLIN ONCOL; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519	42	798	830	5	81	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUN 12	2007	8								166	10.1186/1471-2164-8-166			20	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	185YF	WOS:000247745600002	17565689	Green Published, gold			2022-01-24	
J	Vissers, LELM; van Ravenswaaij, CMA; Admiraal, R; Hurst, JA; de Vries, BBA; Janssen, IM; van der Vliet, WA; Huys, EHLPG; de Jong, PJ; Hamel, BCJ; Schoenmakers, EFPM; Brunner, HG; Veltman, JA; van Kessel, AG				Vissers, LELM; van Ravenswaaij, CMA; Admiraal, R; Hurst, JA; de Vries, BBA; Janssen, IM; van der Vliet, WA; Huys, EHLPG; de Jong, PJ; Hamel, BCJ; Schoenmakers, EFPM; Brunner, HG; Veltman, JA; van Kessel, AG			Mutations in a new member of the chromodomain gene family cause CHARGE syndrome	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ASSOCIATION; PROTEINS; EXCLUSION	CHARGE syndrome is a common cause of congenital anomalies affecting several tissues in a nonrandom fashion. We report a 2.3-Mb de novo overlapping microdeletion on chromosome 8q12 identified by array comparative genomic hybridization in two individuals with CHARGE syndrome. Sequence analysis of genes located in this region detected mutations in the gene CHD7 in 10 of 17 individuals with CHARGE syndrome without microdeletions, accounting for the disease in most affected individuals.	Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA		Veltman, JA (corresponding author), Univ Med Ctr Nijmegen, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.veltman@antrg.umcn.nl	Admiraal, R.J.C./L-4171-2015; Brunner, Han/C-9928-2013; van Kessel, Ad Geurts/A-2810-2010; Janssen, Irene M/V-3667-2018; Vissers, Lisenka ELM/A-2598-2015; Veltman, Joris A/F-5128-2010	Vissers, Lisenka ELM/0000-0001-6470-5497; Veltman, Joris A/0000-0002-3218-8250			Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; de Lonlay-Debeney P, 1997, J MED GENET, V34, P986, DOI 10.1136/jmg.34.12.986; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; HURST JA, 1991, J MED GENET, V28, P54, DOI 10.1136/jmg.28.1.54; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; Kallen K, 1999, TERATOLOGY, V60, P334; Lalani SR, 2003, AM J MED GENET A, V118A, P260, DOI 10.1002/ajmg.a.20002; Martin DM, 2002, AM J MED GENET, V111, P27, DOI 10.1002/ajmg.10473; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Sanlaville D, 2002, CLIN GENET, V61, P135, DOI 10.1034/j.1399-0004.2002.610208.x; Tellier AL, 2000, AM J MED GENET, V93, P85, DOI 10.1002/1096-8628(20000717)93:2<85::AID-AJMG1>3.0.CO;2-B; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	15	797	822	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					955	957		10.1038/ng1407			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	WOS:000223658100020	15300250	Bronze			2022-01-24	
J	Astuti, D; Latif, F; Dallol, A; Dahia, PLM; Douglas, F; George, E; Skoldberg, F; Husebye, ES; Eng, C; Maher, ER				Astuti, D; Latif, F; Dallol, A; Dahia, PLM; Douglas, F; George, E; Skoldberg, F; Husebye, ES; Eng, C; Maher, ER			Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU-DISEASE; COMPLEX-II; VHL; RET; MITOCHONDRIA; INVOLVEMENT; APOPTOSIS; BINDING	The pheochromocytomas are an important cause of secondary hypertension. Although pheochromocytoma susceptibility may be associated with germline mutations in the tumor-suppressor genes VHL and NF1 and in the proto-oncogene RET, the genetic basis for most cases of nonsyndromic familial pheochromocytoma is unknown. Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations. Germline SDHD mutations were originally described in hereditary paraganglioma, a dominantly inherited disorder characterized by vascular tumors in the head and the neck, most frequently at the carotid bifurcation. The gene products of two components of succinate dehydrogenase, SDHC and SDHD, anchor the gene products of two other components, SDHA and SDHB, which form the catalytic core, to the inner-mitochondrial membrane. Although mutations in SDHC and in SDHD may cause hereditary paraganglioma, germline SDHA mutations are associated with juvenile encephalopathy, and the phenotypic consequences of SDHB mutations have not been defined. To investigate the genetic causes of pheochromocytoma, we analyzed SDHB and SDHC, in familial and in sporadic cases. Inactivating SDHB mutations were detected in two of the five kindreds with familial pheochromocytoma, two of the three kindreds with pheochromocytoma and paraganglioma susceptibility, and 1 of the 24 cases of sporadic pheochromocytoma. These findings extend the link between mitochondrial dysfunction and tumorigenesis and suggest that germline SDHB mutations are an important cause of pheochromocytoma susceptibility.	Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Royal Victoria Infirm, No Reg Genet Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Kings Lynn Hosp, Dept Med, Norfolk, England; Uppsala Univ, Dept Med Sci, Uppsala, Sweden; Ohio State Univ, Ctr Comprehens Canc, Clin Canc Genet Programs, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Univ Cambridge, CRC, Human Canc Genet Res Grp, Cambridge, England		Maher, ER (corresponding author), Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.		MAHER, EAMONN R/A-9507-2008; Dallol, Ashraf/H-8661-2012	MAHER, EAMONN R/0000-0002-6226-6918; Dallol, Ashraf/0000-0002-8803-228X	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA016058, P30 CA16058] Funding Source: Medline		AGUIAR RCT, IN PRESS J CLIN ENDO; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2000, CANCER RES, V60, P7048; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cavalli LR, 1998, MUTAT RES-FUND MOL M, V398, P19, DOI 10.1016/S0027-5107(97)00223-6; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1995, J MED GENET, V32, P885, DOI 10.1136/jmg.32.11.885; Gimm O, 2000, CANCER RES, V60, P6822; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hofstra RMW, 1996, J CLIN ENDOCR METAB, V81, P2881, DOI 10.1210/jc.81.8.2881; JENSEN JC, 1991, J UROLOGY, V145, P1040, DOI 10.1016/S0022-5347(17)38524-5; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; MAHER ER, 2000, GENETICS ENDOCRINE M; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; NEUMANN HPH, 1995, JAMA-J AM MED ASSOC, V274, P1149; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; PRITCHETT JW, 1982, CANCER, V49, P2578, DOI 10.1002/1097-0142(19820615)49:12<2578::AID-CNCR2820491227>3.0.CO;2-M; Skoldberg F, 1998, CLIN ENDOCRINOL, V48, P11; Woodward ER, 1997, HUM MOL GENET, V6, P1051, DOI 10.1093/hmg/6.7.1051	26	797	826	1	29	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					49	54		10.1086/321282			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	WOS:000170108100005	11404820	Green Published, Bronze			2022-01-24	
J	Deng, ZM; Morse, JH; Slager, SL; Cuervo, N; Moore, KJ; Venetos, G; Kalachikov, S; Cayanis, E; Fischer, SG; Barst, RJ; Hodge, SE; Knowles, JA				Deng, ZM; Morse, JH; Slager, SL; Cuervo, N; Moore, KJ; Venetos, G; Kalachikov, S; Cayanis, E; Fischer, SG; Barst, RJ; Hodge, SE; Knowles, JA			Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TGF-BETA; CLONING; DOMAINS; TOOL	Familial primary pulmonary hypertension is a rare autosomal dominant disorder that has reduced penetrance and that has been mapped to a 3-cM region on chromosome 2q33 (locus PPH1). The phenotype is characterized by monoclonal plexiform lesions of proliferating endothelial cells in pulmonary arterioles. These lesions lead to elevated pulmonary-artery pressures, right-ventricular failure, and death. Although primary pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs, including phentermine-fenfluramine. We genotyped 35 multiplex families with the disorder, using 27 microsatellite markers; we constructed disease haplotypes; and we looked for evidence of haplotype sharing across families, using the program TRANSMIT. Suggestive evidence of sharing was observed with markers GGAA19e07 and D2S307, and three nearby candidate genes were examined by denaturing high-performance liquid chromatography on individuals from 19 families. One of these genes (BMPR2), which encodes bone morphogenetic protein receptor type II, was found to contain five mutations that predict premature termination of the protein product and two missense mutations. These mutations were not observed in 196 control chromosomes. These findings indicate that the bone morphogenetic protein-signaling pathway is defective in patients with primary pulmonary hypertension and may implicate the pathway in the nonfamilial forms of the disease.	Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Med, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Sch Publ Hlth, Div Biostat, New York, NY USA; Taub Inst Res Alzheimers Dis Aging Brain, New York, NY USA		Knowles, JA (corresponding author), Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Columbia Genome Ctr, 1051 Riverside Dr,Room 5916,Unit 28, New York, NY 10032 USA.		Slager, Susan L./B-6756-2009		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL060056, HL60056-1] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK31813, R01 DK031813] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL060056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK031813, R55DK031813] Funding Source: NIH RePORTER		Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; BRAND T, 1995, J BIOL CHEM, V270, P8274, DOI 10.1074/jbc.270.14.8274; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J RESP CRIT CARE, V161, P1055, DOI 10.1164/ajrccm.161.3.9906051; DOUGLAS JG, 1981, BMJ-BRIT MED J, V283, P881, DOI 10.1136/bmj.283.6296.881; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; MORSE JH, 1994, SEMIN RESP CRIT CARE, V15, P222, DOI 10.1055/s-2007-1006366; MORSE JH, 1996, CIRCULATION, V94, P1; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; PASQUE MK, 1995, CIRCULATION, V92, P2252, DOI 10.1161/01.CIR.92.8.2252; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Soda H, 1998, ANTI-CANCER DRUG, V9, P327, DOI 10.1097/00001813-199804000-00006; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239	37	797	836	1	32	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					737	744		10.1086/303059			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	WOS:000089002300019	10903931	Green Published, Bronze			2022-01-24	
J	COOK, EH; STEIN, MA; KRASOWSKI, MD; COX, NJ; OLKON, DM; KIEFFER, JE; LEVENTHAL, BL				COOK, EH; STEIN, MA; KRASOWSKI, MD; COX, NJ; OLKON, DM; KIEFFER, JE; LEVENTHAL, BL			ASSOCIATION OF ATTENTION-DEFICIT DISORDER AND THE DOPAMINE TRANSPORTER GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D2-DOPAMINE RECEPTOR GENE; HAPLOTYPE RELATIVE RISK; HYPERACTIVITY DISORDER; POINT MUTATIONS; CHILDREN; ALCOHOLISM; POLYMORPHISMS; ALLELE	Attention-deficit hyperactivity disorder (ADHD) has been shown to be familial and heritable, in previous studies. As with most psychiatric disorders, examination of pedigrees has not revealed a consistent Mendelian mode of transmission. The response of ADHD patients to medications that inhibit the dopamine transporter, including methylphenidate, amphetamine, pemoline, and bupropion, led us to consider the dopamine transporter as a primary candidate gene for ADHD. To avoid effects of population stratification and to avoid the problem of classification of relatives with other psychiatric disorders as affected or unaffected, we used the haplotype-based haplotype relative risk (HHRR) method to test for association between a VNTR polymorphism at the dopamine transporter locus (DAT1) and DSM-III-R-diagnosed ADHD (N = 49) and undifferentiated attention-deficit disorder (UADD) (N = 8) in trios composed of father, mother, and affected offspring. HHRR analysis revealed significant association between ADHD/UADD and the 480-bp DAT1 allele (chi(2) 7.51, 1 df, P = .006). When cases of UADD were dropped from the analysis, similar results were found (chi(2) 7.29, 1 df, P = .007). If these findings are replicated, molecular analysis of the dopamine transporter gene may identify mutations that increase susceptibility to ADHD/UADD. Biochemical analysis of such mutations may lead to development of more effective therapeutic interventions.	UNIV CHICAGO,DEPT PSYCHIAT,CHICAGO,IL 60637; UNIV CHICAGO,HARRIS CTR DEV STUDIES,DEV NEUROSCI LAB,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637				Krasowski, Matthew/ABA-8590-2020	Krasowski, Matthew/0000-0003-0856-8402	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K07 MH00822] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K07MH000822] Funding Source: NIH RePORTER		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ALBERTSCORUSH J, 1986, AM J ORTHOPSYCHIAT, V56, P413, DOI 10.1111/j.1939-0025.1986.tb03473.x; ASKEW GR, 1993, MOL CELL BIOL, V13, P4115, DOI 10.1128/MCB.13.7.4115; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BIEDERMAN J, 1990, J AM ACAD CHILD PSY, V29, P526, DOI 10.1097/00004583-199007000-00004; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BYERLEY W, 1993, HUM HERED, V43, P319, DOI 10.1159/000154151; CANTWELL DP, 1972, ARCH GEN PSYCHIAT, V27, P414; CASAT CD, 1987, PSYCHOPHARMACOL BULL, V23, P120; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; GELERNTER J, 1991, JAMA-J AM MED ASSOC, V266, P1801, DOI 10.1001/jama.266.13.1801; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; GREENHILL LL, 1992, PSYCHIAT CLIN N AM, V15, P1; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; HECHTMAN L, 1994, J PSYCHIATR NEUROSCI, V19, P193; HECHTMAN L, 1993, CAN J PSYCHIAT, V38, P458, DOI 10.1177/070674379303800614; Hollingshead A.B, 1957, 2 FACTOR INDEX SOCIA; IALONGO NS, 1993, J AM ACAD CHILD PSY, V32, P182, DOI 10.1097/00004583-199301000-00026; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PERSICO AM, 1993, BIOL PSYCHIAT, V34, P265, DOI 10.1016/0006-3223(93)90081-N; RAPPORT MD, 1994, J AM ACAD CHILD PSY, V33, P882, DOI 10.1097/00004583-199407000-00015; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; STEVENSON J, 1992, BEHAV GENET, V22, P337, DOI 10.1007/BF01066665; ULLMANN RK, 1984, PSYCHOPHARMACOL BULL, V20, P160; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Wechsler D., 1967, WECHSLER PRESCHOOL P; Wechsler D., 1991, WECHSLER INTELLIGENC; WEISS RE, 1994, J CLIN ENDOCR METAB, V78, P1525, DOI 10.1210/jc.78.6.1525; WEISS RE, 1993, J PEDIATR-US, V123, P539, DOI 10.1016/S0022-3476(05)80947-3; ZAMETKIN AJ, 1987, J AM ACAD CHILD PSY, V26, P676, DOI 10.1097/00004583-198709000-00011; 1994, DIAGNOSTIC STATISTIC	36	797	818	3	72	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					993	998					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	QP663	WOS:A1995QP66300021	7717410				2022-01-24	
J	Halushka, MK; Fan, JB; Bentley, K; Hsie, L; Shen, NP; Weder, A; Cooper, R; Lipshutz, R; Chakravarti, A				Halushka, MK; Fan, JB; Bentley, K; Hsie, L; Shen, NP; Weder, A; Cooper, R; Lipshutz, R; Chakravarti, A			Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis	NATURE GENETICS			English	Article							HUMAN-GENOME; ESSENTIAL-HYPERTENSION; LINKAGE; RECOMBINATION; DIVERSITY; GENETICS; DISEASES; CLUSTER; GLOBIN; ARRAYS	Sequence variation in human genes is largely confined to single-nucleotide polymorphisms (SNPs) and is valuable in tests of association with common diseases and pharmacogenetic traits. We performed a systematic and comprehensive survey of molecular variation to assess the nature, pattern and frequency of SNPs in 75 candidate human genes for blood-pressure homeostasis and hypertension. We assayed 28 Mb(190 kb in 148 alleles) of genomic sequence, comprising the 5' and 3' untranslated regions (UTRs), introns and coding sequence of these genes, for sequence differences in individuals of African and Northern European descent using high-density variant detection arrays (VDAs). We identified 874 candidate human SNPs, of which 22% were confirmed by DNA sequencing to reveal a discordancy rate of 21% for VDA detection. The SNPs detected have an average minor allele frequency of 11%, and 387 are within the coding sequence (cSNPs). Of all cSNPs, 54% lead to a predicted change in the protein sequence, implying a high level of human protein diversity. These protein-altering SNPs are 38% of the total number of such SNPs expected, are more likely to be population-specific and are rarer in the human population, directly demonstrating the effects of natural selection on human genes. Overall, the degree of nucleotide polymorphism across these human genes, and orthologous great ape sequences, is highly variable and is correlated with the effects of functional conservation on gene sequences.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Affymetrix Inc, Santa Clara, CA 95051 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Loyola Univ, Med Ctr, Dept Epidemiol, Maywood, IL 60153 USA		Chakravarti, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.			Halushka, Marc/0000-0002-7112-7389	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U10HL054466] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG001847] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG01847] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U10 HL54466] Funding Source: Medline		Angrist M, 1998, GENOMICS, V48, P354, DOI 10.1006/geno.1997.5191; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Gerhold D, 1996, BIOESSAYS, V18, P973, DOI 10.1002/bies.950181207; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hacia JG, 1998, NAT GENET, V18, P155, DOI 10.1038/ng0298-155; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; Housman D, 1998, NAT BIOTECHNOL, V16, P492, DOI 10.1038/nbt0698-492; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JORDE LB, 1994, AM J HUM GENET, V54, P884; Kaplan N, 1994, CLIN HYPERTENSION; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; KURTZ TW, 1993, AM J MED, V94, P77, DOI 10.1016/0002-9343(93)90124-8; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Li W.H., 1997, MOL EVOLUTION; LI WH, 1991, GENETICS, V129, P513; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; MOCKRIN SC, 1996, MOL GENETICS GENE TH; Nachman MW, 1998, GENETICS, V150, P1133; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SMITHIES O, 1995, P NATL ACAD SCI USA, V92, P5266, DOI 10.1073/pnas.92.12.5266; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WARD R, 1990, HYPERTENSION PATHOPH, P81; Wolfsberg TG, 1997, NUCLEIC ACIDS RES, V25, P1626, DOI 10.1093/nar/25.8.1626	44	796	860	2	68	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1999	22	3					239	247		10.1038/10297			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	210VT	WOS:000081125900015	10391210				2022-01-24	
J	Wolf, FA; Angerer, P; Theis, FJ				Wolf, F. Alexander; Angerer, Philipp; Theis, Fabian J.			SCANPY: large-scale single-cell gene expression data analysis	GENOME BIOLOGY			English	Article						Single-cell transcriptomics; Machine learning; Scalability; Graph analysis; Clustering; Pseudotemporal ordering; Trajectory inference; Differential expression testing; Visualization; Bioinformatics	HETEROGENEITY; RECONSTRUCTION; VISUALIZATION	SCANPY is a scalable toolkit for analyzing single-cell gene expression data. It includes methods for preprocessing, visualization, clustering, pseudotime and trajectory inference, differential expression testing, and simulation of gene regulatory networks. Its Python-based implementation efficiently deals with data sets of more than one million cells (https://github.com/theislab/Scanpy). Along with SCANPY, we present ANNDATA, a generic class for handling annotated data matrices (https://github.com/theislab/anndata).	[Wolf, F. Alexander; Angerer, Philipp; Theis, Fabian J.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Munich, Germany		Wolf, FA; Theis, FJ (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Munich, Germany.; Theis, FJ (corresponding author), Tech Univ Munich, Dept Math, Munich, Germany.	alex.wolf@helmholtz-muenchen.de; fabian.theis@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021; Angerer, Philipp/L-5236-2019	Theis, Fabian J/0000-0002-2419-1943; Angerer, Philipp/0000-0002-0369-2888; Wolf, F. Alexander/0000-0002-8760-7838	Helmholtz Postdoc Programme, Initiative and Networking Fund of the Helmholtz Association; German Research Foundation (DFG) within the Collaborative Research CentreGerman Research Foundation (DFG) [1243]	FAW acknowledges the support of the Helmholtz Postdoc Programme, Initiative and Networking Fund of the Helmholtz Association. FJT acknowledges support from the German Research Foundation (DFG) within the Collaborative Research Centre 1243, Subproject A17.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Angerer Philipp, 2017, Current Opinion in Systems Biology, V4, P85, DOI 10.1016/j.coisb.2017.07.004; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Bastian M., 2009, P INT AAAI C WEB SOC, V3; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Buettner F, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1334-8; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Chen Z., 2015, TENSORFLOW LARGE SCA; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Collette A., 2013, PYTHON AND HDF5; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; de Matthews AG G, 2017, J MACH LEARN RES, V18, P1; DeTomaso D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1176-5; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Eulenberg P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00623-3; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Giecold G, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw452; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lippert C, 2014, LIMIX GENETIC ANAL M; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lun ATL, 2017, BIORXIV; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Matthews AGD, 2017, J MACH LEARN RES, V18, P1; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Millman J, 2010, P 9 PYTHON SCI C, P56; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perktold J, 2010, 9 PYTH SCI C; Peterson P., 2001, SCIPY OPEN SOURCE SC; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Regev A, 2017, SCI FORUM, V6; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shekhar K, 2013, AUTOMATIC CLASSIFICA, P202; Svensson V, 2017, NAT METHODS, V14, P381, DOI 10.1038/nmeth.4220; Traag V, 2017, GITHUB; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Ulyanov D., 2016, MULTICORE TSNE; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Waskom M, 2016, SEABORN; Weinreb C, 2017, BIORXIV; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	52	795	799	22	54	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	FEB 6	2018	19								15	10.1186/s13059-017-1382-0			5	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	FV1SZ	WOS:000424346300002	29409532	Green Published, gold, Green Submitted	Y	N	2022-01-24	
J	Hulsen, T; de Vlieg, J; Alkema, W				Hulsen, Tim; de Vlieg, Jacob; Alkema, Wynand			BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams	BMC GENOMICS			English	Article							COG DATABASE; TOOL	Background: In many genomics projects, numerous lists containing biological identifiers are produced. Often it is useful to see the overlap between different lists, enabling researchers to quickly observe similarities and differences between the data sets they are analyzing. One of the most popular methods to visualize the overlap and differences between data sets is the Venn diagram: a diagram consisting of two or more circles in which each circle corresponds to a data set, and the overlap between the circles corresponds to the overlap between the data sets. Venn diagrams are especially useful when they are 'area-proportional' i.e. the sizes of the circles and the overlaps correspond to the sizes of the data sets. Currently there are no programs available that can create area-proportional Venn diagrams connected to a wide range of biological databases. Results: We designed a web application named BioVenn to summarize the overlap between two or three lists of identifiers, using area-proportional Venn diagrams. The user only needs to input these lists of identifiers in the textboxes and push the submit button. Parameters like colors and text size can be adjusted easily through the web interface. The position of the text can be adjusted by 'drag-and-drop' principle. The output Venn diagram can be shown as an SVG or PNG image embedded in the web application, or as a standalone SVG or PNG image. The latter option is useful for batch queries. Besides the Venn diagram, BioVenn outputs lists of identifiers for each of the resulting subsets. If an identifier is recognized as belonging to one of the supported biological databases, the output is linked to that database. Finally, BioVenn can map Affymetrix and EntrezGene identifiers to Ensembl genes. Conclusion: BioVenn is an easy-to-use web application to generate area-proportional Venn diagrams from lists of biological identifiers. It supports a wide range of identifiers from the most used biological databases currently available. Its implementation on the World Wide Web makes it available for use on any computer with internet connection, independent of operating system and without the need to install programs locally. BioVenn is freely accessible at http://www.cmbi.ru.nl/cdd/biovenn/.	[Hulsen, Tim; de Vlieg, Jacob] Radboud Univ Nijmegen, Med Ctr, NCMLS, CMBI,CDD, NL-6500 HB Nijmegen, Netherlands; [de Vlieg, Jacob; Alkema, Wynand] Schering Plough Corp, Mol Design & Informat, NL-5340 BH Oss, Netherlands		Hulsen, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, NCMLS, CMBI,CDD, POB 9101, NL-6500 HB Nijmegen, Netherlands.	T.Hulsen@cmbi.ru.nl; J.deVlieg@cmbi.ru.nl; wynand.alkema@spcorp.com	Alkema, Wynand/G-5826-2018; Hulsen, Tim/G-9990-2011	Alkema, Wynand/0000-0002-5523-9217; Hulsen, Tim/0000-0002-0208-8443	Netherlands Bioinformatics Centre (NBIC) [SP3.2.2]	This work was part of BioRange project SP3.2.2 of the Netherlands Bioinformatics Centre (NBIC).	Alexandersson Erik, 2007, P186, DOI 10.1007/978-3-540-72617-3_13; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chow S, 2004, LECT NOTES COMPUT SC, V2912, P466; CHOW S, 2005, EUL DIAGR WORKSH; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; *GOOGL, GOOGL CHART API; Hulsen T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-398; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kestler HA, 2005, BIOINFORMATICS, V21, P1592, DOI 10.1093/bioinformatics/bti169; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; *MATHWORLD WOLFR W, CIRCL CIRCLE INT; *MATHWORLD WOLFR W, VENN DIAGR; Nitterus K, 2007, SCAND J FOREST RES, V22, P231, DOI 10.1080/02827580701352955; Nordstrom A, 2008, ANAL CHEM, V80, P421, DOI 10.1021/ac701982e; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Venn JI., 1880, PHILOS MAG, V10, P1; Yap G, 2002, PHARMACOGENOMICS, V3, P709, DOI 10.1517/14622416.3.5.709; VENNY INTERACTIVE TO; DRAWVENN	24	795	798	1	24	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	OCT 16	2008	9								488	10.1186/1471-2164-9-488			6	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	376FN	WOS:000261169600001	18925949	gold, Green Published			2022-01-24	
J	RISCH, N				RISCH, N			LINKAGE STRATEGIES FOR GENETICALLY COMPLEX TRAITS .2. THE POWER OF AFFECTED RELATIVE PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510		RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM39812] Funding Source: Medline		BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; CLAUS EB, IN PRESS AM J EPIDEM; CLAUS EB, UNPUB AUTOSOMAL DOMI; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KAPLAN EB, 1972, I STATISTICS MIMEO, V823; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; PAYAMI H, 1988, ANN HUM GENET, V49, P303; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; SCHWARTZ AG, 1985, JNCI-J NATL CANCER I, V75, P665; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; WAGENER DK, 1982, DIABETES, V31, P225; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; [No title captured]	21	795	802	1	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					229	241					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	WOS:A1990CM93800003	2301393				2022-01-24	
J	O'Roak, BJ; Deriziotis, P; Lee, C; Vives, L; Schwartz, JJ; Girirajan, S; Karakoc, E; MacKenzie, AP; Ng, SB; Baker, C; Rieder, MJ; Nickerson, DA; Bernier, R; Fisher, SE; Shendure, J; Eichler, EE				O'Roak, Brian J.; Deriziotis, Pelagia; Lee, Choli; Vives, Laura; Schwartz, Jerrod J.; Girirajan, Santhosh; Karakoc, Emre; MacKenzie, Alexandra P.; Ng, Sarah B.; Baker, Carl; Rieder, Mark J.; Nickerson, Deborah A.; Bernier, Raphael; Fisher, Simon E.; Shendure, Jay; Eichler, Evan E.			Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations	NATURE GENETICS			English	Article							HUMAN-GENOME; RECURRENT MICRODELETIONS; SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; LANGUAGE DISORDER; GENE; SPEECH; SCN1A; FOXP1; RISK	Evidence for the etiology of autism spectrum disorders (ASDs) has consistently pointed to a strong genetic component complicated by substantial locus heterogeneity(1,2). We sequenced the exomes of 20 individuals with sporadic ASD (cases) and their parents, reasoning that these families would be enriched for de novo mutations of major effect. We identified 21 de novo mutations, 11 of which were protein altering. Protein-altering mutations were significantly enriched for changes at highly conserved residues. We identified potentially causative de novo events in 4 out of 20 probands, particularly among more severely affected individuals, in FOXP1, GRIN2B, SCN1A and LAMC3. In the FOXP1 mutation carrier, we also observed a rare inherited CNTNAP2 missense variant, and we provide functional support for a multi-hit model for disease risk(3). Our results show that trio-based exome sequencing is a powerful approach for identifying new candidate genes for ASDs and suggest that de novo mutations may contribute substantially to the genetic etiology of ASDs.	[O'Roak, Brian J.; Lee, Choli; Vives, Laura; Schwartz, Jerrod J.; Girirajan, Santhosh; Karakoc, Emre; MacKenzie, Alexandra P.; Ng, Sarah B.; Baker, Carl; Rieder, Mark J.; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Deriziotis, Pelagia; Fisher, Simon E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Eichler, Evan E.] Howard Hughes Med Inst, Washington, DC USA		Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; eee@gs.washington.edu	Derizioti, Pelagia/C-3857-2015; Shendure, Jay/AAU-3684-2021; Fisher, Simon E./E-9130-2012	Derizioti, Pelagia/0000-0001-5544-8345; Fisher, Simon E./0000-0002-3132-1996; O'Roak, Brian/0000-0002-4141-0095; Derizioti, Pelagia/0000-0001-5004-6865; Shendure, Jay/0000-0002-1516-1865	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD065285]; Wellcome TrustWellcome TrustEuropean Commission [075491/Z/04]; Max Planck SocietyMax Planck SocietyFoundation CELLEX; Simons Foundation Autism Research Initiative (SFARI) [191889, 137578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [RC2HL102926, RC2HL102924, UC2HL102924, R01HL094976, UC2HL102926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [RC2HG005608] Funding Source: NIH RePORTER	We would like to thank and recognize the following ongoing studies that produced and provided exome variant calls for comparison: National Heart, Lung, and Blood Institute (NHBLI) Lung Cohort Sequencing Project (HL 1029230), NHLBI Women's Health Initiative (WHI) Sequencing Project (HL 102924), National Institute of Environmental Health Sciences (NIEHS) SNPs (HHSN273200800010C), NHLBI/National Human Genome Research Institute (NHGRI) SeattleSeq (HL 094976), NHGRI Next Generation Mendelian Genetics (HG 005608) and the Northwest Genomics Center (HL 102926). We also thank M.-C. King and S. Stray for processing and managing DNA samples, B. H. King and E. Bliss for their work in subject recruitment and phenotype collection, E. Turner, C. Igartua, I. Stanaway, M. Dennis and B. Coe for thoughtful discussions, M. State for providing SNP genotyping data and especially the families that volunteered their time to participate in this research. This work was supported by US National Institutes of Health grant HD065285 (E. E. E. and J.S.), Wellcome Trust core award 075491/Z/04 (S. E. F. and P. D.), the Max Planck Society (S. E. F.) and grants from the Simons Foundation Autism Research Initiative (SFARI) (191889 and 137578) (E. E. E., R. B., S. E. F. and P. D.). E. E. E. is an Investigator of the Howard Hughes Medical Institute.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Hurley RSE, 2007, J AUTISM DEV DISORD, V37, P1679, DOI 10.1007/s10803-006-0299-3; Igartua C, 2010, CURR PROTOC HUM GENE, V18; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241	52	794	810	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					585	U125		10.1038/ng.835			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	WOS:000291017000018	21572417	Green Accepted	Y	N	2022-01-24	
J	Allen, NC; Bagade, S; McQueen, MB; Ioannidis, JPA; Kavvoura, FK; Khoury, MJ; Tanzi, RE; Bertram, L				Allen, Nicole C.; Bagade, Sachin; McQueen, Matthew B.; Ioannidis, John P. A.; Kavvoura, Fotini K.; Khoury, Muin J.; Tanzi, Rudolph E.; Bertram, Lars			Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database	NATURE GENETICS			English	Article							PUBLISHED RESEARCH; BIPOLAR DISORDER; COMMON MUTATION; RISK-FACTOR; SUSCEPTIBILITY; COMPLEX; POLYMORPHISMS; HETEROGENEITY; CANDIDATE; VALIDITY	In an effort to pinpoint potential genetic risk factors for schizophrenia, research groups worldwide have published over 1,000 genetic association studies with largely inconsistent results. To facilitate the interpretation of these findings, we have created a regularly updated online database of all published genetic association studies for schizophrenia ('SzGene'). For all polymorphisms having genotype data available in at least four independent case-control samples, we systematically carried out random-effects meta-analyses using allelic contrasts. Across 118 meta-analyses, a total of 24 genetic variants in 16 different genes (APOE, COMT, DAO, DRD1, DRD2, DRD4, DTNBP1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SLC6A4, TP53 and TPH1) showed nominally significant effects with average summary odds ratios of similar to 1.23. Seven of these variants had not been previously meta-analyzed. According to recently proposed criteria for the assessment of cumulative evidence in genetic association studies, four of the significant results can be characterized as showing 'strong' epidemiological credibility. Our project represents the first comprehensive online resource for systematically synthesized and graded evidence of genetic association studies in schizophrenia. As such, it could serve as a model for field synopses of genetic associations in other common and genetically complex disorders.	[Allen, Nicole C.; Bagade, Sachin; Tanzi, Rudolph E.; Bertram, Lars] Massachusetts Gen Hosp, MIND, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [McQueen, Matthew B.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Ioannidis, John P. A.; Kavvoura, Fotini K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Inst Biomed Res, Ioannina 45110, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02110 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Gen, Atlanta, GA 30341 USA		Bertram, L (corresponding author), Massachusetts Gen Hosp, MIND, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA.	bertram@helix.mgh.harvard.edu	Ioannidis, John P. A./G-9836-2011; Bertram, Lars/K-3889-2015; Tanzi, Rudolph/AAE-9622-2019; McQueen, Matthew/X-5845-2019	Bertram, Lars/0000-0002-0108-124X; Tanzi, Rudolph/0000-0002-7032-1454; 	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD060726] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD060726] Funding Source: NIH RePORTER		Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Fujii T, 2007, PROG NEURO-PSYCHOPH, V31, P873, DOI 10.1016/j.pnpbp.2007.01.027; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li DW, 2007, GENET MED, V9, P4, DOI 10.1097/01.gim.0000250507.96760.4b; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mah S, 2006, MOL PSYCHIATR, V11, P471, DOI 10.1038/sj.mp.4001785; MCGORRY PD, 1995, AM J PSYCHIAT, V152, P220; Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Roffman JL, 2008, BIOL PSYCHIAT, V63, P42, DOI 10.1016/j.biopsych.2006.12.017; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tauscher J, 2004, AM J PSYCHIAT, V161, P1620, DOI 10.1176/appi.ajp.161.9.1620; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams NM, 2005, SCHIZOPHRENIA BULL, V31, P800, DOI 10.1093/schbul/sbi061	39	794	828	4	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					827	834		10.1038/ng.171			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	WOS:000257166500015	18583979				2022-01-24	
J	Musaro, A; McCullagh, K; Paul, A; Houghton, L; Dobrowolny, G; Molinaro, M; Barton, ER; Sweeney, HL; Rosenthal, N				Musaro, A; McCullagh, K; Paul, A; Houghton, L; Dobrowolny, G; Molinaro, M; Barton, ER; Sweeney, HL; Rosenthal, N			Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle	NATURE GENETICS			English	Article							GROWTH-FACTOR-I; DEPENDENT TRANSCRIPTIONAL PATHWAY; CARDIAC-HYPERTROPHY; MICE; DIFFERENTIATION; CALCINEURIN; PROLIFERATION; MYOGENESIS; GENES	Aging skeletal muscles suffer a steady decline in mass and functional performance, and compromised muscle integrity as fibrotic invasions replace contractile tissue, accompanied by a characteristic loss in the fastest, most powerful muscle fibers(1,2). The same programmed deficits in muscle structure and function are found in numerous neurodegenerative syndromes and disease-related cachexia(3). We have generated a model of persistent, functional myocyte hypertrophy using a tissue-restricted transgene encoding a locally acting isoform of insulin-like growth factor-1 that is expressed in skeletal muscle (mlgf-1), Transgenic embryos developed normally, and postnatal increases in muscle mass and strength were not accompanied by the additional pathological changes seen in other Igf-l transgenic models. Expression of CATA-2, a transcription factor normally undetected in skeletal muscle, marked hypertrophic myocytes that escaped age-related muscle atrophy and retained the proliferative response to muscle injury characteristic: of younger animals. The preservation of muscle architecture and age-independent regenerative capacity through localized mlgf-1 transgene expression suggests clinical strategies for the treatment of age or disease-related muscle frailty.	Massachusetts Gen Hosp E, Cardiovasc Res Ctr, Charlestown, MA USA; Univ Rome La Sapienza, Dept Histol & Med Embryol, Rome, Italy; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA		Rosenthal, N (corresponding author), Massachusetts Gen Hosp E, Cardiovasc Res Ctr, Charlestown, MA USA.		Musaro, Antonio/P-2953-2019; Sweeney, H Lee/F-1862-2010; Musaro, Antonio/K-9598-2016	Musaro, Antonio/0000-0002-2944-9739; Musaro, Antonio/0000-0002-2944-9739; Rosenthal, Nadia/0000-0002-7599-7365; Dobrowolny, Gabriella/0000-0001-8693-0724			Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; ADAMO ML, 1993, ADV EXP MED BIOL, V343, P1; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bigard X, 2000, J BIOL CHEM, V275, P19653, DOI 10.1074/jbc.M000430200; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/er.17.5.481; GRIESHAMMER U, 1992, CELL, V69, P79, DOI 10.1016/0092-8674(92)90120-2; LEROITH D, 1991, MOL CELL ENDOCRINOL, V77, pC57, DOI 10.1016/0303-7207(91)90054-V; Lescaudron L, 1997, J MUSCLE RES CELL M, V18, P631, DOI 10.1023/A:1018679722112; Lim HW, 2000, J MOL CELL CARDIOL, V32, P697, DOI 10.1006/jmcc.2000.1113; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MUSARO A, 1995, EXP CELL RES, V221, P241, DOI 10.1006/excr.1995.1372; Musaro A, 1999, MOL CELL BIOL, V19, P3115; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Nelson KA, 2000, SEMIN ONCOL, V27, P64; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; ROSENTHAL SM, 1995, P NATL ACAD SCI USA, V92, P10307, DOI 10.1073/pnas.92.22.10307; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005	29	793	820	2	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					195	200		10.1038/84839			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	WOS:000166839200022	11175789				2022-01-24	
J	Gerlinger, M; Horswell, S; Larkin, J; Rowan, AJ; Salm, MP; Varela, I; Fisher, R; McGranahan, N; Matthews, N; Santos, CR; Martinez, P; Phillimore, B; Begum, S; Rabinowitz, A; Spencer-Dene, B; Gulati, S; Bates, PA; Stamp, G; Pickering, L; Gore, M; Nicol, DL; Hazell, S; Futreal, PA; Stewart, A; Swanton, C				Gerlinger, Marco; Horswell, Stuart; Larkin, James; Rowan, Andrew J.; Salm, Max P.; Varela, Ignacio; Fisher, Rosalie; McGranahan, Nicholas; Matthews, Nicholas; Santos, Claudio R.; Martinez, Pierre; Phillimore, Benjamin; Begum, Sharmin; Rabinowitz, Adam; Spencer-Dene, Bradley; Gulati, Sakshi; Bates, Paul A.; Stamp, Gordon; Pickering, Lisa; Gore, Martin; Nicol, David L.; Hazell, Steven; Futreal, P. Andrew; Stewart, Aengus; Swanton, Charles			Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; INTRATUMOR HETEROGENEITY; SOMATIC MUTATIONS; CANCER; PATTERNS; DIVERSITY; DELETIONS; PBRM1	Clear cell renal carcinomas (ccRCCs) can display intratumor heterogeneity (ITH). We applied multiregion exome sequencing (M-seq) to resolve the genetic architecture and evolutionary histories of ten ccRCCs. Ultra-deep sequencing identified ITH in all cases. We found that 73-75% of identified ccRCC driver aberrations were subclonal, confounding estimates of driver mutation prevalence. ITH increased with the number of biopsies analyzed, without evidence of saturation in most tumors. Chromosome 3p loss and VHL aberrations were the only ubiquitous events. The proportion of C>T transitions at CpG sites increased during tumor progression. M-seq permits the temporal resolution of ccRCC evolution and refines mutational signatures occurring during tumor development.	[Gerlinger, Marco; Rowan, Andrew J.; McGranahan, Nicholas; Santos, Claudio R.; Martinez, Pierre; Swanton, Charles] Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London WC2A 3PX, England; [Horswell, Stuart; Salm, Max P.; Spencer-Dene, Bradley; Gulati, Sakshi; Bates, Paul A.; Stamp, Gordon; Stewart, Aengus] Canc Res UK London Res Inst, London WC2A 3PX, England; [Larkin, James; Fisher, Rosalie; Pickering, Lisa; Gore, Martin] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England; [Varela, Ignacio] Univ Cantabria, Dept Biol Mol, CSIC UC Sodercan, Inst Biomed & Biotecnol Cantabria, E-39005 Santander, Spain; [Matthews, Nicholas; Phillimore, Benjamin; Begum, Sharmin; Rabinowitz, Adam] Canc Res UK London Res Inst, Adv Sequencing Facil, London WC2A 3PX, England; [Nicol, David L.] Royal Marsden Hosp, Dept Urol, London SW3 6JJ, England; [Hazell, Steven] Royal Marsden Hosp, Dept Pathol, London SW3 6JJ, England; [Futreal, P. Andrew] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Swanton, Charles] UCL, Inst Canc, London, England		Swanton, C (corresponding author), Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London WC2A 3PX, England.	charles.swanton@cancer.org.uk	Nicol, David L/M-6809-2016; Varela, Ignacio/G-1699-2016; McGranahan, Nicholas/ABD-6561-2021; Bates, Paul A/AAF-8561-2020; Varela, Ignacio/AAA-7680-2021; wang, edwin/G-5372-2010	Nicol, David L/0000-0002-5623-7467; Varela, Ignacio/0000-0002-0969-506X; McGranahan, Nicholas/0000-0001-9537-4045; Bates, Paul A/0000-0003-0621-0925; Varela, Ignacio/0000-0002-0969-506X; Martinez, Pierre/0000-0001-7069-4413; Santos, Claudio/0000-0002-8766-2247; Swanton, Charles/0000-0002-4299-3018; Horswell, Stuart/0000-0003-2787-1933; Salm, Max/0000-0002-5742-3376; Larkin, James/0000-0001-5569-9523; Gerlinger, Marco/0000-0003-2719-299X; Nicol, David/0000-0003-0107-6990	Cancer Research UK Biomarkers and Imaging Discovery and Development Committee (BIDD); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Seventh European Union Framework Programme; Breast Cancer Research Foundation; Rosetrees TrustRosetrees Trust; Ramon y Cajal program of the Ministerio de Economia y Competitividad, Spain; NovartisNovartis; National Institute for Health Research Biomedical Research Centres at University College London Hospitals; Royal Marsden HospitalRoyal Society of New ZealandMarsden Fund (NZ); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0902275] Funding Source: UKRI; Cancer Research UKCancer Research UK [10748] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0902275] Funding Source: researchfish	We thank the patients, the research nurses at the Royal Marsden Hospital, and Lifetech and Westminster Genomic Services at the University of Westminster, London, for their assistance with validation. C.S. and M. Gerlinger are supported by grants from Cancer Research UK Biomarkers and Imaging Discovery and Development Committee (BIDD), the Medical Research Council and the Seventh European Union Framework Programme, and C.S. is supported by the Breast Cancer Research Foundation and the Rosetrees Trust. We acknowledge the Ramon y Cajal program of the Ministerio de Economia y Competitividad, Spain, and Novartis for funding support for E-PREDICT clinical trials. This study was supported by researchers at the National Institute for Health Research Biomedical Research Centres at University College London Hospitals and at the Royal Marsden Hospital.	Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Purdom PW, 2000, BIOINFORMATICS, V16, P140, DOI 10.1093/bioinformatics/16.2.140; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	43	792	806	2	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					225	+		10.1038/ng.2891			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	WOS:000332036700006	24487277	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Ramirez, A; Heimbach, A; Gruendemann, J; Stiller, B; Hampshire, D; Cid, LP; Goebel, I; Mubaidin, AF; Wriekat, AL; Roeper, J; Al-Din, A; Hillmer, AM; Karsak, M; Liss, B; Woods, CG; Behrens, MI; Kubisch, C				Ramirez, Alfredo; Heimbach, Andre; Gruendemann, Jan; Stiller, Barbara; Hampshire, Dan; Cid, L. Pablo; Goebel, Ingrid; Mubaidin, Ammar F.; Wriekat, Abdul-Latif; Roeper, Jochen; Al-Din, Amir; Hillmer, Axel M.; Karsak, Meliha; Liss, Birgit; Woods, C. Geoffrey; Behrens, Maria I.; Kubisch, Christian			Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase	NATURE GENETICS			English	Article							PALLIDO-PYRAMIDAL DEGENERATION; SUPRANUCLEAR UPGAZE PARESIS; ALPHA-SYNUCLEIN; DISEASE; DEGRADATION; GENE; ALZHEIMERS; UBIQUITIN; NEURONS; BIOLOGY	Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders(1). Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases(2). This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system(3-6). Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-on-set parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome(7,8)). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity(9) to the protein networks implicated in neurodegeneration and parkinsonism.	Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Marburg, Inst Physiol, D-35037 Marburg, Germany; Univ Leeds, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Ctr Estudios Cient, Valdivia 5099100, Chile; King Hussein Med Ctr, Dept Neurol, Amman 11947, Jordan; Pinderfields Gen Hosp, Dept Neurol, Wakefield WF1 4DG, England; Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; Univ Bonn, Life & Brain Ctr, Dept Mol Psychiat, D-53127 Bonn, Germany; Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Univ Chile, Dept Neurol & Neurosurg, Santiago 8207257, Chile		Kubisch, C (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	christian.kubisch@uk-koeln.de	Behrens, Maria I I/I-1083-2013; Ramirez, Alfredo/S-5126-2019; Hillmer, Axel M/B-7485-2015; woods, christopher g/A-1361-2010; Kubisch, Christian/F-1893-2011; Hillmer, Axel M/N-2927-2014	Behrens, Maria I I/0000-0003-0964-426X; Ramirez, Alfredo/0000-0003-4991-763X; Hillmer, Axel M/0000-0002-3381-7266; Kubisch, Christian/0000-0003-4220-0978; Hillmer, Axel M/0000-0002-3381-7266; liss, Birgit/0000-0002-6733-9207; Grundemann, Jan/0000-0002-3149-0001; Roeper, Jochen/0000-0003-2145-8742	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Hampshire DJ, 2001, J MED GENET, V38, P680, DOI 10.1136/jmg.38.10.680; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Liss B, 1999, J NEUROSCI, V19, P8839, DOI 10.1523/JNEUROSCI.19-20-08839.1999; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511	30	792	823	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1184	1191		10.1038/ng1884			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	WOS:000241251100019	16964263				2022-01-24	
J	Manning, K; Tor, M; Poole, M; Hong, Y; Thompson, AJ; King, GJ; Giovannoni, JJ; Seymour, GB				Manning, Kenneth; Tor, Mahmut; Poole, Mervin; Hong, Yiguo; Thompson, Andrew J.; King, Graham J.; Giovannoni, James J.; Seymour, Graham B.			A naturally occurring epigenetic mutation in a gene encoding an SBP-box transcription factor inhibits tomato fruit ripening	NATURE GENETICS			English	Article							DNA METHYLATION; ARABIDOPSIS; CNR; INHERITANCE	A major component in the regulatory network controlling fruit ripening is likely to be the gene at the tomato Colorless nonripening (Cnr) locus(1,2). The Cnr mutation results in colorless fruits with a substantial loss of cell-to-cell adhesion. The nature of the mutation and the identity of the Cnr gene were previously unknown. Using positional cloning and virus-induced gene silencing, here we demonstrate that an SBP-box (SQUAMOSA promoter binding protein-like) gene resides at the Cnr locus. Furthermore, the Cnr phenotype results from a spontaneous epigenetic change in the SBP-box promoter. The discovery that Cnr is an epimutation was unexpected, as very few spontaneous epimutations have been described in plants(3,4). This study demonstrates that an SBP-box gene is critical for normal ripening and highlights the likely importance of epialleles in plant development and the generation of natural variation.	Univ Nottingham, Sch Biosci, Plant Sci Div, Loughborough LE12 5RD, Leics, England; Univ Warwick, Warwick Hort Res Int, Warwick CV35 9EF, England; Rothamsted Res, Harpenden AL5 2JQ, Herts, England; Cornell Univ, Boyce Thompson Inst Plant Sci Res, Ithaca, NY 14853 USA; USDA ARS, Ithaca, NY 14853 USA		Seymour, GB (corresponding author), Univ Nottingham, Sch Biosci, Plant Sci Div, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	Graham.Seymour@nottingham.ac.uk	Tor, Mahmut/AAU-4624-2020; Thompson, Andrew/AAF-3017-2020; Poole, Mervin C/A-5639-2009; Seymour, Graham B/N-4539-2014; Hong, Yiguo/AAI-2303-2020; tor, mahmut/C-1132-2009; Tor, Mahmut/AAF-6449-2020; King, Graham J/AAW-3368-2020	Thompson, Andrew/0000-0002-7419-3402; Poole, Mervin C/0000-0001-8624-5022; Tor, Mahmut/0000-0002-4416-5048; King, Graham J/0000-0002-5975-6051; Seymour, Graham/0000-0001-8365-4947	Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [D20300, D20300/2] Funding Source: Medline		Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Fraser PD, 2001, PHYTOCHEMISTRY, V58, P75, DOI 10.1016/S0031-9422(01)00175-3; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Orfila C, 2002, PLANTA, V215, P440, DOI 10.1007/s00425-002-0753-1; Orfila C, 2001, PLANT PHYSIOL, V126, P210, DOI 10.1104/pp.126.1.210; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; TANKSLEY SD, 1992, GENETICS, V132, P1141; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Tor M, 2002, THEOR APPL GENET, V104, P165, DOI 10.1007/s001220100760; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; van Wezel R, 2001, MOL PLANT MICROBE IN, V14, P1125, DOI 10.1094/MPMI.2001.14.9.1125; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Zhang Z, 2000, GENE, V253, P145, DOI 10.1016/S0378-1119(00)00289-4; Zou NX, 2003, BIOTECHNIQUES, V35, P758, DOI 10.2144/03354st06	30	792	874	16	219	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					948	952		10.1038/ng1841			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	WOS:000239325700027	16832354				2022-01-24	
J	Suzuki, A; Yamada, R; Chang, XT; Tokuhiro, S; Sawada, T; Suzuki, M; Nagasaki, M; Nakayama-Hamada, M; Kawaida, R; Ono, M; Ohtsuki, M; Furukawa, H; Yoshino, S; Yukioka, M; Tohma, S; Matsubara, T; Wakitani, S; Teshima, R; Nishioka, Y; Sekine, A; Iida, A; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K				Suzuki, A; Yamada, R; Chang, XT; Tokuhiro, S; Sawada, T; Suzuki, M; Nagasaki, M; Nakayama-Hamada, M; Kawaida, R; Ono, M; Ohtsuki, M; Furukawa, H; Yoshino, S; Yukioka, M; Tohma, S; Matsubara, T; Wakitani, S; Teshima, R; Nishioka, Y; Sekine, A; Iida, A; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K			Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis	NATURE GENETICS			English	Article							SHARED EPITOPE HYPOTHESIS; ANTIFILAGGRIN AUTOANTIBODIES; IMMUNOBLOTTING DETECTION; ANTIKERATIN ANTIBODIES; MESSENGER-RNA; SUSCEPTIBILITY; LINKAGE; POLYMORPHISMS; DIAGNOSIS; FILAGGRIN	Individuals with rheumatoid arthritis frequently have autoantibodies to citrullinated peptides, suggesting the involvement of the peptidylarginine deiminases citrullinating enzymes (encoded by PADI genes) in rheumatoid arthritis. Previous linkage studies have shown that a susceptibility locus for rheumatoid arthritis includes four PADI genes but did not establish which PADI gene confers susceptibility to rheumatoid arthritis. We used a case-control linkage disequilibrium study to show that PADI type 4 is a susceptibility locus for rheumatoid arthritis (P = 0.000008). PADI4 was expressed in hematological and rheumatoid arthritis synovial tissues. We also identified a haplotype of PADI4 associated with susceptibility to rheumatoid arthritis that affected stability of transcripts and was associated with levels of antibody to citrullinated peptide in sera from individuals with rheumatoid arthritis. Our results imply that the PADI4 haplotype associated with susceptibility to rheumatoid arthritis increases production of citrullinated peptides acting as autoantigens, resulting in heightened risk of developing the disease.	Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Sankyo Co Ltd, Tokyo 140, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Nippon Med Coll, Dept Joint Dis & Rheumatism, Tokyo 113, Japan; Yukioka Hosp, Osaka, Japan; Natl Sagamihara Hosp, Kanagawa, Japan; Matsubara Mayflower Hosp, Hyogo, Japan; Osaka Minami Natl Hosp, Osaka, Japan; Tottori Univ, Dept Orthoped Surg, Tottori 680, Japan; Yamanashi Prefectural Cent Hosp, Yamanashi, Japan; Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Kanagawa, Japan; Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Kanagawa, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan		Yamada, R (corresponding author), Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis, Tsurumi Ku, 1-7-22 Suehirocho, Yokohama, Kanagawa 2300045, Japan.		Suzuki, Akari/N-5389-2015; Yamamoto, Kazuhiko/N-5096-2015; Tsunoda, Tatsuhiko/K-2061-2014; Peng, Bo/A-6920-2009	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Peng, Bo/0000-0001-8225-2284; Yamada, Ryo/0000-0002-1587-630X			ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; Baeten D, 2001, ARTHRITIS RHEUM, V44, P2255, DOI 10.1002/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Cuadrado A, 2002, NUCLEIC ACIDS RES, V30, P2202, DOI 10.1093/nar/30.10.2202; de Vries N, 2002, ARTHRITIS RHEUM-US, V46, P921, DOI 10.1002/art.10210; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; GOMESDAUDRIX V, 1994, ANN RHEUM DIS, V53, P735, DOI 10.1136/ard.53.11.735; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hirano T, 2002, NAT IMMUNOL, V3, P342, DOI 10.1038/ni0402-342; Jansen ALMA, 2002, J RHEUMATOL, V29, P2074; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Menard HA, 2000, ARTHRITIS RES, V2, P429, DOI 10.1186/ar122; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nepom GT, 1998, ADV IMMUNOL, V68, P315, DOI 10.1016/S0065-2776(08)60563-5; Nogueira L, 2001, ANN RHEUM DIS, V60, P882; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb01862.x; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Schildkraut Joellen M., 1998, P379; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; van Venrooij WJ, 2000, ARTHRITIS RES, V2, P249, DOI 10.1186/ar95; VINCENT C, 1989, ANN RHEUM DIS, V48, P712, DOI 10.1136/ard.48.9.712; Vincent C, 1998, J RHEUMATOL, V25, P838; Vincent C, 2002, ARTHRITIS RHEUM, V46, P2051, DOI 10.1002/art.10436; Weyand CM, 2000, ARTHRITIS RES, V2, P212, DOI 10.1186/ar90; Yang TY, 2003, J BIOL CHEM, V278, P15291, DOI 10.1074/jbc.M300954200; Zhou XD, 2002, ARTHRITIS RHEUM-US, V46, P2990, DOI 10.1002/art.10601; Zhou ZJ, 2002, CURR OPIN RHEUMATOL, V14, P250, DOI 10.1097/00002281-200205000-00010	40	792	861	1	30	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					395	402		10.1038/ng1206			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	WOS:000184470500017	12833157				2022-01-24	
J	Kohler, S; Bauer, S; Horn, D; Robinson, PN				Koehler, Sebastian; Bauer, Sebastian; Horn, Denise; Robinson, Peter N.			Walking the interactome for prioritization of candidate disease genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERACTION NETWORK; PROTEIN; MUTATIONS; DATABASE; SEQUENCE; IDENTIFICATION; INTEGRATION; PREDICTION; DISCOVERY; RESOURCE	The identification of genes associated with hereditary disorders has contributed to improving medical care and to a better understanding of gene functions, interactions, and pathways. However, there are well over 1500 Mendelian disorders whose molecular basis remains unknown. At present, methods such as linkage analysis can identify the chromosomal region in which unknown disease genes are located, but the regions could contain up to hundreds of candidate genes. In this work, we present a method for prioritization of candidate genes by use of a global network distance measure, random walk analysis, for definition of similarities in protein-protein interaction networks. We tested our method on 110 disease-gene families with a total of 783 genes and achieved an area under the ROC curve of up to 98% on simulated linkage intervals of 100 genes surrounding the disease gene, significantly outperforming previous methods based on local distance measures. Our results not only provide an improved tool for positional-cloning projects but also add weight to the assumption that phenotypically similar diseases are associated with disturbances of subnetworks within the larger protein interactome that extend beyond the disease proteins themselves.	[Koehler, Sebastian; Bauer, Sebastian; Horn, Denise; Robinson, Peter N.] Charite, Inst Med Genet, D-13353 Berlin, Germany		Robinson, PN (corresponding author), Charite, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.robinson@charite.de	Kohler, Sebastian/A-2029-2012; Kohler, Sebastian/H-3301-2019	Kohler, Sebastian/0000-0002-5316-1399; Kohler, Sebastian/0000-0002-5316-1399; Robinson, Peter/0000-0002-0736-9199			Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Can T, 2005, BIOKDD 05 P 5 INT WO, P61; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; George RA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl707; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kondor Risi Imre, 2002, P 19 INT C MACH LEAR, V19, P315; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pagel P, 2004, TRENDS GENET, V20, P72, DOI 10.1016/j.tig.2003.12.007; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2006, CURR OPIN CHEM BIOL, V10, P551, DOI 10.1016/j.cbpa.2006.10.005; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Turner FS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r75; van Driel MA, 2003, EUR J HUM GENET, V11, P57, DOI 10.1038/sj.ejhg.5200918; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825	44	791	804	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					949	958		10.1016/j.ajhg.2008.02.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	WOS:000255103900013	18371930	Green Published, Bronze			2022-01-24	
J	Ohm, JE; McGarvey, KM; Yu, X; Cheng, LZ; Schuebel, KE; Cope, L; Mohammad, HP; Chen, W; Daniel, VC; Yu, W; Berman, DM; Jenuwein, T; Pruitt, K; Sharkis, SJ; Watkins, DN; Herman, JG; Baylin, SB				Ohm, Joyce E.; McGarvey, Kelly M.; Yu, Xiaobing; Cheng, Linzhao; Schuebel, Kornel E.; Cope, Leslie; Mohammad, Helai P.; Chen, Wei; Daniel, Vincent C.; Yu, Wayne; Berman, David M.; Jenuwein, Thomas; Pruitt, Kevin; Sharkis, Saul J.; Watkins, D. Neil; Herman, James G.; Baylin, Stephen B.			A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing	NATURE GENETICS			English	Article							HISTONE H3 LYSINE-9; CANCER-CELLS; DEVELOPMENTAL REGULATORS; METHYLATION; POLYCOMB; EXPRESSION; PATHWAY; MARKS; FATE	Adult cancers may derive from stem or early progenitor cells(1,2). Epigenetic modulation of gene expression is essential for normal function of these early cells but is highly abnormal in cancers, which often show aberrant promoter CpG island hypermethylation and transcriptional silencing of tumor suppressor genes and pro-differentiation factors(3-5). We find that for such genes, both normal and malignant embryonic cells generally lack the hypermethylation of DNA found in adult cancers. In embryonic stem cells, these genes are held in a 'transcription- ready' state mediated by a 'bivalent' promoter chromatin pattern consisting of the repressive mark, histone H3 methylated at Lys27 ( H3K27) by Polycomb group proteins, plus the active mark, methylated H3K4. However, embryonic carcinoma cells add two key repressive marks, dimethylated H3K9 and trimethylated H3K9, both associated with DNA hypermethylation in adult cancers(6-8). We hypothesize that cell chromatin patterns and transient silencing of these important regulatory genes in stem or progenitor cells may leave these genes vulnerable to aberrant DNA hypermethylation and heritable gene silencing during tumor initiation and progression.	Johns Hopkins Univ, Inst Med, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Inst Cell Engn, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Biometry & Clin Trials Div, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Program Human Genet & Mol Biol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Dept Pathol, Baltimore, MD 21231 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria		Baylin, SB (corresponding author), Johns Hopkins Univ, Inst Med, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu	Ohm, Joyce E/B-1497-2012; Watkins, David N/I-6113-2013		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA043318, R01CA116160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073781] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA116160, CA116160, R01 CA116160-04, R01 CA043318, CA043318, R01 CA043318-23] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL073781] Funding Source: Medline		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANDREWS DF, 1989, MOL CELL BIOL, V9, P2748, DOI 10.1128/MCB.9.6.2748; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Fahrner JA, 2002, CANCER RES, V62, P7213; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Nguyen CT, 2002, CANCER RES, V62, P6456; PRUITT K, 2006, PLOS GENET, V2, P344, DOI ARTN e40; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431	29	791	811	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					237	242		10.1038/ng1972			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900023	17211412	Green Accepted			2022-01-24	
J	Ciriello, G; Miller, ML; Aksoy, BA; Senbabaoglu, Y; Schultz, N; Sander, C				Ciriello, Giovanni; Miller, Martin L.; Aksoy, Buelent Arman; Senbabaoglu, Yasin; Schultz, Nikolaus; Sander, Chris			Emerging landscape of oncogenic signatures across human cancers	NATURE GENETICS			English	Article							MUTATIONS; CTCF; ONCOLOGY; PROMOTER; BINDING; PROTEIN; ARID1A; TARGET; BREAST	Cancer therapy is challenged by the diversity of molecular implementations of oncogenic processes and by the resulting variation in therapeutic responses. Projects such as The Cancer Genome Atlas (TCGA) provide molecular tumor maps in unprecedented detail. The interpretation of these maps remains a major challenge. Here we distilled thousands of genetic and epigenetic features altered in cancers to similar to 500 selected functional events (SFEs). Using this simplified description, we derived a hierarchical classification of 3,299 TCGA tumors from 12 cancer types. The top classes are dominated by either mutations (M class) or copy number changes (C class). This distinction is clearest at the extremes of genomic instability, indicating the presence of different oncogenic processes. The full hierarchy shows functional event patterns characteristic of multiple cross-tissue groups of tumors, termed oncogenic signature classes. Targetable functional events in a tumor class are suggestive of class-specific combination therapy. These results may assist in the definition of clinical trials to match actionable oncogenic signatures with personalized therapies.	[Ciriello, Giovanni; Miller, Martin L.; Aksoy, Buelent Arman; Senbabaoglu, Yasin; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA		Ciriello, G (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	pancan@cbio.mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Senbabaoglu, Yasin/I-4922-2013	Senbabaoglu, Yasin/0000-0003-0958-958X; Schultz, Nikolaus/0000-0002-0131-4904; Ciriello, Giovanni/0000-0003-2021-8683; Miller, Martin L/0000-0003-3161-8690	US National Cancer Institute funding of the TCGA Genome Data Analysis Center [U24 CA143840]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U41 HG006623]; Stand Up To Cancer Dream Team Translational Research Grant; Program of the Entertainment Industry Foundation [SU2C-AACR-DT0209]; US National Institutes of Health funding of the National Resource for Network BiologyUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41 GM103504]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA143858, U24CA143840] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U41HG006623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P41GM103504] Funding Source: NIH RePORTER	We gratefully acknowledge contributions from the TCGA Research Network and its TCGA Pan-Cancer Analysis Working Group (contributing consortium members are listed in the Supplementary Note). The TCGA Pan-Cancer Analysis Working Group is coordinated by J.M. Stuart, C. S. and I. Shmulevich. We also thank E. Oricchio, X. Jing, S. Domcke, R. Sinha, J.J. Gao, G. B. Mills, J.J. Hsieh, B. S. Taylor, D. B. Solit, G. Ratsch, D. S. Marks and D. Bemis for discussions and/or critical reading of the manuscript. This work was supported by US National Cancer Institute funding of the TCGA Genome Data Analysis Center (U24 CA143840), US National Institutes of Health funding of Pathway Commons (U41 HG006623), by a Stand Up To Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0209) and by US National Institutes of Health funding of the National Resource for Network Biology (P41 GM103504).	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiang WF, 2011, ORAL DIS, V17, P53, DOI 10.1111/j.1601-0825.2010.01702.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gardner, 1941, DEEP S SOCIAL ANTHR; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guha M, 2013, NAT BIOTECHNOL, V31, P187, DOI 10.1038/nbt0313-187a; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imoto I, 2003, CANCER RES, V63, P5691; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Schuetz P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046112; Scott J., 1980, ANATOMY SCOTTISH CAP; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361	37	790	799	4	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1127	U247		10.1038/ng.2762			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	WOS:000324989600007	24071851	Green Submitted, Green Accepted, hybrid	Y	N	2022-01-24	
J	Meijers-Heijboer, H; van den Ouweland, A; Klijn, J; Wasielewski, M; de Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; van Veghel-Plandsoen, M; Elstrodt, F; van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, DF; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, DG; Houlston, R; Murday, V; Narod, S; Peretz, T; Peto, J; Phelan, C; Zhang, HX; Szabo, C; Devilee, P; Goldgar, D; Futreal, PA; Nathanson, KL; Weber, BL; Rahman, N; Stratton, MR				Meijers-Heijboer, H; van den Ouweland, A; Klijn, J; Wasielewski, M; de Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; van Veghel-Plandsoen, M; Elstrodt, F; van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, DF; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, DG; Houlston, R; Murday, V; Narod, S; Peretz, T; Peto, J; Phelan, C; Zhang, HX; Szabo, C; Devilee, P; Goldgar, D; Futreal, PA; Nathanson, KL; Weber, BL; Rahman, N; Stratton, MR		CHEK2-Breast Canc Consortium	Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations	NATURE GENETICS			English	Article							LI-FRAUMENI-SYNDROME; DNA-DAMAGE CHECKPOINT; CHK2; GENES; P53; PHOSPHORYLATION; FAMILIES; ATM	Mutations in BRCA1 and BRCA2 confer a high risk of breast and ovarian cancer(1), but account for only a small fraction of breast cancer susceptibility(1,2). To find additional genes conferring susceptibility to breast cancer, we analyzed CHEK2 (also known as CHK2), which encodes a cell-cycle checkpoint kinase that is implicated in DNA repair processes involving BRCA1 and p53 (refs 3-5). We show that CHEK2*1100delC, a truncating variant that abrogates the kinase activity(6), has a frequency of 1.1% in healthy individuals. However, this variant is present in 5.1% of individuals with breast cancer from 718 families that do not carry mutations in BRCA1 or BRCA2 (P=0.00000003), including 13.5% of individuals from families with male breast cancer (P=0.00015). We estimate that the CHEK2*1100delC variant results in an approximately twofold increase of breast cancer risk in women and a tenfold increase of risk in men. By contrast, the variant confers no increased cancer risk in carriers of BRCA1 or BRCA2 mutations. This suggests that the biological mechanisms underlying the elevated risk of breast cancer in CHEK2 mutation carriers are already subverted in carriers of BRCA1 or BRCA2 mutations, which is consistent with participation of the encoded proteins in the same pathway.	Inst Canc Res, Haddow Labs, Canc Genet Sect, Sutton SM2 5NG, Surrey, England; Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Surg Oncol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pathol, Rotterdam, Netherlands; Univ Cambridge, Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge CB2 1TN, England; German Canc Res Ctr, Div Epidemiol, D-6900 Heidelberg, Germany; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; St Georges Med Sch, Med Genet Unit, London, England; Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON M5S 1B2, Canada; Hadassah Univ Hosp, Sharett Inst Oncol, IL-91120 Jerusalem, Israel; Inst Canc Res, Haddow Labs, Epidemiol Sect, Surrey, England; London Sch Hyg & Trop Med, London WC1, England; Univ Penn, Med Ctr, Dept Hematol Oncol, Philadelphia, PA 19104 USA; Int Agcy Res Canc, F-69372 Lyon, France; Leiden Univ, Dept Pathol Human Genet, Leiden, Netherlands; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England		Rahman, N (corresponding author), Inst Canc Res, Haddow Labs, Canc Genet Sect, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.		Eccles, Diana/K-6327-2019; Rahman, Nazneen/B-8890-2012; Narod, Steven A/AAA-6112-2022; Rahman, Nazneen/D-2802-2013	Eccles, Diana/0000-0002-9935-3169; Eeles, Rosalind/0000-0002-3698-6241; Evans, Gareth/0000-0002-8482-5784; Rahman, Nazneen/0000-0003-4376-0440; Houlston, Richard/0000-0002-5268-0242; Hollestelle, Antoinette/0000-0003-1166-1966; Nathanson, Katherine/0000-0002-6740-0901; Van Duijn, Cornelia/0000-0002-2374-9204			Ahn JY, 2000, CANCER RES, V60, P5934; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Shieh SY, 2000, GENE DEV, V14, P289; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Sodha N, 2000, Science, V289, P359; Vahteristo P, 2001, CANCER RES, V61, P5718; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200	19	790	810	1	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2002	31	1					55	59		10.1038/ng879			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	WOS:000175362500014	11967536	Bronze			2022-01-24	
J	Salamov, AA; Solovyev, VV				Salamov, AA; Solovyev, VV			Ab initio gene finding in Drosophila genomic DNA	GENOME RESEARCH			English	Article							MESSENGER-RNA; PROTEIN; PREDICTION; SEQUENCE; MELANOGASTER; SIMILARITY; DATABASE	Ab initio gene identification in the genomic sequence of Drosophila melanogaster was obtained using Fgenes (human gene predictor) and Fgenesh programs that have organism-specific parameters for human, Drosophila, plants, yeast, and nematode. We did not use information about cDNA/EST in most predictions to model a real situation for Finding new genes because information about complete cDNA is often absent or based on very small partial Fragments. We investigated the accuracy of gene prediction on different levels and designed several schemes to predict an unambiguous set of genes (annotation CGG1), a set of reliable exons (annotation CGG2), and the most complete set of exons (annotation CGG3). For 49 genes, protein products of which have clear homologs in protein databases, predictions were recomputed by Fgenesh+ program. The first annotation serves as the optimal computational description of new sequence to be presented in a database. Reliable exons from the second annotation serve as good candidates for selecting the PCR primers for experimental work For gene structure verification. Our results shows that we can identify similar to 90% of coding nucleotides with 20% false positives. At the exon level we accurately predicted 65% of exons and 89% including overlapping exons with 49% false positives. Optimizing accuracy of prediction, we designed a gene identification scheme using Fgenesh, which provided sensitivity (Sn) = 98% and specificity (Sp) = 86% at the base level, Sn = 81% (97% including overlapping exons) and Sp = 58% at the exon level and Sn = 72% and Sp = 39% at the gene level (estimating sensitivity on std1 set and specificity on std3 set). In general, these results showed that computational gene prediction can be a reliable tool for annotating new genomic sequences, giving accurate Information on 90% of coding sequences with 14% false positives. However, exact gene prediction (especially at the gene level) needs additional improvement using gene prediction algorithms. The Fgenesh program was also tested for predicting genes of human Chromosome 22 (the last variant of Fgenesh can analyze the whole chromosome sequence). This analysis has demonstrated that the 88% of manually annotated exons in Chromosome 22 were among the ab initio predicted exons. The suite of gene identification programs is available through the WWW server of Computational Genomics Group at http://genomic.sanger.ac.uk/gf.html.	Sanger Ctr, Cambridge CB10 1SA, England		Solovyev, VV (corresponding author), Sanger Ctr, Cambridge CB10 1SA, England.		Solovyev, Victor/C-4614-2013	Solovyev, Victor/0000-0001-8885-493X	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 1999, GENETICS, V153, P179; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Etzold T, 1996, METHOD ENZYMOL, V266, P114; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; KULP D, 1996, 26TH P ISMB, V4, P134; MARSHALL TK, 1990, NUCLEIC ACIDS RES, V18, P6293, DOI 10.1093/nar/18.21.6293; REESE MG, 2000, GENOME RES; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; SELEDTSOV I, 1999, GENES PICTURES INTER; SNYDER EE, 1993, NUCLEIC ACIDS RES, V21, P607, DOI 10.1093/nar/21.3.607; SOLOVYEV V, 1997, ISMB, V5, P294; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; SOLOVYEV VV, 1993, INTELL SYST MOL VIOL, V1, P371; STORMO G, 1994, INTELL SYST MOL BIOL, V2, P369; Wadman M, 1998, NATURE, V393, P399, DOI 10.1038/30790; XU Y, 1994, ISMB, V2, P376	27	790	830	3	62	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	APR	2000	10	4					516	522		10.1101/gr.10.4.516			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	309AD	WOS:000086744300014	10779491	Bronze, Green Published			2022-01-24	
J	Zimin, AV; Delcher, AL; Florea, L; Kelley, DR; Schatz, MC; Puiu, D; Hanrahan, F; Pertea, G; Van Tassell, CP; Sonstegard, TS; Marcais, G; Roberts, M; Subramanian, P; Yorke, JA; Salzberg, SL				Zimin, Aleksey V.; Delcher, Arthur L.; Florea, Liliana; Kelley, David R.; Schatz, Michael C.; Puiu, Daniela; Hanrahan, Finnian; Pertea, Geo; Van Tassell, Curtis P.; Sonstegard, Tad S.; Marcais, Guillaume; Roberts, Michael; Subramanian, Poorani; Yorke, James A.; Salzberg, Steven L.			A whole-genome assembly of the domestic cow, Bos taurus	GENOME BIOLOGY			English	Article							SEQUENCE; ALIGNMENT; GENE	Background: The genome of the domestic cow, Bos taurus, was sequenced using a mixture of hierarchical and whole-genome shotgun sequencing methods. Results: We have assembled the 35 million sequence reads and applied a variety of assembly improvement techniques, creating an assembly of 2.86 billion base pairs that has multiple improvements over previous assemblies: it is more complete, covering more of the genome; thousands of gaps have been closed; many erroneous inversions, deletions, and translocations have been corrected; and thousands of single-nucleotide errors have been corrected. Our evaluation using independent metrics demonstrates that the resulting assembly is substantially more accurate and complete than alternative versions. Conclusions: By using independent mapping data and conserved synteny between the cow and human genomes, we were able to construct an assembly with excellent large-scale contiguity in which a large majority (approximately 91%) of the genome has been placed onto the 30 B. taurus chromosomes. We constructed a new cow-human synteny map that expands upon previous maps. We also identified for the first time a portion of the B. taurus Y chromosome.	[Delcher, Arthur L.; Florea, Liliana; Kelley, David R.; Schatz, Michael C.; Puiu, Daniela; Hanrahan, Finnian; Pertea, Geo; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Zimin, Aleksey V.; Marcais, Guillaume; Roberts, Michael; Subramanian, Poorani; Yorke, James A.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Van Tassell, Curtis P.; Sonstegard, Tad S.] ARS, USDA, Beltsville, MD 20705 USA		Salzberg, SL (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	salzberg@umd.edu	Salzberg, Steven/Q-6514-2019; Van Tassell, Curtis P./O-4247-2019; Salzberg, Steven L/F-6162-2011; Schatz, Michael/L-2690-2019	Salzberg, Steven/0000-0002-8859-7432; Van Tassell, Curtis P./0000-0002-8416-2087; Salzberg, Steven L/0000-0002-8859-7432; Schatz, Michael/0000-0002-4118-4446; Subramanian, Poorani/0000-0003-4371-7290	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-LM006845, R01-GM083873, R01-HG002945]; USDAUnited States Department of Agriculture (USDA) [200804049]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM006845] Funding Source: NIH RePORTER	This work was supported in part by NIH grants R01-LM006845 and R01-GM083873 to SLS and R01-HG002945 to JAY, and by USDA grant 200804049 to SLS and JAY. The authors wish to thank the Human Genome Sequencing Center at the Baylor College of Medicine for generating the raw sequence data and making it publicly available at the NCBI Trace Archive.	Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CELNIKER SE, 2002, GENOME BIOL, V0003; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Florea L, 2005, GENOME RES, V15, P54, DOI 10.1101/gr.2889405; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roberts M, 2004, J COMPUT BIOL, V11, P734; Roberts M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001836; Snelling WM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r165; STRAIL S, 2004, P NATL ACAD SCI USA, V101, P1916; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WIND A, 2005, P NATL ACAD SCI USA, V102, P18526; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	19	789	1006	5	68	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2009	10	4							R42	10.1186/gb-2009-10-4-r42			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	452MP	WOS:000266544600014	19393038	Green Published, hybrid, Green Accepted			2022-01-24	
J	Widschwendter, M; Fiegl, H; Egle, D; Mueller-Holzner, E; Spizzo, G; Marth, C; Weisenberger, DJ; Campan, M; Young, J; Jacobs, I; Laird, PW				Widschwendter, Martin; Fiegl, Heidi; Egle, Daniel; Mueller-Holzner, Elisabeth; Spizzo, Gilbert; Marth, Christian; Weisenberger, Daniel J.; Campan, Mihaela; Young, Joanne; Jacobs, Ian; Laird, Peter W.			Epigenetic stem cell signature in cancer	NATURE GENETICS			English	Article							PROMOTER METHYLATION; POLYCOMB; GENOME; HYPERMETHYLATION; BIOLOGY; ORIGIN	Embryonic stem cells rely on Polycomb group proteins to reversibly repress genes required for differentiation. We report that stem cell Polycomb group targets are up to 12-fold more likely to have cancer- specific promoter DNA hypermethylation than non-targets, supporting a stem cell origin of cancer in which reversible gene repression is replaced by permanent silencing, locking the cell into a perpetual state of self-renewal and thereby predisposing to subsequent malignant transformation.	Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem, Los Angeles, CA USA; Univ So Calif, Norris Comprehens Canc Ctr, Dept Biol Mol, Los Angeles, CA USA; UCL, Inst Womens Hlth, Dept Gynecol Oncol, London WC1E 6DH, England; Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria; Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria; Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia		Laird, PW (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA.	M.Widschwendter@ucl.ac.uk; plaird@usc.edu	Young, Joanne P/H-7774-2014; Young, Joanne P/B-9981-2011; Spizzo, Gilbert/Q-6707-2016; Weisenberger, Daniel/AAA-8314-2020; Laird, Peter W/G-8683-2012; Fiegl, Heidi/K-4445-2017	Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Spizzo, Gilbert/0000-0003-4121-0146; Widschwendter, Martin/0000-0002-7778-8380; Jacobs, Ian/0000-0002-5005-2672; Fiegl, Heidi/0000-0002-1236-6806; Young, Joanne/0000-0002-1514-1522	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA075090, R01 CA096958, R01 CA001815] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA001815, R01CA096958, R01CA075090] Funding Source: NIH RePORTER		Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Eads CA, 2000, CANCER RES, V60, P5021; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; HOUGHTON J, 2006, SEMIN CANCER BIOL, DOI DOI 10.1016/J.SEMICANCER.2006.04.003; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2006, NATURE, V442, P754, DOI 10.1038/442754a; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	15	789	811	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					157	158		10.1038/ng1941			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900010	17200673				2022-01-24	
J	Bridge, AJ; Pebernard, S; Ducraux, A; Nicoulaz, AL; Iggo, R				Bridge, AJ; Pebernard, S; Ducraux, A; Nicoulaz, AL; Iggo, R			Induction of an interferon response by RNAi vectors in mammalian cells	NATURE GENETICS			English	Article							EXPRESSION; VIRUS; GENE	DNA vectors that express short hairpin RNAs (shRNAs) from RNA polymerase III (Pol III) promoters are a promising new tool to reduce gene expression in mammalian cells. shRNAs are processed to small interfering RNAs (siRNAs) of 21 nucleotides (nt) that guide the cleavage of the cognate mRNA by the RNA-induced silencing complex. Although siRNAs are thought to be too short to induce interferon expression, we report here that a substantial number of shRNA vectors can trigger an interferon response.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland		Iggo, R (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.		Kaser-Pebernard, Stephanie GM/C-4219-2014; Iggo, Richard/G-3546-2014; Bridge, Alan/U-4209-2018	Kaser-Pebernard, Stephanie GM/0000-0002-6035-6979; Bridge, Alan/0000-0003-2148-9135			AKUSJARVI G, 1987, MOL CELL BIOL, V7, P549, DOI 10.1128/MCB.7.1.549; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002	6	786	830	0	29	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					263	264		10.1038/ng1173			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	WOS:000183815300011	12796781				2022-01-24	
J	Stoffers, DA; Zinkin, NT; Stanojevic, V; Clarke, WL; Habener, JF				Stoffers, DA; Zinkin, NT; Stanojevic, V; Clarke, WL; Habener, JF			Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR EXPRESSION; INSULIN GENE; GLUCOSE-CONCENTRATION; CONGENITAL ABSENCE; DIABETES-MELLITUS; HOMEOBOX FACTOR; FACTOR STF-1; ISLET CELLS; HOMEODOMAIN; INSUFFICIENCY	The homeodomain protein IPF1 (also known as IDX1, STF1 and PDX1; see Methods) is critical for development of the pancreas in mice and is a key factor for the regulation of the insulin gene in the beta-cells of the endocrine pancreas(1-6). Targeted disruption of the Ipf1 gene encoding IPF1 in transgenic mice results in a failure of the pancreas to develop (pancreatic agenesis)(4,7). Here, we report the identification of a single nucleotide deletion within codon 63 of the human IPF1 gene (13q12.1) in a patient with pancreatic agenesis. The patient is homozygous for the point deletion, whereas both parents are heterozygotes for the same mutation. The deletion was not found in 184 chromosomes from normal individuals, indicating that the mutation is unlikely to be a rare polymorphism. The point deletion causes a frame shift at the C-terminal border of the transactivation domain of IPF1 resulting in the translation of 59 novel codons before termination, aminoproximal to the homeodomain essential for DNA binding, Expression of mutant IPF1 in Cos-1 cells confirms the expression of a prematurely terminated truncated protein of 16 kD. Thus, the affected patient should have no functional IPF1 protein. Given the essential role of IPF1 in pancreas development, it is likely that this autosomal recessive mutation is the cause of the pancreatic agenesis phenotype in this patient. Thus, IPF1 appears to be a critical regulator of pancreas development in humans as well as mice.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,LAB MOL ENDOCRINOL,HOWARD HUGHES MED INST,BOSTON,MA 02114; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA 22908				Stoffers, Doris/H-6157-2012				Ausubel FM, 1995, CURRENT PROTOCOLS MO; CARROLL PB, 1992, PANCREAS, V7, P21, DOI 10.1097/00006676-199201000-00004; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; DODGE JA, 1977, ARCH DIS CHILD, V52, P411, DOI 10.1136/adc.52.5.411; DOUROV N, 1969, ARCH FR PEDIATR, V26, P641; HOWARD CP, 1980, J PEDIATR-US, V97, P786, DOI 10.1016/S0022-3476(80)80270-8; INOUE H, 1996, GENE DIABETES, V45, P789; JONNSON J, 1994, NATURE, V371, P606; LEMONS JA, 1979, PEDIATRICS, V64, P255; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Lu M, 1996, ENDOCRINOLOGY, V137, P2959, DOI 10.1210/en.137.7.2959; MEHES K, 1976, ACTA PAEDIATR HUNG, V17, P175; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; PEERS B, 1995, MOL CELL BIOL, V15, P7091; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sambrook J., 1989, MOL CLONING LAB MANU; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; SHERWOOD WG, 1995, PEDIATR RES, V8, P360; STOFFEL M, GENOMICS, V28, P125; WIDNESS JA, 1982, J PEDIATR-US, V100, P926, DOI 10.1016/S0022-3476(82)80517-9; WINTER WE, 1986, J PEDIATR-US, V109, P465, DOI 10.1016/S0022-3476(86)80119-6; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; WRIGHT NM, 1993, AM J DIS CHILD, V147, P607	29	786	809	1	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					106	110		10.1038/ng0197-106			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300032	8988180				2022-01-24	
J	Peri, S; Navarro, JD; Amanchy, R; Kristiansen, TZ; Jonnalagadda, CK; Surendranath, V; Niranjan, V; Muthusamy, B; Gandhi, TKB; Gronborg, M; Ibarrola, N; Deshpande, N; Shanker, K; Shivashankar, HN; Rashmi, BP; Ramya, MA; Zhao, ZX; Chandrika, KN; Padma, N; Harsha, HC; Yatish, AJ; Kavitha, MP; Menezes, M; Choudhury, DR; Suresh, S; Ghosh, N; Saravana, R; Chandran, S; Krishna, S; Joy, M; Anand, SK; Madavan, V; Joseph, A; Wong, GW; Schiemann, WP; Constantinescu, SN; Huang, LL; Khosravi-Far, R; Steen, H; Tewari, M; Ghaffari, S; Blobe, GC; Dang, CV; Garcia, JGN; Pevsner, J; Jensen, ON; Roepstorff, P; Deshpande, KS; Chinnaiyan, AM; Hamosh, A; Chakravarti, A; Pandey, A				Peri, S; Navarro, JD; Amanchy, R; Kristiansen, TZ; Jonnalagadda, CK; Surendranath, V; Niranjan, V; Muthusamy, B; Gandhi, TKB; Gronborg, M; Ibarrola, N; Deshpande, N; Shanker, K; Shivashankar, HN; Rashmi, BP; Ramya, MA; Zhao, ZX; Chandrika, KN; Padma, N; Harsha, HC; Yatish, AJ; Kavitha, MP; Menezes, M; Choudhury, DR; Suresh, S; Ghosh, N; Saravana, R; Chandran, S; Krishna, S; Joy, M; Anand, SK; Madavan, V; Joseph, A; Wong, GW; Schiemann, WP; Constantinescu, SN; Huang, LL; Khosravi-Far, R; Steen, H; Tewari, M; Ghaffari, S; Blobe, GC; Dang, CV; Garcia, JGN; Pevsner, J; Jensen, ON; Roepstorff, P; Deshpande, KS; Chinnaiyan, AM; Hamosh, A; Chakravarti, A; Pandey, A			Development of human protein reference database as an initial platform for approaching systems biology in humans	GENOME RESEARCH			English	Article							SACCHAROMYCES-CEREVISIAE; CANCER SUSCEPTIBILITY; HUMAN GENOME; YEAST; PHOSPHORYLATION; IDENTIFICATION; KNOWLEDGEBASE; MICROARRAYS; PROTEOMICS; COMPLEXES	Human Protein Reference Database (HPRD) is an object database that integrates a wealth of information relevant to the function of human proteins in health and disease. Data pertaining to thousands of protein-protein interactions, posttranslational modifications, enzyme/substrate relationships, disease associations, tissue expression, and subcellular localization were extracted from the literature for a nonredundant set of 2750 human proteins. Almost all the information was obtained manually by biologists who read and interpreted >300,000 published articles during the annotation process. This database, which has an intuitive query interface allowing easy access to all the features of proteins, was built by using open source technologies and will be freely available at http://www.hprd.org to the academic community. This unified bioinformatics platform will be useful in cataloging and mining the large number of proteomic interactions and alterations that will be discovered in the postgenomic era.	Johns Hopkins Univ, McKursick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Kennedy Krieger Res Inst, Baltimore, MD 21287 USA; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; Univ Navarra, CIMA, Unidad Proteom, Div Hepatol & Terapia Gen, Pamplona 31008, Spain; Int Technol Pk Ltd, Inst Bioinformat, Bangalore 560066, Karnataka, India; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Natl Jewish Med & Res Ctr, Denver, CO 80202 USA; Ludwig Inst Canc Res, Brussels, Belgium; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Mt Sinai Sch Med, New York, NY 10029 USA; Duke Univ, Pharmacol & Canc Biol Program, Durham, NC 27710 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA		Pandey, A (corresponding author), Johns Hopkins Univ, McKursick Nathans Inst Genet Med, Baltimore, MD 21287 USA.	pandey@jhmi.edu	Niranjan, Vidya/AAF-5553-2019; Prasad, Rashmi B/H-7381-2016; Amanchy, Ramars/K-1273-2016; Garcia, Joe GN/E-8862-2010; Dang, Chi/Y-3375-2019; Niranjan, Vidya/O-6464-2016; Jensen, Ole N/J-1763-2012; Kalyana-Sundaram, Shanker/F-6860-2012; Gowda, Harsha/A-8526-2011; Blobe, Gerard/AAJ-5945-2020; Prasad, Rashmi/Y-4276-2019; Khosravi-Far, Roya/C-3789-2008; Pandey, Akhilesh/B-4127-2009; Prasad, Rashmi B/D-7067-2017; Constantinescu, Stefan N/E-5277-2012	Niranjan, Vidya/0000-0001-9187-7753; Prasad, Rashmi B/0000-0002-4400-6741; Amanchy, Ramars/0000-0001-9315-8488; Niranjan, Vidya/0000-0001-9187-7753; Jensen, Ole N/0000-0003-1862-8528; Gowda, Harsha/0000-0002-4118-6855; Blobe, Gerard/0000-0002-4274-8901; Prasad, Rashmi/0000-0002-4400-6741; Pandey, Akhilesh/0000-0001-9943-6127; Prasad, Rashmi B/0000-0002-4400-6741; Steen, Hanno/0000-0003-0179-6648; Wong, G. William/0000-0002-5286-6506; Constantinescu, Stefan/0000-0002-8599-2699; T. K. Boopathy, Gandhi/0000-0002-1821-9540; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Dang, Chi/0000-0002-4031-2522; Deshpande, Chandrika/0000-0002-5557-519X; Surendranath, Vineeth/0000-0003-1593-6461			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Batagelj V, 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Birney E, 2002, ANNU REV GENOM HUM G, V3, P293, DOI 10.1146/annurev.genom.3.030502.101529; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hart Gerald W, 2003, Methods Mol Biol, V213, P3; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hood L, 2003, NATURE, V421, P444, DOI 10.1038/nature01410; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; Navarro JD, 2003, TRENDS BIOTECHNOL, V21, P263, DOI 10.1016/S0167-7799(03)00108-2; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Romero F, 1998, J BIOL CHEM, V273, P7776, DOI 10.1074/jbc.273.13.7776; Schachter V, 2002, BIOTECHNIQUES, P16; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	39	785	823	0	44	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	OCT	2003	13	10					2363	2371		10.1101/gr.1680803			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	731GR	WOS:000185876400019	14525934	Green Published, Bronze			2022-01-24	
J	Morgante, M; Hanafey, M; Powell, W				Morgante, M; Hanafey, M; Powell, W			Microsatellites are preferentially associated with nonrepetitive DNA in plant genomes	NATURE GENETICS			English	Article							SIMPLE SEQUENCE REPEATS; REPETITIVE ELEMENTS; RETROTRANSPOSONS; ORGANIZATION; ABUNDANCE; METHYLATION; EVOLUTION	Microsatellites are a ubiquitous class of simple repetitive DNA sequence. An excess of such repetitive tracts has been described in all eukaryotes analyzed and is thought to result from the mutational effects of replication slippage(1). Large-scale genomic and EST sequencing provides the opportunity to evaluate the abundance and relative distribution of microsatellites(2) between transcribed and nontranscribed regions and the relationship of these features to haploid genome size. Although this has been studied in microbial and animal genomes(3-6), information in plants is limited. We assessed microsatellite frequency in plant species with a 50-fold range in genome size that is mostly attributable to the recent amplification of repetitive DNA(7). Among species, the overall frequency of microsatellites was inversely related to genome size and to the proportion of repetitive DNA but remained constant in the transcribed portion of the genome. This indicates that most microsatellites reside in regions pre-dating the recent genome expansion in many plants. The microsatellite frequency was higher in transcribed regions, especially in the untranslated portions, than in genomic DNA. Contrary to previous reports suggesting a preferential mechanism for the origin of microsatellites from repetitive DNA in both animals(8,9) and plants(10), our findings show a significant association with the low-copy fraction of plant genomes.	Dupont Co Inc, DuPont Agr & Nutr Mol Genet, Newark, DE USA		Morgante, M (corresponding author), Dupont Co Inc, DuPont Agr & Nutr Mol Genet, Newark, DE USA.	michele.morgante@usa.dupont.com		MORGANTE, Michele/0000-0003-2591-2156; Powell, Wayne/0000-0002-5612-3398			Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; Cardle L, 2000, GENETICS, V156, P847; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; DHAR MS, 1988, PLANT SCI, V55, P43, DOI 10.1016/0168-9452(88)90040-4; Elgar G, 1999, GENOME RES, V9, P960, DOI 10.1101/gr.9.10.960; GOLDBERG RB, 1978, BIOCHEM GENET, V16, P45, DOI 10.1007/BF00484384; Gur-Arie R, 2000, GENOME RES, V10, P62; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Hancock JM, 1996, BIOESSAYS, V18, P421, DOI 10.1002/bies.950180512; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; Keller B, 2000, TRENDS PLANT SCI, V5, P246, DOI 10.1016/S1360-1385(00)01629-0; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Metzgar D, 2000, GENOME RES, V10, P72; Meyerowitz E. M., 1992, Methods in Arabidopsis research., P100; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Pfeiffer A, 1997, GENOME, V40, P411, DOI 10.1139/g97-055; Pupko T, 1999, J MOL EVOL, V48, P313, DOI 10.1007/PL00006474; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Schlotterer C, 2000, MOL BIOL EVOL, V17, P1641, DOI 10.1093/oxfordjournals.molbev.a026263; Shama S, 1996, EUR J BIOCHEM, V236, P383, DOI 10.1111/j.1432-1033.1996.00383.x; SMITH DB, 1976, NUCLEIC ACIDS RES, V3, P2811, DOI 10.1093/nar/3.10.2811; Stuart-Rogers C, 2001, MOL BIOL EVOL, V18, P155, DOI 10.1093/oxfordjournals.molbev.a003789; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967	36	785	939	3	92	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					194	200		10.1038/ng822			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	WOS:000173708700021	11799393				2022-01-24	
J	Kay, MA; Manno, CS; Ragni, MV; Larson, PJ; Couto, LB; McClelland, A; Glader, B; Chew, AJ; Tai, SJ; Herzog, RW; Arruda, V; Johnson, F; Scallan, C; Skarsgard, E; Flake, AW; High, KA				Kay, MA; Manno, CS; Ragni, MV; Larson, PJ; Couto, LB; McClelland, A; Glader, B; Chew, AJ; Tai, SJ; Herzog, RW; Arruda, V; Johnson, F; Scallan, C; Skarsgard, E; Flake, AW; High, KA			Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector	NATURE GENETICS			English	Article							ADENOASSOCIATED VIRUS	Pre-clinical studies in mice and haemophilic dogs have shown that introduction of an adeno-associated viral (AAV) vector encoding blood coagulation factor IX (F.IX) into skeletal muscle results in sustained expression of F.IX at levels sufficient to correct the haemophilic phenotype(1,2). On the basis of these data and additional pre-clinical studies demonstrating an absence of vector-related toxicity, we initiated a clinical study of intramuscular injection of an AAV vector expressing human F.IX in adults with severe haemophilia B. The study has a dose-escalation design, and all patients have now been enrolled in the initial dose cohort (2x10(11) vg/kg), Assessment in the first three patients of safety and gene transfer and expression show no evidence of germline transmission of vector sequences or formation of inhibitory antibodies against F.IX. We found that the vector sequences are present in muscle by PCR and Southern-blot analyses of muscle biopsies and we demonstrated expression of F.IX by immunohistochemistry. We observed modest changes in clinical endpoints including circulating levels of F.IX and frequency of F.IX protein infusion. The evidence of gene expression at low doses of vector suggests that dose calculations based on animal data may have overestimated the amount of vector required to achieve therapeutic levels in humans, and that the approach offers the possibility of converting severe haemophilia B to a milder form of the disease.	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Surg, Palo Alto, CA 94304 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; Avigen Inc, Alameda, CA USA		High, KA (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.		High, Katherine A./AAB-9322-2020	Skarsgard, Erik/0000-0003-3713-8196; Manno, Catherine/0000-0001-8029-0391; Kay, Mark/0000-0002-2799-2615; McClelland, Alan/0000-0003-2949-3542	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL61921, R01 HL53682, HL53668] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL053682, R01HL061921, R01HL053668] Funding Source: NIH RePORTER		Burton M, 1999, P NATL ACAD SCI USA, V96, P12725, DOI 10.1073/pnas.96.22.12725; Cheung WF, 1996, P NATL ACAD SCI USA, V93, P11068, DOI 10.1073/pnas.93.20.11068; Herzog RW, 1999, NAT MED, V5, P56, DOI 10.1038/4743; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; KURACHI S, 1995, J BIOL CHEM, V270, P5276, DOI 10.1074/jbc.270.10.5276; Ljung RCR, 1998, BRIT J HAEMATOL, V101, P215, DOI 10.1046/j.1365-2141.1998.00707.x; Lofqvist T, 1997, J INTERN MED, V241, P395, DOI 10.1046/j.1365-2796.1997.130135000.x; MANNO CS, 1999, GUIDELINES RES INVOL; Mannucci PM, 1999, SEMIN HEMATOL, V36, P104; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Miller J., 1972, EXPT MOL GENETICS, P352; PARKS W P, 1970, Infection and Immunity, V2, P716; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Walter J, 1996, P NATL ACAD SCI USA, V93, P3056, DOI 10.1073/pnas.93.7.3056; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	16	783	806	0	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					257	261		10.1038/73464			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	WOS:000085590600015	10700178				2022-01-24	
J	Basson, CT; Bachinsky, DR; Lin, RC; Levi, T; Elkins, JA; Soults, J; Grayzel, D; Kroumpouzou, E; Traill, TA; LeblancStraceski, J; Renault, B; Kucherlapati, R; Seidman, JG; Seidman, CE				Basson, CT; Bachinsky, DR; Lin, RC; Levi, T; Elkins, JA; Soults, J; Grayzel, D; Kroumpouzou, E; Traill, TA; LeblancStraceski, J; Renault, B; Kucherlapati, R; Seidman, JG; Seidman, CE			Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome	NATURE GENETICS			English	Article							CONSERVED PROTEIN MOTIF; GRAM SYNDROME; GENES; EMBRYOGENESIS; BRACHYURY; DISEASE; HOMOLOG; FAMILY; LOCUS; MAPS	Holt-Gram syndrome is characterized by upper limb malformations and cardiac septation defects, Here, we demonstrate that mutations in the human TBX5 gene underlie this disorder. TBX5 was cloned from the disease locus on human chromosome 12q24.1 and identified as a member of the T-box transcription factor family, A nonsense mutation in TBX5 causes Holt-Gram syndrome in affected members of one family; a TBX5 missense mutation was identified in affected members of another, We conclude that TBX5 is critical for limb and heart development and suggest that haploinsufficiency of TBX5 causes Holt-Gram syndrome.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115; JOHNS HOPKINS UNIV HOSP,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21205; ALBERT EINSTEIN COLL MED,DEPT MOL GENET,BRONX,NY 10461; BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115		Basson, CT (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOVASC,75 FRANCIS ST,BOSTON,MA 02115, USA.		Kucherlapati, Raju/ABC-8807-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL003468] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P01HG000965] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00965] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL03468-01] Funding Source: Medline		Agulnik SI, 1996, GENETICS, V144, P249; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; BASSON CT, 1995, CIRCULATION, V91, P1326, DOI 10.1161/01.CIR.91.5.1326; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; BONNET D, 1994, NAT GENET, V6, P405, DOI 10.1038/ng0494-405; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; DALTON ME, 1993, NEW ENGL J MED, V328, P114; Edwards YH, 1996, GENOME RES, V6, P226, DOI 10.1101/gr.6.3.226; FOOTE S, 1996, CURRENT PROTOCOLS HU; GALL JC, 1966, AM J HUM GENET, V18, P187; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HOLT M, 1960, BRIT HEART J, V22, P236; HUANG JX, 1995, ANN NY ACAD SCI, V752, P217; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KULLMANN F, 1993, DEUT MED WOCHENSCHR, V118, P1455, DOI 10.1055/s-2008-1059473; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LEBLANCSTRACESKI JM, 1994, GENOMICS, V19, P341, DOI 10.1006/geno.1994.1067; LETTS RM, 1976, CLIN ORTHOPAEDICS, V116, P149; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; OTT J, 1976, AM J HUM GENET, V28, P528; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; PRUZNANSKI W, 1964, CARDIOLOGIA, V45, P1; Rossant J, 1996, CIRC RES, V78, P349, DOI 10.1161/01.RES.78.3.349; RUZIC B, 1981, RADIOLOGE, V21, P296; SAHN DJ, 1981, CHEST, V79, P113, DOI 10.1378/chest.79.1.113; SATOH N, 1995, TRENDS GENET, V11, P354, DOI 10.1016/S0168-9525(00)89106-4; SMITH AT, 1979, J PEDIATR-US, V95, P538, DOI 10.1016/S0022-3476(79)80758-1; STARKE H, 1967, AM J CARDIOL, V19, P588, DOI 10.1016/0002-9149(67)90436-5; STERNBERG NL, 1996, CURRENT PROTOCOLS HU; TERRETT JA, 1994, NAT GENET, V6, P401, DOI 10.1038/ng0494-401; Terrett JA, 1996, AM J HUM GENET, V59, P1337; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WESLEY CS, 1993, NUCLEIC ACIDS RES, V22, P538; ZHANG KZ, 1986, AM HEART J, V111, P572, DOI 10.1016/0002-8703(86)90066-9	45	783	799	1	358	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					30	35		10.1038/ng0197-30			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300017	8988165				2022-01-24	
J	Draghici, S; Khatri, P; Tarca, AL; Amin, K; Done, A; Voichita, C; Georgescu, C; Romero, R				Draghici, Sorin; Khatri, Purvesh; Tarca, Adi Laurentiu; Amin, Kashyap; Done, Arina; Voichita, Calin; Georgescu, Constantin; Romero, Roberto			A systems biology approach for pathway level analysis	GENOME RESEARCH			English	Article							FOCAL ADHESION KINASE; GENE-EXPRESSION DATA; MICROARRAY DATA; SMALL-CELL; APOPTOSIS; TOOL; ASSOCIATION; SURVIVAL; DESIGN; MODELS	A common challenge in the analysis of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions taking place on various signaling pathways. A statistical approach using various models is universally used to identify the most relevant pathways in a given experiment. Here, we show that the existing pathway analysis methods fail to take into consideration important biological aspects and may provide incorrect results in certain situations. By using a systems biology approach, we developed an impact analysis that includes the classical statistics but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc. The impact analysis is an attempt to a deeper level of statistical analysis, informed by more pathway- specific biology than the existing techniques. On several illustrative data sets, the classical analysis produces both false positives and false negatives, while the impact analysis provides biologically meaningful results. This analysis method has been implemented as a Web- based tool, Pathway- Express, freely available as part of the Onto- Tools (http:// vortex. cs. wayne. edu).	Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; NICHD, Perinatol Res Branch, NIH, Detroit, MI 48201 USA		Draghici, S (corresponding author), Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA.	sod@cs.wayne.edu	Draghici, Sorin/B-3074-2013; Romero, Roberto/A-5268-2019	Draghici, Sorin/0000-0002-0786-8377; Romero, Roberto/0000-0002-4448-5121	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA022453, R21CA100740, U01CA117478] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR017857] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB000990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045207] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1U01CA117478-01, R21 CA100740, 1R21CA100740-01, 2P30 CA022453-24, U01 CA117478, P30 CA022453] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10 RR017857, 1S10 RR017857-01] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [1R01HG003491-01A1, R01 HG003491] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [5R21EB00090-03, R21 EB000990] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045207, 1R01NS045207-01] Funding Source: Medline		Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Beviglia L, 2003, BIOCHEM J, V373, P201, DOI 10.1042/BJ20021846; Breslin T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-163; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chung HJ, 2004, NUCLEIC ACIDS RES, V32, pW460, DOI 10.1093/nar/gkh476; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2002, DRUG DISCOV TODAY, V7, pS55, DOI 10.1016/S1359-6446(02)02292-4; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Golubovskaya V, 2002, J BIOL CHEM, V277, P38978, DOI 10.1074/jbc.M205002200; Grosu P, 2002, GENOME RES, V12, P1121, DOI 10.1101/gr.226602; Holford M, 2005, BIOINFORMATICS, V21, P1596, DOI 10.1093/bioinformatics/bti153; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Khatri P, 2005, BIOINFORMATICS, V21, P3587, DOI 10.1093/bioinformatics/bti565; Maydt J, 2004, STAT APPL GENET MOL, V3, P1, DOI [DOI 10.2202/1544-6115.1055, 10.2202/1544-6115.1055]; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Nikolic-Vukosavljevic D, 2004, CLIN EXP METASTAS, V21, P581; Page L., 1999, TECHNICAL REPORT; Pan DY, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-56; Panani AD, 2006, CANCER LETT, V239, P1, DOI 10.1016/j.canlet.2005.06.030; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Robinson PN, 2004, BIOINFORMATICS, V20, P979, DOI 10.1093/bioinformatics/bth040; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Sanders TAB, 1999, AM J CLIN NUTR, V69, P220; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SLEBOS RJC, 1989, EUR RESPIR J, V2, P461; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Swagell CD, 2005, BIOCHEM BIOPH RES CO, V328, P432, DOI 10.1016/j.bbrc.2004.12.188; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Todorovic-Rakovic N, 2005, MED HYPOTHESES, V65, P546, DOI 10.1016/j.mehy.2005.03.019; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; van Nimwegen MJ, 2006, MOL PHARMACOL, V70, P1330, DOI 10.1124/mol.106.026195; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vincenzi B, 2006, HISTOL HISTOPATHOL, V21, P423, DOI 10.14670/HH-21.423; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	50	782	795	1	53	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2007	17	10					1537	1545		10.1101/gr.6202607			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	216HN	WOS:000249869200015	17785539	Green Published, Bronze			2022-01-24	
J	Oosthuyse, B; Moons, L; Storkebaum, E; Beck, H; Nuyens, D; Brusselmans, K; Van Dorpe, J; Hellings, P; Gorselink, M; Heymans, S; Theilmeier, G; Dewerchin, M; Laudenbach, V; Vermylen, P; Raat, H; Acker, T; Vleminckx, V; Van den Bosch, L; Cashman, N; Fujisawa, H; Drost, MR; Sciot, R; Bruyninckx, F; Hicklin, DJ; Ince, C; Gressens, P; Lupu, F; Plate, KH; Robberecht, W; Herbert, JM; Collen, D; Carmeliet, P				Oosthuyse, B; Moons, L; Storkebaum, E; Beck, H; Nuyens, D; Brusselmans, K; Van Dorpe, J; Hellings, P; Gorselink, M; Heymans, S; Theilmeier, G; Dewerchin, M; Laudenbach, V; Vermylen, P; Raat, H; Acker, T; Vleminckx, V; Van den Bosch, L; Cashman, N; Fujisawa, H; Drost, MR; Sciot, R; Bruyninckx, F; Hicklin, DJ; Ince, C; Gressens, P; Lupu, F; Plate, KH; Robberecht, W; Herbert, JM; Collen, D; Carmeliet, P			Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration	NATURE GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FACTOR MESSENGER-RNA; SPINAL-CORD; INDUCIBLE FACTOR-1; FACTOR EXPRESSION; MODEL; VEGF; MECHANISMS; BINDING; ANGIOGENESIS	Hypoxia stimulates angiogenesis through the binding of hypoxia-inducible factors to the hypoxia-response element in the vascular endothelial growth factor (Vegf) promotor. Here, we report that deletion of the hypoxia-response element in the Vegf promotor reduced hypoxic Vegf expression in the spinal cord and caused adult-onset progressive motor neuron degeneration, reminiscent of amyotrophic lateral sclerosis, The neurodegeneration seemed to be due to reduced neural vascular perfusion. In addition. Vegf(165) promoted survival of motor neurons during hypoxia through binding to Vegf receptor 2 and neuropilin 1. Acute ischemia is known to cause nonselective neuronal death. Our results indicate that chronic vascular insufficiency and, possibly, insufficient Vegf-dependent neuroprotection lead to the select degeneration of motor neurons.	Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; FAU Erlangen Nurnberg, Dept Neuropathol, D-91054 Erlangen, Germany; Katholieke Univ Leuven, Fac Med, B-3000 Louvain, Belgium; Univ Maastricht, CARIM, NL-6200 MD Maastricht, Netherlands; Hop Robert Debre, INSERM E9935, F-75019 Paris, France; Hop Robert Debre, Serv Neruol Pediat, F-75019 Paris, France; Univ Amsterdam, Dept Anesthesiol, Amsterdam, Netherlands; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Nagoya Univ, Dept Biol Mol, Nagoya, Aichi 46401, Japan; ImClone Syst Inc, New York, NY 10014 USA; Thrombosis Res Inst, Vasc Biol Lab, London SW3 6LR, England		Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Van Den Bosch, Ludo/B-7258-2012; Storkebaum, Erik/B-5389-2017; gressens, pierre/M-7557-2017; Lupu, Florea/C-3162-2009; Hellings, Peter W/I-4068-2018; Lupu, Florea/AAV-3257-2021; Carmeliet, Peter/AAQ-5140-2020	Storkebaum, Erik/0000-0002-9519-5642; gressens, pierre/0000-0002-0909-4221; Lupu, Florea/0000-0003-1249-9278; Hellings, Peter W/0000-0001-6898-688X; Lupu, Florea/0000-0003-1249-9278; Carmeliet, Peter/0000-0001-7961-1821; Nuyens, Dieter/0000-0001-9390-3273; Acker, Till/0000-0001-6357-7227; Van Den Bosch, Ludo/0000-0003-0104-4067; sciot, raf/0000-0003-2244-5839; Moons, Lieve (Godelieve)/0000-0003-0186-1411			Al Theys P, 1999, J NEUROL, V246, P438, DOI 10.1007/s004150050379; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Bromberg MB, 1999, CURR OPIN NEUROL, V12, P581, DOI 10.1097/00019052-199910000-00012; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Dor Y, 1997, TRENDS CARDIOVAS MED, V7, P289, DOI 10.1016/S1050-1738(97)00091-1; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gorselink M, 2000, PFLUG ARCH EUR J PHY, V439, P665, DOI 10.1007/s004240050991; Green SL, 1999, LAB ANIM SCI, V49, P480; Gupta M, 2000, BLOOD, V96, P491; Hayashi T, 1999, NEUROPATH APPL NEURO, V25, P63; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; KAWAMURA Y, 1977, J NEUROPATH EXP NEUR, V36, P853, DOI 10.1097/00005072-197709000-00009; Knight JA, 1997, ANN CLIN LAB SCI, V27, P11; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, ANN NEUROL, V41, P497, DOI 10.1002/ana.410410413; Lang-Lazdunski L, 2000, STROKE, V31, P208, DOI 10.1161/01.STR.31.1.208; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; Martin LJ, 2000, INT J MOL MED, V5, P3; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Nohl H, 1997, EXP GERONTOL, V32, P485, DOI 10.1016/S0531-5565(96)00169-6; Ochiai-Kanai R, 1999, BRAIN RES, V847, P59, DOI 10.1016/S0006-8993(99)02020-X; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; ROBBERECHT WL, 2000, AMYOTROPHIC LATERAL, P211; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Schultz A, 1999, CIRCULATION, V100, P547, DOI 10.1161/01.CIR.100.5.547; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vandenberghe W, 1998, BRAIN RES, V807, P1, DOI 10.1016/S0006-8993(98)00569-1; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	46	782	810	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					131	138		10.1038/88842			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	WOS:000169011800014	11381259				2022-01-24	
J	Rotig, A; deLonlay, P; Chretien, D; Foury, F; Koenig, M; Sidi, D; Munnich, A; Rustin, P				Rotig, A; deLonlay, P; Chretien, D; Foury, F; Koenig, M; Sidi, D; Munnich, A; Rustin, P			Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN	Friedreich ataxia (FRDA) is a common autosomal recessive degenerative disease (1/50,000 live births) characterized by a progressive gait and limb ataxia with lack of tendon reflexes in the legs, dysarthria and pyramidal weakness of the inferior limbs(1,2). Hypertrophic cardiomyopathy is observed in most FRDA patients. The gene associated with the disease has been mapped to chromosome 9q13 (ref. 3) and encodes a 210-amino-acid protein, frataxin. FRDA is caused primarily by a GAA repeat expansion within the first intron of the frataxin gene, which accounts for 98% of mutant alleles(4). The function of the protein is unknown, but an increased iron content has been reported in hearts of FRDA patients(5) and the mitochondria of yeast strains carrying a deleted frataxin gene counterpart (YFH1), suggesting that frataxin plays a major role in regulating mitochondrial iron transport(6.7). Here, we report a deficient activity of the iron-sulphur (Fe-S) cluster-containing subunits of mitochondrial respiratory complexes I, II and III in the endomyocardial biopsy of two unrelated FRDA patients. Aconitase, an iron-sulphur protein involved in iron homeostasis, was found to be deficient as well. Moreover, disruption of the YFH1 gene resulted in multiple Fe-S-dependent enzyme deficiencies in yeast. The deficiency of Fe-S-dependent enzyme activities in both FRDA patients and yeast should be related to mitochondrial iron accumulation, especially as Fe-S proteins are remarkably sensitive to free radicals(8). Mutated frataxin triggers aconitase and mitochondrial Fe-S respiratory enzyme deficiency in FRDA, which should therefore be regarded as a mitochondrial disorder.	HOP NECKER ENFANTS MALAD,INSERM,U393,DEPT GENET,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT,F-75743 PARIS 15,FRANCE; UNIV CATHOLIQUE LOUVAIN,UNITE BIOCHIM PHYSIOL,B-1348 LOUVAIN,BELGIUM; INST GENET & BIOL MOL & CELLULAIRE,INSERM,CNRS,F-67404 ILLKIRCH GRAFFENS,FRANCE				Rotig, Agnes/G-9592-2017	Rotig, Agnes/0000-0003-0589-0703			BABOCK M, 1997, SCIENCE, V276, P1709; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CEDARBAUM JM, 1986, NEUROCHEM PATHOL, V4, P43, DOI 10.1007/BF02834298; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; Darley-Usmar V.M, 1987, MITOCHONDRIA PRACTIC, P1; Filla A, 1996, AM J HUM GENET, V59, P554; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HARDING AE, 1981, BRAIN, V104, P598; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jacq C, 1997, NATURE, V387, P75, DOI 10.1038/387s075; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; LI Y, 1996, NAT GENET, V11, P376; Paul R, 1996, TRENDS GENET, V12, P131; Robinson Jr JB, 1987, MITOCHONDRIA PRACTIC, P153; RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V; SANCHEZCASIS G, 1977, CAN J NEUROL SCI, V3, P349	21	782	791	1	41	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					215	217		10.1038/ng1097-215			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	WOS:A1997XZ55500032	9326946				2022-01-24	
J	Estrada, K; Styrkarsdottir, U; Evangelou, E; Hsu, YH; Duncan, EL; Ntzani, EE; Oei, L; Albagha, OME; Amin, N; Kemp, JP; Koller, DL; Li, G; Liu, CT; Minster, RL; Moayyeri, A; Vandenput, L; Willner, D; Xiao, SM; Yerges-Armstrong, LM; Zheng, HF; Alonso, N; Eriksson, J; Kammerer, CM; Kaptoge, SK; Leo, PJ; Thorleifsson, G; Wilson, SG; Wilson, JF; Aalto, V; Alen, M; Aragaki, AK; Aspelund, T; Center, JR; Dailiana, Z; Duggan, DJ; Garcia, M; Garcia-Giralt, N; Giroux, S; Hallmans, G; Hocking, LJ; Husted, LB; Jameson, KA; Khusainova, R; Kim, GS; Kooperberg, C; Koromila, T; Kruk, M; Laaksonen, M; Lacroix, AZ; Lee, SH; Leung, PC; Lewis, JR; Masi, L; Mencej-Bedrac, S; Nguyen, TV; Nogues, X; Patel, MS; Prezelj, J; Rose, LM; Scollen, S; Siggeirsdottir, K; Smith, AV; Svensson, O; Trompet, S; Trummer, O; van Schoor, NM; Woo, J; Zhu, K; Balcells, S; Brandi, ML; Buckley, BM; Cheng, SL; Christiansen, C; Cooper, C; Dedoussis, G; Ford, I; Frost, M; Goltzman, D; Gonzalez-Macias, J; Kahonen, M; Karlsson, M; Khusnutdinova, E; Koh, JM; Kollia, P; Langdahl, BL; Leslie, WD; Lips, P; Ljunggren, O; Lorenc, RS; Marc, J; Mellstrom, D; Obermayer-Pietsch, B; Olmos, JM; Pettersson-Kymmer, U; Reid, DM; Riancho, JA; Ridker, PM; Rousseau, F; Slagboom, PE; Tang, NLS; Urreizti, R; Van Hul, W; Viikari, J; Zarrabeitia, MT; Aulchenko, YS; Castano-Betancourt, M; Grundberg, E; Herrera, L; Ingvarsson, T; Johannsdottir, H; Kwan, T; Li, R; Luben, R; Medina-Gomez, C; Palsson, ST; Reppe, S; Rotter, JI; Sigurdsson, G; van Meurs, JBJ; Verlaan, D; Williams, FMK; Wood, AR; Zhou, YH; Gautvik, KM; Pastinen, T; Raychaudhuri, S; Cauley, JA; Chasman, DI; Clark, GR; Cummings, SR; Danoy, P; Dennison, EM; Eastell, R; Eisman, JA; Gudnason, V; Hofman, A; Jackson, RD; Jones, G; Jukema, JW; Khaw, KT; Lehtimaki, T; Liu, YM; Lorentzon, M; McCloskey, E; Mitchell, BD; Nandakumar, K; Nicholson, GC; Oostra, BA; Peacock, M; Pols, HAP; Prince, RL; Raitakari, O; Reid, IR; Robbins, J; Sambrook, PN; Sham, PC; Shuldiner, AR; Tylavsky, FA; van Duijn, CM; Wareham, NJ; Cupples, LA; Econs, MJ; Evans, DM; Harris, TB; Kung, AWC; Psaty, BM; Reeve, J; Spector, TD; Streeten, EA; Zillikens, MC; Thorsteinsdottir, U; Ohlsson, C; Karasik, D; Richards, JB; Brown, MA; Stefansson, K; Uitterlinden, AG; Ralston, SH; Ioannidis, JPA; Kiel, DP; Rivadeneira, F				Estrada, Karol; Styrkarsdottir, Unnur; Evangelou, Evangelos; Hsu, Yi-Hsiang; Duncan, Emma L.; Ntzani, Evangelia E.; Oei, Ling; Albagha, Omar M. E.; Amin, Najaf; Kemp, John P.; Koller, Daniel L.; Li, Guo; Liu, Ching-Ti; Minster, Ryan L.; Moayyeri, Alireza; Vandenput, Liesbeth; Willner, Dana; Xiao, Su-Mei; Yerges-Armstrong, Laura M.; Zheng, Hou-Feng; Alonso, Nerea; Eriksson, Joel; Kammerer, Candace M.; Kaptoge, Stephen K.; Leo, Paul J.; Thorleifsson, Gudmar; Wilson, Scott G.; Wilson, James F.; Aalto, Ville; Alen, Markku; Aragaki, Aaron K.; Aspelund, Thor; Center, Jacqueline R.; Dailiana, Zoe; Duggan, David J.; Garcia, Melissa; Garcia-Giralt, Natalia; Giroux, Sylvie; Hallmans, Goran; Hocking, Lynne J.; Husted, Lise Bjerre; Jameson, Karen A.; Khusainova, Rita; Kim, Ghi Su; Kooperberg, Charles; Koromila, Theodora; Kruk, Marcin; Laaksonen, Marika; Lacroix, Andrea Z.; Lee, Seung Hun; Leung, Ping C.; Lewis, Joshua R.; Masi, Laura; Mencej-Bedrac, Simona; Nguyen, Tuan V.; Nogues, Xavier; Patel, Millan S.; Prezelj, Janez; Rose, Lynda M.; Scollen, Serena; Siggeirsdottir, Kristin; Smith, Albert V.; Svensson, Olle; Trompet, Stella; Trummer, Olivia; van Schoor, Natasja M.; Woo, Jean; Zhu, Kun; Balcells, Susana; Brandi, Maria Luisa; Buckley, Brendan M.; Cheng, Sulin; Christiansen, Claus; Cooper, Cyrus; Dedoussis, George; Ford, Ian; Frost, Morten; Goltzman, David; Gonzalez-Macias, Jesus; Kahonen, Mika; Karlsson, Magnus; Khusnutdinova, Elza; Koh, Jung-Min; Kollia, Panagoula; Langdahl, Bente Lomholt; Leslie, William D.; Lips, Paul; Ljunggren, Osten; Lorenc, Roman S.; Marc, Janja; Mellstrom, Dan; Obermayer-Pietsch, Barbara; Olmos, Jose M.; Pettersson-Kymmer, Ulrika; Reid, David M.; Riancho, Jose A.; Ridker, Paul M.; Rousseau, Francois; Slagboom, P. Eline; Tang, Nelson L. S.; Urreizti, Roser; Van Hul, Wim; Viikari, Jorma; Zarrabeitia, Maria T.; Aulchenko, Yurii S.; Castano-Betancourt, Martha; Grundberg, Elin; Herrera, Lizbeth; Ingvarsson, Thorvaldur; Johannsdottir, Hrefna; Kwan, Tony; Li, Rui; Luben, Robert; Medina-Gomez, Carolina; Palsson, Stefan Th; Reppe, Sjur; Rotter, Jerome I.; Sigurdsson, Gunnar; van Meurs, Joyce B. J.; Verlaan, Dominique; Williams, Frances M. K.; Wood, Andrew R.; Zhou, Yanhua; Gautvik, Kaare M.; Pastinen, Tomi; Raychaudhuri, Soumya; Cauley, Jane A.; Chasman, Daniel I.; Clark, Graeme R.; Cummings, Steven R.; Danoy, Patrick; Dennison, Elaine M.; Eastell, Richard; Eisman, John A.; Gudnason, Vilmundur; Hofman, Albert; Jackson, Rebecca D.; Jones, Graeme; Jukema, J. Wouter; Khaw, Kay-Tee; Lehtimaki, Terho; Liu, Yongmei; Lorentzon, Mattias; McCloskey, Eugene; Mitchell, Braxton D.; Nandakumar, Kannabiran; Nicholson, Geoffrey C.; Oostra, Ben A.; Peacock, Munro; Pols, Huibert A. P.; Prince, Richard L.; Raitakari, Olli; Reid, Ian R.; Robbins, John; Sambrook, Philip N.; Sham, Pak Chung; Shuldiner, Alan R.; Tylavsky, Frances A.; van Duijn, Cornelia M.; Wareham, Nick J.; Cupples, L. Adrienne; Econs, Michael J.; Evans, David M.; Harris, Tamara B.; Kung, Annie Wai Chee; Psaty, Bruce M.; Reeve, Jonathan; Spector, Timothy D.; Streeten, Elizabeth A.; Zillikens, M. Carola; Thorsteinsdottir, Unnur; Ohlsson, Claes; Karasik, David; Richards, J. Brent; Brown, Matthew A.; Stefansson, Kari; Uitterlinden, Andre G.; Ralston, Stuart H.; Ioannidis, John P. A.; Kiel, Douglas P.; Rivadeneira, Fernando			Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture	NATURE GENETICS			English	Article							OSTEOPOROTIC FRACTURES; GENE; VARIANTS; LRP5; EXPRESSION; PATTERNS; DISEASE; BURDEN; WOMEN; HIP	Bone mineral density (BMD) is the most widely used predictor of fracture risk. We performed the largest meta-analysis to date on lumbar spine and femoral neck BMD, including 17 genome-wide association studies and 32,961 individuals of European and east Asian ancestry. We tested the top BMD-associated markers for replication in 50,933 independent subjects and for association with risk of low-trauma fracture in 31,016 individuals with a history of fracture (cases) and 102,444 controls. We identified 56 loci (32 new) associated with BMD at genome-wide significance (P < 5 x 10(-8)). Several of these factors cluster within the RANK-RANKL-OPG, mesenchymal stem cell differentiation, endochondral ossification and Wnt signaling pathways. However, we also discovered loci that were localized to genes not known to have a role in bone biology. Fourteen BMD-associated loci were also associated with fracture risk (P < 5 x 10(-4), Bonferroni corrected), of which six reached P < 5 x 10(-8), including at 18p11.21 (FAM210A), 7q21.3 (SLC25A13), 11q13.2 (LRP5), 4q22.1 (MEPE), 2p16.2 (SPTBN1) and 10q21.1 (DKK1). These findings shed light on the genetic architecture and pathophysiological mechanisms underlying BMD variation and fracture susceptibility.	[Estrada, Karol; Oei, Ling; Castano-Betancourt, Martha; Herrera, Lizbeth; Medina-Gomez, Carolina; van Meurs, Joyce B. J.; Pols, Huibert A. P.; Zillikens, M. Carola; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Estrada, Karol; Oei, Ling; Amin, Najaf; Aulchenko, Yurii S.; Castano-Betancourt, Martha; Medina-Gomez, Carolina; van Meurs, Joyce B. J.; Hofman, Albert; Pols, Huibert A. P.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Estrada, Karol; Oei, Ling; Slagboom, P. Eline; Castano-Betancourt, Martha; van Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre G.; Rivadeneira, Fernando] Netherlands Genom Initiat NGI Sponsored Netherlan, Leiden, Netherlands; [Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Johannsdottir, Hrefna; Palsson, Stefan Th; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Evangelou, Evangelos; Ntzani, Evangelia E.; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Hsu, Yi-Hsiang; Nandakumar, Kannabiran; Karasik, David; Kiel, Douglas P.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Hsu, Yi-Hsiang; Nandakumar, Kannabiran; Karasik, David; Kiel, Douglas P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Duncan, Emma L.; Willner, Dana; Leo, Paul J.; Clark, Graeme R.; Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Human Genet Grp, Brisbane, Qld, Australia; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Endocrinol, Brisbane, Qld, Australia; [Albagha, Omar M. E.; Alonso, Nerea; Ralston, Stuart H.] Univ Edinburgh, Rheumat Dis Unit, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Kemp, John P.; Evans, David M.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Koller, Daniel L.; Econs, Michael J.] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Li, Guo] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Liu, Ching-Ti; Zhou, Yanhua; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Minster, Ryan L.; Kammerer, Candace M.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Moayyeri, Alireza; Kaptoge, Stephen K.; Luben, Robert; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Moayyeri, Alireza; Wilson, Scott G.; Williams, Frances M. K.; Spector, Timothy D.; Richards, J. Brent] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Vandenput, Liesbeth; Eriksson, Joel; Mellstrom, Dan; Lorentzon, Mattias; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Willner, Dana] Univ Queensland, Australian Ctr Ecogenom, Brisbane, Qld, Australia; [Xiao, Su-Mei; Kung, Annie Wai Chee] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xiao, Su-Mei; Kung, Annie Wai Chee] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Yerges-Armstrong, Laura M.; Mitchell, Braxton D.; Shuldiner, Alan R.; Streeten, Elizabeth A.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Zheng, Hou-Feng; Richards, J. Brent] McGill Univ, Dept Human Genet, Lady Davis Inst, Montreal, PQ, Canada; [Wilson, Scott G.; Lewis, Joshua R.; Zhu, Kun; Prince, Richard L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Wilson, Scott G.; Lewis, Joshua R.; Zhu, Kun; Prince, Richard L.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Wilson, James F.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Aalto, Ville; Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Aalto, Ville; Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Alen, Markku] Oulu Univ Hosp, Dept Med Rehabil, Oulu, Finland; [Alen, Markku] Inst Hlth Sci, Oulu, Finland; [Aragaki, Aaron K.; Kooperberg, Charles; Lacroix, Andrea Z.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Aspelund, Thor; Siggeirsdottir, Kristin; Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Smith, Albert V.; Ingvarsson, Thorvaldur; Sigurdsson, Gunnar; Gudnason, Vilmundur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Garvan Inst Med Res, Osteoporosis & Bone Biol Program, Sydney, NSW, Australia; [Nguyen, Tuan V.; Eisman, John A.] Univ New S Wales, Dept Med, Sydney, NSW, Australia; [Center, Jacqueline R.; Eisman, John A.] St Vincents Hosp, Dept Endocrinol, Sydney, NSW 2010, Australia; [Dailiana, Zoe] Univ Thessalia, Sch Med, Dept Orthopaed Surg, Larisa, Greece; [Duggan, David J.] Translat Genom Res Inst, Phoenix, AZ USA; [Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Garcia-Giralt, Natalia; Nogues, Xavier] Univ Autonoma Barcelona, Red Lemat Invest Cooperat Envejecimiento & Fragil, Dept Internal Med, Hosp Mar,IMIM, E-08193 Barcelona, Spain; [Giroux, Sylvie; Rousseau, Francois] CHUQ HSFA, Unite Rech Genet Humaine & Mol, Ctr Rech, Quebec City, PQ, Canada; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hocking, Lynne J.; Reid, David M.] Univ Aberdeen, Musculoskeletal Res Programme, Div Appl Med, Aberdeen, Scotland; [Husted, Lise Bjerre; Langdahl, Bente Lomholt] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus C, Denmark; [Jameson, Karen A.; Cooper, Cyrus; Dennison, Elaine M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Khusainova, Rita; Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Khusainova, Rita; Khusnutdinova, Elza] Bashkir State Univ, Dept Biol, Ufa 450074, Russia; [Kim, Ghi Su; Lee, Seung Hun; Koh, Jung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Div Endocrinol & Metab, Seoul, South Korea; [Koromila, Theodora; Kollia, Panagoula] Univ Athens, Fac Biol, Dept Genet & Biotechnol, Athens, Greece; [Kruk, Marcin; Lorenc, Roman S.] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, Warsaw, Poland; [Laaksonen, Marika] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Leung, Ping C.] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Masi, Laura; Brandi, Maria Luisa] Univ Florence, Dept Internal Med, Florence, Italy; [Mencej-Bedrac, Simona; Marc, Janja] Univ Ljubljana, Dept Clin Biochem, Ljubljana, Slovenia; [Patel, Millan S.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Prezelj, Janez] Univ Med Ctr, Dept Endocrinol, Ljubljana, Slovenia; [Rose, Lynda M.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Scollen, Serena] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Svensson, Olle] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Trummer, Olivia; Obermayer-Pietsch, Barbara] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [van Schoor, Natasja M.] Vrije Univ, Univ Med Ctr, Dept Epidemiol & Biostat, Extramuraal Geneeskundig Onderzoek EMGO Inst Hlth, Amsterdam, Netherlands; [Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Balcells, Susana; Urreizti, Roser] Univ Barcelona, Dept Genet, Inst Biomed, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Cheng, Sulin] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Cheng, Sulin] Kuopio Univ Hosp, Dept Orthopaed & Traumatol, SF-70210 Kuopio, Finland; [Christiansen, Claus] Ctr Clin & Basic Res CCBR Synarc, Ballerup, Denmark; [Dedoussis, George] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Frost, Morten] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Frost, Morten] Univ So Denmark, Clin Inst, Odense, Denmark; [Goltzman, David] McGill Univ, Dept Med, Montreal, PQ, Canada; [Gonzalez-Macias, Jesus; Olmos, Jose M.; Riancho, Jose A.] Univ Cantabria, Dept Med, E-39005 Santander, Spain; [Gonzalez-Macias, Jesus; Olmos, Jose M.; Riancho, Jose A.] Hosp Univ Marques de Valdecilla, Dept Internal Med, Santander, Spain; [Gonzalez-Macias, Jesus; Olmos, Jose M.; Riancho, Jose A.] Inst Formac & Invest Marques de Valdecilla IFIMAV, Santander, Spain; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Karlsson, Magnus] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Malmo, Sweden; [Karlsson, Magnus] Lund Univ, Dept Orthopaed, Malmo, Sweden; [Leslie, William D.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Lips, Paul] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, Amsterdam, Netherlands; [Lips, Paul] Vrije Univ Amsterdam, Med Ctr, Extramuraal Geneeskundig Onderzoek EMGO Inst Hlth, Amsterdam, Netherlands; [Ljunggren, Osten] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Pettersson-Kymmer, Ulrika] Umea Univ, Dept Pharmacol & Neurosci, Umea, Sweden; [Rousseau, Francois] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Rousseau, Francois] Univ Laval, APOGFF Net CanGeneTest Network Genet Hlth Serv &, Quebec City, PQ, Canada; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Van Hul, Wim] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Viikari, Jorma] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Zarrabeitia, Maria T.] Univ Cantabria, Dept Legal Med, E-39005 Santander, Spain; [Grundberg, Elin; Kwan, Tony; Verlaan, Dominique; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Grundberg, Elin; Kwan, Tony; Verlaan, Dominique; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Grundberg, Elin] Wellcome Trust Sanger Inst, Cambridge, England; [Ingvarsson, Thorvaldur] Akureyri Hosp, Dept Orthoped Surg, Akureyri, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, Akureyri, Iceland; [Li, Rui; Richards, J. Brent] McGill Univ, Dept Epidemiol & Biostat, Lady Davis Inst, Montreal, PQ, Canada; [Reppe, Sjur; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Sigurdsson, Gunnar] Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Wood, Andrew R.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Gautvik, Kaare M.] Lovisenberg Deacon Hosp, Dept Clin Biochem, Oslo, Norway; [Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Pastinen, Tomi] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ, Canada; [Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet & Rheumatol, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, San Francisco, CA USA; [Eastell, Richard; McCloskey, Eugene] Univ Sheffield, NIHR, Musculoskeletal Biomed Res Unit, Sheffield, S Yorkshire, England; [Jackson, Rebecca D.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Jackson, Rebecca D.] Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA; [Jones, Graeme] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Fimlab, Tampere, Finland; [Liu, Yongmei] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; [McCloskey, Eugene] Univ Sheffield, Acad Unit Bone Metab, Metab Bone Ctr, Sheffield, S Yorkshire, England; [Nicholson, Geoffrey C.] Univ Queensland, Rural Clin Sch, Toowoomba, Qld, Australia; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Peacock, Munro; Econs, Michael J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Reid, Ian R.] Univ Auckland, Dept Med, Auckland, New Zealand; [Robbins, John] Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA; [Sambrook, Philip N.] Univ Sydney, Kolling Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Shuldiner, Alan R.; Streeten, Elizabeth A.] Vet Adm Med Ctr, GRECC, Baltimore, MD 21218 USA; [Tylavsky, Frances A.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Wareham, Nick J.] MRC, MRC Epidemiol Unit Box 285, Cambridge, England; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Richards, J. Brent] McGill Univ, Dept Med, Lady Davis Inst, Montreal, PQ, Canada; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA		Rivadeneira, F (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	f.rivadeneira@erasmusmc.nl	Nguyen, Tuan V./AAD-9503-2020; Zheng, Houfeng/K-4424-2012; Balcells, Susana/C-5222-2017; Khaw, Kay-Tee/AAZ-3209-2021; McCloskey, Eugene/T-5197-2019; Luben, Robert N/H-5519-2015; Wilson, James F/A-5704-2009; Urreizti, Roser/M-6402-2014; Duncan, Emma L/L-1224-2013; Lorentzon, Mattias/W-7878-2019; Garcia-Giralt, Natalia/AAA-7588-2021; Medina-Gomez, Carolina/I-1725-2019; Eastell, Richard/G-5851-2011; Stefansson, Kari/AAE-7187-2019; Kemp, John P./R-3091-2018; Lewis, Joshua/D-5077-2013; Rivadeneira, Fernando/O-5385-2015; Nicholson, Geoffrey C/F-1901-2010; Tang, Nelson L/P-5018-2017; Leo, Paul J/B-3470-2011; Khusainova, Rita/E-6061-2014; Li, Guo/E-5613-2012; Wood, Andrew R/AAB-3807-2019; Richards, J Brent/AAF-4225-2019; Rotter, Jerome/AAY-6598-2021; Evans, David M/H-6325-2013; Dedoussis, George/AAN-7252-2021; Ntzani, Evangelina E./K-1565-2019; LaCroix, Andrea/N-9880-2018; Moayyeri, Alireza/N-3332-2014; Leo, Paul/R-4464-2019; Reeve, Jonathan/C-7551-2012; Vandenput, Liesbeth/AAP-3655-2020; Brown, Matthew A/E-5749-2010; Woo, Jean/K-2625-2014; Vandenput, Liesbeth/AAI-4100-2021; Eisman, John A/C-2886-2014; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Ioannidis, John P. A./G-9836-2011; Oei, Ling/E-8163-2013; Ford, Ian/ABE-6145-2020; Evangelou, Evangelos/C-3033-2013; Raitakari, Olli/AAQ-7389-2021; Khusnutdinova, Elza Kamilevna/A-4810-2013; Jukema, J. Wouter/ABD-6503-2021; Amin, Najaf N/D-1859-2012; Frost, Morten/G-9410-2011; Aulchenko, Yurii/M-8270-2013; Center, Jacqueline/AAY-8712-2021; Aspelund, Thor/C-5983-2008; Slagboom, P. Eline/R-4790-2016; Zhu, Kun/L-2208-2013; Smith, Albert Vernon/K-5150-2015	Nguyen, Tuan V./0000-0002-3246-6281; Zheng, Houfeng/0000-0001-5681-8598; Balcells, Susana/0000-0003-1211-1907; Luben, Robert N/0000-0002-5088-6343; Wilson, James F/0000-0001-5751-9178; Urreizti, Roser/0000-0003-3617-7134; Duncan, Emma L/0000-0002-8143-4403; Lorentzon, Mattias/0000-0003-0749-1431; Garcia-Giralt, Natalia/0000-0001-6507-0147; Medina-Gomez, Carolina/0000-0001-7999-5538; Eastell, Richard/0000-0002-0323-3366; Kemp, John P./0000-0002-9105-2249; Lewis, Joshua/0000-0003-1003-8443; Rivadeneira, Fernando/0000-0001-9435-9441; Nicholson, Geoffrey C/0000-0002-0152-1153; Tang, Nelson L/0000-0002-3607-5819; Leo, Paul J/0000-0001-8325-4134; Khusainova, Rita/0000-0002-8643-850X; Richards, J Brent/0000-0002-3746-9086; Evans, David M/0000-0003-0663-4621; Dedoussis, George/0000-0002-7798-6221; LaCroix, Andrea/0000-0002-9532-976X; Moayyeri, Alireza/0000-0002-9143-2161; Reeve, Jonathan/0000-0002-4364-2682; Brown, Matthew A/0000-0003-0538-8211; Woo, Jean/0000-0001-7593-3081; Vandenput, Liesbeth/0000-0002-1712-6131; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Oei, Ling/0000-0003-3523-458X; Evangelou, Evangelos/0000-0002-5488-2999; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Jukema, J. Wouter/0000-0002-3246-8359; Frost, Morten/0000-0002-5608-1589; Aulchenko, Yurii/0000-0002-7899-1575; Center, Jacqueline/0000-0002-5278-4527; Aspelund, Thor/0000-0002-7998-5433; Slagboom, P. Eline/0000-0002-2875-4723; Zhu, Kun/0000-0002-8723-7574; Smith, Albert Vernon/0000-0003-1942-5845; Mitchell, Braxton/0000-0003-4920-4744; Olmos, Jose M./0000-0002-7765-0891; Cupples, L. Adrienne/0000-0003-0273-7965; Styrkarsdottir, Unnur/0000-0001-8146-8278; Kammerer, Candace M/0000-0002-2841-4761; marc, janja/0000-0001-6013-9758; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; Minster, Ryan/0000-0001-7382-6717; Scollen, Serena/0000-0002-9311-1337; Raychaudhuri, Soumya/0000-0002-1901-8265; Reid, Ian/0000-0001-6021-5458; Williams, Frances/0000-0002-2998-2744; Wilson, Scott/0000-0002-0357-1373; Leslie, William/0000-0002-1056-1691; Patel, Millan/0000-0001-7061-6837; Li, Rui/0000-0001-8353-6772; Karasik, David/0000-0002-8826-0530; Amin, Najaf/0000-0002-8944-1771; Nogues, Xavier/0000-0001-8201-9933; Shuldiner, Alan/0000-0001-9921-4305; Nogues, Xavier/0000-0002-5537-1859; Van Duijn, Cornelia/0000-0002-2374-9204; Zarrabeitia, Maria T./0000-0002-2836-7766; Van Hul, Wim/0000-0002-5065-7858; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nandakumar, Kannabiran/0000-0001-7185-8483; Kahonen, Mika/0000-0002-4510-7341; Hocking / Mennie, Lynne J/0000-0002-2414-2826; Kiel, Douglas/0000-0001-8474-0310; Ohlsson, Claes/0000-0002-9633-2805; Liu, Ching-Ti/0000-0002-0703-0742; Cauley, Jane A/0000-0003-0752-4408; Cooper, Cyrus/0000-0003-3510-0709; van Meurs, Joyce/0000-0001-6245-2123; Wood, Andrew/0000-0003-1726-948X; Koromila, Theodora/0000-0001-5504-1369; van Schoor, Natasja/0000-0002-0870-0795	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [HEALTH-F2-2008-201865-GEFOS, QLRT-2001-02629]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG18728, R01 HL088119, R01AR046838, U01 HL084756, P30 DK072488, T32 AG000262, F32 AR059469, P01 AG-18397, R01 AG041517, M01 RR-00750, N01-AG-12100]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-023629, AG-15928, AG-20098, AG-027058]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [511132, 569807]; Australian Cancer Research Foundation; Rebecca Cooper Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MRC G0800582, 254627, 303169, 572604]; Health Research Council of New ZealandHealth Research Council of New Zealand; Sanofi-AventisSanofi-Aventis; Eli LillyEli Lilly; PfizerPfizer; Proctor & Gamble PharmaceuticalsProcter & Gamble; RocheRoche Holding; Living Well Foundation; Ernst Heine Family Foundation; Arthritis Research UKVersus Arthritis [17539, 15389]; Victorian Health Promotion Foundation; Geelong Region Medical Research Foundation, Australia [628582]; Action Research UK; UK Food Standards Agency; BioPersMed [825329]; Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT); Austrian Federal Ministry of Economics and Labour (BMWA); Austrian Federal Ministry of Economy, Family and Youth (BMWFJ); Styrian Business Promotion Agency (SFG); Red de Envejecimiento y Fragilidad (RETICEF); Instituto Carlos IIIInstituto de Salud Carlos III; Spanish Ministry of Education and ScienceSpanish Government [SAF2010-15707]; Government of CataloniaGeneralitat de Catalunya [2009SGR971, 2009SGR818]; Instituto de Salud Carlos III-Fondo de Investigaciones SanitariasInstituto de Salud Carlos III [PI 06/0034, PI08/0183]; Healthway Health Promotion Foundation of Western Australia; Australasian Menopause Society; Australian National HealthNational Health and Medical Research Council of Australia; Merck Frosst Canada; Eli Lilly CanadaEli Lilly; Novartis PharmaceuticalsNovartis; Procter & Gamble Pharmaceuticals CanadaProcter & Gamble; Servier CanadaServier; Amgen CanadaAmgen; Dairy Farmers of Canada; Arthritis Society; US National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295, HL075366, HL087652, HL105756 NINDS, HL 043851, HL69757, CA 047988]; Framingham Heart StudyUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HC-25195]; Affymetrix, Inc, for genotyping services [N02-HL-6-4278]; Eli Lilly InternationalEli Lilly; AmgenAmgen; GE-LunarGeneral Electric; Merck Australia; Sanofi-Aventis AustraliaSanofi-Aventis; ServierServier; US National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR00425]; US National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK063491]; deCODE Genetics; UK National Institute for Medical Research (NIMR) Biomedical Research Centre; Cancer Research CampaignCancer Research UK; Stroke Association; British Heart FoundationBritish Heart Foundation; UK Department of Health; Europe Against Cancer Programme Commission of the European Union; Ministry of Agriculture, Fisheries and Food, EU Biomed 1 [BMHICT920182, CIPDCT925012, ERBC1PDCT 940229, ERBC1PDCT930105]; UK MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9321536, G9800062]; Wellcome Trust Collaborative Research InitiativeWellcome Trust; MAFFMinistry of Agriculture Forestry & Fisheries - Japan [AN0523]; EUEuropean Commission [QLK6-CT-2002-02629, LSHG-CT-2006-018947, HEALTH-F2-2009-223004 PHASE]; Food Standards Agency [N05046]; Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO); Erasmus University Medical Center; Centre for Medical Systems Biology of the Netherlands Genomics Initiative (NGI) [CMSB1, CMSB2]; F.I.R.M.O. Fondazione Raffaella Becagli; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AR/AG 41398, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098, R01 AR 050066]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [86748]; Ministry of Education and Science of the Russian Federation Scientific and Pedagogical Staff of Innovative Russia [P-601]; Federal Program Research and Development of Prior Directions of Scientific-Technological Complex of Russia [16.512.11.2032]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2010-54X-09894-19-3, 2006-3832, K2010-52X-20229-05-3, K20006-72X-20155013]; Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research; ALF/LUA; Lundberg FoundationEuropean Commission; Torsten and Ragnar Sderberg's Foundation; Vastra Gotaland Foundation; Goteborg Medical Society; Novo Nordisk foundation, University of Athens, Greece; UK NIHR Musculoskeletal BRU Oxford; UK NIHR Nutrition BRU Southampton; Center for Inherited Disease Research (CIDR); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN268200782096C]; Hong Kong Research Grant CouncilHong Kong Research Grants Council [HKU 768610M]; HKU FoundationUniversity of Hong Kong; KC Wong Education Foundation [201007176237]; Committee of Research and Conference Grants (CRCG); Osteoporosis and Endocrine Research Fund; Genomics Strategic Research Theme of The University of Hong Kong; Chinese University of Hong KongChinese University of Hong Kong; Korea Health 21 Research & Development Project; Korean Ministry of Health & Welfare, Republic of Korea [A010252]; Korea Healthcare Technology Research & Development Project; Ministry for Health, Welfare and Family Affairs [A110536]; Netherlands Ministry of Health, Welfare and Sports Directorate of Long-Term Care; World Anti-Doping Agency; Danish Ministry of Culture; Institute of Clinical Research of the University of Southern Denmark; Chief Scientists Office of the Scottish Government [CZB/4/276]; Royal SocietyRoyal Society of LondonEuropean Commission; Netherlands Organization of Scientific Research NWO InvestmentsNetherlands Organization for Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [RIDE2; 014-93-015]; Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging [01 IG 07015 G]; NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); Chronic Disease Research Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Foundation for InnovationCanada Foundation for Innovation; Fonds de la Recherche en Sante QuebecFonds de la Recherche en Sante du Quebec; Lady Davis Institute; Jewish General HospitalGeneral Electric; Ministere du Developpement Economique; Swedish Sports Research Council [87/06]; Swedish Society of Medicine; Kempe Foundation [JCK-1021]; Medical Faculty of Umea University [ALFVLL:968:22-2005, ALFVL:-937-2006, ALFVLL:223:11-2007, ALFVLL:78151-2009]; County Council of Vasterbotten (Spjutspetsanslag) [VLL:159:33-2007]; Donald W. Reynolds Foundation; Fondation LeducqLeducq Foundation; Academy of FinlandAcademy of FinlandEuropean Commission [126925, 121584, 124282, 129378, 117787, 41071]; Social Insurance Institution of Finland; Tampere and Turku University; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation [K08AR055688]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC085085, N01HC055222, N01HC085079, N01HC075150, N01HC085084, N01HC085086, N01HC045133, N01HC025195, N01HC035129, N01HC015103] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA015704, R01CA047988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000425, M01RR000750] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL075366, R01HL087652, U01HL069757, U01HL080295, R01HL080295, U01HL084756, R01HL088119, R01HL105756, R01HL043851, R01HL085083, R01HL064278, U19HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [F32AR059469, R01AR050066, R01AR046838, K08AR055688, R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK063491, P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG018397, R01AG032098, R56AG023629, R01AG041517, N01AG062106, R01AG027058, R01AG015928, R56AG020098, N01AG012100, R01AG023629, R01AG020098, R01AG018728, N01AG062103, T32AG000262, N01AG062101] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_U127561128, G9800062, G0600705, G0800582] Funding Source: UKRI; British Heart FoundationBritish Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0401527, U1475000001, MC_PC_U127561128, G0800582, MC_U147585824, G0600705, G1000143, MC_UP_A620_1014, G9800062] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish	We thank all study participants for making this work possible. This research and the Genetic Factors for Osteoporosis (GEFOS) consortium have been funded by the European Commission (HEALTH-F2-2008-201865-GEFOS). We acknowledge funding from the following organizations: the US National Institutes of Health (NIH; R01 AG18728, R01 HL088119, R01AR046838, U01 HL084756, P30 DK072488, T32 AG000262, F32 AR059469, P01 AG-18397, R01 AG041517, M01 RR-00750 and N01-AG-12100), the NIA Intramural Research Program (AG-023629, AG-15928, AG-20098 and AG-027058), Hjartavernd (the Icelandic Heart Association), the Althingi (the Icelandic Parliament), the Australian National Health and Medical Research Council (511132), the Australian Cancer Research Foundation and the Rebecca Cooper Foundation, the Australian National Health and Medical Research Council Career Development Award (569807 to E. L. D.), an MRC New Investigator Award (MRC G0800582 to D. M. E.), the Health Research Council of New Zealand, Sanofi-Aventis, Eli Lilly, Pfizer, Proctor & Gamble Pharmaceuticals, Roche, the Medical Benefits Fund (MBF) Living Well Foundation, the Ernst Heine Family Foundation, Arthritis Research UK (17539 and 15389), The Victorian Health Promotion Foundation, Geelong Region Medical Research Foundation, Australia (628582), Action Research UK, the European Commission (QLRT-2001-02629), the UK Food Standards Agency, BioPersMed (COMET K-project 825329), the Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT), the Austrian Federal Ministry of Economics and Labour (BMWA), the Austrian Federal Ministry of Economy, Family and Youth (BMWFJ), the Styrian Business Promotion Agency (SFG), the Red de Envejecimiento y Fragilidad (RETICEF), Instituto Carlos III, the Spanish Ministry of Education and Science (SAF2010-15707), the Government of Catalonia (2009SGR971 and 2009SGR818), Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (PI 06/0034 and PI08/0183), Healthway Health Promotion Foundation of Western Australia, Australasian Menopause Society and the Australian National Health and MRC Project (254627, 303169 and 572604), the Finnish Ministry of Education, Merck Frosst Canada, Eli Lilly Canada, Novartis Pharmaceuticals, Procter & Gamble Pharmaceuticals Canada, Servier Canada, Amgen Canada, The Dairy Farmers of Canada, The Arthritis Society, the US National Heart, Lung, and Blood Institute (NHLBI; N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295, HL075366, HL087652, HL105756 NINDS, HL 043851 and HL69757, CA 047988, and the Framingham Heart Study (N01-HC-25195) and its contract with Affymetrix, Inc, for genotyping services (N02-HL-6-4278)). Untied Educational Grants were provided by Amgen, Eli Lilly International, GE-Lunar, Merck Australia, Sanofi-Aventis Australia and Servier.; Additional support was provided by the US National Center for Research Resources (M01-RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping Core), the US National Institute of Diabetes and Digestive and Kidney Diseases (DK063491 to the Southern California Diabetes Endocrinology Research Center), deCODE Genetics, The UK National Institute for Medical Research (NIMR) Biomedical Research Centre, the Cancer Research Campaign, the Stroke Association, the British Heart Foundation, the UK Department of Health, the Europe Against Cancer Programme Commission of the European Union, the Ministry of Agriculture, Fisheries and Food, EU Biomed 1 (BMHICT920182, CIPDCT925012, ERBC1PDCT 940229 and ERBC1PDCT930105), the UK MRC (G9321536 and G9800062), the Wellcome Trust Collaborative Research Initiative 1995, MAFF AN0523, EU Framework Programme 5 (FP5; QLK6-CT-2002-02629), the Food Standards Agency (N05046), the Netherlands Organization for Scientific Research (NWO), Erasmus University Medical Center, the Centre for Medical Systems Biology (CMSB1 and CMSB2) of the Netherlands Genomics Initiative (NGI), the F.I.R.M.O. Fondazione Raffaella Becagli, the National Institute for Arthritis, Musculoskeletal and Skin Diseases, the National Institute on Aging (R01 AR/AG 41398, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098 and R01 AR 050066), the Canadian Institutes for Health Research (86748), Federal Program of the Ministry of Education and Science of the Russian Federation Scientific and Pedagogical Staff of Innovative Russia in 2009-2013 (P-601), the Federal Program Research and Development of Prior Directions of Scientific-Technological Complex of Russia in 2007-2012 (16.512.11.2032), the Swedish Research Council (K2010-54X-09894-19-3, 2006-3832, K2010-52X-20229-05-3 and K20006-72X-20155013) the Swedish Foundation for Strategic Research, the ALF/LUA research grant in Gothenburg, the Lundberg Foundation, the Torsten and Ragnar Sderberg's Foundation, the Vastra Gotaland Foundation, the Goteborg Medical Society, the Novo Nordisk foundation, University of Athens, Greece (Kapodistrias 2009), the UK NIHR Musculoskeletal BRU Oxford, the UK NIHR Nutrition BRU Southampton, The Center for Inherited Disease Research (CIDR), National Institutes of Health (HHSN268200782096C), the Hong Kong Research Grant Council (HKU 768610M), The Bone Health Fund of the HKU Foundation, The KC Wong Education Foundation, Small Project Funding (201007176237), Matching Grant, Committee of Research and Conference Grants (CRCG) Grant, the Osteoporosis and Endocrine Research Fund, the Genomics Strategic Research Theme of The University of Hong Kong, Chinese University of Hong Kong, the Korea Health 21 Research & Development Project, the Korean Ministry of Health & Welfare, Republic of Korea (A010252), the Korea Healthcare Technology Research & Development Project, the Ministry for Health, Welfare and Family Affairs (A110536), The Netherlands Ministry of Health, Welfare and Sports Directorate of Long-Term Care, the World Anti-Doping Agency, the Danish Ministry of Culture, the Institute of Clinical Research of the University of Southern Denmark, the Chief Scientists Office of the Scottish Government (CZB/4/276), a Royal Society University Research Fellowship (to J.F.W.), the European Union Framework Program 6 EUROSPAN project (LSHG-CT-2006-018947), the European Union's Seventh Framework Programme (FP7/2007-2013; HEALTH-F2-2009-223004 PHASE), the Netherlands Organization of Scientific Research NWO Investments (175.010.2005.; 011 and 911-03-012), the Research Institute for Diseases in the Elderly (RIDE2; 014-93-015), the Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging (050-060-810), the German Bundesministerium fuer Forschung und Technology (01 AK 803 A-H and 01 IG 07015 G), the NIHR Biomedical Research Centre (grant to Guys' and St. Thomas' Hospitals and King's College London), the Chronic Disease Research Foundation, the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, the Fonds de la Recherche en Sante Quebec, The Lady Davis Institute, the Jewish General Hospital, the Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec, the Swedish Sports Research Council (87/06), the Swedish Society of Medicine, the Kempe Foundation (JCK-1021), the Medical Faculty of Umea University (ALFVLL:968:22-2005, ALFVL:-937-2006, ALFVLL:223:11-2007 and ALFVLL:78151-2009), the County Council of Vasterbotten (Spjutspetsanslag; VLL:159:33-2007), the US National Cancer Institute, the Donald W. Reynolds Foundation, the Fondation Leducq, the Academy of Finland (126925, 121584, 124282, 129378 (Salve), 117787 (Gendi) and 41071 (Skidi)), the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds (9M048 for TeLeht), the Juho Vainio Foundation, the Paavo Nurmi Foundation, the Finnish Foundation of Cardiovascular Research, the Finnish Cultural Foundation, the Tampere Tuberculosis Foundation and the Emil Aaltonen Foundation (K08AR055688 to T. L.). A detailed list of acknowledgments by study is given in the Supplementary Note. The members of the GEFOS Consortium mourn the passing of co-author Philip Neil Sambrook, a good friend, respected colleague and outstanding research scientist in the prevention, treatment, epidemiology and genetics of osteoporosis.; This work was done under the auspices of the European Commission-sponsored Genetic Factors for Osteoporosis (GEFOS) consortium.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bagger YZ, 2007, OSTEOPOROSIS INT, V18, P505, DOI 10.1007/s00198-006-0255-2; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Duan YB, 2003, J BONE MINER RES, V18, P1766, DOI 10.1359/jbmr.2003.18.10.1766; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Estrada K, 2009, BIOINFORMATICS, V25, P2750, DOI 10.1093/bioinformatics/btp497; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Karasik D, 2008, ANN HUM GENET, V72, P696, DOI 10.1111/j.1469-1809.2008.00447.x; Kiel DP, 2007, BONE, V40, P587, DOI 10.1016/j.bone.2006.09.029; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mosekilde L, 2011, CURR DRUG SAF, V6, P62, DOI 10.2174/157488611795684712; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Panagiotou OA, 2010, AM J EPIDEMIOL, V172, P869, DOI 10.1093/aje/kwq234; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Pereira TV, 2009, AM J EPIDEMIOL, V170, P1197, DOI 10.1093/aje/kwp262; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reppe S, 2010, BONE, V46, P604, DOI 10.1016/j.bone.2009.11.007; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Sundaram K, 2011, ENDOCRINOLOGY, V152, P4180, DOI 10.1210/en.2011-1225; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	55	780	810	6	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					491	+		10.1038/ng.2249			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	WOS:000303416300007	22504420	Green Published, Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Nicolas, M; Wolfer, A; Raj, K; Kummer, JA; Mill, P; van Noort, M; Hui, CC; Clevers, H; Dotto, GP; Radtke, F				Nicolas, M; Wolfer, A; Raj, K; Kummer, JA; Mill, P; van Noort, M; Hui, CC; Clevers, H; Dotto, GP; Radtke, F			Notch1 functions as a tumor suppressor in mouse skin	NATURE GENETICS			English	Article							NEOPLASTIC TRANSFORMATION; KERATINOCYTE GROWTH; MICE; DIFFERENTIATION; GENE; DETERMINANT; EXPRESSION; HOMOLOG; MAMMARY; GLI	Notch proteins are important in binary cell-fate decisions and inhibiting differentiation in many developmental systems(1), and aberrant Notch signaling is associated with tumorigenesis(2-5). The role of Notch signaling in mammalian skin is less well characterized and is mainly based on in vitro studies, which suggest that Notch signaling induces differentiation in mammalian skin(6,7). Conventional gene targeting is not applicable to establishing the role of Notch receptors or ligands in the skin because Notch1(-/-) embryos die during gestation(8-12). Therefore, we used a tissue-specific inducible gene-targeting approach to study the physiological role of the Notch1 receptor in the mouse epidermis and the corneal epithelium of adult mice. Unexpectedly, ablation of Notch1 results in epidermal and corneal hyperplasia followed by the development of skin tumors and facilitated chemical-induced skin carcinogenesis. Notch1 deficiency in skin and in primary keratinocytes results in increased and sustained expression of Gli2, causing the development of basal-cell carcinoma-like tumors. Furthermore, Notch1 inactivation in the epidermis results in derepressed beta-catenin signaling in cells that should normally undergo differentiation. Enhanced beta-catenin signaling can be reversed by re-introduction of a dominant active form of the Notch1 receptor. This leads to a reduction in the signaling-competent pool of beta-catenin, indicating that Notch1 can inhibit beta-catenin-mediated signaling. Our results indicate that Notch1 functions as a tumor-suppressor gene in mammalian skin.	Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; Univ Toronto, Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; Univ Med Ctr Utrecht, Dept Immunol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; Harvard Med Sch, Charlestown, MA USA		Radtke, F (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland.	Freddy.Radtke@isrec.unil.ch	Radtke, Freddy/Q-3198-2017; Mill, Pleasantine/AAE-4718-2019; Wolfer, Anita/AAK-1720-2021	Radtke, Freddy/0000-0003-4315-4045; Mill, Pleasantine/0000-0001-5218-134X			Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Callahan CA, 2001, CURR OPIN GENET DEV, V11, P541, DOI 10.1016/S0959-437X(00)00230-6; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dahmane N, 2001, DEVELOPMENT, V128, P5201; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hamada Y, 1999, DEVELOPMENT, V126, P3415; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/ng0501-53; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Polakis P, 2000, GENE DEV, V14, P1837; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Weinberg WC, 1999, CANCER RES, V59, P2050; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414	30	776	831	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					416	421		10.1038/ng1099			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	WOS:000181312700022	12590261				2022-01-24	
J	Beerli, P; Felsenstein, J				Beerli, P; Felsenstein, J			Maximum-likelihood estimation of migration rates and effective population numbers in two populations using a coalescent approach	GENETICS			English	Article							DNA-SEQUENCE DATA; GENE FLOW; MONTE-CARLO; SEGREGATING SITES; ISLAND MODEL; SIZE; EVOLUTION; ALLELES; PHYLOGENIES; PAIRWISE	A new method for the estimation of migration rates and effective population sizes is described. It uses a maximum-likelihood framework based on coalescence theory. The parameters are estimated by Metropolis-Hastings importance sampling. In a two-population model this method estimates four parameters: the effective population size and the immigration rate for each population relative to the mutation rate. Summarizing over loci can be done by assuming either that the mutation rate is the same for all loci or that the mutation rates are gamma distributed among loci but the same for all sites of a locus. The estimates are as good as or better than those from an optimized Far-based measure. The program is available on the World Wide Web at http://evolution.genetics.washington.edu/lamarc.html/.	Univ Washington, Dept Genet, Seattle, WA 98195 USA		Beerli, P (corresponding author), Univ Washington, Dept Genet, Box 357360, Seattle, WA 98195 USA.		Beerli, Peter/A-3638-2009; Peng, Bo/A-6920-2009	Beerli, Peter/0000-0003-0947-5451; Peng, Bo/0000-0001-8225-2284	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM51929] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM051929] Funding Source: NIH RePORTER		BEERLI P, 1997, MIGRATE DOCUMENTATIO; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Dahlquist G., 1974, NUMERICAL METHODS; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Hanscomb DC., 1964, MONTE CARLO METHODS; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1992, GENETICS, V132, P583; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Kass RE, 1998, AM STAT, V52, P93, DOI 10.2307/2685466; KINGMAN J, 1982, ESSAYS STAT SCI, P27; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kuhner MK, 1998, GENETICS, V149, P429; KUHNER MK, 1995, GENETICS, V140, P1421; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; NATH HB, 1993, J MATH BIOL, V31, P841, DOI 10.1007/BF00168049; Nath HB, 1996, THEOR POPUL BIOL, V50, P227, DOI 10.1006/tpbi.1996.0030; NEI M, 1972, THEOR POPUL BIOL, V3, P460, DOI 10.1016/0040-5809(72)90017-2; NOTOHARA M, 1990, J MATH BIOL, V29, P59, DOI 10.1007/BF00173909; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; SIKORSKI K, 1984, ACM T MATH SOFTWARE, V10, P152, DOI 10.1145/399.449; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; SLATKIN M, 1989, GENETICS, V123, P603; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; SMITH JM, 1970, AM NAT, V104, P231, DOI 10.1086/282657; Swofford David L., 1996, P407; TAKAHATA N, 1988, GENET RES, V52, P213, DOI 10.1017/S0016672300027683; TAKAHATA N, 1990, THEOR POPUL BIOL, V38, P331, DOI 10.1016/0040-5809(90)90018-Q; Tufto J, 1996, GENETICS, V144, P1911; Wakeley J, 1998, THEOR POPUL BIOL, V53, P166, DOI 10.1006/tpbi.1997.1355; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	41	776	790	1	63	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JUN	1999	152	2					763	773					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203VT	WOS:000080729400025	10353916				2022-01-24	
J	Furberg, H; Kim, Y; Dackor, J; Boerwinkle, E; Franceschini, N; Ardissino, D; Bernardinelli, L; Mannucci, PM; Mauri, F; Merlini, PA; Absher, D; Assimes, TL; Fortmann, SP; Iribarren, C; Knowles, JW; Quertermous, T; Ferrucci, L; Tanaka, T; Bis, JC; Furberg, CD; Haritunians, T; McKnight, B; Psaty, BM; Taylor, KD; Thacker, EL; Almgren, P; Groop, L; Ladenvall, C; Boehnke, M; Jackson, AU; Mohlke, KL; Stringham, HM; Tuomilehto, J; Benjamin, EJ; Hwang, SJ; Levy, D; Preis, SR; Vasan, RS; Duan, J; Gejman, PV; Levinson, DF; Sanders, AR; Shi, JX; Lips, EH; Mckay, JD; Agudo, A; Barzan, L; Bencko, V; Benhamou, S; Castellsague, X; Canova, C; Conway, DI; Fabianova, E; Foretova, L; Janout, V; Healy, CM; Holcatova, I; Kjaerheim, K; Lagiou, P; Lissowska, J; Lowry, R; Macfarlane, TV; Mates, D; Richiardi, L; Rudnai, P; Szeszenia-Dabrowska, N; Zaridze, D; Znaor, A; Lathrop, M; Brennan, P; Bandinelli, S; Frayling, TM; Guralnik, JM; Milaneschi, Y; Perry, JRB; Altshuler, D; Elosua, R; Kathiresan, S; Lucas, G; Melander, O; O'Donnell, CJ; Salomaa, V; Schwartz, SM; Voight, BF; Penninx, BW; Smit, JH; Vogelzangs, N; Boomsma, DI; de Geus, EJC; Vink, JM; Willemsen, G; Chanock, SJ; Gu, FY; Hankinson, SE; Hunter, DJ; Hofman, A; Tiemeier, H; Uitterlinden, AG; van Duijn, CM; Walter, S; Chasman, DI; Everett, BM; Pare, G; Ridker, PM; Li, MD; Maes, HH; Audrain-McGovern, J; Posthuma, D; Thornton, LM; Lerman, C; Kaprio, J; Rose, JE; Ioannidis, JPA; Kraft, P; Lin, DY; Sullivan, PF				Furberg, Helena; Kim, YunJung; Dackor, Jennifer; Boerwinkle, Eric; Franceschini, Nora; Ardissino, Diego; Bernardinelli, Luisa; Mannucci, Pier M.; Mauri, Francesco; Merlini, Piera A.; Absher, Devin; Assimes, Themistocles L.; Fortmann, Stephen P.; Iribarren, Carlos; Knowles, Joshua W.; Quertermous, Thomas; Ferrucci, Luigi; Tanaka, Toshiko; Bis, Joshua C.; Furberg, Curt D.; Haritunians, Talin; McKnight, Barbara; Psaty, Bruce M.; Taylor, Kent D.; Thacker, Evan L.; Almgren, Peter; Groop, Leif; Ladenvall, Claes; Boehnke, Michael; Jackson, Anne U.; Mohlke, Karen L.; Stringham, Heather M.; Tuomilehto, Jaakko; Benjamin, Emelia J.; Hwang, Shih-Jen; Levy, Daniel; Preis, Sarah Rosner; Vasan, Ramachandran S.; Duan, Jubao; Gejman, Pablo V.; Levinson, Douglas F.; Sanders, Alan R.; Shi, Jianxin; Lips, Esther H.; Mckay, James D.; Agudo, Antonio; Barzan, Luigi; Bencko, Vladimir; Benhamou, Simone; Castellsague, Xavier; Canova, Cristina; Conway, David I.; Fabianova, Eleonora; Foretova, Lenka; Janout, Vladimir; Healy, Claire M.; Holcatova, Ivana; Kjaerheim, Kristina; Lagiou, Pagona; Lissowska, Jolanta; Lowry, Ray; Macfarlane, Tatiana V.; Mates, Dana; Richiardi, Lorenzo; Rudnai, Peter; Szeszenia-Dabrowska, Neonilia; Zaridze, David; Znaor, Ariana; Lathrop, Mark; Brennan, Paul; Bandinelli, Stefania; Frayling, Timothy M.; Guralnik, Jack M.; Milaneschi, Yuri; Perry, John R. B.; Altshuler, David; Elosua, Roberto; Kathiresan, Sek; Lucas, Gavin; Melander, Olle; O'Donnell, Christopher J.; Salomaa, Veikko; Schwartz, Stephen M.; Voight, Benjamin F.; Penninx, Brenda W.; Smit, Johannes H.; Vogelzangs, Nicole; Boomsma, Dorret I.; de Geus, Eco J. C.; Vink, Jacqueline M.; Willemsen, Gonneke; Chanock, Stephen J.; Gu, Fangyi; Hankinson, Susan E.; Hunter, David J.; Hofman, Albert; Tiemeier, Henning; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Walter, Stefan; Chasman, Daniel I.; Everett, Brendan M.; Pare, Guillaume; Ridker, Paul M.; Li, Ming D.; Maes, Hermine H.; Audrain-McGovern, Janet; Posthuma, Danielle; Thornton, Laura M.; Lerman, Caryn; Kaprio, Jaakko; Rose, Jed E.; Ioannidis, John P. A.; Kraft, Peter; Lin, Dan-Yu; Sullivan, Patrick F.			Genome-wide meta-analyses identify multiple loci associated with smoking behavior	NATURE GENETICS			English	Article							NICOTINE DEPENDENCE; ENVIRONMENTAL-FACTORS; SEQUENCE VARIANTS; IMPUTATION; DISEASES; GENES	Consistent but indirect evidence has implicated genetic factors in smoking behavior1,2. We report meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium (n = 74,053). We also partnered with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia to follow up the 15 most significant regions (n > 140,000). We identified three loci associated with number of cigarettes smoked per day. The strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3 (rs1051730[A], b = 1.03, standard error (s.e.) = 0.053, beta = 2.8 x 10(-73)). Two 10q25 SNPs (rs1329650[G], b = 0.367, s. e. = 0.059, beta = 5.7 x 10(-10); and rs1028936[A], b = 0.446, s. e. = 0.074, beta = 1.3 x 10(-9)) and one 9q13 SNP in EGLN2 (rs3733829[G], b = 0.333, s. e. = 0.058, P = 1.0 x 10(-8)) also exceeded genome-wide significance for cigarettes per day. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in BDNF on chromosome 11 (rs6265[C], odds ratio (OR) = 1.06, 95% confidence interval (Cl) 1.04-1.08, P = 1.8 x 10(-8)). One SNP located near DBH on chromosome 9 (rs3025343[G], OR = 1.12, 95% Cl 1.08-1.18, P = 3.6 x 10(-8)) was significantly associated with smoking cessation.	[Furberg, Helena; Kim, YunJung; Dackor, Jennifer; Mohlke, Karen L.; Ioannidis, John P. A.; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Furberg, Helena; Mohlke, Karen L.; Ioannidis, John P. A.; Sullivan, Patrick F.] Univ N Carolina, Univ N Carolina Lineberger Comprehens Canc Ct, Chapel Hill, NC USA; [Boerwinkle, Eric; Lin, Dan-Yu] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric; Lin, Dan-Yu] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Ardissino, Diego] Univ Parma, Azienda Osped, Div Cardiol, I-43100 Parma, Italy; [Bernardinelli, Luisa] Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB2 1SB, England; [Bernardinelli, Luisa] Univ Pavia, Dept Appl Hlth Sci, I-27100 Pavia, Italy; [Mannucci, Pier M.] Univ Milan, Dept Internal Med & Med Specialties, Fondaz Ist Ricovero & Cura Carattere Sci, Osped Maggiore, Milan, Italy; [Mauri, Francesco; Merlini, Piera A.] Azienda Osped Niguarda Ca Granda, Dept Cardiol, Milan, Italy; [Absher, Devin; Ioannidis, John P. A.; Lin, Dan-Yu] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Assimes, Themistocles L.; Knowles, Joshua W.; Quertermous, Thomas] Stanford Univ, Stanford, CA 94305 USA; [Fortmann, Stephen P.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Iribarren, Carlos] Kaiser Permanente No Calif Div Res, Oakland, CA USA; [Tanaka, Toshiko] NIA, Medstart Res Inst, Baltimore, MD 21224 USA; [Bis, Joshua C.; McKnight, Barbara; Psaty, Bruce M.; Thacker, Evan L.; Schwartz, Stephen M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Furberg, Curt D.] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Winston Salem, NC USA; [Haritunians, Talin; Taylor, Kent D.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Thacker, Evan L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Almgren, Peter; Groop, Leif; Ladenvall, Claes] Lund Univ, Diabet & Endocrinol Unit, Dept Clin Sci, Malmo, Sweden; [Boehnke, Michael; Jackson, Anne U.; Stringham, Heather M.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Tuomilehto, Jaakko; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] Finland S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Hwang, Shih-Jen; Preis, Sarah Rosner] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Levy, Daniel; Vasan, Ramachandran S.] Boston Univ, Sect Prevent Med, Dept Med, Sch Med, Boston, MA 02118 USA; [Levy, Daniel; Vasan, Ramachandran S.] Boston Univ, Cardiol Sect, Dept Med, Sch Med, Boston, MA 02118 USA; [Duan, Jubao; Gejman, Pablo V.; Sanders, Alan R.] NorthShore Univ, Ctr Psychiat Genet, HealthSyst Res Inst, Evanston, IL USA; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Lips, Esther H.; Mckay, James D.; Brennan, Paul] IARC, Lyon, France; [Agudo, Antonio; Castellsague, Xavier] Inst Catala Oncol, Barcelona, Spain; [Barzan, Luigi] Gen Hosp, Pordenone, Italy; [Bencko, Vladimir; Holcatova, Ivana] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Benhamou, Simone] INSERM, U794, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, Villejuif, France; [Canova, Cristina] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Conway, David I.] Univ Glasgow, Sch Dent, Fac Med, Glasgow, Lanark, Scotland; [Fabianova, Eleonora] Specialized Inst Hyg & Epidemiol, Banska Bystrica, Slovakia; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Healy, Claire M.] Trinity Coll Dublin, Sch Dent Sci, Dublin, Ireland; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Lagiou, Pagona] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Lissowska, Jolanta] Maria Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lowry, Ray] Univ Newcastle, Sch Dent, Newcastle Upon Tyne, Tyne & Wear, England; [Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania; [Richiardi, Lorenzo] Univ Turin, Ctr Expt Res & Med Studies, Turin, Italy; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Zaridze, David] Inst Carcinogenesis Canc Res Ctr, Moscow, Russia; [Znaor, Ariana] Croatian Natl Canc Registry, Zagreb, Croatia; [Lathrop, Mark] Inst Genom Comissariat Energie Atom, Ctr Natl Genotypage, Evry, France; [Lathrop, Mark] Fondat Jean Dausset Ctr Etud Polymorphisme Humain, Paris, France; [Bandinelli, Stefania] Azienda Sanitaria Firenze, Geriatr Unit, Florence, Italy; [Frayling, Timothy M.; Perry, John R. B.] Univ Exeter, Peninsula Med Sch, Genet Complex Traits, Exeter, Devon, England; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD USA; [Milaneschi, Yuri] Tuscany Hlth Reg Agcy, Florence, Italy; [Altshuler, David; Kathiresan, Sek] Broad Inst Harvard, Cambridge, MA USA; [Altshuler, David; Kathiresan, Sek] MIT, Cambridge, MA 02139 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Altshuler, David; Kathiresan, Sek] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Elosua, Roberto; Lucas, Gavin] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Salomaa, Veikko; Kaprio, Jaakko] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Voight, Benjamin F.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Penninx, Brenda W.; Smit, Johannes H.; Vogelzangs, Nicole] Vrije Univ VU, EMGO Inst, Med Ctr, Amsterdam, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.; Vogelzangs, Nicole] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Boomsma, Dorret I.; de Geus, Eco J. C.; Vink, Jacqueline M.; Willemsen, Gonneke] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gu, Fangyi; Hunter, David J.; Kraft, Peter] Harvard Univ, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Hankinson, Susan E.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Hofman, Albert; Tiemeier, Henning; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Walter, Stefan] Erasmus MC, Member Netherlands Consortium Healthy Aging, Dept Epidemiol, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van Duijn, Cornelia M.] Erasmus MC, Ctr Med Syst Biol, Rotterdam, Netherlands; [Walter, Stefan] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Chasman, Daniel I.; Everett, Brendan M.; Pare, Guillaume; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Prevent Med,Sch Med, Boston, MA 02115 USA; [Everett, Brendan M.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med,Sch Med, Boston, MA 02115 USA; [Li, Ming D.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Maes, Hermine H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Maes, Hermine H.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Audrain-McGovern, Janet; Lerman, Caryn] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Posthuma, Danielle] Vrije Univ Amsterdam, Dept Funct Gen, Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Med Genom, Amsterdam, Netherlands; [Thornton, Laura M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Lerman, Caryn] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Rose, Jed E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Tufts Univ, Sch Med, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Genet Epidemiol & Modeling, Boston, MA USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA		Furberg, H (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	helena_furberg@med.unc.edu; pfsulliv@med.unc.edu	Altshuler, David M/A-4476-2009; Hernandez, Tonia/J-9335-2012; Bernardinelli, Luisa/AAL-5750-2021; Ioannidis, John P. A./G-9836-2011; Lucas, Gavin/D-4346-2012; Pare, Guillaume/T-9631-2018; Vink, Jacqueline/A-7648-2012; Lissowska, Jolanta/AAH-3252-2020; Levy, Daniel/ABB-2752-2021; Znaor, A/H-6718-2019; Tiemeier, Henning/H-6534-2019; Janout, Vladimir/M-5133-2014; Holcatova, Ivana/C-8327-2017; Gu, Fangyi/I-5957-2014; Benjamin, Emelia/E-7103-2011; Benhamou, Simone/ABD-2590-2020; Kaprio, Jaakko/A-1820-2008; Boomsma, Dorret I/AAX-4470-2020; Ardissino, Diego/AAC-4041-2022; Pique, Xavier Castellsague/N-5795-2014; Bencko, Vladimir/H-8598-2017; Voight, Benjamin/F-1775-2011; Ramachandran, Vasan/Y-2527-2019; Zaridze, David/K-5605-2013; Benhamou, Simone/K-6554-2015; de Geus, Eco J.C./M-9318-2015; Szeszenia-Dabrowska, Neonila/F-7190-2010; ****, ****/F-3368-2011; richiardi, lorenzo/J-3480-2018; Agudo, Antonio/J-1805-2016	Altshuler, David M/0000-0002-7250-4107; Pare, Guillaume/0000-0002-6795-4760; Lissowska, Jolanta/0000-0003-2695-5799; Tiemeier, Henning/0000-0002-4395-1397; Holcatova, Ivana/0000-0002-1366-0337; Benjamin, Emelia/0000-0003-4076-2336; Kaprio, Jaakko/0000-0002-3716-2455; Pique, Xavier Castellsague/0000-0002-0802-3595; Bencko, Vladimir/0000-0003-1935-2228; Ramachandran, Vasan/0000-0001-7357-5970; de Geus, Eco J.C./0000-0001-6022-2666; solinas, emilia/0000-0003-3532-1317; Healy, Claire/0000-0003-0583-6360; Macfarlane, Tatiana/0000-0002-9392-0812; Posthuma, Danielle/0000-0001-7582-2365; Van Duijn, Cornelia/0000-0002-2374-9204; Thacker, Evan/0000-0002-3813-0885; BENHAMOU, Simone/0000-0001-5853-8047; Melander, Olle/0000-0002-2581-484X; Conway, David/0000-0001-7762-4063; richiardi, lorenzo/0000-0003-0316-9402; Willemsen, Gonneke/0000-0003-3755-0236; Agudo, Antonio/0000-0001-9900-5677; Foretova, Lenka/0000-0003-0494-2620; CANOVA, CRISTINA/0000-0001-7027-7935; Lucas, Gavin/0000-0003-4166-9416; Venkatasubramanian, Siddharth/0000-0002-5860-0768; mates, dana/0000-0002-6219-9807; Kjaerheim, Kristina/0000-0003-0691-3735; Walter, Stefan/0000-0002-6010-7550; Healy, Claire M/0000-0001-7940-4611	University of North Carolina Lineberger Comprehensive Cancer Center University; US National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K07 CA118412]; Netherlands Scientific Organization [NWO 480-05-003]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K07CA118412, R01CA082659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL087647, U01HL054527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK072193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA012844] Funding Source: NIH RePORTER	This work was funded by the University of North Carolina Lineberger Comprehensive Cancer Center University Cancer Research Fund Award and by US National Cancer Institute K07 CA118412 to H. F. Statistical analyses were carried out on the Genetic Cluster Computer (see URLs), which is supported by the Netherlands Scientific Organization (NWO 480-05-003). Acknowledgments for studies included in TAG are listed in the Supplementary Note.	Centers for Disease Contral and Prevention. Cigarette smoking among adults-United States, 2006, MMWR-MORBID MORTAL W, V56, P1157; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; FIORE MC, 1994, JAMA-J AM MED ASSOC, V271, P1940, DOI 10.1001/jama.271.24.1940; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/twin.5.5.366; Kaprio J, 2002, TWIN RES, V5, P358, DOI 10.1375/136905202320906093; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lin DY, 2009, GENET EPIDEMIOL, V33, P256, DOI 10.1002/gepi.20377; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mwenifumbo Jill C, 2009, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-540-69248-5_9; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Pereira TV, 2009, AM J EPIDEMIOL, V170, P1197, DOI 10.1093/aje/kwp262; Pomerleau OF, 2007, NICOTINE TOB RES, V9, P883, DOI 10.1080/14622200701485125; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Ray R, 2009, J NEUROGENET, V23, P252, DOI 10.1080/01677060802572887; ROSE RJ, 2009, HDB BEHAV GENETICS, V1, P411; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1281; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	41	775	777	0	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					441	U134		10.1038/ng.571			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	WOS:000277179500017	20418890	Green Accepted, Green Submitted			2022-01-24	
J	KIMURA, M				KIMURA, M			ON PROBABILITY OF FIXATION OF MUTANT GENES IN A POPULATION	GENETICS			English	Article																	FISHER R. A., 1930, PROC ROY SOC EDINBURGH, V50, P204; Fisher Ronald A., 1922, P R SOC EDINBURGH, V42, P321, DOI DOI 10.1007/BF02459576; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; KIMURA M, 1955, COLD SPRING HARB SYM, V20, P33, DOI 10.1101/SQB.1955.020.01.006; KIMURA M, 1954, GENETICS, V39, P280; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1949, P365; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5; Wright S, 1938, P NATL ACAD SCI USA, V24, P253, DOI 10.1073/pnas.24.7.253	11	774	777	0	34	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1962	47	6					713	&					0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	1898B	WOS:A19621898B00007	14456043				2022-01-24	
J	CLAUS, EB; RISCH, N; THOMPSON, WD				CLAUS, EB; RISCH, N; THOMPSON, WD			GENETIC-ANALYSIS OF BREAST-CANCER IN THE CANCER AND STEROID-HORMONE STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGREGATION ANALYSIS; FAMILY HISTORY; RISK; HETEROGENEITY	The familial risk of breast cancer is investigated in a large population-based, case-control study conducted by the Centers for Disease Control. The data set is based on 4,730 histologically confirmed breast cancer cases aged 20 to 54 years and on 4,688 controls who were frequency matched to the basis of both geographic region and 5-year categories of age, and it includes family histories, obtained through interviews of cases and controls, of breast cancer in mothers and sisters. Segregation analysis and goodness-of-fit tests of genetic models provide evidence for the existence of a rare autosomal dominant allele (q = .0033) leading to increased susceptibility to breast cancer. The effect of genotype on the risk of breast cancer is shown to be a function of a woman's age. Although, compared with noncarriers, carriers of the allele appear to be at greater risk at all ages, the ratio of age-specific risks is greatest at young ages and declines steadily thereafter. The proportion of cases predicted to carry the allele is highest (36%) among cases aged 20-29 years. This proportion gradually decreases to 1% among cases aged 80 years or older. The cumulative lifetime risk of breast cancer for women who carry the susceptibility allele is predicted to be high, approximately 92%, while the cumulative lifetime risk for noncarriers is estimated to be approximately 10%.	YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV SO MAINE,PORTLAND,ME 04103		CLAUS, EB (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,NEW HAVEN,CT 06510, USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007085] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [3-Y01-HD-8-1037] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [2-T32-ES07085] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM39812] Funding Source: Medline		BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; CLAUS EB, 1990, ANN HUM GENET, V54, P169, DOI 10.1111/j.1469-1809.1990.tb00373.x; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; GO RCP, 1983, J NATL CANCER I, V71, P455; GOLDSTEIN AM, 1987, JNCI-J NATL CANCER I, V78, P911; GOLDSTEIN AM, 1988, GENET EPIDEMIOL, V5, P121, DOI 10.1002/gepi.1370050207; KAPLAN EB, 1972, I STAT MIMEO SER, V823; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1980, 3 POP GEN LAB TECH R; LYNCH HT, 1988, BREAST CANCER RES TR, V12, P275, DOI 10.1007/BF01811240; LYNCH HT, 1988, BREAST CANCER RES TR, V11, P263, DOI 10.1007/BF01807285; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; SATTIN RW, 1985, JAMA-J AM MED ASSOC, V253, P1908, DOI 10.1001/jama.253.13.1908; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; SCHWARTZ AG, 1985, JNCI-J NATL CANCER I, V75, P665; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; WINGO PA, 1988, AM J EPIDEMIOL, V128, P206, DOI 10.1093/oxfordjournals.aje.a114942; [No title captured]	18	773	786	0	23	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					232	242					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	WOS:A1991EV74400008	1990835				2022-01-24	
J	Steinthorsdottir, V; Thorleifsson, G; Reynisdottir, I; Benediktsson, R; Jonsdottir, T; Walters, GB; Styrkarsdottir, U; Gretarsdottir, S; Emilsson, V; Ghosh, S; Baker, A; Snorradottir, S; Bjarnason, H; Ng, MCY; Hansen, T; Bagger, Y; Wilensky, RL; Reilly, MP; Adeyemo, A; Chen, YX; Zhou, J; Gudnason, V; Chen, GJ; Huang, HX; Lashley, K; Doumatey, A; So, WY; Ma, RCY; Andersen, G; Borch-Johnsen, K; Jorgensen, T; van Vliet-Ostaptchouk, JV; Hofker, MH; Wijmenga, C; Christiansen, C; Rader, DJ; Rotimi, C; Gurney, M; Chan, JCN; Pedersen, O; Sigurdsson, G; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Reynisdottir, Inga; Benediktsson, Rafn; Jonsdottir, Thorbjorg; Walters, G. Bragi; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Emilsson, Valur; Ghosh, Shyamali; Baker, Adam; Snorradottir, Steinunn; Bjarnason, Hjordis; Ng, Maggie C. Y.; Hansen, Torben; Bagger, Yu; Wilensky, Robert L.; Reilly, Muredach P.; Adeyemo, Adebowale; Chen, Yuanxiu; Zhou, Jie; Gudnason, Vilmundur; Chen, Guanjie; Huang, Hanxia; Lashley, Kerrie; Doumatey, Ayo; So, Wing-Yee; Ma, Ronald C. Y.; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; van Vliet-Ostaptchouk, Jana V.; Hofker, Marten H.; Wijmenga, Cisca; Christiansen, Claus; Rader, Daniel J.; Rotimi, Charles; Gurney, Mark; Chan, Juliana C. N.; Pedersen, Oluf; Sigurdsson, Gunnar; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			A variant in CDKAL1 influences insulin response and risk of type 2 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CONFERS RISK; GENE; GLUCOSE; IDENTIFICATION; SECRETION; STROKE; IMPACT	We conducted a genome-wide association study for type 2 diabetes (T2D) in Icelandic cases and controls, and we found that a previously described variant in the transcription factor 7-like 2 gene (TCF7L2) gene conferred the most significant risk. In addition to confirming two recently identified risk variants(1), we identified a variant in the CDKAL1 gene that was associated with T2D in individuals of European ancestry (allele-specific odds ratio (OR) = 1.20 (95% confidence interval, 1.13 - 1.27), P = 7.7 x 10(-9)) and individuals from Hong Kong of Han Chinese ancestry (OR = 1.25 (1.11 - 1.40), P = 0.00018). The genotype OR of this variant suggested that the effect was substantially stronger in homozygous carriers than in heterozygous carriers. The ORs for homozygotes were 1.50 (1.31 - 1.72) and 1.55 (1.23 - 1.95) in the European and Hong Kong groups, respectively. The insulin response for homozygotes was approximately 20% lower than for heterozygotes or noncarriers, suggesting that this variant confers risk of T2D through reduced insulin secretion.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, IS-101 Reykjavik, Iceland; Icelandic Heart Assoc, IS-201 Kopavogur, Iceland; Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Howard Univ, Natl Human Genome Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Aarhus Univ, Fac Hlth Sci, DK-8000 Aarhus, Denmark; Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; Univ Groningen, Med Ctr, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Genet, NL-9700 RB Groningen, Netherlands; Univ Utrecht, Med Ctr, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands		Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	vstein@decode.is; kstefans@decode.is	Pedersen, Oluf/AAG-8015-2020; Wijmenga, Cisca/D-2173-2009; Gudnason, Vilmundur/K-6885-2015; Pedersen, Oluf/Z-1731-2019; Ma, Ronald/C-2788-2009; Stefansson, Kari/AAE-7187-2019; Wijmenga, Cisca/AAE-7719-2019; Walters, G. Bragi/L-4215-2013; Gudnason, Vilmundur/AAE-7126-2019; Jorgensen, Torben/Z-1335-2018; Benediktsson, Rafn/R-2457-2018; Chan, Juliana/B-7918-2016	Gudnason, Vilmundur/0000-0001-5696-0084; Pedersen, Oluf/0000-0002-3321-3972; Ma, Ronald/0000-0002-1227-803X; Wijmenga, Cisca/0000-0002-5635-1614; Walters, G. Bragi/0000-0002-5415-6487; Gudnason, Vilmundur/0000-0001-5696-0084; Benediktsson, Rafn/0000-0002-2954-9801; Chan, Juliana/0000-0003-1325-1194; Jorgensen, Torben/0000-0001-9453-2830; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Kong, Augustine/0000-0001-8193-5438; Reilly, Muredach/0000-0002-3035-9386; Hansen, Torben/0000-0001-8748-3831; Styrkarsdottir, Unnur/0000-0001-8146-8278; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Emilsson, Valur/0000-0001-9982-0524; Adeyemo, Adebowale/0000-0002-3105-3231	FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [T37TW000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK072128] Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [3T37TW00041-03S2] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR03048] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK072128] Funding Source: Medline		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; Rice JA., 1995, MATH STAT DATA ANAL, V2nd edn; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273	26	770	807	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					770	775		10.1038/ng2043			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	WOS:000246859100021	17460697	Green Published			2022-01-24	
J	Babitt, JL; Huang, FW; Wrighting, DM; Xia, Y; Sidis, Y; Samad, TA; Campagna, JA; Chung, RT; Schneyer, AL; Woolf, CJ; Andrews, NC; Lin, HY				Babitt, JL; Huang, FW; Wrighting, DM; Xia, Y; Sidis, Y; Samad, TA; Campagna, JA; Chung, RT; Schneyer, AL; Woolf, CJ; Andrews, NC; Lin, HY			Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression	NATURE GENETICS			English	Article							REPULSIVE GUIDANCE MOLECULE; 1Q-LINKED JUVENILE HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE HEPCIDIN; GROWTH-FACTOR-BETA; IRON OVERLOAD; GENE-EXPRESSION; LIVER-CELLS; I RECEPTOR; MOUSE; INFLAMMATION	Hepcidin is a key regulator of systemic iron homeostasis. Hepcidin deficiency induces iron overload, whereas hepcidin excess induces anemia. Mutations in the gene encoding hemojuvelin (HFE2, also known as HJV) cause severe iron overload and correlate with low hepcidin levels, suggesting that hemojuvelin positively regulates hepcidin expression. Hemojuvelin is a member of the repulsive guidance molecule (RGM) family, which also includes the bone morphogenetic protein (BMP) coreceptors RGMA and DRAGON (RGMB). Here, we report that hemojuvelin is a BMP coreceptor and that hemojuvelin mutants associated with hemochromatosis have impaired BMP signaling ability. Furthermore, BMP upregulates hepatocyte hepcidin expression, a process enhanced by hemojuvelin and blunted in Hfe2(-/-) hepatocytes. Our data suggest a mechanism by which HFE2 mutations cause hemochromatosis: hemojuvelin dysfunction decreases BMP signaling, thereby lowering hepcidin expression.	Harvard Univ, Sch Med, Program Membrane Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Nephrol, Massachusetts Gen Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neural Plast Res Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA		Lin, HY (corresponding author), Harvard Univ, Sch Med, Program Membrane Biol, Boston, MA 02115 USA.	hlin@partners.org	Xia, Yin/M-5440-2018; Woolf, Clifford/A-9784-2010	Xia, Yin/0000-0003-0315-7532; Andrews, Nancy/0000-0003-0243-4462	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK069533, F32DK068997, K08DK075846, R01DK066373, R01DK071837] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL07623] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K08 DK075846-01, R01 DK066373-03, F32 DK068997-02, F32 DK068997, K08 DK075846, R01 DK066373, DK-71837, F32 DK-068997, DK-69533] Funding Source: Medline		ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1016/0270-9139(94)90203-8; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7; del Re E, 2004, J BIOL CHEM, V279, P22765, DOI 10.1074/jbc.M401350200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Huang FW, 2004, BLOOD, V104, P2176, DOI 10.1182/blood-2004-01-0400; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Knittel T, 1997, EXP CELL RES, V232, P263, DOI 10.1006/excr.1997.3504; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee PL, 2004, BLOOD, V103, P4669, DOI 10.1182/blood-2004-01-0072; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Martinez AR, 2004, HAEMATOLOGICA, V89, P1441; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Miller SI, 2000, AM J ADDICTION, V9, P275; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	50	769	819	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					531	539		10.1038/ng1777			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	WOS:000237147500014	16604073				2022-01-24	
J	Moffitt, RA; Marayati, R; Flate, EL; Volmar, KE; Loeza, SGH; Hoadley, KA; Rashid, NU; Williams, LA; Eaton, SC; Chung, AH; Smyla, JK; Anderson, JM; Kim, HJ; Bentrem, DJ; Talamonti, MS; Iacobuzio-Donahue, CA; Hollingsworth, MA; Yeh, JJ				Moffitt, Richard A.; Marayati, Raoud; Flate, Elizabeth L.; Volmar, Keith E.; Loeza, S. Gabriela Herrera; Hoadley, Katherine A.; Rashid, Naim U.; Williams, Lindsay A.; Eaton, Samuel C.; Chung, Alexander H.; Smyla, Jadwiga K.; Anderson, Judy M.; Kim, Hong Jin; Bentrem, David J.; Talamonti, Mark S.; Iacobuzio-Donahue, Christine A.; Hollingsworth, Michael A.; Yeh, Jen Jen			Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma	NATURE GENETICS			English	Article							GENE-EXPRESSION; MUTATIONAL PROCESSES; CANCER TYPES; PATTERNS; FIBROBLASTS; SIGNATURES; ENRICHMENT; LANDSCAPE; INSIGHTS; PATHWAYS	Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes capturing precise tumor-specific molecular information difficult. Here we have overcome this problem by applying blind source separation to a diverse collection of PDAC gene expression microarray data, including data from primary tumor, metastatic and normal samples. By digitally separating tumor, stromal and normal gene expression, we have identified and validated two tumor subtypes, including a 'basal-like' subtype that has worse outcome and is molecularly similar to basal tumors in bladder and breast cancers. Furthermore, we define 'normal' and 'activated' stromal subtypes, which are independently prognostic. Our results provide new insights into the molecular composition of PDAC, which may be used to tailor therapies or provide decision support in a clinical setting where the choice and timing of therapies are critical.	[Moffitt, Richard A.; Marayati, Raoud; Flate, Elizabeth L.; Loeza, S. Gabriela Herrera; Hoadley, Katherine A.; Rashid, Naim U.; Williams, Lindsay A.; Smyla, Jadwiga K.; Kim, Hong Jin; Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Volmar, Keith E.] Univ N Carolina, Rex Healthcare, Chapel Hill, NC USA; [Hoadley, Katherine A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Williams, Lindsay A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Eaton, Samuel C.; Chung, Alexander H.; Yeh, Jen Jen] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Anderson, Judy M.; Hollingsworth, Michael A.] Univ Nebraska, Eppley Canc Inst, Lincoln, NE USA; [Kim, Hong Jin; Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Bentrem, David J.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Bentrem, David J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Talamonti, Mark S.] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, David Rubenstein Ctr Pancreat Canc Res, Human Oncol & Pathogenesis Program, New York, NY 10021 USA		Yeh, JJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jen_jen_yeh@med.unc.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Hoadley, Katherine/0000-0002-1216-477X; Williams, Lindsay/0000-0003-3842-4629; Moffitt, Richard/0000-0003-2723-5902	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30-DK034897]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-CA140424]; Kimmel Foundation; American College of Surgeons; University Cancer Research Fund; UNC Lineberger Comprehensive Cancer Center Postdoctoral Training Grant from the US NIH [T32-CA009156]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA060553, T32CA009156, R01CA140424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES010126] Funding Source: NIH RePORTER	We thank the University of North Carolina (UNC) Tissue Procurement, Translational Pathology Laboratory, Animal Studies, Animal Histopathology, and Center for Gastrointestinal Biology and Disease Histopathology core facilities (NIH grant P30-DK034897), the PDX Program and Department of Pharmacology for tremendous technical support. We thank the patients and their families who generously donated their samples to research and in particular to the University of Nebraska Medical Center Rapid Autopsy Pancreatic Program and the Johns Hopkins Gastrointestinal Cancer Rapid Medical Donation Program. This work was partially supported by grant R01-CA140424 from the US National Institutes of Health (NIH) (J.J.Y.), the Kimmel Foundation (J.J.Y.), the American College of Surgeons (J.J.Y.), the University Cancer Research Fund (J.J.Y.) and UNC Lineberger Comprehensive Cancer Center Postdoctoral Training Grant T32-CA009156 from the US NIH (R.A.M.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dal Molin M, 2015, CLIN CANCER RES, V21, P1944, DOI 10.1158/1078-0432.CCR-14-2600; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Haeger SM, 2016, ONCOGENE, V35, P577, DOI 10.1038/onc.2015.112; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JJ, 2014, P NATL ACAD SCI USA, V111, pE3091, DOI 10.1073/pnas.1411679111; Logsdon CD, 2003, CANCER RES, V63, P2649; McConkey D, 2015, EUR UROL, V67, pE76, DOI 10.1016/j.eururo.2014.08.064; Neel NF, 2014, MOL CANCER THER, V13, P122, DOI 10.1158/1535-7163.MCT-12-1232; Nishimura D. BioCarta, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI 10.1089/152791601750294344; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Stolze B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08535; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wamunyokoli FW, 2006, CLIN CANCER RES, V12, P690, DOI 10.1158/1078-0432.CCR-05-1110; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	61	766	782	5	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1168	+		10.1038/ng.3398			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	WOS:000361969900012	26343385	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Vilella, AJ; Severin, J; Ureta-Vidal, A; Heng, L; Durbin, R; Birney, E				Vilella, Albert J.; Severin, Jessica; Ureta-Vidal, Abel; Heng, Li; Durbin, Richard; Birney, Ewan			EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates	GENOME RESEARCH			English	Article							MAXIMUM-LIKELIHOOD; GENOME SEQUENCE; DATABASE; EVOLUTION; INSIGHTS; ALGORITHM; ORTHOLOGS; FAMILIES; PARALOGS	We have developed a comprehensive gene orientated phylogenetic resource, EnsemblCompara GeneTrees, based on a computational pipeline to handle clustering, multiple alignment, and tree generation, including the handling of large gene families. We developed two novel non-sequence-based metrics of gene tree correctness and benchmarked a number of tree methods. The TreeBeST method from TreeFam shows the best performance in our hands. We also compared this phylogenetic approach to clustering approaches for ortholog prediction, showing a large increase in coverage using the phylogenetic approach. All data are made available in a number of formats and will be kept up to date with the Ensembl project.	[Vilella, Albert J.; Severin, Jessica; Ureta-Vidal, Abel; Birney, Ewan] EMBL EBI, Cambridge CB10 1SD, England; [Heng, Li; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England		Birney, E (corresponding author), EMBL EBI, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	birney@ebi.ac.uk	Li, Heng/D-9344-2011; Durbin, Richard/AAE-7178-2019; Vilella, Albert/A-8586-2008; Severin, Jessica/AAQ-2723-2020	Li, Heng/0000-0003-4874-2874; Durbin, Richard/0000-0002-9130-1006; Severin, Jessica/0000-0003-1274-208X; Vilella, Albert/0000-0002-2005-2516; Birney, Ewan/0000-0001-8314-8497	Wellcome TrustWellcome TrustEuropean Commission; EMBL	We thank Chris Ponting, Leo Goodstadt, and Andreas Heger for providing the recent PhyOP run and many useful discussions. We also thank the rest of the TreeFam and the Ensembl teams for many insightful discussions. We thank Michael Hoffman for his assistance in using R. We also thank the Sanger Institute computer services for the reliable running of the compute farm. A. V., A. U.-V., and J. S. were supported by the Wellcome Trust; E. B. was supported by EMBL; R. D. and L. H. were supported by the Wellcome Trust via the Sanger Institute.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dehal PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-201; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENNIG W, 1952, GRUNDZUGE THEORIE PH; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	27	765	771	1	49	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2009	19	2					327	335		10.1101/gr.073585.107			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	404ED	WOS:000263132600016	19029536	Green Published, Bronze			2022-01-24	
J	Do, CB; Mahabhashyam, MSP; Brudno, M; Batzoglou, S				Do, CB; Mahabhashyam, MSP; Brudno, M; Batzoglou, S			ProbCons: Probabilistic consistency-based multiple sequence alignment	GENOME RESEARCH			English	Article							PROTEIN-STRUCTURE ALIGNMENTS; STRUCTURE PREDICTION; SECONDARY STRUCTURE; PHYLOGENETIC TREES; TWILIGHT ZONE; LINEAR-SPACE; DATABASE; ALGORITHM; FAMILIES; ACCURACY	To study gene evolution across a wide range of organisms, biologists need accurate tools for Multiple sequence alignment of protein families. Obtaining accurate alignments, however, is a difficult computational problem because of not only the high computational cost but also the lack of proper objective functions for measuring alignment quality. In this paper, we introduce probabilistic consistency, a novel scoring function for multiple sequence comparisons. We present ProbCons, a practical tool for progressive protein multiple sequence alignment based oil probabilistic consistency, and evaluate its performance on several standard alignment benchmark data sets. On the BAHBASE, SABmark, and PREFAB benchmark alignment databases, ProbCons achieves statistically significant improvement over other leading methods while maintaining practical speed. ProbCons is publicly available as a Web resource.	Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA		Batzoglou, S (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	serafim@cs.stanford.edu			NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01 HG003162, U01-HG003162] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG003162] Funding Source: NIH RePORTER		ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1989, J MOL BIOL, V207, P647, DOI 10.1016/0022-2836(89)90234-9; Attwood Terri K, 2002, Brief Bioinform, V3, P252, DOI 10.1093/bib/3.3.252; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479; BOUTONNET NS, 1995, PROTEIN ENG, V8, P647, DOI 10.1093/protein/8.7.647; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; CARRILLO H, 1988, SIAM J APPL MATH, V48, P1073, DOI 10.1137/0148063; Castillo-Davis CI, 2004, GENOME RES, V14, P802, DOI 10.1101/gr.2195604; CHAO KM, 1993, COMPUT APPL BIOSCI, V9, P387; Do CB, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P703; Durbin R, 1998, BIOL SEQUENCE ANAL; EDDY SR, 1995, P 3 INT C INT SYST M, P114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; GOTOH O, 1990, B MATH BIOL, V52, P509, DOI 10.1016/S0092-8240(05)80359-3; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; HEGER A, 2003, P 7 ANN INT C COMP M, P139; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P1091; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Holmes I, 1998, J COMPUT BIOL, V5, P493, DOI 10.1089/cmb.1998.5.493; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Jaroszewski L, 2002, PROTEIN SCI, V11, P1702, DOI 10.1110/ps.4820102; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KECECIOGLU J, 1993, P 4 S COMB PATT MATC, V684, P106; KIM J, 1994, COMPUT APPL BIOSCI, V10, P419; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; KSCHISCHO M, 2000, PAC S BIOCOMPUT, V5, P621; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Miyazawa S, 1995, PROTEIN ENG, V8, P999, DOI 10.1093/protein/8.10.999; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Morgenstern B, 1998, BIOINFORMATICS, V14, P290, DOI 10.1093/bioinformatics/14.3.290; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1016/S0022-2836(05)80134-2; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notredame C, 1996, NUCLEIC ACIDS RES, V24, P1515, DOI 10.1093/nar/24.8.1515; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Notredame C, 1998, BIOINFORMATICS, V14, P407, DOI 10.1093/bioinformatics/14.5.407; Orcutt B., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Phillips A, 2000, MOL PHYLOGENET EVOL, V16, P317, DOI 10.1006/mpev.2000.0785; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Schlosshauer M, 2002, BIOINFORMATICS, V18, P847, DOI 10.1093/bioinformatics/18.6.847; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sneath P. H. A., 1973, NUMERICAL TAXONOMY; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Thompson JD, 1999, BIOINFORMATICS, V15, P87, DOI 10.1093/bioinformatics/15.1.87; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Van Walle I, 2004, BIOINFORMATICS, V20, P1428, DOI 10.1093/bioinformatics/bth116; VINGRON M, 1994, J MOL BIOL, V235, P1, DOI 10.1016/S0022-2836(05)80006-3; VINGRON M, 1990, PROTEIN ENG, V3, P565, DOI 10.1093/protein/3.7.565; VINGRON M, 1989, COMPUT APPL BIOSCI, V5, P115; VINGRON M, 1991, J MATH BIOL, V218, P34; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010	65	765	796	0	29	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2005	15	2					330	340		10.1101/gr.2821705			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	894AP	WOS:000226762500016	15687296	Bronze, Green Published			2022-01-24	
J	Jackson, RS; Creemers, JWM; Ohagi, S; RaffinSanson, ML; Sanders, L; Montague, CT; Hutton, JC; ORahilly, S				Jackson, RS; Creemers, JWM; Ohagi, S; RaffinSanson, ML; Sanders, L; Montague, CT; Hutton, JC; ORahilly, S			Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene	NATURE GENETICS			English	Article							CLEAVAGE; FURIN		UNIV CAMBRIDGE, DEPT MED, CAMBRIDGE CB2 2QQ, ENGLAND; UNIV CAMBRIDGE, DEPT CLIN BIOCHEM, CAMBRIDGE CB2 2QQ, ENGLAND; ADDENBROOKES HOSP, DEPT CLIN BIOCHEM, CAMBRIDGE CB2 2QQ, ENGLAND; UNIV LOUVAIN, MOL ONCOL LAB, CTR HUMAN GENET, B-3000 LOUVAIN, BELGIUM; FLANDERS INTERUNIV INST BIOTECHNOL, B-3000 LOUVAIN, BELGIUM; WAKAYAMA UNIV MED SCI, DEPT MED 1, WAKAYAMA 640, JAPAN; UNIV PARIS 05, INST COCHIN GENET MOL, INSERM CJF9208, GRP ETUD PHYSIOPATHOL ENDOCRINENNE, PARIS, FRANCE; UNIV COLORADO, HLTH SCI CTR, BARBARA DAVIS CTR CHILDHOOD DIABET, DENVER, CO 80262 USA					Montague, Carl/0000-0001-5411-9291	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Creemers JWM, 1996, J BIOL CHEM, V271, P25284, DOI 10.1074/jbc.271.41.25284; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fricker LD, 1996, J BIOL CHEM, V271, P30619, DOI 10.1074/jbc.271.48.30619; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KRAWCZAK M, 1992, HUM GENET, V90, P41; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Ohagi S, 1996, DIABETES, V45, P897, DOI 10.2337/diabetes.45.7.897; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SCRIVER CR, 1995, METABOLIC MOL BASIS, P269; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Taylor NA, 1997, BIOCHEM J, V321, P367, DOI 10.1042/bj3210367; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; YI Z, 1993, J BIOL CHEM, V268, P5615; Zaidi FK, 1997, DIABETIC MED, V14, P228, DOI 10.1002/(SICI)1096-9136(199703)14:3<228::AID-DIA330>3.0.CO;2-N	22	764	780	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1997	16	3					303	306		10.1038/ng0797-303			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	WOS:A1997XG60900029	9207799				2022-01-24	
J	Oda, T; Elkahloun, AG; Pike, BL; Okajima, K; Krantz, ID; Genin, A; Piccoli, DA; Meltzer, PS; Spinner, NB; Collins, FS; Chandrasekharappa, SC				Oda, T; Elkahloun, AG; Pike, BL; Okajima, K; Krantz, ID; Genin, A; Piccoli, DA; Meltzer, PS; Spinner, NB; Collins, FS; Chandrasekharappa, SC			Mutations in the human Jagged1 gene are responsible for Alagille syndrome	NATURE GENETICS			English	Article							ARTERIOHEPATIC DYSPLASIA; DELETION; FAMILY; NOTCH; MICRODELETIONS; CHROMOSOME-20; DROSOPHILA; REGION; 20P	Alagille syndrome (AGS) is an autosomal-dominant disorder characterized by intrahepatic cholestasis and abnormalities of heart, eye and vertebrae, as well as a characteristic facial appearance. Identification of rare AGS patients with cytogenetic deletions has allowed mapping of the gene to 20p12. We have generated a cloned contig of the critical region and used fluorescent in situ hybridization on cells from patients with submicroscopic deletions to narrow the candidate region to only 250 kb. Within this region we identified JAG1, the human homologue of rat Jagged1, which encodes a ligand for the Notch receptor. Cell-cell Jagged/Notch interactions are known to be critical for determination of cell fates in early development, making this an attractive candidate gene for a developmental disorder in humans. Determining the complete exon-intron structure of JAG1 allowed detailed mutational analysis of DNA samples from non-deletion ACS patients, revealing three frame-shift mutations, two splice donor mutations and one mutation abolishing RNA expression from the altered allele. We conclude that AGS is caused by haploinsufficiency of JAG1.	NATL HUMAN GENOME RES INST,LAB GENE TRANSFER,NIH,BETHESDA,MD 20892; NATL HUMAN GENOME RES INST,CANC GENET LAB,NIH,BETHESDA,MD 20892; NAGOYA CITY UNIV,SCH MED,DEPT PEDIAT,NAGOYA,AICHI 467,JAPAN; CHILDRENS HOSP,PHILADELPHIA,PA 19104; RES GENET INC,HUNTSVILLE,AL 35801								ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bao ZZ, 1997, J NEUROSCI, V17, P1425; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BYRNE JLB, 1986, AM J MED GENET, V24, P673, DOI 10.1002/ajmg.1320240411; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; Deleuze Jean-Francois, 1994, European Journal of Human Genetics, V2, P185; DELEUZE JF, 1994, MAMM GENOME, V5, P663, DOI 10.1007/BF00426072; DESMAZE C, 1992, J MED GENET, V29, P233, DOI 10.1136/jmg.29.4.233; DHOMEPOLLET S, 1994, J MED GENET, V31, P453; Elkahloun AG, 1996, GENE CHROMOSOME CANC, V17, P205, DOI 10.1002/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.0.CO;2-7; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; ELMSLIE FV, 1995, J MED GENET, V32, P264, DOI 10.1136/jmg.32.4.264; Garrod A, 1928, LANCET, V1, P1055; HATTORI M, 1995, NIPPON SHONIKA GAKKA, V99, P1984; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HOL FA, 1995, HUM GENET, V95, P687; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Krantz I. D., 1996, American Journal of Human Genetics, V59, pA224; Krantz ID, 1996, CYTOGENET CELL GENET, V74, P304; LEGIUS E, 1990, AM J MED GENET, V35, P532, DOI 10.1002/ajmg.1320350419; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; NYE JS, 1995, CURR BIOL, V5, P966, DOI 10.1016/S0960-9822(95)00189-8; ODA T, IN PRESS GENOMCIS; POLLET N, 1995, GENOMICS, V27, P467, DOI 10.1006/geno.1995.1078; RAND EB, 1995, AM J HUM GENET, V57, P1068; SCHNITTGER S, 1989, HUM GENET, V83, P239, DOI 10.1007/BF00285164; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Spinner N. B., 1995, American Journal of Human Genetics, V57, pA35; SPINNER NB, 1994, AM J HUM GENET, V55, P238; SPINNER NB, IN PRESS CYTOGENET C; TEEBI AS, 1992, AM J MED GENET, V42, P35, DOI 10.1002/ajmg.1320420109	37	763	786	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					235	242		10.1038/ng0797-235			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	WOS:A1997XG60900017	9207787	Green Published			2022-01-24	
J	TAJIMA, F				TAJIMA, F			SIMPLE METHODS FOR TESTING THE MOLECULAR EVOLUTIONARY CLOCK HYPOTHESIS	GENETICS			English	Article							RATES; PHYLOGENY	Simple statistical methods for testing the molecular evolutionary clock hypothesis are developed which can be applied to both nucleotide and amino acid sequences. These methods are based on the chi-square test and are applicable even when the pattern of substitution rates is unknown and/or the substitution rate varies among different sites. Furthermore, some of the methods can be applied even when the outgroup is unknown. Using computer simulations, these methods were compared with the likelihood ratio test and the relative rate test. The results indicate that the powers of the present methods are similar to those of the likelihood ratio test and the relative rate test, in spite of the fact that the latter two tests assume that the pattern of substitution rates follows a certain model and that the substitution rate is the same among different sites, while such assumptions are not necessary to apply the present methods. Therefore, the present methods might be useful.			TAJIMA, F (corresponding author), NATL INST GENET,DEPT POPULAT GENET,MISHIMA,SHIZUOKA 411,JAPAN.						EASTEAL S, 1990, GENETICS, V124, P165; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; JIN L, 1990, MOL BIOL EVOL, V7, P82; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL E; LI WH, 1990, P NATL ACAD SCI USA, V87, P6703, DOI 10.1073/pnas.87.17.6703; Marks J, 1992, CURR OPIN GENET DEV, V2, P883, DOI 10.1016/S0959-437X(05)80111-X; MUSE SV, 1992, GENETICS, V132, P269; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; ZUCKERKANDL EMILE, 1965, P97	13	763	780	2	31	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1993	135	2					599	607					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ432	WOS:A1993LZ43200029	8244016				2022-01-24	
J	Ondov, BD; Treangen, TJ; Melsted, P; Mallonee, AB; Bergman, NH; Koren, S; Phillippy, AM				Ondov, Brian D.; Treangen, Todd J.; Melsted, Pall; Mallonee, Adam B.; Bergman, Nicholas H.; Koren, Sergey; Phillippy, Adam M.			Mash: fast genome and metagenome distance estimation using MinHash	GENOME BIOLOGY			English	Article						Comparative genomics; Genomic distance; Alignment; Sequencing; Nanopore; Metagenomics	ALIGNMENT; SIMILARITY; ALGORITHM; SEQUENCES; SEARCH	Mash extends the MinHash dimensionality-reduction technique to include a pairwise mutation distance and P value significance test, enabling the efficient clustering and search of massive sequence collections. Mash reduces large sequences and sequence sets to small, representative sketches, from which global mutation distances can be rapidly estimated. We demonstrate several use cases, including the clustering of all 54,118 NCBI RefSeq genomes in 33 CPU h; real-time database search using assembled or unassembled Illumina, Pacific Biosciences, and Oxford Nanopore data; and the scalable clustering of hundreds of metagenomic samples by composition. Mash is freely released under a BSD license (https://github.com/marbl/mash).	[Ondov, Brian D.; Treangen, Todd J.; Mallonee, Adam B.; Bergman, Nicholas H.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA; [Melsted, Pall] Univ Iceland, Fac Ind Engn, Mech Engn & Comp Sci, Reykjavik, Iceland; [Koren, Sergey; Phillippy, Adam M.] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA		Phillippy, AM (corresponding author), NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA.	adam.phillippy@nih.gov	Phillippy, Adam M/U-5731-2018; Koren, Sergey/AAE-8314-2019; Melsted, Pall/K-8759-2015	Phillippy, Adam M/0000-0003-2983-8934; Koren, Sergey/0000-0002-1472-8962; Melsted, Pall/0000-0002-8418-6724	Intramural Research Program of the National Human Genome Research Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); Department of Homeland Security (DHS) Science and Technology Directorate (S&T) for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC)United States Department of Homeland Security (DHS) [HSHQDC-07-C-00020]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG200398] Funding Source: NIH RePORTER	This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, and under Contract No. HSHQDC-07-C-00020 awarded by the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the DHS or S&T. In no event shall the DHS, NBACC, S&T, or Battelle National Biodefense Institute (BNBI) have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. DHS does not endorse any products or commercial services mentioned in this publication.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bar-Yossef Z., 2002, Randomization and Approximation Techniques in Computer Science. 6th International Workshop, RANDOM 2002. Proceedings (Lecture Notes in Computer Science Vol.2483), P1; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Broder AZ, 2000, LECT NOTES COMPUT SC, V1848, P1; Chum O, 2008, P BRIT MACH VIS C 20; De Cristofaro E, 2012, P 2012 ACM WORKSH PR; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Deorowicz S, 2015, BIOINFORMATICS, V31, P1569, DOI 10.1093/bioinformatics/btv022; Drew J, 2014, P 5 ACM C BIOINF COM; Fan H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1647-5; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fofanov Y, 2004, BIOINFORMATICS, V20, P2421, DOI 10.1093/bioinformatics/bth266; Freedman MJ, 2004, LECT NOTES COMPUT SC, V3027, P1; Gough B., 2009, GNU SCI LIB REFERENC; Haubold B, 2015, BIOINFORMATICS, V31, P1169, DOI 10.1093/bioinformatics/btu815; Haubold B, 2014, BRIEF BIOINFORM, V15, P407, DOI 10.1093/bib/bbt083; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Indyk P, 1998, P 30 ANN ACM S THER; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lippert RA, 2002, P NATL ACAD SCI USA, V99, P13980, DOI 10.1073/pnas.202468099; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Maillet N, 2014, IEEE INT C BIOINFORM; Maillet N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S10; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Narayanan M, 2004, LECT NOTES COMPUT SC, V3240, P74; Patrascu M, 2012, J ACM, V59, DOI 10.1145/2220357.2220361; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rasheed Z, 2013, 2013 IEEE INT S PAR; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Roberts M, 2004, J COMPUT BIOL, V11, P734; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schatz MC, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-4; Seth S, 2014, BIOINFORMATICS, V30, P2471, DOI 10.1093/bioinformatics/btu340; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siek J. G., 2001, BOOST GRAPH LIB USER; Solomon B, 2015, BIORXIV, DOI [10.1101/ 017087, DOI 10.1101/017087]; Song L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0509-9; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Torney DC, 1990, COMPUTERS AND DNA; UKKONEN E, 1992, THEOR COMPUT SCI, V92, P191, DOI 10.1016/0304-3975(92)90143-4; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xiao Yang, 2011, Proceedings of the 25th IEEE International Parallel & Distributed Processing Symposium (IPDPS 2011), P1223, DOI 10.1109/IPDPS.2011.116; Yang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn075; Yi HG, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt003	55	762	767	10	50	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	JUN 20	2016	17								132	10.1186/s13059-016-0997-x			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	DQ0OZ	WOS:000378900700001	27323842	Green Published, Green Submitted, gold	Y	N	2022-01-24	
J	Dixon, AL; Liang, L; Moffatt, MF; Chen, W; Heath, S; Wong, KCC; Taylor, J; Burnett, E; Gut, I; Farrall, M; Lathrop, GM; Abecasis, GR; Cookson, WOC				Dixon, Anna L.; Liang, Liming; Moffatt, Miriam F.; Chen, Wei; Heath, Simon; Wong, Kenny C. C.; Taylor, Jenny; Burnett, Edward; Gut, Ivo; Farrall, Martin; Lathrop, G. Mark; Abecasis, Goncalo R.; Cookson, William O. C.			A genome-wide association study of global gene expression	NATURE GENETICS			English	Article							NORMALIZATION; VARIANTS; RISK	We have created a global map of the effects of polymorphism on gene expression in 400 children from families recruited through a proband with asthma. We genotyped 408,273 SNPs and identified expression quantitative trait loci from measurements of 54,675 transcripts representing 20,599 genes in Epstein-Barr virus-transformed lymphoblastoid cell lines. We found that 15,084 transcripts (28%) representing 6,660 genes had narrow-sense heritabilities (H-2) > 0.3. We executed genome-wide association scans for these traits and found peak lod scores between 3.68 and 59.1. The most highly heritable traits were markedly enriched in Gene Ontology descriptors for response to unfolded protein (chaperonins and heat shock proteins), regulation of progression through the cell cycle, RNA processing, DNA repair, immune responses and apoptosis. SNPs that regulate expression of these genes are candidates in the study of degenerative diseases, malignancy, infection and inflammation. We have created a downloadable database to facilitate use of our findings in the mapping of complex disease loci.	Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Ctr Stat Genet, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Ctr Natl Genotypage, Inst Genom, Commissariat Lenergie Atom, F-91057 Evry, France; European Collect Cell Cultures, Salisbury SP4 0JG, Wilts, England		Cookson, WOC (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Gut, Ivo/ABF-3188-2020; Abecasis, Goncalo R/B-7840-2010; Heath, Simon C/J-4138-2012; Taylor, Jennifer M/A-1686-2010; Chen, Wei/AAX-5994-2020	Heath, Simon C/0000-0002-9550-0897; Taylor, Jennifer M/0000-0003-4231-0181; Chen, Wei/0000-0001-7196-8703; Abecasis, Goncalo/0000-0003-1509-1825	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEATY JS, 1995, MOL CELL BIOL, V15, P4771; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; *BRIT THOR SOC, 2003, THORAX S1, V58, pI1; Cardon LR, 1999, AM J HUM GENET, V65, pA245; CHEN WM, IN PRESS AM J HUM GE; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	26	761	781	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1202	1207		10.1038/ng2109			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	WOS:000249737400015	17873877				2022-01-24	
J	Ozelius, LJ; Hewett, JW; Page, CE; Bressman, SB; Kramer, PL; Shalish, C; deLeon, D; Brin, MF; Raymond, D; Corey, DP; Fahn, S; Risch, NJ; Buckler, AJ; Gusella, JF; Breakefield, XO				Ozelius, LJ; Hewett, JW; Page, CE; Bressman, SB; Kramer, PL; Shalish, C; deLeon, D; Brin, MF; Raymond, D; Corey, DP; Fahn, S; Risch, NJ; Buckler, AJ; Gusella, JF; Breakefield, XO			The early-onset torsion dystonia gene (DYT1) encodes an ATP binding protein	NATURE GENETICS			English	Article							AUTOSOMAL DOMINANT INHERITANCE; TYROSINE-HYDROXYLASE GENE; ASHKENAZI JEWS; EXON AMPLIFICATION; RECEPTOR-BINDING; HUMAN-CHROMOSOME; MESSENGER-RNAS; POINT MUTATION; PARKINSONISM; CONSTRUCTION	Early-onset torsion dystonia is a movement disorder, characterized by twisting muscle contractures, that begins in childhood. Symptoms are believed to result from altered neuronal communication in the basal ganglia, This study identifies the DMI gene on human chromosome 9q34 as being responsible for this dominant disease. Almost all cases of early-onset dystonia have a unique 3-bp deletion that appears to have arisen independently in different ethnic populations. This deletion results in loss of one of a pair of glutamic-acid residues in a conserved region of a novel ATP-binding protein, termed torsinA. This protein has homologues in nematode, rat, mouse and humans, with some resemblance to the family of heat-shock proteins and Clp proteases.	HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02114; COLUMBIA PRESBYTERIAN MED CTR,DEPT NEUROL,DYSTONIA CLIN RES CTR,NEW YORK,NY 10032; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; MT SINAI HOSP,MOVEMENT DISORDERS CTR,NEW YORK,NY 10029; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305		Ozelius, LJ (corresponding author), MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,BOSTON,MA 02114, USA.			Corey, David/0000-0003-4497-6016	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS024279, R01NS028384, R01NS026656] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS24279, NS28384, NS26656] Funding Source: Medline		AKIYAMA Y, 1994, J BIOL CHEM, V269, P5225; ALMASY L, IN PRESS NEUROLOGY; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; APTE AN, 1993, BIOTECHNIQUES, V15, P890; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; Brashear A, 1996, MOVEMENT DISORD, V11, P151, DOI 10.1002/mds.870110206; BRESSMAN SB, 1994, NEUROLOGY, V44, P283, DOI 10.1212/WNL.44.2.283; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURKE RE, 1982, NEUROLOGY, V32, P1335, DOI 10.1212/WNL.32.12.1335; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTIAN CD, 1958, NEW ENGL J MED, V259, P828, DOI 10.1056/NEJM195810232591708; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CHUTORIAN AH, 1996, ACTA NEUROPEDIATR, V2, P33; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; DOOLING EC, 1975, BRAIN, V98, P29, DOI 10.1093/brain/98.1.29; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; Endo Kotaro, 1995, V14, P120; Fahn S, 1988, Adv Neurol, V50, P1; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Fink JK, 1996, AM J HUM GENET, V59, P140; FONTAINE B, 1994, NAT GENET, V6, P267, DOI 10.1038/ng0394-267; Fouad GT, 1996, AM J HUM GENET, V59, P135; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FURUKAWA Y, 1996, ADV NUROL, V69, P37; Gasser T, 1996, MOVEMENT DISORD, V11, P163, DOI 10.1002/mds.870110208; GRAEBER MB, 1992, P NATL ACAD SCI USA, V89, P8245, DOI 10.1073/pnas.89.17.8245; GREENE P, 1995, MOVEMENT DISORD, V10, P143, DOI 10.1002/mds.870100204; GROSSON CL, 1995, NEUROL DISORD, V6, P27; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; Gusella JF, 1997, MOL MED, V3, P238, DOI 10.1007/BF03401677; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; Hedreen J C, 1988, Adv Neurol, V50, P123; KNAPPSKOG PM, 1995, HUM MOL GENET, V4, P1209, DOI 10.1093/hmg/4.7.1209; KORCZYN AD, 1980, ANN NEUROL, V8, P387, DOI 10.1002/ana.410080409; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KRAMER PL, 1994, AM J HUM GENET, V55, P468; KULISEVSKY J, 1993, MOVEMENT DISORD, V8, P239, DOI 10.1002/mds.870080230; LEDOUX MS, 1995, BRAIN RES, V697, P91, DOI 10.1016/0006-8993(95)00792-O; LUDECKE B, 1995, HUM GENET, V95, P123; LUEBE B, 1996, HUM MOL GENET, V5, P1673; MCCORMICK MK, 1993, GENOMICS, V18, P553, DOI 10.1016/S0888-7543(05)80355-6; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; MURRELL J, 1995, GENOMICS, V25, P59, DOI 10.1016/0888-7543(95)80109-Y; NEWMAN PJ, 1988, J CLIN INVEST, V22, P739; NOBREGA JN, 1995, NEUROSCIENCE, V64, P229, DOI 10.1016/0306-4522(94)00334-2; Nobrega JN, 1996, NEUROSCIENCE, V71, P927, DOI 10.1016/0306-4522(95)00511-0; NUTT JG, 1988, MOVEMENT DISORD, V3, P188, DOI 10.1002/mds.870030302; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; Ozelius LJ, 1997, GENOME RES, V7, P483, DOI 10.1101/gr.7.5.483; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; PERIER F, 1995, GENE, V152, P157, DOI 10.1016/0378-1119(94)00697-Q; PRATT GD, 1995, J NEUROCHEM, V64, P2153; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RISCH NJ, 1990, AM J HUM GENET, V46, P533; Sambrook J., 1989, MOL CLONING LAB MANU; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; TABADDOR K, 1978, NEUROLOGY, V28, P1249, DOI 10.1212/WNL.28.12.1249; VANDILLA MA, 1990, CYTOMETRY, V11, P208, DOI 10.1002/cyto.990110124; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATKINS H, 1993, AM J HUM GENET, V53, P1180; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203; Wolfson L I, 1988, Adv Neurol, V50, P177; Zeman W, 1967, Psychiatr Neurol Neurochir, V70, P77	74	761	779	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					40	48		10.1038/ng0997-40			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	WOS:A1997XU72400016	9288096				2022-01-24	
J	Shore, EM; Xu, MQ; Feldman, GJ; Fenstermacher, DA; Brown, MA; Kaplan, FS				Shore, EM; Xu, MQ; Feldman, GJ; Fenstermacher, DA; Brown, MA; Kaplan, FS		FOP Int Res Consortium	A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva	NATURE GENETICS			English	Article							DISORDER; INHIBITOR	Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification. We mapped FOP to chromosome 2q23-24 by linkage analysis and identified an identical heterozygous mutation (617G -> A; R206H) in the glycine-serine (GS) activation domain of ACVR1, a BMP type I receptor, in all affected individuals examined. Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP.	Univ Penn, Sch Med, Ctr Res FOP & Related Disorders, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Biomed Informat Facil, Philadelphia, PA 19104 USA; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA		Kaplan, FS (corresponding author), Univ Penn, Sch Med, Ctr Res FOP & Related Disorders, Philadelphia, PA 19104 USA.	Frederick.Kaplan@uphs.upenn.edu	Brown, Matthew A/E-5749-2010; Shore, Eileen/D-2593-2009	Brown, Matthew A/0000-0003-0538-8211; 	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01 AR041916, R01-AR41916] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR041916] Funding Source: NIH RePORTER		Ahn J, 2003, J BONE JOINT SURG AM, V85A, P667, DOI 10.2106/00004623-200304000-00013; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; de la Pena LS, 2005, J BONE MINER RES, V20, P1168, DOI 10.1359/JBMR.050305; Feldman G, 2000, AM J HUM GENET, V66, P128, DOI 10.1086/302724; Fiori JL, 2006, J BONE MINER RES, V21, P902, DOI 10.1359/JBMR.060215; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Kaplan F.S., 2002, CONNECTIVE TISSUE IT, P827; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Payne TL, 2001, MECH DEVELOP, V100, P275, DOI 10.1016/S0925-4773(00)00541-4; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shore EM, 2005, CLIN REV BONE MINER, V3, P201, DOI 10.1385/BMM:3:3-4:201; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Xu MQ, 2000, CLIN GENET, V58, P291, DOI 10.1034/j.1399-0004.2000.580407.x; Xu MQ, 2002, AM J MED GENET, V109, P161, DOI 10.1002/ajmg.10288; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593	15	760	788	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					525	527		10.1038/ng1783			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	WOS:000237147500012	16642017				2022-01-24	
J	Lo, YMD; Zhang, J; Leung, TN; Lau, TK; Chang, AMZ; Hjelm, NM				Lo, YMD; Zhang, J; Leung, TN; Lau, TK; Chang, AMZ; Hjelm, NM			Rapid clearance of fetal DNA from maternal plasma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL SEX DETERMINATION; MICROSATELLITE ALTERATIONS; DEOXYRIBONUCLEIC-ACID; PERIPHERAL-BLOOD; CELLS; AMPLIFICATION; LOCALIZATION; PRODUCT; SERUM; TIME	Fetal DNA has been detected in maternal plasma during pregnancy. We investigated the clearance of circulating fetal DNA after delivery, using quantitative PCR analysis of the sex-determining region Y gene as a marker for male fetuses. We analyzed plasma samples from 12 women 1-42 d after delivery of male babies and found that circulating fetal DNA was undetectable by day 1 after delivery. To obtain a higher time-resolution picture of fetal DNA clearance, we performed serial sampling of eight women, which indicated that most women (seven) had undetectable levels of circulating fetal DNA by 2 h postpartum. The mean half-life for circulating fetal DNA was 16.3 min (range 4-30 min). Plasma nucleases were found to account for only part of the clearance of plasma fetal DNA, The rapid turnover of circulating DNA suggests that plasma DNA analysis may be less susceptible to false-positive results, which result from carryover from previous pregnancies, than is the detection of fetal cells in maternal blood; also, rapid turnover may be useful for the monitoring of fete-maternal events with rapid dynamics. These results also may have implications for the study of other types of nonhost DNA in plasma, such as circulating tumor-derived and graft-derived DNA in oncology and transplant patients, respectively.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, New Territories, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynecol, Shatin, New Territories, Peoples R China		Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, New Territories, Peoples R China.	loym@cuhk.edu.hk	Chang, Allan M/B-1882-2009; Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410			Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 1998, AM J HUM GENET, V62, P763, DOI 10.1086/301809; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Chen XQ, 1996, NAT MED, V2, P1033; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; CHUSED TM, 1972, CLIN EXP IMMUNOL, V12, P465; EMLEN W, 1984, CLIN EXP IMMUNOL, V56, P185; EMLEN W, 1978, J EXP MED, V147, P684, DOI 10.1084/jem.147.3.684; FROST P. G., 1968, CLIN EXP IMMUNOL, V3, P447; GOSSE C, 1965, CANCER RES, V25, P877; HAMADA H, 1994, AM J OBSTET GYNECOL, V170, P1188, DOI 10.1016/S0002-9378(94)70120-2; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HERRIOTT RM, 1961, NATURE, V189, P817, DOI 10.1038/189817a0; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HSIEH TT, 1993, HUM GENET, V92, P204; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lo YMD, 1996, BLOOD, V88, P4390; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; LO YMD, 1989, LANCET, V2, P1363; LO YMD, 1993, HUM GENET, V90, P483; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; PAOLETTI C, 1963, BIOCHEMISTRY-US, V28, P531; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Simpson JL, 1995, HUM REPROD UPDATE, V1, P409, DOI 10.1093/humupd/1.4.409; THOMAS MR, 1995, PRENATAL DIAG, V15, P641, DOI 10.1002/pd.1970150709; TSUMITA T, 1963, NATURE, V198, P1088, DOI 10.1038/1981088a0; WALKNOWSKA J, 1969, LANCET, V1, P1119	34	760	815	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					218	224		10.1086/302205			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	WOS:000078477400027	9915961	Green Published, Bronze			2022-01-24	
J	Osborne, CS; Chakalova, L; Brown, KE; Carter, D; Horton, A; Debrand, E; Goyenechea, B; Mitchell, JA; Lopes, S; Reik, W; Fraser, P				Osborne, CS; Chakalova, L; Brown, KE; Carter, D; Horton, A; Debrand, E; Goyenechea, B; Mitchell, JA; Lopes, S; Reik, W; Fraser, P			Active genes dynamically colocalize to shared sites of ongoing transcription	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; RNA-POLYMERASE-II; CHROMOSOME TERRITORIES; IN-VIVO; CENTROMERIC HETEROCHROMATIN; INTERGENIC TRANSCRIPTION; INTERPHASE NUCLEI; EXPRESSED GENES; CHROMATIN; CELLS	The intranuclear position of many genes has been correlated with their activity state, suggesting that migration to functional subcompartments may influence gene expression. Indeed, nascent RNA production and RNA polymerase II seem to be localized into discrete foci or '`transcription factories'. Current estimates from cultured cells indicate that multiple genes could occupy the same factory, although this has not yet been observed. Here we show that, during transcription in vivo, distal genes colocalize to the same transcription factory at high frequencies. Active genes are dynamically organized into shared nuclear subcompartments, and movement into or out of these factories results in activation or abatement of transcription. Thus, rather than recruiting and assembling transcription complexes, active genes migrate to preassembled transcription sites.	Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England; Imperial Coll Fac Med, Chromosome Biol Grp, London W12 0NN, England; Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England		Fraser, P (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB2 4AT, England.	peter.fraser@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Fraser, Peter/B-7549-2009; Chakalova, Lyubomira/C-6810-2012; Reik, Wolf/I-6794-2012	Osborne, Cameron/0000-0003-4126-2499; Reik, Wolf/0000-0003-0216-9881; Fraser, Peter/0000-0002-0041-1227; Mitchell, Jennifer/0000-0002-7147-4604	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U120081295] Funding Source: Medline		Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Grande MA, 1997, J CELL SCI, V110, P1781; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HUNT JA, 1974, BIOCHEM J, V138, P499, DOI 10.1042/bj1380499; Iborra FJ, 1996, J CELL SCI, V109, P1427; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; OSHEIM YN, 1985, CELL, V43, P143, DOI 10.1016/0092-8674(85)90019-4; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Schubeler D, 2000, GENE DEV, V14, P940; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Sutherland HGE, 1997, MOL CELL BIOL, V17, P1607, DOI 10.1128/MCB.17.3.1607; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Volpi EV, 2000, J CELL SCI, V113, P1565; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499	50	759	787	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1065	1071		10.1038/ng1423			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	WOS:000224156500014	15361872	Bronze			2022-01-24	
J	Miyata, M; Smith, JD				Miyata, M; Smith, JD			Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides	NATURE GENETICS			English	Article							ISOFORM-SPECIFIC BINDING; ONSET ALZHEIMER-DISEASE; E-DEFICIENT MICE; PLASMA-LIPOPROTEINS; DENSITY-LIPOPROTEIN; LIPID-PEROXIDATION; PROTEIN TOXICITY; EPSILON-4; CELLS; GENE	The apolipoprotein E (APOE) E4 allele is associated with Alzheimer's disease, cardiovascular disease, and decreased longevity. To probe the mechanism of these associations, cell lines were created which secrete each apoE isoform. ApoE conditioned media, purified apoE, and commercially obtained apoE protected B12 cells from hydrogen peroxide cytotoxicity with E2 > E3 > E4. Physiological levels of apoE protected cells from P-amyloid peptides, while higher doses of apoE led to increased cytotoxicity. E2 > E3 > E4 possessed antioxidant activity, and apoE bound certain metal ions. The decreased antioxidant activity of E4 could contribute to its association with Alzheimer's disease, cardiovascular disease and decreased longevity.	ROCKEFELLER UNIV,BIOCHEM GENET & METAB LAB,NEW YORK,NY 10021				Zito, Giancarlo/F-9008-2010; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X			BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Buege J A, 1978, Methods Enzymol, V52, P302; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUTTERFIELD DA, 1994, BIOCHEM BIOPH RES CO, V200, P710, DOI 10.1006/bbrc.1994.1508; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; EHRENWALD E, 1994, J CLIN INVEST, V93, P1493, DOI 10.1172/JCI117127; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARTMANN H, 1994, BIOCHEM BIOPH RES CO, V200, P1185, DOI 10.1006/bbrc.1994.1576; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V201, P1567, DOI 10.1006/bbrc.1994.1883; HENDRIE HC, 1995, ANN NEUROL, V37, P118, DOI 10.1002/ana.410370123; JAECKLE S, 1989, P NATL ACAD SCI USA, V86, P1880, DOI 10.1073/pnas.86.6.1880; KUNITAKE ST, 1992, P NATL ACAD SCI USA, V89, P6993, DOI 10.1073/pnas.89.15.6993; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; LEHTIMAKI T, 1995, HUM GENET, V95, P39; LOUHIJA J, 1994, ARTERIOSCLER THROMB, V14, P1084, DOI 10.1161/01.ATV.14.7.1084; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; MAXWELL SRJ, 1994, ATHEROSCLEROSIS, V111, P79, DOI 10.1016/0021-9150(94)90193-7; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; REGAN L, 1995, TRENDS BIOCHEM SCI, V20, P280, DOI 10.1016/S0968-0004(00)89044-1; RINNINGER F, 1989, J BIOL CHEM, V264, P6111; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SMITH JD, 1988, J BIOL CHEM, V263, P8300; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; VANBOCKXMEER FM, 1994, ATHEROSCLEROSIS, V110, P195, DOI 10.1016/0021-9150(94)90204-6; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; WHITSON JS, 1994, BIOCHEM BIOPH RES CO, V199, P163, DOI 10.1006/bbrc.1994.1209; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100	46	759	774	2	26	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1996	14	1					55	61		10.1038/ng0996-55			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	WOS:A1996VF61100021	8782820				2022-01-24	
J	Li, B; Severson, E; Pignon, JC; Zhao, HQ; Li, TW; Novak, J; Jiang, P; Shen, H; Aster, JC; Rodig, S; Signoretti, S; Liu, JS; Liu, XS				Li, Bo; Severson, Eric; Pignon, Jean-Christophe; Zhao, Haoquan; Li, Taiwen; Novak, Jesse; Jiang, Peng; Shen, Hui; Aster, Jon C.; Rodig, Scott; Signoretti, Sabina; Liu, Jun S.; Liu, X. Shirley			Comprehensive analyses of tumor immunity: implications for cancer immunotherapy	GENOME BIOLOGY			English	Article						Cancer immunity; Tumor immune infiltration; Cancer immunotherapies; Cancer vaccine; Checkpoint blockade	CELLS; REVEALS; BLOCKADE; CLASSIFICATION; IMMUNOSCORE; LYMPHOCYTES; LANDSCAPE; PATTERNS; SURVIVAL; TARGETS	Background: Understanding the interactions between tumor and the host immune system is critical to finding prognostic biomarkers, reducing drug resistance, and developing new therapies. Novel computational methods are needed to estimate tumor-infiltrating immune cells and understand tumor-immune interactions in cancers. Results: We analyze tumor-infiltrating immune cells in over 10,000 RNA-seq samples across 23 cancer types from The Cancer Genome Atlas (TCGA). Our computationally inferred immune infiltrates associate much more strongly with patient clinical features, viral infection status, and cancer genetic alterations than other computational approaches. Analysis of cancer/testis antigen expression and CD8 T-cell abundance suggests that MAGEA3 is a potential immune target in melanoma, but not in non-small cell lung cancer, and implicates SPAG5 as an alternative cancer vaccine target in multiple cancers. We find that melanomas expressing high levels of CTLA4 separate into two distinct groups with respect to CD8 T-cell infiltration, which might influence clinical responses to anti-CTLA4 agents. We observe similar dichotomy of TIM3 expression with respect to CD8 T cells in kidney cancer and validate it experimentally. The abundance of immune infiltration, together with our downstream analyses and findings, are accessible through TIMER, a public resource at http://cistrome.org/TIMER. Conclusions: We develop a computational approach to study tumor-infiltrating immune cells and their interactions with cancer cells. Our resource of immune-infiltrate levels, clinical associations, as well as predicted therapeutic markers may inform effective cancer vaccine and checkpoint blockade therapies.	[Li, Bo; Severson, Eric; Zhao, Haoquan; Jiang, Peng; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, 450 Brookline Ave, Boston, MA 02215 USA; [Li, Bo; Liu, Jun S.] Harvard Univ, Dept Stat, 1 Oxford St, Cambridge, MA 02138 USA; [Severson, Eric; Pignon, Jean-Christophe; Novak, Jesse; Aster, Jon C.; Rodig, Scott; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02215 USA; [Severson, Eric; Pignon, Jean-Christophe; Novak, Jesse; Aster, Jon C.; Rodig, Scott; Signoretti, Sabina] Harvard Med Sch, 75 Francis St, Boston, MA 02215 USA; [Li, Taiwen] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, 14 Renmin South Rd 3rd Sect, Chengdu 610041, Sichuan, Peoples R China; [Shen, Hui] Van Andel Res Inst, Ctr Epigenet, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA		Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, 450 Brookline Ave, Boston, MA 02215 USA.; Liu, JS (corresponding author), Harvard Univ, Dept Stat, 1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu; xsliu@jimmy.harvard.edu	Rodig, Scott/Y-3889-2019; Shen, Hui/AAO-4387-2020	Jiang, Peng/0000-0002-7828-5486; Shen, Hui/0000-0001-9767-4084	NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1U01 CA180980]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31329003]; Chinese Scholarship council fellowship; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA180980] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007627] Funding Source: NIH RePORTER	This work was supported by NCI 1U01 CA180980 (to X.S.L.), National Natural Science Foundation of China 31329003 (to X.S.L.), and Chinese Scholarship council fellowship (to T.L.).	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Alvaro T, 2008, CLIN CANCER RES, V14, P685, DOI 10.1158/1078-0432.CCR-07-1246; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Anitei MG, 2014, CLIN CANCER RES, V20, P1891, DOI 10.1158/1078-0432.CCR-13-2830; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Dhodapkar MV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008068; Di Giacomo AM, 2013, CANCER IMMUNOL IMMUN, V62, P1021, DOI 10.1007/s00262-013-1418-6; Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Komohara Y, 2015, CANCER IMMUNOL RES, V3, P999, DOI 10.1158/2326-6066.CIR-14-0156; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0473-4; Li B, 2012, CLIN CANCER RES, V18, P5595, DOI 10.1158/1078-0432.CCR-12-1427; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; MACKENSEN A, 1993, CANCER RES, V53, P3569; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; R Development Core Team, 2014, R LANG ENV STAT COMP; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shibuya TY, 2002, CLIN CANCER RES, V8, P745; Silina K, 2011, J IMMUNOTHER, V34, P28, DOI 10.1097/CJI.0b013e3181fb64fa; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Storey J, 2015, QVALUE Q VALUE ESTIM; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	43	758	766	11	68	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	AUG 22	2016	17								174	10.1186/s13059-016-1028-7			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	DT8EL	WOS:000381721800001	27549193	Green Published, gold	Y	N	2022-01-24	
J	Brudno, M; Do, CB; Cooper, GM; Kim, MF; Davydov, E; Green, ED; Sidow, A; Batzoglou, S				Brudno, M; Do, CB; Cooper, GM; Kim, MF; Davydov, E; Green, ED; Sidow, A; Batzoglou, S		NISC Comparative Sequencing Progra	LAGAN and Multi-LAGAN: Efficient tools for large-scale multiple alignment of genomic DNA	GENOME RESEARCH			English	Article							SEQUENCE ALIGNMENTS; SEARCH; CONSERVATION; SIMILARITIES; IMPROVEMENT; PROGRAM; DIALIGN; SERVER; BLAST	To compare entire genomes from different species, biologists increasingly need alignment methods that are efficient enough to handle long sequences, and accurate enough to correctly align the conserved biological features between distant species. We present LAGAN, a system for rapid global alignment of two homologous genomic sequences, and Multi-LAGAN, a system for multiple global alignment of genomic sequences. We tested our systems on a data set consisting of greater than 12 Mb of high-quality sequence from 12 vertebrate species. All the sequence was derived from the genomic region orthologous to an similar to1.5-Mb region on human chromosome 7q31.3. We found that both LAGAN and Multi-LAGAN compare favorably with other leading alignment methods in correctly aligning protein-coding exons, especially between distant homologs such as human and chicken, or human and fugu. Multi-LAGAN produced the most accurate alignments, while requiring just 75 minutes on a personal computer to obtain the multiple alignment of all 12 sequences. Multi-LAGAN is a practical method for generating multiple alignments of long genomic sequences at any evolutionary distance. Our systems are publicly available at http:/ / lagan.stanford.edu.	Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA		Batzoglou, S (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	serafim@cs.stanford.edu	Cooper, Gregory/D-6914-2011	Cooper, Gregory/0000-0001-5509-9923	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG000060, Z01HG000196, Z01HG000060, ZIBHG000196] Funding Source: NIH RePORTER		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anson EL, 1997, J COMPUT BIOL, V4, P369, DOI 10.1089/cmb.1997.4.369; BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Bonizzoni P, 2001, THEOR COMPUT SCI, V259, P63, DOI 10.1016/S0304-3975(99)00324-2; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Brudno M, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P138, DOI 10.1109/CSB.2002.1039337; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; EPPSTEIN D, 1992, J ACM, V39, P546, DOI 10.1145/146637.146656; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; Gottgens B, 2002, GENOME RES, V12, P749, DOI 10.1101/gr.45502; GUSFIELD D, 1999, ALGORITHMS STRINGS T, P351; HARDISON R, 1994, GENOMICS, V21, P344, DOI 10.1006/geno.1994.1275; HARDISON R, 1993, DNA SEQUENCE, V4, P163, DOI 10.3109/10425179309015629; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holmes I, 2001, BIOINFORMATICS, V17, P803, DOI 10.1093/bioinformatics/17.9.803; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Miller W, 2001, BIOINFORMATICS, V17, P391, DOI 10.1093/bioinformatics/17.5.391; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Morgenstern B, 1998, BIOINFORMATICS, V14, P290, DOI 10.1093/bioinformatics/14.3.290; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Sankoff D, 1999, BIOINFORMATICS, V15, P909, DOI 10.1093/bioinformatics/15.11.909; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Simon AL, 2002, P NATL ACAD SCI USA, V99, P2912, DOI 10.1073/pnas.042692299; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stanfel LE, 1996, J THEOR BIOL, V183, P195, DOI 10.1006/jtbi.1996.0213; TAYLOR WR, 1988, J MOL EVOL, V28, P161, DOI 10.1007/BF02143508; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; [No title captured]	37	758	792	1	12	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2003	13	4					721	731		10.1101/gr.926603			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	664DK	WOS:000182046300018	12654723	Green Published, Bronze			2022-01-24	
J	Krauthammer, M; Kong, Y; Ha, BH; Evans, P; Bacchiocchi, A; McCusker, JP; Cheng, E; Davis, MJ; Goh, G; Choi, M; Ariyan, S; Narayan, D; Dutton-Regester, K; Capatana, A; Holman, EC; Bosenberg, M; Sznol, M; Kluger, HM; Brash, DE; Stern, DF; Materin, MA; Lo, RS; Mane, S; Ma, SG; Kidd, KK; Hayward, NK; Lifton, RP; Schlessinger, J; Boggon, TJ; Halaban, R				Krauthammer, Michael; Kong, Yong; Ha, Byung Hak; Evans, Perry; Bacchiocchi, Antonella; McCusker, James P.; Cheng, Elaine; Davis, Matthew J.; Goh, Gerald; Choi, Murim; Ariyan, Stephan; Narayan, Deepak; Dutton-Regester, Ken; Capatana, Ana; Holman, Edna C.; Bosenberg, Marcus; Sznol, Mario; Kluger, Harriet M.; Brash, Douglas E.; Stern, David F.; Materin, Miguel A.; Lo, Roger S.; Mane, Shrikant; Ma, Shuangge; Kidd, Kenneth K.; Hayward, Nicholas K.; Lifton, Richard P.; Schlessinger, Joseph; Boggon, Titus J.; Halaban, Ruth			Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma	NATURE GENETICS			English	Article							KINASE INHIBITOR; BRAF MUTATIONS; MORPHOLOGIC FEATURES; MOLECULAR-GRAPHICS; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; AURORA KINASE; IN-VIVO; PROTEIN; CELLS	We characterized the mutational landscape of melanoma, the form of skin cancer with the highest mortality rate, by sequencing the exomes of 147 melanomas. Sun-exposed melanomas had markedly more ultraviolet ( UV)-like C> T somatic mutations compared to sun-shielded acral, mucosal and uveal melanomas. Among the newly identified cancer genes was PPP6C, encoding a serine/threonine phosphatase, which harbored mutations that clustered in the active site in 12% of sun-exposed melanomas, exclusively in tumors with mutations in BRAF or NRAS. Notably, we identified a recurrent UV-signature, an activating mutation in RAC1 in 9.2% of sun-exposed melanomas. This activating mutation, the third most frequent in our cohort of sun-exposed melanoma after those of BRAF and NRAS, changes Pro29 to serine ( RAC1(P29S)) in the highly conserved switch I domain. Crystal structures, and biochemical and functional studies of RAC1(P29S) showed that the alteration releases the conformational restraint conferred by the conserved proline, causes an increased binding of the protein to downstream effectors, and promotes melanocyte proliferation and migration. These findings raise the possibility that pharmacological inhibition of downstream effectors of RAC1 signaling could be of therapeutic benefit.	[Bacchiocchi, Antonella; Cheng, Elaine; Holman, Edna C.; Bosenberg, Marcus; Brash, Douglas E.; Halaban, Ruth] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Krauthammer, Michael; Evans, Perry; McCusker, James P.; Capatana, Ana; Stern, David F.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kong, Yong] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Kong, Yong] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT USA; [Ha, Byung Hak; Davis, Matthew J.; Schlessinger, Joseph; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Goh, Gerald; Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Ariyan, Stephan; Narayan, Deepak] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Dutton-Regester, Ken] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia; [Dutton-Regester, Ken; Hayward, Nicholas K.] Queensland Inst Med Res, Dept Genet & Computat Biol, Brisbane, Qld 4006, Australia; [Sznol, Mario; Kluger, Harriet M.] Yale Univ, Sch Med, Ctr Comprehens Canc, Sect Med Oncol, New Haven, CT 06510 USA; [Brash, Douglas E.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Materin, Miguel A.] Yale Univ, Sch Med, Dept Ophthalmol, New Haven, CT USA; [Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Dermatol, Dept Med, Los Angeles, CA 90024 USA; [Mane, Shrikant] Yale Univ, Sch Med, Ctr Human Genet & Genom, New Haven, CT USA; [Mane, Shrikant] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT USA; [Ma, Shuangge] Yale Univ, Sch Med, Sch Publ Hlth, New Haven, CT USA		Halaban, R (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	ruth.halaban@yale.edu	Goh, Gerald/N-1684-2015; Materin, Miguel A./S-4933-2019; hayward, nicholas k/C-1367-2015; hayward, nick/AAV-8802-2020; Kong, Yong/B-5105-2014; Choi, Murim/AAP-9120-2021; Goh, Gerald/E-9158-2014; Holman, Edna/D-1536-2011	Goh, Gerald/0000-0002-3832-6466; hayward, nicholas k/0000-0003-4760-1033; Kong, Yong/0000-0002-2881-5274; Goh, Gerald/0000-0002-3832-6466; Holman, Edna/0000-0001-6949-5003; McCusker, Jamie/0000-0003-1085-6059; Krauthammer, Michael/0000-0002-4808-1845; Dutton-Regester, Ken/0000-0002-8884-6355	Yale SPORE in Skin Cancer; National Cancer Institute grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1 P50 CA121974]; Melanoma Research Alliance; National Library of Medicine Training grant [5T15LM007056]; Department of Dermatology; Yale Comprehensive Cancer Center; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Gilead Sciences, Inc.Gilead Sciences; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA121974] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007056] Funding Source: NIH RePORTER	This work was supported by the Yale SPORE in Skin Cancer funded by the National Cancer Institute grant number 1 P50 CA121974 (principal investigator, R.H.), the Melanoma Research Alliance (a Team award to R.H., M.B., M.K. and D.F.S.), The National Library of Medicine Training grant 5T15LM007056 (P.E.), the Department of Dermatology (R.H.), Yale Comprehensive Cancer Center (M.K.), the National Health and Medical Research Council of Australia (N.K.H. and K.D.-R.), Gilead Sciences, Inc. (J.S., M.K., R H. and T.J.B.) and a generous gift from Roz and Jerry Meyer (R.H., M.S. and H.M.K.). We thank C. Truini, W. Meng, B. Speed, E. Straka, A. Raefski, M. Scallion and S. Levin for technical support, P. Parsons, C. Schmidt and colleagues at the Queensland Institute of Medical Research for generously providing many of the melanoma cell lines, the Yale Center for Genome Analysis and the Northeastern Collaborative Access Team (NE-CAT) facility at the Advanced Photon Source at Argonne National Laboratory.	Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Bauer J, 2011, PIGM CELL MELANOMA R, V24, P345, DOI 10.1111/j.1755-148X.2011.00837.x; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bernet A, 2008, EXPERT OPIN THER TAR, V12, P995, DOI 10.1517/14728222.12.8.995 ; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BRASH DE, 1982, NATURE, V298, P189, DOI 10.1038/298189a0; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Donnelly MP, 2010, AM J HUM GENET, V86, P161, DOI 10.1016/j.ajhg.2010.01.007; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fears TR, 2002, CANCER RES, V62, P3992; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; Furney SJ, 2012, PIGM CELL MELANOMA R, V25, P488, DOI 10.1111/j.1755-148X.2012.01016.x; Garla V, 2011, BIOINFORMATICS, V27, P416, DOI 10.1093/bioinformatics/btq658; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Jensen JSRE, 2012, PLANTA MED, V78, P448, DOI 10.1055/s-0031-1298230; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Li A, 2011, DEV CELL, V21, P722, DOI 10.1016/j.devcel.2011.07.008; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Macarulla T, 2010, MOL CANCER THER, V9, P2844, DOI 10.1158/1535-7163.MCT-10-0299; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MENARD L, 1993, BIOCHEMISTRY-US, V32, P13357, DOI 10.1021/bi00211a050; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; Onken MD, 2007, CLIN CANCER RES, V13, P2923, DOI 10.1158/1078-0432.CCR-06-2383; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sehdev V, 2012, MOL CANCER THER, V11, P763, DOI 10.1158/1535-7163.MCT-11-0623; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Tworkoski K, 2011, MOL CANCER RES, V9, P801, DOI 10.1158/1541-7786.MCR-10-0512; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	81	757	766	6	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1006	+		10.1038/ng.2359			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	WOS:000308491200011	22842228	Green Accepted	Y	N	2022-01-24	
J	FRANCIS, F; HENNIG, S; KORN, B; REINHARDT, R; DEJONG, P; POUSTKA, A; LEHRACH, H; ROWE, PSN; GOULDING, JN; SUMMERFIELD, T; MOUNTFORD, R; READ, AP; POPOWSKA, E; PRONICKA, E; DAVIES, KE; ORIORDAN, JLH; ECONS, MJ; NESBITT, T; DREZNER, MK; OUDET, C; PANNETIER, S; HANAUER, A; STROM, TM; MEINDL, A; LORENZ, B; CAGNOLI, M; MOHNIKE, KL; MURKEN, J; MEITINGER, T				FRANCIS, F; HENNIG, S; KORN, B; REINHARDT, R; DEJONG, P; POUSTKA, A; LEHRACH, H; ROWE, PSN; GOULDING, JN; SUMMERFIELD, T; MOUNTFORD, R; READ, AP; POPOWSKA, E; PRONICKA, E; DAVIES, KE; ORIORDAN, JLH; ECONS, MJ; NESBITT, T; DREZNER, MK; OUDET, C; PANNETIER, S; HANAUER, A; STROM, TM; MEINDL, A; LORENZ, B; CAGNOLI, M; MOHNIKE, KL; MURKEN, J; MEITINGER, T			A GENE (PEX) WITH HOMOLOGIES TO ENDOPEPTIDASES IS MUTATED IN PATIENTS WITH X-LINKED HYPOPHOSPHATEMIC RICKETS	NATURE GENETICS			English	Article							D-RESISTANT RICKETS; MOLECULAR-CLONING; LINKAGE ANALYSIS; HYP MICE; MARKERS; PROTEIN; MOUSE; SEQUENCES; LIBRARIES; REGIONS	X-linked hypophosphatemic rickets (HYP) is a dominant disorder characterised by impaired phosphate uptake in the kidney, which is likely to be caused by abnormal regulation of sodium phosphate cotransport in the proximal tubules. By positional cloning, we have isolated a candidate gene from the HYP region in Xp22.1, This gene exhibits homology to a family of endopeptidase genes, members of which are involved in the degradation or activation of a variety of peptide hormones. This gene (which we have called PEX) is composed of multiple exons which span at least five cosmids. Intragenic non-overlapping deletions from four different families and three mutations (two splice sites and one frameshift) have been detected in HYP patients, which suggest that the PEX gene is involved in the HYP disorder.	MAX PLANCK INST MOLEC GENET, D-14195 BERLIN, GERMANY; DEUTSCH KREBSFORSCHUNGSZENTRUM, W-6900 HEIDELBERG, GERMANY; ROSWELL PK CANC INST, BUFFALO, NY 14263 USA; UCL, MIDDLESEX HOSP, DEPT MED, LONDON W1N 8AA, ENGLAND; UNIV MANCHESTER, DEPT MED GENET, MANCHESTER M13 0JH, LANCS, ENGLAND; CTR ZDROWIA DZIECKA, DEPT METAB DIS, PL-04736 WARSAW, POLAND; UNIV OXFORD, JOHN RADCLIFFE HOSP, MOLEC GENET GRP, OXFORD OX3 9DU, ENGLAND; DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA; IGBMC, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; UNIV MUNICH, KINDER POLIKLIN, PADIAT GENET ABT, D-80336 MUNICH, GERMANY; OTTO VONGUERICKE UNIV, ZENTRUM KINDERHEILKUNDE, D-39112 MAGDEBURG, GERMANY				Francis, Fiona/B-5854-2016	Pronicka, Ewa/0000-0002-5705-4814; Reinhardt, Richard/0000-0001-9376-2132; Summerfield, Tina/0000-0003-1878-7019; Meitinger, Thomas/0000-0002-8838-8403			ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BURNETT CH, 1964, AM J MED, V36, P222, DOI 10.1016/0002-9343(64)90085-3; CHONG SS, 1993, GENOMICS, V18, P355, DOI 10.1006/geno.1993.1476; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; ECONS MJ, 1994, J CLIN ENDOCR METAB, V79, P1351, DOI 10.1210/jc.79.5.1351; ECONS MJ, 1993, J BONE MINER RES, V8, P1149; ECONS MJ, 1992, DISORDERS BONE MINER, P935; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; FRANCIS F, 1994, GENOMICS, V21, P229, DOI 10.1006/geno.1994.1247; FRANCIS F, 1994, GENET ANAL-BIOMOL E, V11, P148, DOI 10.1016/1050-3862(94)90035-3; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KHAMLICHI S, 1995, EUR J BIOCHEM, V228, P931, DOI 10.1111/j.1432-1033.1995.0931m.x; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; KOS CH, 1994, GENOMICS, V19, P176, DOI 10.1006/geno.1994.1034; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; MACHLER M, 1986, HUM GENET, V73, P271, DOI 10.1007/BF00401243; McKusick V.A., 1992, MENDELIAN INHERITANC; MEYER RA, 1989, J BONE MINER RES, V4, P493; MORGAN JM, 1974, ARCH INTERN MED, V134, P549, DOI 10.1001/archinte.134.3.549; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NESBITT T, 1992, J CLIN INVEST, V89, P1453, DOI 10.1172/JCI115735; NESBITT T, IN PRESS J BONE MINE; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; QIU ZQ, 1993, GENET RES, V62, P39, DOI 10.1017/S0016672300031542; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; ROWE PSN, 1993, HUM GENET, V91, P571; ROWE PSN, 1994, HUM GENET, V94, P457; ROWE PSN, 1994, HUM GENET, V93, P291, DOI 10.1007/BF00212025; ROWE PSN, IN PRESS HUM GENET; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SHIPP MA, 1991, P NATL ACAD SCI USA, V88, P10662, DOI 10.1073/pnas.88.23.10662; SHIPP MA, 1990, NATURE, V347, P394, DOI 10.1038/347394a0; STADEN R, 1987, NUCLEIC ACID PROTEIN, P173; TENENHOUSE HS, 1994, J CLIN INVEST, V93, P671, DOI 10.1172/JCI117019; THAKKER RV, 1987, J MED GENET, V24, P756, DOI 10.1136/jmg.24.12.756; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; YORIMITSU K, 1995, BIOCHEM BIOPH RES CO, V208, P721, DOI 10.1006/bbrc.1995.1397	47	757	783	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					130	136		10.1038/ng1095-130			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	WOS:A1995RX80600013					2022-01-24	
J	GOLDSTEIN, DB; LINARES, AR; CAVALLISFORZA, LL; FELDMAN, MW				GOLDSTEIN, DB; LINARES, AR; CAVALLISFORZA, LL; FELDMAN, MW			AN EVALUATION OF GENETIC DISTANCES FOR USE WITH MICROSATELLITE LOCI	GENETICS			English	Article							STEPWISE MUTATION MODEL; SIMPLE SEQUENCE DNA	Mutations of alleles at microsatellite loci tend to result in alleles with repeat scores similar to those of the alleles from which they were derived. Therefore the difference in repeat score between alleles carries information about the amount of time that has passed since they shared a common ancestral allele. This information is ignored by genetic distances based on the infinite alleles model. Here we develop a genetic distance based on the stepwise mutation model that includes allelic repeat score. We adapt earlier treatments of the stepwise mutation model to show analytically that the expectation of this distance is a linear function of time. We then use computer simulations to evaluate the overall reliability of this distance and to compare it with allele sharing and Nei's distance. We find that no distance is uniformly superior for all purposes, but that for phylogenetic reconstruction of taxa that are sufficiently diverged, our new distance is preferable.	STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA; UNIV ANTIOQUIA, FAC MED, CTR INVEST MED, MEDELLIN, COLOMBIA; STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA				Klein, Richard G/B-5910-2009; Ruiz-Linares, Andres/AAR-1104-2021	Ruiz-Linares, Andres/0000-0001-8372-1011	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM020467, R01GM028016, P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-20467, GM-28428, GM-28016] Funding Source: Medline		BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BOWEN B, 1993, CONSERV BIOL, V7, P834, DOI 10.1046/j.1523-1739.1993.740834.x; BROWN AHD, 1975, GENET RES, V25, P137, DOI 10.1017/S0016672300015536; CHAKRABORTY R, 1993, EXS, V67, P153; DIETRICH W, 1992, GENETICS, V131, P423; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; GOLDSTEIN DB, 1994, THEOR POPUL BIOL, V45, P219, DOI 10.1006/tpbi.1994.1012; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JEFFREYS AJ, 1993, EXS, V67, P1; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KELLY R, 1991, P ROY SOC B-BIOL SCI, V245, P235, DOI 10.1098/rspb.1991.0115; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; MORAN PAP, 1975, THEOR POPUL BIOL, V8, P318, DOI 10.1016/0040-5809(75)90049-0; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SHRIVER MD, 1993, GENETICS, V134, P983; SLATKIN M, 1995, GENETICS, V139, P457; STEPHENS JC, 1992, MOL BIOL EVOL, V9, P729; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; TAJIMA F, 1994, MOL BIOL EVOL, V11, P278; TAUTZ D, 1993, EXS, V67, P21; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; VALDES AM, 1993, GENETICS, V133, P737; WALSH JB, 1987, GENETICS, V115, P553; WEHRHAHN CF, 1975, GENETICS, V80, P375; WEIR BS, 1976, GENETICS, V84, P639	31	757	802	0	49	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	1995	139	1					463	471					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ248	WOS:A1995PZ24800040	7705647				2022-01-24	
J	Lesage, S; Zouali, H; Cezard, JP; Colombel, JF; Belaiche, J; Almer, S; Tysk, C; O'Morain, C; Gassull, M; Binder, V; Finkel, Y; Modigliani, R; Gower-Rousseau, C; Macry, J; Merlin, F; Chamaillard, M; Jannot, AS; Thomas, G; Hugot, JP				Lesage, S; Zouali, H; Cezard, JP; Colombel, JF; Belaiche, J; Almer, S; Tysk, C; O'Morain, C; Gassull, M; Binder, V; Finkel, Y; Modigliani, R; Gower-Rousseau, C; Macry, J; Merlin, F; Chamaillard, M; Jannot, AS; Thomas, G; Hugot, JP		EPWG-IBD Grp; EPIMAD Grp; GETAID Grp	CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; CIGARETTE-SMOKING; PROVIDES EVIDENCE; KAPPA-B; FAMILIES; ETIOLOGY; PROTEIN; LINKAGE	CARD15/NOD2 encodes a protein involved in bacterial recognition by monocytes. Mutations in CARD15 have recently been found in patients with Crohn disease (CD), a chronic inflammatory condition of the digestive tract. Here, we report the mutational analyses of CARD15 in 453 patients with CD, including 166 sporadic and 287 familial cases, 159 patients with ulcerative colitis (UC), and 103 healthy control subjects. Of 67 sequence variations identified, 9 had an allele frequency >5% in patients with CD. Six of them were considered to be polymorphisms, and three (R702W, G908R, and 1007fs) were confirmed to be independently associated with susceptibility to CD. Also considered as potential disease-causing mutations (DCMs) were 27 rare additional mutations. The three main variants (R702W, G908R, and 1007fs) represented 32%, 18%, and 31%, respectively, of the total CD mutations, whereas the total of the 27 rare mutations represented 19% of DCMs. Altogether, 93% of the mutations were located in the distal third of the gene. No mutations were found to be associated with UC. In contrast, 50% of patients with CD carried at least one DCM, including 17% who had a double mutation. This observation confirmed the gene-dosage effect in CD. The patients with double-dose mutations were characterized by a younger age at onset (16.9 years vs. 19.8 years;), a more frequent stricturing phenotype (53% vs. 28%; P = .00003; odds ratio 2.92), and a less frequent colonic involvement (43% vs. 62%; odds ratio 0.44) than were seen in those patients who had no mutation. The severity of the disease and extraintestinal manifestations were not different for any of the CARD15 genotypes. The proportion of familial and sporadic cases and the proportion of patients with smoking habits were similar in the groups of patients with CD with or without mutation. These findings provide tools for a DNA-based test of susceptibility and for genetic counseling in inflammatory bowel disease.	Fdn Jean Dausset, CEPH, F-75010 Paris, France; Hop Robert Debre, Dept Paediat Gastroenterol, European Paediat Working Grp Genet Inflammatory B, F-75019 Paris, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France; Hop St Louis, Dept Gastroenterol, Paris, France; Hop Calmette, Serv Epidemiol & Sante Publ, Registre EPIMAD, Lille, France; CHU Liege, Dept Gastroenterol, Grp Etud Therapeut Affect Inflammatoires Digest, Liege, Belgium; Linkoping Univ, Inst Mol Klin Med, Div Gastroenterol & Hepatol, Linkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, S-70185 Orebro, Sweden; Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona, Spain; Adelaide & Meath Hosp, Dept Gastroenterol, Dublin, Ireland; Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; Karolinska Childrens Hosp, Dept Gastroenterol, Stockholm, Sweden; INSERM, U535, F-94275 Le Kremlin Bicetre, France		Hugot, JP (corresponding author), Fdn Jean Dausset, CEPH, 27 Rue Juliette Dodu, F-75010 Paris, France.	jean-pierre.hugot@cephb.fr	Hugot, Jean-Pierre/F-6594-2012; Gower, Corinne/I-2553-2018	Almer, Sven/0000-0001-9334-1821; Hugot, Jean-Pierre/0000-0002-8446-6056; Jannot, Anne-Sophie/0000-0002-8001-8539; Gower, Corinne/0000-0002-3925-5364			Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Brant SR, 2000, GASTROENTEROLOGY, V119, P1483, DOI 10.1053/gast.2000.20245; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; Cooper DN, 1995, METABOLIC MOL BASES, P259; Cosnes J, 1996, GASTROENTEROLOGY, V110, P424, DOI 10.1053/gast.1996.v110.pm8566589; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1999, INT J COLORECTAL DIS, V14, P2, DOI 10.1007/s003840050175; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Lee JCW, 1996, GASTROENTEROLOGY, V111, P587, DOI 10.1053/gast.1996.v111.pm8780561; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; TOBIN MV, 1987, GASTROENTEROLOGY, V93, P316, DOI 10.1016/0016-5085(87)91021-3; Vermeire S, 2001, GASTROENTEROLOGY, V120, P834, DOI 10.1053/gast.2001.22453; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	30	756	780	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					845	857		10.1086/339432			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	WOS:000174252100002	11875755	Green Published, Bronze			2022-01-24	
J	Michailidou, K; Hall, P; Gonzalez-Neira, A; Ghoussaini, M; Dennis, J; Milne, RL; Schmidt, MK; Chang-Claude, J; Bojesen, SE; Bolla, MK; Wang, Q; Dicks, E; Lee, A; Turnbull, C; Rahman, N; Fletcher, O; Peto, J; Gibson, L; Silva, ID; Nevanlinna, H; Muranen, TA; Aittomaki, K; Blomqvist, C; Czene, K; Irwanto, A; Liu, JJ; Waisfisz, Q; Meijers-Heijboer, H; Adank, M; van der Luijt, RB; Hein, R; Dahmen, N; Beckman, L; Meindl, A; Schmutzler, RK; Muller-Myhsok, B; Lichtner, P; Hopper, JL; Southey, MC; Makalic, E; Schmidt, DF; Uitterlinden, AG; Hofman, A; Hunter, DJ; Chanock, SJ; Vincent, D; Bacot, F; Tessier, DC; Canisius, S; Wessels, LFA; Haiman, CA; Shah, M; Luben, R; Brown, J; Luccarini, C; Schoof, N; Humphreys, K; Li, JM; Nordestgaard, BG; Nielsen, SF; Flyger, H; Couch, FJ; Wang, XS; Vachon, C; Stevens, KN; Lambrechts, D; Moisse, M; Paridaens, R; Christiaens, MR; Rudolph, A; Nickels, S; Flesch-Janys, D; Johnson, N; Aitken, Z; Aaltonen, K; Heikkinen, T; Broeks, A; Van't Veer, LJ; van der Schoot, CE; Guenel, P; Truong, T; Laurent-Puig, P; Menegaux, F; Marme, F; Schneeweiss, A; Sohn, C; Burwinke, B; Zamora, MP; Perez, JIA; Pita, G; Alonso, MR; Cox, A; Brock, IW; Cross, SS; Reed, MWR; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Henderson, BE; Schumacher, F; Le Marchand, L; Andrulis, IL; Knight, JA; Glendon, G; Mulligan, AM; Lindblom, A; Margolin, S; Hooning, MJ; Hollestelle, A; van den Ouweland, AMW; Jager, A; Bui, QM; Stone, J; Dite, GS; Apicella, C; Tsimiklis, H; Giles, GG; Severi, G; Baglietto, L; Fasching, PA; Haeberle, L; Ekici, AB; Beckmann, MW; Brenner, H; Muller, H; Arndt, V; Stegmaier, C; Swerdlown, A; Ashworth, A; Orr, N; Jones, M; Figueroa, J; Lissowska, J; Brinton, L; Goldberg, MS; Labreche, F; Dumont, M; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Brauch, H; Hamann, U; Bruning, T; Radice, P; Peterlongo, P; Manouldan, S; Bonanni, B; Devilee, P; Tollenaar, RAEM; Seynaeve, C; van Asperen, CJ; Jakubowska, A; Lubinski, J; Jaworska, K; Durda, K; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Bogdanova, NV; Antonenkova, NN; Dork, T; Kristensen, VN; Anton-Culver, H; Slager, S; Toland, AE; Edge, S; Fostira, F; Kang, D; Yoo, KY; Noh, DY; Matsuo, K; Ito, H; Iwata, H; Sueta, A; Wu, AH; Tseng, CC; Van den Berg, D; Stram, DO; Shu, XO; Lu, W; Gao, YT; Cai, H; Teo, SH; Yip, CH; Phuah, SY; Cornes, BK; Hartman, M; Miao, H; Lim, WY; Sng, JH; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Shen, CY; Hsiung, CN; Wu, PE; Ding, SL; Sangrajrang, S; Gaborieau, V; Brennan, P; Mckay, J; Blot, WJ; Signorello, LB; Cai, QY; Zheng, W; Deming-Halverson, S; Shrubsole, M; Long, JR; Simard, J; Garcia-Closas, M; Pharoah, PDP; Chenevix-Trench, G; Dunning, AM; Benitez, J; Easton, DF				Michailidou, Kyriaki; Hall, Per; Gonzalez-Neira, Anna; Ghoussaini, Maya; Dennis, Joe; Milne, Roger L.; Schmidt, Marjanka K.; Chang-Claude, Jenny; Bojesen, Stig E.; Bolla, Manjeet K.; Wang, Qin; Dicks, Ed; Lee, Andrew; Turnbull, Clare; Rahman, Nazneen; Fletcher, Olivia; Peto, Julian; Gibson, Lorna; Silva, Isabel dos Santos; Nevanlinna, Heli; Muranen, Taru A.; Aittomaki, Kristiina; Blomqvist, Carl; Czene, Kamila; Irwanto, Astrid; Liu, Jianjun; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel; van der Luijt, Rob B.; Hein, Rebecca; Dahmen, Norbert; Beckman, Lars; Meindl, Alfons; Schmutzler, Rita K.; Mueller-Myhsok, Bertram; Lichtner, Peter; Hopper, John L.; Southey, Melissa C.; Makalic, Enes; Schmidt, Daniel F.; Uitterlinden, Andre G.; Hofman, Albert; Hunter, David J.; Chanock, Stephen J.; Vincent, Daniel; Bacot, Francois; Tessier, Daniel C.; Canisius, Sander; Wessels, Lodewyk F. A.; Haiman, Christopher A.; Shah, Mitul; Luben, Robert; Brown, Judith; Luccarini, Craig; Schoof, Nils; Humphreys, Keith; Li, Jingmei; Nordestgaard, Borge G.; Nielsen, Sune F.; Flyger, Henrik; Couch, Fergus J.; Wang, Xianshu; Vachon, Celine; Stevens, Kristen N.; Lambrechts, Diether; Moisse, Matthieu; Paridaens, Robert; Christiaens, Marie-Rose; Rudolph, Anja; Nickels, Stefan; Flesch-Janys, Dieter; Johnson, Nichola; Aitken, Zoe; Aaltonen, Kirsimari; Heikkinen, Tuomas; Broeks, Annegien; Van't Veer, Laura J.; van der Schoot, C. Ellen; Guenel, Pascal; Truong, Therese; Laurent-Puig, Pierre; Menegaux, Florence; Marme, Frederik; Schneeweiss, Andreas; Sohn, Christof; Burwinke, Barbara; Pilar Zamora, M.; Arias Perez, Jose Ignacio; Pita, Guillermo; Rosario Alonso, M.; Cox, Angela; Brock, Ian W.; Cross, Simon S.; Reed, Malcolm W. R.; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Henderson, Brian E.; Schumacher, Fredrick; Le Marchand, Loic; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Lindblom, Annika; Margolin, Sara; Hooning, Maartje J.; Hollestelle, Antoinette; van den Ouweland, Ans M. W.; Jager, Agnes; Bui, Quang M.; Stone, Jennifer; Dite, Gillian S.; Apicella, Carmel; Tsimiklis, Helen; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; Fasching, Peter A.; Haeberle, Lothar; Ekici, Arif B.; Beckmann, Matthias W.; Brenner, Hermann; Mueller, Heiko; Arndt, Volker; Stegmaier, Christa; Swerdlown, Anthony; Ashworth, Alan; Orr, Nick; Jones, Michael; Figueroa, Jonine; Lissowska, Jolanta; Brinton, Louise; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Brauch, Hiltrud; Hamann, Ute; Bruening, Thomas; Radice, Paolo; Peterlongo, Paolo; Manouldan, Siranoush; Bonanni, Bernardo; Devilee, Peter; Tollenaar, Rob A. E. M.; Seynaeve, Caroline; van Asperen, Christi J.; Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Durda, Katarzyna; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Bogdanova, Natalia V.; Antonenkova, Natalia N.; Doerk, Thilo; Kristensen, Vessela N.; Anton-Culver, Hoda; Slager, Susan; Toland, Amanda E.; Edge, Stephen; Fostira, Florentia; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Sueta, Aiko; Wu, Anna H.; Tseng, Chiu-Chen; Van den Berg, David; Stram, Daniel O.; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Teo, Soo Hwang; Yip, Cheng Har; Phuah, Sze Yee; Cornes, Belinda K.; Hartman, Mikael; Miao, Hui; Lim, Wei Yen; Sng, Jen-Hwei; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei; Ding, Shian-Ling; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; McKay, James; Blot, William J.; Signorello, Lisa B.; Cai, Qiuyin; Zheng, Wei; Deming-Halverson, Sandra; Shrubsole, Martha; Long, Jirong; Simard, Jacques; Garcia-Closas, Montse; Pharoah, Paul D. P.; Chenevix-Trench, Georgia; Dunning, Alison M.; Benitez, Javier; Easton, Douglas F.		Breast Ovarian Canc Susceptibility; Hereditary Breast Ovarian Canc Res; kConFab Investigators; Australian Ovarian Can Study Grp; GENICA Gene Environm Interaction B	Large-scale genotyping identifies 41 new loci associated with breast cancer risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; COMMON VARIANTS; CONFER SUSCEPTIBILITY; SIGNALING PATHWAY; GENE; EXPRESSION; PROSTATE; ALLELES; 1P11.2	Breast cancer is the most common cancer among women. Common variants at 27 loci have been identified as associated with susceptibility to breast cancer, and these account for similar to 9% of the familial risk of the disease. We report here a meta-analysis of 9 genome-wide association studies, including 10,052 breast cancer cases and 12,575 controls of European ancestry, from which we selected 29,807 SNPs for further genotyping. These SNPs were genotyped in 45,290 cases and 41,880 controls of European ancestry from 41 studies in the Breast Cancer Association Consortium (BCAC). The SNPs were genotyped as part of a collaborative genotyping experiment involving four consortia (Collaborative Oncological Gene-environment Study, COGS) and used a custom Illumina iSelect genotyping array, iCOGS, comprising more than 200,000 SNPs. We identified SNPs at 41 new breast cancer susceptibility loci at genome-wide significance (P < 5 x 10(-8)). Further analyses suggest that more than 1,000 additional loci are involved in breast cancer susceptibility.	[Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K.; Wang, Qin; Lee, Andrew; Luben, Robert; Brown, Judith; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Czene, Kamila; Hofman, Albert; Schoof, Nils; Humphreys, Keith] Karolinska Inst, Stockholm, Sweden; [Gonzalez-Neira, Anna; Hofman, Albert; Pita, Guillermo; Rosario Alonso, M.; Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Programme, Human Genotyping Unit, Ctr Nacl Genotipado CEGEN, Madrid, Spain; [Ghoussaini, Maya; Dicks, Ed; Shah, Mitul; Luccarini, Craig; Pharoah, Paul D. P.; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Milne, Roger L.] CNIO, Human Canc Genet Programme, Genet & Mol Epidemiol Grp, Madrid, Spain; [Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Chang-Claude, Jenny; Hein, Rebecca; Rudolph, Anja; Nickels, Stefan; Flesch-Janys, Dieter] Deutsch Krebsforschungszentrum, Div Canc Epidemiol, Heidelberg, Germany; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Nielsen, Sune F.; kConFab Investigators] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Turnbull, Clare; Rahman, Nazneen; Swerdlown, Anthony; Jones, Michael; Garcia-Closas, Montse] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Fletcher, Olivia; Johnson, Nichola; Ashworth, Alan; Orr, Nick; Garcia-Closas, Montse] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian; Gibson, Lorna; Silva, Isabel dos Santos; Aitken, Zoe] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Nevanlinna, Heli; Muranen, Taru A.; Aaltonen, Kirsimari; Heikkinen, Tuomas] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli; Muranen, Taru A.; Aittomaki, Kristiina; Blomqvist, Carl; Aaltonen, Kirsimari; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aittomaki, Kristiina; Aaltonen, Kirsimari] Univ Helsinki, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl; Aaltonen, Kirsimari] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Irwanto, Astrid; Liu, Jianjun; Li, Jingmei] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Oncogenet, Amsterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Hein, Rebecca] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, PMV Primar Med Versorgung Res Grp, D-50931 Cologne, Germany; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-55122 Mainz, Germany; [Beckman, Lars] Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany; [Meindl, Alfons] Tech Univ Munich, Clin Gynaecol & Obstet, Div Gynaecol Tumor Genet, D-80290 Munich, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Familial Breast & Ovarian Canc, D-50931 Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany; [Mueller-Myhsok, Bertram] Univ Cologne, Max Planck Inst Psychiat, D-50931 Cologne, Germany; [Lichtner, Peter] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Human Genet, Neuherberg, Germany; [Hopper, John L.; Makalic, Enes; Schmidt, Daniel F.; Bui, Quang M.; Stone, Jennifer; Dite, Gillian S.; Apicella, Carmel; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.; Tsimiklis, Helen] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Chanock, Stephen J.; Figueroa, Jonine; Brinton, Louise] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Vincent, Daniel; Bacot, Francois; Tessier, Daniel C.] McGill Univ, Montreal, PQ, Canada; [Vincent, Daniel; Bacot, Francois; Tessier, Daniel C.] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Canisius, Sander; Wessels, Lodewyk F. A.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Wu, Anna H.; Tseng, Chiu-Chen; Van den Berg, David; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Copenhagen, Denmark; [Couch, Fergus J.; Wang, Xianshu] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Vachon, Celine; Stevens, Kristen N.; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Lambrechts, Diether; Moisse, Matthieu] VIB, Vesalius Res Ctr, Louvain, Belgium; [Lambrechts, Diether; Moisse, Matthieu] Univ Louvain, Dept Oncol, Lab Translat Genet, Louvain, Belgium; [Paridaens, Robert; Christiaens, Marie-Rose] Univ Louvain, Dept Oncol, Univ Hosp Gasthuisberg, Louvain, Belgium; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [van der Schoot, C. Ellen] Sanquin Res, Amsterdam, Netherlands; [Guenel, Pascal; Truong, Therese; Menegaux, Florence] INSERM Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Guenel, Pascal; Truong, Therese; Menegaux, Florence] Univ Paris 11, Unite Mixte Rech Sci UMRS 1018, Villejuif, France; [Laurent-Puig, Pierre] Univ Paris 04, INSERM, UMRS 775, Paris, France; [Marme, Frederik; Schneeweiss, Andreas; Sohn, Christof; Burwinke, Barbara] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Marme, Frederik; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Burwinke, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Pilar Zamora, M.] Hosp Univ La Paz, Med Oncol Serv, Madrid, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirurgia Gen & Especialidades, Oviedo, Spain; [Cox, Angela; Brock, Ian W.; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Sawyer, Elinor J.] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust Par, Div Canc Studies, NIHR, Comprehens Biomed Res Ctr, London, England; [Tomlinson, Ian] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Univ Hosp Galway, Inst Clin Sci, Galway, Ireland; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ontario Canc Genet Network, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hooning, Maartje J.; Hollestelle, Antoinette; Jager, Agnes] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands; [van den Ouweland, Ans M. W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Fasching, Peter A.; Haeberle, Lothar; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Univ Breast Ctr Franconia, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Miller, Nicola; Brenner, Hermann; Arndt, Volker] DKFZ, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Ashworth, Alan; Orr, Nick; Garcia-Closas, Montse] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Labreche, France] Univ Montreal, Dept Sante Environm & Sante Travail, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Dumont, Martine] CHU Quebec, Canc Genom Lab, Quebec City, PQ, Canada; [Dumont, Martine; Simard, Jacques] Univ Laval, Quebec City, PQ, Canada; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Oulu Univ Hosp, Lab Canc Genet & Tumor Biol, Dept Clin Genet, Oulu, Finland; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Bioctr, Oulu Univ Hosp, Oulu, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu, Finland; [Grip, Mervi] Univ Oulu, Dept Surg, Oulu Univ Hosp, Oulu, Finland; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Hamann, Ute] DKFZ, Heidelberg, Germany; [Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany; [Radice, Paolo; Peterlongo, Paolo] Fdn IRCCS Ist Nazl Tumori INT, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Radice, Paolo; Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol, Ist FIRC Oncol Mol IFOM, Milan, Italy; [Manouldan, Siranoush] Fdn IRCCS INT, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Bonanni, Bernardo] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Devilee, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Tollenaar, Rob A. E. M.] Leiden Univ, Dept Surg Oncol, Med Ctr, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus Med Ctr Daniel den Hoed Canc Ctr, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [van Asperen, Christi J.] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Kristensen, Vessela N.] Warsaw Med Univ, Postgrad Sch Mol Med, Warsaw, Poland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Sch Med, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Canc Ctr Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Kataja, Vesa] Univ Eastern Finland, Inst Clin Med & Oncol, Sch Med, Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Bogdanova, Natalia V.; Doerk, Thilo] Hannover Med Schbol, Dept Obstet & Gynaecol, Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Schbol, Dept Radiat Oncol, Hannover, Germany; [Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Epidemiol & Mol Biol EpiGen, Oslo, Norway; [Kristensen, Vessela N.] Rikshosp Radiumhosp, Inst Canc Res, Dept Genet, Grp Canc Genome Variat, Oslo, Norway; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Toland, Amanda E.] Univ Calif Irvine, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Irvine, CA USA; [Edge, Stephen] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Fostira, Florentia] Natl Ctr Sci Res Demokritos, IRRP, Mol Diagnost Lab, Athens, Greece; [Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Matsuo, Keitaro; Ito, Hidemi; Sueta, Aiko] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Shu, Xiao-Ou; Cai, Hui; Cai, Qiuyin; Zheng, Wei; Deming-Halverson, Sandra; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr,Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Malaysia; [Teo, Soo Hwang; Phuah, Sze Yee] Canc Res Initiat Fdn, Sims Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har] Univ Malaya, Med Ctr, Univ Malaya Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Cornes, Belinda K.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Hartman, Mikael; Miao, Hui; Lim, Wei Yen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael; Sng, Jen-Hwei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Bangkok, Thailand; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Taichong, Taiwan; [Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Ding, Shian-Ling] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok, Thailand; [Gaborieau, Valerie; Brennan, Paul; McKay, James] Int Agcy Res Canc, Lyon, France; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD USA; [Chenevix-Trench, Georgia] Queensland Inst Med Res, Dept Genet, Brisbane, Qld 4006, Australia; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain		Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	per.hall@ki.se; dfe20@medschl.cam.ac.uk	Bruning, Thomas/G-8120-2015; Flyger, Henrik/AAM-6494-2021; Hartikainen, Jaana M/E-6256-2015; Fostira, Florentia/Z-5730-2019; Radice, Paolo/O-3119-2013; Severi, Gianluca/H-3774-2018; Guenel, Pascal/H-3728-2018; Garcia-Closas, Montserrat/F-3871-2015; Arndt, Volker/AAI-7282-2020; van Asperen, Christi J/D-3970-2012; Miller, Nicola/F-4009-2018; Liu, Jianjun/AAK-4989-2020; Knight, Julia/R-5617-2019; Stone, Jennifer/AAS-3805-2020; Bowtell, David/H-1007-2016; Verdrengh, Evelien/H-4571-2012; Severi, Gianluca/Q-1824-2019; Brinton, Louise A/G-7486-2015; Schumacher, Fredrick/R-6043-2019; Bonanni, Bernardo/AAM-7928-2020; Noh, Dong-Young/G-5531-2011; Shrubsole, Martha J/K-5052-2015; Ekici, Arif B/C-3971-2013; Bogdanova, Natalia V./Y-2205-2019; manoukian, siranoush/E-7132-2017; Muranen, Taru/AAC-8418-2019; Zheng, Wei/O-3351-2013; Lissowska, Jolanta/AAH-3252-2020; Knight, Julia A/A-6843-2012; Toland, Amanda Ewart/E-4202-2011; Luben, Robert N/H-5519-2015; Schmidt, Marjanka K/G-9058-2011; Dork, Thilo/J-8620-2012; Teo, Soo-hwang/H-2353-2014; Peterlongo, Paolo/Q-4717-2018; Menegaux, Florence/H-4261-2018; Margolin, Sara/AAX-9034-2020; Baglietto, Laura/AAB-9051-2019; jager, agnes/V-6381-2017; Li, Jingmei/I-2904-2012; Chenevix-Trench, Georgia/AAV-2014-2020; laurent-puig, pierre/B-2226-2013; Turnbull, Clare/AAA-6596-2019; truong, therese/A-2837-2013; Purrington, Kristen/AAN-6494-2021; Arndt, Volker/B-4999-2014; Reed, Malcolm Walter/AAG-9219-2020; Brenner, Hermann/B-4627-2017; Kerin, Michael J/D-6748-2013; Andrulis, Irene L./E-7267-2013; Pharoah, Paul/V-6658-2019; Yip, Cheng-Har/B-1909-2010; Matsuo, Keitaro/H-6758-2019; Michailidou, Kyriaki/ABD-5122-2020; Gonzalez-Neira, Anna/C-5791-2015; Van Den Berg, David J/G-8598-2017; Guenel, Pascal/AAS-7688-2021; Jakubowska, Anna/O-8050-2014; Laurent-Puig, Pierre/K-3641-2019; /AAM-5330-2020; Fasching, Peter/ABH-9912-2020; Lambrechts, Diether/AAJ-3167-2020; Rahman, Nazneen/D-2802-2013; Hartman, Mikael/B-4324-2011	Bruning, Thomas/0000-0001-9560-5464; Hartikainen, Jaana M/0000-0001-8267-1905; Radice, Paolo/0000-0001-6298-4111; Severi, Gianluca/0000-0001-7157-419X; Guenel, Pascal/0000-0002-8359-518X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Arndt, Volker/0000-0001-9320-8684; van Asperen, Christi J/0000-0002-1436-7650; Miller, Nicola/0000-0002-5416-7047; Liu, Jianjun/0000-0002-3255-3019; Knight, Julia/0000-0002-7610-7635; Bowtell, David/0000-0001-9089-7525; Severi, Gianluca/0000-0001-7157-419X; Brinton, Louise A/0000-0003-3853-8562; Schumacher, Fredrick/0000-0002-3073-7463; Shrubsole, Martha J/0000-0002-5591-7575; Ekici, Arif B/0000-0001-6099-7066; manoukian, siranoush/0000-0002-6034-7562; Muranen, Taru/0000-0002-5895-1808; Zheng, Wei/0000-0003-1226-070X; Lissowska, Jolanta/0000-0003-2695-5799; Luben, Robert N/0000-0002-5088-6343; Schmidt, Marjanka K/0000-0002-2228-429X; Dork, Thilo/0000-0002-9458-0282; Peterlongo, Paolo/0000-0001-6951-6855; Menegaux, Florence/0000-0003-3363-6411; jager, agnes/0000-0002-7713-1450; Li, Jingmei/0000-0001-8587-7511; Chenevix-Trench, Georgia/0000-0002-1878-2587; laurent-puig, pierre/0000-0001-8475-5459; truong, therese/0000-0002-2943-6786; Purrington, Kristen/0000-0002-5710-1692; Arndt, Volker/0000-0001-9320-8684; Reed, Malcolm Walter/0000-0001-7442-2132; Brenner, Hermann/0000-0002-6129-1572; Pharoah, Paul/0000-0001-8494-732X; Matsuo, Keitaro/0000-0003-1761-6314; Michailidou, Kyriaki/0000-0001-7065-1237; Gonzalez-Neira, Anna/0000-0002-5421-2020; Van Den Berg, David J/0000-0002-5404-5218; Guenel, Pascal/0000-0002-8359-518X; Jakubowska, Anna/0000-0002-5650-0501; Laurent-Puig, Pierre/0000-0001-8475-5459; Nevanlinna, Heli/0000-0002-0916-2976; Simard, Jacques/0000-0001-6906-3390; Moisse, Matthieu/0000-0001-8880-9311; Southey, Melissa/0000-0002-6313-9005; Kerin, Michael/0000-0003-4164-5561; dos Santos Silva, Isabel/0000-0002-6596-8798; Figueroa, Jonine/0000-0002-5100-623X; Bui, Minh/0000-0002-9099-6870; Kataja, Vesa/0000-0003-4846-4843; Roth, Rebecca/0000-0002-2841-4921; Dunning, Alison Margaret/0000-0001-6651-7166; Dennis, Joe/0000-0003-4591-1214; Jones, Michael/0000-0001-7479-3451; Mulligan, Anna Marie/0000-0002-7239-5297; Cross, Simon/0000-0003-2044-1754; Stone, Jennifer/0000-0001-5077-0124; Arias Perez, Jose Ignacio/0000-0003-4500-397X; Long, Jirong/0000-0002-7433-9766; Kang, Daehee/0000-0003-4031-5878; Aitken, Zoe/0000-0002-5413-2450; Dite, Gillian/0000-0002-2448-2548; Fletcher, Olivia/0000-0001-9387-7116; Winqvist, Robert/0000-0003-0932-9104; Rudolph, Anja/0000-0001-7520-2035; Brauch, Hiltrud/0000-0001-7531-2736; van der Luijt, Rob/0000-0002-0018-1089; Blomqvist, Carl/0000-0003-3041-1938; Turnbull, Clare/0000-0002-1734-5772; Rahman, Nazneen/0000-0003-4376-0440; Giles, Graham/0000-0003-4946-9099; Swerdlow, Anthony/0000-0001-5550-4159; Devilee, Peter/0000-0002-8023-2009; Cox, Angela/0000-0002-5138-1099; Hartman, Mikael/0000-0001-5726-9965; Baglietto, Laura/0000-0002-8193-7529; Pita, Guillermo/0000-0003-2393-0510; Pylkas, Katri/0000-0002-2449-0521; Hollestelle, Antoinette/0000-0003-1166-1966; Lambrechts, Diether/0000-0002-3429-302X; Labreche, France/0000-0001-8722-0433; Ito, Hidemi/0000-0002-8023-4581; Durocher, Francine/0000-0001-8012-4641; Lubinski, Jan/0000-0003-2931-3003; Heikkinen, Tuomas/0000-0003-1154-6204; Czene, Kamila/0000-0002-3233-5695	Cancer Research UKCancer Research UK [C1287/A10118, C1287/Al2014, C1287/A10710]; European Community's Seventh Framework ProgrammeEuropean Commission [223175, HEALTH-F2-2009-223175]; European Union European Cooperation in Science and Technology (COST) [BM0606]; European UnionEuropean Commission [HEALTH-F2-2009-223175]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer programCanadian Institutes of Health Research (CIHR); Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; US National Institutes of Health (NIH) Cancer Post-Cancer GWAS [1 U19 CA 148065-01]; Cancer Research UKCancer Research UK [16561, 11022, 10118, 15106, 16565] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [03/DHCS/03/G121/51] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06, PF-11-20] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA148667, T32CA148056, R01CA128978, R01CA067262, R01CA050385, R01CA160565, R01CA100374, R25CA092049, R01CA049449, P30CA016058, R01CA092447, R01CA122340, U01CA098233, ZIACP010201, R01CA064277, U19CA148065, R01CA065725, P50CA116201, R37CA070867] Funding Source: NIH RePORTER	The authors wish to thank all the individuals who took part in these studies and all the researchers, clinicians, technicians and administrative staff who have enabled this work to be carried out. BCAC is funded by Cancer Research UK (C1287/A10118 and C1287/Al2014) and by the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS). Meetings of BCAC have been funded by the European Union European Cooperation in Science and Technology (COST) programme (BM0606). Genotyping of the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program and the Ministry of Economic Development, Innovation and Export Trade of Quebec (grant PSR-SIIRI-701). Combining the GWAS data was supported in part by the US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative grant 1 U19 CA 148065-01 (DRIVE, part of the GAME-ON initiative). A full description of funding and acknowledgments is provided in the Supplementary Note.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Castro P, 2002, GENOMICS, V80, P78, DOI 10.1006/geno.2002.6805; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Debily MA, 2004, HUM MOL GENET, V13, P323, DOI 10.1093/hmg/ddh024; Dunbar ME, 1996, AM J MED SCI, V312, P287, DOI 10.1097/00000441-199612000-00007; Dunbar ME, 1998, DEV BIOL, V203, P75, DOI 10.1006/dbio.1998.9029; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Esseghir S, 2007, CLIN CANCER RES, V13, P3164, DOI 10.1158/1078-0432.CCR-07-0224; Figueroa JD, 2011, HUM MOL GENET, V20, P4693, DOI 10.1093/hmg/ddr368; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hemphill AW, 2008, MOL GENET METAB, V94, P38, DOI 10.1016/j.ymgme.2007.11.012; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jingushi K, 2012, BIOCHEM PHARMACOL, V83, P47, DOI 10.1016/j.bcp.2011.10.001; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Lambrechts D, 2012, HUM MUTAT, V33, P1123, DOI 10.1002/humu.22089; Lee JC, 2008, CELL BIOCHEM FUNCT, V26, P892, DOI 10.1002/cbf.1522; Leong S, 2012, J PROTEOME RES, V11, P1240, DOI 10.1021/pr200935y; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ma XY, 2012, CANCER EPIDEM BIOMAR, V21, P1176, DOI 10.1158/1055-9965.EPI-12-0118; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Murfuni I, 2013, ONCOGENE, V32, P610, DOI 10.1038/onc.2012.80; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Nakamura T, 2001, BBA-GENE STRUCT EXPR, V1518, P63, DOI 10.1016/S0167-4781(01)00168-3; Pamidi A, 2007, CANCER RES, V67, P8527, DOI 10.1158/0008-5472.CAN-07-1161; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Scollen S, 2011, CANCER EPIDEM BIOMAR, V20, P1112, DOI 10.1158/1055-9965.EPI-11-0062; Shimozawa N, 2004, HUM MUTAT, V23, P552, DOI 10.1002/humu.20032; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	61	755	761	5	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					353	361		10.1038/ng.2563			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	WOS:000316840600005	23535729	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Habier, D; Fernando, RL; Dekkers, JCM				Habier, D.; Fernando, R. L.; Dekkers, J. C. M.			The impact of genetic relationship information on genome-assisted breeding values	GENETICS			English	Article								The success of genomic selection depends on the potential to predict genome-assisted breeding values (GEBVs) with high accuracy over several generations without additional phenotypinig after estimating marker effects. Results from both simulations and practical applications have to be evaluated for this potential, which requires linkage disequilibrium (LD) between markers and QTL This study shows that markers can capture genetic relationships among genotyped animals, thereby affecting accuracies of GEBVs. Strategies to validate the accuracy of GEBVs due to LD are given. Simulations were used to show that accuracies of GEBVs obtained by fixed regression-least squares (FR-LS), random regression-best linear unibased prediction (RR-BLUP), and Bayes-B are nonzero even without LD. When LD was present, accuracies decrease rapidly in generations after estimation due to the decay of genetic relationships. However, there is a persistent accuracy due to LD, which can be estimated by modeling the decay of genetic relationships and the decay of LD. The impact of genetic relationships was greatest for RR-BLUP The accuracy of GEBVs can result entirely from genetic relationships captured by markers, and to validate the potential of genomic selection, several genenerations have to be analyzed to estimate the accuracy due to LD. The method of choice was Bayes-B; FR-LS should be investigated further, whereas RR-BLUP cannot be recommended.	[Habier, D.; Fernando, R. L.; Dekkers, J. C. M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Habier, D.; Fernando, R. L.; Dekkers, J. C. M.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA		Habier, D (corresponding author), Iowa State Univ, Dept Anim Sci, 233 Kildee Hall, Ames, IA 50011 USA.	dhabier@iastate.edu					Fernando R., 1998, V26, P329; Karlin S., 1984, HUMAN POPULATION GEN, P209; Kutner MH., 2005, APPL LINEAR STAT MOD; LEGARRA A, 2007, WORKSH QTL MARK ASS; Malecot G, 1948, MATH HEREDITE; Meuwissen THE, 2001, GENETICS, V157, P1819; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; PIVASATIAN N, 2006, J ANIM SCI S2, V84, P134; Solberg TR, 2006, 8 WORLD C GEN APPL L; SVED JA, 1969, THEOR POPUL BIOL, V2, P125; VanRaden PM, 2007, POULTRY SCI, V86, P374	11	755	777	7	77	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	2007	177	4					2389	2397		10.1534/genetics.107.081190			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	245QF	WOS:000251949800035	18073436	Bronze, Green Published			2022-01-24	
J	Finucane, HK; Bulik-Sullivan, B; Gusev, A; Trynka, G; Reshef, Y; Loh, PR; Anttila, V; Xu, H; Zang, CZ; Farh, K; Ripke, S; Day, FR; Purcell, S; Stahl, E; Lindstrom, S; Perry, JRB; Okada, Y; Raychaudhuri, S; Daly, MJ; Patterson, N; Neale, BM; Price, AL				Finucane, Hilary K.; Bulik-Sullivan, Brendan; Gusev, Alexander; Trynka, Gosia; Reshef, Yakir; Loh, Po-Ru; Anttila, Verneri; Xu, Han; Zang, Chongzhi; Farh, Kyle; Ripke, Stephan; Day, Felix R.; Purcell, Shaun; Stahl, Eli; Lindstrom, Sara; Perry, John R. B.; Okada, Yukinori; Raychaudhuri, Soumya; Daly, Mark J.; Patterson, Nick; Neale, Benjamin M.; Price, Alkes L.		ReproGen Consortium; Psychiat Genomics Consortium; RACI Consortium	Partitioning heritability by functional annotation using genome-wide association summary statistics	NATURE GENETICS			English	Article							BODY-MASS INDEX; GENETIC ARCHITECTURE; HUMAN HEIGHT; COMMON SNPS; CELL-TYPES; VARIANTS; LOCI; DISEASE; SUSCEPTIBILITY; PROPORTION	Recent work has demonstrated that some functional categories of the genome contribute disproportionately to the heritability of complex diseases. Here we analyze a broad set of functional elements, including cell type-specific elements, to estimate their polygenic contributions to heritability in genome-wide association studies (GWAS) of 17 complex diseases and traits with an average sample size of 73,599. To enable this analysis, we introduce a new method, stratified LD score regression, for partitioning heritability from GWAS summary statistics while accounting for linked markers. This new method is computationally tractable at very large sample sizes and leverages genome-wide information. Our findings include a large enrichment of heritability in conserved regions across many traits, a very large immunological disease-specific enrichment of heritability in FANTOM5 enhancers and many cell type-specific enrichments, including significant enrichment of central nervous system cell types in the heritability of body mass index, age at menarche, educational attainment and smoking behavior.	[Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Finucane, Hilary K.; Gusev, Alexander; Loh, Po-Ru; Lindstrom, Sara; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bulik-Sullivan, Brendan; Anttila, Verneri; Farh, Kyle; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Bulik-Sullivan, Brendan; Anttila, Verneri; Farh, Kyle; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Harvard Univ, Sch Med, Boston, MA USA; [Bulik-Sullivan, Brendan; Anttila, Verneri; Ripke, Stephan; Daly, Mark J.; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Trynka, Gosia; Purcell, Shaun; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA USA; [Trynka, Gosia; Purcell, Shaun; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Rheumatol, Brigham & Womens Hosp, Boston, MA USA; [Trynka, Gosia; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Trynka, Gosia; Anttila, Verneri; Raychaudhuri, Soumya; Daly, Mark J.; Patterson, Nick; Neale, Benjamin M.; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Trynka, Gosia] Wellcome Trust Sanger Inst, Cambridge, England; [Reshef, Yakir] Harvard Univ, Dept Comp Sci, Cambridge, MA 02138 USA; [Xu, Han; Zang, Chongzhi] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Xu, Han; Zang, Chongzhi] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Farh, Kyle] Broad Inst MIT & Harvard, Epigen Program, Cambridge, MA USA; [Day, Felix R.; Perry, John R. B.] Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med,Inst Metab Sci, Cambridge, England; [Purcell, Shaun; Stahl, Eli] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England		Finucane, HK (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.	hilaryf@mit.edu; bulik@broadinstitute.org; bneale@broadinstitute.org; aprice@hsph.harvard.edu	Hansen, Thomas Folkmann/O-5965-2014; Webb, Bradley T/B-1459-2009; Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021; Zang, Chongzhi/D-1445-2011; Grove, Jakob/K-8112-2015	Hansen, Thomas Folkmann/0000-0001-6703-7762; Webb, Bradley T/0000-0002-0576-5366; Daly, Mark J/0000-0002-0949-8752; Zang, Chongzhi/0000-0003-4812-3627; Anttila, Verneri/0000-0002-0073-4675; Day, Felix/0000-0003-3789-7651; Gusev, Alexander/0000-0002-7980-4620; Raychaudhuri, Soumya/0000-0002-1901-8265; Grove, Jakob/0000-0003-2284-5744; ripke, stephan/0000-0003-3622-835X	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH101244, R01 HG006399, R03 CA173785, R21 CA182821, F32 GM106584, U01 HG0070033]; Fannie and John Hertz Foundation; Wellcome Trust Sanger InstituteWellcome Trust [WT098051]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007753]; Arthritis Foundation; Doris Duke Clinical Scientist Development AwardDoris Duke Charitable Foundation (DDCF); Wellcome TrustWellcome TrustEuropean Commission [076113]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH101244, R01 HG006399, R03 CA173785, R21 CA182821, F32 GM106584, U01 HG0070033]; Fannie and John Hertz Foundation; Wellcome Trust Sanger InstituteWellcome Trust [WT098051]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007753]; Arthritis Foundation; Doris Duke Clinical Scientist Development AwardDoris Duke Charitable Foundation (DDCF); Wellcome TrustWellcome TrustEuropean Commission [076113]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15H05670] Funding Source: KAKEN; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U106179472, MC_UU_12015/2] Funding Source: UKRI; Lundbeck FoundationLundbeckfonden [R155-2014-1724] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UU_12015/2, MC_U106179472] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA182821, R03CA173785] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007753, F32GM106584, T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101244] Funding Source: NIH RePORTER	We thank B. Bernstein, M. Finucane, A. Forrest, E. Hodis, D. Kotliar, X.S. Liu, M. Kellis, M. O'Donovan, B. Pasaniuc, A. Sandelin, A. Sarkar, P. Sullivan, B. Vilhjalmsson, A. Veres and the anonymous reviewers for helpful discussions and/or comments. This research was funded by US National Institutes of Health grants R01 MH101244, R01 HG006399, R03 CA173785, R21 CA182821, F32 GM106584 and U01 HG0070033. H.K.F. was also supported by the Fannie and John Hertz Foundation. G.T. is supported by the Wellcome Trust Sanger Institute (WT098051). Y.R. was supported by award T32 GM007753 from the National Institute of General Medical Sciences. S. Raychaudhuri is supported by funding from the Arthritis Foundation and by a Doris Duke Clinical Scientist Development Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) and the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the WTCCC data is available at http://www.wtccc.org.uk/. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Farooqi IS, 2014, CLIN MED, V14, P286, DOI 10.7861/clinmedicine.14-3-286; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kettyle William M., 1998, ENDOCRINE PATHOPHYSI; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lilly L.S., 2012, PATHOPHYSIOLOGY HEAR; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	49	754	753	7	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1228	+		10.1038/ng.3404			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	WOS:000363988200005	26414678	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Strautnieks, SS; Bull, LN; Knisely, AS; Kocoshis, S; Dahl, N; Arnell, H; Sokal, E; Dahan, K; Childs, S; Ling, V; Tanner, MS; Kagalwalla, AF; Nemeth, A; Pawlowska, J; Baker, A; Mieli-Vergani, G; Freimer, NB; Gardiner, RM; Thompson, RJ				Strautnieks, SS; Bull, LN; Knisely, AS; Kocoshis, S; Dahl, N; Arnell, H; Sokal, E; Dahan, K; Childs, S; Ling, V; Tanner, MS; Kagalwalla, AF; Nemeth, A; Pawlowska, J; Baker, A; Mieli-Vergani, G; Freimer, NB; Gardiner, RM; Thompson, RJ			A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis	NATURE GENETICS			English	Article							BYLER-DISEASE; P-GLYCOPROTEIN; IDENTIFICATION; HETEROGENEITY; LOCUS; ACID; 18Q21-Q22; SECRETION; MUTATIONS; MEMBRANE	The progressive familiar intrahepatic cholestases (PFIC) are a group of inherited disorders with severe cholestatic liver disease from early infancy. A subgroup characterized by normal serum cholesterol and gamma-glutamyltranspeptidase (gamma GT) levels is genetically heterogeneous with loci on chromosomes 2q (PFIC2) and 18q. The phenotype of the PFIC2-linked group is consistent with defective bile acid transport at the hepatocyte canalicular membrane. The PFIC2 gene has now been identified by mutations in a positional candidate, BSEP, which encodes a liver-specific ATP-binding cassette (ABC) transporter, sister of p-glycoprotein (SPGP). The product of the orthologous rat gene has been shown to be an effective bile acid transporter in vitro. These data provide evidence that SPCP is the human bile salt export pump (BSEP).	UCL, Sch Med, Dept Paediat, London W1N 8AA, England; Univ Calif San Francisco, Dept Psychiat, Ctr Neurobiol & Psychiat, Neurogenet Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; Univ Texas, Med Branch, Div Surg Pathol, Galveston, TX 77550 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Univ Catholique Louvain, Dept Pediat, B-1348 Louvain, Belgium; Univ Catholique Louvain, Dept Med Genet, B-1348 Louvain, Belgium; British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; Huddinge Univ Hosp, Dept Pediat, S-14186 Huddinge, Sweden; Childrens Mem Hlth Inst, Warsaw, Poland; Kings Coll London Hosp, Dept Child Hlth, London, England; Kings Coll London, Sch Med & Dent, London, England; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA		Thompson, RJ (corresponding author), UCL, Sch Med, Dept Paediat, Mortimer St, London W1N 8AA, England.	richard.j.thompson@kcl.ac.uk	Mieli-Vergani, Giorgina/G-5616-2011; Childs, Sarah/AAG-5111-2021; Thompson, Richard J/B-7954-2009	Mieli-Vergani, Giorgina/0000-0002-8215-4489; Thompson, Richard J/0000-0001-5652-0150; Childs, Sarah/0000-0003-2261-580X; Nemeth, Antal/0000-0002-6229-5882; Pawlowska, Joanna/0000-0003-1154-8824; Sokal, Etienne/0000-0001-5597-4708	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK050697] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK50697] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; ALONSO EM, 1994, J PEDIATR GASTR NUTR, V18, P128, DOI 10.1097/00005176-199402000-00002; Arnell H, 1997, HUM GENET, V100, P378, DOI 10.1007/s004390050519; BROWN RS, 1995, P NATL ACAD SCI USA, V92, P5421, DOI 10.1073/pnas.92.12.5421; Bull LN, 1997, HEPATOLOGY, V26, P155; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; CARLTON VEH, 1995, HUM MOL GENET, V4, P1049, DOI 10.1093/hmg/4.6.1049; CHEN CJ, 1990, J BIOL CHEM, V265, P506; Childs S, 1998, CANCER RES, V58, P4160; CHILDS S, 1995, CANCER RES, V55, P2029; CLAYTON RJ, 1969, AM J DIS CHILD, V117, P112, DOI 10.1001/archpedi.1969.02100030114014; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; JACQUEMIN E, 1994, EUR J PEDIATR, V153, P424; JAVITT NB, 1967, GASTROENTEROLOGY, V53, P171; MAGGIORE G, 1987, J PEDIATR-US, V111, P251, DOI 10.1016/S0022-3476(87)80079-3; Marinelli RA, 1997, HEPATOLOGY, V26, P1081, DOI 10.1002/hep.510260539; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; NIELSEN IM, 1986, ACTA PAEDIATR SCAND, V75, P1010, DOI 10.1111/j.1651-2227.1986.tb10332.x; Popper H, 1970, Hum Pathol, V1, P1, DOI 10.1016/S0046-8177(70)80002-8; RAYMOND M, 1989, P NATL ACAD SCI USA, V86, P6488, DOI 10.1073/pnas.86.17.6488; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Strautnieks SS, 1996, J MED GENET, V33, P833, DOI 10.1136/jmg.33.10.833; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; Suchy FJ, 1997, FASEB J, V11, P199, DOI 10.1096/fasebj.11.4.9068608; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003	37	754	769	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					233	238		10.1038/3034			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	WOS:000076698100015	9806540				2022-01-24	
J	Nachman, MW; Crowell, SL				Nachman, MW; Crowell, SL			Estimate of the mutation rate per nucleotide in humans	GENETICS			English	Article							MALE-DRIVEN EVOLUTION; DNA-SEQUENCES; DELETERIOUS MUTATION; DROSOPHILA-MELANOGASTER; NEUTRAL THEORY; X-CHROMOSOME; HEMOPHILIA-B; GENOME; SUBSTITUTIONS; INFERENCES	Many previous estimates of the mutation rate in humans have relied on screens of visible mutants. We investigated the rate and pattern of mutations at the nucleotide level by comparing pseudogenes in humans and chimpanzees to (i) provide an estimate of the average mutation rate per nucleotide, (ii) assess heterogeneity of mutation rate at different sites and for different types of mutations, (iii) test the hypothesis that the X chromosome has a lower mutation rate than autosomes, and (iv) estimate the deleterious mutation rate. Eighteen processed pseudogenes were sequenced, including 12 on autosomes and 6 on the X chromosome. The average mutation rate was estimated to be similar to 2.5 X 10(-8) mutations per nucleotide site or 175 mutations per diploid genome per generation. Rates of mutation for both transitions and transversions at CpG dinucleotides are one order of magnitude higher than mutation rates at other sites. Single nucleotide substitutions are 10 times more frequent than length mutations. Comparison of rates of evolution for X-linked and autosomal pseudogenes suggests that the male mutation rate is 4 times the female mutation rate, but provides no evidence for a reduction in mutation rate that is specific to the X chromosome. Using conservative calculations of the proportion of the genome subject to purifying selection, we estimate that the genomic deleterious mutation rate (U) is at least 3. This high rate is difficult to reconcile with multiplicative fitness effects of individual mutations and suggests that synergistic epistasis among harmful mutations may be common.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA		Nachman, MW (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Biosci W Bldg, Tucson, AZ 85721 USA.						Anagnostopoulos T, 1999, AM J HUM GENET, V64, P508, DOI 10.1086/302250; Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Cooper D. N., 1993, HUMAN GENE MUTATION; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Drake JW, 1998, GENETICS, V148, P1667; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fry JD, 1999, P NATL ACAD SCI USA, V96, P574, DOI 10.1073/pnas.96.2.574; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Haldane JBS., 1932, CAUSES EVOLUTION; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Huang W, 1997, J MOL EVOL, V44, P463, DOI 10.1007/PL00006166; Hurst LD, 1998, TRENDS GENET, V14, P446, DOI 10.1016/S0168-9525(98)01577-7; Keightley PD, 1997, P NATL ACAD SCI USA, V94, P3823, DOI 10.1073/pnas.94.8.3823; Keightley PD, 1996, GENETICS, V144, P1993; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1983, MOL BIOL EVOL, V1, P84; KIMURA M, 1966, GENETICS, V54, P1337; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL E; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Li W-H, 1991, FUNDAMENTALS MOL EVO; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Marshall E, 1999, SCIENCE, V284, P1906, DOI 10.1126/science.284.5422.1906; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MUKAI T, 1972, GENETICS, V72, P335; MULLER HJ, 1950, AM J HUM GENET, V2, P111; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Smith NGC, 1999, GENETICS, V152, P661; Sommer SS, 1996, HUM MOL GENET, V5, P1505, DOI 10.1093/hmg/5.Supplement_1.1505; SOMMER SS, 1995, TRENDS GENET, V11, P141, DOI 10.1016/S0168-9525(00)89028-9; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Vogel F, 1997, HUMAN GENETICS PROBL; Wallace B., 1981, BASIC POPULATION GEN; Wallace B., 1991, 50 YEARS GENETIC LOA; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	51	753	773	5	85	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	SEP	2000	156	1					297	304					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	352HQ	WOS:000089209800024	10978293				2022-01-24	
J	Galloway, SM; McNatty, KP; Cambridge, LM; Laitinen, MPE; Juengel, JL; Jokiranta, TS; McLaren, RJ; Luiro, K; Dodds, KG; Montgomery, GW; Beattie, AE; Davis, GH; Ritvos, O				Galloway, SM; McNatty, KP; Cambridge, LM; Laitinen, MPE; Juengel, JL; Jokiranta, TS; McLaren, RJ; Luiro, K; Dodds, KG; Montgomery, GW; Beattie, AE; Davis, GH; Ritvos, O			Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner	NATURE GENETICS			English	Article							DIFFERENTIATION FACTOR-9; X-CHROMOSOME; MESSENGER-RNA; 3-DIMENSIONAL STRUCTURE; HOMOLOG GDF-9B; SHEEP OVARY; FACTOR-BETA; FOLLICLES; FECX(1); EWES	Multiple ovulations are uncommon in humans, cattle and many breeds of sheep. Pituitary gonadotrophins and as yet unidentified ovarian factors precisely regulate follicular development so that, normally, only one follicle is selected to ovulate. The Inverdale (FecX(I)) sheep, however, carries a naturally occurring X-linked mutation that causes increased ovulation rate and twin and triplet births in heterozygotes (FecX(I)/FecX(+); ref. 1). but primary ovarian failure in homozygotes (FecX(I)/FecX(I); ref. 2). Germcell development, formation of the follicle and the earliest stages of follicular growth are normal in FecX(I)/FecX(I) sheep, but follicular development beyond the primary stage is impaired(3,4). A second family unrelated to the Inverdale sheep also has the same X-linked phenotype(5) (Hanna, FecX(H)). Crossing FecX(I) with FecXH animals produces FecX(I)/FecX(H) infertile females phenotypically indistinguishable from FecX(I)/FecX(I) females(6). We report here that the FecX(I) locus maps to an orthologous chromosomal region syntenic to human Xp11.2-11.4, which contains BMP15, encoding bone morphogenetic protein 15 (also known as growth differentiation factor 9B (GDF9B)). Whereas BMP15 is a member of the transforming growth factor beta (TGF beta) superfamily and is specifically expressed in oocytes, its function is unknown(7-9). We show that independent germline point mutations exist in FecX(I) and FecX(H) carriers. These findings establish that BMP15 is essential for female fertility and that natural mutations in an ovary-derived factor can cause both increased ovulation rate and infertility phenotypes in a dosage-sensitive manner.	AgRes, Mol Biol Unit, Dunedin, New Zealand; Univ Otago, Dept Biochem, Ctr Gene Res, Dunedin, New Zealand; AgRes, Wallaceville Anim Res Ctr, Upper Hutt, New Zealand; Biomedicum Helsinki, Programme Dev & Reprod Biol, Helsinki, Finland; Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; AgRes, Invermay Agr Ctr, Mosgiel, New Zealand		Galloway, SM (corresponding author), AgRes, Mol Biol Unit, Dunedin, New Zealand.		Montgomery, Grant W/B-7148-2008; Jokiranta, T. Sakari/F-1906-2011	Montgomery, Grant W/0000-0002-4140-8139; Luiro, Kaisu/0000-0003-0736-2891; Juengel, Jennifer/0000-0002-2717-7311; Dodds, Ken/0000-0002-9347-6379; Ritvos, Olli/0000-0001-7017-6931			Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Bodensteiner KJ, 2000, BIOL REPROD, V62, P1479, DOI 10.1095/biolreprod62.6.1479; BRAWTAL R, 1993, BIOL REPROD, V49, P895, DOI 10.1095/biolreprod49.5.895; Cambridge LM, 1997, ANIM GENET, V28, P457, DOI 10.1111/j.1365-2052.1997.tb03295.x; DAVIES AH, 1994, EUR J VASCULAR SURG, V8, P249, DOI 10.1016/S0950-821X(05)80138-0; Davies KP, 1996, ANIM GENET, V27, P382, DOI 10.1111/j.1365-2052.1996.tb00998.x; DAVIS GH, 1992, BIOL REPROD, V46, P636, DOI 10.1095/biolreprod46.4.636; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; DAVIS R, 1995, PSYCHOLOGIST, V8, P55; Davison RM, 1999, CLIN ENDOCRINOL, V51, P673, DOI 10.1046/j.1365-2265.1999.00926.x; DOLLING CHS, 1996, MENDELIAN INHERITANC, P7; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Galloway SM, 1996, GENOME RES, V6, P667, DOI 10.1101/gr.6.8.667; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; HANRAHAN V, 1994, ANIM GENET, V25, P287, DOI 10.1111/j.1365-2052.1994.tb00212.x; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; HENDERSON KM, 1988, J REPROD FERTIL, V84, P187, DOI 10.1530/jrf.0.0840187; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Jaatinen R, 1999, MOL CELL ENDOCRINOL, V156, P189, DOI 10.1016/S0303-7207(99)00100-8; JOKIRANTA TS, 1995, FEBS LETT, V376, P31, DOI 10.1016/0014-5793(95)01239-7; Juengel JL, 1997, J REPROD FERTIL, V110, P291, DOI 10.1530/jrf.0.1100291; Laitinen M, 1998, MECH DEVELOP, V78, P135, DOI 10.1016/S0925-4773(98)00161-0; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; SHACKELL GH, 1993, BIOL REPROD, V48, P1150, DOI 10.1095/biolreprod48.5.1150; Smith P, 1997, BIOL REPROD, V57, P1183, DOI 10.1095/biolreprod57.5.1183; TISDALL DJ, 1994, J MOL ENDOCRINOL, V12, P181, DOI 10.1677/jme.0.0120181	30	753	851	0	69	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					279	283		10.1038/77033			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900013	10888873				2022-01-24	
J	BISHOP, MD; KAPPES, SM; KEELE, JW; STONE, RT; SUNDEN, SLF; HAWKINS, GA; TOLDO, SS; FRIES, R; GROSZ, MD; YOO, JY; BEATTIE, CW				BISHOP, MD; KAPPES, SM; KEELE, JW; STONE, RT; SUNDEN, SLF; HAWKINS, GA; TOLDO, SS; FRIES, R; GROSZ, MD; YOO, JY; BEATTIE, CW			A GENETIC-LINKAGE MAP FOR CATTLE	GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION; BOVINE MICROSATELLITE; DNA POLYMORPHISMS; BETA-GLOBIN; OVINE; LOCUS; SEQUENCE; ASSOCIATION	We report the most extensive physically anchored linkage map for cattle produced to date. Three-hundred thirteen genetic markers ordered in 30 linkage groups, anchored to 24 autosomal chromesomes (n = 29), the X and Y chromosomes, four unanchored syntenic groups and two unassigned linkage groups spanning 2464 chi of the bovine genome are summarized. The map also assigns 19 type I loci to specific chromosomes and/or syntenic groups and four cosmid clones containing informative microsatellites to chromosomes 13, 25 and 29 anchoring syntenic groups U11, U7 and U8, respectively. This map provides the skeletal framework prerequisite to development of a comprehensive genetic map for cattle and analysis of economic trait loci (ETL).	SWISS FED INST TECHNOL, CH-8092 ZURICH, SWITZERLAND		BISHOP, MD (corresponding author), US ARS, ROMAN L HRUSKA US MEAT ANIM RES CTR, CLAY CTR, NE 68933 USA.		Keele, John W/A-5846-2009	Fries, Ruedi/0000-0002-4657-1787			ANDERSSON L, 1993, ANIM GENET, V24, P205, DOI 10.1111/j.1365-2052.1993.tb00290.x; ANSARI HA, 1993, 8TH P N AM C DOM AN, P59; BARENDSE W, 1991, CYTOGENET CELL GENET, V58, P2123; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BISHOP MD, 1991, J ANIM SCI, V69, P4306, DOI 10.2527/1991.69114306x; BISHOP MD, 1993, J ANIM SCI, V71, P2277, DOI 10.2527/1993.7182277x; BREZINSKY L, 1992, ANIM GENET, V23, P81, DOI 10.1111/j.1365-2052.1992.tb00022.x; BREZINSKY L, 1993, ANIM GENET, V24, P75, DOI 10.1111/j.1365-2052.1993.tb00936.x; BREZINSKY L, 1993, ANIM GENET, V24, P73; BREZINSKY L, 1992, 22 INT C AN GEN INT, P62; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; BUCHANAN FC, 1992, ANIM GENET, V23, P185, DOI 10.1111/j.1365-2052.1992.tb00043.x; BUCHANAN FC, 1992, ANIM GENET, V23, P85, DOI 10.1111/j.1365-2052.1992.tb00026.x; BUCHANAN FC, 1993, IN PRESS ANIM GENET; Ciampolini R, 1993, ANIM GENET, V24, P221, DOI 10.1111/j.1365-2052.1993.tb00299.x; CLARK TG, 1990, NUCLEIC ACIDS RES, V18, P3147, DOI 10.1093/nar/18.11.3147; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CRAWFORD AM, 1991, ANIM GENET, V22, P371, DOI 10.1111/j.1365-2052.1991.tb00693.x; CREIGHTON P, 1992, GENOMICS, V14, P526, DOI 10.1016/S0888-7543(05)80260-5; CUTICCHIA AJ, 1993, NUCLEIC ACIDS RES, V21, P3003, DOI 10.1093/nar/21.13.3003; DIBERARDINO D, 1990, CYTOGENET CELL GENET, V53, P65, DOI 10.1159/000132898; DIETRICH W, 1992, GENETICS, V131, P423; DIETZ AB, 1992, THESIS TEXAS A M U T; EDE AJ, 1993, IN PRESS ANIM GENET; EGGEN A, 1992, MAMM GENOME, V3, P559, DOI 10.1007/BF00350621; FRIES R, 1993, MAMM GENOME, V4, P405, DOI 10.1007/BF00296815; FRIES R, 1988, GENOMICS, V3, P302, DOI 10.1016/0888-7543(88)90120-6; FRIES R, 1993, ANIM GENET, V24, P111, DOI 10.1111/j.1365-2052.1993.tb00250.x; FRIES R, 1991, CYTOGENET CELL GENET, V57, P135, DOI 10.1159/000133132; GALLAGHER DS, 1993, IN PRESS MAMM GENOME, V4; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; GEORGES M, 1992, WO9213102 WORLD INT; GREEN P, 1989, DOCUMENTATION CRI MA; GROSZ MD, 1992, GENOMICS, V14, P863, DOI 10.1016/S0888-7543(05)80106-5; GROSZ MD, 1992, THESIS TEXAS A M U T; HALLERMAN EM, 1988, ANIM GENET, V19, P123; Hanrahan V, 1993, ANIM GENET, V24, P223, DOI 10.1111/j.1365-2052.1993.tb00301.x; HAWKINS GA, 1994, IN PRESS BIOTECHNIQU; HAYES CH, 1993, MAMM GENOME, V4, P207; HOESCHELE I, 1990, J DAIRY SCI, V73, P2503, DOI 10.3168/jds.S0022-0302(90)78936-9; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAPPES SM, 1994, IN PRESS ANIM GENET; KAUKINEN J, 1992, NUCLEIC ACIDS RES, V20, P2955, DOI 10.1093/nar/20.12.2955; Kaukinen J., 1993, Animal Genetics, V24, P148, DOI 10.1111/j.1365-2052.1993.tb00274.x; KEELE JW, 1994, IN PRESS COMPUT BIOL; KEMP SJ, 1993, ANIM GENET, V24, P74, DOI 10.1111/j.1365-2052.1993.tb00934.x; KEMP SJ, 1992, ANIM GENET, V23, P184, DOI 10.1111/j.1365-2052.1992.tb00042.x; KIRKPATRICK BW, 1992, ANIM GENET, V23, P179, DOI 10.1111/j.1365-2052.1992.tb00038.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LARSEN B, 1971, Annales de Genetique et de Selection Animale, V3, P59, DOI 10.1186/1297-9686-3-1-59; LENSTRA JA, 1993, ANIM GENET, V24, P33, DOI 10.1111/j.1365-2052.1993.tb00916.x; LEVEZIEL H, 1984, GENET SEL EVOL, V16, P405, DOI 10.1186/1297-9686-16-4-405; LIPKIN VM, 1989, FEBS LETT, V254, P69, DOI 10.1016/0014-5793(89)81011-7; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MONTGOMERY GW, 1993, NAT GENET, V4, P410, DOI 10.1038/ng0893-410; MOORE SS, 1992, ANIM GENET, V23, P463, DOI 10.1111/j.1365-2052.1992.tb02168.x; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OBRIEN SJ, 1991, CYTOGENET CELL GENET, V58, P1124, DOI 10.1159/000133725; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Penty JM, 1993, ANIM GENET, V24, P219, DOI 10.1111/j.1365-2052.1993.tb00295.x; ROHRER GA, 1994, GENETICS, V136, P231; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; SAHEKI T, 1991, J BIOL CHEM, V266, P11122; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SASSO MP, 1991, NUCLEIC ACIDS RES, V19, P6469, DOI 10.1093/nar/19.23.6469; SKOW LC, 1988, DNA CELL BIOL, V7, P153; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Sun H. S., 1993, Journal of Animal Science, V71, P100; SUNDEN SL, 1993, 8TH P N AM C DOM AN, P175; SWARBRICK PA, 1992, ANIM GENET, V23, P182, DOI 10.1111/j.1365-2052.1992.tb00040.x; SWARBRICK PA, 1991, ANIM GENET, V22, P369, DOI 10.1111/j.1365-2052.1991.tb00692.x; SWARBRICK PA, 1992, ANIM GENET, V23, P187, DOI 10.1111/j.1365-2052.1992.tb00045.x; SWARBRICK PA, 1990, ANIM GENET, V21, P191; SYMONS DBA, 1992, MOL IMMUNOL, V29, P1407, DOI 10.1016/0161-5890(92)90178-Z; THREADGILL DS, 1991, CYTOGENET CELL GENET, V57, P123, DOI 10.1159/000133130; THREADGILL DS, 1991, P NATL ACAD SCI USA, V88, P154, DOI 10.1073/pnas.88.1.154; THREADGILL DW, 1990, CYTOGENET CELL GENET, V53, P32, DOI 10.1159/000132890; THREADGILL DW, 1990, NUCLEIC ACIDS RES, V18, P6935, DOI 10.1093/nar/18.23.6935; TOLDO SS, 1993, IN PRESS MAMM GENOME; VAIMAN D, 1992, ANIM GENET, V23, P537, DOI 10.1111/j.1365-2052.1992.tb00175.x; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOMACK JE, 1991, CYTOGENET CELL GENET, V58, P2132; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P1151; YUILLE MAR, 1991, NUCLEIC ACIDS RES, V19, P1950, DOI 10.1093/nar/19.8.1950	92	753	801	0	38	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	FEB	1994	136	2					619	639					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MT824	WOS:A1994MT82400017	7908653				2022-01-24	
J	ESHED, Y; ZAMIR, D				ESHED, Y; ZAMIR, D			AN INTROGRESSION LINE POPULATION OF LYCOPERSICON PENNELLII IN THE CULTIVATED TOMATO ENABLES THE IDENTIFICATION AND FINE MAPPING OF YIELD-ASSOCIATED QTL	GENETICS			English	Article							MOLECULAR LINKAGE MAPS; QUANTITATIVE TRAITS; MENDELIAN FACTORS; LOCI; RESISTANCE; CROSS	Methodologies for mapping of genes underlying quantitative traits have advanced considerably but have not been accompanied by a parallel development of new population structures. We present a novel population consisting of 50 introgression lines (ILs) originating from a cross between the green-fruited species Lycopersicon pennellii and the cultivated tomato (cv M82). Each of the lines contains a single homozygous restriction fragment length polymorphism-defined L. pennellii chromosome segment, and together the lines provide complete coverage of the genome and a set of lines nearly isogenic to M82. A field trial of the ILs and their hybrids revealed at least 23 quantitative trait loci (QTL) for total soluble solids content and 18 for fruit mass; these estimates are twice as high as previously reported estimates based on traditional mapping populations. For finer mapping of a QTL affecting fruit mass, the introgressed segment was recombined into smaller fragments that allowed the identification of three linked loci. At least 16 QTL for plant weight, 22 for percentage green fruit weight, 11 for total yield and 14 for total soluble solids yield were identified. Gene action for fruit and plant characteristics was mainly additive, while overdominance (or pseudo-overdominance) of wild species introgressions was detected for yield.	HEBREW UNIV JERUSALEM, FAC AGR, DEPT FIELD & VEGETABLE CROPS, IL-76100 REHOVOT, ISRAEL; HEBREW UNIV JERUSALEM, FAC AGR, OTTO WARBURG CTR BIOTECHNOL, IL-76100 REHOVOT, ISRAEL					Eshed, Yuval/0000-0001-8290-0018			Bernatzky R., 1986, PLANT MOL BIOL REP, V4, P37, DOI [10.1007/BF02672487, DOI 10.1007/BF02672487]; CAUSSE MA, 1994, GENETICS, V138, P1251; Crow J. F., 1952, Heterosis., P282; DARVASI A, 1993, GENETICS, V134, P943; DEVICENTE MC, 1993, GENETICS, V134, P585; DOEBLEY J, 1991, GENETICS, V129, P285; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; EMERY GC, 1970, J AM SOC HORTIC SCI, V95, P410; Eshed Y, 1992, THEOR APPL GENET, V83, P1027, DOI 10.1007/BF00232968; ESHED Y, 1994, THEOR APPL GENET, V88, P891, DOI 10.1007/BF01254002; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; FATOKUN CA, 1992, GENETICS, V132, P841; GOLDMAN IL, 1995, THEOR APPL GENET, V90, P925, DOI 10.1007/BF00222905; KEIM P, 1990, GENETICS, V126, P735; LIEDL BE, 1993, TOMATO GENET COOP, V43, P33; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; NIENHUIS J, 1987, CROP SCI, V27, P797, DOI 10.2135/cropsci1987.0011183X002700040039x; PATERSON AH, 1991, GENETICS, V127, P181; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PATERSON AH, 1990, GENETICS, V124, P735; Rick C. M., 1982, Plant improvement and somatic cell genetics, P1; RICK CM, 1969, GENETICS, V62, P753; RICK CM, 1974, HILGARDIA, V42, P493, DOI 10.3733/hilg.v42n15p493; SEGAL G, 1992, MOL GEN GENET, V231, P179, DOI 10.1007/BF00279789; STEVENS MA, 1978, HORTSCIENCE, V13, P673; STURER CW, 1992, GENETICS, V132, P823; TANKSLEY SD, 1992, GENETICS, V132, P1141; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; WEHRHAHN C, 1965, GENETICS, V51, P109; WEIDE R, 1993, GENETICS, V135, P1175; [No title captured]; 1994, JMP STATISTICS GRAPH	32	752	913	3	86	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	1995	141	3					1147	1162					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TB629	WOS:A1995TB62900031	8582620				2022-01-24	
J	Dankort, D; Curley, DP; Cartlidge, RA; Nelson, B; Karnezis, AN; Damsky, WE; You, MJ; DePinho, RA; McMahon, M; Bosenberg, M				Dankort, David; Curley, David P.; Cartlidge, Robert A.; Nelson, Betsy; Karnezis, Anthony N.; Damsky, William E., Jr.; You, Mingjian J.; DePinho, Ronald A.; McMahon, Martin; Bosenberg, Marcus			Braf(V600E) cooperates with Pten loss to induce metastatic melanoma	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; MALIGNANT-MELANOMA; BRAF MUTATIONS; B-RAF; SENESCENCE; GENETICS; PROTEIN; MODELS; KINASE; POTENT	Mutational activation of BRAF is the earliest and most common genetic alteration in human melanoma. To build a model of human melanoma, we generated mice with conditional melanocyte-specific expression of BRaf(V600E). Upon induction of BRaf(V600E) expression, mice developed benign melanocytic hyperplasias that failed to progress to melanoma over 15-20 months. By contrast, expression of BRaf(V600E) combined with Pten tumor suppressor gene silencing elicited development of melanoma with 100% penetrance, short latency and with metastases observed in lymph nodes and lungs. Melanoma was prevented by inhibitors of mTorc1 (rapamycin) or MEK1/2 (PD325901) but, upon cessation of drug administration, mice developed melanoma, indicating the presence of long-lived melanoma-initiating cells in this system. Notably, combined treatment with rapamycin and PD325901 led to shrinkage of established melanomas. These mice, engineered with a common genetic profile to human melanoma, provide a system to study melanoma's cardinal feature of metastasis and for preclinical evaluation of agents designed to prevent or treat metastatic disease.	[Dankort, David; Cartlidge, Robert A.; Karnezis, Anthony N.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA; [Curley, David P.; Nelson, Betsy; Damsky, William E., Jr.; Bosenberg, Marcus] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Dankort, David; Cartlidge, Robert A.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Cell & Mol Pharmacol, San Francisco, CA 94143 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Pathol, San Francisco, CA 94143 USA; [You, Mingjian J.; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [You, Mingjian J.; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [You, Mingjian J.; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Genet, Boston, MA 02115 USA; [You, Mingjian J.; DePinho, Ronald A.] Harvard Univ, Sch Med, Boston, MA USA		McMahon, M (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA.	mcmahon@cc.ucsf.edu; marcus.bosenberg@yale.edu	McMahon, Martin/L-3303-2013	McMahon, Martin/0000-0003-2812-1042; DePinho, Ronald/0000-0002-5625-577X; Dankort, David/0000-0002-5862-6829	University of California San Francisco Helen Diller Family Comprehensive Cancer Center Mouse Pathology and Pre-Clinical Therapeutics coresUniversity of California System; Melanoma Research Foundation; U.C. Discovery Award; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA 108972, CA 84313, CA 89124, CA 112054]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA112054, R01CA108972, K08CA089124, U01CA084313] Funding Source: NIH RePORTER	We thank the members of the McMahon and Bosenberg laboratories as well as B. Bastian, L. Chin, E. Filenova, B. Hann, M. Herlyn, L. Johnson, G. Merlino, P. P. Pandolfi, V. Hearing, M. Held, G. Kay and D. Matzen for the provision of mouse strains, reagents, advice and support. M. M. thanks A. Ricart and J. Sebolt-Leopold (Pfizer) for provision of PD325901 and acknowledges the support of the University of California San Francisco Helen Diller Family Comprehensive Cancer Center Mouse Pathology and Pre-Clinical Therapeutics cores. R. A. D. is supported as an American Cancer Society Research Professor. This work was supported by grants from the Melanoma Research Foundation, U.C. Discovery Award and from the US National Institutes of Health (CA 108972 to M. M., CA 84313 to R. A. D. and CA 89124 and CA 112054 to M. B., respectively).	Bardeesy N, 2000, ADV CANCER RES, V79, P123, DOI 10.1016/S0065-230X(00)79004-X; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Sosman JA, 2006, CLIN CANCER RES, V12, p2376S, DOI 10.1158/1078-0432.CCR-05-2558; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0; Tonks ID, 2003, GENESIS, V37, P131, DOI 10.1002/gene.10242; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2000, CANCER RES, V60, P1800; Walker GJ, 2002, J INVEST DERMATOL, V119, P783, DOI 10.1046/j.1523-1747.2002.00217.x; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Willmore-Payne C, 2006, HUM PATHOL, V37, P520, DOI 10.1016/j.humpath.2006.01.003; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	50	751	761	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					544	552		10.1038/ng.356			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	WOS:000265575600015	19282848	Green Accepted, Green Published			2022-01-24	
J	Jonkers, J; Meuwissen, R; van der Gulden, H; Peterse, H; van der Valk, M; Berns, A				Jonkers, J; Meuwissen, R; van der Gulden, H; Peterse, H; van der Valk, M; Berns, A			Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENE; P53-DEFICIENT MICE; TRANSGENIC MICE; DNA-REPAIR; STEM-CELLS; MUTATION; RAD51; SPECTRUM; DELETION; TUMORIGENESIS	Inheritance of one defective BRCA2 allele predisposes humans to breast cancer, To establish a mouse model for BRCA2-associated breast cancer, we generated mouse conditional mutants with BRCA2 and/or p53 inactivated in various epithelial tissues, including mammary-gland epithelium. Although no tumors arose in mice carrying conditional Brca2 alleles, mammary and skin tumors developed frequently in females carrying conditional Brca2 and Trp53 alleles. The presence of one wildtype Brca2 allele resulted in a markedly delayed tumor formation; loss of the wildtype Brca2 allele occurred in a subset of these tumors. Our results show that inactivation of BRCA2 and of p53 combine to mediate mammary tumorigenesis, and indicate that disruption of the p53 pathway is pivotal in BRCA2-associated breast cancer.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands		Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792			Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bogliolo M, 2000, ONCOGENE, V19, P5781, DOI 10.1038/sj.onc.1203951; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Cancer risks in BRCA2 mutation carriers, 1999, J NATL CANC I, V91, P1310; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Friedman LS, 1998, CANCER RES, V58, P1338; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hogan B., 1994, MANIPULATING MOUSE E; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PURDIE CA, 1994, ONCOGENE, V9, P603; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Rasmussen SB, 2000, METHODS MAMMARY GLAN, P75; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sambrook J., 1989, MOL CLONING LAB MANU; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; VANDERPUTTEN H, 1979, CELL, V18, P109, DOI 10.1016/0092-8674(79)90359-3; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Venkitaraman AR, 2000, PHILOS T R SOC B, V355, P191, DOI 10.1098/rstb.2000.0558; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yu VPCC, 2000, GENE DEV, V14, P1400	50	749	753	0	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					418	425		10.1038/ng747			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	WOS:000172507500017	11694875				2022-01-24	
J	KIDWELL, MG; KIDWELL, JF; SVED, JA				KIDWELL, MG; KIDWELL, JF; SVED, JA			HYBRID DYSGENESIS IN DROSOPHILA-MELANOGASTER - SYNDROME OF ABERRANT TRAITS INCLUDING MUTATION, STERILITY AND MALE RECOMBINATION	GENETICS			English	Article									BROWN UNIV,DIV BIOL & MED,PROVIDENCE,RI 02912; UNIV SYDNEY,SCH BIOL SCI,SYDNEY 2006,NEW S WALES,AUSTRALIA								BUCHETON A, 1973, CR ACAD SCI D NAT, V276, P641; CARDELLINO RA, 1975, GENETICS, V80, P567; DOBZHANSKY T, 1974, HEREDITAS, V77, P81; FRANCA ZM, 1968, HEREDITY, V23, P199, DOI 10.1038/hdy.1968.28; GOWEN JW, 1946, AM NAT, V80, P149, DOI 10.1086/281373; GREEN MM, 1973, GENETICS, V73, P187; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hartl D. L, 1976, GENETICS DROSOPHIL B, V1b, P615; HINTON CW, 1975, GENETICS, V80, pS42; Hinton CW, 1974, MECHANISMS RECOMBINA, P391; HIRAIZUMI Y, 1971, P NATL ACAD SCI USA, V68, P268, DOI 10.1073/pnas.68.2.268; HIRAIZUMI Y, 1973, GENETICS, V73, P439; IVES PT, 1950, EVOLUTION, V4, P236, DOI 10.2307/2405334; KIDWELL MG, 1977, MUTAT RES, V42, P89, DOI 10.1016/S0027-5107(77)80011-0; KIDWELL MG, 1976, GENETICS, V84, P333; KIDWELL MG, 1973, GENETICS, V75, P133; KIDWELL MG, 1975, GENETICS, V80, pS47; KIDWELL MG, 1975, NATURE, V253, P755, DOI 10.1038/253755a0; KIDWELL MG, 1975, J HERED, V66, P367, DOI 10.1093/oxfordjournals.jhered.a108649; KIDWELL MG, IN PRESS; KIKKAWA H., 1935, CYTOLOGIA, V6, P190, DOI 10.1508/cytologia.6.190; LINDSLEY DL, 1968, 627 CARN I WASH PUBL; MINAMORI S, 1969, JPN J GENET, V44, P347, DOI 10.1266/jjg.44.347; MUKAI T, 1974, GENETICS, V76, P339; MUKAI T, 1959, GENETICS, V44, P211; OBRIEN SJ, 1969, AM NAT, V103, P97, DOI 10.1086/282587; Philip U, 1944, NATURE, V153, P223, DOI 10.1038/153223a0; PICARD G, 1976, CR ACAD SCI D NAT, V282, P1813; PICARD G, 1976, GENETICS, V83, P107; PICARD G, IN PRESS; ROBERTS PA, 1976, GENETICS BIOL DROS A, V1, P67; SLATKO B, 1975, GENETICS, V80, pS76; SLATKO BE, 1973, GENETICS, V75, P643; SOCHACKA JHM, 1976, NATURE, V262, P287, DOI 10.1038/262287a0; Sturtevant AH, 1939, P NATL ACAD SCI USA, V25, P308, DOI 10.1073/pnas.25.7.308; SVED JA, 1973, NATURE, V241, P453, DOI 10.1038/241453a0; SVED JA, 1976, AUST J BIOL SCI, V29, P375, DOI 10.1071/BI9760375; SVED JA, 1976, GENETICS, V83, pS75; SVED JA, 1974, GENETICS, V77, pS64; VOELKER RA, 1974, MUTAT RES, V22, P265, DOI 10.1016/0165-1218(74)90147-5; WADDLE FR, 1974, J GENET, V61, P177, DOI 10.1007/BF02984082; WOODRUFF RC, 1976, HEREDITY, V37, P295, DOI 10.1038/hdy.1976.90; WOODRUFF RC, 1977, HEREDITY, V38, P291, DOI 10.1038/hdy.1977.92; WOODRUFF RC, 1975, GENETICS, V80, pS86; YAMAGUCHI O, 1974, GENETICS, V78, P1209; YAMAGUCHI O, 1976, MUTAT RES, V34, P389, DOI 10.1016/0027-5107(76)90217-7	46	749	766	0	21	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1977	86	4					813	833					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV590	WOS:A1977DV59000008	17248751				2022-01-24	
J	Ashburner, M; Ball, CA; Blake, JA; Butler, H; Cherry, JM; Corradi, J; Dolinski, K; Eppig, JT; Harris, M; Hill, DP; Lewis, S; Marshall, B; Mungall, C; Reiser, L; Rhee, S; Richardson, JE; Richter, J; Ringwald, M; Rubin, GM; Sherlock, G; Yoon, J				Ashburner, M; Ball, CA; Blake, JA; Butler, H; Cherry, JM; Corradi, J; Dolinski, K; Eppig, JT; Harris, M; Hill, DP; Lewis, S; Marshall, B; Mungall, C; Reiser, L; Rhee, S; Richardson, JE; Richter, J; Ringwald, M; Rubin, GM; Sherlock, G; Yoon, J		Gene Ontology Consortium	Creating the gene ontology resource: Design and implementation	GENOME RESEARCH			English	Article							LABORATORY MOUSE; GENOME DATABASE; SEQUENCE	The exponential growth in the volume of accessible biological information has generated a confusion of voices surrounding the annotation of molecular information about genes and their products. The Gene Ontology (GO) project seeks to provide a set of structured vocabularies for specific biological domains that can be used to describe gene products in any organism. This work includes building three extensive ontologies to describe molecular function, biological process, and cellular component, and providing a community database resource that Supports the use of these ontologies. The GO Consortium was initiated by scientists associated with three model organism databases: SGD, the Saccharomyces Genome database; FlyBase, the Drosophila genome database; and MGD/GXD, the Mouse Genome Informatics databases. Additional model organism database groups are joining the project. Each of these model organism information systems is annotating genes and gene products using GO vocabulary terms and incorporating these annotations into their respective model organism databases. Each database contributes its annotation files to a shared GO data resource accessible to the public at http://www.geneontology.org/. The GO site can be used by the community both to recover the GO vocabularies and to access the annotated gene product data sets from the model organism databases. The GO Consortium supports the development of the GO database resource and provides tools enabling curators and researchers to query and manipulate the vocabularies. We believe that the shared development of this molecular annotation resource will contribute to the unification of biological information.					Mungall, Chris/I-6006-2019; Sherlock, Gavin J/B-1831-2009; Sherlock, Gavin J/E-9110-2012	Mungall, Chris/0000-0002-6601-2165; Corradi, John/0000-0003-3456-4974; Harris, Midori/0000-0003-4148-4606; Dolinski, Kara/0000-0002-7010-0264; Blake, Judith/0000-0001-8522-334X; Rubin, Gerald/0000-0001-8762-8703	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P41 HG000739, HG02273, P41 HG01315, R01 HG002273, U41 HG000739, U41 HG001315, P41 HG000330, P41 HG002273, U41 HG002273, P41 HG001315, P41 HG00330, P41 HG00739] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD033745, HD33745] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD033745] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U41HG002273, P41HG001315, P41HG000739, U41HG001315, R01HG002273, P41HG002273, P41HG000330, U41HG000739] Funding Source: NIH RePORTER		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Blake JA, 2000, NUCLEIC ACIDS RES, V28, P108, DOI 10.1093/nar/28.1.108; Delozier Eric P., 1992, Medical Reference Services Quarterly, V11, P29; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; GRUBER TR, 1998, FORMAL ONTOLOGY INFO; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Jones DM, 1999, DATA KNOWL ENG, V31, P99, DOI 10.1016/S0169-023X(99)00022-1; Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Ringwald M, 2000, NUCLEIC ACIDS RES, V28, P115, DOI 10.1093/nar/28.1.115; Rison Stuart C. G., 2000, Functional and Integrative Genomics, V1, P56; SCHULZEKREMER S, 1998, 6 INT C INT SYST MOL; Smith, 1997, OXFORD DICT BIOCH MO	19	748	763	2	41	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	AUG	2001	11	8					1425	1433					9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	459RC	WOS:000170263900015	11483584				2022-01-24	
J	He, XC; Zhang, JW; Tong, WG; Tawfik, O; Ross, J; Scoville, DH; Tian, Q; Zeng, X; He, X; Wiedemann, LM; Mishina, Y; Li, LH				He, XC; Zhang, JW; Tong, WG; Tawfik, O; Ross, J; Scoville, DH; Tian, Q; Zeng, X; He, X; Wiedemann, LM; Mishina, Y; Li, LH			BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling	NATURE GENETICS			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; TUMOR-SUPPRESSOR; JUVENILE POLYPOSIS; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATION; GERMLINE MUTATIONS; PTEN; GENE; TRANSDUCTION; GROWTH	In humans, mutations in BMPR1A, SMAD4 and PTEN are responsible for juvenile polyposis syndrome(1), juvenile intestinal polyposis(2) and Cowden disease(3), respectively. The development of polyposis is a common feature of these diseases, suggesting that there is an association between BMP and PTEN pathways(4,5). The mechanistic link between BMP and PTEN pathways and the related etiology of juvenile polyposis is unresolved. Here we show that conditional inactivation of Bmpr1a in mice disturbs homeostasis of intestinal epithelial regeneration with an expansion of the stem and progenitor cell populations, eventually leading to intestinal polyposis resembling human juvenile polyposis syndrome. We show that BMP signaling suppresses Wnt signaling to ensure a balanced control of stem cell self-renewal. Mechanistically, PTEN, through phosphatidylinosital-3 kinase-Akt, mediates the convergence of the BMP and Wnt pathways on control of beta-catenin. Thus, BMP signaling may control the duplication of intestinal stem cells, thereby preventing crypt fission and the subsequent increase in crypt number.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Inst Systemsbiol, Seattle, WA 98103 USA; Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; NIEHS, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA		Li, LH (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Wiedemann, Leanne/E-3316-2010	Li, Linheng/0000-0001-9963-430X; Wiedemann, Leanne/0000-0002-0964-4676	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES071004] Funding Source: NIH RePORTER		Besson A, 1999, EUR J BIOCHEM, V263, P605, DOI 10.1046/j.1432-1327.1999.00542.x; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Mutter GL, 2001, AM J PATHOL, V158, P1895, DOI 10.1016/S0002-9440(10)64656-1; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Potten CS, 2002, J CELL SCI, V115, P2381; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roberts DJ, 2000, DEV DYNAM, V219, P109, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1047>3.3.CO;2-Y; ROTH KA, 1991, P NATL ACAD SCI USA, V88, P9407, DOI 10.1073/pnas.88.21.9407; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	747	781	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1117	1121		10.1038/ng1430			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	WOS:000224156500022	15378062	Bronze			2022-01-24	
J	Charlier, C; Singh, NA; Ryan, SG; Lewis, TB; Reus, BE; Leach, RJ; Leppert, M				Charlier, C; Singh, NA; Ryan, SG; Lewis, TB; Reus, BE; Leach, RJ; Leppert, M			A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family	NATURE GENETICS			English	Article							NEONATAL CONVULSIONS; GENERALIZED EPILEPSY; HETEROGENEITY; CHROMOSOME-8Q; CONFIRMATION; LOCUS; MAP	Epileptic disorders affect about 20-40 million people worldwide, and 40% of these are idiopathic generalized epilepsies (IGEs: ref. 1). Most of the IGEs that are inherited are complex, multigenic diseases. To address basic mechanisms for epilepsies, we have focused on one well-defined class of IGEs with an autosomal-dominant mode of inheritance: the benign familiar neonatal convulsions (BFNC: refs 2,3). Genetic heterogeneity of BFNC has been observed(4). Two loci, EBN1 and EBN2, have been mapped by linkage analysis to chromosome 20q13 (refs 5,6) and chromosome 8q24 (refs 7,8), respectively. By positional cloning, we recently identified the gene for EBN1 as KCNQ2 (ref. 9). This gene, a voltage-gated potassium channel, based on homology, is a member of the KQT-like family(10). Here we describe an additional member, KCNQ3. We mapped this new gene to chromosome 8, between markers D8S256 and D8S284 on a radiation hybrid map(11). We screened KCNQ3 for mutations in the large BFNC family(4,7) previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype. The same conserved amino acid is also mutated in KVLQT1 (KCNQ1) in an LQT patient(12). KCNQ2, KCNQ3 and undiscovered genes of the same family of K+ channels are strong candidates for other IGEs.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat Neurol, Philadelphia, PA 19104 USA; Indiana Univ, Sch Med, Dept Med Genet, Indianapolis, IN 46902 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA		Leppert, M (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.			Charlier, Carole/0000-0002-9694-094X; Leach, Robin/0000-0002-3201-5579	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA042014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P01HG000470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032666] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5P30CA42014] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P01-HG00470] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS32666] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEPPERT M, 1993, BRAIN PATHOL, V3, P357, DOI 10.1111/j.1750-3639.1993.tb00764.x; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; LEWIS TB, 1993, AM J HUM GENET, V53, P670; LEWIS TB, 1995, GENOME RES, V5, P334, DOI 10.1101/gr.5.4.334; MALAFOSSE A, 1992, HUM GENET, V89, P54, DOI 10.1007/BF00207042; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Plouin P., 1994, IDIOPATHIC GEN EPILE, P39; REUTENS DC, 1995, NEUROLOGY, V45, P1469, DOI 10.1212/WNL.45.8.1469; RONEN GM, 1993, NEUROLOGY, V43, P1355, DOI 10.1212/WNL.43.7.1355; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Steinlein O, 1997, AM J MED GENET, V74, P445, DOI 10.1002/(SICI)1096-8628(19970725)74:4<445::AID-AJMG18>3.0.CO;2-I; STEINLEIN O, 1995, HUM GENET, V95, P411; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	25	747	769	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					53	55		10.1038/ng0198-53			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600021	9425900				2022-01-24	
J	Jiao, YQ; Wang, YH; Xue, DW; Wang, J; Yan, MX; Liu, GF; Dong, GJ; Zeng, DL; Lu, ZF; Zhu, XD; Qian, Q; Li, JY				Jiao, Yongqing; Wang, Yonghong; Xue, Dawei; Wang, Jing; Yan, Meixian; Liu, Guifu; Dong, Guojun; Zeng, Dali; Lu, Zefu; Zhu, Xudong; Qian, Qian; Li, Jiayang			Regulation of OsSPL14 by OsmiR156 defines ideal plant architecture in rice	NATURE GENETICS			English	Article							SBP-BOX GENE; TRANSLATIONAL INHIBITION; TRANSCRIPTION FACTORS; ARABIDOPSIS; MIR156; SPL8	Increasing crop yield is a major challenge for modern agriculture. The development of new plant types, which is known as ideal plant architecture (IPA), has been proposed as a means to enhance rice yield potential over that of existing high-yield varieties(1,2). Here, we report the cloning and characterization of a semidominant quantitative trait locus, IPA1 (Ideal Plant Architecture 1), which profoundly changes rice plant architecture and substantially enhances rice grain yield. The IPA1 quantitative trait locus encodes OsSPL14 (SOUAMOSA PROMOTER BINDING PROTEIN-LIKE 14) and is regulated by microRNA (miRNA) OsmiR156 in vivo. We demonstrate that a point mutation in OsSPL14 perturbs OsmiR156-directed regulation of OsSPL14, generating an 'ideal' rice plant with a reduced tiller number, increased lodging resistance and enhanced grain yield. Our study suggests that OsSPL14 may help improve rice grain yield by facilitating the breeding of new elite rice varieties.	[Jiao, Yongqing; Wang, Yonghong; Wang, Jing; Liu, Guifu; Lu, Zefu; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Jiao, Yongqing; Wang, Yonghong; Wang, Jing; Liu, Guifu; Lu, Zefu; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Xue, Dawei; Yan, Meixian; Dong, Guojun; Zeng, Dali; Zhu, Xudong; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China		Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China.	qianqian188@hotmail.com; jyli@genetics.ac.cn	XUE, Dawei/B-3262-2010; Xue, Dawei/H-2324-2018; Li, Jiayang/AAG-4377-2020; yan, mei/AAA-1379-2022	XUE, Dawei/0000-0001-9904-7615; Xue, Dawei/0000-0001-9904-7615; Lu, Zefu/0000-0001-9322-8351	Ministry of Agriculture of the People's Republic of ChinaMinistry of Agriculture, China [2008ZX08009]; Ministry of Science and Technology [2005CB1208]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30710103903]	We thank K. Chong (Institute of Botany, Chinese Academy of Sciences) for providing the pTCK303 vector. This work was supported by grants from Ministry of Agriculture of the People's Republic of China (2008ZX08009), Ministry of Science and Technology (2005CB1208) and National Natural Science Foundation of China (30710103903).	Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; FUKUTA Y, 2004, PLANT ANIMAL GENOME, V12, P167; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khush G. S., 1995, Geojournal, V35, P329, DOI 10.1007/BF00989140; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Miyamoto N, 2004, THEOR APPL GENET, V109, P700, DOI 10.1007/s00122-004-1690-0; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Virk PS, 2004, I RICE RES NOTES, V29, pS1; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6	26	746	890	37	450	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					541	U36		10.1038/ng.591			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	WOS:000278081500022	20495565				2022-01-24	
J	Ferguson, JN; Young, LJ; Hearn, EF; Matzuk, MM; Insel, TR; Winslow, JT				Ferguson, JN; Young, LJ; Hearn, EF; Matzuk, MM; Insel, TR; Winslow, JT			Social amnesia in mice lacking the oxytocin gene	NATURE GENETICS			English	Article							OLFACTORY-BULB; NEUROHYPOPHYSEAL PEPTIDES; MATERNAL-BEHAVIOR; MALE-MOUSE; RECOGNITION; RATS; MEMORY; VASOPRESSIN; MODULATION; LESIONS	The development of social familiarity in rodents depends predominantly on olfactory cues and can critically influence reproductive success(1,2). Researchers have operationally defined this memory by a reliable decrease in olfactory investigation in repeated or prolonged encounters with a conspecific(3-6). Brain oxytocin (OT) and vasopressin (AVP) seem to modulate a range of social behaviour from parental care to mate guarding(7). Pharmacological studies indicate that AVP administration may enhance social memory(8-10), whereas OT administration may either inhibit or facilitate social memory depending on dose, route or paradigm(1,11-13). We found that male mice mutant for the oxytocin gene (Oxt(-/-)) failed to develop social memory, whereas wild-type (Oxt(+/+)) mice showed intact social memory. Measurement of both olfactory foraging and olfactory habituation tasks indicated that olfactory detection of non-social stimuli is intact in Oxt(-/-) mice. Spatial memory and behavioural inhibition measured in a Morris water-maze, Y-maze. or habituation of an acoustic startle also seemed intact. Treatment with OT but not AVP rescued social memory in Oxt(-/-) mice, and treatment with an OT antagonist produced a social amnesia-like effect in Oxt(+/+) mice. Our data indicate that OT is necessary for the normal development of social memory in mice and support the hypothesis that social memory has a neural basis distinct from other forms of memory.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Yerkes Reg Primate Res Ctr, Atlanta, GA 30322 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cellular & Mol Biol, Houston, TX 77030 USA		Winslow, JT (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA.				NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR0016] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD33438] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R01M56538-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD033438] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD033438] Funding Source: NIH RePORTER		BENELLI A, 1995, NEUROPEPTIDES, V28, P251, DOI 10.1016/0143-4179(95)90029-2; Contarino A, 1999, BRAIN RES, V835, P1, DOI 10.1016/S0006-8993(98)01158-5; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; Dantzer R, 1998, PROG BRAIN RES, V119, P409; Dluzen DE, 1998, NEUROSCI LETT, V254, P161, DOI 10.1016/S0304-3940(98)00691-0; DLUZEN DE, 1993, BRAIN RES, V609, P98, DOI 10.1016/0006-8993(93)90860-P; Engelmann M, 1998, BEHAV BRAIN RES, V90, P89, DOI 10.1016/S0166-4328(97)00084-3; Engelmann M, 1996, NEUROSCI BIOBEHAV R, V20, P341, DOI 10.1016/0149-7634(95)00059-3; GHEUSI G, 1994, BEHAV PROCESS, V33, P59, DOI 10.1016/0376-6357(94)90060-4; Insel TR, 1998, ADV EXP MED BIOL, V449, P215; JIRIKOWSKI GF, 1991, CELL TISSUE RES, V266, P399, DOI 10.1007/BF00318196; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Keverne EB, 1996, J PHYSIOLOGY-PARIS, V90, P399, DOI 10.1016/S0928-4257(97)87929-6; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; LEVY F, 1995, BRAIN RES, V669, P197, DOI 10.1016/0006-8993(94)01236-B; MENCIOWSZALEK T, 1992, BEHAV NEURAL BIOL, V57, P205, DOI 10.1016/0163-1047(92)90164-Y; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; PAOLINI AG, 1993, NEUROSCIENCE, V57, P717, DOI 10.1016/0306-4522(93)90017-A; Paolini AG, 1996, BEHAV BRAIN RES, V81, P223, DOI 10.1016/S0166-4328(96)89082-6; Popik P, 1991, Eur Neuropsychopharmacol, V1, P555, DOI 10.1016/0924-977X(91)90010-R; POPIK P, 1992, BEHAV PHARMACOL, V3, P351; Popik P, 1998, PROG BRAIN RES, V119, P415; POPIK P, 1992, PSYCHOPHARMACOLOGY, V106, P71, DOI 10.1007/BF02253591; POPIK P, 1991, NEUROPEPTIDES, V18, P23, DOI 10.1016/0143-4179(91)90159-G; POPIK P, 1993, EUR NEUROPSYCHOPHARM, V30, P200; Smith CP, 1997, J PHARMACOL EXP THER, V280, P710; THOR DH, 1981, ANIM LEARN BEHAV, V9, P28; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; Yu GZ, 1996, NEUROSCIENCE, V72, P1083, DOI 10.1016/0306-4522(95)00600-1	30	746	762	4	115	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					284	288		10.1038/77040			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900014	10888874				2022-01-24	
J	Anders, S; Reyes, A; Huber, W				Anders, Simon; Reyes, Alejandro; Huber, Wolfgang			Detecting differential usage of exons from RNA-seq data	GENOME RESEARCH			English	Article							EXPRESSION ANALYSIS; SAGE; QUANTIFICATION; BIOCONDUCTOR; TRANSCRIPTS; ACTIVATION	RNA-seq is a powerful tool for the study of alternative splicing and other forms of alternative isoform expression. Understanding the regulation of these processes requires sensitive and specific detection of differential isoform abundance in comparisons between conditions, cell types, or tissues. We present DEXSeq, a statistical method to test for differential exon usage in RNA-seq data. DEXSeq uses generalized linear models and offers reliable control of false discoveries by taking biological variation into account. DEXSeq detects with high sensitivity genes, and in many cases exons, that are subject to differential exon usage. We demonstrate the versatility of DEXSeq by applying it to several data sets. The method facilitates the study of regulation and function of alternative exon usage on a genome-wide scale. An implementation of DEXSeq is available as an R/Bioconductor package.	[Anders, Simon; Reyes, Alejandro; Huber, Wolfgang] European Mol Biol Lab, D-69111 Heidelberg, Germany		Anders, S (corresponding author), European Mol Biol Lab, D-69111 Heidelberg, Germany.	sanders@fs.tum.de	Anders, Simon/D-4087-2011; Reyes, Alejandro/D-8258-2017	Anders, Simon/0000-0003-4868-1805; Reyes, Alejandro/0000-0001-8717-6612; Huber, Wolfgang/0000-0002-0474-2218			Anders S., 2011, HTSEQ ANAL HIGH THRO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Cameron AC, 1998, REGRESSION ANAL COUN; Cline MS, 2005, BIOINFORMATICS, V21, pI107, DOI 10.1093/bioinformatics/bti1010; COX DR, 1987, J ROY STAT SOC B MET, V49, P1; deLecea L, 1997, GENOMICS, V42, P499, DOI 10.1006/geno.1997.4763; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lu J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-165; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCullagh P, 1989, GEN LINEAR MODELS; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; R Core Team R, 2017, R LANG ENV STAT COMP; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson M, 2010, EDGER EMPIRICAL ANAL; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronchetti, 1981, ROBUST STAT; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Smyth GK, 1996, J ROY STAT SOC B MET, V58, P565; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Urbanek S., 2011, MULTICORE PARALLEL P; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n	52	745	750	6	86	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2012	22	10					2008	2017		10.1101/gr.133744.111			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	013SJ	WOS:000309325900017	22722343	Green Published, hybrid, Green Submitted	Y	N	2022-01-24	
J	GALILI, N; DAVIS, RJ; FREDERICKS, WJ; MUKHOPADHYAY, S; RAUSCHER, FJ; EMANUEL, BS; ROVERA, G; BARR, FG				GALILI, N; DAVIS, RJ; FREDERICKS, WJ; MUKHOPADHYAY, S; RAUSCHER, FJ; EMANUEL, BS; ROVERA, G; BARR, FG			FUSION OF A FORK HEAD DOMAIN GENE TO PAX3 IN THE SOLID TUMOR ALVEOLAR RHABDOMYOSARCOMA	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; PROTEIN; ENCODES; FAMILY	We have examined the structure and expression of the products associated with the t(2;13)(q35;q14) translocation associated with alveolar rhabdomyosarcoma. The chromosome 13 gene (FKHR) is identified as a member of the fork head domain family of transcription factors characterized by a conserved DNA binding motif. Polymerase chain reaction analysis demonstrates that a 5' PAX3-3' FKHR chimaeric transcript is expressed in all eight alveolar rhabdomyosarcomas investigated. Immunoprecipitation experiments detect the predicted fusion protein. These findings indicate that the t(2;13) generates a potentially tumorigenic fusion transcription factor consisting of intact PAX3 DNA binding domains, a truncated fork head DNA binding domain and C-terminal FKHR regions.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BARR FG, 1992, GENOMICS, V13, P1150, DOI 10.1016/0888-7543(92)90030-V; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; HOTH CF, 1993, AM J HUM GENET, V52, P455; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LI J, 1993, P NATL ACAD SCI USA, V90, P4490, DOI 10.1073/pnas.90.10.4490; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SASAKI H, 1993, DEVELOPMENT, V118, P47; TAU W, 1992, NEURON, V8, P957; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5	29	745	758	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					230	235		10.1038/ng1193-230			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	WOS:A1993MF12200011	8275086				2022-01-24	
J	Haab, BB; Dunham, MJ; Brown, PO				Haab, Brian B.; Dunham, Maitreya J.; Brown, Patrick O.			Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions	GENOME BIOLOGY			English	Article							GENE-EXPRESSION; IMMUNOASSAY; PATTERNS; ARRAYS	Background: We have developed and tested a method for printing protein microarrays and using these microarrays in a comparative fluorescence assay to measure the abundance of many specific proteins in complex solutions. A robotic device was used to print hundreds of specific antibody or antigen solutions in an array on the surface of derivatized microscope slides. Two complex protein samples, one serving as a standard for comparative quantitation, the other representing an experimental sample in which the protein quantities were to be measured, were labeled by covalent attachment of spectrally resolvable fluorescent dyes. Results: Specific antibody-antigen interactions localized specific components of the complex mixtures to defined cognate spots in the array, where the relative intensity of the fluorescent signal representing the experimental sample and the reference standard provided a measure of each protein's abundance in the experimental sample. To test the specificity, sensitivity and accuracy of this assay, we analyzed the performance of 115 antibody/antigen pairs. 50% of the arrayed antigens and 20% of the arrayed antibodies provided specific and accurate measurements of their cognate ligands at or below concentrations of 0.34 mu g/ml and 1.6 mu g/ml, respectively. Some of the antibody/antigen pairs allowed detection of the cognate ligands at absolute concentrations below 1 ng/ml, and partial concentrations of 1 part in 106, sensitivities sufficient for measurement of many clinically important proteins in patient blood samples. Conclusions: These results suggest that protein microarrays can provide a practical means to characterize patterns of variation in hundreds of thousands of different proteins in clinical or research applications.	[Brown, Patrick O.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA		Brown, PO (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pbrown@cmgm.stanford.edu		Dunham, Maitreya/0000-0001-9944-2666	Van Andel Institute; NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA85129]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N65236-99-1-5428]; Howard Hughes Medical InstituteHoward Hughes Medical Institute	We thank B. D. Transduction Labs and Research Genetics for the gifts of the antibodies and antigens. We thank the members of the Brown and Botstein labs for helpful interactions and advice. B. H. was supported by a postdoctoral research grant from the Van Andel Institute. M. D. is a Howard Hughes Medical Institute Predoctoral Fellow and a Stanford Graduate Fellow. P.O.B. is an associate investigator of the Howard Hughes Medical Institute. This work was supported by grant CA85129 from the NCI, grant N65236-99-1-5428 from DARPA, and by the Howard Hughes Medical Institute.	Abbott A, 1999, NATURE, V402, P715, DOI 10.1038/45350; ANTHONY BF, 1994, J INFECT DIS, V170, P717, DOI 10.1093/infdis/170.3.717; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Bussow K, 2000, GENOMICS, V65, P1, DOI 10.1006/geno.2000.6141; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; DeRisi J, 1996, NAT GENET, V14, P457; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Emmert-Buck MR, 2000, MOL CARCINOGEN, V27, P158, DOI 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Ge H., 2000, NUCLEIC ACIDS RES, V28, pe3; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; GRANOFF DM, 1986, NEW ENGL J MED, V315, P1584, DOI 10.1056/NEJM198612183152505; HumpherySmith I, 1997, J PROTEIN CHEM, V16, P537, DOI 10.1023/A:1026330015280; Kardamakis D, 1996, ANTICANCER RES, V16, P2285; Khan J, 1999, BBA-REV CANCER, V1423, pM17, DOI 10.1016/S0304-419X(99)00004-9; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; MacBeath G, 2000, SCIENCE, V289, P1760; Mendoza LG, 1999, BIOTECHNIQUES, V27, P778, DOI 10.2144/99274rr01; Molina R, 1998, BREAST CANCER RES TR, V51, P109, DOI 10.1023/A:1005734429304; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; PATTERSON SD, 1995, ELECTROPHORESIS, V16, P1791, DOI 10.1002/elps.11501601299; Rabilloud T, 2000, ANAL CHEM, V72, p48A, DOI 10.1021/ac002709u; Rowe CA, 1999, ANAL CHEM, V71, P433, DOI 10.1021/ac980798t; Silzel JW, 1998, CLIN CHEM, V44, P2036; PROTEIN MICROARRAYS; STANFORD MICROARRAY	28	744	777	0	37	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2001	2	2							0004				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	V12EX	WOS:000207583600009					2022-01-24	
J	JANSEN, RC; STAM, P				JANSEN, RC; STAM, P			HIGH-RESOLUTION OF QUANTITATIVE TRAITS INTO MULTIPLE LOCI VIA INTERVAL MAPPING	GENETICS			English	Article							MOLECULAR MARKERS; MENDELIAN FACTORS; LINE CROSSES; MAP	A very general method is described for multiple linear regression of a quantitative phenotype on genotype [putative quantitative trait loci (QTLs) and markers] in segregating generations obtained from line crosses. The method exploits two features, (a) the use of additional parental and F-1 data, which fixes the joint QTL effects and the environmental error, and (b) the use of markers as cofactors, which reduces the genetic background noise. As a result, a significant increase of QTL detection power is achieved in comparison with conventional QTL mapping. The core of the method is the completion of any missing genotypic (QTL and marker) observations, which is embedded in a general and simple expectation maximization (EM) algorithm to obtain maximum likelihood estimates of the model parameters. The method is described in detail for the analysis of an F-2 generation. Because of the generality of the approach, it is easily applicable to other generations, such as backcross progenies and recombinant inbred lines. An example is presented in which multiple QTLs for plant height in tomato are mapped in an F-2 progeny, using additional data from the parents and their F-1 progeny.	AGR UNIV WAGENINGEN,DEPT GENET,6703 AH WAGENINGEN,NETHERLANDS		JANSEN, RC (corresponding author), CPRO,DLO,DEPT POPULAT BIOL,POB 16,6700 AA WAGENINGEN,NETHERLANDS.		Jansen, Ritsert C/C-1160-2013	Jansen, Ritsert C/0000-0003-2977-9110			BECKMANN JS, 1989, DEV APPLICATION MOL, P117; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; JANSEN RC, 1993, GENETICS, V135, P205; JANSEN RC, 1992, THEOR APPL GENET, V85, P252, DOI 10.1007/BF00222867; KNAPP SJ, 1991, THEOR APPL GENET, V81, P333, DOI 10.1007/BF00228673; KNOTT SA, 1992, GENET RES, V60, P139, DOI 10.1017/S0016672300030822; LANDER ES, 1989, GENETICS, V121, P185; MCCULLAGH P, 1989, MONOGRAPHS STATISTIC, V37; PATERSON AH, 1991, GENETICS, V127, P181; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; SAKAMOTO Y, 1986, AKAIKE INFORM CRITER, V0081; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; STAM P, 1991, 8TH P M EUC SECT BIO; STUBER CW, 1992, GENETICS, V132, P823; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; WELLER JI, 1986, BIOMETRICS, V42, P627, DOI 10.2307/2531212; 1987, GENSTAT 5 REFERENCE	17	744	782	0	29	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	APR	1994	136	4					1447	1455					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NB821	WOS:A1994NB82100021	8013917				2022-01-24	
J	Akalin, A; Kormaksson, M; Li, S; Garrett-Bakelman, FE; Figueroa, ME; Melnick, A; Mason, CE				Akalin, Altuna; Kormaksson, Matthias; Li, Sheng; Garrett-Bakelman, Francine E.; Figueroa, Maria E.; Melnick, Ari; Mason, Christopher E.			methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles	GENOME BIOLOGY			English	Article							SINGLE-BASE RESOLUTION; BREAST-CANCER; CELLS; 5-HYDROXYMETHYLCYTOSINE; HYPERMETHYLATION; PLURIPOTENT; ARABIDOPSIS; CHROMATIN; MAPS	DNA methylation is a chemical modification of cytosine bases that is pivotal for gene regulation, cellular specification and cancer development. Here, we describe an R package, methylKit, that rapidly analyzes genome-wide cytosine epigenetic profiles from high-throughput methylation and hydroxymethylation sequencing experiments. methylKit includes functions for clustering, sample quality visualization, differential methylation analysis and annotation features, thus automating and simplifying many of the steps for discerning statistically significant bases or regions of DNA methylation. Finally, we demonstrate methylKit on breast cancer data, in which we find statistically significant regions of differential methylation and stratify tumor subtypes. methylKit is available at http://code.google.com/p/methylkit.	[Akalin, Altuna; Li, Sheng; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Akalin, Altuna; Li, Sheng; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Kormaksson, Matthias] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA; [Garrett-Bakelman, Francine E.; Melnick, Ari] Weill Cornell Med Coll, Div Hematol Oncol, Dept Med, New York, NY 10065 USA; [Figueroa, Maria E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA		Akalin, A (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1305 York Ave, New York, NY 10065 USA.	ala2027@med.cornell.edu; chm2042@med.cornell.edu	Li, Sheng/A-1964-2014; Figueroa, Maria/AAE-8662-2019; Melnick, Ari/AAA-5763-2020; AKALIN, ALTUNA/A-4424-2012	AKALIN, ALTUNA/0000-0002-0468-0117; Figueroa, Maria Eugenia/0000-0003-4887-4981	Leukemia & Lymphoma Society Special Fellow AwardLeukemia and Lymphoma Society; Doris Duke Clinical Scientist Development AwardDoris Duke Charitable Foundation (DDCF); Sass Foundation Judah Folkman Fellowship; LLS SCOR grant [7132-08]; Burroughs Wellcome Clinical Translational Scientist Award; Starr Cancer Consortium grant [I4-A442]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [I4-A442, I4-A411, 1R01NS076465-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013283] Funding Source: NIH RePORTER	We wish to acknowledge the invaluable contribution of the WCMC Epigenomics Core Facility. MEF is supported by the Leukemia & Lymphoma Society Special Fellow Award and a Doris Duke Clinical Scientist Development Award. FGB is supported by a Sass Foundation Judah Folkman Fellowship. AM is supported by an LLS SCOR grant (7132-08) and a Burroughs Wellcome Clinical Translational Scientist Award. AM and CEM are supported by a Starr Cancer Consortium grant (I4-A442). CEM is supported by the National Institutes of Health (I4-A411, I4-A442, and 1R01NS076465-01).	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI [10.2217/epi.09.33, 10.2217/EPI.09.33]; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esteller M, 2001, CANCER RES, V61, P3225; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Frith MC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks275; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Joliffe I., 2002, PRINCIPAL COMPONENT; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Rodriguez J, 2008, NUCLEIC ACIDS RES, V36, P770, DOI 10.1093/nar/gkm1105; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	43	743	745	4	53	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2012	13	10			SI				R87	10.1186/gb-2012-13-10-R87			9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	065XQ	WOS:000313183900006	23034086	hybrid, Green Published, Green Accepted	Y	N	2022-01-24	
J	Reed, JL; Vo, TD; Schilling, CH; Palsson, BO				Reed, JL; Vo, TD; Schilling, CH; Palsson, BO			An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR)	GENOME BIOLOGY			English	Article							IN-SILICO MODELS; GROWTH	Background: Diverse datasets, including genomic, transcriptomic, proteomic and metabolomic data, are becoming readily available for specific organisms. There is currently a need to integrate these datasets within an in silico modeling framework. Constraint-based models of Escherichia coli K-12 MG1655 have been developed and used to study the bacterium's metabolism and phenotypic behavior. The most comprehensive E. coli model to date (E. coli iJE660a GSM) accounts for 660 genes and includes 627 unique biochemical reactions. Results: An expanded genome-scale metabolic model of E. coli (iJR904 GSM/GPR) has been reconstructed which includes 904 genes and 931 unique biochemical reactions. The reactions in the expanded model are both elementally and charge balanced. Network gap analysis led to putative assignments for 55 open reading frames (ORFs). Gene to protein to reaction associations (GPR) are now directly included in the model. Comparisons between predictions made by iJR904 and iJE660a models show that they are generally similar but differ under certain circumstances. Analysis of genome-scale proton balancing shows how the flux of protons into and out of the medium is important for maximizing cellular growth. Conclusions: E. coli iJR904 has improved capabilities over iJE660a. iJR904 is a more complete and chemically accurate description of E. coli metabolism than iJE660a. Perhaps most importantly, iJR904 can be used for analyzing and integrating the diverse datasets. iJR904 will help to outline the genotype-phenotype relationship for E. coli K-12, as it can account for genomic, transcriptomic, proteomic and fluxomic data simultaneously.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92092 USA; Genomatica Inc, San Diego, CA 92121 USA		Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, Gilman Dr, La Jolla, CA 92092 USA.	bpalsson@be-research.ucsd.edu	Reed, Jennifer L/E-5137-2011	Reed, Jennifer L/0000-0001-7854-6220; Palsson, Bernhard/0000-0003-2357-6785	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM062791, R43GM057092] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM57092, R01 GM062791, GM62791] Funding Source: Medline		Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bonarius HPJ, 1997, TRENDS BIOTECHNOL, V15, P308, DOI 10.1016/S0167-7799(97)01067-6; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; *HMMER, PROF HMMS PROT SEQ A; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Palsson B, 2000, NAT BIOTECHNOL, V18, P1147, DOI 10.1038/81125; Palsson B, 2002, NAT BIOTECHNOL, V20, P649, DOI 10.1038/nbt0702-649; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Serres MH, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-9-research0035; *TC DB, TRANSP PROT DAT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368	26	743	767	3	73	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2003	4	9							R54	10.1186/gb-2003-4-9-r54			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	716UR	WOS:000185048100007	12952533	Bronze, Green Published			2022-01-24	
J	Follenzi, A; Ailles, LE; Bakovic, S; Geuna, M; Naldini, L				Follenzi, A; Ailles, LE; Bakovic, S; Geuna, M; Naldini, L			Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences	NATURE GENETICS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HEMATOPOIETIC STEM-CELLS; MURINE LEUKEMIA-VIRUS; IN-VIVO; NONDIVIDING CELLS; POLYPURINE TRACT; REVERSE TRANSCRIPTION; STABLE TRANSDUCTION; MATRIX PROTEIN; CD34(+) CELLS	Gene-transfer vectors based on lentiviruses are distinguished by their ability to transduce non-dividing cells(1,2). The HIV-1 proteins Matrix, Vpr and Integrase have been implicated in the nuclear import of the viral genome in non-dividing cells(3-5). Here we show that a sequence within polis also required in cis. It contains structural elements previously associated with the progress of reverse transcription in target cells(6-9). We restored these elements in cis within late-generation lentiviral vectors(10,11). The new vector transduced to a much higher efficiency several types of human primary cells, when both growing and growth-arrested, including haematopoietic stem cells assayed by longterm repopulation of NOD/SCID mice. On in vivo administration into SCID mice, the vector induced higher plasma levels of human clotting factor IX (F.IX) than non-modified vector. Our results indicate that nuclear translocation of the genome is a rate-limiting step in lentiviral infection of both dividing and non-dividing cells, and that it depends on protein and nucleic acid sequence determinants. Full rescue of this step in lentivirus-based vectors improves performance for gene-therapy applications.	Univ Turin, Sch Med, Labs Gene Transfer & Therapy, Turin, Italy; Univ Turin, IRCCS, Labs Tumor Immunol, Inst Canc Res & Treatment, Turin, Italy		Naldini, L (corresponding author), Univ Turin, Sch Med, Labs Gene Transfer & Therapy, Turin, Italy.		Naldini, Luigi/E-9083-2012; Geuna, Massimo/AAY-1441-2021	Geuna, Massimo/0000-0002-6475-5547; NALDINI, Luigi/0000-0002-7835-527X; Follenzi, Antonia/0000-0001-9780-300X	TelethonFondazione Telethon [A.143] Funding Source: Medline		Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Andreadis ST, 1997, J VIROL, V71, P7541, DOI 10.1128/JVI.71.10.7541-7548.1997; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; CHARNEAU P, 1991, J VIROL, V65, P2415, DOI 10.1128/JVI.65.5.2415-2421.1991; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Conneally E, 1998, BLOOD, V91, P3487, DOI 10.1182/blood.V91.9.3487.3487_3487_3493; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; GALLAY P, 1995, CELL, V80, P379, DOI 10.1016/0092-8674(95)90488-3; Hansen MST, 1999, NAT BIOTECHNOL, V17, P578, DOI 10.1038/9886; Ilyinskii PO, 1998, EMBO J, V17, P3766, DOI 10.1093/emboj/17.13.3766; Kay MA, 1999, P NATL ACAD SCI USA, V96, P9973, DOI 10.1073/pnas.96.18.9973; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Marandin A, 1998, HUM GENE THER, V9, P1497, DOI 10.1089/hum.1998.9.10-1497; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Sutton RE, 1998, J VIROL, V72, P5781, DOI 10.1128/JVI.72.7.5781-5788.1998; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	30	743	758	0	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					217	+		10.1038/76095			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200025	10835641				2022-01-24	
J	LIU, B; NICOLAIDES, NC; MARKOWITZ, S; WILLSON, JKV; PARSONS, RE; JEN, J; PAPADOPOLOUS, N; PELTOMAKI, P; DELACHAPELLE, A; HAMILTON, SR; KINZLER, KW; VOGELSTEIN, B				LIU, B; NICOLAIDES, NC; MARKOWITZ, S; WILLSON, JKV; PARSONS, RE; JEN, J; PAPADOPOLOUS, N; PELTOMAKI, P; DELACHAPELLE, A; HAMILTON, SR; KINZLER, KW; VOGELSTEIN, B			MISMATCH REPAIR GENE DEFECTS IN SPORADIC COLORECTAL CANCERS WITH MICROSATELLITE INSTABILITY	NATURE GENETICS			English	Article							NONPOLYPOSIS COLON-CANCER; HEREDITARY; MUTATIONS; CARCINOMA; POLYPOSIS; HOMOLOG; HISTORY	Microsatellite instability has been observed in both sporadic and hereditary forms of colorectal cancer. In the hereditary form, this instability is generally due to germline mutations in mismatch repair (MMR) genes. However, only one in ten patients with sporadic tumours exhibiting microsatellite instability had a detectable germline mutation. Moreover, only three of seven sporadic tumour cell lines with microsatellite instability had mutations in a MMR gene, and these mutations could occur somatically. These results demonstrate that tumours can acquire somatic mutations that presumably do not directly affect cell growth but result only in genetic instability. They also suggest that many sporadic tumours with microsatellite instability have alterations in genes other than the four now known to participate in MMR.	JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231; CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,DEPT MED,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,IRELAND CANC CTR,CLEVELAND,OH 44106; UNIV HELSINKI,DEPT MED GENET,SF-00290 HELSINKI,FINLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205					Parsons, Ramon/0000-0002-6656-3514; Peltomaki, Paivi/0000-0001-8819-2980	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R29CA051504, P01CA051183] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA51183, CA51504, CA57208] Funding Source: Medline		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURKS RT, 1994, ONCOGENE, V9, P1163; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GIANNELLI F, 1994, NUCLEIC ACIDS RES, V22, P3534, DOI 10.1093/nar/22.17.3534; GLEBOV OK, 1994, CANCER RES, V54, P3703; HAN HJ, 1993, CANCER RES, V53, P5087; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; KIM H, 1994, AM J PATHOL, V145, P1; KNUDSON AG, 1985, CANCER RES, V45, P1437; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1994, CANCER RES, V54, P4590; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MERLO A, 1994, CANCER RES, V54, P2098; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; ORTH K, 1994, P NATL ACAD SCI USA, V91, P9495, DOI 10.1073/pnas.91.20.9495; PALOMBO F, 1994, NATURE, V367, P417, DOI 10.1038/367417a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, CANCER RES, V53, P5853; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RISINGER JI, 1993, CANCER RES, V53, P5100; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TUDDENHAM EGD, 1994, NUCLEIC ACIDS RES, V22, P3511, DOI 10.1093/nar/22.17.3511; UMAR A, 1994, J BIOL CHEM, V269, P14367; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WILLSON JKV, 1987, CANCER RES, V47, P2704; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152	37	743	761	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					48	55		10.1038/ng0195-48			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	WOS:A1995PZ91300014	7704024				2022-01-24	
J	Tuzun, E; Sharp, AJ; Bailey, JA; Kaul, R; Morrison, VA; Pertz, LM; Haugen, E; Hayden, H; Albertson, D; Pinkel, D; Olson, MV; Eichler, EE				Tuzun, E; Sharp, AJ; Bailey, JA; Kaul, R; Morrison, VA; Pertz, LM; Haugen, E; Hayden, H; Albertson, D; Pinkel, D; Olson, MV; Eichler, EE			Fine-scale structural variation of the human genome	NATURE GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; SEQUENCE; GENE; POLYMORPHISM; INVERSION; DNA; ANEUPLOIDY; GENOTYPES; DELETION; REPEATS	Inversions, deletions and insertions are important mediators of disease and disease susceptibility(1). We systematically compared the human genome reference sequence with a second genome ( represented by fosmid paired- end sequences) to detect intermediate- sized structural variants > 8 kb in length. We identified 297 sites of structural variation: 139 insertions, 102 deletions and 56 inversion breakpoints. Using combined literature, sequence and experimental analyses, we validated 112 of the structural variants, including several that are of biomedical relevance. These data provide a fine- scale structural variation map of the human genome and the requisite sequence precision for subsequent genetic studies of human disease.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Univ Washington Genome Sequencing Ctr, Seattle, WA 98195 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA		Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Sharp, Andrew/A-5783-2008; Tuzun, Eray/B-5949-2018; Tuzun, Eray/AAD-7282-2021	Tuzun, Eray/0000-0002-5550-7816; Tuzun, Eray/0000-0002-5550-7816; Kaul, Rajinder/0000-0002-7895-9284; Haugen, Eric/0000-0001-7444-8981			Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; COLIN Y, 1991, BLOOD, V78, P2747; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Koppens PFJ, 2002, HUM GENET, V111, P405, DOI 10.1007/s00439-002-0810-7; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LEE GF, 1995, HUM ECOL RISK ASSESS, V1, P5; LINDSLEY DL, 1972, GENETICS, V71, P157; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong GKS, 1997, P NATL ACAD SCI USA, V94, P5225, DOI 10.1073/pnas.94.10.5225	27	742	784	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					727	732		10.1038/ng1562			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	WOS:000230196400019	15895083				2022-01-24	
J	Fuks, F; Burgers, WA; Brehm, A; Hughes-Davies, L; Kouzarides, T				Fuks, F; Burgers, WA; Brehm, A; Hughes-Davies, L; Kouzarides, T			DNA methyltransferase Dnmt1 associates with histone deacetylase activity	NATURE GENETICS			English	Article							REPRESS TRANSCRIPTION; TRICHOSTATIN-A; METHYLATION; ACETYLATION; PROTEINS; COMPONENT; INTERACTS; DOMAINS; COMPLEX; MOTIF	The DNA methyltransferase Dnmt1 is responsible for cytosine methylation in mammals and has a role in gene silencing(1-4) DNA methylation represses genes partly by recruitment of the methyl-CpG-binding protein MeCP2, which in turn recruits a histone deacetylase activity(5,6). Here we show that Dnmt1 is itself associated with histone deacetylase activity in vivo. Consistent with this association, we find that one of the known histone deacetylases, HDAC1, has the ability to bind Dnmt1 and can purify methyltransferase activity from nuclear extracts. We have identified a transcriptional repression domain in Dnmt1 that functions, at least partly, by recruiting histone deacetylase activity and shows homology to the repressor domain of the trithorax-related protein HRX (also known as MLL and ALL-1). Our data show a more direct connection between DNA methylation and histone deacetylation than was previously considered. We suggest that the process of DNA methylation, mediated by Dnmt1, may depend on or generate an altered chromatin state via histone deacetylase activity.	Univ Cambridge, Wellcome CRC Inst, Cambridge, England; Univ Cambridge, Dept Pathol, Cambridge, England		Kouzarides, T (corresponding author), Univ Cambridge, Wellcome CRC Inst, Cambridge, England.			Kouzarides, Tony/0000-0002-8918-4162; Burgers, Wendy/0000-0003-3396-9398			Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; HAGEMEIER C, 1992, J VIROL, V66, P4452, DOI 10.1128/JVI.66.7.4452-4456.1992; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MA Q, 1993, P NATL ACAD SCI USA, V90, P6350, DOI 10.1073/pnas.90.13.6350; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Morkel M, 1997, NATURE, V390, P567, DOI 10.1038/37507; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Prasad R, 1995, P NATL ACAD SCI USA, V92, P12160, DOI 10.1073/pnas.92.26.12160; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	29	742	765	4	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2000	24	1					88	91		10.1038/71750			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	WOS:000084609200023	10615135				2022-01-24	
J	Timpl, P; Spanagel, R; Sillaber, I; Kresse, A; Reul, JMHM; Stalla, GK; Blanquet, V; Steckler, T; Holsboer, F; Wurst, W				Timpl, P; Spanagel, R; Sillaber, I; Kresse, A; Reul, JMHM; Stalla, GK; Blanquet, V; Steckler, T; Holsboer, F; Wurst, W			Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1	NATURE GENETICS			English	Article							ETHANOL WITHDRAWAL; CENTRAL NUCLEUS; ADRENAL-CORTEX; AMYGDALA; ALCOHOL; CELLS; RAT; PHARMACOLOGY; EXPRESSION; PHYSIOLOGY	Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol(1,2). Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse(3,4). Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase(5,6). Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.	Max Planck Inst Psychiat, D-80804 Munich, Germany; GSF Munich, Res Ctr, Inst Mammalian Genet, D-85764 Munich, Germany		Wurst, W (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	Wurst@mpipsykl.mpg.de	Reul, Johannes/B-4132-2019; Steckler, Thomas/AAF-3975-2020	Reul, Johannes/0000-0002-8787-4012; Wurst, Wolfgang/0000-0003-4422-7410			Aguilera G, 1988, Adv Exp Med Biol, V245, P83; BILEZIKJIAN LM, 1983, ENDOCRINOLOGY, V113, P657, DOI 10.1210/endo-113-2-657; BORNSTEIN SR, 1990, ENDOCRINOLOGY, V127, P900, DOI 10.1210/endo-127-2-900; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; CONTI LH, 1994, PHARMACOL BIOCHEM BE, V48, P497, DOI 10.1016/0091-3057(94)90559-2; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; EDWARDS AV, 1987, J PHYSIOL-LONDON, V390, P23, DOI 10.1113/jphysiol.1987.sp016683; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; HOLSBOER F, 1992, PROG BRAIN RES, V93, P385; Karanth S, 1997, ENDOCRINOLOGY, V138, P3476, DOI 10.1210/en.138.8.3476; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; MENZAGHI F, 1994, ANN NY ACAD SCI, V739, P176, DOI 10.1111/j.1749-6632.1994.tb19819.x; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; OWENS MJ, 1991, PHARMACOL REV, V43, P425; PICH EM, 1995, J NEUROSCI, V15, P5439; RASSNICK S, 1993, BRAIN RES, V605, P25, DOI 10.1016/0006-8993(93)91352-S; Spanagel R, 1996, EUR J PHARMACOL, V305, P45, DOI 10.1016/0014-2999(96)00175-6; STALLA GK, 1988, ENDOCRINOLOGY, V122, P618; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; SWANSON LW, 1989, J COMP NEUROL, V285, P413, DOI 10.1002/cne.902850402; Tabakoff B, 1996, NEURON, V16, P909, DOI 10.1016/S0896-6273(00)80113-0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Wurst W., 1993, Gene targeting: a practical approach., P33	30	740	747	5	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					162	166		10.1038/520			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	WOS:000073865100024	9620773				2022-01-24	
J	Aran, D; Hu, ZC; Butte, AJ				Aran, Dvir; Hu, Zicheng; Butte, Atul J.			xCell: digitally portraying the tissue cellular heterogeneity landscape	GENOME BIOLOGY			English	Article							IMMUNE CELLS; ENCYCLOPEDIA; REVEAL; GENES	Tissues are complex milieus consisting of numerous cell types. Several recent methods have attempted to enumerate cell subsets from transcriptomes. However, the available methods have used limited sources for training and give only a partial portrayal of the full cellular landscape. Here we present xCell, a novel gene signature-based method, and use it to infer 64 immune and stromal cell types. We harmonized 1822 pure human cell type transcriptomes from various sources and employed a curve fitting approach for linear comparison of cell types and introduced a novel spillover compensation technique for separating them. Using extensive in silico analyses and comparison to cytometry immunophenotyping, we show that xCell outperforms other methods. xCell is available at http://xCell.ucsf.edu/.	[Aran, Dvir; Hu, Zicheng; Butte, Atul J.] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94158 USA		Aran, D; Butte, AJ (corresponding author), Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94158 USA.	dvir.aran@ucsf.edu; atul.butte@ucsf.edu	Aran, Dvir/AAV-5625-2020	Aran, Dvir/0000-0001-6334-5039	Gruss Lipper Postdoctoral Fellowship; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24 CA195858]; National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [HHSN272201200028C]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA195858] Funding Source: NIH RePORTER	This work was supported by the Gruss Lipper Postdoctoral Fellowship to D.A., and the National Cancer Institute (U24 CA195858) and the National Institute of Allergy and Infectious Diseases (Bioinformatics Support Contract HHSN272201200028C) to A.J.B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Abbas AR, 2010, EXPRESSION PROFILES; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Aran D, 2017, XCELL R PACKAGE DEV; Aran D, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0995-z; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; BAGWELL CB, 1993, ANN NY ACAD SCI, V677, P167, DOI 10.1111/j.1749-6632.1993.tb38775.x; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Iglesia MD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw144; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Linsley PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109760; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Mabbott NA, 2013, EXPRESSION ATLAS HUM; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Newman AM, 2016, CURR OPIN IMMUNOL, V41, P77, DOI 10.1016/j.coi.2016.06.006; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Novershtern N, 2011, DENSELY INTERCONNECT; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Smirnov P, 2016, BIOINFORMATICS, V32, P1244, DOI 10.1093/bioinformatics/btv723; Speake C, 2015, NEXT GENERATION SEQU; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772	39	739	742	10	28	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	NOV 15	2017	18								220	10.1186/s13059-017-1349-1			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	FM8BA	WOS:000415307100001	29141660	gold, Green Published, Green Submitted	Y	N	2022-01-24	
J	Wang, JL				Wang, JL			Sibship reconstruction from genetic data with typing errors	GENETICS			English	Article							NATURAL-POPULATIONS; MULTIPLE PATERNITY; PARENTAGE ANALYSIS; SPERM COMPETITION; PAIR LINKAGE; INDIVIDUALS; INFERENCE; MICROSATELLITES; FREQUENCY; MARKERS	Likelihood methods have been developed to partition individuals in a sample into full-sib and half-sib families using genetic marker data without parental information. They invariably make the critical assumption that marker data are free of genotyping errors and mutations and are thus completely reliable in inferring sibships. Unfortunately, however, this assumption is rarely tenable for virtually all kinds of genetic markers in practical use and, if violated, can severely bias sibship estimates as shown by simulations in this article. I propose a new likelihood method With simple and robust models of typing error incorporated into it. Simulations show that the new method call be used to infer full- and half-sibships accurately from marker data with a high error rate and to identify typing errors at each locus in each reconstructed sib family. The new method also improves previous ones by adopting a Fresh iterative procedure for updating allele frequencies with reconstructed sibships taken into account, by allowing for the use of parental information, and by using efficient algorithms for calculating the likelihood function and searching for the maximum-likelihood configuration. It is tested extensively oil simulated data with a varying number of marker loci, different rates of typing errors, and various sample sizes and family structures and applied to two empirical data sets to demonstrate its usefulness.	Zool Soc London, Inst Zool, London NW1 4RY, England		Wang, JL (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	jinliang.wang@ioz.ac.uk					Almudevar A, 1999, J AGR BIOL ENVIR ST, V4, P136, DOI 10.2307/1400594; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gerber S, 2000, MOL ECOL, V9, P1037, DOI 10.1046/j.1365-294x.2000.00961.x; Hammond RL, 2001, MOL ECOL, V10, P2719, DOI 10.1046/j.0962-1083.2001.01394.x; Harshman LG, 1998, EVOLUTION, V52, P1334, DOI [10.2307/2411303, 10.1111/j.1558-5646.1998.tb02015.x]; Herbinger CM, 1995, AQUACULTURE, V137, P245, DOI 10.1016/0044-8486(95)01109-9; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones B, 2003, GENETICS, V163, P1193; Kichler K, 1999, MOL ECOL, V8, P819; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Neff BD, 2002, J HERED, V93, P406, DOI 10.1093/jhered/93.6.406; O'Reilly PT, 1998, ANIM GENET, V29, P363, DOI 10.1046/j.1365-2052.1998.295359.x; Painter Ian, 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P212, DOI 10.2307/1400404; Pedersen JS, 1999, MOL ECOL, V8, P577, DOI 10.1046/j.1365-294x.1999.00573.x; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Sancristobal M, 1997, GENET RES, V70, P53, DOI 10.1017/S0016672397002851; Sieberts SK, 2002, AM J HUM GENET, V70, P170, DOI 10.1086/338444; Smith BR, 2001, GENETICS, V158, P1329; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; TALBOT CC, 1995, HUM MOL GENET, V4, P1193, DOI 10.1093/hmg/4.7.1193; Thomas SC, 2000, GENETICS, V155, P1961; Thomas SC, 2002, GENET RES, V79, P227, DOI 10.1017/S0016672302005669; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; Wang JL, 2003, GENETICS, V163, P429	34	739	752	3	124	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	APR	2004	166	4					1963	1979		10.1534/genetics.166.4.1963			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820HH	WOS:000221377700031	15126412	Green Published, Bronze			2022-01-24	
J	Maleck, K; Levine, A; Eulgem, T; Morgan, A; Schmid, J; Lawton, KA; Dangl, JL; Dietrich, RA				Maleck, K; Levine, A; Eulgem, T; Morgan, A; Schmid, J; Lawton, KA; Dangl, JL; Dietrich, RA			The transcriptome of Arabidopsis thaliana during systemic acquired resistance	NATURE GENETICS			English	Article							ELICITOR-RESPONSIVE ELEMENT; PLANT-DISEASE RESISTANCE; SALICYLIC-ACID; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; LEAF SENESCENCE; HYDROGEN-PEROXIDE; NUCLEAR EVENTS; CELL-DEATH; PR-1 GENE	Infected plants undergo transcriptional reprogramming during initiation of both local defence and systemic acquired resistance (SAR). We monitored gene-expression changes in Arabidopsis thaliana under 14 different SAR-inducing or SAR-repressing conditions using a DNA microarray representing approximately 25-30% of all A. thaliana genes. We derived groups of genes with common regulation patterns, or regulons. The regulon containing PR-1, a reliable marker gene for SAR in A. thaliana, contains known PR genes and novel genes likely to function during SAR and disease resistance. We identified a common promoter element in genes of this regulon that binds members of a plant-specific transcription factor family. Our results extend expression profiling to definition of regulatory networks and gene discovery in plants.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA; Syngenta, Res Triangle Pk, NC 27709 USA		Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Levine, Aaron/E-6495-2010; Bruening, Stefan/B-8505-2011; Levine, Alex/A-6867-2008				Batz O, 1998, BIOL CHEM, V379, P1127, DOI 10.1515/bchm.1998.379.8-9.1127; BI YM, 1995, PLANT J, V8, P235, DOI 10.1046/j.1365-313X.1995.08020235.x; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Delseny M, 1997, FEBS LETT, V403, P221, DOI 10.1016/S0014-5793(97)00075-6; DEPRES D, 2000, PLANT CELL, V12, P279; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; DrogeLaser W, 1997, EMBO J, V16, P726, DOI 10.1093/emboj/16.4.726; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fukuda Y, 1997, PLANT MOL BIOL, V34, P81, DOI 10.1023/A:1005737128339; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; NEUENSCHWANDER U, 1995, PLANT J, V8, P227, DOI 10.1046/j.1365-313X.1995.08020227.x; Oh SA, 1996, PLANT MOL BIOL, V30, P739, DOI 10.1007/BF00019008; Park JH, 1998, PLANT MOL BIOL, V37, P445, DOI 10.1023/A:1005958300951; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Ruan Y, 1998, PLANT J, V15, P821, DOI 10.1046/j.1365-313X.1998.00254.x; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHINDLER U, 1992, PLANT CELL, V4, P1309, DOI 10.1105/tpc.4.10.1309; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; UKNES S, 1993, MOL PLANT MICROBE IN, V6, P692, DOI 10.1094/MPMI-6-692; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	49	738	808	5	96	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					403	410		10.1038/82521			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	WOS:000165671700010	11101835				2022-01-24	
J	Kirschner, LS; Carney, JA; Pack, SD; Taymans, SE; Giatzakis, C; Cho, YS; Cho-Chung, YS; Stratakis, CA				Kirschner, LS; Carney, JA; Pack, SD; Taymans, SE; Giatzakis, C; Cho, YS; Cho-Chung, YS; Stratakis, CA			Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex	NATURE GENETICS			English	Article							SPOTTY SKIN PIGMENTATION; ENDOCRINE OVERACTIVITY; ACTIVATING MUTATIONS; CARDIAC MYXOMAS; RI-ALPHA; SCHWANNOMAS; DIAGNOSIS; DISEASE; TUMORS; MICE	Carney complex (CNC) is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumours and psammomatous melanotic schwannomas(1-5). CNC is inherited as an autosomal dominant trait and the genes responsible have been mapped to 2p16 and 17q22-24 (refs 6,7). Because of its similarities to the McCune-Albright syndrome(5,8) and other features, such as paradoxical responses to endocrine signals(9), genes implicated in cyclic nucleotide-dependent signalling have been considered candidates for causing CNC (ref. 10). In CNC families mapping to 17q. we detected loss of heterozygosity (LOH) in the vicinity of the gene (PRKAR1A) encoding protein kinase A regulatory subunit 1-alpha (Rl alpha), including a polymorphic site within its 5' region. We subsequently identified three unrelated kindreds with an identical mutation in the coding region of PRKAR1A. Analysis of additional cases revealed the same mutation in a sporadic case of CNC, and different mutations in three other families, including one with isolated inherited cardiac myxomas. Analysis of PKA activity in CNC tumours demonstrated a decreased basal activity, but an increase in cAMP-stimulated activity compared with non-CNC tumours, We conclude that germline mutations in PRKAR1A, an apparent tumour-suppressor gene, are responsible for the CNC phenotype in a subset of patients with this disease.	NICHHD, Unit Genet & Endocrinol, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; NCI, Cellular Biochem Sect, Tumor Immunol & Biol Lab, NIH, Bethesda, MD 20892 USA; Mayo Clin, Emeritus Staff, Dept Lab Med & Pathol, Rochester, MN USA		Stratakis, CA (corresponding author), NICHHD, Unit Genet & Endocrinol, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA.	stratakc@ccl.nichd.nih.gov	Pack, Svetlana D./C-2020-2014; Stratakis, Constantine A./AAP-4745-2020	Pack, Svetlana D./0000-0003-3256-6626; /0000-0002-6224-6685	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD000642, Z01HD000642] Funding Source: NIH RePORTER		Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; BEEBE SJ, 1984, J BIOL CHEM, V259, P3539; CARNEY JA, 1995, SEMIN DERMATOL, V14, P90, DOI 10.1016/S1085-5629(05)80003-3; CARNEY JA, 1986, MAYO CLIN PROC, V61, P165, DOI 10.1016/S0025-6196(12)61843-6; Carney JA, 1992, ENDOCRINOLOGIST, V2, DOI [DOI 10.1097/00019616-199201000-00003, 10.1097/00019616-199201000-00003]; Casey M, 1998, CIRCULATION, V98, P2560, DOI 10.1161/01.CIR.98.23.2560; Cho YS, 2000, P NATL ACAD SCI USA, V97, P835, DOI 10.1073/pnas.97.2.835; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DANOFF A, 1987, ARCH INTERN MED, V147, P443, DOI 10.1001/archinte.147.3.443; DeMarco L, 1996, HUM GENET, V98, P185, DOI 10.1007/s004390050187; Jones AC, 1999, CLIN CHEM, V45, P1133; KUO JF, 1970, BIOCHIM BIOPHYS ACTA, V212, P79, DOI 10.1016/0005-2744(70)90180-4; LIEBLER GA, 1976, J THORAC CARDIOV SUR, V71, P605; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Schoenberg-Fejzo M, 1999, AM J HUM GENET, V65, pA444; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Solberg R, 1997, ENDOCRINOLOGY, V138, P169, DOI 10.1210/en.138.1.169; Stratakis CA, 1998, AM J MED GENET, V80, P183, DOI 10.1002/(SICI)1096-8628(19981102)80:2<183::AID-AJMG19>3.0.CO;2-I; Stratakis CA, 1996, J CLIN INVEST, V97, P699, DOI 10.1172/JCI118467; Stratakis CA, 1999, ANN INTERN MED, V131, P585, DOI 10.7326/0003-4819-131-8-199910190-00006; Stratakis CA, 1998, J CLIN ENDOCR METAB, V83, P2972, DOI 10.1210/jc.83.8.2972; Stratakis CA, 1996, J CLIN ENDOCR METAB, V81, P3607, DOI 10.1210/jc.81.10.3607; Stratakis CA, 1999, AM J HUM GENET, V65, pA447; Stratakis CA, 2000, FRONT BIOSCI-LANDMRK, V5, pD353, DOI 10.2741/Stratakis; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	28	736	757	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					89	92		10.1038/79238			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000025	10973256				2022-01-24	
J	Escayg, A; MacDonald, BT; Meisler, MH; Baulac, S; Huberfeld, G; An-Gourfinkel, I; Brice, A; LeGuern, E; Moulard, B; Chaigne, D; Buresi, C; Malafosse, A				Escayg, A; MacDonald, BT; Meisler, MH; Baulac, S; Huberfeld, G; An-Gourfinkel, I; Brice, A; LeGuern, E; Moulard, B; Chaigne, D; Buresi, C; Malafosse, A			Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2	NATURE GENETICS			English	Article							GENERALIZED EPILEPSY; FEBRILE SEIZURES		Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Hop La Pitie Salpetriere, INSERM, U289, Paris, France; Hop La Pitie Salpetriere, Ctr Epilepsie, Paris, France; Genethon, Evry, France; Hop Univ Geneve, Div Neuropsychiat, Chene Bourg, Switzerland; Clin St Odile, Strasbourg, France		Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.		Brice, Alexis/A-2170-2009; Baulac, Stephanie/O-2099-2016; brice, alexis/AAE-8275-2019	Baulac, Stephanie/0000-0001-6430-4693; brice, alexis/0000-0002-0941-3990	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034509] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34509] Funding Source: Medline		Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Bulman DE, 1997, HUM MOL GENET, V6, P1679, DOI 10.1093/hmg/6.10.1679; Catterall W A, 1999, Adv Neurol, V79, P441; ESCAYG A, IN PRESS AM J HUM GE; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; LEHMANNHORN F, 1999, PHYSIOL REV, V79, P137; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; NODA M, 1987, J RECEPTOR RES, V7, P467, DOI 10.3109/10799898709054998; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Smith RD, 1998, J NEUROSCI, V18, P811; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wattanasirichaigoon D, 1999, AM J MED GENET, V86, P470, DOI 10.1002/(SICI)1096-8628(19991029)86:5<470::AID-AJMG13>3.0.CO;2-Y	15	736	767	0	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					343	345		10.1038/74159			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	WOS:000086192800010	10742094				2022-01-24	
J	Wang, YM; Medvid, R; Melton, C; Jaenisch, R; Blelloch, R				Wang, Yangming; Medvid, Rostislav; Melton, Collin; Jaenisch, Rudolf; Blelloch, Robert			DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal	NATURE GENETICS			English	Article							NUCLEAR EXPORT; DICER; COMPLEX	The molecular controls that govern the differentiation of embryonic stem (ES) cells remain poorly understood. DGCR8 is an RNA-binding protein that assists the RNase III enzyme Drosha in the processing of microRNAs (miRNAs), a subclass of small RNAs. Here we study the role of miRNAs in ES cell differentiation by generating a Dgcr8 knockout model. Analysis of mouse knockout ES cells shows that DGCR8 is essential for biogenesis of miRNAs. On the induction of differentiation, DGCR8-deficient ES cells do not fully downregulate pluripotency markers and retain the ability to produce ES cell colonies; however, they do express some markers of differentiation. This phenotype differs from that reported for Dicer1 knockout cells, suggesting that Dicer has miRNA-independent roles in ES cell function. Our findings indicate that miRNAs function in the silencing of ES cell self-renewal that normally occurs with the induction of differentiation.	Univ Calif San Francisco, Dept Urol, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA		Blelloch, R (corresponding author), Univ Calif San Francisco, Dept Urol, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu	Wang, Yangming/J-8939-2015	Wang, Yangming/0000-0001-6974-6060	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS048118, K08 NS048118-01A1, K08 NS048118-02, K08 NS48118] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS048118] Funding Source: NIH RePORTER		Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han J, 2001, DRUG DELIV, V8, P125; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Pelton TA, 2002, J CELL SCI, V115, P329; Rathjen J, 1999, J CELL SCI, V112, P601; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	28	735	783	3	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					380	385		10.1038/ng1969			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	WOS:000244480000021	17259983	Green Accepted			2022-01-24	
J	Lahav, G; Rosenfeld, N; Sigal, A; Geva-Zatorsky, N; Levine, AJ; Elowitz, MB; Alon, U				Lahav, G; Rosenfeld, N; Sigal, A; Geva-Zatorsky, N; Levine, AJ; Elowitz, MB; Alon, U			Dynamics of the p53-Mdm2 feedback loop in individual cells	NATURE GENETICS			English	Article							P53; GENE; MDM2; PROTEIN; PHOSPHORYLATION; EXPRESSION; MODULE	The tumor suppressor p53, one of the most intensely investigated proteins(1-5), is usually studied by experiments that are averaged over cell populations, potentially masking the dynamic behavior in individual cells. We present a system for following, in individual living cells, the dynamics of p53 and its negative regulator Mdm2 (refs.1, 4-7) : this system uses functional p53-CFP and Mdm2-YFP fusion proteins and time-lapse fluorescence microscopy. We found that p53 was expressed in a series of discrete pulses after DNA damage. Genetically identical cells had different numbers of pulses: zero, one, two or more. The mean height and duration of each pulse were fixed and did not depend on the amount of DNA damage. The mean number of pulses, however, increased with DNA damage. This approach can be used to study other signaling systems and suggests that the p53-Mdm2 feedback loop generates a digital clock that releases well-timed quanta of p53 until damage is repaired or the cell dies.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Inst Adv Studies, Sch Nat Sci, Princeton, NJ 08540 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA		Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sigal, Alex/0000-0001-8571-2004			Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; ANDERSEN RD, 1987, MOL CELL BIOL, V7, P3574, DOI 10.1128/MCB.7.10.3574; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bonner WM, 2003, P NATL ACAD SCI USA, V100, P4973, DOI 10.1073/pnas.1031538100; Deguin-Chambon V, 2000, ONCOGENE, V19, P5831, DOI 10.1038/sj.onc.1203960; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; LARKIN ND, 1999, ONCOGENE, V18, P7644; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Mihalas GI, 2000, J BIOL SYST, V8, P21, DOI 10.1142/S0218339000000031; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Offer H, 2001, CANCER RES, V61, P88; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOJTESEK B, 1993, J CELL SCI, V105, P607; Zhang TT, 2001, J BIOL CHEM, V276, P29702, DOI 10.1074/jbc.M011326200	30	735	768	5	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					147	150		10.1038/ng1293			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	WOS:000188542700015	14730303	Bronze			2022-01-24	
J	HEDRICK, PW				HEDRICK, PW			GAMETIC DISEQUILIBRIUM MEASURES - PROCEED WITH CAUTION	GENETICS			English	Article									UNIV CALIF BERKELEY,DEPT GENET,BERKELEY,CA 94720						EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD012731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM035326] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 12731] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 35326] Funding Source: Medline		ASMUSSEN MA, 1982, J MATH BIOL, V14, P37, DOI 10.1007/BF02154752; AVERY PJ, 1979, GENETICS, V91, P817; Bishop Y.M., 1975, DISCRETE MULTIVARIAT; BROWN AHD, 1980, GENETICS, V96, P523; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CLEGG MT, 1976, GENETICS, V83, P793; Ewens W.J., 1979, MATH POPULATION GENE; FRANKLIN I, 1970, GENETICS, V65, P707; FUERST P, 1986, GENETICS, V113, pS44; GOLDING GB, 1984, GENETICS, V108, P257; Hedrick P., 1978, Evolutionary biology. Volume 11., P101; Hedrick P., 1983, GENETICS POPULATIONS; HEDRICK PW, 1980, GENETICS, V94, P791; HEDRICK PW, 1986, GENETICS, V112, P135; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; HUDSON RR, 1985, GENETICS, V109, P611; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; KARLIN S, 1981, ANN HUM GENET, V45, P79, DOI 10.1111/j.1469-1809.1981.tb00308.x; Kimura M., 1982, MOL EVOLUTION PROTEI, P151; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; OHTA T, 1969, GENET RES, V13, P47, DOI 10.1017/S001667230000272X; OHTA T, 1980, GENET RES, V36, P181, DOI 10.1017/S0016672300019790; Sokal R.R., 1981, BIOMETRY; SVED JA, 1968, GENETICS, V59, P543; YAMAZAKI T, 1977, GENETICS, V86, P227	27	732	744	0	13	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1987	117	2					331	341					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K3673	WOS:A1987K367300017	3666445				2022-01-24	
J	Robertson, KD; Ait-Si-Ali, S; Yokochi, T; Wade, PA; Jones, PL; Wolffe, AP				Robertson, KD; Ait-Si-Ali, S; Yokochi, T; Wade, PA; Jones, PL; Wolffe, AP			DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; IMMUNODEFICIENCY SYNDROME; CYTOSINE METHYLATION; REPLICATION; MUTATIONS; MECP2	Methylation of CpG islands is associated with transcriptional silencing and the formation of nuclease-resistant chromatin structures enriched in hypoacetylated histones(1-3). Methyl-CpG-binding proteins, such as MeCP2, provide a link between methylated DNA and hypoacetylated histones by recruiting histone deacetylase(4,5), but the mechanisms establishing the methylation patterns themselves are unknown. Whether DNA methylation is always causal for the assembly of repressive chromatin or whether features of transcriptionally silent chromatin might target methyltransferase remains unresolved. Mammalian DNA methyltransferases show little sequence specificity in vitro, yet methylation can be targeted in vivo within chromosomes to repetitive elements(6,7), centromeress(8-10) and imprinted loci(11). This targeting is frequently disrupted in tumour cells, resulting in the improper silencing of tumour-suppressor genes associated with CpG islands(1,2). Here we show that the predominant mammalian DNA methyltransferase, DNMT1, co-purifies with the retinoblastoma (Rb) tumour suppressor gene product, E2F1. and HDAC1 and that DNMT1 cooperates with Rb to repress transcription from promoters containing E2F-binding sites. These results establish a link between DNA methylation, histone deacetylase and sequence-specific DNA binding activity, as well as a growth-regulatory pathway that is disrupted in nearly all cancer cells.	NICHD, Mol Embryol Lab, NIH, Bethesda, MD USA		Wolffe, AP (corresponding author), Sangamo Biosci Inc, Point Richmond Tech Ctr, Richmond, CA USA.	awolffe@sangamo.com	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X; Robertson, Keith/0000-0002-7508-3328	DIVISION OF BASIC SCIENCES - NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01BC010420] Funding Source: NIH RePORTER		Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; ISSA JP, 1997, LEUKEMIA S1, V11, P7; ISSA JPJ, 1993, J NATL CANCER I, V85, P1235, DOI 10.1093/jnci/85.15.1235; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; ROBERTS JD, 1991, CONCEPT MAGNETIC RES, V0003, P00027, DOI DOI 10.1002/cmr.1820030104; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	28	731	751	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2000	25	3					338	342		10.1038/77124			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900026	10888886				2022-01-24	
J	Johnson, DW; Berg, JN; Baldwin, MA; Gallione, CJ; Marondel, I; Yoon, SJ; Stenzel, TT; Speer, M; PericakVance, MA; Diamond, A; Guttmacher, AE; Jackson, CE; Attisano, L; Kucherlapati, R; Porteous, MEM; Marchuk, DA				Johnson, DW; Berg, JN; Baldwin, MA; Gallione, CJ; Marondel, I; Yoon, SJ; Stenzel, TT; Speer, M; PericakVance, MA; Diamond, A; Guttmacher, AE; Jackson, CE; Attisano, L; Kucherlapati, R; Porteous, MEM; Marchuk, DA			Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2	NATURE GENETICS			English	Article							HUMAN ENDOTHELIAL-CELLS; BETA; ENDOGLIN	Hereditary haemorrhagic telangiectasia, or Osler-Rendu-Weber (ORW) syndrome, is an autosomal dominant vascular dysplasia. So far, two loci have been demonstrated for ORW. Linkage studies established an ORW locus at chromosome 9q3; endoglin was subsequently identified as the ORW1 gene. A second locus, designated ORW2, was mapped to chromosome 12. Here we report a new 4 cM interval for ORW2 that does not overlap with any previously defined. A 1.38-Mb YAC contig spans the entire interval. It includes the activin receptor like kinase 1 gene (ACVRLK1 or ALK1), a member of the serine-threonine kinase receptor family expressed in endothelium. We report three mutations in the coding sequence of the ALK1 gene in those families which show linkage of the ORW phenotype to chromosome 12. Our data suggest a critical role for ALK1 in the control of blood vessel development or repair.	DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; WESTERN GEN HOSP,DEPT HUMAN GENET,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOLEC GENET,BRONX,NY 10461; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,DURHAM,NC 27710; UNIV NEWCASTLE UPON TYNE,DEPT IMMUNOL,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND; UNIV VERMONT,DEPT PEDIAT,BURLINGTON,VT 05401; HENRY FORD HOSP,DEPT MED,DIV CLIN & MOL GENET,DETROIT,MI 48202; UNIV TORONTO,DEPT ANAT & CELL BIOL,TORONTO,ON M5S 1A8,CANADA				Kucherlapati, Raju/ABC-8807-2021	Marchuk, Douglas/0000-0002-3110-6671	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL049171, F32HL009349, F32HL009394] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1F32 HL09349, 1F32 HL09394, HL 49171] Funding Source: Medline		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CHOI ME, 1995, J BIOL CHEM, V270, P21144, DOI 10.1074/jbc.270.36.21144; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; GUTTMACHER AE, 1994, AM J MED GENET, V52, P252, DOI 10.1002/ajmg.1320520232; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HEUTINK P, 1994, J MED GENET, V31, P933, DOI 10.1136/jmg.31.12.933; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; KRAUTER K, 1995, NATURE, V377, P321; KUCHERLAPATI R, 1994, CYTOGENET CELL GENET, V67, P246; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; LUSCINSKAS FW, 1994, FASEB J, V8, P929, DOI 10.1096/fasebj.8.12.7522194; MADRI JA, 1992, ENDOTHELIAL CELL DYS; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; Miyazono Kohei, 1994, Seminars in Cell Biology, V5, P389, DOI 10.1006/scel.1994.1046; PORTEOUS MEM, 1994, J MED GENET, V31, P925, DOI 10.1136/jmg.31.12.925; SHOVLIN CL, 1994, NAT GENET, V6, P205, DOI 10.1038/ng0294-205; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Ten Dijke Peter, 1994, Progress in Growth Factor Research, V5, P55, DOI 10.1016/0955-2235(94)90017-5; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; VINCENT P, 1995, HUM MOL GENET, V4, P945, DOI 10.1093/hmg/4.5.945; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837	35	731	755	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					189	195		10.1038/ng0696-189			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	WOS:A1996UN39500018	8640225				2022-01-24	
J	Helgadottir, A; Manolescu, A; Thorleifsson, G; Gretarsdottir, S; Jonsdottir, H; Thorsteinsdottir, U; Samani, NJ; Gudmundsson, G; Grant, SFA; Thorgeirsson, G; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Johannsson, H; Gudmundsdottir, O; Gurney, ME; Sainz, J; Thorhallsdottir, M; Andresdottir, M; Frigge, ML; Topol, EJ; Kong, A; Gudnason, V; Hakonarson, H; Gulcher, JR; Stefansson, K				Helgadottir, A; Manolescu, A; Thorleifsson, G; Gretarsdottir, S; Jonsdottir, H; Thorsteinsdottir, U; Samani, NJ; Gudmundsson, G; Grant, SFA; Thorgeirsson, G; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Johannsson, H; Gudmundsdottir, O; Gurney, ME; Sainz, J; Thorhallsdottir, M; Andresdottir, M; Frigge, ML; Topol, EJ; Kong, A; Gudnason, V; Hakonarson, H; Gulcher, JR; Stefansson, K			The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; CORONARY; SUSCEPTIBILITY; LEUKOTRIENES; DISEASE; POLYMORPHISMS; LOCALIZATION; SUGGESTS; LOCUS; CELLS	We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12-13. A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is associated with a two times greater risk of myocardial infarction in Iceland. This haplotype also confers almost two times greater risk of stroke. Another ALOX5AP haplotype is associated with myocardial infarction in individuals from the UK. Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype. We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene production and inflammation in the arterial wall.	deCODE Genet, Reykjavik, Iceland; Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Iceland Heart Assoc, Reykjavik, Iceland		Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, Reykjavik, Iceland.	kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Manolescu, Andrei/G-4565-2014; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015	Manolescu, Andrei/0000-0002-0713-4664; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Topol, Eric/0000-0002-1478-4729; Grant, Struan/0000-0003-2025-5302			Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; [Anonymous], 1979, Circulation, V59, P607; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; BURKE JA, 1982, J PHARMACOL EXP THER, V221, P235; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; DAHINDEN CA, 1985, P NATL ACAD SCI USA, V82, P6632, DOI 10.1073/pnas.82.19.6632; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gudmundsson G, 2002, AM J HUM GENET, V70, P586, DOI 10.1086/339251; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; HILL WG, 1968, GENETICS, V60, P615; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Koshino T, 1999, Mol Cell Biol Res Commun, V2, P32, DOI 10.1006/mcbr.1999.0147; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEWONTIN RC, 1964, GENETICS, V50, P757; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; NICOLAE D, 1999, ALLELE SHARING MODEL; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; POOLE JCF, 1958, J PATHOL BACTERIOL, V75, P245, DOI 10.1002/path.1700750202; ROTH DM, 1983, PROSTAGLANDINS, V26, P573, DOI 10.1016/0090-6980(83)90195-8; Sala A, 1996, J BIOL CHEM, V271, P17944, DOI 10.1074/jbc.271.30.17944; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Steeds R, 1998, THROMB HAEMOSTASIS, V79, P980; STRATFORD N, 1986, ATHEROSCLEROSIS, V59, P271, DOI 10.1016/0021-9150(86)90122-X; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WARGOVICH T, 1985, J AM COLL CARDIOL, V6, P1047, DOI 10.1016/S0735-1097(85)80307-7; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; [No title captured]	50	730	779	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					233	239		10.1038/ng1311			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	WOS:000189250400011	14770184	Bronze			2022-01-24	
J	Forster, J; Famili, I; Fu, P; Palsson, BO; Nielsen, J				Forster, J; Famili, I; Fu, P; Palsson, BO; Nielsen, J			Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network	GENOME RESEARCH			English	Article							ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; LIPID-COMPOSITION; YEAST; EXPRESSION; IDENTIFICATION; TRANSPORTERS; CAPABILITIES; PHYSIOLOGY; DELETION	The metabolic network in the yeast Saccharomyces cerevisiae was reconstructed using currently available genomic, biochemical, and physiological information. The metabolic reactions were compartmentalized between the cytosol and the mitochondria, and transport steps between the compartments and the environment were included. A total of 708 structural open reading frames (ORFs) were accounted for in the reconstructed network, corresponding to 1035 metabolic reactions. Further, 140 reactions were included on the basis of biochemical evidence resulting in a genome-scale reconstructed metabolic network containing 1175 metabolic reactions and 584 metabolites. The number of gene functions included in the reconstructed network corresponds to similar to16% of all characterized ORFs in S. cerevisiae. Using the reconstructed network, the metabolic capabilities of S. cerevisiae were calculated and compared with Escherichia coli. The reconstructed metabolic network is the first comprehensive network for a eukaryotic organism, and it may be used as the basis for in silico analysis of phenotypic functions.	Tech Univ Denmark, Bioctr, Ctr Proc Biotechnol, DK-2800 Lyngby, Denmark; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA		Nielsen, J (corresponding author), Tech Univ Denmark, Bioctr, Ctr Proc Biotechnol, DK-2800 Lyngby, Denmark.	jn@biocentrum.dtu.dk	; Nielsen, Jens/Q-1347-2017	Palsson, Bernhard/0000-0003-2357-6785; Nielsen, Jens/0000-0002-9955-6003	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM057089] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM57089, R01 GM057089] Funding Source: Medline		Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; Bertsimas D., 1997, LINEAR OPTIMIZATION; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DICKINSON JR, 1998, METABOLISM MOL PHYSL, P1798; DICKSON R, 2000, BIOCHIM BIOPHYS ACTA, V1438, P305; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Edwards J.S., 1999, METAB ENG, P13; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Forster J, 2002, BIOTECHNOL BIOENG, V79, P703, DOI 10.1002/bit.10378; Goffeau A., 1997, NATURE, V387, P5, DOI DOI 10.1038/387005B0.PUBMED:9169864; Gombert AK, 2000, CURR OPIN BIOTECH, V11, P180, DOI 10.1016/S0958-1669(00)00079-3; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; HUNTER K, 1972, BIOCHIM BIOPHYS ACTA, V260, P639, DOI 10.1016/0005-2760(72)90013-6; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; KANEKO H, 1976, LIPIDS, V11, P837, DOI 10.1007/BF02532989; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; MICHAL G, 1999, BIOCH PATHWAYS; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; Nissen TL, 2001, YEAST, V18, P19, DOI 10.1002/1097-0061(200101)18:1<19::AID-YEA650>3.3.CO;2-X; NURMINEN T, 1975, CHEM PHYS LIPIDS, V14, P15, DOI 10.1016/0009-3084(75)90012-2; Oliver SG, 1998, METHOD MICROBIOL, V26, P1; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; Oura E, 1972, EFFECT AERATION GROW; Overkamp KM, 2000, J BACTERIOL, V182, P2823, DOI 10.1128/JB.182.10.2823-2830.2000; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; PALMIERI L, 2000, J BIOL CHEM, V32, P22184; PARKS LW, 1978, CRC CR REV MICROBIOL, V6, P301, DOI 10.3109/10408417809090625; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; REGENBERG B, 1999, AMINO ACID UPTAKE SA; Remize F, 2000, APPL ENVIRON MICROB, V66, P3151, DOI 10.1128/AEM.66.8.3151-3159.2000; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P288, DOI 10.1021/bp9900357; SCHILLING CH, 2000, SYSTEMS BIOL PATHWAY; Schulze U., 1995, ANAEROBIC PHYSL SACC; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; Selkov E, 2000, P NATL ACAD SCI USA, V97, P3509, DOI 10.1073/pnas.97.7.3509; Stephanopoulos G., 1998, METABOLIC ENG PRINCI; Stouthamer A. H., 1979, INT REV BIOCHEM, V21, P1; Strathern J.N., 1982, MOL BIOL YEAST SACCH; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; VAUGHANMARTINI A, 1993, SYST APPL MICROBIOL, V16, P113; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; VERDUYN C, 1990, J GEN MICROBIOL, V136, P395, DOI 10.1099/00221287-136-3-395; VERDUYN C, 1991, ANTON LEEUW INT J G, V59, P49, DOI 10.1007/BF00582119; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zimmerman FK, 1997, YEAST SUGAR METABOLI; [No title captured]	65	730	771	2	90	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2003	13	2					244	253		10.1101/gr.234503			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	642TY	WOS:000180821900011	12566402	Green Published, Bronze			2022-01-24	
J	Carter, SL; Eklund, AC; Kohane, IS; Harris, LN; Szallasi, Z				Carter, Scott L.; Eklund, Aron C.; Kohane, Isaac S.; Harris, Lyndsay N.; Szallasi, Zoltan			A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers	NATURE GENETICS			English	Article							BREAST-CANCER; GENOMIC INSTABILITY; SPINDLE MIDZONE; SURVIVAL; TUMORS; CLASSIFICATION; PROGRESSION; METASTASIS; SUBCLASSES; PROGNOSIS	We developed a computational method to characterize aneuploidy in tumor samples based on coordinated aberrations in expression of genes localized to each chromosomal region. We summarized the total level of chromosomal aberration in a given tumor in a univariate measure termed total functional aneuploidy. We identified a signature of chromosomal instability from specific genes whose expression was consistently correlated with total functional aneuploidy in several cancer types. Net overexpression of this signature was predictive of poor clinical outcome in 12 cancer data sets(1-12) representing six cancer types. Also, the signature of chromosomal instability was higher in metastasis samples than in primary tumors and was able to stratify grade 1 and grade 2 breast tumors according to clinical outcome. These results provide a means to assess the potential role of chromosomal instability in determining malignant potential over a broad range of tumors.	Harvard Univ, Childrens Hosp, Sch Med, Harvard Mit Div Hlth Sci & Technol,Informat Progr, Boston, MA 02115 USA; Brigham & Womens Hosp, Lab Funct Geonom, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Breast Dis Unit, New Haven, CT 06520 USA; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark		Szallasi, Z (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Harvard Mit Div Hlth Sci & Technol,Informat Progr, Boston, MA 02115 USA.	zszallasi@chip.org	Kohane, Isaac Kohane/K-3716-2012; Teh, Muy-Teck/B-9284-2016	Kohane, Isaac Kohane/0000-0003-2192-5160; Teh, Muy-Teck/0000-0002-7725-8355; Eklund, Aron Charles/0000-0003-0861-1001; Szallasi, Zoltan/0000-0001-5395-7509	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1P01CA-092644-01] Funding Source: Medline; NLM NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [5U54LM008748-02] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA092644] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [U54LM008748] Funding Source: NIH RePORTER		Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Diaz LA, 2005, SEMIN CANCER BIOL, V15, P67, DOI 10.1016/j.semcancer.2004.09.009; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Heidebrecht HJ, 2003, MOL CANCER RES, V1, P271; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Nutt CL, 2003, CANCER RES, V63, P1602; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roschke AV, 2003, CANCER RES, V63, P8634; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059	29	729	737	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1043	1048		10.1038/ng1861			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	WOS:000240112100022	16921376				2022-01-24	
J	Risch, HA; McLaughlin, JR; Cole, DEC; Rosen, B; Bradley, L; Kwan, E; Jack, E; Vesprini, DJ; Kuperstein, G; Abrahamson, JLA; Fan, I; Wong, B; Narod, SA				Risch, HA; McLaughlin, JR; Cole, DEC; Rosen, B; Bradley, L; Kwan, E; Jack, E; Vesprini, DJ; Kuperstein, G; Abrahamson, JLA; Fan, I; Wong, B; Narod, SA			Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; 185DELAG MUTATION; FOUNDER BRCA1; GENETIC-HETEROGENEITY; JEWISH WOMEN; FREQUENCY; RISK; FAMILIES; FEATURES	A population-based series of 649 unselected incident cases of ovarian cancer diagnosed in Ontario, Canada, during 1995-96 was screened for germline mutations in BRCA1 and BRCA2. We specifically tested for 11 of the most commonly reported mutations in the two genes. Then, cases were assessed with the protein-truncation test (PTT) for exon 11 of BRCA1, with denaturing gradient gel electrophoresis for the remainder of BRCA1, and with PTT for exons 10 and 11 of BRCA2. No mutations were found in all 134 women with tumors of borderline histology. Among the 515 women with invasive cancers, we identified 60 mutations, 39 in BRCA1 and 21 in BRCA2. The total mutation frequency among women with invasive cancers, 11.7% (95% confidence interval [95% CI] 9.2%-14.8%), is higher than previous estimates. Hereditary ovarian cancers diagnosed at age <50 years were mostly (83%) due to BRCA1, whereas the majority (60%) of those diagnosed at age >60 years were due to BRCA2. Mutations were found in 19% of women reporting first-degree relatives with breast or ovarian cancer and in 6.5% of women with no affected first-degree relatives. Risks of ovarian, breast, and stomach cancers and leukemias/ lymphomas were increased nine-, five-, six- and threefold, respectively, among first-degree relatives of cases carrying BRCA1 mutations, compared with relatives of noncarriers, and risk of colorectal cancer was increased threefold for relatives of cases carrying BRCA2 mutations. For carriers of BRCA1 mutations, the estimated penetrance by age 80 years was 36% for ovarian cancer and 68% for breast cancer. In breast-cancer risk for first-degree relatives, there was a strong trend according to mutation location along the coding sequence of BRCA1, with little evidence of increased risk for mutations in the 5' fifth, but 8.8-fold increased risk for mutations in the 3' fifth (95% CI 3.6-22.0), corresponding to a carrier penetrance of essentially 100%. Ovarian, colorectal, stomach, pancreatic, and prostate cancer occurred among first-degree relatives of carriers of BRCA2 mutations only when mutations were in the ovarian cancer-cluster region (OCCR) of exon 11, whereas an excess of breast cancer was seen when mutations were outside the OCCR. For cancers of all sites combined, the estimated penetrance of BRCA2 mutations was greater for males than for females, 53% versus 38%. Past studies may have underestimated the contribution of BRCA2 to ovarian cancer, because mutations in this gene cause predominantly late-onset cancer, and previous work has focused more on early-onset disease. If confirmed in future studies, the trend in breast-cancer penetrance, according to mutation location along the BRCA1 coding sequence, may have significant impact on treatment decisions for carriers of BRCA1-mutations. As well, BRCA2 mutations may prove to be a greater cause of cancer in male carriers than previously has been thought.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Dept Clin Biochem, Toronto, ON, Canada; Toronto Hosp, Dept Gynecol, Toronto, ON M5T 2S8, Canada; Womens Coll Hosp, Dept Med, Toronto, ON M5S 1B2, Canada		Risch, HA (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St,POB 208034, New Haven, CT 06520 USA.	harvey.risch@yale.edu	Narod, Steven A/AAA-6112-2022; McLaughlin, John R/E-4577-2013		NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA063682, R01 CA063678, R01 CA 63682, R01 CA 63678] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA063678, R01CA063682] Funding Source: NIH RePORTER		Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foster KA, 1996, CANCER RES, V56, P3622; Frank LS, 1998, ASYMPTOTIC ANAL, V16, P1; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gotlieb WH, 1998, JNCI-J NATL CANCER I, V90, P995, DOI 10.1093/jnci/90.13.995; Janezic SA, 1999, HUM MOL GENET, V8, P889, DOI 10.1093/hmg/8.5.889; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Khoo U S, 2000, Hum Mutat, V16, P88, DOI 10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G; Kuperstein G, 2000, CLIN GENET, V57, P213, DOI 10.1034/j.1399-0004.2000.570307.x; Lehrer S, 1998, BRIT J CANCER, V78, P771, DOI 10.1038/bjc.1998.576; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; MATSUSHIMA M, 1995, HUM MOL GENET, V4, P1953, DOI 10.1093/hmg/4.10.1953; Mazoyer S, 2000, AM J HUM GENET, V67, P207, DOI 10.1086/302974; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Muto MG, 1996, CANCER RES, V56, P1250; NAROD S, 1995, AM J HUM GENET, V57, P957; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Ries LAG, 1994, NIH PUBL; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Sinclair CS, 2000, CANCER RES, V60, P1371; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Stratton JF, 1999, AM J HUM GENET, V65, P1725, DOI 10.1086/302671; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Takahashi H, 1996, CANCER RES, V56, P2738; TAKAHASHI H, 1995, CANCER RES, V55, P2998; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Van der Looij M, 2000, INT J CANCER, V86, P737, DOI 10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1; Wacholder S, 1998, AM J EPIDEMIOL, V148, P623, DOI 10.1093/aje/148.7.623; Whittemore AS, 1997, AM J HUM GENET, V60, P496	40	729	742	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					700	710		10.1086/318787			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	WOS:000166994200014	11179017	Green Published, Bronze			2022-01-24	
J	Redmond, TM; Yu, S; Lee, E; Bok, D; Hamasaki, D; Chen, N; Goletz, P; Ma, JX; Crouch, RK; Pfeifer, K				Redmond, TM; Yu, S; Lee, E; Bok, D; Hamasaki, D; Chen, N; Goletz, P; Ma, JX; Crouch, RK; Pfeifer, K			Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle	NATURE GENETICS			English	Article							PIGMENT-EPITHELIUM; BINDING-PROTEIN; GENE-TRANSFER; VITAMIN-A; MICROSOMAL PROTEIN; MOUSE RETINA; CELLS; MICE; ISOMERASE; RHODOPSIN	Mutation of RPE65 can cause severe blindness from birth or early childhood, and RPE65 protein is associated with retinal pigment epithelium (RPE) vitamin A metabolism. Here. we show that Rpe65-deficient mice exhibit changes in retinal physiology and biochemistry. Outer segment discs of rod photoreceptors in Rpe65(-/-) mice are disorganized compared with those of Rpe65(+/+) and Rpe65(+/-) mice. Rod function, as measured by electroretinography, is abolished in Rpe65(-/-) mice, although cone function remains. Rpe65(-/-) mice lack rhodopsin, but not opsin apoprotein. Furthermore, all-trans-retinyl esters over-accumulate in the RPE of Rpe65(-/-) mice, whereas 11-cis-retinyl esters are absent. Disruption of the RPE-based metabolism of all-trans-retinyl esters to 11-cis-retinal thus appears to underlie the Rpe65(-/-) phenotype, although cone pigment regeneration may be dependent on a separate pathway.	NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL 33101 USA; Med Univ S Carolina, Storm Eye Inst, Charleston, SC 29425 USA		Redmond, TM (corresponding author), NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	redmond@helix.nih.gov			NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY12231, EY00444, EY00331] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R37EY000444, P30EY000331, R01EY012231, R01EY000444] Funding Source: NIH RePORTER		Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; BARRY RJ, 1989, J BIOL CHEM, V264, P9231; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; BENNETT J, 1994, INVEST OPHTH VIS SCI, V35, P2535; BERNSTEIN PS, 1987, J BIOL CHEM, V262, P16848; BRIDGES CDB, 1982, METHOD ENZYMOL, V81, P463; BRIDGES CDB, 1989, VISION RES, V29, P1711, DOI 10.1016/0042-6989(89)90153-3; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; GOLDSTEIN EB, 1967, VISION RES, V7, P837, DOI 10.1016/0042-6989(67)90004-1; GOLDSTIEN EB, 1973, VISION RES, V83, P527; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; HELLER J, 1976, AM J OPHTHALMOL, V81, P93, DOI 10.1016/0002-9394(76)90198-7; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; LAI YL, 1982, NATURE, V298, P848, DOI 10.1038/298848a0; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Liou GI, 1998, J NEUROSCI, V18, P4511; MA JX, IN PRESS BIOCH BIOPH; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; NOY N, 1991, BIOCHEMISTRY-US, V30, P6380, DOI 10.1021/bi00240a005; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; ROBISON WG, 1977, INVEST OPHTH VIS SCI, V16, P1110; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1994, BIOCHEMISTRY-US, V33, P3106, DOI 10.1021/bi00176a045; Saari John C., 1994, P351; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; Sullivan DM, 1996, INVEST OPHTH VIS SCI, V37, P766; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WIGGERT B, 1977, BIOCHIM BIOPHYS ACTA, V498, P366, DOI 10.1016/0304-4165(77)90275-6; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Wright AF, 1997, NAT GENET, V17, P132, DOI 10.1038/ng1097-132; YOUNG RW, 1970, INVEST OPHTH VISUAL, V9, P524	48	729	742	0	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					344	351		10.1038/3813			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	WOS:000077199600020	9843205				2022-01-24	
J	CRYSTAL, RG; MCELVANEY, NG; ROSENFELD, MA; CHU, CS; MASTRANGELI, A; HAY, JG; BRODY, SL; JAFFE, HA; EISSA, NT; DANEL, C				CRYSTAL, RG; MCELVANEY, NG; ROSENFELD, MA; CHU, CS; MASTRANGELI, A; HAY, JG; BRODY, SL; JAFFE, HA; EISSA, NT; DANEL, C			ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MEDIATED GENE-TRANSFER; CHLORIDE CHANNEL; INTERLEUKIN-6; EXPRESSION; INVIVO; IDENTIFICATION; PATHOGENESIS; TRANSCRIPTS; EPITHELIUM	We have administered a recombinant adenovirus vector (AdCFTR) containing the normal human CFTR cDNA to the nasal and bronchial epithelium of four individuals with cystic fibrosis (CF). We show that this vector can express the CFTR cDNA in the CF respiratory epithelium in vivo. With doses up to 2 x 10(9) pfu, there was no recombination/ complementation or shedding of the vector or rise of neutralizing antibody titres. At 2 x 10(9) pfu, a transient systemic and pulmonary syndrome was observed, possibly mediated by interleukin-6. Follow-up at 6-12 months demonstrated no long term adverse effects. Thus, it is feasible to use an adenovirus vector to transfer and express the CFTR cDNA in the respiratory epithelium of individuals with CF. Correction of the CF phenotype of the airway epithelium might be achieved with this strategy.	NHLBI,PULM BRANCH,BETHESDA,MD 20892		CRYSTAL, RG (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,DIV PULM & CRIT CARE MED,520 E 70 ST,ST-505,NEW YORK,NY 10021, USA.		McElvaney, Noel/A-6809-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL051746] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 P01 HL51746-01] Funding Source: Medline		BEDDROSSIAN CWM, 1976, HUM PATHOL, V7, P195; BLAESE RM, 1990, HUM GENE THER, V1, P327; Boat T, 1989, METABOLIC BASIS INHE, P2649; BONFIELD TL, 1993, PEDIATR PULM, V8, pA312; BOUCHER RC, 1993, FED REGISTER, V58, P53814; BOUT A, 1994, HUM GENE THER, V5, P3, DOI 10.1089/hum.1994.5.1-3; BRODY SL, 1994, HUM GENE THER, V5; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; COUCH RB, 1966, AM REV RESPIR DIS, V93, P529; CRYSTAL RG, 1992, FED REGISTER, V58, P21737; DANEL C, 1992, American Review of Respiratory Disease, V145, pA689; Devergne O, 1991, Eur Cytokine Netw, V2, P183; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; EISSA NT, 1994, HUM GENE THER, V5, P1105, DOI 10.1089/hum.1994.5.9-1105; ENGLEHARDT J, 1993, PEDIATR PULMONOL, V9; ENGLEHARDT JF, 1993, HUM GENE THER, V4, P759; ENGLEHARDT JF, 1993, NAT GENET, V4, P27; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; GINSBERG HS, 1955, J CLIN INVEST, V34, P820, DOI 10.1172/JCI103137; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; HACK CE, 1989, BLOOD, V74, P1704; HOROWITZ MS, 1990, VIROLOGY, P1679; HUEBNER RJ, 1958, ANNU REV MICROBIOL, V12, P49, DOI 10.1146/annurev.mi.12.100158.000405; KASEL JA, 1979, DIAGNOSTIC PROCEDURE, P229; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KRONBORG G, 1993, PEDIATR PULM, V15, P292, DOI 10.1002/ppul.1950150506; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MELANI C, 1993, BLOOD, V81, P2744; RICH DP, 1993, HUM GENE THER, V4, P461, DOI 10.1089/hum.1993.4.4-461; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1994, HUM GENE THER, V5, P331, DOI 10.1089/hum.1994.5.3-331; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; RUEF C, 1993, EUR RESPIR J, V6, P1429; RYFFEL B, 1993, INT REV EXP PATHOL, V34, P79; SALTINI C, 1989, NEW ENGL J MED, V320, P1103, DOI 10.1056/NEJM198904273201702; SETOGUCHI Y, 1994, AM J RESP CELL MOL, V10, P369, DOI 10.1165/ajrcmb.10.4.8136153; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SMITH SF, 1988, EUR RESPIR J, V1, P792; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; SPERGEL JM, 1991, P NATL ACAD SCI USA, V88, P6472, DOI 10.1073/pnas.88.15.6472; SPERGEL JM, 1992, J VIROL, V66, P1021, DOI 10.1128/JVI.66.2.1021-1030.1992; Strauss SE, 1984, ADENOVIRUSES, P451; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.iy.08.040190.001345; WEBER J, 1993, J CLIN ONCOL, V11, P499, DOI 10.1200/JCO.1993.11.3.499; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WELSH MJ, 1992, FED REGISTER, V58, P21737; WILMOTT RW, 1993, FED REGISTER, V58, P21739; WILSON JM, 1992, FED REGISTER, V58, P47906; XIN Z, 1993, AM J RESP CELL MOL B, V9, P225; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K; ZABNER J, 1994, NAT GENET, V6, P75, DOI 10.1038/ng0194-75; 1993, MINOR MODIFICATION N	67	729	734	1	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					42	51		10.1038/ng0994-42			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	WOS:A1994PE15700014	7527271				2022-01-24	
J	POLLOCK, JD; WILLIAMS, DA; GIFFORD, MAC; LI, LL; DU, XX; FISHERMAN, J; ORKIN, SH; DOERSCHUK, CM; DINAUER, MC				POLLOCK, JD; WILLIAMS, DA; GIFFORD, MAC; LI, LL; DU, XX; FISHERMAN, J; ORKIN, SH; DOERSCHUK, CM; DINAUER, MC			MOUSE MODEL OF X-LINKED CHRONIC GRANULOMATOUS-DISEASE, AN INHERITED DEFECT IN PHAGOCYTE SUPEROXIDE PRODUCTION	NATURE GENETICS			English	Article							NEUTROPHIL CYTOCHROME-B; NADPH OXIDASE; CHROMOSOMAL LOCATION; GENE; ASPERGILLOSIS; COMPONENT; ABSENCE; MICE; MACROPHAGES; DEFICIENCY	Chronic granulomatous disease (CGD) is a recessive disorder characterized by a defective phagocyte respiratory burst oxidase, life-threatening pyogenic infections and inflammatory granulomas. Gene targeting was used to generate mice with a null allele of the gene involved in X-linked CGD, which encodes the 91 kD subunit of the oxidase cytochrome b. Affected hemizygous male mice lacked phagocyte superoxide production, manifested an increased susceptibility to infection with Staphylococcus aureus and Aspergillus fumigatus and had an altered inflammatory response in thioglycollate peritonitis. This animal model should aid in developing new treatments for CGD and in evaluating the role of phagocyte-derived oxidants in inflammation.	INDIANA UNIV,MED CTR,HERMAN B WELLS CTR PEDIAT RES,DEPT PEDIAT,INDIANAPOLIS,IN 46202; INDIANA UNIV,MED CTR,JAMES WHITCOMB RILEY HOSP CHILDREN,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,HOWARD HUGHES MED INST,INDIANAPOLIS,IN 46202; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CHILDRENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115				Pollock, Jonathan D/B-1554-2009				BAEHNER RL, 1968, NEW ENGL J MED, V278, P971, DOI 10.1056/NEJM196805022781801; BROCKDORFF N, 1988, CYTOGENET CELL GENET, V48, P124, DOI 10.1159/000132605; CURNUTTE JT, 1993, HEMATOLOGY INFANCY C, P904; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; DESCHENES SM, 1994, GENOMICS, V23, P62, DOI 10.1006/geno.1994.1459; DIAMOND RD, 1978, AM J PATHOL, V91, P313; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DIXON DM, 1989, INFECT IMMUN, V57, P1452, DOI 10.1128/IAI.57.5.1452-1456.1989; DU XX, 1993, BLOOD, V81, P27; Elsbach P, 1992, INFLAMMATION BASIC P, P603; GALLIN JI, 1983, ANN INTERN MED, V99, P657, DOI 10.7326/0003-4819-99-5-657; GALLIN JI, 1983, INFLAMMATION, V7, P227, DOI 10.1007/BF00917259; GRAYBILL JR, 1984, AM REV RESPIR DIS, V129, P292; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; JACKSON JH, 1988, HEMATOL ONCOL CLIN N, V2, P317, DOI 10.1016/S0889-8588(18)30624-5; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MAYO LA, 1990, METHOD ENZYMOL, V186, P567; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; OCHS HD, 1973, J PEDIATR-US, V83, P77, DOI 10.1016/S0022-3476(73)80316-6; ODELL EW, 1991, J MED MICROBIOL, V34, P129, DOI 10.1099/00222615-34-3-129; PADGETT E, 1968, ADV VET SCI, V12, P239; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB; ROOS D, 1992, J LEUKOCYTE BIOL, V51, P164, DOI 10.1002/jlb.51.2.164; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; SCHAFFNER A, 1994, MACROPHAGE PATHOGEN, P545; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1978, LANCET, V2, P446; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; XIE QW, 1992, BIOL OXIDANTS GENERA, P213; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	42	727	734	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					202	209		10.1038/ng0295-202			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	WOS:A1995QE67200024	7719350				2022-01-24	
J	Thomas, G; Jacobs, KB; Yeager, M; Kraft, P; Wacholder, S; Orr, N; Yu, K; Chatterjee, N; Welch, R; Hutchinson, A; Crenshaw, A; Cancel-Tassin, G; Staats, BJ; Wang, Z; Gonzalez-Bosquet, J; Fang, J; Deng, X; Berndt, SI; Calle, EE; Feigelson, HS; Thun, MJ; Rodriguez, C; Albanes, D; Virtamo, J; Weinstein, S; Schumacher, FR; Giovannucci, E; Willett, WC; Cussenot, O; Valeri, A; Andriole, GL; Crawford, ED; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, R; Hayes, RB; Hunter, DJ; Chanock, SJ				Thomas, Gilles; Jacobs, Kevin B.; Yeager, Meredith; Kraft, Peter; Wacholder, Sholom; Orr, Nick; Yu, Kai; Chatterjee, Nilanjan; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Cancel-Tassin, Geraldine; Staats, Brian J.; Wang, Zhaoming; Gonzalez-Bosquet, Jesus; Fang, Jun; Deng, Xiang; Berndt, Sonja I.; Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R.; Giovannucci, Edward; Willett, Walter C.; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L.; Crawford, E. David; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hayes, Richard B.; Hunter, David J.; Chanock, Stephen J.			Multiple loci identified in a genome-wide association study of prostate cancer	NATURE GENETICS			English	Article							94 AMINO-ACIDS; SECRETORY PROTEIN; BINDING-PROTEIN; GENE; SUSCEPTIBILITY; VARIANTS; RISK	We followed our initial genome-wide association study (GWAS) of 527,869 SNPs on 1,172 individuals with prostate cancer and 1,157 controls of European origin-nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial prospective study-by testing 26,958 SNPs in four independent studies (total of 3,941 cases and 3,964 controls). In the combined joint analysis, we confirmed three previously reported loci (two independent SNPs at 8q24 and one in HNF1B (formerly known as TCF2 on 17q); P < 10(-10)). In addition, loci on chromosomes 7, 10 (two loci) and 11 were highly significant (between P < 7.31 x 10(-13) and P < 2.14 x 10(-6)). Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer. Of the nine loci that showed highly suggestive associations (P < 2.5 x 10(-5)), four best fit a recessive model and included candidate susceptibility genes: CPNE3, IL16 and CDH13. Our findings point to multiple loci with moderate effects associated with susceptibility to prostate cancer that, taken together, in the future may predict high risk in select individuals.	[Thomas, Gilles; Yeager, Meredith; Wacholder, Sholom; Orr, Nick; Yu, Kai; Chatterjee, Nilanjan; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Staats, Brian J.; Wang, Zhaoming; Gonzalez-Bosquet, Jesus; Fang, Jun; Deng, Xiang; Berndt, Sonja I.; Albanes, Demetrius; Weinstein, Stephanie; Tucker, Margaret; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hayes, Richard B.; Hunter, David J.; Chanock, Stephen J.] NCI, NIH, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; [Yeager, Meredith; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Staats, Brian J.; Wang, Zhaoming; Deng, Xiang] NCI Frederick, SAIC Frederick Inc, Adv Technol Program, Core Genotyping Facil, Frederick, MD 21702 USA; [Kraft, Peter; Schumacher, Fredrick R.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FIN-0030 Helsinki, Finland; [Thomas, Gilles; Giovannucci, Edward; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63108 USA; [Crawford, E. David] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80014 USA; [Gerhard, Daniela S.] NCI, NIH, Dept Hlth & Human Serv, Ctr Canc Res,Off Canc Genom, Bethesda, MD 20892 USA; [Chanock, Stephen J.] NCI, NIH, Dept Hlth & Human Serv, Ctr Canc Res,Pediat Oncol Branch, Bethesda, MD 20892 USA; [Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine] CeRePP Hop Tenon, AP HP, F-75970 Paris, France		Chanock, SJ (corresponding author), NCI, NIH, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Albanes, Demetrius/B-9749-2015; Tucker, Margaret A/B-4297-2015; Schumacher, Fredrick/R-6043-2019; Yeager, Meredith/AAA-5322-2020; Berndt, Sonja I/J-8423-2016; Wang, Zhaoming/R-5527-2018; Weinstein, Stephanie J/P-1627-2017	Schumacher, Fredrick/0000-0002-3073-7463; Wang, Zhaoming/0000-0001-7556-3869; Weinstein, Stephanie J/0000-0002-3834-1535; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Gonzalez Bosquet, Jesus/0000-0002-2079-4528; cussenot, olivier/0000-0002-9912-0533; Hayes, Richard/0000-0002-0918-661X	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N01-CO-12400, T32 CA 09001, CA55075, U01 CA098710, U01CA098233, N01-CN-45165] Funding Source: Medline; CCR NIH HHS [N01-RC-45035, N01-RC-37004] Funding Source: Medline; Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0820821] Funding Source: National Science Foundation; Div Of Molecular and Cellular BioscienceNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1021718, 0821096] Funding Source: National Science Foundation; DIVISION OF CANCER PREVENTION AND CONTROLUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009001, U01CA098233, U01CA098710, Z01CP010178] Funding Source: NIH RePORTER		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970.abs; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gimm O, 2001, J CLIN ENDOCR METAB, V86, P1801, DOI 10.1210/jc.86.4.1801; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Janssen JWG, 2000, BLOOD, V95, P2691; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Paliwal S, 2007, CANCER RES, V67, P9322, DOI 10.1158/0008-5472.CAN-07-1743; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Valeri A, 2003, ANN HUM GENET, V67, P125, DOI 10.1046/j.1469-1809.2003.00022.x; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	30	726	758	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					310	315		10.1038/ng.91			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	WOS:000253548400021	18264096	Green Published			2022-01-24	
J	Drummond, AJ; Nicholls, GK; Rodrigo, AG; Solomon, W				Drummond, AJ; Nicholls, GK; Rodrigo, AG; Solomon, W			Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data	GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; BAYESIAN PHYLOGENETIC INFERENCE; IMMUNODEFICIENCY-VIRUS TYPE-1; DNA-SEQUENCES; ANCESTRAL INFERENCE; RECOMBINATION RATES; MOLECULAR EVOLUTION; URSUS-SPELAEUS; ANCIENT DNA; CAVE BEAR	Molecular sequences obtained at different sampling times from populations of rapidly evolving pathogens and from ancient subfossil and fossil sources are increasingly available with modern sequencing technology. Here, we present a Bayesian statistical inference approach to the joint estimation of mutation rate and population size that incorporates the uncertainty in the genealogy of such temporally spaced sequences by using Markov chain Monte Carlo (MCMC) integration. The Kingman coalescent model is used to describe the time structure of the ancestral tree. We recover information about the unknown true ancestral coalescent tree, population size, and the overall mutation rate from temporally spaced data, that is, from nucleotide sequences gathered at different times, from different individuals, in an evolving haploid population. We briefly discuss the methodological implications and show what can be inferred, in various practically relevant states of prior knowledge. We develop extensions for exponentially growing population size and joint estimation of substitution model parameters. We illustrate some of the important features of this approach on a genealogy of HIV-1 envelope (env) partial sequences.	Univ Auckland, Sch Biol Sci, Dept Math, Auckland 1001, New Zealand; Univ Auckland, Sch Biol Sci, Dept Stat, Auckland 1001, New Zealand		Drummond, AJ (corresponding author), Univ Oxford, Dept Stat, S Parks Rd, Oxford OX1 3PS, England.	alexei.drummond@zoology.oxford.ac.uk	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317; Nicholls, Geoffrey/0000-0002-1595-9041; Drummond, Alexei/0000-0003-4454-2576	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM059174] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 59174] Funding Source: Medline		Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond A, 2001, MOL BIOL EVOL, V18, P1365, DOI 10.1093/oxfordjournals.molbev.a003920; Drummond A, 2000, MOL BIOL EVOL, V17, P1807, DOI 10.1093/oxfordjournals.molbev.a026281; Fearnhead P, 2001, GENETICS, V159, P1299; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fisher, 1930, GENETICAL THEORY NAT; FU YX, 1994, GENETICS, V136, P685; Geyer C.J., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; HANNI C, 1994, P NATL ACAD SCI USA, V91, P12336, DOI 10.1073/pnas.91.25.12336; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; HOLMES EC, 1992, P NATL ACAD SCI USA, V89, P4835, DOI 10.1073/pnas.89.11.4835; Huelsenbeck JP, 2000, GENETICS, V154, P1879; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; Kuhner MK, 1998, GENETICS, V149, P429; KUHNER MK, 1995, GENETICS, V140, P1421; Kuhner MK, 2000, GENETICS, V156, P1393; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; NEE S, 1995, PHILOS T ROY SOC B, V349, P25, DOI 10.1098/rstb.1995.0087; Pybus OG, 2000, GENETICS, V155, P1429; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SLATKIN M, 1991, GENETICS, V129, P555; SOKAL AD, 1989, COURS 3 CYCL PHYS SU; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Wilson IJ, 1998, GENETICS, V150, P499; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wright S, 1931, GENETICS, V16, P0097; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; [No title captured]	48	725	740	0	53	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2002	161	3					1307	1320					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	579RW	WOS:000177192500032	12136032				2022-01-24	
J	Papanikolaou, G; Samuels, ME; Ludwig, EH; MacDonald, MLE; Franchini, PL; Dube, MP; Andres, L; MacFarlane, J; Sakellaropoulos, N; Politou, M; Nemeth, E; Thompson, J; Risler, JK; Zaborowska, C; Babakaiff, R; Radomski, CC; Pape, TD; Davidas, O; Christakis, J; Brissot, P; Lockitch, G; Ganz, T; Hayden, MR; Goldberg, YP				Papanikolaou, G; Samuels, ME; Ludwig, EH; MacDonald, MLE; Franchini, PL; Dube, MP; Andres, L; MacFarlane, J; Sakellaropoulos, N; Politou, M; Nemeth, E; Thompson, J; Risler, JK; Zaborowska, C; Babakaiff, R; Radomski, CC; Pape, TD; Davidas, O; Christakis, J; Brissot, P; Lockitch, G; Ganz, T; Hayden, MR; Goldberg, YP			Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis	NATURE GENETICS			English	Article							ANTIMICROBIAL PEPTIDE HEPCIDIN; CHRONIC DISEASE; HEREDITARY HEMOCHROMATOSIS; GENETIC-HETEROGENEITY; LIVER HEPCIDIN; LOCUS MAPS; ANEMIA; EXPRESSION; PROTEIN; MOUSE	Juvenile hemochromatosis is an early-onset autosomal recessive disorder of iron overload resulting in cardiomyopathy, diabetes and hypogonadism that presents in the teens and early 20s (refs. 1,2). Juvenile hemochromatosis has previously been linked to the centromeric region of chromosome 1q (refs. 3 6), a region that is incomplete in the human genome assembly. Here we report the positional cloning of the locus associated with juvenile hemochromatosis and the identification of a new gene crucial to iron metabolism. We finely mapped the recombinant interval in families of Greek descent and identified multiple deleterious mutations in a transcription unit of previously unknown function (LOC148738), now called HFE2, whose protein product we call hemojuvelin. Analysis of Greek, Canadian and French families indicated that one mutation, the amino acid substitution G320V, was observed in all three populations and accounted for two-thirds of the mutations found. HFE2 transcript expression was restricted to liver, heart and skeletal muscle, similar to that of hepcidin, a key protein implicated in iron metabolism(7-9). Urinary hepcidin levels were depressed in individuals with juvenile hemochromatosis, suggesting that hemojuvelin is probably not the hepcidin receptor. Rather, HFE2 seems to modulate hepcidin expression.	Xenon Genet, Burnaby, BC V5G 4W8, Canada; Univ Athens, Dept Internal Med 1, Sch Med, Laikon Gen Hosp, Athens 11527, Greece; Xenon Genet Res, Montreal, PQ H3A 1L2, Canada; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Theagenio Canc Ctr, Dept Hematol, Thessaloniki 54007, Greece; Univ Rennes, Serv Malad Foie, F-35033 Rennes, France; Univ Rennes, INSERM, U522, F-35033 Rennes, France; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada		Hayden, MR (corresponding author), Xenon Genet, Burnaby, BC V5G 4W8, Canada.	mrh@cmmt.ubc.ca	Girelli, Domenico/B-1183-2008; PAPANIKOLAOU, GEORGE/AAL-9017-2021; Hayden, Michael R/D-8581-2011; Ganz, Tomas/AAN-3308-2020; Dube, Marie-Pierre/B-9364-2008; Ganz, Tomas/D-4567-2009	Girelli, Domenico/0000-0001-9684-1899; PAPANIKOLAOU, GEORGE/0000-0002-6755-3633; Hayden, Michael R/0000-0001-5159-1419; Dube, Marie-Pierre/0000-0001-8442-4393; MacDonald, Marcia/0000-0001-7946-0023; Nemeth, Elizabeta/0000-0002-3477-2397; Ganz, Tomas/0000-0002-2830-5469			Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Camaschella C, 2002, SEMIN HEMATOL, V39, P242, DOI 10.1053/shem.2002.35635; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P8160, DOI 10.1073/pnas.161296298; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Means RT, 2000, BEST PRACT RES CL HA, V13, P151, DOI 10.1053/beha.1999.0065; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Papanikolaou G, 2000, BLOOD CELL MOL DIS, V26, P163, DOI 10.1006/bcmd.2000.0292; Papanikolaou G, 2002, BLOOD CELL MOL DIS, V29, P168, DOI 10.1006/bcmd.2002.0553; Papanikolaou G, 2001, BLOOD CELL MOL DIS, V27, P744, DOI 10.1006/bcmd.2001.0444; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rivard SR, 2003, EUR J HUM GENET, V11, P585, DOI 10.1038/sj.ejhg.5201009; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Roy CN, 2003, PEDIATR RES, V53, P507, DOI 10.1203/01.PDR.0000049513.67410.2D; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193	29	724	752	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					77	82		10.1038/ng1274			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	WOS:000187666800017	14647275	Bronze			2022-01-24	
J	Imbert, G; Saudou, F; Yvert, G; Devys, D; Trottier, Y; Garnier, JM; Weber, C; Mandel, JL; Cancel, G; Abbas, N; Durr, A; Didierjean, O; Stevanin, G; Agid, Y; Brice, A				Imbert, G; Saudou, F; Yvert, G; Devys, D; Trottier, Y; Garnier, JM; Weber, C; Mandel, JL; Cancel, G; Abbas, N; Durr, A; Didierjean, O; Stevanin, G; Agid, Y; Brice, A			Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; TRINUCLEOTIDE CAG REPEAT; MACHADO-JOSEPH DISEASE; AGE-OF-ONSET; HUNTINGTONS-DISEASE; CHROMOSOME 3P12-P21.1; CLINICAL-FEATURES; MUSCULAR-ATROPHY; FMR1 GENE; INSTABILITY	Two forms of the neurodegenerative disorder spinocerebellar ataxia are known to be caused by the expansion of a CAG (polyglutamine) trinucleotide repeat. By screening cDNA expression libraries, using an antibody specific for polyglutamine repeats, we identified six novel genes containing CAG stretches. One of them is mutated in patients with spinocerebellar ataxia linked to chromosome 12q (SCA2). This gene shows ubiquitous expression and encodes a protein of unknown function. Normal SCA2 alleles (17 to 29 CAG repeats) contain one to three CAAs in the repeat. Mutated alleles (37 to 50 repeats) appear particularly unstable, upon both paternal and maternal transmissions. The sequence of three of them revealed pure CAG stretches. The steep inverse correlation between age of onset and CAG number suggests a higher sensitivity to polyglutamine length than in the other polyglutamine expansion diseases.	ULP, INSERM, CNRS, IGBMC, F-67404 ILLKIRCH GRAFFENSTADEN, STRASBOURG, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, FEDERAT NEUROL, F-75651 PARIS 13, FRANCE				SAUDOU, Frederic/L-3454-2014; Trottier, Yvon/H-8852-2016; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; brice, alexis/AAE-8275-2019	SAUDOU, Frederic/0000-0001-6107-1046; Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Yvert, Gael/0000-0003-1955-4786; Trottier, Yvon/0000-0001-7230-4810; Devys, Didier/0000-0001-9655-3512			ALLOTEY R, 1995, AM J HUM GENET, V57, P185; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BELAL S, 1994, NEUROLOGY, V44, P1423, DOI 10.1212/WNL.44.8.1423; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; BROHOLM J, 1994, NEUROLOGY, V44, P1533; BURK K, IN PRESS BRAIN; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Gastier JM, 1996, GENOMICS, V32, P75, DOI 10.1006/geno.1996.0078; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Gispert S, 1995, Am J Hum Genet, V57, P972; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IHARA T, 1994, JPN J HUM GENET, V39, P305, DOI 10.1007/BF01874049; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; IMBERT G, 1994, GENOMICS, V21, P667, DOI 10.1006/geno.1994.1335; JIANG JX, 1995, GENOMICS, V30, P91, DOI 10.1006/geno.1995.0015; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAUTER K, 1995, NATURE, V377, P321; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; Lezin A, 1996, HUM GENET, V97, P671; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Neri C, 1996, HUM MOL GENET, V5, P1001, DOI 10.1093/hmg/5.7.1001; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANEN NG, 1995, AM J HUM GENET, V57, P593; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; RIGGINS GJ, 1993, NAT GENET, V3, P273, DOI 10.1038/ng0393-273b; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Zoghbi HY, 1991, CURR NEUROL, V11, P121	62	724	736	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					285	291		10.1038/ng1196-285			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	WOS:A1996VQ14600022	8896557				2022-01-24	
J	Broccoli, D; Smogorzewska, A; Chong, L; deLange, T				Broccoli, D; Smogorzewska, A; Chong, L; deLange, T			Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2	NATURE GENETICS			English	Article							DNA-BINDING DOMAIN; SEQUENCE; COMPLEX; YEAST; RAP1	Human telomeres are composed of long arrays of TTAGGG repeats that form a nucleoprotein complex required for the protection and replication of chromosome ends. One component of human telomeres is the TTAGGG repeat binding factor 1 (TRF1), a ubiquitously expressed protein, related to the protooncogene Myb, that is present at telomeres throughout the cell cycle(1-6). Recent evidence has implicated TRF1 in the control of telomere length(7). TRF1 is proposed to be an inhibitor of telomerase, acting in cis to limit the elongation of individual chromosome ends. Here we report the cloning of TRF2, a distant homologue of TRF1 that carries a very similar Myb-related DNA-binding motif. Like TRF1, TRF2 was ubiquitously expressed, bound specifically to duplex TTAGGG repeats in vitro and localized to all human telomeres in metaphase chromosomes. TRF2 was shown to have an architecture similar to that of TRF1 in that it carries a C-terminal Myb motif and a large TRF1-related dimerization domain near its N terminus. However, the dimerization domain of TRF1 and TRF2 did not interact, suggesting that these proteins exist predominantly as homodimers. While having similar telomere binding activity and domain organization, TRF2 differed from TRF1 in that its N terminus was basic rather than acidic, and TRF2 was much more conserved than TRF1. The results indicate that the TTAGGG repeat arrays at the ends of human and mouse chromosomes bind to two related proteins. Because TRF1 and TRF2 showed significant differences, we suggest that these factors have distinct functions at telomeres.	ROCKEFELLER UNIV,NEW YORK,NY 10021				Smogorzewska, Agata/B-8891-2011; de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5 T32 GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007739] Funding Source: NIH RePORTER		Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Broccoli D, 1997, HUM MOL GENET, V6, P69, DOI 10.1093/hmg/6.1.69; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	19	723	747	1	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					231	235		10.1038/ng1097-231			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	WOS:A1997XZ55500036	9326950				2022-01-24	
J	PROETZEL, G; PAWLOWSKI, SA; WILES, MV; YIN, MY; BOIVIN, GP; HOWLES, PN; DING, JX; FERGUSON, MWJ; DOETSCHMAN, T				PROETZEL, G; PAWLOWSKI, SA; WILES, MV; YIN, MY; BOIVIN, GP; HOWLES, PN; DING, JX; FERGUSON, MWJ; DOETSCHMAN, T			TRANSFORMING GROWTH FACTOR-BETA-3 IS REQUIRED FOR SECONDARY PALATE FUSION	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSFORMATION; FACTOR-ALPHA-GENE; DIFFERENTIAL EXPRESSION; MEDIAL EDGE; FACTOR-BETA; CELL DIFFERENTIATION; MOUSE EMBRYO; CLEFT-PALATE; TGF BETA-1; CULTURE	Mice lacking IGF-beta 3 exhibit an incompletely penetrant failure of the palatal shelves to fuse leading to cleft palate. The defect appears to result from impaired adhesion of the apposing medial edge epithelia of the palatal shelves and subsequent elimination of the mid-line epithelial seam. No craniofacial abnormalities were observed. This result demonstrates that TGF-beta 3 affects palatal shelf fusion by an intrinsic, primary mechanism rather than by effects secondary to craniofacial defects.	UNIV CINCINNATI,COLL MED,DEPT MOLEC GENET BIOCHEM & MICROBIOL,CINCINNATI,OH 45267; UNIV CINCINNATI,COLL MED,DEPT PATHOL,CINCINNATI,OH 45267; BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND; UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER,LANCS,ENGLAND						EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD026471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL046826, P01HL041496] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL41496, HL46826] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD26471, R01 HD026471] Funding Source: Medline		ANSCHER MS, 1994, INT J RADIAT ONCOL, V30, P671, DOI 10.1016/0360-3016(92)90954-G; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BOIVIN GP, 1995, AM J PATHOL, V146, P276; Brown K S, 1980, Prog Clin Biol Res, V46, P77; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; CARETTE MJM, 1992, DEVELOPMENT, V114, P379; CARETTE MJM, 1991, DIFFERENTIATION, V47, P149, DOI 10.1111/j.1432-0436.1991.tb00233.x; CHAI Y, 1994, DEV BIOL, V162, P85, DOI 10.1006/dbio.1994.1069; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DANGELO M, 1994, J EXP ZOOL, V270, P189, DOI 10.1002/jez.1402700208; DIXON MJ, 1992, ARCH ORAL BIOL, V37, P395, DOI 10.1016/0003-9969(92)90024-3; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FERGUSON MWJ, 1994, NAT GENET, V6, P329, DOI 10.1038/ng0494-329; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; GEHRIS AL, 1992, DIFFERENTIATION, V49, P167, DOI 10.1111/j.1432-0436.1992.tb00664.x; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; GREENE RM, 1976, J EMBRYOL EXP MORPH, V36, P225; GRIFFITH CM, 1992, DEVELOPMENT, V116, P1087; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; KULKARNI AB, 1995, AM J PATHOL, V146, P264; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MORRISWIMAN J, 1992, ANAT RECORD, V234, P575, DOI 10.1002/ar.1092340413; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; PROETZEL G, 1994, THESIS U CINCINNATI, P1; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; ROBERTS AB, 1990, HDB EXPT PHARM PEPTI, P419; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; RUNYAN RB, 1992, MOL REPROD DEV, V32, P152, DOI 10.1002/mrd.1080320211; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SCHMID P, 1991, DEVELOPMENT, V111, P117; SHAH M, 1995, J CELL SCI, V108, P985; SHIANG R, 1993, AM J HUM GENET, V53, P836; SHULER CF, 1992, DEV BIOL, V154, P318, DOI 10.1016/0012-1606(92)90071-N; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; Wilson J.G., 1965, TERATOLOGY PRINCIPLE, P262	53	723	746	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					409	414		10.1038/ng1295-409			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	WOS:A1995TH62900018	7493021	Green Accepted			2022-01-24	
J	Rannala, B; Yang, ZH				Rannala, B; Yang, ZH			Bayes estimation of species divergence times and ancestral population sizes using DNA sequences from multiple loci	GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; INFERENCE; MIGRATION; HOMINOIDS; REGION; PHYLOGENY; TREES	The effective population sizes of ancestral as well as modern species are important parameters ill models of population genetics and human evolution. The commonly used method for estimating ancestral population sizes, based on counting mismatches between the species tree and the inferred gene trees, is highly biased as it ignores uncertainties in gene tree reconstruction. In this article, we develop a Bayes method for simultaneous estimation of the species divergence times and current and ancestral population sizes. The method uses DNA sequence data from multiple loci and extracts information about conflicts among gene tree topologies and coalescent times to estimate ancestral population sizes. The topology, of the species free is assumed known. A Markov chain Monte Carlo algorithm is implemented to integrate over uncertain gene trees and branch lengths (or coalescence times) at each locus as well as species divergence times. The method call handle any species tree and allows different numbers of sequences at different loci. We apply the method to published noncoding DNA sequences from the human and the great apes. There are strong correlations between posterior estimates of speciation times and ancestral population sizes. With the use of an informative prior for the human-chimpanzee divergence date, the population size of the common ancestor of the two species is estimated to be similar to20,000, with a 95% credibility interval (8000, 40,000). Our estimates, however, are affected by model assumptions as well as data quality. We suggest that reliable estimates have yet to await more data and more realistic models.	UCL, Dept Biol, Galton Lab, London WC1E 6BT, England; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada		Rannala, B (corresponding author), UCL, Dept Biol, Galton Lab, Darwin Bldg,Gower St, London WC1E 6BT, England.	z.yang@ucl.ac.uk	Yang, Ziheng/C-1358-2008; Rannala, Bruce/M-3188-2014	Rannala, Bruce/0000-0002-8355-9955	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG001988] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG 01988] Funding Source: Medline		Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Edwards SV, 2000, EVOLUTION, V54, P1839; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FU YX, 1994, GENETICS, V138, P1375; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hacia JG, 2001, TRENDS GENET, V17, P637, DOI 10.1016/S0168-9525(01)02494-5; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Jukes T. H., 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1016/B978-1-4832-3211-9.50009-7; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Makova KD, 2001, GENETICS, V158, P1253; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Rubin D.B., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Silverman B. W., 1986, DENSITY ESTIMATION S; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Swofford D.L., 1996, MOL SYSTEMATICS, P411; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; TAKAHATA N, 2002, DEV THEORETICAL POPU, P52; Wall JD, 2003, GENETICS, V163, P395; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson IJ, 1998, GENETICS, V150, P499; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; WU CI, 1991, GENETICS, V127, P429; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2002, GENETICS, V162, P1811; Yang ZH, 1997, GENET RES, V69, P111, DOI 10.1017/S001667239700270X; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197; [No title captured]	37	722	727	0	79	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	2003	164	4					1645	1656					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	720EF	WOS:000185248000036	12930768				2022-01-24	
J	IOANNOU, PA; AMEMIYA, CT; GARNES, J; KROISEL, PM; SHIZUYA, H; CHEN, C; BATZER, MA; DEJONG, PJ				IOANNOU, PA; AMEMIYA, CT; GARNES, J; KROISEL, PM; SHIZUYA, H; CHEN, C; BATZER, MA; DEJONG, PJ			A NEW BACTERIOPHAGE P1-DERIVED VECTOR FOR THE PROPAGATION OF LARGE HUMAN DNA FRAGMENTS	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; ESCHERICHIA-COLI; CLONING; LIBRARIES; REGION; CLONES; GENOME; INVITRO; MOUSE; HYBRIDIZATION	We have designed a P1 vector (pCYPAC-1) for the introduction of recombinant DNA into E coli using electroporation procedures. The new cloning system, P1-derived arteficial chromosomes (PACs), was used to establish an initial 15,000 clone library with an average insert size of 130-150 kilobase pairs (kb). No chimaerism has been observed in 34 clones, by fluorescence in situ hybridization. Similarly, no insert instability has been observed after extended culturing, for 20 clones. We conclude that the PAC cloning system will be useful in the mapping and detailed analysis of complex genomes.	ROSWELL PK CANC INST, DEPT HUMAN GENET, ELM & CARLTON ST, BUFFALO, NY 14263 USA; LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME L452, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94550 USA; CALTECH, DIV BIOL, PASADENA, CA 91125 USA								ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BALDINI A, 1992, GENOMICS, V14, P181, DOI 10.1016/S0888-7543(05)80303-9; BATES GP, 1992, NAT GENET, V1, P180, DOI 10.1038/ng0692-180; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURKE DT, 1991, METHOD ENZYMOL, V194, P251; CHARTIER FL, 1992, NAT GENET, V1, P132, DOI 10.1038/ng0592-132; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COLLINS J, 1978, P NATL ACAD SCI USA, V75, P4242, DOI 10.1073/pnas.75.9.4242; CRAIG AG, 1990, NUCLEIC ACIDS RES, V18, P2653; Dausset J, 1992, Behring Inst Mitt, P13; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FUSCOE JC, 1989, CYTOGENET CELL GENET, V50, P211, DOI 10.1159/000132762; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HARRISONLAVOIE KJ, 1989, GENOMICS, V5, P501, DOI 10.1016/0888-7543(89)90016-5; HOSODA F, 1990, NUCLEIC ACIDS RES, V11, P3863; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; KOPPES LJH, 1992, J BACTERIOL, V174, P2121, DOI 10.1128/JB.174.7.2121-2123.1992; KROISEL PM, 1994, CYTOGENET CELL GENET, V65, P97, DOI 10.1159/000133609; LARIN Z, 1990, GENET RES, V56, P203, DOI 10.1017/S0016672300035308; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEONARDO ED, 1990, BIO-TECHNOL, V8, P841, DOI 10.1038/nbt0990-841; MAIER E, 1992, NAT GENET, V1, P273, DOI 10.1038/ng0792-273; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; OLSEN AS, 1993, BIOTECHNIQUES, V14, P116; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; PIERCE JC, 1992, P NATL ACAD SCI USA, V89, P2056, DOI 10.1073/pnas.89.6.2056; RAO VB, 1992, GENE, V113, P25, DOI 10.1016/0378-1119(92)90666-D; SAMBROOK J, 1979, NUCLEIC ACIDS RES, V7, P1513; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; SHEDL A, 1993, NATURE, V362, P258; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; STERNBERG N, 1990, New Biologist, V2, P151; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; Vilageliu L., 1992, Techniques for the analysis of complex genomes., P93; YOKOBATA K, 1991, NUCLEIC ACIDS RES, V19, P403, DOI 10.1093/nar/19.2.403	46	722	743	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1994	6	1					84	89					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	WOS:A1994MQ17700019	8136839				2022-01-24	
J	Dostie, J; Richmond, TA; Arnaout, RA; Selzer, RR; Lee, WL; Honan, TA; Rubio, ED; Krumm, A; Lamb, J; Nusbaum, C; Green, RD; Dekker, J				Dostie, Josee; Richmond, Todd A.; Arnaout, Ramy A.; Selzer, Rebecca R.; Lee, William L.; Honan, Tracey A.; Rubio, Eric D.; Krumm, Anton; Lamb, Justin; Nusbaum, Chad; Green, Roland D.; Dekker, Job			Chromosome Conformation Capture Carbon Copy (5C): A massively parallel solution for mapping interactions between genomic elements	GENOME RESEARCH			English	Article							GLOBIN LOCUS REQUIRES; GENE-EXPRESSION; SPATIAL-ORGANIZATION; CONTROL REGION; BETA; DELETION; MOUSE; TRANSCRIPTION; PROMOTERS; LIGASE	Physical interactions between genetic elements located throughout the genome play important roles in gene regulation and can be identified with the Chromosome Conformation Capture (3C) methodology. 3C converts physical chromatin interactions into specific ligation products, which are quantified individually by PCR. Here we present a high-throughput 3C approach, 3C-Carbon Copy (5C), that employs microarrays or quantitative DNA sequencing using 454-technology as detection methods. We applied 5C to analyze a 400-kb region containing the human beta-globin locus and a 100-kb conserved gene desert region. We validated 5C by detection of several previously identified looping interactions in the beta-globin locus. We also identified a new looping interaction in K562 cells between the beta-globin Locus Control Region and the beta-delta-globin intergenic region. Interestingly, this region has been implicated in the control of developmental globin gene switching. 5C should be widely applicable for large-scale mapping of cis- and trans-interaction networks of genomic elements and for the study of higher-order chromosome structure.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Program Evolut Dynam, Cambridge, MA 02138 USA; Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98104 USA		Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Job.Dekker@umassmed.edu			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA109597, R01 CA109597] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG003143, HG003143, HG003129, R01 HG003129] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM078986, R01 GM078986-01, R01GM078986] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA109597] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003143, R01HG003129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM078986] Funding Source: NIH RePORTER		Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; Calzolari R, 1999, EMBO J, V18, P949, DOI 10.1093/emboj/18.4.949; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Chambeyron S, 2004, CURR OPIN CELL BIOL, V16, P256, DOI 10.1016/j.ceb.2004.03.004; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Li JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni163; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miele A., 2006, CURRENT PROTOCOLS MO; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; O'Neill D, 1999, P NATL ACAD SCI USA, V96, P349, DOI 10.1073/pnas.96.2.349; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	49	721	767	3	63	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2006	16	10					1299	1309		10.1101/gr.5571506			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	090OE	WOS:000240959800014	16954542	Green Published			2022-01-24	
J	Schadt, EE; Lamb, J; Yang, X; Zhu, J; Edwards, S; GuhaThakurta, D; Sieberts, SK; Monks, S; Reitman, M; Zhang, CS; Lum, PY; Leonardson, A; Thieringer, R; Metzger, JM; Yang, LM; Castle, J; Zhu, HY; Kash, SF; Drake, TA; Sachs, A; Lusis, AJ				Schadt, EE; Lamb, J; Yang, X; Zhu, J; Edwards, S; GuhaThakurta, D; Sieberts, SK; Monks, S; Reitman, M; Zhang, CS; Lum, PY; Leonardson, A; Thieringer, R; Metzger, JM; Yang, LM; Castle, J; Zhu, HY; Kash, SF; Drake, TA; Sachs, A; Lusis, AJ			An integrative genomics approach to infer causal associations between gene expression and disease	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; TRANSFORMING GROWTH FACTOR-BETA(1); SELECTIVE-INHIBITION; INSULIN SENSITIVITY; HYPERGLYCEMIC MICE; SERUM COMPLEMENT; MICROARRAYS; OBESITY; ACTIVATION; MARKERS	A key goal of biomedical research is to elucidate the complex network of gene interactions underlying complex traits such as common human diseases. Here we detail a multistep procedure for identifying potential key drivers of complex traits that integrates DNA- variation and gene- expression data with other complex trait data in segregating mouse populations. Ordering gene expression traits relative to one another and relative to other complex traits is achieved by systematically testing whether variations in DNA that lead to variations in relative transcript abundances statistically support an independent, causative or reactive function relative to the complex traits under consideration. We show that this approach can predict transcriptional responses to single gene- perturbation experiments using gene- expression data in the context of a segregating mouse population. We also demonstrate the utility of this approach by identifying and experimentally validating the involvement of three new genes in susceptibility to obesity.	Rosetta Inpharmat, Seattle, WA 98109 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA; Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA; Deltagen Inc, San Carlos, CA 94070 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA		Schadt, EE (corresponding author), Rosetta Inpharmat, Seattle, WA 98109 USA.	eric_schadt@merck.com	Pillay, Nischalan/F-9536-2012; Edwards, Stephen W/G-4482-2011; Califano, Andrea/F-7239-2012; Reitman, Marc/B-4448-2013; Longo, Kenneth A/A-5631-2010	Reitman, Marc/0000-0002-0426-9475; Edwards, Stephen/0000-0002-7985-111X	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01 HL028481, P01 HL030568, R01 HL094322, P01 HL028481-21A10010, P01 HL028481-21A1, P01 HL030568-220011, P01 HL030568-220009] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL030568, P01HL028481, R01HL094322] Funding Source: NIH RePORTER		Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344; Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Carlborg O, 2005, BIOINFORMATICS, V21, P2383, DOI 10.1093/bioinformatics/bti241; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Choy LN, 1996, OBES RES, V4, P521, DOI 10.1002/j.1550-8528.1996.tb00266.x; DePrimo SE, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-3; Drake TA, 2001, PHYSIOL GENOMICS, V5, P205, DOI 10.1152/physiolgenomics.2001.5.4.205; GHAZALPOUR A, IN PRESS GENOME BIOL; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; JIANG CJ, 1995, GENETICS, V140, P1111; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kao CH, 2002, GENETICS, V160, P1243; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Langfitt T W, 1981, Prog Neurol Surg, V10, P14, DOI 10.1159/000384767; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Miller A.J, 1990, SUBSET SELECTION REG; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pearl J, 2014, PROBABILISTIC REASON; Pomeroy C, 1997, CLIN EXP IMMUNOL, V108, P507, DOI 10.1046/j.1365-2249.1997.3921287.x; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Romano M, 2003, J CLIN ENDOCR METAB, V88, P5321, DOI 10.1210/jc.2003-030508; Rosmond R, 2003, HORM RES, V59, P191, DOI 10.1159/000069323; SAKAMOTO Y, 1986, AKAIKE INFORM CRITER, V0081; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHUPF N, 1983, J NEUROIMMUNOL, V5, P305, DOI 10.1016/0165-5728(83)90051-6; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waring JF, 2002, TOXICOLOGY, V181, P537, DOI 10.1016/S0300-483X(02)00477-8; Ylitalo K, 1997, ATHEROSCLEROSIS, V129, P271, DOI 10.1016/S0021-9150(96)06054-6; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeng ZB, 2000, GENETICS, V154, P299; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; [No title captured]	49	720	738	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					710	717		10.1038/ng1589			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	WOS:000230196400017	15965475	Green Accepted			2022-01-24	
J	CRANDALL, KA; TEMPLETON, AR				CRANDALL, KA; TEMPLETON, AR			EMPIRICAL TESTS OF SOME PREDICTIONS FROM COALESCENT THEORY WITH APPLICATIONS TO INTRASPECIFIC PHYLOGENY RECONSTRUCTION	GENETICS			English	Article							RESTRICTION-MAP VARIATION; ACHAETE-SCUTE REGION; DROSOPHILA-ANANASSAE POPULATIONS; MOLECULAR GENETIC-VARIATION; NATURAL-POPULATIONS; MITOCHONDRIAL-DNA; CENTROMERIC REGION; 2 POPULATIONS; X-CHROMOSOME; MELANOGASTER	Empirical data sets of intraspecific restriction site polymorphism in Drosophila have been gathered in order to test hypotheses derived from coalescent theory. Three main ideas are tested: (1) haplotype frequency in the sample contains information on the topological position of a given haplotype in a cladogram, (2) the frequency of a haplotype is related to the number of mutational connections to other haplotypes in the cladogram and (3) geographic location can be used to infer topological positioning of haplotypes in a cladogram. These relationships can then be used to better estimate intraspecific phylogenies in two ways: (1) rooting the phylogeny and (2) resolving ambiguities in a cladogram. This information will allow one to reduce the number of alternative phylogenies and incorporate the uncertainties involved in reconstructing intraspecific phylogenies into subsequent analyses that depend heavily on the topology of the tree.	WASHINGTON UNIV,DEPT MATH,ST LOUIS,MO 63130		CRANDALL, KA (corresponding author), WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130, USA.		Crandall, Keith A./H-2789-2019; Templeton, Alan R./F-5963-2011	Crandall, Keith A./0000-0002-0836-3389; Templeton, Alan/0000-0002-0167-845X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL039107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM031571] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 R01 HL39107] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM31571] Funding Source: Medline		AGUADE M, 1988, GENETICS, V119, P135; AGUADE M, 1989, MOL BIOL EVOL, V6, P123; AGUADE M, 1989, GENETICS, V122, P607; AQUADRO CF, 1988, GENETICS, V119, P875; AQUADRO CF, 1986, GENETICS, V114, P1165; AQUADRO CF, 1991, P NATL ACAD SCI USA, V88, P305, DOI 10.1073/pnas.88.1.305; BEECH RN, 1989, GENET RES, V53, P7, DOI 10.1017/S0016672300027804; BROWN AJL, 1983, P NATL ACAD SCI-BIOL, V80, P5350, DOI 10.1073/pnas.80.17.5350; DESALLE R, 1984, THESIS WASHINGTON U; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; EANES WF, 1989, MOL BIOL EVOL, V6, P384; EANES WF, 1989, MOL BIOL EVOL, V6, P492; EFRON B, 1982, CBMS REGIONAL C SERI, V38; EWENS WJ, 1990, MATH STAT DEV EVOLUT, P177; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; GAME AY, 1990, GENETICS, V126, P1021; GOLDING GB, 1987, GENET RES, V49, P71, DOI 10.1017/S0016672300026768; GRIFFITHS RC, 1987, J MATH BIOL, V25, P423, DOI 10.1007/BF00277166; GRIFFITHS RC, 1989, J MATH BIOL, V27, P667, DOI 10.1007/BF00276949; HALE LR, 1987, MOL BIOL EVOL, V4, P622; HEIN J, 1990, MATH BIOSCI, V98, P185, DOI 10.1016/0025-5564(90)90123-G; HOLLANDER M, 1973, NONPARAMETRIC STATIS; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; KELLY FP, 1977, ADV APPL PROBAB, V9, P197, DOI 10.2307/1426347; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; KREITMAN M, 1986, P NATL ACAD SCI USA, V83, P3562, DOI 10.1073/pnas.83.10.3562; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LANGE BW, 1990, GENETICS, V126, P921; LANGLEY CH, 1982, P NATL ACAD SCI-BIOL, V79, P5631, DOI 10.1073/pnas.79.18.5631; LANGLEY CH, 1988, GENETICS, V119, P619; LANGLEY CH, 1987, MOL BIOL EVOL, V4, P651; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; ROZAS J, 1991, MOL BIOL EVOL, V8, P202; SCHAEFFER SW, 1988, MOL BIOL EVOL, V5, P30; SLATKIN M, 1989, GENETICS, V123, P603; Sokal R.R., 1981, BIOMETRY; STEPHAN W, 1989, GENETICS, V121, P89; STEPHAN W, 1989, MOL BIOL EVOL, V6, P624; SWOFFORD DL, 1991, PAUP PHYLOGENETIC AN; TAKAHATA N, 1988, GENET RES, V52, P213, DOI 10.1017/S0016672300027683; TAMURA K, 1991, MOL BIOL EVOL, V8, P104; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Templeton A.R., 1983, STAT ANAL DNA SEQUEN, P151; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1992, GENETICS, V132, P619; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; WATTERSON GA, 1985, THEOR POPUL BIOL, V27, P298, DOI 10.1016/0040-5809(85)90003-6; WATTERSON GA, 1976, THEOR POPUL BIOL, V10, P239, DOI 10.1016/0040-5809(76)90018-6	48	720	752	0	24	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUL	1993	134	3					959	969					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ513	WOS:A1993LJ51300025	8349118				2022-01-24	
J	Groth, AC; Fish, M; Nusse, R; Calos, MP				Groth, AC; Fish, M; Nusse, R; Calos, MP			Construction of transgenic Drosophila by using the site-specific integrase from phage phi C31	GENETICS			English	Article							NONVIRAL GENETIC CORRECTION; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; EPIDERMOLYSIS-BULLOSA; GENOMIC INTEGRATION; DNA; MELANOGASTER; COPLACEMENT; EXPRESSION; CRE/LOXP	The phiC31 integrase functions efficiently in vitro and in Escherichia coli, yeast, and mammalian cells, mediating unidirectional site-specific recombination between its attB and attP recognition sites. Here we show that this site-specific integration system also functions efficiently in Drosophila melanogaster in cultured cells and in embryos. Intramolecular recombination in S2 cells on transfected plasmid DNA carrying the attB and attP recognition sites occurred at a frequency of 47%. In addition, several endogenous pseudo attP sites were identified in the fly genome that were recognized by the integrase and used as substrates for integration in S2 cells. Two lines of Drosophila were created by integrating an attP site into the genome with a P element. phiC31 integrase injected into embryos as mRNA functioned to promote integration of an attB-containing plasmid into the attP site, resulting in tip to 55% of fertile adults producing transgenic offspring. A total of 100% of these progeny carried a precise integration event at the genomic attP site. These experiments demonstrate the potential for precise genetic engineering of the Drosophila genome with the phiC31 integrase system and will likely benefit research in Drosciphila and other insects.	Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA		Calos, MP (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	calos@stanford.edu			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA09302] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL68112] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5 R01 GM60388] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R56HL068112, R01HL068112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060388] Funding Source: NIH RePORTER		Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; LEBKOWSKI JS, 1984, MOL CELL BIOL, V4, P1951, DOI 10.1128/MCB.4.10.1951; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Olivares EC, 2001, GENE, V278, P167, DOI 10.1016/S0378-1119(01)00711-9; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ortiz-Urda S, 2003, HUM GENE THER, V14, P923, DOI 10.1089/104303403765701204; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Siegal ML, 1996, GENETICS, V144, P715; Siegal ML, 2000, METH MOL B, V136, P487; SMITH JG, 1995, CHROMOSOMA, V103, P597; Spradling AC, 1999, GENETICS, V153, P135; Stoll SM, 2002, J BACTERIOL, V184, P3657, DOI 10.1128/JB.184.13.3657-3663.2002; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1	25	719	736	2	62	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2004	166	4					1775	1782		10.1534/genetics.166.4.1775			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820HH	WOS:000221377700016	15126397	Green Published, Bronze			2022-01-24	
J	HUMBERT, R; ADLER, DA; DISTECHE, CM; HASSETT, C; OMIECINSKI, CJ; FURLONG, CE				HUMBERT, R; ADLER, DA; DISTECHE, CM; HASSETT, C; OMIECINSKI, CJ; FURLONG, CE			THE MOLECULAR-BASIS OF THE HUMAN SERUM PARAOXONASE ACTIVITY POLYMORPHISM	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; LINKED DNA MARKERS; CHLORPYRIFOS-OXON; IDENTIFICATION; ARYLESTERASE; HYDROLYSIS; LINKAGE; PURIFICATION; LOCALIZATION; RABBIT	The organophosphate cholinesterase inhibitor paraoxon is hydrolysed by serum paraoxonase/arylesterase. A genetic polymorphism of paraoxonase (PON) activity which determines high versus low paraoxon hydrolysis in human populations, may determine sensitivity to parathion poisoning. We demonstrate that arginine at position 192 specifies high activity PON whereas a glutamine specifies the low activity variant. Allele-specific probes or restriction enzyme analysis of amplified DNA allow for the genotyping of individuals. PON maps to chromosome 7q21-22, proximal to the cystic fibrosis gene, in agreement with previous genetic linkage studies.	UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DANA PROGRAM ECOGENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ENVIRONM HLTH,SEATTLE,WA 98195						NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES004978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM032281] Funding Source: NIH RePORTER		ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BUTLER EG, 1985, DRUG METAB DISPOS, V13, P640; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Costa L. G., 1987, TOXICOLOGY PESTICIDE, P263; COSTA LG, 1990, TOXICOL APPL PHARM, V103, P66, DOI 10.1016/0041-008X(90)90263-T; DAVISON AN, 1955, BIOCHEM J, V61, P203, DOI 10.1042/bj0610203; DIGGLE WM, 1951, NATURE, V168, P998, DOI 10.1038/168998a0; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; EIBERG H, 1985, CLIN GENET, V28, P265; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; FURLONG CE, 1989, ANAL BIOCHEM, V180, P242, DOI 10.1016/0003-2697(89)90424-7; FURLONG CE, 1988, AM J HUM GENET, V43, P230; FURLONG CE, 1991, BIOCHEMISTRY-US, V30, P10133, DOI 10.1021/bi00106a009; GAGE JC, 1954, BIOCHEM J, V54, P426; GELDMACH.M, 1969, ARCH TOXIKOL, V25, P223; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; GELDMACHERVONMALLINCKRODT M, 1988, TOXICOL ENVIRON CHEM, V18, P79, DOI 10.1080/02772248809357310; GELDMACHERVONMALLINCKRODT M, 1987, TOXICOL ENVIRON CHEM, V14, P165, DOI 10.1080/02772248709357202; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; MACKNESS MI, 1983, BIOCHEM PHARMACOL, V32, P2291, DOI 10.1016/0006-2952(83)90175-2; MAIN AR, 1956, CAN J BIOCHEM PHYS, V34, P197; MARTH JD, 1986, P NATL ACAD SCI USA, V83, P7400, DOI 10.1073/pnas.83.19.7400; MCCOLLIS.SB, 1974, FOOD COSMET TOXICOL, V12, P45, DOI 10.1016/0015-6264(74)90321-6; MCELVEEN J, 1986, CLIN CHEM, V32, P671; MUELLER RF, 1983, AM J HUM GENET, V35, P393; ORTIGOZAFERADO J, 1984, AM J HUM GENET, V36, P295; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; POORE RE, 1972, TOXICOL APPL PHARM, V23, P759, DOI 10.1016/0041-008X(72)90117-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAHA N, 1991, CLIN GENET, V40, P277; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMIEGELOW K, 1986, CLIN GENET, V29, P374; SMOLEN A, 1991, DRUG METAB DISPOS, V19, P107; TSUI LC, 1986, AM J HUM GENET, V39, P720; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	47	719	747	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					73	76		10.1038/ng0193-73			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	WOS:A1993KF37200016	8098250				2022-01-24	
J	Breseghello, F; Sorrells, ME				Breseghello, F; Sorrells, ME			Association mapping of kernel size and milling quality in wheat (Triticum aestivum L.) cultivars	GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; SEQUENCE POLYMORPHISM; ORYZA-SATIVA; SSR MARKERS; GENOME; DIVERSITY; LOCI; SELECTION; PATTERNS	Association mapping is a method for detection of gene effects based on linkage disequilibrium (LD) that complements QTL analysis in the development of tools for molecular plant breeding. In this study, association snapping was performed on a selected sample of 95 cultivars of soft winter wheat. Population structure was estimated on the basis of 36 unlinked simple-sequence repeat (SSR) markers. The extent of LD was estimated on chromosomes 2D and part of 5A, relative to the LD observed among unlinked markers. Consistent LD on chromosome 2D was 1 cM, whereas in the centromeric region of 5A, LD extended for similar to 5 cM. Association of 62 SSR loci on chromosomes 2D, 5A, and 5B with kernel morphology and milling quality was analyzed through a mixed-effects model, where subpopulation was considered as a random factor and the marker tested was considered as a fixed factor. Permutations were used to adjust the threshold of significance for multiple testing within chromosomes. In agreement with previous QTL analysis, significant markers for kernel size were detected on the three chromosomes tested, and alleles potentially useful for selection were identified. Our results demonstrated that association snapping could complement and enhance previous QTL information for marker-assisted selection.	Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; Embrapa Rice & Beans, BR-75375 Santo Antonio De Goias, Go, Brazil		Sorrells, ME (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, 240 Emerson Hall, Ithaca, NY 14853 USA.	mes12@cornell.edu	Breseghello, Flavio/J-6768-2012				Andreas EL, 2002, ADV FLUID MECH SER, V33, P1; ARAGUMUGANATHAN K, 1991, PLANT MOL BIOL REP, V9, P208; Belkhir K., 1996, GENETIX 4 05 LOGICIE; Benzecri J. P, 1973, ANAL DONNEES; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Clark, 1997, PRINCIPLES POPULATIO; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Coventry SJ, 2003, AUST J AGR RES, V54, P1103, DOI 10.1071/AR02194; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Falush D, 2003, GENETICS, V164, P1567; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Garris AJ, 2003, GENETICS, V165, P759; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Guyomarc'h H, 2002, THEOR APPL GENET, V104, P1164, DOI 10.1007/s00122-001-0827-7; Hamblin MT, 2004, GENETICS, V167, P471, DOI 10.1534/genetics.167.1.471; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Jones LE, 2002, THEOR APPL GENET, V104, P1204, DOI 10.1007/s00122-002-0876-6; KENNEDY BW, 1992, J ANIM SCI, V70, P2000, DOI 10.2527/1992.7072000x; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Lu H, 2005, CROP SCI, V45, P66, DOI 10.2135/cropsci2005.0066; Lynch M, 1999, GENETICS, V152, P1753; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Matthews DE, 2003, NUCLEIC ACIDS RES, V31, P183, DOI 10.1093/nar/gkg058; McIntosh R. A., 1995, P 8 INT WHEAT GEN S, P1333; Neter J., 1996, APPL LINEAR STAT MOD; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pinheiro JC, 2004, MIXED EFFECTS MODELS; PRITCHARD J.K., 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski JA, 2002, PLANT SCI, V162, P329, DOI 10.1016/S0168-9452(01)00587-8; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Ritland K, 2000, MOL ECOL, V9, P1195, DOI 10.1046/j.1365-294x.2000.00971.x; Roder MS, 1998, GENETICS, V149, P2007; Roder MS, 2002, THEOR APPL GENET, V106, P67, DOI 10.1007/s00122-002-1061-7; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Simko I, 2004, THEOR APPL GENET, V108, P225, DOI 10.1007/s00122-003-1448-0; SLATKIN M, 1994, GENETICS, V137, P331; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Stachel M, 2000, THEOR APPL GENET, V100, P242, DOI 10.1007/s001220050032; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Xu YB, 2004, CROP SCI, V44, P1947, DOI 10.2135/cropsci2004.1947; YAMAZAKI WT, 1982, CEREAL CHEM, V59, P41; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhu YL, 2003, GENETICS, V163, P1123; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	57	718	842	1	159	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	2006	172	2					1165	1177		10.1534/genetics.105.044586			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	024ER	WOS:000236178800040	16079235	Green Published, Bronze			2022-01-24	
J	Tartaglia, M; Niemeyer, CM; Fragale, A; Song, XL; Buechner, J; Jung, A; Hahlen, K; Hasle, H; Licht, JD; Gelb, BD				Tartaglia, M; Niemeyer, CM; Fragale, A; Song, XL; Buechner, J; Jung, A; Hahlen, K; Hasle, H; Licht, JD; Gelb, BD			Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE SHP-2; NOONAN-SYNDROME	We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML. Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML). Functional analyses documented that the two most common mutations in PTPN11 associated with JMML caused a gain of function.	CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Ist Super Sanita, Lab Metab & Biochim Patol, I-00161 Rome, Italy; Univ Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; Ist Super Sanita, Lab Biol Cellulare, I-00161 Rome, Italy; Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; Sophia Childrens Univ Hosp, Rotterdam, Netherlands; Skejby Hosp, Dept Pediat, Aarhus, Denmark; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA		Gelb, BD (corresponding author), CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA.		Licht, Jonathan/L-4239-2019; Tartaglia, Marco/K-2955-2018; Fragale, Alessandra/K-1071-2016	Tartaglia, Marco/0000-0001-7736-9672; Fragale, Alessandra/0000-0002-0362-1983; Buechner, Jochen/0000-0001-5848-4501; Licht, Jonathan/0000-0002-3942-1369; Hasle, Henrik/0000-0003-3976-9231			BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; Emanuel PD, 1996, MOL MED TODAY, V2, P468, DOI 10.1016/1357-4310(96)10044-7; Fukuda M, 1997, J PEDIAT HEMATOL ONC, V19, P177, DOI 10.1097/00043426-199703000-00019; Hasle H, 1999, LEUKEMIA, V13, P376, DOI 10.1038/sj.leu.2401342; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847	10	718	747	0	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					148	150		10.1038/ng1156			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	WOS:000183200500018	12717436				2022-01-24	
J	Richards, M; Macaulay, V; Hickey, E; Vega, E; Sykes, B; Guida, V; Rengo, C; Sellitto, D; Cruciani, F; Kivisild, T; Villems, R; Thomas, M; Rychkov, S; Rychkov, O; Rychkov, Y; Golge, M; Dimitrov, D; Hill, E; Bradley, D; Romano, V; Cali, F; Vona, G; Demaine, A; Papiha, S; Triantaphyllidis, C; Stefanescu, G; Hatina, J; Belledi, M; Di Rienzo, A; Novelletto, A; Oppenheim, A; Norby, S; Al-Zaheri, N; Santachiara-Benerecetti, S; Scozzari, R; Torroni, A; Bandelt, HJ				Richards, M; Macaulay, V; Hickey, E; Vega, E; Sykes, B; Guida, V; Rengo, C; Sellitto, D; Cruciani, F; Kivisild, T; Villems, R; Thomas, M; Rychkov, S; Rychkov, O; Rychkov, Y; Golge, M; Dimitrov, D; Hill, E; Bradley, D; Romano, V; Cali, F; Vona, G; Demaine, A; Papiha, S; Triantaphyllidis, C; Stefanescu, G; Hatina, J; Belledi, M; Di Rienzo, A; Novelletto, A; Oppenheim, A; Norby, S; Al-Zaheri, N; Santachiara-Benerecetti, S; Scozzari, R; Torroni, A; Bandelt, HJ			Tracing European founder lineages in the near eastern mtDNA pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; AFRICAN POPULATIONS REVEALS; Y-CHROMOSOME POLYMORPHISMS; HUMAN-GENE-FREQUENCIES; D-LOOP; CONTROL-REGION; GEOGRAPHIC-VARIATION; NEOLITHIC LINEAGES; IBERIAN PENINSULA; SEQUENCE-ANALYSIS	Founder analysis is a method for analysis of nonrecombining DNA sequence data, with the aim of identification and dating of migrations into new territory. The method picks out founder sequence types in potential source populations and dates lineage clusters deriving from them in the settlement zone of interest. Here, using mtDNA, we apply the approach to the colonization of Europe, to estimate the proportion of modern lineages whose ancestors arrived during each major phase of settlement. To estimate the Palaeolithic and Neolithic contributions to European mtDNA diversity more accurately than was previously achievable, we have now extended the Near Eastern, European, and northern-Caucasus databases to 1,234, 2,804, and 208 samples, respectively. Both back-migration into the source population and recurrent mutation in the source and derived populations represent major obstacles to this approach. We have developed phylogenetic criteria to take account of both these factors, and we suggest a way to account for multiple dispersals of common sequence types. We conclude that (i) there has been substantial back-migration into the Near East, (ii) the majority of extant mtDNA lineages entered Europe in several waves during the Upper Palaeolithic, (iii) there was a founder effect or bottleneck associated with the Last Glacial Maximum, 20,000 years ago, from which derives the largest fraction of surviving lineages, and (iv) the immigrant Neolithic component is likely to comprise less than one-quarter of the mtDNA pool of modern Europeans.	Univ Oxford, Inst Mol Med, Oxford, England; Univ Oxford, Dept Stat, Oxford, England; UCL, Dept Biol, London, England; UCL, Ctr Genet Anthropol, Dept Anthropol, London, England; UCL, Dept Biol, London, England; Linnaean Soc London, London, England; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Med Legale, Rome, Italy; Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; Russian Acad Sci, Inst Gen Genet, Human Genet Lab, Moscow V71, Russia; Univ Kiel, Dept Physiol, Kiel, Germany; Trinity Coll Dublin, Dept Genet, Dublin, Ireland; Assoc Oasi Maria SS, Ist Ricovero & Cura, Carattere Sci Studio Ritardo Mentale & Involuzion, Troina, Italy; Univ Palermo, Dipartimento Biopatol & Metodol Biomed, Palermo, Italy; Univ Cagliari, Dipartimento Biol Sperimentale, Sezione Antropol, Cagliari, Italy; Univ Plymouth, Postgrad Med Sch, Plymouth PL4 8AA, Devon, England; Newcastle Univ, Dept Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; Inst Cercetari Biol, Iasi, Romania; Univ Pilsen, Fac Med, Inst Biol, Pilsen, Italy; Dipartimento Biol Evolut, Sezione Biol Umana, Parma, Italy; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel; Univ Copenhagen, Inst Forens Med, Lab Biol Anthropol, Copenhagen, Denmark; Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad, Iraq; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Urbino, Ist Biochim, I-61029 Urbino, Italy; Univ Hamburg, Fachbereich Math, Hamburg, Germany		Richards, M (corresponding author), Univ Huddersfield, Dept Chem & Biol Sci, Queensgate, Huddersfield HD1 3DH, W Yorkshire, England.	M.B.Richards@hud.ac.uk	Torroni, Antonio/E-1557-2011; Guida, Valentina/K-4517-2015; Kivisild, Toomas/P-5889-2017; Cali, Francesco/D-9178-2017; Al-Zahery, Nadia/AAV-5878-2020; Cruciani, Fulvio/G-6105-2012; Bradley, Daniel G/A-3240-2012; Thomas, Mark G/A-2219-2012	Torroni, Antonio/0000-0002-4163-4478; Guida, Valentina/0000-0003-3946-645X; Kivisild, Toomas/0000-0002-6297-7808; Cali, Francesco/0000-0001-8667-8223; Thomas, Mark G/0000-0002-2452-981X; Stefanescu, Gheorghe/0000-0002-6200-0992; Novelletto, Andrea/0000-0002-1146-7680; Hill, Emmeline/0000-0002-1805-2250; Cruciani, Fulvio/0000-0002-6900-024X; RICHARDS, MARTIN/0000-0003-3118-0967			Adams J, 1999, CURR ANTHROPOL, V40, P73, DOI 10.1086/515804; Ammerman Albert, 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BALLINGER SW, 1992, GENETICS, V130, P139; BANDELT HJ, 1995, GENETICS, V141, P743; Bar-Yosef O, 1998, CAMB ARCHAEOL J, V8, P141, DOI 10.1017/S0959774300001815; Barbujani G, 1998, AM J HUM GENET, V62, P488, DOI 10.1086/301719; Barker G., 1985, PREHISTORIC FARMING; Belledi M, 2000, EUR J HUM GENET, V8, P480, DOI 10.1038/sj.ejhg.5200443; Berger J.O., 1985, STAT DECISION THEORY; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BIETTI A, 1990, J WORLD PREHIST, V4, P95, DOI 10.1007/BF00974820; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; CHEN YS, 1995, AM J HUM GENET, V57, P133; Chikhi L, 1998, HUM BIOL, V70, P643; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DENNELL R, 1983, EUROPEAN ECONOMIC PR; Diamond JM, 1997, NATURE, V389, P544, DOI 10.1038/39184; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DOLUKHANOV P, 1994, ENV ETHNICITY ANCIEN; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Gamble C, 1999, PALAEOLITHIC SOC EUR; Gamble Clive S., 1986, PALAEOLITHIC SETTLEM; GILEAD I, 1991, J WORLD PREHIST, V5, P105, DOI 10.1007/BF00974677; Harris DR, 1996, ORIGINS SPREAD AGR P; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Henry DO, 1989, FORAGING AGR; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Housley R. A., 1997, P PREHISTORIC SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Jochim M, 1987, PLEISTOCENE OLD WORL, P317, DOI DOI 10.1007/978-1-4613-1817-020; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; KUHRT A, 1995, ANCIENT NEAR E, V1, P3000; Leighton R., 1999, SICILY HIST; LEWIS B, 1998, MULTIPLE IDENTIES MI; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Malyarchuk BA, 1999, ANN HUM GENET, V63, P489, DOI 10.1017/S0003480099007794; MELLARS PA, 1992, PHILOS T ROY SOC B, V337, P225, DOI 10.1098/rstb.1992.0100; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; OLSZEWSKI DI, 1994, CURR ANTHROPOL, V35, P68, DOI 10.1086/204242; Opdal SH, 1998, ACTA PAEDIATR, V87, P1039, DOI 10.1080/080352598750031347; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Passarino G, 1996, AM J HUM GENET, V59, P927; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Passarino G, 1992, Gene Geogr, V6, P139; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; PULT I, 1994, BIOL CHEM H-S, V375, P837; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Redgate Anne Elizabeth, 1998, ARMENIANS; Renfrew C, 1998, MEM CALIF ACAD SCI, P171; Richards M, 1998, AM J HUM GENET, V62, P491, DOI 10.1086/301733; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; SAILLARD J, IN PRESS HUM BIOL; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Semino O, 1996, AM J HUM GENET, V59, P964; SHERRATT A, 1994, OXFORD ILLUSTRATED P; Soffer O., 1987, PLEISTOCENE OLD WORL, P333; SOKAL RR, 1989, AM J PHYS ANTHROPOL, V80, P267, DOI 10.1002/ajpa.1330800302; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Straus Lawrence Guy, 1995, Evolutionary Anthropology, V4, P4, DOI 10.1002/evan.1360040103; SYKES B, 1995, AM J HUM GENET, V57, P1463; TEMPLETON AR, 1995, GENETICS, V140, P767; TERRELL JE, 1986, PREHISTORY PACIFIC H; THORPE IJ, 1996, ORIGINS AGR EUROPE; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Tubb J.N., 1998, CANAANITES; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WHITTLE A, 1996, EUROPE NEOLITHIC; Zilhao J, 1998, CURR ANTHROPOL, V39, P690, DOI 10.1086/204791; Zilhao J., 1993, J MEDITERR ARCHAEOL, V6, P5, DOI DOI 10.1558/JMEA.V6I1.5; ZVELEBIL M, 1989, ANTIQUITY, V63, P379, DOI 10.1017/S0003598X00076110; ZVELEBIL M, 1986, HUNTERS TRANSITION M, P00005	103	718	745	3	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1251	1276		10.1016/S0002-9297(07)62954-1			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	WOS:000165091600021	11032788	Bronze, Green Published			2022-01-24	
J	Suzuki, H; Gabrielson, E; Chen, W; Anbazhagan, R; van Engeland, M; Weijenberg, MP; Herman, JG; Baylin, SB				Suzuki, H; Gabrielson, E; Chen, W; Anbazhagan, R; van Engeland, M; Weijenberg, MP; Herman, JG; Baylin, SB			A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer	NATURE GENETICS			English	Article							METHYLATED CPG ISLAND; DIFFERENTIAL EXPRESSION; BETA-CATENIN; ANNEXIN-II; DNA; HYPERMETHYLATION; IDENTIFICATION; FAMILY; ASSAY; APC	Aberrant hypermethylation of gene promoters is a major mechanism associated with inactivation of tumor-suppressor genes in cancer. We previously showed this transcriptional silencing to be mediated by both methylation and histone deacetylase activity, with methylation being dominant. Here, we have used cDNA microarray analysis to screen for genes that are epigenetically silenced in human colorectal cancer. By screening over 10,000 genes, we show that our approach can identify a substantial number of genes with promoter hypermethylation in a given cancer; these are distinct from genes with unmethylated promoters, for which increased expression is produced by histone deacetylase inhibition alone. Many of the hypermethylated genes we identified have high potential for roles in tumorigenesis by virtue of their predicted function and chromosome position. We also identified a group of genes that are preferentially hypermethylated in colorectal cancer and gastric cancer. One of these genes, SFRP1, belongs to a gene family; we show that hypermethylation of four genes in this family occurs very frequently in colorectal cancer, providing for (i) a unique potential mechanism for loss of tumor-suppressor gene function and (ii) construction of a molecular marker panel that could detect virtually all colorectal cancer.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD USA; Univ Maastricht, Dept Pathol, Maastricht, Netherlands; Univ Maastricht, Dept Epidemiol, Maastricht, Netherlands; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA		Baylin, SB (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, 1650 Orleans St, Baltimore, MD 21231 USA.		van Engeland, Manon/A-7479-2009	van Engeland, Manon/0000-0002-7952-6843			Abu-Jawdeh G, 1999, LAB INVEST, V79, P439; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bachman KE, 1999, CANCER RES, V59, P798; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575; Chetcuti A, 2001, CANCER RES, V61, P6331; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Esteller M, 2001, CANCER RES, V61, P3225; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Frattini A, 1997, GENOMICS, V46, P167, DOI 10.1006/geno.1997.5006; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gonzalgo ML, 1997, CANCER RES, V57, P594; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Heston WDW, 1997, UROLOGY, V49, P104, DOI 10.1016/S0090-4295(97)00177-5; KUBE E, 1991, GENE, V102, P255, DOI 10.1016/0378-1119(91)90086-Q; MAKOSWALES M, 1995, NAT MED, V1, P570; Matsuo K, 2001, BLOOD, V97, P3205, DOI 10.1182/blood.V97.10.3205; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mimori-Kiyosue Y, 2001, J CELL BIOL, V154, P1105, DOI 10.1083/jcb.200106113; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Nishioka M, 2000, ONCOGENE, V19, P6251, DOI 10.1038/sj.onc.1204031; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Song CY, 2001, CANCER RES, V61, P3272; Strehl S, 1998, GENOMICS, V53, P81, DOI 10.1006/geno.1998.5467; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2000, CANCER RES, V60, P4044; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; White GRM, 1998, ONCOGENE, V17, P3513, DOI 10.1038/sj.onc.1202487; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	41	717	756	1	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					141	149		10.1038/ng892			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	WOS:000175903500009	11992124	Green Published			2022-01-24	
J	Michalakis, Y; Excoffier, L				Michalakis, Y; Excoffier, L			A generic estimation of population subdivision using distances between alleles with special reference for microsatellite loci	GENETICS			English	Article							F-STATISTICS; FLOW; DIFFERENTIATION	Several estimators of population differentiation have been proposed in the recent past to deal with various types of genetic markers (i.e., allozymes, nucleotide sequences, restriction fragment length polymorphisms, or microsatellites). We discuss the relationships among these estimators and show how a single analysis of variance framework can accomodate these qualitatively different data types.	UNIV GENEVA,DEPT ANTHROPOL & ECOL,GENET & BIOMETRY LAB,CH-1211 GENEVA 24,SWITZERLAND		Michalakis, Y (corresponding author), UNIV PARIS 06,CNRS URA 258,ECOL LAB,7 QUAI ST BERNARD,F-75252 PARIS,FRANCE.		Excoffier, Laurent/D-3498-2013	Excoffier, Laurent/0000-0002-7507-6494; Michalakis, Yannis/0000-0003-1929-0848			CHAKRABORTY R, 1982, GENET RES, V39, P303, DOI 10.1017/S0016672300020978; Chakraborty R, 1991, HDB STATISTICS, V8, P203; COCKERHAM CC, 1993, EVOLUTION, V47, P855, DOI [10.1111/j.1558-5646.1993.tb01239.x, 10.2307/2410189]; COCKERHAM CC, 1973, GENETICS, V74, P679; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; EXCOFFIER L, 1992, GENETICS, V131, P479; HUDSON RR, 1992, GENETICS, V132, P583; LONG JC, 1986, GENETICS, V112, P629; LONG JC, 1995, AM J HUM GENET, V56, P799; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; RICHARDSON RH, 1976, BIOCHEM GENET, V14, P447, DOI 10.1007/BF00486126; RICHARDSON RH, 1977, GENETICS, V85, P141; SLATKIN M, 1995, GENETICS, V139, P457; TAKAHATA N, 1985, GENETICS, V109, P441; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	17	714	731	0	40	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAR	1996	142	3					1061	1064					4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TX455	WOS:A1996TX45500037	8849912				2022-01-24	
J	Boetzer, M; Pirovano, W				Boetzer, Marten; Pirovano, Walter			Toward almost closed genomes with GapFiller	GENOME BIOLOGY			English	Article							PAIRED READS; SEQUENCE; ASSEMBLIES; ALGORITHMS; ALIGNMENT	De novo assembly is a commonly used application of next-generation sequencing experiments. The ultimate goal is to puzzle millions of reads into one complete genome, although draft assemblies usually result in a number of gapped scaffold sequences. In this paper we propose an automated strategy, called GapFiller, to reliably close gaps within scaffolds using paired reads. The method shows good results on both bacterial and eukaryotic datasets, allowing only few errors. As a consequence, the amount of additional wetlab work needed to close a genome is drastically reduced. The software is available at http://www.baseclear.com/bioinformatics-tools/.	[Boetzer, Marten; Pirovano, Walter] BaseClear BV, NL-2333 CC Leiden, Netherlands		Pirovano, W (corresponding author), BaseClear BV, Einsteinweg 5, NL-2333 CC Leiden, Netherlands.	walter.pirovano@baseclear.com		Pirovano, Walter/0000-0002-2717-4735	WBSO [SO201101, SO201209]	This research was partially funded by the WBSO (BaseClear grants SO201101 and SO201209).	Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	11	713	723	1	41	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2012	13	6							R56	10.1186/gb-2012-13-6-r56			9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	002QD	WOS:000308546300010	22731987	Green Published, hybrid	Y	N	2022-01-24	
J	Laurent, L; Wong, E; Li, G; Huynh, T; Tsirigos, A; Ong, CT; Low, HM; Sung, KWK; Rigoutsos, I; Loring, J; Wei, CL				Laurent, Louise; Wong, Eleanor; Li, Guoliang; Huynh, Tien; Tsirigos, Aristotelis; Ong, Chin Thing; Low, Hwee Meng; Sung, Ken Wing Kin; Rigoutsos, Isidore; Loring, Jeanne; Wei, Chia-Lin			Dynamic changes in the human methylome during differentiation	GENOME RESEARCH			English	Article							EMBRYONIC STEM-CELLS; NON-CPG METHYLATION; DNA METHYLATION; MAMMALIAN DEVELOPMENT; HUMAN GENOME; CHROMATIN; GENE; TRANSCRIPTION; REVEALS; BINDING	DNA methylation is a critical epigenetic regulator in mammalian development. Here, we present a whole-genome comparative view of DNA methylation using bisulfite sequencing of three cultured cell types representing progressive stages of differentiation: human embryonic stem cells (hESCs), a fibroblastic differentiated derivative of the hESCs, and neonatal fibroblasts. As a reference, we compared our maps with a methylome map of a fully differentiated adult cell type, mature peripheral blood mononuclear cells (monocytes). We observed many notable common and cell-type-specific features among all cell types. Promoter hypomethylation (both CG and CA) and higher levels of gene body methylation were positively correlated with transcription in all cell types. Exons were more highly methylated than introns, and sharp transitions of methylation occurred at exon-intron boundaries, suggesting a role for differential methylation in transcript splicing. Developmental stage was reflected in both the level of global methylation and extent of non-CpG methylation, with hESC highest, fibroblasts intermediate, and monocytes lowest. Differentiation-associated differential methylation profiles were observed for developmentally regulated genes, including the HOX clusters, other homeobox transcription factors, and pluripotence-associated genes such as POU5F1, TCF3, and KLF4. Our results highlight the value of high-resolution methylation maps, in conjunction with other systems-level analyses, for investigation of previously undetectable developmental regulatory mechanisms.	[Huynh, Tien; Tsirigos, Aristotelis; Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; [Laurent, Louise] Univ Calif San Diego, Med Ctr, Dept Reprod Med, San Diego, CA 92103 USA; [Laurent, Louise; Loring, Jeanne] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Wong, Eleanor; Ong, Chin Thing; Low, Hwee Meng; Wei, Chia-Lin] Genome Inst Singapore, Genome Technol & Biol Grp, Singapore 138672, Singapore; [Wong, Eleanor; Wei, Chia-Lin] Natl Univ Singapore, Dept Biol Sci, Singapore 119077, Singapore; [Sung, Ken Wing Kin] Natl Univ Singapore, Sch Comp, Dept Comp Sci, Singapore 119077, Singapore		Rigoutsos, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA.	rigoutso@us.ibm.com; jloring@scripps.edu; weicl@gis.a-star.edu.sg	Loring, Jeanne F/A-1620-2011; Rigoutsos, Isidore/C-5381-2012; Li, Guoliang/D-8014-2012	Loring, Jeanne F/0000-0001-6226-9767; Li, Guoliang/0000-0003-1601-6640; Laurent, Louise/0000-0002-2095-7534; Rigoutsos, Isidore/0000-0003-1529-8631; Wong, Eleanor/0000-0001-7094-7679; Sung, Wing-Kin/0000-0001-7806-7086; Tsirigos, Aristotelis/0000-0002-7512-8477	A*STAR of SingaporeAgency for Science Technology & Research (ASTAR); NIH ENCODEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HG004456-01, R01HG003521-01, 1U54HG004557-01]; CIRMCalifornia Institute for Regenerative Medicine [CL1-00502-1, RT1-1108, TR1-01250]; Esther B. O'Keeffe Foundation; NICHD Career Development AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004456, R01HG003521, U54HG004557] Funding Source: NIH RePORTER	We thank Jun Wang and Yingrui Li from the Beijing Genome Institute for mapping assistance and for sharing their unpublished monocyte methylome map for use as an adult cell reference standard. We thank Candace Lynch of TSRI and the Genome Technology and Biology Group at the Genome Institute of Singapore for technical support, and A. Shahab and C. S. Chen for computing support. We also thank Courtney Harper from Illumina for sequencing support, and Yubo Zheng for performing the GO analysis. Funding for this work was provided by A*STAR of Singapore (C. L. W.), NIH ENCODE grants (R01 HG004456-01, R01HG003521-01, and 1U54HG004557-01) (C. L. W.), CIRM grants (CL1-00502-1, RT1-1108, and TR1-01250) (J. FL.), the Esther B. O'Keeffe Foundation (J. F. L.), and an NICHD Career Development Award (L. C. L.). David Barker and Franz-Josef Mueller provided critical comments on the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Custodio N, 2007, J CELL BIOL, V179, P199, DOI 10.1083/jcb.200612109; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gonzalez Rodolfo, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c05s4; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Lyko F, 2000, MECH DEVELOP, V95, P215, DOI 10.1016/S0925-4773(00)00325-7; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	44	712	728	0	51	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	MAR	2010	20	3					320	331		10.1101/gr.101907.109			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	563JJ	WOS:000275124600004	20133333	Green Published, Bronze			2022-01-24	
J	Mestdagh, P; Van Vlierberghe, P; De Weer, A; Muth, D; Westermann, F; Speleman, F; Vandesompele, J				Mestdagh, Pieter; Van Vlierberghe, Pieter; De Weer, An; Muth, Daniel; Westermann, Frank; Speleman, Frank; Vandesompele, Jo			A novel and universal method for microRNA RT-qPCR data normalization	GENOME BIOLOGY			English	Article							GENE-EXPRESSION; REFERENCE RNA; PCR; PATTERNS; DIFFERENTIATION; QUANTIFICATION; NEUROBLASTOMA; POLYCISTRON; GUIDELINES; SYSTEM	Gene expression analysis of microRNA molecules is becoming increasingly important. In this study we assess the use of the mean expression value of all expressed microRNAs in a given sample as a normalization factor for microRNA real-time quantitative PCR data and compare its performance to the currently adopted approach. We demonstrate that the mean expression value outperforms the current normalization strategy in terms of better reduction of technical variation and more accurate appreciation of biological changes.	[Mestdagh, Pieter; Van Vlierberghe, Pieter; De Weer, An; Speleman, Frank; Vandesompele, Jo] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Muth, Daniel; Westermann, Frank] German Canc Res Ctr, Dept Tumour Genet, D-6900 Heidelberg, Germany		Vandesompele, J (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Pintelaan 185, B-9000 Ghent, Belgium.	Joke.Vandesompele@UGent.be	Westermann, Frank/F-7509-2013; Vandesompele, Jo/W-3411-2018; speleman, frank/AAR-5184-2020; Van Vlierberghe, Pieter/G-8894-2013	Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; Van Vlierberghe, Pieter/0000-0001-9063-7205; Mestdagh, Pieter/0000-0001-7821-9684	Kinderkankerfonds; Ghent University Research Fund (BOF)Ghent University [01D31406]	The authors gratefully acknowledge Applied Biosystems for providing prerelease access to the Megaplex and PreAmp based miRNA profiling technology, Dr Y Chen and Dr R Stallings for providing their miRNA RT-qPCR dataset. This work was supported by Kinderkankerfonds (a nonprofit childhood cancer foundation under Belgian law) and the Ghent University Research Fund (BOF) [01D31406 to PM].	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Castoldi M, 2008, NAT PROTOC, V3, P321, DOI 10.1038/nprot.2008.4; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; *MIQE, MIQE GUID; *MYCNOT, MYCNOT DAT; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sarkar D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn932; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Sioud M, 2004, BIOTECHNIQUES, V37, P574, DOI 10.2144/04374ST01; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Smith RD, 2003, BIOTECHNIQUES, V34, P88, DOI 10.2144/03341st05; Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; WORKMAN C, 2002, GENOME BIOL, V0003; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309	46	712	724	4	92	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2009	10	6							R64	10.1186/gb-2009-10-6-r64			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	465RK	WOS:000267604300014	19531210	hybrid, Green Published			2022-01-24	
J	Kawaguchi, Y; Cooper, B; Gannon, M; Ray, M; MacDonald, RJ; Wright, CVE				Kawaguchi, Y; Cooper, B; Gannon, M; Ray, M; MacDonald, RJ; Wright, CVE			The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors	NATURE GENETICS			English	Article							CRE-MEDIATED RECOMBINATION; DIFFERENTIATION; GENE; CELLS; EXOCRINE; PROTEIN; PDX-1; P48; EXPRESSION; PHENOTYPE	Pancreas development begins with the formation of buds at specific sites in the embryonic foregut endoderm. We used recombination-based lineage tracing in vivo to show that Ptf1a (also known as PTF1-p48) is expressed at these early stages in the progenitors of pancreatic ducts, exocrine and endocrine cells, rather than being an exocrine-specific gene as previously described. Moreover, inactivation of Ptf1a switches the character of pancreatic progenitors such that their progeny proliferate in and adopt the normal fates of duodenal epithelium, including its stem-cell compartment. Consistent with the proposal that Ptf1a supports the specification of precursors of all three pancreatic cell types, transgene-based expression of Pdx1, a gene essential to pancreas formation, from Ptf1a cis-regulatory sequences restores pancreas tissue to Pdx1-null mice that otherwise lack mature exocrine and endocrine cells because of an early arrest in organogenesis. These experiments provide evidence that Ptf1a expression is specifically connected to the acquisition of pancreatic fate by undifferentiated foregut endoderm.	Vanderbilt Univ, Sch Med, Vanderbilt Dev Biol Program, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med & Mol Physiol & Biophys, Nashville, TN 37232 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX USA		Wright, CVE (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Dev Biol Program, 1161 21st Ave S, Nashville, TN 37232 USA.		Gannon, Maureen A/F-9060-2012; MacDonald, Ray/AAA-1290-2022				Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; GU G, 2000, DEVELOPMENT, V129, P2447; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HOGAN B, 1994, MANIPUALTING MOUSE E; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Li H, 2001, DEV BIOL, V240, P247, DOI 10.1006/dbio.2001.0440; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; MACDONALD RJ, 1977, J BIOL CHEM, V252, P5522; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Offield MF, 1996, DEVELOPMENT, V122, P983; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Sasaki H, 1996, GENES CELLS, V1, P59, DOI 10.1046/j.1365-2443.1996.04004.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3	26	712	721	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					128	134		10.1038/ng959			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	WOS:000177714900011	12185368				2022-01-24	
J	Wu, KJ; Grandori, C; Amacker, M; Simon-Vermot, N; Polack, A; Lingner, J; Dalla-Favera, R				Wu, KJ; Grandori, C; Amacker, M; Simon-Vermot, N; Polack, A; Lingner, J; Dalla-Favera, R			Direct activation of TERT transcription by c-MYC	NATURE GENETICS			English	Article							TELOMERASE ACTIVITY; CATALYTIC SUBUNIT; CELL-PROLIFERATION; ESTROGEN-RECEPTOR; GENE; PROTEINS; DIFFERENTIATION; SENESCENCE; MAX	The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation(1). Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis(2). The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified(3). Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length(4-6). c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase(7-9) (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase(10,11). TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells(1,9,12,13), and can both induce immortalization when constitutively expressed in transfected cells(2,10,11). Consistent with the recently reported association between MYC overexpression and induction of telomerase activity(14), we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.	Columbia Univ, Dept Pathol, New York, NY 10027 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; GSF Munich, Natl Res Inst Environm & Hlth, Inst Clin Mol Biol & Tumor Gent, D-81377 Munich, Germany		Dalla-Favera, R (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10027 USA.	rd10@columbia.edu	Wu, Kou-Juey/P-4654-2015	Lingner, Joachim/0000-0002-2853-5803	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA20525, CA37165, CA75125-01] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA037165, R29CA075125, R01CA020525, R37CA020525] Funding Source: NIH RePORTER		AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; KEMPKES B, 1995, EMBO J, V14, P88, DOI 10.1002/j.1460-2075.1995.tb06978.x; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LARSSON LG, 1988, P NATL ACAD SCI USA, V85, P2638, DOI 10.1073/pnas.85.8.2638; Lingner J, 1998, CURR OPIN GENET DEV, V8, P226, DOI 10.1016/S0959-437X(98)80145-7; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Pan CG, 1997, EXP CELL RES, V231, P346, DOI 10.1006/excr.1997.3475; Polack A, 1996, P NATL ACAD SCI USA, V93, P10411, DOI 10.1073/pnas.93.19.10411; Ramakrishnan S, 1998, CANCER RES, V58, P622; SASSON S, 1991, PATHOL BIOL, V39, P59; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; WRIGHT WE, 1995, TRENDS CELL BIOL, V5, P293, DOI 10.1016/S0962-8924(00)89044-3; WU KJ, IN PRESS SCIENCE	30	712	762	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1999	21	2					220	224		10.1038/6010			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	WOS:000078399500028	9988278				2022-01-24	
J	Bell, DM; Leung, KKH; Wheatley, SC; Ng, LJ; Zhou, S; Ling, KW; Sham, MH; Koopman, P; Tam, PPL; Cheah, KSE				Bell, DM; Leung, KKH; Wheatley, SC; Ng, LJ; Zhou, S; Ling, KW; Sham, MH; Koopman, P; Tam, PPL; Cheah, KSE			SOX9 directly regulates the type-II collagen gene	NATURE GENETICS			English	Article							SRY-RELATED GENE; CHONDROCYTE EXPRESSION; ACTIVATION DOMAIN; TRANSGENIC MICE; COL2A1 GENE; BINDING; MOUSE; ENHANCER; MUTATIONS; PROTEIN	Mutations in human SOX9 are associated with campomelic dysplasia (CD), characterised by skeletal malformation and XY sex reversal(1-3). During chondrogenesis in the mouse, Sox9 is coexpressed with Col2a1, the gene encoding type-II collagen, the major cartilage matrix protein(4). Col2a1 is therefore a candidate regulatory target of SOX9. Regulatory sequences required for chondrocyte-specific expression of the type-II collagen gene have been localized to conserved sequences in the first intron in rats, mice and humans(5-8). We show here that SOX9 protein binds specifically to sequences in the first intron of human COL2A1, Mutation of these sequences abolishes SOX9 binding and chondrocyte-specific expression of a COL2A1-driven reporter gene (COL2A1-lacZ) in transgenic mice. Furthermore, ectopic expression of Sox9 trans-activates both a COL2A1-driven reporter gene and the endogenous Col2a1 gene in transgenic mice. These results demonstrate that COL2A1 expression is directly regulated by SOX9 protein in vivo and implicate abnormal regulation of COL2A1 during chondrogenesis as a cause of the skeletal abnormalities associated with campomelic dysplasia.	UNIV HONG KONG,DEPT BIOCHEM,HONG KONG,HONG KONG; UNIV QUEENSLAND,CTR CELLULAR & MOL BIOL,BRISBANE,QLD 4072,AUSTRALIA; UNIV QUEENSLAND,DEPT ANAT SCI,BRISBANE,QLD 4072,AUSTRALIA; CHILDRENS MED RES INST,WENTWORTHVILLE 2145,AUSTRALIA				Koopman, Peter A/C-9416-2009; Sham, Mai Har/C-4387-2009; Cheah, Kathryn/C-4222-2009; Leung, Keith/C-4491-2009; Sham, Mai Har/AAX-3781-2020	Koopman, Peter A/0000-0001-6939-0914; Sham, Mai Har/0000-0003-1179-7839; Bell, Donald/0000-0002-3788-1580			CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HOSKING BM, 1995, NUCLEIC ACIDS RES, V23, P2626, DOI 10.1093/nar/23.14.2626; KAMACHI YS, 1995, EMBO J, V14, P1310; KANAI Y, 1996, J CELL BIOL, V133, P1; Kent J, 1996, DEVELOPMENT, V122, P2813; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; NG LJ, 1993, DEV BIOL, V159, P403, DOI 10.1006/dbio.1993.1251; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nonchev S, 1996, DEVELOPMENT, V122, P543; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; RITVANIEMI P, 1995, ARTHRITIS RHEUM, V38, P999, DOI 10.1002/art.1780380717; SAVAGNER P, 1995, DNA CELL BIOL, V14, P501, DOI 10.1089/dna.1995.14.501; Schafer AJ, 1996, ANN NY ACAD SCI, V785, P137, DOI 10.1111/j.1749-6632.1996.tb56252.x; SEGHATOLESLAMI MR, 1994, MATRIX BIOL, V14, P753; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; WAGNER T, 1994, CELL, V79, P111; WANG LQ, 1991, J BIOL CHEM, V266, P19878; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; ZHOU G, 1995, J CELL SCI, V108, P3677	30	711	740	4	45	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					174	178		10.1038/ng0697-174			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	WOS:A1997XB54300018	9171829				2022-01-24	
J	Parkhill, J; Sebaihia, M; Preston, A; Murphy, LD; Thomson, N; Harris, DE; Holden, MTG; Churcher, CM; Bentley, SD; Mungall, KL; Cerdeno-Tarraga, AM; Temple, L; James, K; Harris, B; Quail, MA; Achtman, M; Atkin, R; Baker, S; Basham, D; Bason, N; Cherevach, I; Chillingworth, T; Collins, M; Cronin, A; Davis, P; Doggett, J; Feltwell, T; Goble, A; Hamlin, N; Hauser, H; Holroyd, S; Jagels, K; Leather, S; Moule, S; Norberczak, H; O'Neil, S; Ormond, D; Price, C; Rabbinowitsch, E; Rutter, S; Sanders, M; Saunders, D; Seeger, K; Sharp, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Unwin, L; Whitehead, S; Barrell, BG; Maskell, DJ				Parkhill, J; Sebaihia, M; Preston, A; Murphy, LD; Thomson, N; Harris, DE; Holden, MTG; Churcher, CM; Bentley, SD; Mungall, KL; Cerdeno-Tarraga, AM; Temple, L; James, K; Harris, B; Quail, MA; Achtman, M; Atkin, R; Baker, S; Basham, D; Bason, N; Cherevach, I; Chillingworth, T; Collins, M; Cronin, A; Davis, P; Doggett, J; Feltwell, T; Goble, A; Hamlin, N; Hauser, H; Holroyd, S; Jagels, K; Leather, S; Moule, S; Norberczak, H; O'Neil, S; Ormond, D; Price, C; Rabbinowitsch, E; Rutter, S; Sanders, M; Saunders, D; Seeger, K; Sharp, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Unwin, L; Whitehead, S; Barrell, BG; Maskell, DJ			Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica	NATURE GENETICS			English	Article							III SECRETION; FILAMENTOUS HEMAGGLUTININ; GENE; VIRULENCE; TOXIN; PATHOGENICITY; ADHERENCE; PROMOTER; BACTERIA; CLONING	Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica are closely related Gram-negative beta-proteobacteria that colonize the respiratory tracts of mammals. B. pertussis is a strict human pathogen of recent evolutionary origin and is the primary etiologic agent of whooping cough. B. parapertussis can also cause whooping cough, and B. bronchiseptica causes chronic respiratory infections in a wide range of animals. We sequenced the genomes of B. bronchiseptica RB50 (5,338,400 bp; 5,007 predicted genes), B. parapertussis 12822 (4,773,551 bp; 4,404 genes) and B. pertussis Tohama I (4,086,186 bp; 3,816 genes). Our analysis indicates that B. parapertussis and B. pertussis are independent derivatives of B. bronchiseptica-like ancestors. During the evolution of these two host-restricted species there was large-scale gene loss and inactivation; host adaptation seems to be a consequence of loss, not gain, of function, and differences in virulence may be related to loss of regulatory or control functions.	Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Clin Vet Med, Cambridge CB3 0ES, England; Drew Univ, Madison, NJ 07940 USA; Max Planck Inst Infekt Biol, Dept Biol Mol, D-10117 Berlin, Germany		Parkhill, J (corresponding author), Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk; djm47@cam.ac.uk	Sebaihia, Mohammed/AAF-6589-2019; Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014; Parkhill, Julian/G-4703-2011; Thomson, Nicholas/P-5988-2014	Sebaihia, Mohammed/0000-0002-3324-3346; Holden, Matthew TG/0000-0002-4958-2166; Parkhill, Julian/0000-0002-7069-5958; Murphy, Lee/0000-0001-6467-7449; Davis, Paul/0000-0001-5545-0824; Thomson, Nicholas/0000-0002-4432-8505; Achtman, Mark/0000-0001-6815-0070; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Baker, Stephen/0000-0003-1308-5755; Preston, Andrew/0000-0002-1489-280X			ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; Brockmeier SL, 2002, INFECT IMMUN, V70, P481, DOI 10.1128/IAI.70.2.481-490.2002; Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259; Cotter PA, 2001, PRINCIPLES BACTERIAL, P619; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Coutte L, 2001, EMBO J, V20, P5040, DOI 10.1093/emboj/20.18.5040; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; Foreman-Wykert AK, 2003, TRENDS MICROBIOL, V11, P105, DOI 10.1016/S0966-842X(03)00007-6; FROSCH M, 1991, MOL MICROBIOL, V5, P1251, DOI 10.1111/j.1365-2958.1991.tb01899.x; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Jacob-Dubuisson F, 2000, MICROBIOL-SGM, V146, P1211, DOI 10.1099/00221287-146-5-1211; Kania SA, 2000, GENE, V256, P149, DOI 10.1016/S0378-1119(00)00360-7; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; KUWANO A, 1992, J VET MED SCI, V54, P1057, DOI 10.1292/jvms.54.1057; LIVEY I, 1987, MOL MICROBIOL, V1, P203, DOI 10.1111/j.1365-2958.1987.tb00513.x; Mackiewicz P, 2001, GENOME BIOL, V2; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; MOOI FR, 1990, FEMS MICROBIOL LETT, V66, P327, DOI 10.1016/0378-1097(90)90307-C; MOORE CH, 1995, J BACTERIOL, V177, P1116, DOI 10.1128/jb.177.4.1116-1118.1995; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; NEI M, 1986, MOL BIOL EVOL, V3, P418; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PEDRONI P, 1988, MOL MICROBIOL, V2, P539, DOI 10.1111/j.1365-2958.1988.tb00061.x; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J.J., 2001, MOL CLONING LAB MANU, V3; STIBITZ S, 1992, J BACTERIOL, V174, P7770, DOI 10.1128/JB.174.23.7770-7777.1992; Stibitz S, 1999, J BACTERIOL, V181, P5512, DOI 10.1128/JB.181.17.5512-5515.1999; Stockbauer KE, 2003, CELL MICROBIOL, V5, P123, DOI 10.1046/j.1462-5822.2003.00260.x; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; TUOMANEN E, 1988, J EXP MED, V168, P267, DOI 10.1084/jem.168.1.267; TUOMANEN EI, 1983, INFECT IMMUN, V42, P692, DOI 10.1128/IAI.42.2.692-695.1983; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; Vinogradov E, 2000, EUR J BIOCHEM, V267, P7230, DOI 10.1046/j.1432-1327.2000.01835.x; WEISS AA, 1989, INFECT IMMUN, V57, P2674, DOI 10.1128/IAI.57.9.2674-2682.1989; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; WHO, 2002, RED RISKS PROM HLTH; WILLEMS RJL, 1992, MOL MICROBIOL, V6, P2661, DOI 10.1111/j.1365-2958.1992.tb01443.x; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	49	710	2291	0	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					32	40		10.1038/ng1227			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	WOS:000185018500008	12910271	Bronze			2022-01-24	
J	BULMER, M				BULMER, M			THE SELECTION-MUTATION-DRIFT THEORY OF SYNONYMOUS CODON USAGE	GENETICS			English	Article							ESCHERICHIA-COLI; TRANSFER-RNA; UNFAVORABLE CODONS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; MAXIMUM RATE; TRANSCRIPTION ATTENUATION; UNICELLULAR ORGANISMS; HETEROLOGOUS ORGANISM	It is argued that the bias in synonymous codon usage observed in unicellular organisms is due to a balance between the forces of selection and mutation in a finite population, with greater bias in highly expressed genes reflecting stronger selection for efficiency of translation. A population genetic model is developed taking into account population size and selective differences between synonymous codons. A biochemical model is then developed to predict the magnitude of selective differences between synonymous codons in unicellular organisms in which growth rate (or possibly growth yield) can be equated with fitness. Selection can arise from differences in either the speed or the accuracy of translation. A model for the effect of speed of translation on fitnes is considered in detail, a similar model for accuracy more briefly. The model is successful in predicting a difference in the degree of bias at the beginning than in the rest of the gene under some circumstances, as observed in Escherichia coli, but grossly overestimates the amount of bias expected. Possible reasons for this discrepancy are discussed.	UNIV OXFORD, DEPT STAT, OXFORD OX1 3TG, ENGLAND								ANDERSEN KB, 1980, J BACTERIOL, V144, P114, DOI 10.1128/JB.144.1.114-123.1980; ANDERSSON DI, 1986, ARCH MICROBIOL, V144, P96, DOI 10.1007/BF00454963; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; BILGIN N, 1988, FEBS LETT, V233, P95, DOI 10.1016/0014-5793(88)81362-0; BONEKAMP F, 1985, NUCLEIC ACIDS RES, V13, P4113, DOI 10.1093/nar/13.11.4113; BUCKINGHAM RH, 1986, ACCURACY MOL PROCESS, P83; BULMER M, 1988, J THEOR BIOL, V133, P67, DOI 10.1016/S0022-5193(88)80024-9; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; BULMER M, 1990, NUCLEIC ACIDS RES, V18, P2869, DOI 10.1093/nar/18.10.2869; BULMER M, 1989, NUCLEIC ACIDS RES, V17, P1839, DOI 10.1093/nar/17.5.1839; CARTER PW, 1986, P NATL ACAD SCI USA, V83, P8127, DOI 10.1073/pnas.83.21.8127; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEAN AM, 1986, GENET RES, V48, P1, DOI 10.1017/S0016672300024587; DEBOER HA, 1986, MAXIMIZING GENE EXPR, P225; DRAKE JW, 1974, S SOC GEN MICROBIOL, V24, P41; EHRENBERG M, 1990, J MOL BIOL, V211, P739, DOI 10.1016/0022-2836(90)90074-V; EHRENBERG M, 1986, ACCURACY MOL PROCESS, P329; FELSENSTEIN J, 1974, GENETICS, V78, P737; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GOUY M, 1980, FEBS LETT, V115, P151, DOI 10.1016/0014-5793(80)81155-0; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; HARLEY CB, 1981, J BIOL CHEM, V256, P786; HARMS E, 1987, J BACTERIOL, V169, P5668, DOI 10.1128/jb.169.12.5668-5677.1987; HASEGAWA M, 1979, NUCLEIC ACIDS RES, V7, P2073, DOI 10.1093/nar/7.7.2073; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HINDS PW, 1985, J BIOMOL STRUCT DYN, V3, P543, DOI 10.1080/07391102.1985.10508442; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingraham J. L., 1983, GROWTH BACTERIAL CEL; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KATO M, 1990, J THEOR BIOL, V142, P35, DOI 10.1016/S0022-5193(05)80011-6; Kennell D, 1986, MAXIMIZING GENE EXPR, P101; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P5773, DOI 10.1073/pnas.78.9.5773; Kimura M., 1983, NEUTRAL THEORY MOL E; Kirkwood T. B. L., 1986, ACCURACY MOL PROCESS; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; KONIGSBERG W, 1983, P NATL ACAD SCI-BIOL, V80, P687, DOI 10.1073/pnas.80.3.687; KOZAK M, 1983, MICROBIOL REV, V47, P1; KURLAND CG, 1986, ACCURACY MOL PROCESS, P127; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LEVIN BR, 1981, GENETICS, V99, P1; LI WH, 1987, J MOL EVOL, V24, P337, DOI 10.1007/BF02134132; LILJENSTROM H, 1987, J THEOR BIOL, V124, P43, DOI 10.1016/S0022-5193(87)80251-5; MCPHERSON DT, 1988, NUCLEIC ACIDS RES, V16, P4111, DOI 10.1093/nar/16.9.4111; MILKMAN R, 1990, GENETICS, V126, P505; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PETERSEN GB, 1988, EMBO J, V7, P3957, DOI 10.1002/j.1460-2075.1988.tb03282.x; ROBINSON M, 1984, NUCLEIC ACIDS RES, V12, P6663, DOI 10.1093/nar/12.17.6663; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; SAWYER SA, 1987, P NATL ACAD SCI USA, V84, P6225, DOI 10.1073/pnas.84.17.6225; Selander RK, 1987, ESCHERICHIA COLI SAL, P1625; Sharp P.M., 1989, P23; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1990, GENETICS BIOTECHNOLO, V3, P89; SHIELDS DC, 1990, J MOL EVOL, V31, P71, DOI 10.1007/BF02109476; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; SHIELDS DC, 1987, NUCLEIC ACIDS RES, V15, P8023, DOI 10.1093/nar/15.19.8023; SHPAER EG, 1986, J MOL BIOL, V188, P555, DOI 10.1016/S0022-2836(86)80005-5; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; SORENSEN MA, 1990, 13TH INT TRANSF RNA; SPRENGART ML, 1990, NUCLEIC ACIDS RES, V18, P1719, DOI 10.1093/nar/18.7.1719; TOMICH CSC, 1989, NUCLEIC ACIDS RES, V17, P3179, DOI 10.1093/nar/17.8.3179; VARENNE S, 1986, J THEOR BIOL, V120, P99, DOI 10.1016/S0022-5193(86)80020-0; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VARENNE S, 1989, BIOCHIMIE, V71, P1221, DOI 10.1016/0300-9084(89)90027-8; VONHEIJNE G, 1987, J THEOR BIOL, V125, P1, DOI 10.1016/S0022-5193(87)80175-3; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Wright S, 1931, GENETICS, V16, P0097; YANOFSKY C, 1988, J BIOL CHEM, V263, P609	74	710	776	2	40	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	1991	129	3					897	907					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL996	WOS:A1991GL99600030	1752426				2022-01-24	
J	Han, JW; Zheng, HF; Cui, Y; Sun, LD; Ye, DQ; Hu, Z; Xu, JH; Cai, ZM; Huang, W; Zhao, GP; Xie, HF; Fang, H; Lu, QJ; Xu, JH; Li, XP; Pan, YF; Deng, DQ; Zeng, FQ; Ye, ZZ; Zhang, XY; Wang, QW; Hao, F; Ma, L; Zuo, XB; Zhou, FS; Du, WH; Cheng, YL; Yang, JQ; Shen, SK; Li, J; Sheng, YJ; Zuo, XX; Zhu, WF; Gao, F; Zhang, PL; Guo, Q; Li, B; Gao, M; Xiao, FL; Quan, C; Zhang, C; Zhang, Z; Zhu, KJ; Li, Y; Hu, DY; Lu, WS; Huang, JL; Liu, SX; Li, H; Ren, YQ; Wang, ZX; Yang, CJ; Wang, PG; Zhou, WM; Lv, YM; Zhang, AP; Zhang, SQ; Lin, D; Li, Y; Low, HQ; Shen, M; Zhai, ZF; Wang, Y; Zhang, FY; Yang, S; Liu, JJ; Zhang, XJ				Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Xu, Jin-Hua; Cai, Zhi-Ming; Huang, Wei; Zhao, Guo-Ping; Xie, Hong-Fu; Fang, Hong; Lu, Qian-Jin; Xu, Jian-Hua; Li, Xiang-Pei; Pan, Yun-Feng; Deng, Dan-Qi; Zeng, Fan-Qin; Ye, Zhi-Zhong; Zhang, Xiao-Yan; Wang, Qing-Wen; Hao, Fei; Ma, Li; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Zuo, Xiao-Xia; Zhu, Wei-Fang; Gao, Fei; Zhang, Pei-Lian; Guo, Qing; Li, Bo; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Huang, Jian-Lin; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Li, Yi; Low, Hui Qi; Shen, Min; Zhai, Zhi-Fang; Wang, Ying; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun			Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus	NATURE GENETICS			English	Article							GENE; VARIANTS; ITGAM; EPIDEMIOLOGY; EXPRESSION; PSORIASIS; SCAN; SLE; PXK	We performed a genome-wide association study (GWAS) of systemic lupus erythematosus (SLE) in a Chinese Han population by genotyping 1,047 cases and 1,205 controls using Illumina Human610-Quad BeadChips and replicating 78 SNPs in two additional cohorts (3,152 cases and 7,050 controls). We identified nine new susceptibility loci (ETS1, IKZF1, RASGRP3, SLC15A4, TNIP1, 7q11.23, 10q11.22, 11q23.3 and 16p11.2; 1.77 x 10(-25) <= P-combined <= 2.77 x 10(-8)) and confirmed seven previously reported loci (BLK, IRF5, STAT4, TNFAIP3, TNFSF4, 6q21 and 22q11.21; 5.17 x 10(-42) <= P-combined <= 5.18 x 10(-12)). Comparison with previous GWAS findings highlighted the genetic heterogeneity of SLE susceptibility between Chinese Han and European populations. This study not only advances our understanding of the genetic basis of SLE but also highlights the value of performing GWAS in diverse ancestral populations.	[Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Han, Jian-Wen; Zheng, Hou-Feng; Cui, Yong; Sun, Liang-Dan; Ye, Dong-Qing; Hu, Zhi; Zuo, Xian-Bo; Zhou, Fu-Sheng; Du, Wen-Hui; Cheng, Yi-Lin; Yang, Jian-Qiang; Shen, Song-Ke; Li, Jian; Sheng, Yu-Jun; Gao, Min; Xiao, Feng-Li; Quan, Cheng; Zhang, Chi; Zhang, Zheng; Zhu, Kun-Ju; Li, Yang; Hu, Da-Yan; Lu, Wen-Sheng; Liu, Sheng-Xiu; Li, Hui; Ren, Yun-Qing; Wang, Zai-Xing; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lv, Yong-Mei; Zhang, An-Ping; Zhang, Sheng-Quan; Lin, Da; Zhang, Feng-Yu; Yang, Sen; Liu, Jian-Jun; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Xu, Jin-Hua; Zhang, Xue-Jun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Cai, Zhi-Ming; Wang, Qing-Wen] Peking Univ, Shenzhen Hosp, Dept Rheumatol, Shenzhen, Guangdong, Peoples R China; [Huang, Wei; Zhao, Guo-Ping; Shen, Min; Wang, Ying] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Xie, Hong-Fu; Zuo, Xiao-Xia] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Fang, Hong; Zhu, Wei-Fang] Zhejiang Univ, Dept Dermatol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Qian-Jin; Gao, Fei] Cent S Univ, Epigenet Res Ctr, Dept Dermatol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Xu, Jian-Hua] Anhui Med Univ, Dept Rheumatol, Hosp 1, Hefei, Anhui, Peoples R China; [Li, Xiang-Pei] Anhui Med Univ, Dept Rheumatol, Affiliated Prov Hosp, Hefei, Anhui, Peoples R China; [Pan, Yun-Feng; Huang, Jian-Lin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Dan-Qi; Zhang, Pei-Lian] Kunming Med Univ, Affiliated Hosp 2, Dept Dermatol, Kunming, Yunnan, Peoples R China; [Zeng, Fan-Qin; Guo, Qing] Sun Yat Sen Univ, Dept Dermatol, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Zhi-Zhong; Li, Bo] Shenzhen Fourth Peoples Hosp, Dept Rheumatol, Shenzhen, Guangdong, Peoples R China; [Zhang, Xiao-Yan; Ma, Li] China Japan Friendship Hosp, Dept Dermatol, Beijing, Peoples R China; [Hao, Fei; Zhai, Zhi-Fang] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China; [Li, Yi; Low, Hui Qi] Genome Inst Singapore, Singapore, Singapore		Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.	liuj3@gis.a-star.edu.sg; ayzxj@vip.sina.com	Cui, Yong/AAF-9300-2020; Zheng, Houfeng/K-4424-2012; Zhang, Fengyu/M-1396-2019; Chen, Gang/G-2722-2010; Zhu, Kunju/AAN-5264-2020; Liu, Jianjun/AAK-4989-2020	Zheng, Houfeng/0000-0001-5681-8598; Zhang, Fengyu/0000-0001-8504-0770; Zhu, Kunju/0000-0002-3649-209X; Liu, Jianjun/0000-0002-3255-3019	National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [30972727, 30530670, 30830089]; Anhui Provincial Special Scientific Program [2007-7]; Anhui Skin Genetic Study Innovative Research Team Program [TD200701]	We thank all study participants. This study was funded by the National Natural Science Foundation (30972727), the Key Project of National Natural Science Foundation (30530670 and 30830089), the Anhui Provincial Special Scientific Program (2007-7) and the Anhui Skin Genetic Study Innovative Research Team Program (TD200701).	Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; HOPKINSON ND, 1994, ANN RHEUM DIS, V53, P675, DOI 10.1136/ard.53.10.675; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lau CS, 2006, LUPUS, V15, P715, DOI 10.1177/0961203306072311; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2004, GENOME RES, V14, P1345, DOI 10.1101/gr.1758204; Wang J, 2007, ARCH DERMATOL RES, V298, P485, DOI 10.1007/s00403-006-0719-4; Wojcik H, 2007, EUR J IMMUNOL, V37, P1022, DOI 10.1002/eji.200637026; Yang W, 2009, GENES IMMUN, V10, P219, DOI 10.1038/gene.2009.1; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	28	709	755	6	242	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1234	U98		10.1038/ng.472			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	WOS:000271247600017	19838193				2022-01-24	
J	Pugliese, A; Zeller, M; Fernandez, A; Zalcberg, LJ; Bartlett, RJ; Ricordi, C; Pietropaolo, M; Eisenbarth, GS; Bennett, ST; Patel, DD				Pugliese, A; Zeller, M; Fernandez, A; Zalcberg, LJ; Bartlett, RJ; Ricordi, C; Pietropaolo, M; Eisenbarth, GS; Bennett, ST; Patel, DD			The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes	NATURE GENETICS			English	Article							MOLECULAR-CLONING; II GENE; REGION; AUTOANTIBODIES; EXPRESSION; PROINSULIN; MELLITUS; IDDM; MINISATELLITE; AUTOANTIGEN	Type 1, or insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease associated with loss of tolerance to several pancreatic islet cell molecules, including insulin, glutamic acid decarboxylase (CAD), ICA69 and the tyrosine phosphatase IA-2 (refs 1-3). Among several predisposing loci, IDDM2 maps to the insulin gene (INS) VNTR (variable number of tandem repeats) minisatellite on chromosome 11p15 (refs 4-9). Allelic variation at this VNTR locus correlates with steady-state levels of INS mRNA in pancreas(8,10,11) and transfected rodent cell lines(12-14), but it is difficult to reconcile the association of lower INS mRNA levels in the pancreas with class III VNTRs that are dominantly protective from IDDM(8,15). We show that during fetal development and childhood, mRNAs for insulin and other islet cell autoantigens (GAD, ICA69, IA-2) are expressed at low levels in the human thymus. Critically, we also detect proinsulin and insulin protein. VNTR alleles correlate with differential INS mRNA expression in the thymus where, in contrast to the pancreas, protective class III VNTRs are associated with higher steady-state levels of INS mRNA expression. This finding provides a plausible explanation for the dominant protective effect of class III VNTRs, and suggests that diabetes susceptibility and resistance associated with IDDM2 may derive from the VNTR influence on INS transcription in the thymus. Higher levels of (pro)insulin in the thymus may promote negative selection (deletion) of insulin-specific T-lymphocytes which play a critical role in the pathogenesis of type-1 diabetes.	UNIV PITTSBURGH, CHILDRENS HOSP, DIV IMMUNOGENET, PITTSBURGH, PA 15260 USA; UNIV COLORADO, HLTH SCI CTR, BARBARA DAVIS CTR CHILDHOOD DIABET, DENVER, CO 80262 USA; UNIV OXFORD, NUFFIELD DEPT SURG, WELLCOME TRUST CTR HUMAN GENET, OXFORD, ENGLAND; DUKE UNIV, MED CTR, DEPT MED & IMMUNOL, DURHAM, NC USA		Pugliese, A (corresponding author), UNIV MIAMI, SCH MED, DIABET RES INST, MIAMI, FL USA.		RICORDI, CAMILLO/AAA-4740-2019	Ricordi, Camillo/0000-0001-8092-7153	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD-3-3199] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U24HD033199] Funding Source: NIH RePORTER		ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; CASTANO L, 1993, DIABETES, V42, P1202, DOI 10.2337/diabetes.42.8.1202; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; GRIFFIN AC, 1995, AM J PATHOL, V147, P845; Hoffman A.R., 1996, SCI AM, V1, P52; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KEILACKER H, 1995, HORM METAB RES, V27, P90, DOI 10.1055/s-2007-979915; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KUGLIN B, 1988, DIABETES, V37, P130, DOI 10.2337/diabetes.37.1.130; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; Mally MI, 1996, DIABETOLOGIA, V39, P474, DOI 10.1007/BF00400680; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; Owerbach D, 1996, DIABETES, V45, P544, DOI 10.2337/diabetes.45.5.544; PIETROPAOLO M, 1993, J CLIN INVEST, V92, P359, DOI 10.1172/JCI116574; POLYCHRONAKOS C, 1995, DIABETOLOGIA, V38, P715, DOI 10.1007/BF00401845; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; RABIN DU, 1994, J IMMUNOL, V152, P3183; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; UNDLIEN DE, 1995, DIABETES, V44, P620, DOI 10.2337/diabetes.44.6.620; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542	34	709	720	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					293	297		10.1038/ng0397-293			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	WOS:A1997WK38600022	9054945				2022-01-24	
J	Hansen, KD; Timp, W; Bravo, HC; Sabunciyan, S; Langmead, B; McDonald, OG; Wen, B; Wu, H; Liu, Y; Diep, D; Briem, E; Zhang, K; Irizarry, RA; Feinberg, AP				Hansen, Kasper Daniel; Timp, Winston; Bravo, Hector Corrada; Sabunciyan, Sarven; Langmead, Benjamin; McDonald, Oliver G.; Wen, Bo; Wu, Hao; Liu, Yun; Diep, Dinh; Briem, Eirikur; Zhang, Kun; Irizarry, Rafael A.; Feinberg, Andrew P.			Increased methylation variation in epigenetic domains across cancer types	NATURE GENETICS			English	Article							DNA METHYLATION; EXPRESSION; REVEALS	Tumor heterogeneity is a major barrier to effective cancer diagnosis and treatment. We recently identified cancer-specific differentially DNA-methylated regions (cDMRs) in colon cancer, which also distinguish normal tissue types from each other, suggesting that these cDMRs might be generalized across cancer types. Here we show stochastic methylation variation of the same cDMRs, distinguishing cancer from normal tissue, in colon, lung, breast, thyroid and Wilms' tumors, with intermediate variation in adenomas. Whole-genome bisulfite sequencing shows these variable cDMRs are related to loss of sharply delimited methylation boundaries at CpG islands. Furthermore, we find hypomethylation of discrete blocks encompassing half the genome, with extreme gene expression variability. Genes associated with the cDMRs and large blocks are involved in mitosis and matrix remodeling, respectively. We suggest a model for cancer involving loss of epigenetic stability of well-defined genomic domains that underlies increased methylation variability in cancer that may contribute to tumor heterogeneity.	[Hansen, Kasper Daniel; Langmead, Benjamin; Irizarry, Rafael A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Hansen, Kasper Daniel; Timp, Winston; Bravo, Hector Corrada; Sabunciyan, Sarven; Langmead, Benjamin; McDonald, Oliver G.; Wen, Bo; Liu, Yun; Briem, Eirikur; Irizarry, Rafael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Timp, Winston; Wen, Bo; Liu, Yun; Briem, Eirikur; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Timp, Winston] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Bravo, Hector Corrada] Univ Maryland, Dept Comp Sci, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Sabunciyan, Sarven] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [McDonald, Oliver G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wu, Hao] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Diep, Dinh; Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, San Diego, CA 92103 USA; [Diep, Dinh; Zhang, Kun] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA		Irizarry, RA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.	rafa@jhu.edu; afeinberg@jhu.edu	Wen, Bo/P-5332-2019; Wu, Hao/H-3899-2017; Corrada Bravo, Hector/G-6584-2011; Langmead, Ben/F-4218-2012; Feinberg, Andrew/AAY-7666-2020; Zhang, Kun/ABE-6349-2020; Liu, Yun/I-5755-2012; Hansen, Kasper D/E-6094-2011; Wu, Hao/AAG-8660-2020; Timp, Winston/B-5215-2008	Wen, Bo/0000-0003-0394-7366; Wu, Hao/0000-0003-1269-7354; Langmead, Ben/0000-0003-2437-1976; Zhang, Kun/0000-0002-7596-5224; Liu, Yun/0000-0002-3917-0600; Hansen, Kasper D/0000-0003-0086-0687; Wu, Hao/0000-0003-1269-7354; Timp, Winston/0000-0003-2083-6027; Sabunciyan, Sarven/0000-0002-7231-0820; Corrada Bravo, Hector/0000-0002-1255-4444; Liu, Yun/0000-0001-5753-1265; Feinberg, Andrew/0000-0002-8364-1991	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37CA054358, R01HG005220, 5P50HG003233, F32CA138111, 5R01GM083084, R01DA025779]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA054358, R01CA054358, F32CA138111] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50HG003233, R01HG005220, R01HG006102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA025779] Funding Source: NIH RePORTER	We thank C. Adams and Applied Biosystems, Inc. for supplying reagents for the sequencing experiments, B. Vogelstein, F. Giardiello and M. Zeiger for tumor samples and M. Newhouse for computer assistance. This work was supported by US National Institutes of Health grants R37CA054358, R01HG005220, 5P50HG003233, F32CA138111, 5R01GM083084 and R01DA025779 (K.Z.).	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Aryee MJ, 2011, BIOSTATISTICS, V12, P197, DOI 10.1093/biostatistics/kxq055; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-264; Chung CAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009320; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Eurich K, 2009, WORLD J GASTROENTERO, V15, P5249, DOI 10.3748/wjg.15.5249; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FEINBERG AP, 1988, CANCER RES, V48, P1159; Fischer H, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-17; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loader C., 1999, LOCAL REGRESSION LIK; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Smith JC, 2008, J INVEST DERMATOL, V128, P1298, DOI 10.1038/sj.jid.5701149; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yu AE, 1997, DRUG AGING, V11, P229, DOI 10.2165/00002512-199711030-00006; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	42	708	723	0	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2011	43	8					768	U77		10.1038/ng.865			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	WOS:000293178300013	21706001	Green Accepted	Y	N	2022-01-24	
J	Roberts, A; Trapnell, C; Donaghey, J; Rinn, JL; Pachter, L				Roberts, Adam; Trapnell, Cole; Donaghey, Julie; Rinn, John L.; Pachter, Lior			Improving RNA-Seq expression estimates by correcting for fragment bias	GENOME BIOLOGY			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; SPLICE JUNCTIONS; REVEALS	The biochemistry of RNA-Seq library preparation results in cDNA fragments that are not uniformly distributed within the transcripts they represent. This non-uniformity must be accounted for when estimating expression levels, and we show how to perform the needed corrections using a likelihood based approach. We find improvements in expression estimates as measured by correlation with independently performed qRT-PCR and show that correction of bias leads to improved replicability of results across libraries and sequencing technologies.	[Roberts, Adam; Pachter, Lior] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Trapnell, Cole; Donaghey, Julie; Rinn, John L.] 7 Cambridge Ctr, Broad Inst, Cambridge, MA 02142 USA; [Trapnell, Cole; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA		Pachter, L (corresponding author), Univ Calif Berkeley, Dept Comp Sci, 387 Soda Hall, Berkeley, CA 94720 USA.	lpachter@math.berkeley.edu		Rinn, John/0000-0002-7231-7539; Pachter, Lior/0000-0002-9164-6231	NSFNational Science Foundation (NSF); NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG006102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083873] Funding Source: NIH RePORTER	We thank Joshua Levin and Mitchell Guttman for their help with the NanoString experiment. Anat Caspi was instrumental in helping us obtain the SOLID data. Adam Roberts was supported by an NSF graduate research fellowship.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bohnert R, 2010, NUCLEIC ACIDS RES, V38, pW348, DOI 10.1093/nar/gkq448; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Buhlmann P, 1999, ANN STAT, V27, P480; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GRAVELEY B, 2001, NATURE, V471, P473; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-P26; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r50; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Nicolae M, 2010, LECT N BIOINFORMAT, V6293, P202, DOI 10.1007/978-3-642-15294-8_17; Pasaniuc B, 2010, LECT N BIOINFORMAT, V6044, P397; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; CUFFLINKS SOFTWARE	30	708	721	7	89	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2011	12	3							R22	10.1186/gb-2011-12-3-r22			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	773LQ	WOS:000291309200002	21410973	hybrid, Green Published, Green Accepted	Y	N	2022-01-24	
J	Cho, YS; Go, MJ; Kim, YJ; Heo, JY; Oh, JH; Ban, HJ; Yoon, D; Lee, MH; Kim, DJ; Park, M; Cha, SH; Kim, JW; Han, BG; Min, H; Ahn, Y; Park, MS; Han, HR; Jang, HY; Cho, EY; Lee, JE; Cho, NH; Shin, C; Park, T; Park, JW; Lee, JK; Cardon, L; Clarke, G; McCarthy, MI; Lee, JY; Lee, JK; Oh, B; Kim, HL				Cho, Yoon Shin; Go, Min Jin; Kim, Young Jin; Heo, Jee Yeon; Oh, Ji Hee; Ban, Hyo-Jeong; Yoon, Dankyu; Lee, Mi Hee; Kim, Dong-Joon; Park, Miey; Cha, Seung-Hun; Kim, Jun-Woo; Han, Bok-Ghee; Min, Haesook; Ahn, Younjhin; Park, Man Suk; Han, Hye Ree; Jang, Hye-Yoon; Cho, Eun Young; Lee, Jong-Eun; Cho, Nam H.; Shin, Chol; Park, Taesung; Park, Ji Wan; Lee, Jong-Keuk; Cardon, Lon; Clarke, Geraldine; McCarthy, Mark I.; Lee, Jong-Young; Lee, Jong-Koo; Oh, Bermseok; Kim, Hyung-Lae			A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits	NATURE GENETICS			English	Article							PLASMA-MEMBRANE; CELLS; OBESITY; HEIGHT; MASS; EXPRESSION; VARIANTS; PROTEINS; ARRAYS; LOCI	To identify genetic factors influencing quantitative traits of biomedical importance, we conducted a genome-wide association study in 8,842 samples from population-based cohorts recruited in Korea. For height and body mass index, most variants detected overlapped those reported in European samples. For the other traits examined, replication of promising GWAS signals in 7,861 independent Korean samples identified six previously unknown loci. For pulse rate, signals reaching genome-wide significance mapped to chromosomes 1q32 (rs12731740, P = 2.9 x 10(-9)) and 6q22 (rs12110693, P = 1.6 x 10(-9)), with the latter similar to 400 kb from the coding sequence of GJA1. For systolic blood pressure, the most compelling association involved chromosome 12q21 and variants near the ATP2B1 gene (rs17249754, P = 1.3 x 10(-7)). For waist-hip ratio, variants on chromosome 12q24 (rs2074356, P = 7.8 x 10(-12)) showed convincing associations, although no regional transcript has strong biological candidacy. Finally, we identified two loci influencing bone mineral density at multiple sites. On chromosome 7q31, rs7776725 (within the FAM3C gene) was associated with bone density at the radius (P = 1.0 x 10(-11)), tibia (P = 1.6 x 10(-6)) and heel (P = 1.9 x 10(-10)). On chromosome 7p14, rs1721400 (mapping close to SFRP4, a frizzled protein gene) showed consistent associations at the same three sites (P = 2.2 x 10(-3), P = 1.4 x 10(-7) and P = 6.0 x 10(-4), respectively). This large-scale GWA analysis of well-characterized Korean population-based samples highlights previously unknown biological pathways.	[Cho, Yoon Shin; Go, Min Jin; Kim, Young Jin; Heo, Jee Yeon; Oh, Ji Hee; Ban, Hyo-Jeong; Lee, Mi Hee; Kim, Dong-Joon; Park, Miey; Cha, Seung-Hun; Kim, Jun-Woo; Han, Bok-Ghee; Min, Haesook; Ahn, Younjhin; Park, Man Suk; Han, Hye Ree; Lee, Jong-Keuk; Oh, Bermseok; Kim, Hyung-Lae] Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea; [Yoon, Dankyu; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Han, Hye Ree; Jang, Hye-Yoon; Cho, Eun Young] DNA Link, Seoul, South Korea; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon 441749, South Korea; [Shin, Chol] Korea Univ, Ansan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Ansan, South Korea; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea; [Park, Ji Wan] Hallym Univ, Coll Med, Dept Med Genet, Chunchon, South Korea; [Lee, Jong-Keuk] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea; [Cardon, Lon] GlaxoSmithKline Inc, Philadelphia, PA USA; [Clarke, Geraldine; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Lee, Jong-Koo] Korea Ctr Dis Control & Prevent, Seoul, South Korea; [Oh, Bermseok] Kyung Hee Univ, Sch Med, Dept Biomed Engn, Seoul, South Korea		Kim, HL (corresponding author), Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea.	ohbs@khu.ac.kr; hyung505@nih.go.kr	Lee, Jong-Young/M-6319-2013; Lee, JongGu/B-7384-2013; LEE, Jong-koo/E-4166-2012; McCarthy, Mark/M-3763-2015	Lee, Jong-Young/0000-0002-0092-9958; McCarthy, Mark/0000-0002-4393-0510; Park, Ji Wan/0000-0003-0840-1696	Ministry for Health, Welfare and Family Affairs, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [4845-301-430-260-00]; Korea National Institute of Health, Korea Center for Disease Control, Republic of Korea [4845-301-430-210-13]	This work was supported by a grant from the Ministry for Health, Welfare and Family Affairs, Republic of Korea (4845-301-430-260-00), and an intramural grant from the Korea National Institute of Health, Korea Center for Disease Control, Republic of Korea (4845-301-430-210-13).	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dooley DC, 2004, STEM CELLS, V22, P556, DOI 10.1634/stemcells.22-4-556; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Howarth FC, 2007, MOL CELL BIOCHEM, V305, P145, DOI 10.1007/s11010-007-9537-z; HUI L, 2008, CURR PROTOC HUM GENE; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pati N, 2004, J BIOCHEM BIOPH METH, V60, P1, DOI 10.1016/j.jbbm.2003.11.005; Peters NS, 1996, CLIN SCI, V90, P447, DOI 10.1042/cs0900447; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	28	708	780	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					527	534		10.1038/ng.357			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	WOS:000265575600013	19396169				2022-01-24	
J	Churchill, G; Airey, DC; Allayee, H; Angel, JM; Attie, AD; Beatty, J; Beavis, WD; Belknap, JK; Bennett, B; Berrettini, W; Bleich, A; Bogue, M; Broman, KW; Buck, KJ; Buckler, E; Burmeister, M; Chesler, EJ; Cheverud, JM; Clapcote, S; Cook, MN; Cox, RD; Crabbe, JC; Crusio, WE; Darvasi, A; Deschnepper, CF; Doerge, RW; Farber, CR; Forejt, J; Gaile, D; Garlow, SJ; Geiger, H; Gershenfeld, H; Gordon, T; Gu, J; Gu, WK; de Haan, G; Hayes, NL; Heller, C; Himmelbauer, H; Hitzemann, R; Hunter, K; Hsu, HC; Iraqi, FA; Ivandic, B; Jacob, HJ; Jansen, RC; Jjepsen, KJ; Johnson, DK; Johnson, TE; Kempermann, G; Kendziorski, C; Kotb, M; Kooy, RF; Llamas, B; Lammert, F; Lassalle, JM; Lowenstein, PR; Lu, L; Lusiss, A; Manly, KF; Marcucio, R; Matthews, D; Medrano, JF; Miller, DR; Mittleman, G; Mock, BA; Mogil, JS; Montagutelli, X; Morahan, G; Morris, DG; Mott, R; Nadeau, JH; Nagase, H; Nowakowski, RS; O'Hara, BF; Osadchuk, AV; Page, GP; Paigen, B; Paigen, K; Palmer, AA; Pan, HJ; Peltonen-Palotie, L; Peirce, J; Pomp, D; Pravenec, M; Prows, DR; Qi, ZH; Reeves, RH; Roder, J; Rosen, GD; Schadt, EE; Schalkwyk, LC; Seltzer, Z; Shimomura, K; Shou, SM; Sillanpaa, MJ; Siracusa, LD; Snoeck, HW; Spearow, JL; Svenson, K; Tarantino, LM; Threadgill, D; Toth, LA; Valdar, W; de Villena, FPM; Warden, C; Whatley, S; Williams, RW; Wiltshire, T; Yi, NJ; Zhang, DB; Zhang, M; Zou, F				Churchill, G; Airey, DC; Allayee, H; Angel, JM; Attie, AD; Beatty, J; Beavis, WD; Belknap, JK; Bennett, B; Berrettini, W; Bleich, A; Bogue, M; Broman, KW; Buck, KJ; Buckler, E; Burmeister, M; Chesler, EJ; Cheverud, JM; Clapcote, S; Cook, MN; Cox, RD; Crabbe, JC; Crusio, WE; Darvasi, A; Deschnepper, CF; Doerge, RW; Farber, CR; Forejt, J; Gaile, D; Garlow, SJ; Geiger, H; Gershenfeld, H; Gordon, T; Gu, J; Gu, WK; de Haan, G; Hayes, NL; Heller, C; Himmelbauer, H; Hitzemann, R; Hunter, K; Hsu, HC; Iraqi, FA; Ivandic, B; Jacob, HJ; Jansen, RC; Jjepsen, KJ; Johnson, DK; Johnson, TE; Kempermann, G; Kendziorski, C; Kotb, M; Kooy, RF; Llamas, B; Lammert, F; Lassalle, JM; Lowenstein, PR; Lu, L; Lusiss, A; Manly, KF; Marcucio, R; Matthews, D; Medrano, JF; Miller, DR; Mittleman, G; Mock, BA; Mogil, JS; Montagutelli, X; Morahan, G; Morris, DG; Mott, R; Nadeau, JH; Nagase, H; Nowakowski, RS; O'Hara, BF; Osadchuk, AV; Page, GP; Paigen, B; Paigen, K; Palmer, AA; Pan, HJ; Peltonen-Palotie, L; Peirce, J; Pomp, D; Pravenec, M; Prows, DR; Qi, ZH; Reeves, RH; Roder, J; Rosen, GD; Schadt, EE; Schalkwyk, LC; Seltzer, Z; Shimomura, K; Shou, SM; Sillanpaa, MJ; Siracusa, LD; Snoeck, HW; Spearow, JL; Svenson, K; Tarantino, LM; Threadgill, D; Toth, LA; Valdar, W; de Villena, FPM; Warden, C; Whatley, S; Williams, RW; Wiltshire, T; Yi, NJ; Zhang, DB; Zhang, M; Zou, F		Complex Trait Consortium	The Collaborative Cross, a community resource for the genetic analysis of complex traits	NATURE GENETICS			English	Article							ENVIRONMENT; STRAINS; MICE	The goal of the Complex Trait Consortium is to promote the development of resources that can be used to understand, treat and ultimately prevent pervasive human diseases. Existing and proposed mouse resources that are optimized to study the actions of isolated genetic loci on a fixed background are less effective for studying intact polygenic networks and interactions among genes, environments, pathogens and other factors. The Collaborative Cross will provide a common reference panel specifically designed for the integrative analysis of complex systems and will change the way we approach human health and disease.	Jackson Lab, Bar Harbor, ME 04609 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; Univ So Calif, Keck Sch Med, Los Angeles, CA USA; Univ Texas, MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; Natl Ctr Genome Resources, Santa Fe, NM USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Hannover Med Sch, Inst Lab Anim Sci & Cent Anim Facil, D-3000 Hannover, Germany; Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; Vet Affairs Med Ctr, Dept Behav Neurosci, Portland, OR USA; Cornell Univ, Inst Genom Divers, Ithaca, NY USA; Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI USA; Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; QTL & Modifier Loci Grp, MRC Mammalian Genet Unit, Harwell, Oxon, England; Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA USA; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Evolut Systemat & Ecol, IL-91905 Jerusalem, Israel; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; ASCR, Inst Genet Mol, Videnska, Czech Republic; SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY 14260 USA; Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; Univ Cincinnati, Med Ctr, Div Expt Hematol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45267 USA; Univ Texas SW, Dallas, TX USA; NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg Campbell Clin, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Ctr Genom & Bioinformat, Dept Pathol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Ctr Dis Connect Tissues, Memphis, TN 38163 USA; Univ Groningen, Dept Stem Cell Biol, NL-9700 AB Groningen, Netherlands; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Stanford Univ, Stanford, CA 94305 USA; Max Planck Inst Mol Genet, Berlin, Germany; NIH, Bethesda, MD 20892 USA; Univ Alabama Birmingham, Clin Immunol & Rheumatol, Birmingham, AL USA; Int Livestock Res Inst, Nairobi, Kenya; Heidelberg Univ, Dept Med 3, Heidelberg, Germany; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Groningen Bioinformat Ctr, Inst Math & Comp Sci, Groningen, Netherlands; Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA; Oak Ridge Natl Lab, Div Life Sci, Mammalian Genet Grp, Oak Ridge, TN USA; Charite Univ Med Berlin, Max Delbruck Ctr Mol Med, Dept Expt Neurol, Berlin, Germany; Univ Wisconsin, Med Sci Ctr, Dept Biostat & Med Informat, Madison, WI USA; Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Aachen, Univ Hosp Aachen, Dept Med 3, Aachen, Germany; Univ Toulouse 3, Ctr Rech Cognit Anim, F-31062 Toulouse, France; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; Cedars Sinai Med Ctr, Gene Therapeut Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept MIMG, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Orthopaed Surg, San Francisco, CA USA; NCI, CCR, NIH, Bethesda, MD 20892 USA; McGill Univ, Dept Psychol, Montreal, PQ, Canada; McGill Univ, Ctr Res Pain, Montreal, PQ, Canada; Inst Pasteur, Unite Genet Mammiferes, Paris, France; Western Australian Inst Med Res, Ctr Diabet Res, Perth, WA, Australia; Yale Univ, Sch Med Pulm & Crit Care Med, New Haven, CT USA; Wellcome Trust Ctr Human Genet, Oxford, England; Case Western Reserve Univ, Cleveland, OH 44106 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Univ Kentucky, Lexington, KY USA; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; Columbia Genome Ctr, New York, NY USA; Univ Helsinki, Dept Med Genet, Natl Publ Hlth Inst, Biomedicum Helsinki,Dept Mol Med, FIN-00014 Helsinki, Finland; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; Univ Nebraska, Dept Anim Sci, Lincoln, NE USA; Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; McKusick Nathans Inst Genet Med, Baltimore, MD USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Rosetta Inpharmat LLC Merck & Co, Res Genet, Seattle, WA USA; Inst Psychiat, SGDP Ctr, London, England; Univ Toronto, Ctr Study Pain, Pain Genet & Phenom Res Unit, Toronto, ON, Canada; Program Neurosci, Toronto, ON, Canada; Northwestern Univ, Ctr Funct Genom, Evanston, IL USA; Shriners Hosp Crippled Children, Res Ctr, Portland, OR USA; Univ Helsinki, Rolf Nevanlinna Inst, Dept Math & Stat, FIN-00014 Helsinki, Finland; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Mt Sinai Sch Med, Dept Cell & Gene Med, New York, NY USA; Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; Novartis Res Fdn, Genom Inst, San Diego, CA USA; Univ N Carolina, Dept Genet, Chapel Hill, NC USA; So Illinois Univ, Sch Med, Springfield, IL USA; KCL Inst Psychiat, Dept Neurosci, London, England; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA		Churchill, G (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	garyc@jax.org	Crusio, Wim/ABD-5214-2021; Jansen, Ritsert C/C-1160-2013; Forejt, Jiri/AAF-5276-2019; Burmeister, Margit/A-3157-2013; Mogil, Jeffrey S./AAA-9611-2019; Churchill, Gary/AAY-7496-2020; Schalkwyk, Leonard C/A-2150-2010; Llamas, Bastien/AAK-1693-2021; Crusio, Wim/ABE-1287-2021; Kooy, Frank/F-5276-2014; Crusio, Wim/A-7070-2008; Matthews, Douglas/F-6867-2012; Threadgill, David W/N-4425-2013; Forejt, Jiri/G-7719-2012; Nowakowski, Richard/C-3217-2016; de Haan, Gerald/D-2081-2015; Llamas, Bastien/Y-2781-2018; Palmer, Abraham/L-2158-2014; Roder, John/G-6468-2013; Valdar, William/AAE-4354-2019; de Haan, Gerald/AAF-8963-2019; Morahan, Grant/T-7501-2019; Pravenec, Michal/B-1666-2012; Mock, Beverly A/B-3110-2015; Chesler, Elissa/K-4641-2019; Kempermann, Gerd/F-5416-2010; Buckler, Edward/L-7651-2019; Spearow, Jimmy/AAL-2798-2020; Williams, Robert W./H-8789-2016; Deschepper, Christian/J-4783-2015	Crusio, Wim/0000-0001-6638-202X; Jansen, Ritsert C/0000-0003-2977-9110; Forejt, Jiri/0000-0002-2793-3623; Burmeister, Margit/0000-0002-1914-2434; Mogil, Jeffrey S./0000-0003-1359-5720; Churchill, Gary/0000-0001-9190-9284; Schalkwyk, Leonard C/0000-0001-7030-5756; Llamas, Bastien/0000-0002-5550-9176; Kooy, Frank/0000-0003-2024-0485; Crusio, Wim/0000-0001-6638-202X; Threadgill, David W/0000-0003-3538-1635; Forejt, Jiri/0000-0002-2793-3623; de Haan, Gerald/0000-0001-9706-0138; Llamas, Bastien/0000-0002-5550-9176; Palmer, Abraham/0000-0003-3634-0747; de Haan, Gerald/0000-0001-9706-0138; Pravenec, Michal/0000-0001-9197-5871; Mock, Beverly A/0000-0003-2479-4549; Chesler, Elissa/0000-0002-5642-5062; Kempermann, Gerd/0000-0002-5304-4061; Buckler, Edward/0000-0002-3100-371X; Mott, Richard/0000-0002-1022-9330; Williams, Robert W./0000-0001-8924-4447; Deschepper, Christian/0000-0001-6234-4667; Nowakowski, Richard/0000-0002-5006-3670; Himmelbauer, Heinz/0000-0001-8897-2928; Rosen, Glenn/0000-0001-8281-5446; Cox, Roger/0000-0001-7170-5014; Page, Grier/0000-0003-2582-3786; Sillanpaa, Mikko J./0000-0003-2808-2768; Farber, Charles/0000-0002-6748-4711; Broman, Karl/0000-0002-4914-6671; Marcucio, Ralph/0000-0002-0537-818X; /0000-0001-7147-8237	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P60AA010760] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL073760] Funding Source: Medline; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P60 AA010760] Funding Source: Medline		Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; CLARK AG, 1999, LIMITS KNOWLEDGE EVO; Gibson G, 2002, GENET RES, V80, P1, DOI 10.1017/S0016672302005839; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; JIN C, IN PRESS GENETICS; Nadeau JH, 2003, GENOME RES, V13, P2082, DOI 10.1101/gr.1186603; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; SILLANPAA MJ, IN PRESS ANN HUM GEN; Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y; Williams SM, 2004, BIOESSAYS, V26, P170, DOI 10.1002/bies.10401; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	16	708	725	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1133	1137		10.1038/ng1104-1133			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	WOS:000224832800005	15514660	Bronze			2022-01-24	
J	Lunter, G; Goodson, M				Lunter, Gerton; Goodson, Martin			Stampy: A statistical algorithm for sensitive and fast mapping of Illumina sequence reads	GENOME RESEARCH			English	Article							ALIGNMENT; TOOL	High-volume sequencing of DNA and RNA is now within reach of any research laboratory and is quickly becoming established as a key research tool. In many workflows, each of the short sequences ("reads'') resulting from a sequencing run are first "mapped'' (aligned) to a reference sequence to infer the read from which the genomic location derived, a challenging task because of the high data volumes and often large genomes. Existing read mapping software excel in either speed (e. g., BWA, Bowtie, ELAND) or sensitivity (e. g., Novoalign), but not in both. In addition, performance often deteriorates in the presence of sequence variation, particularly so for short insertions and deletions (indels). Here, we present a read mapper, Stampy, which uses a hybrid mapping algorithm and a detailed statistical model to achieve both speed and sensitivity, particularly when reads include sequence variation. This results in a higher useable sequence yield and improved accuracy compared to that of existing software.	[Lunter, Gerton; Goodson, Martin] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England		Lunter, G (corresponding author), Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	gerton.lunter@well.ox.ac.uk	Lunter, Gerton/H-4939-2016	Lunter, Gerton/0000-0002-3798-2058	Wellcome TrustWellcome TrustEuropean Commission [075491/Z/04]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0900747, G0501331] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0501331, G0900747] Funding Source: researchfish	We thank David Adams for use of the M. spretus data, Ioannis Ragoussis for use of the MCF7 mRNA-seq data, and Cornelis A. Albers and Zam Iqbal for helpful discussions. This work was supported by the Wellcome Trust, grant no. 075491/Z/04.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cox A, 2007, ELAND EFFICIENT LARG; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	10	707	711	2	62	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2011	21	6					936	939		10.1101/gr.111120.110			4	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	771JQ	WOS:000291153400013	20980556	Green Published, Bronze	Y	N	2022-01-24	
J	Crisponi, L; Deiana, M; Loi, A; Chiappe, F; Uda, M; Amati, P; Bisceglia, L; Zelante, L; Nagaraja, R; Porcu, S; Ristaldi, MS; Marzella, R; Rocchi, M; Nicolino, M; Lienhardt-Roussie, A; Nivelon, A; Verloes, A; Schlessinger, D; Gasparini, P; Bonneau, D; Cao, A; Pilia, G				Crisponi, L; Deiana, M; Loi, A; Chiappe, F; Uda, M; Amati, P; Bisceglia, L; Zelante, L; Nagaraja, R; Porcu, S; Ristaldi, MS; Marzella, R; Rocchi, M; Nicolino, M; Lienhardt-Roussie, A; Nivelon, A; Verloes, A; Schlessinger, D; Gasparini, P; Bonneau, D; Cao, A; Pilia, G			The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome	NATURE GENETICS			English	Article							PREMATURE OVARIAN FAILURE; IN-SITU HYBRIDIZATION; EYELID DEVELOPMENT; HELIX GENE; HUMAN HOMOLOG; BLEPHAROPHIMOSIS; PTOSIS; MOUSE; POSITION; MAP	In type I blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), eyelid abnormalities are associated with ovarian failure. Type II BPES shows only the eyelid defects, but both types map to chromosome 3q23. We have positionally cloned a novel. putative winged helix/forkhead transcription factor gene, FOXL2, that is mutated to produce truncated proteins in type I families and larger proteins in type II. Consistent with an involvement in those tissues, FOXL2 is selectively expressed in the mesenchyme of developing mouse eyelids and in adult ovarian follicles; in adult humans, it appears predominantly in the ovary. FOXL2 represents a candidate gene for the polled/intersex syndrome XX sex-reversal goat.	Univ Cagliari, CNR, Ist Ric Talassemie & Anemie Mediterranee, Cagliari, Italy; Univ Cagliari, Osped Reg Microcitemie, Dipartimento Sci Biomed & Biotecnol, Cagliari, Italy; Ctr Hosp Univ Poitiers, Serv Genet Med, Poitiers, France; Osped CSS, IRCCS, Serv Genet Med, I-71013 San Giovanni Rotondo, Italy; NIA, Genet Lab, Baltimore, MD 21224 USA; Univ Bari, DAPEG, Sezione Genet, Bari, Italy; Hop Debrousse, Serv Endocrinol Pediat, Lyon, France; Ctr Hosp Univ Limoges, Serv Pediat, Limoges, France; Ctr Hosp Univ Dijion, Serv Genet, Dijon, France; Univ Liege, Wallonia Ctr Human Genet, Liege, Belgium		Pilia, G (corresponding author), Univ Cagliari, CNR, Ist Ric Talassemie & Anemie Mediterranee, Cagliari, Italy.	pilia@unica.it	Uda, Manuela/AAC-2645-2019; Porcu, Susanna/AAC-3031-2019; Ristaldi, Maria S/N-8549-2013; Gasparini, Paolo/B-6173-2014; PORCU, SUSANNA/AAY-3325-2020; Crisponi, Laura/AAC-2642-2019; Ristaldi, Maria Serafina/AAW-6270-2020; Bisceglia, Luigi/B-8720-2017; Bonneau, Dominique/K-6110-2015; Rocchi, Mariano/B-8451-2011; VERLOES, Alain/E-7287-2014	Uda, Manuela/0000-0002-4890-6456; PORCU, SUSANNA/0000-0001-8053-7075; Crisponi, Laura/0000-0001-9128-8537; Bisceglia, Luigi/0000-0001-5367-8518; VERLOES, Alain/0000-0003-4819-0264; Ristaldi, Maria Serafina/0000-0003-4122-9293; Gasparini, Paolo/0000-0002-0859-0856	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [Z01AG000647, ZIAAG000647] Funding Source: NIH RePORTER; TelethonFondazione Telethon [E.0357] Funding Source: Medline		AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Amati P, 1996, AM J HUM GENET, V58, P1089; AMATI P, 1995, HUM GENET, V96, P213, DOI 10.1007/BF00207381; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Bisceglia L, 1998, MOL CELL PROBE, V12, P255, DOI 10.1006/mcpr.1998.0171; BOCCIA M, 1994, S DAK REV, V32, P51; Brown CW, 2000, NAT GENET, V25, P453, DOI 10.1038/78140; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; De Baere E, 1999, GENOMICS, V57, P70, DOI 10.1006/geno.1999.5747; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; FINDLATER GS, 1993, J ANAT, V183, P121; FRASER IS, 1988, FERTIL STERIL, V50, P747; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Juriloff DM, 2000, MAMM GENOME, V11, P440, DOI 10.1007/s003350010084; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Kaestner KH, 2000, GENE DEV, V14, P142; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Labosky PA, 1997, DEVELOPMENT, V124, P1263; LAWSON CT, 1995, HUM MOL GENET, V4, P963, DOI 10.1093/hmg/4.5.963; Layman LC, 1998, FERTIL STERIL, V69, P300, DOI 10.1016/S0015-0282(97)00480-9; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NICOLINO M, 1995, J PEDIATR ENDOCR MET, V8, P127; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Pilia G, 1999, HUM MUTAT, V14, P394, DOI 10.1002/(SICI)1098-1004(199911)14:5<394::AID-HUMU5>3.0.CO;2-1; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Prueitt RL, 2000, CYTOGENET CELL GENET, V89, P44, DOI 10.1159/000015560; SAMBROOK J, 1989, MOL CLONING MOL LAB; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; SMALL KW, 1995, HUM MOL GENET, V4, P443, DOI 10.1093/hmg/4.3.443; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Vaiman D, 1999, GENOMICS, V56, P31, DOI 10.1006/geno.1998.5691; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; Vegetti W, 2000, MOL CELL ENDOCRINOL, V161, P53, DOI 10.1016/S0303-7207(99)00224-5; WALL DA, 1994, WEED TECHNOL, V8, P785, DOI 10.1017/S0890037X00028694; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020; [No title captured]	51	707	748	11	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					159	166		10.1038/84781			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	WOS:000166839200016	11175783				2022-01-24	
J	Loewer, S; Cabili, MN; Guttman, M; Loh, YH; Thomas, K; Park, IH; Garber, M; Curran, M; Onder, T; Agarwal, S; Manos, PD; Datta, S; Lander, ES; Schlaeger, TM; Daley, GQ; Rinn, JL				Loewer, Sabine; Cabili, Moran N.; Guttman, Mitchell; Loh, Yuin-Han; Thomas, Kelly; Park, In Hyun; Garber, Manuel; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Lander, Eric S.; Schlaeger, Thorsten M.; Daley, George Q.; Rinn, John L.			Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells	NATURE GENETICS			English	Article							DEVELOPMENTAL REGULATORS; EXPRESSION; GENERATION; POLYCOMB; TRANSCRIPTION; FIBROBLASTS; METHYLATION; COMPLEXES; NETWORK; TISSUE	The conversion of lineage-committed cells to induced pluripotent stem cells (iPSCs) by reprogramming is accompanied by a global remodeling of the epigenome(1-5), resulting in altered patterns of gene expression(2,6-9). Here we characterize the transcriptional reorganization of large intergenic non-coding RNAs (lincRNAs)(10,11) that occurs upon derivation of human iPSCs and identify numerous lincRNAs whose expression is linked to pluripotency. Among these, we defined ten lincRNAs whose expression was elevated in iPSCs compared with embryonic stem cells, suggesting that their activation may promote the emergence of iPSCs. Supporting this, our results indicate that these lincRNAs are direct targets of key pluripotency transcription factors. Using loss-of-function and gain-of-function approaches, we found that one such lincRNA (lincRNA-RoR) modulates reprogramming, thus providing a first demonstration for critical functions of lincRNAs in the derivation of pluripotent stem cells.	[Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Onder, Tamer; Agarwal, Suneet; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Onder, Tamer; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp Boston, Stem Cell Program, Boston, MA USA; [Cabili, Moran N.; Guttman, Mitchell; Thomas, Kelly; Garber, Manuel; Lander, Eric S.; Rinn, John L.] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA USA; [Guttman, Mitchell; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Cabili, Moran N.; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomas, Kelly; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Rinn, John L.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA		Daley, GQ (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA USA.	george.daley@childrens.harvard.edu	Loh, Yuin-Han/E-1096-2014; Onder, Tamer/O-3669-2019; Onder, Tamer/H-3330-2013	Loh, Yuin-Han/0000-0002-4715-6454; Onder, Tamer/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158; Schlaeger, Thorsten/0000-0002-1599-9908; Rinn, John/0000-0002-7231-7539	Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 RC2-HL102815, RC2 HL102815, K08 HL089150] Funding Source: Medline; NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2OD00667-01, DP2 OD006670-01, DP2 OD006670] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL089150, RC2HL102815] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD006670] Funding Source: NIH RePORTER		Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	35	706	754	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1113	+		10.1038/ng.710			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	WOS:000284578800015	21057500	Green Accepted, Green Submitted			2022-01-24	
J	Strange, A; Capon, F; Spencer, CCA; Knight, J; Weale, ME; Allen, MH; Barton, A; Band, G; Bellenguez, C; Bergboer, JGM; Blackwell, JM; Bramon, E; Bumpstead, SJ; Casas, JP; Cork, MJ; Corvin, A; Deloukas, P; Dilthey, A; Duncanson, A; Edkins, S; Estivill, X; Fitzgerald, O; Freeman, C; Giardina, E; Gray, E; Hofer, A; Huffmeier, U; Hunt, SE; Irvine, AD; Jankowski, J; Kirby, B; Langford, C; Lascorz, J; Leman, J; Leslie, S; Mallbris, L; Markus, HS; Mathew, CG; McLean, WHI; McManus, R; Mossner, R; Moutsianas, L; Naluai, AT; Nestle, FO; Novelli, G; Onoufriadis, A; Palmer, CNA; Perricone, C; Pirinen, M; Plomin, R; Potter, SC; Pujol, RM; Rautanen, A; Riveira-Munoz, E; Ryan, AW; Salmhofer, W; Samuelsson, L; Sawcer, SJ; Schalkwijk, J; Smith, CH; Stahle, M; Su, Z; Tazi-Ahnini, R; Traupe, H; Viswanathan, AC; Warren, RB; Weger, W; Wolk, K; Wood, N; Worthington, J; Young, HS; Zeeuwen, PLJM; Hayday, A; Burden, AD; Griffiths, CEM; Kere, J; Reis, A; McVean, G; Evans, DM; Brown, MA; Barker, JN; Peltonen, L; Donnelly, P; Trembath, RC				Strange, Amy; Capon, Francesca; Spencer, Chris C. A.; Knight, Jo; Weale, Michael E.; Allen, Michael H.; Barton, Anne; Band, Gavin; Bellenguez, Celine; Bergboer, Judith G. M.; Blackwell, Jenefer M.; Bramon, Elvira; Bumpstead, Suzannah J.; Casas, Juan P.; Cork, Michael J.; Corvin, Aiden; Deloukas, Panos; Dilthey, Alexander; Duncanson, Audrey; Edkins, Sarah; Estivill, Xavier; Fitzgerald, Oliver; Freeman, Colin; Giardina, Emiliano; Gray, Emma; Hofer, Angelika; Hueffmeier, Ulrike; Hunt, Sarah E.; Irvine, Alan D.; Jankowski, Janusz; Kirby, Brian; Langford, Cordelia; Lascorz, Jesus; Leman, Joyce; Leslie, Stephen; Mallbris, Lotus; Markus, Hugh S.; Mathew, Christopher G.; McLean, W. H. Irwin; McManus, Ross; Moessner, Rotraut; Moutsianas, Loukas; Naluai, Asa T.; Nestle, Frank O.; Novelli, Giuseppe; Onoufriadis, Alexandros; Palmer, Colin N. A.; Perricone, Carlo; Pirinen, Matti; Plomin, Robert; Potter, Simon C.; Pujol, Ramon M.; Rautanen, Anna; Riveira-Munoz, Eva; Ryan, Anthony W.; Salmhofer, Wolfgang; Samuelsson, Lena; Sawcer, Stephen J.; Schalkwijk, Joost; Smith, Catherine H.; Stahle, Mona; Su, Zhan; Tazi-Ahnini, Rachid; Traupe, Heiko; Viswanathan, Ananth C.; Warren, Richard B.; Weger, Wolfgang; Wolk, Katarina; Wood, Nicholas; Worthington, Jane; Young, Helen S.; Zeeuwen, Patrick L. J. M.; Hayday, Adrian; Burden, A. David; Griffiths, Christopher E. M.; Kere, Juha; Reis, Andre; McVean, Gilean; Evans, David M.; Brown, Matthew A.; Barker, Jonathan N.; Peltonen, Leena; Donnelly, Peter; Trembath, Richard C.		Genetic Anal Psoriasis Consortium; Wellcome Trust Case Control	A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1	NATURE GENETICS			English	Article							STATISTICAL-METHOD; DISEASES; GENE; VARIANTS; AUTOIMMUNITY; RESPONSES; PATHWAYS; COMPLEX; FAMILY; SCAN	To identify new susceptibility loci for psoriasis, we undertook a genome-wide association study of 594,224 SNPs in 2,622 individuals with psoriasis and 5,667 controls. We identified associations at eight previously unreported genomic loci. Seven loci harbored genes with recognized immune functions (IL28RA, REL, IFIH1, ERAP1, TRAF3IP2, NFKBIA and TYK2). These associations were replicated in 9,079 European samples (six loci with a combined P < 5 x 10(-8) and two loci with a combined P < 5 x 10(-7)). We also report compelling evidence for an interaction between the HLA-C and ERAP1 loci (combined P = 6.95 x 10(-6)). ERAP1 plays an important role in MHC class I peptide processing. ERAP1 variants only influenced psoriasis susceptibility in individuals carrying the HLA-C risk allele. Our findings implicate pathways that integrate epidermal barrier dysfunction with innate and adaptive immune dysregulation in psoriasis pathogenesis.	[Strange, Amy; Spencer, Chris C. A.; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Pirinen, Matti; Rautanen, Anna; Su, Zhan; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford, England; [Capon, Francesca; Knight, Jo; Weale, Michael E.; Allen, Michael H.; Mathew, Christopher G.; Nestle, Frank O.; Onoufriadis, Alexandros; Smith, Catherine H.; Barker, Jonathan N.; Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Knight, Jo; Nestle, Frank O.; Trembath, Richard C.] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Barton, Anne] Univ Manchester, UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Bergboer, Judith G. M.; Schalkwijk, Joost; Zeeuwen, Patrick L. J. M.] Radboud Univ Nijmegen Med Ctr, Dept Dermatol, Nijmegen, Netherlands; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Bramon, Elvira] Kings Coll London, Div Psychol Med & Psychiat, Biomed Res Ctr Mental Hlth, Inst Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Bumpstead, Suzannah J.; Deloukas, Panos; Edkins, Sarah; Gray, Emma; Hunt, Sarah E.; Langford, Cordelia; Potter, Simon C.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Cork, Michael J.; Tazi-Ahnini, Rachid] Univ Sheffield, Dept Infect & Immun, Acad Unit Dermatol Res, Sheffield, S Yorkshire, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Dilthey, Alexander; Leslie, Stephen; Moutsianas, Loukas; McVean, Gilean; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Estivill, Xavier; Riveira-Munoz, Eva] CRG, Genes & Dis Programme, Barcelona, Spain; [Estivill, Xavier; Riveira-Munoz, Eva] Publ Hlth & Epidemiol Network Biomed Res Ctr CIBE, Barcelona, Spain; [Fitzgerald, Oliver; Kirby, Brian] St Vincents Univ Hosp, Dublin 4, Ireland; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Sch Med, Dept Biopathol, Ctr Excellence Genom Risk Assessment Multifactori, Rome, Italy; [Hofer, Angelika; Salmhofer, Wolfgang; Weger, Wolfgang] Med Univ Graz, Dept Dermatol, Graz, Austria; [Hueffmeier, Ulrike; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Irvine, Alan D.] Our Ladys Childrens Hosp Crumlin, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Lascorz, Jesus] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Leman, Joyce; Burden, A. David] Western Infirm & Associated Hosp, Dept Dermatol, Glasgow, Lanark, Scotland; [Mallbris, Lotus; Stahle, Mona; Wolk, Katarina] Karolinska Inst, Dept Med, Dermatol Unit, Stockholm, Sweden; [Markus, Hugh S.] St Georges Univ London, London, England; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Epithelial Genet Grp, Coll Life Sci & Med, Dundee, Scotland; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Epithelial Genet Grp, Coll Dent, Dundee, Scotland; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Epithelial Genet Grp, Coll Nursing, Dundee, Scotland; [McManus, Ross; Ryan, Anthony W.] St James Hosp, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [McManus, Ross; Ryan, Anthony W.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Moessner, Rotraut] Univ Gottingen, Dept Dermatol, Gottingen, Germany; [Naluai, Asa T.; Samuelsson, Lena] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med & Clin Genet, Gothenburg, Sweden; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Perricone, Carlo] Univ Roma La Sapienza, Rheumatol Unit, Dept Clin & Med Therapy, Rome, Italy; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Pujol, Ramon M.] Hosp del Mar, IMAS, Dermatol Serv, Barcelona, Spain; [Sawcer, Stephen J.; Hayday, Adrian] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Smith, Catherine H.; Barker, Jonathan N.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Traupe, Heiko] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Dept Genet, Inst Ophthalmol, London, England; [Warren, Richard B.; Young, Helen S.; Griffiths, Christopher E. M.] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Wood, Nicholas] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hayday, Adrian] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Hayday, Adrian] London Res Inst, Immuno Surveillance Lab, London, England; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Kere, Juha] Sci Life Lab, Stockholm, Sweden; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Evans, David M.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Evans, David M.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia		Donnelly, P (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	peter.donnelly@well.ox.ac.uk; richard.trembath@kcl.ac.uk	Schalkwijk, Joost/N-1774-2013; Young, Helen/H-5247-2015; Bellenguez, Celine/X-4004-2019; Blackwell, Jenefer M/H-3015-2015; Evans, David M/H-6325-2013; Naluai, Asa Torinsson/P-3269-2015; Estivill, Xavier/E-2957-2012; Mathew, Christopher G/G-3434-2015; Huffmeier, Ulrike/D-2806-2013; McLean, William HI/C-6352-2009; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Warren, Richard B/G-4929-2015; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013; Capon, Francesca/F-4763-2011; Mallbris, Lotus/L-8607-2019; Bramon, Elvira/A-9463-2011; Zeeuwen, Patrick LJM/N-1779-2013; Smith, Catherine H./G-5268-2012; Irvine, Alan D/A-3982-2008; Weale, Michael E/F-2587-2010; Barton, Anne/N-2053-2014; Jankowski, Janusz/H-2706-2012; Schalkwijk, Joost/R-7509-2019; Reis, Andre/D-2309-2009; Wood, Nicholas W/C-2505-2009; Plomin, Robert/B-8911-2008; Worthington, Jane/M-9770-2014; Giardina, Emiliano/J-1965-2012; Knight, Jo/F-4946-2011; Palmer, Colin NA/C-7053-2008; Ryan, Anthony W/A-1336-2010; Brown, Matthew A/E-5749-2010; Naluai, Asa Torinsson/AAB-2166-2021; McManus, Ross/AAE-9236-2020; Belllenguez, Celine/Y-3183-2018; Deloukas, Panos/B-2922-2013; Griffiths, Christopher E.M./P-5448-2014; Estivill, Xavier/A-3125-2013	Young, Helen/0000-0003-1538-445X; Bellenguez, Celine/0000-0002-1240-7874; Evans, David M/0000-0003-0663-4621; Naluai, Asa Torinsson/0000-0002-0504-6492; Mathew, Christopher G/0000-0003-4178-1838; Huffmeier, Ulrike/0000-0001-6448-4671; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Warren, Richard B/0000-0002-2918-6481; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Capon, Francesca/0000-0003-2432-5793; Zeeuwen, Patrick LJM/0000-0002-6878-2438; Smith, Catherine H./0000-0001-9918-1144; Irvine, Alan D/0000-0002-9048-2044; Weale, Michael E/0000-0003-4593-1186; Barton, Anne/0000-0003-3316-2527; Jankowski, Janusz/0000-0003-2130-9181; Schalkwijk, Joost/0000-0002-1308-1319; Reis, Andre/0000-0002-6301-6363; Wood, Nicholas W/0000-0002-9500-3348; Worthington, Jane/0000-0003-0544-042X; Palmer, Colin NA/0000-0002-6415-6560; Brown, Matthew A/0000-0003-0538-8211; Naluai, Asa Torinsson/0000-0002-0504-6492; Belllenguez, Celine/0000-0002-1240-7874; Deloukas, Panos/0000-0001-9251-070X; Griffiths, Christopher E.M./0000-0001-5371-4427; Estivill, Xavier/0000-0002-0723-2256; McLean, William Henry Irwin/0000-0001-5539-5757; Knight, Joanne/0000-0002-7148-1660; Walters, James/0000-0002-6980-4053; Riveira Munoz, Eva/0000-0002-6396-1162; Trembath, Richard/0000-0003-0550-3400; Cork, Michael/0000-0003-4428-2428; Potter, Simon/0000-0003-4208-4102; McManus, Ross/0000-0002-0529-9617; Bramon, Elvira/0000-0003-1369-5983; Hunt, Sarah/0000-0002-8350-1235; Corvin, Aiden/0000-0001-6717-4089; PUJOL, RAMON M/0000-0002-5622-6055; Edkins, Sarah/0000-0003-0717-1972; FitzGerald, Oliver/0000-0002-6607-6070; Perricone, Carlo/0000-0003-4771-6981; HAYDAY, ADRIAN/0000-0002-9495-5793; Ryan, Anthony/0000-0001-5005-3344; Plomin, Robert/0000-0002-0756-3629; Pirinen, Matti/0000-0002-1664-1350; giardina, emiliano/0000-0002-2741-5009; Barker, Jonathan/0000-0002-9030-183X; Donnelly, Peter/0000-0001-9495-3408	Wellcome TrustWellcome TrustEuropean Commission [083948/Z/07/Z]; Netherlands Organization for Health Research and Development (P.L.J.M.Z.)Netherlands Organization for Health Research and Development; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; Karolinska InstitutetKarolinska Institutet; Karolinska University HospitalKarolinska Institutet; Psoriasis Foundation; AFA Insurance and Welander Finsen Foundation; Association for the Defence of Psoriasis Patients; Psoriasis Association and the Cecil King Memorial Foundation; Swedish Psoriasis Association; German Research FoundationGerman Research Foundation (DFG) [Tr 228/5-4, Re 679/104]; Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg [IZKF B32/A8]; Spanish Ministry of Science and InnovationSpanish Government [SAF 2008-00357]; Departments of Health and Universities and Innovation; Genetic Repository in Ireland for Psoriasis and Psoriatic Arthritis; Irish Health Research Board; Wellcome Trust and Science Foundation IrelandScience Foundation Ireland [078173/Z/05/Z, 068545/Z/02]; National Institute for Health ResearchNational Institute for Health Research (NIHR); Manchester Biomedical Research CentreNational Institute for Health Research (NIHR); Arthritis Research UKVersus Arthritis [17552]; Wolfson-Royal SocietyRoyal Society of London; Generation Trust; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601387]; Department of Health through the National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); St. Thomas' National Health Service (NHS) Foundation Trust; King's College LondonGeneral Electric; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600705, G0000934, G19/2, G0901310, G0800582, G0601387, G0700314] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9817803B, G19/2, G0800582, G0600705, G0901310, G0700314, G0601387, G0600698B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10379, PDA/02/06/016, CL-2008-06-002] Funding Source: researchfish	The principal funding for this study was provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project (083948/Z/07/Z). We also thank S. Bertrand, J. Bryant, S.L. Clark, J.S. Conquer, T. Dibling, J.C. Eldred, S. Gamble, C. Hind, A. Wilk, C.R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We thank D. Davison for making available his program 'Shellfish' for calculating principal components in large genetic datasets. Case collections were supported by the Netherlands Organization for Health Research and Development (P.L.J.M.Z.); the Swedish Medical Research Council, Karolinska Institutet, Karolinska University Hospital, Psoriasis Foundation, AFA Insurance and Welander Finsen Foundation (M. S.); the Association for the Defence of Psoriasis Patients (G.N.); Psoriasis Association and the Cecil King Memorial Foundation (M.J.C.); the Swedish Psoriasis Association (L.S.); the German Research Foundation (Tr 228/5-4 and Re 679/104) and The Interdisciplinary Centre for Clinical Research (IZKF B32/A8) of the University of Erlangen-Nuremberg (A. Reis); the Spanish Ministry of Science and Innovation (grant SAF 2008-00357) and the 'Generalitat de Catalunya' Departments of Health and Universities and Innovation (X. E.); the Genetic Repository in Ireland for Psoriasis and Psoriatic Arthritis (GRIPPsA), the Dublin Centre for Clinical Research (DCCR, funded by the Irish Health Research Board), The Wellcome Trust and Science Foundation Ireland (R. McManus); National Institute for Health Research, Manchester Biomedical Research Centre (J.W., C.E.M.G., R.B.W., H.S.Y.); and Arthritis Research UK (J.W., grant 17552). P.Donnelly was supported in part by a Wolfson-Royal Society Merit Award, and A.O. was supported by a PhD studentship from The Generation Trust. We also acknowledge support from the UK Medical Research Council (to R.C.T.,F.O.N., A.H. and J.N.B., grant G0601387), the Wellcome Trust (F.O.N., grant 078173/Z/05/Z) and the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London (J. Knight., M.E.W., C.G.M., F.O.N., A. Hayday and J.N.B.) and the NIHR award to Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology (A.C.V.). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and of the UK National Blood Service controls funded by the Wellcome Trust. We thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust.	Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Orsmark-Pietras C, 2008, HUM MOL GENET, V17, P1673, DOI 10.1093/hmg/ddn058; Oyamada A, 2009, J IMMUNOL, V183, P7539, DOI 10.4049/jimmunol.0902740; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; R Development Core Team, 2010, R LANG ENV STAT COMP; SCHOUTEN EG, 1993, STAT MED, V12, P1733, DOI 10.1002/sim.4780121808; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	37	706	718	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					985	U106		10.1038/ng.694			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	WOS:000283540500016	20953190	Green Accepted			2022-01-24	
J	Grisart, B; Coppieters, W; Farnir, F; Karim, L; Ford, C; Berzi, P; Cambisano, N; Mni, M; Reid, S; Simon, P; Spelman, R; Georges, M; Snell, R				Grisart, B; Coppieters, W; Farnir, F; Karim, L; Ford, C; Berzi, P; Cambisano, N; Mni, M; Reid, S; Simon, P; Spelman, R; Georges, M; Snell, R			Positional candidate cloning of a QTL in dairy cattle: Identification of a missense mutation in the bovine DGAT1 gene with major effect on milk yield and composition	GENOME RESEARCH			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; MARKER LOCI	We recently mapped a quantitative trait locus (QTL) with a major effect on milk composition-particularly fat content-to the centromeric end of bovine chromosome 14. We subsequently exploited linkage disequilibrium to refine the map position of this QTL to a 3-cM chromosome interval bounded by microsatellite markers BULGE13 and BULGE09. We herein report the positional candidate cloning of this QTL, involving (I) the construction of a BAC contig spanning the corresponding marker interval, (2) the demonstration that a very strong candidate gene, acylCoA:diacylglycerol acyltransferase (DGATf), maps to that contig, and (3) the identification of a nonconservative K232A substitution in the DGAT1 gene with a major effect on milk fat content and other milk characteristics.	Univ Liege, Fac Vet Med, Dept Genet, B-4000 Liege, Belgium; Univ Auckland, Sch Med, ViaLactia Biosci NZ Ltd, Auckland, New Zealand; Livestock Improvement Corp, Hamilton, New Zealand		Georges, M (corresponding author), Univ Liege, Fac Vet Med, Dept Genet, B43, B-4000 Liege, Belgium.	michel.georges@ulg.ac.be	Coppieters, Wouter/AAF-5030-2021	Coppieters, Wouter/0000-0001-8109-7825; Reid, Suzanne/0000-0002-8068-6529; Snell, Russell/0000-0002-8166-4014; Georges, Michel/0000-0003-4124-2375			Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Boldman KG, 1995, MANUAL USE MTDFREML; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; FARNIR F, 2002, IN PRESS GENETICS; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Karim L, 2000, ANIM GENET, V31, P396, DOI 10.1046/j.1365-2052.2000.00684.x; LALOUEL JM, 1983, CONTRIB EPIDEMIOL BI, V4, P235; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Looft C, 2001, MAMM GENOME, V12, P646, DOI 10.1007/s003350020003; Lynch M, 1997, GENETICS ANAL QUANTI; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Riquet J, 1999, P NATL ACAD SCI USA, V96, P9252, DOI 10.1073/pnas.96.16.9252; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Warren W, 2000, MAMM GENOME, V11, P662, DOI 10.1007/s003350010126; WELLER JI, 1990, J DAIRY SCI, V73, P2525, DOI 10.3168/jds.S0022-0302(90)78938-2; Womack JE, 1997, MAMM GENOME, V8, P854, DOI 10.1007/s003359900593	28	706	767	0	51	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	FEB	2002	12	2					222	231		10.1101/gr.224202			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	518VY	WOS:000173689600003	11827942	Bronze			2022-01-24	
J	Dean, FB; Nelson, JR; Giesler, TL; Lasken, RS				Dean, FB; Nelson, JR; Giesler, TL; Lasken, RS			Rapid amplification of plasmid and phage DNA using phi29 DNA polymerase and multiply-primed rolling circle amplification	GENOME RESEARCH			English	Article							REPLICATION	We describe a simple method of using rolling circle amplification to amplify vector DNA such as M13 or plasmid DNA from single colonies or plaques. Using random primers and phi 29 DNA polymerase, circular DNA templates can be amplified 10,000-fold in a few hours. This procedure removes the need for lengthy growth periods and traditional DNA isolation methods. Reaction products can be used directly for DNA sequencing after phosphatase treatment to inactivate unincorporated nucleotides. Amplified products can also be used for in vitro cloning, library construction, and other molecular biology applications.	Mol Staging Inc, New Haven, CT 06511 USA; Amersham Pharma Biotech, Piscataway, NJ 08855 USA		Lasken, RS (corresponding author), Mol Staging Inc, New Haven, CT 06511 USA.			Dean, Frank/0000-0002-9416-4449			Baner J, 1998, NUCLEIC ACIDS RES, V26, P5073, DOI 10.1093/nar/26.22.5073; BLANCO L, 1989, J BIOL CHEM, V264, P8935; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; INNIS MA, 1990, PCR PROTOCOLS; Kornberg A., 1992, DNA REPLICATION, V2nd ed.; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Sambrook J., 1989, MOL CLONING LAB MANU	9	706	758	20	222	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	JUN	2001	11	6					1095	1099		10.1101/gr.180501			5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	438GQ	WOS:000169045600016	11381035	Green Published, Bronze			2022-01-24	
J	Witt, H; Luck, W; Hennies, HC; Classen, M; Kage, A; Lass, U; Landt, O; Becker, M				Witt, H; Luck, W; Hennies, HC; Classen, M; Kage, A; Lass, U; Landt, O; Becker, M			Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis	NATURE GENETICS			English	Article							CATIONIC TRYPSINOGEN GENE; CYSTIC-FIBROSIS GENE; HEREDITARY PANCREATITIS; LINKAGE DISEQUILIBRIUM	Chronic pancreatitis (CP) is a continuing or relapsing inflammatory disease of the pancreas. In approximately one-third of all cases, no aetiological factor can be found, and these patients are classified as having idiopathic disease. Pathophysiologically, autodigestion and inflammation may be caused by either increased proteolytic activity or decreased protease inhibition. Several studies have demonstrated mutations in the cationic trypsinogen gene (PRSS1) in patients with hereditary(1-3) or idiopathic(4) CP. It is thought that these mutations result in increased trypsin activity within the pancreatic parenchyma. Most patients with idiopathic or hereditary CP. however, do not have mutations in PRSS1 (ref. 4). Here we analysed 96 unrelated children and adolescents with CP for mutations in the gene encoding the serine protease inhibitor. Kazal type 1 (SPINK1). a pancreatic trypsin inhibitor. We found mutations in 23% of the patients. In 18 patients. 6 of whom were homozygous. we detected a missense mutation of codon 34 (N34S). We also found four other sequence variants. Our results indicate that mutations in SPINK1 are associated with chronic pancreatitis.	Humboldt Univ, Dept Pediat, Charite, Berlin, Germany; Max Delbruck Ctr Mol Med, Dept Mol Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Zent Krankenhaus Links der Weser, Dept Pediat, Bremen, Germany; Humboldt Univ, Inst Lab Med & Pathobiochem, Berlin, Germany; TIB MOLBIOL, Berlin, Germany		Witt, H (corresponding author), Humboldt Univ, Dept Pediat, Charite, Campus Virchow Klinikum, Berlin, Germany.		Hennies, Hans C/G-9424-2014	Hennies, Hans C/0000-0001-7210-2389			BARTELT DC, 1977, ARCH BIOCHEM BIOPHYS, V179, P189, DOI 10.1016/0003-9861(77)90103-5; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ferec C, 1999, J MED GENET, V36, P228; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; HORII A, 1987, BIOCHEM BIOPH RES CO, V149, P635, DOI 10.1016/0006-291X(87)90415-3; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Marchbank T, 1998, DIGESTION, V59, P167, DOI 10.1159/000007485; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rinderknecht Heinrich, 1993, P219; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3	16	705	722	1	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					213	216		10.1038/76088			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200024	10835640				2022-01-24	
J	HUGHES, J; WARD, CJ; PERAL, B; ASPINWALL, R; CLARK, K; SANMILLAN, JL; GAMBLE, V; HARRIS, PC				HUGHES, J; WARD, CJ; PERAL, B; ASPINWALL, R; CLARK, K; SANMILLAN, JL; GAMBLE, V; HARRIS, PC			THE POLYCYSTIC KIDNEY-DISEASE-1 (PKD1) GENE ENCODES A NOVEL PROTEIN WITH MULTIPLE CELL RECOGNITION DOMAINS	NATURE GENETICS			English	Article							IMMUNOGLOBULIN SUPERFAMILY; MEMBRANE-PROTEINS; SURFACE RECOGNITION; RECEPTOR; SEQUENCES; FIBRONECTIN; CONTAINS; MEMBER; FAMILY; REGION	Characterization of the polycystic kidney disease 1 (PKD1) gene has been complicated by genomic rearrangements on chromosome 16. We have used an exon linking strategy, taking RNA from a cell line containing PKD1 but not the duplicate loci, to clone a cDNA contig of the entire transcript. The transcript consists of 14,148 bp (including a correction to the previously described C terminus), distributed among 46 exons spanning 52 kb. The predicted PKD1 protein, polycystin, is a glycoprotein with multiple transmembrane domains and a cytoplasmic C-tail. The N-terminal extracellular region of over 2,500 aa contains leucine-rich repeats, a C-type lectin, 16 immunoglobulin-like repeats and four type III fibronectin-related domains. Our results indicate that polycystin is an integral membrane protein involved in cell-cell/matrix interactions.	JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HEMATOL UNIT, OXFORD OX3 9DU, ENGLAND				San-Millan, Jose L./F-9944-2015; Peral, Belen/F-4562-2015	Peral, Belen/0000-0003-4984-4020	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BORK P, 1993, PROTEIN SCI, V2, P1185, DOI 10.1002/pro.5560020714; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; BRUMMENDORF T, 1994, PROTEIN PROFILE, V1, P951; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; CARONE FA, 1994, LAB INVEST, V70, P437; CARONE FA, 1995, KIDNEY INT, V47, P861, DOI 10.1038/ki.1995.129; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DALGAARD O. Z., 1957, ACTA MED SCAND SUPPL, V158, P1; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DRICKAMER K, 1987, KIDNEY INT, V32, pS167; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; EKBLOM P, 1989, FASEB J, V3, P2141, DOI 10.1096/fasebj.3.10.2666230; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GOWER HJ, 1988, CELL, V55, P955, DOI 10.1016/0092-8674(88)90241-3; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIMMELBAUER H, 1991, AM J HUM GENET, V48, P325; JIA R, 1994, J BIOL CHEM, V269, P1839; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUMA K, 1993, MOL BIOL EVOL, V10, P539; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; MATSUSHITA O, 1994, J BACTERIOL, V176, P149, DOI 10.1128/JB.176.1.149-156.1994; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MILUTINOVIC J, 1980, AM J CLIN PATHOL, V73, P740; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; NAKASHIMA H, 1992, FEBS LETT, V303, P141, DOI 10.1016/0014-5793(92)80506-C; NELLIST M, 1993, CELL, V75, P1305; OLDBERG A, 1987, BIOCHEM J, V243, P255, DOI 10.1042/bj2430255; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1986, LANCET, V2, P6; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROTH GJ, 1991, BLOOD, V77, P5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SCHAFER K, 1994, KIDNEY INT, V46, P134, DOI 10.1038/ki.1994.253; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; SOMIO S, 1993, J AM SOC NEPHROL, V4, P1371; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; TAKAGI T, 1990, J BIOL CHEM, V265, P19721; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; VANADELSBERG JS, 1995, NAT MED, V1, P359, DOI 10.1038/nm0495-359; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WARD CJ, 1994, CELL, V77, P881; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILSON PD, 1991, KIDNEY INT, V39, P450, DOI 10.1038/ki.1991.56	63	705	727	3	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					151	160		10.1038/ng0695-151			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	WOS:A1995RA85700011	7663510				2022-01-24	
J	CORRALDEBRINSKI, M; HORTON, T; LOTT, MT; SHOFFNER, JM; BEAL, MF; WALLACE, DC				CORRALDEBRINSKI, M; HORTON, T; LOTT, MT; SHOFFNER, JM; BEAL, MF; WALLACE, DC			MITOCHONDRIAL-DNA DELETIONS IN HUMAN BRAIN - REGIONAL VARIABILITY AND INCREASE WITH ADVANCED AGE	NATURE GENETICS			English	Article							ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; NUCLEAR-DNA; HUMAN-HEART; DAMAGE; CARDIOMYOCYTES; METABOLISM; DECLINE; TISSUES	We have examined the role of somatic mitochondrial DNA (mtDNA) mutations in human ageing by quantitating the accumulation of the common 4977 nucleotide pair (np) deletion (mtDNA4977) in the cortex, putamen and cerebellum. A significant increase in the mtDNA4977 deletion was seen in elderly individuals. In the cortex, the deleted to total mtDNA ratio ranged from 0.00023 to 0.012 in 67-77 year old brains and up to 0.034 in subjects over 80. In the putamen, the deletion level ranged from 0.0016 to 0.010 in 67 to 77 years old up to 0.12 in individuals over the age of 80. The cerebellum remained relatively devoid of mtDNA deletions. Similar changes were observed with a different 7436 np deletion. These changes suggest that somatic mtDNA deletions might contribute to the neurological impairment often associated with ageing.	EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114					Lott, Marie/0000-0003-2035-479X			AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; CHAWLUK JB, 1987, J CEREB BLOOD FLO S1, V7, pS411; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; DITTER SM, 1987, NEUROLOGY, V37, P754, DOI 10.1212/WNL.37.5.754; DRAYER B, 1986, AM J NEURORADIOL, V7, P373; DRAYER BP, 1988, RADIOLOGY, V166, P785, DOI 10.1148/radiology.166.3.3277247; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FRACKOWIAK RSJ, 1984, ANN NEUROL, V15, pS112; FUKUNAGA M, 1979, BIOCHEM BIOPH RES CO, V90, P582, DOI 10.1016/0006-291X(79)91275-0; GOLDSTEIN S, 1991, CLIN NEUROPHARMACOL, V14, pS34, DOI 10.1097/00002826-199114001-00006; HARMAN D, 1986, FREE RADICALS AGING, P3; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; KATAYAMA M, 1991, BIOCHEM INT, V25, P47; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MCCORD JM, 1988, FREE RADICAL BIO MED, V4, P9, DOI 10.1016/0891-5849(88)90005-6; MCGEER PL, 1977, ARCH NEUROL-CHICAGO, V34, P33, DOI 10.1001/archneur.1977.00500130053010; MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I; MIQUEL J, 1986, FREE RADICALS AGING, V51; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1991, GERIATRICS, V46, P47; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; PARKER WD, 1992, ANN NY ACAD SCI, V640, P59; PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SOKAL RR, 1969, BIOMETRY, P387; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; UAMAGUCHI T, 1986, STROKE I, V17, P220; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0; YOSHII F, 1988, J CEREBR BLOOD F MET, V8, P654, DOI 10.1038/jcbfm.1988.112; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	40	704	717	1	26	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					324	329		10.1038/ng1292-324			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	WOS:A1992KB49500019	1303288				2022-01-24	
J	Kadoch, C; Hargreaves, DC; Hodges, C; Elias, L; Ho, L; Ranish, J; Crabtree, GR				Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney; Elias, Laura; Ho, Lena; Ranish, Jeff; Crabtree, Gerald R.			Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy	NATURE GENETICS			English	Article							CHROMATIN REMODELING COMPLEX; ACUTE LYMPHOBLASTIC-LEUKEMIA; COMPREHENSIVE GENOMIC CHARACTERIZATION; HISTONE-MODIFYING GENES; SQUAMOUS-CELL CARCINOMA; HUMAN SYNOVIAL SARCOMA; SWI-SNF COMPLEX; SOMATIC MUTATIONS; FREQUENT MUTATION; TUMOR-SUPPRESSOR	Subunits of mammalian SWI/SNF (mSWI/SNF or BAF) complexes have recently been implicated as tumor suppressors in human malignancies. To understand the full extent of their involvement, we conducted a proteomic analysis of endogenous mSWI/SNF complexes, which identified several new dedicated, stable subunits not found in yeast SWI/SNF complexes, including BCL7A, BCL7B and BCL7C, BCL11A and BCL11B, BRD9 and SS18. Incorporating these new members, we determined mSWI/SNF subunit mutation frequency in exome and whole-genome sequencing studies of primary human tumors. Notably, mSWI/SNF subunits are mutated in 19.6% of all human tumors reported in 44 studies. Our analysis suggests that specific subunits protect against cancer in specific tissues. In addition, mutations affecting more than one subunit, defined here as compound heterozygosity, are prevalent in certain cancers. Our studies demonstrate that mSWI/SNF is the most frequently mutated chromatin-regulatory complex (CRC) in human cancer, exhibiting a broad mutation pattern, similar to that of TP53. Thus, proper functioning of polymorphic BAF complexes may constitute a major mechanism of tumor suppression.	[Kadoch, Cigall; Crabtree, Gerald R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney; Elias, Laura; Ho, Lena; Crabtree, Gerald R.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney; Elias, Laura; Ho, Lena; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney; Elias, Laura; Ho, Lena; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Ranish, Jeff] Inst Syst Biol, Seattle, WA USA		Crabtree, GR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	crabtree@stanford.edu		Ho, Lena/0000-0002-9358-621X; Hodges, H. Courtney/0000-0003-4441-497X	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS046789, CA163915]; National Science Foundation (Graduate Research Fellowship Program)National Science Foundation (NSF); Helen Hay Whitney Foundation Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development Fellowship [F32HD072627]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD072627] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009302, R01CA163915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS046789, R01NS046789] Funding Source: NIH RePORTER	This work was supported in part by US National Institutes of Health (NIH) grants NS046789 and CA163915 (both to G.R.C.). G.R.C. is an Investigator of the Howard Hughes Medical Institute. C.K. is supported by the National Science Foundation (Graduate Research Fellowship Program). D.C.H. is supported by a Helen Hay Whitney Foundation Fellowship. C.H. is supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Fellowship F32HD072627.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; ATSMON A, 1969, J MOL BIOL, V45, P125, DOI 10.1016/0022-2836(69)90215-0; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger R, 2003, LEUKEMIA, V17, P1851, DOI 10.1038/sj.leu.2403061; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Biegel JA, 1999, CANCER RES, V59, P74; Bodor C, 2011, LEUKEMIA, V25, P726, DOI 10.1038/leu.2010.311; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; DelBove J, 2011, EPIGENETICS-US, V6, P1444, DOI 10.4161/epi.6.12.18492; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Durum SK, 2003, NAT IMMUNOL, V4, P512, DOI 10.1038/ni0603-512; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heeboll S, 2008, HISTOL HISTOPATHOL, V23, P1069, DOI 10.14670/HH-23.1069; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoyal Carolyn R, 2005, J Carcinog, V4, P13, DOI 10.1186/1477-3163-4-13; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kannan K, 2012, ONCOTARGET, V3, P1194; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Park SW, 2011, LEUKEMIA RES, V35, pE6, DOI 10.1016/j.leukres.2010.08.018; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; ROBERTS ME, 1970, BIOCHIM BIOPHYS ACTA, V199, P184, DOI 10.1016/0005-2787(70)90707-0; ROBINSON A, 1971, BIOCHIM BIOPHYS ACTA, V238, P99, DOI 10.1016/0005-2787(71)90014-1; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; Ryan RJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028585; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; SPITNIKELSON P, 1969, J MOL BIOL, V45, P113, DOI 10.1016/0022-2836(69)90214-9; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Takita J, 2004, GENE CHROMOSOME CANC, V40, P120, DOI 10.1002/gcc.20021; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Uno K, 2002, GENE CHROMOSOME CANC, V34, P33, DOI 10.1002/gcc.10052; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong AKC, 2000, CANCER RES, V60, P6171; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	105	703	720	4	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					592	+		10.1038/ng.2628			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	WOS:000319563900006	23644491	Green Accepted	Y	N	2022-01-24	
J	Dewannieux, M; Esnault, C; Heidmann, T				Dewannieux, M; Esnault, C; Heidmann, T			LINE-mediated retrotransposition of marked Alu sequences	NATURE GENETICS			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; SIGNAL RECOGNITION PARTICLE; RIBONUCLEOPROTEIN-PARTICLES; INDICATOR GENE; L1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; MAMMALIAN-CELLS; ORF1 PROTEIN; HUMAN GENOME; RNA-BINDING	Alu elements are the most successful transposons in humans. They are 300-bp non-coding sequences transcribed by RNA polymerase III (Pol III) and are expected to retrotranspose with the aid of reverse transcriptases of cellular origin. We previously showed that human LINEs can generate cDNA copies of any mRNA transcript by means of a retroposition process involving reverse transcription and integration by the LINE-encoded endonuclease and reverse transcriptase. Here we show mobility of marked Alu sequences in human HeLa cells with the canonical features of a retrotransposition process, including splicing out of an autocatalytic intron introduced into the marked sequence, target site duplications of varying lengths and integrations into consensus A-rich sequences. We further show that the poly-A stretch at the Alu 3' end is essential for mobility, that LINEs are required for transposition and that the rate of retroposition is 100 1,000 times higher for Alu transcripts than for control mRNAs, thus accounting for the high mutational activity of these elements observed in humans.	Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France		Heidmann, T (corresponding author), Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	heidmann@igr.fr		Dewannieux, Marie/0000-0003-3918-2414			Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Boeke J. D., 1997, P343; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Bovia F, 1996, J CELL SCI, V109, P2601; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Chaboissier MC, 2000, NUCLEIC ACIDS RES, V28, P2467, DOI 10.1093/nar/28.13.2467; CHANG DY, 1995, MOL CELL BIOL, V15, P2109; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Deininger PL, 1989, MOBILE DNA, P619; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e49; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; JENSEN S, 1991, EMBO J, V10, P1927, DOI 10.1002/j.1460-2075.1991.tb07719.x; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P487, DOI 10.1093/nar/20.3.487; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Sarrowa J, 1997, MOL CELL BIOL, V17, P1144, DOI 10.1128/MCB.17.3.1144; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; SINNETT D, 1991, J BIOL CHEM, V266, P8675; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; TCHENIO T, 1995, J VIROL, V69, P1079; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.biochem.55.1.631; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Willoughby DA, 2000, J BIOL CHEM, V275, P759, DOI 10.1074/jbc.275.2.759	49	703	725	6	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					41	48		10.1038/ng1223			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	WOS:000185018500009	12897783				2022-01-24	
J	Emamian, ES; Hall, D; Birnbaum, MJ; Karayiorgou, M; Gogos, JA				Emamian, ES; Hall, D; Birnbaum, MJ; Karayiorgou, M; Gogos, JA			Convergent evidence for impaired AKT1-GSK3 beta signaling in schizophrenia	NATURE GENETICS			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROPATHOLOGY-CONSORTIUM; BIPOLAR-DISORDER; AKT; DISEQUILIBRIUM; ASSOCIATION; INHIBITION; PATHWAY; LITHIUM	AKT-GSK3beta signaling is a target of lithium and as such has been implicated in the pathogenesis of mood disorders. Here, we provide evidence that this signaling pathway also has a role in schizophrenia. Specifically, we present convergent evidence for a decrease in AKT1 protein levels and levels of phosphorylation of GSK3beta at Ser9 in the peripheral lymphocytes and brains of individuals with schizophrenia; a significant association between schizophrenia and an AKT1 haplotype associated with lower AKT1 protein levels; and a greater sensitivity to the sensorimotor gating disruptive effect of amphetamine, conferred by AKT1 deficiency. Our findings support the proposal that alterations in AKT1-GSK3beta signaling contribute to schizophrenia pathogenesis and identify AKT1 as a potential schizophrenia susceptibility gene. Consistent with this proposal, we also show that haloperidol induces a stepwise increase in regulatory phosphorylation of AKT1 in the brains of treated mice that could compensate for an impaired function of this signaling pathway in schizophrenia.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Rockefeller Univ, Lab Human Neurogenet, New York, NY 10021 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA		Gogos, JA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, 630 W 168th St,P&S 11-519, New York, NY 10032 USA.	karayim@rockefeller.edu; jag90@columbia.edu		Birnbaum, Morris/0000-0001-9972-8680			Akama KT, 2003, J NEUROSCI, V23, P2333; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; LEWONTIN RC, 1988, GENETICS, V120, P849; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Toyota T, 2003, NEUROSCI LETT, V339, P5, DOI 10.1016/S0304-3940(02)01428-3; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1	30	702	739	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					131	137		10.1038/ng1296			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	WOS:000188542700013	14745448	Bronze			2022-01-24	
J	SanMiguel, P; Gaut, BS; Tikhonov, A; Nakajima, Y; Bennetzen, JL				SanMiguel, P; Gaut, BS; Tikhonov, A; Nakajima, Y; Bennetzen, JL			The paleontology of intergene retrotransposons of maize	NATURE GENETICS			English	Article							NUCLEOTIDE-SEQUENCE; HIGHER-PLANTS; DNA; GENE; GENOME; METHYLATION; EVOLUTION; REGIONS; RETROELEMENTS; RECOMBINATION	Retrotransposons, transposable elements related to animal retroviruses, are found in all eukaryotes investigated and make up the majority of many plant genomes(1-5). Their ubiquity points to their importance, especially in their contribution to the large-scale structure of complex genomes. The nature and frequency of retro-element appearance, activation and amplification are poorly understood in all higher eukaryotes. Here we employ a novel approach to determine the insertion dates for 17 of 23 retrotransposons found near the maize adh1 gene, and two others from unlinked sites in the maize genome, by comparison of long terminal repeat (LTR) divergences with the sequence divergence between adh1 in maize and sorghum. All retrotransposons examined have inserted within the last six million years, most in the last three million years. The structure of the adh? region appears to be standard relative to the other gene-containing regions of the maize genome, thus suggesting that retrotransposon insertions have increased the size of the maize genome from approximately 1200 Mb to 2400 Mb in the last three million years. Furthermore, the results indicate an increased mutation rate in retrotransposons compared with genes.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Genet Program, W Lafayette, IN 47907 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA		Bennetzen, JL (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	maize@bilbo.bio.purdue.edu	Tikhonov, Alexander/I-1453-2012; SanMiguel, Phillip J/I-2196-2015	Tikhonov, Alexander/0000-0003-3808-9701; SanMiguel, Phillip J/0000-0002-3742-9527			Avramova Z, 1996, PLANT J, V10, P1163, DOI 10.1046/j.1365-313X.1996.10061163.x; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; FLAVELL AJ, 1992, NUCLEIC ACIDS RES, V20, P3639, DOI 10.1093/nar/20.14.3639; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; GAUT BS, 1993, P NATL ACAD SCI USA, V90, P5095, DOI 10.1073/pnas.90.11.5095; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; GAUT BS, 1994, MOL BIOL EVOL, V11, P620; GRANDBASTIEN MA, 1992, TRENDS GENET, V8, P103, DOI 10.1016/0168-9525(92)90198-D; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; HU WM, 1995, MOL GEN GENET, V248, P471, DOI 10.1007/BF02191647; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; JIN YK, 1989, P NATL ACAD SCI USA, V86, P6235, DOI 10.1073/pnas.86.16.6235; JOHNS MA, 1983, GENETICS, V105, P733; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LEWIN B, 1997, GENES, V6, P603; NEI M, 1986, MOL BIOL EVOL, V3, P418; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; SELKER EU, 1985, P NATL ACAD SCI USA, V82, P8114, DOI 10.1073/pnas.82.23.8114; Sokal RR, 1995, BIOMETRY; Turcich MP, 1996, SEX PLANT REPROD, V9, P65, DOI 10.1007/BF02153053; VOYTAS DF, 1992, P NATL ACAD SCI USA, V89, P7124, DOI 10.1073/pnas.89.15.7124; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder JA, 1996, BIOL CHEM, V377, P605	30	702	741	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					43	45		10.1038/1695			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	WOS:000075671400016	9731528				2022-01-24	
J	Puls, I; Jonnakuty, C; LaMonte, BH; Holzbaur, ELF; Tokito, M; Mann, E; Floeter, MK; Bidus, K; Drayna, D; Oh, SJ; Brown, RH; Ludlow, CL; Fischbeck, KH				Puls, I; Jonnakuty, C; LaMonte, BH; Holzbaur, ELF; Tokito, M; Mann, E; Floeter, MK; Bidus, K; Drayna, D; Oh, SJ; Brown, RH; Ludlow, CL; Fischbeck, KH			Mutant dynactin in motor neuron disease	NATURE GENETICS			English	Article							FAST AXONAL-TRANSPORT; DROSOPHILA-MELANOGASTER; P150(GLUED) COMPONENT; CYTOPLASMIC DYNEIN; SWISS-MODEL; COMPLEX	Impaired axonal transport in motor neurons has been proposed as a mechanism for neuronal degeneration in motor neuron disease. Here we show linkage of a lower m neuron disease to a region of 4 Mb at chromosome 2p13. Mutation analysis of a gene this interval that encodes the largest subunit of the axonal transport protein dynactin showed a single base-pair change resulting in an amino-acid substitution that is p dicted to distort the folding of dynactin's microtubule-binding domain. Binding assays show decreased binding of the mutant protein to microtubules. Our results show the dysfunction of dynactin-mediated transport can lead to human motor neuron disease.	NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; NINDS, Laryngeal & Speech Sect, NIH, Bethesda, MD 20892 USA; NINDS, Electromyography Sect, NIH, Bethesda, MD 20892 USA; NIDCD, Sect Syst Biol Commun Disorders, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; Massachusetts Gen Hosp, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA		Puls, I (corresponding author), NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA.			Ludlow, Christy/0000-0002-2015-6171	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002976, Z01NS002974, ZIANS002980, Z01NS002980, ZIANS002974, Z01NS002976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER		Dupuis L, 2000, NEUROBIOL DIS, V7, P274, DOI 10.1006/nbdi.2000.0292; Gepner J, 1996, GENETICS, V142, P865; GRIFFIN JW, 1988, ANN NEUROL, V23, P3, DOI 10.1002/ana.410230103; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARTE PJ, 1983, DEV BIOL, V99, P88, DOI 10.1016/0012-1606(83)90256-7; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	701	722	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					455	456		10.1038/ng1123			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	WOS:000181928600011	12627231	Bronze			2022-01-24	
J	Lappe-Siefke, C; Goebbels, S; Gravel, M; Nicksch, E; Lee, J; Braun, PE; Griffiths, IR; Nave, KA				Lappe-Siefke, C; Goebbels, S; Gravel, M; Nicksch, E; Lee, J; Braun, PE; Griffiths, IR; Nave, KA			Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination	NATURE GENETICS			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; CENTRAL-NERVOUS-SYSTEM; PROTEOLIPID PROTEIN; SPINAL-CORD; CNS MYELIN; SUBCELLULAR-DISTRIBUTION; MULTIPLE-SCLEROSIS; MESSENGER-RNA; MICE; 3-PHOSPHODIESTERASE	Myelination of axons by oligodendrocytes enables rapid impulse propagation in the central nervous system. But long-term interactions between axons and their myelin sheaths are poorly understood. Here we show that Cnp1, which encodes 2',3'-cyclic nucleotide phosphodiesterase in oligodendrocytes, is essential for axonal survival but not for myelin assembly. In the absence of glial cyclic nucleotide phosphodiesterase, mice developed axonal swellings and neurodegeneration throughout the brain, leading to hydrocephalus and premature death. But, in contrast to previously studied myelin mutants, the ultrastructure, periodicity and physical stability of myelin were not altered in these mice. Genetically, the chief function of glia in supporting axonal integrity can thus be completely uncoupled from its function in maintaining compact myelin. Oligodendrocyte dysfunction, such as that in multiple sclerosis lesions, may suffice to cause secondary axonal loss.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Univ Glasgow, Appl Neurobiol Grp, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland		Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany.	nave@em.mpg.de	Nave, Klaus-Armin/C-8883-2011; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			AGRAWAL HC, 1990, J BIOL CHEM, V265, P11849; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Ballestero RP, 1999, J NEUROCHEM, V72, P1362, DOI 10.1046/j.1471-4159.1999.721362.x; BENNETT SAL, 1995, ACTA NEUROPATHOL, V89, P126; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; BOISON D, 1995, J NEUROSCI, V15, P5502; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BRAUN PE, 1988, J NEUROSCI, V8, P3057; BRAUN PE, 1991, J NEUROSCI RES, V30, P540, DOI 10.1002/jnr.490300311; Chandross KJ, 1999, J NEUROSCI, V19, P759, DOI 10.1523/jneurosci.19-02-00759.1999; DEANGELIS D, 1994, NATO ADV SCI INST SE, V258, P49; DEANGELIS DA, 1994, J NEUROSCI RES, V39, P386, DOI 10.1002/jnr.490390405; Gallyas F, 1979, Neurol Res, V1, P203; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GIULIAN D, 1980, J BIOL CHEM, V255, P5993; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; GRIFFITHS IR, 1981, J NEUROCYTOL, V10, P847, DOI 10.1007/BF01262657; Heaton PA, 1996, NUCLEIC ACIDS RES, V24, P850, DOI 10.1093/nar/24.5.850; HOTCHKISS RD, 1948, ARCH BIOCHEM, V16, P131; JOYNER AL, 1993, GENE TARGETING PRACT; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; KURIHARA T, 1967, J NEUROCHEM, V14, P1167, DOI 10.1111/j.1471-4159.1967.tb06164.x; Laezza C, 1997, FEBS LETT, V413, P260, DOI 10.1016/S0014-5793(97)00924-1; Lee J, 2002, J NEUROCHEM, V81, P65; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; McFerran BW, 1997, J CELL SCI, V110, P2979; NAVE KA, 2002, GLIAL CELL DEV; NISHIZAWA Y, 1985, NEUROCHEM RES, V10, P1107, DOI 10.1007/BF00965885; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; ONeill RC, 1997, J NEUROSCI RES, V50, P248; Raine CS., 1984, MYELIN, P1; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Rosenbluth J, 1996, J COMP NEUROL, V371, P336, DOI 10.1002/(SICI)1096-9861(19960722)371:2<336::AID-CNE12>3.0.CO;2-Q; SCHERER SS, 1994, NEURON, V12, P1363, DOI 10.1016/0896-6273(94)90451-0; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; SOGIN DC, 1976, J NEUROCHEM, V27, P1333, DOI 10.1111/j.1471-4159.1976.tb02612.x; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; SPRINKLE TJ, 1985, NEUROCHEM RES, V10, P919, DOI 10.1007/BF00964629; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Tsukada Yasuzo, 1992, P449; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Yin X, 1997, J NEUROSCI RES, V50, P238, DOI 10.1002/(SICI)1097-4547(19971015)50:2<238::AID-JNR12>3.0.CO;2-4; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2	48	700	710	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					366	374		10.1038/ng1095			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	WOS:000181312700013	12590258				2022-01-24	
J	Chen, AS; Marsh, DJ; Trumbauer, ME; Frazier, EG; Guan, XM; Yu, H; Rosenblum, CI; Vongs, A; Feng, Y; Cao, LH; Metzger, JM; Strack, AM; Camacho, RE; Mellin, TN; Nunes, CN; Min, W; Fisher, J; Gopal-Truter, S; MacIntyre, DE; Chen, HY; Van der Ploeg, LHT				Chen, AS; Marsh, DJ; Trumbauer, ME; Frazier, EG; Guan, XM; Yu, H; Rosenblum, CI; Vongs, A; Feng, Y; Cao, LH; Metzger, JM; Strack, AM; Camacho, RE; Mellin, TN; Nunes, CN; Min, W; Fisher, J; Gopal-Truter, S; MacIntyre, DE; Chen, HY; Van der Ploeg, LHT			Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass	NATURE GENETICS			English	Article							FRAMESHIFT MUTATION; OBESITY; MICE; IDENTIFICATION; MELANOTROPIN; ANTAGONIST; PEPTIDES; LINKAGE; PROTEIN; MC4R	Genetic(1-8) and pharmacological(6,9-12) studies have defined a role for the melanocortin-4 receptor (Mc4r) in the regulation of energy homeostasis. The physiological function of Mc3r, a melanocortin receptor expressed at high levels in the hypothalamus(13), has remained unknown. We evaluated the potential role of Mc3r in energy homeostasis by studying Mc3r-deficient (Mc3r(-/-)) mice and compared the functions of Mc3r and Mc4r in mice deficient for both genes. The 4-6-month Mc3r(-/-) mice have increased fat mass, reduced lean mass and higher feed efficiency than wild-type littermates. despite being hypophagic and maintaining normal metabolic rates. (Feed efficiency is the ratio of weight gain to food intake.) Consistent with increased fat mass. Mc3r(-/-) mice are hyperleptinaemic and male Mc3r(-/-) mice develop mild hyperinsulinaemia. Mc3r(-/-) mice did not have significantly altered corticosterone or total thyroxine (T4) levels. Mice lacking both Mc3r and Mc4r become significantly heavier than Mc4r(-/-) mice. We conclude that Mc3r and Mc4r serve nonredundant roles in the regulation of energy homeostasis.	Merck Res Labs, Dept Obes Res, Rahway, NJ 07065 USA; Merck Res Labs, Dept Anim Pharmacol, Rahway, NJ USA; Merck Res Labs, Dept Comparat Med, Rahway, NJ USA		Van der Ploeg, LHT (corresponding author), Merck Res Labs, Dept Obes Res, Rahway, NJ 07065 USA.						Bagnol D, 1999, J NEUROSCI, V19; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; CHEN A, IN PRESS TRANSGENIC; Chhajlani V, 1996, BIOCHEM MOL BIOL INT, V38, P73; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fekete C, 2000, J NEUROSCI, V20, P1550; FRIGERI LG, 1988, INT J OBESITY, V12, P305; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Guan XM, 1998, MOL BRAIN RES, V59, P273, DOI 10.1016/S0169-328X(98)00150-8; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JOHNSON PR, 1972, J LIPID RES, V13, P2; Jones BH, 1996, AM J PHYSIOL-ENDOC M, V270, pE192, DOI 10.1152/ajpendo.1996.270.1.E192; Kelly TL, 1998, APPL RADIAT ISOTOPES, V49, P511, DOI 10.1016/S0969-8043(97)00226-1; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; SHIMIZU H, 1989, LIFE SCI, V45, P543, DOI 10.1016/0024-3205(89)90105-7; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391; YEN T T T, 1970, Hormone and Metabolic Research, V2, P200; YEN TT, 1976, BIOCHIM BIOPHYS ACTA, V441, P213, DOI 10.1016/0005-2760(76)90164-8; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	30	700	720	5	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					97	102		10.1038/79254			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000027	10973258				2022-01-24	
J	Colvin, JS; Bohne, BA; Harding, GW; McEwen, DG; Ornitz, DM				Colvin, JS; Bohne, BA; Harding, GW; McEwen, DG; Ornitz, DM			Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3	NATURE GENETICS			English	Article							DISRUPTION; MOUSE; GENE; ORGANOGENESIS; OSSIFICATION; EXPRESSION; DEFECTS; FAMILY	Fibroblast growth factor receptor 3 (Fgfr3) is a tyrosine kinase receptor expressed in developing bone, cochlea, brain and spinal cord. Achondroplasia, the most common genetic form of dwarfism, is caused by mutations in FGFR3. Here we show that mice homozygous for a targeted disruption of Fgfr3 exhibit skeletal and inner ear defects. Skeletal defects include kyphosis, scoliosis, crooked tails and curvature and overgrowth of long bones and vertebrae. Contrasts between the skeletal phenotype and achondroplasia suggest that activation of FGFR3 causes achondroplasia. Inner ear defects include failure of pillar cell differentiation and tunnel of Corti formation and result in profound deafness. Our results demonstrate that Fgfr3 is essential for normal endochondral ossification and inner ear development.	WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT OTOLARYNGOL, ST LOUIS, MO 63110 USA				Bohne, Barbara/A-9113-2008	Bohne, Barbara/0000-0003-3874-7620; Ornitz, David/0000-0003-1592-7629	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC00071] Funding Source: Medline		BARON J, 1994, ENDOCRINOLOGY, V135, P2790, DOI 10.1210/en.135.6.2790; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BOHNE BA, 1972, LARYNGOSCOPE, V82, P1; BRINER J, 1991, PATHOL RES PRACT, V187, P271; Caplan, 1987, BONE MINERAL RES, V5, P117; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; DAVIS H, 1953, J ACOUST SOC AM, V25, P1180, DOI 10.1121/1.1907260; Engstrom H., 1966, STRUCTURAL PATTERN O; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; HENRY KR, 1979, AUDIOLOGY, V18, P93; HENRY KR, 1979, ACTA OTO-LARYNGOL, V87, P61, DOI 10.3109/00016487909126387; IANNOTTI JP, 1990, ORTHOP CLIN N AM, V21, P1; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KATO Y, 1990, J BIOL CHEM, V265, P5903; Kikuchi K, 1965, Acta Otolaryngol, V60, P207, DOI 10.3109/00016486509127003; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; MIKAELIAN DO, 1974, ACTA OTO-LARYNGOL, V77, P327, DOI 10.3109/00016487409124632; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; PEREZCASTRO AV, 1995, GENOMICS, V30, P157, DOI 10.1006/geno.1995.9890; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; PETERS KG, 1992, DEVELOPMENT, V114, P233; PINELLI V, 1988, HUMAN ACHONDROPLASIA, P149; PIRVOLA U, 1995, P NATL ACAD SCI USA, V92, P9269, DOI 10.1073/pnas.92.20.9269; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; RIMOIN DL, 1970, NEW ENGL J MED, V283, P728, DOI 10.1056/NEJM197010012831404; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHEN MM, 1994, EMBO J, V13, P1375, DOI 10.1002/j.1460-2075.1994.tb06391.x; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Sidman R.L., 1965, CATALOG NEUROLOGICAL; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WALLIN J, 1994, DEVELOPMENT, V120, P1109	38	700	712	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					390	397		10.1038/ng0496-390			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	WOS:A1996UC55300017	8630492				2022-01-24	
J	PATERSON, AH; DAMON, S; HEWITT, JD; ZAMIR, D; RABINOWITCH, HD; LINCOLN, SE; LANDER, ES; TANKSLEY, SD				PATERSON, AH; DAMON, S; HEWITT, JD; ZAMIR, D; RABINOWITCH, HD; LINCOLN, SE; LANDER, ES; TANKSLEY, SD			MENDELIAN FACTORS UNDERLYING QUANTITATIVE TRAITS IN TOMATO - COMPARISON ACROSS SPECIES, GENERATIONS, AND ENVIRONMENTS	GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; SOLUBLE SOLIDS CONTENT; GENETIC-LINKAGE MAP; MAIZE; PLANTS	As part of ongoing studies regarding the genetic basis of quantitative variation in phenotype, we have determined the chromosomal locations of quantitative trait loci (QTLs) affecting fruit size, soluble solids concentration, and pH, in a cross between the domestic tomato (Lycopersicon esculentum Mill.) and a closely-related wild species, L. cheesmanii. Using a RFLP map of the tomato genome, we compared the inheritance patterns of polymorphisms in 350 F2 individuals with phenotypes scored in three different ways: (1) from the F2 progeny themselves, grown near Davis, California; (2) from F3 families obtained by selfing each F2 individual, grown near Gilroy, California (F3-CA); and (3) from equivalent F3 families grown near Rehovot, Israel (F3-IS). Maximum likelihood methods were used to estimate the approximate chromosomal locations, phenotypic effects (both additive effects and dominance deviations), and gene action of QTLs underlying phenotypic variation in each of these three environments. A total of 29 putative QTLs were detected in the three environments. These QTLs were distributed over 11 of the 12 chromosomes, accounted for 4.7-42.0% of the phenotypic variance in a trait, and showed different types of gene action. Among these 29 QTLs, 4 were detected in all three environments, 10 in two environments, and 15 only in a single environment. The two California environments were most similar, sharing 11/25 (44%) QTLs, while the Israel environment was quite different, sharing 7/20 (35%) and 5/26 (19%) QTLs with the respective California environments. One major goal of QTL mapping is to predict, with maximum accuracy, which individuals will produce progeny showing particular phenotypes. Traditionally, the phenotype of an individual alone has been used to predict the phenotype of its progeny. Our results suggested that, for a trait with low heritability (soluble solids), the phenotype of F3 progeny could be predicted more accurately from the genotype of the F2 parent at QTLs than from the phenotype of the F2 individual. For a trait with intermediate heritability (fruit pH), QTL genotype and observed phenotype were about equally effective at predicting progeny phenotype. For a trait with high heritability (mass per fruit), knowing the QTL genotype of an individual added little if any predictive value, to simply knowing the phenotype. The QTLs mapped in the L. esculentum x L. cheesmanii F2 appear to be at similar locations to many of those mapped in a previous cross with a different wild tomato (L. chmielewskii). One possible explanation of this similarity is that genetic factors at some of the same loci may affect the traits in the two distantly-related wild species. Potentially major implications of such similarity across broad genetic distances are discussed, in regard to plant and animal breeding, germplasm introgression, and cloning of QTLs.	CORNELL UNIV,DEPT PLANT BREEDING & BIOMETRY,ITHACA,NY 14853; UNIV CALIF DAVIS,DEPT VEGETABLE CROPS,DAVIS,CA 95616; NORTHRUP KING RES,GILROY,CA 95021; HEBREW UNIV JERUSALEM,DEPT FIELD & VEGETABLE CROPS,IL-76100 REHOVOT,ISRAEL; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; HARVARD UNIV,CAMBRIDGE,MA 02138				Rabinowitch, Haim/Q-7106-2019				ALLARD R. W., 1956, HILGARDIA, V24, P235; ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; [Anonymous], 1909, ELEMENTE EXAKTEN ERB; BERNATZKY R, 1986, GENETICS, V112, P887; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURR B, 1988, GENETICS, V118, P519; BURR B, 1983, GENETIC ENG PRINCIPL, V5, P45; DAVISSON MT, 1981, GENETIC VARIANTS STR, P416; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EAST EM, 1915, GENETICS, V1, P164; EDWARDS MD, 1987, GENETICS, V116, P113; EMERY GC, 1966, J AM SOC HORTIC SCI, V95, P410; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FREY K. J., 1957, AGRON JOUR, V49, P59; GADISH I, 1987, GENOME, V29, P156, DOI 10.1139/g87-026; GOLDENBERG J. B., 1966, Bol. genet. Inst. Fitotec. Castelar, V2, P1; Gruneberg H, 1938, PROC R SOC SER B-BIO, V125, P123, DOI 10.1098/rspb.1938.0017; IBARBIA EA, 1969, J AM SOC HORTIC SCI, V94, P496; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDE R, 1981, GENETICS, V99, P541; LANDE R, 1990, GENETICS, V124, P743; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; MAEDA TAKESHIGE, 1939, JAP JOUR GENETICS, V15, P118, DOI 10.1266/jjg.15.118; Mather K., 1971, BIOMETRICAL GENETICS; MILLER JD, 1990, IN PRESS THEOR APPL; Morgan TH, 1914, BIOL BULL-US, V26, P195, DOI 10.2307/1536193; Nilsson-Ehle H., 1909, LUNDS U AARSKR, V2 5, P1; OSBORN TC, 1987, THEOR APPL GENET, V73, P350, DOI 10.1007/BF00262500; OTT J, 1985, ANAL HUMAN GENETIC L; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PATERSON AH, 1990, GENETICS, V124, P735; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; RHOADES M. M., 1941, JOUR AMER SOC AGRON, V33, P603; RICK CM, 1974, HILGARDIA, V42, P493, DOI 10.3733/hilg.v42n15p493; RICK CM, 1979, BIOL SOLANACEAE, P677; ROBERTSON DS, 1984, GENETICS, V107, P117; Sax K, 1923, GENETICS, V8, P552; SHRIMPTON AE, 1988, GENETICS, V118, P445; SIMMONDS NW, 1981, PRINCIPLES CROP IMPR; SMITH J. D., 1965, Crop Sin., V5, P595; SOLLER M, 1988, 2ND P INT C QUANT GE, P161; SPICKETT SG, 1966, GENET RES, V7, P96, DOI 10.1017/S0016672300009502; STUBER CW, 1986, 41ST P ANN CORN SORG, V41, P70; TANKSLEY D, 1981, THEOR APPL GENET, V60, P291, DOI 10.1007/BF00263721; TANKSLEY SD, 1988, THEOR APPL GENET, V75, P811, DOI 10.1007/BF00265610; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; TANKSLEY SD, 1988, 18TH P STADL GEN S, P157; Tazima, 1964, GENETICS SILKWORM; Wright S., 1968, EVOLUTION GENETICS P; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322; [No title captured]; 1988, SAS USERS GUIDE STAT	53	700	792	0	131	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JAN	1991	127	1					181	197					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EP811	WOS:A1991EP81100017	1673106				2022-01-24	
J	Quesada, V; Conde, L; Villamor, N; Ordonez, GR; Jares, P; Bassaganyas, L; Ramsay, AJ; Bea, S; Pinyol, M; Martinez-Trillos, A; Lopez-Guerra, M; Colomer, D; Navarro, A; Baumann, T; Aymerich, M; Rozman, M; Delgado, J; Gine, E; Hernandez, JM; Gonzalez-Diaz, M; Puente, DA; Velasco, G; Freije, JMP; Tubio, JMC; Royo, R; Gelpi, JL; Orozco, M; Pisano, DG; Zamora, J; Vazquez, M; Valencia, A; Himmelbauer, H; Bayes, M; Heath, S; Gut, M; Gut, I; Estivill, X; Lopez-Guillermo, A; Puente, XS; Campo, E; Lopez-Otin, C				Quesada, Victor; Conde, Laura; Villamor, Neus; Ordonez, Gonzalo R.; Jares, Pedro; Bassaganyas, Laia; Ramsay, Andrew J.; Bea, Silvia; Pinyol, Magda; Martinez-Trillos, Alejandra; Lopez-Guerra, Monica; Colomer, Dolors; Navarro, Alba; Baumann, Tycho; Aymerich, Marta; Rozman, Maria; Delgado, Julio; Gine, Eva; Hernandez, Jesus M.; Gonzalez-Diaz, Marcos; Puente, Diana A.; Velasco, Gloria; Freije, Jose M. P.; Tubio, Jose M. C.; Royo, Romina; Gelpi, Josep L.; Orozco, Modesto; Pisano, David G.; Zamora, Jorge; Vazquez, Miguel; Valencia, Alfonso; Himmelbauer, Heinz; Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo; Estivill, Xavier; Lopez-Guillermo, Armando; Puente, Xose S.; Campo, Elias; Lopez-Otin, Carlos			Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia	NATURE GENETICS			English	Article							PRE-MESSENGER-RNA; CANCER GENOME; SOMATIC MUTATIONS; MYELODYSPLASIA; SPLICEOSTATIN; ACTIVATION; EXPRESSION; PATHWAYS	Here we perform whole-exome sequencing of samples from 105 individuals with chronic lymphocytic leukemia (CLL)(1,2), the most frequent leukemia in adults in Western countries. We found 1,246 somatic mutations potentially affecting gene function and identified 78 genes with predicted functional alterations in more than one tumor sample. Among these genes, SF3B1, encoding a subunit of the spliceosomal U2 small nuclear ribonucleoprotein (snRNP), is somatically mutated in 9.7% of affected individuals. Further analysis in 279 individuals with CLL showed that SF3B1 mutations were associated with faster disease progression and poor overall survival. This work provides the first comprehensive catalog of somatic mutations in CLL with relevant clinical correlates and defines a large set of new genes that may drive the development of this common form of leukemia. The results reinforce the idea that targeting several well-known genetic pathways, including mRNA splicing, could be useful in the treatment of CLL and other malignancies.	[Quesada, Victor; Ordonez, Gonzalo R.; Ramsay, Andrew J.; Puente, Diana A.; Velasco, Gloria; Freije, Jose M. P.; Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain; [Conde, Laura; Villamor, Neus; Jares, Pedro; Bea, Silvia; Lopez-Guerra, Monica; Colomer, Dolors; Navarro, Alba; Aymerich, Marta; Rozman, Maria; Campo, Elias] Univ Barcelona, Unidad Hematopatol, Serv Anat Patol, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain; [Bassaganyas, Laia; Tubio, Jose M. C.; Estivill, Xavier] Pompeu Fabra Univ CRG UPF, Ctr Genom Regulat, Genes & Dis Programme, Barcelona, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona, Spain; [Baumann, Tycho; Delgado, Julio; Gine, Eva] Univ Barcelona, Serv Hematol, Hosp Clin, Barcelona, Spain; [Hernandez, Jesus M.; Gonzalez-Diaz, Marcos] Univ Salamanca, Serv Hematol, Univ Hosp, Ctr Invest Canc, E-37008 Salamanca, Spain; [Royo, Romina; Gelpi, Josep L.; Orozco, Modesto] Univ Barcelona, Programa Conjunto Biol Computac, BSC, IRB,Spanish Natl Bioinformat Inst, Barcelona, Spain; [Pisano, David G.; Zamora, Jorge; Vazquez, Miguel; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain; [Himmelbauer, Heinz] CRG UPF, Ultrasequencing Unit, Barcelona, Spain; [Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona, Spain		Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain.	ecampo@clinic.ub.es; clo@uniovi.es	Estivill, Xavier/A-3125-2013; Hernandez, Jesus M/B-5459-2017; Heath, Simon C/J-4138-2012; COLOMER, DOLORS/ABG-6894-2020; Quesada, Victor/ABC-5437-2020; Tubio, Jose/AAG-7345-2019; Gut, Ivo/ABF-3188-2020; Pisano, David/N-5817-2014; Valencia, Alfonso/I-3127-2015; Gelpi, Josep Ll./M-6401-2013; Velasco, Gloria/AAS-5842-2021; Delgado, Julio/D-4891-2013; Jares, Pedro/T-3778-2019; Navarro, Alba/H-2611-2015; Lopez-Guillermo, Armando/Z-5684-2019; bea, silvia/K-7699-2014; Tubio, Jose M.C./H-5076-2015; Quesada, Victor/B-6557-2014; Puente, Xose S/ABG-3163-2020; Campo, Elias/AAC-5593-2019; Estivill, Xavier/E-2957-2012; Freije, Jose M.P./A-6535-2008; Lopez-Otin, Carlos/AAB-2106-2020; Vazquez, Miguel/I-2593-2015	Estivill, Xavier/0000-0002-0723-2256; Hernandez, Jesus M/0000-0002-9661-9371; Heath, Simon C/0000-0002-9550-0897; Quesada, Victor/0000-0002-8398-3457; Tubio, Jose/0000-0003-3540-2459; Pisano, David/0000-0002-4895-4124; Valencia, Alfonso/0000-0002-8937-6789; Gelpi, Josep Ll./0000-0002-0566-7723; Velasco, Gloria/0000-0001-8032-5056; Delgado, Julio/0000-0002-5157-4376; Navarro, Alba/0000-0002-4041-0974; bea, silvia/0000-0001-7192-2385; Tubio, Jose M.C./0000-0003-3540-2459; Quesada, Victor/0000-0002-8398-3457; Puente, Xose S/0000-0001-9525-1483; Campo, Elias/0000-0001-9850-9793; Freije, Jose M.P./0000-0002-4688-8266; Lopez-Otin, Carlos/0000-0001-6964-1904; Vazquez, Miguel/0000-0002-5713-1058; Orozco Lopez, Modesto/0000-0002-8608-3278; BASSAGANYAS, LAIA/0000-0002-4575-0214; JARES, PEDRO/0000-0002-8401-579X; Baumann, Tycho Stephan/0000-0003-4421-0088; Gonzalez Diaz, Marcos/0000-0001-6637-1072; COLOMER, DOLORS/0000-0001-7486-8484; Royo, Romina/0000-0003-3493-0874; Rozman, Maria/0000-0002-2641-1110; Himmelbauer, Heinz/0000-0001-8897-2928	Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	We are grateful to P. Klatt for continuous support, E. Montserrat, J. Valcarcel, P. Nicolas and C. Romeo-Casabona for helpful comments, S. Guijarro, S. Martin, C. Capdevila, M. Sanchez and L. Pla for excellent technical assistance, and N. Villahoz and C. Muro for excellent work in the coordination of the CLL Spanish Consortium. We are also very grateful to all the individuals with CLL who participated in this study. This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. C.L-O. is an Investigator of the Botin Foundation.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudot A, 2010, EMBO REP, V11, P805, DOI 10.1038/embor.2010.133; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; Bulwin GC, 2006, J IMMUNOL, V177, P6833, DOI 10.4049/jimmunol.177.10.6833; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen AA, 2009, CARCINOGENESIS, V30, P977, DOI 10.1093/carcin/bgp076; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greif PA, 2011, LEUKEMIA, V25, P821, DOI 10.1038/leu.2011.19; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; PETO R, 1973, BIOMETRICS, V29, P579, DOI 10.2307/2529177; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prazeres H, 2011, ONCOGENE, V30, P1302, DOI 10.1038/onc.2010.512; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zainuddin N, 2011, LEUKEMIA RES, V35, P272, DOI 10.1016/j.leukres.2010.08.023; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang X, 2011, LEUKEMIA, V25, P1908, DOI 10.1038/leu.2011.163	43	699	713	4	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					47	52		10.1038/ng.1032			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	WOS:000298664000012	22158541		Y	N	2022-01-24	
J	Treangen, TJ; Ondov, BD; Koren, S; Phillippy, AM				Treangen, Todd J.; Ondov, Brian D.; Koren, Sergey; Phillippy, Adam M.			The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes	GENOME BIOLOGY			English	Article							MULTIPLE-SEQUENCE ALIGNMENT; BURROWS-WHEELER TRANSFORM; CLOSTRIDIUM-DIFFICILE; ESCHERICHIA-COLI; READ ALIGNMENT; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; HIGH-THROUGHPUT; WHOLE GENOMES	Whole-genome sequences are now available for many microbial species and clades, however existing whole-genome alignment methods are limited in their ability to perform sequence comparisons of multiple sequences simultaneously. Here we present the Harvest suite of core-genome alignment and visualization tools for the rapid and simultaneous analysis of thousands of intraspecific microbial strains. Harvest includes Parsnp, a fast core-genome multi-aligner, and Gingr, a dynamic visual platform. Together they provide interactive core-genome alignments, variant calls, recombination detection, and phylogenetic trees. Using simulated and real data we demonstrate that our approach exhibits unrivaled speed while maintaining the accuracy of existing methods. The Harvest suite is open-source and freely available from: http://github.com/marbl/harvest.	[Treangen, Todd J.; Ondov, Brian D.; Koren, Sergey; Phillippy, Adam M.] Natl Biodefense Anal & Countermeasures Ctr, Frederick, MD 21702 USA		Treangen, TJ (corresponding author), Natl Biodefense Anal & Countermeasures Ctr, 110 Thomas Johnson Dr, Frederick, MD 21702 USA.	treangent@nbacc.net	Koren, Sergey/AAE-8314-2019; Phillippy, Adam M/U-5731-2018	Phillippy, Adam M/0000-0003-2983-8934; Koren, Sergey/0000-0002-1472-8962	Department of Homeland Security Science and Technology Directorate (DHS/ST)United States Department of Homeland Security (DHS) [HSHQDC-07-C-00020]; Federally Funded Research and Development Center	We would like to thank Inaki Comas for providing the raw data for the TB study; Xiangyu Deng for helpful comments on the manuscript and software; and Bradd Haley, Bill Klimke, Jason Sahl, Maliha Aziz, and Suzanne Bialek-Davenet for feedback on early versions of the software. This work was funded under Agreement No. HSHQDC-07-C-00020 awarded by the Department of Homeland Security Science and Technology Directorate (DHS/S&T) for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. In no event shall the DHS, NBACC, or Battelle National Biodefense Institute (BNBI) have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication.	Alekseyev MA, 2009, GENOME RES, V19, P943, DOI 10.1101/gr.082784.108; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Castillo-Ramirez S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r126; Chan CX, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-3; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chor B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r108; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dale J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001381; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling Aaron E., 2007, V396, P135; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dawson LF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-86; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Didelot X, 2009, GENOME RES, V19, P306, DOI 10.1101/gr.082263.108; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Garrison E, ARXIV2012; Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; Harris SR, 2013, NAT BIOTECHNOL, V31, P592, DOI 10.1038/nbt.2616; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayward A, 2013, P NATL ACAD SCI USA, V110, P20146, DOI 10.1073/pnas.1315419110; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Hohl Michael, 2002, Bioinformatics, V18 Suppl 1, pS312; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Koren S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-126; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lipman D, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2010-12-3-402, 10.1186/gb-2011-12-3-402]; Liu K, 2014, METHODS MOL BIOL, V1079, P219, DOI 10.1007/978-1-62703-646-7_15; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Loytynoja A, 2012, BIOINFORMATICS, V28, P1684, DOI 10.1093/bioinformatics/bts198; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Posada D, 2013, J MOL EVOL, V76, P351, DOI 10.1007/s00239-013-9566-z; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440; Sahl JW, 2014, PEERJ, V2, DOI 10.7717/peerj.332; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Swidan F, 2006, PLOS COMPUT BIOL, V2, P870, DOI 10.1371/journal.pcbi.0020075; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van Vugt-Lussenburg BMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055549; Venugopal AA, 2012, CLIN INFECT DIS, V55, pS71, DOI 10.1093/cid/cis355; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yahara K, 2014, MOL BIOL EVOL, V31, P1593, DOI 10.1093/molbev/msu082; YOUNG GP, 1985, GASTROENTEROLOGY, V89, P1038, DOI 10.1016/0016-5085(85)90206-9; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31	112	697	706	14	51	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2014	15	11							524	10.1186/s13059-014-0524-x			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AW9XA	WOS:000346607300019	25410596	Green Submitted, Green Published, gold	Y	N	2022-01-24	
J	Doniger, SW; Salomonis, N; Dahlquist, KD; Vranizan, K; Lawlor, SC; Conklin, BR				Doniger, SW; Salomonis, N; Dahlquist, KD; Vranizan, K; Lawlor, SC; Conklin, BR			MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data	GENOME BIOLOGY			English	Article							GENOME; APOPTOSIS; PATTERNS; MOUSE; HEART; TOOL	MAPPFinder is a tool that creates a global gene-expression profile across all areas of biology by integrating the annotations of the Gene Ontology (GO) Project with the free software package GenMAPP (http://www.GenMAPP.org). The results are displayed in a searchable browser, allowing the user to rapidly identify GO terms with over-represented numbers of gene-expression changes. Clicking on GO terms generates GenMAPP graphical files where gene relationships can be explored, annotated, and files can be freely exchanged.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA		Conklin, BR (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA.		Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000083] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR00083, M01 RR000083] Funding Source: Medline		Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fritz HL, 1999, HISTOCHEM CELL BIOL, V112, P359, DOI 10.1007/s004180050417; Grosu P, 2002, GENOME RES, V12, P1121, DOI 10.1101/gr.226602; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Kubalak SW, 2002, DEVELOPMENT, V129, P733; LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172; Luyf ACM, 2002, BIOINFORMATICS, V18, P813, DOI 10.1093/bioinformatics/18.6.813; Nakao, 1999, Genome Inform Ser Workshop Genome Inform, V10, P94; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Poelmann RE, 2000, CELL TISSUE RES, V301, P43, DOI 10.1007/s004410000227; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; ZHU H, 1997, MYOCARDIUM, P33	17	696	727	0	10	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1465-6914			GENOME BIOL	Genome Biol.		2003	4	1							R7	10.1186/gb-2003-4-1-r7			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	675DN	WOS:000182677900012	12540299				2022-01-24	
J	Underhill, PA; Shen, PD; Lin, AA; Jin, L; Passarino, G; Yang, WH; Kauffman, E; Bonne-Tamir, B; Bertranpetit, J; Francalacci, P; Ibrahim, M; Jenkins, T; Kidd, JR; Mehdi, SQ; Seielstad, MT; Wells, RS; Piazza, A; Davis, RW; Feldman, MW; Cavalli-Sforza, LL; Oefner, PJ				Underhill, PA; Shen, PD; Lin, AA; Jin, L; Passarino, G; Yang, WH; Kauffman, E; Bonne-Tamir, B; Bertranpetit, J; Francalacci, P; Ibrahim, M; Jenkins, T; Kidd, JR; Mehdi, SQ; Seielstad, MT; Wells, RS; Piazza, A; Davis, RW; Feldman, MW; Cavalli-Sforza, LL; Oefner, PJ			Y chromosome sequence variation and the history of human populations	NATURE GENETICS			English	Article							GENETIC-EVIDENCE; HAPLOTYPES; AFRICA	Binary polymorphisms associated with the non-recombining region of the human Y chromosome (NRY) preserve the paternal genetic: legacy of our species that has persisted to the present, permitting inference of human evolution, population affinity and demographic history(1). We used denaturing highperformance liquid chromatography (DHPLC; ref. 2) to identify 160 of the 166 bi-allelic and 1 tri-allelic site that formed a parsimonious; genealogy of 116 haplotypes, several of which display distinct population affinities based on the analysis of 1062 globally representative individuals. A minority of contemporary East Africans and Khoisan represent the descendants of the most ancestral patrilineages of anatomically modern humans that left Africa between 35,000 and 89,000 years ago.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA USA; Univ Texas, Ctr Human Genet, Houston, TX USA; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Univ Pompeu Fabra, Fac Ciencies Salut Vida, Unitat Biol Evolut, Barcelona, Spain; Univ Sassari, Dipartimento Zool & Antropol Biol, I-07100 Sassari, Italy; Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; S African Inst Med Res, Sch Pathol, Dept Human Genet, Johannesburg, South Africa; Univ Witwatersrand, Johannesburg, South Africa; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Biomed & Genet Engn Labs, Dr AQ Khan Res Labs, Islamabad, Pakistan; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Univ Turin, Dept Genet, Dept Genet Biol & Biochem, Turin, Italy; Stanford Univ, Dept Biol Sci, Herrin Labs, Stanford, CA 94305 USA		Underhill, PA (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	under@stanford.edu	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Mehdi, Syed Qasim/L-2385-2015; Seielstad, Mark/T-7841-2019; Bertranpetit, Jaume/F-8550-2012	Jin, Li/0000-0002-4546-2415; Bertranpetit, Jaume/0000-0003-0100-0590; Seielstad, Mark/0000-0001-5783-1401; FRANCALACCI, Paolo/0000-0001-7912-162X; Piazza, Alberto/0000-0002-2355-4183			Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Cavalli-Sforza L., HIST GEOGRAPHY HUMAN; Diamond J, 1999, GUNS GERMS STEEL; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Jaruzelska J, 1999, MOL BIOL EVOL, V16, P1633, DOI 10.1093/oxfordjournals.molbev.a026076; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Klein R. G., 1999, HUMAN CAREER HUMAN B; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Nachman MW, 1998, MOL BIOL EVOL, V15, P1744, DOI 10.1093/oxfordjournals.molbev.a025900; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; TAJIMA F, 1989, GENETICS, V123, P585; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zerjal T, 1997, AM J HUM GENET, V60, P1174	26	696	745	4	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					358	361		10.1038/81685			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500029	11062480				2022-01-24	
J	Semina, EV; Reiter, R; Leysens, NJ; Alward, WLM; Small, KW; Datson, NA; SiegelBartelt, J; BierkeNelson, D; Bitoun, P; Zabel, BU; Carey, JC; Murray, JC				Semina, EV; Reiter, R; Leysens, NJ; Alward, WLM; Small, KW; Datson, NA; SiegelBartelt, J; BierkeNelson, D; Bitoun, P; Zabel, BU; Carey, JC; Murray, JC			Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome	NATURE GENETICS			English	Article							IN-SITU HYBRIDIZATION; MESSENGER-RNA; CLEFT-PALATE; EVOLUTIONARY CONSERVATION; WAARDENBURG SYNDROME; HOMEODOMAIN PROTEIN; EXPRESSION PATTERNS; MOUSE EMBRYO; MAJOR LOCUS; BOX GENE	Rieger syndrome (RIEG) is an autosomal-dominant human disorder that includes anomalies of the anterior chamber of the eye, dental hypoplasia and a protuberant umbilicus. We report the human cDNA and genomic characterization of a new homeobox gene, RIEG, causing this disorder. Six mutations in RIEG were found in individuals with the disorder. The cDNA sequence of Rieg, the murine homologue of RIEG, has also been isolated and shows strong homology with the human sequence. In mouse embryos Rieg mRNA localized in the periocular mesenchyme, maxillary and mandibular epithelia, and umbilicus, all consistent with RIEG abnormalities. The gene is also expressed in Rathke's pouch, vitelline vessels and the limb mesenchyme. RIEG characterization provides opportunities for understanding ocular, dental and umbilical development and the pleiotropic interactions of pituitary and limb morphogenesis.	UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT BIOL SCI,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV CALIF LOS ANGELES,MED CTR,DEPT OPHTHALMOL,JULES STEIN EYE INST,LOS ANGELES,CA 90095; LEIDEN UNIV,SECTIE ANTHROPOGENET,SYLVIUS LAB,NL-2333 AL LEIDEN,NETHERLANDS; HOSP SICK CHILDREN,DEPT CLIN GENET,TORONTO,ON M5G 1X8,CANADA; DULUTH CLIN,DULUTH,MN 55805; HOP JEAN VERDIER,F-93143 BONDY,FRANCE; UNIV MAINZ,KLINIKUM JOHANNES GUTENBERG,DEPT PEDIAT,D-55101 MAINZ,GERMANY; UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,SALT LAKE CITY,UT 84132				Datson, Nicole A./O-8797-2014; Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Bitoun, Pierre/0000-0001-6557-6826; Datson, Nicole/0000-0003-2887-0238	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [P50DE009170, R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK025295] Funding Source: NIH RePORTER; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [DE09170, DE08559] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK25295] Funding Source: Medline		Alkemade P., 1969, DYSGENESIS MESODERMA; ASSONBATRES MA, 1994, P NATL ACAD SCI USA, V91, P1318, DOI 10.1073/pnas.91.4.1318; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CRAWFORD RA, 1967, BRIT J OPHTHALMOL, V51, P438, DOI 10.1136/bjo.51.7.438; DARWIN C, 1893, ANIMALS PLANTS DOMES, V1, P434; DATSON N, IN PRESS AM J HUM GE; Dixon J, 1996, NAT GENET, V12, P130; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; EIBERG H, 1987, CLIN GENET, V32, P129; FEINGOLD M, 1969, PEDIATRICS, V44, P564; FITCH N, 1978, J MED GENET, V15, P30, DOI 10.1136/jmg.15.1.30; GASSER DL, 1991, J CRAN GENET DEV BIO, V11, P366; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; HANES SD, 1994, MOL CELL BIOL, V14, P3364, DOI 10.1128/MCB.14.5.3364; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEON E, 1995, HUM MOL GENET, V4, P1435, DOI 10.1093/hmg/4.8.1435; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; JURILOFF DM, 1995, MAMM GENOME, V6, P63, DOI 10.1007/BF00303246; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KAROLYI J, 1994, J CRANIOFAC GENET DE, V13, P1; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KRESPI YP, 1979, AM J GASTROENTEROL, V71, P608; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; MURRAY JC, 1990, AM J HUM GENET, V46, P486; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PASTERIS NG, 1994, CELL, V79, P669; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Phillips JC, 1996, AM J HUM GENET, V59, P613; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; RIEGER H, 1935, Z AUGENHEILKD, V86, P333; ROGERS RC, 1988, P GREENWOOD GENET CT, V7, P9; SADEGHIN.A, 1974, J PEDIATR-US, V85, P644, DOI 10.1016/S0022-3476(74)80507-X; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SCHNEITZ K, 1993, GENE DEV, V7, P114, DOI 10.1101/gad.7.1.114; SEMINA E, IN PRESS AM J HUM GE; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1994, NEURON, V13, P81; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Slaney SF, 1996, AM J HUM GENET, V58, P923; SLAVKIN HC, 1993, AM J MED GENET, V47, P689, DOI 10.1002/ajmg.1320470521; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THEILER K, 1989, HOUSE MOUSE; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; VOSSIUS A, 1883, KLIN MONATSBL AUGENH, V21, P233; Winter RM, 1996, NAT GENET, V12, P124, DOI 10.1038/ng0296-124; ZHAO GQ, 1994, MECH DEVELOP, V48, P245, DOI 10.1016/0925-4773(94)90063-9	72	696	712	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					392	399		10.1038/ng1296-392			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	WOS:A1996VV73000014	8944018				2022-01-24	
J	Wright, S				Wright, S			Systems of mating. I. The biometric relations between parent and offspring	GENETICS			English	Article									Bur Anim Ind, US Dept Agr, Washington, DC USA								Fish HD, 1914, AM NAT, V48, P759, DOI 10.1086/279447; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Jennings HS, 1916, GENETICS, V1, P53; Jennings HS, 1917, GENETICS, V2, P97; Jennings HS, 1914, AM NAT, V48, P693, DOI 10.1086/279440; JENNINGS HS, 1912, AM NAT, V45, P487; Jones, 1919, INBREEDING OUTBREEDI; Pearl R, 1914, AM NAT, V48, P57, DOI 10.1086/279388; Pearl R, 1913, AM NAT, V47, P577, DOI 10.1086/279374; Pearl R, 1914, AM NAT, V48, P491, DOI 10.1086/279422; Pearson K, 1904, PHILOS T R SOC LOND, V203, P53, DOI 10.1098/rsta.1904.0015; Robbins RB, 1918, GENETICS, V3, P375; Robbins RB, 1918, GENETICS, V3, P73; Robbins RB, 1918, GENETICS, V3, P390; Robbins RB, 1917, GENETICS, V2, P489; Sumner FB, 1918, AM NAT, V52, P439, DOI 10.1086/279681; Sumner FB, 1918, AM NAT, V52, P290, DOI 10.1086/279671; Sumner FB, 1918, AM NAT, V52, P177, DOI 10.1086/279662; Wentworth EN, 1916, GENETICS, V1, P608; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; Wright S., 1921, J AGR RES, V10, P557	21	696	722	2	31	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	MAR	1921	6	2					111	123					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V23LP	WOS:000201584900001	17245958				2022-01-24	
J	Rappsilber, J; Ryder, U; Lamond, AI; Mann, M				Rappsilber, J; Ryder, U; Lamond, AI; Mann, M			Large-scale proteomic analysis of the human splicesome	GENOME RESEARCH			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; ELECTROSPRAY MASS-SPECTROMETRY; SPLICING FACTOR SF1; MESSENGER-RNA; PROTEIN IDENTIFICATION; POLYACRYLAMIDE GELS; FUNCTIONAL-ANALYSIS; SEQUENCE DATABASES; PORE COMPLEX; YEAST	In a previous proteomic study of the human spliceosome, we identified 42 spliceosome-associated factors, including 19 novel ones. Using enhanced mass spectrometric tools and improved databases, we now report identification of 311 proteins that copurify with splicing complexes assembled on two separate pre-mRNAs. All known essential human splicing factors were found, and 96 novel proteins were identified, of which 55 contain domains directly linking them to functions in splicing/RNA processing. We also detected 20 proteins related to transcription, which indicates a direct connection between this process and splicing. This investigation provides the most detailed inventory of human spliceosome-associated factors to date, and the data indicate a number of interesting links coordinating splicing with other steps in the gene expression pathway.	Univ So Denmark, Dept Biochem & Mol Biol, Prot Interact Lab, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland		Mann, M (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Prot Interact Lab, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark.		Mann, Matthias/A-3454-2013; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015	Mann, Matthias/0000-0003-1292-4799; Rappsilber, Juri/0000-0001-5999-1310; Lamond, Angus/0000-0001-6204-6045			Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; ANDERSEN JS, 2002, 50 ASMS C MASS SPECT; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Blencowe BJ, 1999, TRENDS BIOCHEM SCI, V24, P179, DOI 10.1016/S0968-0004(99)01387-0; CALVIO C, 1995, RNA, V1, P724; Chernushevich IV, 2000, EUR J MASS SPECTROM, V6, P471, DOI 10.1255/ejms.377; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; FRANK D, 1992, GENE DEV, V6, P2112, DOI 10.1101/gad.6.11.2112; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Gottschalk A, 1998, RNA, V4, P374; Graveley BR, 2002, CELL, V109, P409, DOI 10.1016/S0092-8674(02)00750-X; Griffin TJ, 2001, J BIOL CHEM, V276, P45497, DOI 10.1074/jbc.R100014200; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; ISHIHAMA Y, 2002, IN PRESS J CHROMATOG; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2002, TRENDS BIOCHEM SCI, V27, P74, DOI 10.1016/S0968-0004(01)02021-7; Rappsilber J, 2001, J BIOL CHEM, V276, P31142, DOI 10.1074/jbc.M103620200; RASMUSSEN HH, 1992, ELECTROPHORESIS, V13, P960, DOI 10.1002/elps.11501301199; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; REED R, 1990, P NATL ACAD SCI USA, V87, P8031, DOI 10.1073/pnas.87.20.8031; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tan JA, 2002, J BIOL CHEM, V277, P16993, DOI 10.1074/jbc.M109217200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	60	695	713	2	35	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	AUG	2002	12	8					1231	1245		10.1101/gr.473902			15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	583WQ	WOS:000177434300011	12176931	Green Published, Bronze			2022-01-24	
J	Ng, HH; Zhang, Y; Hendrich, B; Johnson, CA; Turner, BM; Erdjument-Bromage, H; Tempst, P; Reinberg, D; Bird, A				Ng, HH; Zhang, Y; Hendrich, B; Johnson, CA; Turner, BM; Erdjument-Bromage, H; Tempst, P; Reinberg, D; Bird, A			MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex	NATURE GENETICS			English	Article							CPG BINDING-PROTEIN; DNA METHYLATION; CHROMOSOMAL PROTEIN; TRICHOSTATIN-A; IDENTIFICATION; LOCALIZATION; ACETYLATION; COMPONENT	Mammalian DNA is methylated at many CpG dinucleotides. The biological consequences of methylation are mediated by a family of methyl-CpG binding proteins(1-4). The best characterized family member is MeCP2, a transcriptional repressor that recruits histone deacetylases(5-7). Our report concerns MBD2, which can bind methylated DNA in vivo and in vitro(4) and has been reported to actively demethylate DNA (ref. 8). As DNA methylation causes gene silencing, the MBD2 demethylase is a candidate transcriptional activator. Using specific antibodies, however, we find here that MBD2 in Hela cells is associated with histone deacetylase (HDAC) in the MeCP1 repressor complex(1,9). An affinity-purified HDAC1 corepressor complex(10,11) also contains MBD2, suggesting that MeCP1 corresponds to a fraction of this complex. Exogenous MBD2 represses transcription in a transient assay, and repression can he relieved by the deacetylase inhibitor trichostatin A (TSA; ref. 12). in our hands, MBDZ does not demethylate DNA. Our data suggest that Hela cells, which lack the known methylation-dependent repressor MeCP2, use an alternative pathway involving MBD2 to silence methylated genes.	Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucle Acids Enzymol,Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Birmingham, Sch Med, Dept Anat, Birmingham B15 2TT, W Midlands, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA		Bird, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.		Ng, Huck Hui/A-1135-2009; Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Bird, Adrian/0000-0002-8600-0372; Johnson, Colin/0000-0002-2979-8234; Zhang, Yi/0000-0002-2789-0811; Reinberg, Danny/0000-0003-4288-2016	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; WHITE DA, IN PRESS METHODS; YEUNG KC, 1994, GENE DEV, V8, P2097, DOI 10.1101/gad.8.17.2097; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhang BG, 1997, DYN CONTIN DISCRET I, V3, P89; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	24	694	724	3	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					58	61		10.1038/12659			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	WOS:000082337300016	10471499	Green Published			2022-01-24	
J	Zhu, ZH; Zhang, FT; Hu, H; Bakshi, A; Robinson, MR; Powell, JE; Montgomery, GW; Goddard, ME; Wray, NR; Visscher, PM; Yang, J				Zhu, Zhihong; Zhang, Futao; Hu, Han; Bakshi, Andrew; Robinson, Matthew R.; Powell, Joseph E.; Montgomery, Grant W.; Goddard, Michael E.; Wray, Naomi R.; Visscher, Peter M.; Yang, Jian			Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; RHEUMATOID-ARTHRITIS; HUMAN BRAIN; RISK; SCHIZOPHRENIA; EPIDEMIOLOGY; DISEASE; 16P11.2; LOCI	Genome-wide association studies (GWAS) have identified thousands of genetic variants associated with human complex traits. However, the genes or functional DNA elements through which these variants exert their effects on the traits are often unknown. We propose a method (called SMR) that integrates summary-level data from GWAS with data from expression quantitative trait locus (eQTL) studies to identify genes whose expression levels are associated with a complex trait because of pleiotropy. We apply the method to five human complex traits using GWAS data on up to 339,224 individuals and eQTL data on 5,311 individuals, and we prioritize 126 genes (for example, TRAF1 and ANKRD55 for rheumatoid arthritis and SNX19 and NMRAL1 for schizophrenia), of which 25 genes are new candidates; 77 genes are not the nearest annotated gene to the top associated GWAS SNP. These genes provide important leads to design future functional studies to understand the mechanism whereby DNA variation leads to complex trait variation.	[Zhu, Zhihong; Zhang, Futao; Bakshi, Andrew; Robinson, Matthew R.; Powell, Joseph E.; Wray, Naomi R.; Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hu, Han] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Powell, Joseph E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol, Brisbane, Qld, Australia; [Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Econ Dev Jobs Transport & Resources, Biosci Res Div, Bundoora, Vic, Australia; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia		Yang, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Yang, J (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia.	jian.yang@uq.edu.au	Visscher, Peter/ABB-6151-2020; Zhu, Zhihong/F-8720-2015; Yang, Jian/A-5852-2010; Wray, Naomi/C-8639-2015; Montgomery, Grant W/B-7148-2008; Hu, Han/I-7652-2016; Zhang, Futao/D-2733-2017	Visscher, Peter/0000-0002-2143-8760; Zhu, Zhihong/0000-0002-6783-3037; Yang, Jian/0000-0003-2001-2474; Wray, Naomi/0000-0001-7421-3357; Montgomery, Grant W/0000-0002-4140-8139; Hu, Han/0000-0001-9317-6133; Zhang, Futao/0000-0002-6043-1756; Robinson, Matthew/0000-0001-8982-8813; Goddard, Michael/0000-0001-9917-7946; Bakshi, Andrew/0000-0001-5650-7036	Australian Research CouncilAustralian Research Council [DP130102666]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1078037, 1048853, 1046880]; Sylvia and Charles Viertel Charitable Foundation	We thank J. McGrath for helpful comments. This research was supported by the Australian Research Council (DP130102666), the Australian National Health and Medical Research Council (grants 1078037, 1048853 and 1046880) and the Sylvia and Charles Viertel Charitable Foundation. This study makes use of data from the database of Genotypes and Phenotypes (dbGaP) available under accession phs000090.v3.p1 (see the Supplementary Note for the full set of acknowledgments for these data).	Albers HM, 2008, ANN RHEUM DIS, V67, P1578, DOI 10.1136/ard.2008.089060; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Chung JY, 2002, J CELL SCI, V115, P679; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; DAVIES RB, 1973, BIOMETRIKA, V60, P415, DOI 10.2307/2334555; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Freeman G, 2013, INT J EPIDEMIOL, V42, P1157, DOI 10.1093/ije/dyt110; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Inoue A, 2010, REV ECON STAT, V92, P557, DOI 10.1162/REST_a_00011; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; KATAN MB, 1986, LANCET, V1, P507; Kuonen D, 1999, BIOMETRIKA, V86, P929, DOI 10.1093/biomet/86.4.929; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lynch M., 1998, GENETICS ANAL QUANTI; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKenzie M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-31; Nemani K, 2015, PROG NEURO-PSYCHOPH, V56, P155, DOI 10.1016/j.pnpbp.2014.08.018; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	50	693	702	14	197	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					481	+		10.1038/ng.3538			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	WOS:000374834100005	27019110		Y	N	2022-01-24	
J	WILKIE, AOM; SLANEY, SF; OLDRIDGE, M; POOLE, MD; ASHWORTH, GJ; HOCKLEY, AD; HAYWARD, RD; DAVID, DJ; PULLEYN, LJ; RUTLAND, P; MALCOLM, S; WINTER, RM; REARDON, W				WILKIE, AOM; SLANEY, SF; OLDRIDGE, M; POOLE, MD; ASHWORTH, GJ; HOCKLEY, AD; HAYWARD, RD; DAVID, DJ; PULLEYN, LJ; RUTLAND, P; MALCOLM, S; WINTER, RM; REARDON, W			APERT SYNDROME RESULTS FROM LOCALIZED MUTATIONS OF FGFR2 AND IS ALLELIC WITH CROUZON SYNDROME	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTORS; POINT MUTATIONS; LIGAND-BINDING; HUMAN GENOME; LINKAGE MAP; EXPRESSION; GENE; SPECIFICITY; MARKERS; MOUSE	Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet. We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied. Crouzon syndrome, characterized by craniosynostosis but normal limbs, was previously shown to result from allelic mutations of the third Ig domain of FGFR2. The contrasting effects of these mutations provide a genetic resource for dissecting the complex effects of signal transduction through FGFRs in cranial and limb morphogenesis.	CHURCHILL HOSP,DEPT CLIN GENET,OXFORD OX3 7LJ,ENGLAND; RADCLIFFE INFIRM NHS TRUST,OXFORD CRANIOFACIAL UNIT,OXFORD OX2 6HE,ENGLAND; QUEEN ELIZABETH HOSP,W MIDLANDS CRANIOFACIAL UNIT,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; CHILDRENS HOSP,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; GREAT ORMOND ST HOSP CHILDREN NHS TRUST,CRANIOFACIAL UNIT,LONDON WC1N 3JH,ENGLAND; WOMENS & CHILDRENS HOSP,AUSTRALIAN CRANIOFACIAL UNIT,ADELAIDE,SA 5006,AUSTRALIA; INST CHILD HLTH,GENET & FETAL MED CLIN,MOTHERCARE UNIT,LONDON WC1N 1EH,ENGLAND; INST CHILD HLTH,MOLEC GENET UNIT,LONDON WC1N 1EH,ENGLAND		WILKIE, AOM (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,HEADINGTON,OXFORD OX3 9DU,ENGLAND.		Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Reardon, Willie/0000-0001-7329-9179	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ANDERSON R, 1993, DEVELOPMENT, V117, P1421; Apert E, 1906, B SOC MED HOP PARIS, V23, P1310; AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; BLANK CE, 1960, ANN HUM GENET, V24, P151; CAMPIS LB, 1991, CLIN PLAST SURG, V18, P409; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN MM, 1993, AM J MED GENET, V47, P624, DOI 10.1002/ajmg.1320470509; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; COHEN MM, 1990, AM J MED GENET, V35, P36, DOI 10.1002/ajmg.1320350108; COHEN MM, 1993, AM J MED GENET, V45, P758, DOI 10.1002/ajmg.1320450618; COOPER DN, 1990, HUM GENET, V85, P55; DAVIDSON DR, 1991, NATURE, V352, P429, DOI 10.1038/352429a0; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DIONNE CA, 1992, CYTOGENET CELL GENET, V60, P34, DOI 10.1159/000133290; ERICKSON JD, 1974, ANN HUM GENET, V38, P89, DOI 10.1111/j.1469-1809.1974.tb01996.x; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; GRUNEBERG H, 1962, GENET RES, V3, P157, DOI 10.1017/S0016672300003153; Gruneberg H., 1956, Journal of Genetics, V54, P113, DOI 10.1007/BF02981706; GRUNEBERG H, 1960, GENET RES, V1, P196; GRUNEBERG HANS, 1961, GENET RES, V2, P33, DOI 10.1017/S0016672300000525; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; HOU JZ, 1992, J BIOL CHEM, V267, P17804; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; JABS EW, 1993, CELL, V75, P43; JARVIK GP, 1994, AM J HUM GENET, V55, P710; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JOHNSON DE, 1993, ADV CANCER RES, V6, P1; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KETTERLING RP, 1994, AM J HUM GENET, V54, P831; LEWANDA AF, 1993, AM J DIS CHILD, V147, P1306, DOI 10.1001/archpedi.1993.02160360048016; LI XA, 1994, GENOMICS, V22, P418, DOI 10.1006/geno.1994.1403; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MATTEI MG, 1991, HUM GENET, V87, P84, DOI 10.1007/BF01213098; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NISWANDER L, 1993, CELL, V75, P759; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; PATTON MA, 1988, J MED GENET, V25, P164, DOI 10.1136/jmg.25.3.164; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; PETERS KG, 1992, DEVELOPMENT, V114, P233; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROBERT B, 1991, GENE DEV, V5, P2363, DOI 10.1101/gad.5.12b.2363; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; Taylor S. A. M., 1992, Human Molecular Genetics, V1, P142, DOI 10.1093/hmg/1.2.142-a; THEIN SL, 1991, BRIT J HAEMATOL, V79, P113, DOI 10.1111/j.1365-2141.1991.tb08016.x; UPTON J, 1991, CLIN PLAST SURG, V18, P321; UPTON J, 1991, CLIN PLAST SURG, V18, P1; VELINOV M, 1994, NAT GENET, V6, P314, DOI 10.1038/ng0394-314; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; XU JM, 1992, J BIOL CHEM, V267, P17792; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; YU CE, 1994, HUM MOL GENET, V3, P212, DOI 10.1093/hmg/3.1.212; ZIMMER Y, 1993, J BIOL CHEM, V268, P7899	70	693	712	1	84	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					165	172		10.1038/ng0295-165			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	WOS:A1995QE67200018	7719344				2022-01-24	
J	Simon, DB; Karet, FE; Hamdan, JM; DiPietro, A; Sanjad, SA; Lifton, RP				Simon, DB; Karet, FE; Hamdan, JM; DiPietro, A; Sanjad, SA; Lifton, RP			Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2	NATURE GENETICS			English	Article							DNA; PROSTAGLANDINS; INDOMETHACIN; GENE; LOOP	Inherited hypokalaemic alkalosis with low blood pressure can be divided into two groups - Gitelman's syndrome, featuring hypocalciuria, hypomagnesaemia and milder clinical manifestations, and Bartter's syndrome, featuring hypercalciuria and early presentation with severe volume depletion. Mutations in the renal Na-Cl cotransporter have been shown to cause Gitelman's syndrome. We demonstrate linkage of Bartter's syndrome to the renal Na-K-2Cl cotransporter gene NKCC2, and identify frameshift or non-conservative missense mutations for this gene that co-segregate with the disease. These findings demonstrate the molecular basis of Bartter's syndrome, provide the basis for molecular classification of patients with inherited hypokalaemic alkalosis, and suggest potential phenotypes in heterozygous carriers of NKCC2 mutations.	YALE UNIV,SCH MED,BOYER CTR MOLEC MED,HOWARD HUGES MED INST,DEPT MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,BOYER CTR MOLEC MED,DEPT GENET,NEW HAVEN,CT 06510; DHARAN HLTH CTR,SPECIALTY PEDIAT SERV DIV,DHAHRAN 31311,SAUDI ARABIA; OSPED ANTONIO CARDARELLI,DIV PEDIAT 28,I-80131 NAPLES,ITALY; KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PEDIAT,RIYADH 11211,SAUDI ARABIA					Karet, Fiona/0000-0002-2457-2869			BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; BIANCHETTI MG, 1992, CLIN NEPHROL, V38, P338; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; CLIVE DM, 1995, AM J KIDNEY DIS, V25, P813, DOI 10.1016/0272-6386(95)90562-6; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Di Pietro A, 1991, Pediatr Med Chir, V13, P279; DUNN MJ, 1981, KIDNEY INT, V19, P86, DOI 10.1038/ki.1981.12; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GILL JR, 1978, AM J MED, V65, P766, DOI 10.1016/0002-9343(78)90794-5; GILL JR, 1976, AM J MED, V61, P43, DOI 10.1016/0002-9343(76)90029-2; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; GLADZIWA U, 1995, NEPHROL DIAL TRANSPL, V10, P1607; GOODMAN AD, 1969, NEW ENGL J MED, V281, P1435, DOI 10.1056/NEJM196912252812601; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; GREGER R, 1983, KLIN WOCHENSCHR, V61, P1019, DOI 10.1007/BF01537500; GULLNER HG, 1981, AM J MED, V71, P578, DOI 10.1016/0002-9343(81)90209-6; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HETZEL W, 1991, NERVENARZT, V62, P500; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Iwata Fujihiko, 1993, Acta Paediatrica Japonica, V35, P252; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LARRONDO SZ, 1992, NEPHRON, V62, P340; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MARCOFRANCO JE, 1994, CLIN NEPHROL, V42, P33; MATSUMOTO J, 1989, AM J ROENTGENOL, V152, P1251, DOI 10.2214/ajr.152.6.1251; MCCREDIE DA, 1974, AUST PAEDIATR J, V10, P286; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; QUAGGIN SE, 1995, MAMM GENOME, V6, P557, DOI 10.1007/BF00356178; SEYBERTH HW, 1987, PEDIATR NEPHROL, V1, P491, DOI 10.1007/BF00849259; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SILVERBERG AB, 1978, AM J MED, V64, P231, DOI 10.1016/0002-9343(78)90050-5; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SIMOPOULOS AP, 1979, NEPHRON, V23, P130, DOI 10.1159/000181622; SMILDE TJ, 1994, J RHEUMATOL, V21, P1515; SUTTON RAL, 1981, KIDNEY, P551; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	46	692	710	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					183	188		10.1038/ng0696-183			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	WOS:A1996UN39500017	8640224				2022-01-24	
J	Locasale, JW; Grassian, AR; Melman, T; Lyssiotis, CA; Mattaini, KR; Bass, AJ; Heffron, G; Metallo, CM; Muranen, T; Sharfi, H; Sasaki, AT; Anastasiou, D; Mullarky, E; Vokes, NI; Sasaki, M; Beroukhim, R; Stephanopoulos, G; Ligon, AH; Meyerson, M; Richardson, AL; Chin, L; Wagner, G; Asara, JM; Brugge, JS; Cantley, LC; Vander Heiden, MG				Locasale, Jason W.; Grassian, Alexandra R.; Melman, Tamar; Lyssiotis, Costas A.; Mattaini, Katherine R.; Bass, Adam J.; Heffron, Gregory; Metallo, Christian M.; Muranen, Taru; Sharfi, Hadar; Sasaki, Atsuo T.; Anastasiou, Dimitrios; Mullarky, Edouard; Vokes, Natalie I.; Sasaki, Mika; Beroukhim, Rameen; Stephanopoulos, Gregory; Ligon, Azra H.; Meyerson, Matthew; Richardson, Andrea L.; Chin, Lynda; Wagner, Gerhard; Asara, John M.; Brugge, Joan S.; Cantley, Lewis C.; Vander Heiden, Matthew G.			Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis	NATURE GENETICS			English	Article							MASS ISOTOPOMER DISTRIBUTIONS; HUMAN-BREAST-CANCER; 3-PHOSPHOGLYCERATE DEHYDROGENASE; METABOLISM; SERINE; PROLIFERATION; BIOSYNTHESIS; EXPRESSION; ABUNDANCE; GLYCINE	Most tumors exhibit increased glucose metabolism to lactate, however, the extent to which glucose-derived metabolic fluxes are used for alternative processes is poorly understood(1,2). Using a metabolomics approach with isotope labeling, we found that in some cancer cells a relatively large amount of glycolytic carbon is diverted into serine and glycine metabolism through phosphoglycerate dehydrogenase (PHGDH). An analysis of human cancers showed that PHGDH is recurrently amplified in a genomic region of focal copy number gain most commonly found in melanoma. Decreasing PHGDH expression impaired proliferation in amplified cell lines. Increased expression was also associated with breast cancer subtypes, and ectopic expression of PHGDH in mammary epithelial cells disrupted acinar morphogenesis and induced other phenotypic alterations that may predispose cells to transformation. Our findings show that the diversion of glycolytic flux into a specific alternate pathway can be selected during tumor development and may contribute to the pathogenesis of human cancer.	[Locasale, Jason W.; Melman, Tamar; Lyssiotis, Costas A.; Sharfi, Hadar; Sasaki, Atsuo T.; Anastasiou, Dimitrios; Mullarky, Edouard; Sasaki, Mika; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Locasale, Jason W.; Melman, Tamar; Lyssiotis, Costas A.; Sharfi, Hadar; Sasaki, Atsuo T.; Anastasiou, Dimitrios; Mullarky, Edouard; Sasaki, Mika; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Grassian, Alexandra R.; Muranen, Taru; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Mattaini, Katherine R.; Vokes, Natalie I.; Vander Heiden, Matthew G.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA USA; [Bass, Adam J.; Beroukhim, Rameen; Ligon, Azra H.; Meyerson, Matthew; Richardson, Andrea L.; Chin, Lynda; Vander Heiden, Matthew G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bass, Adam J.; Beroukhim, Rameen; Meyerson, Matthew] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Heffron, Gregory; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, Boston, MA USA; [Metallo, Christian M.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ligon, Azra H.; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA		Locasale, JW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jlocasal@bidmc.harvard.edu; lcantley@hms.harvard.edu; mvh@mit.edu	Muranen, Taru/AAM-9349-2021; Lyssiotis, Costas A/AAI-1923-2019; Meyerson, Matthew L/E-7123-2012; Locasale, Jason W/ABE-6505-2020; ravegnini, gloria/K-1330-2016; Cantley, Lewis C/D-1800-2014	Lyssiotis, Costas A/0000-0001-9309-6141; Locasale, Jason W/0000-0002-7766-3502; ravegnini, gloria/0000-0002-7774-402X; Cantley, Lewis C/0000-0002-1298-7653; Anastasiou, Dimitrios/0000-0002-1269-843X; Muranen, Taru/0000-0003-4158-9002; Meyerson, Matthew/0000-0002-9133-8108; Sasaki, Atsuo/0000-0003-2963-4501	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; American Cancer SocietyAmerican Cancer Society; National Science Foundation (NSF)National Science Foundation (NSF); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); Damon Runyon Cancer Research Foundation; Burroughs Wellcome FundBurroughs Wellcome Fund; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA120964, P30CA014051, R01CA160458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM056203] Funding Source: NIH RePORTER	Microscopy data for this study were acquired and analyzed in the Nikon Imaging Center at Harvard Medical School. J.W.L. was supported by postdoctoral fellowships from the US National Institutes of Health (NIH) and the American Cancer Society. A. R. G. is a recipient of a National Science Foundation (NSF) Graduate Research Fellowship. L. C. C. and J.S.B. were supported by grants from the NIH and the National Cancer Institute (NCI). M. G. V. H. was supported by grants from the NIH, NCI, Smith Family, Damon Runyon Cancer Research Foundation and the Burroughs Wellcome Fund. We thank N. Vena for technical assistance with the FISH analysis and K. Webster and I. Carrecedo for help with immunohistochemistry. We thank J. Rabinowitz, A. Carrecedo and S.-C. Ng for helpful comments on the manuscript.	Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BISMUT H, 1995, BIOCHEM J, V308, P761, DOI 10.1042/bj3080761; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; KIT S, 1955, CANCER RES, V15, P715; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SNELL K, 1987, BIOCHEM J, V245, P609, DOI 10.1042/bj2450609; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Warburg O., 1924, BIOCHEM Z, V152, P319	31	691	702	10	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					869	U79		10.1038/ng.890			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	WOS:000294325800013	21804546	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Niemann, S; Muller, U				Niemann, S; Muller, U			Mutations in SDHC cause autosomal dominant paraganglioma, type 3	NATURE GENETICS			English	Article							CHROMOSOME; TUMORS; 11Q23; GENE		Univ Giessen, Inst Human Genet, Giessen, Germany		Muller, U (corresponding author), Univ Giessen, Inst Human Genet, Giessen, Germany.						Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 1999, HUM GENET, V104, P219, DOI 10.1007/s004390050939; GRUFFERMAN S, 1980, CANCER, V46, P2116, DOI 10.1002/1097-0142(19801101)46:9<2116::AID-CNCR2820460934>3.0.CO;2-S; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Hirawake H, 1997, CYTOGENET CELL GENET, V79, P132, DOI 10.1159/000134700; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Niemann S, 1999, NEUROGENETICS, V2, P167, DOI 10.1007/s100480050078; VANDERMEY AGL, 1989, LANCET, V2, P1291	8	691	708	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					268	270		10.1038/81551			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500009	11062460				2022-01-24	
J	REEVES, RH; IRVING, NG; MORAN, TH; WOHN, A; KITT, C; SISODIA, SS; SCHMIDT, C; BRONSON, RT; DAVISSON, MT				REEVES, RH; IRVING, NG; MORAN, TH; WOHN, A; KITT, C; SISODIA, SS; SCHMIDT, C; BRONSON, RT; DAVISSON, MT			A MOUSE MODEL FOR DOWN-SYNDROME EXHIBITS LEARNING AND BEHAVIOR DEFICITS	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; CU/ZN-SUPEROXIDE DISMUTASE; ALZHEIMERS-DISEASE; DOWNS-SYNDROME; CHROMOSOMAL LOCALIZATION; GENETIC-LINKAGE; TRANSGENIC MICE; MESSENGER-RNA; ANIMAL-MODEL; EXPRESSION	Trisomy 21 or Down syndrome (DS) is the most frequent genetic cause of mental retardation, affecting one in 800 live born human beings. Mice with segmental trisomy 16 (Ts65Dn mice) are at dosage imbalance for genes corresponding to those on human chromosome 21q21-22.3-which includes the so-called DS 'critical region'. They do not show early-onset of Alzheimer disease pathology; however, Ts65Dn mice do demonstrate impaired performance in a complex learning task requiring the integration of visual and spatial information. The reproducibility of this phenotype among Ts65Dn mice indicates that dosage imbalance for a gene or genes in this region contributes to this impairment. The corresponding dosage imbalance for the human homologues of these genes may contribute to cognitive deficits in DS.	JOHNS HOPKINS UNIV, SCH MED, DEPT PSYCHIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA		REEVES, RH (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PHYSIOL, 725 N WOLFE ST, BALTIMORE, MD 21205 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD024605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000405] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00405] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD24605, HD13131] Funding Source: Medline		BAUTISTA JR, 1994, BRAIN RES BULL, V34, P31, DOI 10.1016/0361-9230(94)90183-X; BENDOTTI C, 1988, P NATL ACAD SCI USA, V85, P3628, DOI 10.1073/pnas.85.10.3628; BUCAN M, 1993, HUM MOL GENET, V2, P1245, DOI 10.1093/hmg/2.8.1245; BURGER PC, 1973, AM J PATHOL, V73, P457; Cabin D E, 1995, Prog Clin Biol Res, V393, P213; CAMPER SA, 1990, GENOMICS, V8, P586, DOI 10.1016/0888-7543(90)90050-5; CHENG SV, 1988, P NATL ACAD SCI USA, V85, P6032, DOI 10.1073/pnas.85.16.6032; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; COYLE JT, 1986, BRAIN RES BULL, V16, P773, DOI 10.1016/0361-9230(86)90074-2; CROME L, 1966, J MENT DEFIC RES, V10, P69; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DAVISSON MT, 1987, CYTOGENET CELL GENET, V45, P70, DOI 10.1159/000132432; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; DELABAR JM, 1993, GENOMICS, V18, P735, DOI 10.1016/S0888-7543(05)80390-8; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; ELLIS WG, 1974, NEUROLOGY, V24, P101, DOI 10.1212/WNL.24.2.101; ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; EPSTEIN CJ, 1985, ANN NY ACAD SCI, V450, P157, DOI 10.1111/j.1749-6632.1985.tb21490.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GEARHART JD, 1986, BRAIN RES BULL, V16, P815, DOI 10.1016/0361-9230(86)90077-8; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/jmg.30.10.807; GREGOR P, 1993, P NATL ACAD SCI USA, V90, P3053, DOI 10.1073/pnas.90.7.3053; GUILARTE T, 1991, BRAIN RES B, V34, P31; Haberland C, 1969, Acta Neurol Psychiatr Belg, V69, P369; HOOK EB, 1981, TRISOMY, V21, P3; IRVING NG, 1993, MAMM GENOME, V4, P364, DOI 10.1007/BF00360586; IRVING NG, 1991, GENOMICS, V9, P386, DOI 10.1016/0888-7543(91)90271-F; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; MARCELL MM, 1982, AM J MENT DEF, V87, P86; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MIYABARA S, 1983, J EXP ZOOL, V228, P253; MJAATVEDT AE, 1993, GENOMICS, V17, P382, DOI 10.1006/geno.1993.1336; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; OHARA BF, 1989, DEV BRAIN RES, V49, P300, DOI 10.1016/0165-3806(89)90031-X; OHARA BF, 1988, MOL BRAIN RES, V4, P283, DOI 10.1016/0169-328X(88)90037-X; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; PUSSCHEL S, 1988, PSYCHOBIOLOGY DOWN S, P199; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; REEVES RH, 1994, MAMM GENOME, V5, pS229; REEVES RH, 1987, MOL BRAIN RES, V2, P215, DOI 10.1016/0169-328X(87)90028-3; SANBERG PR, 1987, ANIMAL MODELS DEMENT, P253; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SOLITARE GB, 1966, AM J MENT DEF, V70, P840; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; WATSON DK, 1986, P NATL ACAD SCI USA, V83, P1792, DOI 10.1073/pnas.83.6.1792; WISHART J, 1988, PSYCHOBIOLOGY DOWN S, P7; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	57	691	699	5	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1995	11	2					177	184		10.1038/ng1095-177			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	WOS:A1995RX80600020	7550346				2022-01-24	
J	Brunkow, ME; Gardner, JC; Van Ness, J; Paeper, BW; Kovacevich, BR; Proll, S; Skonier, JE; Zhao, L; Sabo, PJ; Fu, YH; Alisch, RS; Gillett, L; Colbert, T; Tacconi, P; Galas, D; Hamersma, H; Beighton, P; Mulligan, JT				Brunkow, ME; Gardner, JC; Van Ness, J; Paeper, BW; Kovacevich, BR; Proll, S; Skonier, JE; Zhao, L; Sabo, PJ; Fu, YH; Alisch, RS; Gillett, L; Colbert, T; Tacconi, P; Galas, D; Hamersma, H; Beighton, P; Mulligan, JT			Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MORPHOGENETIC PROTEINS; CHROMOSOME 17Q12-Q21; DISEASE; DNA; HOMOZYGOSITY; FAMILY; DECAY; MAPS	Sclerosteosis is an autosomal recessive sclerosing bone dysplasia characterized by progressive skeletal overgrowth. The majority of affected individuals have been reported in the Afrikaner population of South Africa, where a high incidence of the disorder occurs as a result of a founder effect. Homozygosity mapping in Afrikaner families along with analysis of historical recombinants localized sclerosteosis to an interval of similar to2 cM between the loci D17S1787 and D17S930 on chromosome 17q12-q21. Here we report two independent mutations in a novel gene, termed "SOST." Affected Afrikaners carry a nonsense mutation near the amino terminus of the encoded protein, whereas an unrelated affected person of Senegalese origin carries a splicing mutation within the single intron of the gene. The SOST gene encodes a protein that shares similarity with a class of cystine knot-containing factors including dan, cerberus, gremlin, prdc, and caronte. The specific and progressive effect on bone formation observed in individuals affected with sclerosteosis, along with the data presented in this study, together suggest that the SOST gene encodes an important new regulator of bone homeostasis.	Celltech Inc, Bothell, WA 98021 USA; Univ Cape Town, Sch Med, Observatory, ZA-7700 Rondebosch, South Africa; Univ Cagliari, Ist Neurol, Cagliari, Italy		Brunkow, ME (corresponding author), Celltech Inc, 1631 220th St SE, Bothell, WA 98021 USA.	mary.brunkow@sea.celltechgroup.com					ALVES AFD, 1982, REV BRAS GENET, V5, P825; Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; BEIGHTON P, 1976, ANN INTERN MED, V84, P393, DOI 10.7326/0003-4819-84-4-393; BEIGHTON P, 1977, CLIN GENET, V11, P1; BEIGHTON P, 1988, J MED GENET, V25, P200, DOI 10.1136/jmg.25.3.200; BEIGHTON P, 1979, S AFR MED J, V55, P783; BEIGHTON P, 1984, CLIN GENET, V25, P175; BEIGHTON P, 1999, 8 BIENN SO AFR SOC H; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; BUENO M, 1994, J MED GENET, V31, P976, DOI 10.1136/jmg.31.12.976; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox LA, 1998, J LIPID RES, V39, P1319; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIXON JM, 1982, J NEUROL NEUROSUR PS, V45, P913, DOI 10.1136/jnnp.45.10.913; EPSTEIN S, 1979, S AFR MED J, V55, P1105; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; FRYNS JP, 1988, EUR J PEDIATR, V147, P99, DOI 10.1007/BF00442624; GARDNER J, 1999, THESIS U CAPE TOWN C; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hausen H, 1967, HDB KINDERHEILKUNDE, V6, P351; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Higinbotham N., 1941, AM J SURG, V53, P444; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lunetta KL, 1996, AM J HUM GENET, V59, P717; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MEITINGER T, 1993, NAT GENET, V5, P376, DOI 10.1038/ng1293-376; Nakamura Y, 1997, EUR J CANCER, V33, P1986, DOI 10.1016/S0959-8049(97)00333-X; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Peitrushka G., 1958, KLIN MONATSBL AUGENK, V132, P509; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; STEIN SA, 1983, NEUROLOGY, V33, P267, DOI 10.1212/WNL.33.3.267; SUGIURA Y, 1975, J BONE JOINT SURG AM, VA 57, P273, DOI 10.2106/00004623-197557020-00026; Tacconi P, 1998, CLIN GENET, V53, P497; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Van Buchem FSPP, 1976, HYPEROSTOSIS CORTICA; Van Hul W, 1998, AM J HUM GENET, V62, P391, DOI 10.1086/301721; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755	51	690	739	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					577	589		10.1086/318811			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	WOS:000166994200003	11179006	Green Published, Bronze			2022-01-24	
J	Daly, AK; Donaldson, PT; Bhatnagar, P; Shen, YF; Pe'er, I; Floratos, A; Daly, MJ; Goldstein, DB; John, S; Nelson, MR; Graham, J; Park, BK; Dillon, JF; Bernal, W; Cordell, HJ; Pirmohamed, M; Aithal, GP; Day, CP				Daly, Ann K.; Donaldson, Peter T.; Bhatnagar, Pallav; Shen, Yufeng; Pe'er, Itsik; Floratos, Aris; Daly, Mark J.; Goldstein, David B.; John, Sally; Nelson, Matthew R.; Graham, Julia; Park, B. Kevin; Dillon, John F.; Bernal, William; Cordell, Heather J.; Pirmohamed, Munir; Aithal, Guruprasad P.; Day, Christopher P.		DILIGEN Study; Int SAE Consortium	HLA-B(star)5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; POPULATION; DISEASE; HLA; SIALYLTRANSFERASE; POLYMORPHISMS; INFLAMMATION; CLOXACILLIN; GENETICS; SAMPLE	Drug-induced liver injury (DILI) is an important cause of serious liver disease. The antimicrobial agent flucloxacillin is a common cause of DILI, but the genetic basis for susceptibility remains unclear. We conducted a genome-wide association (GWA) study using 866,399 markers in 51 cases of flucloxacillin DILI and 282 controls matched for sex and ancestry. The GWA showed an association peak in the major histocompatibility complex (MHC) region with the strongest association (P = 8.7 x 10(-33)) seen for rs2395029[G], a marker in complete linkage disequilibrium (LD) with HLA-B* 5701. Further MHC genotyping, which included 64 flucloxacillintolerant controls, confirmed the association with HLA-B*5701 (OR = 80.6, P = 9.0 x 10(-19)). The association was replicated in a second cohort of 23 cases. In HLA-B*5701 carrier cases, rs10937275 in ST6GAL1 on chromosome 3 also showed genome-wide significance (OR = 4.1, P = 1.4 x 10(-8)). These findings provide new insights the mechanism of flucloxacillin DILI and have the potential to substantially improve diagnosis of this serious disease.	[Daly, Ann K.; Donaldson, Peter T.; Bhatnagar, Pallav; Graham, Julia; Cordell, Heather J.; Day, Christopher P.] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Daly, Ann K.; Donaldson, Peter T.; Bhatnagar, Pallav; Graham, Julia; Cordell, Heather J.; Day, Christopher P.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Shen, Yufeng; Pe'er, Itsik; Floratos, Aris] Columbia Univ, New York, NY USA; [Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA USA; [Goldstein, David B.] Duke Univ, Durham, NC USA; [John, Sally] Pfizer Inc, New London, CT USA; [Nelson, Matthew R.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Park, B. Kevin; Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; [Dillon, John F.] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Bernal, William] Kings Coll Hosp London, London, England; [Aithal, Guruprasad P.] Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham, England		Daly, AK (corresponding author), Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	a.k.daly@ncl.ac.uk	Bhatnagar, Pallav/A-1280-2013; Day, Christopher/Z-3305-2019; Pirmohamed, Munir/H-6004-2011; Dillon, John F/A-2478-2013; Daly, Mark J/B-2453-2017; Daly, Ann K/H-3144-2011	Pirmohamed, Munir/0000-0002-7534-7266; Daly, Mark J/0000-0002-0949-8752; Daly, Ann K/0000-0002-7321-0629; Cordell, Heather/0000-0002-1879-5572; Aithal, Guruprasad/0000-0003-3924-4830; Dillon, John/0000-0002-2164-4476	Department of HealthEuropean Commission Funding Source: Medline		Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; BROWNER WS, 1989, AM J PUBLIC HEALTH, V79, P1289, DOI 10.2105/AJPH.79.9.1289; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Colombo S, 2008, J INFECT DIS, V198, P864, DOI 10.1086/591184; Daly Ann K, 2006, Methods Mol Biol, V320, P193; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Donaldson PT, 2004, GUT, V53, P599, DOI 10.1136/gut.2003.031732; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; FAIRLEY CK, 1993, BRIT MED J, V306, P233, DOI 10.1136/bmj.306.6872.233; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Grove J, 1997, HEPATOLOGY, V26, P143, DOI 10.1002/hep.510260119; Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Lakehal F, 2001, CHEM RES TOXICOL, V14, P694, DOI 10.1021/tx0002435; MANN R, 2006, PHARMACOVIGILANCE; Maria VAJ, 1997, GUT, V41, P534, DOI 10.1136/gut.41.4.534; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nelson MR, 2009, PHARMACOGENOMICS J, V9, P23, DOI 10.1038/tpj.2008.4; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Donohue J, 2000, GUT, V47, P717, DOI 10.1136/gut.47.5.717; OLSSON R, 1992, J HEPATOL, V15, P154, DOI 10.1016/0168-8278(92)90029-O; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Russmann S, 2005, BRIT J CLIN PHARMACO, V60, P76, DOI 10.1111/j.1365-2125.2005.02370.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; SUTHERLAND R, 1970, BMJ-BRIT MED J, V4, P455, DOI 10.1136/bmj.4.5733.455; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	37	689	722	4	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					816	U71		10.1038/ng.379			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	WOS:000267786200012	19483685				2022-01-24	
J	Enattah, NS; Sahi, T; Savilahti, E; Terwilliger, JD; Peltonen, L; Jarvela, I				Enattah, NS; Sahi, T; Savilahti, E; Terwilliger, JD; Peltonen, L; Jarvela, I			Identification of a variant associated with adult-type hypolactasia	NATURE GENETICS			English	Article							PERSISTENCE/NON-PERSISTENCE POLYMORPHISM; LACTASE-PHLORIZIN HYDROLASE; LINKAGE ANALYSIS; POINT MUTATIONS; GENE; DISEQUILIBRIUM; DEFICIENCY; EVOLUTION; CHILDREN; HUMANS	Adult-type hypolactasia, also known as lactase non-persistence (lactose intolerance), is a common autosomal recessive condition resulting from the physiological decline in activity of the lactase-phlorizin hydrolase (LPH) in intestinal cells after weaning. LPH hydrolyzes lactose into glucose and galactose. Sequence analyses of the coding and promoter regions of LCT, the gene encoding LPH, has revealed no DNA variations correlating with lactase nonpersistence(1,2). An associated haplotype spanning LCT, as well as a distinct difference in the transcript levels of 'non-persistence' and 'persistence' alleles in heterozygotes, suggest that a cis-acting element contributes to the lactase non-persistence phenotype(3,4). Using linkage disequilibrium (LD) and haplotype analysis of nine extended Finnish families, we restricted the locus to a 47-kb interval on 2q21. Sequence analysis of the complete region and subsequent association analyses revealed that a DNA variant, C/T-13910, roughly 14 kb upstream from the LCT locus, completely associates with biochemically verified lactase non-persistence in Finnish families and a sample set of 236 individuals from four different populations. A second variant, G/A(-22018), 8 kb telomeric to C/T-13910, is also associated with the trait in 229 of 236 cases. Prevalence of the C/T-13910 variant in 1,047 DNA samples is consistent with the reported prevalence of adult-type hypolactasla in four different populations. That the variant (C/T-13910) occurs in distantly related populations indicates that it is very old.	Natl Publ Hlth Inst, Dept Mol Med, FIN-00251 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; New York State Psychiat Inst & Hosp, Div Med Genet, New York, NY 10032 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; HUCH, Diagnost Lab, Mol Genet Lab, FIN-00290 Helsinki, Finland		Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Haartmaninkatu 8,POB 104, FIN-00251 Helsinki, Finland.	lpeltonen@mednet.ucla.edu	Jarvela, Irma E/L-5836-2013	Jarvela, Irma E/0000-0002-1770-6187			AROLA H, 1994, SCAND J GASTROENTERO, V29, P26, DOI 10.3109/00365529409091742; BOLL W, 1991, AM J HUM GENET, V48, P889; CLARE H, 1997, HUM BIOL, V69, P605; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUDDENEC Y, 1982, GASTROEN CLIN BIOL, V6, P776; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Harvey CB, 1996, FEBS LETT, V398, P135, DOI 10.1016/S0014-5793(96)01189-1; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; IHALAINEN J, 1994, BIOTECHNIQUES, V16, P938; Jarvela I, 1998, AM J HUM GENET, V63, P1078, DOI 10.1086/302064; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; MCCRACKEN RD, 1971, CURR ANTHROPOL, V12, P479, DOI 10.1086/201234; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MESSER M, 1966, ANAL BIOCHEM, V14, P376, DOI 10.1016/0003-2697(66)90280-6; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; SAHI T, 1974, SCAND J GASTROENTERO, V9, P7; SAHI T, 1972, ACTA PAEDIATR SCAND, V61, P11, DOI 10.1111/j.1651-2227.1972.tb15897.x; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; SYVANEN AC, 1994, HUM MUTAT, V3, P172, DOI 10.1002/humu.1380030303; Wang YX, 1998, GASTROENTEROLOGY, V114, P1230, DOI 10.1016/S0016-5085(98)70429-9; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657	26	689	720	3	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					233	237		10.1038/ng826			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	WOS:000173708700028	11788828				2022-01-24	
J	Costoya, JA; Hobbs, RM; Barna, M; Cattoretti, G; Manova, K; Sukhwani, M; Orwig, KE; Wolgemuth, DJ; Pandolfi, PP				Costoya, JA; Hobbs, RM; Barna, M; Cattoretti, G; Manova, K; Sukhwani, M; Orwig, KE; Wolgemuth, DJ; Pandolfi, PP			Essential role of Plzf in maintenance of spermatogonial stem cells	NATURE GENETICS			English	Article							LEUKEMIA ZINC-FINGER; PROMYELOCYTIC LEUKEMIA; MALE-INFERTILITY; PROTEIN PLZF; MOUSE; EXPRESSION; TESTIS; GERM; GENE; DIFFERENTIATION	Little is known of the molecular mechanisms whereby spermatogonia, mitotic germ cells of the testis, self-renew and differentiate into sperm(1,2). Here we show that Zfp145, encoding the transcriptional repressor Plzf, has a crucial role in spermatogenesis. Zfp145 expression was restricted to gonocytes and undifferentiated spermatogonia and was absent in tubules of W/W-v mutants that lack these cells. Mice lacking Zfp145 underwent a progressive loss of spermatogonia with age, associated with increases in apoptosis and subsequent loss of tubule structure but without overt differentiation defects or loss of the supporting Sertoli cells. Spermatogonial transplantation experiments revealed a depletion of spermatogonial stem cells in the adult. Microarray analysis of isolated spermatogonia from Zfp145-null mice before testis degeneration showed alterations in the expression profile of genes associated with spermatogenesis. These results identify Plzf as a spermatogonia-specific transcription factor in the testis that is required to regulate self-renewal and maintenance of the stem cell pool.	Mem Sloan Kettering Canc Ctr, Dept Pathol, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, Dev Biol Program, Mol Cytol Core Facil, New York, NY 10021 USA; Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA		Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Costoya, Jose A./B-2718-2009; Cattoretti, Giorgio/H-2340-2011; Hobbs, Robin/I-2577-2014	Costoya, Jose A./0000-0003-3691-6419; Hobbs, Robin/0000-0002-3853-2614; Orwig, Kyle/0000-0002-7952-8419; Cattoretti, Giorgio/0000-0003-3799-3221			Andersson S, 1995, J STEROID BIOCHEM, V55, P533, DOI 10.1016/0960-0760(95)00202-2; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Beumer TL, 1999, ENDOCRINOLOGY, V140, P1834, DOI 10.1210/en.140.4.1834; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; BUAAS FW, 2004, NAT GENET       0523; COOK M, 1995, P NATL ACAD SCI USA, V92, P2249, DOI 10.1073/pnas.92.6.2249; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Costoya JA, 2001, CURR OPIN HEMATOL, V8, P212, DOI 10.1097/00062752-200107000-00006; COULOMBRE JL, 1954, J EXP ZOOL, V126, P277, DOI 10.1002/jez.1401260207; Cunningham DB, 1998, DEV BIOL, V204, P345, DOI 10.1006/dbio.1998.9004; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Handel MA, 1999, J EXP ZOOL, V285, P243, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;243::AID-JEZ7&gt;3.0.CO;2-#; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; MANOVA K, 1990, DEVELOPMENT, V110, P1057; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Narula A, 2002, AM J PATHOL, V161, P1723, DOI 10.1016/S0002-9440(10)64449-5; Orwig KE, 2002, BIOL REPROD, V66, P944, DOI 10.1095/biolreprod66.4.944; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Venables JP, 1999, CURR OPIN GENET DEV, V9, P346, DOI 10.1016/S0959-437X(99)80052-5; Wrobel KH, 1996, CELL TISSUE RES, V283, P191, DOI 10.1007/s004410050529; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375	30	688	729	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					653	659		10.1038/ng1367			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	WOS:000221763700026	15156143	Bronze			2022-01-24	
J	Raj, A; Stephens, M; Pritchard, JK				Raj, Anil; Stephens, Matthew; Pritchard, Jonathan K.			fastSTRUCTURE: Variational Inference of Population Structure in Large SNP Data Sets	GENETICS			English	Article							ASSOCIATION; SELECTION	Tools for estimating population structure from genetic data are now used in a wide variety of applications in population genetics. However, inferring population structure in large modern data sets imposes severe computational challenges. Here, we develop efficient algorithms for approximate inference of the model underlying the STRUCTURE program using a variational Bayesian framework. Variational methods pose the problem of computing relevant posterior distributions as an optimization problem, allowing us to build on recent advances in optimization theory to develop fast inference tools. In addition, we propose useful heuristic scores to identify the number of populations represented in a data set and a new hierarchical prior to detect weak population structure in the data. We test the variational algorithms on simulated data and illustrate using genotype data from the CEPH-Human Genome Diversity Panel. The variational algorithms are almost two orders of magnitude faster than STRUCTURE and achieve accuracies comparable to those of ADMIXTURE. Furthermore, our results show that the heuristic scores for choosing model complexity provide a reasonable range of values for the number of populations represented in the data, with minimal bias toward detecting structure when it is very weak. Our algorithm, fastSTRUCTURE, is freely available online at http://pritchardlab.stanford.edu/structure.html.	[Raj, Anil; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA		Raj, A (corresponding author), Stanford Univ, 300 Pasteur Dr,Alway Bldg,M337, Stanford, CA 94305 USA.	rajanil@stanford.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG007036, HG002585]; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG007036, R01HG002585] Funding Source: NIH RePORTER	We thank Tim Flutre, Shyam Gopalakrishnan, and Ida Moltke for fruitful discussions on this project and the editor and two anonymous reviewers for their helpful comments and suggestions. This work was funded by grants from the National Institutes of Health (HG007036,HG002585) and by the Howard Hughes Medical Institute.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Beal MJ, 2003, VARIATIONAL ALGORITH; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Falush D, 2003, GENETICS, V164, P1567; Hofman JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258701; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kadanoff LP, 2009, J STAT PHYS, V137, P777, DOI 10.1007/s10955-009-9814-1; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Logsdon BA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-58; MacKay D. J., 2003, INFORM THEORY INFERE; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Raydan M, 2002, COMPUT OPTIM APPL, V21, P155, DOI 10.1023/A:1013708715892; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Teh Yee W, 2007, ADV NEURAL INFORM PR, P1353; Varadhan R, 2008, SCAND J STAT, V35, P335, DOI 10.1111/j.1467-9469.2007.00585.x	30	687	699	9	148	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	2014	197	2					573	U207		10.1534/genetics.114.164350			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK8RZ	WOS:000338697000013	24700103	Green Published, Green Submitted	Y	N	2022-01-24	
J	Garris, AJ; Tai, TH; Coburn, J; Kresovich, S; McCouch, S				Garris, AJ; Tai, TH; Coburn, J; Kresovich, S; McCouch, S			Genetic structure and diversity in Oryza sativa L.	GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; CULTIVATED RICE; MICROSATELLITE MARKERS; MAIZE; DNA; DOMESTICATION; ASSOCIATIONS; POLYMORPHISM; EVOLUTION	The population structure of domesticated species is influenced by the natural history of the populations of predomesticated ancestors, as well as by the breeding system and complexity of the breeding practices exercised by humans. Within Oryza saliva, there is an ancient and well-established divergence between the two major subspecies, indica and japonica, but finer levels of genetic structure are suggested by the breeding history. In this study, a sample of 234 accessions of rice was genotyped at 169 nuclear SSRs and two chloroplast loci. The data were analyzed to resolve the genetic structure and to interpret the evolutionary relationships between groups. Five distinct groups were detected, corresponding to indica, aus, aromatic, temperate japonica, and tropical japonica rices. Nuclear and chloroplast data support a closer evolutionary relationship between the indica and the aus and among the tropical japonica, temperate japonica, and aromatic groups. Group differences can be explained through contrasting demographic histories. With the availability of rice genome sequence, coupled with a large collection of publicly available genetic resources, it is of interest to develop a population-based framework for the molecular analysis of diversity in O. sativa.	Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; USDA ARS, Natl Rice Res Ctr, Stuttgart, AZ 72160 USA		McCouch, S (corresponding author), Cornell Univ, Dept Plant Breeding, 162 Emerson Hall, Ithaca, NY 14853 USA.	srm4@cornell.edu					AHUJA SC, 1995, BASMATI RICE SCENTED; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Coburn JR, 2002, CROP SCI, V42, P2092, DOI 10.2135/cropsci2002.2092; Cornuet JM, 1996, GENETICS, V144, P2001; DEIJAPORTA SL, 1983, PLANT MOL BIOL REP, V1, P19; DOI KK, 2002, IRRI C SEPT 16 19 20, P275; Falush D, 2003, GENETICS, V164, P1567; Garland S, 2000, THEOR APPL GENET, V101, P364, DOI 10.1007/s001220051492; Garris AJ, 2003, GENETICS, V165, P759; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jiang N, 2002, GENETICS, V161, P1293; Kato S H K, 1928, CTR AGR I KYUSHU IMP, V2, P241; Labate JA, 2003, CROP SCI, V43, P80, DOI 10.2135/cropsci2003.0080; Liu K., 2004, POWERMARKER NEW GENE; Liu KJ, 2003, GENETICS, V165, P2117; Lorieux M, 1996, THEOR APPL GENET, V93, P1145, DOI 10.1007/BF00230138; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Matsuo T, 1997, SCI RICE PLANT; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Nakamura I, 1998, RICE GENET NEWSLETT, V15, P80; NAKANO M, 1992, RICE GENET NEWSL, V9, P132; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Oka H. I., 1988, Origin of cultivated rice.; Olufowote JO, 1997, GENOME, V40, P370, DOI 10.1139/g97-050; Parsons BJ, 1999, GENET RESOUR CROP EV, V46, P587, DOI 10.1023/A:1008749532171; PINSON SRM, 1994, CROP SCI, V34, P1151, DOI 10.2135/cropsci1994.0011183X003400050002x; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg N.A, 2002, DISTRUCT PROGRAM GRA; RUBINSZTEIN DC, 1995, NAT GENET, V10, P337, DOI 10.1038/ng0795-337; Schneider S, 1999, GENETICS, V152, P1079; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Sharma G. R., 1980, EXCAVATIONS MAHAGARA, V6; SOLHEIM WG, 1972, SCI AM, V266, P34; Takezaki N, 1996, GENETICS, V144, P389; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vigouroux Y, 2003, MOL BIOL EVOL, V20, P1480, DOI 10.1093/molbev/msg156; WANG ZY, 1989, GENOME, V32, P1113, DOI 10.1139/g89-563; Weir BS, 1996, GENETIC DATA ANAL; Yamanaka S, 2004, THEOR APPL GENET, V108, P1200, DOI 10.1007/s00122-003-1564-x; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zohary D., 2000, DOMESTICATION PLANTS	50	687	764	5	222	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAR	2005	169	3					1631	1638		10.1534/genetics.104.035642			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	917HD	WOS:000228450800036	15654106	Green Published, Bronze			2022-01-24	
J	Ning, ZM; Cox, AJ; Mullikin, JC				Ning, ZM; Cox, AJ; Mullikin, JC			SSAHA: A fast search method for large DNA databases	GENOME RESEARCH			English	Article							SEQUENCE; IDENTIFICATION; ALGORITHM; ALIGNMENT	We describe an algorithm, SSAHA (Sequence Search and Alignment by Hashing Algorithm), for performing fast searches on databases containing multiple gigabases of DNA. Sequences in the database are preprocessed by breaking them into consecutive k-tuples of k contiguous bases and then using a hash table to store the position of each occurrence of each k-tuple. Searching for a query sequence in the database is done by obtaining from the hash table the "hits" for each k-tuple in the query sequence and then performing a sort on the results. We discuss the effect of the tuple length k on the search speed, memory usage, and sensitivity of the algorithm and present the results of computational experiments which show that Ss: HA can be three to four orders of magnitude faster than BLAST or FASTA, while requiring less memory than suffix tree methods. The SSAHA algorithm is used for high-throughput single nucleotide polymorphism (SNP) detection and very large scale sequence assembly. Also, it provides Web-based sequence search facilities for Ensembl projects.	Sanger Ctr, Informat Div, Cambridge CB10 1SA, England		Mullikin, JC (corresponding author), Sanger Ctr, Informat Div, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	jcm@sanger.ac.uk	Ning, Zemin/D-2411-2013	Cox, Anthony/0000-0002-6534-749X; Ning, Zemin/0000-0003-4359-776X			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Gusfield D., 1997, ACM SIGACT NEWS, V28, P41; Knuth DE, 1998, ART COMPUTER PROGRAM, V3; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Miller C, 1999, BIOINFORMATICS, V15, P111, DOI 10.1093/bioinformatics/15.2.111; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Waterman MS, 1995, INTRO COMPUTATIONAL; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; [No title captured]	16	687	708	0	28	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2001	11	10					1725	1729		10.1101/gr.194201			5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	480HM	WOS:000171456000014	11591649	Bronze, Green Published			2022-01-24	
J	Haeussler, M; Schonig, K; Eckert, H; Eschstruth, A; Mianne, J; Renaud, JB; Schneider-Maunoury, S; Shkumatava, A; Teboul, L; Kent, J; Joly, JS; Concordet, JP				Haeussler, Maximilian; Schoenig, Kai; Eckert, Helene; Eschstruth, Alexis; Mianne, Joffrey; Renaud, Jean-Baptiste; Schneider-Maunoury, Sylvie; Shkumatava, Alena; Teboul, Lydia; Kent, Jim; Joly, Jean-Stephane; Concordet, Jean-Paul			Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR	GENOME BIOLOGY			English	Article							HOMOLOGY-DIRECTED REPAIR; CRISPR-CAS9 SYSTEM; CRISPR/CAS9 SYSTEM; SGRNA DESIGN; DIGENOME-SEQ; HUMAN GENOME; HUMAN-CELLS; WEB TOOL; IN-VIVO; NUCLEASES	Background: The success of the CRISPR/Cas9 genome editing technique depends on the choice of the guide RNA sequence, which is facilitated by various websites. Despite the importance and popularity of these algorithms, it is unclear to which extent their predictions are in agreement with actual measurements. Results: We conduct the first independent evaluation of CRISPR/Cas9 predictions. To this end, we collect data from eight SpCas9 off-target studies and compare them with the sites predicted by popular algorithms. We identify problems in one implementation but found that sequence-based off-target predictions are very reliable, identifying most off-targets with mutation rates superior to 0.1 %, while the number of false positives can be largely reduced with a cutoff on the off-target score. We also evaluate on-target efficiency prediction algorithms against available datasets. The correlation between the predictions and the guide activity varied considerably, especially for zebrafish. Together with novel data from our labs, we find that the optimal on-target efficiency prediction model strongly depends on whether the guide RNA is expressed from a U6 promoter or transcribed in vitro. We further demonstrate that the best predictions can significantly reduce the time spent on guide screening. Conclusions: To make these guidelines easily accessible to anyone planning a CRISPR genome editing experiment, we built a new website (http://crispor.org) that predicts off-targets and helps select and clone efficient guide sequences for more than 120 genomes using different Cas9 proteins and the eight efficiency scoring systems evaluated here.	[Haeussler, Maximilian; Kent, Jim] Univ Calif Santa Cruz, Santa Cruz Genom Inst, MS CBSE, 1156 High St, Santa Cruz, CA 95064 USA; [Schoenig, Kai] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Sq J5, D-68159 Mannheim, Germany; [Eckert, Helene] Inst Curie, CNRS UMR3215, INSERM U934, F-75248 Paris 05, France; [Eschstruth, Alexis; Schneider-Maunoury, Sylvie] Univ Paris 06, Sorbonne Univ, INSERM U1156, CNRS UMR 7622, Paris, France; [Mianne, Joffrey; Teboul, Lydia] MRC Harwell, Mary Lyon Ctr, Didcot, Oxon, England; [Renaud, Jean-Baptiste; Joly, Jean-Stephane] TEFOR Infrastruct, Gif Sur Yvette, France; [Concordet, Jean-Paul] Museum Natl Hist Nat, CNRS UMR 7196, INSERM U1154, Paris, France		Haeussler, M (corresponding author), Univ Calif Santa Cruz, Santa Cruz Genom Inst, MS CBSE, 1156 High St, Santa Cruz, CA 95064 USA.; Concordet, JP (corresponding author), Museum Natl Hist Nat, CNRS UMR 7196, INSERM U1154, Paris, France.	max@soe.ucsc.edu; jean-paul.concordet@mnhn.fr	Schneider-Maunoury, Sylvie/K-6795-2017; concordet, jean-paul/C-3417-2015; Teboul, Lydia/P-2428-2019; Haeussler, Maximilian/AAY-1649-2021	Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Teboul, Lydia/0000-0002-2789-8637; Mianne, Joffrey/0000-0003-0893-9947; Concordet, Jean-Paul/0000-0001-8924-4316	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [53658]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U42OD011174]; California Institute of Regenerative MedicineCalifornia Institute for Regenerative Medicine [CIRM GC1R-06673C]; Agence Nationale pour la Recherche (Funding "CILIAINTHEBRAIN")French National Research Agency (ANR); Fondation pour la Recherche Medicale (Equipe FRM)Fondation pour la Recherche Medicale [DEQ20140329544];  [NIH/NHGRI 5U41HG002371-15];  [NIH/NCI 5U54HG007990-02]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UP_1502/3] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UP_1502/3] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG007990, U41HG002371] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U42OD011174] Funding Source: NIH RePORTER	We acknowledge the International Phenotyping Consortium at MRC Harwell funded by both the Medical Research Council (Award number 53658) and National Institute of Health (Grant number U42OD011174). MH is funded by grants NIH/NHGRI 5U41HG002371-15 and NIH/NCI 5U54HG007990-02 and by a grant from the California Institute of Regenerative Medicine, CIRM GC1R-06673C. Work in the SSM lab was supported by the Agence Nationale pour la Recherche (Funding "CILIAINTHEBRAIN") and the Fondation pour la Recherche Medicale (Equipe FRM DEQ20140329544). This work has benefited from the facilities and expertise of TEFOR-Investissement d'avenir-ANR-II-INBS-0014.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2014, SCIENCE, V344, P707, DOI 10.1126/science.1252964; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fusi N, 2015, BIORXIV; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gandhi S, 2016, BIORXIV; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19675; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Malina A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10124; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	54	686	698	9	102	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	JUL 5	2016	17								148	10.1186/s13059-016-1012-2			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	DQ6MW	WOS:000379320300003	27380939	Green Published, gold	Y	N	2022-01-24	
J	Snijders, AM; Nowak, N; Segraves, R; Blackwood, S; Brown, N; Conroy, J; Hamilton, G; Hindle, AK; Huey, B; Kimura, K; Law, S; Myambo, K; Palmer, J; Ylstra, B; Yue, JP; Gray, JW; Jain, AN; Pinkel, D; Albertson, DG				Snijders, AM; Nowak, N; Segraves, R; Blackwood, S; Brown, N; Conroy, J; Hamilton, G; Hindle, AK; Huey, B; Kimura, K; Law, S; Myambo, K; Palmer, J; Ylstra, B; Yue, JP; Gray, JW; Jain, AN; Pinkel, D; Albertson, DG			Assembly of microarrays for genome-wide measurement of DNA copy number.	NATURE GENETICS			English	Article							HYBRIDIZATION; CELLS	We have assembled arrays of approximately 2,400 BAC clones for measurement of DNA copy number across the human genome. The arrays provide precise measurement (s.d. of log(2) ratios=0.05-0.10) in cell lines and clinical material, so that we can reliably detect and quantify high-level amplifications and single-copy alterations in diploid, polyploid and heterogeneous backgrounds.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; New York State Dept Hlth, Roswell Pk Canc Inst, Buffalo, NY 14263 USA		Albertson, DG (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.		Ylstra, Bauke/D-2906-2012	Ylstra, Bauke/0000-0001-9479-3010	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD017665] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA058207, U01CA084118, R01CA083040, R01CA080314] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA84118, CA83040, CA80314, CA58207] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD17665] Funding Source: Medline		Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Geschwind DH, 1998, DEV GENET, V23, P215, DOI 10.1002/(SICI)1520-6408(1998)23:3<215::AID-DVG7>3.0.CO;2-X; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Lucito R, 2000, GENOME RES, V10, P1726, DOI 10.1101/gr.138300; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524	7	686	705	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					263	264		10.1038/ng754			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	WOS:000171911000010	11687795				2022-01-24	
J	Miceli-Richard, C; Lesage, S; Rybojad, M; Prieur, AM; Manouvrier-Hanu, S; Hafner, R; Chamaillard, M; Zouali, H; Thomas, G; Hugot, JP				Miceli-Richard, C; Lesage, S; Rybojad, M; Prieur, AM; Manouvrier-Hanu, S; Hafner, R; Chamaillard, M; Zouali, H; Thomas, G; Hugot, JP			CARD15 mutations in Blau syndrome	NATURE GENETICS			English	Article							FAMILIAL GRANULOMATOUS ARTHRITIS; EARLY-ONSET; SKIN RASH; SARCOIDOSIS; IRITIS	We have identified three missense mutations in the nucleotide-binding domain (NBD) of CARD15/NOD2 in four French and German families with Blau syndrome. Our findings indicate that, in addition to Crohn disease, CARD15 is involved in the susceptibility to a second granulomatous disorder.	CEPH, Fdn Jean Dausset, Paris, France; Hop Robert Debre, F-75019 Paris, France; Hop Necker Enfants Malad, Dept Pediat Immunol, Paris, France; Hop Jeanne de Flandre, Dept Genet, Lille, France; Childrens Hosp, Dept Pediat Rheumatol, Garmish Partenkirchen, Germany; INSERM, U434, Paris, France		Hugot, JP (corresponding author), CEPH, Fdn Jean Dausset, Paris, France.		Chamaillard, Mathias/L-6542-2013; Hugot, Jean-Pierre/F-6594-2012	Chamaillard, Mathias/0000-0002-0243-9717; Hugot, Jean-Pierre/0000-0002-8446-6056			BLAU EB, 1985, J PEDIATR-US, V107, P689, DOI 10.1016/S0022-3476(85)80394-2; HAFNER R, 1993, CLIN EXP RHEUMATOL, V11, P685; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Manouvrier-Hanu S, 1998, AM J MED GENET, V76, P217, DOI 10.1002/(SICI)1096-8628(19980319)76:3<217::AID-AJMG4>3.0.CO;2-N; MILLER JJ, 1986, J PEDIATR-US, V109, P387, DOI 10.1016/S0022-3476(86)80411-5; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P21228, DOI 10.1074/jbc.M011381200; Tromp G, 1996, AM J HUM GENET, V59, P1097	9	686	714	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					19	20		10.1038/ng720			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	WOS:000170781300008	11528384				2022-01-24	
J	McCarroll, SA; Kuruvilla, FG; Korn, JM; Cawley, S; Nemesh, J; Wysoker, A; Shapero, MH; de Bakker, PIW; Maller, JB; Kirby, A; Elliott, AL; Parkin, M; Hubbell, E; Webster, T; Mei, R; Veitch, J; Collins, PJ; Handsaker, R; Lincoln, S; Nizzari, M; Blume, J; Jones, KW; Rava, R; Daly, MJ; Gabriel, SB; Altshuler, D				McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Cawley, Simon; Nemesh, James; Wysoker, Alec; Shapero, Michael H.; de Bakker, Paul I. W.; Maller, Julian B.; Kirby, Andrew; Elliott, Amanda L.; Parkin, Melissa; Hubbell, Earl; Webster, Teresa; Mei, Rui; Veitch, James; Collins, Patrick J.; Handsaker, Robert; Lincoln, Steve; Nizzari, Marcia; Blume, John; Jones, Keith W.; Rava, Rich; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David			Integrated detection and population-genetic analysis of SNPs and copy number variation	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; POLYMORPHISMS; HAPLOTYPE; VARIANTS	Dissecting the genetic basis of disease risk requires measuring all forms of genetic variation, including SNPs and copy number variants (CNVs), and is enabled by accurate maps of their locations, frequencies and population-genetic properties. We designed a hybrid genotyping array (Affymetrix SNP 6.0) to simultaneously measure 906,600 SNPs and copy number at 1.8 million genomic locations. By characterizing 270 HapMap samples, we developed a map of human CNV (at 2-kb breakpoint resolution) informed by integer genotypes for 1,320 copy number polymorphisms (CNPs) that segregate at an allele frequency >1%. More than 80% of the sequence in previously reported CNV regions fell outside our estimated CNV boundaries, indicating that large (>100 kb) CNVs affect much less of the genome than initially reported. Approximately 80% of observed copy number differences between pairs of individuals were due to common CNPs with an allele frequency >5%, and more than 99% derived from inheritance rather than new mutation. Most common, diallelic CNPs were in strong linkage disequilibrium with SNPs, and most low-frequency CNVs segregated on specific SNP haplotypes.	[McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Nemesh, James; Wysoker, Alec; de Bakker, Paul I. W.; Elliott, Amanda L.; Parkin, Melissa; Handsaker, Robert; Nizzari, Marcia; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David] MIT, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Nemesh, James; Wysoker, Alec; de Bakker, Paul I. W.; Elliott, Amanda L.; Parkin, Melissa; Handsaker, Robert; Nizzari, Marcia; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David] Harvard Univ, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Maller, Julian B.; Kirby, Andrew; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; de Bakker, Paul I. W.; Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Korn, Joshua M.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Cawley, Simon; Shapero, Michael H.; Hubbell, Earl; Webster, Teresa; Mei, Rui; Veitch, James; Collins, Patrick J.; Lincoln, Steve; Blume, John; Jones, Keith W.; Rava, Rich] Affymetrix Inc, Santa Clara, CA 95051 USA; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Partners HealthCare Syst Ctr Genet & Genom, Boston, MA 02115 USA; [Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA		McCarroll, SA (corresponding author), MIT, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA.	smccarro@broad.mit.edu; altshuler@molbio.mgh.harvard.edu	Handsaker, Bob/AAX-9095-2021; Daly, Mark J/B-2453-2017; McCarroll, Steven A/A-8433-2009; de Bakker, Paul IW/B-8730-2009; Altshuler, David M/A-4476-2009; maller, julian B/A-9323-2009; Elliott, Amanda/G-5120-2012	Handsaker, Bob/0000-0002-3128-3547; Daly, Mark J/0000-0002-0949-8752; de Bakker, Paul IW/0000-0001-7735-7858; Altshuler, David M/0000-0002-7250-4107; McCarroll, Steven/0000-0002-6954-8184; Blume, John/0000-0003-3026-953X; Hubbell, Earl/0000-0001-7301-3759; Maller, Julian/0000-0002-1565-9559			Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antipova AA, 2002, GENOME BIOL, V3; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shen F, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-27; Smemo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000287; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	29	685	708	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1166	1174		10.1038/ng.238			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	WOS:000259651000015	18776908				2022-01-24	
J	BIONE, S; MAESTRINI, E; RIVELLA, S; MANCINI, M; REGIS, S; ROMEO, G; TONIOLO, D				BIONE, S; MAESTRINI, E; RIVELLA, S; MANCINI, M; REGIS, S; ROMEO, G; TONIOLO, D			IDENTIFICATION OF A NOVEL X-LINKED GENE RESPONSIBLE FOR EMERY-DREIFUSS MUSCULAR-DYSTROPHY	NATURE GENETICS			English	Article							SEQUENCES; XQ28	Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive disorder characterized by slowly progressing contractures, wasting of skeletal muscle and cardiomyopathy. Heart block is a frequent cause of death. The disease gene has been mapped to distal Xq28. Among many genes in this region, we selected eight transcripts expressed at high levels in skeletal muscle, heart and/or brain as the best candidates for the disease. We now report, in all five patients studied, unique mutations in one of the genes, STA: these mutations result in the loss of all or part of the protein, The EDMD gene encodes a novel serine-rich protein termed emerin, which contains a 20 amino acid hydrophobic domain at the C terminus, similar to that described for many membrane proteins of the secretory pathway involved in vesicular transport.	CNR, IST GENET BIOCHIM & EVOLUZIONIST, I-27100 PAVIA, ITALY; IST GIANNINA GASLINI, GENET MOLEC LAB, I-16148 GENOA, ITALY				Maestrini, Elena/K-7508-2012; Toniolo, Daniela/AAE-2969-2019; Rivella, Stefano/A-1597-2010; Regis, Stefano/AAA-7794-2020	Maestrini, Elena/0000-0001-5924-3179; Toniolo, Daniela/0000-0001-9545-6032; Regis, Stefano/0000-0002-7723-2294; Rivella, Stefano/0000-0002-0938-6558; Bione, Silvia/0000-0002-3924-4606	TelethonFondazione Telethon [271, 325] Funding Source: Medline		BIENVENU T, 1994, HUM GENET, V94, P65, DOI 10.1007/BF02272843; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; HARRIS CA, 1994, P NATL ACAD SCI USA, V91, P6283, DOI 10.1073/pnas.91.14.6283; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; McKusick VA, 1990, MENDELIAN INHERITANC; ROMEO G, 1988, HUM GENET, V80, P59, DOI 10.1007/BF00451457; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; TRIBIOLI C, 1994, HUM MOL GENET, V3, P1061, DOI 10.1093/hmg/3.7.1061; WARREN G, 1993, NATURE, V362, P297, DOI 10.1038/362297a0; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; WONG C, 1989, BLOOD, V73, P914; YATES JRW, 1993, J MED GENET, V30, P108, DOI 10.1136/jmg.30.2.108	18	685	704	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1994	8	4					323	327		10.1038/ng1294-323			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	WOS:A1994PV68200010	7894480				2022-01-24	
J	Rahman, N; Seal, S; Thompson, D; Kelly, P; Renwick, A; Elliott, A; Reid, S; Spanova, K; Barfoot, R; Chagtai, T; Jayatilake, H; McGuffog, L; Hanks, S; Evans, DG; Eccles, D; Easton, DF; Stratton, MR				Rahman, Nazneen; Seal, Sheila; Thompson, Deborah; Kelly, Patrick; Renwick, Anthony; Elliott, Anna; Reid, Sarah; Spanova, Katarina; Barfoot, Rita; Chagtai, Tasnim; Jayatilake, Hiran; McGuffog, Lesley; Hanks, Sandra; Evans, D. Gareth; Eccles, Diana; Easton, Douglas F.; Stratton, Michael R.		Breast Canc Susceptibility Collabo	PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene	NATURE GENETICS			English	Article							FANCONI-ANEMIA; HELICASE BRIP1; BRCA2; MUTATIONS	PALB2 interacts with BRCA2, and biallelic mutations in PALB2 ( also known as FANCN), similar to biallelic BRCA2 mutations, cause Fanconi anemia. We identified monoallelic truncating PALB2 mutations in 10/ 923 individuals with familial breast cancer compared with 0/1,084 controls ( P= 0.0004) and show that such mutations confer a 2.3- fold higher risk of breast cancer ( 95% confidence interval (c.i.) 1.4 - 3.9, P =0.0025). The results show that PALB2 is a breast cancer susceptibility gene and further demonstrate the close relationship of the Fanconi anemia - DNA repair pathway and breast cancer predisposition.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Strangeways Res Lab, Cambridge, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YA, Hants, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England		Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Eccles, Diana/K-6327-2019; Rahman, Nazneen/D-2802-2013	Eccles, Diana/0000-0002-9935-3169; Evans, Gareth/0000-0002-8482-5784; Rahman, Nazneen/0000-0003-4376-0440	Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02, 077012] Funding Source: Medline; Breast Cancer Now [2005NOV53, 2003:592] Funding Source: Medline		Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2003, CANCER RES, V63, P8596; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	15	684	692	0	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					165	167		10.1038/ng1959			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900013	17200668	Green Accepted			2022-01-24	
J	Lee, SS; Lee, RYN; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G				Lee, SS; Lee, RYN; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G			A systematic RNAi screen identifies a critical role for mitochondria in C-elegans longevity	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE STRESS; TELOMERE LENGTH; FAMILY MEMBER; GENE; INSULIN; YEAST; DAF-2; RESISTANCE	We report a systematic RNA interference (RNAi) screen of 5,690 Caenorhabditis elegans genes for gene inactivations that increase lifespan. We found that genes important for mitochondrial function stand out as a principal group of genes affecting C. elegans lifespan. A classical genetic screen identified a mutation in the mitochondrial leucyl-tRNA synthetase gene (lrs-2) that impaired mitochondrial function and was associated with longer-lifespan. The long-lived worms with impaired mitochondria had lower ATP content and oxygen consumption, but differential responses to free-radical and other stresses. These data suggest that the longer lifespan of C. elegans with compromised mitochrondria cannot simply be assigned to lower free radical production and suggest a more complex coupling of metabolism and longevity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Dept Genet, Sch Med, Boston, MA 02114 USA; Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge, England		Ruvkun, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA.			Lee, Raymond/0000-0002-8151-7479; Fraser, Andrew/0000-0001-9939-6014; Ahringer, Julie/0000-0002-7074-4051	Wellcome TrustWellcome TrustEuropean Commission [054523] Funding Source: Medline		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Benard C, 2001, DEVELOPMENT, V128, P4045; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finch C.E., 1990, LONGEVITY SENESCENCE; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRIEDMAN DB, 1988, GENETICS, V118, P75; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Jazwinski SM, 2001, MECH AGEING DEV, V122, P865, DOI 10.1016/S0047-6374(01)00244-5; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAMATH R, 2002, IN PRESS NATURE; Kelly WG, 1997, GENETICS, V146, P227; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirchman PA, 1999, GENETICS, V152, P179; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lim CS, 2001, CURR BIOL, V11, P1706, DOI 10.1016/S0960-9822(01)00526-7; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; OKIMOTO R, 1992, GENETICS, V130, P471; Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pearl R., 1928, RATE LIVING; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rose MR, 1999, EXP GERONTOL, V34, P577, DOI 10.1016/S0531-5565(99)00042-X; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; Tzagoloff A, 1990, Prog Nucleic Acid Res Mol Biol, V39, P129, DOI 10.1016/S0079-6603(08)60625-X; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	46	684	726	2	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					40	48		10.1038/ng1056			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	WOS:000180136100015	12447374				2022-01-24	
J	Cummings, CJ; Mancini, MA; Antalffy, B; DeFranco, DB; Orr, HT; Zoghbi, HY				Cummings, CJ; Mancini, MA; Antalffy, B; DeFranco, DB; Orr, HT; Zoghbi, HY			Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; ESCHERICHIA-COLI; NEURODEGENERATIVE DISEASES; MOLECULAR CHAPERONES; GLUTAMINE REPEATS; HSP70; DEGRADATION; HOMOLOG; INVOLVEMENT; UBIQUITIN	Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by expansion of a polyglutamine tract in ataxin-1. In affected neurons of SCA1 patients and transgenic mice, mutant ataxin-1 accumulates in a single, ubiquitin-positive nuclear inclusion. In this study, we show that these inclusions stain positively for the 205 proteasome and the molecular chaperone HDJ-2/HSDJ. Similarly, HeLa cells transfected with mutant ataxin-1 develop nuclear aggregates which colocalize with the 205 proteasome and endogenous HDJ-2/HSDJ. Overexpression of wild-type HDJ-2/HSDJ in HeLa cells decreases the frequency of ataxin-1 aggregation. These data suggest that protein misfolding is responsible for the nuclear aggregates seen in SCA1, and that over-expression of a DnaJ chaperone promotes the recognition of a misfolded polyglutamine repeat protein, allowing its refolding and/or ubiquitin-dependent degradation.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Pittsburgh, Dept Biol Sci & Pharmacol, Pittsburgh, PA USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA		Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.			Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS022920, R37NS022920, R01NS027699] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS22920, NS27699] Funding Source: Medline		Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Attaix D, 1997, MOL BIOL REP, V24, P95, DOI 10.1023/A:1006806103675; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Bush KT, 1997, J BIOL CHEM, V272, P9086; CHELLAIAH A, 1993, BIOCHIM BIOPHYS ACTA, V1174, P111, DOI 10.1016/0167-4781(93)90103-K; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; MATILLA T, 1997, NATURE, V389, P974; OH S, 1993, BIOCHIM BIOPHYS ACTA, V1174, P114, DOI 10.1016/0167-4781(93)90104-L; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHERMAN MY, 1992, EMBO J, V11, P71; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; STRAUS DB, 1988, GENE DEV, V2, P1851, DOI 10.1101/gad.2.12b.1851; Tang YT, 1997, MOL BIOL CELL, V8, P795, DOI 10.1091/mbc.8.5.795; Welch WJ, 1998, NATURE, V392, P23, DOI 10.1038/32049; Wisniewski T, 1997, NEUROBIOL DIS, V4, P313, DOI 10.1006/nbdi.1997.0147; ZHOU M, 1996, J BIOL CHEM, V271, P247; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	44	684	698	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					148	154		10.1038/502			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	WOS:000073865100021	9620770				2022-01-24	
J	Unseld, M; Marienfeld, JR; Brandt, P; Brennicke, A				Unseld, M; Marienfeld, JR; Brandt, P; Brennicke, A			The mitochondrial genome of Arabidopsis thaliana contains 57 genes in 366,924 nucleotides	NATURE GENETICS			English	Article							II INTRON SEQUENCES; PLANT-MITOCHONDRIA; CHLAMYDOMONAS-REINHARDTII; WHEAT MITOCHONDRIA; DNA; RNA; EXON; TRANSCRIPTION; ORGANIZATION; NUCLEUS	We have determined the complete sequence of the mitochondrial DNA in the model plant species Arabidopsis thaliana, affording access to the first of its three genomes. The 366,924 nucleotides code for 57 identified genes, which cover only 10% of the genome. Introns in these genes add about 8%, open reading frames larger than 100 amino acids represent 10% of the genome, duplications account for 7%, remnants of retrotransposons of nuclear origin contribute 4% and integrated plastid sequences amount to 1% - leaving 60% of the genome unaccounted for. With the significant contribution of duplications, imported foreign DNA and the extensive background of apparently functionless sequences, the mosaic structure of the Arabidopsis thaliana mitochondrial genome features many aspects of size-relaxed nuclear genomes.	INST GENBIOL FORSCH,D-14195 BERLIN,GERMANY; UNIV ULM,D-89069 ULM,GERMANY								BENDICH AJ, 1993, CURR GENET, V24, P279, DOI 10.1007/BF00336777; BINDER S, 1993, J BIOL CHEM, V268, P7849; BLACKBOURN H, 1986, TRENDS PLANT SCI, V1, P291; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; BRANDT P, 1992, MOL GEN GENET, V236, P33, DOI 10.1007/BF00279640; BRENNER SE, 1995, NATURE, V378, P140, DOI 10.1038/378140a0; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; FOX TD, 1981, CELL, V26, P315, DOI 10.1016/0092-8674(81)90200-2; GOODMAN HM, 1995, P NATL ACAD SCI USA, V92, P10831, DOI 10.1073/pnas.92.24.10831; GRAY MW, 1988, PHILOS T R SOC B, V319, P135, DOI 10.1098/rstb.1988.0038; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P5461, DOI 10.1093/nar/17.14.5461; KLEIN M, 1994, PLANT J, V6, P447, DOI 10.1046/j.1365-313X.1994.06030447.x; Knoop V, 1996, GENETICS, V142, P579; KNOOP V, 1994, J MOL BIOL, V242, P389, DOI 10.1006/jmbi.1994.1589; KNOOP V, 1991, EMBO J, V10, P3483, DOI 10.1002/j.1460-2075.1991.tb04912.x; KNOOP V, 1994, J MOL EVOL, V39, P144; Knoop Volker, 1993, P221; Lang BF, 1996, J MOL BIOL, V261, P607, DOI 10.1006/jmbi.1996.0486; LEVINGS CS, 1990, SCIENCE, V250, P942, DOI 10.1126/science.250.4983.942; LIPPOK B, 1996, BIOL CHEM, V337, P251; MARECHALDROUARD L, 1993, ANNU REV PLANT PHYS, V44, P13, DOI 10.1146/annurev.pp.44.060193.000305; MEYEROWITZ EM, 1994, ARAQBIDOPSIS; MICHAELIS G, 1990, MOL GEN GENET, V223, P211, DOI 10.1007/BF00265056; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; OHTA E, 1993, NUCLEIC ACIDS RES, V21, P1297, DOI 10.1093/nar/21.5.1297; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1984, NATURE, V307, P411; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B	34	684	835	1	55	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					57	61		10.1038/ng0197-57			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300021	8988169				2022-01-24	
J	Verde, I; Abbott, AG; Scalabrin, S; Jung, S; Shu, SQ; Marroni, F; Zhebentyayeva, T; Dettori, MT; Grimwood, J; Cattonaro, F; Zuccolo, A; Rossini, L; Jenkins, J; Vendramin, E; Meisel, LA; Decroocq, V; Sosinski, B; Prochnik, S; Mitros, T; Policriti, A; Cipriani, G; Dondini, L; Ficklin, S; Goodstein, DM; Xuan, PF; Del Fabbro, C; Aramini, V; Copetti, D; Gonzalez, S; Horner, DS; Falchi, R; Lucas, S; Mica, E; Maldonado, J; Lazzari, B; Bielenberg, D; Pirona, R; Miculan, M; Barakat, A; Testolin, R; Stella, A; Tartarini, S; Tonutti, P; Arus, P; Orellana, A; Wells, C; Main, D; Vizzotto, G; Silva, H; Salamini, F; Schmutz, J; Morgante, M; Rokhsar, DS				Verde, Ignazio; Abbott, Albert G.; Scalabrin, Simone; Jung, Sook; Shu, Shengqiang; Marroni, Fabio; Zhebentyayeva, Tatyana; Dettori, Maria Teresa; Grimwood, Jane; Cattonaro, Federica; Zuccolo, Andrea; Rossini, Laura; Jenkins, Jerry; Vendramin, Elisa; Meisel, Lee A.; Decroocq, Veronique; Sosinski, Bryon; Prochnik, Simon; Mitros, Therese; Policriti, Alberto; Cipriani, Guido; Dondini, Luca; Ficklin, Stephen; Goodstein, David M.; Xuan, Pengfei; Del Fabbro, Cristian; Aramini, Valeria; Copetti, Dario; Gonzalez, Susana; Horner, David S.; Falchi, Rachele; Lucas, Susan; Mica, Erica; Maldonado, Jonathan; Lazzari, Barbara; Bielenberg, Douglas; Pirona, Raul; Miculan, Mara; Barakat, Abdelali; Testolin, Raffaele; Stella, Alessandra; Tartarini, Stefano; Tonutti, Pietro; Arus, Pere; Orellana, Ariel; Wells, Christina; Main, Dorrie; Vizzotto, Giannina; Silva, Herman; Salamini, Francesco; Schmutz, Jeremy; Morgante, Michele; Rokhsar, Daniel S.		Int Peach Genome Initiative	The high-quality draft genome of peach (Prunus persica) identifies unique patterns of genetic diversity, domestication and genome evolution	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SORBITOL TRANSPORTERS; NUCLEOTIDE DIVERSITY; ARABIDOPSIS-THALIANA; SEQUENCE; APPLE; PLANT; CULTIVARS; LEAVES; PHLOEM	Rosaceae is the most important fruit-producing clade, and its key commercially relevant genera (Fragaria, Rosa, Rubus and Prunus) show broadly diverse growth habits, fruit types and compact diploid genomes. Peach, a diploid Prunus species, is one of the best genetically characterized deciduous trees. Here we describe the high-quality genome sequence of peach obtained from a completely homozygous genotype. We obtained a complete chromosome-scale assembly using Sanger whole-genome shotgun methods. We predicted 27,852 protein-coding genes, as well as noncoding RNAs. We investigated the path of peach domestication through whole-genome resequencing of 14 Prunus accessions. The analyses suggest major genetic bottlenecks that have substantially shaped peach genome diversity. Furthermore, comparative analyses showed that peach has not undergone recent whole-genome duplication, and even though the ancestral triplicated blocks in peach are fragmentary compared to those in grape, all seven paleosets of paralogs from the putative paleoancestor are detectable.	[Verde, Ignazio; Dettori, Maria Teresa; Vendramin, Elisa; Cipriani, Guido; Aramini, Valeria] Ctr Ric Frutticoltura, Consiglio Ric & Sperimentaz Agr CRA, Rome, Italy; [Abbott, Albert G.; Zhebentyayeva, Tatyana; Barakat, Abdelali] Clemson Univ, Dept Genet & Biochem, Clemson, SC USA; [Abbott, Albert G.; Decroocq, Veronique] Univ Bordeaux, INRA, UMR Biol Fruit & Pathol BFP 1332, Villenave Dornon, France; [Scalabrin, Simone; Marroni, Fabio; Cattonaro, Federica; Zuccolo, Andrea; Policriti, Alberto; Del Fabbro, Cristian; Copetti, Dario; Miculan, Mara; Testolin, Raffaele; Morgante, Michele] IGA, Udine, Italy; [Jung, Sook; Ficklin, Stephen; Main, Dorrie] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; [Shu, Shengqiang; Grimwood, Jane; Jenkins, Jerry; Prochnik, Simon; Goodstein, David M.; Lucas, Susan; Schmutz, Jeremy; Rokhsar, Daniel S.] US Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Marroni, Fabio; Cipriani, Guido; Falchi, Rachele; Testolin, Raffaele; Vizzotto, Giannina; Morgante, Michele] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; [Grimwood, Jane; Jenkins, Jerry; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Zuccolo, Andrea; Mica, Erica; Tonutti, Pietro] SSSA, Pisa, Italy; [Rossini, Laura; Lazzari, Barbara; Pirona, Raul; Stella, Alessandra; Salamini, Francesco] Parco Tecnol Padano, Lodi, Italy; [Rossini, Laura] Univ Milan, Dipartimento Sci Agr & Ambientali Prod, Milan, Italy; [Meisel, Lee A.] Univ Chile, INTA, Santiago, Chile; [Meisel, Lee A.] Univ Andres Bello, Fac Ciencias Biol, Ctr Biotecnol Vegetal, Santiago, Chile; [Sosinski, Bryon] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA; [Mitros, Therese] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Policriti, Alberto] Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy; [Dondini, Luca; Tartarini, Stefano] Univ Bologna, Dept Fruit Tree & Woody Plant Sci, Bologna, Italy; [Xuan, Pengfei] Clemson Univ, Sch Comp, Clemson, SC USA; [Gonzalez, Susana; Orellana, Ariel] Univ Andres Bello, Fondo Invest Avanzada Areas Prioritarias FONDAP, Ctr Genome Regulat, Ctr Biotecnol Vegetal,Fac Ciencias Biol, Santiago, Chile; [Horner, David S.] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy; [Maldonado, Jonathan; Silva, Herman] Univ Chile, Fac Ciencias Agron, Lab Genom Func & Bioinformat, La Pintana, Chile; [Bielenberg, Douglas; Wells, Christina] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC USA; [Stella, Alessandra] CNR, Ist Biol & Biotecnol Agr, Lodi, Italy; [Arus, Pere] Univ Barcelona, Univ Autonoma Barcelona, IRTA, Ctr Recerca Agrigenom,CSIC,IRTA, Barcelona, Spain; [Salamini, Francesco] Fdn Edmund Mach, IASMA, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA		Verde, I (corresponding author), Ctr Ric Frutticoltura, Consiglio Ric & Sperimentaz Agr CRA, Rome, Italy.	ignazio.verde@entecra.it; aalbert@clemson.edu; michele.morgante@uniud.it; dsrokhsar@gmail.com	Bielenberg, Douglas/G-3893-2010; Decroocq, Veronique/M-1059-2016; Miculan, Mara/AAM-6109-2021; Xuan, Pengfei/J-4454-2019; mica, erica/AAA-3931-2020; Jenkins, Jerry/ABE-6479-2020; Orellana, Ariel/E-2166-2014; Ficklin, Stephen/L-4324-2019; Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; Silva, Herman P/C-7252-2012; Zuccolo, Andrea/H-5636-2019; Meisel, Lee/J-6755-2012; Pirona, Raul/AAA-5542-2020; Marroni, Fabio/R-1819-2017; Del Fabbro, Cristian/C-5523-2014; Decroocq, Veronique/C-9980-2019; Dondini, Luca/N-8797-2015; Stella, Alessandra/AAY-7322-2020; Vendramin, Elisa/AAI-8762-2020; Maldonado, Jonathan E/J-6429-2012; Verde, Ignazio/K-6348-2019; Rossini, Laura/J-7873-2012; Horner, David/AAC-2274-2022; Orellana, Ariel/AAE-4866-2021; Arus, Pere/F-6443-2015; Pirona, Raul/L-3201-2013; stella, Alessandra/ABB-1952-2021; Testolin, Raffaele/J-5306-2019	Bielenberg, Douglas/0000-0002-4853-2984; Decroocq, Veronique/0000-0001-6745-6350; Miculan, Mara/0000-0002-9884-5727; Jenkins, Jerry/0000-0002-7943-3997; Orellana, Ariel/0000-0002-9243-808X; Ficklin, Stephen/0000-0001-9138-6292; Schmutz, Jeremy/0000-0001-8062-9172; Silva, Herman P/0000-0003-1007-7442; Zuccolo, Andrea/0000-0001-7574-0714; Meisel, Lee/0000-0002-4806-6864; Pirona, Raul/0000-0002-1817-344X; Marroni, Fabio/0000-0002-1556-5907; Del Fabbro, Cristian/0000-0001-8189-6192; Decroocq, Veronique/0000-0001-6745-6350; Dondini, Luca/0000-0002-3547-9731; Maldonado, Jonathan E/0000-0002-9967-0885; Rossini, Laura/0000-0001-6509-9177; Orellana, Ariel/0000-0002-9243-808X; Arus, Pere/0000-0003-0939-8038; Pirona, Raul/0000-0002-1817-344X; stella, Alessandra/0000-0003-2850-3964; TARTARINI, STEFANO/0000-0002-3920-5658; MORGANTE, Michele/0000-0003-2591-2156; Shu, Shengqiang/0000-0002-4336-8994; Copetti, Dario/0000-0002-2680-2568; Verde, Ignazio/0000-0002-9139-955X; Goodstein, David/0000-0001-6287-2697; VIZZOTTO, Giannina/0000-0002-9147-7570; Dettori, Maria Teresa/0000-0003-0528-2855; Rokhsar, Daniel/0000-0002-8704-2224; Vendramin, Elisa/0000-0002-7324-7237	Office of Science of the US Department of EnergyUnited States Department of Energy (DOE) [DE-AC02-05CH11231]; Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF) [DM14999/7303/08]; US Department of Agriculture (USDA) through USDA National Institute of Food and Agriculture (NIFA) Specialty Crop Research Initiative (SCRI) [2010-2010-03255]; Robert and Louis Coker Chair for Plant Molecular Genetics; Chilean government [FDI G02P1001]; Basal ProgramPB-16Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL; FONDAP [CRG15090007]; Spanish Ministry of Science and InnovationSpanish Government [CSD2007-00036]; French National Research Agency (ANR) through Chex-ABRIWG ANR/INRAFrench National Research Agency (ANR) [22000552]	This work was jointly supported by the Office of Science of the US Department of Energy under contract number DE-AC02-05CH11231 and the Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF, http://www.politicheagricole.it) through the project 'DRUPOMICS' (grant DM14999/7303/08). We would also like to thank the US Department of Agriculture (USDA) for their support of the peach genomics program through USDA National Institute of Food and Agriculture (NIFA) Specialty Crop Research Initiative (SCRI) grant 2010-2010-03255, the Robert and Louis Coker Chair for Plant Molecular Genetics for their grant to Clemson University, the Chilean government for supporting this work through FDI G02P1001 (Chilean Genome Initiative), Basal ProgramPB-16 and FONDAP CRG15090007, the Consolider-Ingenio 2010 Program (CSD2007-00036) from the Spanish Ministry of Science and Innovation, the French National Research Agency (ANR) for supporting this work through Chex-ABRIWG ANR/INRA 22000552, G. Reighard (Clemson University) for providing the leaf material of the Lovell double haploid, R. Quarta (Centro di Ricerca per la Frutticoltura di Roma (CRA-FRU)) and C. Pozzi (Fondazione Edmund Mach (FEM) S. Michele all'Adige) for their efforts in the drafting of the DRUPOMICS proposal, T. Pascal (Institut National de la Recherche Agronomique (INRA) Avignon) for providing leaf material for the resequencing, T. Candresse (INRA Bordeaux) for his critical reading of the manuscript, M. Troggio (FEM S. Michele all'Adige) for her help with the data analysis and G. Zhongshan (Zhejiang University) for the information provided about the Chinese peach accessions.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Bieleski R. L., 1982, ENCY PLANT PHYSL A, V13A, P185; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Cannon SB, 2002, J MOL EVOL, V54, P548, DOI [10.1007/s00239-001-0057-2, 10.1007/s0023901-0057-2]; Cantin CM, 2010, POSTHARVEST BIOL TEC, V58, P79, DOI 10.1016/j.postharvbio.2010.06.002; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Dewey Colin N., 2007, V395, P221; Dirlewanger E, 2012, HEREDITY, V109, P280, DOI 10.1038/hdy.2012.38; Eduardo I, 2011, TREE GENET GENOMES, V7, P323, DOI 10.1007/s11295-010-0334-6; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Faust M., 1995, Horticultural Reviews, V17, P331, DOI 10.1002/9780470650585.ch10; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hancock JF, 2000, TEMPERATE FRUIT CROPS IN WARM CLIMATES, P445; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klages K, 2001, AUST J PLANT PHYSIOL, V28, P131; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li RQ, 2005, PLOS COMPUT BIOL, V1, P313, DOI 10.1371/journal.pcbi.0010043; Lo Bianco R, 1999, TREE PHYSIOL, V19, P103; LOESCHER WH, 1982, PLANT PHYSIOL, V70, P335, DOI 10.1104/pp.70.2.335; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meng RG, 2002, J AM SOC HORTIC SCI, V127, P767, DOI 10.21273/JASHS.127.5.767; Moing A, 1997, PHYSIOL PLANTARUM, V101, P489, DOI 10.1111/j.1399-3054.1997.tb01028.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Okie WR, 2003, ACTA HORTIC, P261, DOI 10.17660/ActaHortic.2003.622.24; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quilot B, 2004, THEOR APPL GENET, V109, P884, DOI 10.1007/s00122-004-1703-z; R Development Core team, 2012, R LANG ENV STAT COMP; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SCORZA R, 1985, J AM SOC HORTIC SCI, V110, P547; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; TAJIMA F, 1989, GENETICS, V123, P585; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vezzi F, 2012, BIOINFORMATICS, V28, P123, DOI 10.1093/bioinformatics/btr617; WALLAART RAM, 1980, PHYTOCHEMISTRY, V19, P2603, DOI 10.1016/S0031-9422(00)83927-8; Watari J, 2004, PLANT CELL PHYSIOL, V45, P1032, DOI 10.1093/pcp/pch121; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xing Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-43; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yoon JH, 2006, J AM SOC HORTIC SCI, V131, P513, DOI 10.21273/JASHS.131.4.513	66	683	731	28	329	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2013	45	5					487	U47		10.1038/ng.2586			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	WOS:000318158200009	23525075	hybrid, Green Published	Y	N	2022-01-24	
J	Binder, EB; Salyakina, D; Lichtner, P; Wochnik, GM; Ising, M; Putz, B; Papiol, S; Seaman, S; Lucae, S; Kohli, MA; Nickel, T; Kunzel, HE; Fuchs, B; Majer, M; Pfennig, A; Kern, N; Brunner, J; Modell, S; Baghai, T; Deiml, T; Zill, P; Bondy, B; Rupprecht, R; Messer, T; Kohnlein, O; Dabitz, H; Bruckl, T; Muller, N; Pfister, H; Lieb, R; Mueller, JC; Lohmussaar, E; Strom, TM; Bettecken, T; Meitinger, T; Uhr, M; Rein, T; Holsboer, F; Muller-Myhsok, B				Binder, EB; Salyakina, D; Lichtner, P; Wochnik, GM; Ising, M; Putz, B; Papiol, S; Seaman, S; Lucae, S; Kohli, MA; Nickel, T; Kunzel, HE; Fuchs, B; Majer, M; Pfennig, A; Kern, N; Brunner, J; Modell, S; Baghai, T; Deiml, T; Zill, P; Bondy, B; Rupprecht, R; Messer, T; Kohnlein, O; Dabitz, H; Bruckl, T; Muller, N; Pfister, H; Lieb, R; Mueller, JC; Lohmussaar, E; Strom, TM; Bettecken, T; Meitinger, T; Uhr, M; Rein, T; Holsboer, F; Muller-Myhsok, B			Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment	NATURE GENETICS			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENOCORTICAL REGULATION; HORMONE-RECEPTOR 1; GLUCOCORTICOID-RECEPTOR; IMMUNOPHILIN FKBP51; STEROID-RECEPTORS; MAJOR DEPRESSION; DISORDERS; BINDING; ANXIETY	The stress hormone-regulating hypothalamic-pituitary-adrenal (HPA) axis has been implicated in the causality1 as well as the treatment of depression(2). To investigate a possible association between genes regulating the HPA axis and response to antidepressants and susceptibility for depression, we genotyped single-nucleotide polymorphisms in eight of these genes in depressed individuals and matched controls. We found significant associations of response to antidepressants and the recurrence of depressive episodes with single-nucleotide polymorphisms in FKBP5, a glucocorticoid receptor-regulating cochaperone of hsp-90, in two independent samples. These single-nucleotide polymorphisms were also associated with increased intracellular FKBP5 protein expression, which triggers adaptive changes in glucocorticoid receptor and, thereby, HPA-axis regulation. Individuals carrying the associated genotypes had less HPA-axis hyperactivity during the depressive episode. We propose that the FKBP5 variant-dependent alterations in HPA-axis regulation could be related to the faster response to antidepressant drug treatment and the increased recurrence of depressive episodes observed in this subgroup of depressed individuals. These findings support a central role of genes regulating the HPA axis in the causality of depression and the mechanism of action of antidepressant drugs.	Max Planck Inst Psychiat, D-80804 Munich, Germany; Tech Univ, Inst Human Genet, D-85764 Neuherberg, Germany; GSF Natl res Ctr Environm & Hlth, D-85764 Neuherberg, Germany; Univ Barcelona, Fac Biol, Unitat Antropol, E-08028 Barcelona, Spain; Univ Munich, Dept Psychiat, D-80336 Munich, Germany; Bezirkskrankenhaus Augsburg, D-86156 Augsburg, Germany; Klinikum Ingolstadt, D-85049 Ingolstadt, Germany		Binder, EB (corresponding author), Max Planck Inst Psychiat, D-80804 Munich, Germany.	ebinder@genetics.emory.edu	Putz, Benno/P-2630-2016; Meitinger, Thomas/O-1318-2015; Org, Elin/AAJ-9631-2021; Muller-Myhsok, Bertram/A-3289-2013; Binder, Elisabeth B/K-8905-2014	Putz, Benno/0000-0002-2208-209X; Meitinger, Thomas/0000-0002-8838-8403; Rein, Theo/0000-0003-2850-4289; Org, Elin/0000-0001-8688-9717; Papiol, Sergi/0000-0001-9366-8728; Salyakina, Daria/0000-0003-3283-3691; Seaman, Shaun/0000-0003-3726-5937			Barden N, 1997, NEUROENDOCRINOLOGY, V66, P212, DOI 10.1159/000127240; Cheung J, 2000, MOL ENDOCRINOL, V14, P939, DOI 10.1210/me.14.7.939; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Fisher R.A., 1932, STAT METHODS RES WOR; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; HOLSBOER F, 1995, NEUROENDOCRINOLOGY, V62, P340, DOI 10.1159/000127023; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; LEWONTIN RC, 1988, GENETICS, V120, P849; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; NEMEROFF CB, 1988, PHARMACOPSYCHIATRY, V21, P76, DOI 10.1055/s-2007-1014652; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Purba JS, 1996, ARCH GEN PSYCHIAT, V53, P137; Reynolds PD, 1998, LAB ANIM SCI, V48, P364; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Schiene-Fischer C, 2001, FEBS LETT, V495, P1, DOI 10.1016/S0014-5793(01)02326-2; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wittchen H-U., 1999, INT J METHOD PSYCHIA, V8, P59, DOI DOI 10.1002/MPR.57; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	30	683	706	1	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2004	36	12					1319	1325		10.1038/ng1479			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	WOS:000225354100021	15565110				2022-01-24	
J	Lin, K; Hsin, H; Libina, N; Kenyon, C				Lin, K; Hsin, H; Libina, N; Kenyon, C			Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FKHR; AGE-1 PI3 KINASE; LIFE-SPAN; GENETIC-ANALYSIS; DAUER FORMATION; FACTOR AFX; DIAPAUSE; HOMOLOG; PHOSPHORYLATION; PATHWAY	The lifespan of Caenorhabditis elegans is regulated by the insulin/insulin-like growth factor (IGF)-1 receptor homolog DAF-2, which signals through a conserved phosphatidylinositol 3-kinase (PI 3-kinase)/Akt pathway(1-7) Mutants in this pathway remain youthful and active much longer than normal animals and can live more than twice as long, This lifespan extension requires DAF-16, a forkhead/winged-helix transcription factor(8,9). DAF-16 is thought to be the main target of the DAF-2 pathway. Insulin/IGF-1 signaling is thought to lead to phosphorylation of DAF-16 by AKT activity, which in turn shortens lifespan. Here, we show that the DAF-2 pathway prevents DAF-16 accumulation in nuclei. Disrupting Akt-consensus phosphorylation sites in DAF-16 causes nuclear accumulation in wild-type animals, but, surprisingly, has little effect on lifespan. Thus the DAF-2 pathway must have additional outputs. Lifespan in C. elegans can be extended by perturbing sensory neurons or germ cells(10,11). In both cases, lifespan extension requires DAF-16. We find that both sensory neurons and germline activity regulate DAF-16 accumulation in nuclei, but the nuclear localization patterns are different. Together these findings reveal unexpected complexity in the DAF-16-dependent pathways that regulate aging.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Genentech Inc, Dept Cell Biol & Technol, San Francisco, CA 94080 USA		Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Hsin, Honor/0000-0002-0510-7494			Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; DORMAN JB, 1995, GENETICS, V141, P1399; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; GOTTLIEB S, 1994, GENETICS, V137, P107; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lin SY, 1997, QUAL RELIAB ENG INT, V13, P9, DOI 10.1002/(SICI)1099-1638(199701)13:1<9::AID-QRE58>3.0.CO;2-W; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Malone EA, 1996, GENETICS, V143, P1193; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Priess J.R., 1997, C ELEGANS 2 1997, P739; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; VOWELS JJ, 1992, GENETICS, V130, P105; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	31	683	708	5	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					139	145		10.1038/88850			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	WOS:000169011800015	11381260				2022-01-24	
J	Roberts, SA; Lawrence, MS; Klimczak, LJ; Grimm, SA; Fargo, D; Stojanov, P; Kiezun, A; Kryukov, GV; Carter, SL; Saksena, G; Harris, S; Shah, RR; Resnick, MA; Getz, G; Gordenin, DA				Roberts, Steven A.; Lawrence, Michael S.; Klimczak, Leszek J.; Grimm, Sara A.; Fargo, David; Stojanov, Petar; Kiezun, Adam; Kryukov, Gregory V.; Carter, Scott L.; Saksena, Gordon; Harris, Shawn; Shah, Ruchir R.; Resnick, Michael A.; Getz, Gad; Gordenin, Dmitry A.			An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers	NATURE GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; SOMATIC MUTATIONS; GENOMIC DNA; BREAST; REPLICATION; MECHANISMS; RECURRENT; DAMAGE; RETROTRANSPOSITION; EXPRESSION	Recent studies indicate that a subclass of APOBEC cytidine deaminases, which convert cytosine to uracil during RNA editing and retrovirus or retrotransposon restriction, may induce mutation clusters in human tumors. We show here that throughout cancer genomes APOBEC-mediated mutagenesis is pervasive and correlates with APOBEC mRNA levels. Mutation clusters in whole-genome and exome data sets conformed to the stringent criteria indicative of an APOBEC mutation pattern. Applying these criteria to 954,247 mutations in 2,680 exomes from 14 cancer types, mostly from The Cancer Genome Atlas (TCGA), showed a significant presence of the APOBEC mutation pattern in bladder, cervical, breast, head and neck, and lung cancers, reaching 68% of all mutations in some samples. Within breast cancer, the HER2-enriched subtype was clearly enriched for tumors with the APOBEC mutation pattern, suggesting that this type of mutagenesis is functionally linked with cancer development. The APOBEC mutation pattern also extended to cancer-associated genes, implying that ubiquitous APOBEC-mediated mutagenesis is carcinogenic.	[Roberts, Steven A.; Resnick, Michael A.] Natl Inst Environm Hlth Sci, Mol Genet Lab, Durham, NC USA; [Lawrence, Michael S.; Stojanov, Petar; Kiezun, Adam; Kryukov, Gregory V.; Carter, Scott L.; Saksena, Gordon; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Klimczak, Leszek J.; Grimm, Sara A.; Fargo, David] Natl Inst Environm Hlth Sci, Durham, NC USA; [Kryukov, Gregory V.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Harris, Shawn; Shah, Ruchir R.] SRA Int Inc, Durham, NC USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA		Gordenin, DA (corresponding author), Natl Inst Environm Hlth Sci, Mol Genet Lab, Durham, NC USA.	gadgetz@broadinstitute.org; gordenin@niehs.nih.gov	Dmitry, Gordenin/C-3907-2018; Kryukov, Gregory V/A-9592-2008; resnick, Michael/F-1668-2019; Lawrence, Michael/AAC-8202-2020	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506; Kryukov, Gregory/0000-0002-6131-9483; Harris, Shawn/0000-0003-3169-9128	Intramural Research Program of the US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ES065073, GS-23F-9806H, HHSN273201000086U]; National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZIAES065073, Z01ES065073] Funding Source: NIH RePORTER	We would like to thank J. Taylor, P. Wade and D. Zaykin for helpful discussions and critical reading of the manuscript. The results published here are in part based on data generated by the TCGA project established by the National Cancer Institute and the National Human Genome Research Institute (database of Genotypes and Phenotypes (dbGaP) accession phs000178.v8.p7). The work was supported in part by the Intramural Research Program of the US National Institutes of Health, the National Institute of Environmental Health Sciences (project ES065073 to M.A.R.; contract GS-23F-9806H and order HHSN273201000086U to R.R.S.) and by the National Human Genome Research Institute (grant U54HG003067 to G.G.).	Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chan K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003149; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Conticello SG, 2012, ANN NY ACAD SCI, V1267, P79, DOI 10.1111/j.1749-6632.2012.06614.x; Douville C, 2013, BIOINFORMATICS, V29, P647, DOI 10.1093/bioinformatics/btt017; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; GIBBS PEM, 1995, J MOL BIOL, V251, P229, DOI 10.1006/jmbi.1995.0430; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harfe BD, 2000, MOL CELL, V6, P1491, DOI 10.1016/S1097-2765(00)00145-3; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; LOEB LA, 1991, CANCER RES, V51, P3075; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Menendez D, 2013, CURR OPIN ONCOL, V25, P85, DOI 10.1097/CCO.0b013e32835b6386; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Sakamoto AN, 2007, DNA REPAIR, V6, P1829, DOI 10.1016/j.dnarep.2007.07.002; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036	51	682	693	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					970	+		10.1038/ng.2702			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	WOS:000323748200005	23852170	Green Accepted	Y	N	2022-01-24	
J	Pasqualucci, L; Trifonov, V; Fabbri, G; Ma, J; Rossi, D; Chiarenza, A; Wells, VA; Grunn, A; Messina, M; Elliot, O; Chan, J; Bhagat, G; Chadburn, A; Gaidano, G; Mullighan, CG; Rabadan, R; Dalla-Favera, R				Pasqualucci, Laura; Trifonov, Vladimir; Fabbri, Giulia; Ma, Jing; Rossi, Davide; Chiarenza, Annalisa; Wells, Victoria A.; Grunn, Adina; Messina, Monica; Elliot, Oliver; Chan, Joseph; Bhagat, Govind; Chadburn, Amy; Gaidano, Gianluca; Mullighan, Charles G.; Rabadan, Raul; Dalla-Favera, Riccardo			Analysis of the coding genome of diffuse large B-cell lymphoma	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; GENETIC ALTERATIONS; MULTIPLE-MYELOMA; HODGKIN LYMPHOMA; ANALYSIS REVEALS; PHD FINGER; MUTATIONS; CANCER	Diffuse large B-cell lymphoma (DLBCL) is the most common form of human lymphoma. Although a number of structural alterations have been associated with the pathogenesis of this malignancy, the full spectrum of genetic lesions that are present in the DLBCL genome, and therefore the identity of dysregulated cellular pathways, remains unknown. By combining next-generation sequencing and copy number analysis, we show that the DLBCL coding genome contains, on average, more than 30 clonally represented gene alterations per case. This analysis also revealed mutations in genes not previously implicated in DLBCL pathogenesis, including those regulating chromatin methylation (MLL2; 24% of samples) and immune recognition by T cells. These results provide initial data on the complexity of the DLBCL coding genome and identify novel dysregulated pathways underlying its pathogenesis.	[Pasqualucci, Laura; Fabbri, Giulia; Chiarenza, Annalisa; Wells, Victoria A.; Grunn, Adina; Messina, Monica; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Pasqualucci, Laura; Bhagat, Govind; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Pasqualucci, Laura; Bhagat, Govind; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Trifonov, Vladimir; Elliot, Oliver; Chan, Joseph; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Elliot, Oliver; Chan, Joseph; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Ma, Jing; Mullighan, Charles G.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, Novara, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Chadburn, Amy] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY USA		Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	lp171@columbia.edu; rd10@columbia.edu	Chiarenza, Annalisa/AAC-2013-2019; Rabadan, Raul/AAZ-7367-2020; Bhagat, Govind/AAE-9493-2021; Mullighan, Charles/H-3253-2011; Gaidano, Gianluca/AAW-2773-2021	Chiarenza, Annalisa/0000-0002-8759-4854; Mullighan, Charles/0000-0002-1871-1850; Gaidano, Gianluca/0000-0002-4681-0151; Bhagat, Govind/0000-0001-6250-048X; Chan, Joseph/0000-0001-5249-7395; Messina, Monica/0000-0003-3531-4766; Rabadan, Raul/0000-0001-7946-9255	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1-CA092625, RO1-CA37295]; Leukemia & Lymphoma SocietyLeukemia and Lymphoma Society; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA121852-05]; Northeast Biodefense Center [U54-AI057158]; National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [1R01LM010140-01]; Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, ItalyFondazione AIRC per la ricerca sul cancro [10007]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U54CA121852, R01CA037295, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010140] Funding Source: NIH RePORTER	We would like to thank T. Palomero, E. Tzilianos, V. Miljkovic and the Genomics Technologies Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University; D. Burgess at Roche NimbleGen (Madison, Wisconsin, USA) and B. Boese at 454 Life Sciences (Branford, Connecticut, USA) for assistance with the whole-exome capture and sequencing procedure; K. Basso and A. Holmes for help with the manual curation and analysis of the copy number data; M. Malladi and Y. K. Lieu for help with the analysis of B2M and CD58; and J. Zhang for filtering the list of candidate mutations against the database of germline variants discovered from the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project. The Affymetrix SNP6.0 array experiments were processed in part at the Affymetrix Research Services Laboratory. Automated DNA sequencing was performed at Genewiz, Inc. This work was supported by US National Institutes of Health (NIH) Grants PO1-CA092625 and RO1-CA37295 (to R. D.-F.), a Specialized Center of Research grant from the Leukemia & Lymphoma Society (to R. D.-F.), NIH Grant CA121852-05, the Northeast Biodefense Center (U54-AI057158) and the National Library of Medicine (1R01LM010140-01) (to R. R.), and the Associazione Italiana per la Ricerca sul Cancro (AIRC) Special Program Molecular Clinical Oncology-5 per mille (Contract No. 10007, Milan, Italy). A. Chiarenza was on leave from the Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy.	Abramson JS, 2005, BLOOD, V106, P1164, DOI 10.1182/blood-2005-02-0687; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.3.CO;2-W; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Jordanova ES, 2003, INT J CANCER, V103, P393, DOI 10.1002/ijc.10824; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; MENDEZLAGO M, 2010, BLOOD, P116; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Riemersma SA, 2000, BLOOD, V96, P3569, DOI 10.1182/blood.V96.10.3569.h8003569_3569_3577; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Swerdlow S.H., 2008, WHO CLASSIFICATION T; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	65	682	696	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					830	U33		10.1038/ng.892			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	WOS:000294325800007	21804550	Green Accepted	Y	N	2022-01-24	
J	Lambrechts, D; Storkebaum, E; Morimoto, M; Del-Favero, J; Desmet, F; Marklund, SL; Wyns, S; Thijs, V; Andersson, J; van Marion, I; Al-Chalabi, A; Bornes, S; Musson, R; Hansen, V; Beckman, L; Adolfsson, R; Pall, HS; Prats, H; Vermeire, S; Rutgeerts, P; Katayama, S; Awata, T; Leigh, N; Lang-Lazdunski, L; Dewerchin, M; Shaw, C; Moons, L; Vlietinck, R; Morrison, KE; Robberecht, W; Van Broeckhoven, C; Collen, D; Andersen, PM; Carmeliet, P				Lambrechts, D; Storkebaum, E; Morimoto, M; Del-Favero, J; Desmet, F; Marklund, SL; Wyns, S; Thijs, V; Andersson, J; van Marion, I; Al-Chalabi, A; Bornes, S; Musson, R; Hansen, V; Beckman, L; Adolfsson, R; Pall, HS; Prats, H; Vermeire, S; Rutgeerts, P; Katayama, S; Awata, T; Leigh, N; Lang-Lazdunski, L; Dewerchin, M; Shaw, C; Moons, L; Vlietinck, R; Morrison, KE; Robberecht, W; Van Broeckhoven, C; Collen, D; Andersen, PM; Carmeliet, P			VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEAVY NEUROFILAMENT SUBUNIT; HIPPOCAMPAL-NEURONS; GENETIC ASSOCIATION; MESSENGER-RNA; SPORADIC ALS; POLYMORPHISM; DISEASE; TRANSFORMATION; PATHOGENESIS	Amyotrophic lateral sclerosis (ALS) is an incurable degenerative disorder of motoneurons. We recently reported that reduced expression of Vegfa causes ALS-like motoneuron degeneration in Vegfa(partial derivative/partial derivative) mice. In a meta-analysis of over 900 individuals from Sweden and over 1,000 individuals from Belgium and England, we now report that subjects homozygous with respect to the haplotypes -2,578A/-1,154A/-634G or -2,578A/-1,154G/-634G in the VEGF promoter/leader sequence had a 1.8 times greater risk of ALS (P = 0.00004). These at-risk haplotypes lowered circulating VEGF levels in vivo and reduced VEGF gene transcription, IRES-mediated VEGF expression and translation of a novel large-VEGF isoform (L-VEGF) in vivo. Moreover, SOD1(G93A) mice crossbred with Vegfa(partial derivative/partial derivative) mice died earlier due to more severe motoneuron degeneration. Vegfa(partial derivative/partial derivative) mice were unusually susceptible to persistent paralysis after spinal cord ischemia, and treatment with Vegfa protected mice against ischemic motoneuron death. These findings indicate that VEGF is a modifier of motoneuron degeneration in human ALS and unveil a therapeutic potential of Vegfa for stressed motoneurons in mice.	Katholieke Univ Leuven VIB, Univ Hosp Gasthuisberg, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Internal Med, B-3000 Louvain, Belgium; Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; Umea Univ Hosp, Dept Neurol, S-90185 Umea, Sweden; Umea Univ, Inst Clin Neurosci & Med Genet, S-90185 Umea, Sweden; Univ Birmingham, Sch Med, Dept Neurol, Birmingham B15 2TT, W Midlands, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Neurol, London SE5 8AF, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London SE5 8AF, England; Kings Coll London, Inst Psychiat, London SE5 8AF, England; CHU Rangueil, Inst Federat Rech Louis Bugnard, INSERM 397, F-31403 Toulouse 4, France; Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; Saitama Med Sch, Dept Med 4, Moroyama, Saitama 3500495, Japan; Hop Europeen Georges Pompidou, Serv Chirurg Thorac, F-75015 Paris, France; Univ Maastricht, Dept Populat Genet Genom & Bioinformat, NL-6200 MD Maastricht, Netherlands		Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Univ Hosp Gasthuisberg, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Carmeliet, Peter/AAQ-5140-2020; Bornes, Stephanie/C-2142-2015; Al-Chalabi, Ammar/E-5361-2010; Van Broeckhoven, Christine/G-8362-2017; Verdrengh, Evelien/H-4571-2012; De Smet, Frederik/Q-7808-2016; Van Broeckhoven, Christine/M-7853-2019; Lambrechts, Diether/AAJ-3167-2020; Thijs, Vincent/C-3647-2009; Storkebaum, Erik/B-5389-2017	Carmeliet, Peter/0000-0001-7961-1821; Al-Chalabi, Ammar/0000-0002-4924-7712; Van Broeckhoven, Christine/0000-0003-0183-7665; De Smet, Frederik/0000-0002-6669-3335; Van Broeckhoven, Christine/0000-0003-0183-7665; Thijs, Vincent/0000-0002-6614-8417; Storkebaum, Erik/0000-0002-9519-5642; Awata, Takuya/0000-0003-2622-8129; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Morrison, Karen/0000-0003-0216-5717; Del Favero, jurgen/0000-0002-7427-7489; Prats, Herve/0000-0002-4861-2167; Vermeire, Severine/0000-0001-9942-3019; Lambrechts, Diether/0000-0002-3429-302X; Adolfsson, Rolf/0000-0001-9785-8473			Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Andersen PM, 2001, AMYOTROPH LATERAL SC, V2, pS37; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Brown RH, 2001, SEMIN NEUROL, V21, P131; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Giess R, 2000, NEUROLOGY, V54, P1003, DOI 10.1212/WNL.54.4.1003; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Hand CK, 2002, MUSCLE NERVE, V25, P135; Hudder A, 2000, J BIOL CHEM, V275, P34586, DOI 10.1074/jbc.M005199200; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Lang-Lazdunski L, 2000, STROKE, V31, P208, DOI 10.1161/01.STR.31.1.208; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li BL, 2003, MOL BRAIN RES, V111, P155, DOI 10.1016/S0169-328X(03)00025-1; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McCarron SL, 2002, CANCER RES, V62, P3369; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Panas M, 2000, J NEUROL, V247, P940, DOI 10.1007/s004150070050; Prats AC, 2002, PROG NUCLEIC ACID RE, V72, P367, DOI 10.1016/S0079-6603(02)72075-8; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Siddique T, 1998, NEUROGENETICS, V1, P213, DOI 10.1007/s100480050031; Siddique Teepu, 2002, Adv Neurol, V88, P21; Skene JHP, 2001, NAT GENET, V28, P107, DOI 10.1038/88805; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Terwilliger JD, 1994, HDB HUMAN GENETIC LI; Thijs V, 2000, ACTA NEUROL BELG, V100, P84; Turner MR, 2001, SEMIN NEUROL, V21, P167, DOI 10.1055/s-2001-15262; Van Landeghem GF, 1999, EUR J NEUROL, V6, P639; Veldink JH, 2001, NEUROLOGY, V56, P749, DOI 10.1212/WNL.56.6.749; West MJ, 1995, ONCOGENE, V11, P2515; Wick A, 2002, J NEUROSCI, V22, P6401; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yang ZJ, 2002, J NEUROSCI RES, V70, P140, DOI 10.1002/jnr.10380	50	681	710	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					383	394		10.1038/ng1211			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	WOS:000184470500016	12847526	Green Published			2022-01-24	
J	Siffert, W; Rosskopf, D; Siffert, G; Busch, S; Moritz, A; Erbel, R; Sharma, AM; Ritz, E; Wichmann, HE; Jakobs, KH; Horsthemke, B				Siffert, W; Rosskopf, D; Siffert, G; Busch, S; Moritz, A; Erbel, R; Sharma, AM; Ritz, E; Wichmann, HE; Jakobs, KH; Horsthemke, B			Association of a human G-protein beta 3 subunit variant with hypertension	NATURE GENETICS			English	Article							SODIUM-PROTON EXCHANGE; IMMORTALIZED LYMPHOBLASTS	Hypertension is a common disorder of multifactorial origin that constitutes a major risk factor for cardiovascular events such as stroke and myocardial infarction. Previous studies demonstrated an enhanced signal transduction via pertussis toxin-sensitive G proteins in lymphoblasts and fibroblasts from selected patients with essential hypertension. We have detected a novel polymorphism (C825T) in exon 10 of the gene encoding the beta 3 subunit of heterotrimeric G proteins (GNB3). The T allele is associated with the occurrence of a splice variant, GNB3-s (encoding G beta 3-s), in which the nucleotides 498-620 of exon 9 are deleted. This in-frame deletion causes the loss of 41 amino acids and one WD repeat domain of the G beta subunit. By western-blot analysis, G beta 3-s appears to be predominantly expressed in cells from individuals carrying the T allele. Significant enhancement of stimulated GTP gamma S binding to Sf9 insect cells expressing G beta 3-s together with G alpha(i)2 and G gamma 5 indicates that this splice variant is biologically active. Genotype analysis of 427 normotensive and 426 hypertensive subjects suggests a significant association of the T allele with essential hypertension.	Univ Essen Gesamthsch Klinikum, Inst Pharmakol, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Abt Kardiol, D-45122 Essen, Germany; Free Univ Berlin, Klinikum Benjamin Franklin, Abt Endokrinol & Nephrol, D-12200 Berlin, Germany; Klinikum Univ Heidelberg, Sekt Nephrol, D-69115 Heidelberg, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, D-85764 Neuherberg, Germany; Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-45122 Essen, Germany		Siffert, W (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Pharmakol, Hufelandstr 55, D-45122 Essen, Germany.		Wichmann, Heinz Erich/AAA-5695-2022				AALKJAER C, 1989, J HYPERTENS, V7, P305; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Gruska S, 1997, J HYPERTENS, V15, P29, DOI 10.1097/00004872-199715010-00003; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; KALKBRENNER RF, 1996, BIOCHIM BIOPHYS ACTA, V1314, P125; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; MacrezLepretre N, 1997, J BIOL CHEM, V272, P5261, DOI 10.1074/jbc.272.8.5261; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Pietruck F, 1996, CIRC RES, V79, P974, DOI 10.1161/01.RES.79.5.974; ROSSKOPF D, 1993, J CLIN INVEST, V92, P2553, DOI 10.1172/JCI116865; ROSSKOPF D, 1993, HYPERTENSION, V21, P607, DOI 10.1161/01.HYP.21.5.607; ROSSKOPF D, 1992, J HYPERTENS, V10, P839; SIFFERT W, 1995, HYPERTENSION, V26, P649, DOI 10.1161/01.HYP.26.4.649; SIFFERT W, 1995, J CLIN INVEST, V96, P759, DOI 10.1172/JCI118120; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; StallingsMann ML, 1996, P NATL ACAD SCI USA, V93, P12394, DOI 10.1073/pnas.93.22.12394	25	681	725	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					45	48		10.1038/ng0198-45			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600019	9425898				2022-01-24	
J	CROZIER, RH; CROZIER, YC				CROZIER, RH; CROZIER, YC			THE MITOCHONDRIAL GENOME OF THE HONEYBEE APIS-MELLIFERA - COMPLETE SEQUENCE AND GENOME ORGANIZATION	GENETICS			English	Article							TRANSFER-RNA GENES; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCES; RIBOSOMAL-RNA; EVOLUTION; REGION; ORIGIN; MODEL; SUBSTITUTIONS	The complete sequence of honeybee (Apis mellifera) mitochondrial DNA is reported being 16,343 bp long in the strain sequenced. Relative to their positions in the Drosophila map, 11 of the tRNA genes are in altered positions, but the other genes and regions are in the same relative positions. Comparisons of the predicted protein sequences indicate that the honeybee mitochondrial genetic code is the same as that for Drosophila; but the anticodons of two tRNAs differ between these two insects. The base composition shows extreme bias, being 84.9% AT (cf. 78.6% in Drosophila yakuba). In protein-encoding genes, the AT bias is strongest at the third codon positions (which in some cases lack guanines altogether), and least in second codon positions. Multiple stepwise regression analysis of the predicted products of the protein-encoding genes shows a significant association between the numbers of occurrences of amino acids and %T in codon family, but not with the number of codons per codon family or other parameters associated with codon family base composition. Differences in amino acid abundances are apparent between the predicted Apis and Drosophila proteins, with a relative abundance in the Apis proteins of lysine and a relative deficiency of alanine. Drosophila alanine residues are as often replaced by serine as conserved in Apis. The differences in abundances between Drosophila and Apis are associated with %AT in the codon families, and the degree of divergence in amino acid composition between proteins correlates with the divergence in %AT at the second codon positions. Overall, transversions are about twice as abundant as transitions when comparing Drosophila and Apis protein-encoding genes, but this ratio varies between codon positions. Marked excesses of transitions over chance expectation are seen for the third positions of protein-coding genes and for the gene for the small subunit of ribosomal RNA. For the third codon positions the excess of transitions is adequately explained as due to the restriction of observable substitutions to transitions for conserved amino acids with two-codon families; the excess of transitions over expectation for the small ribosomal subunit suggests that the conservation of nucleotide size is favored by selection.			CROZIER, RH (corresponding author), LA TROBE UNIV, DEPT GENET & HUMAN VARIAT, BUNDOORA, VIC 3083, AUSTRALIA.		Crozier, Ross H/C-6773-2009				ALMAGOR H, 1983, J THEOR BIOL, V104, P633, DOI 10.1016/0022-5193(83)90251-5; BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Brown WM, 1985, MOL EVOLUTIONARY GEN, P95; CARPENTER FM, 1985, ANNU REV EARTH PL SC, V13, P297; Clary D O, 1984, Nucleic Acids Res, V12, P3747, DOI 10.1093/nar/12.9.3747; Clary D O, 1983, Nucleic Acids Res, V11, P6859, DOI 10.1093/nar/11.19.6859; Clary D O, 1983, Nucleic Acids Res, V11, P4211, DOI 10.1093/nar/11.12.4211; Clary D O, 1984, Nucleic Acids Res, V12, P2367, DOI 10.1093/nar/12.5.2367; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; CORNUET JM, 1991, GENETICS, V128, P393; Crozier R.H., 1980, Life Sciences Research Report, P129; CROZIER RH, 1992, MOL BIOL EVOL, V9, P474; CROZIER RH, 1989, MOL BIOL EVOL, V6, P399; CROZIER RH, 1992, IN PRESS MOL APPROAC; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; DESALLE R, 1987, J MOL EVOL, V26, P157, DOI 10.1007/BF02111289; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; FRENCH S, 1983, J MOL EVOL, V19, P171, DOI 10.1007/BF02300754; GILBERT DG, 1989, IUBIO ARCH MOL GENER; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; GODDARD JM, 1978, P NATL ACAD SCI USA, V75, P3886, DOI 10.1073/pnas.75.8.3886; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; HSUCHEN CC, 1984, NUCLEIC ACIDS RES, V12, P7771, DOI 10.1093/nar/12.20.7771; HSUCHEN CC, 1984, BIOCHEM INT, V8, P385; JUKES TH, 1986, J MOL EVOL, V24, P39, DOI 10.1007/BF02099949; KOULIANOS S, 1991, APIDOLOGIE, V22, P621, DOI 10.1051/apido:19910605; MADDOX J, 1992, NATURE, V358, P103, DOI 10.1038/358103a0; OCLARY D, 1982, NUCLEIC ACIDS RES, V10, P6619, DOI 10.1093/nar/10.21.6619; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OKIMOTO R, 1992, GENETICS, V130, P471; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; PAABO S, 1991, J MOL EVOL, V33, P426, DOI 10.1007/BF02103134; REBECK GW, 1991, J BACTERIOL, V173, P2068, DOI 10.1128/jb.173.6.2068-2076.1991; ROE BA, 1985, J BIOL CHEM, V260, P9759; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SATTA Y, 1987, MOL BIOL EVOL, V4, P638; SMITH DR, 1988, EXPERIENTIA, V44, P257, DOI 10.1007/BF01941730; SOKAL RR, 1981, BIOMETRY, P661; THOMAS WK, 1991, GENETICS, V128, P269; UHLENBUSCH I, 1987, NATURWISSENSCHAFTEN, V74, P142, DOI 10.1007/BF00366528; VLASAK I, 1987, NUCLEIC ACIDS RES, V15, P2388, DOI 10.1093/nar/15.5.2388; WATSON JD, 1987, IN PRESS INT REV CYT, V141, P346; WOLSTENHOLME DR, 1985, GENETICS, V109, P725; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324	48	681	756	0	35	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	1993	133	1					97	117					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KE783	WOS:A1993KE78300011	8417993				2022-01-24	
J	Sharp, AJ; Locke, DP; McGrath, SD; Cheng, Z; Bailey, JA; Vallente, RU; Pertz, LM; Clark, RA; Schwartz, S; Segraves, R; Oseroff, VV; Albertson, DG; Pinkel, D; Eichler, EE				Sharp, AJ; Locke, DP; McGrath, SD; Cheng, Z; Bailey, JA; Vallente, RU; Pertz, LM; Clark, RA; Schwartz, S; Segraves, R; Oseroff, VV; Albertson, DG; Pinkel, D; Eichler, EE			Segmental duplications and copy-number variation in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; CHROMOSOME; SEQUENCE; DELETION; REARRANGEMENTS; POLYMORPHISM; HYBRIDIZATION; MICROARRAY; RECOMBINATION; EVOLUTION	The human genome contains numerous blocks of highly homologous duplicated sequence. This higher- order architecture provides a substrate for recombination and recurrent chromosomal rearrangement associated with genomic disease. However, an assessment of the role of segmental duplications in normal variation has not yet been made. On the basis of the duplication architecture of the human genome, we defined a set of 130 potential rearrangement hotspots and constructed a targeted bacterial artificial chromosome ( BAC) microarray ( with 2,194 BACs) to assess copy- number variation in these regions by array comparative genomic hybridization. Using our segmental duplication BAC microarray, we screened a panel of 47 normal individuals, who represented populations from four continents, and we identified 119 regions of copy- number polymorphism ( CNP), 73 of which were previously unreported. We observed an equal frequency of duplications and deletions, as well as a 4- fold enrichment of CNPs within hotspot regions, compared with control BACs ( P <.000001), which suggests that segmental duplications are a major catalyst of large- scale variation in the human genome. Importantly, segmental duplications themselves were also significantly enriched > 4- fold within regions of CNP. Almost without exception, CNPs were not confined to a single population, suggesting that these either are recurrent events, having occurred independently in multiple founders, or were present in early human populations. Our study demonstrates that segmental duplications define hotspots of chromosomal rearrangement, likely acting as mediators of normal variation as well as genomic disease, and it suggests that the consideration of genomic architecture can significantly improve the ascertainment of large- scale rearrangements. Our specialized segmental duplication BAC microarray and associated database of structural polymorphisms will provide an important resource for the future characterization of human genomic disorders.	Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA		Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	McGrath, Sean/AAT-3540-2020; Sharp, Andrew/A-5783-2008	McGrath, Sean/0000-0001-9064-8449; Locke, Devin/0000-0002-2527-0475	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD043569, HD043569] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007250] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD043569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007250] Funding Source: NIH RePORTER		Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barber JCK, 1999, HUM GENET, V104, P211, DOI 10.1007/s004390050938; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Dalen P, 1998, CLIN PHARMACOL THER, V63, P444, DOI 10.1016/S0009-9236(98)90040-6; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Fantes JA, 2002, J MED GENET, V39, P170, DOI 10.1136/jmg.39.3.170; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; McLellan RA, 1997, MOL PHARMACOL, V52, P958, DOI 10.1124/mol.52.6.958; Mehan Michael R., 2004, Human Genomics, V1, P335; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Rao YS, 2000, MOL PHARMACOL, V58, P747, DOI 10.1124/mol.58.4.747; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SASSO EH, 1995, J CLIN INVEST, V96, P1591, DOI 10.1172/JCI118198; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Siniscalco M, 2000, TRENDS GENET, V16, P435, DOI 10.1016/S0168-9525(00)02101-6; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Snijders Antoine M, 2004, Methods Mol Biol, V256, P39; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; TUZUN E, 2005, NAT GENET       0515; van der Burg M, 2002, J IMMUNOL, V169, P271, DOI 10.4049/jimmunol.169.1.271; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350	54	680	705	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					78	88		10.1086/431652			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	WOS:000229794500007	15918152	Green Published, Bronze			2022-01-24	
J	Polyak, K; Li, YB; Zhu, H; Lengauer, C; Willson, JKV; Markowitz, SD; Trush, MA; Kinzler, KW; Vogelstein, B				Polyak, K; Li, YB; Zhu, H; Lengauer, C; Willson, JKV; Markowitz, SD; Trush, MA; Kinzler, KW; Vogelstein, B			Somatic mutations of the mitochondrial genome in human colorectal tumours	NATURE GENETICS			English	Article							DNA; DISEASE; INSTABILITY; CANCER; CELLS; SEGREGATION; SELECTION; NUCLEAR; TUMORS	Alterations of oxidative phosphorylation in tumour cells were originally believed to have a causative role in cancerous growth(1). More recently, mitochondria have again received attention with regards to neoplasia, largely because of their role in apoptosis and other aspects of tumour biology(2-8). The mitochondrial genome is particularly susceptible to mutations because of the high level of reactive oxygen species (ROS) generation in this organelle, coupled with a low level of DNA repair(9-12). However, no detailed analysis of mitochondrial DNA in human tumours has yet been reported. In this study, we analysed the complete mtDNA genome of ten human colorectal cancer cell lines by sequencing and found mutations in seven (70%). The majority of mutations were transitions at purines, consistent with an ROS-related derivation. The mutations were somatic, and those evaluated occurred in the primary tumour from which the cell line was derived. Most of the mutations were homoplasmic, indicating that the mutant genome was dominant at the intracellular and intercellular levels. We showed that mitochondria can rapidly become homogeneous in colorectal cancer cells using cell fusions. These findings provide the first examples of homoplasmic mutations in the mtDNA of tumour cells and have potential implications for the abnormal metabolic and apoptotic processes in cancer.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Ctr Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Environm Hlth Sci, Div Toxicol Sci, Baltimore, MD 21231 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA		Vogelstein, B (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Howard Hughes Med Inst, Baltimore, MD 21231 USA.	vogelbe@welchlink.welch.jhu.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA057345, R01CA067409, R01CA057345, R01CA043460, R37CA043460] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 57345, CA 43460, CA 67409] Funding Source: Medline		ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2; AUGENLICHT LH, 1992, J CELL BIOCHEM, P151; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; BURGART LJ, 1995, AM J PATHOL, V147, P1105; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Cavalli LR, 1998, MUTAT RES-FUND MOL M, V398, P19, DOI 10.1016/S0027-5107(97)00223-6; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; HEERDT BG, 1994, CANCER RES, V54, P3912; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LI Y, 1997, OXYGEN RADICALS DIS, P237; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666; PARSONS R, 1995, CANCER RES, V55, P5548; Rudin CM, 1997, ANNU REV MED, V48, P267; SHAY JW, 1990, ANTICANCER RES, V10, P279; TALLINI G, 1994, CYTOGENET CELL GENET, V66, P253, DOI 10.1159/000133706; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wallace Douglas C., 1998, Biofactors, V7, P187; Wang HG, 1998, HISTOL HISTOPATHOL, V13, P521, DOI 10.14670/HH-13.521; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WELTER C, 1989, GENE CHROMOSOME CANC, V1, P79, DOI 10.1002/gcc.2870010112; YAMAMOTO H, 1992, BIOCHEM BIOPH RES CO, V182, P913, DOI 10.1016/0006-291X(92)91819-C	32	680	722	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					291	293		10.1038/3108			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	WOS:000076698100026	9806551				2022-01-24	
J	Nishimura, AL; Mitne-Neto, M; Silva, HCA; Richieri-Costa, A; Middleton, S; Cascio, D; Kok, F; Oliveira, JRM; Gillingwater, T; Webb, J; Skehel, P; Zatz, M				Nishimura, AL; Mitne-Neto, M; Silva, HCA; Richieri-Costa, A; Middleton, S; Cascio, D; Kok, F; Oliveira, JRM; Gillingwater, T; Webb, J; Skehel, P; Zatz, M			A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; BINDING PROTEIN; 3 FAMILIES; GENE; DYSTROPHY; VAMP; PHENOTYPES; HELICASE; HOMOLOG	Motor neuron diseases (MNDs) are a group of neurodegenerative disorders with involvement of upper and/or lower motor neurons, such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), progressive bulbar palsy, and primary lateral sclerosis. Recently, we have mapped a new locus for an atypical form of ALS/MND ( atypical amyotrophic lateral sclerosis [ALS8]) at 20q13.3 in a large white Brazilian family. Here, we report the finding of a novel missense mutation in the vesicle-associated membrane protein/synaptobrevin-associated membrane protein B (VAPB) gene in patients from this family. Subsequently, the same mutation was identified in patients from six additional kindreds but with different clinical courses, such as ALS8, late-onset SMA, and typical severe ALS with rapid progression. Although it was not possible to link all these families, haplotype analysis suggests a founder effect. Members of the vesicle-associated proteins are intracellular membrane proteins that can associate with microtubules and that have been shown to have a function in membrane transport. These data suggest that clinically variable MNDs may be caused by a dysfunction in intracellular membrane trafficking.	Univ Sao Paulo, Inst Biociencias, Dept Biol, Human Genome Res Ctr, Sao Paulo, Brazil; Univ Fed Sao Paulo, Sch Med, Anesthesiol Pain & Intens Care Dept, Sao Paulo, Brazil; Univ Sao Paulo, Hosp Rehabil Craniofacial Anomalies, Genet Serv, Bauru, Brazil; Univ Edinburgh, Dept Neurosci, Edinburgh, Midlothian, Scotland; Univ Calif Los Angeles, Dept Energy, Inst Mol Biol, Inst Genom & Proteom, Los Angeles, CA USA		Zatz, M (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Biol, Human Genome Res Ctr, Rua Matao 277, Sao Paulo, Brazil.	mayazatz@usp.br	Richieri-Costa, Antonio/B-2514-2013; Nishimura, Agnes L/B-2905-2011; Zatz, Mayana/M-5338-2015; Kok, Fernando/E-7865-2016; Silva, Helga C/D-8959-2012	Zatz, Mayana/0000-0003-3970-8025; Silva, Helga C/0000-0002-9372-7019; Nishimura, Agnes/0000-0001-5295-797X; Gillingwater, Thomas/0000-0002-0306-5577			BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bullock TL, 1996, J MOL BIOL, V263, P284, DOI 10.1006/jmbi.1996.0575; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Corcia P, 2002, NEUROLOGY, V59, P1464, DOI 10.1212/01.WNL.0000032500.73621.C5; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Illarioshkin SN, 1996, BRAIN, V119, P1895, DOI 10.1093/brain/119.6.1895; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mallick P, 2002, P NATL ACAD SCI USA, V99, P16041, DOI 10.1073/pnas.252626399; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; RICHIERICOSTA A, 1981, AM J MED GENET, V9, P119, DOI 10.1002/ajmg.1320090206; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Takata RI, 2004, J MED GENET, V41, P224, DOI 10.1136/jmg.2003.013201; Weiler T, 1996, AM J HUM GENET, V59, P872; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zatz M, 2003, NEUROMUSCULAR DISORD, V13, P532, DOI 10.1016/S0960-8966(03)00100-7; Zatz M, 2000, CURR OPIN NEUROL, V13, P511, DOI 10.1097/00019052-200010000-00002	31	679	702	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					822	831		10.1086/425287			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	WOS:000224303500007	15372378	Green Published, Bronze			2022-01-24	
J	PERICAKVANCE, MA; BEBOUT, JL; GASKELL, PC; YAMAOKA, LH; HUNG, WY; ALBERTS, MJ; WALKER, AP; BARTLETT, RJ; HAYNES, CA; WELSH, KA; EARL, NL; HEYMAN, A; CLARK, CM; ROSES, AD				PERICAKVANCE, MA; BEBOUT, JL; GASKELL, PC; YAMAOKA, LH; HUNG, WY; ALBERTS, MJ; WALKER, AP; BARTLETT, RJ; HAYNES, CA; WELSH, KA; EARL, NL; HEYMAN, A; CLARK, CM; ROSES, AD			LINKAGE STUDIES IN FAMILIAL ALZHEIMER-DISEASE - EVIDENCE FOR CHROMOSOME-19 LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY; TIGHT LINKAGE; RELATIVES; COMMITTEE; RISK	A genetic component in the etiology of Alzheimer disease (AD) has been supported by indirect evidence for several years, with autosomal dominant inheritance with age-dependent penetrance being suggested to explain the familial aggregation of affecteds. St. George Hyslop et al. reported linkage of familial AD (FAD) in four early-onset families (mean age at onset [M] < 50 years). Subsequent studies have been inconsistent in their results; Goate et al. also reported positive lod scores. However, both Pericak-Vance et al.'s study of a series of mainly late-onset FAD families (M > 60 years) and Schellenberg et al.'s study failed to confirm linkage to chromosome 21 (CH21). These various studies suggest the possibility of genetic heterogeneity, with some families linked to CH21 and others unlocalized. Recently, St. George Hyslop et al. extended their analysis to include additional families. The extended analyses supported their earlier finding of linkage to CH21, while showing strong evidence of heterogeneity between early-onset (M < 65 years) and late-onset (M > 60 years) FAD families. Because our families did not show linkage to CH21, we undertook a genomic search for an additional locus for FAD. Because of both the confounding factor of late age at onset of FAD and the lack of clear evidence of Mendelian transmission in some of our families, we employed the affected-pedigree-member (APM) method of linkage analysis as an initial screen for possible linkage. Using this method, we identified two regions suggesting linkage: the proximal long arm of chromosome 19 (CH19) and the CH21 region of FAD linkage reported by St. George Hyslop et al. Application of standard likelihood (LOD score) analysis to these data support the possibility of an FAD gene located on CH19, particularly in the late-onset FAD families. These data further suggest genetic heterogeneity and delineate this region of CH19 as an area needing additional investigation in FAD.	DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT PSYCHIAT, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, JOSEPH & KATHLEEN BRYAN ALZHEIMER & DIS RES CTR, DURHAM, NC 27710 USA		PERICAKVANCE, MA (corresponding author), DUKE UNIV, MED CTR, DEPT MED NEUROL, DIV NEUROL, BOX 2900, DURHAM, NC 27710 USA.		Walker, Ann P/C-1628-2008		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG05128, AG07922] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS-26630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R35AG007922] Funding Source: NIH RePORTER		BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876; BREITNER JCS, 1988, NEUROLOGY, V38, P207; Elston RC, 1987, ESSENTIALS BIOSTATIS; FARRER L A, 1988, American Journal of Human Genetics, V43, pA213; George Hyslop P. St., 1990, NATURE, V347, P194; GOATE AM, 1989, LANCET, V1, P352; HAINES J L, 1988, American Journal of Human Genetics, V43, pA145; HAYNES C, 1986, GENET EPIDEMIOL, P235; HAYNES C S, 1988, American Journal of Human Genetics, V43, pA146; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HYSLOP PHS, 1987, SCIENCE, V235, P885; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LANGE K, 1990, WORLD REV NUTR DIET, V63, P236; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1956, AM J HUM GENET, V8, P80; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PERICAKVANCE MA, 1988, AUST PAEDIATR J, V24, P87; PERICAKVANCE MA, 1986, NEUROLOGY, V36, P1418, DOI 10.1212/WNL.36.11.1418; PERICAKVANCE MA, 1986, GENET EPIDEMIOL, P197; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PERICAKVANCE MA, 1989, FAMILIAL ALZHEIMERS, P85; PERICAKVANCE MA, IN PRESS P INT S DEM; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1990, AM J HUM GENET S, V47, pA198; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WEEKS DE, 1988, AM J HUM GENET, V42, P315; YAMAOKA LH, 1990, NEUROLOGY, V40, P222, DOI 10.1212/WNL.40.2.222	33	679	694	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1034	1050					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	WOS:A1991FP09200003	2035524				2022-01-24	
J	NAGAFUCHI, S; YANAGISAWA, H; SATO, K; SHIRAYAMA, T; OHSAKI, E; BUNDO, M; TAKEDA, T; TADOKORO, K; KONDO, I; MURAYAMA, N; TANAKA, Y; KIKUSHIMA, H; UMINO, K; KUROSAWA, H; FURUKAWA, T; NIHEI, K; INOUE, T; SANO, A; KOMURE, O; TAKAHASHI, M; YOSHIZAWA, T; KANAZAWA, I; YAMADA, M				NAGAFUCHI, S; YANAGISAWA, H; SATO, K; SHIRAYAMA, T; OHSAKI, E; BUNDO, M; TAKEDA, T; TADOKORO, K; KONDO, I; MURAYAMA, N; TANAKA, Y; KIKUSHIMA, H; UMINO, K; KUROSAWA, H; FURUKAWA, T; NIHEI, K; INOUE, T; SANO, A; KOMURE, O; TAKAHASHI, M; YOSHIZAWA, T; KANAZAWA, I; YAMADA, M			DENTATORUBRAL AND PALLIDOLUYSIAN ATROPHY EXPANSION OF AN UNSTABLE CAG TRINUCLEOTIDE ON CHROMOSOME-12P	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; MYOTONIC-DYSTROPHY; CTG REPEAT; GENE; REGION; DNA; FRAGMENT	Dentatorubral and pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder characterized by combined systemic degeneration of the dentatofugal and pallidofugal pathways. We investigated a candidate gene and found that DRPLA patients had an expanded CAG trinucleotide repeat in a gene on the short arm of chromosome 12. The repeat size varied from 7-23 in normal individuals. In patients one allele was expanded to between 49-75 repeats or occasionally even more. Expansion was usually associated with paternal transmission and only occasionally with maternal transmission. Repeat size showed a close correlation with age of onset of symptoms and disease severity. We conclude that DRPLA is the seventh genetic disorder known to be associated with expansion of an unstable trinucleotide repeat.	NATL CHILDRENS MED RES CTR,3-35-31 TAISHIDO,SETAGAYA KU,TOKYO 154,JAPAN; NIHON UNIV,NUCLE ACID SCI LAB,FUHISAWA 252,JAPAN; EHIME UNIV,SCH MED,DEPT HYG,SHIGENOBU,EHIME 79102,JAPAN; EHIME UNIV,SCH MED,DEPT NEUROPSYCHIAT,SHIGENOBU,EHIME 79102,JAPAN; DOKKYO UNIV,SCH MED,DEPT PEDIAT 2,MIBU,TOCHIGI 32102,JAPAN; NATL CHILDRENS HOSP,TOKYO 154,JAPAN; KOBE UNIV,SCH MED,DEPT NEUROL & PSYCHIAT,KOBE 650,JAPAN; KOCHI UNIV,DEPT NEUROPSYCHIAT,NANKOKU,KOCHI 783,JAPAN; UNIV TSUKUBA,INST CLIN MED,DEPT NEUROL,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,INST BRAIN RES,TOKYO 113,JAPAN					Yanagisawa, Hiroko/0000-0002-6917-5218; Sano, Akira/0000-0001-5843-9786; Bundo, Miki/0000-0002-5786-0509			ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KONDO I, 1990, J MED GENET, V27, P105, DOI 10.1136/jmg.27.2.105; KUROSAWA H, 1987, ONCOGENE, V2, P85; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; NEUMANN MA, 1959, NEUROLOGY, V9, P430, DOI 10.1212/WNL.9.6.430; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PHILLIPS SC, 1992, GENE, V116, P181, DOI 10.1016/0378-1119(92)90514-P; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; TADOKORO K, 1992, ONCOGENE, V7, P1215; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TAKIGUCHI Y, 1992, DOKKYO MED J, V7, P283; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	31	678	684	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					14	18		10.1038/ng0194-14			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	WOS:A1994MQ17700007	8136826				2022-01-24	
J	Bass, AJ; Watanabe, H; Mermel, CH; Yu, SY; Perner, S; Verhaak, RG; Kim, SY; Wardwell, L; Tamayo, P; Gat-Viks, I; Ramos, AH; Woo, MS; Weir, BA; Getz, G; Beroukhim, R; O'Kelly, M; Dutt, A; Rozenblatt-Rosen, O; Dziunycz, P; Komisarof, J; Chirieac, LR; LaFargue, CJ; Scheble, V; Wilbertz, T; Ma, CQ; Rao, S; Nakagawa, H; Stairs, DB; Lin, L; Giordano, TJ; Wagner, P; Minna, JD; Gazdar, AF; Zhu, CQ; Brose, MS; Cecconello, I; Ribeiro, U; Marie, SK; Dahl, O; Shivdasani, RA; Tsao, MS; Rubin, MA; Wong, KK; Regev, A; Hahn, WC; Beer, DG; Rustgi, AK; Meyerson, M				Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Yu, Soyoung; Perner, Sven; Verhaak, Roel G.; Kim, So Young; Wardwell, Leslie; Tamayo, Pablo; Gat-Viks, Irit; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Getz, Gad; Beroukhim, Rameen; O'Kelly, Michael; Dutt, Amit; Rozenblatt-Rosen, Orit; Dziunycz, Piotr; Komisarof, Justin; Chirieac, Lucian R.; LaFargue, Christopher J.; Scheble, Veit; Wilbertz, Theresia; Ma, Changqing; Rao, Shilpa; Nakagawa, Hiroshi; Stairs, Douglas B.; Lin, Lin; Giordano, Thomas J.; Wagner, Patrick; Minna, John D.; Gazdar, Adi F.; Zhu, Chang Qi; Brose, Marcia S.; Cecconello, Ivan; Ribeiro, Ulysses, Jr.; Marie, Suely K.; Dahl, Olav; Shivdasani, Ramesh A.; Tsao, Ming-Sound; Rubin, Mark A.; Wong, Kwok K.; Regev, Aviv; Hahn, William C.; Beer, David G.; Rustgi, Anil K.; Meyerson, Matthew			SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas	NATURE GENETICS			English	Article							GENE; EXPRESSION; CANCER; REVEALS; ADENOCARCINOMAS; DIFFERENTIATION; IDENTIFICATION; AMPLIFICATION; DEPENDENCY; CONSISTENT	Lineage-survival oncogenes are activated by somatic DNA alterations in cancers arising from the cell lineages in which these genes play a role in normal development(1,2). Here we show that a peak of genomic amplification on chromosome 3q26.33 found in squamous cell carcinomas (SCCs) of the lung and esophagus contains the transcription factor gene SOX2, which is mutated in hereditary human esophageal malformations(3), is necessary for normal esophageal squamous development(4), promotes differentiation and proliferation of basal tracheal cells(5) and cooperates in induction of pluripotent stem cells(6-8). SOX2 expression is required for proliferation and anchorage-independent growth of lung and esophageal cell lines, as shown by RNA interference experiments. Furthermore, ectopic expression of SOX2 here cooperated with FOXE1 or FGFR2 to transform immortalized tracheobronchial epithelial cells. SOX2-driven tumors show expression of markers of both squamous differentiation and pluripotency. These characteristics identify SOX2 as a lineage-survival oncogene in lung and esophageal SCC.	[Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Yu, Soyoung; Verhaak, Roel G.; Kim, So Young; Wardwell, Leslie; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Beroukhim, Rameen; Dutt, Amit; Rozenblatt-Rosen, Orit; Dziunycz, Piotr; Komisarof, Justin; Shivdasani, Ramesh A.; Wong, Kwok K.; Hahn, William C.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bass, Adam J.; Beroukhim, Rameen; Shivdasani, Ramesh A.; Wong, Kwok K.; Hahn, William C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Yu, Soyoung; Verhaak, Roel G.; Kim, So Young; Wardwell, Leslie; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Beroukhim, Rameen; Dutt, Amit; Rozenblatt-Rosen, Orit; Hahn, William C.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Bass, Adam J.; Watanabe, Hideo; Mermel, Craig H.; Verhaak, Roel G.; Tamayo, Pablo; Gat-Viks, Irit; Ramos, Alex H.; Woo, Michele S.; Weir, Barbara A.; Getz, Gad; Beroukhim, Rameen; O'Kelly, Michael; Dutt, Amit; Regev, Aviv; Hahn, William C.; Meyerson, Matthew] Broad Inst, Cambridge, MA USA; [Perner, Sven; LaFargue, Christopher J.; Wagner, Patrick; Rubin, Mark A.] Cornell Univ, Dept Pathol, Weill Med Coll, New York, NY 10021 USA; [Perner, Sven; Scheble, Veit; Wilbertz, Theresia] Univ Tubingen Hosp, Inst Pathol, Ctr Comprehens Canc, Tubingen, Germany; [Chirieac, Lucian R.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ma, Changqing; Rao, Shilpa; Nakagawa, Hiroshi; Stairs, Douglas B.; Brose, Marcia S.; Rustgi, Anil K.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Nakagawa, Hiroshi; Stairs, Douglas B.; Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lin, Lin; Beer, David G.] Univ Michigan, Dept Surg, Thorac Surg Sect, Ann Arbor, MI 48109 USA; [Giordano, Thomas J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Minna, John D.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zhu, Chang Qi; Tsao, Ming-Sound] Univ Hlth Network, Toronto, ON, Canada; [Zhu, Chang Qi; Tsao, Ming-Sound] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Brose, Marcia S.] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Cecconello, Ivan; Ribeiro, Ulysses, Jr.; Marie, Suely K.] Univ Sao Paulo, Sch Med, Bauru, SP, Brazil; [Dahl, Olav] Univ Bergen, Sect Oncol, Bergen, Norway; [Rustgi, Anil K.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA		Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Mermel, Craig/AAZ-7322-2020; Chirieac, Lucian R./AAD-2030-2019; Cecconello, Ivan/A-3918-2013; Meyerson, Matthew L/E-7123-2012; Tsao, Ming-Sound/M-3503-2017; Marie, Suely Kazue Nagahashi/D-1870-2012; Wagner, Patrick/AAZ-7790-2021; Dutt, Amit/I-1911-2013; Verhaak, Roel/ABE-7058-2020; Ribeiro, Ulysses/G-5942-2012	Mermel, Craig/0000-0002-0816-3395; Cecconello, Ivan/0000-0002-3535-4170; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Dutt, Amit/0000-0002-1119-4774; Ribeiro, Ulysses/0000-0003-1711-7347; Zhu, ChangQi/0000-0002-9992-0258; LaFargue, Christopher/0000-0001-6473-8061; Rubin, Mark/0000-0002-8321-9950; Tsao, Ming/0000-0002-9160-5405; Giordano, Thomas/0000-0003-0641-8873	Ruth L. Kirschstein NRSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; KWF KankerbestrijdingKWF Kankerbestrijding; US Department of DefenseUnited States Department of Defense; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K08CA134931, P50CA70907, R33CA128625, R01CA071606-12, P01CA098101-05, R01CA109038, P50CA90578]; Genentech, Inc.Roche HoldingGenentech; Sara Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA109038, R01CA071606, R33CA128625, P50CA090578, K08CA134931, R01CA154365, P01CA098101, P30CA016520, P20CA090578, T32CA009172, P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP1OD003958] Funding Source: NIH RePORTER	We thank J. Francis, J. Cho, A. Schinzel, R. Firestein, I. Guney and J. Boehm for technical advice and discussions. A. J. B. is supported by the Harvard Clinical Investigator Training Program and American Society of Clinical Oncology. H. W. is supported by a Ruth L. Kirschstein NRSA T32 institutional training grant. R. G. V. is supported by the KWF Kankerbestrijding. The Morphology, Molecular Biology and Cell Culture Core of 5P01CA098101-05 (A. K. R.) provided tissue processing for this project. This work was supported by US Department of Defense VITAL grant (J. D. M, A. F. G.) and by National Cancer Institute grants K08CA134931 (A. J. B.), P50CA70907 (J. D. M, A. F. G.), R33CA128625 (W. C. H.), R01CA071606-12 (D. G. B.), P01CA098101-05 (A. K. R.) and R01CA109038 and P50CA90578 (M. M.). Funding for lung SCC SNP arrays was provided by Genentech, Inc. Funding was provided by the Sara Thomas Monopoli Lung Cancer Research Fund and the Seaman Corporation Fund for Lung Cancer Research.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chen XX, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-1; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Dathan N, 2002, DEV DYNAM, V224, P450, DOI 10.1002/dvdy.10118; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huber W, 2004, BIOINFORMATICS, V20, P1651, DOI 10.1093/bioinformatics/bth133; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Massion PP, 2003, CANCER RES, V63, P7113; Pack SD, 1999, GENE CHROMOSOME CANC, V25, P160, DOI 10.1002/(SICI)1098-2264(199906)25:2<160::AID-GCC12>3.0.CO;2-U; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Woenckhaus J, 2002, J PATHOL, V198, P335, DOI 10.1002/path.1207; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	677	704	3	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1238	U105		10.1038/ng.465			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	WOS:000271247600018	19801978	Green Accepted, Green Submitted			2022-01-24	
J	Holland, EC; Celestino, J; Dai, CK; Schaefer, L; Sawaya, RE; Fuller, GN				Holland, EC; Celestino, J; Dai, CK; Schaefer, L; Sawaya, RE; Fuller, GN			Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice	NATURE GENETICS			English	Article							GROWTH-FACTOR-I; HUMAN ASTROCYTOMAS; RECEPTOR; PATHWAYS; PROLIFERATION; EXPRESSION; PROTEIN	Gliomas are the most common primary malignant brain tumours and are classified into four clinical grades', with the most aggressive tumours being grade 4 astrocytomas (also known as glioblastoma multiforme; GBM). Frequent genetic alterations in GBMs (refs 2-5) result in stimulation of common signal transduction pathways involving Ras, Akt and other proteins(6-10). It is not known which of these pathways, if any, are sufficient to induce GBM formation, Here we transfer, in a tissue-specific manner, genes encoding activated forms of Ras and Akt to astrocytes and neural progenitors in mice. We found that although neither activated Ras nor Akt alone is sufficient to induce GBM formation, the combination of activated Ras and Akt induces high-grade gliomas with the histological features of human GBMs. These tumours appear to arise after gene transfer to neural progenitors, but not after transfer to differentiated astrocytes. Increased activity of RAS is found in many human GBMs (ref. 11), and we show here that Akt activity is increased in most of these tumours, implying that combined activation of these two pathways accurately models the biology of this disease.	Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA		Holland, EC (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Fuller, Gregory/0000-0001-9447-2647	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA16672] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016672] Funding Source: NIH RePORTER		ANTONIADES HN, 1992, INT J CANCER, V50, P215, DOI 10.1002/ijc.2910500210; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Feldkamp MM, 1997, J NEURO-ONCOL, V35, P223, DOI 10.1023/A:1005800114912; GROSS JL, 1990, J NEUROSCI RES, V27, P689, DOI 10.1002/jnr.490270429; Guha A, 1997, ONCOGENE, V15, P2755, DOI 10.1038/sj.onc.1201455; Hermanson M, 1996, CANCER RES, V56, P164; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kim BS, 1998, J BIOL CHEM, V273, P34543, DOI 10.1074/jbc.273.51.34543; KLEHUES P, 1993, HISTOLOGICAL TYPING; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Li J, 1998, CANCER RES, V58, P5667; SCHLEGEL J, 1994, INT J CANCER, V56, P72	15	676	694	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					55	57		10.1038/75596			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	WOS:000086884000016	10802656				2022-01-24	
J	Robinson, DR; Wu, YM; Vats, P; Su, FY; Lonigro, RJ; Cao, XH; Kalyana-Sundaram, S; Wang, R; Ning, Y; Hodges, L; Gursky, A; Siddiqui, J; Tomlins, SA; Roychowdhury, S; Pienta, KJ; Kim, SY; Roberts, JS; Rae, JM; Van Poznak, CH; Hayes, DF; Chugh, R; Kunju, LP; Talpaz, M; Schott, AF; Chinnaiyan, AM				Robinson, Dan R.; Wu, Yi-Mi; Vats, Pankaj; Su, Fengyun; Lonigro, Robert J.; Cao, Xuhong; Kalyana-Sundaram, Shanker; Wang, Rui; Ning, Yu; Hodges, Lynda; Gursky, Amy; Siddiqui, Javed; Tomlins, Scott A.; Roychowdhury, Sameek; Pienta, Kenneth J.; Kim, Scott Y.; Roberts, J. Scott; Rae, James M.; Van Poznak, Catherine H.; Hayes, Daniel F.; Chugh, Rashmi; Kunju, Lakshmi P.; Talpaz, Moshe; Schott, Anne F.; Chinnaiyan, Arul M.			Activating ESR1 mutations in hormone-resistant metastatic breast cancer	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; LIGAND-BINDING; AROMATASE INHIBITION; SOMATIC MUTATION; THERAPY; TAMOXIFEN; GENE; IDENTIFICATION; CONFORMATION; EXPRESSION	Breast cancer is the most prevalent cancer in women, and over two-thirds of cases express estrogen receptor-alpha (ER-alpha, encoded by ESR1). Through a prospective clinical sequencing program for advanced cancers, we enrolled 11 patients with ER-positive metastatic breast cancer. Whole-exome and transcriptome analysis showed that six cases harbored mutations of ESR1 affecting its ligand-binding domain (LBD), all of whom had been treated with anti-estrogens and estrogen deprivation therapies. A survey of The Cancer Genome Atlas (TCGA) identified four endometrial cancers with similar mutations of ESR1. The five new LBD-localized ESR1 mutations identified here (encoding p.Leu536Gln, p.Tyr537Ser, p.Tyr537Cys, p.Tyr537Asn and p.Asp538Gly) were shown to result in constitutive activity and continued responsiveness to antiestrogen therapies in vitro. Taken together, these studies suggest that activating mutations in ESR1 are a key mechanism in acquired endocrine resistance in breast cancer therapy.	[Robinson, Dan R.; Wu, Yi-Mi; Vats, Pankaj; Su, Fengyun; Lonigro, Robert J.; Cao, Xuhong; Kalyana-Sundaram, Shanker; Wang, Rui; Ning, Yu; Hodges, Lynda; Gursky, Amy; Siddiqui, Javed; Tomlins, Scott A.; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Wu, Yi-Mi; Vats, Pankaj; Su, Fengyun; Kalyana-Sundaram, Shanker; Wang, Rui; Ning, Yu; Gursky, Amy; Siddiqui, Javed; Tomlins, Scott A.; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Lonigro, Robert J.; Rae, James M.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Roychowdhury, Sameek] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Pienta, Kenneth J.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Baltimore, MD USA; [Kim, Scott Y.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Roberts, J. Scott] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Rae, James M.; Van Poznak, Catherine H.; Hayes, Daniel F.; Chugh, Rashmi; Talpaz, Moshe; Schott, Anne F.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA		Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Hayes, Daniel/ABE-1129-2020; Vats, Pankaj/AAL-1443-2020; Schott, Anne/AAD-1902-2019	Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Talpaz, Moshe/0000-0003-3361-3981	Prostate Cancer Foundation; National Cancer Institute Early Detection Research NetworkUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01 CA111275]; National Human Genome Research Institute Clinical Sequencing Exploratory Research (CSER) Consortium [1UM1HG006508]; US Department of DefenseUnited States Department of Defense [W81XWH-12-1-0080]; Department of DefenseUnited States Department of Defense; Alfred A. Taubman Institute; American Cancer SocietyAmerican Cancer Society; Howard Hughes Medical InstituteHoward Hughes Medical Institute; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA111275] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [UM1HG006508] Funding Source: NIH RePORTER	The authors thank D. Miller, T. Barrette and D. Gibbs for hardware and database management, K. Giles for assistance with manuscript preparation, physicians M. Wicha, L. Pierce, D. Smith, K. Levin and F. Feng for referring patients, and C. Betts and J. Athanikar for assistance with tumor boards. We also thank the larger MI-ONCOSEQ team, including clinical research coordinator E. Williams, pathologist R. Mehra, genetic counselors J. Everett, S. Gustafson and V. Raymond, and radiologists E. Higgins, E. Caoili and R. Dunnick. This project is supported in part by the Prostate Cancer Foundation with funding for our sequencing infrastructure, the National Cancer Institute Early Detection Research Network (U01 CA111275), National Human Genome Research Institute Clinical Sequencing Exploratory Research (CSER) Consortium (1UM1HG006508), US Department of Defense contract W81XWH-12-1-0080 and a Department of Defense Era of Hope Scholar Award. A. M. C. is also supported by the Alfred A. Taubman Institute, the American Cancer Society, the Howard Hughes Medical Institute and a Doris Duke Charitable Foundation Clinical Scientist Award.	Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huang HJ, 2002, MOL ENDOCRINOL, V16, P1778, DOI 10.1210/me.2002-0089; Ingle JN, 2006, J CLIN ONCOL, V24, P1052, DOI 10.1200/JCO.2005.04.1053; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Lonning PE, 2013, ENDOCR-RELAT CANCER, V20, pR183, DOI 10.1530/ERC-13-0099; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pearce ST, 2003, J BIOL CHEM, V278, P7630, DOI 10.1074/jbc.M211129200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Skafar DF, 2000, CELL BIOCHEM BIOPHYS, V33, P53, DOI 10.1385/CBB:33:1:53; Sokolosky ML, 2011, ONCOTARGET, V2, P538, DOI 10.18632/oncotarget.302; Swaby RF, 2008, CLIN BREAST CANCER, V8, P124, DOI 10.3816/CBC.2008.n.012; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zhao CQ, 2003, J BIOL CHEM, V278, P27278, DOI 10.1074/jbc.M303840200	40	674	690	3	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1446	U197		10.1038/ng.2823			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	WOS:000327715800009	24185510	Green Accepted	Y	N	2022-01-24	
J	Challen, GA; Sun, DQ; Jeong, M; Luo, M; Jelinek, J; Berg, JS; Bock, C; Vasanthakumar, A; Gu, HC; Xi, YX; Liang, SD; Lu, Y; Darlington, GJ; Meissner, A; Issa, JPJ; Godley, LA; Li, W; Goodell, MA				Challen, Grant A.; Sun, Deqiang; Jeong, Mira; Luo, Min; Jelinek, Jaroslav; Berg, Jonathan S.; Bock, Christoph; Vasanthakumar, Aparna; Gu, Hongcang; Xi, Yuanxin; Liang, Shoudan; Lu, Yue; Darlington, Gretchen J.; Meissner, Alexander; Issa, Jean-Pierre J.; Godley, Lucy A.; Li, Wei; Goodell, Margaret A.			Dnmt3a is essential for hematopoietic stem cell differentiation	NATURE GENETICS			English	Article							NOVO DNA METHYLTRANSFERASE; MAMMALIAN DNA; SELF-RENEWAL; METHYLATION; GENE; HYPERMETHYLATION; TRANSCRIPTION; HYPOMETHYLATION; MUTATIONS; EXPRESSION	Loss of the de novo DNA methyltransferases Dnmt3a and Dnmt3b in embryonic stem cells obstructs differentiation; however, the role of these enzymes in somatic stem cells is largely unknown. Using conditional ablation, we show that Dnmt3a loss progressively impairs hematopoietic stem cell (HSC) differentiation over serial transplantation, while simultaneously expanding HSC numbers in the bone marrow. Dnmt3a-null HSCs show both increased and decreased methylation at distinct loci, including substantial CpG island hypermethylation. Dnmt3a-null HSCs upregulate HSC multipotency genes and downregulate differentiation factors, and their progeny exhibit global hypomethylation and incomplete repression of HSC-specific genes. These data establish Dnmt3a as a critical participant in the epigenetic silencing of HSC regulatory genes, thereby enabling efficient differentiation.	[Challen, Grant A.; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Challen, Grant A.; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Challen, Grant A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Sun, Deqiang; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Sun, Deqiang; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Luo, Min; Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Jelinek, Jaroslav; Gu, Hongcang; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Berg, Jonathan S.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Berg, Jonathan S.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA		Goodell, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	WL1@bcm.edu; goodell@bcm.edu	Jelinek, Jaroslav/O-6876-2019; Bock, Christoph/AAE-7618-2019	Bock, Christoph/0000-0001-6091-3088; Gu, Hongcang/0000-0002-1439-7606; Berg, Jonathan/0000-0003-2360-2664; luo, min/0000-0003-4883-4189; Issa, Jean-Pierre/0000-0003-2258-5030; Goodell, Margaret/0000-0003-1111-2932; Li, Wei/0000-0001-9931-5990; sun, deqiang/0000-0002-5806-7289; Lu, Yue/0000-0002-5479-9095	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH K99 DK084259-01A1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG036562, HL086223, CA100632, CA129831, P50CA126752, DK092883, CA125123, DK58192]; Ellison foundationLawrence Ellison Foundation; American Heart Association (CPRIT)American Heart Association [RP110028]; Functional Genomics Core [P30 DK056338]	The authors would like to thank all members of the Goodell laboratory for scientific advice, A. Rosen, Y. Zheng and L. Yang for mouse management and technical support, C. Threeton for flow cytometry, L. White (microarray core) and A. Gnirke for assistance with the RRBS technique. G. A. C. was supported by a grant from the US National Institutes of Health (NIH K99 DK084259-01A1) and is an American Society of Hematology Scholar. This work was also supported by NIH grants (AG036562, HL086223, CA100632, CA129831, P50CA126752, DK092883, CA125123 and DK58192), the Ellison foundation, the American Heart Association (CPRIT grant RP110028) and the Functional Genomics Core (P30 DK056338).	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cho YH, 2010, ANTICANCER RES, V30, P2489; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890; Fahrner JA, 2002, CANCER RES, V62, P7213; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Jelinek J, 2009, BLOOD, V114, P567; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Lei H, 1996, DEVELOPMENT, V122, P3195; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	49	674	696	4	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					23	U43		10.1038/ng.1009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	WOS:000298664000009	22138693	Green Published, Green Accepted	Y	N	2022-01-24	
J	Li, RQ; Li, YR; Fang, XD; Yang, HM; Wang, J; Kristiansen, K; Wang, J				Li, Ruiqiang; Li, Yingrui; Fang, Xiaodong; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Wang, Jun			SNP detection for massively parallel whole-genome resequencing	GENOME RESEARCH			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SEQUENCE VARIATION; HAPLOTYPE MAP; DISCOVERY; SELECTION	Next-generation massively parallel sequencing technologies provide ultrahigh throughput at two orders of magnitude lower unit cost than capillary Sanger sequencing technology. One of the key applications of next-generation sequencing is studying genetic variation between individuals using whole-genome or target region resequencing. Here, we have developed a consensus-calling and SNP-detection method for sequencing-by-synthesis Illumina Genome Analyzer technology. We designed this method by carefully considering the data quality, alignment, and experimental errors common to this technology. All of this information was integrated into a single quality score for each base under Bayesian theory to measure the accuracy of consensus calling. We tested this methodology using a large-scale human resequencing data set of 36 x coverage and assembled a high-quality nonrepetitive consensus sequence for 92.25% of the diploid autosomes and 88.07% of the haploid X chromosome. Comparison of the consensus sequence with Illumina human 1M BeadChip genotyped alleles from the same DNA sample showed that 98.6% of the 37,933 genotyped alleles on the X chromosome and 98% of 999,981 genotyped alleles on autosomes were covered at 99.97% and 99.84% consistency, respectively. At a low sequencing depth, we used prior probability of dbSNP alleles and were able to improve coverage of the dbSNP sites significantly as compared to that obtained using a nonimputation model. Our analyses demonstrate that our method has a very low false call rate at any sequencing depth and excellent genome coverage at a high sequencing depth.	[Li, Ruiqiang; Li, Yingrui; Fang, Xiaodong; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Wang, Jun] Beijing Genom Inst Shenzhen, Shenzhen 518000, Peoples R China; [Li, Ruiqiang; Kristiansen, Karsten; Wang, Jun] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark		Wang, J (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen 518000, Peoples R China.	wangj@genomics.org.cn	Li, Yingrui/K-1064-2015; Fang, Xiaodong/K-6743-2018; Wang, Jun/A-7261-2013; Kristiansen, Karsten/J-5148-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Fang, Xiaodong/0000-0001-7061-3337; Kristiansen, Karsten/0000-0002-6024-0917; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Chinese Academy of ScienceChinese Academy of Sciences [GJHZ0701-6, KSCX2-YWN-023]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30725008, 90403130, 90608010, 30221004, 90612019, 30392130]; Chinese 973 programNational Basic Research Program of China [2007CB815701, 2007CB815703, 2007CB815705]; Chinese 863 programNational High Technology Research and Development Program of China [2006AA02Z334, 2006AA10A121, 2006AA02Z177]; Chinese Municipal Science and Technology Commission [D07030200740000]; Danish Platform for Integrative Biology; Ole Romer grant from the Danish Natural Science Research Council; Danish Research Council and the Solexa [272-07-0196]; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction; Prevention and Care ( LUCAMP).	This project is supported by the Chinese Academy of Science (GJHZ0701-6; KSCX2-YWN-023); the National Natural Science Foundation of China ( 30725008; 90403130; 90608010; 30221004; 90612019; 30392130); the Chinese 973 program ( 2007CB815701; 2007CB815703; 2007CB815705); the Chinese 863 program ( 2006AA02Z334; 2006AA10A121; 2006AA02Z177); the Chinese Municipal Science and Technology Commission ( D07030200740000); the Danish Platform for Integrative Biology; the Ole Romer grant from the Danish Natural Science Research Council; a pig bioinformatics grant from the Danish Research Council and the Solexa project (272-07-0196); and the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care ( LUCAMP). Laurie Goodman edited the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhao Z, 2002, GENOME RES, V12, P1679, DOI 10.1101/gr.287302	32	674	712	3	97	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	JUN	2009	19	6					1124	1132		10.1101/gr.088013.108			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	452DZ	WOS:000266521500018	19420381	Bronze, Green Published			2022-01-24	
J	Torroni, A; Huoponen, K; Francalacci, P; Petrozzi, M; Morelli, L; Scozzari, R; Obinu, D; Savontaus, ML; Wallace, DC				Torroni, A; Huoponen, K; Francalacci, P; Petrozzi, M; Morelli, L; Scozzari, R; Obinu, D; Savontaus, ML; Wallace, DC			Classification of European mtDNAs from an analysis three European populations	GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; HUMAN-EVOLUTION; CONTROL REGION; AFRICAN POPULATIONS; ALZHEIMER-DISEASE; ANCIENT DNA; D-LOOP; POLYMORPHISMS; SEQUENCE; GENES	Mitochondrial DNA (mtDNA) sequence variation was examined in Finns, Swedes and Tuscans by PCR amplification and restriction analysis. About 99% of the mtDNAs were subsumed within 10 mtDNA haplogroups (H, I, J, K, M, T, U, V, W, and X) suggesting that the identified haplogroups could encompass virtually all European mtDNAs. Because both hypervariable segments of the mtDNA control region were previously sequenced in the Tuscan samples, the mtDNA haplogroups and control region sequences could be compared. Using a combination of haplogroup-specific restriction site changes and control region nucleotide substitutions, the distribution of the haplogroups was surveyed through the published restriction site polymorphism and control region sequence data of Caucasoids. This supported the conclusion that most haplogroups observed in Europe are Caucasoid-specific, and that at least some of them occur at varying frequencies in different Caucasoid populations. The classification of almost all European mtDNA variation in a number of well defined haplogroups could provide additional insights about the origin and relationships of Caucasoid populations and the process of human colonization of Europe, and is valuable for the definition of the role played by mtDNA backgrounds in the expression of pathological mtDNA mutations.	EMORY UNIV, SCH MED, DEPT MOL & MED GENET, ATLANTA, GA 30322 USA; UNIV SASSARI, IST ANTROPOL, I-07100 SASSARI, ITALY; CNR, CTR GENET EVOLUZ, ROME, ITALY; TURKU UNIV, DEPT MED GENET, SF-20520 TURKU, FINLAND		Torroni, A (corresponding author), UNIV ROMA LA SAPIENZA, DIPARTIMENTO GENET & BIOL MOL, P A MORO 5, I-00185 ROME, ITALY.		Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; FRANCALACCI, Paolo/0000-0001-7912-162X	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-46915] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM046915] Funding Source: NIH RePORTER		Ammerman Albert, 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASTRINIDIS A, 1994, HUM BIOL, V66, P601; BALLINGER SW, 1992, GENETICS, V130, P139; BANDELT HJ, 1995, GENETICS, V141, P743; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; CHEN YS, 1995, AM J HUM GENET, V57, P133; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; FELSENSTEIN J, 1983, PHYLIP PHYLOGENY INF; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Gimbutas M., 1991, CIVILIZATION GODDESS; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Kumar S, 1993, MOL EVOLUTIONARY GEN; LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393; LI WH, 1995, SYST BIOL, V44, P49, DOI 10.2307/2413482; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; MOUNTAIN JL, 1994, M J HUM GENET, V56, P979; NEI M, 1983, GENETICS, V105, P207; Passarino G, 1996, AM J HUM GENET, V59, P927; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; RITTE U, 1993, HUM BIOL, V65, P359; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Santachiara Benerecetti A S, 1988, Ann Hum Genet, V52, P39; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SEMINO O, 1991, ANN HUM GENET, V55, P123, DOI 10.1111/j.1469-1809.1991.tb00405.x; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Soodyall H, 1996, AM J HUM GENET, V58, P595; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; STONEKING M, 1995, AM J HUM GENET, V57, P1259; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1991, AM J HUM GENET, V48, P370; Swofford D.L., 1993, PHYLOGENETIC ANAL US; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 1996, AM J HUM GENET, V59, P248; TORRONI A, 1990, INT J ANTHR, V5, P97; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720	69	674	701	5	125	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	1996	144	4					1835	1850					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VY931	WOS:A1996VY93100047	8978068				2022-01-24	
J	Corander, J; Waldmann, P; Sillanpaa, MJ				Corander, J; Waldmann, P; Sillanpaa, MJ			Bayesian analysis of genetic differentiation between populations	GENETICS			English	Article							SUBDIVIDED POPULATIONS; F-STATISTICS; DIVERSITY; PERSPECTIVE; VARIANCE	We introduce a Bayesian method for estimating hidden population substructure using multilocus molecular markers and geographical information provided by the sampling design. The joint posterior distribution of the substructure and allele frequencies of the respective populations is available in an analytical form when the number of populations is small, whereas an approximation based on a Markov chain Monte Carlo simulation approach can be obtained for a moderate or large number of populations. Using the joint posterior distribution, posteriors can also be derived for any evolutionary population parameters, such as the traditional fixation indices. A major advantage compared to most earlier methods is that the number of populations is treated here as an unknown parameter. What is traditionally considered as two genetically distinct populations, either recently founded or connected by considerable gene flow, is here considered as one panmictic population with a certain probability based on marker data and prior information. Analyses of previously published data on the Moroccan argan tree (Argania spinosa) and of simulated data sets suggest that our method is capable of estimating a population substructure, while not artificially enforcing a substructure when it does not exist. The software (BAPS) used for the computations is freely available from http://www.rni.helsinki.fi/-mjs.	Univ Helsinki, Res Inst Math Stat & Comp Sci, Rolf Nevanlinna Inst, FIN-00014 Helsinki, Finland; Oulu Univ, Dept Biol, Oulu, Finland		Sillanpaa, MJ (corresponding author), Univ Helsinki, Res Inst Math Stat & Comp Sci, Rolf Nevanlinna Inst, POB 4, FIN-00014 Helsinki, Finland.		TATSUTA, HARUKI/F-2997-2010	Waldmann, Patrik/0000-0003-2390-6609; Sillanpaa, Mikko J./0000-0003-2808-2768			Aarts E. H. L., 1989, SIMULATED ANNEALING; ABRAMOVITZ M, 1969, HDB MATH FUNCTIONS F; Anderson EC, 2002, GENETICS, V160, P1217; Ayres KL, 2001, GENETICS, V157, P413; Ayres KL, 1998, HEREDITY, V80, P769, DOI 10.1046/j.1365-2540.1998.00360.x; Ball RD, 2001, GENETICS, V159, P1351; Bernardo J. M., 1994, BAYESIAN THEORY; Dawson KJ, 2001, GENET RES, V78, P59, DOI 10.1017/S001667230100502X; Edwards SV, 2000, EVOLUTION, V54, P1839; EXCOFFIER L, 2001, HDB STAT GENETICS, P00271, DOI DOI 10.1002/9780470061619CH29; Holsinger KE, 1999, HEREDITAS, V130, P245, DOI 10.1111/j.1601-5223.1999.00245.x; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Kitada S, 2000, GENETICS, V156, P2063; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Nagylaki T, 1998, GENETICS, V148, P1325; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 1998, HEREDITY, V80, P56, DOI 10.1046/j.1365-2540.1998.00282.x; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Richardson S, 1996, MARKOV CHAIN MONTE C; SCHAFER JL, 2000, ANAL INCOMPLETE MULT; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; Tomiuk J, 1998, GENETICA, V102-3, P545, DOI 10.1023/A:1017080119277; Uimari P, 2001, GENET EPIDEMIOL, V21, P224, DOI 10.1002/gepi.1031; Weir BS, 1996, GENETIC DATA ANAL; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x; [No title captured]; [No title captured]	31	673	683	2	90	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JAN	2003	163	1					367	374					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	646MW	WOS:000181039700032	12586722				2022-01-24	
J	Mears, AJ; Kondo, M; Swain, PK; Takada, Y; Bush, RA; Saunders, TL; Sieving, PA; Swaroop, A				Mears, AJ; Kondo, M; Swain, PK; Takada, Y; Bush, RA; Saunders, TL; Sieving, PA; Swaroop, A			Nrl is required for rod photoreceptor development	NATURE GENETICS			English	Article							CELL-FATE DETERMINATION; LEUCINE-ZIPPER; PROTEIN; DEGENERATION; RECEPTOR; RETINA; GENE; CRX; HOMEODOMAIN; DISRUPTION	The protein neural retina leucine zipper (Nrl) is a basic motif-leucine zipper transcription factor that is preferentially expressed in rod photoreceptors(1,2). it acts synergistically with Crx to regulate rhodopsin transcription(3-5). Missense mutations in human NRL have been associated with autosomal dominant retinitis pigmentosa(6,7). Here we report that deletion of Nrl in mice results in the complete loss of rod function and super-normal cone function, mediated by S cones. The photoreceptors in the Nrl(-/-) retina have cone-like nuclear morphology(8) and short, sparse outer segments with abnormal disks. Analysis of retinal gene expression confirms the apparent functional transformation of rods into S cones in the Nrl(-/-) retina. On the basis of these findings, we postulate that Nrl acts as a 'molecular switch' during rod-cell development by directly modulating rod-specific genes while simultaneously inhibiting the S-cone pathway through the activation of Nr2e3.	Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Nagoya Univ, Sch Med, Dept Ophthalmol, Nagoya, Aichi 4668550, Japan; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; NEI, NIH, Bethesda, MD 20892 USA		Swaroop, A (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, 1500 E Med Ctr Dr, Ann Arbor, MI 48105 USA.	swaroop@umich.edu		Saunders, Thom/0000-0003-2015-101X; Swaroop, Anand/0000-0002-1975-1141	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY011115] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY07003, EY11115] Funding Source: Medline		Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Coligan JE, 1999, CURRENT PROTOCOLS PR; Fan W, 1996, EXP EYE RES, V63, P9, DOI 10.1006/exer.1996.0086; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HITCHCOCK PF, 1989, J COMP NEUROL, V283, P177, DOI 10.1002/cne.902830203; Trujillo MJ, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<80::AID-HUMU27>3.0.CO;2-G; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kosaka J, 1998, J NEUROSCI RES, V54, P655, DOI 10.1002/(SICI)1097-4547(19981201)54:5<655::AID-JNR10>3.0.CO;2-Z; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Saari JC, 1997, GLIA, V21, P259; Sambrook J., 2001, MOL CLONING LAB MANU; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERDERBER L, 1995, INVEST OPHTH VIS SCI, V36, P1137; WILLIAMS DS, 1991, BIOESSAYS, V13, P171, DOI 10.1002/bies.950130405; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124	31	673	682	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					447	452		10.1038/ng774			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	WOS:000172507500021	11694879				2022-01-24	
J	Aulchenko, YS; Ripatti, S; Lindqvist, I; Boomsma, D; Heid, IM; Pramstaller, PP; Penninx, BWJH; Janssens, ACJW; Wilson, JF; Spector, T; Martin, NG; Pedersen, NL; Kyvik, KO; Kaprio, J; Hofman, A; Freimer, NB; Jarvelin, MR; Gyllensten, U; Campbell, H; Rudan, I; Johansson, A; Marroni, F; Hayward, C; Vitart, V; Jonasson, I; Pattaro, C; Wright, A; Hastie, N; Pichler, I; Hicks, AA; Falchi, M; Willemsen, G; Hottenga, JJ; de Geus, EJC; Montgomery, GW; Whitfield, J; Magnusson, P; Saharinen, J; Perola, M; Silander, K; Isaacs, A; Sijbrands, EJG; Uitterlinden, AG; Witteman, JCM; Oostra, BA; Elliott, P; Ruokonen, A; Sabatti, C; Gieger, C; Meitinger, T; Kronenberg, F; Doring, A; Wichmann, HE; Smit, JH; McCarthy, MI; van Duijn, CM; Peltonen, L				Aulchenko, Yurii S.; Ripatti, Samuli; Lindqvist, Ida; Boomsma, Dorret; Heid, Iris M.; Pramstaller, Peter P.; Penninx, Brenda W. J. H.; Janssens, A. Cecile J. W.; Wilson, James F.; Spector, Tim; Martin, Nicholas G.; Pedersen, Nancy L.; Kyvik, Kirsten Ohm; Kaprio, Jaakko; Hofman, Albert; Freimer, Nelson B.; Jarvelin, Marjo-Riitta; Gyllensten, Ulf; Campbell, Harry; Rudan, Igor; Johansson, Asa; Marroni, Fabio; Hayward, Caroline; Vitart, Veronique; Jonasson, Inger; Pattaro, Cristian; Wright, Alan; Hastie, Nick; Pichler, Irene; Hicks, Andrew A.; Falchi, Mario; Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.; Montgomery, Grant W.; Whitfield, John; Magnusson, Patrik; Saharinen, Juha; Perola, Markus; Silander, Kaisa; Isaacs, Aaron; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.; Oostra, Ben A.; Elliott, Paul; Ruokonen, Aimo; Sabatti, Chiara; Gieger, Christian; Meitinger, Thomas; Kronenberg, Florian; Doering, Angela; Wichmann, H-Erich; Smit, Johannes H.; McCarthy, Mark I.; van Duijn, Cornelia M.; Peltonen, Leena		Engage Consortium	Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; PLASMA; POLYMORPHISMS; OBJECTIVES; SPECTRUM; DESIGN; KORA	Recent genome-wide association (GWA) studies of lipids have been conducted in samples ascertained for other phenotypes, particularly diabetes. Here we report the first GWA analysis of loci affecting total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides sampled randomly from 16 population-based cohorts and genotyped using mainly the Illumina HumanHap300-Duo platform. Our study included a total of 17,797-22,562 persons, aged 18-104 years and from geographic regions spanning from the Nordic countries to Southern Europe. We established 22 loci associated with serum lipid levels at a genome-wide significance level (P < 5 x 10(-8)), including 16 loci that were identified by previous GWA studies. The six newly identified loci in our cohort samples are ABCG5 (TC, P = 1.5 x 10(-11); LDL, P = 2.6 x 10(-10)), TMEM57 (TC, P = 5.4 x 10(-10)), CTCF-PRMT8 region (HDL, P = 8.3 x 10(-16)), DNAH11 (LDL, P = 6.1 x 10(-9)), FADS3-FADS2 (TC, P = 1.5 x 10(-10); LDL, P = 4.4 x 10(-13)) and MADD-FOLH1 region (HDL, P = 6 x 10(-11)). For three loci, effect sizes differed significantly by sex. Genetic risk scores based on lipid loci explain up to 4.8% of variation in lipids and were also associated with increased intima media thickness (P = 0.001) and coronary heart disease incidence (P = 0.04). The genetic risk score improves the screening of high-risk groups of dyslipidemia over classical risk factors.	[Ripatti, Samuli; Lindqvist, Ida; Perola, Markus; Silander, Kaisa; Peltonen, Leena] Natl Publ Hlth Inst, Biomedicum, Helsinki 00251, Finland; [Aulchenko, Yurii S.; Janssens, A. Cecile J. W.; Hofman, Albert; Isaacs, Aaron; Sijbrands, Eric J. G.; Witteman, Jacqueline C. M.] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; [Ripatti, Samuli; Lindqvist, Ida; Perola, Markus; Silander, Kaisa; Peltonen, Leena] Inst Mol Med, FIMM, Helsinki 00251, Finland; [Boomsma, Dorret; Willemsen, Gonneke; Hottenga, Jouke-Jan; de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Heid, Iris M.; Gieger, Christian; Doering, Angela; Wichmann, H-Erich] Helmholtz Ctr Munich, Inst Epidemiol, D-85764 Neuherberg, Germany; [Heid, Iris M.; Wichmann, H-Erich] Univ Munich, IBE, Chair Epidemiol, D-81377 Munich, Germany; [Pramstaller, Peter P.; Marroni, Fabio; Pattaro, Cristian; Pichler, Irene; Hicks, Andrew A.] EURAC Res, Inst Med Genet, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Penninx, Brenda W. J. H.; Smit, Johannes H.] Vrije Univ Amsterdam Med Ctr, Inst Neurosci, EMGO Inst, Dept Psychiat, Amsterdam, Netherlands; [Wilson, James F.; Campbell, Harry; Rudan, Igor] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Wilson, James F.; Hayward, Caroline; Wright, Alan; Hastie, Nick] MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Spector, Tim; Falchi, Mario] Kings Coll London, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England; [Martin, Nicholas G.; Montgomery, Grant W.; Whitfield, John] PO Royal Brisbane Hosp, Queensland Inst Med Res, Genet Epidemiol Unit, Brisbane, Qld 4029, Australia; [Pedersen, Nancy L.; Magnusson, Patrik] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Inst Reg Hlth Res, DK-5000 Odense, Denmark; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, DK-5000 Odense, Denmark; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Fac Med, FIN-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Ctr Neurobehav Genet,Jane & Terry Semel Inst Neur, Los Angeles, CA 90095 USA; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; [Gyllensten, Ulf; Johansson, Asa; Jonasson, Inger] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Rudan, Igor] Univ Split Med Sch, Croatian Ctr Global Hlth, Split 21000, Croatia; [Rudan, Igor] Univ Hosp Sestre Milosrdnice, Inst Clin Med Res, Zagreb 10000, Croatia; [Falchi, Mario] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Sijbrands, Eric J. G.; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Oostra, Ben A.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Ruokonen, Aimo] Univ Hosp Oulu, Dept Biochem, Oulu 90220, Finland; [Sabatti, Chiara] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Meitinger, Thomas] Helmholtz Ctr Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Peltonen, Leena] MIT, Broad Inst, Cambridge, MA 02142 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst Wellcome Trust Genom C, Cambridge CB10 1SA, England		Peltonen, L (corresponding author), Natl Publ Hlth Inst, Biomedicum, POB 104, Helsinki 00251, Finland.	leena@sanger.ac.uk	Kyvik, Kirsten O/K-5680-2016; Wilson, James F/A-5704-2009; Spector, Tim D/F-6533-2012; Wichmann, Heinz Erich/AAA-5695-2022; Marroni, Fabio/R-1819-2017; Rudan, Igor/I-1467-2012; Hicks, Andrew Anthony/E-9518-2017; Hayward, Caroline/M-8818-2016; Aulchenko, Yurii/M-8270-2013; Pramstaller, Peter P/C-2357-2008; de Geus, Eco J.C./M-9318-2015; Sijbrands, Eric/A-1065-2009; Boomsma, Dorret I/AAX-4470-2020; Johansson, Asa/G-5270-2011; Magnusson, Patrik KE/C-4458-2017; Johansson, Asa/AAG-6799-2021; Campbell, Harry/E-2959-2010; Kaprio, Jaakko/A-1820-2008; Montgomery, Grant W/B-7148-2008; Kronenberg, Florian/B-1736-2008; Meitinger, Thomas/O-1318-2015; Ripatti, Samuli/H-9446-2014; Penninx, Brenda WJH/S-7627-2017; Falchi, Mario/F-5956-2013; McCarthy, Mark/M-3763-2015	Kyvik, Kirsten O/0000-0003-2981-0245; Wilson, James F/0000-0001-5751-9178; Marroni, Fabio/0000-0002-1556-5907; Rudan, Igor/0000-0001-6993-6884; Hicks, Andrew Anthony/0000-0001-6320-0411; Hayward, Caroline/0000-0002-9405-9550; Aulchenko, Yurii/0000-0002-7899-1575; de Geus, Eco J.C./0000-0001-6022-2666; Sijbrands, Eric/0000-0001-8857-7389; Johansson, Asa/0000-0002-2915-4498; Magnusson, Patrik KE/0000-0002-7315-7899; Johansson, Asa/0000-0002-2915-4498; Campbell, Harry/0000-0002-6169-6262; Kaprio, Jaakko/0000-0002-3716-2455; Montgomery, Grant W/0000-0002-4140-8139; Kronenberg, Florian/0000-0003-2229-1120; Ripatti, Samuli/0000-0002-0504-1202; Penninx, Brenda WJH/0000-0001-7779-9672; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; McCarthy, Mark/0000-0002-4393-0510; Gieger, Christian/0000-0001-6986-9554; Van Duijn, Cornelia/0000-0002-2374-9204; Pichler, Irene/0000-0001-8251-0757; Willemsen, Gonneke/0000-0003-3755-0236; Vitart, Veronique/0000-0002-4991-3797; Falchi, Mario/0000-0002-5646-1004; Elliott, Paul/0000-0002-7511-5684; Martin, Nicholas/0000-0003-4069-8020; Janssens, A Cecile/0000-0002-6153-4976; Meitinger, Thomas/0000-0002-8838-8403	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U127561128] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5R01HL087679-02, R01 HL087679] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [089061] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL087679] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127561128] Funding Source: UKRI		ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; ENDO A, 1992, J LIPID RES, V33, P1569; Fauci, 2005, HARRISONS PRINCIPLES; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedlander Y, 1997, AM J HUM GENET, V60, P1502, DOI 10.1086/515462; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Howard BV, 2003, ENDOCRIN METAB CLIN, V32, P855, DOI 10.1016/S0889-8529(03)00073-2; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, CURR OPIN LIPIDOL, V19, P122, DOI 10.1097/MOL.0b013e3282f70296; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Law S W, 1986, Adv Exp Med Biol, V201, P151; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Peltonen L, 2003, TWIN RES, V6, P354, DOI 10.1375/136905203770326358; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RANTAKALLIO P, 1969, ACTA PAEDIAT SC S193, V0193; Rudan I, 1999, COLLEGIUM ANTROPOL, V23, P531; Rudkowska I, 2008, NUTR REV, V66, P343, DOI 10.1111/j.1753-4887.2008.00042.x; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SING CF, 1985, AM J HUM GENET, V37, P268; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Tunstall-Pedoe, 2003, MONICA MONOGRAPH MUL; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	41	672	684	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					47	55		10.1038/ng.269			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	WOS:000262085300015	19060911	Green Published, Green Accepted, Green Submitted			2022-01-24	
J	Kunkle, BW; Grenier-Boley, B; Sims, R; Bis, JC; Damotte, V; Naj, AC; Boland, A; Vronskaya, M; van der Lee, SJ; Amlie-Wolf, A; Bellenguez, C; Frizatti, A; Chouraki, V; Martin, ER; Sleegers, K; Badarinarayan, N; Jakobsdottir, J; Hamilton-Nelson, KL; Moreno-Grau, S; Olaso, R; Raybould, R; Chen, YN; Kuzma, AB; Hiltunen, M; Morgan, T; Ahmad, S; Vardarajan, BN; Epelbaum, J; Hoffmann, P; Boada, M; Beecham, GW; Garnier, JG; Harold, D; Fitzpatrick, AL; Valladares, O; Moutet, ML; Gerrish, A; Smith, AV; Qu, LM; Bacq, D; Denning, N; Jian, XQ; Zhao, Y; Del Zompo, M; Fox, NC; Choi, SH; Mateo, I; Hughes, JT; Adams, HH; Malamon, J; Sanchez-Garcia, F; Patel, Y; Brody, JA; Dombroski, BA; Naranjo, MCD; Daniilidou, M; Eiriksdottir, G; Mukherjee, S; Wallon, D; Uphill, J; Aspelund, T; Cantwell, LB; Garzia, F; Galimberti, D; Hofer, E; Butkiewicz, M; Fin, B; Scarpini, E; Sarnowski, C; Bush, WS; Meslage, S; Kornhuber, J; White, CC; Song, Y; Barber, RC; Engelborghs, S; Sordon, S; Voijnovic, D; Adams, PM; Vandenberghe, R; Mayhaus, M; Cupples, LA; Albert, MS; De Deyn, PP; Gu, W; Himali, JJ; Beekly, D; Squassina, A; Hartmann, AM; Orellana, A; Blacker, D; Rodriguez-Rodriguez, E; Lovestone, S; Garcia, ME; Doody, RS; Munoz-Fernadez, C; Sussams, R; Lin, HH; Fairchild, TJ; Benito, YA; Holmes, C; Karamujic-Comic, H; Frosch, MP; Thonberg, H; Maier, W; Roschupkin, G; Ghetti, B; Giedraitis, V; Kawalia, A; Li, S; Huebinger, RM; Kilander, L; Moebus, S; Hernandez, I; Kamboh, MI; Brundin, R; Turton, J; Yang, Q; Katz, MJ; Concari, L; Lord, J; Beiser, AS; Keene, CD; Helisalmi, S; Kloszewska, I; Kukull, WA; Koivisto, AM; Lynch, A; Tarraga, L; Larson, EB; Haapasalo, A; Lawlor, B; Mosley, TH; Lipton, RB; Solfrizzi, V; Gill, M; Longstreth, WT; Montine, TJ; Frisardi, V; Diez-Fairen, M; Rivadeneira, F; Petersen, RC; Deramecourt, V; Alvarez, I; Salani, F; Ciaramella, A; Boerwinkle, E; Reiman, EM; Fievet, N; Rotter, JI; Reisch, JS; Hanon, O; Cupidi, C; Uitterlinden, AGA; Royall, DR; Dufouil, C; Maletta, RG; de Rojas, I; Sano, M; Brice, A; Cecchetti, R; St George-Hyslop, P; Ritchie, K; Tsolaki, M; Tsuang, DW; Dubois, B; Craig, D; Wu, CK; Soininen, H; Avramidou, D; Albin, RL; Fratiglioni, L; Germanou, A; Apostolova, LG; Keller, L; Koutroumani, M; Arnold, SE; Panza, F; Gkatzima, O; Asthana, S; Hannequin, D; Whitehead, P; Atwood, CS; Caffarra, P; Hampel, H; Quintela, I; Carracedo, A; Lannfelt, L; Rubinsztein, DC; Barnes, LL; Pasquier, F; Frolich, L; Barral, S; McGuinness, B; Beach, TG; Johnston, JA; Becker, JT; Passmore, P; Bigio, EH; Schott, JM; Bird, TD; Warren, JD; Boeve, BF; Lupton, MK; Bowen, JD; Proitsi, P; Boxer, A; Powell, JF; Burke, JR; Kauwe, JSK; Burns, JM; Mancuso, M; Buxbaum, JD; Bonuccelli, U; Cairns, NJ; McQuillin, A; Cao, CH; Livingston, G; Carlson, CS; Bass, NJ; Carlsson, CM; Hardy, J; Carney, RM; Bras, J; Carrasquillo, MM; Guerreiro, R; Allen, M; Chui, HC; Fisher, E; Masullo, C; Crocco, EA; DeCarli, C; Bisceglio, G; Dick, M; Ma, L; Duara, R; Graff-Radford, NR; Evans, DA; Hodges, A; Faber, KM; Scherer, M; Fallon, KB; Riemenschneider, M; Fardo, DW; Heun, R; Farlow, MR; Kolsch, H; Ferris, S; Leber, M; Foroud, TM; Heuser, I; Galasko, DR; Giegling, I; Gearing, M; Hull, M; Geschwind, DH; Gilbert, JR; Morris, J; Green, RC; Mayo, K; Growdon, JH; Feulner, T; Hamilton, RL; Harrell, LE; Drichel, D; Honig, LS; Cushion, TD; Huentelman, MJ; Hollingworth, P; Hulette, CM; Hyman, BT; Marshall, R; Jarvik, GP; Meggy, A; Abner, E; Menzies, GE; Jin, LW; Leonenko, G; Real, LM; Jun, GR; Baldwin, CT; Grozeva, D; Karydas, A; Russo, G; Kaye, JA; Kim, R; Jessen, F; Kowall, NW; Vellas, B; Kramer, JH; Vardy, E; LaFerla, FM; Jockel, KH; Lah, JJ; Dichgans, M; Leverenz, JB; Mann, D; Levey, AI; Pickering-Brown, S; Lieberman, AP; Klopp, N; Lunetta, KL; Wichmann, HE; Lyketsos, CG; Morgan, K; Marson, DC; Brown, K; Martiniuk, F; Medway, C; Mash, DC; Nothen, MM; Masliah, E; Hooper, NM; McCormick, WC; Daniele, A; McCurry, SM; Bayer, A; McDavid, AN; Gallacher, J; McKee, AC; van den Bussche, H; Mesulam, M; Brayne, C; Miller, BL; Riedel-Heller, S; Miller, CA; Miller, JW; Al-Chalabi, A; Morris, JC; Shaw, CE; Myers, AJ; Wiltfang, J; O'Bryant, S; Olichney, JM; Alvarez, V; Parisi, JE; Singleton, AB; Paulson, HL; Collinge, J; Perry, WR; Mead, S; Peskind, E; Cribbs, DH; Rossor, M; Pierce, A; Ryan, NS; Poon, WW; Nacmias, B; Potter, H; Sorbi, S; Quinn, JF; Sacchinelli, E; Raj, A; Spalletta, G; Raskind, M; Caltagirone, C; Bossu, P; Orfei, MD; Reisberg, B; Clarke, R; Reitz, C; Smith, AD; Ringman, JM; Warden, D; Roberson, ED; Wilcock, G; Rogaeva, E; Bruni, AC; Rosen, HJ; Gallo, M; Rosenberg, RN; Ben-Shlomo, Y; Sager, MA; Mecocci, P; Saykin, AJ; Pastor, P; Cuccaro, ML; Vance, JM; Schneider, JA; Schneider, LS; Slifer, S; Seeley, WW; Smith, AG; Sonnen, JA; Spina, S; Stern, RA; Swerdlow, RH; Tang, M; Tanzi, RE; Trojanowski, JQ; Troncoso, JC; Van Deerlin, VM; Van Eldik, LJ; Vinters, HV; Vonsattel, JP; Weintraub, S; Welsh-Bohmer, KA; Wilhelmsen, KC; Williamson, J; Wingo, TS; Woltjer, RL; Wright, CB; Yu, CE; Yu, L; Saba, Y; Pilotto, A; Bullido, MJ; Peters, O; Crane, PK; Bennett, D; Bosco, P; Coto, E; Boccardi, V; De Jager, PL; Lleo, A; Warner, N; Lopez, OL; Ingelsson, M; Deloukas, P; Cruchaga, C; Graff, C; Gwilliam, R; Fornage, M; Goate, AM; Sanchez-Juan, P; Kehoe, PG; Amin, N; Ertekin-Taner, N; Berr, C; Debette, S; Love, S; Launer, LJ; Younkin, SG; Dartigues, JF; Corcoran, C; Ikram, MA; Dickson, DW; Nicolas, G; Campion, D; Tschanz, J; Schmidt, H; Hakonarson, H; Clarimon, J; Munger, R; Schmidt, R; Farrer, LA; Van Broeckhoven, C; O'Donovan, MC; DeStefano, AL; Jones, L; Haines, JL; Deleuze, JF; Owen, MJ; Gudnason, V; Mayeux, R; Escott-Price, V; Psaty, BM; Ramirez, A; Wang, LS; Ruiz, A; van Duijn, CM; Holmans, PA; Seshadri, S; Williams, J; Amouyel, P; Schellenberg, GD; Lambert, JC; Pericak-Vance, MA				Kunkle, Brian W.; Grenier-Boley, Benjamin; Sims, Rebecca; Bis, Joshua C.; Damotte, Vincent; Naj, Adam C.; Boland, Anne; Vronskaya, Maria; van der Lee, Sven J.; Amlie-Wolf, Alexandre; Bellenguez, Celine; Frizatti, Aura; Chouraki, Vincent; Martin, Eden R.; Sleegers, Kristel; Badarinarayan, Nandini; Jakobsdottir, Johanna; Hamilton-Nelson, Kara L.; Moreno-Grau, Sonia; Olaso, Robert; Raybould, Rachel; Chen, Yuning; Kuzma, Amanda B.; Hiltunen, Mikko; Morgan, Taniesha; Ahmad, Shahzad; Vardarajan, Badri N.; Epelbaum, Jacques; Hoffmann, Per; Boada, Merce; Beecham, Gary W.; Garnier, Jean-Guillaume; Harold, Denise; Fitzpatrick, Annette L.; Valladares, Otto; Moutet, Marie-Laure; Gerrish, Amy; Smith, Albert, V; Qu, Liming; Bacq, Delphine; Denning, Nicola; Jian, Xueqiu; Zhao, Yi; Del Zompo, Maria; Fox, Nick C.; Choi, Seung-Hoan; Mateo, Ignacio; Hughes, Joseph T.; Adams, Hieab H.; Malamon, John; Sanchez-Garcia, Florentino; Patel, Yogen; Brody, Jennifer A.; Dombroski, Beth A.; Naranjo, Maria Candida Deniz; Daniilidou, Makrina; Eiriksdottir, Gudny; Mukherjee, Shubhabrata; Wallon, David; Uphill, James; Aspelund, Thor; Cantwell, Laura B.; Garzia, Fabienne; Galimberti, Daniela; Hofer, Edith; Butkiewicz, Mariusz; Fin, Bertrand; Scarpini, Elio; Sarnowski, Chloe; Bush, Will S.; Meslage, Stphane; Kornhuber, Johannes; White, Charles C.; Song, Yuenjoo; Barber, Robert C.; Engelborghs, Sebastiaan; Sordon, Sabrina; Voijnovic, Dina; Adams, Perrie M.; Vandenberghe, Rik; Mayhaus, Manuel; Cupples, L. Adrienne; Albert, Marilyn S.; De Deyn, Peter P.; Gu, Wei; Himali, Jayanadra J.; Beekly, Duane; Squassina, Alessio; Hartmann, Annette M.; Orellana, Adelina; Blacker, Deborah; Rodriguez-Rodriguez, Eloy; Lovestone, Simon; Garcia, Melissa E.; Doody, Rachelle S.; Munoz-Fernadez, Carmen; Sussams, Rebecca; Lin, Honghuang; Fairchild, Thomas J.; Benito, Yolanda A.; Holmes, Clive; Karamujic-Comic, Hata; Frosch, Matthew P.; Thonberg, Hakan; Maier, Wolfgang; Roschupkin, Gena; Ghetti, Bernardino; Giedraitis, Vilmantas; Kawalia, Amit; Li, Shuo; Huebinger, Ryan M.; Kilander, Lena; Moebus, Susanne; Hernandez, Isabel; Kamboh, M. Ilyas; Brundin, Rosemarie; Turton, James; Yang, Qiong; Katz, Mindy J.; Concari, Letizia; Lord, Jenny; Beiser, Alexa S.; Keene, C. Dirk; Helisalmi, Seppo; Kloszewska, Iwona; Kukull, Walter A.; Koivisto, Anne Maria; Lynch, Aoibhinn; Tarraga, Lluis; Larson, Eric B.; Haapasalo, Annakaisa; Lawlor, Brian; Mosley, Thomas H.; Lipton, Richard B.; Solfrizzi, Vincenzo; Gill, Michael; Longstreth, W. T., Jr.; Montine, Thomas J.; Frisardi, Vincenza; Diez-Fairen, Monica; Rivadeneira, Fernando; Petersen, Ronald C.; Deramecourt, Vincent; Alvarez, Ignacio; Salani, Francesca; Ciaramella, Antonio; Boerwinkle, Eric; Reiman, Eric M.; Fievet, Nathalie; Rotter, Jerome, I; Reisch, Joan S.; Hanon, Olivier; Cupidi, Chiara; Uitterlinden, A. G. Andre; Royall, Donald R.; Dufouil, Carole; Maletta, Raffaele Giovanni; de Rojas, Itziar; Sano, Mary; Brice, Alexis; Cecchetti, Roberta; St George-Hyslop, Peter; Ritchie, Karen; Tsolaki, Magda; Tsuang, Debby W.; Dubois, Bruno; Craig, David; Wu, Chuang-Kuo; Soininen, Hilkka; Avramidou, Despoina; Albin, Roger L.; Fratiglioni, Laura; Germanou, Antonia; Apostolova, Liana G.; Keller, Lina; Koutroumani, Maria; Arnold, Steven E.; Panza, Francesco; Gkatzima, Olymbia; Asthana, Sanjay; Hannequin, Didier; Whitehead, Patrice; Atwood, Craig S.; Caffarra, Paolo; Hampel, Harald; Quintela, Ines; Carracedo, Angel; Lannfelt, Lars; Rubinsztein, David C.; Barnes, Lisa L.; Pasquier, Florence; Froelich, Lutz; Barral, Sandra; McGuinness, Bernadette; Beach, Thomas G.; Johnston, Janet A.; Becker, James T.; Passmore, Peter; Bigio, Eileen H.; Schott, Jonathan M.; Bird, Thomas D.; Warren, Jason D.; Boeve, Bradley F.; Lupton, Michelle K.; Bowen, James D.; Proitsi, Petra; Boxer, Adam; Powell, John F.; Burke, James R.; Kauwe, John S. K.; Burns, Jeffrey M.; Mancuso, Michelangelo; Buxbaum, Joseph D.; Bonuccelli, Ubaldo; Cairns, Nigel J.; McQuillin, Andrew; Cao, Chuanhai; Livingston, Gill; Carlson, Chris S.; Bass, Nicholas J.; Carlsson, Cynthia M.; Hardy, John; Carney, Regina M.; Bras, Jose; Carrasquillo, Minerva M.; Guerreiro, Rita; Allen, Mariet; Chui, Helena C.; Fisher, Elizabeth; Masullo, Carlo; Crocco, Elizabeth A.; DeCarli, Charles; Bisceglio, Gina; Dick, Malcolm; Ma, Li; Duara, Ranjan; Graff-Radford, Neill R.; Evans, Denis A.; Hodges, Angela; Faber, Kelley M.; Scherer, Martin; Fallon, Kenneth B.; Riemenschneider, Matthias; Fardo, David W.; Heun, Reinhard; Farlow, Martin R.; Koelsch, Heike; Ferris, Steven; Leber, Markus; Foroud, Tatiana M.; Heuser, Isabella; Galasko, Douglas R.; Giegling, Ina; Gearing, Marla; Huell, Michael; Geschwind, Daniel H.; Gilbert, John R.; Morris, John; Green, Robert C.; Mayo, Kevin; Growdon, John H.; Feulner, Thomas; Hamilton, Ronald L.; Harrell, Lindy E.; Drichel, Dmitriy; Honig, Lawrence S.; Cushion, Thomas D.; Huentelman, Matthew J.; Hollingworth, Paul; Hulette, Christine M.; Hyman, Bradley T.; Marshall, Rachel; Jarvik, Gail P.; Meggy, Alun; Abner, Erin; Menzies, Georgina E.; Jin, Lee-Way; Leonenko, Ganna; Real, Luis M.; Jun, Gyungah R.; Baldwin, Clinton T.; Grozeva, Detelina; Karydas, Anna; Russo, Giancarlo; Kaye, Jeffrey A.; Kim, Ronald; Jessen, Frank; Kowall, Neil W.; Vellas, Bruno; Kramer, Joel H.; Vardy, Emma; LaFerla, Frank M.; Joeckel, Karl-Heinz; Lah, James J.; Dichgans, Martin; Leverenz, James B.; Mann, David; Levey, Allan, I; Pickering-Brown, Stuart; Lieberman, Andrew P.; Klopp, Norman; Lunetta, Kathryn L.; Wichmann, H-Erich; Lyketsos, Constantine G.; Morgan, Kevin; Marson, Daniel C.; Brown, Kristelle; Martiniuk, Frank; Medway, Christopher; Mash, Deborah C.; Noethen, Markus M.; Masliah, Eliezer; Hooper, Nigel M.; McCormick, Wayne C.; Daniele, Antonio; McCurry, Susan M.; Bayer, Anthony; McDavid, Andrew N.; Gallacher, John; McKee, Ann C.; van den Bussche, Hendrik; Mesulam, Marsel; Brayne, Carol; Miller, Bruce L.; Riedel-Heller, Steffi; Miller, Carol A.; Miller, Joshua W.; Al-Chalabi, Ammar; Morris, John C.; Shaw, Christopher E.; Myers, Amanda J.; Wiltfang, Jens; O'Bryant, Sid; Olichney, John M.; Alvarez, Victoria; Parisi, Joseph E.; Singleton, Andrew B.; Paulson, Henry L.; Collinge, John; Perry, William R.; Mead, Simon; Peskind, Elaine; Cribbs, David H.; Rossor, Martin; Pierce, Aimee; Ryan, Natalie S.; Poon, Wayne W.; Nacmias, Benedetta; Potter, Huntington; Sorbi, Sandro; Quinn, Joseph F.; Sacchinelli, Eleonora; Raj, Ashok; Spalletta, Gianfranco; Raskind, Murray; Caltagirone, Carlo; Bossu, Paola; Orfei, Maria Donata; Reisberg, Barry; Clarke, Robert; Reitz, Christiane; Smith, A. David; Ringman, John M.; Warden, Donald; Roberson, Erik D.; Wilcock, Gordon; Rogaeva, Ekaterina; Bruni, Amalia Cecilia; Rosen, Howard J.; Gallo, Maura; Rosenberg, Roger N.; Ben-Shlomo, Yoav; Sager, Mark A.; Mecocci, Patrizia; Saykin, Andrew J.; Pastor, Pau; Cuccaro, Michael L.; Vance, Jeffery M.; Schneider, Julie A.; Schneider, Lori S.; Slifer, Susan; Seeley, William W.; Smith, Amanda G.; Sonnen, Joshua A.; Spina, Salvatore; Stern, Robert A.; Swerdlow, Russell H.; Tang, Mitchell; Tanzi, Rudolph E.; Trojanowski, John Q.; Troncoso, Juan C.; Van Deerlin, Vivianna M.; Van Eldik, Linda J.; Vinters, Harry V.; Vonsattel, Jean Paul; Weintraub, Sandra; Welsh-Bohmer, Kathleen A.; Wilhelmsen, Kirk C.; Williamson, Jennifer; Wingo, Thomas S.; Woltjer, Randall L.; Wright, Clinton B.; Yu, Chang-En; Yu, Lei; Saba, Yasaman; Pilotto, Alberto; Bullido, Maria J.; Peters, Oliver; Crane, Paul K.; Bennett, David; Bosco, Paola; Coto, Eliecer; Boccardi, Virginia; De Jager, Phil L.; Lleo, Alberto; Warner, Nick; Lopez, Oscar L.; Ingelsson, Martin; Deloukas, Panagiotis; Cruchaga, Carlos; Graff, Caroline; Gwilliam, Rhian; Fornage, Myriam; Goate, Alison M.; Sanchez-Juan, Pascual; Kehoe, Patrick G.; Amin, Najaf; Ertekin-Taner, Nilifur; Berr, Claudine; Debette, Stphanie; Love, Seth; Launer, Lenore J.; Younkin, Steven G.; Dartigues, Jean-Francois; Corcoran, Chris; Ikram, M. Arfan; Dickson, Dennis W.; Nicolas, Gael; Campion, Dominique; Tschanz, JoAnn; Schmidt, Helena; Hakonarson, Hakon; Clarimon, Jordi; Munger, Ron; Schmidt, Reinhold; Farrer, Lindsay A.; Van Broeckhoven, Christine; O'Donovan, Michael C.; DeStefano, Anita L.; Jones, Lesley; Haines, Jonathan L.; Deleuze, Jean-Francois; Owen, Michael J.; Gudnason, Vilmundur; Mayeux, Richard; Escott-Price, Valentina; Psaty, Bruce M.; Ramirez, Alfredo; Wang, Li-San; Ruiz, Agustin; van Duijn, Cornelia M.; Holmans, Peter A.; Seshadri, Sudha; Williams, Julie; Amouyel, Phillippe; Schellenberg, Gerard D.; Lambert, Jean-Charles; Pericak-Vance, Margaret A.		Alzheimer Dis Genetics Consortium; European Alzheimers Dis Initiative; Cohorts Heart Aging Res Genomic Ep; Genetic Environm Risk AD Defining	Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DOMAIN-CONTAINING OXIDOREDUCTASE; ANGIOTENSIN-CONVERTING ENZYME; AMYLOID-BETA; TRANSCRIPTION FACTOR; GENOTYPE IMPUTATION; APOLIPOPROTEIN-E; COMMON VARIANTS; ONSET; MUTATIONS	Risk for late-onset Alzheimer's disease (LOAD), the most prevalent dementia, is partially driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association meta-analysis of clinically diagnosed LOAD (94,437 individuals). We confirm 20 previous LOAD risk loci and identify five new genome-wide loci (IQCK, ACE, ADAM10, ADAMTS1, and WWOX), two of which (ADAM10, ACE) were identified in a recent genome-wide association (GWAS)-by-familial-proxy of Alzheimer's or dementia. Fine-mapping of the human leukocyte antigen (HLA) region confirms the neurological and immune-mediated disease haplotype HLA-DR15 as a risk factor for LOAD. Pathway analysis implicates immunity, lipid metabolism, tau binding proteins, and amyloid precursor protein (APP) metabolism, showing that genetic variants affecting APP and A beta processing are associated not only with early-onset autosomal dominant Alzheimer's disease but also with LOAD. Analyses of risk genes and pathways show enrichment for rare variants (P = 1.32 x 10(-7)), indicating that additional rare variants remain to be identified. We also identify important genetic correlations between LOAD and traits such as family history of dementia and education.	[Kunkle, Brian W.; Martin, Eden R.; Hamilton-Nelson, Kara L.; Beecham, Gary W.; Whitehead, Patrice; Gilbert, John R.; Perry, William R.; Cuccaro, Michael L.; Vance, Jeffery M.; Slifer, Susan; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Grenier-Boley, Benjamin; Damotte, Vincent; Bellenguez, Celine; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Phillippe; Lambert, Jean-Charles] Inserm, RID AGE Risk Factors & Mol Determinants Aging Rel, U1167, Lille, France; [Grenier-Boley, Benjamin; Damotte, Vincent; Bellenguez, Celine; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Phillippe; Lambert, Jean-Charles] Inst Pasteur, Lille, France; [Grenier-Boley, Benjamin; Damotte, Vincent; Bellenguez, Celine; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Phillippe; Lambert, Jean-Charles] Univ Lille, U1167, Excellence Lab LabEx DISTALZ, Lille, France; [Sims, Rebecca; Vronskaya, Maria; Frizatti, Aura; Badarinarayan, Nandini; Raybould, Rachel; Morgan, Taniesha; Denning, Nicola; Cushion, Thomas D.; Hollingworth, Paul; Marshall, Rachel; Meggy, Alun; Menzies, Georgina E.; Leonenko, Ganna; Grozeva, Detelina; O'Donovan, Michael C.; Jones, Lesley; Owen, Michael J.; Escott-Price, Valentina; Holmans, Peter A.; Williams, Julie] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Sims, Rebecca; Raybould, Rachel; Denning, Nicola; Cushion, Thomas D.; Menzies, Georgina E.; Jones, Lesley; Escott-Price, Valentina; Williams, Julie] Cardiff Univ, UK Dementia Res Inst Cardiff, Cardiff, S Glam, Wales; [Bis, Joshua C.; Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Naj, Adam C.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Boland, Anne; Olaso, Robert; Garnier, Jean-Guillaume; Moutet, Marie-Laure; Bacq, Delphine; Garzia, Fabienne; Fin, Bertrand; Meslage, Stphane; Deleuze, Jean-Francois] Univ Paris Saclay, CEA, Inst Biol Francois Jacob, Ctr Natl Rech Genom Humaine, Evry, France; [Boland, Anne; Olaso, Robert; Garnier, Jean-Guillaume; Moutet, Marie-Laure; Bacq, Delphine; Garzia, Fabienne; Fin, Bertrand; Meslage, Stphane; Deleuze, Jean-Francois] LabEx GENMED, Evry, France; [van der Lee, Sven J.; Ahmad, Shahzad; Adams, Hieab H.; Voijnovic, Dina; Karamujic-Comic, Hata; Roschupkin, Gena; Rivadeneira, Fernando; Uitterlinden, A. G. Andre; Amin, Najaf; Ikram, M. Arfan; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Amlie-Wolf, Alexandre; Kuzma, Amanda B.; Valladares, Otto; Qu, Liming; Zhao, Yi; Malamon, John; Dombroski, Beth A.; Cantwell, Laura B.; Tang, Mitchell; Wang, Li-San; Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Penn Neurodegenerat Genom Ctr, Philadelphia, PA 19104 USA; [Chouraki, Vincent; Cupples, L. Adrienne; Himali, Jayanadra J.; Beiser, Alexa S.; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Chouraki, Vincent; Himali, Jayanadra J.; Beiser, Alexa S.; Kowall, Neil W.; McKee, Ann C.; Stern, Robert A.; Farrer, Lindsay A.; DeStefano, Anita L.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Sleegers, Kristel; Van Broeckhoven, Christine] VIB, Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Antwerp, Belgium; [Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, Antwerp, Belgium; [Jakobsdottir, Johanna; Eiriksdottir, Gudny; Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Moreno-Grau, Sonia; Boada, Merce; Choi, Seung-Hoan; Orellana, Adelina; Hernandez, Isabel; Tarraga, Lluis; de Rojas, Itziar; Ruiz, Agustin] Univ Int Catalunya, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin Fundacio ACE, Barcelona, Spain; [Moreno-Grau, Sonia; Boada, Merce; Hernandez, Isabel; Tarraga, Lluis; de Rojas, Itziar; Bullido, Maria J.; Lleo, Alberto; Clarimon, Jordi; Ruiz, Agustin] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Chen, Yuning; Sarnowski, Chloe; Cupples, L. Adrienne; Himali, Jayanadra J.; Li, Shuo; Yang, Qiong; Beiser, Alexa S.; Lunetta, Kathryn L.; Farrer, Lindsay A.; DeStefano, Anita L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hiltunen, Mikko; Helisalmi, Seppo; Koivisto, Anne Maria; Soininen, Hilkka] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Hiltunen, Mikko; Helisalmi, Seppo; Koivisto, Anne Maria; Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland; [Vardarajan, Badri N.; Barral, Sandra; Honig, Lawrence S.; Reitz, Christiane; Williamson, Jennifer; Mayeux, Richard] Columbia Univ, Dept Neurol, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Vardarajan, Badri N.; Barral, Sandra; Reitz, Christiane; Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Vardarajan, Badri N.; Barral, Sandra; Mayeux, Richard] Columbia Univ, Dept Neurol, New York, NY USA; [Epelbaum, Jacques] Univ Paris 05, Inserm, Ctr Psychiat & Neurosci, UMR 894, Paris, France; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Hoffmann, Per] Univ Basel, Univ Hosp, Div Med Genet, Basel, Switzerland; [Hoffmann, Per] Univ Basel, Dept Biomed, Basel, Switzerland; [Harold, Denise] Dublin City Univ, Sch Biotechnol, Dublin, Ireland; [Fitzpatrick, Annette L.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Fitzpatrick, Annette L.; Kukull, Walter A.; Longstreth, W. T., Jr.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Gerrish, Amy; Fox, Nick C.; Schott, Jonathan M.; Warren, Jason D.; Rossor, Martin] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, England; [Smith, Albert, V] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Smith, Albert, V; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jian, Xueqiu; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Del Zompo, Maria; Squassina, Alessio] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy; [Fox, Nick C.; Bras, Jose; Guerreiro, Rita] UCL Inst Neurol, UK Dementia Res Inst UCL, Dept Neurodegenerat Dis, London, England; [Mateo, Ignacio; Rodriguez-Rodriguez, Eloy; Sanchez-Juan, Pascual] Univ Cantabria, Marques de Valdecilla Univ Hosp, Neurol Serv, Santander, Spain; [Mateo, Ignacio; Rodriguez-Rodriguez, Eloy; Sanchez-Juan, Pascual] Univ Cantabria, Marques de Valdecilla Univ Hosp, CIBERNED, Santander, Spain; [Mateo, Ignacio; Rodriguez-Rodriguez, Eloy; Sanchez-Juan, Pascual] IDIVAL, Santander, Spain; [Hughes, Joseph T.; Patel, Yogen; Hannequin, Didier; Lupton, Michelle K.; Proitsi, Petra; Powell, John F.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England; [Sanchez-Garcia, Florentino; Naranjo, Maria Candida Deniz; Munoz-Fernadez, Carmen; Benito, Yolanda A.] Hosp Univ Doctor Negrin, Dept Immunol, Las Palmas Gran Canaria, Spain; [Daniilidou, Makrina; Tsolaki, Magda; Avramidou, Despoina; Germanou, Antonia; Koutroumani, Maria; Gkatzima, Olymbia] Aristotle Univ Thessaloniki, Med Sch, Dept Neurol, Thessaloniki, Greece; [Mukherjee, Shubhabrata; McCormick, Wayne C.; Yu, Chang-En; Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA USA; [Wallon, David; Nicolas, Gael; Campion, Dominique] Normandie Univ, UNIROUEN, Inserm U1245, Rouen, France; [Wallon, David; Nicolas, Gael; Campion, Dominique] Rouen Univ Hosp, Dept Neurol, Dept Genet, Rouen, France; [Wallon, David; Nicolas, Gael; Campion, Dominique] CNR MAJ, Normandy Ctr Genom & Personalized Med, Rouen, France; [Uphill, James; Collinge, John; Mead, Simon; Ryan, Natalie S.] Inst Prion Dis, MRC Prion Unit UCL, Dept Neurodegenerat Dis, London, England; [Aspelund, Thor] Univ Iceland, Ctr Publ Hlth, Reykjavik, Iceland; [Galimberti, Daniela; Scarpini, Elio] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Neurodegenerat Dis Unit, Milan, Italy; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Ctr Dino Ferrari, Milan, Italy; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Butkiewicz, Mariusz; Bush, Will S.; Song, Yuenjoo; Haines, Jonathan L.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Inst Computat Biol, Cleveland, OH 44106 USA; [Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [White, Charles C.] Brd Inst, Program Med & Populat Genet, Cambridge, MA USA; [Barber, Robert C.; O'Bryant, Sid] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Engelborghs, Sebastiaan; De Deyn, Peter P.] Univ Antwerp, Inst Born Bunge, Lab Neurochem & Behav, Antwerp, Belgium; [Engelborghs, Sebastiaan; De Deyn, Peter P.] Hosp Network Antwerp, Dept Neurol, Antwerp, Belgium; [Engelborghs, Sebastiaan; De Deyn, Peter P.] Hosp Network Antwerp, Memory Clin, Antwerp, Belgium; [Sordon, Sabrina; Mayhaus, Manuel; Gu, Wei; Riemenschneider, Matthias; Feulner, Thomas] Univ Hosp, Dept Psychiat & Psychotherapy, Saarland, Germany; [Adams, Perrie M.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Vandenberghe, Rik] Univ Hosp, Dept Neurol, Lab Cognit Neurol, Leuven, Belgium; [Vandenberghe, Rik] Univ Leuven, Leuven, Belgium; [Albert, Marilyn S.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Beekly, Duane] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Hartmann, Annette M.; Giegling, Ina] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Germany; [Blacker, Deborah] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Blacker, Deborah] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Lovestone, Simon; Gallacher, John] Univ Oxford, Dept Psychiat, Oxford, England; [Garcia, Melissa E.; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Doody, Rachelle S.] Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Houston, TX 77030 USA; [Sussams, Rebecca; Holmes, Clive] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [Lin, Honghuang] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Fairchild, Thomas J.] Univ North Texas, Hlth Sci Ctr, Off Strategy & Measurement, Ft Worth, TX USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kub Lab Neuropathol, Charlestown, MA USA; [Thonberg, Hakan; Graff, Caroline] Karolinska Univ Hosp Solna, Unit Hereditary Dementias, Theme Aging, Stockholm, Sweden; [Thonberg, Hakan; Graff, Caroline] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Res Ctr, Div Neurogeriatr, Solna, Sweden; [Maier, Wolfgang; Jessen, Frank] German Ctr Neurodegenerat Dis, Bonn, Germany; [Maier, Wolfgang; Heun, Reinhard; Koelsch, Heike; Jessen, Frank] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Ghetti, Bernardino; Spina, Salvatore] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA; [Giedraitis, Vilmantas; Kilander, Lena; Brundin, Rosemarie; Lannfelt, Lars; Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; [Kawalia, Amit; Ramirez, Alfredo] Univ Hosp Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, Bonn, Germany; [Huebinger, Ryan M.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Moebus, Susanne; Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Kamboh, M. Ilyas; Becker, James T.; Lopez, Oscar L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Kamboh, M. Ilyas; Caffarra, Paolo; Lopez, Oscar L.] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA USA; [Turton, James; Lord, Jenny; Caffarra, Paolo; Brown, Kristelle; Medway, Christopher] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham, England; [Katz, Mindy J.; Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Concari, Letizia] Univ Parma, DIMEC, Sect Neurosci, Parma, Italy; [Concari, Letizia] FERB Alzheimer Ctr, Gazzaniga, Bergamo, Italy; [Keene, C. Dirk; Montine, Thomas J.; Sonnen, Joshua A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kloszewska, Iwona] Med Univ Lodz, Elderly & Psychiat Disorders Dept, Lodz, Poland; [Lynch, Aoibhinn; Lawlor, Brian; Gill, Michael] St James Hosp, Mercers Inst Res Aging, Dublin, Ireland; [Lynch, Aoibhinn; Lawlor, Brian; Gill, Michael] Trinity Coll Dublin, Dublin, Ireland; [Lynch, Aoibhinn; Lawlor, Brian; Gill, Michael] St James Hosp, Dublin, Ireland; [Larson, Eric B.; Psaty, Bruce M.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA USA; [Haapasalo, Annakaisa] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Geriatr, Jackson, MS 39216 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Gerontol, Jackson, MS 39216 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; [Solfrizzi, Vincenzo] Univ Bari, Interdisciplinary Dept Med, Geriatr Med & Memory Unity, Bari, Italy; [Longstreth, W. T., Jr.; Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Frisardi, Vincenza; Panza, Francesco] Univ Bari, Ctr Aging Brain, Dept Geriatr, Bari, Italy; [Diez-Fairen, Monica; Alvarez, Ignacio; Pastor, Pau] Fundacio Recerca Biomed & Social Mutua Terrassa, Barcelona, Spain; [Diez-Fairen, Monica; Alvarez, Ignacio; Pastor, Pau] Hosp Univ Mutua Terrassa, Dept Neurol, Memory Disorders Unit, Barcelona, Spain; [Rivadeneira, Fernando; Uitterlinden, A. G. Andre] Erasmus Univ, Dept Internal Med, Med Ctr, Rotterdamt, Netherlands; [Rivadeneira, Fernando; Uitterlinden, A. G. Andre] Netherlands Consortium Hlth Aging & Natl Genom In, Leiden, Netherlands; [Petersen, Ronald C.; Boeve, Bradley F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Deramecourt, Vincent; Pasquier, Florence] CHU Lille, Memory Ctr Lille, Ctr Memoire Ressources & Rech, Lille, France; [Salani, Francesca; Ciaramella, Antonio; Sacchinelli, Eleonora; Bossu, Paola] IRCCS Santa Lucia Fdn, Expt Neuropsychobiol Lab, Dept Clin & Behav Neurol, Rome, Italy; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Reiman, Eric M.; Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Reiman, Eric M.] Univ Arizona, Dept Psychiat, Phoenix, AZ USA; [Rotter, Jerome, I] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Rotter, Jerome, I] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Dept Med, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Reisch, Joan S.] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Hanon, Olivier] Univ Paris 05, Hop Broca, AP HP, Geriatr Dept,EA 4468, Paris, France; [Cupidi, Chiara; Maletta, Raffaele Giovanni; Bruni, Amalia Cecilia; Gallo, Maura] ASP Catanzaro, Reg Neurogenet Ctr CRN, Lamezia Terme, Italy; [Royall, Donald R.] UT Hlth Sci Ctr San Antonio, South Texas Vet Hlth Adm Geriatr Res Educ & Clin, Dept Psychiat, San Antonio, TX USA; [Royall, Donald R.] UT Hlth Sci Ctr San Antonio, South Texas Vet Hlth Adm Geriatr Res Educ & Clin, Dept Med, San Antonio, TX USA; [Royall, Donald R.] UT Hlth Sci Ctr San Antonio, South Texas Vet Hlth Adm Geriatr Res Educ & Clin, Dept Family & Community Med, San Antonio, TX USA; [Dufouil, Carole] Univ Bordeaux, Inserm 1219, Bordeaux, France; [Dufouil, Carole] Bordeaux Univ Hosp, CHU Bordeaux, Dept Neurol, Bordeaux, France; [Sano, Mary; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Brice, Alexis; Debette, Stphanie] UPMC Univ Paris 06, Inst Cerveau & Moelle Epiniere, UMRS 1127, Inserm U1127,CNRS UMR 7225,Sorbonne Univ, Paris, France; [Brice, Alexis; Debette, Stphanie] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Cecchetti, Roberta; Mecocci, Patrizia; Boccardi, Virginia] Univ Perugia, Dept Med, Sect Gerontol & Geriatr, Perugia, Italy; [St George-Hyslop, Peter; Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [St George-Hyslop, Peter; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ritchie, Karen; Berr, Claudine] La Colombiere Hosp, Inserm Neuropsychiat U1061, Montpellier, France; [Ritchie, Karen; Berr, Claudine] Montpellier Univ, Montpellier, France; [Ritchie, Karen] Univ Edinburgh, Dept Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Tsuang, Debby W.; Bird, Thomas D.] GRECC, VA Puget Sound Hlth Care Syst GRECC, Seattle, WA USA; [Tsuang, Debby W.; Peskind, Elaine; Raskind, Murray] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Dubois, Bruno] Hop La Pitie Salpetriere, Dept Neurol, Inst Memoire & Malad Alzheimer, Paris, France; [Dubois, Bruno] Hop La Pitie Salpetriere, Dept Neurol, Inst Cerveau & Moelle Epiniere, Paris, France; [Dubois, Bruno] Inst Cerveau & Moelle Epiniere, Inst Neurosci Translat Paris, Paris, France; [Dubois, Bruno] Inst Cerveau & Moelle Epiniere, UMR 5975, CNRS, Inserm, Paris, France; [Dubois, Bruno] Univ Paris 06, Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Paris, France; [Craig, David; McGuinness, Bernadette; Johnston, Janet A.; Passmore, Peter] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Ageing Grp, Belfast, Antrim, North Ireland; [Wu, Chuang-Kuo] Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, Lubbock, TX 79409 USA; [Wu, Chuang-Kuo] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol, Lubbock, TX 79409 USA; [Wu, Chuang-Kuo] Texas Tech Univ, Hlth Sci Ctr, Dept Neurosci, Lubbock, TX 79409 USA; [Albin, Roger L.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Albin, Roger L.] VAAAHS, GRECC, Ann Arbor, MI USA; [Albin, Roger L.; Paulson, Henry L.] Michigan Alzheimer Dis Ctr, Ann Arbor, MI USA; [Fratiglioni, Laura; Keller, Lina] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Fratiglioni, Laura; Keller, Lina] Stockholm Univ, Stockholm, Sweden; [Apostolova, Liana G.; Faber, Kelley M.; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimers Dis Ctr, Indianapolis, IN 46202 USA; [Apostolova, Liana G.; Atwood, Craig S.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Apostolova, Liana G.; Atwood, Craig S.; Farlow, Martin R.; Saykin, Andrew J.] Indiana Univ, Dept Neurol, Indianapolis, IN 46204 USA; [Apostolova, Liana G.; Atwood, Craig S.] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA; [Arnold, Steven E.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asthana, Sanjay] Univ Wisconsin, GRECC, Madison, WI USA; [Asthana, Sanjay; Carlson, Chris S.; Sager, Mark A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Asthana, Sanjay; Carlson, Chris S.] Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA; [Hampel, Harald] AXA Res Fund, Paris, France; [Hampel, Harald] Sorbonne Univ Chair, Paris, France; [Hampel, Harald] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, GRC 21,APM, Paris, France; [Hampel, Harald] Inserm U 1127, Brain & Spine Inst, CNRS UMR 7225, Paris, France; [Hampel, Harald] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Inst Memory & Alzheimers Dis, Paris, France; [Quintela, Ines; Carracedo, Angel] Univ Santiago de Compostela, Grp Med Xenom, Ctr Nacl Genotipado, Ctr Invest Biomed Red Enfermedades Raras, Santiago De Compostela, Spain; [Rubinsztein, David C.] Univ Cambridge, UK Dementia Res Inst, Cambridge, England; [Barnes, Lisa L.; Schneider, Julie A.; Yu, Lei; Bennett, David] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Barnes, Lisa L.; Schneider, Julie A.; Yu, Lei; Bennett, David] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Froelich, Lutz] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Heidelberg, Germany; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Phoenix, AZ USA; [Becker, James T.; Lopez, Oscar L.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Becker, James T.] Univ Pittsburgh, Sch Med, Dept Psychol, Pittsburgh, PA USA; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Bigio, Eileen H.; Mesulam, Marsel; Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Mesulam Ctr Cognit Neurol & Alzheimers Dis, Chicago, IL 60611 USA; [Lupton, Michelle K.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Herston, Qld, Australia; [Bowen, James D.; Karydas, Anna] Swedish Med Ctr, Seattle, WA USA; [Boxer, Adam; Rosen, Howard J.; Seeley, William W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Burke, James R.; Welsh-Bohmer, Kathleen A.] Duke Univ, Dept Neurol, Durham, NC USA; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT USA; [Burns, Jeffrey M.; Swerdlow, Russell H.] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, KS 66103 USA; [Mancuso, Michelangelo; Bonuccelli, Ubaldo] Univ Pisa, Neurol Inst, Dept Expt & Clin Med, Pisa, Italy; [Buxbaum, Joseph D.; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [McQuillin, Andrew; Livingston, Gill; Bass, Nicholas J.] UCL, Div Psychiat, London, England; [Cao, Chuanhai; McDavid, Andrew N.; Raj, Ashok; Smith, Amanda G.] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Carlsson, Cynthia M.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Hardy, John] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Carney, Regina M.] Bruce Carter VA Med Ctr, Mental Hlth & Behav Sci Serv, Miami, FL USA; [Bras, Jose; Guerreiro, Rita; Fisher, Elizabeth] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Carrasquillo, Minerva M.; Allen, Mariet; Bisceglio, Gina; Ma, Li; Graff-Radford, Neill R.; Ertekin-Taner, Nilifur; Younkin, Steven G.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Chui, Helena C.; Schneider, Lori S.] Univ Southern Calif, Dept Neurol, Los Angeles, CA USA; [Masullo, Carlo] Univ Cattolica Sacro Cuore, Dept Neurol, Rome, Italy; [Crocco, Elizabeth A.; Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [DeCarli, Charles; Olichney, John M.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Dick, Malcolm; Poon, Wayne W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Duara, Ranjan] Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Memory Disorders, Miami Beach, FL 33140 USA; [Evans, Denis A.] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Hodges, Angela] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England; [Scherer, Martin; van den Bussche, Hendrik; Quinn, Joseph F.] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Fallon, Kenneth B.; Quinn, Joseph F.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Fardo, David W.] Univ Kentucky, Sanders Brown Ctr Aging, Dept Biostat, Lexington, KY 40536 USA; [Ferris, Steven; Reisberg, Barry] NYU, Dept Psychiat, 550 1St Ave, New York, NY 10016 USA; [Leber, Markus; Jessen, Frank; Ramirez, Alfredo] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Heuser, Isabella; Peters, Oliver] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Galasko, Douglas R.; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gearing, Marla] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Emory Alzheimers Dis Ctr, Atlanta, GA 30322 USA; [Huell, Michael] Univ Freiburg, Dept Psychiat, Freiburg, Germany; [Geschwind, Daniel H.] Univ Calif Los Angeles, Neurogenet Program, Los Angeles, CA USA; [Morris, John; Mayo, Kevin; Cruchaga, Carlos] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Morris, John; Cruchaga, Carlos] Washington Univ, Sch Med, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Green, Robert C.] Brigham & Womens Hosp, Partners Ctr Personalized Genet Med, 75 Francis St, Boston, MA 02115 USA; [Green, Robert C.] Harvard Med Sch, Boston, MA 02115 USA; [Mayo, Kevin; Morris, John C.] Washington Univ, Dept Neurol, St Louis, MO USA; [Mayo, Kevin] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Growdon, John H.; Hyman, Bradley T.; Tanzi, Rudolph E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Dept Pathol Neuropathol, Pittsburgh, PA USA; [Harrell, Lindy E.; Marson, Daniel C.; Roberson, Erik D.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Drichel, Dmitriy] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Hulette, Christine M.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Abner, Erin] Univ Kentucky, Dept Epidemiol, Coll Publ Hlth, Sanders Brown Ctr Aging, Lexington, KY USA; [Jin, Lee-Way; Real, Luis M.] Hosp Univ Valme, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain; [Jun, Gyungah R.; Baldwin, Clinton T.; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Russo, Giancarlo] ETH Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Kaye, Jeffrey A.] Portland VA Med Ctr, Dept Neurol, Portland, OR USA; [Kim, Ronald] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Kowall, Neil W.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Vellas, Bruno] Univ Toulouse, Inserm U558, Toulouse, France; [Kramer, Joel H.] Univ Calif San Francisco, Dept Neuropsychol, San Francisco, CA 94143 USA; [Vardy, Emma] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Lah, James J.; Levey, Allan, I; Wingo, Thomas S.] Emory Univ, Dept Neurol, Atlanta, GA USA; [Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] German Ctr Neurodegenerat Dis, Munich, Germany; [Leverenz, James B.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA; [Mann, David; Pickering-Brown, Stuart; Hooper, Nigel M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol,Sch Biol Sci, Manchester, Lancs, England; [Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Klopp, Norman] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth Neuherberg, Inst Epidemiol, Munich, Germany; [Wichmann, H-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Wichmann, H-Erich] Ludwig Maximilians Univ Chair Epidemiol, Munich, Germany; [Wichmann, H-Erich] Joint Biobank Munich, Baltimore, MD USA; [Wichmann, H-Erich] KORA Biobank, Baltimore, MD USA; [Lyketsos, Constantine G.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA; [Morgan, Kevin] Univ Nottingham, Sch Life Sci & Med, Human Genet, Nottingham, England; [Martiniuk, Frank] NYU, Dept Med Pulm, New York, NY USA; [Mash, Deborah C.] Univ Miami, Dept Neurol, Miami, FL USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Daniele, Antonio] Catholic Univ Sacred Hearth, Inst Neurol, Rome, Italy; [McCurry, Susan M.] Univ Washington, Sch Nursing Northwest Res Grp Aging, Seattle, WA 98195 USA; [Bayer, Anthony] Cardiff Univ, Univ Hosp Wales, Inst Primary Care & Publ Hlth, Cardiff, S Glam, Wales; [Mesulam, Marsel] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Sch Clin Med, Cambridge, England; [Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Riedel-Heller, Steffi] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Miller, Carol A.] Univ Southern Calif, Dept Pathol, Los Angeles, CA USA; [Miller, Joshua W.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Al-Chalabi, Ammar; Shaw, Christopher E.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Shaw, Christopher E.] Kings Coll London, UK Dementia Res Inst, London, England; [Wiltfang, Jens] Univ Med Ctr Goettingen, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Wiltfang, Jens] German Ctr Neurodegenerat Dis, Gottingen, Germany; [Wiltfang, Jens] Univ Aveiro, Med Sci Dept, IBiMED, Aveiro, Portugal; [Alvarez, Victoria; Coto, Eliecer] Univ Cent Asturias, Mol Genet Lab Hosp, Oviedo, Spain; [Parisi, Joseph E.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Singleton, Andrew B.] NIA, Mol Genet Sect, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Cribbs, David H.; Pierce, Aimee] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Nacmias, Benedetta; Sorbi, Sandro] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Nacmias, Benedetta] Univ Florence, Ctr Ric Trasferimento & Alta Formaz DENOTHE, Florence, Italy; [Potter, Huntington] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Sorbi, Sandro] IRCCS Fdn Don Carlo Gnocchi, Florence, Italy; [Spalletta, Gianfranco; Caltagirone, Carlo; Orfei, Maria Donata] IRCCS Santa Lucia Fdn, Lab Neuropsychiat, Rome, Italy; [Spalletta, Gianfranco] Baylor Coll Med, Dept Psychiat & Behav Sci, Div Neuropsychiat, Houston, TX 77030 USA; [Reisberg, Barry] NYU, Alzheimers Dis Ctr New, New York, NY USA; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford Hlth Aging Project, Oxford, England; [Reitz, Christiane] Columbia Univ, Dept Epidemiol, New York, NY USA; [Smith, A. David; Warden, Donald; Wilcock, Gordon] Univ Oxford, Oxford Project Investigate Memory & Ageing, Nuffield Dept Clin Neurosci, John Radcliffe Hosp, Oxford, England; [Ringman, John M.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA USA; [Rosenberg, Roger N.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Ben-Shlomo, Yoav] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol Neuropathol, Chicago, IL 60612 USA; [Schneider, Lori S.] Univ Southern Calif, Dept Psychiat, Los Angeles, CA USA; [Trojanowski, John Q.; Van Deerlin, Vivianna M.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Troncoso, Juan C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Neurosci, Sanders Brown Ctr Aging, Lexington, KY USA; [Vinters, Harry V.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Vinters, Harry V.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Vonsattel, Jean Paul] Columbia Univ, Dept Pathol, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Wilhelmsen, Kirk C.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Wingo, Thomas S.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Wright, Clinton B.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Div Mol Biol & Biochem, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Graz, Austria; [Pilotto, Alberto] IRCCS Casa Sollievo Sofferenza, Gerontol & Geriatr Res Lab, San Giovanni Rotondo, Italy; [Pilotto, Alberto] Galliera Hosp, Dept Geriatr Care Orthogeriatr & Rehabil, Genoa, Italy; [Bullido, Maria J.] Inst Invest Sanitaria Paz, IdiPAZ, Madrid, Spain; [Bullido, Maria J.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Peters, Oliver] German Ctr Neurodegenerat Dis, Berlin, Germany; [Bosco, Paola] Associaz Oasi Maria Santissima Srl, Inst Ricovero & Cura Carattere Sci, Troina, Italy; [De Jager, Phil L.] Columbia Univ, Med Ctr, Dept Neurol, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [Lleo, Alberto; Clarimon, Jordi] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Neurol Dept, Memory Unit, Barcelona, Spain; [Lleo, Alberto; Clarimon, Jordi] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, St Pau Biomed Res Inst, Barcelona, Spain; [Warner, Nick] Somerset Partnership NHS Trust, Somerset, England; [Deloukas, Panagiotis; Gwilliam, Rhian] Wellcome Trust Sanger Inst, Cambridge, England; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Kehoe, Patrick G.; Love, Seth] Univ Bristol, Learning & Res Level 2, Med Sch, Southmead Hosp, Bristol, Avon, England; [Ertekin-Taner, Nilifur; Younkin, Steven G.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Dartigues, Jean-Francois] CMRR Bordeaux, Memory Res & Resources Ctr, Bordeaux, France; [Corcoran, Chris; Tschanz, JoAnn; Munger, Ron] Utah State Univ, Logan, UT 84322 USA; [Ikram, M. Arfan] Erasmus MC Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC Univ, Dept Radiol, Med Ctr, Rotterdam, Netherlands; [Campion, Dominique] Dept Res Rouvray Psychiat Hosp, Sotteville Les Rouen, France; [Schmidt, Helena] Med Univ Graz, Dept Neurol, Graz, Austria; [Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Seshadri, Sudha] Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX USA; [Amouyel, Phillippe] CHU Lille, Lille, France		Kunkle, BW; Pericak-Vance, MA (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.; Lambert, JC (corresponding author), Inserm, RID AGE Risk Factors & Mol Determinants Aging Rel, U1167, Lille, France.; Lambert, JC (corresponding author), Inst Pasteur, Lille, France.; Lambert, JC (corresponding author), Univ Lille, U1167, Excellence Lab LabEx DISTALZ, Lille, France.	bkunkle@miami.edu; jean-charles.lambert@pasteur-lille.fr; mpericak@miami.edu	Gu, Wei/G-4003-2010; , Bob/ABA-8507-2020; Ruiz, Agustin/G-5677-2012; Diez-Fairen, Monica/AAC-2467-2020; Bellenguez, Celine/X-4004-2019; Lord, Jenny/AAR-5643-2021; Powell, John F/G-4412-2011; lambert, jean-charles/F-8787-2013; Cruchaga, Carlos/ABF-4065-2020; , beccie/AAM-3770-2021; Rotter, Jerome/AAY-6598-2021; Rodriguez-Rodriguez, Eloy/G-5826-2013; Gudnason, Vilmundur/AAE-7126-2019; berr, Claudine/D-5238-2014; Cushion, Thomas D/O-3986-2017; Lipton, Richard B/B-5060-2011; Galimberti, Daniela/N-7209-2019; Brayne, Carol/AAA-4285-2020; Lambert, jean-charles/A-9553-2014; , Craig/AAB-3963-2022; Bullido, Maria/C-8509-2014; Burke, James R/E-4245-2016; Dufouil, Carole/F-5751-2014; Haines, Jonathan/C-3374-2012; Ben-Shlomo, Yoav/ABD-2004-2021; DeCarli, Charles/B-5541-2009; Chen, Yuning/ABE-1239-2020; Epelbaum, Jacques/B-2263-2013; Olaso, Robert/AAC-4162-2019; Frolich, Lutz/AAA-6940-2019; frisardi, vincenza/AAB-9688-2019; McQuillin, Andrew/C-1623-2008; Cruz e Silva, Odete/AAH-5595-2020; Melief, Erica/M-6436-2019; Damotte, Vincent/ABH-4760-2020; Berr, Claudine/AAD-8539-2020; Vandenberghe, Rik/K-2145-2014; Wichmann, Heinz Erich/AAA-5695-2022; Ikram, M. Arfan/AAM-5225-2021; Carracedo, Angel/D-4257-2012; brice, alexis/AAE-8275-2019; McCurry, Susan M/E-4731-2015; Farrer, Lindsay/AAS-1035-2020; Frosch, Matthew P/ABD-7456-2021; frisardi, vincenza/Y-3309-2019; Panza, Francesco/M-6804-2017; Aspelund, Thor/K-7022-2019; Ritchie, Karen/G-3571-2013; Bayer, Antony/H-4434-2019; Wallon, David/AAI-1352-2020; Cairns, Nigel/AAB-9713-2020; Brice, Alexis/A-2170-2009; DARTIGUES, Jean Francois/T-4513-2019; Tanzi, Rudolph/AAE-9622-2019; Real, Luis M/K-9646-2014; Rubinsztein, David C/C-3472-2011; Mancuso, Michelangelo/K-4170-2016; Kauwe, John/AAC-6646-2021; ciaramella, antonio/F-1170-2011; Lipton, Richard Bruce/AAY-2818-2021; Pastor, Pau/C-9834-2009; Alvarez, Ignacio/AAB-3929-2019; Schmidt, Reinhold/E-1137-2014; Sonnen, Joshua/AAT-5788-2021; Schott, Jonathan M/A-9065-2011; Riedel-Heller, Steffi/ABG-1537-2021; Rivadeneira, Fernando/O-5385-2015; Ahmad, Shahzad/AAY-7240-2020; Welsh-Bohmer, Kathleen/AAA-3178-2020; Jessen, Frank/AAK-6170-2020; Nacmias, Benedetta/J-5084-2018; ciaramella, antonio/P-9009-2019; Ramirez, Alfredo/S-5126-2019; Singleton, Andrew B/C-3010-2009; Bush, William/N-1369-2019; Buxbaum, Joseph D/G-6001-2010; Spalletta, Gianfranco/K-3828-2018; Vandenberghe, Rik/AAR-7485-2020; Mecocci, Patrizia/W-2116-2019; McGuinness, Bernadette/AAH-2755-2021; Panza, Francesco/Y-2539-2019; Dufouil, Carole/J-4968-2012; Hartmann, Annette/AAS-6331-2021; Hardy, John/C-2451-2009; Bosso, Paola/E-4832-2014; alvarez, victoria/ABC-7891-2021; Lleo, Alberto/K-5783-2019; Yu, Lei/AAT-3685-2020; Giegling, Ina/ABA-3677-2021; Croucher, Rebecca/R-6006-2019; graff, caroline/A-2545-2009; Lin, Honghuang/A-3269-2019; Fisher, Elizabeth/C-2168-2008; Al-Chalabi, Ammar/E-5361-2010; Bruni, Amalia/K-5038-2016; Kehoe, Patrick/P-8760-2018; Fox, Nick/B-1319-2009; Smith, Albert Vernon/K-5150-2015; debette, stephanie/T-4946-2019	Gu, Wei/0000-0003-3951-6680; Diez-Fairen, Monica/0000-0003-1882-0309; Bellenguez, Celine/0000-0002-1240-7874; Lord, Jenny/0000-0002-0539-9343; Powell, John F/0000-0001-6124-439X; lambert, jean-charles/0000-0003-0829-7817; Cruchaga, Carlos/0000-0002-0276-2899; , beccie/0000-0002-3885-1199; Gudnason, Vilmundur/0000-0001-5696-0084; berr, Claudine/0000-0001-5254-7655; Cushion, Thomas D/0000-0002-0040-0069; Galimberti, Daniela/0000-0002-9284-5953; Brayne, Carol/0000-0001-5307-663X; Lambert, jean-charles/0000-0003-0829-7817; Bullido, Maria/0000-0002-6477-1117; Burke, James R/0000-0002-3408-7787; Dufouil, Carole/0000-0003-2442-4476; Haines, Jonathan/0000-0002-4351-4728; Chen, Yuning/0000-0002-7358-7055; Frolich, Lutz/0000-0003-1494-0813; frisardi, vincenza/0000-0003-0764-7387; McQuillin, Andrew/0000-0003-1567-2240; Damotte, Vincent/0000-0002-7321-8575; Berr, Claudine/0000-0001-5254-7655; Vandenberghe, Rik/0000-0001-6237-2502; Carracedo, Angel/0000-0003-1085-8986; brice, alexis/0000-0002-0941-3990; McCurry, Susan M/0000-0001-8624-3772; Frosch, Matthew P/0000-0002-3940-9861; Panza, Francesco/0000-0002-7220-0656; Aspelund, Thor/0000-0002-7998-5433; Ritchie, Karen/0000-0002-0688-8982; Bayer, Antony/0000-0002-7514-248X; Cairns, Nigel/0000-0001-9858-3344; Tanzi, Rudolph/0000-0002-7032-1454; Real, Luis M/0000-0003-4932-7429; Mancuso, Michelangelo/0000-0003-2738-8562; Kauwe, John/0000-0001-8641-2468; ciaramella, antonio/0000-0001-9888-8156; Pastor, Pau/0000-0002-7493-8777; Alvarez, Ignacio/0000-0002-8537-3935; Schott, Jonathan M/0000-0003-2059-024X; Rivadeneira, Fernando/0000-0001-9435-9441; Nacmias, Benedetta/0000-0001-9338-9040; Ramirez, Alfredo/0000-0003-4991-763X; Bush, William/0000-0002-9729-6519; Spalletta, Gianfranco/0000-0002-7432-4249; Vandenberghe, Rik/0000-0001-6237-2502; Mecocci, Patrizia/0000-0003-0729-5246; McGuinness, Bernadette/0000-0002-7028-5633; Panza, Francesco/0000-0002-7220-0656; Hardy, John/0000-0002-3122-0423; Bosso, Paola/0000-0002-1432-0078; alvarez, victoria/0000-0002-1916-2523; Turton, James/0000-0003-2681-0477; Lin, Honghuang/0000-0003-3043-3942; Nicolas, Gael/0000-0001-9391-7800; Ahmad, Shahzad/0000-0002-8658-3790; Ferris, Steven/0000-0001-8641-6223; Fisher, Elizabeth/0000-0003-2850-9936; Buxbaum, Joseph/0000-0001-8898-8313; Jakobsdottir, Johanna/0000-0002-8019-9683; Al-Chalabi, Ammar/0000-0002-4924-7712; Shaw, Christopher/0000-0003-0251-0146; Bruni, Amalia/0000-0003-3471-3343; Livingston, Gill/0000-0001-6741-5516; Reisberg, Barry/0000-0002-9104-7423; Burns, Jeffrey/0000-0001-7609-8954; Van Duijn, Cornelia/0000-0002-2374-9204; Rodriguez-Rodriguez, Eloy/0000-0001-7742-677X; Ruiz Laza, Agustin/0000-0003-2633-2495; Lupton, Michelle/0000-0002-7274-7299; Holmes, Clive/0000-0003-1999-6912; Deloukas, Panos/0000-0001-9251-070X; russo, giancarlo/0000-0003-0707-2640; Tsolaki, Magda/0000-0002-2072-8010; Proitsi, Petroula/0000-0002-2553-6974; Poon, Wayne/0000-0003-0625-3968; Wallon, David/0000-0002-2634-7198; Graff, Caroline/0000-0002-9949-2951; Mead, Simon/0000-0002-4326-1468; Peters, Oliver/0000-0003-0568-2998; Wiltfang, Jens/0000-0003-1492-5330; Love, Seth/0000-0001-8683-3625; Bras, Jose/0000-0001-8186-0333; Gallacher, John/0000-0002-2394-5299; Escott-Price, Valentina/0000-0003-1784-5483; Haapasalo, Annakaisa/0000-0003-0959-2957; van der Lee, Sven/0000-0003-1606-8643; Hooper, Nigel/0000-0002-5811-3484; Hodges, Angela/0000-0002-5565-6678; sorbi, sandro/0000-0002-0380-6670; Sarnowski, Chloe/0000-0002-6090-7099; Lunetta, Kathryn/0000-0002-9268-810X; Quintela, Ines/0000-0002-0239-7975; Grozeva, Detelina/0000-0003-3239-8415; de Rojas, Itziar/0000-0002-2148-381X; Morris, John/0000-0001-9820-5618; Kehoe, Patrick/0000-0002-7542-1139; Song, Yeunjoo/0000-0002-7452-3731; Orfei, Maria Donata/0000-0003-2006-7555; Amlie-Wolf, Alexandre/0000-0002-2073-1519; Fox, Nick/0000-0002-6660-657X; /0000-0003-1391-9481; Bass, Nicholas James/0000-0002-4481-778X; Williams, Julie/0000-0002-4069-0259; Smith, Albert Vernon/0000-0003-1942-5845; Pickering-Brown, Stuart/0000-0003-1561-6054; Seshadri, Sudha/0000-0001-6135-2622; Warren, Jason/0000-0002-5405-0826; Guerreiro, Rita/0000-0001-5879-3486; Ikram, Mohammad Arfan/0000-0003-0372-8585; Badarinarayan, Nandini/0000-0002-6944-748X; debette, stephanie/0000-0001-8675-7968; St George-Hyslop, Peter/0000-0003-0796-7209	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG016976, K25AG055620, P30AG010124, R01AG041232, P50AG005681, P30AG017266, P01AG026276, R01AG017917, P30AG010129, P30AG013854, RF1AG051504, U24AG056270, P01AG003991, P30AG010161, R01AG015819, R01AG018454, R01AG061796, P01AG019724, R01AG054076, R01AG054060, P01AG017586, U01AG046139, P30AG053760] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L021803/1, G0300429, MR/N026004/1, G0902227, G0701075, MC_PC_18025, MC_UU_00024/1, MR/M009076/1, MR/K013041/1, MR/L023784/1, MR/K01417X/1, G0600974, MR/L023784/2, G0801418, G0900688, MR/M024784/1, MC_U123160657, G0900421, MC_UU_00024/9, G0600237, G0500289, G0901254, MC_PC_14095, UKDRI-1001, UKDRI-3003, G9810900, MR/R024804/1, UKDRI-1009] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500289, MC_PC_18025, MR/L010305/1, MR/L023784/2, G0801418, MC_UU_00024/1, MR/N026004/1, MR/M009076/1, G0900688, MC_UU_00024/9, G0600237, MR/L501517/1, G0600974, MR/R024804/1, MR/K013041/1, G0902227, G0900421, MR/L501542/1, MR/L021803/1, MR/L023784/1, MR/K01417X/1, MC_U123160657, MR/L501529/1, MC_PC_14095, G0701075, MR/M024784/1, G9810900, G0300429, G0901254] Funding Source: Medline; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001414, UL1 TR002369] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL120393, U01 HL120393, R01 HL105756] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG019724, U01 AG049505, P30 AG013854, P30 AG053760, R01 AG054060, P30 AG010124, U01 AG032438, R01 AG054076, P01 AG017586, U01 AG032984, R01 AG015819, R01 AG018454, P30 AG010129, RF1 AG015473, U01 AG046139, R01 AG041232, R01 AG061796, P30 AG010161, RF1 AG051504, U01 AG016976, P01 AG003991, P50 AG005681, U24 AG056270, P01 AG026276, P30 AG017266, K25 AG055620, R01 AG017917, RF1 AG054023] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS017950] Funding Source: Medline; Parkinson&apos;s UKParkinson&apos;s UK [G-0907] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-DOBSON/APR14/829-791, SHAW/NOV14/985-797] Funding Source: Medline		Adams P. M, 2016, NEUROBIOL AGING, V41, P1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amlie-Wolf A, 2018, NUCLEIC ACIDS RES, V46, P8740, DOI 10.1093/nar/gky686; [Anonymous], 2018, HAPLO STATS V 1 7 9; Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Arvanitakis Z, 2018, NEUROLOGY, V91, pE517, DOI 10.1212/WNL.0000000000005951; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bai ZX, 2016, MOL NEUROBIOL, V53, P310, DOI 10.1007/s12035-014-9011-3; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Belbin O, 2011, J ALZHEIMERS DIS, V24, P587, DOI 10.3233/JAD-2011-101914; Bellenguez C, 2017, NEUROBIOL AGING, V59, DOI 10.1016/j.neurobiolaging.2017.07.001; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Brouwers N, 2012, MOL PSYCHIATR, V17, P223, DOI 10.1038/mp.2011.24; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cai GQ, 2012, NEUROBIOL AGING, V33, P416, DOI 10.1016/j.neurobiolaging.2010.03.003; Campion D, 2016, MOL PSYCHIATR, V21, P861, DOI 10.1038/mp.2016.38; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cedar D, 2018, JAMA PSYCHIAT, V75, P723, DOI 10.1001/jamapsychiatry.2018.1012; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chang JY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.3; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Chapuis J, 2017, ACTA NEUROPATHOL, V133, P955, DOI 10.1007/s00401-016-1652-z; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Cool BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010351; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; De Roeck A, 2018, ACTA NEUROPATHOL, V135, P827, DOI 10.1007/s00401-018-1841-z; De Roeck A, 2017, ACTA NEUROPATHOL, V134, P475, DOI 10.1007/s00401-017-1714-x; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Desikan RS, 2015, CIRCULATION, V131, P2061, DOI 10.1161/CIRCULATIONAHA.115.015489; Douaud G, 2014, P NATL ACAD SCI USA, V111, P17648, DOI 10.1073/pnas.1410378111; Dourlen P, 2017, MOL PSYCHIATR, V22, P874, DOI 10.1038/mp.2016.59; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Farrer LA, 2000, ARCH NEUROL-CHICAGO, V57, P210, DOI 10.1001/archneur.57.2.210; Flister MJ, 2013, GENOME RES, V23, P1996, DOI 10.1101/gr.160283.113; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Hinney A, 2014, AM J MED GENET B, V165, P283, DOI 10.1002/ajmg.b.32234; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang DD, 2018, NUCLEIC ACIDS RES, V46, pW114, DOI 10.1093/nar/gky407; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Inostroza-Nieves Y, 2012, IMMUNOL LETT, V147, P67, DOI 10.1016/j.imlet.2012.06.005; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Jochemsen HM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt257; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Jun GR, 2017, ALZHEIMERS DEMENT, V13, P727, DOI 10.1016/j.jalz.2016.12.012; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Karnes JH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8708; Kauwe JSK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004758; Kehoe PG, 2018, J ALZHEIMERS DIS, V61, P803, DOI 10.3233/JAD-170101; Kehoe PG, 2018, J ALZHEIMERS DIS, V62, P1443, DOI 10.3233/JAD-171119; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim K, 2007, IMMUNOLOGY, V120, P242, DOI 10.1111/j.1365-2567.2006.02495.x; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Knickmeyer RC, 2016, NEUROLOGY, V87, P558, DOI 10.1212/WNL.0000000000002956; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kunkle BW, 2017, NEUROSCI LETT, V649, P124, DOI 10.1016/j.neulet.2017.04.014; Kurabayashi N, 2013, DEVELOPMENT, V140, P4335, DOI 10.1242/dev.099754; Kuzma E, 2018, J ALZHEIMERS DIS, V36, P215; Lachmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03751-6; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larsson SC, 2017, J ALZHEIMERS DIS, V60, P691, DOI 10.3233/JAD-170528; Le Guennec K, 2016, NEUROLOGY, V86, P2134, DOI 10.1212/WNL.0000000000002627; Lee JC, 2008, AM J HUM GENET, V83, P180, DOI 10.1016/j.ajhg.2008.07.002; Lee Ming-Hui, 2017, Alzheimers Dement (N Y), V3, P189, DOI 10.1016/j.trci.2017.02.001; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; MacArthur DG, 2017, REGIONAL MISSENSE CO, DOI [10.1101/148353, DOI 10.1101/148353]; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Marden JR, 2017, AM J EPIDEMIOL, V186, P805, DOI 10.1093/aje/kwx155; Marioni RE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0150-6; May P, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000224; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meng Y, 2006, AM J HUM GENET, V78, P871, DOI 10.1086/503687; Miguel RF, 2005, MOL BRAIN RES, V133, P1, DOI 10.1016/j.molbrainres.2004.09.008; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miners S, 2009, AM J TRANSL RES, V1, P163; Misra MK, 2018, IMMUNOLOGY, V153, P399, DOI 10.1111/imm.12869; Morawski M, 2014, PROG BRAIN RES, V214, P207, DOI 10.1016/B978-0-444-63486-3.00010-4; Mrissa NF, 2013, TRANSFUS APHER SCI, V49, P200, DOI 10.1016/j.transci.2013.01.012; Mukherjee S, 2015, ALZHEIMERS DEMENT, V11, P1439, DOI 10.1016/j.jalz.2015.05.015; Murray ME, 2015, BRAIN, V138, P1370, DOI 10.1093/brain/awv050; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; Ostergaard SD, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001841; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pugliese A, 2016, DIABETES, V65, P1109, DOI 10.2337/db15-1105; Qi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04558-1; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Saez ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-148; Santos A, 2015, PEERJ, V3, DOI 10.7717/peerj.1054; Schmidt H, 2007, AM J EPIDEMIOL, V165, P1097, DOI 10.1093/aje/kwk118; Schramm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093844; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Shulman JM, 2014, HUM MOL GENET, V23, P870, DOI 10.1093/hmg/ddt478; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steele N. Z, 2017, PLOS MED, V14, P1; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Suttkus A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.25; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takeda A, 2000, ACTA NEUROPATHOL, V99, P296, DOI 10.1007/PL00007441; Tan ZS, 2008, ARCH INTERN MED, V168, P1514, DOI 10.1001/archinte.168.14.1514; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; Vasquez JB, 2013, NEUROSCI LETT, V556, P58, DOI 10.1016/j.neulet.2013.09.058; Vassar R, 2013, NEURON, V80, P250, DOI 10.1016/j.neuron.2013.09.031; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Verheijen J, 2016, ACTA NEUROPATHOL, V132, P213, DOI 10.1007/s00401-016-1566-9; Wang K, 2011, PLOS ONE, V6, P3; Wang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111406; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilcock Donna M, 2012, Curr Gerontol Geriatr Res, V2012, P170276, DOI 10.1155/2012/170276; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wissemann WT, 2013, AM J HUM GENET, V93, P984, DOI 10.1016/j.ajhg.2013.10.009; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zheng J, 2017, BIOINFORMATICS, V33; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	183	671	675	39	276	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2019	51	3					414	+		10.1038/s41588-019-0358-2			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN1KZ	WOS:000459947200011	30820047	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Jaks, V; Barker, N; Kasper, M; Van Es, JH; Snippert, HJ; Clevers, H; Toftgard, R				Jaks, Viljar; Barker, Nick; Kasper, Maria; Van Es, Johan H.; Snippert, Hugo J.; Clevers, Hans; Toftgard, Rune			Lgr5 marks cycling, yet long-lived, hair follicle stem cells	NATURE GENETICS			English	Article							LABEL-RETAINING CELLS; SONIC-HEDGEHOG; POPULATION; KERATINOCYTES; BULGE; IDENTIFICATION; PROLIFERATION; DISTINCT; RENEWAL; NICHE	In mouse hair follicles, a group of quiescent cells in the bulge is believed to have stem cell activity. Lgr5, a marker of intestinal stem cells, is expressed in actively cycling cells in the bulge and secondary germ of telogen hair follicles and in the lower outer root sheath of anagen hair follicles. Here we show that Lgr5(+) cells comprise an actively proliferating and multipotent stem cell population able to give rise to new hair follicles and maintain all cell lineages of the hair follicle over long periods of time. Lgr5(+) progeny repopulate other stem cell compartments in the hair follicle, supporting the existence of a stem or progenitor cell hierarchy. By marking Lgr5(+) cells during trafficking through the lower outer root sheath, we show that these cells retain stem cell properties and contribute to hair follicle growth during the next anagen. Expression analysis suggests involvement of autocrine Hedgehog signaling in maintaining the Lgr5(+) stem cell population.	[Jaks, Viljar; Kasper, Maria; Toftgard, Rune] Novum, Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; [Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Jaks, Viljar] Estonian Bioctr, EE-51010 Tartu, Estonia; [Barker, Nick; Van Es, Johan H.; Snippert, Hugo J.; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands		Clevers, H (corresponding author), Novum, Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	h.clevers@niob.knaw.nl; rune.toftgard@ki.se	Barker, Nick/A-5535-2011; Kasper, Maria/Q-6318-2016; van+Es, Johan/ABD-5411-2021; Jaks, Viljar/H-2467-2012; Barker, Nick/AAE-9833-2021; Barker, Nick/AAS-2774-2020	Jaks, Viljar/0000-0002-2221-6262; Barker, Nick/0000-0003-3566-4475; Kasper, Maria/0000-0002-6117-2717	Swedish Cancer SocietySwedish Cancer Society; Swedish Research CouncilSwedish Research CouncilEuropean Commission; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AR47898, U01CA105491]; Genmab BVGenmab; Koninklijke Nederlandse Akademie van Wetenschappen; Koningin Wilhelmina Fonds; Louis Jeantet Foundation; International Agency for Research on Cancer Research Training Fellowship; Marie-Curie Intra-European FellowshipEuropean Commission; Wenner-Gren Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA105491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01AR047898] Funding Source: NIH RePORTER	We thank D. Roop and W. Buitrago for help with setting up the keratinocyte transplantation assay; A.-L. Dackland for help with cell sorting; A. Bergstrom and I. Sur for contributions during work with animals and preparation of samples; and M. van den Born, M. Cozijnsen and H. Begthel for help with histological procedures. This work was supported by the Swedish Cancer Society (to R. T.), the Swedish Research Council (to R. T.), the National Institutes of Health (AR47898 and U01CA105491 to R. T.), Genmab BV (to H. C.), Koninklijke Nederlandse Akademie van Wetenschappen (to H. C.), Koningin Wilhelmina Fonds (to H. C.), the Louis Jeantet Foundation (to H. C.), an International Agency for Research on Cancer Research Training Fellowship (to V. J.), a Marie-Curie Intra-European Fellowship (to V. J.) and a fellowship from the Wenner-Gren Foundation (M. K.).	Albert MR, 2001, J INVEST DERMATOL, V117, P943, DOI 10.1046/j.0022-202x.2001.01517.x; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; DRY FW, 1925, J GENET, V16, P278; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Lee J, 1997, DEVELOPMENT, V124, P2537; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2007, J INVEST DERMATOL, V127, P2904, DOI 10.1038/sj.jid.5700917; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wu WY, 2004, METH MOL B, V289, P79; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	671	684	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1291	1299		10.1038/ng.239			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	WOS:000260501500020	18849992				2022-01-24	
J	Simon, DB; Bindra, RS; Mansfield, TA; NelsonWilliams, C; Mendonca, E; Stone, R; Schurman, S; Nayir, A; Alpay, H; Bakkaloglu, A; RodriguezSoriano, J; Morales, JM; Sanjad, SA; Taylor, CM; Pilz, D; Brem, A; Trachtman, H; Griswold, W; Richard, GA; John, E; Lifton, RP				Simon, DB; Bindra, RS; Mansfield, TA; NelsonWilliams, C; Mendonca, E; Stone, R; Schurman, S; Nayir, A; Alpay, H; Bakkaloglu, A; RodriguezSoriano, J; Morales, JM; Sanjad, SA; Taylor, CM; Pilz, D; Brem, A; Trachtman, H; Griswold, W; Richard, GA; John, E; Lifton, RP			Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III	NATURE GENETICS			English	Article							EPITHELIAL SODIUM-CHANNEL; THICK ASCENDING LIMB; HYPOKALEMIC ALKALOSIS; MOLECULAR-GENETICS; HUMAN HYPERTENSION; HENLE LOOP; KIDNEY; DNA; COTRANSPORTER; HETEROGENEITY	Analysis of patients with inherited hypokalaemic alkalosis resulting from salt-wasting has proved fertile ground for identification of essential elements of renal salt homeostasis and blood-pressure regulation. We now demonstrate linkage of this phenotype to a segment of chromosome 1 containing the gene encoding a renal chloride channel, CLCNKB. Examination of this gene reveals loss-of-function mutations that impair renal chloride reabsorption in the thick ascending limb of Henle's loop. Mutations in seventeen kindreds have been identified, and they include large deletions and nonsense and missense mutations. Some of the deletions are shown to have arisen by unequal crossing over between CLCNKB and the nearby related gene, CLCNKA. Patients who harbour CLCNKB mutations are characterized by hypokalaemic alkalosis with salt-wasting, low blood pressure, normal magnesium and hyper-or normocalciuria; they define a distinct subset of patients with Bartter's syndrome in whom nephrocalcinosis is absent. These findings demonstrate the critical role of CLCNKB in renal salt reabsorption and blood-pressure homeostasis, and demonstrate the potential role of specific CLCNKB antagonists as diuretic antihypertensive agents.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED,BOYER CTR MOL MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOYER CTR MOL MED,NEW HAVEN,CT 06510; HOSP SANTA MARIA,UNIDADE NEFROL PEDIAT,LISBON,PORTUGAL; UNIV S FLORIDA,ALL CHILDRENS HOSP,DEPT PEDIAT,ST PETERSBURG,FL 33701; UNIV ISTANBUL,DEPT PEDIAT NEPHROL,ISTANBUL,TURKEY; HACETTEPE UNIV,CHILDRENS HOSP,DEPT PEDIAT NEPHROL,ANKARA,TURKEY; HOSP CRUCES,DEPT PEDIAT,BARACALDO,SPAIN; HOSP UNIV 12 OCTUBRE,DEPT MED,MADRID,SPAIN; KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PEDIAT,RIYADH 11211,SAUDI ARABIA; CHILDRENS HOSP,DEPT NEPHROL,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; UNIV WALES HOSP,INST MED GENET,CARDIFF CF4 4XW,S GLAM,WALES; RHODE ISL HOSP,DEPT PEDIAT NEPHROL,PROVIDENCE,RI 02903; SCHNEIDER CHILDRENS HOSP,ALBERT EINSTEIN COLL MED,DEPT PEDIAT,NEW HYDE PK,NY 11040; CHILDRENS HOSP SAN DIEGO,DEPT PEDIAT,SAN DIEGO,CA 92123; UNIV FLORIDA,DEPT PEDIAT,GAINESVILLE,FL 32610; UNIV ILLINOIS,DEPT PEDIAT,CHICAGO,IL 60612					Stone, Rosario/0000-0002-7939-836X			ADACHI S, 1994, J BIOL CHEM, V269, P17677; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; GILL JR, 1978, AM J MED, V65, P766, DOI 10.1016/0002-9343(78)90794-5; GREGER R, 1983, PFLUG ARCH EUR J PHY, V396, P325, DOI 10.1007/BF01063938; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; JENTSCH TJ, 1996, BIOESSAYS, V19, P117; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MATSUMOTO J, 1989, AM J ROENTGENOL, V152, P1251, DOI 10.2214/ajr.152.6.1251; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1985, ANAL HUMAN GENETIC L; Reeves W B, 1994, Adv Nephrol Necker Hosp, V23, P177; SaitoOhara F, 1996, GENOMICS, V36, P372, DOI 10.1006/geno.1996.0479; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; VANDEWALLE A, 1995, AM J PHYSIOL, V272, pF678; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436	28	671	701	2	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					171	178		10.1038/ng1097-171			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	WOS:A1997XZ55500022	9326936				2022-01-24	
J	Dunham, MA; Neumann, AA; Fasching, CL; Reddel, RR				Dunham, MA; Neumann, AA; Fasching, CL; Reddel, RR			Telomere maintenance by recombination in human cells	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; ALTERNATIVE MECHANISM; HUMAN CANCER; ELONGATION; SENESCENCE; YEAST; CHROMOSOMES; SEQUENCES; PATHWAY; DEFECT	Telomeres of eukaryotic chromosomes contain many tandem repeats of a G-rich sequence (for example, TTAGGC in vertebrates(1)). In most normal human cells, telomeres shorten with each cell division, and it is proposed that this limits the number of times these cells can replicate(2). Telomeres may be maintained in germline cells, and in many immortalized cells and cancers, by the telomerase holoenzyme(3) (first discovered in the ciliate Tetrahymena(4)), which uses an RNA subunit as template for synthesis of telomeric DNA by the reverse transcriptase catalytic subunit(5). Some immortalized human cell lines and some tumours maintain their telomeres in the absence of any detectable telomerase activity by a mechanism referred to as alternative lengthening of telomeres(6,7) (ALT). Here we show that DNA sequences are copied from telomere to telomere in an immortalized human ALT cell line, indicating that ALT occurs by means of homologous recombination and copy switching.	Childrens Med Res Inst, Canc Res Unit, Sydney, NSW, Australia		Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, Sydney, NSW, Australia.		Neumann, Axel/D-3319-2012; Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107			BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; COLGIN LM, IN PRESS NEOPLASIA; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; Lendvay TS, 1996, GENETICS, V144, P1399; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MURNANE JP, 1993, MOL CELL BIOL, V13, P977, DOI 10.1128/MCB.13.2.977; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477; Reddel RR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1254; Roth CW, 1997, MOL CELL BIOL, V17, P5176, DOI 10.1128/MCB.17.9.5176; SAXON PJ, 1985, MOL CELL BIOL, V5, P140, DOI 10.1128/MCB.5.1.140; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sprung CN, 1999, EXP CELL RES, V247, P29, DOI 10.1006/excr.1998.4293; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; Yeager TR, 1999, CANCER RES, V59, P4175	29	670	699	0	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					447	450		10.1038/82586			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	WOS:000165671700018	11101843				2022-01-24	
J	Mahajan, A; Go, MJ; Zhang, WH; Below, JE; Gaulton, KJ; Ferreira, T; Horikoshi, M; Johnson, AD; Ng, MCY; Prokopenko, I; Saleheen, D; Wang, X; Zeggini, E; Abecasis, GR; Adair, LS; Almgren, P; Atalay, M; Aung, T; Baldassarre, D; Balkau, B; Bao, YQ; Barnett, AH; Barroso, I; Basit, A; Been, LF; Beilby, J; Bell, GI; Benediktsson, R; Bergman, RN; Boehm, BO; Boerwinkle, E; Bonnycastle, LL; Burtt, N; Cai, QY; Campbell, H; Carey, J; Cauchi, S; Caulfield, M; Chan, JCN; Chang, LC; Chang, TJ; Chang, YC; Charpentier, G; Chen, CH; Chen, H; Chen, YT; Chia, KS; Chidambaram, M; Chines, PS; Cho, NH; Cho, YM; Chuang, LM; Collins, FS; Cornelis, MC; Couper, DJ; Crenshaw, AT; van Dam, RM; Danesh, J; Das, D; de Faire, U; Dedoussis, G; Deloukas, P; Dimas, AS; Dina, C; Doney, ASF; Donnelly, PJ; Dorkhan, M; van Duijn, C; Dupuis, J; Edkins, S; Elliott, P; Emilsson, V; Erbel, R; Eriksson, JG; Escobedo, J; Esko, T; Eury, E; Florez, JC; Fontanillas, P; Forouhi, NG; Forsen, T; Fox, C; Fraser, RM; Frayling, TM; Froguel, P; Frossard, P; Gao, YT; Gertow, K; Gieger, C; Gigante, B; Grallert, H; Grant, GB; Groop, LC; Groves, CJ; Grundberg, E; Guiducci, C; Hamsten, A; Han, BG; Hara, K; Hassanali, N; Hattersley, AT; Hayward, C; Hedman, AK; Herder, C; Hofman, A; Holmen, OL; Hovingh, K; Hreidarsson, AB; Hu, C; Hu, FB; Hui, J; Humphries, SE; Hunt, SE; Hunter, DJ; Hveem, K; Hydrie, ZI; Ikegami, H; Illig, T; Ingelsson, E; Islam, M; Isomaa, B; Jackson, AU; Jafar, T; James, A; Jia, WP; Jockel, KH; Jonsson, A; Jowett, JBM; Kadowaki, T; Kang, HM; Kanoni, S; Kao, WHL; Kathiresan, S; Kato, N; Katulanda, P; Keinanen-Kiukaanniemi, SM; Kelly, AM; Khan, H; Khaw, KT; Khor, CC; Kim, HL; Kim, S; Kim, YJ; Kinnunen, L; Klopp, N; Kong, A; Korpi-Hyovalti, E; Kowlessur, S; Kraft, P; Kravic, J; Kristensen, MM; Krithika, S; Kumar, A; Kumate, J; Kuusisto, J; Kwak, SH; Laakso, M; Lagou, V; Lakka, TA; Langenberg, C; Langford, C; Lawrence, R; Leander, K; Lee, JM; Lee, NR; Li, M; Li, XZ; Li, Y; Liang, JB; Liju, S; Lim, WY; Lind, L; Lindgren, CM; Lindholm, E; Liu, CT; Liu, JJ; Lobbens, S; Long, JR; Loos, RJF; Lu, W; Luan, JA; Lyssenko, V; Ma, RCW; Maeda, S; Magi, R; Mannisto, S; Matthews, DR; Meigs, JB; Melander, O; Metspalu, A; Meyer, J; Mirza, G; Mihailov, E; Moebus, S; Mohan, V; Mohlke, KL; Morris, AD; Muhleisen, TW; Muller-Nurasyid, M; Musk, B; Nakamura, J; Nakashima, E; Navarro, P; Ng, PK; Nica, AC; Nilsson, PM; Njolstad, I; Nothen, MM; Ohnaka, K; Ong, TH; Owen, KR; Palmer, CNA; Pankow, JS; Park, KS; Parkin, M; Pechlivanis, S; Pedersen, NL; Peltonen, L; Perry, JRB; Peters, A; Pinidiyapathirage, JM; Platou, CGP; Potter, S; Price, JF; Qi, L; Radha, V; Rallidis, L; Rasheed, A; Rathmann, W; Rauramaa, R; Raychaudhuri, S; Rayner, NW; Rees, SD; Rehnberg, E; Ripatti, S; Robertson, N; Roden, M; Rossin, EJ; Rudan, I; Rybin, D; Saaristo, TE; Salomaa, V; Saltevo, J; Samuel, M; Sanghera, DK; Saramies, J; Scott, J; Scott, LJ; Scott, RA; Segre, AV; Sehmi, J; Sennblad, B; Shah, N; Shah, S; Shera, AS; Shu, XO; Shuldiner, AR; Sigurdsson, G; Sijbrands, E; Silveira, A; Sim, X; Sivapalaratnam, S; Small, KS; So, WY; Stancakova, A; Stefansson, K; Steinbach, G; Steinthorsdottir, V; Stirrups, K; Strawbridge, RJ; Stringham, HM; Sun, Q; Suo, C; Syvanen, AC; Takayanagi, R; Takeuchi, F; Tay, WT; Teslovich, TM; Thorand, B; Thorleifsson, G; Thorsteinsdottir, U; Tikkanen, E; Trakalo, J; Tremoli, E; Trip, MD; Tsai, FJ; Tuomi, T; Tuomilehto, J; Uitterlinden, AG; Valladares-Salgado, A; Vedantam, S; Veglia, F; Voight, BF; Wang, CR; Wareham, NJ; Wennauer, R; Wickremasinghe, AR; Wilsgaard, T; Wilson, JF; Wiltshire, S; Winckler, W; Wong, TY; Wood, AR; Wu, JY; Wu, Y; Yamamoto, K; Yamauchi, T; Yang, MY; Yengo, L; Yokota, M; Young, R; Zabaneh, D; Zhang, F; Zhang, R; Zheng, W; Zimmet, PZ; Altshuler, D; Bowden, DW; Cho, YS; Cox, NJ; Cruz, M; Hanis, CL; Kooner, J; Lee, JY; Seielstad, M; Teo, YY; Boehnke, M; Parra, EJ; Chambers, JC; Tai, ES; McCarthy, MI; Morris, AP				Mahajan, Anubha; Go, Min Jin; Zhang, Weihua; Below, Jennifer E.; Gaulton, Kyle J.; Ferreira, Teresa; Horikoshi, Momoko; Johnson, Andrew D.; Ng, Maggie C. Y.; Prokopenko, Inga; Saleheen, Danish; Wang, Xu; Zeggini, Eleftheria; Abecasis, Goncalo R.; Adair, Linda S.; Almgren, Peter; Atalay, Mustafa; Aung, Tin; Baldassarre, Damiano; Balkau, Beverley; Bao, Yuqian; Barnett, Anthony H.; Barroso, Ines; Basit, Abdul; Been, Latonya F.; Beilby, John; Bell, Graeme I.; Benediktsson, Rafn; Bergman, Richard N.; Boehm, Bernhard O.; Boerwinkle, Eric; Bonnycastle, Lori L.; Burtt, Noel; Cai, Qiuyin; Campbell, Harry; Carey, Jason; Cauchi, Stephane; Caulfield, Mark; Chan, Juliana C. N.; Chang, Li-Ching; Chang, Tien-Jyun; Chang, Yi-Cheng; Charpentier, Guillaume; Chen, Chien-Hsiun; Chen, Han; Chen, Yuan-Tsong; Chia, Kee-Seng; Chidambaram, Manickam; Chines, Peter S.; Cho, Nam H.; Cho, Young Min; Chuang, Lee-Ming; Collins, Francis S.; Cornelis, Marilyn C.; Couper, David J.; Crenshaw, Andrew T.; van Dam, Rob M.; Danesh, John; Das, Debashish; de Faire, Ulf; Dedoussis, George; Deloukas, Panos; Dimas, Antigone S.; Dina, Christian; Doney, Alex S. F.; Donnelly, Peter J.; Dorkhan, Mozhgan; van Duijn, Cornelia; Dupuis, Josee; Edkins, Sarah; Elliott, Paul; Emilsson, Valur; Erbel, Raimund; Eriksson, Johan G.; Escobedo, Jorge; Esko, Tonu; Eury, Elodie; Florez, Jose C.; Fontanillas, Pierre; Forouhi, Nita G.; Forsen, Tom; Fox, Caroline; Fraser, Ross M.; Frayling, Timothy M.; Froguel, Philippe; Frossard, Philippe; Gao, Yutang; Gertow, Karl; Gieger, Christian; Gigante, Bruna; Grallert, Harald; Grant, George B.; Groop, Leif C.; Groves, Christopher J.; Grundberg, Elin; Guiducci, Candace; Hamsten, Anders; Han, Bok-Ghee; Hara, Kazuo; Hassanali, Neelam; Hattersley, Andrew T.; Hayward, Caroline; Hedman, Asa K.; Herder, Christian; Hofman, Albert; Holmen, Oddgeir L.; Hovingh, Kees; Hreidarsson, Astradur B.; Hu, Cheng; Hu, Frank B.; Hui, Jennie; Humphries, Steve E.; Hunt, Sarah E.; Hunter, David J.; Hveem, Kristian; Hydrie, Zafar I.; Ikegami, Hiroshi; Illig, Thomas; Ingelsson, Erik; Islam, Muhammed; Isomaa, Bo; Jackson, Anne U.; Jafar, Tazeen; James, Alan; Jia, Weiping; Joeckel, Karl-Heinz; Jonsson, Anna; Jowett, Jeremy B. M.; Kadowaki, Takashi; Kang, Hyun Min; Kanoni, Stavroula; Kao, Wen Hong L.; Kathiresan, Sekar; Kato, Norihiro; Katulanda, Prasad; Keinanen-Kiukaanniemi, Sirkka M.; Kelly, Ann M.; Khan, Hassan; Khaw, Kay-Tee; Khor, Chiea-Chuen; Kim, Hyung-Lae; Kim, Sangsoo; Kim, Young Jin; Kinnunen, Leena; Klopp, Norman; Kong, Augustine; Korpi-Hyovalti, Eeva; Kowlessur, Sudhir; Kraft, Peter; Kravic, Jasmina; Kristensen, Malene M.; Krithika, S.; Kumar, Ashish; Kumate, Jesus; Kuusisto, Johanna; Kwak, Soo Heon; Laakso, Markku; Lagou, Vasiliki; Lakka, Timo A.; Langenberg, Claudia; Langford, Cordelia; Lawrence, Robert; Leander, Karin; Lee, Jen-Mai; Lee, Nanette R.; Li, Man; Li, Xinzhong; Li, Yun; Liang, Junbin; Liju, Samuel; Lim, Wei-Yen; Lind, Lars; Lindgren, Cecilia M.; Lindholm, Eero; Liu, Ching-Ti; Liu, Jian Jun; Lobbens, Stephane; Long, Jirong; Loos, Ruth J. F.; Lu, Wei; Luan, Jian'an; Lyssenko, Valeriya; Ma, Ronald C. W.; Maeda, Shiro; Maegi, Reedik; Mannisto, Satu; Matthews, David R.; Meigs, James B.; Melander, Olle; Metspalu, Andres; Meyer, Julia; Mirza, Ghazala; Mihailov, Evelin; Moebus, Susanne; Mohan, Viswanathan; Mohlke, Karen L.; Morris, Andrew D.; Muehleisen, Thomas W.; Mueller-Nurasyid, Martina; Musk, Bill; Nakamura, Jiro; Nakashima, Eitaro; Navarro, Pau; Peng-Keat Ng; Nica, Alexandra C.; Nilsson, Peter M.; Njolstad, Inger; Noethen, Markus M.; Ohnaka, Keizo; Ong, Twee Hee; Owen, Katharine R.; Palmer, Colin N. A.; Pankow, James S.; Park, Kyong Soo; Parkin, Melissa; Pechlivanis, Sonali; Pedersen, Nancy L.; Peltonen, Leena; Perry, John R. B.; Peters, Annette; Pinidiyapathirage, Janani M.; Platou, Carl G. P.; Potter, Simon; Price, Jackie F.; Qi, Lu; Radha, Venkatesan; Rallidis, Loukianos; Rasheed, Asif; Rathmann, Wolfgang; Rauramaa, Rainer; Raychaudhuri, Soumya; Rayner, N. William; Rees, Simon D.; Rehnberg, Emil; Ripatti, Samuli; Robertson, Neil; Roden, Michael; Rossin, Elizabeth J.; Rudan, Igor; Rybin, Denis; Saaristo, Timo E.; Salomaa, Veikko; Saltevo, Juha; Samuel, Maria; Sanghera, Dharambir K.; Saramies, Jouko; Scott, James; Scott, Laura J.; Scott, Robert A.; Segre, Ayellet V.; Sehmi, Joban; Sennblad, Bengt; Shah, Nabi; Shah, Sonia; Shera, A. Samad; Shu, Xiao Ou; Shuldiner, Alan R.; Sigurdsson, Gunnar; Sijbrands, Eric; Silveira, Angela; Sim, Xueling; Sivapalaratnam, Suthesh; Small, Kerrin S.; So, Wing Yee; Stancakova, Alena; Stefansson, Kari; Steinbach, Gerald; Steinthorsdottir, Valgerdur; Stirrups, Kathleen; Strawbridge, Rona J.; Stringham, Heather M.; Sun, Qi; Suo, Chen; Syvanen, Ann-Christine; Takayanagi, Ryoichi; Takeuchi, Fumihiko; Tay, Wan Ting; Teslovich, Tanya M.; Thorand, Barbara; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Tikkanen, Emmi; Trakalo, Joseph; Tremoli, Elena; Trip, Mieke D.; Tsai, Fuu Jen; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Uitterlinden, Andre G.; Valladares-Salgado, Adan; Vedantam, Sailaja; Veglia, Fabrizio; Voight, Benjamin F.; Wang, Congrong; Wareham, Nicholas J.; Wennauer, Roman; Wickremasinghe, Ananda R.; Wilsgaard, Tom; Wilson, James F.; Wiltshire, Steven; Winckler, Wendy; Wong, Tien Yin; Wood, Andrew R.; Wu, Jer-Yuarn; Wu, Ying; Yamamoto, Ken; Yamauchi, Toshimasa; Yang, Mingyu; Yengo, Loic; Yokota, Mitsuhiro; Young, Robin; Zabaneh, Delilah; Zhang, Fan; Zhang, Rong; Zheng, Wei; Zimmet, Paul Z.; Altshuler, David; Bowden, Donald W.; Cho, Yoon Shin; Cox, Nancy J.; Cruz, Miguel; Hanis, Craig L.; Kooner, Jaspal; Lee, Jong-Young; Seielstad, Mark; Teo, Yik Ying; Boehnke, Michael; Parra, Esteban J.; Chambers, John C.; Tai, E. Shyong; McCarthy, Mark I.; Morris, Andrew P.		DIAbet Genetics Replication & Meta; Asian Genetic Epidemiology Network; South Asian Type Diabet SAT2D Cons; Mexican Amer Type 2 Diabet MAT2D C; Type 2 Diabet Genetic Exploration	Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility	NATURE GENETICS			English	Article							ASSOCIATION ANALYSES; GLUCOSE-HOMEOSTASIS; LOCI; VARIANTS; INDIVIDUALS; CHROMATIN; IDENTIFY	To further understanding of the genetic basis of type 2 diabetes (T2D) susceptibility, we aggregated published meta-analyses of genome-wide association studies (GWAS), including 26,488 cases and 83,964 controls of European, east Asian, south Asian and Mexican and Mexican American ancestry. We observed a significant excess in the directional consistency of T2D risk alleles across ancestry groups, even at SNPs demonstrating only weak evidence of association. By following up the strongest signals of association from the trans-ethnic meta-analysis in an additional 21,491 cases and 55,647 controls of European ancestry, we identified seven new T2D susceptibility loci. Furthermore, we observed considerable improvements in the fine-mapping resolution of common variant association signals at several T2D susceptibility loci. These observations highlight the benefits of trans-ethnic GWAS for the discovery and characterization of complex trait loci and emphasize an exciting opportunity to extend insight into the genetic architecture and pathogenesis of human diseases across populations of diverse ancestry.	[Mahajan, Anubha; Gaulton, Kyle J.; Ferreira, Teresa; Horikoshi, Momoko; Prokopenko, Inga; Dimas, Antigone S.; Donnelly, Peter J.; Hedman, Asa K.; Ingelsson, Erik; Kumar, Ashish; Lagou, Vasiliki; Lindgren, Cecilia M.; Mirza, Ghazala; Perry, John R. B.; Rayner, N. William; Robertson, Neil; Trakalo, Joseph; Wiltshire, Steven; McCarthy, Mark I.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Go, Min Jin; Han, Bok-Ghee; Kim, Young Jin; Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Gangoe Myeon, Yeonje Ri, South Korea; [Zhang, Weihua; Boehm, Bernhard O.; Elliott, Paul; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, London, England; [Below, Jennifer E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Horikoshi, Momoko; Prokopenko, Inga; Groves, Christopher J.; Hassanali, Neelam; Katulanda, Prasad; Matthews, David R.; Owen, Katharine R.; Rayner, N. William; Robertson, Neil; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX1 2JD, England; [Johnson, Andrew D.; Dupuis, Josee; Fox, Caroline] NHLBI, Framingham Heart Study, Framingham, MA USA; [Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Prokopenko, Inga; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Saleheen, Danish; Danesh, John; Khan, Hassan; Khaw, Kay-Tee; Young, Robin] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Saleheen, Danish; Frossard, Philippe; Rasheed, Asif; Samuel, Maria; Shah, Nabi] Ctr Noncommunicable Dis Pakistan, Karachi, Pakistan; [Wang, Xu; Chia, Kee-Seng; Lee, Jen-Mai; Peng-Keat Ng; Ong, Twee Hee; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Zeggini, Eleftheria; Barroso, Ines; Deloukas, Panos; Edkins, Sarah; Hunt, Sarah E.; Kanoni, Stavroula; Langford, Cordelia; Peltonen, Leena; Potter, Simon; Ripatti, Samuli; Small, Kerrin S.; Stirrups, Kathleen] Wellcome Trust Sanger Inst, Cambridge, England; [Abecasis, Goncalo R.; Jackson, Anne U.; Kang, Hyun Min; Scott, Laura J.; Sim, Xueling; Stringham, Heather M.; Teslovich, Tanya M.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Almgren, Peter; Dorkhan, Mozhgan; Groop, Leif C.; Jonsson, Anna; Kravic, Jasmina; Lindholm, Eero; Lyssenko, Valeriya; Melander, Olle; Nilsson, Peter M.] Lund Univ, Scania Univ Hosp, Dept Clin Sci Malmo, Ctr Diabet, Malmo, Sweden; [Atalay, Mustafa; Lakka, Timo A.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Aung, Tin; Khor, Chiea-Chuen; Tay, Wan Ting; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Baldassarre, Damiano; Tremoli, Elena; Veglia, Fabrizio] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Baldassarre, Damiano; Tremoli, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Balkau, Beverley] INSERM, Ctr Rech Epidemiol & Sante Populat CESP, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Bao, Yuqian; Hu, Cheng; Jia, Weiping; Wang, Congrong; Zhang, Rong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Key Lab Diabet Mellitus,Shanghai Diabet, Shanghai 200030, Peoples R China; [Barnett, Anthony H.; Kelly, Ann M.; Rees, Simon D.] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Barnett, Anthony H.; Kelly, Ann M.; Rees, Simon D.] Heart England Natl Hlth Serv NHS Fdn Trust, Ctr Biomed Res, Birmingham, W Midlands, England; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Barroso, Ines] Addenbrookes Hosp, Inst Metab Sci, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Basit, Abdul; Hydrie, Zafar I.] Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan; [Been, Latonya F.; Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Pediat,Sect Genet, Oklahoma City, OK 73190 USA; [Beilby, John; Hui, Jennie; James, Alan; Musk, Bill] Sir Charles Gairdner Hosp, Busselton Populat Med Res Inst, Nedlands, WA 6009, Australia; [Beilby, John] Queen Elizabeth II Med Ctr, PathWest Lab Med Western Australia, Nedlands, WA, Australia; [Beilby, John] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Bell, Graeme I.; Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bell, Graeme I.; Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Benediktsson, Rafn; Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Benediktsson, Rafn; Hreidarsson, Astradur B.; Sigurdsson, Gunnar] Landspitali Univ Hosp, Reykjavik, Iceland; [Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Boehm, Bernhard O.] Univ Med Ctr Ulm, Div Endocrinol & Diabet, Dept Internal Med, Ulm, Germany; [Boehm, Bernhard O.] Nanyang Technol Univ, Lee Kong Chian LKC Sch Med, Singapore 639798, Singapore; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Burtt, Noel; Carey, Jason; Crenshaw, Andrew T.; Fontanillas, Pierre; Grant, George B.; Guiducci, Candace; Kathiresan, Sekar; Lindgren, Cecilia M.; Parkin, Melissa; Peltonen, Leena; Raychaudhuri, Soumya; Rossin, Elizabeth J.; Segre, Ayellet V.; Voight, Benjamin F.; Winckler, Wendy; Altshuler, David] Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA; [Cai, Qiuyin; Long, Jirong; Shu, Xiao Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr,Dept Med, Nashville, TN 37212 USA; [Campbell, Harry; Fraser, Ross M.; Price, Jackie F.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Campbell, Harry; Hayward, Caroline; Navarro, Pau; Wilson, James F.] Univ Edinburgh, Western Gen Hosp, MRC, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Cauchi, Stephane; Eury, Elodie; Froguel, Philippe; Lobbens, Stephane; Yengo, Loic] CNRS, Unite Mixte Rech UMR 8199, Inst Biol, Lille, France; [Cauchi, Stephane; Eury, Elodie; Froguel, Philippe; Lobbens, Stephane; Yengo, Loic] Univ Lille 2, Inst Pasteur, Lille, France; [Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Barts & London Genome Ctr, London, England; [Chan, Juliana C. N.; Ma, Ronald C. W.; So, Wing Yee] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chang, Li-Ching; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Tien-Jyun; Chang, Yi-Cheng; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Chen, Chien-Hsiun; Tsai, Fuu Jen; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Han; Dupuis, Josee; Liu, Ching-Ti] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Chia, Kee-Seng; Khor, Chiea-Chuen; Lim, Wei-Yen; Sim, Xueling; Suo, Chen; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Chidambaram, Manickam; Liju, Samuel; Mohan, Viswanathan; Radha, Venkatesan] Indian Council Med Res, Adv Ctr Genom Diabet, Madras Diabet Res Fdn, Dept Mol Genet, Madras, Tamil Nadu, India; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon 441749, South Korea; [Cho, Young Min; Kwak, Soo Heon; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Chuang, Lee-Ming; Maeda, Shiro] Natl Taiwan Univ, Sch Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Cornelis, Marilyn C.; van Dam, Rob M.; Hu, Frank B.; Hunter, David J.; Kraft, Peter; Qi, Lu; Sun, Qi] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA; [Couper, David J.] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Das, Debashish; Sehmi, Joban; Kooner, Jaspal; Chambers, John C.] Ealing Hosp NHS Trust, Southall, Middx, England; [de Faire, Ulf; Gigante, Bruna; Leander, Karin] Karolinska Inst, Inst Environm Med, Divis Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Dedoussis, George] Harokopio Univ, Dept Dietet Nutr, Athens, Greece; [Dimas, Antigone S.; Nica, Alexandra C.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dimas, Antigone S.] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Dina, Christian] INSERM, UMR 1087, Nantes, France; [Dina, Christian] CNRS, UMR 6291, Nantes, France; [Dina, Christian] Univ Nantes, Nantes, France; [Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Diabet Res Ctr, Dundee, Scotland; [Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Pharmacogen Ctr, Dundee, Scotland; [Donnelly, Peter J.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [van Duijn, Cornelia; Hofman, Albert; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [van Duijn, Cornelia; Uitterlinden, Andre G.] Netherlands Consortium Healthy Ageing, Netherland Genom Initiat, Rotterdam, Netherlands; [van Duijn, Cornelia; Uitterlinden, Andre G.] Ctr Med Syst Biol, Rotterdam, Netherlands; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC, Hlth Protect Agcy, Ctr Environm & Hlth, London, England; [Emilsson, Valur; Sigurdsson, Gunnar] Iceland Heart Assoc, Kopavogur, Iceland; [Erbel, Raimund] Univ Duisburg Essen, Univ Hosp Essen, West German Heart Ctr, Clin Cardiol, Essen, Germany; [Eriksson, Johan G.; Mannisto, Satu; Peltonen, Leena; Ripatti, Samuli; Salomaa, Veikko; Tikkanen, Emmi] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.; Forsen, Tom] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Gen Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.; Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Escobedo, Jorge] Inst Mexicano Seguro Social, Hosp Gen Reg 1, Unidad Invest Epidemiol Clin, Mexico City, DF, Mexico; [Esko, Tonu; Maegi, Reedik; Metspalu, Andres; Mihailov, Evelin] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Esko, Tonu; Florez, Jose C.; Rossin, Elizabeth J.; Vedantam, Sailaja] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu; Florez, Jose C.; Vedantam, Sailaja] Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Florez, Jose C.; Meigs, James B.; Segre, Ayellet V.; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Florez, Jose C.; Kathiresan, Sekar; Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; [Forouhi, Nita G.; Langenberg, Claudia; Loos, Ruth J. F.; Luan, Jian'an; Scott, Robert A.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Forsen, Tom] Vaasa Hlth Care Ctr, Vaasa, Finland; [Fox, Caroline] Brigham & Womens Hosp, Div Endocrinol & Metab, Boston, MA 02115 USA; [Fox, Caroline; Hu, Frank B.; Hunter, David J.; Qi, Lu; Sun, Qi] Harvard Univ, Sch Med, Boston, MA USA; [Frayling, Timothy M.; Perry, John R. B.; Wood, Andrew R.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Gao, Yutang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Gertow, Karl; Hamsten, Anders; Sennblad, Bengt; Silveira, Angela; Strawbridge, Rona J.] Karolinska Inst, Dept Med Solna, Atherosclerosis Res Unit, Stockholm, Sweden; [Gertow, Karl; Hamsten, Anders; Sennblad, Bengt; Silveira, Angela; Strawbridge, Rona J.] Karolinska Univ, Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Gieger, Christian; Meyer, Julia; Mueller-Nurasyid, Martina] Helmholtz Zentrum Muenchen, Inst Genet Epidemiol, Neuherberg, Germany; [Grallert, Harald; Illig, Thomas; Klopp, Norman] Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Grallert, Harald] Univ Munich, Clin Cooperat Grp Diabet, Munich, Germany; [Grallert, Harald] Helmholtz Zentrum Muenchen, Munich, Germany; [Grallert, Harald] Tech Univ Munich, Clin Cooperat Grp Nutrigen & Type Diabet 2, Munich, Germany; [Grallert, Harald] German Ctr Diabet Res DZD, Neuherberg, Germany; [Grundberg, Elin; Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Hara, Kazuo; Kadowaki, Takashi; Yamauchi, Toshimasa] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Hattersley, Andrew T.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Holmen, Oddgeir L.; Hveem, Kristian; Platou, Carl G. P.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Hovingh, Kees; Sivapalaratnam, Suthesh; Trip, Mieke D.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hu, Frank B.; Hunter, David J.; Qi, Lu; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hui, Jennie; Musk, Bill] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Humphries, Steve E.] UCL, Inst Cardiovasc Sci, London, England; [Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Ikegami, Hiroshi] Kinki Univ, Sch Med, Dept Diabet Endocrinol & Metab, Osaka 589, Japan; [Illig, Thomas; Klopp, Norman] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Ingelsson, Erik] Univ Uppsala Hosp, Dept Mol Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Islam, Muhammed; Jafar, Tazeen] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Jafar, Tazeen] Aga Khan Univ, Dept Med, Karachi, Pakistan; [James, Alan] Queen Elizabeth II Med Ctr, West Australian Sleep Disorders Res Inst, Dept Pulm Physiol & Sleep Med, Nedlands, WA, Australia; [James, Alan; Musk, Bill] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Joeckel, Karl-Heinz; Moebus, Susanne; Pechlivanis, Sonali] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Jowett, Jeremy B. M.; Kristensen, Malene M.; Zimmet, Paul Z.] Heart & Diabet Inst, Baker Int Diabet Inst IDI, Melbourne, Australia; [Kao, Wen Hong L.; Li, Man] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kato, Norihiro; Takeuchi, Fumihiko] Natl Ctr Global Hlth & Med, Res Inst, Shinjuku Ku, Tokyo, Japan; [Katulanda, Prasad] Univ Colombo, Dept Clin Med, Diabet Res Unit, Colombo, Sri Lanka; [Keinanen-Kiukaanniemi, Sirkka M.] Univ Oulu, Inst Hlth Sci, Fac Med, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka M.] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Khor, Chiea-Chuen; Liu, Jian Jun; Seielstad, Mark; Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Kim, Sangsoo] Soongsil Univ, Sch Syst Biomed Sci, Seoul, South Korea; [Kinnunen, Leena; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Kong, Augustine; Stefansson, Kari; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur] deCODE Genet, Reykjavik, Iceland; [Korpi-Hyovalti, Eeva] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Kowlessur, Sudhir] Minist Hlth, Port Louis, Mauritius; [Krithika, S.; Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Kumate, Jesus] Fdn IMSS, Mexico City, DF, Mexico; [Kuusisto, Johanna; Laakso, Markku; Stancakova, Alena] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku; Stancakova, Alena] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lakka, Timo A.; Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Lawrence, Robert] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Nedlands, WA 6009, Australia; [Lee, Nanette R.] Univ San Carlos, Off Populat Studies Fdn Inc, Cebu, Philippines; [Li, Xinzhong; Scott, James; Sehmi, Joban; Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Li, Yun; Mohlke, Karen L.; Wu, Ying] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liang, Junbin; Yang, Mingyu; Zhang, Fan] Beijing Genom Inst, Shenzhen, Peoples R China; [Lind, Lars] Uppsala Univ, Akad Sjukhuset, Dept Med Sci, Uppsala, Sweden; [Loos, Ruth J. F.] Mt Sinai Sch Med, Charles R Bronfman Inst Personalized Med, New York, NY USA; [Loos, Ruth J. F.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY USA; [Loos, Ruth J. F.] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [Lu, Wei] Shanghai Inst Prevent Med, Shanghai, Peoples R China; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Mohan, Viswanathan] Dr Mohans Diabet Specialties Ctr, Madras, Tamil Nadu, India; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Musk, Bill] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia; [Nakamura, Jiro; Nakashima, Eitaro] Nagoya Univ, Grad Sch Med, Div Endocrinol & Diabet, Dept Internal Med, Nagoya, Aichi 4648601, Japan; [Nakashima, Eitaro] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Njolstad, Inger; Wilsgaard, Tom] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Higashi Ku, Fukuoka 812, Japan; [Owen, Katharine R.; McCarthy, Mark I.] Churchill Hosp, Hlth Res Biomed Res Ctr, Oxford Natl Inst, Oxford OX3 7LJ, England; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Park, Kyong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, World Class Univ Program, Seoul, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Pedersen, Nancy L.; Rehnberg, Emil] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Peltonen, Leena; Ripatti, Samuli; Tikkanen, Emmi] Inst Mol Med Finland FIMM, Helsinki, Finland; [Peters, Annette; Thorand, Barbara] Helmholtz Zentrum Muenchen, Inst Epidemiol 2, Neuherberg, Germany; [Pinidiyapathirage, Janani M.; Wickremasinghe, Ananda R.] Univ Kelaniya, Fac Med, Dept Publ Hlth, Ragama, Sri Lanka; [Platou, Carl G. P.] Nord Trondelag Hlth Trust, Levanger Hosp, Dept Internal Med, Levanger, Norway; [Rallidis, Loukianos] Univ Gen Hosp Attikon, Athens, Greece; [Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Partners Ctr Personalized Genom Med, Boston, MA USA; [Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Dusseldorf, Germany; [Rossin, Elizabeth J.] Harvard Univ, Hlth Sci & Technol MD Program, Boston, MA 02115 USA; [Rossin, Elizabeth J.] MIT, Boston, MA USA; [Rossin, Elizabeth J.] Harvard Univ, Harvard Biol & Biomed Sci Program, Boston, MA 02115 USA; [Rybin, Denis] Boston Univ, Data Coordinating Ctr, Boston, MA 02215 USA; [Saaristo, Timo E.] Finnish Diabet Assoc, Tampere, Finland; [Saaristo, Timo E.] Pirkanmaa Hosp Dist, Tampere, Finland; [Saltevo, Juha] Cent Finland Cent Hosp, Dept Med, Jyvaskyla, Finland; [Saramies, Jouko] South Karelia Cent Hosp, Lappeenranta, Finland; [Shah, Sonia; Zabaneh, Delilah] UCL, Dept Genet Evolut & Environm, Genet Inst, London, England; [Shera, A. Samad] Diabet Assoc Pakistan, Karachi, Pakistan; [Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Baltimore, MD USA; [Shuldiner, Alan R.] Univ Maryland, Sch Med, Program Personalised & Genom Med, Baltimore, MD 21201 USA; [Sijbrands, Eric; Uitterlinden, Andre G.; Wennauer, Roman] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Steinbach, Gerald] Univ Ulm, Dept Clin Chem, D-89069 Ulm, Germany; [Steinbach, Gerald] Univ Ulm, Cent Lab, D-89069 Ulm, Germany; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Internal Med & Bioregulatory Sci, Higashi Ku, Fukuoka 812, Japan; [Tuomi, Tiinamaija] Univ Helsinki, Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [Tuomilehto, Jaakko] Hosp Univ LaPaz IdiPAZ, Inst Invest Sanitaria, Madrid, Spain; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Valladares-Salgado, Adan; Cruz, Miguel] IMSS, Ctr Med Nacl Siglo 21, Hosp Especialidades, Unidad Invest Med Bioquim, Mexico City, DF, Mexico; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal,Higashi Ku, Fukuoka 812, Japan; [Yengo, Loic] Univ Lille 1, Math Lab, CNRS UMR 8524, MODAL Team,INRIA Lille Nord Europe, F-59655 Villeneuve Dascq, France; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Bowden, Donald W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Bowden, Donald W.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon, Gangwon Do, South Korea; [Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Kooner, Jaspal; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London, England; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Seielstad, Mark] Blood Syst Res Inst, San Francisco, CA USA; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England		Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	boehnke@umich.edu; esteban.parra@utoronto.ca; john.chambers@imperial.ac.uk; e_shyong_tai@nuhs.edu.sg; mark.mccarthy@drl.ox.ac.uk; a.p.morris@liverpool.ac.uk	Johnson, Andrew D/G-6520-2013; Boehm, Bernhard Otto/F-8750-2015; Seielstad, Mark/T-7841-2019; Sijbrands, Eric/A-1065-2009; Zheng, Wei/O-3351-2013; Shah, Nabi/Q-1008-2016; Hayward, Caroline/M-8818-2016; Njolstad, Inger/X-3784-2019; Tsai, Fuu-Jen/J-4140-2015; Altshuler, David M/A-4476-2009; Lopez, Miguel Cruz/O-5493-2018; Gigante, Bruna/I-9252-2012; Campbell, Harry/E-2959-2010; van Dam, Rob M/F-9674-2010; Khan, Hassan/D-6267-2013; Shah, Sonia/N-7547-2013; Ma, Ronald/C-2788-2009; Magi, Reedik/AAJ-9679-2021; Wood, Andrew R/AAB-3807-2019; FROGUEL, Philippe/O-6799-2017; Wong, Tien Y/AAC-9724-2020; Chuang, Lee-Ming/AAF-3324-2019; Loos, Ruth J F/Q-2862-2016; Grallert, Harald/B-3424-2013; Dedoussis, George/AAN-7252-2021; Prokopenko, Inga/AAU-9895-2020; Yengo, Loic/D-2692-2017; Chan, Juliana/B-7918-2016; Khaw, Kay-Tee/AAZ-3209-2021; Stancakova, Alena/AAN-6723-2020; Jia, Weiping/B-7483-2012; Study, GoDARTS/K-9448-2016; Roden, Michael/AAD-3843-2019; Chen, Chien Hsiun/Q-3826-2018; Below, Jennifer E/W-2179-2018; Langenberg, Claudia/ABG-9067-2021; Doney, Alexander SF/P-7437-2017; Lee, Jong-Young/M-6319-2013; Hydrie, Muhammad Zafar Iqbal/H-8490-2017; Navarro, Pau/AAJ-8091-2021; Shah, Nabi/AAG-7378-2021; Meigs, James/P-3927-2019; Deloukas, Panos/B-2922-2013; Kinnunen, Leena/B-7059-2012; Liu, Jianjun/AAK-4989-2020; Zimmet, Paul/O-8486-2019; Benediktsson, Rafn/R-2457-2018; Chang, Yi-cheng/O-1334-2018; Muller-Nurasyid, Martina/I-8735-2018; Palmer, Colin NA/C-7053-2008; Nakamura, Jiro/L-3693-2019; Kwak, Soo Heon/H-1463-2011; Wu, Jer-Yuarn/S-7010-2018; Prokopenko, Inga/H-3241-2014; Pinidiyapathirage, Janani/AAR-8074-2021; Wilson, James F/A-5704-2009; Leander, Karin/C-7261-2017; Sim, Xueling/AAZ-6652-2020; Thorand, Barbara/B-5349-2014; Hu, Cheng/C-3346-2008; Escobedo, Jorge/AAH-3917-2020; Stefansson, Kari/AAE-7187-2019; Veglia, Fabrizio/K-1958-2016; Fraser, Ross M/J-9519-2012; Horikoshi, Momoko/AAF-9034-2019; Rudan, Igor/I-1467-2012; Baldassarre, Damiano/J-3295-2016; Strawbridge, Rona J./H-5422-2012; Ripatti, Samuli/H-9446-2014; Dina, Christian R/D-3535-2015; Wang, Congrong/AAL-8178-2020; Li, Man/AAX-3400-2020; Kanoni, Stavroula/AAN-7161-2021; Peters, Annette/A-6117-2011; Hui, Jennie/A-9543-2013; TREMOLI, ELENA/I-8126-2018; McCarthy, Mark/M-3763-2015; Park, Kyong Soo/C-2265-2008; Hemingway, Harry/C-1219-2009	Johnson, Andrew D/0000-0001-6369-5178; Sijbrands, Eric/0000-0001-8857-7389; Zheng, Wei/0000-0003-1226-070X; Shah, Nabi/0000-0003-2764-3615; Hayward, Caroline/0000-0002-9405-9550; Altshuler, David M/0000-0002-7250-4107; Lopez, Miguel Cruz/0000-0001-9985-6172; Campbell, Harry/0000-0002-6169-6262; van Dam, Rob M/0000-0002-7354-8734; Khan, Hassan/0000-0003-1468-8654; Shah, Sonia/0000-0001-5860-4526; Ma, Ronald/0000-0002-1227-803X; FROGUEL, Philippe/0000-0003-2972-0784; Wong, Tien Y/0000-0002-8448-1264; Loos, Ruth J F/0000-0002-8532-5087; Dedoussis, George/0000-0002-7798-6221; Yengo, Loic/0000-0002-4272-9305; Chan, Juliana/0000-0003-1325-1194; Stancakova, Alena/0000-0002-1375-0252; Below, Jennifer E/0000-0002-1346-1872; Langenberg, Claudia/0000-0002-5017-7344; Doney, Alexander SF/0000-0002-6210-5620; Lee, Jong-Young/0000-0002-0092-9958; Hydrie, Muhammad Zafar Iqbal/0000-0002-1317-6975; Navarro, Pau/0000-0001-5576-8584; Shah, Nabi/0000-0003-2764-3615; Meigs, James/0000-0002-2439-2657; Deloukas, Panos/0000-0001-9251-070X; Kinnunen, Leena/0000-0001-8739-4812; Liu, Jianjun/0000-0002-3255-3019; Zimmet, Paul/0000-0003-0627-0776; Benediktsson, Rafn/0000-0002-2954-9801; Chang, Yi-cheng/0000-0002-8077-5011; Muller-Nurasyid, Martina/0000-0003-3793-5910; Palmer, Colin NA/0000-0002-6415-6560; Kwak, Soo Heon/0000-0003-1230-0919; Prokopenko, Inga/0000-0003-1624-7457; Pinidiyapathirage, Janani/0000-0003-2947-3015; Wilson, James F/0000-0001-5751-9178; Leander, Karin/0000-0002-1404-9222; Sim, Xueling/0000-0002-1233-7642; Thorand, Barbara/0000-0002-8416-6440; Hu, Cheng/0000-0003-4314-2386; Escobedo, Jorge/0000-0003-1942-7402; Veglia, Fabrizio/0000-0002-9378-8874; Fraser, Ross M/0000-0003-0488-2592; Rudan, Igor/0000-0001-6993-6884; Baldassarre, Damiano/0000-0002-2766-8882; Strawbridge, Rona J./0000-0001-8506-3585; Ripatti, Samuli/0000-0002-0504-1202; Dina, Christian R/0000-0002-7722-7348; Li, Man/0000-0002-3839-0281; Kanoni, Stavroula/0000-0002-1691-9615; Peters, Annette/0000-0001-6645-0985; Hui, Jennie/0000-0002-1653-2496; Nothen, Markus/0000-0002-8770-2464; Seielstad, Mark/0000-0001-5783-1401; Mahajan, Anubha/0000-0001-5585-3420; Morris, Andrew/0000-0002-6805-6014; TREMOLI, ELENA/0000-0002-0929-6106; Hattersley, Andrew/0000-0001-5620-473X; Kong, Augustine/0000-0001-8193-5438; Emilsson, Valur/0000-0001-9982-0524; Couper, David/0000-0002-4313-9235; Raychaudhuri, Soumya/0000-0002-1901-8265; Manickam, Chidambaram/0000-0001-8750-8576; Chen, Han/0000-0002-9510-4923; Forouhi, Nita/0000-0002-5041-248X; Beilby, John/0000-0002-4915-2254; Rybin, Denis/0000-0002-3657-4829; Lindholm, Eero/0000-0002-8869-681X; Eriksson, Johan/0000-0002-2516-2060; Zeggini, Eleftheria/0000-0003-4238-659X; Pankow, James/0000-0001-7076-483X; Shuldiner, Alan/0000-0001-9921-4305; CHANG, TIEN-JYUN/0000-0001-9437-5847; Gieger, Christian/0000-0001-6986-9554; Tai, E Shyong/0000-0003-2929-8966; Lakka, Timo/0000-0002-9199-2871; McCarthy, Mark/0000-0002-4393-0510; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Park, Kyong Soo/0000-0003-3597-342X; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Khor, Chiea Chuen/0000-0002-1128-4729; Van Duijn, Cornelia/0000-0002-2374-9204; Below, Jennifer/0000-0002-6372-6402; Katulanda, Prasad/0000-0003-4313-7528; Elliott, Paul/0000-0002-7511-5684; Hemingway, Harry/0000-0003-2279-0624; Melander, Olle/0000-0002-2581-484X; Meyer, Julia/0000-0002-1356-7597; Gigante, Bruna/0000-0003-4508-7990; Humphries, Stephen E/0000-0002-8221-6547; Edkins, Sarah/0000-0003-0717-1972; Liu, Ching-Ti/0000-0002-0703-0742; Wood, Andrew/0000-0003-1726-948X; CHUANG, LEE-MING/0000-0003-0978-2662; Jonsson, Anna/0000-0003-1252-8673; Hedman, Asa/0000-0001-5413-204X; Magi, Reedik/0000-0002-2964-6011; Rossin, Elizabeth/0000-0002-0052-9575; Tuomi, Tiinamaija/0000-0002-8306-6202; Kumar, Ashish/0000-0002-7075-5930; Dupuis, Josee/0000-0003-2871-3603; parra, esteban J/0000-0002-2057-8577; Caulfield, Mark/0000-0001-9295-3594; Lindgren, Cecilia/0000-0002-4903-9374; Dorkhan, Mozhgan/0000-0002-2478-1409; Barroso, Ines/0000-0001-5800-4520; Small, Kerrin/0000-0003-4566-0005	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); European Commission (ENGAGE FP7)European Commission [HEALTH-F4-2007-201413]; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601261]; Mexico Convocatoria [SSA/IMMS/ISSSTE-CONACYT 2012-2, clave 150352, IMSS R-2011-785-018, CONACYT Salud-2007-C01-71068]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK062370, HG000376, DK085584, DK085545, DK073541, DK085501]; Wellcome TrustWellcome TrustEuropean Commission [WT098017, WT090532, WT090367, WT098381, WT081682, WT085475]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24591347, 24591346, 23591327] Funding Source: KAKEN; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9521010, MC_UU_12015/5, G1002084, MC_UU_12015/1, MC_UP_A100_1003, MC_PC_U127592696, MR/L003120/1, MC_UU_12015/2, G0601261, G0801056] Funding Source: UKRI; British Heart FoundationBritish Heart Foundation [RG/08/008/25291, RG/08/014/24067] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601261, MR/K006584/1, MC_UU_12015/2, G9521010, MC_UP_A100_1003, MR/L003120/1, MC_UU_12015/1, G1002084, MC_U106179471, G0801056, MC_PC_U127592696, MC_UU_12015/5] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10136, NF-SI-0611-10219, NF-SI-0512-10165, NF-SI-0611-10099, NF-SI-0512-10113] Funding Source: researchfish; Novo Nordisk FondenNovo Nordisk Foundation [NNF14OC0009819, NNF12OC1016467, NNF13OC0005339] Funding Source: researchfish; Chief Scientist Office [CZB/4/710, CZB/4/672] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050924] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [ZIAHL006170] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R29HG000376, R01HG000376, R56HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK062370, U01DK085501, R01DK072193, R56DK062370, R01DK073541, U01DK085584, R01DK093757, U01DK085545, K24DK080140, U01DK062370, R01DK078616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007753] Funding Source: NIH RePORTER	Funding for the research undertaken in this study has been received from the following: the Canadian Institutes of Health Research; the European Commission (ENGAGE FP7 HEALTH-F4-2007-201413); the Medical Research Council UK (G0601261); the Mexico Convocatoria (SSA/IMMS/ISSSTE-CONACYT 2012-2, clave 150352, IMSS R-2011-785-018 and CONACYT Salud-2007-C01-71068); the US National Institutes of Health (DK062370, HG000376, DK085584, DK085545, DK073541 and DK085501); and the Wellcome Trust (WT098017, WT090532, WT090367, WT098381, WT081682 and WT085475). We acknowledge the many colleagues who contributed to collection and phenotypic characterization of the clinical samples and the genotyping and analysis of the GWAS data, full details of which are provided in the contributing consortia papers<SUP>5,11,13,15</SUP>. We also thank those individuals who agreed to participate in this study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fogarty MP, 2013, DIABETES, V62, P1756, DOI 10.2337/db12-0972; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grant SFA, 2010, ENDOCR REV, V31, P183, DOI 10.1210/er.2009-0029; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nelson SC, 2013, G3-GENES GENOM GENET, V3, P1795, DOI 10.1534/g3.113.007161; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Saxena R, 2012, AM J HUM GENET, V90, P753, DOI 10.1016/j.ajhg.2012.03.001; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Sung YJ, 2012, HUM HERED, V73, P18, DOI 10.1159/000334084; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng HF, 2012, J GENET GENOMICS, V39, P545, DOI 10.1016/j.jgg.2012.07.002	51	669	675	5	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					234	+		10.1038/ng.2897			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	WOS:000332036700007	24509480	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Toy, W; Shen, Y; Won, H; Green, B; Sakr, RA; Will, M; Li, ZQ; Gala, K; Fanning, S; King, TA; Hudis, C; Chen, D; Taran, T; Hortobagyi, G; Greene, G; Berger, M; Baselga, J; Chandarlapaty, S				Toy, Weiyi; Shen, Yang; Won, Helen; Green, Bradley; Sakr, Rita A.; Will, Marie; Li, Zhiqiang; Gala, Kinisha; Fanning, Sean; King, Tari A.; Hudis, Clifford; Chen, David; Taran, Tetiana; Hortobagyi, Gabriel; Greene, Geoffrey; Berger, Michael; Baselga, Jose; Chandarlapaty, Sarat			ESR1 ligand-binding domain mutations in hormone-resistant breast cancer	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; PHOSPHORYLATION; IDENTIFICATION; AMPLIFICATION; TAMOXIFEN; DYNAMICS; THERAPY; HER-2; AIB1	Seventy percent of breast cancers express estrogen receptor (ER), and most of these are sensitive to ER inhibition. However, many such tumors for unknown reasons become refractory to inhibition of estrogen action in the metastatic setting. We conducted a comprehensive genetic analysis of two independent cohorts of metastatic ER-positive breast tumors and identified mutations in ESR1 affecting the ligand-binding domain (LBD) in 14 of 80 cases. These included highly recurrent mutations encoding p.Tyr537Ser, p.Tyr537Asn and p.Asp538Gly alterations. Molecular dynamics simulations suggest that the structures of the Tyr537Ser and Asp538Gly mutants involve hydrogen bonding of the mutant amino acids with Asp351, thus favoring the agonist conformation of the receptor. Consistent with this model, mutant receptors drive ER-dependent transcription and proliferation in the absence of hormone and reduce the efficacy of ER antagonists. These data implicate LBD-mutant forms of ER in mediating clinical resistance to hormonal therapy and suggest that more potent ER antagonists may be of substantial therapeutic benefit.	[Toy, Weiyi; Won, Helen; Li, Zhiqiang; Gala, Kinisha; Berger, Michael; Baselga, Jose; Chandarlapaty, Sarat] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Shen, Yang] Toyota Technol Inst Chicago, Chicago, IL USA; [Green, Bradley; Fanning, Sean; Greene, Geoffrey] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Sakr, Rita A.; King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA; [Will, Marie; Hudis, Clifford; Baselga, Jose; Chandarlapaty, Sarat] Weill Cornell Med Coll, New York, NY USA; [Hudis, Clifford; Chandarlapaty, Sarat] Mem Sloan Kettering Canc Ctr, Dept Med, Solid Tumor Div, Breast Canc Med Serv, New York, NY 10021 USA; [Chen, David; Taran, Tetiana] Novartis Pharmaceut, E Hanover, NJ USA; [Hortobagyi, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Berger, Michael] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA		Chandarlapaty, S (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chandars@mskcc.org	Hudis, Clifford/AAW-9482-2021; Fanning, Sean/AAP-2517-2021; Shen, Yang/A-7939-2012; Toy, Weiyi/ABH-3914-2020	Hudis, Clifford/0000-0001-7144-8791; Fanning, Sean/0000-0002-9428-0060; Shen, Yang/0000-0002-1703-7796; Li, Zhiqiang/0000-0002-2768-5332; Toy, Weiyi/0000-0002-1369-123X	Damon Runyon Cancer Research Foundation; Louis V. Gerstner Jr. Young Investigator Award; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Argonne Leadership Computing Facility at the Argonne National Laboratory; Office of Science of the US Department of EnergyUnited States Department of Energy (DOE) [DE-AC02-06CH1135]; Toyota Technological Institute at Chicago; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA008748, P30CA016672, K08CA134833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007739] Funding Source: NIH RePORTER	We would like to thank N. Rosen and C. Sawyers for their insights and critical reading of the manuscript, P. Chi and S. Lowe (MSKCC) for plasmids and J.S. Reis-Filho (MSKCC) for cell lines. S. C. is funded by the Damon Runyon Cancer Research Foundation and a Louis V. Gerstner Jr. Young Investigator Award. M. B. and H. W. are funded by the Starr Cancer Consortium and the Geoffrey Beene Cancer Research Center, respectively. Individual support for this study was also provided by Julie Laub (to C. H.). Molecular dynamics simulations were performed using computational resources awarded to Y.S. by the Argonne Leadership Computing Facility at the Argonne National Laboratory, which is supported by the Office of Science of the US Department of Energy under contract DE-AC02-06CH11357. Y.S. is partially funded by the Toyota Technological Institute at Chicago.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Azorsa DO, 2001, BREAST CANCER RES TR, V70, P89, DOI 10.1023/A:1012972808558; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lipton A, 2005, CANCER, V104, P257, DOI 10.1002/cncr.21202; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Zhang QX, 1997, CANCER RES, V57, P1244	35	669	690	4	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1439	U189		10.1038/ng.2822			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	WOS:000327715800008	24185512	Green Accepted	Y	N	2022-01-24	
J	Marchini, J; Donnelly, P; Cardon, LR				Marchini, J; Donnelly, P; Cardon, LR			Genome-wide strategies for detecting multiple loci that influence complex diseases	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; QUANTITATIVE TRAIT; SUSCEPTIBILITY; EPISTASIS; MODELS; POLYMORPHISM; METABOLISM; SNPS	After nearly 10 years of intense academic and commercial research effort, large genome-wide association studies for common complex diseases are now imminent. Although these conditions involve a complex relationship between genotype and phenotype, including interactions between unlinked loci(1), the prevailing strategies for analysis of such studies focus on the locus-by-locus paradigm. Here we consider analytical methods that explicitly look for statistical interactions between loci. We show first that they are computationally feasible, even for studies of hundreds of thousands of loci, and second that even with a conservative correction for multiple testing, they can be more powerful than traditional analyses under a range of models for interlocus interactions. We also show that plausible variations across populations in allele frequencies among interacting loci can markedly affect the power to detect their marginal effects, which may account in part for the well-known difficulties in replicating association results. These results suggest that searching for interactions among genetic loci can be fruitfully incorporated into analysis strategies for genome-wide association studies.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England		Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020	Marchini, Jonathan/0000-0003-0610-8322; Donnelly, Peter/0000-0001-9495-3408			Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2001, CURR OPIN CHEM BIOL, V5, P78, DOI 10.1016/S1367-5931(00)00171-X; CLAYTON D, 2001, HDB STAT GENETICS, P519; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Hoh J, 2000, ANN HUM GENET, V64, P413, DOI 10.1046/j.1469-1809.2000.6450413.x; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kempthorne O., 1957, INTRO GENETIC STAT; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Phillips PC, 1998, GENETICS, V149, P1167; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROSES A, 2003, NAT GENET S2, V33, P217; Routman EJ, 1997, EVOLUTION, V51, P1654, DOI [10.1111/j.1558-5646.1997.tb01488.x, 10.2307/2411217]; Schlesselman JJ., 1982, CASE CONTROL STUDIES; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SHAM P, 1997, STAT HUMAN GENETICS; SING CF, 1985, AM J HUM GENET, V37, P268; Thomas DC, 2004, STAT METHODS GENETIC; Tiwari HK, 1997, GENET EPIDEMIOL, V14, P1131, DOI 10.1002/(SICI)1098-2272(1997)14:6<1131::AID-GEPI95>3.3.CO;2-7; Williams SM, 2004, BIOESSAYS, V26, P170, DOI 10.1002/bies.10401; Zerba KE, 2000, HUM GENET, V107, P466, DOI 10.1007/s004390000394; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270; [No title captured]	29	669	693	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					413	417		10.1038/ng1537			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	WOS:000228040000025	15793588				2022-01-24	
J	Neyroud, N; Tesson, F; Denjoy, I; Leibovici, M; Donger, C; Barhanin, J; Faure, S; Gary, F; Coumel, P; Petit, C; Schwartz, K; Guicheney, P				Neyroud, N; Tesson, F; Denjoy, I; Leibovici, M; Donger, C; Barhanin, J; Faure, S; Gary, F; Coumel, P; Petit, C; Schwartz, K; Guicheney, P			A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome	NATURE GENETICS			English	Article							LONG QT SYNDROME; STRIA VASCULARIS; CARDIAC-ARRHYTHMIA; K+ CHANNEL; PROTEIN; LOCALIZATION; VOLTAGE; EXPRESSION; CLONING; CELLS	The Jervell and Lange-Nielsen (JLN) syndrome (MIM 220400) is an inherited autosomal recessive disease characterized by a congenital bilateral deafness associated with a QT prolongation on the electrocardiogram, syncopal attacks due to ventricular arrhythmias and a high risk of sudden death(1). JLN syndrome is a rare disease, which seems to affect less than one percent of all deaf children(2-4) Linkage to chromosome 11p15.5 markers was found by analysing four consanguinous families. Recombinants allowed us to map the JLN gene between D11S922 and D11S4146, to a 6-cM interval where KVLQT1, a potassium channel gene causing Romano-Ward (RW) syndrome, the dominant form of long QT syndrome, has been previously localized(5), An homozygous deletion-insertion event (1244, -7 +8) in the C-terminal domain of this gene was detected in three affected children of two families. We found that KVLQT1 is expressed in the stria vascularis of mouse inner ear by in situ hybridization. Taken together, our data indicate that KVLQT1 is responsible for both JLN and RW syndromes and has a key role not only in the ventricular repolarization but also in normal hearing, probably via the control of endolymph homeostasis.	GRP HOSP PITIE SALPETRIERE, INST MYOL, INSERM UR153, F-75013 PARIS, FRANCE; HOP LARIBOISIERE, SERV CARDIOL, F-75010 PARIS, FRANCE; CHATEAU COTES, F-78350 LES LOGES EN JOSAS, FRANCE; INST PASTEUR, CNRS URA 1968, MOL GENET UNIT, F-75015 PARIS, FRANCE; CNRS, INST PHARMACOL MOL & CELLULAIRE, F-06560 VALBONNE, FRANCE; GENETHON CNRS URA 1922, F-91002 EVRY, FRANCE				Neyroud, Nathalie/D-1013-2017; Guicheney, Pascale/D-1034-2017; Leibovici, Michel/ABB-6745-2020; Tesson, Frederique/A-3218-2013	Neyroud, Nathalie/0000-0003-3382-7680; Guicheney, Pascale/0000-0002-7663-2050; Petit, Christine/0000-0002-9069-002X			ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; DAUSSE E, 1995, CR ACAD SCI III-VIE, V318, P879; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRASER GR, 1964, ANN HUM GENET, V28, P133, DOI 10.1111/j.1469-1809.1964.tb00469.x; FRASER GR, 1964, Q J MED, V33, P361; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOFFMAN EP, 1995, CELL, V80, P681, DOI 10.1016/0092-8674(95)90345-3; HONORE E, 1991, EMBO J, V10, P2805, DOI 10.1002/j.1460-2075.1991.tb07829.x; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JEFFERY S, 1992, LANCET, V339, P255, DOI 10.1016/0140-6736(92)90071-A; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MORI N, 1993, EUR ARCH OTO-RHINO-L, V250, P186; PERNOT C, 1972, ARCH MAL COEUR VAISS, V65, P261; PERNOT C, 1974, COEUR MED INTERNE, V13, P429; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tesson F, 1996, J MOL CELL CARDIOL, V28, P2051, DOI 10.1006/jmcc.1996.0198; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; WYMORE RS, 1994, GENOMICS, V20, P191, DOI 10.1006/geno.1994.1153	31	669	687	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1997	15	2					186	189		10.1038/ng0297-186			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	WOS:A1997WF08700020	9020846				2022-01-24	
J	Gudmundsson, J; Sulem, P; Manolescu, A; Amundadottir, LT; Gudbjartsson, D; Helgason, A; Rafnar, T; Bergthorsson, JT; Agnarsson, BA; Baker, A; Sigurdsson, A; Benediktsdottir, KR; Jakobsdottir, M; Xu, JF; Blondal, T; Kostic, J; Sun, JL; Ghosh, S; Stacey, SN; Mouy, M; Saemundsdottir, J; Backman, VM; Kristjansson, K; Tres, A; Partin, AW; Albers-Akkers, MT; Marcos, JGI; Walsh, PC; Swinkels, DW; Navarrete, S; Isaacs, SD; Aben, KK; Graif, T; Cashy, J; Ruiz-Echarri, M; Wiley, KE; Suarez, BK; Witjes, JA; Frigge, M; Ober, C; Jonsson, E; Einarsson, GV; Mayordomo, JI; Kiemeney, LA; Isaacs, WB; Catalona, WJ; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Manolescu, Andrei; Amundadottir, Laufey T.; Gudbjartsson, Daniel; Helgason, Agnar; Rafnar, Thorunn; Bergthorsson, Jon T.; Agnarsson, Bjarni A.; Baker, Adam; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Jakobsdottir, Margret; Xu, Jianfeng; Blondal, Thorarinn; Kostic, Jelena; Sun, Jielin; Ghosh, Shyamali; Stacey, Simon N.; Mouy, Magali; Saemundsdottir, Jona; Backman, Valgerdur M.; Kristjansson, Kristleifur; Tres, Alejandro; Partin, Alan W.; Albers-Akkers, Marjo T.; Marcos, Javier Godino-Ivan; Walsh, Patrick C.; Swinkels, Dorine W.; Navarrete, Sebastian; Isaacs, Sarah D.; Aben, Katja K.; Graif, Theresa; Cashy, John; Ruiz-Echarri, Manuel; Wiley, Kathleen E.; Suarez, Brian K.; Witjes, J. Alfred; Frigge, Mike; Ober, Carole; Jonsson, Eirikur; Einarsson, Gudmundur V.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Isaacs, William B.; Catalona, William J.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24	NATURE GENETICS			English	Article							CERVICAL-CARCINOMA; CONFERS RISK; METAANALYSIS; INTEGRATION; DISEASES; LOCUS	Prostate cancer is the most prevalent noncutaneous cancer in males in developed regions(1), with African American men having among the highest worldwide incidence and mortality rates(2). Here we report a second genetic variant in the 8q24 region that, in conjunction with another variant we recently discovered(3), accounts for about 11% - 13% of prostate cancer cases in individuals of European descent and 31% of cases in African Americans. We made the current discovery through a genome-wide association scan of 1,453 affected Icelandic individuals and 3,064 controls using the Illumina HumanHap 300 BeadChip followed by four replication studies. A key step in the discovery was the construction of a 14-SNP haplotype that efficiently tags a relatively uncommon (2% - 4%) susceptibility variant in individuals of European descent that happens to be very common (similar to 42%) in African Americans. The newly identified variant shows a stronger association with affected individuals who have an earlier age at diagnosis.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21209 USA; Thrombosis Serv, NL-6503 GM Nijmegen, Netherlands; Inst Hlth Sci, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, Nijmegen, Netherlands; Univ Hosp, Div Radiat Oncol, Zaragoza, Spain; Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Landspital Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands		Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	augustine.kong@decode.is; kstefans@decode.is	Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019; Kiemeney, Lambertus A./D-3357-2009; Swinkels, Dorine W./H-8098-2014; Helgason, Agnar/K-1522-2015; Amundadottir, Laufey T/L-7656-2016; Backman, Vadim/B-6689-2009; Aben, Katja KH/G-9686-2016; Mayordomo, Jose/K-3453-2013; Witjes, Fred/N-9665-2013	Manolescu, Andrei/0000-0002-0713-4664; Kiemeney, Lambertus A./0000-0002-2368-1326; Swinkels, Dorine W./0000-0002-1040-9446; Amundadottir, Laufey T/0000-0003-1859-8971; Aben, Katja KH/0000-0002-0214-2147; Kong, Augustine/0000-0001-8193-5438; Bergthorsson, Jon Thor/0000-0002-0560-2639; Ober, Carole/0000-0003-4626-9809; Gudbjartsson, Daniel/0000-0002-5222-9857			Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Ferber MJ, 2004, CANCER GENET CYTOGEN, V154, P1, DOI 10.1016/j.cancergencyto.2004.01.028; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MANTEL N, 1959, J NATL CANCER I, V22, P719; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; REES LAG, 2006, SEER CANC STAT REV 1; Taylor ML, 2005, FAM MED, V37, P506; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	22	668	690	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					631	637		10.1038/ng1999			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	WOS:000245971300018	17401366				2022-01-24	
J	FRIEDMAN, DB; JOHNSON, TE				FRIEDMAN, DB; JOHNSON, TE			A MUTATION IN THE AGE-1 GENE IN CAENORHABDITIS-ELEGANS LENGTHENS LIFE AND REDUCES HERMAPHRODITE FERTILITY	GENETICS			English	Article									UNIV CALIF IRVINE, DEPT MOLEC BIOL & BIOCHEM, IRVINE, CA 92717 USA					/0000-0001-7147-8237	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG05720, N01-AG-9-2113] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG005720] Funding Source: NIH RePORTER		BRENNER S, 1974, GENETICS, V77, P71; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.1093/biomet/57.3.579; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Charlesworth B, 1980, EVOLUTION AGE STRUCT; EMMONS SW, 1984, CELL, V36, P599, DOI 10.1016/0092-8674(84)90339-8; Falconer DS, 1981, INTRO QUANTITATIVE G; FINCH CE, 1985, HDB BIOL AGING; FRIEDMAN DB, 1988, IN PRESS J GERONTOL; GOLDSTEIN S, 1971, NEW ENGL J MED, V285, P1120, DOI 10.1056/NEJM197111112852005; GOULD AB, 1977, EXP GERONTOL, V12, P107, DOI 10.1016/0531-5565(77)90017-1; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; HAYFLICK L, 1987, MODERN BIOL THEORIES, P21; HAYFLICK L, 1985, PRINCIPLES GERIATRIC, P9; HODGKIN J, 1983, GENETICS, V103, P43; HULL CH, 1979, SPSS UPDATE; Johnson T.E., 1984, P59; JOHNSON TE, 1986, BEHAV GENET, V16, P221, DOI 10.1007/BF01065487; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; JOHNSON TE, 1985, MECH AGEING DEV, V30, P285, DOI 10.1016/0047-6374(85)90118-6; JOHNSON TE, 1987, MODERN BIOL THEORIES, P63; Kirkwood T.B.L., 1985, HDB BIOL AGING, P27; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; LEFFELAAR D, 1984, DEV GENET, V4, P199; LINTS FA, 1978, GENETICS AGEING INTE, V14; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MASORO EJ, 1985, MOL BIOL AGING, P105; Medawar P.B., 1952, UNSOLVED PROBLEM BIO; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; ROSE MR, 1985, THEOR POPUL BIOL, V28, P342, DOI 10.1016/0040-5809(85)90034-6; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; ROTHSTEIN M, 1983, REV BIOL RES AGING, V1; ROTHSTEIN M, 1987, REV BIOL RES AGING, V3; ROTHSTEIN M, 1985, REV BIOL RES AGING, V2; RUSSELL EA, 1976, GENETIC EFFECTS AGIN, P515; SACHER GA, 1977, HDB BIOL AGING, P00582; SIGURDSON DC, 1984, GENETICS, V108, P331; Sokal R.R., 1981, BIOMETRY; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; WEINDRUCH R, 1984, FREE RADICALS MOL BI, P181; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; [No title captured]; [No title captured]	47	668	692	4	50	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	1988	118	1					75	86					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L6921	WOS:A1988L692100009	8608934				2022-01-24	
J	Smith, FJD; Irvine, AD; Terron-Kwiatkowski, A; Sandilands, A; Campbell, LE; Zhao, YW; Liao, HH; Evans, AT; Goudie, DR; Lewis-Jones, S; Arseculeratne, G; Munro, CS; Sergeant, A; O'Regan, G; Bale, SJ; Compton, JG; DiGiovanna, JJ; Presland, RB; Fleckman, P; McLean, WHI				Smith, FJD; Irvine, AD; Terron-Kwiatkowski, A; Sandilands, A; Campbell, LE; Zhao, YW; Liao, HH; Evans, AT; Goudie, DR; Lewis-Jones, S; Arseculeratne, G; Munro, CS; Sergeant, A; O'Regan, G; Bale, SJ; Compton, JG; DiGiovanna, JJ; Presland, RB; Fleckman, P; McLean, WHI			Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris	NATURE GENETICS			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; N-TERMINAL DOMAIN; FLAKY TAIL; GENOMIC ORGANIZATION; LAMELLAR ICHTHYOSIS; HUMAN PROFILAGGRIN; SKIN; IDENTIFICATION; EXPRESSION; PROTEINS	Ichthyosis vulgaris (OMIM 146700) is the most common inherited disorder of keratinization and one of the most frequent single-gene disorders in humans. The most widely cited incidence figure is 1 in 250 based on a survey of 6,051 healthy English schoolchildren(1). We have identified homozygous or compound heterozygous mutations R501X and 2282del4 in the gene encoding filaggrin (FLG) as the cause of moderate or severe ichthyosis vulgaris in 15 kindreds. In addition, these mutations are semidominant; heterozygotes show a very mild phenotype with incomplete penetrance. The mutations show a combined allele frequency of similar to 4% in populations of European ancestry, explaining the high incidence of ichthyosis vulgaris. Profilaggrin is the major protein of keratohyalin granules in the epidermis. During terminal differentiation, it is cleaved into multiple filaggrin peptides that aggregate keratin filaments. The resultant matrix is cross-linked to form a major component of the cornified cell envelope. We find that loss or reduction of this major structural protein leads to varying degrees of impaired keratinization.	Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Human Genet Unit,Epithelial Genet Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Univ Hosp NHS Trust, Dundee DD1 9SY, Scotland; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; S Glasgow Univ Hosp NHS Trust, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Gene Dx, Gaithersburg, MD 20877 USA; Rhode Isl Hosp, Providence, RI 02903 USA; Brown Univ, Sch Med, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA; NCI, Basic Res Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Washington, Sch Dent, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98195 USA		McLean, WHI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Human Genet Unit,Epithelial Genet Grp, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk	Irvine, Alan D/A-3982-2008; McLean, William HI/C-6352-2009	Irvine, Alan D/0000-0002-9048-2044; Presland, Richard/0000-0003-1440-7402; McLean, William Henry Irwin/0000-0001-5539-5757	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700314] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Bale SJ, 1996, J INVEST DERMATOL, V107, P140, DOI 10.1111/1523-1747.ep12298430; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Compton JG, 2002, EXP DERMATOL, V11, P518, DOI 10.1034/j.1600-0625.2002.110604.x; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; Eady R. A. J., 1985, METHODS SKIN RES, P1; FLECKMAN P, 1987, J INVEST DERMATOL, V88, P640, DOI 10.1111/1523-1747.ep12470251; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Ishida-Yamamoto A, 1998, LAB INVEST, V78, P1245; JUDGE MR, 2004, ROOKS TXB DERMATOLOG, V2, P56; Kuokkanen K, 1969, Acta Derm Venereol Suppl (Stockh), V62, P1; LANE PW, 1972, J HERED, V63, P135, DOI 10.1093/oxfordjournals.jhered.a108252; Listwan P, 2004, METHOD CELL BIOL, V78, P817; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nirunsuksiri W, 1998, J INVEST DERMATOL, V110, P854, DOI 10.1046/j.1523-1747.1998.00208.x; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Penabad CP, 1998, BRIT J DERMATOL, V139, P958; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; ROTHNAGEL JA, 1994, GENOMICS, V23, P450, DOI 10.1006/geno.1994.1522; ROTHNAGEL JA, 1990, J BIOL CHEM, V265, P1862; Smith FJD, 1998, J INVEST DERMATOL, V111, P817, DOI 10.1046/j.1523-1747.1998.00371.x; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; SYBERT VP, 1985, J INVEST DERMATOL, V84, P191, DOI 10.1111/1523-1747.ep12264813; Tay YK, 1999, ASIAN PAC J ALLERGY, V17, P137; WELLS RS, 1966, BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5493.947; Zhong W, 2003, J HUM GENET, V48, P390, DOI 10.1007/s10038-003-0043-1	30	667	702	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					337	342		10.1038/ng1743			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	WOS:000235589600016	16444271				2022-01-24	
J	HOWARDFLANDERS, P; THERIOT, L				HOWARDFLANDERS, P; THERIOT, L			MUTANTS OF ESCHERICHIA COLI K-12 DEFECTIVE IN DNA REPAIR AND IN GENETIC RECOMBINATION	GENETICS			English	Article																	ADELBERG EA, 1960, J BACTERIOL, V79, P321, DOI 10.1128/JB.79.3.321-330.1960; BOYCE RP, 1964, P NATL ACAD SCI USA, V51, P293, DOI 10.1073/pnas.51.2.293; BURNET FM, 1959, VIRUSES, V2, P281; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; CLARK AJ, SUBMITTED PUBLICATIO; HOWARDFLANDERS P, 1964, GENETICS, V50, P256; LEVINTHAL C, 1959, VIRUSES, V2, P281; MESELSON M, 1964, J MOL BIOL, V9, P734, DOI 10.1016/S0022-2836(64)80178-9; MESELSON M, 1961, P NATL ACAD SCI USA, V47, P857, DOI 10.1073/pnas.47.6.857; PETTIJOHN DE, 1964, J MOL BIOL, V9, P395, DOI 10.1016/S0022-2836(64)80216-3; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; SETLOW RB, 1965, P NATL ACAD SCI USA, V53, P1111, DOI 10.1073/pnas.53.5.1111; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226	13	667	672	0	7	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1966	53	6					1137	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	78709	WOS:A19667870900009	5335129				2022-01-24	
J	Lam, HM; Xu, X; Liu, X; Chen, WB; Yang, GH; Wong, FL; Li, MW; He, WM; Qin, N; Wang, B; Li, J; Jian, M; Wang, JA; Shao, GH; Wang, J; Sun, SSM; Zhang, GY				Lam, Hon-Ming; Xu, Xun; Liu, Xin; Chen, Wenbin; Yang, Guohua; Wong, Fuk-Ling; Li, Man-Wah; He, Weiming; Qin, Nan; Wang, Bo; Li, Jun; Jian, Min; Wang, Jian; Shao, Guihua; Wang, Jun; Sun, Samuel Sai-Ming; Zhang, Gengyun			Resequencing of 31 wild and cultivated soybean genomes identifies patterns of genetic diversity and selection	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ARABIDOPSIS-THALIANA; DOMESTICATION; SEQUENCE; RICE; ALIGNMENT; TOOL; MAP; RECOMBINATION; POLYMORPHISM	We report a large-scale analysis of the patterns of genome-wide genetic variation in soybeans. We re-sequenced a total of 17 wild and 14 cultivated soybean genomes to an average of approximately x5 depth and > 90% coverage using the Illumina Genome Analyzer II platform. We compared the patterns of genetic variation between wild and cultivated soybeans and identified higher allelic diversity in wild soybeans. We identified a high level of linkage disequilibrium in the soybean genome, suggesting that marker-assisted breeding of soybean will be less challenging than map-based cloning. We report linkage disequilibrium block location and distribution, and we identified a set of 205,614 tag SNPs that may be useful for QTL mapping and association studies. The data here provide a valuable resource for the analysis of wild soybeans and to facilitate future breeding and quantitative trait analysis.	[Lam, Hon-Ming; Liu, Xin; Wong, Fuk-Ling; Li, Man-Wah; Shao, Guihua; Sun, Samuel Sai-Ming] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Xu, Xun; Zhang, Gengyun] BGI Shenzhen, Key Lab Genom, Minist Agr, Shenzhen, Peoples R China; [Shao, Guihua] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Lam, Hon-Ming; Liu, Xin; Wong, Fuk-Ling; Li, Man-Wah; Shao, Guihua; Sun, Samuel Sai-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China		Lam, HM (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk; wangj@genomics.cn; ssun@cuhk.edu.hk; zhanggengyun@genomics.cn	Li, Man-Wah/AAZ-5631-2021; Xu, Xun/AAI-6763-2020; Lam, Hon-Ming/A-9866-2008; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Li, Man-Wah/0000-0003-4859-5683; Xu, Xun/0000-0002-5338-5173; Lam, Hon-Ming/0000-0002-6673-8740; Wang, Jun/0000-0002-8540-8931; Liu, Xin/0000-0003-3256-2940; Wang, Jun/0000-0002-2113-5874	Hong Kong RGCHong Kong Research Grants Council [468610]; Hong Kong UGC AoE Center for Plant and Agricultural Biotechnology [AoE-B-07/09]; Resource Allocation Committee; Chinese University of Hong KongChinese University of Hong Kong; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30725008]; Chinese 973 programNational Basic Research Program of China [2007CB815703, 2007CB815705]; Chinese Ministry of AgricultureMinistry of Agriculture, China; Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China [ZYC200903240077A, CXB200903110066A]	T. Han, X. Yan, H. Liao, B. Zhuang and Y.-K. Lau provided valuable advice, information and other aid. This work was partially supported by the Hong Kong RGC General Research Fund 468610 (to H.-M.L.), the Hong Kong UGC AoE Center for Plant and Agricultural Biotechnology Project AoE-B-07/09 and a special fund from the Resource Allocation Committee, The Chinese University of Hong Kong (to H.-M.L. and S. S.-M.S.). We also acknowledge the funding support from the National Natural Science Foundation of China (30725008), the Chinese 973 program (2007CB815703; 2007CB815705), Chinese Ministry of Agriculture (948 program), the Shenzhen Municipal Government of China and grants from Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A). We thank L. Goodman for assistance in editing the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Doyle JJ., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Huang ZhongWen, 2008, Acta Agronomica Sinica, V34, P944, DOI 10.3724/SP.J.1006.2008.00944; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HYMOWITZ T, 1983, ECON BOT, V37, P371, DOI 10.1007/BF02904196; HYMOWITZ T, 1970, ECON BOT, V24, P408, DOI 10.1007/BF02860745; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li HY, 2010, THEOR APPL GENET, V120, P1405, DOI 10.1007/s00122-010-1264-2; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Pritchard JK, 2000, GENETICS, V155, P945; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msr121; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	47	666	729	6	265	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2010	42	12					1053	U41		10.1038/ng.715			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	WOS:000284578800007	21076406				2022-01-24	
J	Bale, TL; Contarino, AB; Smith, GW; Chan, R; Gold, LH; Sawchenko, PE; Koob, GF; Vale, WW; Lee, KF				Bale, TL; Contarino, AB; Smith, GW; Chan, R; Gold, LH; Sawchenko, PE; Koob, GF; Vale, WW; Lee, KF			Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress	NATURE GENETICS			English	Article							ACOUSTIC STARTLE REFLEX; CENTRAL NUCLEUS; ACTH-SECRETION; RAT-BRAIN; NEUROPEPTIDE; UROCORTIN; AMYGDALA; PARTICIPATION; HYPOTHALAMUS; EXPRESSION	Corticotropin-releasing hormone (Crh) is a critical coordinator of the hypothalamic-pituitary-adrenal (HPA) axis. In response to stress, Crh released from the paraventricular nucleus (PVN) of the hypothalamus activates Crh receptors on anterior pituitary corticotropes, resulting in release of adrenocorticotropic hormone (Acth) into the bloodstream. Acth in turn activates Acth receptors in the adrenal cortex to increase synthesis and release of glucocorticoids(1). The receptors for Crh, Crhr1 and Crhr2, are found throughout the central nervous system and periphery. Crh has a higher affinity for Crhr1 than for Crhr2, and urocortin (Ucn); a Crh-related peptide, is thought to be the endogenous ligand for Crhr2 because it binds with almost 40-fold higher affinity than does Crh (ref. 2). Crhr1 and Crhr2 share approximately 71% amino acid sequence similarity and are distinct in their localization within the brain and peripheral tissues(3-6). We generated mice deficient for Crhr2 to determine the physiological role of this receptor. Crhr2-mutant mice are hypersensitive to stress and display increased anxiety-like behaviour. Mutant mice have normal basal feeding and weight gain, but decreased food intake following food deprivation. intravenous Ucn produces no effect on mean arterial pressure in the mutant mice.	Salk Inst, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Salk Inst, Neuronal Struct & Funct Lab, La Jolla, CA USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA USA		Lee, KF (corresponding author), Salk Inst, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA.		Contarino, Angelo/C-9429-2014	Contarino, Angelo/0000-0002-7286-6941	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK026741, F32DK009841, F32DK009551] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK09551, DK-26741, DK09841] Funding Source: Medline		ALLEN JP, 1975, NEUROENDOCRINOLOGY, V19, P115, DOI 10.1159/000122432; BALE TL, 1995, ENDOCRINOLOGY, V136, P27, DOI 10.1210/en.136.1.27; BEAULIEU S, 1987, NEUROENDOCRINOLOGY, V45, P37, DOI 10.1159/000124701; BEAULIEU S, 1986, NEUROENDOCRINOLOGY, V44, P247, DOI 10.1159/000124652; BELZUNG C, 1994, PHYSIOL BEHAV, V56, P623, DOI 10.1016/0031-9384(94)90311-5; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; KING FA, 1958, SCIENCE, V128, P655, DOI 10.1126/science.128.3325.655; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Lee YL, 1997, J NEUROSCI, V17, P6424; LIANG KC, 1992, J NEUROSCI, V12, P2313; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Marcilhac A, 1996, EXP PHYSIOL, V81, P1035, DOI 10.1113/expphysiol.1996.sp003987; MELIA KR, 1991, PHYSIOL BEHAV, V49, P603, DOI 10.1016/0031-9384(91)90286-W; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; STENZEL P, 1995, MOL ENDOCRINOL, V9, P537; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0	24	666	673	1	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					410	414		10.1038/74263			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	WOS:000086192800023	10742108				2022-01-24	
J	Miller, MR; Dunham, JP; Amores, A; Cresko, WA; Johnson, EA				Miller, Michael R.; Dunham, Joseph P.; Amores, Angel; Cresko, William A.; Johnson, Eric A.			Rapid and cost-effective polymorphism identification and genotyping using restriction site associated DNA (RAD) markers	GENOME RESEARCH			English	Article							LARGE-SCALE IDENTIFICATION; THREESPINE STICKLEBACKS; GENETIC ARCHITECTURE; GENOME; EVOLUTION; POPULATIONS; DIVERGENCE; ARRAYS; MAP	Restriction site associated DNA (RAD) tags are a genome-wide representation of every site of a particular restriction enzyme by short DNA tags. Most organisms segregate large numbers of DNA sequence polymorphisms that disrupt restriction sites, which allows RAD tags to serve as genetic markers spread at a high density throughout the genome. Here, we demonstrate the applicability of RAD markers for both individual and bulk-segregant genotyping. First, we show that these markers can be identified and typed on pre-existing microarray formats. Second, we present a method that uses RAD marker DNA to rapidly produce a low-cost microarray genotyping resource that can be used to efficiently identify and type thousands of RAD markers. We demonstrate the utility of the former approach by using a tiling path array for the fruit fly to map a recombination breakpoint, and the latter approach by creating and using an enriched RAD marker array for the threespine stickleback. The high number of RAD markers enabled localization of a previously identified region, as well as a second region also associated with the lateral plate phenotype. Taken together, our results demonstrate that RAD markers, and the method to develop a RAD marker microarray resource, allow high-throughput, high-resolution genotyping in both model and nonmodel systems.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA		Johnson, EA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	eric-johnson@molbio.uoregon.edu	Cresko, William/H-4010-2014	Cresko, William/0000-0002-3496-8074; Amores, Angel/0000-0002-9307-3609	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR020833] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01 RR020833, 5R01RR020833] Funding Source: Medline		Bell MA., 1994, EVOLUTIONARY BIOL TH; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Carroll S, 2005, DNA DIVERSITY; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; CRESKO WA, 2006, GENETICA; Davidson E. H., 2001, GENOMIC REGULATORY S; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Fisher, 1930, GENETICAL THEORY NAT; Hollich V, 2004, BIOTECHNIQUES, V37, P282, DOI 10.2144/04372MT01; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kingsley DM, 2004, BEHAVIOUR, V141, P1331, DOI 10.1163/1568539042948150; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Peichel CL, 2005, DEV DYNAM, V234, P815, DOI 10.1002/dvdy.20564; Raghavachari N, 2003, ANAL BIOCHEM, V312, P101, DOI 10.1016/S0003-2697(02)00440-2; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wootton R.J., 1976, BIOL STICKLEBACKS	32	664	710	6	274	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	FEB	2007	17	2					240	248		10.1101/gr.5681207			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	132KR	WOS:000243942200013	17189378	Green Published, Bronze			2022-01-24	
J	DeBaun, MR; Niemitz, EL; Feinberg, AP				DeBaun, MR; Niemitz, EL; Feinberg, AP			Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILMS-TUMOR; DISRUPTION; EXPRESSION; CULTURE; INSTABILITY; TRANSCRIPT; CHILDREN; EMBRYOS; CANCER; LOCUS	Recent data in humans and animals suggest that assisted reproductive technology (ART) might affect the epigenetics of early embryogenesis and might cause birth defects. We report the first evidence, to our knowledge, that ART is associated with a human overgrowth syndrome-namely, Beckwith-Wiedemann syndrome (BWS). In a prospective study, the prevalence of ART was 4.6% (3 of 65), versus the background rate of 0.8% in the United States. A total of seven children with BWS were born after ART-five of whom were conceived after intracytoplasmic sperm injection. Molecular studies of six of the children indicate that five of the six have specific epigenetic alterations associated with BWS-four at LIT1 and one at both LIT1 and H19. We discuss the implications of our finding that ART is associated with human overgrowth, similar to the large offspring syndrome reported in ruminants.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Washington Univ, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63130 USA		Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 1064 Ross,720 Rutland Ave, Baltimore, MD 21205 USA.		Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37 CA054358, R01 CA054358, CA54358, R37 CA054358-13] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA054358, R37CA054358] Funding Source: NIH RePORTER		Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Sutcliffe AG, 1995, HUM REPROD, V10, P3332, DOI 10.1093/oxfordjournals.humrep.a135915; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	22	664	699	3	60	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					156	160		10.1086/346031			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	WOS:000180186800015	12439823	Green Published, Bronze			2022-01-24	
J	FromontRacine, M; Rain, JC; Legrain, P				FromontRacine, M; Rain, JC; Legrain, P			Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; SPLICING FACTORS; 2-HYBRID SYSTEM; IDENTIFICATION; COMPLEX; IDENTIFY; PRP11; SM; U6; U2		INST PASTEUR,CNRS URA 1300,LAB METAB,ARN,F-75724 PARIS 15,FRANCE					RAIN, Jean-Christophe/0000-0001-8110-0641; Fromont-Racine, Micheline/0000-0001-9906-0334			ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Arning S, 1996, RNA, V2, P794; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; Bordonne R, 1996, GENE, V176, P111, DOI 10.1016/0378-1119(96)00230-2; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; GARRELS, 1996, YEAST PROTEOME HDB; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; He F, 1996, RNA, V2, P153; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LEGRAIN P, 1993, GENE DEV, V7, P1390, DOI 10.1101/gad.7.7b.1390; Racevskis J, 1996, CELL GROWTH DIFFER, V7, P271; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; RIAN JC, 1996, RNA, V2, P535; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Sourdive DJD, 1997, NUCLEIC ACIDS RES, V25, P1476, DOI 10.1093/nar/25.8.1476; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; STUTZ F, 1995, CELL, V82, P495, DOI 10.1016/0092-8674(95)90438-7; vanVenrooij WJ, 1995, CURR OPIN IMMUNOL, V7, P819, DOI 10.1016/0952-7915(95)80054-9; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wells SE, 1996, GENE DEV, V10, P220, DOI 10.1101/gad.10.2.220	32	664	681	0	32	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					277	282		10.1038/ng0797-277			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	WOS:A1997XG60900024	9207794				2022-01-24	
J	Prokunina-Olsson, L; Muchmore, B; Tang, W; Pfeiffer, RM; Park, H; Dickensheets, H; Hergott, D; Porter-Gill, P; Mumy, A; Kohaar, I; Chen, S; Brand, N; Tarway, M; Liu, LY; Sheikh, F; Astemborski, J; Bonkovsky, HL; Edlin, BR; Howell, CD; Morgan, TR; Thomas, DL; Rehermann, B; Donnelly, RP; O'Brien, TR				Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei; Pfeiffer, Ruth M.; Park, Heiyoung; Dickensheets, Harold; Hergott, Dianna; Porter-Gill, Patricia; Mumy, Adam; Kohaar, Indu; Chen, Sabrina; Brand, Nathan; Tarway, McAnthony; Liu, Luyang; Sheikh, Faruk; Astemborski, Jacquie; Bonkovsky, Herbert L.; Edlin, Brian R.; Howell, Charles D.; Morgan, Timothy R.; Thomas, David L.; Rehermann, Barbara; Donnelly, Raymond P.; O'Brien, Thomas R.			A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus	NATURE GENETICS			English	Article							EARLY VIRAL KINETICS; INTERLEUKIN 28B; MULTIETHNIC COHORT; STIMULATED GENES; LAMBDA; EXPRESSION; GENOTYPE; RIBAVIRIN; THERAPY; FOS	Chronic infection with hepatitis C virus (HCV) is a common cause of liver cirrhosis and cancer. We performed RNA sequencing in primary human hepatocytes activated with synthetic double-stranded RNA to mimic HCV infection. Upstream of IFNL3 (IL28B) on chromosome 19q13.13, we discovered a new transiently induced region that harbors a dinucleotide variant ss469415590 (TT or Delta G), which is in high linkage disequilibrium with rs12979860, a genetic marker strongly associated with HCV clearance. ss469415590[Delta G] is a frameshift variant that creates a novel gene, designated IFNL4, encoding the interferon-lambda 4 protein (IFNL4), which is moderately similar to IFNL3. Compared to rs12979860, ss469415590 is more strongly associated with HCV clearance in individuals of African ancestry, although it provides comparable information in Europeans and Asians. Transient overexpression of IFNL4 in a hepatoma cell line induced STAT1 and STAT2 phosphorylation and the expression of interferon-stimulated genes. Our findings provide new insights into the genetic regulation of HCV clearance and its clinical management.	[Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei; Hergott, Dianna; Porter-Gill, Patricia; Mumy, Adam; Kohaar, Indu; Brand, Nathan; Tarway, McAnthony; Liu, Luyang] NCI, Lab Translat Gen, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Park, Heiyoung; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, US NIH, Bethesda, MD 20892 USA; [Dickensheets, Harold; Sheikh, Faruk; Donnelly, Raymond P.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Hergott, Dianna; O'Brien, Thomas R.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Chen, Sabrina] Informat Management Serv Inc, Silver Spring, MD USA; [Astemborski, Jacquie; Thomas, David L.] Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Med, Charlotte, NC 28203 USA; [Edlin, Brian R.] Natl Dev & Res Inst Inc, New York, NY USA; [Edlin, Brian R.] Cornell Univ, Ctr Study Hepatitis C, Weill Med Coll, New York, NY 10021 USA; [Howell, Charles D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Morgan, Timothy R.] Vet Affairs VA Long Beach Healthcare Syst, Gastroenterol Serv, Long Beach, CA USA; [Morgan, Timothy R.] Univ Calif Irvine, Div Gastroenterol, Irvine, CA USA; [Thomas, David L.] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA		Prokunina-Olsson, L (corresponding author), NCI, Lab Translat Gen, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA.	prokuninal@mail.nih.gov; obrient@mail.nih.gov	Tang, Wei/H-7103-2013; Kohaar, Indu/W-2530-2019; Prokunina-Olsson, Ludmila/A-8240-2019; Edlin, Brian R/F-2966-2018; Prokunina-Olsson, Ludmila/V-7960-2019; Kohaar, Indu/AAA-2405-2020; Bonkovsky, Herbert L./AAH-1892-2021	Tang, Wei/0000-0002-7089-4391; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Edlin, Brian R/0000-0001-8172-8797; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Bonkovsky, Herbert L./0000-0001-7387-3230; Rehermann, Barbara/0000-0001-6832-9951; Donnelly, Raymond/0000-0002-0695-5276	Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics; Intramural Research Program of the US National Institutes of Health (National Institute for Diabetes, Digestive and Kidney Diseases); ALIVE cohort [R01-DA-04334, R01-DA-12568]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-DA09532, R01-DA12109, R01-DA13245, R01-DA16159]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N02-CP-91027, N01-CO-12400]; Substance Abuse and Mental Health Services AdministrationUnited States Department of Health & Human Services [H79-TI12103]; National Cancer Institute Director's Innovation Award; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK);  [DA R01 013324]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [ZIADK054516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA016159, R01DA004334, R01DA013324, U01DA036297, R01DA012568, R01DA009532, R01DA013245, R01DA012109] Funding Source: NIH RePORTER	We thank the National Cancer Institute Sequencing Core Facility for help with RNA-seq. This research was supported by the Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics; National Institute for Diabetes, Digestive and Kidney Diseases), as well as the following grants: DA R01 013324 (J.A. and D.L.T.); ALIVE cohort, R01-DA-04334 and R01-DA-12568, and US National Institutes of Health grants R01-DA09532, R01-DA12109, R01-DA13245 and R01-DA16159 (B.R.E.); National Cancer Institute contracts N02-CP-91027 and N01-CO-12400 (B.R.E.); Substance Abuse and Mental Health Services Administration grant H79-TI12103 (B.R.E.); and the National Cancer Institute Director's Innovation Award (L.P.-O.). The Virahep-C and HALT-C studies were conducted, respectively, by the Virahep-C and HALT-C Investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases. The data and samples from the Virahep-C and HALT-C studies reported here were supplied by the National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories. This manuscript was not prepared in collaboration with the Virahep-C study group or the HALT-C study group and does not necessarily reflect the opinions or views of the Virahep-C Trial and HALT-C Trial, the National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories or the National Institute of Diabetes and Digestive and Kidney Diseases. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; [Anonymous], 2002, Gastroenterology, V123, P2082, DOI 10.1053/gast.2002.1232082; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Trivella DBB, 2010, CELL MOL LIFE SCI, V67, P2909, DOI 10.1007/s00018-010-0380-0; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Davar D, 2012, CANCER J, V18, P192, DOI 10.1097/PPO.0b013e31824f118b; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Howell CD, 2012, J HEPATOL, V56, P557, DOI 10.1016/j.jhep.2011.10.004; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Kang SM, 2011, FEBS LETT, V585, P3236, DOI 10.1016/j.febslet.2011.08.041; Katsounas A, 2011, INT REV IMMUNOL, V30, P366, DOI 10.3109/08830185.2011.593105; Kempuraj D, 2004, INT J IMMUNOPATH PH, V17, P103, DOI 10.1177/039463200401700201; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lampertico P, 2013, HEPATOLOGY, V57, P890, DOI 10.1002/hep.25749; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Okamura K, 2006, GENOMICS, V88, P690, DOI 10.1016/j.ygeno.2006.06.009; Onomoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019799; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tappero G, 1997, ITAL J GASTROENTEROL, V29, P148; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Uccellini L, 2012, HEPATOLOGY, V56, P86, DOI 10.1002/hep.25652; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vlahov D, 1991, NIDA Res Monogr, V109, P75; WHITE SH, 1994, J MOL EVOL, V38, P383, DOI 10.1007/BF00163155; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	54	663	693	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					164	171		10.1038/ng.2521			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	WOS:000314333000011	23291588	Green Accepted	Y	N	2022-01-24	
J	Tomlins, SA; Mehra, R; Rhodes, DR; Cao, XH; Wang, L; Dhanasekaran, SM; Kalyana-Sundaram, S; Wei, JT; Rubin, MA; Pienta, KJ; Shah, RB; Chinnaiyan, AM				Tomlins, Scott A.; Mehra, Rohit; Rhodes, Daniel R.; Cao, Xuhong; Wang, Lei; Dhanasekaran, Saravana M.; Kalyana-Sundaram, Shanker; Wei, John T.; Rubin, Mark A.; Pienta, Kenneth J.; Shah, Rajal B.; Chinnaiyan, Arul M.			Integrative molecular concept modeling of prostate cancer progression	NATURE GENETICS			English	Article							GENE-EXPRESSION; HIGH-GRADE; INTRAEPITHELIAL NEOPLASIA; CARCINOMA; TRANSCRIPTOME; PROFILES; MARKERS; CARCINOGENESIS; ADENOCARCINOMA; TMPRSS2	Despite efforts to profile prostate cancer, the genetic alterations and biological processes that correlate with the observed histological progression are unclear. Using laser-capture microdissection to isolate 101 cell populations, we have profiled prostate cancer progression from benign epithelium to metastatic disease. By analyzing expression signatures in the context of over 14,000 'molecular concepts', or sets of biologically connected genes, we generated an integrative model of progression. Molecular concepts that demarcate critical transitions in progression include protein biosynthesis, E26 transformation-specific (ETS) family transcriptional targets, androgen signaling and cell proliferation. Of note, relative to low-grade prostate cancer (Gleason pattern 3), high-grade cancer (Gleason pattern 4) shows an attenuated androgen signaling signature, similar to metastatic prostate cancer, which may reflect dedifferentiation and explain the clinical association of grade with prognosis. Taken together, these data show that analyzing gene expression signatures in the context of a compendium of molecular concepts is useful in understanding cancer biology.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA		Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Wei, John T/E-8967-2012; Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Tomlins, Scott/0000-0001-8661-9821; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Rubin, Mark/0000-0002-8321-9950	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA102872, P50CA069568, U01CA111275, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [U54DA021519] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [UO1 CA111275-01, R01 CA102872, P50CA69568, 5P30 CA46592] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [U54 DA021519-01A1] Funding Source: Medline		Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Best CJM, 2003, DIAGN MOL PATHOL, V12, P63, DOI 10.1097/00019606-200306000-00001; Bostwick DG, 2004, MODERN PATHOL, V17, P360, DOI 10.1038/modpathol.3800053; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; De Marzo AM, 2004, J CELL BIOCHEM, V91, P459, DOI 10.1002/jcb.10747; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fischer AH, 2004, J CELL BIOCHEM, V91, P170, DOI 10.1002/jcb.10735; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Konishi N, 2005, PATHOL INT, V55, P531, DOI 10.1111/j.1440-1827.2005.01865.x; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin BY, 1999, CANCER RES, V59, P4180; Moore S, 2005, INT J CANCER, V114, P563, DOI 10.1002/ijc.20773; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nelson Peter S, 2004, J Urol, V172, pS28, DOI 10.1097/01.ju.0000142067.17181.68; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Vaillancourt L, 1996, AM J SURG PATHOL, V20, P86, DOI 10.1097/00000478-199601000-00010; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Welsh JB, 2001, CANCER RES, V61, P5974	50	663	677	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					41	51		10.1038/ng1935			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	WOS:000243136500016	17173048				2022-01-24	
J	Ozaki, K; Ohnishi, Y; Iida, A; Sekine, A; Yamada, R; Tsunoda, T; Sato, H; Sato, H; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, K; Ohnishi, Y; Iida, A; Sekine, A; Yamada, R; Tsunoda, T; Sato, H; Sato, H; Hori, M; Nakamura, Y; Tanaka, T			Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction	NATURE GENETICS			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; MAXIMUM-LIKELIHOOD-ESTIMATION; E-SELECTIN; HEART-DISEASE; MAST-CELLS; ATHEROSCLEROSIS; RUPTURE; PLAQUE; GENOME; VCAM-1	By means of a large-scale, case-control association study using 92,788 gene-based single-nucleotide polymorphism (SNP) markers, we identified a candidate locus on chromosome 6p21 associated with susceptibility to myocardial infarction. Subsequent linkage-disequilibrium (LD) mapping and analyses of haplotype structure showed significant associations between myocardial infarction and a single 50 kb halpotype comprised of five SNPs in LTA (encoding lymphotoxin-alpha), NFKBIL1 (encoding nuclear factor of kappa light polypeptide gene enhancer in B cells, inhibitor-like 1) and BAT1 (encoding HLA-B associated transcript 1). Homozygosity with respect to each of the two SNPs in LTA was significantly associated with increased risk for myocardial infarction (odds ratio=1.78, chi(2)=21.6, P=0.00000033; 1,133 affected individuals versus 1,006 controls). In vitro functional analyses indicated that one SNP in the coding region of LTA, which changed an amino-acid residue from threonine to asparagine (Thr26Asn), effected a twofold increase in induction of several cell-adhesion molecules, including VCAM1, in vascular smooth-muscle cells of human coronary artery. Moreover, the SNP, in intron 1 of LTA, enhanced the transcriptional level of LTA. These results indicate that variants in the LTA are risk factors for myocardial infraction and implicate LTA in the pathogenesis of the disorder.	RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Lab Genotyping, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Lab Rheumat Dis, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Lab Med Informat,SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan		Tanaka, T (corresponding author), RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Tanaka, Toshihiro/J-9310-2014; Tsunoda, Tatsuhiko/K-2061-2014	Tanaka, Toshihiro/0000-0001-6201-9784; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ozaki, Kouichi/0000-0003-0028-1570; Yamada, Ryo/0000-0002-1587-630X			ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Belch JJF, 1997, CIRCULATION, V95, P2027, DOI 10.1161/01.CIR.95.8.2027; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Breslow JL, 1997, NAT MED, V3, P600, DOI 10.1038/nm0697-600; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAVIES MJ, 1985, BRIT HEART J, V53, P363; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; GALLIS ZS, 1994, CIRC RES, V75, P181; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hwang SJ, 1997, CIRCULATION, V96, P4219; Iida A, 2001, J HUM GENET, V46, P668, DOI 10.1007/s100380170019; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; Kaartinen M, 1996, CIRCULATION, V94, P2787, DOI 10.1161/01.CIR.94.11.2787; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Morisaki N, 1997, ATHEROSCLEROSIS, V131, P43, DOI 10.1016/S0021-9150(97)06083-8; OBrien KD, 1996, CIRCULATION, V93, P672, DOI 10.1161/01.CIR.93.4.672; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Squadrito F, 1996, INFLAMM RES, V45, P14, DOI 10.1007/BF02263499; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; VANHAESEBROECK B, 1991, CANCER RES, V51, P2469; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789	27	663	703	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					650	654		10.1038/ng1047			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	WOS:000179593000019	12426569				2022-01-24	
J	Wade, PA; Gegonne, A; Jones, PL; Ballestar, E; Aubry, F; Wolffe, AP				Wade, PA; Gegonne, A; Jones, PL; Ballestar, E; Aubry, F; Wolffe, AP			Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation	NATURE GENETICS			English	Article							PROTEIN; GENE; IDENTIFICATION; METASTASIS; FAMILY; MTA1	Methylation of DNA at the dinucleotide CpG is essential for mammalian development and is correlated with stable transcriptional silencing(1-3). This transcriptional silencing has recently been linked at a molecular level to histone deacetylation MeCP2 (refs 4,5). We previously purified a histone deacetylase through the demonstration of a physical association between histone deacetylases and the methyl CpG-binding protein complex from Xenopus laevis egg extracts that consists of six subunits, including an Rpd3-like deacetylase, the RbA p48/p46 histone-binding protein and the nucleosome-stimulated ATPase Mi-2 (ref. 6). Similar species were subsequently isolated from human cell lines(7-9), implying functional conservation across evolution. This complex represents the most abundant form of deacetylase in amphibian eggs and cultured mammalian cells(6-9). Here we identify the remaining three subunits of this across enzyme complex, One of them binds specifically to methylated DNA in vitro and molecular cloning reveals a similarity to a known methyl CpG-binding protein. Our data substantiate the mechanistic link between DNA methylation, histone deacetylation and transcriptional silencing.	NICHHD, Mol Embryol Lab, NIH, Bethesda, MD 20892 USA; INSERM, U435, F-35042 Rennes, France		Wade, PA (corresponding author), NICHHD, Mol Embryol Lab, NIH, Bldg 18T Room 106, Bethesda, MD 20892 USA.	awlme@helix.nih.gov	Wade, Paul A/D-2374-2019; Aubry, Florence/I-2746-2015	Wade, Paul A/0000-0002-6042-357X; Ballestar, Esteban/0000-0002-1400-2440			Aubry F, 1998, EUR J BIOCHEM, V254, P558, DOI 10.1046/j.1432-1327.1998.2540558.x; Ausubel FM, 1995, CURRENT PROTOCOLS MO; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bird A, 1995, J CELL SCI, P37; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; Futamura M, 1999, J HUM GENET, V44, P52, DOI 10.1007/s100380050107; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Martienssen R, 1999, NAT GENET, V22, P6, DOI 10.1038/8708; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Solari F, 1999, DEVELOPMENT, V126, P2483; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; VAUTIER D, 1994, MOL REPROD DEV, V38, P119, DOI 10.1002/mrd.1080380202; Vermaak D, 1999, MOL CELL BIOL, V19, P5847; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wong JM, 1998, EMBO J, V17, P520, DOI 10.1093/emboj/17.2.520; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	30	663	680	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1999	23	1					62	66		10.1038/12664			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	WOS:000082337300017	10471500				2022-01-24	
J	Parkes, TL; Elia, AJ; Dickinson, D; Hilliker, AJ; Phillips, JP; Boulianne, GL				Parkes, TL; Elia, AJ; Dickinson, D; Hilliker, AJ; Phillips, JP; Boulianne, GL			Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons	NATURE GENETICS			English	Article							ZINC SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; MELANOGASTER; SPAN; MUTATIONS	Reactive oxygen (RO) has been identified as an important effector in ageing and lifespan determination(1-3). The specific cell types, however, in which oxidative damage acts to limit lifespan of the whole organism have not been explicitly identified. The association between mutations in the gene encoding the oxygen radical metabolizing enzyme CuZn superoxide dismutase (SOD1) and loss of motorneurons in the brain and spinal cord that occurs in the life-shortening paralytic disease, Familial Amyotrophic Lateral Sclerosis (FALS; ref. 4), suggests that chronic and unrepaired oxidative damage occurring specifically in motor neurons could be a critical causative factor in ageing. To test this hypothesis, we generated transgenic Drosophila which express human SOD1 specifically in adult motorneurons. We show that overexpression of a single gene, SOD1, in a single cell type, the motorneuron, extends normal lifespan by up to 40% and rescues the lifespan of a short-lived Sod null mutant. Elevated resistance to oxidative stress suggests that the lifespan extension observed in these flies is due to enhanced RO metabolism. These results show that SOD activity in motorneurons is an important factor in ageing and lifespan determination in Drosophila.	Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada; Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Zool, Toronto, ON, Canada		Phillips, JP (corresponding author), Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada.	jphillip@uoguelph.ca					BRAND AH, 1993, DEVELOPMENT, V118, P401; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; LEE YM, 1981, J BIOL CHEM, V256, P8506; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111; PARKES TL, IN PRESS GENOME; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; Stauffer J.F., 1964, MANOMETRIC TECHNIQUE; STAVELEY BE, 1990, GENOME, V33, P867, DOI 10.1139/g90-130; Tower J, 1996, BIOESSAYS, V18, P799, DOI 10.1002/bies.950181006; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	18	663	681	0	54	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					171	174		10.1038/534			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	WOS:000073865100026	9620775				2022-01-24	
J	Feldkotter, M; Schwarzer, V; Wirth, R; Wienker, TF; Wirth, B				Feldkotter, M; Schwarzer, V; Wirth, R; Wienker, TF; Wirth, B			Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE COPY NUMBER; SINGLE NUCLEOTIDE; SURVIVAL; SMA; IDENTIFICATION; PROTEIN; CLASSIFICATION; PHENOTYPE; DELETION; GENOTYPE	Spinal muscular atrophy (SMA) is a common autosomal recessive disorder in humans, caused by homozygous absence of the survival motor neuron gene 1 (SMN1). SMN2, a copy gene, influences the severity of SMA and may be used in somatic gene therapy of patients with SMA in the future. We present a new, fast, and highly reliable quantitative test, based on real-time LightCycler PCR that amplifies either SMN1 or SMN2. The SMN1 copies were determined and validated in 329 carriers and controls. The specificity of the test is 100%, whereas the sensitivity is 96.2%. The quantitative analysis of SMN2 copies in 375 patients with type I, type II, or type III SMA showed a significant correlation between SMN2 copy number and type of SMA as well as duration of survival. Thus, 80% of patients with type I SMA carry one or two SMN2 copies, and 82% of patients with type II SMA carry three SMN2 copies, whereas 96% of patients with type III SMA carry three or four SMN2 copies. Among 113 patients with type I SMA, 9 with one SMN2 copy lived <11 mo, 88/ 94 with two SMN2 copies lived <21 mo, and 8/10 with three SMN2 copies lived 33-66 mo. On the basis of SMN2 copy number, we calculated the posterior probability that a child with homozygous absence of SMN1 will develop type I, type II, or type III SMA.	Univ Bonn, Univ Clin, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Univ Clin, Dept Surg, D-53111 Bonn, Germany; Univ Bonn, Univ Clin, Inst Med Biometry Informat & Epidemiol, D-53111 Bonn, Germany		Wirth, B (corresponding author), Univ Bonn, Univ Clin, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Wirth, Brunhilde/H-3192-2019	Wirth, Brunhilde/0000-0003-4051-5191			Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; HAUSMANOWAPETRUSEWICZ I, 1985, J MED GENET, V22, P350, DOI 10.1136/jmg.22.5.350; Helmken C, 2000, EUR J HUM GENET, V8, P493, DOI 10.1038/sj.ejhg.5200479; Helmken C, 2000, HUM GENET, V107, P554, DOI 10.1007/s004390000409; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hosmer D.W., 2000, APPL LOGISTIC REGRES, DOI DOI 10.1002/0471722146; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; PEARN J, 1980, LANCET, V1, P919; *SAS I, 1996, SAS STAT SOFTW CHANG; Scheffer H, 2001, EUR J HUM GENET, V9, P484, DOI 10.1038/sj.ejhg.5200667; Scheffer H, 2000, EUR J HUM GENET, V8, P79, DOI 10.1038/sj.ejhg.5200404; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	29	660	686	1	28	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					358	368		10.1086/338627			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	WOS:000173254300009	11791208	Green Published, Bronze			2022-01-24	
J	Postlethwait, JH; Yan, YL; Gates, MA; Horne, S; Amores, A; Brownlie, A; Donovan, A; Egan, ES; Force, A; Gong, ZY; Goutel, C; Fritz, A; Kelsh, R; Knapik, E; Liao, E; Paw, B; Ransom, D; Singer, A; Thomson, M; Abduljabbar, TS; Yelick, P; Beier, D; Joly, JS; Larhammar, D; Rosa, F; Westerfield, M; Zon, LI; Johnson, SL; Talbot, WS				Postlethwait, JH; Yan, YL; Gates, MA; Horne, S; Amores, A; Brownlie, A; Donovan, A; Egan, ES; Force, A; Gong, ZY; Goutel, C; Fritz, A; Kelsh, R; Knapik, E; Liao, E; Paw, B; Ransom, D; Singer, A; Thomson, M; Abduljabbar, TS; Yelick, P; Beier, D; Joly, JS; Larhammar, D; Rosa, F; Westerfield, M; Zon, LI; Johnson, SL; Talbot, WS			Vertebrate genome evolution and the zebrafish gene map	NATURE GENETICS			English	Article							NEURAL CREST; EXPRESSION; MUTATIONS	In chordate phylogeny, changes in the nervous system. jaws. and appendages transformed meek filter feeders into fearsome predators(1). Gene duplication is thought to promote such innovation(2). Vertebrate ancestors probably had single copies of genes now found in multiple copies in vertebrates(3) and gene maps suggest that this occurred by polyploidization(2-7). It has been suggested that one genome duplication event occurred before, and one after the divergence of ray-finned and lobe-finned fishes(5). Holland et at, however. have argued that because various vertebrates have several HOX clusters. two rounds of duplication occurred before the origin of jawed fishes(3). Such gene-number data. however. do not distinguish between tandem duplications and polyploidization events, nor whether independent duplications occurred in different lineages. To investigate these matters. we mapped 144 zebrafish genes and compared the resulting map with mammalian maps. Comparison revealed large conserved chromosome segments. Because duplicated chromosome segments in zebrafish often correspond with specific chromosome segments in mammals. it is likely that two polyploidization events occurred prior to the divergence of fish and mammal lineages. This zebrafish gene map will facilitate molecular identification of mutated zebrafish genes, which can suggest functions for human genes known only by sequence.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; NYU, Med Ctr, Skirball Inst, Dev Genet Program, New York, NY 10016 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Natl Univ Singapore, Dept Zool, Singapore 117548, Singapore; Ecole Normale Super, F-75231 Paris, France; Univ Bath, Sch Biol & Biochem, Dev Biol Programme, Bath BA2 7AY, Avon, England; Massachusetts Gen Hosp, Charlestown, MA USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Lab Genet Poissons, Jouy En Josas, France; Uppsala Univ, Dept Med Pharmacol, Uppsala, Sweden; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Forsyth Dent Ctr, Dept Cytokine Biol, Boston, MA 02115 USA		Postlethwait, JH (corresponding author), Univ Oregon, Inst Neurosci, 1254, Eugene, OR 97403 USA.	jpostle@oregon.uoregon.edu	Knapik, Ela W./J-6172-2014; Kelsh, Robert/B-6445-2008; Yelick, Pamela/AAP-5826-2020; Rosa, Frederic/L-5990-2017; Gong, Zhiyuan/H-8794-2012; Abduljabbar, Tariq/E-6491-2017	Knapik, Ela W./0000-0002-2977-3619; Kelsh, Robert/0000-0002-9381-0066; Gong, Zhiyuan/0000-0002-9660-5260; Paw, Barry/0000-0002-0492-1419; Liao, Eric/0000-0001-6385-7448; Amores, Angel/0000-0002-9307-3609; Cutts, Alison/0000-0002-4986-573X	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR12349, R01RR10715] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD22486] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR012349, R01RR010715] Funding Source: NIH RePORTER		AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; ALEXANDRE D, 1996, DEVELOPMENT, V122, P7835; Brady KP, 1997, GENOME RES, V7, P1085, DOI 10.1101/gr.7.11.1085; Driever W, 1996, DEVELOPMENT, V123, P37; EKKER M, 1992, DEVELOPMENT, V116, P1001; Elgar G, 1996, TRENDS GENET, V12, P145, DOI 10.1016/0168-9525(96)10018-4; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Haffter P, 1996, DEVELOPMENT, V123, P1; Henion PD, 1996, DEV GENET, V18, P11; HOLLAND PWH, 1994, DEVELOPMENT, P125; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Johnson SL, 1996, GENETICS, V142, P1277; Kasahara M, 1996, P NATL ACAD SCI USA, V93, P9096, DOI 10.1073/pnas.93.17.9096; Katsanis N, 1996, GENOMICS, V35, P101, DOI 10.1006/geno.1996.0328; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; Knapik EW, 1996, DEVELOPMENT, V123, P451; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Meyer A, 1998, NATURE, V391, P225, DOI 10.1038/34530; MOLVEN A, 1992, INT J DEV BIOL, V36, P229; MORIZOT DC, 1990, PROG CLIN BIOL RES, V344, P207; NORTHCUTT RG, 1983, Q REV BIOL, V58, P1, DOI 10.1086/413055; Ohno S., 1970, EVOLUTION GENE DUPLI; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Prince VE, 1998, DEVELOPMENT, V125, P407; RILEY BB, 1995, P NATL ACAD SCI USA, V92, P5997, DOI 10.1073/pnas.92.13.5997; RUDDLE FH, 1994, DEVELOPMENT, P155; Sampath K, 1996, BIOCHEM BIOPH RES CO, V219, P565, DOI 10.1006/bbrc.1996.0274; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	660	681	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					345	349		10.1038/ng0498-345			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	WOS:000072755500016	9537416				2022-01-24	
J	SING, CF; DAVIGNON, J				SING, CF; DAVIGNON, J			ROLE OF THE APOLIPOPROTEIN-E POLYMORPHISM IN DETERMINING NORMAL PLASMA-LIPID AND LIPOPROTEIN VARIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CLIN RES INST MONTREAL, DEPT LIPID METAB & ATHEROSCLEROSIS RES, MONTREAL H2W 1R7, QUEBEC, CANADA		SING, CF (corresponding author), UNIV NANCY 1, SCH MED, DEPT HUMAN GENET, F-54506 VANDOEUVRE LES NANCY, FRANCE.			Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-24489] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL024489] Funding Source: NIH RePORTER		ALLAIN CC, 1974, CLIN CHEM, V20, P470; BASU SK, 1983, SCIENCE, V219, P871, DOI 10.1126/science.6823554; BASU SK, 1982, J BIOL CHEM, V257, P9788; BILHEIMER DW, 1971, CIRCULATION, V44, P41; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; BOUTHILLIER D, 1983, J LIPID RES, V24, P1060; BRESLOW JL, 1982, J LIPID RES, V23, P1224; Brewer GJ, 1983, GENETICS; CAVALLI L, 1971, GENETICS HUMAN POPUL; CONNOR SL, 1982, CIRCULATION, V65, P1290, DOI 10.1161/01.CIR.65.7.1290; CUMMING AM, 1984, CLIN GENET, V25, P310; DAVIGNON J, 1983, ANN MED INTERNE, V134, P483; DAVIGNON J, 1984, LATENT DYSLIPOPROTEI, P213; EGUSA G, 1982, CIRCULATION, V66, P240; EISENBERG S, 1976, ATHEROSCLER REV, V1, P23; GHISELLI G, 1982, LANCET, V2, P405; GHISELLI G, 1982, J CLIN INVEST, V70, P474, DOI 10.1172/JCI110638; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; GREGG RE, 1983, J CLIN ENDOCR METAB, V57, P969, DOI 10.1210/jcem-57-5-969; GREGG RE, 1982, CIRCULATION, V66, P160; Hartl D L, 1980, PRINCIPLES POPULATIO, P488; HAVEL RJ, 1980, P NATL ACAD SCI-BIOL, V77, P4349, DOI 10.1073/pnas.77.7.4349; HAVEL RJ, 1982, MED CLIN N AM, V66, P441, DOI 10.1016/S0025-7125(16)31429-8; HAZZARD WR, 1981, METABOLISM, V30, P79, DOI 10.1016/0026-0495(81)90223-7; HEWITT D, 1977, CAN MED ASSOC J, V117, P1020; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; JAIN RS, 1979, LIFE SCI, V25, P1315, DOI 10.1016/0024-3205(79)90397-7; JONES GJL, 1980, CAN MED ASSOC J, V122, P37; KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85; MAHLEY RW, 1982, MED CLIN N AM, V66, P375, DOI 10.1016/S0025-7125(16)31426-2; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; MAHLEY RW, 1981, J CLIN INVEST, V68, P1197, DOI 10.1172/JCI110365; MCLEAN JW, 1983, ARTERIOSCLEROSIS, V3, pA514; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; Mourant AE, 1976, DISTRIBUTION HUMAN B, V2nd; MULLER DPR, 1978, BRIT J OBSTET GYNAEC, V85, P127, DOI 10.1111/j.1471-0528.1978.tb10466.x; NETER J, 1978, APPLIED STATISTICS, P743; NEVO E, 1978, THEOR POPUL BIOL, V13, P121, DOI 10.1016/0040-5809(78)90039-4; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1983, J CLIN INVEST, V71, P1023, DOI 10.1172/JCI110829; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; REARDON MF, 1981, CLIN CHEM, V27, P892; ROHEIM PS, 1979, P NATL ACAD SCI USA, V76, P4646, DOI 10.1073/pnas.76.9.4646; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; ROSENBLUM BB, 1983, BIOL PROSPECTIVE, V1, P85; ROSSENEU M, 1981, ANAL BIOCHEM, V116, P204, DOI 10.1016/0003-2697(81)90345-6; SAMPSON EJ, 1975, CLIN CHEM, V21, P1983; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; SING CF, 1978, AM J HUM GENET, V30, P491; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1975, AM J HUM GENET, V27, P333; UTERMANN G, 1982, HUM GENET, V60, P344, DOI 10.1007/BF00569216; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, CLIN GENET, V15, P63; WARDELL MR, 1982, J LIPID RES, V23, P1174; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059; ZANNIS VI, 1982, J LIPID RES, V23, P911; [No title captured]; 1974, NIH75628 DHEW PUBL, P1	61	660	678	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					268	285					18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	WOS:A1985AGY5900003	3985008				2022-01-24	
J	WRIGHT, S				WRIGHT, S			ISOLATION BY DISTANCE UNDER DIVERSE SYSTEMS OF MATING	GENETICS			English	Article																	Dobzhansky T, 1943, GENETICS, V28, P304; Wright S, 1921, GENETICS, V6, P111; Wright S, 1943, GENETICS, V28, P114; Wright S, 1943, GENETICS, V28, P139	4	660	678	2	53	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1946	31	1					39	59					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW826	WOS:A1946XW82600004	21009706				2022-01-24	
J	Bersaglieri, T; Sabeti, PC; Patterson, N; Vanderploeg, T; Schaffner, SF; Drake, JA; Rhodes, M; Reich, DE; Hirschhorn, JN				Bersaglieri, T; Sabeti, PC; Patterson, N; Vanderploeg, T; Schaffner, SF; Drake, JA; Rhodes, M; Reich, DE; Hirschhorn, JN			Genetic signatures of strong recent positive selection at the lactase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADULT LACTOSE INTOLERANCE; LINKAGE DISEQUILIBRIUM; HUMAN GENOME; NATURAL-SELECTION; CULTURAL INTERRELATIONS; HAPLOTYPE DIVERSITY; DNA POLYMORPHISMS; MILKING HABIT; POPULATION; ORIGIN	In most human populations, the ability to digest lactose contained in milk usually disappears in childhood, but in European-derived populations, lactase activity frequently persists into adulthood (Scrimshaw and Murray 1988). It has been suggested (Cavalli-Sforza 1973; Hollox et al. 2001; Enattah et al. 2002; Poulter et al. 2003) that a selective advantage based on additional nutrition from dairy explains these genetically determined population differences (Simoons 1970; Kretchmer 1971; Scrimshaw and Murray 1988; Enattah et al. 2002), but formal population-genetics-based evidence of selection has not yet been provided. To assess the population-genetics evidence for selection, we typed 101 single-nucleotide polymorphisms covering 3.2 Mb around the lactase gene. In northern European-derived populations, two alleles that are tightly associated with lactase persistence ( Enattah et al. 2002) uniquely mark a common (similar to77%) haplotype that extends largely undisrupted for >1 Mb. We provide two new lines of genetic evidence that this long, common haplotype arose rapidly due to recent selection: ( 1) by use of the traditional F-ST measure and a novel test based on p(excess), we demonstrate large frequency differences among populations for the persistence-associated markers and for flanking markers throughout the haplotype, and ( 2) we show that the haplotype is unusually long, given its high frequency-a hallmark of recent selection. We estimate that strong selection occurred within the past 5,000-10,000 years, consistent with an advantage to lactase persistence in the setting of dairy farming; the signals of selection we observe are among the strongest yet seen for any gene in the genome.	Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Whitehead MIT Ctr Genome Res, Program Med & Populat Genet, Cambridge, MA USA		Hirschhorn, JN (corresponding author), Childrens Hosp, Div Genet, Enders 561,300 Longwood Ave, Boston, MA 02115 USA.	joel.hirschhorn@childrens.harvard.edu	Schaffner, Stephen F/D-1189-2011				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BAYLESS TM, 1966, J AMER MED ASSOC, V197, P968, DOI 10.1001/jama.197.12.968; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BRAVERMAN JM, 1995, GENETICS, V140, P783; CAVALLISFORZA LL, 1973, AM J HUM GENET, V25, P82; Clark, 1997, PRINCIPLES POPULATIO; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grand RJ, 2003, GUT, V52, P617, DOI 10.1136/gut.52.5.617; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRETCHMER N, 1971, GASTROENTEROLOGY, V61, P805; LEWONTIN RC, 1973, GENETICS, V74, P175; LI WH, 1975, AM J HUM GENET, V27, P274; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; REICH DE, 1998, MICROSATELLITES EVOL; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosner B., 1982, FUNDAMENTALS BIOSTAT; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SCRIMSHAW N S, 1988, American Journal of Clinical Nutrition, V48, P1083; SIMOONS FJ, 1969, AM J DIG DIS, V14, P819, DOI 10.1007/BF02233204; SIMOONS FJ, 1970, AM J DIG DIS, V15, P695, DOI 10.1007/BF02235991; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Toomajian C, 2003, GENETICS, V165, P287; Wiuf C, 2001, GENET RES, V78, P41, DOI 10.1017/S0016672301005195; [No title captured]	40	659	675	6	230	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1111	1120		10.1086/421051			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	WOS:000221651900004	15114531	Green Published, Bronze			2022-01-24	
J	Akey, JM; Zhang, G; Zhang, K; Jin, L; Shriver, MD				Akey, JM; Zhang, G; Zhang, K; Jin, L; Shriver, MD			Interrogating a high-density SNP map for signatures of natural selection	GENOME RESEARCH			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; POPULATION-STRUCTURE; LINKAGE-DISEQUILIBRIUM; HAPLOTYPE DIVERSITY; RECENT ORIGIN; EVOLUTION; NEUTRALITY; RECOMBINATION; HITCHHIKING; DISCOVERY	Identifying genomic regions that have been targets of natural selection remains one of the most important and challenging areas of research in genetics. To this end, we report an analysis of 26,530 single nucleotide polymorphisms (SNPs) with allele frequencies that were determined in three populations. Specifically, we calculated a measure of genetic differentiation, F-ST, for each locus and examined its distribution at the level of the genome, the chromosome, and individual genes. Through a variety of analyses, we have found statistically significant evidence supporting the hypothesis that selection has influenced extant patterns of human genetic variation. Importantly, by contrasting the F-ST of individual SNPs to the empirical genome-wide distribution of F-ST, our results are not confounded by tenuous assumptions of population demographic history. Furthermore, we have identified 174 candidate genes with distribution of genetic variation that indicates that they have been targets of selection. Our work provides a first generation natural selection map of the human genome and provides compelling evidence that selection has shaped extant patterns of human genomic variation.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Texas, Ctr Human Genet, Houston, TX 77225 USA; Univ Cincinnati, Ctr Genome Informat, Cincinnati, OH 45221 USA		Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	mds17@psu.edu	Jin, Li/M-5063-2019; Zhang, Kun/ABE-6349-2020; Jin, Li/C-1468-2009; Zhang, Ge/F-1809-2011	Zhang, Kun/0000-0002-7596-5224; Jin, Li/0000-0002-4546-2415; Shriver, Mark/0000-0003-0006-0479	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG002154, R01 HG002154] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002154] Funding Source: NIH RePORTER		Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Black WC, 2001, ANNU REV ENTOMOL, V46, P441, DOI 10.1146/annurev.ento.46.1.441; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Eberle MA, 2000, GENET EPIDEMIOL, V19, pS29, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI5>3.0.CO;2-P; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Fay JC, 2001, CURR OPIN GENET DEV, V11, P642, DOI 10.1016/S0959-437X(00)00247-1; Fay JC, 2001, GENETICS, V158, P1227; Fu YX, 1999, THEOR POPUL BIOL, V56, P1, DOI 10.1006/tpbi.1999.1421; Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Hull J, 2001, AM J HUM GENET, V69, P413, DOI 10.1086/321291; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kitano T, 1999, J MOL EVOL, V49, P615, DOI 10.1007/PL00006583; Koda Y, 2001, GENETICS, V158, P747; Kuhner MK, 2000, GENETICS, V156, P439; LEWONTIN RC, 1973, GENETICS, V74, P175; Lindqvist PG, 1998, THROMB HAEMOSTASIS, V79, P69; Majewski J, 1999, GENETICS, V152, P1459; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Nei M., 1990, MOL EVOLUTIONARY GEN; Nielsen R, 2000, GENETICS, V154, P931; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; OHTA T, 1969, GENETICS, V63, P229; Otto SP, 2000, TRENDS GENET, V16, P526, DOI 10.1016/S0168-9525(00)02141-7; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Rana BK, 1999, GENETICS, V151, P1547; Richman A, 2000, MOL ECOL, V9, P1953, DOI 10.1046/j.1365-294X.2000.01125.x; Robertson D, 2001, NAT BIOTECHNOL, V19, P795, DOI 10.1038/nbt0901-795b; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Slatkin M, 1998, GENET RES, V71, P155, DOI 10.1017/S001667239800319X; Slatkin M, 2001, GENETICS, V158, P865; Sullivan AD, 2001, P NATL ACAD SCI USA, V98, P10214, DOI 10.1073/pnas.181325198; Sunyaev SR, 2000, TRENDS GENET, V16, P335, DOI 10.1016/S0168-9525(00)02058-8; TAJIMA F, 1989, GENETICS, V123, P597; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Vitalis R, 2001, GENETICS, V158, P1811; Wakeley J, 2001, AM J HUM GENET, V69, P1332, DOI 10.1086/324521; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS, 1996, GENETIC DATA ANAL, P161; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	59	659	685	1	93	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2002	12	12					1805	1814		10.1101/gr.631202			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	621PW	WOS:000179599400001	12466284	Green Published, Bronze			2022-01-24	
J	Warrick, JM; Chan, HYE; Gray-Board, GL; Chai, YH; Paulson, HL; Bonini, NM				Warrick, JM; Chan, HYE; Gray-Board, GL; Chai, YH; Paulson, HL; Bonini, NM			Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70	NATURE GENETICS			English	Article							MACHADO-JOSEPH DISEASE; NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE; SPINOCEREBELLAR ATAXIA; PROTEIN; AGGREGATION; HUNTINGTIN; LOCALIZATION; DEGENERATION; EXPRESSION	At least eight inherited human neurodegenerative diseases are caused by expansion of a polyglutamine domain within the respective proteins(1,2). This confers dominant toxicity on the proteins, leading to dysfunction and loss of neurons. Expanded polyglutamine proteins form aggregates, including nuclear inclusions (NI), within neurons, possibly due to misfolding of the proteins(3-5). MI are ubiquitinated and sequester molecular chaperone proteins and proteasome components(6-9), suggesting that disease pathogenesis includes activation of cellular stress pathways to help refold, disaggregate or degrade the mutant disease proteins. Overexpression of specific chaperone proteins reduces polyglutamine aggregation in transfected cells(7-9), but whether this alters toxicity is unknown. Using a Drosophila melanogaster model of polyglutamine disease(10), we show that directed expression of the molecular chaperone HSP70 suppresses polyglutamine-induced neurodegeneration in vivo. Suppression by HSP70 occurred without a visible effect on NI formation, indicating that polyglutamine toxicity can be dissociated from formation of large aggregates. Our studies indicate that HSP70 or related molecular chaperones may provide a means of treating these and other neurodegenerative diseases associated with abnormal protein conformation and toxicity.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Iowa, Coll Med, Iowa City, IA USA		Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.		Chan, H.Y. Edwin/A-9478-2011	Chan, H.Y. Edwin/0000-0003-4307-474X			BRAND AH, 1993, DEVELOPMENT, V118, P401; CAHI Y, IN PRESS J NEUROSCI; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LANDSBURU P, 1997, NEURON, V19, P1151; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wolff Tanya, 1993, P1277	29	659	676	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					425	428		10.1038/70532			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	WOS:000084023900017	10581028				2022-01-24	
J	Ota, T; Suzuki, Y; Nishikawa, T; Otsuki, T; Sugiyama, T; Irie, R; Wakamatsu, A; Hayashi, K; Sato, H; Nagai, K; Kimura, K; Makita, H; Sekine, M; Obayashi, M; Nishi, T; Shibahara, T; Tanaka, T; Ishii, S; Yamamoto, J; Saito, K; Kawai, Y; Isono, Y; Nakamura, Y; Nagahari, K; Murakami, K; Yasuda, T; Iwayanagi, T; Wagatsuma, M; Shiratori, A; Sudo, H; Hosoiri, T; Kaku, Y; Kodaira, H; Kondo, H; Sugawara, M; Takahashi, M; Kanda, K; Yokoi, T; Furuya, T; Kikkawa, E; Omura, Y; Abe, K; Kamihara, K; Katsuta, N; Sato, K; Tanikawa, M; Yamazaki, M; Ninomiya, K; Ishibashi, T; Yamashita, H; Murakawa, K; Fujimori, K; Tanai, H; Kimata, M; Watanabe, M; Hiraoka, S; Chiba, Y; Ishida, S; Ono, Y; Takiguchi, S; Watanabe, S; Yosida, M; Hotuta, T; Kusano, J; Kanehori, K; Takahashi-Fujii, A; Hara, H; Tanase, T; Nomura, Y; Togiya, S; Komai, F; Hara, R; Takeuchi, K; Arita, M; Imose, N; Musashino, K; Yuuki, H; Oshima, A; Sasaki, N; Aotsuka, S; Yoshikawa, Y; Matsunawa, H; Ichihara, T; Shiohata, N; Sano, S; Moriya, S; Momiyama, H; Satoh, N; Takami, S; Terashima, Y; Suzuki, O; Nakagawa, S; Senoh, A; Mizoguchi, H; Goto, Y; Shimizu, F; Wakebe, H; Hishigaki, H; Watanabe, T; Sugiyama, A; Takemoto, M; Kawakami, B; Yamazaki, M; Watanabe, K; Kumagai, A; Itakura, S; Fukuzumi, Y; Fujimori, Y; Komiyama, M; Tashiro, H; Tanigami, A; Fujiwara, T; Ono, T; Yamada, K; Fujii, Y; Ozaki, K; Hirao, M; Ohmori, Y; Kawabata, A; Hikiji, T; Kobatake, N; Inagaki, H; Ikema, Y; Okamoto, S; Okitani, R; Kawakami, T; Noguchi, S; Itoh, T; Shigeta, K; Senba, T; Matsumura, K; Nakajima, Y; Mizuno, T; Morinaga, M; Sasaki, M; Togashi, T; Oyama, M; Hata, H; Watanabe, M; Komatsu, T; Mizushima-Sugano, J; Satoh, T; Shirai, Y; Takahashi, Y; Nakagawa, K; Okumura, K; Nagase, T; Nomura, N; Kikuchi, H; Masuho, Y; Yamashita, R; Nakai, K; Yada, T; Nakamura, Y; Ohara, O; Isogai, T; Sugano, S				Ota, T; Suzuki, Y; Nishikawa, T; Otsuki, T; Sugiyama, T; Irie, R; Wakamatsu, A; Hayashi, K; Sato, H; Nagai, K; Kimura, K; Makita, H; Sekine, M; Obayashi, M; Nishi, T; Shibahara, T; Tanaka, T; Ishii, S; Yamamoto, J; Saito, K; Kawai, Y; Isono, Y; Nakamura, Y; Nagahari, K; Murakami, K; Yasuda, T; Iwayanagi, T; Wagatsuma, M; Shiratori, A; Sudo, H; Hosoiri, T; Kaku, Y; Kodaira, H; Kondo, H; Sugawara, M; Takahashi, M; Kanda, K; Yokoi, T; Furuya, T; Kikkawa, E; Omura, Y; Abe, K; Kamihara, K; Katsuta, N; Sato, K; Tanikawa, M; Yamazaki, M; Ninomiya, K; Ishibashi, T; Yamashita, H; Murakawa, K; Fujimori, K; Tanai, H; Kimata, M; Watanabe, M; Hiraoka, S; Chiba, Y; Ishida, S; Ono, Y; Takiguchi, S; Watanabe, S; Yosida, M; Hotuta, T; Kusano, J; Kanehori, K; Takahashi-Fujii, A; Hara, H; Tanase, T; Nomura, Y; Togiya, S; Komai, F; Hara, R; Takeuchi, K; Arita, M; Imose, N; Musashino, K; Yuuki, H; Oshima, A; Sasaki, N; Aotsuka, S; Yoshikawa, Y; Matsunawa, H; Ichihara, T; Shiohata, N; Sano, S; Moriya, S; Momiyama, H; Satoh, N; Takami, S; Terashima, Y; Suzuki, O; Nakagawa, S; Senoh, A; Mizoguchi, H; Goto, Y; Shimizu, F; Wakebe, H; Hishigaki, H; Watanabe, T; Sugiyama, A; Takemoto, M; Kawakami, B; Yamazaki, M; Watanabe, K; Kumagai, A; Itakura, S; Fukuzumi, Y; Fujimori, Y; Komiyama, M; Tashiro, H; Tanigami, A; Fujiwara, T; Ono, T; Yamada, K; Fujii, Y; Ozaki, K; Hirao, M; Ohmori, Y; Kawabata, A; Hikiji, T; Kobatake, N; Inagaki, H; Ikema, Y; Okamoto, S; Okitani, R; Kawakami, T; Noguchi, S; Itoh, T; Shigeta, K; Senba, T; Matsumura, K; Nakajima, Y; Mizuno, T; Morinaga, M; Sasaki, M; Togashi, T; Oyama, M; Hata, H; Watanabe, M; Komatsu, T; Mizushima-Sugano, J; Satoh, T; Shirai, Y; Takahashi, Y; Nakagawa, K; Okumura, K; Nagase, T; Nomura, N; Kikuchi, H; Masuho, Y; Yamashita, R; Nakai, K; Yada, T; Nakamura, Y; Ohara, O; Isogai, T; Sugano, S			Complete sequencing and characterization of 21,243 full-length human cDNAs	NATURE GENETICS			English	Article							DNA-SEQUENCE; MESSENGER-RNAS; GENE; DATABASE; ORGANIZATION; GENOME	As a base for human transcriptome and functional genomics, we created the "full-length long Japan" (FLJ) collection of sequenced human cDNAs. We determined the entire sequence of 21,243 selected clones and found that 14,490 cDNAs (10,897 clusters) were unique to the FLJ collection. About half of them (5,416) seemed to be protein-coding. Of those, 1,999 clusters had not been predicted by computational methods. The distribution of GC content of nonpredicted cDNAs had a peak at similar to58% compared with a peak at similar to42% for predicted cDNAs. Thus, there seems to be a slight bias against GC-rich transcripts in current gene prediction procedures. The rest of the cDNAs unique to the FLJ collection (5,481) contained no obvious open reading frames (ORFs) and thus are candidate noncoding RNAs. About one-fourth of them (1,378) showed a clear pattern of splicing. The distribution of GC content of noncoding cDNAs was narrow and had a peak at similar to42%, relatively low compared with that of protein-coding cDNAs.	Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Helix Res Inst, Chiba 2920812, Japan; Kyowa Hakko Kogyo Co Ltd, Tokyo Res Lab, Tokyo 1948533, Japan; Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan; Natl Inst Technol & Evaluat, Shibuya Ku, Tokyo 1510066, Japan; Otsuka Pharmaceut Co Ltd, Tokushima 7710192, Japan; Hitachi, Life Sci Grp, Kawagoe, Saitama 3501165, Japan; Hitachi Sci Syst, Tokyo 1858601, Japan; Takara Shuzo Co Ltd, Shiga 5250055, Japan; Nisshinbo Ind, Midori Ku, Chiba 2670056, Japan; Toyobo, Fukui 9140047, Japan; Fujiya, Kanagawa 2570031, Japan; Aisin Cosmos Res & Dev Co Ltd, Chiba 2920812, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan; AIST, BIRC, Koto Ku, Tokyo 1350064, Japan		Sugano, S (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ssugano@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009; Ohara, Osamu/A-9119-2012; Tanaka, Toshihiro/J-9310-2014; murakami, katsuhiko/C-2083-2009; Komatsu, Toru/AAH-8504-2019; Ohara, Osamu/G-5448-2015	Nakai, Kenta/0000-0002-8721-8883; Tanaka, Toshihiro/0000-0001-6201-9784; murakami, katsuhiko/0000-0002-1923-4259; Ohara, Osamu/0000-0002-3328-9571; Ozaki, Kouichi/0000-0003-0028-1570; Oyama, Masaaki/0000-0001-6478-3735			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERNARDI G, 1993, GENE, V135, P57, DOI 10.1016/0378-1119(93)90049-9; BOGUSKI MS, 1995, TRENDS BIOCHEM SCI, V20, P295, DOI 10.1016/S0968-0004(00)89051-9; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Chance MR, 2002, PROTEIN SCI, V11, P723, DOI 10.1110/ps.4570102; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fickett JW, 1998, METHOD BIOCHEM ANAL, V39, P231; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIESECKE H, 1992, J VIROL METHODS, V38, P47, DOI 10.1016/0166-0934(92)90168-D; HATTORI A, 2001, DNA RES, V7, P1; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARUYAMA K, 1994, GENE, V138, P171; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Yudate HT, 2001, NUCLEIC ACIDS RES, V29, P185, DOI 10.1093/nar/29.1.185	29	658	11061	4	195	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					40	45		10.1038/ng1285			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	WOS:000187666800012	14702039	Bronze			2022-01-24	
J	ROUSSET, F; RAYMOND, M				ROUSSET, F; RAYMOND, M			TESTING HETEROZYGOTE EXCESS AND DEFICIENCY	GENETICS			English	Article							HARDY-WEINBERG; MULTIPLE ALLELES; FREQUENCIES; POPULATION	Currently used tests of Hardy-Weinberg proportions do not take into account the nature of the alternative hypothesis, which is generally a heterozygote deficiency. Different exact tests, appropriate for small sample size and large number of alleles, are proposed in this perspective, and their properties are evaluated by power comparisons. Some tests are found to be close to optimal for the detection of inbreeding or heterozygote excess, one of which is a score test closely related to Robertson and Hill's estimator of the inbreeding coefficient. This test is also easily applied to multiple samples. Such tests are not always the most appropriate if alternative hypotheses differ from those considered here.	UNIV MONTPELLIER 2, INST SCI EVOLUT, EQUIPE GENET & ENVIRONNEMENT, F-34095 MONTPELLIER, FRANCE; UPPSALA UNIV, DEPT GENET, S-75007 UPPSALA, SWEDEN				Rousset, Francois/C-7360-2008; Raymond, Michel/C-9049-2015	Rousset, Francois/0000-0003-4670-0371; Raymond, Michel/0000-0002-1714-6984			CHAKRABORTY R, 1994, HUM HERED, V44, P1, DOI 10.1159/000154181; CHAKRABORTY R, 1991, HDB STATISTICS, V8, P205; COCKERHAM CC, 1973, GENETICS, V74, P679; Cox DR, 1974, THEORETICAL STATISTI; CURIECOHEN M, 1982, GENETICS, V100, P339; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; HERNANDEZ JL, 1989, BIOMETRICS, V45, P53, DOI 10.2307/2532034; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; LEHMANN EL, 1993, J AM STAT ASSOC, V88, P1242; LESSIOS HA, 1992, MAR BIOL, V112, P517, DOI 10.1007/BF00356299; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; LI CC, 1953, AM J HUM GENET, V5, P107; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; PAMILO P, 1984, MAR BIOL, V79, P99, DOI 10.1007/BF00404990; Press W.H., 1988, NUMERICAL RECIPES C; RAYMOND M, 1995, IN PRESS J HERED; ROBERTSON A, 1984, GENETICS, V107, P703; STUART A, 1991, KENDALLS ADV THEORY, V0002; THORNIHILL NW, 1993, NATURAL HIST INBREED; TOCHER KD, 1950, BIOMETRIKA, V37, P130, DOI 10.2307/2332156; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS, 1990, GENETIC DATA ANAL; YASUDA N, 1968, BIOMETRICS, V24, P915, DOI 10.2307/2528880; YATES F, 1955, BIOMETRIKA, V42, P382, DOI 10.2307/2333385; [No title captured]	30	658	677	0	37	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	1995	140	4					1413	1419					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL508	WOS:A1995RL50800022	7498780				2022-01-24	
J	Eeles, RA; Kote-Jarai, Z; Giles, GG; Al Olama, AA; Guy, M; Jugurnauth, SK; Mulholland, S; Leongamornlert, DA; Edwards, SM; Morrison, J; Field, HI; Southey, MC; Severi, G; Donovan, JL; Hamdy, FC; Dearnaley, DP; Muir, KR; Smith, C; Bagnato, M; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Gehr-Swain, BN; Wilkinson, RA; Cox, A; Lewis, S; Brown, PM; Jhavar, SG; Tymrakiewicz, M; Lophatananon, A; Bryant, SL; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Fisher, C; Jamieson, C; Cooper, CS; English, DR; Hopper, JL; Neal, DE; Easton, DF				Eeles, Rosalind A.; Kote-Jarai, Zsofia; Giles, Graham G.; Al Olama, Ali Amin; Guy, Michelle; Jugurnauth, Sarah K.; Mulholland, Shani; Leongamornlert, Daniel A.; Edwards, Stephen M.; Morrison, Jonathan; Field, Helen I.; Southey, Melissa C.; Severi, Gianluca; Donovan, Jenny L.; Hamdy, Freddie C.; Dearnaley, David P.; Muir, Kenneth R.; Smith, Charmaine; Bagnato, Melisa; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Gehr-Swain, Beatrice N.; Wilkinson, Rosemary A.; Cox, Angie; Lewis, Sarah; Brown, Paul M.; Jhavar, Sameer G.; Tymrakiewicz, Malgorzata; Lophatananon, Artitaya; Bryant, Sarah L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles; Cooper, Colin S.; English, Dallas R.; Hopper, John L.; Neal, David E.; Easton, Douglas F.		Uk Genetic Prostate Canc Study Col; British Assoc Urological Surg Sect; Uk ProtecT Study Collaborators	Multiple newly identified loci associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; AUSTRALIAN CASE-CONTROL; RADICAL PROSTATECTOMY; ANTIGEN LEVELS; RISK LOCUS; GENE; MEN; POLYMORPHISMS; VARIANTS; PROMOTER	Prostate cancer is the most common cancer affecting males in developed countries. It shows consistent evidence of familial aggregation, but the causes of this aggregation are mostly unknown. To identify common alleles associated with prostate cancer risk, we conducted a genome-wide association study (GWAS) using blood DNA samples from 1,854 individuals with clinically detected prostate cancer diagnosed at <= 60 years or with a family history of disease, and 1,894 population-screened controls with a low prostate-specific antigen (PSA) concentration (< 0.5 ng/ml). We analyzed these samples for 541,129 SNPs using the Illumina Infinium platform. Initial putative associations were confirmed using a further 3,268 cases and 3,366 controls. We identified seven loci associated with prostate cancer on chromosomes 3, 6, 7, 10, 11, 19 and X (P = 2.7 x 10(-8) to P = 8.7 x 10(-29)). We confirmed previous reports of common loci associated with prostate cancer at 8q24 and 17q. Moreover, we found that three of the newly identified loci contain candidate susceptibility genes: MSMB, LMTK2 and KLK3.	[Eeles, Rosalind A.; Kote-Jarai, Zsofia; Guy, Michelle; Jugurnauth, Sarah K.; Mulholland, Shani; Leongamornlert, Daniel A.; Edwards, Stephen M.; Dearnaley, David P.; Hall, Amanda L.; O'Brien, Lynne T.; Gehr-Swain, Beatrice N.; Wilkinson, Rosemary A.; Jhavar, Sameer G.; Tymrakiewicz, Malgorzata; Bryant, Sarah L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Gehr-Swain, Beatrice N.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Gehr-Swain, Beatrice N.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Giles, Graham G.; Severi, Gianluca; Smith, Charmaine; Bagnato, Melisa] Canc Epidemiol Ctr, Canc Council Vic, Melbourne, Vic 3053, Australia; [Giles, Graham G.; Severi, Gianluca; English, Dallas R.; Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3053, Australia; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Strangeways Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; [Field, Helen I.] Univ Cambridge, Strangeways Lab, Dept Oncol, Cambridge CB1 8RN, England; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Donovan, Jenny L.; Lewis, Sarah] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Hamdy, Freddie C.; Cox, Angie] Univ Sheffield, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England; [Muir, Kenneth R.; Lophatananon, Artitaya] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England; [Brown, Paul M.; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Brown, Paul M.; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; [Neal, David E.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England		Eeles, RA (corresponding author), Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	rosalind.eeles@icr.ac.uk	Severi, Gianluca/H-3774-2018; McNicholas, Tom A/C-2268-2014; Severi, Gianluca/Q-1824-2019; English, Dallas/AAH-5005-2019; Dearnaley, David P/J-2318-2014	Severi, Gianluca/0000-0001-7157-419X; McNicholas, Tom A/0000-0001-9971-8765; Severi, Gianluca/0000-0001-7157-419X; English, Dallas/0000-0001-7828-8188; Dearnaley, David P/0000-0002-3954-2806; Lewis, Sarah/0000-0003-4311-6890; Leongamornlert, Daniel/0000-0002-3486-3168; Giles, Graham/0000-0003-4946-9099; Hamdy, Freddie/0000-0003-2627-2154; Neal, David/0000-0002-6033-5086; Southey, Melissa/0000-0002-6313-9005; huddart, robert/0000-0003-3604-1990; Cox, Angela/0000-0002-5138-1099; Eeles, Rosalind/0000-0002-3698-6241	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0500966, G0501019] Funding Source: UKRI; Cancer Research UKCancer Research UK [10118] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500966, G0501019] Funding Source: Medline		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Cramer SD, 2003, JNCI-J NATL CANCER I, V95, P1044, DOI 10.1093/jnci/95.14.1044; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Eeles RA, 1999, PROSTATE CANCER P D, V2, P9, DOI 10.1038/sj.pcan.4500279; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Lai J, 2007, CARCINOGENESIS, V28, P1032, DOI 10.1093/carcin/bgl236; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; MacInnis RJ, 2003, CANCER EPIDEM BIOMAR, V12, P1417; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P86, DOI 10.1158/1055-9965.EPI-05-0633; Severi G, 2003, J NATL CANCER I, V95, P818, DOI 10.1093/jnci/95.11.818; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P1142, DOI 10.1158/1055-9965.EPI-05-0984; Steuber T, 2006, INT J CANCER, V118, P1234, DOI 10.1002/ijc.21474; Steuber T, 2007, WORLD J UROL, V25, P111, DOI 10.1007/s00345-007-0160-0; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	28	657	674	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					316	321		10.1038/ng.90			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	WOS:000253548400022	18264097				2022-01-24	
J	Praitis, V; Casey, E; Collar, D; Austin, J				Praitis, V; Casey, E; Collar, D; Austin, J			Creation of low-copy integrated transgenic lines in Caenorhabditis elegans	GENETICS			English	Article							GENE-EXPRESSION; NUCLEAR TRANSFORMATION; PARTICLE BOMBARDMENT; DNA TRANSFER; C-ELEGANS; GERMLINE; CELLS; NEMATODES; RECOMBINATION; REQUIREMENTS	In Caenorhabditis elegans, transgenic lines are typically created by injecting DNA into the hermaphrodite germline to form multicopy extrachromosomal DNA arrays. This technique is a reliable means of expressing transgenes in C. elegans, but its use has limitations. Because extrachromosomal arrays are semistable, only a fraction of the animals in a transgenic extrachromosomal array line are transformed. In addition, because extrachromosomal arrays can contain hundreds of copies of the transforming DNA, transgenes may be overexpressed, misexpressed, or silenced. We have developed an alternative method for C. elegans transformation, using microparticle bombardment, that produces single- and low-copy chromosomal insertions. Using this method, we find that it is possible to create integrated transgenic lines that reproducibly express GFP reporter constructs without the variations in expression level and pattern frequently exhibited by extrachromosomal array lines. In addition, we find that low-copy integrated lines can also be used to express transgenes in the C. elegans germline, where conventional extrachromosomal arrays typically fail to express due to germline silencing.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA		Austin, J (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.			Collar, David/0000-0003-2631-6743			ARMALEO D, 1990, CURR GENET, V17, P97, DOI 10.1007/BF00312852; BROVERMAN S, 1993, P NATL ACAD SCI USA, V90, P4359, DOI 10.1073/pnas.90.10.4359; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CassidyHanley D, 1997, GENETICS, V146, P135; CHRISTOU P, 1988, PLANT PHYSIOL, V87, P671, DOI 10.1104/pp.87.3.671; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Jackstadt P, 1999, MOL BIOCHEM PARASIT, V103, P261, DOI 10.1016/S0166-6851(99)00089-4; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 1997, GENETICS, V146, P227; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; KLEIN TM, 1988, P NATL ACAD SCI USA, V85, P8502, DOI 10.1073/pnas.85.22.8502; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; KRAUSE M, 1994, DEV BIOL, V166, P133, DOI 10.1006/dbio.1994.1302; Lewis J. A., 1995, CAENORHABDITIS ELEGA, P3; MACMORRIS M, 1994, MOL CELL BIOL, V14, P484, DOI 10.1128/MCB.14.1.484; MADURO M, 1995, GENETICS, V141, P977; MCKIM KS, 1988, GENETICS, V120, P987; Mello C, 1995, CAENORHABDITIS ELEGA, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; OKKEMA PG, 1993, GENETICS, V135, P385; ROSENBLUTH RE, 1990, GENETICS, V124, P615; ROSENBLUTH RE, 1981, GENETICS, V99, P415; Seydoux G, 1999, DEVELOPMENT, V126, P3275; SPIETH J, 1988, DEV BIOL, V130, P285, DOI 10.1016/0012-1606(88)90434-4; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Thatcher JD, 1999, DEVELOPMENT, V126, P97; WILLIAMS BD, 1992, GENETICS, V131, P609; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; ZELENIN AV, 1991, FEBS LETT, V280, P94, DOI 10.1016/0014-5793(91)80212-L; ZETKA MC, 1992, GENETICS, V131, P321	32	657	679	0	19	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	MAR	2001	157	3					1217	1226					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	410BK	WOS:000167420000025	11238406				2022-01-24	
J	Schmutz, J; McClean, PE; Mamidi, S; Wu, GA; Cannon, SB; Grimwood, J; Jenkins, J; Shu, SQ; Song, QJ; Chavarro, C; Torres-Torres, M; Geffroy, V; Moghaddam, SM; Gao, DY; Abernathy, B; Barry, K; Blair, M; Brick, MA; Chovatia, M; Gepts, P; Goodstein, DM; Gonzales, M; Hellsten, U; Hyten, DL; Jia, GF; Kelly, JD; Kudrna, D; Lee, R; Richard, MMS; Miklas, PN; Osorno, JM; Rodrigues, J; Thareau, V; Urrea, CA; Wang, M; Yu, Y; Zhang, M; Wing, RA; Cregan, PB; Rokhsar, DS; Jackson, SA				Schmutz, Jeremy; McClean, Phillip E.; Mamidi, Sujan; Wu, G. Albert; Cannon, Steven B.; Grimwood, Jane; Jenkins, Jerry; Shu, Shengqiang; Song, Qijian; Chavarro, Carolina; Torres-Torres, Mirayda; Geffroy, Valerie; Moghaddam, Samira Mafi; Gao, Dongying; Abernathy, Brian; Barry, Kerrie; Blair, Matthew; Brick, Mark A.; Chovatia, Mansi; Gepts, Paul; Goodstein, David M.; Gonzales, Michael; Hellsten, Uffe; Hyten, David L.; Jia, Gaofeng; Kelly, James D.; Kudrna, Dave; Lee, Rian; Richard, Manon M. S.; Miklas, Phillip N.; Osorno, Juan M.; Rodrigues, Josiane; Thareau, Vincent; Urrea, Carlos A.; Wang, Mei; Yu, Yeisoo; Zhang, Ming; Wing, Rod A.; Cregan, Perry B.; Rokhsar, Daniel S.; Jackson, Scott A.			A reference genome for common bean and genome-wide analysis of dual domestications	NATURE GENETICS			English	Article							RESISTANCE GENE-CLUSTER; PHASEOLUS-VULGARIS; DIVERSIFICATION; SEQUENCE; REVEALS; ORIGIN	Common bean (Phaseolus vulgaris L.) is the most important grain legume for human consumption and has a role in sustainable agriculture owing to its ability to fix atmospheric nitrogen. We assembled 473 Mb of the 587-Mb genome and genetically anchored 98% of this sequence in 11 chromosome-scale pseudomolecules. We compared the genome for the common bean against the soybean genome to find changes in soybean resulting from polyploidy. Using resequencing of 60 wild individuals and 100 landraces from the genetically differentiated Mesoamerican and Andean gene pools, we confirmed 2 independent domestications from genetic pools that diverged before human colonization. Less than 10% of the 74 Mb of sequence putatively involved in domestication was shared by the two domestication events. We identified a set of genes linked with increased leaf and seed size and combined these results with quantitative trait locus data from Mesoamerican cultivars. Genes affected by domestication may be useful for genomics-enabled crop improvement.	[Schmutz, Jeremy; Wu, G. Albert; Shu, Shengqiang; Barry, Kerrie; Chovatia, Mansi; Goodstein, David M.; Hellsten, Uffe; Wang, Mei; Zhang, Ming; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Schmutz, Jeremy; Grimwood, Jane; Jenkins, Jerry] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [McClean, Phillip E.; Mamidi, Sujan; Moghaddam, Samira Mafi; Lee, Rian; Osorno, Juan M.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Cannon, Steven B.] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Song, Qijian; Hyten, David L.; Jia, Gaofeng; Rodrigues, Josiane; Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Chavarro, Carolina; Torres-Torres, Mirayda; Gao, Dongying; Abernathy, Brian; Gonzales, Michael; Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Geffroy, Valerie; Richard, Manon M. S.; Thareau, Vincent] Univ Paris 11, CNRS, Inst Biol Plantes, UMR 8618, F-91405 Orsay, France; [Geffroy, Valerie] Univ Paris 11, INRA, Unite Mixte Rech Genet Vegetale, Gif Sur Yvette, France; [Blair, Matthew] Tennessee State Univ, Dept Agr & Nat Sci, Nashville, TN 37203 USA; [Brick, Mark A.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [Gepts, Paul] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Kudrna, Dave; Yu, Yeisoo; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Tucson, AZ USA; [Miklas, Phillip N.] USDA ARS, Vegetable & Forage Crop Res Unit, Prosser, WA 99350 USA; [Urrea, Carlos A.] Univ Nebraska, Panhandle Res & Extens Ctr, Scottsbluff, NE USA		Jackson, SA (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	jschmutz@hudsonalpha.org; phillip.mcclean@ndsu.edu; sjackson@uga.edu	Barry, Kerrie/AAA-5500-2020; Osorno, Juan M/C-6971-2009; Wing, Rod A/Z-2885-2019; Wu, Guohong/W-3217-2019; Grimwood, Jane/ABD-5737-2021; mamidi, sujan/P-7009-2018; Schmutz, Jeremy/N-3173-2013; Gepts, Paul/O-8229-2019; Jenkins, Jerry/ABE-6479-2020	Barry, Kerrie/0000-0002-8999-6785; Wing, Rod A/0000-0001-6633-6226; mamidi, sujan/0000-0002-3837-6121; Schmutz, Jeremy/0000-0001-8062-9172; Gepts, Paul/0000-0002-1056-4665; Jenkins, Jerry/0000-0002-7943-3997; Richard, Manon/0000-0002-7903-024X; Shu, Shengqiang/0000-0002-4336-8994; Rokhsar, Daniel/0000-0002-8704-2224; Goodstein, David/0000-0001-6287-2697; Hyten, David/0000-0001-6324-9389; Yu, Yeisoo/0000-0002-8410-0310; Chovatia, Mansi/0000-0001-8175-782X; jackson, scott/0000-0002-3172-1607; Cannon, Steven/0000-0003-2777-8034	Office of Science of the US Department of Energy - US Department of Agriculture National Institute for Food and Agriculture [DE-AC02-05CH11231, 2006-35300-17266]; National Science FoundationNational Science Foundation (NSF) [DBI 0822258]; US Department of Agriculture Cooperative State Research, Education and Extension ServiceUnited States Department of Agriculture (USDA)National Institute of Food and Agriculture [2009-01860, 2009-01929]; ARSUnited States Department of Agriculture (USDA)USDA Agricultural Research Service [ARS-0423588] Funding Source: Federal RePORTER	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract DE-AC02-05CH11231. This research was funded by grants from the US Department of Agriculture National Institute for Food and Agriculture (2006-35300-17266) and the National Science Foundation (DBI 0822258) to S.A.J. and from the US Department of Agriculture Cooperative State Research, Education and Extension Service (2009-01860 and 2009-01929) to S.A.J. and P.E.M., respectively.	ANDERSON JW, 1984, AM J CLIN NUTR, V40, P1146, DOI 10.1093/ajcn/40.6.1146; Beebe S., 2012, Plant Breeding Reviews, V36, P357; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Chen NWG, 2010, NEW PHYTOL, V187, P941, DOI 10.1111/j.1469-8137.2010.03337.x; Cichy KA, 2009, CROP SCI, V49, P1742, DOI 10.2135/cropsci2008.10.0605; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Geffroy V, 2009, GENETICS, V181, P405, DOI 10.1534/genetics.108.093583; GEIL PB, 1994, J AM COLL NUTR, V13, P549; GEPTS P, 1986, ECON BOT, V40, P469, DOI 10.1007/BF02859660; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Koinange EMK, 1996, CROP SCI, V36, P1037, DOI 10.2135/cropsci1996.0011183X003600040037x; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; Gonzalez AM, 2010, MOL BREEDING, V25, P723, DOI 10.1007/s11032-009-9370-z; McClean PE, 2002, J HERED, V93, P148, DOI 10.1093/jhered/93.2.148; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Vega E, 2010, THEOR APPL GENET, V120, P1367, DOI 10.1007/s00122-010-1261-5; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Van Daele I, 2012, PLANT BIOTECHNOL J, V10, P488, DOI 10.1111/j.1467-7652.2012.00687.x; Weeden NF, 2007, ANN BOT-LONDON, V100, P1017, DOI 10.1093/aob/mcm122; Zizumbo-Villarreal D, 2010, GENET RESOUR CROP EV, V57, P813, DOI 10.1007/s10722-009-9521-4	45	656	675	6	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					707	713		10.1038/ng.3008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	WOS:000338093800011	24908249	hybrid, Green Published, Green Submitted	Y	N	2022-01-24	
J	Ortega, S; Prieto, I; Odajima, J; Martin, A; Dubus, P; Sotillo, R; Barbero, JL; Malumbres, M; Barbacid, M				Ortega, S; Prieto, I; Odajima, J; Martin, A; Dubus, P; Sotillo, R; Barbero, JL; Malumbres, M; Barbacid, M			Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice	NATURE GENETICS			English	Article							CYCLIN-DEPENDENT KINASES; HISTONE GENE-TRANSCRIPTION; CHROMOSOME SYNAPSIS; MEIOTIC PROPHASE; CENTROSOME DUPLICATION; RETINOBLASTOMA PROTEIN; CDK2 KINASE; S-PHASE; MOUSE; PHOSPHORYLATION	We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells. Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture. Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation. Cdk2(-/-) mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types. But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.	Ctr Nacl Invest Oncol, Mol Oncol Program, E-28029 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28029 Madrid, Spain; Univ Bordeaux 2, EA 2406, F-33076 Bordeaux, France		Ortega, S (corresponding author), Ctr Nacl Invest Oncol, Mol Oncol Program, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.		Malumbres, Marcos/E-8834-2011; Barbero, Jose Luis/J-9833-2014	Malumbres, Marcos/0000-0002-0829-6315; Sotillo, Rocio/0000-0002-0855-7917; BARBERO, JOSE LUIS/0000-0002-1226-0323; Dubus, Pierre/0000-0003-1803-4711			Ashley T, 2001, J CELL SCI, V114, P685; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; ELLEDGE SJ, 1991, EMBO J, V10, P2653, DOI 10.1002/j.1460-2075.1991.tb07808.x; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; GENG Y, IN PRESS CELL; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Hanks MC, 1998, DEVELOPMENT, V125, P4521; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; HULTEN MA, 2001, HUMAN CYTOGENETICS C, P211; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Kneitz B, 2000, GENE DEV, V14, P1085; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lane ME, 2000, GENETICS, V155, P233; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARISI T, IN PRESS EMBO J; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sotillo R, 2001, EMBO J, V20, P6637, DOI 10.1093/emboj/20.23.6637; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; TSAI LH, 1993, ONCOGENE, V8, P1593; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	52	656	673	2	58	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					25	31		10.1038/ng1232			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	WOS:000185018500007	12923533				2022-01-24	
J	Hartley, JL; Temple, GF; Brasch, MA				Hartley, JL; Temple, GF; Brasch, MA			DNA cloning using in vitro site-specific recombination	GENOME RESEARCH			English	Article							ESCHERICHIA-COLI; EFFICIENT GENERATION; RAPID CONSTRUCTION; PCR PRODUCTS; BACULOVIRUSES; YEAST	As a result of numerous genome sequencing projects, large numbers of candidate open reading frames are being identified, many of which have no known function. Analysis of these genes typically involves the transfer of DNA segments into a variety of vector backgrounds for protein expression and functional analysis. We describe a method called recombinational cloning that uses in vitro site-specific recombination to accomplish the directional cloning of PCR products and the subsequent automatic subcloning of the DNA segment into new vector backbones at high efficiency. Numerous DNA segments can be transferred in parallel into many different vector backgrounds, providing an approach to high-throughput, in-depth functional analysis of genes and rapid optimization of protein expression. The resulting subclones maintain orientation and reading frame register, allowing amino- and carboxy-terminal translation fusions to be generated. In this paper, we outline the concepts of this approach and provide several examples that highlight some of its potential.	Life Technol Inc, Rockville, MD 20850 USA		Brasch, MA (corresponding author), Life Technol Inc, Rockville, MD 20850 USA.	jhartley@lifetech.com					ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; BOYD AC, 1993, NUCLEIC ACIDS RES, V21, P817, DOI 10.1093/nar/21.4.817; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; CHAPIN SJ, 1995, BIOCHEMISTRY-US, V34, P2289, DOI 10.1021/bi00007a025; Degryse E, 1996, GENE, V170, P45, DOI 10.1016/0378-1119(95)00858-6; Guo F, 1999, P NATL ACAD SCI USA, V96, P7143, DOI 10.1073/pnas.96.13.7143; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; PEAKMAN TC, 1992, NUCLEIC ACIDS RES, V20, P495, DOI 10.1093/nar/20.3.495; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WEISBERG RA, 1983, LAMBDA, V2; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	21	656	728	5	5	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2000	10	11					1788	1795		10.1101/gr.143000			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	374VH	WOS:000165364700016	11076863	Green Published, Bronze			2022-01-24	
J	Li, QY; NewburyEcob, RA; Terrett, JA; Wilson, DI; Curtis, ARJ; Yi, CH; Gebuhr, T; Bullen, PJ; Robson, SC; Strachan, T; Bonnet, D; Lyonnet, S; Young, ID; Raeburn, JA; Buckler, AJ; Law, DJ; Brook, JD				Li, QY; NewburyEcob, RA; Terrett, JA; Wilson, DI; Curtis, ARJ; Yi, CH; Gebuhr, T; Bullen, PJ; Robson, SC; Strachan, T; Bonnet, D; Lyonnet, S; Young, ID; Raeburn, JA; Buckler, AJ; Law, DJ; Brook, JD			Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family	NATURE GENETICS			English	Article							CONSERVED PROTEIN MOTIF; HEART-HAND SYNDROME; MESODERM FORMATION; DROSOPHILA-MELANOGASTER; INSITU HYBRIDIZATION; WAARDENBURG SYNDROME; MOUSE BRACHYURY; OPTOMOTOR-BLIND; GRAM SYNDROME; SYNDROME MAPS	Holt-Gram syndrome is a developmental disorder affecting the heart and upper limb, the gene for which was mapped to chromosome 12 two years ago. We have now identified a gene for this disorder (HOS1). The gene (TBX5) is a member of the Brachyury (T) family corresponding to the mouse Tbx5 gene. We have identified six mutations, three in HOS families and three in sporadic HOS cases. Each of the mutations introduces a premature stop codon in the TBX5 gene product. Tissue in situ hybridization studies on human embryos from days 26 to 52 of gestation reveal expression of TBX5 in heart and limb. consistent with a role in human embryonic development.	UNIV NOTTINGHAM, QUEENS MED CTR, SCH MED, DEPT GENET, NOTTINGHAM NG7 2UH, ENGLAND; UNIV NOTTINGHAM, CITY HOSP, NHS TRUST, CTR GENET MED, NOTTINGHAM NG5 1PB, ENGLAND; ROYAL HOSP SICK CHILDREN, DEPT CLIN GENET, BRISTOL BS2 8JJ, AVON, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT FETAL MED, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; HOP NECKER ENFANTS MALAD, DEPT PEDIAT, INSERM U393, F-75743 PARIS, FRANCE; MASSACHUSETTS GEN HOSP, DEPT NEUROGENET, CHARLESTOWN, MA USA				Wilson, David I/A-6264-2010; Lyonnet, Stanislas/H-5483-2017	Wilson, David I/0000-0001-8779-2060; Lyonnet, Stanislas/0000-0001-5426-9417; Brook, John David/0000-0002-5946-6740	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00209] Funding Source: Medline		AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; Agulnik SI, 1996, GENETICS, V144, P249; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BAMSHAD M, 1995, HUM MOL GENET, V4, P1973, DOI 10.1093/hmg/4.10.1973; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; BONNET D, 1994, NAT GENET, V6, P405, DOI 10.1038/ng0494-405; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Burn J, 1996, CURR OPIN GENET DEV, V6, P322, DOI 10.1016/S0959-437X(96)80009-8; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; DELAFUENTE SR, 1980, HUM GENET, V55, P43; Dixon J, 1996, NAT GENET, V12, P130; DRIESEN MS, 1991, GENOMICS, V11, P1079, DOI 10.1016/0888-7543(91)90035-D; Edwards YH, 1996, GENOME RES, V6, P226, DOI 10.1101/gr.6.3.226; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; FRIEDMAN WF, 1992, HEART DIS TXB CARDIO, V2, P865; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/S0092-8674(05)80087-X; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HOLT M, 1960, BRIT HEART J, V22, P236; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Larsen WJ, 1993, HUMAN EMBRYOLOGY, P479; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; Li QY, 1996, GENOMICS, V32, P218, DOI 10.1006/geno.1996.0108; LI QY, 1988, CHINESE J PLANT PATH, V18, P225; Lyons GE, 1996, CURR OPIN GENET DEV, V6, P454, DOI 10.1016/S0959-437X(96)80067-0; MOORMAN AFM, 1993, HISTOCHEM J, V25, P251, DOI 10.1007/BF00159117; Morrison K, 1996, HUM MOL GENET, V5, P669, DOI 10.1093/hmg/5.5.669; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Notenboom RGE, 1996, DEVELOPMENT, V122, P321; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; PASTERIS NG, 1994, CELL, V79, P669; PFLUGFELDER GO, 1990, GENETICS, V126, P91; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; PFLUGFELDER GO, 1992, P NATL ACAD SCI USA, V89, P1199, DOI 10.1073/pnas.89.4.1199; PYERITZ RE, 1992, HEART DIS TXB CARDIO, V2, P1622; REARDON W, 1994, NAT GENET, V8, P95; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SILENGO MC, 1990, CLIN GENET, V38, P105; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SOOTHILL PW, 1994, LANCET, V343, P1096, DOI 10.1016/S0140-6736(94)90205-4; STOTTLER CJ, 1995, AM J HUM GENET SA56, V57; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; SWAROOP A, 1993, CYTOGENET CELL GENET, V64, P292, DOI 10.1159/000133595; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TEMTAMY S, 1978, BIRTH DEFECTS, V14, P241; TERRETT JA, 1994, NAT GENET, V6, P401, DOI 10.1038/ng0494-401; TERRETT JA, 1995, AM J HUM GENET, V59, P1337; THIERFELDER L, 1995, CURRENT PROTOCOLS HU, V2; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Verma RS, 1989, HUMAN CHROMOSOMES MA; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WARREN W, 1995, CURRENT PROTOCOLS HU, V2; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WILLISON K, 1990, TRENDS GENET, V6, P104, DOI 10.1016/0168-9525(90)90106-G; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707	86	656	673	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1997	15	1					21	29					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300016	8988164				2022-01-24	
J	LAKICH, D; KAZAZIAN, HH; ANTONARAKIS, SE; GITSCHIER, J				LAKICH, D; KAZAZIAN, HH; ANTONARAKIS, SE; GITSCHIER, J			INVERSIONS DISRUPTING THE FACTOR-VIII GENE ARE A COMMON-CAUSE OF SEVERE HEMOPHILIA-A	NATURE GENETICS			English	Article							HEMOPHILIA-A; MOLECULAR CHARACTERIZATION; DELETIONS; CLUSTER; LOCUS; DNA; RECOMBINATION; REARRANGEMENT; REGIONS; YEAST	Mutations in the factor VIII gene have been discovered for barely more than half of the examined cases of severe haemophilia A. To account for the unidentified mutations, we propose a model based on the possibility of recombination between homologous sequences located in intron 22 and upstream of the factor VIII gene. Such a recombination would lead to an inversion of all intervening DNA and a disruption of the gene. We present evidence to support this model and describe a Southern blot assay that detects the inversion. These findings should be valuable for genetic prediction of haemophilia A in approximately 45% of families with severe disease.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21287; UNIV GENEVA,SCH MED,DEPT GENET,CH-1211 GENEVA 4,SWITZERLAND				Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823			CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; EFREMOV GD, 1978, HEMOGLOBIN, V2, P197, DOI 10.3109/03630267809007068; FREIJE D, 1992, AM J HUM GENET, V51, P66; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P7405, DOI 10.1073/pnas.88.16.7405; JONES RW, 1981, NATURE, V291, P39, DOI 10.1038/291039a0; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; KATZ BZ, 1989, J INFECT DIS, V160, P589, DOI 10.1093/infdis/160.4.589; KENWRICK S, 1989, AM J HUM GENET, V45, P873; KULOZIK AE, 1992, BLOOD, V79, P2455; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; LEVINSON B, 1992, GENOMICS, V14, P585, DOI 10.1016/S0888-7543(05)80155-7; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; PATTERSON M, 1989, AM J HUM GENET, V44, P679; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; RIZZA CR, 1983, BRIT MED J, V286, P929, DOI 10.1136/bmj.286.6369.929; SMITHIES O, 1964, COLD SPRING HARB SYM, V29, P309, DOI 10.1101/SQB.1964.029.01.033; TUDDENHAM EGD, 1991, NUCLEIC ACIDS RES, V19, P4821, DOI 10.1093/nar/19.18.4821; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	23	655	683	1	44	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					236	241		10.1038/ng1193-236			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	WOS:A1993MF12200012	8275087				2022-01-24	
J	Taylor, JS; Braasch, I; Frickey, T; Meyer, A; Van de Peer, Y				Taylor, JS; Braasch, I; Frickey, T; Meyer, A; Van de Peer, Y			Genome duplication, a trait shared by 22,000 species of ray-finned fish	GENOME RESEARCH			English	Article							GENE DUPLICATION; EVOLUTIONARY CONSERVATION; ZEBRAFISH; SEQUENCE; FUGU; DNA; EXPRESSION; PARSIMONY; DIVERGENT; PATTERNS	Through phylogeny reconstruction we identified 49 genes with a single copy in man, mouse, and chicken, one or two copies in the tetraploid frog Xenopus laevis, and two copies in zebrafish (Danlo rerio). For 22 of these genes, both zebrafish duplicates had orthologs in the pufferfish (Takifugu rubripes). For another 20 of these genes, we found only one pufferfish ortholog but in each case it was more closely related to one of the zebrafish duplicates than to the other. Forty-three pairs of duplicated genes map to 24 of the 25 zebrafish linkage groups but they are not randomly distributed; we identified 10 duplicated regions of the zebrafish genome that each contain between two and five sets of paralogous genes. These phylogeny and synteny data suggest that the common ancestor of zebrafish and pufferfish, a fish that gave rise to similar to22,000 species, experienced a large-scale gene or complete genome duplication event and that the pufferfish has lost many duplicates that the zebrafish has retained.	Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Univ Victoria, Dept Biol, Victoria, BC V8W 3N6, Canada; Univ Ghent, Dept Plant Syst Biol, B-9000 Ghent, Belgium		Meyer, A (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	axel.meyer@uni-konstanz.de	Van de Peer, Yves/AAE-7666-2019; Braasch, Ingo/A-6948-2010; Van de Peer, Yves/D-4388-2009; Meyer, Axel/C-9826-2009	Van de Peer, Yves/0000-0003-4327-3730; Braasch, Ingo/0000-0003-4766-611X; Van de Peer, Yves/0000-0003-4327-3730; Meyer, Axel/0000-0002-0888-8193; Tayor, John/0000-0001-6960-9293			ALLENDORF FW, 1978, NATURE, V272, P76, DOI 10.1038/272076a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Arratia Gloria, 1999, P265; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; Dulai KS, 1999, GENOME RES, V9, P629; Elgar G, 1999, GENOME RES, V9, P960, DOI 10.1101/gr.9.10.960; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FERRIS SD, 1977, NATURE, V265, P258, DOI 10.1038/265258a0; Force A, 1999, GENETICS, V151, P1531; Friedman R, 2001, GENOME RES, V11, P1842, DOI 10.1101/gr.200601; Gates MA, 1999, GENOME RES, V9, P334; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gu X, 2002, GENOME RES, V12, P1, DOI 10.1101/gr.214402; Hall TA, 1999, NUCL ACIDS S SER, P95; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kwok C, 1998, NUCLEIC ACIDS RES, V26, P3562, DOI 10.1093/nar/26.15.3562; LI WH, 1980, GENETICS, V95, P237; Liu TX, 2002, P NATL ACAD SCI USA, V99, P6136, DOI 10.1073/pnas.072560099; Ludwig A, 2001, GENETICS, V158, P1203; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, TRENDS ECOL EVOL, V16, P420, DOI 10.1016/S0169-5347(01)02242-X; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nelson J. S., 1994, FISHES WORLD; Ohno S., 1970, P1; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prince VE, 1998, DEVELOPMENT, V125, P407; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Robinson-Rechavi M, 2001, CURR BIOL, V11, pR458, DOI 10.1016/S0960-9822(01)00280-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SCHMIDTKE J, 1979, CHROMOSOMA, V75, P185, DOI 10.1007/BF00292207; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; STEPHENS SG, 1951, ADV GENET, V4, P247, DOI 10.1016/S0065-2660(08)60237-0; Stock DW, 1997, MOL BIOL EVOL, V14, P1273, DOI 10.1093/oxfordjournals.molbev.a025737; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Taylor JS, 2001, CURR BIOL, V11, pR1005, DOI 10.1016/S0960-9822(01)00610-8; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Taylor JS, 2001, TRENDS GENET, V17, P299, DOI 10.1016/S0168-9525(01)02318-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UYENO T, 1972, SCIENCE, V175, P644, DOI 10.1126/science.175.4022.644; Van de Peer Y, 2002, GENE, V295, P205, DOI 10.1016/S0378-1119(02)00689-3; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Westerfield M., 1993, ZEBRAFISH BOOK; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Yu WP, 2001, ONCOGENE, V20, P5554, DOI 10.1038/sj.onc.1204679; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; [No title captured]	60	654	686	0	52	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2003	13	3					382	390		10.1101/gr.640303			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	653CX	WOS:000181418600006	12618368	Bronze, Green Published			2022-01-24	
J	Roetto, A; Papanikolaou, G; Politou, M; Alberti, F; Girelli, D; Christakis, J; Loukopoulos, D; Camaschella, C				Roetto, A; Papanikolaou, G; Politou, M; Alberti, F; Girelli, D; Christakis, J; Loukopoulos, D; Camaschella, C			Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; IRON OVERLOAD; GENE; MUTATION; SLC11A3; LIVER	Animal models indicate that the antimicrobial peptide hepcidin (HAMP; OMIM 606464) is probably a key regulator of iron absorption in mammals. Here we report the identification of two mutations (93delG and 166C-->T) in HAMP on 19q13 in two families with a new type of juvenile hemochromatosis.	Univ Turin, Dept Clin & Biol Sci, Azienda Osped San Luigi, I-10043 Orbassano, Italy; Univ Athens, Sch Med, Dept Med 1, Laikon Hosp, GR-11527 Athens, Greece; Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; Theagenio Canc Ctr, Dept Hematol, Thessaloniki, Greece		Camaschella, C (corresponding author), Univ Turin, Dept Clin & Biol Sci, Azienda Osped San Luigi, I-10043 Orbassano, Italy.		Girelli, Domenico/B-1183-2008; PAPANIKOLAOU, GEORGE/AAL-9017-2021; Roetto, Antonella/K-4731-2016; Camaschella, Clara/A-3289-2015	Girelli, Domenico/0000-0001-9684-1899; PAPANIKOLAOU, GEORGE/0000-0002-6755-3633; ROETTO, Antonella/0000-0003-1188-7375	TelethonFondazione Telethon [GP0255Y01] Funding Source: Medline		Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Camaschella C, 1997, EUR J HUM GENET, V5, P371, DOI 10.1159/000484794; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI13468; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Papanikolaou G, 2002, BLOOD CELL MOL DIS, V29, P168, DOI 10.1006/bcmd.2002.0553; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379; Roetto A, 2001, BLOOD, V97, P2555, DOI 10.1182/blood.V97.9.2555; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260	15	654	684	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					21	22		10.1038/ng1053			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	WOS:000180136100011	12469120				2022-01-24	
J	Verbanck, M; Chen, CY; Neale, B; Do, R				Verbanck, Marie; Chen, Chia-Yen; Neale, Benjamin; Do, Ron			Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases	NATURE GENETICS			English	Article							MULTIPLE GENETIC-VARIANTS; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RISK; COMMON; LOCI; EPIDEMIOLOGY; INSIGHTS	Horizontal pleiotropy occurs when the variant has an effect on disease outside of its effect on the exposure in Mendelian randomization (MR). Violation of the 'no horizontal pleiotropy' assumption can cause severe bias in MR. We developed the Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) test to identify horizontal pleiotropic outliers in multi-instrument summary-level MR testing. We showed using simulations that the MR-PRESSO test is best suited when horizontal pleiotropy occurs in <50% of instruments. Next we applied the MR-PRESSO test, along with several other MR tests, to complex traits and diseases and found that horizontal pleiotropy (i) was detectable in over 48% of significant causal relationships in MR; (ii) introduced distortions in the causal estimates in MR that ranged on average from -131% to 201%; (iii) induced false-positive causal relationships in up to 10% of relationships; and (iv) could be corrected in some but not all instances.	[Verbanck, Marie; Do, Ron] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Verbanck, Marie; Do, Ron] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Verbanck, Marie; Do, Ron] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Chia-Yen; Neale, Benjamin] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Chen, Chia-Yen; Neale, Benjamin] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Chen, Chia-Yen; Neale, Benjamin] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA		Do, R (corresponding author), Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA.; Do, R (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Do, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Neale, B (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Neale, B (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.; Neale, B (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA.	bneale@broadinstitute.org; ron.do@mssm.edu		Verbanck, Marie/0000-0002-1669-572X; Chen, Chia-Yen/0000-0001-9548-5597	National Institute Of General Medical Sciences of the US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R35GM124836]; National Heart, Lung, Blood Institute of the US National Institutes of Health [R01HL139865]; AstraZenecaAstraZeneca; Goldfinch Bio; American Heart Association Cardiovascular Genome-Phenome Discovery grant [15CVGPSD27130014]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01MH094469, 1R01MH107649-01, 5U01HG009088-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL139865] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG009088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R35GM124836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH107649, R01MH094469] Funding Source: NIH RePORTER	We thank the various GWA consortia for generously sharing the GWA summary statistics. We thank A. Dobbyn and D. Jordan for critical comments on the manuscript. R.D. is supported by R35GM124836 from the National Institute Of General Medical Sciences of the US National Institutes of Health, R01HL139865 from the National Heart, Lung, Blood Institute of the US National Institutes of Health, research grants from AstraZeneca and Goldfinch Bio and, previously, an American Heart Association Cardiovascular Genome-Phenome Discovery grant (15CVGPSD27130014). B.N. is supported by 1R01MH094469, 1R01MH107649-01 and 5U01HG009088-02 from the US National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bowden J, 2017, BIORXIV, DOI DOI 10.1101/159442; Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burgess S, 2017, EPIDEMIOLOGY, V28, P30, DOI 10.1097/EDE.0000000000000559; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Corbin LJ, 2016, DIABETES, V65, P3002, DOI 10.2337/db16-0418; Davey SG, 2015, BIORXIV, DOI [10.1101/021386, DOI 10.1101/021386]; Del Greco MF, 2015, STAT MED, V34, P2926, DOI 10.1002/sim.6522; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Evans DM, 2015, ANNU REV GENOM HUM G, V16, P327, DOI 10.1146/annurev-genom-090314-050016; Fox J, 1990, MODERN METHODS DATA; Grassmann F, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0418-0; Gratten J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0332-x; Hartwig FP, 2017, INT J EPIDEMIOL, V46, P1985, DOI 10.1093/ije/dyx102; Hemani G., 2017, AUTOMATING MENDELIAN, DOI [10.1101/173682, DOI 10.1101/173682]; Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Lyngdoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039321; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mokry LE, 2015, J MED GENET, V52, P71, DOI 10.1136/jmedgenet-2014-102438; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pickrell J.K., 2015, BIORXIV, DOI [10.1101/018150, DOI 10.1101/018150]; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056	40	653	654	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					693	+		10.1038/s41588-018-0099-7			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	WOS:000431394900012	29686387	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Zuccato, C; Tartari, M; Crotti, A; Goffredo, D; Valenza, M; Conti, L; Cataudella, T; Leavitt, BR; Hayden, MR; Timmusk, T; Rigamonti, D; Cattaneo, E				Zuccato, C; Tartari, M; Crotti, A; Goffredo, D; Valenza, M; Conti, L; Cataudella, T; Leavitt, BR; Hayden, MR; Timmusk, T; Rigamonti, D; Cattaneo, E			Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes	NATURE GENETICS			English	Article							RESTRICTIVE SILENCER FACTOR; WILD-TYPE HUNTINGTIN; HISTONE DEACETYLASE; MULTIPLE PROMOTERS; MUTANT HUNTINGTIN; BDNF-GENE; DISEASE; EXPRESSION; BRAIN; MOUSE	Huntingtin protein is mutated in Huntington disease(1). We previously reported that wild-type but not mutant huntingtin stimulates transcription of the gene encoding brain-derived neurotrophic factor (BDNF; ref. 2). Here we show that the neuron restrictive silencer element (NRSE) is the target of wildtype huntingtin activity on BDNF promoter II. Wild-type huntingtin inhibits the silencing activity of NRSE, increasing transcription of BDNF. We show that this effect occurs through cytoplasmic sequestering of repressor element-1 transcription factor/neuron restrictive silencer factor (REST/NRSF), the transcription factor that binds to NRSE3,4. In contrast, aberrant accumulation of REST/NRSF in the nucleus is present in Huntington disease. We show that wild-type huntingtin coimmunoprecipitates with REST/NRSF and that less immunoprecipitated material is found in brain tissue with Huntington disease. We also report that wild-type huntingtin acts as a positive transcriptional regulator for other NRSE-containing genes involved in the maintenance of the neuronal phenotype(5). Consistently, loss of expression of NRSE-controlled neuronal genes is shown in cells, mice and human brain with Huntington disease. We conclude that wild-type huntingtin acts in the cytoplasm of neurons to regulate the availability of REST/NRSF to its nuclear NRSE-binding site and that this control is lost in the pathology of Huntington disease. These data identify a new mechanism by which mutation of huntingtin causes loss of transcription of neuronal genes.	Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; Univ British Columbia, Dept Med Genet, Ctr mol Med & Therapeut, Vancouver, BC, Canada; Univ Helsinki, Inst Biotechnol, Helsinki, Finland; Tallinn Univ Technol, Dept Gene Technol, EE-200108 Tallinn, Estonia; NICPB, Tallinn, Estonia		Cattaneo, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.cattaneo@unimi.it	Conti, Luciano/H-4184-2012; Hayden, Michael R/D-8581-2011; Leavitt, Blair R/G-1934-2012; Timmusk, Tonis/H-4889-2015; VALENZA, MARTA/B-7763-2017	Conti, Luciano/0000-0002-2050-9846; Hayden, Michael R/0000-0001-5159-1419; Timmusk, Tonis/0000-0002-1015-3348; CATTANEO, ELENA/0000-0002-0755-4917; ZUCCATO, CHIARA/0000-0003-1771-3392; VALENZA, MARTA/0000-0002-7048-9257	TelethonFondazione Telethon [E.0840] Funding Source: Medline		Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Koenigsberger C, 2000, P NATL ACAD SCI USA, V97, P2291, DOI 10.1073/pnas.050578797; Lee JH, 2000, MOL BRAIN RES, V80, P88, DOI 10.1016/S0169-328X(00)00129-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; Timmusk T, 1999, J BIOL CHEM, V274, P1078; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; ZHANG Y, IN PRESS J NEUROCHEM; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	30	653	669	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					76	83		10.1038/ng1219			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	WOS:000185018500014	12881722				2022-01-24	
J	ECKERSON, HW; WYTE, CM; LADU, BN				ECKERSON, HW; WYTE, CM; LADU, BN			THE HUMAN-SERUM PARAOXONASE ARYLESTERASE POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ECKERSON, HW (corresponding author), UNIV MICHIGAN,DEPT PHARMACOL,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM027028] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM27028] Funding Source: Medline		ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; ALDRIDGE WN, 1975, ENZYME INHIBITORS SU, P176; AUGUSTINSSON K, 1958, NATURE, V181, P1786, DOI 10.1038/1811786a0; AUGUSTINSSON K, 1961, ANN NY ACAD SCI, V94, P844, DOI 10.1111/j.1749-6632.1961.tb35578.x; AUGUSTINSSON KB, 1962, ACTA CHEM SCAND, V16, P240, DOI 10.3891/acta.chem.scand.16-0240; AUGUSTINSSON KB, 1964, J HISTOCHEM CYTOCHEM, V12, P744, DOI 10.1177/12.10.744; BACHORIK PS, 1976, CLIN CHEM, V22, P1828; BLANCO A, 1966, B JOHNS HOPKINS HOSP, V118, P27; BURLINA A, 1977, EUR J CLIN INVEST, V7, P17, DOI 10.1111/j.1365-2362.1977.tb01564.x; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; CHOI SS, 1967, J DAIRY SCI, V50, P1088, DOI 10.3168/jds.S0022-0302(67)87570-2; CHOI SS, 1967, J DAIRY SCI, V50, P837, DOI 10.3168/jds.S0022-0302(67)87532-5; DON MM, 1975, BIOCHEM J, V151, P625, DOI 10.1042/bj1510625; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1982, AM J HUM GENET, V34, pA50; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; ERDOES EG, 1961, NATURE, V190, P716, DOI 10.1038/190716a0; ERDOS EG, 1960, BIOCHEM PHARMACOL, V5, P173, DOI 10.1016/0006-2952(60)90061-7; FLUGEL M, 1978, KLIN WOCHENSCHR, V56, P911, DOI 10.1007/BF01489217; Geldermacher-Von M.M, 1978, HUM GENET S, V1, P65; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; HEIN DW, 1982, J PHARMACOL EXP THER, V220, P1; HUGGINS C, 1947, J BIOL CHEM, V170, P467; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; LADU BN, 1971, HDB EXPTL PHARMACOLO, V28, P477; MAIN AR, 1960, BIOCHEM J, V74, P10, DOI 10.1042/bj0740010; MAIN AR, 1960, BIOCHEM J, V75, P188, DOI 10.1042/bj0750188; MARTON AV, 1962, CAN J BIOCHEM PHYS, V40, P319; MENDOZA CE, 1976, COMP BIOCHEM PHYS C, V55, P23, DOI 10.1016/0306-4492(76)90006-X; MOUNTER LA, 1953, BIOCHEM J, V54, P551, DOI 10.1042/bj0540551; PATTERSON E, 1980, MOL PHARMACOL, V17, P367; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SIMPSON NE, 1971, AM J HUM GENET, V23, P375; SMOLEN A, 1982, AM J HUM GENET, V34, pA63; WILLE LE, 1976, CLIN CHIM ACTA, V71, P355, DOI 10.1016/0009-8981(76)90554-4; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6; ZELLER EA, 1956, ARCH BIOCHEM BIOPHYS, V61, P231, DOI 10.1016/0003-9861(56)90335-6	39	653	665	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1126	1138					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	WOS:A1983RU70500008	6316781				2022-01-24	
J	Menasche, G; Pastural, E; Feldmann, J; Certain, S; Ersoy, F; Dupuis, S; Wulffraat, N; Bianchi, D; Fischer, A; Le Deist, F; de Saint Basile, G				Menasche, G; Pastural, E; Feldmann, J; Certain, S; Ersoy, F; Dupuis, S; Wulffraat, N; Bianchi, D; Fischer, A; Le Deist, F; de Saint Basile, G			Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome	NATURE GENETICS			English	Article							BRAIN MYOSIN-V; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; UNCONVENTIONAL MYOSIN; PARTIAL ALBINISM; PROTEINS; GENE; IMMUNODEFICIENCY; TRANSPORT; GTPASES; CLONING	Griscelli syndrome (GS, MIM 214450), a rare, autosomal recessive disorder, results in pigmentary dilution of the skin and the hair, the presence of large clumps of pigment in hair shafts and an accumulation of melanosomes in melanocytes. Most patients also develop an uncontrolled T-lymphocyte and macrophage activation syndrome (known as haemophagocytic syndrome, HS), leading to death in the absence of bone-marrow transplantation(1,2). In contrast, early in life some GS patients show a severe neurological impairment without apparent immune abnormalities(3-5). We previously mapped the GS locus to chromosome 15q21 and found a mutation in a gene (MY05A) encoding a molecular motor in two patients(5). Further linkage analysis suggested a second gene associated with CS was in the same chromosomal region(6). Homozygosity mapping in additional families narrowed the candidate region to a 3.1-cM interval between D1551003 and D155962. We detected mutations in RAB27A, which lies within this interval, in 16 patients with CS. Unlike MYO5A, the GTP-binding protein RAB27A appears to be involved in the control of the immune system, as all patients with RAB27A mutations, but none with the MY05A mutation, developed HS. In addition, RAB27A-deficient T cells exhibited reduced cytotoxicity and cytolytic granule exocytosis, whereas MYO5A-defective T cells did not. RAB27A appears to be a key effector of cytotoxic granule exocytosis, a pathway essential for immune homeostasis.	INSERM, U429, Unite Rech Dev Normal & Pathol Syst Immunitaire, Paris, France; Hacettepe Univ, Hacettepe Childrens Hosp, Pediat Immunol Unit, Ankara, Turkey; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, Paris, France; Wilhelmina Childrens Hosp, Utrecht, Netherlands; Tufts Univ New England Med Ctr, Boston, MA 02111 USA		de Saint Basile, G (corresponding author), INSERM, U429, Unite Rech Dev Normal & Pathol Syst Immunitaire, Paris, France.	sbasile@necker.fr	menasche, gael/D-8280-2017; de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269; Menasche, Gael/0000-0001-6671-3642; DOGNIAUX, Stephanie/0000-0003-3309-1204			Barrat FJ, 1999, P NATL ACAD SCI USA, V96, P8645, DOI 10.1073/pnas.96.15.8645; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/S0092-8674(05)80080-7; Dufourcq-Lagelouse R, 1999, INT J MOL MED, V4, P127; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; ELEJALDE BR, 1979, AM J MED GENET, V3, P65, DOI 10.1002/ajmg.1320030112; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; HURVITZ H, 1993, EUR J PEDIATR, V152, P402, DOI 10.1007/BF01955897; Kim S, 1998, CELL IMMUNOL, V183, P106, DOI 10.1006/cimm.1998.1252; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; Mazerolles F, 1998, INT IMMUNOL, V10, P1897, DOI 10.1093/intimm/10.12.1897; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Tolmachova T, 1999, GENE, V239, P109, DOI 10.1016/S0378-1119(99)00371-6	23	652	675	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					173	176		10.1038/76024			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200015	10835631				2022-01-24	
J	Smith, SJ; Cases, S; Jensen, DR; Chen, HC; Sande, E; Tow, B; Sanan, DA; Raber, J; Eckel, RH; Farese, RV				Smith, SJ; Cases, S; Jensen, DR; Chen, HC; Sande, E; Tow, B; Sanan, DA; Raber, J; Eckel, RH; Farese, RV			Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat	NATURE GENETICS			English	Article							CHOLESTEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; DIABETES-MELLITUS; LEPTIN; GENE; LIPODYSTROPHY; ENZYMES; FAT	Triglycerides (or triacylglycerols) represent the major form of stored energy in eukaryotes. Triglyceride synthesis has been assumed to occur primarily through acyl CoA:diacylglycerol transferase (Dgat), a microsomal enzyme that catalyses the final and only committed step in the glycerol phosphate pathway(1-3). Therefore, Dgat has been considered necessary for adipose tissue formation and essential for survival. Here we show that Dgat-deficient (Dgat(-/-)) mice are viable and can still synthesize triglycerides, Moreover, these mice are lean and resistant to diet-induced obesity. The obesity resistance involves increased energy expenditure and increased activity. Dgat deficiency also alters triglyceride metabolism in other tissues, including the mammary gland, where lactation is defective in Dgat(-/-) females. Our findings indicate that multiple mechanisms exist for triglyceride synthesis and suggest that the selective inhibition of Dgat-mediated triglyceride synthesis may be useful for treating obesity.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Neurol, San Francisco, CA 94141 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA		Farese, RV (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.			Chen, Hubert/0000-0002-7599-7218			BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRINDLEY DN, 1991, BIOCH LIPIDS LIPOPRO, P171; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795; ERICKSON SK, 1980, J LIPID RES, V21, P930; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Jensen DR, 1997, AM J PHYSIOL-REG I, V273, pR683, DOI 10.1152/ajpregu.1997.273.2.R683; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; MAHLEY RW, 1995, J LIPID RES, V36, P839; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; [No title captured]	19	652	676	0	38	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					87	90		10.1038/75651			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	WOS:000086884000023	10802663				2022-01-24	
J	Tomlinson, I; Webb, E; Carvajal-Carmona, L; Broderick, P; Kemp, Z; Spain, S; Penegar, S; Chandler, I; Gorman, M; Wood, W; Barclay, E; Lubbe, S; Martin, L; Sellick, G; Jaeger, E; Hubner, R; Wild, R; Rowan, A; Fielding, S; Howarth, K; Silver, A; Atkin, W; Muir, K; Logan, R; Kerr, D; Johnstone, E; Sieber, O; Gray, R; Thomas, H; Peto, J; Cazier, B; Houlston, R				Tomlinson, Ian; Webb, Emily; Carvajal-Carmona, Luis; Broderick, Peter; Kemp, Zoe; Spain, Sarah; Penegar, Steven; Chandler, Ian; Gorman, Maggie; Wood, Wendy; Barclay, Ella; Lubbe, Steven; Martin, Lynn; Sellick, Gabrielle; Jaeger, Emma; Hubner, Richard; Wild, Ruth; Rowan, Andrew; Fielding, Sarah; Howarth, Kimberley; Silver, Andrew; Atkin, Wendy; Muir, Kenneth; Logan, Richard; Kerr, David; Johnstone, Elaine; Sieber, Oliver; Gray, Richard; Thomas, Huw; Peto, Julian; Cazier, Baptiste; Houlston, Richard		CORGI Consortium	A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21	NATURE GENETICS			English	Article							PROSTATE-CANCER; RISK; METAANALYSIS; TUMORS	Much of the variation in inherited risk of colorectal cancer (CRC) is probably due to combinations of common low risk variants. We conducted a genome- wide association study of 550,000 tag SNPs in 930 familial colorectal tumor cases and 960 controls. The most strongly associated SNP (P = 1.72 x 10(-7), allelic test) was rs6983267 at 8q24.21. To validate this finding, we genotyped rs6983267 in three additional CRC case-control series (4,361 affected individuals and 3,752 controls; 1,901 affected individuals and 1,079 controls; 1,072 affected individuals and 415 controls) and replicated the association, providing P = 1.27 x 10(-14) (allelic test) overall, with odds ratios (ORs) of 1.27 (95% confidence interval (c.i.): 1.16-1.39) and 1.47 (95% c.i.: 1.34-1.62) for heterozygotes and rare homozygotes, respectively. Analyses based on 1,477 individuals with colorectal adenoma and 2,136 controls suggest that susceptibility to CRC is mediated through development of adenomas (OR = 1.21, 95% c.i.: 1.10-1.34; P = 6.89 x 10(-5)). These data show that common, low-penetrance susceptibility alleles predispose to colorectal neoplasia.	Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England; Univ London, Queen Mary Coll, Barts & London Med Sch, Inst Canc, London WC1E 7HU, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; St Marks Hosp, Canc Res UK, Colorectal Canc Unit, Harrow HA1 3UJ, Middx, England; Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Queens Med Ctr, Nottingham NG7 2UH, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; Univ Oxford, Canc & Immunogenet Lab, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2RR, W Midlands, England; St Marks Hosp, Canc Res UK, Family Canc Clin, Harrow HA1 3UJ, Middx, England; Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England; Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England		Tomlinson, I (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England.	ian.tomlinson@cancer.org.uk	Hubner, Richard/N-8051-2015; Sieber, Oliver/ABA-9211-2021; Lubbe, Steven/L-8261-2013; Cazier, Jean-Baptiste/F-2369-2010; Sieber, Oliver/M-9473-2015; Carvajal-Carmona, Luis G/B-3882-2010; Spain, Sarah/G-1968-2010	Hubner, Richard/0000-0002-7081-8823; Sieber, Oliver/0000-0001-9480-0786; Lubbe, Steven/0000-0002-7103-6671; Sieber, Oliver/0000-0001-9480-0786; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Broderick, Peter/0000-0002-8348-5829; Spain, Sarah/0000-0002-7591-8364; Penegar, Steven/0000-0002-3768-0236; Webb, Emily/0000-0002-4019-7456; Houlston, Richard/0000-0002-5268-0242; Gray, Richard/0000-0003-4440-574X; Cazier, Jean-Baptiste/0000-0001-7581-9051; Atkin, Wendy/0000-0001-9073-9658	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0301100, G9615910] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0301100, G9615910] Funding Source: UKRI		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Boland CR, 1998, CANCER RES, V58, P5248; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LOGAN RFA, 2006, GUT, V55, pA90; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; PETITTI D, 1994, MEAT ANAL DECISION A; WHO, 1977, INT CLASS DIS; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	16	651	680	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					984	988		10.1038/ng2085			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	WOS:000248446900015	17618284				2022-01-24	
J	Pugh, TJ; Morozova, O; Attiyeh, EF; Asgharzadeh, S; Wei, JS; Auclair, D; Carter, SL; Cibulskis, K; Hanna, M; Kiezun, A; Kim, J; Lawrence, MS; Lichenstein, L; McKenna, A; Pedamallu, CS; Ramos, AH; Shefler, E; Sivachenko, A; Sougnez, C; Stewart, C; Ally, A; Birol, I; Chiu, R; Corbett, RD; Hirst, M; Jackman, SD; Kamoh, B; Khodabakshi, AH; Krzywinski, M; Lo, A; Moore, RA; Mungall, KL; Qian, J; Tam, A; Thiessen, N; Zhao, YJ; Cole, KA; Diamond, M; Diskin, SJ; Mosse, YP; Wood, AC; Ji, LY; Sposto, R; Badgett, T; London, WB; Moyer, Y; Gastier-Foster, JM; Smith, MA; Auvil, JMG; Gerhard, DS; Hogarty, MD; Jones, SJM; Lander, ES; Gabriel, SB; Getz, G; Seeger, RC; Khan, J; Marra, MA; Meyerson, M; Maris, JM				Pugh, Trevor J.; Morozova, Olena; Attiyeh, Edward F.; Asgharzadeh, Shahab; Wei, Jun S.; Auclair, Daniel; Carter, Scott L.; Cibulskis, Kristian; Hanna, Megan; Kiezun, Adam; Kim, Jaegil; Lawrence, Michael S.; Lichenstein, Lee; McKenna, Aaron; Pedamallu, Chandra Sekhar; Ramos, Alex H.; Shefler, Erica; Sivachenko, Andrey; Sougnez, Carrie; Stewart, Chip; Ally, Adrian; Birol, Inanc; Chiu, Readman; Corbett, Richard D.; Hirst, Martin; Jackman, Shaun D.; Kamoh, Baljit; Khodabakshi, Alireza Hadj; Krzywinski, Martin; Lo, Allan; Moore, Richard A.; Mungall, Karen L.; Qian, Jenny; Tam, Angela; Thiessen, Nina; Zhao, Yongjun; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Ji, Lingyun; Sposto, Richard; Badgett, Thomas; London, Wendy B.; Moyer, Yvonne; Gastier-Foster, Julie M.; Smith, Malcolm A.; Auvil, Jaime M. Guidry; Gerhard, Daniela S.; Hogarty, Michael D.; Jones, Steven J. M.; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Seeger, Robert C.; Khan, Javed; Marra, Marco A.; Meyerson, Matthew; Maris, John M.			The genetic landscape of high-risk neuroblastoma	NATURE GENETICS			English	Article							ACTIVATING MUTATIONS; SOMATIC MUTATIONS; NOONAN-SYNDROME; SOLID TUMORS; ALK KINASE; CANCER; PTPN11; SUSCEPTIBILITY; AMPLIFICATION; PROTEINS	Neuroblastoma is a malignancy of the developing sympathetic nervous system that often presents with widespread metastatic disease, resulting in survival rates of less than 50%. To determine the spectrum of somatic mutation in high-risk neuroblastoma, we studied 240 affected individuals (cases) using a combination of whole-exome, genome and transcriptome sequencing as part of the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. Here we report a low median exonic mutation frequency of 0.60 per Mb (0.48 nonsilent) and notably few recurrently mutated genes in these tumors. Genes with significant somatic mutation frequencies included ALK (9.2% of cases), PTPN11 (2.9%), ATRX (2.5%, and an additional 7.1% had focal deletions), MYCN (1.7%, causing a recurrent p.Pro44Leu alteration) and NRAS (0.83%). Rare, potentially pathogenic germline variants were significantly enriched in ALK, CHEK2, PINK1 and BARD1. The relative paucity of recurrent somatic mutations in neuroblastoma challenges current therapeutic strategies that rely on frequently altered oncogenic drivers.	[Pugh, Trevor J.; Auclair, Daniel; Carter, Scott L.; Cibulskis, Kristian; Hanna, Megan; Kiezun, Adam; Kim, Jaegil; Lawrence, Michael S.; Lichenstein, Lee; McKenna, Aaron; Pedamallu, Chandra Sekhar; Ramos, Alex H.; Shefler, Erica; Sivachenko, Andrey; Sougnez, Carrie; Stewart, Chip; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA USA; [Pugh, Trevor J.; Ramos, Alex H.; London, Wendy B.; Meyerson, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Pugh, Trevor J.; Hanna, Megan; Pedamallu, Chandra Sekhar; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Morozova, Olena; Ally, Adrian; Birol, Inanc; Chiu, Readman; Corbett, Richard D.; Hirst, Martin; Jackman, Shaun D.; Kamoh, Baljit; Khodabakshi, Alireza Hadj; Krzywinski, Martin; Lo, Allan; Moore, Richard A.; Mungall, Karen L.; Qian, Jenny; Tam, Angela; Thiessen, Nina; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.] Univ British Columbia, British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada; [Morozova, Olena; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Attiyeh, Edward F.; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Hogarty, Michael D.; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asgharzadeh, Shahab; Ji, Lingyun; Sposto, Richard; Seeger, Robert C.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Ji, Lingyun; Sposto, Richard; Seeger, Robert C.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Ji, Lingyun; Sposto, Richard; Seeger, Robert C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Wei, Jun S.; Badgett, Thomas; Khan, Javed] NIH, Pediat Oncol Branch, Oncogen Sect, Ctr Canc Res, Gaithersburg, MD USA; [London, Wendy B.] Childrens Hosp Boston, Dana Farber Canc Inst, Boston, MA USA; [London, Wendy B.] Childrens Oncol Grp, Boston, MA USA; [Moyer, Yvonne; Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Biopathol Ctr, Columbus, OH USA; [Moyer, Yvonne; Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Auvil, Jaime M. Guidry; Gerhard, Daniela S.] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Maris, John M.] Abramson Family Canc Res Inst, Philadelphia, PA USA		Marra, MA (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada.	mmarra@bcgsc.ca; matthew_meyerson@dfci.harvard.edu; maris@chop.edu	Pedamallu, Chandra Sekhar/AAV-6745-2020; London, Wendy Beth/ABA-8948-2021; Birol, Inanc/G-5440-2011; Lawrence, Michael/AAC-8202-2020; Hirst, Martin/B-7684-2016; Khan, Javed/P-9157-2014; Marra, Marco A/B-5987-2008; Pugh, Trevor/Y-2535-2019; Cole, Kristina/M-3922-2015; Jones, Steven J/C-3621-2009; London, Wendy/ABD-4624-2021; Pedamallu, Chandra Sekhar/AAV-6723-2020; Cibulskis, Kristian/AAC-7380-2019; Jackman, Shaun/G-9622-2013	London, Wendy Beth/0000-0003-3571-6538; Birol, Inanc/0000-0003-0950-7839; Marra, Marco A/0000-0001-7146-7175; Pugh, Trevor/0000-0002-8073-5888; Jones, Steven J/0000-0003-3394-2208; Smith, Malcolm/0000-0001-9880-9876; Meyerson, Matthew/0000-0002-9133-8108; Jackman, Shaun/0000-0002-9275-5966; Vaske, Olena/0000-0002-1677-417X	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA98543, CA98413, RC1MD004418, CA124709, CA060104]; National Human Genome Research Institute grant [U54HG003067]; National Cancer Institute, US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [HHSN261200800001E]; Canadian Institutes of Health Research FellowshipCanadian Institutes of Health Research (CIHR); Roman M. Babicki Fellowship in Medical Research at the University of British Columbia; Canada Research Chair in Genome Science; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Arms Wide Open Foundation; Cookies for Kids Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIASC010366, ZIABC010998] Funding Source: NIH RePORTER	We thank the Children's Oncology Group for the collection and annotation of samples for this study, and all TARGET co-investigators for scientific support of this project. Funding was provided by US National Institutes of Health grants CA98543 and CA98413 to the Children's Oncology Group, RC1MD004418 to the TARGET consortium, CA124709 (J.M.M.) and CA060104 (R.C.S.) and National Human Genome Research Institute grant U54HG003067 (E.S.L., D.A., S.B.G., G.G. and M.M.), as well as a contract from the National Cancer Institute, US National Institutes of Health (HHSN261200800001E). Additional support included a Canadian Institutes of Health Research Fellowship (T.J.P.), a Roman M. Babicki Fellowship in Medical Research at the University of British Columbia (O.M.), the Canada Research Chair in Genome Science (M.A.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Arms Wide Open Foundation (J.M.M.) and the Cookies for Kids Foundation (J.M.M.). We thank E. Nickerson, S. Charmer, K. Novik, C. Suragh and R. Roscoe for project management support. We also thank the staff of the Genome Sciences Centre Biospecimen Core, Library Construction, Sequencing and Bioinformatics teams, and the staff of the Broad Institute Biological Samples, Genome Sequencing and Genetic Analysis Platforms for their expertise in genomic processing of samples, and generating the sequencing data used in this analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Choi JM, 2008, NEUROGENETICS, V9, P263, DOI 10.1007/s10048-008-0138-0; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Deyell RJ, 2011, CANCER GENET-NY, V204, P113, DOI 10.1016/j.cancergen.2011.03.001; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Klein C, 2005, EUR J HUM GENET, V13, P1086, DOI 10.1038/sj.ejhg.5201455; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee SB, 2001, CANCER RES, V61, P8062; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Marongiu R, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20719; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Sarkozy A, 2004, EUR J HUM GENET, V12, P1069, DOI 10.1038/sj.ejhg.5201290; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Sijmons RH, 2008, HERED CANCER CLIN PR, V6, P22, DOI 10.1186/1897-4287-6-1-22; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	69	650	663	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					279	284		10.1038/ng.2529			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	WOS:000315664800011	23334666	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Cao, J; Schneeberger, K; Ossowski, S; Gunther, T; Bender, S; Fitz, J; Koenig, D; Lanz, C; Stegle, O; Lippert, C; Wang, X; Ott, F; Muller, J; Alonso-Blanco, C; Borgwardt, K; Schmid, KJ; Weigel, D				Cao, Jun; Schneeberger, Korbinian; Ossowski, Stephan; Guenther, Torsten; Bender, Sebastian; Fitz, Joffrey; Koenig, Daniel; Lanz, Christa; Stegle, Oliver; Lippert, Christoph; Wang, Xi; Ott, Felix; Mueller, Jonas; Alonso-Blanco, Carlos; Borgwardt, Karsten; Schmid, Karl J.; Weigel, Detlef			Whole-genome sequencing of multiple Arabidopsis thaliana populations	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; GENETIC-VARIATION; WIDE ASSOCIATION; EVOLUTION; ALIGNMENT; REVEALS; LYRATA; POLYMORPHISMS; RECOMBINATION	The plant Arabidopsis thaliana occurs naturally in many different habitats throughout Eurasia. As a foundation for identifying genetic variation contributing to adaptation to diverse environments, a 1001 Genomes Project to sequence geographically diverse A. thaliana strains has been initiated. Here we present the first phase of this project, based on population-scale sequencing of 80 strains drawn from eight regions throughout the species' native range. We describe the majority of common small-scale polymorphisms as well as many larger insertions and deletions in the A. thaliana pan-genome, their effects on gene function, and the patterns of local and global linkage among these variants. The action of processes other than spontaneous mutation is identified by comparing the spectrum of mutations that have accumulated since A. thaliana diverged from its closest relative 10 million years ago with the spectrum observed in the laboratory. Recent species-wide selective sweeps are rare, and potentially deleterious mutations are more common in marginal populations.	[Cao, Jun; Schneeberger, Korbinian; Ossowski, Stephan; Bender, Sebastian; Fitz, Joffrey; Koenig, Daniel; Lanz, Christa; Stegle, Oliver; Lippert, Christoph; Wang, Xi; Ott, Felix; Mueller, Jonas; Borgwardt, Karsten; Weigel, Detlef] Max Planck Inst Dev Biol, Tubingen, Germany; [Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Ossowski, Stephan] Ctr Genom Regulat, Barcelona, Spain; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona, Spain; [Guenther, Torsten; Schmid, Karl J.] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Gene, D-7000 Stuttgart, Germany; [Stegle, Oliver; Lippert, Christoph; Borgwardt, Karsten] Max Planck Inst Intelligent Syst, Machine Learning & Computat Biol Res Grp, Tubingen, Germany; [Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biotecnol, Madrid, Spain		Weigel, D (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/AAR-3312-2021; Ossowski, Stephan/E-2139-2011; Gunther, Torsten/I-3355-2019; Stegle, Oliver/AAU-9177-2020; Alonso-Blanco, Carlos/F-8864-2016; Cao, Jun/E-5422-2012; Weigel, Detlef/C-1418-2008; Schneeberger, Korbinian/U-6329-2019; Lippert, Christoph/M-2992-2016	Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Gunther, Torsten/0000-0001-9460-390X; Stegle, Oliver/0000-0002-8818-7193; Alonso-Blanco, Carlos/0000-0002-4738-5556; Weigel, Detlef/0000-0002-2114-7963; Schneeberger, Korbinian/0000-0002-5512-0443; Lippert, Christoph/0000-0001-6363-2556; Koenig, Daniel/0000-0002-1037-5346; Borgwardt, Karsten/0000-0001-7221-2393	German Federal Ministry of Education and Research (BMBF)-Bioenergy Initiative (BioOl)Federal Ministry of Education & Research (BMBF) [0315429C]; Volkswagen FoundationVolkswagen [I/84 225]; BMBFFederal Ministry of Education & Research (BMBF); German Research Foundation (DFG)German Research Foundation (DFG); Max Planck SocietyMax Planck Society	We thank M. Koch for discussion of Arabidopsis phylogeography; P. Salome for F<INF>2</INF> recombination data; E. Chae, T. Hu, M. Nordborg and P. Salome for improving the manuscript with their comments; and P. Calabrese, T. Hu and M. Nordborg for communicating their observations regarding the potential effects of biased gene conversion. This work has been supported by grants from the German Federal Ministry of Education and Research (BMBF)-Bioenergy 2021 Initiative (BioOl, 0315429C; K.J.S.), the Volkswagen Foundation (I/84 225; T. G.), ERA-PG grant ARABRAS and GABI-FUTURE grant GABI-GNADE from the BMBF (D. W.), a Gottfried Wilhelm Leibniz Award of the German Research Foundation (DFG) (D. W.) and the Max Planck Society (K.B., D.W.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Fay JC, 2000, GENETICS, V155, P1405; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Friedman N, 2002, J COMPUT BIOL, V9, P331, DOI 10.1089/10665270252935494; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; GAN X, 2011, NATURE IN PRESS; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Gunther T, 2010, THEOR APPL GENET, V121, P157, DOI 10.1007/s00122-010-1299-4; Gunther Torsten, 2011, BMC Res Notes, V4, P232, DOI 10.1186/1756-0500-4-232; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ionita-Laza I, 2009, P NATL ACAD SCI USA, V106, P5008, DOI 10.1073/pnas.0807815106; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le Corre V, 2002, MOL BIOL EVOL, V19, P1261, DOI 10.1093/oxfordjournals.molbev.a004187; Lee S, 2008, BIOINFORMATICS, V24, pI59, DOI 10.1093/bioinformatics/btn176; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lynch M, 2007, ORIGINS GENOME ARCHI; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Vlad D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000945; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	75	650	666	9	222	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					956	U60		10.1038/ng.911			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	WOS:000295316200009	21874002	Bronze	Y	N	2022-01-24	
J	Zhu, H; Klemic, JF; Chang, S; Bertone, P; Casamayor, A; Klemic, KG; Smith, D; Gerstein, M; Reed, MA; Snyder, M				Zhu, H; Klemic, JF; Chang, S; Bertone, P; Casamayor, A; Klemic, KG; Smith, D; Gerstein, M; Reed, MA; Snyder, M			Analysis of yeast protein kinases using protein chips	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; SEQUENCE DATABASE; CATALYTIC DOMAIN; GENE; EXPRESSION; COMPLEX; ORGANIZATION; CHECKPOINT; REQUIRES	We have developed a novel protein chip technology that allows the high-throughput analysis of biochemical activities, and used this approach to analyse nearly all of the protein kinases from Saccharomyces cerevisiae. Protein chips are disposable arrays of microwells in silicone elastomer sheets placed on top of microscope slides. The high density and small size of the wells allows for high-throughput batch processing and simultaneous analysis of many individual samples. Only small amounts of protein are required. Of 122 known and predicted yeast protein kinases, 119 were overexpressed and analysed using 17 different substrates and protein chips. We found many novel activities and that a large number of protein kinases are capable of phosphorylating tyrosine. The tyrosine phosphorylating enzymes often share common amino acid residues that lie near the catalytic region. Thus, our study identified a number of novel features of protein kinases and demonstrates that protein chip technology is useful for high-throughput screening of protein biochemical activity.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Elect Engn, New Haven, CT USA; Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA		Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Bertone, Paul/A-6600-2013; Casamayor, Antonio/C-2509-2017; Reed, Mark/A-9970-2011; Casamayor, Antonio/A-3190-2012; Bertone, Paul/Z-3734-2019	Bertone, Paul/0000-0001-5059-4829; Reed, Mark/0000-0001-6479-7256; Casamayor, Antonio/0000-0003-2788-7329; Bertone, Paul/0000-0001-5059-4829			Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Barker WC, 1999, NUCLEIC ACIDS RES, V27, P39, DOI 10.1093/nar/27.1.39; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN, P345; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fields S, 1999, P NATL ACAD SCI USA, V96, P8825, DOI 10.1073/pnas.96.16.8825; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heyman JA, 1999, GENOME RES, V9, P383; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T., 1991, METHOD ENZYMOL, V200, P33, DOI 10.1016/0076-6879(91)00125-G; Jackman RJ, 1999, LANGMUIR, V15, P2973, DOI 10.1021/la981591y; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Malathi K, 1999, GENETICS, V153, P1145; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MENEES TM, 1992, MOL CELL BIOL, V12, P1340, DOI 10.1128/MCB.12.3.1340; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MYLIN LM, 1990, METHOD ENZYMOL, V185, P297; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Richman TJ, 1999, J BIOL CHEM, V274, P16861, DOI 10.1074/jbc.274.24.16861; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Rogers YH, 1999, ANAL BIOCHEM, V266, P23, DOI 10.1006/abio.1998.2857; Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775; STERN DF, 1991, MOL CELL BIOL, V11, P987, DOI 10.1128/MCB.11.2.987; WEINERT TA, 1993, GENETICS, V134, P63; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347	43	650	700	3	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					283	289		10.1038/81576			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500015	11062466				2022-01-24	
J	VAZIRI, H; SCHACHTER, F; UCHIDA, I; WEI, L; ZHU, XM; EFFROS, R; COHEN, D; HARLEY, CB				VAZIRI, H; SCHACHTER, F; UCHIDA, I; WEI, L; ZHU, XM; EFFROS, R; COHEN, D; HARLEY, CB			LOSS OF TELOMERIC DNA DURING AGING OF NORMAL AND TRISOMY-21 HUMAN-LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOWNS-SYNDROME; DENSITY GRADIENT; PERCOLL; YEAST; CELLS	The telomere hypothesis of cellular aging proposes that loss of telomeric DNA (TTAGGG) from human chromosomes may ultimately cause cell-cycle exit during replicative senescence. Since lymphocytes have. a limited replicative capacity and since blood cells were previously shown to lose telomeric DNA during aging in vivo, we wished to determine (a) whether accelerated telomere loss is associated with the premature immunosenescence of lymphocytes in individuals with Down syndrome (DS) and (b) whether telomeric DNA is also lost during aging of lymphocytes in vitro. To investigate the effects of aging and trisomy 21 on telomere loss in vivo, genomic DNA was isolated from peripheral blood lymphocytes of 140 individuals (age 0-107 years), including 21 DS patients (age 0-45 years). Digestion with restriction enzymes HinfI and RsaI generated terminal restriction fragments (TRFs), which were detected by Southern analysis using a telomere-specific probe (P-32-(C3TA2)3). The rate of telomere loss was calculated from the decrease in mean TRF length, as a function of donor age. DS patients showed a significantly higher rate of telomere loss with donor age (133 +/- 15 bp/year) compared with age-matched controls (41 +/- 7.7 bp/year) (P < .0005), suggesting that accelerated telomere loss is a biomarker of premature immunosenescence of DS patients and that it may play a role in this process. Telomere loss during aging in vitro was calculated for lymphocytes from four normal individuals, grown in culture for 10-30 population doublings. The rate of telomere loss was approximately 120 bp/cell doubling, comparable to that seen in other somatic cells. Moreover, telomere lengths of lymphocytes from centenarians and from older DS patients were similar to those of senescent lymphocytes in culture, which suggests that replicative senescence could partially account for aging of the immune system in DS patients and in elderly individuals.	MCMASTER UNIV, DEPT BIOCHEM, HAMILTON L8N 3Z5, ONTARIO, CANADA; MCMASTER UNIV, DEPT PEDIAT, HAMILTON L8N 3Z5, ONTARIO, CANADA; CTR ETUD POLYMORPHISM HUMAIN, PARIS, FRANCE; UNIV CALIF LOS ANGELES, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90024 USA						NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG009383, R37AG009383, R01AG005309] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG09383A, AG05309] Funding Source: Medline		ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BENDER MA, 1989, MUTAT RES, V212, P149, DOI 10.1016/0027-5107(89)90065-1; BENN PA, 1976, AM J HUM GENET, V28, P465; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COSSARIZZA A, 1991, BLOOD, V77, P1263; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DOOLEY DC, 1982, EXP HEMATOL, V10, P591; EFFROS RB, 1990, UCLA SYM BI, V123, P265; FRANCESCHI C, 1991, ANN NY ACAD SCI, V621, P428; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUTIERREZ C, 1979, J IMMUNOL METHODS, V29, P57, DOI 10.1016/0022-1759(79)90125-X; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Murasko D M, 1990, Annu Rev Gerontol Geriatr, V10, P71; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; RABINOWE SL, 1989, J AUTOIMMUN, V2, P25, DOI 10.1016/0896-8411(89)90105-4; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; THOMAN ML, 1989, ADV IMMUNOL, V46, P221, DOI 10.1016/S0065-2776(08)60655-0; UGAZIO AG, 1990, AM J MED GENET, P204; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0	31	650	663	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					661	667					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	WOS:A1993KY05900002	8460632				2022-01-24	
J	Bellen, HJ; Levis, RW; Liao, GC; He, YC; Carlson, JW; Tsang, G; Evans-Holm, M; Hiesinger, PR; Schulze, KL; Rubin, GM; Hoskins, RA; Spradling, AC				Bellen, HJ; Levis, RW; Liao, GC; He, YC; Carlson, JW; Tsang, G; Evans-Holm, M; Hiesinger, PR; Schulze, KL; Rubin, GM; Hoskins, RA; Spradling, AC			The BDGP gene disruption project: Single transposon insertions associated with 40% of Drosophila genes	GENETICS			English	Article							MEDIATED ENHANCER DETECTION; INDUCED MALE RECOMBINATION; P-ELEMENT INSERTIONS; PREFERENTIAL TRANSPOSITION; TARGETED TRANSPOSITION; 3RD CHROMOSOME; MOBILE ELEMENT; SEARCH SYSTEM; LARGE-SCALE; MUTAGENESIS	The Berkeley Drosophila Genome Project (BDGP) strives to disrupt each Drosophila gene by the insertion of a single transposable element. As part of this effort, transposons in >30,000 fly strains were localized and analyzed relative to predicted Drosophila gene Structures. Approximately 6300 lines that maximize genomic coverage were selected to be sent to the Bloomington Stock Center for public distribution, bringing the size of the BDGP gene disruption collection to 7140 lines. It now includes individual lines predicted to disrupt 5362 of the 13,666 currently annotated Drosophila genes (39%). Other lines contain an insertion at least 2 kb from others in the collection and likely mutate additional incompletely annotated or uncharacterized genes and chromosomal regulatory elements. The remaining strains contain insertions likely to disrupt alternative gene promoters or to allow gene misexpression. The expanded BDGP gene disruption collection provides a public resource that will facilitate the application of Drosophila,genetics to diverse biological problems. Finally, the project reveals new insight into how transposons interact with a eukaryotic genome and helps define optimal strategies for using insertional mutagenesis as a genomic tool.	Carnegie Inst Sci, Howard Hughes Med Inst, Dept Embryol, Baltimore, MD 21210 USA; Baylor Coll Med, Dept Mol & Human Genet, Howard Hughes Med Inst, Program Dev Biol, Houston, TX 77030 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Berkeley, CA 94720 USA		Spradling, AC (corresponding author), Carnegie Inst Sci, Howard Hughes Med Inst, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	spradling@ciwemb.edu		Bellen, Hugo/0000-0001-5992-5989; Rubin, Gerald/0000-0001-8762-8703; Levis, Robert/0000-0003-3453-2390	Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aigaki T, 2001, J NEUROGENET, V15, P169, DOI 10.3109/01677060109167374; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; AKIEDA Y, 2001, DROS INF SERV, V84, P130; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amsterdam A, 2003, DEV DYNAM, V228, P523, DOI 10.1002/dvdy.10381; Ashburner M, 1999, GENETICS, V153, P179; Bellen HJ, 1999, PLANT CELL, V11, P2271, DOI 10.1105/tpc.11.12.2271; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BERG CA, 1991, GENETICS, V127, P515; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BIDLINGMAIER S, 2002, FUNCT INTEGR GENOMIC, V6, P345; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; CELNIKER SE, 2002, GENOME BIOL, V0003; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; COOLEY L, 1990, P NATL ACAD SCI USA, V87, P3170, DOI 10.1073/pnas.87.8.3170; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Deak P, 1997, GENETICS, V147, P1697; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fadool JM, 1998, P NATL ACAD SCI USA, V95, P5182, DOI 10.1073/pnas.95.9.5182; Firon A, 2003, EUKARYOT CELL, V2, P247, DOI 10.1128/EC.2.2.247-255.2003; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; GROSSNIKLAUS U, 1989, DEVELOPMENT, V107, P189; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; HESLIP TR, 1994, GENETICS, V138, P1127; Horn C, 2003, GENETICS, V163, P647; HOSKINS RA, 2002, GENOME BIOL, V0003; Huet F, 2002, P NATL ACAD SCI USA, V99, P9948, DOI 10.1073/pnas.142310099; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; KAMINKER JS, 2002, GENOME BIOL, V0003; KARPEN GH, 1992, GENETICS, V132, P737; Kassis JA, 2002, ADV GENET, V46, P421; Klinakis AG, 2000, EMBO REP, V1, P416, DOI 10.1093/embo-reports/kvd089; Konev AY, 2003, GENETICS, V165, P2039; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LENGYEL JA, 2001, DROS INF SERV, V84, P218; Lewis S. E., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Lukacsovich T, 2001, GENETICS, V157, P727; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Misra S., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0083, DOI 10.1186/GB-2002-3-12-RESEARCH0083]; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mohr SE, 2002, GENETICS, V162, P165; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Oh SW, 2003, GENETICS, V163, P195; Ohler U., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATTON JS, 1992, NUCLEIC ACIDS RES, V20, P5859, DOI 10.1093/nar/20.21.5859; Preston CR, 1996, GENETICS, V144, P1611; Preston CR, 1996, GENETICS, V144, P1623; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Roos DS, 1997, METHODS, V13, P112, DOI 10.1006/meth.1997.0504; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROSEMAN RR, 1995, GENETICS, V141, P1061; Salzberg A, 1997, GENETICS, V147, P1723; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; Sekelsky JJ, 1999, GENETICS, V152, P529; Sepp KJ, 1999, GENETICS, V151, P1093; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; STAPLETON M, 2002, GENOME BIOL, V0003; THOMPSONSTEWART D, 1994, P NATL ACAD SCI USA, V91, P9042, DOI 10.1073/pnas.91.19.9042; Timakov B, 2002, GENETICS, V160, P1011; Toba G, 1999, GENETICS, V151, P725; TOROK T, 1993, GENETICS, V135, P71; TOWER J, 1993, GENETICS, V133, P347; TOWER J, 1994, MOL GEN GENET, V244, P484, DOI 10.1007/BF00583899; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Vidan S, 2001, CURR OPIN BIOTECH, V12, P28, DOI 10.1016/S0958-1669(00)00171-3; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; Yan CM, 2002, GENETICS, V161, P217; Zagoraiou L, 2001, P NATL ACAD SCI USA, V98, P11474, DOI 10.1073/pnas.201392398; ZHANG P, 1994, P NATL ACAD SCI USA, V91, P3539, DOI 10.1073/pnas.91.9.3539	94	649	665	0	30	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	2004	167	2					761	781		10.1534/genetics.104.026427			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	837QN	WOS:000222650500018	15238527	Green Submitted, Green Published, Bronze			2022-01-24	
J	Aird, D; Ross, MG; Chen, WS; Danielsson, M; Fennell, T; Russ, C; Jaffe, DB; Nusbaum, C; Gnirke, A				Aird, Daniel; Ross, Michael G.; Chen, Wei-Sheng; Danielsson, Maxwell; Fennell, Timothy; Russ, Carsten; Jaffe, David B.; Nusbaum, Chad; Gnirke, Andreas			Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries	GENOME BIOLOGY			English	Article							HUMAN GENOME; HIGH-DENSITY; SHORT-READ; DISCOVERY	Despite the ever-increasing output of Illumina sequencing data, loci with extreme base compositions are often under-represented or absent. To evaluate sources of base-composition bias, we traced genomic sequences ranging from 6% to 90% GC through the process by quantitative PCR. We identified PCR during library preparation as a principal source of bias and optimized the conditions. Our improved protocol significantly reduces amplification bias and minimizes the previously severe effects of PCR instrument and temperature ramp rate.	[Aird, Daniel; Ross, Michael G.; Russ, Carsten; Jaffe, David B.; Nusbaum, Chad; Gnirke, Andreas] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA 02141 USA; [Chen, Wei-Sheng; Danielsson, Maxwell] Cambridge Rindge & Latin Sch, Cambridge, MA 02138 USA		Gnirke, A (corresponding author), Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, 320 Charles St, Cambridge, MA 02141 USA.	gnirke@broadinstitute.org			National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [HHSN27220090018C]; National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG03067-05]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067, R01HG003474] Funding Source: NIH RePORTER	We thank the staff of the Broad Institute Sequencing Platform and the Educational Outreach Program. We also thank Lesley Gaffney for last-minute help with the artwork. This project has been funded in part with funds from the National Institute of Allergy and Infectious Diseases under Contract No. HHSN27220090018C, and from the National Human Genome Research Institute (HG03067-05).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Garber M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r60; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/NMETH.1507, 10.1038/nmeth.1507]; Hillier LW, 2008, NAT METHODS, V5, P183, DOI [10.1038/nmeth.1179, 10.1038/NMETH.1179]; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108	22	648	666	6	128	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.		2011	12	2							R18	10.1186/gb-2011-12-2-r18			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	748BS	WOS:000289365600014	21338519	Green Published, hybrid	Y	N	2022-01-24	
J	Heyer, LJ; Kruglyak, S; Yooseph, S				Heyer, LJ; Kruglyak, S; Yooseph, S			Exploring expression data: Identification and analysis of coexpressed genes	GENOME RESEARCH			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; HYBRIDIZATION; MICROARRAY; PATTERNS; YEAST; SCALE	Analysis procedures are needed to extract useful information from the large amount of gene expression data that is becoming available. This work describes a set of analytical tools and their application to yeast cell cycle data. The components of our approach are (1) a similarity measure that reduces the number of False positives, (2) a new clustering algorithm designed specifically For grouping gene expression patterns, and (3) an intel active graphical cluster analysis tool that allows user feedback and validation. We use the clusters generated by our algorithm to summarize genome-wide expression and to initiate supervised clustering of genes into biologically meaningful groups.	Univ So Calif, Dept Math, Los Angeles, CA 90089 USA		Kruglyak, S (corresponding author), Univ So Calif, Dept Math, Los Angeles, CA 90089 USA.			Yooseph, Shibu/0000-0001-5581-5002	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM036230] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM36230] Funding Source: Medline		Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; EFRON B, 1982, CBMS NSF C SER APPL, V38; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Hartigan JA, 1975, CLUSTERING ALGORITHM; Kaufman L, 2009, FINDING GROUPS DATA; KOHONEN T, 1997, SELFORGANIZING MAPS; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Theodoridis S., 1999, PATTERN RECOGNITION; VENABLES WN, 1997, MODERN APPL STAT SPL; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359	20	648	664	0	17	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	NOV	1999	9	11					1106	1115		10.1101/gr.9.11.1106			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	258EL	WOS:000083825100010	10568750	Bronze, Green Published			2022-01-24	
J	Uga, Y; Sugimoto, K; Ogawa, S; Rane, J; Ishitani, M; Hara, N; Kitomi, Y; Inukai, Y; Ono, K; Kanno, N; Inoue, H; Takehisa, H; Motoyama, R; Nagamura, Y; Wu, JZ; Matsumoto, T; Takai, T; Okuno, K; Yano, M				Uga, Yusaku; Sugimoto, Kazuhiko; Ogawa, Satoshi; Rane, Jagadish; Ishitani, Manabu; Hara, Naho; Kitomi, Yuka; Inukai, Yoshiaki; Ono, Kazuko; Kanno, Noriko; Inoue, Haruhiko; Takehisa, Hinako; Motoyama, Ritsuko; Nagamura, Yoshiaki; Wu, Jianzhong; Matsumoto, Takashi; Takai, Toshiyuki; Okuno, Kazutoshi; Yano, Masahiro			Control of root system architecture by DEEPER ROOTING 1 increases rice yield under drought conditions	NATURE GENETICS			English	Article							AUXIN RESPONSE FACTOR; ORYZA-SATIVA L.; GENE FAMILY; EXPRESSION; GROWTH; IDENTIFICATION; FIELD; PHYTOHORMONE; AVOIDANCE; TRANSPORT	The genetic improvement of drought resistance is essential for stable and adequate crop production in drought-prone areas(1). Here we demonstrate that alteration of root system architecture improves drought avoidance through the cloning and characterization of DEEPER ROOTING 1 (DRO1), a rice quantitative trait locus controlling root growth angle. DRO1 is negatively regulated by auxin and is involved in cell elongation in the root tip that causes asymmetric root growth and downward bending of the root in response to gravity. Higher expression of DRO1 increases the root growth angle, whereby roots grow in a more downward direction. Introducing DRO1 into a shallow-rooting rice cultivar by backcrossing enabled the resulting line to avoid drought by increasing deep rooting, which maintained high yield performance under drought conditions relative to the recipient cultivar. Our experiments suggest that control of root system architecture will contribute to drought avoidance in crops.	[Uga, Yusaku; Sugimoto, Kazuhiko; Hara, Naho; Ono, Kazuko; Kanno, Noriko; Inoue, Haruhiko; Takehisa, Hinako; Motoyama, Ritsuko; Nagamura, Yoshiaki; Wu, Jianzhong; Matsumoto, Takashi; Okuno, Kazutoshi; Yano, Masahiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Ogawa, Satoshi; Rane, Jagadish; Ishitani, Manabu] Int Ctr Trop Agr CIAT, Cali, Colombia; [Ogawa, Satoshi] Univ Valle, Fac Sci, Cali, Colombia; [Kitomi, Yuka; Inukai, Yoshiaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Takai, Toshiyuki] Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan		Uga, Y (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	yuga@nias.affrc.go.jp	Okuno, Kazutoshi/AAQ-9507-2021; Yano, Masahiro/AAC-5441-2019; Inukai, Yoshiaki/I-7030-2014; Rane, Jagadish/I-5801-2013; Rane, Jagadish/ABC-9591-2020		Ministry of Agriculture, Forestry and Fisheries of JapanMinistry of Agriculture Forestry & Fisheries - Japan [QTL-4003, RBS-2009]	M. Takimoto, E. Nakao, H. Oode, R. Matsushita and the staff of the technical support section of NIAS for technical assistance during field evaluation; M. Kondo, A. Oyanagi, T. Izawa, E. Yamamoto, T. Hoshino, J. Tohme, C. P. Martinez, N. T. Perea and A. Fernando for valuable discussion; and K. Shinozaki for critical reading of the manuscript. This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (QTL-4003 and RBS-2009).	Araki H, 2002, PLANT PROD SCI, V5, P286, DOI 10.1626/pps.5.286; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Cabuslay GS, 2002, PLANT SCI, V163, P815, DOI 10.1016/S0168-9452(02)00217-0; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Ding XP, 2011, THEOR APPL GENET, V123, P815, DOI 10.1007/s00122-011-1629-1; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Fuse T., 2001, PLANT BIOTECHNOL-NAR, V18, P219, DOI 10.5511/plantbiotechnology.18.219; GARRITY DP, 1995, AGRON J, V87, P773, DOI 10.2134/agronj1995.00021962008700040027x; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Hirano K, 2008, PLANT CELL PHYSIOL, V49, P1429, DOI 10.1093/pcp/pcn123; Hirayama M., 1996, RICE BREEDING MANUAL, P152; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Kato Y, 2008, EUPHYTICA, V160, P423, DOI 10.1007/s10681-007-9605-1; Kawakatsu T, 2009, PLANT J, V59, P908, DOI 10.1111/j.1365-313X.2009.03925.x; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Kitomi Y, 2008, PLANT ROOT, V2, P19, DOI 10.3117/plantroot.2.19; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kondo M, 2000, SOIL SCI PLANT NUTR, V46, P721, DOI 10.1080/00380768.2000.10409137; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Liu SP, 2009, CELL RES, V19, P1110, DOI 10.1038/cr.2009.70; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Matsushita A, 2013, PLANT J, V73, P302, DOI 10.1111/tpj.12035; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Miyashita Y, 2010, PLANT SCI, V178, P424, DOI 10.1016/j.plantsci.2010.02.018; Morita MT, 2004, CURR OPIN PLANT BIOL, V7, P712, DOI 10.1016/j.pbi.2004.09.001; Morita Y, 2007, PLANT CELL PHYSIOL, V48, P540, DOI 10.1093/pcp/pcm024; Mullen JL, 1998, PLANTA, V206, P598, DOI 10.1007/s004250050437; Nemoto H, 1998, BREEDING SCI, V48, P321; Obara M, 2010, THEOR APPL GENET, V121, P535, DOI 10.1007/s00122-010-1328-3; OYANAGI A, 1993, JPN J CROP SCI, V62, P565, DOI 10.1626/jcs.62.565; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Takai T, 2010, FIELD CROP RES, V115, P165, DOI 10.1016/j.fcr.2009.10.019; Takehisa H, 2012, PLANT J, V69, P126, DOI 10.1111/j.1365-313X.2011.04777.x; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Uga Y, 2012, THEOR APPL GENET, V124, P75, DOI 10.1007/s00122-011-1688-3; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Uga Y, 2010, MOL BREEDING, V26, P533, DOI 10.1007/s11032-010-9450-0; Uga Y, 2009, BREEDING SCI, V59, P87, DOI 10.1270/jsbbs.59.87; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Waller F, 2002, PLANT MOL BIOL, V50, P415, DOI 10.1023/A:1019818110761; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Yoshida S., 1982, Drought resistance in crops with emphasis on rice, P97	51	646	704	18	427	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1097	+		10.1038/ng.2725			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	WOS:000323748200024	23913002		Y	N	2022-01-24	
J	Baker, SM; Plug, AW; Prolla, TA; Bronner, CE; Harris, AC; Yao, X; Christie, DM; Monell, C; Arnheim, N; Bradley, A; Ashley, T; Liskay, RM				Baker, SM; Plug, AW; Prolla, TA; Bronner, CE; Harris, AC; Yao, X; Christie, DM; Monell, C; Arnheim, N; Bradley, A; Ashley, T; Liskay, RM			Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; PSEUDOAUTOSOMAL REGION; SYNAPTONEMAL COMPLEX; GENE CONVERSION; RECOMBINATION; SPERMATOCYTES; INITIATION; CHROMOSOME; HOMOLOGS; SEQUENCE	Mice that are deficient in either the Pms2 or Msh2 DNA mismatch repair genes have microsatellite instability and a predisposition to tumours. Interestingly, Pms2-deficient males display sterility associated with abnormal chromosome pairing in meiosis. Here mice deficient in another mismatch repair gene, MIh1, possess not only microsatellite instability but are also infertile (both males and females). MIh1-deficient spermatocytes exhibit high levels of prematurely separated chromosomes and arrest in first division meiosis. We also show that MIh1 appears to localize to sites of crossing over on meiotic chromosomes. Together these findings suggest that MIh1 is involved in DNA mismatch repair and meiotic crossing over.	OREGON HLTH SCI UNIV,DEPT MED & MOLEC GENET,PORTLAND,OR 97201; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030; UNIV SO CALIF,PROGRAM MOLEC BIOL,LOS ANGELES,CA 90089; PHARMINGEN,SAN DIEGO,CA 92121					Bradley, Allan/0000-0002-2349-8839; Arnheim, Norman/0000-0003-1247-1347	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM32741, GM45413, GM49779] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM032741, R01GM049779, R37GM032741, R01GM045413] Funding Source: NIH RePORTER		ALANI E, 1994, GENETICS, V137, P19; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/s004120050088; ASHLEY T, 1994, HUM GENET, V94, P587, DOI 10.1007/BF00206950; AU KG, 1992, J BIOL CHEM, V267, P12142; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; Darlington C.D., 1937, RECENT ADV CYTOLOGY, V2nd ed.; Datta A, 1996, MOL CELL BIOL, V16, P1085; DESTGROTH SF, 1980, TRANSPLANT P, V12, P447; DETLOFF P, 1992, GENETICS, V132, P113; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DIETRICH AJJ, 1983, CHROMOSOMA, V88, P377, DOI 10.1007/BF00285860; DIETRICH AJJ, 1981, CHROMOSOMA, V83, P409, DOI 10.1007/BF00327362; FISHEL R, 1994, CANCER RES, V54, P5539; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GALIRE G, 1977, NATURE, V266, P550; GOETZ P, 1984, J CELL SCI, V65, P249; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; HAWLEY RS, 1987, MEIOSIS, P497; HILLINGSWORTH NM, 1995, GENE DEV, V9, P1728; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KRAMER W, 1989, J BACTERIOL, V171, P5339, DOI 10.1128/jb.171.10.5339-5346.1989; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEEFLANG PE, 1994, CURRENT PROTOCOLS HU, V1; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; MASISCHKY GT, 1996, GENE DEV, V10, P407; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; MOENS PB, 1987, J CELL BIOL, V105, P93, DOI 10.1083/jcb.105.1.93; Moses M J, 1984, Symp Soc Exp Biol, V38, P245; MOSES MJ, 1977, CHROMOSOMA, V60, P127, DOI 10.1007/BF00288460; MOSES MJ, 1984, CHROMOSOMES TODAY, V8, P90; NEW L, 1993, MOL GEN GENET, V239, P97, DOI 10.1007/BF00281607; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PETIT MA, 1991, GENETICS, V129, P327; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; PROLLA TA, 1994, MOL CELL BIOL, V14, P407, DOI 10.1128/MCB.14.1.407; RAMIREZSOLIS R, 1993, GUIDE TECHNIQUES MOU, P855; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; REENAN RAG, 1992, GENETICS, V132, P963; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; ROEDER GS, 1990, TRENDS GENET, V6, P385, DOI 10.1016/0168-9525(90)90297-J; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SELVA EM, 1995, GENETICS, V139, P1175; Solari A.J., 1989, P77; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; WILLIAMSON MS, 1985, GENETICS, V110, P609; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238; [No title captured]	60	646	659	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					336	342		10.1038/ng0796-336			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	WOS:A1996UU28300022	8673133				2022-01-24	
J	Heiss, NS; Knight, SW; Vulliamy, TJ; Klauck, SM; Wiemann, S; Mason, PJ; Poustka, A; Dokal, I				Heiss, NS; Knight, SW; Vulliamy, TJ; Klauck, SM; Wiemann, S; Mason, PJ; Poustka, A; Dokal, I			X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions	NATURE GENETICS			English	Article							FACTOR-VIII GENE; INCONTINENTIA PIGMENTI; XQ28; REGION; CANDIDATE; PROTEIN; DNA; IDENTIFICATION; AMPLIFICATION; TRANSCRIPTS	X-linked recessive dyskeratosis congenita (DKC) is a rare bone-marrow failure disorder linked to Xq28. Hybridization screening with 28 candidate cDNAs resulted in the detection of a 3' deletion in one DKC patient with a cDNA probe (derived from XAP101). Five different missense mutations in five unrelated patients were subsequently identified in XAP101, indicating that it is the gene responsible for X-linked DKC (DKC1). DKC1 is highly conserved across species barriers and is the orthologue of rat NAP57 and Saccharomyces cerevisiae CBF5. The peptide dyskerin contains two TruB pseudouridine (psi) synthase motifs, multiple phosphorylation sites, and a carboxy-terminal lysine-rich repeat domain. By analogy to the function of the known dyskerin orthologues, involvement in the cell cycle and nucleolar function is predicted for the protein.	Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, D-69120 Heidelberg, Germany; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Haematol, London W12 0NN, England; Hammersmith Hosp, London W12 0NN, England		Poustka, A (corresponding author), Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.poustka@dkfz-heidelberg.de; i.dokal@rpms.ac.uk	Wiemann, Stefan/E-4424-2013; Mason, Philip J/B-1087-2008	Wiemann, Stefan/0000-0003-4683-3174; Dokal, Inderjeet/0000-0003-4462-4782	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ARNGRIMSSON R, 1993, J MED GENET, V30, P618, DOI 10.1136/jmg.30.7.618; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Cadwell C, 1997, MOL CELL BIOL, V17, P6175, DOI 10.1128/MCB.17.10.6175; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; COULTHARD S, 1997, BR J HEAMAT, V97, pS1; Coy JF, 1996, GENOMICS, V32, P309, DOI 10.1006/geno.1996.0124; COY JF, 1994, MAMM GENOME, V5, P131, DOI 10.1007/BF00352342; CROSS NCP, 1993, BRIT J HAEMATOL, V84, P67, DOI 10.1111/j.1365-2141.1993.tb03026.x; DAS S, 1994, AM J HUM GENET, V54, P922; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dixon J, 1996, NAT GENET, V12, P130; Dokal I, 1996, BRIT J HAEMATOL, V92, P775, DOI 10.1046/j.1365-2141.1996.355881.x; DOKAL I, 1994, LEUKEMIA LYMPHOMA, V15, P1, DOI 10.3109/10428199409051671; DOKAL I, 1992, BLOOD, V80, P3090; DRACHTMAN RA, 1992, AM J PEDIAT HEMATOL, V14, P297; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Heiss NS, 1997, GENOMICS, V43, P329, DOI 10.1006/geno.1997.4810; Heiss NS, 1996, GENOME RES, V6, P478, DOI 10.1101/gr.6.6.478; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Heiss NS, 1995, METHOD MOL CELL BIOL, V5, P337; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; KENWRICK S, 1992, HUM MOL GENET, V1, P179, DOI 10.1093/hmg/1.3.179; Knight SW, 1996, J MED GENET, V33, P993, DOI 10.1136/jmg.33.12.993; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; MEIER UT, 1992, CELL, V70, P127; Metzenberg Aida B., 1992, Human Molecular Genetics, V1, P97, DOI 10.1093/hmg/1.2.97; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; ROGNER UC, 1994, HUM MOL GENET, V3, P2137, DOI 10.1093/hmg/3.12.2137; Rogner UC, 1996, GENOME RES, V6, P922, DOI 10.1101/gr.6.10.922; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; Vulliamy TJ, 1997, BLOOD, V90, P2213; Wilgenbus KK, 1995, METHOD MOL CELL BIOL, V5, P214; WINKLER AA, IN PRESS YEAST	41	645	666	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					32	38		10.1038/ng0598-32			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	WOS:000073346700013	9590285				2022-01-24	
J	MULLER, HJ				MULLER, HJ			OUR LOAD OF MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																	Altenburg E, 1920, GENETICS, V5, P1; Bedichek S, 1938, ANN EUGENIC, V8, P245, DOI 10.1111/j.1469-1809.1938.tb02178.x; Bell J, 1940, ANN EUGENIC, V10, P370; Berg RL, 1942, CR ACAD SCI URSS, V36, P212; DAHLBERG G, 1947, MATH METHODS POPULAT; DAHLBERG G, 1949, HEREDITAS S, V35, P555; DANFORTH CH, 1923, 2 INT C EUG, V1, P120; Dobzhansky T., 1927, Zeitschrift fuer Induktive Abstammungs und Vererbungslehre Berlin, V43, P330, DOI 10.1007/BF01741014; Dobzhansky T, 1941, GENETICS, V26, P23; DUBININ NP, 1946, GENETICS, V31, P21; Fisher, 1930, GENETICAL THEORY NAT; Fisher RA, 1928, AM NAT, V62, P571, DOI 10.1086/280234; Fisher RA, 1928, AM NAT, V62, P115, DOI 10.1086/280193; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FISHER RA, 1921, 2ND INT C EUG N Y, V1, P115; Gunther M, 1935, J GENET, V31, P413, DOI 10.1007/BF02982409; Haldane J, 1949, HEREDITAS S, V35, P267, DOI [DOI 10.1111/J.1601-5223.1949.TB03339.X), 10.1111/j.1601-5223.1949.tb03339.x, DOI 10.1111/J.1601-5223.1949.TB03339.X]; Haldane JBS, 1940, ANN EUGENIC, V10, P417, DOI 10.1111/j.1469-1809.1940.tb02263.x; Haldane JBS, 1939, ANN EUGENIC, V9, P400, DOI 10.1111/j.1469-1809.1939.tb02220.x; Haldane JBS, 1930, AM NAT, V64, P87, DOI 10.1086/280299; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Haldane JBS, 1939, ANN EUGENIC, V9, P232, DOI 10.1111/j.1469-1809.1939.tb02210.x; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P35, DOI 10.1111/j.1469-1809.1947.tb02377.x; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; HALDANE JBS, 1938, ANN EUGEN CAMBR, V8, P262; Halperin SL, 1945, AM J MENT DEF, V50, P8; HAMAN J O, 1947, West J Surg Obstet Gynecol, V55, P107; Hogben LT, 1946, INTRO MATH GENETICS; Huxley J, 1940, NEW SYSTEMATICS, P185; KERKIS JJ, 1938, IAN SSSR, P75; KERKIS JJ, 1935, 15 INT PHYSL C LEN, P198; Levit SG, 1936, J GENET, V33, P411, DOI 10.1007/BF02982897; LEVIT SG, 1936, P MAXIM GORKY MED GE, V4, P17; LEVIT SG, 1935, C R ACAD SCI U R S S, V2, P428; LEVIT SG, 1936, P MAXIM GORKY MEDICO, V4, P149; LEVIT SG, 1935, C R ACAD SCI URSS, V2, P499; LEVIT SG, 1934, P MAXIM GORKY MED BI, V3, P132; Li C.C., 1948, INTRO POPULATION GEN; MARTIN JH, 1947, BRIT J RADIOL, V20, P279, DOI 10.1259/0007-1285-20-235-279; MAZING RA, 1939, CR ACAD SCI URSS, V23, P835; MAZING RA, 1938, CR ACAD SCI URSS, V20, P173; MEYER HU, 1949, GENETICS, V35, P123; MEYER HU, 1949, REC GENET SOC AM, V18, P103; MORCH ET, 1941, OPERA DOMO BIOL HERE, V3, P1; MORGAN TH, 1915, MECHANISM MENDELIAN; MULLER H. J., 1950, AMER SCIENTIST, V38, P399; MULLER H. J., 1950, AMER SCIENTIST, V38, P33; MULLER H. J., 1928, ZEITSCHR INDUKT ABSTAM U VERERBUNGSL SUPPL, V1, P234; MULLER H. J., 1936, Strahlenthempie, V55, P72; Muller H. J., 1943, GENETICS, V28, P83; Muller H J, 1941, SCIENCE, V93, P438; Muller H. J., 1919, P SOC EXP BIOL MED, V17, P10; Muller HJ, 1918, GENETICS, V3, P422; MULLER HJ, 1947, PROC R SOC SER B-BIO, V134, P1, DOI 10.1098/rspb.1947.0001; Muller HJ, 1928, GENETICS, V13, P279; MULLER HJ, 1948, B NEW YORK ACAD MED, V24, P447; MULLER HJ, 1950, GENETICS, V35, P126; Muller HJ, 1935, AM NAT, V69, P405, DOI 10.1086/280615; MULLER HJ, 1950, J CELL COMPAR PHYSL, V35, P9, DOI 10.1002/jcp.1030350404; Muller HJ, 1935, J GENET, V30, P407, DOI 10.1007/BF02982249; MULLER HJ, 1949, REC GENET SOC AM, V18, P106; MULLER HJ, 1949, SCI NEWS LETT, V55, P379; MULLER HJ, 1927, 5 INT K VER; MULLER HJ, 1949, REC GEN SOC AM, V18, P105; MULLER HJ, 1934, 4TH VERH INT K RAD Z, V2, P100; Muller HJ, 1946, YB 1945, P150; MULLER HJ, 1942, REC GENET SOC AM, V11, P83; MULLER HJ, 1949, GENETICS, V35, P125; Muller HJ, 1950, HARVEY LECT SERIES 4, VXLIII, P165; MULLER HJ, 1923, 2 P INT C EUG NEW YO, V1, P106; MULLER HJ, 1950, IN PRESS FURTHER EVI; MULLER HJ, 1949, SCI NEWS LETT, V55, P374; Muller HJ, 1950, AM SCI, V38, P126; MULLER HJ, 1933, P 6 INT C GEN, V1, P213; NEEL JV, 1947, GENETICS, V32, P38; NEEL JV, 1949, AM J HUM GENET, V1, P19; Penrose L.S., 1934, INFLUENCE HEREDITY D; Penrose LS, 1949, BIOL MENTAL DEFECT; PLUNKETT CR, 1933, 6 P INT C GEN ITH, V2, P158; PLUNKETT CR, 1933, AM NAT, V67, P84; Soper HE, 1914, BIOMETRIKA, V10, P25, DOI 10.2307/2331738; TIMOFEEFF-RESSOVSKY N. W., 1934, STRAHLENTHERAPIE, V51, P658; Timoleeff-Ressovsky N. W., 1935, Nachrichten von der Gesellschaft der Wissenschaften zu Gottingen Berlin Biol (NF), V1, P163; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; WRIGHT S, 1935, J GENET CAMBR, V30, P357; [No title captured]	90	644	653	1	31	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	2					111	176					66	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS389	WOS:A1950XS38900001	14771033				2022-01-24	
J	Spada, M; Pagliardini, S; Yasuda, M; Tukel, T; Thiagarajan, G; Sakuraba, H; Ponzone, A; Desnick, RJ				Spada, Marco; Pagliardini, Severo; Yasuda, Makiko; Tukel, Turgut; Thiagarajan, Geetha; Sakuraba, Hitoshi; Ponzone, Alberto; Desnick, Robert J.			High incidence of later-onset Fabry disease revealed by newborn screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	55th Annual Meeting of the American-Society-of-Human-Genetics	OCT 25-29, 2005	Salt Lake City, UT	Amer Soc Human Genet			LYSOSOMAL STORAGE DISORDERS; ENZYME REPLACEMENT THERAPY; HUMAN ALPHA-GALACTOSIDASE; TANDEM MASS-SPECTROMETRY; ATYPICAL VARIANT; INBORN-ERRORS; A GENE; MUTATIONS; PREVALENCE; DIAGNOSIS	The classic phenotype of Fabry disease, X-linked alpha-galactosidase A ( alpha-Gal A) deficiency, has an estimated incidence of similar to 1 in 50,000 males. The recent recognition of later-onset variants suggested that this treatable lysosomal disease is more frequent. To determine the disease incidence, we undertook newborn screening by assaying the alpha-Gal A activity in blood spots from 37,104 consecutive Italian male neonates. Enzyme-deficient infants were retested, and "doubly screened-positive" infants and their relatives were diagnostically confirmed by enzyme and mutation analyses. Twelve ( 0.03%) neonates had deficient alpha-Gal A activities and specific mutations, including four novel missense mutations ( M51I, E66G, A73V, and R118C), three missense mutations ( F113L, A143T, and N215S) identified previously in later-onset patients, and one splicing defect ( IVS5(+1G -> T)) reported in a patient with the classic phenotype. Molecular modeling and in vitro overexpression of the missense mutations demonstrated structures and residual activities, which were rescued/enhanced by an alpha-Gal A-specific pharmacologic chaperone, consistent with mutations that cause the later-onset phenotype. Family studies revealed undiagnosed Fabry disease in affected individuals. In this population, the incidence of alpha-Gal A deficiency was 1 in similar to 3,100, with an 11.1 ratio of patients with the later-onset: classic phenotypes. If only known disease-causing mutations were included, the incidence would be 1 in similar to 4,600, with a 7: 1 ratio of patients with the later-onset: classic phenotypes. These results suggest that the later-onset phenotype of Fabry disease is underdiagnosed among males with cardiac, cerebrovascular, and/or renal disease. Recognition of these patients would permit family screening and earlier therapeutic intervention. However, the higher incidence of the later-onset phenotype in patients raises ethical issues related to when screening should be performed - in the neonatal period or at early maturity, perhaps in conjunction with screening for other treatable adult-onset disorders.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Regina Margherita Childrens Hosp, Newborn Screening Unit, Turin, Italy; Univ Turin, Dept Pediat, Turin, Italy; Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Tokyo 113, Japan		Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave 100th St, New York, NY 10029 USA.	robert.desnick@mssm.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5 M01 RR00071, M01 RR000071] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37 DK34045, R37 DK034045] Funding Source: Medline		Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; Desnick R.J., 2001, METABOLIC MOL BASES, V8th ed., P3733, DOI [DOI 10.1036/ommbid.181, 10.1036/ommbid.181]; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Desnick RJ, 2002, J INHERIT METAB DIS, V25, pS116; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; ENG CM, 1993, AM J HUM GENET, V53, P1186; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fabry J., 1898, ARCH DERMATOL RES, V43, P187, DOI [10.1007/bf01986897, DOI 10.1007/BF01986897]; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Froissart R, 2003, MOL GENET METAB, V80, P307, DOI 10.1016/S1096-7192(03)00136-7; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Henthorn JS, 2004, BRIT J HAEMATOL, V124, P259, DOI 10.1046/j.1365-2141.2003.04775.x; Ishii S, 2000, ARCH BIOCHEM BIOPHYS, V377, P228, DOI 10.1006/abbi.2000.1743; Kaback MM, 2001, ADV GENET, V44, P253; Kotanko P, 2004, J AM SOC NEPHROL, V15, P1323, DOI 10.1097/01.ASN.0000124671.61963.1E; Li YJ, 2004, CLIN CHEM, V50, P1785, DOI 10.1373/clinchem.2004.035907; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; McCabe LL, 2004, ANNU REV GENOM HUM G, V5, P57, DOI 10.1146/annurev.genom.5.061903.175941; Meikle PJ, 2004, PEDIATRICS, V114, P909, DOI 10.1542/peds.2004-0583; Meikle PJ, 2003, EUR J PEDIATR, V162, pS34, DOI 10.1007/s00431-003-1348-y; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; OKUMIYA T, 1995, HUM GENET, V95, P557; OKUMIYA T, 1995, BIOCHEM BIOPH RES CO, V214, P1219, DOI 10.1006/bbrc.1995.2416; Pagliardini S., 2003, J INHERIT METAB DIS, V26, pS1; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Spada M., 2003, Journal of Inherited Metabolic Disease, V26, P171; Spada M., 2002, Journal of Inherited Metabolic Disease, V25, P113; UTSUMI K, 2000, CLIN EXP NEPHROL, V4, P49, DOI [DOI 10.1007/s101570050061, 10.1007/s101570050061]; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Yasuda M, 2003, HUM MUTAT, V22, P486, DOI 10.1002/humu.10275	44	643	680	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					31	40		10.1086/504601			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Genetics & Heredity	053YD	WOS:000238341200004	16773563	Green Published, Bronze			2022-01-24	
J	Sato, Y; Yoshizato, T; Shiraishi, Y; Maekawa, S; Okuno, Y; Kamura, T; Shimamura, T; Sato-Otsubo, A; Nagae, G; Suzuki, H; Nagata, Y; Yoshida, K; Kon, A; Suzuki, Y; Chiba, K; Tanaka, H; Niida, A; Fujimoto, A; Tsunoda, T; Morikawa, T; Maeda, D; Kume, H; Sugano, S; Fukayama, M; Aburatani, H; Sanada, M; Miyano, S; Homma, Y; Ogawa, S				Sato, Yusuke; Yoshizato, Tetsuichi; Shiraishi, Yuichi; Maekawa, Shigekatsu; Okuno, Yusuke; Kamura, Takumi; Shimamura, Teppei; Sato-Otsubo, Aiko; Nagae, Genta; Suzuki, Hiromichi; Nagata, Yasunobu; Yoshida, Kenichi; Kon, Ayana; Suzuki, Yutaka; Chiba, Kenichi; Tanaka, Hiroko; Niida, Atsushi; Fujimoto, Akihiro; Tsunoda, Tatsuhiko; Morikawa, Teppei; Maeda, Daichi; Kume, Haruki; Sugano, Sumio; Fukayama, Masashi; Aburatani, Hiroyuki; Sanada, Masashi; Miyano, Satoru; Homma, Yukio; Ogawa, Seishi			Integrated molecular analysis of clear-cell renal cell carcinoma	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; HEPATOCELLULAR-CARCINOMA; SOMATIC MUTATION; NRF2 MUTATIONS; CANCER; ACTIVATION; COMPLEX; KEAP1; SUCCINATION; REGULATORS	Clear-cell renal cell carcinoma (ccRCC) is the most prevalent kidney cancer and its molecular pathogenesis is incompletely understood. Here we report an integrated molecular study of ccRCC in which >= 100 ccRCC cases were fully analyzed by whole-genome and/or whole-exome and RNA sequencing as well as by array-based gene expression, copy number and/or methylation analyses. We identified a full spectrum of genetic lesions and analyzed gene expression and DNA methylation signatures and determined their impact on tumor behavior. Defective VHL-mediated proteolysis was a common feature of ccRCC, which was caused not only by VHL inactivation but also by new hotspot TCEB1 mutations, which abolished Elongin C-VHL binding, leading to HIF accumulation. Other newly identified pathways and components recurrently mutated in ccRCC included PI3K-AKT-mTOR signaling, the KEAP1-NRF2-CUL3 apparatus, DNA methylation, p53-related pathways and mRNA processing. This integrated molecular analysis unmasked new correlations between DNA methylation, gene mutation and/or gene expression and copy number profiles, enabling the stratification of clinical risks for patients with ccRCC.	[Sato, Yusuke; Yoshizato, Tetsuichi; Maekawa, Shigekatsu; Okuno, Yusuke; Sato-Otsubo, Aiko; Suzuki, Hiromichi; Nagata, Yasunobu; Yoshida, Kenichi; Kon, Ayana; Sanada, Masashi; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan; [Sato, Yusuke; Maekawa, Shigekatsu; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Shiraishi, Yuichi; Shimamura, Teppei; Chiba, Kenichi; Niida, Atsushi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Kamura, Takumi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan; [Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Fujimoto, Akihiro; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Morikawa, Teppei; Maeda, Daichi; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan		Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo, Japan.	sogawa-tky@umin.ac.jp	Nagae, Genta/AAN-1167-2021; Nagae, Genta/H-6579-2019; Okuno, Yusuke/C-9082-2009; Tsunoda, Tatsuhiko/K-2061-2014; Yoshizato, Tetsuichi/AAD-7308-2019; Ogawa, Seishi/AAE-7088-2019; Suzuki, Hiromichi/AAO-4664-2021	Nagae, Genta/0000-0002-2929-7990; Okuno, Yusuke/0000-0003-3139-9272; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Yoshizato, Tetsuichi/0000-0003-4283-2983; Suzuki, Hiromichi/0000-0002-8858-0294; Shimamura, Teppei/0000-0003-2994-872X; Yoshida, Kenichi/0000-0003-4612-2778; Miyano, Satoru/0000-0002-1753-6616	KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22134006]; New Energy and Industrial Technology Development Organization (NEDO)New Energy and Industrial Technology Development Organization (NEDO) [08C46598a]; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Council for Science and Technology PolicyCouncil for Science and Technology Policy (CSTP); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24112006, 24700272] Funding Source: KAKEN	We thank Y. Mori, M. Nakamura, N. Mizota and S. Ichimura for their technical assistance. We also thank M. Nangaku and N. Takeda for fruitful discussion and comments. We thank T. Kitamura (University of Tokyo) for providing pMXs-puro, M. Onodera (National Center for Child Health and Development, Japan) for providing pGCDNsamIRESEGFP and R. C. Mulligan (Boston Children's Hospital) for providing 293gp cells. This work was supported by KAKENHI (22134006), the Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) (08C46598a) and the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology, initiated by the Council for Science and Technology Policy.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brannon A Rose, 2010, Genes Cancer, V1, P152; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gallou C, 1999, HUM MUTAT, V13, P464, DOI 10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Kinch L, 2011, CANCER CELL, V20, P418, DOI 10.1016/j.ccr.2011.10.005; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; Kuroda N, 2012, HISTOL HISTOPATHOL, V27, P133, DOI 10.14670/HH-27.133; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nabekura T, 2006, MOL THER, V13, P301, DOI 10.1016/j.ymthe.2005.09.021; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ooi A, 2013, CANCER RES, V73, P2044, DOI 10.1158/0008-5472.CAN-12-3227; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ross H, 2010, PATHOLOGY, V42, P369, DOI 10.3109/00313021003767348; Schraml P, 2002, J PATHOL, V196, P186, DOI 10.1002/path.1034; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Takagi Y, 1997, J BIOL CHEM, V272, P27444, DOI 10.1074/jbc.272.43.27444; Tsuji K, 2012, HUM PATHOL, V43, P356, DOI 10.1016/j.humpath.2011.05.004; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	57	641	654	1	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					860	U191		10.1038/ng.2699			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	WOS:000322374900007	23797736		Y	N	2022-01-24	
J	Rudin, CM; Durinck, S; Stawiski, EW; Poirier, JT; Modrusan, Z; Shames, DS; Bergbower, EA; Guan, YH; Shin, J; Guillory, J; Rivers, CS; Foo, CK; Bhatt, D; Stinson, J; Gnad, F; Haverty, PM; Gentleman, R; Chaudhuri, S; Janakiraman, V; Jaiswal, BS; Parikh, C; Yuan, WL; Zhang, ZM; Koeppen, H; Wu, TD; Stern, HM; Yauch, RL; Huffman, KE; Paskulin, DD; Illei, PB; Varella-Garcia, M; Gazdar, AF; de Sauvage, FJ; Bourgon, R; Minna, JD; Brock, MV; Seshagiri, S				Rudin, Charles M.; Durinck, Steffen; Stawiski, Eric W.; Poirier, John T.; Modrusan, Zora; Shames, David S.; Bergbower, Emily A.; Guan, Yinghui; Shin, James; Guillory, Joseph; Rivers, Celina Sanchez; Foo, Catherine K.; Bhatt, Deepali; Stinson, Jeremy; Gnad, Florian; Haverty, Peter M.; Gentleman, Robert; Chaudhuri, Subhra; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Parikh, Chaitali; Yuan, Wenlin; Zhang, Zemin; Koeppen, Hartmut; Wu, Thomas D.; Stern, Howard M.; Yauch, Robert L.; Huffman, Kenneth E.; Paskulin, Diego D.; Illei, Peter B.; Varella-Garcia, Marileila; Gazdar, Adi F.; de Sauvage, Frederic J.; Bourgon, Richard; Minna, John D.; Brock, Malcolm V.; Seshagiri, Somasekar			Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer	NATURE GENETICS			English	Article							NONSMALL CELL; MUTATIONS; CARCINOMA; KINASE; TARGET; GROWTH; DIFFERENTIATION; REARRANGEMENTS; PATHWAY; COMPLEX	Small-cell lung cancer (SCLC) is an exceptionally aggressive disease with poor prognosis. Here, we obtained exome, transcriptome and copy-number alteration data from approximately 53 samples consisting of 36 primary human SCLC and normal tissue pairs and 17 matched SCLC and lymphoblastoid cell lines. We also obtained data for 4 primary tumors and 23 SCLC cell lines. We identified 22 significantly mutated genes in SCLC, including genes encoding kinases, G protein-coupled receptors and chromatin-modifying proteins. We found that several members of the SOX family of genes were mutated in SCLC. We also found SOX2 amplification in similar to 27% of the samples. Suppression of SOX2 using shRNAs blocked proliferation of SOX2-amplified SCLC lines. RNA sequencing identified multiple fusion transcripts and a recurrent RLF-MYCL1 fusion. Silencing of MYCL1 in SCLC cell lines that had the RLF-MYCL1 fusion decreased cell proliferation. These data provide an in-depth view of the spectrum of genomic alterations in SCLC and identify several potential targets for therapeutic intervention.	[Rudin, Charles M.; Poirier, John T.; Bergbower, Emily A.; Shin, James; Illei, Peter B.; Brock, Malcolm V.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Durinck, Steffen; Stawiski, Eric W.; Modrusan, Zora; Guan, Yinghui; Guillory, Joseph; Rivers, Celina Sanchez; Foo, Catherine K.; Bhatt, Deepali; Stinson, Jeremy; Chaudhuri, Subhra; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Parikh, Chaitali; Yuan, Wenlin; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Durinck, Steffen; Stawiski, Eric W.; Gnad, Florian; Haverty, Peter M.; Gentleman, Robert; Zhang, Zemin; Wu, Thomas D.; Bourgon, Richard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Shames, David S.; Yauch, Robert L.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Koeppen, Hartmut; Stern, Howard M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Huffman, Kenneth E.; Gazdar, Adi F.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Paskulin, Diego D.; Varella-Garcia, Marileila] Univ Colorado, Ctr Canc, Div Med Oncol, Aurora, CO USA		Rudin, CM (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	rudin@jhmi.edu; sekar@gene.com	Rudin, Charles/R-2530-2019; de Sauvage, Frederic/ABE-8400-2020	Rudin, Charles/0000-0001-5204-3465; de Sauvage, Frederic/0000-0002-5275-2584; Gnad, Florian/0000-0002-2287-2251; Poirier, John/0000-0001-9795-5644; Bergbower, Emily/0000-0002-7937-2661; Bourgon, Richard/0000-0002-5890-4374	Burroughs Wellcome FundBurroughs Wellcome Fund; Flight Attendant Medical Research Institute; Johns Hopkins Specialized Programs of Research Excellence (SPORE) NCI [P50CA058184]; Colorado SPORE NCI [P50 CA058187]; University of Texas SPORE NCI [P50CA70907]; Coordenacao de Aperfeicoamento de Passoal de Nivel Superior (CAPES) Foundation; Ministry of Education of Brazil; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046934, P30CA006973, P50CA070907, P50CA058187, P50CA058184] Funding Source: NIH RePORTER	The authors would like to thank Genentech DNA Sequencing and Oligo groups for their help with the project. We thank M.A. Huntley and J. Degenhardt for bioinformatics support and the Pathology Core Labs for providing histology, IHC and tissue management support. This work was also supported by grants from the Burroughs Wellcome Fund, the Flight Attendant Medical Research Institute, the Johns Hopkins Specialized Programs of Research Excellence (SPORE) NCI P50CA058184 (M.V.B. and C.M.R.), the Colorado SPORE NCI P50 CA058187 (M.V.-G) and the University of Texas SPORE NCI P50CA70907 (J.D.M., A.F.G. and K.E.H.). D.D.P. is supported by the Coordenacao de Aperfeicoamento de Passoal de Nivel Superior (CAPES) Foundation and the Ministry of Education of Brazil.	Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; CARNEY DN, 1985, RECENT RESULTS CANC, V99, P157; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Hann CL, 2007, TRENDS MOL MED, V13, P150, DOI 10.1016/j.molmed.2007.02.003; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; MAKELA TP, 1991, EMBO J, V10, P1331, DOI 10.1002/j.1460-2075.1991.tb07652.x; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Molderings GJ, 2007, SCAND J GASTROENTERO, V42, P1045, DOI 10.1080/00365520701245744; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; MORI N, 1990, ONCOGENE, V5, P1713; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Onuki N, 1999, CANCER, V85, P600, DOI 10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W; Phelps RM, 1996, J CELL BIOCHEM, P32; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SIMMS E, 1980, CANCER RES, V40, P4356; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tatematsu A, 2008, CLIN CANCER RES, V14, P6092, DOI 10.1158/1078-0432.CCR-08-0332; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Wegner M, 2011, GENE DEV, V25, P2423, DOI 10.1101/gad.181487.111; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956	48	641	664	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1111	+		10.1038/ng.2405			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	WOS:000309550200010	22941189	Green Accepted	Y	N	2022-01-24	
J	Finak, G; McDavid, A; Yajima, M; Deng, JY; Gersuk, V; Shalek, AK; Slichter, CK; Miller, HW; McElrath, MJ; Prlic, M; Linsley, PS; Gottardo, R				Finak, Greg; McDavid, Andrew; Yajima, Masanao; Deng, Jingyuan; Gersuk, Vivian; Shalek, Alex K.; Slichter, Chloe K.; Miller, Hannah W.; McElrath, M. Juliana; Prlic, Martin; Linsley, Peter S.; Gottardo, Raphael			MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data	GENOME BIOLOGY			English	Article						Bimodality; Cellular detection rate; Co-expression; Empirical Bayes; Generalized linear model; Gene set enrichment analysis	DIFFERENTIAL EXPRESSION ANALYSIS; STOCHASTIC GENE-EXPRESSION; MESSENGER-RNA; SEQ DATA; BIOCONDUCTOR; MOLECULES; DISCOVERY; GENOME	Single-cell transcriptomics reveals gene expression heterogeneity but suffers from stochastic dropout and characteristic bimodal expression distributions in which expression is either strongly non-zero or non-detectable. We propose a two-part, generalized linear model for such bimodal data that parameterizes both of these features. We argue that the cellular detection rate, the fraction of genes expressed in a cell, should be adjusted for as a source of nuisance variation. Our model provides gene set enrichment analysis tailored to single-cell data. It provides insights into how networks of co-expressed genes evolve across an experimental treatment.	[Finak, Greg; McDavid, Andrew; Yajima, Masanao; Deng, Jingyuan; Slichter, Chloe K.; Miller, Hannah W.; McElrath, M. Juliana; Prlic, Martin; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Gersuk, Vivian; Linsley, Peter S.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Shalek, Alex K.] MIT, Inst Med Engn & Sci, Boston, MA 01239 USA; [Shalek, Alex K.] MIT, Dept Chem, Boston, MA 01239 USA; [Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA		Gottardo, R (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.	rgottard@fredhutch.org	Shalek, Alex/Y-2434-2019	Shalek, Alex/0000-0001-5670-8778; McDavid, Andrew/0000-0002-6581-1213; Finak, Greg/0000-0003-4341-9090; Prlic, Martin/0000-0002-0685-9321	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2 DE023321, R01 EB008400]; Bill and Melinda Gates FoundationBill & Melinda Gates Foundation [OPP1032317]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [UM1AI068635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB008400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [DP2DE023321] Funding Source: NIH RePORTER	We thank all study volunteers and the Seattle HIV Vaccine Trials Unit for providing samples. We thank the James B. Pendleton Charitable Trust for their generous equipment donation. This work was supported by NIH grants DP2 DE023321 (to MP) and R01 EB008400 (to RG), and a grant from the Bill and Melinda Gates Foundation, OPP1032317 (to RG).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; Cousins RD., 2007, ANNOTATED BIBLIOGRAP; Darlington RB, 2000, PSYCHOL METHODS, V5, P496, DOI 10.1037/1082-989X.5.4.496; deWit H, 1996, EXP HEMATOL, V24, P228; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hicks S. C., 2015, BIORXIV; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Miah MA, 2013, EUR J IMMUNOL, V43, P2484, DOI 10.1002/eji.201243046; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tyznik AJ, 2014, J IMMUNOL, V192, P3676, DOI 10.4049/jimmunol.1300837; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461	35	639	643	4	32	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	DEC 10	2015	16								278	10.1186/s13059-015-0844-5			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CY0OP	WOS:000366105700002	26653891	Green Published, gold, Green Submitted	Y	N	2022-01-24	
J	Tian, F; Bradbury, PJ; Brown, PJ; Hung, H; Sun, Q; Flint-Garcia, S; Rocheford, TR; McMullen, MD; Holland, JB; Buckler, ES				Tian, Feng; Bradbury, Peter J.; Brown, Patrick J.; Hung, Hsiaoyi; Sun, Qi; Flint-Garcia, Sherry; Rocheford, Torbert R.; McMullen, Michael D.; Holland, James B.; Buckler, Edward S.			Genome-wide association study of leaf architecture in the maize nested association mapping population	NATURE GENETICS			English	Article							GENETIC ARCHITECTURE; FLOWERING-TIME; EXPRESSION; DIVERSITY; TRAITS; YIELD; SELECTION; ENHANCER; ENCODES; MODEL	US maize yield has increased eight-fold in the past 80 years, with half of the gain attributed to selection by breeders. During this time, changes in maize leaf angle and size have altered plant architecture, allowing more efficient light capture as planting density has increased. Through a genome-wide association study (GWAS) of the maize nested association mapping panel, we determined the genetic basis of important leaf architecture traits and identified some of the key genes. Overall, we demonstrate that the genetic architecture of the leaf traits is dominated by small effects, with little epistasis, environmental interaction or pleiotropy. In particular, GWAS results show that variations at the liguleless genes have contributed to more upright leaves. These results demonstrate that the use of GWAS with specially designed mapping populations is effective in uncovering the basis of key agronomic traits.	[Tian, Feng; Brown, Patrick J.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Bradbury, Peter J.; Buckler, Edward S.] USDA ARS, Ithaca, NY 14853 USA; [Brown, Patrick J.; Rocheford, Torbert R.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hung, Hsiaoyi; Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY USA; [Flint-Garcia, Sherry; McMullen, Michael D.] USDA ARS, Columbia, MO USA; [Flint-Garcia, Sherry; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Rocheford, Torbert R.] Purdue Univ, Dept Agron, Urbana, IL USA; [Holland, James B.] USDA ARS, Raleigh, NC 27695 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA		Buckler, ES (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	esb33@cornell.edu	Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X; Holland, James/0000-0002-4341-9675; Flint-Garcia, Sherry/0000-0003-4156-5318	US National Science FoundationNational Science Foundation (NSF) [DBI-0820619, 0321467, 0703908, 0638566]; USDA-ARSUnited States Department of Agriculture (USDA)USDA Agricultural Research Service; Division Of Integrative Organismal SystemsNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0820619] Funding Source: National Science Foundation	We thank L. Rigamer Lirette and S. Myles for editing the manuscript. This work was supported by US National Science Foundation grants (DBI-0820619, 0321467, 0703908 and 0638566) and USDA-ARS.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chopra S, 1998, MOL GEN GENET, V260, P372, DOI 10.1007/s004380050906; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Duvick DN, 2005, MAYDICA, V50, P193; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Gilmour A. R., 2006, ASREML USER GUIDE RE; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; LAMBERT RJ, 1978, CROP SCI, V18, P499, DOI 10.2135/cropsci1978.0011183X001800030037x; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mickelson SM, 2002, CROP SCI, V42, P1902, DOI 10.2135/cropsci2002.1902; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; PENDLETON JW, 1968, AGRON J, V60, P422, DOI 10.2134/agronj1968.00021962006000040027x; PEPPER GE, 1977, CROP SCI, V17, P883, DOI 10.2135/cropsci1977.0011183X001700060017x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sinclair TR, 1999, SCIENCE, V283, P1456; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Walsh J, 1998, GENE DEV, V12, P208, DOI 10.1101/gad.12.2.208	36	639	700	13	329	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					159	U113		10.1038/ng.746			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	WOS:000286623800016	21217756		Y	N	2022-01-24	
J	Heid, IM; Jackson, AU; Randall, JC; Winkler, TW; Qi, L; Steinthorsdottir, V; Thorleifsson, G; Zillikens, MC; Speliotes, EK; Magi, R; Workalemahu, T; White, CC; Bouatia-Naji, N; Harris, TB; Berndt, SI; Ingelsson, E; Willer, CJ; Weedon, MN; Luan, JA; Vedantam, S; Esko, T; Kilpelainen, TO; Kutalik, Z; Li, SX; Monda, KL; Dixon, AL; Holmes, CC; Kaplan, LM; Liang, LM; Min, JL; Moffatt, MF; Molony, C; Nicholson, G; Schadt, EE; Zondervan, KT; Feitosa, MF; Ferreira, T; Allen, HL; Weyant, RJ; Wheeler, E; Wood, AR; Estrada, K; Goddard, ME; Lettre, G; Mangino, M; Nyholt, DR; Purcell, S; Smith, AV; Visscher, PM; Yang, JA; McCarroll, SA; Nemesh, J; Voight, BF; Absher, D; Amin, N; Aspelund, T; Coin, L; Glazer, NL; Hayward, C; Heard-Costa, NL; Hottenga, JJ; Johansson, A; Johnson, T; Kaakinen, M; Kapur, K; Ketkar, S; Knowles, JW; Kraft, P; Kraja, AT; Lamina, C; Leitzmann, MF; McKnight, B; Morris, AP; Ong, KK; Perry, JRB; Peters, MJ; Polasek, O; Prokopenko, I; Rayner, NW; Ripatti, S; Rivadeneira, F; Robertson, NR; Sanna, S; Sovio, U; Surakka, I; Teumer, A; van Wingerden, S; Vitart, V; Zhao, JH; Cavalcanti-Proenca, C; Chines, PS; Fisher, E; Kulzer, JR; Lecoeur, C; Narisu, N; Sandholt, C; Scott, LJ; Silander, K; Stark, K; Tammesoo, ML; Teslovich, TM; Timpson, NJ; Watanabe, RM; Welch, R; Chasman, DI; Cooper, MN; Jansson, JO; Kettunen, J; Lawrence, RW; Pellikka, N; Perola, M; Vandenput, L; Alavere, H; Almgren, P; Atwood, LD; Bennett, AJ; Biffar, R; Bonnycastle, LL; Bornstein, SR; Buchanan, TA; Campbell, H; Day, INM; Dei, M; Dorr, M; Elliott, P; Erdos, MR; Eriksson, JG; Freimer, NB; Fu, M; Gaget, S; Geus, EJC; Gjesing, AP; Grallert, H; Grassler, J; Groves, CJ; Guiducci, C; Hartikainen, AL; Hassanali, N; Havulinna, AS; Herzig, KH; Hicks, AA; Hui, JN; Igl, W; Jousilahti, P; Jula, A; Kajantie, E; Kinnunen, L; Kolcic, I; Koskinen, S; Kovacs, P; Kroemer, HK; Krzelj, V; Kuusisto, J; Kvaloy, K; Laitinen, J; Lantieri, O; Lathrop, GM; Lokki, ML; Luben, RN; Ludwig, B; McArdle, WL; McCarthy, A; Morken, MA; Nelis, M; Neville, MJ; Pare, G; Parker, AN; Peden, JF; Pichler, I; Pietilainen, KH; Platou, CGP; Pouta, A; Ridderstrale, M; Samani, NJ; Saramies, J; Sinisalo, J; Smit, JH; Strawbridge, RJ; Stringham, HM; Swift, AJ; Teder-Laving, M; Thomson, B; Usala, G; van Meurs, JBJ; van Ommen, GJ; Vatin, V; Volpato, CB; Wallaschofski, H; Walters, GB; Widen, E; Wild, SH; Willemsen, G; Witte, DR; Zgaga, L; Zitting, P; Beilby, JP; James, AL; Kahonen, M; Lehtimaki, T; Nieminen, MS; Ohlsson, C; Palmer, LJ; Raitakari, O; Ridker, PM; Stumvoll, M; Tonjes, A; Viikari, J; Balkau, B; Ben-Shlomo, Y; Bergman, RN; Boeing, H; Smith, GD; Ebrahim, S; Froguel, P; Hansen, T; Hengstenberg, C; Hveem, K; Isomaa, B; Jorgensen, T; Karpe, F; Khaw, KT; Laakso, M; Lawlor, DA; Marre, M; Meitinger, T; Metspalu, A; Midthjell, K; Pedersen, O; Salomaa, V; Schwarz, PEH; Tuomi, T; Tuomilehto, J; Valle, TT; Wareham, NJ; Arnold, AM; Beckmann, JS; Bergmann, S; Boerwinkle, E; Boomsma, DI; Caulfield, MJ; Collins, FS; Eiriksdottir, G; Gudnason, V; Gyllensten, U; Hamsten, A; Hattersley, AT; Hofman, A; Hu, FB; Illig, T; Iribarren, C; Jarvelin, MR; Kao, WHL; Kaprio, J; Launer, LJ; Munroe, PB; Oostra, B; Penninx, BW; Pramstaller, PP; Psaty, BM; Quertermous, T; Rissanen, A; Rudan, I; Shuldiner, AR; Soranzo, N; Spector, TD; Syvanen, AC; Uda, M; Uitterlinden, A; Volzke, H; Vollenweider, P; Wilson, JF; Witteman, JC; Wright, AF; Abecasis, GR; Boehnke, M; Borecki, IB; Deloukas, P; Frayling, TM; Groop, LC; Haritunians, T; Hunter, DJ; Kaplan, RC; North, KE; O'Connell, JR; Peltonen, L; Schlessinger, D; Strachan, DP; Hirschhorn, JN; Assimes, TL; Wichmann, HE; Thorsteinsdottir, U; van Duijn, CM; Stefansson, K; Cupples, LA; Loos, RJF; Barroso, I; McCarthy, MI; Fox, CS; Mohlke, KL; Lindgren, CM				Heid, Iris M.; Jackson, Anne U.; Randall, Joshua C.; Winkler, Thomas W.; Qi, Lu; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Zillikens, M. Carola; Speliotes, Elizabeth K.; Maegi, Reedik; Workalemahu, Tsegaselassie; White, Charles C.; Bouatia-Naji, Nabila; Harris, Tamara B.; Berndt, Sonja I.; Ingelsson, Erik; Willer, Cristen J.; Weedon, Michael N.; Luan, Jianan; Vedantam, Sailaja; Esko, Tonu; Kilpelaeinen, Tuomas O.; Kutalik, Zoltan; Li, Shengxu; Monda, Keri L.; Dixon, Anna L.; Holmes, Christopher C.; Kaplan, Lee M.; Liang, Liming; Min, Josine L.; Moffatt, Miriam F.; Molony, Cliona; Nicholson, George; Schadt, Eric E.; Zondervan, Krina T.; Feitosa, Mary F.; Ferreira, Teresa; Allen, Hana Lango; Weyant, Robert J.; Wheeler, Eleanor; Wood, Andrew R.; Estrada, Karol; Goddard, Michael E.; Lettre, Guillaume; Mangino, Massimo; Nyholt, Dale R.; Purcell, Shaun; Smith, Albert Vernon; Visscher, Peter M.; Yang, Jian; McCarroll, Steven A.; Nemesh, James; Voight, Benjamin F.; Absher, Devin; Amin, Najaf; Aspelund, Thor; Coin, Lachlan; Glazer, Nicole L.; Hayward, Caroline; Heard-Costa, Nancy L.; Hottenga, Jouke-Jan; Johansson, Asa; Johnson, Toby; Kaakinen, Marika; Kapur, Karen; Ketkar, Shamika; Knowles, Joshua W.; Kraft, Peter; Kraja, Aldi T.; Lamina, Claudia; Leitzmann, Michael F.; McKnight, Barbara; Morris, Andrew P.; Ong, Ken K.; Perry, John R. B.; Peters, Marjolein J.; Polasek, Ozren; Prokopenko, Inga; Rayner, Nigel W.; Ripatti, Samuli; Rivadeneira, Fernando; Robertson, Neil R.; Sanna, Serena; Sovio, Ulla; Surakka, Ida; Teumer, Alexander; van Wingerden, Sophie; Vitart, Veronique; Zhao, Jing Hua; Cavalcanti-Proenca, Christine; Chines, Peter S.; Fisher, Eva; Kulzer, Jennifer R.; Lecoeur, Cecile; Narisu, Narisu; Sandholt, Camilla; Scott, Laura J.; Silander, Kaisa; Stark, Klaus; Tammesoo, Mari-Liis; Teslovich, Tanya M.; Timpson, Nicholas John; Watanabe, Richard M.; Welch, Ryan; Chasman, Daniel I.; Cooper, Matthew N.; Jansson, John-Olov; Kettunen, Johannes; Lawrence, Robert W.; Pellikka, Niina; Perola, Markus; Vandenput, Liesbeth; Alavere, Helene; Almgren, Peter; Atwood, Larry D.; Bennett, Amanda J.; Biffar, Reiner; Bonnycastle, Lori L.; Bornstein, Stefan R.; Buchanan, Thomas A.; Campbell, Harry; Day, Ian N. M.; Dei, Mariano; Doerr, Marcus; Elliott, Paul; Erdos, Michael R.; Eriksson, Johan G.; Freimer, Nelson B.; Fu, Mao; Gaget, Stefan; Geus, Eco J. C.; Gjesing, Anette P.; Grallert, Harald; Graessler, Juergen; Groves, Christopher J.; Guiducci, Candace; Hartikainen, Anna-Liisa; Hassanali, Neelam; Havulinna, Aki S.; Herzig, Karl-Heinz; Hicks, Andrew A.; Hui, Jennie; Igl, Wilmar; Jousilahti, Pekka; Jula, Antti; Kajantie, Eero; Kinnunen, Leena; Kolcic, Ivana; Koskinen, Seppo; Kovacs, Peter; Kroemer, Heyo K.; Krzelj, Vjekoslav; Kuusisto, Johanna; Kvaloy, Kirsti; Laitinen, Jaana; Lantieri, Olivier; Lathrop, G. Mark; Lokki, Marja-Liisa; Luben, Robert N.; Ludwig, Barbara; McArdle, Wendy L.; McCarthy, Anne; Morken, Mario A.; Nelis, Mari; Neville, Matt J.; Pare, Guillaume; Parker, Alex N.; Peden, John F.; Pichler, Irene; Pietilainen, Kirsi H.; Platou, Carl G. P.; Pouta, Anneli; Ridderstrale, Martin; Samani, Nilesh J.; Saramies, Jouko; Sinisalo, Juha; Smit, Jan H.; Strawbridge, Rona J.; Stringham, Heather M.; Swift, Amy J.; Teder-Laving, Maris; Thomson, Brian; Usala, Gianluca; van Meurs, Joyce B. J.; van Ommen, Gert-Jan; Vatin, Vincent; Volpato, Claudia B.; Wallaschofski, Henri; Walters, G. Bragi; Widen, Elisabeth; Wild, Sarah H.; Willemsen, Gonneke; Witte, Daniel R.; Zgaga, Lina; Zitting, Paavo; Beilby, John P.; James, Alan L.; Kahonen, Mika; Lehtimaki, Terho; Nieminen, Markku S.; Ohlsson, Claes; Palmer, Lyle J.; Raitakari, Olli; Ridker, Paul M.; Stumvoll, Michael; Toenjes, Anke; Viikari, Jorma; Balkau, Beverley; Ben-Shlomo, Yoav; Bergman, Richard N.; Boeing, Heiner; Smith, George Davey; Ebrahim, Shah; Froguel, Philippe; Hansen, Torben; Hengstenberg, Christian; Hveem, Kristian; Isomaa, Bo; Jorgensen, Torben; Karpe, Fredrik; Khaw, Kay-Tee; Laakso, Markku; Lawlor, Debbie A.; Marre, Michel; Meitinger, Thomas; Metspalu, Andres; Midthjell, Kristian; Pedersen, Oluf; Salomaa, Veikko; Schwarz, Peter E. H.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Valle, Timo T.; Wareham, Nicholas J.; Arnold, Alice M.; Beckmann, Jacques S.; Bergmann, Sven; Boerwinkle, Eric; Boomsma, Dorret I.; Caulfield, Mark J.; Collins, Francis S.; Eiriksdottir, Gudny; Gudnason, Vilmundur; Gyllensten, Ulf; Hamsten, Anders; Hattersley, Andrew T.; Hofman, Albert; Hu, Frank B.; Illig, Thomas; Iribarren, Carlos; Jarvelin, Marjo-Riitta; Kao, W. H. Linda; Kaprio, Jaakko; Launer, Lenore J.; Munroe, Patricia B.; Oostra, Ben; Penninx, Brenda W.; Pramstaller, Peter P.; Psaty, Bruce M.; Quertermous, Thomas; Rissanen, Aila; Rudan, Igor; Shuldiner, Alan R.; Soranzo, Nicole; Spector, Timothy D.; Syvanen, Ann-Christine; Uda, Manuela; Uitterlinden, Andre; Voelzke, Henry; Vollenweider, Peter; Wilson, James F.; Witteman, Jacqueline C.; Wright, Alan F.; Abecasis, Goncalo R.; Boehnke, Michael; Borecki, Ingrid B.; Deloukas, Panos; Frayling, Timothy M.; Groop, Leif C.; Haritunians, Talin; Hunter, David J.; Kaplan, Robert C.; North, Kari E.; O'Connell, Jeffrey R.; Peltonen, Leena; Schlessinger, David; Strachan, David P.; Hirschhorn, Joel N.; Assimes, Themistocles L.; Wichmann, H-Erich; Thorsteinsdottir, Unnur; van Duijn, Cornelia M.; Stefansson, Kari; Cupples, L. Adrienne; Loos, Ruth J. F.; Barroso, Ines; McCarthy, Mark I.; Fox, Caroline S.; Mohlke, Karen L.; Lindgren, Cecilia M.		MAGIC	Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; BODY-FAT; GLUCOSE-HOMEOSTASIS; ABDOMINAL ADIPOSITY; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; RISK; OBESITY	Waist-hip ratio (WHR) is a measure of body fat distribution and a predictor of metabolic consequences independent of overall adiposity. WHR is heritable, but few genetic variants influencing this trait have been identified. We conducted a meta-analysis of 32 genome-wide association studies for WHR adjusted for body mass index (comprising up to 77,167 participants), following up 16 loci in an additional 29 studies (comprising up to 113,636 subjects). We identified 13 new loci in or near RSPO3, VEGFA, TBX15-WARS2, NFE2L3, GRB14, DNM3-PIGC, ITPR2-SSPN, LY86, HOXC13, ADAMTS9, ZNRF3-KREMEN1, NISCH-STAB1 and CPEB4 (P = 1.9 x 10(-9) to P = 1.8 x 10(-40)) and the known signal at LYPLAL1. Seven of these loci exhibited marked sexual dimorphism, all with a stronger effect on WHR in women than men (P for sex difference = 1.9 x 10(-3) to P = 1.2 x 10(-13)). These findings provide evidence for multiple loci that modulate body fat distribution independent of overall adiposity and reveal strong gene-by-sex interactions.	[Randall, Joshua C.; Maegi, Reedik; Ferreira, Teresa; Morris, Andrew P.; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Peden, John F.; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Heid, Iris M.; Winkler, Thomas W.; Leitzmann, Michael F.] Regensburg Univ Med Ctr, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Heid, Iris M.; Lamina, Claudia; Grallert, Harald; Illig, Thomas; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Jackson, Anne U.; Willer, Cristen J.; Weyant, Robert J.; Scott, Laura J.; Teslovich, Tanya M.; Welch, Ryan; Stringham, Heather M.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Qi, Lu; Workalemahu, Tsegaselassie; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Kaplan, Lee M.; Chasman, Daniel I.; Ridker, Paul M.; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Walters, G. Bragi; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Zillikens, M. Carola; Estrada, Karol; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Uitterlinden, Andre] Erasmus Med Ctr MC, Dept Internal Med, Rotterdam, Netherlands; [Zillikens, M. Carola; Estrada, Karol; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre; Witteman, Jacqueline C.; van Duijn, Cornelia M.] NGI, NCHA, Rotterdam, Netherlands; [Speliotes, Elizabeth K.; Vedantam, Sailaja; Guiducci, Candace; Thomson, Brian; Hirschhorn, Joel N.] Broad Inst, Metab Initiat, Cambridge, MA USA; [Speliotes, Elizabeth K.; Vedantam, Sailaja; Guiducci, Candace; Thomson, Brian; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Speliotes, Elizabeth K.; Kaplan, Lee M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [White, Charles C.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Lecoeur, Cecile; Gaget, Stefan; Vatin, Vincent; Froguel, Philippe] Inst Pasteur, IBL, UMR8199, CNRS, F-59019 Lille, France; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Lecoeur, Cecile; Gaget, Stefan; Vatin, Vincent; Froguel, Philippe] Univ Lille Nord France, Lille, France; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol, NIH, Bethesda, MD 20892 USA; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weedon, Michael N.; Allen, Hana Lango; Wood, Andrew R.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Luan, Jianan; Kilpelaeinen, Tuomas O.; Li, Shengxu; Ong, Ken K.; Zhao, Jing Hua; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Esko, Tonu; Tammesoo, Mari-Liis; Alavere, Helene; Nelis, Mari; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Teder-Laving, Maris; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Teder-Laving, Maris; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Kutalik, Zoltan; Johnson, Toby; Kapur, Karen; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Johnson, Toby; Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Monda, Keri L.; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Dixon, Anna L.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Holmes, Christopher C.] MRC Harwell, Oxford, England; [Holmes, Christopher C.; Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Kaplan, Lee M.] Massachusetts Gen Hosp, Weight Ctr, Boston, MA 02114 USA; [Liang, Liming; Kraft, Peter; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Min, Josine L.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Molony, Cliona] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA USA; [Zondervan, Krina T.] Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Feitosa, Mary F.; Ketkar, Shamika; Kraja, Aldi T.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wheeler, Eleanor; Soranzo, Nicole; Deloukas, Panos; Peltonen, Leena; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Estrada, Karol; Amin, Najaf; Rivadeneira, Fernando; van Wingerden, Sophie; van Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre; Witteman, Jacqueline C.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Goddard, Michael E.] Univ Melbourne, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Primary Ind, Melbourne, Vic, Australia; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Mangino, Massimo; Soranzo, Nicole; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Brisbane, Qld 4006, Australia; [Purcell, Shaun; McCarroll, Steven A.; Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Purcell, Shaun; McCarroll, Steven A.; Nemesh, James; Voight, Benjamin F.; Peltonen, Leena] MIT, Cambridge, MA 02139 USA; [Purcell, Shaun] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Visscher, Peter M.; Yang, Jian] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [McCarroll, Steven A.; Nemesh, James; Voight, Benjamin F.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [McCarroll, Steven A.; Voight, Benjamin F.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Absher, Devin] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Coin, Lachlan; Sovio, Ulla; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Glazer, Nicole L.] Univ Washington, Dept Med, Seattle, WA USA; [Glazer, Nicole L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Heard-Costa, Nancy L.; Atwood, Larry D.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hottenga, Jouke-Jan; Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Univ Amsterdam, Vrije Univ, Dept Biol Psychol, Amsterdam, Netherlands; [Johansson, Asa; Igl, Wilmar; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Johansson, Asa] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Barts & London Genome Ctr, London, England; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Knowles, Joshua W.; Quertermous, Thomas; Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lamina, Claudia] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [McKnight, Barbara; Arnold, Alice M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Polasek, Ozren; Kolcic, Ivana; Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Polasek, Ozren] Gen Info Ltd, Zagreb, Croatia; [Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Bennett, Amanda J.; Groves, Christopher J.; Hassanali, Neelam; Neville, Matt J.; Karpe, Fredrik; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Ripatti, Samuli; Surakka, Ida; Silander, Kaisa; Kettunen, Johannes; Pellikka, Niina; Perola, Markus; Widen, Elisabeth; Kaprio, Jaakko; Peltonen, Leena] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ripatti, Samuli; Surakka, Ida; Silander, Kaisa; Kettunen, Johannes; Pellikka, Niina; Perola, Markus] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Unit Publ Hlth Genom, Helsinki, Finland; [Sanna, Serena; Dei, Mariano; Usala, Gianluca; Uda, Manuela] Ist Neurogenet & Neurofarmacol CNR, Cagliari, Italy; [Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Chines, Peter S.; Narisu, Narisu; Bonnycastle, Lori L.; Erdos, Michael R.; Morken, Mario A.; Swift, Amy J.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Fisher, Eva; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kulzer, Jennifer R.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sandholt, Camilla; Gjesing, Anette P.; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Stark, Klaus] Univ Regensburg, Med Ctr, Clin & Policlin Internal Med 2, Regensburg, Germany; [Timpson, Nicholas John; Day, Ian N. M.; Smith, George Davey; Lawlor, Debbie A.] MRC Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol, Avon, England; [Watanabe, Richard M.; Buchanan, Thomas A.; Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Phys & Biophys, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Cooper, Matthew N.; Lawrence, Robert W.; Hui, Jennie; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [Jansson, John-Olov] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Vandenput, Liesbeth; Ohlsson, Claes] Univ Gothenburg, Inst Med, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden; [Almgren, Peter; Groop, Leif C.] Lund Univ, Ctr Diabet, Dept Clin Sci, Malmo, Sweden; [Biffar, Reiner] Zentrum Zahn Mund & Kieferheilkunde, Greifswald, Germany; [Bornstein, Stefan R.; Graessler, Juergen; Ludwig, Barbara] Univ Dresden, Dept Med 3, Dresden, Germany; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA; [Campbell, Harry; Wild, Sarah H.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Doerr, Marcus] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Elliott, Paul] Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA, London, England; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.; Kajantie, Eero; Peltonen, Leena] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.; Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Fu, Mao; Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Havulinna, Aki S.; Jousilahti, Pekka; Koskinen, Seppo; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Hicks, Andrew A.; Pichler, Irene; Volpato, Claudia B.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hui, Jennie; Beilby, John P.] QEII Med Ctr, Dept Mol Genet, PathW Lab Western Australia, Nedlands, WA, Australia; [Hicks, Andrew A.; Pichler, Irene; Volpato, Claudia B.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Hui, Jennie; Beilby, John P.; James, Alan L.; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn Inc, Nedlands, WA, Australia; [Jula, Antti] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Kinnunen, Leena; Tuomilehto, Jaakko; Valle, Timo T.] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmakol, Greifswald, Germany; [Krzelj, Vjekoslav; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kvaloy, Kirsti; Platou, Carl G. P.; Hveem, Kristian; Midthjell, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Nord Trondelag Hlth Study HUNT Res Ctr, Levanger, Norway; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Lathrop, G. Mark] Ctr Natl Genotypage, Paris, France; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Luben, Robert N.; Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children ALSPAC, Bristol, Avon, England; [McCarthy, Anne] Res Board, Div Hlth, Dublin, Ireland; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Parker, Alex N.] Amgen Inc, Cambridge, MA USA; [Peden, John F.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Finnish Twin Cohort Study, Helsinki, Finland; [Pietilainen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland; [Platou, Carl G. P.] Levanger Hosp, Nord Trondelag Hlth Trust, Dept Med, Levanger, Norway; [Ridderstrale, Martin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, Biomed Res Unit Cardiovasc Dis, Leicester Natl Inst Hlth Res NIHR, Leicester, Leics, England; [Saramies, Jouko] S Karelia Cent Hosp, Lappeenranta, Finland; [Sinisalo, Juha; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Cardiovasc Lab, Div Cardiol, Helsinki, Finland; [Smit, Jan H.; Penninx, Brenda W.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Inst Extramuraal Geneeskundig Onderzoek EMGO Inst, Amsterdam, Netherlands; [Strawbridge, Rona J.; Hamsten, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Leiden, Netherlands; [Wallaschofski, Henri] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem & Lab Med, Greifswald, Germany; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi, Finland; [Beilby, John P.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika; Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, Leipzig, Germany; [Stumvoll, Michael] Univ Leipzig, Leipziger Interdisziplinarer Forschungskomplex Mo, Leipzig, Germany; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Balkau, Beverley] INSERM Ctr Rech Epidemiol & Sante Populat CESP, F-01018 Villejuif, France; [Balkau, Beverley] Univ Paris Sud 11, Unit Mixte Rech Sante UMRS 1018, Villejuif, France; [Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Hengstenberg, Christian] Univ Regensburg, Med Ctr, Innere Med 2, Regensburg, Germany; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Karpe, Fredrik; McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Henri Poincar Nancy 1, Cardiovasc Genet Res Unit, Nancy, France; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Schwarz, Peter E. H.] Univ Dresden, Dept Med Prevent & Care Diabet 3, Dresden, Germany; [Tuomi, Tiinamaija] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; [Tuomi, Tiinamaija] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Arnold, Alice M.] Collaborat Hlth Studies Coordinating Ctr, Seattle, WA USA; [Beckmann, Jacques S.] Univ Lausanne Hosp, CHUV, Serv Med Genet, Lausanne, Switzerland; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Iribarren, Carlos] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Iribarren, Carlos] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol & Med, Baltimore, MD USA; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Kaprio, Jaakko] Unit Child & Adolescent Mental Hlth, Substance Abuse Serv, Helsinki, Finland; [Oostra, Ben] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Voelzke, Henry] Inst Community Med, Greifswald, Germany; [Vollenweider, Peter] Univ Lausanne Hosp, CHUV, Dept Internal Med, Lausanne, Switzerland; [Borecki, Ingrid B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Haritunians, Talin] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Fox, Caroline S.] NHLBI, Div Intramural Res, Framingham Heart Study, Framingham, MA USA		Lindgren, CM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	iris.heid@klinik.uni-regensburg.de; mark.mccarthy@drl.ox.ac.uk; foxca@nhlbi.nih.gov; mohlke@med.unc.edu; celi@well.ox.ac.uk	Lamina, Claudia/F-7608-2010; Meitinger, Thomas/O-1318-2015; Abecasis, Goncalo R/B-7840-2010; Aspelund, Thor/F-4826-2011; Allen, Hana Lango/G-9026-2012; Grallert, Harald/B-3424-2013; Loos, Ruth J F/Q-2862-2016; Krzelj, Vjekoslav/D-6491-2017; Kolcic, Ivana/E-2713-2017; Polasek, Ozren/B-6002-2011; Beckmann, Jacques S/A-9772-2008; Uda, Manuela/AAC-2645-2019; Stark, Klaus/L-7367-2013; mangino, massimo/F-5134-2011; Pedersen, Oluf/AAG-8015-2020; Timpson, Nicholas John/O-7548-2015; Wilson, James F/A-5704-2009; Ripatti, Samuli/H-9446-2014; Johansson, Asa/G-5270-2011; Kinnunen, Leena/B-7059-2012; Gudnason, Vilmundur/K-6885-2015; Stark, Klaus/D-3813-2009; Ben-Shlomo, Yoav/ABD-2004-2021; Magi, Reedik/AAJ-9679-2021; Pedersen, Oluf/Z-1731-2019; Gudnason, Vilmundur/AAE-7126-2019; Dorr, Marcus/F-1919-2010; Nelis, Mari/ABG-7775-2020; sanna, serena/H-3009-2019; Coin, Lachlan/O-4976-2019; Zondervan, Krina T/M-1143-2013; Kaprio, Jaakko/A-1820-2008; Narisu, Narisu/T-6908-2019; Sovio, Ulla/H-8532-2019; de Geus, Eco J.C./M-9318-2015; Hengstenberg, Christian/U-5485-2019; Attrill, Lauren/V-1688-2018; Ridderstrale, Martin/F-7678-2012; Kilpelainen, Tuomas/F-8569-2012; Khaw, Kay-Tee/AAZ-3209-2021; Visscher, Peter/ABB-6151-2020; Campbell, Harry/E-2959-2010; Voight, Benjamin/F-1775-2011; Aspelund, Thor/C-5983-2008; Rivadeneira, Fernando/O-5385-2015; Havulinna, Aki/AAM-4769-2021; Spector, Tim D/F-6533-2012; Witte, Daniel R/C-1722-2008; Raitakari, Olli/AAQ-7389-2021; FROGUEL, Philippe/O-6799-2017; Wichmann, Heinz Erich/AAA-5695-2022; Yang, Jian/A-5852-2010; Walters, G. Bragi/L-4215-2013; Penninx, Brenda WJH/S-7627-2017; Aspelund, Thor/K-7022-2019; Dei, Mariano/AAY-3870-2020; Hicks, Andrew Anthony/E-9518-2017; Prokopenko, Inga/AAU-9895-2020; Pramstaller, Peter P/C-2357-2008; Luben, Robert N/H-5519-2015; Palmer, Lyle John/K-3196-2014; Deloukas, Panos/B-2922-2013; Johansson, Asa/AAG-6799-2021; Berndt, Sonja I/J-8423-2016; Feitosa, Mary F/K-8044-2012; Prokopenko, Inga/H-3241-2014; Boomsma, Dorret I/AAX-4470-2020; Zgaga, Lina/Q-9415-2018; Hui, Jennie/A-9543-2013; Witte, Daniel/AAF-9535-2019; Teumer, Alexander/S-7438-2019; Vandenput, Liesbeth/AAP-3655-2020; Strawbridge, Rona J./H-5422-2012; Palmer, Lyle John/N-1948-2019; Hayward, Caroline/M-8818-2016; Amin, Najaf N/D-1859-2012; Wood, Andrew R/AAB-3807-2019; Coin, Lachlan JM/A-9001-2014; BOUATIA-NAJI, NABILA/D-5863-2013; Vandenput, Liesbeth/AAI-4100-2021; Kaplan, Robert/A-2526-2011; Colaus, PsyColaus/K-6607-2013; Stefansson, Kari/AAE-7187-2019; Jorgensen, Torben/Z-1335-2018; Stumvoll, Michael/ABE-1121-2021; Cooper, Matthew N/J-4420-2014; Rudan, Igor/I-1467-2012; Davey Smith, George/A-7407-2013; Li, Shengxu/D-8915-2012; Smith, Albert Vernon/K-5150-2015; Nyholt, Dale R/J-3174-2017; Pare, Guillaume/T-9631-2018	Lamina, Claudia/0000-0002-5398-5806; Allen, Hana Lango/0000-0002-7803-8688; Loos, Ruth J F/0000-0002-8532-5087; Kolcic, Ivana/0000-0001-7918-6052; Polasek, Ozren/0000-0002-5765-1862; Beckmann, Jacques S/0000-0002-9741-1900; Uda, Manuela/0000-0002-4890-6456; Stark, Klaus/0000-0002-7832-1942; mangino, massimo/0000-0002-2167-7470; Timpson, Nicholas John/0000-0002-7141-9189; Wilson, James F/0000-0001-5751-9178; Ripatti, Samuli/0000-0002-0504-1202; Johansson, Asa/0000-0002-2915-4498; Kinnunen, Leena/0000-0001-8739-4812; Gudnason, Vilmundur/0000-0001-5696-0084; Stark, Klaus/0000-0002-7832-1942; Pedersen, Oluf/0000-0002-3321-3972; Gudnason, Vilmundur/0000-0001-5696-0084; Dorr, Marcus/0000-0001-7471-475X; Nelis, Mari/0000-0001-9748-1020; sanna, serena/0000-0002-3768-1749; Coin, Lachlan/0000-0002-4300-455X; Zondervan, Krina T/0000-0002-0275-9905; Kaprio, Jaakko/0000-0002-3716-2455; Sovio, Ulla/0000-0002-0799-1105; de Geus, Eco J.C./0000-0001-6022-2666; Kilpelainen, Tuomas/0000-0002-8349-3028; Visscher, Peter/0000-0002-2143-8760; Campbell, Harry/0000-0002-6169-6262; Aspelund, Thor/0000-0002-7998-5433; Rivadeneira, Fernando/0000-0001-9435-9441; Witte, Daniel R/0000-0002-0769-2922; FROGUEL, Philippe/0000-0003-2972-0784; Yang, Jian/0000-0003-2001-2474; Walters, G. Bragi/0000-0002-5415-6487; Penninx, Brenda WJH/0000-0001-7779-9672; Aspelund, Thor/0000-0002-7998-5433; Hicks, Andrew Anthony/0000-0001-6320-0411; Luben, Robert N/0000-0002-5088-6343; Palmer, Lyle John/0000-0002-1628-3055; Deloukas, Panos/0000-0001-9251-070X; Johansson, Asa/0000-0002-2915-4498; Feitosa, Mary F/0000-0002-0933-2410; Prokopenko, Inga/0000-0003-1624-7457; Zgaga, Lina/0000-0003-4089-9703; Hui, Jennie/0000-0002-1653-2496; Witte, Daniel/0000-0002-0769-2922; Teumer, Alexander/0000-0002-8309-094X; Strawbridge, Rona J./0000-0001-8506-3585; Palmer, Lyle John/0000-0002-1628-3055; Hayward, Caroline/0000-0002-9405-9550; Coin, Lachlan JM/0000-0002-4300-455X; Vandenput, Liesbeth/0000-0002-1712-6131; Stumvoll, Michael/0000-0001-6225-8240; Cooper, Matthew N/0000-0003-1139-3682; Rudan, Igor/0000-0001-6993-6884; Davey Smith, George/0000-0002-1407-8314; Smith, Albert Vernon/0000-0003-1942-5845; Nyholt, Dale R/0000-0001-7159-3040; Pare, Guillaume/0000-0002-6795-4760; Willer, Cristen/0000-0001-5645-4966; Cupples, L. Adrienne/0000-0003-0273-7965; Hattersley, Andrew/0000-0001-5620-473X; Krzelj, Vjekoslav/0000-0001-6086-4669; Dei, Mariano/0000-0002-7404-508X; Elliott, Paul/0000-0002-7511-5684; Weedon, Michael/0000-0002-6174-6135; Glazer, Nicole/0000-0002-6397-609X; Wood, Andrew/0000-0003-1726-948X; Pichler, Irene/0000-0001-8251-0757; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Shuldiner, Alan/0000-0001-9921-4305; Kahonen, Mika/0000-0002-4510-7341; Gjesing, Anette P/0000-0003-4580-1576; Bergmann, Sven/0000-0002-6785-9034; Ballantyne, Christie/0000-0002-6432-1730; Jorgensen, Torben/0000-0001-9453-2830; Eriksson, Johan/0000-0002-2516-2060; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Esko, Tonu/0000-0003-1982-6569; Ben-Shlomo, Yoav/0000-0001-6648-3007; Wheeler, Eleanor/0000-0002-8616-6444; Tuomi, Tiinamaija/0000-0002-8306-6202; Munroe, Patricia/0000-0002-4176-2947; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Schwarz, Peter/0000-0002-0483-8594; Willemsen, Gonneke/0000-0003-3755-0236; Bouatia-Naji, Nabila/0000-0001-5424-2134; Weyant, Robert/0000-0002-5252-9120; Karpe, Fredrik/0000-0002-2751-1770; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Abecasis, Goncalo/0000-0003-1509-1825; Beilby, John/0000-0002-4915-2254; Marre, Michel/0000-0002-3071-1837; Ohlsson, Claes/0000-0002-9633-2805; van Meurs, Joyce/0000-0001-6245-2123; Graessler, Juergen/0000-0003-3619-8517; Johnson, Toby/0000-0002-5998-3270; Lindgren, Cecilia/0000-0002-4903-9374; Pramstaller, Peter P/0000-0002-9831-8302; Pietilainen, Kirsi/0000-0002-8522-1288; Barroso, Ines/0000-0001-5800-4520; Sinisalo, Juha/0000-0002-0169-5137; Meitinger, Thomas/0000-0002-8838-8403; Magi, Reedik/0000-0002-2964-6011; Kovacs, Peter/0000-0002-0290-5423; Van Duijn, Cornelia/0000-0002-2374-9204; Amin, Najaf/0000-0002-8944-1771; Hansen, Torben/0000-0001-8748-3831; Soranzo, Nicole/0000-0003-1095-3852; Caulfield, Mark/0000-0001-9295-3594; Goddard, Michael/0000-0001-9917-7946; Kaakinen, Marika/0000-0002-9228-0462; Lawlor, Debbie A/0000-0002-6793-2262; Heard-Costa, Nancy/0000-0001-9730-0306; bennett, amanda/0000-0003-2140-8710; Peters, Marjolein/0000-0003-3167-9063; Randall, Joshua/0000-0003-1540-203X	Academy of FinlandAcademy of FinlandEuropean Commission [104781, 120315, 129269, 117797, 121584, 126925, 129418, 129568, 77299, 124243, 129680, 129494, 10404, 213506, 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374]; ADAAmerican Diabetes Association [N02-HL-6-4278]; ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); AmgenAmgen; Augustinus Foundation; Becket Foundation; Biocentrum Helsinki; Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center [DK46200]; British Diabetes AssociationDiabetes UK [1192]; British Diabetic Association Research; British Heart FoundationBritish Heart Foundation [97020, PG/02/128]; Busselton Population Medical Research Foundation; Cambridge NIHR Comprehensive Biomedical Research Centre; CamStrad; Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region de France; Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research CouncilDet Frie Forskningsrad (DFF); DIAB Core (German Network of Diabetes); Diabetes UKDiabetes UK; Donald W. Reynolds Foundation; Dresden University of Technology; Med Drive; EMGO+ institute; Emil and Vera Cornell Foundation; Erasmus Medical Center and Erasmus University, Rotterdam, The NetherlandsNetherlands Government; Estonian Government [SF0180142s08]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [2004310, 212111, 205419, 245536, DG XII, HEALTH-F4-2007-201413, FP7/2007-2013, QLG1-CT-2000-01643, QLG2-CT-2002-01254, LSHG-CT-2006-018947, LSHG-CT-2006-01947, LSHG-CT-2004-512066, LSHM-CT-2007-037273, EU/WLRT-2001-01254, LSHG-CT-2004-518153, SOC 95201408 05F02]; Federal Ministry of Education and Research, GermanyFederal Ministry of Education & Research (BMBF) [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012, 01 EA 9401]; Federal State of Mecklenburg-West Pomerania; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Pediatric Research; Finnish Foundation of Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Finnish Ministry of Education; Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional; Fondation LeDucqLeducq Foundation; Foundation for Life and Health in Finland; GEN-AU 'GOLD' from Austria; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German National Genome Research Net NGFN2 and NGFNplus [01GS0823, FKZ 01GS0823]; German Research CouncilGerman Research Foundation (DFG) [KFO-152]; GlaxoSmithKlineGlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Health Care Center in Vasa; Healthway, Western Australia; Helmholtz Center MunichHelmholtz Association; Helsinki University Central Hospital; Hjartavernd (the Icelandic Heart Association); Ib Henriksen Foundation; IZKF [B27]; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF)Juvenile Diabetes Research Foundation; Karolinska Institute and the Stockholm County CouncilKarolinska Institutet [560183]; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Lundbeck Foundation Centre of Applied Medical Genomics; Knut Krohn, Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (IZKF), University of Leipzig, Germany; MC Health; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrol Ministry of Health; Ministry of Science, Education and Sport of the Republic of CroatiaMinistry of Science, Education and Sports, Republic of Croatia [216-1080315-0302]; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000649, G0601261, G9521010D, G0000934, G0500539, G0600331]; Montreal Heart Institute Foundation; MRC Centre for Obesity-Related Metabolic DiseaseUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Health and Medical Research Council of Australia and the Great Wine Estates AuctionsNational Health and Medical Research Council of Australia; Netherlands Centre for Medical Systems Biology [SPI 56-464-1419]; Netherlands Ministry for Health; Welfare and Sports; Netherlands Ministry of Education, Culture and Science; Netherlands Genomics Initiative; Netherlands Consortium [050-060-810]; Netherlands Organisation of Scientific Research Netherlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) InvestmentsNetherlands Organization for Scientific Research (NWO) [175.010.2005.011, 911-03-012, 904-61-090, 904-61-193, 480-04-004, 400-05-717]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA047988, CA65725, CA87969, CA49449, CA67262, CA50385, DK075787, DK062370, DK58845, DK072193, K23-DK080145, K99HL094535, N01-HC85079, N01-HC85086, N01-HG-65403, N01-AG-12100, N01-HC-25195, N01-HC35129, N01-HC15103, N01-HC55222, N01-HC75150, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-AG-1-2109, HL71981, HG005581, HG002651, HL084729, HL043851, HHSN268200625226C, MH084698, P30-DK072488, R01 HL087652, R01-HL087641, R01-HL59367, R01-HL086694, R01-HL087647, R01-HL087679, R01-HL087700, R01-AG031890, R01-HL088119, R01-DK068336, R01-DK075681, R01-DK-073490, R01-DK075787, R01-MH63706, U01-HL72515, U01-GM074518, U01-HL084756, U01-HG004399, UO1-CA098233, UL1-RR025005, U01-HG004402, U01-DK062418, U01 HL080295, T32-HG00040, 263-MA-410953, 1RL1-MH083268-01, 1Z01-HG000024]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Neuroscience Campus Amsterdam; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited; Novo Nordisk Inc.Novo Nordisk; Ollqvist Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Pew Scholarship for the Biomedical Sciences; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly [014-93-015]; Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR) [A305:188]; Siemens Healthcare, Erlangen, GermanySiemens AG; Signe and Ane Gyllenberg Foundation; Sigrid Juselius FoundationSigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrolean Sparkasse Foundation; State of Bavaria, Germany; Support for Science Funding programme; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research (SSF)Swedish Foundation for Strategic Research; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [8691, K2007-66X-20270-01-3, K2010-54X-09894-19-3]; Swedish Society of Medicine; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [33CSCO-122661]; Royal SocietyRoyal Society of LondonEuropean Commission; Royal Swedish Academy of Science; Torsten and Ragnar Soderberg's Foundation; Turku University Hospitals; UK Department of Health Policy Research Programme; University and Research of the Autonomous Province of Bolzano; University Hospital Medical; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; Vastra Gotaland Foundation; Wellcome TrustWellcome TrustEuropean Commission [077016/Z/05/Z, 068545/Z/02, 072960, 076113, 083270, 085301, 079557, 081682, 075491, 076113/B/04/Z, 091746/Z/10/Z, 079895, WT086596/Z/08/Z]; Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Yrjo Jahnsson Foundation; AstraZeneca ABAstraZeneca; Lundberg FoundationEuropean Commission; Swedish Heart-Lung FoundationSwedish Heart-Lung Foundation; Research Foundation of Copenhagen County; Health care center in Nerpes; Health care center in Korsholm; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_qA137934, G0600331, G0801056, G0500115, MC_U106188470, MC_U106179472, MC_UP_A390_1107, G0000934, G0501184, MC_U127561128, G0600705, G0601261] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601261, G0501184, G0801056, MC_U127561128, MC_UP_A390_1107, G0000934, G0600331, G0801056B, MC_U106188470, G0500115, MC_U106179472, G0401527, G0600705, MC_qA137934] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10212] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC055022, N01HC075150, N01HC055019, N01HC085082, N01HC055015, N01HC085084, N01HC085083, N01HC045133, N01HC035129, N01HC055016, N01HC055020, N01HC055021, N01HC085079, N01HC085086, N01HC025195, N01HC085080, N01HC015103, N01HC085081, N01HC055018, N01HC085085, N01HC055222] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA067262, P01CA087969, R01CA050385, U01CA049449, R01CA065725, U01CA098233, R01CA049449, R01CA047988, U01CA067262] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R42HL055018, R01HL088119, R01HL059367, U01HL072515, ZIAHL006094, R01HL117078, R01HL087641, R01HL087647, U01HL084756, R41HL055018, R01HL087679, U01HL080295, R01HL086694, U01HL084729, K99HL094535, U01HL054527, R41HL055019, R01HL071981, R01HL043851, R01HL087652, R01HL087700] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [N01HG065403, T32HG000040, Z01HG000024, RC2HG005581, R01HG002651, U01HG004399, ZIAHG000024, U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U01DK062370, R01DK073490, R01DK075787, R01DK072193, R01DK062370, R01DK056690, F32DK079466, U01DK062418, R01DK075681, P30DK072488, K23DK080145, R56DK062370, P30DK046200, R01DK068336, R01DK089256, R01DK058845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH063706, RL1MH083268, R01MH084698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000675, R01AG031890, N01AG012100] Funding Source: NIH RePORTER	Funding for this study was provided by the Academy of Finland (grants 104781, 120315, 129269, 117797, 121584, 126925, 129418, 129568, 77299, 124243, 213506, 129680, 129494, 10404, 213506, 129680, 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225 and 216374); an ADA Mentor-Based Postdoctoral Fellowship grant; Affymetrix, Inc., for genotyping services (N02-HL-6-4278); ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; AstraZeneca AB; Augustinus Foundation; Becket Foundation; Biocentrum Helsinki; Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center (DK46200); British Diabetes Association (1192); British Diabetic Association Research; British Heart Foundation (97020, PG/02/128); Busselton Population Medical Research Foundation; Cambridge NIHR Comprehensive Biomedical Research Centre; CamStrad; Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region de France; Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council; DIAB Core (German Network of Diabetes); Diabetes UK; Donald W.; Reynolds Foundation; Dresden University of Technology Funding Grant, Med Drive; EMGO+ institute; Emil and Vera Cornell Foundation; Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands; Estonian Government SF0180142s08; European Commission (2004310, 212111, 205419, 245536, DG XII, HEALTH-F4-2007-201413, FP7/2007-2013, QLG1-CT-2000-01643, QLG2-CT-2002-01254, LSHG-CT-2006-018947, LSHG-CT-2006-01947, LSHG-CT-2004-512066, LSHM-CT-2007-037273, EU/WLRT-2001-01254, LSHG-CT-2004-518153, SOC 95201408 05F02, Marie Curie Intra-European Fellowship); Federal Ministry of Education and Research, Germany (01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012, 01 EA 9401); Federal State of Mecklenburg-West Pomerania; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Pediatric Research; Finnish Foundation of Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Finnish Ministry of Education; Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional; Fondation LeDucq; Foundation for Life and Health in Finland; GEN-AU 'GOLD' from Austria; German Bundesministerium fuer Forschung und Technology (# 01 AK 803 A-H, # 01 IG 07015 G); German National Genome Research Net NGFN2 and NGFNplus (01GS0823, FKZ 01GS0823); German Research Council (KFO-152); GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Healthway, Western Australia; Helmholtz Center Munich; Helsinki University Central Hospital; Hjartavernd ( the Icelandic Heart Association); Ib Henriksen Foundation; IZKF (B27); Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF); Karolinska Institute and the Stockholm County Council (560183); Knut and Alice Wallenberg Foundation; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care; Knut Krohn, Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (IZKF), University of Leipzig, Germany; Lundberg Foundation; MC Health; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrol Ministry of Health; Ministry of Science, Education and Sport of the Republic of Croatia (216-1080315-0302); Medical Research Council UK (G0000649, G0601261, 9521010D, G0000934, G0500539, G0600331, PrevMetSyn); Montreal Heart Institute Foundation; MRC Centre for Obesity-Related Metabolic Disease; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Health and Medical Research Council of Australia and the Great Wine Estates Auctions; Netherlands Centre for Medical Systems Biology (SPI 56-464-1419); Netherlands Ministry for Health, Welfare and Sports; Netherlands Ministry of Education, Culture and Science; Netherlands Genomics Initiative; Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Organisation of Scientific Research Netherlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Investments (175.010.2005.; 011, 911-03-012, 904-61-090, 904-61-193, 480-04-004, 400-05-717); National Institute on Aging Intramural Research Program; US National Institutes of Health (CA047988, CA65725, CA87969, CA49449, CA67262, CA50385, DK075787, DK062370, DK58845, DK072193, K23-DK080145, K99HL094535, N01-HC85079 through N01-HC85086, N01-HG-65403, N01-AG-12100, N01-HC-25195, N01-HC35129, N01-HC15103, N01-HC55222, N01-HC75150, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC-55018, N01-HC-5019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-AG-1-2109, HL71981, HG005581, HG002651, HL084729, HL043851, HHSN268200625226C, K23-DK080145, MH084698, P30-DK072488, R01-DK075787, R01 HL087652, R01-HL087641, R01-HL59367, R01-HL086694, R01-HL087647, R01-HL087679, R01-HL087700, R01-AG031890, R01-HL088119, R01-DK068336, R01-DK075681, R01-DK-073490, R01-DK075787, R01-MH63706, U01-HL72515, U01-GM074518, U01-HL084756, U01-HG004399, UO1-CA098233, UL1-RR025005, UL1-RR025005, U01-HG004402, U01-DK062418, U01 HL080295, T32-HG00040, 263-MA-410953, 1RL1-MH083268-01, intramural project 1Z01-HG000024); National Institute for Health Research (NIHR); Neuroscience Campus Amsterdam; Novo Nordisk Foundation; Novo Nordisk Inc., Research Foundation of Copenhagen County; Ollqvist Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Pew Scholarship for the Biomedical Sciences; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly (014-93-015, RIDE, RIDE2); Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR, A305:188); Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrolean Sparkasse Foundation; State of Bavaria, Germany; Support for Science Funding programme; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research (SSF); Swedish Heart-Lung Foundation; Swedish Medical Research Council (8691, K2007-66X-20270-01-3, K2010-54X-09894-19-3); Swedish Society of Medicine; Swiss National Science Foundation (33CSCO-122661); the Royal Society; the Royal Swedish Academy of Science; Torsten and Ragnar Soderberg's Foundation; Turku University Hospitals; UK Department of Health Policy Research Programme; University and Research of the Autonomous Province of Bolzano; University Hospital Medical funds to Tampere; University Hospital Oulu, Biocenter, University of Oulu, Finland (75617); Vastra Gotaland Foundation; Wellcome Trust (077016/Z/05/Z, 068545/Z/02, 072960, 076113, 083270, 085301, 079557, 081682, 075491, 076113/B/04/Z, 091746/Z/10/Z, 079895, WT086596/Z/08/Z, WT Research Career Development Fellowship; WT Career Development Award); Western Australian Genetic Epidemiology Resource and the Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities); Yrjo Jahnsson Foundation.	Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Cox DR, 1979, THEORETICAL STAT; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de la Torre NG, 2008, J CLIN ENDOCR METAB, V93, P4276, DOI 10.1210/jc.2007-1370; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lanctot C, 2007, EXP CELL RES, V313, P1449, DOI 10.1016/j.yexcr.2007.01.027; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Rose KM, 1998, OBES RES, V6, P383, DOI 10.1002/j.1550-8528.1998.tb00369.x; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scherzer R, 2008, AM J CLIN NUTR, V87, P1809, DOI 10.1093/ajcn/87.6.1809; SELBY JV, 1990, INT J OBESITY, V14, P593; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Souren NY, 2007, DIABETOLOGIA, V50, P2107, DOI 10.1007/s00125-007-0784-z; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams, 1949, ADJUSTMENT ARMY LIFE; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	61	639	651	5	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					949	U160		10.1038/ng.685			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	WOS:000283540500011	20935629	Green Submitted, Green Accepted, Green Published			2022-01-24	
J	Hutchinson, JN; Ensminger, AW; Clemson, CM; Lynch, CR; Lawrence, JB; Chess, A				Hutchinson, John N.; Ensminger, Alexander W.; Clemson, Christine M.; Lynch, Christopher R.; Lawrence, Jeanne B.; Chess, Andrew			A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains	BMC GENOMICS			English	Article							GENE-EXPRESSION; X-CHROMOSOME; FUNCTIONAL-ORGANIZATION; SC-35 DOMAINS; POLY(A) RNA; MOUSE; REPLICATION; METABOLISM; SPECKLES; REGIONS	Background: Noncoding RNA species play a diverse set of roles in the eukaryotic cell. While much recent attention has focused on smaller RNA species, larger noncoding transcripts are also thought to be highly abundant in mammalian cells. To search for large noncoding RNAs that might control gene expression or mRNA metabolism, we used Affymetrix expression arrays to identify polyadenylated RNA transcripts displaying nuclear enrichment. Results: This screen identified no more than three transcripts; XIST, and two unique noncoding nuclear enriched abundant transcripts ( NEAT) RNAs strikingly located less than 70 kb apart on human chromosome II: NEAT1, a noncoding RNA from the locus encoding for TncRNA, and NEAT2 ( also known as MALAT-1). While the two NEAT transcripts share no significant homology with each other, each is conserved within the mammalian lineage, suggesting significant function for these noncoding RNAs. NEAT2 is extraordinarily well conserved for a noncoding RNA, more so than even XIST. Bioinformatic analyses of publicly available mouse transcriptome data support our findings from human cells as they confirm that the murine homologs of these noncoding RNAs are also nuclear enriched. RNA FISH analyses suggest that these noncoding RNAs function in mRNA metabolism as they demonstrate an intimate association of these RNA species with SC35 nuclear speckles in both human and mouse cells. These studies show that one of these transcripts, NEAT1 localizes to the periphery of such domains, whereas the neighboring transcript, NEAT2, is part of the long- sought polyadenylated component of nuclear speckles. Conclusion: Our genome- wide screens in two mammalian species reveal no more than three abundant large non- coding polyadenylated RNAs in the nucleus; the canonical large noncoding RNA XIST and NEAT1 and NEAT2. The function of these noncoding RNAs in mRNA metabolism is suggested by their high levels of conservation and their intimate association with SC35 splicing domains in multiple mammalian species.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA		Chess, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	jhutchinson@chgr.mgh.harvard.edu; ensminger@chgr.mgh.harvard.edu; Christine.Clemson@umassmed.edu; Christopher.Lynch@umassmed.edu; Jeanne.Lawrence@umassmed.edu; chess@chgr.mgh.harvard.edu	Hutchinson, John/AAA-1976-2020	Hutchinson, John/0000-0002-7804-7576; Ensminger, Alexander/0000-0003-0824-3704	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM068138] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM68138, R01 GM068138] Funding Source: Medline		Ashburner M, 1999, GENETICS, V153, P179; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; CARTER KC, 1993, SCIENCE, V259, P1330, DOI 10.1126/science.8446902; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ensminger AW, 2004, HUM MOL GENET, V13, P651, DOI 10.1093/hmg/ddh062; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Geirsson A, 2003, BIOCHEM BIOPH RES CO, V301, P718, DOI 10.1016/S0006-291X(03)00028-7; Guru SC, 1997, GENOME RES, V7, P725, DOI 10.1101/gr.7.7.725; HALL LL, 2006, ANAT REC A; HERMAN R, 1978, J CELL BIOL, V78, P663, DOI 10.1083/jcb.78.3.663; Hong YK, 2000, MAMM GENOME, V11, P220, DOI 10.1007/s003350010040; Huang S, 1996, J CELL BIOCHEM, V62, P191, DOI 10.1002/(SICI)1097-4644(199608)62:2<191::AID-JCB7>3.0.CO;2-N; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; JOHNSON CV, 1991, GENET ANAL-BIOMOL E, V8, P75, DOI 10.1016/1050-3862(91)90052-S; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; Kelley RL, 2000, CURR OPIN GENET DEV, V10, P555, DOI 10.1016/S0959-437X(00)00127-1; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LAWRENCE JB, 1993, COLD SPRING HARB SYM, V58, P807, DOI 10.1101/SQB.1993.058.01.088; Loebel DAF, 2005, GENOMICS, V85, P782, DOI 10.1016/j.ygeno.2005.02.001; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MOEN PT, 1995, HUM MOL GENET, V4, P1779, DOI 10.1093/hmg/4.suppl_1.1779; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; Morey C, 2004, FEBS LETT, V567, P27, DOI 10.1016/j.febslet.2004.03.117; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Peyman JA, 1999, BIOL REPROD, V60, P23, DOI 10.1095/biolreprod60.1.23; Politz JCR, 2006, MOL BIOL CELL, V17, P1239, DOI 10.1091/mbc.E05-10-0952; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Saha S, 2006, J GEN VIROL, V87, P1991, DOI 10.1099/vir.0.81768-0; Schmidt U, 2006, J CELL BIOL, V172, P373, DOI 10.1083/jcb.200503061; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Tam R., 2002, FISH PRACTICAL APPRO, P93; Wei XY, 1999, J CELL BIOL, V146, P543, DOI 10.1083/jcb.146.3.543; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901	46	639	671	5	51	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 1	2007	8								39	10.1186/1471-2164-8-39			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	137XP	WOS:000244326600002	17270048	Green Published, gold			2022-01-24	
J	Fritsche, LG; Igl, W; Bailey, JNC; Grassmann, F; Sengupta, S; Bragg-Gresham, JL; Burdon, KP; Hebbring, SJ; Wen, C; Gorski, M; Kim, IK; Cho, D; Zack, D; Souied, E; Scholl, HPN; Bala, E; Lee, KE; Hunter, DJ; Sardell, RJ; Mitchell, P; Merriam, JE; Cipriani, V; Hoffman, JD; Schick, T; Lechanteur, YTE; Guymer, RH; Johnson, MP; Jiang, YD; Stanton, CM; Buitendijk, GHS; Zhan, XW; Kwong, AM; Boleda, A; Brooks, M; Gieser, L; Ratnapriya, R; Branham, KE; Foerster, JR; Heckenlively, JR; Othman, MI; Vote, BJ; Liang, HH; Souzeau, E; McAllister, IL; Isaacs, T; Hall, J; Lake, S; Mackey, DA; Constable, IJ; Craig, JE; Kitchner, TE; Yang, ZL; Su, ZG; Luo, HR; Chen, D; Hong, OY; Flagg, K; Lin, D; Mao, GP; Ferreyra, H; Starke, K; von Strachwitz, CN; Wolf, A; Brandl, C; Rudolph, G; Olden, M; Morrison, MA; Morgan, DJ; Schu, M; Ahn, J; Silvestri, G; Tsironi, EE; Park, KH; Farrer, LA; Orlin, A; Brucker, A; Li, MY; Curcio, CA; Mohand-Said, S; Sahel, JM; Audo, I; Benchaboune, M; Cree, AJ; Rennie, CA; Goverdhan, SV; Grunin, M; Hagbi-Levi, S; Campochiaro, P; Katsanis, N; Holz, FG; Blond, F; Blanche, H; Deleuze, JF; Igo, RP; Truitt, B; Peachey, NS; Meuer, SM; Myers, CE; Moore, EL; Klein, R; Hauser, MA; Postel, EA; Courtenay, MD; Schwartz, SG; Kovach, JL; Scott, WK; Liew, G; Tan, AG; Gopinath, B; Merriam, JC; Smith, RT; Khan, JC; Shahid, H; Moore, AT; McGrath, JA; Laux, R; Brantley, MA; Agarwal, A; Ersoy, L; Caramoy, A; Langmann, T; Saksens, NTM; de Jong, EK; Hoyng, CB; Cain, MS; Richardson, AJ; Martin, TM; Blangero, J; Weeks, DE; Dhillon, B; van Duijn, CM; Doheny, KF; Romm, J; Klaver, CCW; Hayward, C; Gorin, MB; Klein, ML; Baird, PN; den Hollander, AI; Fauser, S; Yates, JRW; Allikmets, R; Wang, JJ; Schaumberg, DA; Klein, BEK; Hagstrom, SA; Chowers, I; Lotery, AJ; Leveillard, T; Zhang, K; Brilliant, MH; Hewitt, AW; Swaroop, A; Chew, EY; Pericak-Vance, MA; DeAngelis, M; Stambolian, D; Haines, JL; Iyengar, SK; Weber, BHF; Abecasis, GR; Heid, IM				Fritsche, Lars G.; Igl, Wilmar; Bailey, Jessica N. Cooke; Grassmann, Felix; Sengupta, Sebanti; Bragg-Gresham, Jennifer L.; Burdon, Kathryn P.; Hebbring, Scott J.; Wen, Cindy; Gorski, Mathias; Kim, Ivana K.; Cho, David; Zack, Donald; Souied, Eric; Scholl, Hendrik P. N.; Bala, Elisa; Lee, Kristine E.; Hunter, David J.; Sardell, Rebecca J.; Mitchell, Paul; Merriam, Joanna E.; Cipriani, Valentina; Hoffman, Joshua D.; Schick, Tina; Lechanteur, Yara T. E.; Guymer, Robyn H.; Johnson, Matthew P.; Jiang, Yingda; Stanton, Chloe M.; Buitendijk, Gabrielle H. S.; Zhan, Xiaowei; Kwong, Alan M.; Boleda, Alexis; Brooks, Matthew; Gieser, Linn; Ratnapriya, Rinki; Branham, Kari E.; Foerster, Johanna R.; Heckenlively, John R.; Othman, Mohammad I.; Vote, Brendan J.; Liang, Helena Hai; Souzeau, Emmanuelle; McAllister, Ian L.; Isaacs, Timothy; Hall, Janette; Lake, Stewart; Mackey, David A.; Constable, Ian J.; Craig, Jamie E.; Kitchner, Terrie E.; Yang, Zhenglin; Su, Zhiguang; Luo, Hongrong; Chen, Daniel; Hong Ouyang; Flagg, Ken; Lin, Danni; Mao, Guanping; Ferreyra, Henry; Starke, Klaus; von Strachwitz, Claudia N.; Wolf, Armin; Brandl, Caroline; Rudolph, Guenther; Olden, Matthias; Morrison, Margaux A.; Morgan, Denise J.; Schu, Matthew; Ahn, Jeeyun; Silvestri, Giuliana; Tsironi, Evangelia E.; Park, Kyu Hyung; Farrer, Lindsay A.; Orlin, Anton; Brucker, Alexander; Li, Mingyao; Curcio, Christine A.; Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Benchaboune, Mustapha; Cree, Angela J.; Rennie, Christina A.; Goverdhan, Srinivas V.; Grunin, Michelle; Hagbi-Levi, Shira; Campochiaro, Peter; Katsanis, Nicholas; Holz, Frank G.; Blond, Frederic; Blanche, Helene; Deleuze, Jean-Francois; Igo, Robert P., Jr.; Truitt, Barbara; Peachey, Neal S.; Meuer, Stacy M.; Myers, Chelsea E.; Moore, Emily L.; Klein, Ronald; Hauser, Michael A.; Postel, Eric A.; Courtenay, Monique D.; Schwartz, Stephen G.; Kovach, Jaclyn L.; Scott, William K.; Liew, Gerald; Tan, Ava G.; Gopinath, Bamini; Merriam, John C.; Smith, R. Theodore; Khan, Jane C.; Shahid, Humma; Moore, Anthony T.; McGrath, J. Allie; Laux, Renee; Brantley, Milam A., Jr.; Agarwal, Anita; Ersoy, Lebriz; Caramoy, Albert; Langmann, Thomas; Saksens, Nicole T. M.; de Jong, Eiko K.; Hoyng, Carel B.; Cain, Melinda S.; Richardson, Andrea J.; Martin, Tammy M.; Blangero, John; Weeks, Daniel E.; Dhillon, Bal; van Duijn, Cornelia M.; Doheny, Kimberly F.; Romm, Jane; Klaver, Caroline C. W.; Hayward, Caroline; Gorin, Michael B.; Klein, Michael L.; Baird, Paul N.; den Hollander, Anneke I.; Fauser, Sascha; Yates, John R. W.; Allikmets, Rando; Wang, Jie Jin; Schaumberg, Debra A.; Klein, Barbara E. K.; Hagstrom, Stephanie A.; Chowers, Itay; Lotery, Andrew J.; Leveillard, Thierry; Zhang, Kang; Brilliant, Murray H.; Hewitt, Alex W.; Swaroop, Anand; Chew, Emily Y.; Pericak-Vance, Margaret A.; DeAngelis, Margaret; Stambolian, Dwight; Haines, Jonathan L.; Iyengar, Sudha K.; Weber, Bernhard H. F.; Abecasis, Goncalo R.; Heid, Iris M.			A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants	NATURE GENETICS			English	Article							SEQUENCING IDENTIFIES RARE; BODY-MASS INDEX; HIGH-RISK; SUSCEPTIBILITY LOCI; DISEASE; GENE; MUTATION; BIOLOGY; OSTEOARTHRITIS; METAANALYSIS	Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with limited therapeutic options. Here we report on a study of >12 million variants, including 163,714 directly genotyped, mostly rare, protein-altering variants. Analyzing 16,144 patients and 17,832 controls, we identify 52 independently associated common and rare variants (P < 5 x 10(-8)) distributed across 34 loci. Although wet and dry AMD subtypes exhibit predominantly shared genetics, we identify the first genetic association signal specific to wet AMD, near MMP9 (difference P value = 4.1 x 10(-10)). Very rare coding variants (frequency <0.1 %) in CFH, CFI and TIMP3 suggest causal roles for these genes, as does a splice variant in SLC16A8. Our results support the hypothesis that rare coding variants can pinpoint causal genes within known genetic loci and illustrate that applying the approach systematically to detect new loci requires extremely large sample sizes.	[Fritsche, Lars G.; Sengupta, Sebanti; Bragg-Gresham, Jennifer L.; Zhan, Xiaowei; Kwong, Alan M.; Foerster, Johanna R.; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Igl, Wilmar; Gorski, Mathias; Starke, Klaus; Brandl, Caroline; Olden, Matthias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Bailey, Jessica N. Cooke; Igo, Robert P., Jr.; Truitt, Barbara; Laux, Renee; Haines, Jonathan L.; Iyengar, Sudha K.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Grassmann, Felix; Brandl, Caroline; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Bragg-Gresham, Jennifer L.] Univ Michigan, Dept Internal Med Nephrol, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA; [Burdon, Kathryn P.; Vote, Brendan J.; Mackey, David A.; Hewitt, Alex W.] Univ Tasmania, Menzies Res Inst Tasmania, Sch Med, Hobart, Tas, Australia; [Hebbring, Scott J.; Kitchner, Terrie E.; Brilliant, Murray H.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Wen, Cindy; Chen, Daniel; Lin, Danni; Mao, Guanping] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Wen, Cindy; Luo, Hongrong; Chen, Daniel; Hong Ouyang; Flagg, Ken; Lin, Danni; Mao, Guanping; Ferreyra, Henry; Zhang, Kang] Vet Affairs San Diego Hlth Syst, La Jolla, CA USA; [Kim, Ivana K.] Harvard Univ, Sch Med, Dept Ophthalmol, Retina Serv,Massachusetts Eye & Ear, Boston, MA USA; [Cho, David; Stambolian, Dwight] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zack, Donald; Scholl, Hendrik P. N.; Campochiaro, Peter] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald; Campochiaro, Peter] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD USA; [Zack, Donald] Univ Paris 06, Inst Vis, Paris, France; [Souied, Eric] Univ Paris Est Creteil, Hop Henri Mondor, Hop Intercommunal Creteil, Creteil, France; [Scholl, Hendrik P. N.; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Bala, Elisa; Peachey, Neal S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH USA; [Lee, Kristine E.; Meuer, Stacy M.; Myers, Chelsea E.; Moore, Emily L.; Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Hunter, David J.; Schaumberg, Debra A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sardell, Rebecca J.; Courtenay, Monique D.; Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Mitchell, Paul; Liew, Gerald; Tan, Ava G.; Gopinath, Bamini; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Merriam, Joanna E.; Merriam, John C.; Smith, R. Theodore; Allikmets, Rando] CUNY, Dept Ophthalmol, New York, NY 10021 USA; [Cipriani, Valentina; Sahel, Jose-Main; Moore, Anthony T.; Yates, John R. W.] UCL, Inst Ophthalmol, London, England; [Cipriani, Valentina; Moore, Anthony T.; Yates, John R. W.] Moorfields Eye Hosp, London, England; [Hoffman, Joshua D.; McGrath, J. Allie] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Schick, Tina; Ersoy, Lebriz; Caramoy, Albert; Langmann, Thomas; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Lechanteur, Yara T. E.; Saksens, Nicole T. M.; de Jong, Eiko K.; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Guymer, Robyn H.; Liang, Helena Hai; Mackey, David A.; Cain, Melinda S.; Richardson, Andrea J.; Baird, Paul N.; Hewitt, Alex W.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Johnson, Matthew P.; Blangero, John] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX USA; [Jiang, Yingda; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Stanton, Chloe M.; Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Buitendijk, Gabrielle H. S.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrielle H. S.; van Duijn, Cornelia M.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Zhan, Xiaowei] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Zhan, Xiaowei] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Boleda, Alexis; Brooks, Matthew; Gieser, Linn; Ratnapriya, Rinki; Swaroop, Anand] NEI, N NRL, US Natl Inst Hlth, Bethesda, MD USA; [Branham, Kari E.; Heckenlively, John R.; Othman, Mohammad I.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Souzeau, Emmanuelle; Hall, Janette; Lake, Stewart; Craig, Jamie E.] Flinders Univ S Australia, Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA 5001, Australia; [McAllister, Ian L.; Isaacs, Timothy; Mackey, David A.; Constable, Ian J.; Khan, Jane C.; Hewitt, Alex W.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China; [Su, Zhiguang; Zhang, Kang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610064, Peoples R China; [von Strachwitz, Claudia N.] EyeCte Southwest, Stuttgart, Germany; [Wolf, Armin; Rudolph, Guenther] Univ Munich, Univ Eye Clin, Munich, Germany; [Brandl, Caroline] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Morrison, Margaux A.; Morgan, Denise J.; DeAngelis, Margaret] Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med Biomed Genet, Boston, MA USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Ahn, Jeeyun] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Ophthalmol, Seoul, South Korea; [Silvestri, Giuliana] Queens Univ, Ctr Expt Med, Belfast, Antrim, North Ireland; [Tsironi, Evangelia E.] Univ Thessaly, Sch Med, Dept Ophthalmol, Larisa, Greece; [Park, Kyu Hyung] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea; [Orlin, Anton] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brucker, Alexander] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Li, Mingyao] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Curcio, Christine A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Blond, Frederic; Leveillard, Thierry] INSERM, Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Blond, Frederic; Leveillard, Thierry] Inst Vis, Dept Genet, Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Blond, Frederic; Leveillard, Thierry] CNRS, Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Main; Benchaboune, Mustapha] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Sahel, Jose-Main] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Main] Acad Sci, Inst France, Paris, France; [Audo, Isabelle] Inst Ophthalmol, Dept Mol Genet, London, England; [Cree, Angela J.; Goverdhan, Srinivas V.; Lotery, Andrew J.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Rennie, Christina A.] Univ Hosp Southampton, Southampton, Hants, England; [Grunin, Michelle; Hagbi-Levi, Shira; Chowers, Itay] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC USA; [Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Blanche, Helene; Deleuze, Jean-Francois] Fdn Jean Dausset, CEPH, Paris, France; [Deleuze, Jean-Francois] Commissariat Energie Atom & Energies Alternat CEA, Ctr Natl Genotypage, Inst Genom, Evry, France; [Peachey, Neal S.; Hagstrom, Stephanie A.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Hauser, Michael A.; Postel, Eric A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hauser, Michael A.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC USA; [Schwartz, Stephen G.; Kovach, Jaclyn L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Naples, FL USA; [Smith, R. Theodore] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Khan, Jane C.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA 6001, Australia; [Khan, Jane C.; Shahid, Humma; Yates, John R. W.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Shahid, Humma] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Dept Ophthalmol, Cambridge, England; [Moore, Anthony T.] Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA USA; [Brantley, Milam A., Jr.; Agarwal, Anita] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Martin, Tammy M.; Klein, Michael L.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Dhillon, Bal] Univ Edinburgh, Sch Clin Sci, Edinburgh, Midlothian, Scotland; [Doheny, Kimberly F.; Romm, Jane] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD USA; [Gorin, Michael B.] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90024 USA; [Gorin, Michael B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Schaumberg, Debra A.] Univ Utah, Sch Med, Moran Eye Ctr, Ctr Translat Med, Salt Lake City, UT USA; [Schaumberg, Debra A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Chew, Emily Y.] NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Sch Med, Inst Computat Biol, Cleveland, OH 44106 USA		Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.; Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany.; Iyengar, SK (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	ski@case.edu; goncalo@umich.edu; iris.heid@klinik.uni-regensburg.de	Lechanteur, Yara/ABB-6875-2020; Bailey, Jessica Cooke/Q-5062-2019; lake, stewart/AAH-6265-2021; Stark, Klaus/L-7367-2013; Haines, Jonathan/C-3374-2012; Sahel, Jose-Alain/F-3172-2017; Blangero, John/ABA-7175-2021; Igo, Rob/P-3438-2019; Mitchell, Paul/P-1498-2014; Peachey, Neal/G-5533-2010; Fritsche, Lars G/AAF-9387-2019; Mackey, David A/H-5340-2014; Cipriani, Valentina/A-8549-2012; Gopinath, Bamini/K-4286-2019; Branham, Kari/AAA-8336-2022; Farrer, Lindsay/AAS-1035-2020; Hollander, Anneke den/N-4911-2014; Hewitt, Alex W/D-1936-2013; Klaver, Caroline C.W./A-2013-2016; Grunin, Michelle/O-6044-2019; /S-1190-2019; Allikmets, Rando/ABD-4533-2021; Weeks, Daniel E/B-2995-2012; Zhang, Kang/Y-2740-2019; Wang, Jie Jin/P-1499-2014; Burdon, Kathryn/A-5026-2009; Leveillard, Thierry/AAR-1804-2020; Liew, Gerald/AAB-6870-2022; de Jong, Eiko/P-3407-2015; Souzeau, Emmanuelle/AAB-5608-2022	Lechanteur, Yara/0000-0003-0951-4625; Bailey, Jessica Cooke/0000-0002-4001-8702; lake, stewart/0000-0003-0078-3319; Stark, Klaus/0000-0002-7832-1942; Haines, Jonathan/0000-0002-4351-4728; Sahel, Jose-Alain/0000-0002-4831-1153; Igo, Rob/0000-0002-0024-1993; Fritsche, Lars G/0000-0002-2110-1690; Mackey, David A/0000-0001-7914-4709; Cipriani, Valentina/0000-0002-0839-9955; Gopinath, Bamini/0000-0003-3573-359X; Hewitt, Alex W/0000-0002-5123-5999; Grunin, Michelle/0000-0002-3155-2858; /0000-0001-7488-250X; Weeks, Daniel E/0000-0001-9410-7228; Zhang, Kang/0000-0002-4549-1697; Wang, Jie Jin/0000-0001-9491-4898; Burdon, Kathryn/0000-0001-8217-1249; Leveillard, Thierry/0000-0001-5692-8770; de Jong, Eiko/0000-0001-6520-0407; Souzeau, Emmanuelle/0000-0002-2015-6577; Scott, William/0000-0001-9336-6404; Su, Zhiguang/0000-0001-8635-9310; Klaver, Caroline/0000-0002-2355-5258; Ratnapriya, Rinki/0000-0002-0469-4631; Ahn, Jeeyun/0000-0001-9017-1652; Grassmann, Felix/0000-0003-1390-7528; Lotery, Andrew/0000-0001-5541-4305; Van Duijn, Cornelia/0000-0002-2374-9204; Audo, Isabelle/0000-0003-0698-5309; constable, ian/0000-0002-2140-6478; Farrer, Lindsay/0000-0001-5533-4225; Guymer, Robyn/0000-0002-9441-4356; Tan, Ava Grace/0000-0003-3344-0339; Blangero, John/0000-0001-6250-5723; Schu, Matthew/0000-0003-0630-1026; Craig, Jamie/0000-0001-9955-9696; Hagbi-Levi, Shira/0000-0002-2891-0079; Peachey, Neal/0000-0002-4419-7226; Brandl, Caroline/0000-0001-8223-6137; Cree, Angela/0000-0002-1987-8900; Kim, Ivana/0000-0003-0310-6129; Branham, Kari/0000-0002-2492-254X; Blond, Frederic/0000-0002-2314-0570; Weber, Bernhard H.F./0000-0002-8808-7723; smith, theodore/0000-0002-1693-943X	Center for Inherited Diseases Research (CIDR) Program [HHSN268201200008I];  [1X01HG006934-01];  [R01 EY022310]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_U127561128, G0000067] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_U127561128, G0000067] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10204] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY013435, T32EY023194, ZIAEY000489, P30EY001583, U10EY006594, R01EY022310, ZIAEY000546] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG006389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM080178] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [K22LM011938] Funding Source: NIH RePORTER	We thank all participants of all the studies included for enabling this research by their participation in these studies. Computer resources for this project have been provided by the high-performance computing centers of the University of Michigan and the University of Regensburg. Group-specific acknowledgments can be found in the Supplementary Note. The Center for Inherited Diseases Research (CIDR) Program contract number is HHSN268201200008I. This and the main consortium work were predominantly funded by 1X01HG006934-01 to G.R.A. and R01 EY022310 to J.L.H.	Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Chakravarthy U, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c981; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Fritsche LG, 2012, INVEST OPHTH VIS SCI, V53, P2112, DOI 10.1167/iovs.11-8785; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Hussain AA, 2011, INVEST OPHTH VIS SCI, V52, P4459, DOI 10.1167/iovs.10-6678; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lambert C, 2014, ARTHRITIS RHEUMATOL, V66, P960, DOI 10.1002/art.38315; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Logue MW, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.007; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; SHOSHAN V, 1981, P NATL ACAD SCI-BIOL, V78, P4828, DOI 10.1073/pnas.78.8.4828; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; WEBER BHF, 1994, NAT GENET, V7, P158, DOI 10.1038/ng0694-158; Wen XQ, 2014, BIOMETRICS, V70, P73, DOI 10.1111/biom.12112; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	52	638	645	6	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					134	143		10.1038/ng.3448			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	WOS:000369043900010	26691988	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Gamazon, ER; Wheeler, HE; Shah, KP; Mozaffari, SV; Aquino-Michaels, K; Carroll, RJ; Eyler, AE; Denny, JC; Nicolae, DL; Cox, NJ; Im, HK				Gamazon, Eric R.; Wheeler, Heather E.; Shah, Kaanan P.; Mozaffari, Sahar V.; Aquino-Michaels, Keston; Carroll, Robert J.; Eyler, Anne E.; Denny, Joshua C.; Nicolae, Dan L.; Cox, Nancy J.; Im, Hae Kyung		GTEx Consortium	A gene-based association method for mapping traits using reference transcriptome data	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; ARCHITECTURE; PREDICTION; SELECTION; LOCI; SNPS	Genome-wide association studies (GWAS) have identified thousands of variants robustly associated with complex traits. However, the biological mechanisms underlying these associations are, in general, not well understood. We propose a gene-based association method called PrediXcan that directly tests the molecular mechanisms through which genetic variation affects phenotype. The approach estimates the component of gene expression determined by an individual's genetic profile and correlates 'imputed' gene expression with the phenotype under investigation to identify genes involved in the etiology of the phenotype. Genetically regulated gene expression is estimated using whole-genome tissue-dependent prediction models trained with reference transcriptome data sets. PrediXcan enjoys the benefits of gene-based approaches such as reduced multiple-testing burden and a principled approach to the design of follow-up experiments. Our results demonstrate that PrediXcan can detect known and new genes associated with disease traits and provide insights into the mechanism of these associations.	[Gamazon, Eric R.; Shah, Kaanan P.; Aquino-Michaels, Keston; Nicolae, Dan L.; Cox, Nancy J.; Im, Hae Kyung] Univ Chicago, Dept Med, Sect Genet Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Div Genet Med, Nashville, TN 37235 USA; [Wheeler, Heather E.] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Mozaffari, Sahar V.; Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Carroll, Robert J.; Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Eyler, Anne E.] NorthCrest Med Ctr, Ctr Rheumatol, Springfield, TN USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA		Im, HK (corresponding author), Univ Chicago, Dept Med, Sect Genet Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	haky@uchicago.edu	Gamazon, Eric/I-6873-2018; Wheeler, Heather/I-9279-2019; Denny, Josh/AAL-3359-2021; Little, Roger/O-6191-2014	Gamazon, Eric/0000-0003-4204-8734; Wheeler, Heather/0000-0003-1365-9667; Denny, Josh/0000-0002-3049-7332; Mozaffari, Sahar/0000-0002-8216-1670; Little, Roger/0000-0001-6831-0177; Nicolae, Dan/0000-0002-0918-4630	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 CA139160, T32 MH020065, F32 CA165823, R01 MH101820, R01 MH090937, P30 DK20595, P60 DK20595, P50 DA037844, UO1 GM61393, P50 MH094267, U01 GM092691, U19 HL065962]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009594, K12CA139160, F32CA165823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P60DK020595, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01GM092691, T32GM007197, U01GM061393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH094267, R01MH101820, R01MH107666, T32MH020065, R01MH090937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA037844] Funding Source: NIH RePORTER	We thank A. Konkashbaev and C. Fuchsberger for outstanding technical support and N. Knoblauch for assistance in performing the quality control pipeline. We acknowledge the following US National Institutes of Health grants: K12 CA139160 (H.K.I.), T32 MH020065 (K.P.S.), F32 CA165823 (H.E.W.), R01 MH101820 and R01 MH090937 (GTEx), P30 DK20595 and P60 DK20595 (Diabetes Research and Training Center), P50 DA037844 (Rat Genomics), UO1 GM61393 (Pharmacogenomics of Anticancer Agents Research), P50 MH094267 (Conte), U01 GM092691 (J.C.D.) and U19 HL065962 (PGRN Statistical Analysis Resource). Additional acknowledgments can be found in the Supplementary Note.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gamazon E.R., 2013, CONVERGENCE EQTL MAP; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hart AB, 2014, P NATL ACAD SCI USA, V111, P5968, DOI 10.1073/pnas.1318810111; Hart AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042646; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manor O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003396; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Perera MA, 2011, CLIN PHARMACOL THER, V89, P408, DOI 10.1038/clpt.2010.322; Price A.L, 2014, BIORXIV, DOI [10.1101/004309, DOI 10.1101/004309]; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ritchie MD, 2012, HUM GENET, V131, P1615, DOI 10.1007/s00439-012-1221-z; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Wang HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011789; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheeler HE, 2014, GENET EPIDEMIOL, V38, P402, DOI 10.1002/gepi.21808; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	52	638	643	5	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1091	+		10.1038/ng.3367			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	WOS:000360394100022	26258848	Green Submitted, Green Accepted, Green Published	Y	N	2022-01-24	
J	Dubois, PCA; Trynka, G; Franke, L; Hunt, KA; Romanos, J; Curtotti, A; Zhernakova, A; Heap, GAR; Adany, R; Aromaa, A; Bardella, MT; van den Berg, LH; Bockett, NA; de la Concha, EG; Dema, B; Fehrmann, RSN; Fernandez-Arquero, M; Fiatal, S; Grandone, E; Green, PM; Groen, HJM; Gwilliam, R; Houwen, RHJ; Hunt, SE; Kaukinen, K; Kelleher, D; Korponay-Szabo, I; Kurppa, K; MacMathuna, P; Maki, M; Mazzilli, MC; McCann, OT; Mearin, ML; Mein, CA; Mirza, MM; Mistry, V; Mora, B; Morley, KI; Mulder, CJ; Murray, JA; Nunez, C; Oosterom, E; Ophoff, RA; Polanco, I; Peltonen, L; Platteel, M; Rybak, A; Salomaa, V; Schweizer, JJ; Sperandeo, MP; Tack, GJ; Turner, G; Veldink, JH; Verbeek, WHM; Weersma, RK; Wolters, VM; Urcelay, E; Cukrowska, B; Greco, L; Neuhausen, SL; McManus, R; Barisani, D; Deloukas, P; Barrett, JC; Saavalainen, P; Wijmenga, C; van Heel, DA				Dubois, Patrick C. A.; Trynka, Gosia; Franke, Lude; Hunt, Karen A.; Romanos, Jihane; Curtotti, Alessandra; Zhernakova, Alexandra; Heap, Graham A. R.; Adany, Roza; Aromaa, Arpo; Bardella, Maria Teresa; van den Berg, Leonard H.; Bockett, Nicholas A.; de la Concha, Emilio G.; Dema, Barbara; Fehrmann, Rudolf S. N.; Fernandez-Arquero, Miguel; Fiatal, Szilvia; Grandone, Elvira; Green, Peter M.; Groen, Harry J. M.; Gwilliam, Rhian; Houwen, Roderick H. J.; Hunt, Sarah E.; Kaukinen, Katri; Kelleher, Dermot; Korponay-Szabo, Ilma; Kurppa, Kalle; MacMathuna, Padraic; Maki, Markku; Mazzilli, Maria Cristina; McCann, Owen T.; Mearin, M. Luisa; Mein, Charles A.; Mirza, Muddassar M.; Mistry, Vanisha; Mora, Barbara; Morley, Katherine I.; Mulder, Chris J.; Murray, Joseph A.; Nunez, Concepcion; Oosterom, Elvira; Ophoff, Roel A.; Polanco, Isabel; Peltonen, Leena; Platteel, Mathieu; Rybak, Anna; Salomaa, Veikko; Schweizer, Joachim J.; Sperandeo, Maria Pia; Tack, Greetje J.; Turner, Graham; Veldink, Jan H.; Verbeek, Wieke H. M.; Weersma, Rinse K.; Wolters, Victorien M.; Urcelay, Elena; Cukrowska, Bozena; Greco, Luigi; Neuhausen, Susan L.; McManus, Ross; Barisani, Donatella; Deloukas, Panos; Barrett, Jeffrey C.; Saavalainen, Paivi; Wijmenga, Cisca; van Heel, David A.			Multiple common variants for celiac disease influencing immune gene expression	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; RISK VARIANTS; ALLELES; IMPUTATION; SELECTION; DELETION; THYMUS; CELLS	We performed a second-generation genome-wide association study of 4,533 individuals with celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with P-GWAS < 10(-4) and 18 SNPs from 14 known loci in a further 4,918 cases and 5,684 controls. Variants from 13 new regions reached genome-wide significance (P-combined < 5 x 10(-8)); most contain genes with immune functions (BACH2, CCR4, CD80, CIITA-SOCS1-CLEC16A, ICOSLG and ZMIZ1), with ETS1, RUNX3, THEMIS and TNFRSF14 having key roles in thymic T-cell selection. There was evidence to suggest associations for a further 13 regions. In an expression quantitative trait meta-analysis of 1,469 whole blood samples, 20 of 38 (52.6%) tested loci had celiac risk variants correlated (P < 0.0028, FDR 5%) with cis gene expression.	[Dubois, Patrick C. A.; Franke, Lude; Hunt, Karen A.; Heap, Graham A. R.; Bockett, Nicholas A.; Mistry, Vanisha; van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England; [Trynka, Gosia; Franke, Lude; Romanos, Jihane; Fehrmann, Rudolf S. N.; Oosterom, Elvira; Platteel, Mathieu; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Curtotti, Alessandra; Mein, Charles A.] Queen Mary Univ London, Genome Ctr, Barts & London Sch Med & Dent, London, England; [Zhernakova, Alexandra] Univ Med Ctr Utrecht, Div Biomed Genet, Utrecht, Netherlands; [Adany, Roza; Fiatal, Szilvia] Univ Debrecen, Dept Prevent Med, H-4012 Debrecen, Hungary; [Aromaa, Arpo; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Bardella, Maria Teresa] Osped Maggiore Policlin Mangiagalli & Regina Elen, Fdn IRCCS, Milan, Italy; [Bardella, Maria Teresa] Univ Milan, Dept Med Sci, Milan, Italy; [van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de la Concha, Emilio G.; Dema, Barbara; Fernandez-Arquero, Miguel; Nunez, Concepcion; Urcelay, Elena] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [Fiatal, Szilvia] Univ Debrecen, Publ Hlth Res Grp, Hungarian Acad Sci, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Green, Peter M.; Mirza, Muddassar M.] Kings Coll London, Guys Hosp, NIHR GSTFT KCL Comprehens Biomed Res Ctr, Sch Med, London WC2R 2LS, England; [Groen, Harry J. M.] Univ Med Ctr Groningen, Dept Pulmonol, NL-9713 AV Groningen, Netherlands; [Gwilliam, Rhian; Hunt, Sarah E.; McCann, Owen T.; Morley, Katherine I.; Peltonen, Leena; Deloukas, Panos; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge, England; [Houwen, Roderick H. J.; Wolters, Victorien M.] Univ Med Ctr Utrecht, Dept Paediat Gastroenterol, Utrecht, Netherlands; [Kaukinen, Katri; Kurppa, Kalle; Maki, Markku] Univ Tampere, Paediat Res Ctr, Sch Med, FIN-33101 Tampere, Finland; [Kaukinen, Katri; Kurppa, Kalle; Maki, Markku] Tampere Univ Hosp, Tampere, Finland; [Kelleher, Dermot; Turner, Graham; McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Korponay-Szabo, Ilma] Heim Pal Childrens Hosp, Budapest, Hungary; [Korponay-Szabo, Ilma] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pediat, H-4012 Debrecen, Hungary; [MacMathuna, Padraic] Mater Misericordiae Univ Hosp, Gastrointestinal Unit, Dublin, Ireland; [Mazzilli, Maria Cristina; Mora, Barbara] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Mearin, M. Luisa; Schweizer, Joachim J.] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands; [Mulder, Chris J.; Tack, Greetje J.; Verbeek, Wieke H. M.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Murray, Joseph A.] Mayo Clin, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Polanco, Isabel] Hosp La Paz, Dept Pediat Gastroenterol, Madrid, Spain; [Peltonen, Leena] FIMM, Helsinki, Finland; [Rybak, Anna] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Sperandeo, Maria Pia; Greco, Luigi] Univ Naples Federico II, European Lab Food Induced Dis, Naples, Italy; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Cukrowska, Bozena] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Barisani, Donatella] Univ Milano Bicocca, Fac Med, Dept Expt Med, Monza, Italy; [Saavalainen, Paivi] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Saavalainen, Paivi] Univ Helsinki, Res Program Mol Med, Helsinki, Finland		van Heel, DA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England.	lude@cleverfranke.com; d.vanheel@qmul.ac.uk	Zhernakova, Alexandra/ABA-9372-2020; Deloukas, Panos/B-2922-2013; Grandone, Elvira/M-1127-2019; Nunez, Concepcion/H-8517-2017; Weersma, Rinse/ABE-3807-2021; McManus, Ross/AAE-9236-2020; Groen, Harry/AAP-2242-2021; Franke, Lude/P-7036-2016; Wijmenga, Cisca/D-2173-2009; Fehrmann, Rudolf/E-2551-2011; Saavalainen, Paivi M/E-8621-2011; Morley, Katherine I/A-2986-2011; Romanos, Jihane/F-7372-2012; Wijmenga, Cisca/AAE-7719-2019; Dema, Barbara/AAM-2354-2020	Deloukas, Panos/0000-0001-9251-070X; Grandone, Elvira/0000-0002-8980-9783; Franke, Lude/0000-0002-5159-8802; Fehrmann, Rudolf/0000-0002-7516-315X; Morley, Katherine I/0000-0002-2725-5535; Wijmenga, Cisca/0000-0002-5635-1614; Bockett, Nicholas/0000-0002-7630-7637; Trynka, Gosia/0000-0002-6955-9529; Mein, Charles/0000-0003-0811-9658; Urcelay, Elena/0000-0001-8470-8396; Zhernakova, Alexandra/0000-0002-4574-0841; Cukrowska, Bozena/0000-0001-6887-0094; Nunez, Concepcion/0000-0002-9489-1603; Kurppa, Kalle/0000-0003-4757-2164; Hunt, Sarah/0000-0002-8350-1235; murray, joseph/0000-0003-1941-9090; van Heel, David/0000-0002-0637-2265; Heap, Graham/0000-0003-4131-6792; Barrett, Jeffrey/0000-0002-1152-370X; Groen, Harry J.M./0000-0002-2978-5265; McManus, Ross/0000-0002-0529-9617	Wellcome TrustWellcome TrustEuropean Commission [084743, 085475]; Coeliac Disease Consortium; Dutch Government [BSIK03009]; Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [918.66.620]; Italian Ministry of HealthyMinistry of Health, Italy [RC2009]; Prinses Beatrix Fonds; Adessium foundation; Amyotrophic Lateral Sclerosis Association; Netherlands Genomics Initiative [93519031]; NWO (ZonMW)Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development [916.10.135]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700545]; Royal Netherlands Academy of Arts and Sciences; COPACETIC (EU)European Commission [201379]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF)Juvenile Diabetes Research Foundation; Department of Health via the National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK050678, DK081645, NS058980, DK57892, DK071003]; EU CommissionEuropean CommissionEuropean Commission Joint Research Centre [MEXT-CT-2005-025270]; Academy of FinlandAcademy of FinlandEuropean Commission [OTKA 61868]; University of Helsinki Funds; Tampere University Hospital; Foundation of Pediatric Research; Sigrid Juselius FoundationSigrid Juselius Foundation; Hungarian Academy of SciencesHungarian Academy of Sciences [2006TKI247]; UMC Cooperation [6/06/2006/NDON]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [CP08/0213]; Irish Health Research Board;  [U01 DK062418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK071003, R56DK071003, R01DK081645, U01DK062418, R01DK057892, R01DK050678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058980] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700545] Funding Source: researchfish	We thank Coeliac UK for assistance with direct recruitment of individuals with celiac disease, and UK clinicians (L. C. Dinesen, G. K. T. Holmes, P. D. Howdle, J.R.F. Walters, D. S. Sanders, J. Swift, R. Crimmins, P. Kumar, D. P. Jewell, S. P. L. Travis and K. Moriarty) who recruited the celiac disease blood samples described in our previous studies<SUP>1,22</SUP>. We thank the genotyping facility of the UMCG (J. Smolonska and P. van der Vlies) for generating part of the GWAS and replication data and the gene expression data; R. Booij and M. Weenstra for preparation of Italian samples; H. Ahola, A. Heimonen, L. Koskinen, E. Einarsdottir and K. Loytynoja for their work on Finnish sample collection, preparation and data handling; and E. Szathmari, J.B. Kovacs, M. Lorincz and A. Nagy for their work with the Hungarian families. The Health2000 organization, Finrisk consortium, K. Mustalahti, M. Perola, K. Kristiansson and J. Koskinen are thanked for providing the Finnish control genotypes. We thank D. G. Clayton and N. Walker for providing T1DGC data in the required format. We thank the Irish Transfusion Service and Trinity College Dublin Biobank for control samples and V. Trimble, E. Close, G. Lawlor, A. Ryan, M. Abuzakouk, C. O'Morain and G. Horgan for celiac disease sample collection and preparation We acknowledge DNA provided by Mayo Clinic Rochester and thank M. Bonamico and M. Barbato (Department of Paediatrics, Sapienza University of Rome, Italy) for recruiting individuals. We thank Polish clinicians for recruitment of individuals with celiac disease (Z. Domagala, A. Szaflarska-Poplawska, B. Oralewska, W. Cichy, B. Korczowski, K. Fryderek, E. Hapyn, K. Karczewska, A. Zalewska, I. Sakowska-Maliszewska, R. Mozrzymas, A. Zabka, M. Kolasa and B. Iwanczak). We thank M. Szperl for isolating DNA from blood samples provided by the Children's Memorial Health Institute (Warsaw, Poland). Dutch and UK genotyping for the second celiac disease GWAS was funded by the Wellcome Trust (084743 to D. A. v. H.). Italian genotyping for the second celiac disease GWAS was funded by the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009 to C. W.) and by the Netherlands Organisation for Scientific Research (NWO, VICI grant 918.66.620 to C. W.). E. G. is funded by the Italian Ministry of Healthy (grant RC2009). L.H.v.d.B. acknowledges funding from the Prinses Beatrix Fonds, the Adessium foundation and the Amyotrophic Lateral Sclerosis Association. L. F. received a Horizon Breakthrough grant from the Netherlands Genomics Initiative (93519031) and a VENI grant from NWO (ZonMW grant 916.10.135). P. C. A. D. is an MRC Clinical Training Fellow (G0700545). G. T. received a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences (KNAW). The gene expression study was funded in part by COPACETIC (EU grant 201379). This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2 (WTCCC2). A full list of the WTCCC2 investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the WTCCC2 project was provided by the Wellcome Trust under award 085475.; This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Istitute of Child Health and Human Development (NICHD) and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. We acknowledge the use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We acknowledge funding from the NIH: DK050678 and DK081645 (to S. L. N.), NS058980 (to R.A.O.); and DK57892 and DK071003 (to J. A. M.). The collection of Finnish and Hungarian subjects with celiac disease was funded by the EU Commission (MEXT-CT-2005-025270), the Academy of Finland, Hungarian Scientific Research Fund (contract OTKA 61868), the University of Helsinki Funds, the Competitive Research Funding of the Tampere University Hospital, the Foundation of Pediatric Research, the Sigrid Juselius Foundation and the Hungarian Academy of Sciences (2006TKI247 to R. A.). Funding for the collection and genotyping of the Polish samples was provided by UMC Cooperation Project (6/06/2006/NDON). R. M. is funded by Science Foundation Ireland. C. Nunez has a FIS contract (CP08/0213). The Dublin Centre for Clinical Research contributed to collection of samples from affected individuals and is funded by the Irish Health Research Board and the Wellcome Trust. Finally, we thank all individuals with celiac disease and control individuals for participating in this study.	Allen PM, 2009, NAT IMMUNOL, V10, P805, DOI 10.1038/ni0809-805; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Franke L, 2008, AM J HUM GENET, V82, P1316, DOI 10.1016/j.ajhg.2008.05.008; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wang J, 2003, J IMMUNOL, V170, P3986, DOI 10.4049/jimmunol.170.8.3986; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	46	638	648	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					295	U42		10.1038/ng.543			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	WOS:000276150500008	20190752	Green Submitted, Green Accepted			2022-01-24	
J	Frokjaer-Jensen, C; Davis, MW; Hopkins, CE; Newman, BJ; Thummel, JM; Olesen, SP; Grunnet, M; Jorgensen, EM				Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Olesen, Soren-Peter; Grunnet, Morten; Jorgensen, Erik M.			Single-copy insertion of transgenes in Caenorhabditis elegans	NATURE GENETICS			English	Article							INDUCED GAP REPAIR; GENE CONVERSION; C-ELEGANS; DNA TRANSFORMATION; EXPRESSION; PROTEIN; GENOME; DROSOPHILA; TRANSPOSON; SEQUENCES	At present, transgenes in Caenorhabditis elegans are generated by injecting DNA into the germline. The DNA assembles into a semistable extrachromosomal array composed of many copies of injected DNA. These transgenes are typically overexpressed in somatic cells and silenced in the germline. We have developed a method that inserts a single copy of a transgene into a defined site. Mobilization of a Mos1 transposon generates a double-strand break in noncoding DNA. The break is repaired by copying DNA from an extrachromosomal template into the chromosomal site. Homozygous single-copy insertions can be obtained in less than 2 weeks by injecting approximately 20 worms. We have successfully inserted transgenes as long as 9 kb and verified that single copies are inserted at the targeted site. Single-copy transgenes are expressed at endogenous levels and can be expressed in the female and male germlines.	[Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Olesen, Soren-Peter; Grunnet, Morten] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-2200 Copenhagen N, Denmark; [Grunnet, Morten] NeuroSearch AS, DK-2750 Ballerup, Denmark		Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu	Frokjar-Jensen, Christian/ABB-4637-2020; Olesen, Soren P/H-4206-2011; Olesen, Soren-Peter/B-9621-2012	Olesen, Soren P/0000-0002-4381-5192; Davis, Mikel/0000-0003-1867-1593; Frokjaer-Jensen, Christian/0000-0002-3178-0906; Hopkins, Chris/0000-0002-6981-6329	Fonden af 17.12.1981; Lundbeck FoundationLundbeckfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS034307] Funding Source: NIH RePORTER	We thank L. Segalat and the NemaGENETAG consortium for generating and supplying Mos1 insertion alleles; L. Salkoff for twk-18 cDNA clones; G. Seydoux for promoter plasmids; J. Rand for UNC-18 antibodies; C. Thacker at the Utah worm core facility for generating biolistic transformants; G. Stanfield for help in confirming sperm expression; J.-L. Bessereau and V. Robert for sharing unpublished data; and M. Ailion, G. Hollopeter and the rest of the Jorgensen laboratory for scientific input. E. M. J. is an Investigator of the Howard Hughes Medical Institute. S.-P.O. is an Investigator of the Danish National Research Foundation. C.F.-J. was funded by fellowships from Fonden af 17.12.1981 and the Lundbeck Foundation.	Barrett PL, 2004, NAT GENET, V36, P1231, DOI 10.1038/ng1459; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Duverger Y, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1046; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kelly WG, 1997, GENETICS, V146, P227; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; MADURO M, 1995, GENETICS, V141, P977; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; PLASTERK RHA, 1992, EMBO J, V11, P287, DOI 10.1002/j.1460-2075.1992.tb05051.x; Praitis V, 2001, GENETICS, V157, P1217; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robert VJ, 2008, GENETICS, V180, P673, DOI 10.1534/genetics.108.089698; Sha K, 2005, GENETICS, V170, P1633, DOI 10.1534/genetics.104.040303; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a	26	638	647	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1375	1383		10.1038/ng.248			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	WOS:000260501500034	18953339	Green Accepted			2022-01-24	
J	Lee, W; Tillo, D; Bray, N; Morse, RH; Davis, RW; Hughes, TR; Nislow, C				Lee, William; Tillo, Desiree; Bray, Nicolas; Morse, Randall H.; Davis, Ronald W.; Hughes, Timothy R.; Nislow, Corey			A high- resolution atlas of nucleosome occupancy in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC GENOME; RNA-POLYMERASE; BUDDING YEAST; Z-DNA; CHROMATIN; TRANSCRIPTION; BINDING; PROMOTER	We present the first complete high-resolution map of nucleosome occupancy across the whole Saccharomyces cerevisiae genome, identifying over 70,000 positioned nucleosomes occupying 81% of the genome. On a genome-wide scale, the persistent nucleosome-depleted region identified previously in a subset of genes demarcates the transcription start site. Both nucleosome occupancy signatures and overall occupancy correlate with transcript abundance and transcription rate. In addition, functionally related genes can be clustered on the basis of the nucleosome occupancy patterns observed at their promoters. A quantitative model of nucleosome occupancy indicates that DNA structural features may account for much of the global nucleosome occupancy.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Genome Technol, Palo Alto, CA 94304 USA; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Banting & Best Dept Med Res, Toronto, ON M5S 1L6, Canada		Nislow, C (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	corey.nislow@utoronto.ca		Morse, Randall/0000-0003-0000-8718; Nislow, Corey/0000-0002-4016-8874; Lee, William/0000-0001-9582-4413			Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Champ PC, 2004, NUCLEIC ACIDS RES, V32, P6501, DOI 10.1093/nar/gkh988; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; LOHR D, 1995, J BIOL CHEM, V270, P27671, DOI 10.1074/jbc.270.46.27671; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Ponomarenko JV, 1999, BIOINFORMATICS, V15, P654, DOI 10.1093/bioinformatics/15.7.654; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Sivolob A, 2000, J MOL BIOL, V295, P55, DOI 10.1006/jmbi.1999.3302; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wong B, 2007, P NATL ACAD SCI USA, V104, P2229, DOI 10.1073/pnas.0611447104; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	49	638	653	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1235	1244		10.1038/ng2117			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	WOS:000249737400019	17873876				2022-01-24	
J	Liu, PT; Wakamiya, M; Shea, MJ; Albrecht, U; Behringer, RR; Bradley, A				Liu, PT; Wakamiya, M; Shea, MJ; Albrecht, U; Behringer, RR; Bradley, A			Requirement for Wnt3 in vertebrate axis formation	NATURE GENETICS			English	Article							ANTERIOR PRIMITIVE ENDODERM; EMBRYONIC AXIS; MOUSE EMBRYO; EXPRESSION; XENOPUS; GENES; NEUROECTODERM	Several studies have implicated Wnt signalling in primary axis formation during vertebrate embryogenesis, yet no Wnt protein has been shown to be essential for this process(1-3), In the mouse, primitive streak formation is the first overt morphological sign of the anterior-posterior axis, Here we show that Wnt3 is expressed before gastrulation in the proximal epiblast of the egg cylinder, then is restricted to the posterior proximal epiblast and its associated visceral endoderm and subsequently to the primitive streak and mesoderm, Wnt3(-/-) mice develop a normal egg cylinder but do not form a primitive streak, mesoderm or The epiblast continues to proliferate in an undifferentiated state that lacks anterior-posterior neural patterning, but anterior visceral endoderm markers are expressed and correctly positioned. Our results suggest that regional patterning of the visceral endoderm is independent of primitive streak formation, but the subsequent establishment of anterior-posterior neural pattern in the ectoderm is dependent on derivatives of the primitive streak. These studies provide genetic proof for the requirement of Wnt3 in primary axis formation in the mouse.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA		Behringer, RR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.		Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Bradley, Allan/0000-0002-2349-8839			ANG SL, 1993, DEVELOPMENT, V118, P139; ANG SL, 1994, DEVELOPMENT, V120, P2979; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; KRAUSS S, 1992, DEVELOPMENT, V116, P249; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu PT, 1998, GENETICS, V150, P1155; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.0.CO;2-I; PARR BA, 1993, DEVELOPMENT, V119, P247; Popperl H, 1997, DEVELOPMENT, V124, P2997; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; ROELINK H, 1993, GENOMICS, V17, P790, DOI 10.1006/geno.1993.1412; ROELINK H, 1990, P NATL ACAD SCI USA, V87, P4519, DOI 10.1073/pnas.87.12.4519; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; TAM PPL, IN PRESS CURR TOPICS; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949; ZHENG Z, 1997, CELL, V90, P181; [No title captured]	27	638	652	2	34	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1999	22	4					361	365		10.1038/11932			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	WOS:000081772500018	10431240				2022-01-24	
J	Simon, DB; Karet, FE; RodriguezSoriano, J; Hamdan, JH; DiPietro, A; Trachtman, H; Sanjad, SA; Lifton, RP				Simon, DB; Karet, FE; RodriguezSoriano, J; Hamdan, JH; DiPietro, A; Trachtman, H; Sanjad, SA; Lifton, RP			Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK	NATURE GENETICS			English	Article							RENAL POTASSIUM CHANNELS; DNA; CLONING	Mutations in the Na-K-2Cl cotransporter (NKCC2), a mediator of renal salt reabsorption, cause Bartter's syndrome, featuring salt wasting, hypokalaemic alkalosis, hypercalciuria and low blood pressure. NKCC2 mutations can be excluded in some Bartter's kindreds, prompting examination of regulators of cotransporter activity. One regulator is believed to be ROMK, an ATP-sensitive K+ channel that 'recycles' reabsorbed K+ back to the tubule lumen, Examination of the ROMK gene reveals mutations that co-segregate with the disease and disrupt ROMK function in four Bartter's kindreds. Our findings establish the genetic heterogeneity of Bartter's syndrome, and demonstrate the physiologic role of ROMK in vivo.	YALE UNIV, SCH MED,BOYER CTR MOL MED,HOWARD HUGHES MED INST, DEPT MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED,BOYER CTR MOL MED,HOWARD HUGHES MED INST, DEPT GENET, NEW HAVEN, CT 06510 USA; HOSP CRUCES, DEPT PEDIAT, E-48903 BARACALDO, SPAIN; DHARAN HLTH CTR, SPECIALTY PEDIAT SERV DIV, DHAHRAN 31311, SAUDI ARABIA; SCHNEIDER CHILDRENS HOSP, ALBERT EINSTEIN COLL MED, DEPT PEDIAT, I-80131 NAPLES, ITALY; KING FAISAL SPECIALIST HOSP & RES CTR, DEPT PEDIAT, RIYADH 11211, SAUDI ARABIA					Karet, Fiona/0000-0002-2457-2869			BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; GIEBISCH G, 1995, KIDNEY INT, V48, P1004, DOI 10.1038/ki.1995.382; HEBERT SC, 1995, KIDNEY INT, V48, P1010, DOI 10.1038/ki.1995.383; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE WS, 1995, AM J PHYSIOL-RENAL, V268, pF1124, DOI 10.1152/ajprenal.1995.268.6.F1124; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SHUCK ME, 1994, J BIOL CHEM, V269, P24261; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; WANG WH, 1992, ANNU REV PHYSIOL, V54, P81; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; YANO H, 1994, MOL PHARMACOL, V45, P854	16	638	650	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1996	14	2					152	156		10.1038/ng1096-152			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	WOS:A1996VL44600018	8841184				2022-01-24	
J	De Fusco, M; Marconi, R; Silvestri, L; Atorino, L; Rampoldi, L; Morgante, L; Ballabio, A; Aridon, P; Casari, G				De Fusco, M; Marconi, R; Silvestri, L; Atorino, L; Rampoldi, L; Morgante, L; Ballabio, A; Aridon, P; Casari, G			Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha 2 subunit associated with familial hemiplegic migraine type 2	NATURE GENETICS			English	Article							EXTRACELLULAR DOMAIN; NA,K-ATPASE; AURA; POPULATION; LOCUS	Headache attacks and autonomic dysfunctions characterize migraine, a very common, disabling disorder with a prevalence of 12% in the general population of Western countries(1,2). About 20% of individuals affected with migraine experience aura, a visual or sensory-motor neurological dysfunction that usually precedes or accompanies the headache(3). Although the mode of transmission is controversial(4), population-based and twin studies have implicated genetic factors, especially in migraine with aura(5,6). Familial hemiplegic migraine is a hereditary form of migraine characterized by aura and some hemiparesis. Here we show that mutations in the gene ATP1A2 that encodes the alpha2 subunit of the Na+/K+ pump are associated with familial hemiplegic migraine type 2 (FHM2) linked to chromosome 1q23 (OMIM 602481). Functional data indicate that the putative pathogenetic mechanism is triggered by a loss of function of a single allele of ATP1A2. This is the first report associating mutations of Na+K+ pump subunits to genetic diseases.	San Raffaele Sci Inst, Human Mol Genet Unit, I-20132 Milan, Italy; Misericordia Hosp, Dept Neurol, Grosseto, Italy; Univ Messina, Dept Neurosci, Messina, Italy; Univ Naples 2, Fac Med, Naples, Italy; Univ Naples 2, Telethon Inst Genet & Med, Naples, Italy; Univ Palermo, Inst Neuropsychiat, Palermo, Italy		Casari, G (corresponding author), San Raffaele Sci Inst, Human Mol Genet Unit, Via Olgettina 58, I-20132 Milan, Italy.		BALLABIO, Andrea/AAL-2672-2020; De Fusco, Maurizio/AAN-7358-2020; Rampoldi, Luca/AAN-6228-2020; Casari, Giorgio/J-3070-2018; Rampoldi, Luca/L-3639-2018; Silvestri, Laura/A-1417-2015	BALLABIO, Andrea/0000-0003-1381-4604; Rampoldi, Luca/0000-0002-0544-7042; Casari, Giorgio/0000-0002-0115-8980; Rampoldi, Luca/0000-0002-0544-7042; Silvestri, Laura/0000-0002-8726-9808; Aridon, Paolo/0000-0002-7424-9533	TelethonFondazione Telethon [TGM06S01, F.1, TGM03S01] Funding Source: Medline		Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; BLAU JN, 1955, LANCET, V2, P1115; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; FITZSIMONS RB, 1985, BRAIN, V108, pS55; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEMAS MV, 1994, J BIOL CHEM, V269, P825; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; MARCONI R, IN PRESS ANN NEUROL; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; PRICE EM, 1990, J BIOL CHEM, V265, P6638; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x; Russell MB, 2002, HEADACHE, V42, P332, DOI 10.1046/j.1526-4610.2002.02102.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1	26	637	657	1	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					192	196		10.1038/ng1081			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	WOS:000180773700019	12539047				2022-01-24	
J	Testa, JR; Cheung, M; Pei, JM; Below, JE; Tan, YF; Sementino, E; Cox, NJ; Dogan, AU; Pass, HI; Trusa, S; Hesdorffer, M; Nasu, M; Powers, A; Rivera, Z; Comertpay, S; Tanji, M; Gaudino, G; Yang, HN; Carbone, M				Testa, Joseph R.; Cheung, Mitchell; Pei, Jianming; Below, Jennifer E.; Tan, Yinfei; Sementino, Eleonora; Cox, Nancy J.; Dogan, A. Umran; Pass, Harvey I.; Trusa, Sandra; Hesdorffer, Mary; Nasu, Masaki; Powers, Amy; Rivera, Zeyana; Comertpay, Sabahattin; Tanji, Mika; Gaudino, Giovanni; Yang, Haining; Carbone, Michele			Germline BAP1 mutations predispose to malignant mesothelioma	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; PLEURAL MESOTHELIOMA; ASBESTOS; CHROMOSOME-3; ASSOCIATION	Because only a small fraction of asbestos-exposed individuals develop malignant mesothelioma(1), and because mesothelioma clustering is observed in some families, we searched for genetic predisposing factors. We discovered germline mutations in the gene encoding BRCA1 associated protein-1 (BAP1) in two families with a high incidence of mesothelioma, and we observed somatic alterations affecting BAP1 in familial mesotheliomas, indicating biallelic inactivation. In addition to mesothelioma, some BAP1 mutation carriers developed uveal melanoma. We also found germline BAP1 mutations in 2 of 26 sporadic mesotheliomas; both individuals with mutant BAP1 were previously diagnosed with uveal melanoma. We also observed somatic truncating BAP1 mutations and aberrant BAP1 expression in sporadic mesotheliomas without germline mutations. These results identify a BAP1-related cancer syndrome that is characterized by mesothelioma and uveal melanoma. We hypothesize that other cancers may also be involved and that mesothelioma predominates upon asbestos exposure. These findings will help to identify individuals at high risk of mesothelioma who could be targeted for early intervention.	[Testa, Joseph R.; Cheung, Mitchell; Pei, Jianming; Tan, Yinfei; Sementino, Eleonora] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Below, Jennifer E.; Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dogan, A. Umran] King Fahd Univ Petr & Minerals, Dept Earth Sci, Dhahran 31261, Saudi Arabia; [Dogan, A. Umran] Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA; [Pass, Harvey I.; Trusa, Sandra] NYU, Langone Med Ctr, New York, NY USA; [Pass, Harvey I.; Trusa, Sandra] NYU, Ctr Canc, New York, NY USA; [Hesdorffer, Mary] Mesothelioma Appl Res Fdn, Alexandria, VA USA; [Nasu, Masaki; Powers, Amy; Rivera, Zeyana; Comertpay, Sabahattin; Tanji, Mika; Gaudino, Giovanni; Yang, Haining; Carbone, Michele] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Honolulu, HI 96822 USA; [Nasu, Masaki; Rivera, Zeyana; Comertpay, Sabahattin; Tanji, Mika] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Yang, Haining] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pathol, Honolulu, HI 96822 USA		Testa, JR (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	joseph.testa@fccc.edu; mcarbone@cc.hawaii.edu	Ferris, Laura/I-7689-2012; Below, Jennifer E/W-2179-2018; Comertpay, Sabahattin/AAG-4506-2019; Dogan, Ahmet/B-4087-2010	Below, Jennifer E/0000-0002-1346-1872; Comertpay, Sabahattin/0000-0003-4850-6927; Below, Jennifer/0000-0002-6372-6402; Pass, Harvey/0000-0003-3222-3471	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01CA-114047, P30CA-06927, P30CA-71789]; AACR; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006927, P30CA071789, P01CA114047] Funding Source: NIH RePORTER	We are grateful to the affected individuals and their families for their participation in this study. We thank M. Bianchi, C. Menges, I. Pagano, J.D. Rowley and D. C. Ward for advice and review of the manuscript. We also thank J. Talarchek and R. Harrington for technical assistance, K. Aquino-Michaels for assisting in the collection of samples and clinical information, S. C. Jhanwar for providing some of the mesothelioma cell lines, A. Vachani for blood and tissue samples from one member of the L family and B. Luo for providing exome sequence data. This work was supported by US National Institutes of Health (NIH) grants P01CA-114047, P30CA-06927 and P30CA-71789, by the AACR-Landon Award for International Collaboration in Cancer Research to M. Carbone, N.J.C., H. I. P., J. R. T., M. T. and H.Y., and by the Local No. 14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Allied Workers to J.R.T.	ALBERT DM, 2011, CANC PRINCIPLES PRAC, V1, P2090; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; Burki T, 2010, LANCET, V375, P626, DOI 10.1016/S0140-6736(10)60251-6; Carbone M, 2007, NAT REV CANCER, V7, P147, DOI 10.1038/nrc2068; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Carbone M, 2011, P NATL ACAD SCI USA, V108, P13618, DOI 10.1073/pnas.1105887108; Cheung M, 2010, ONCOGENE, V29, P1633, DOI 10.1038/onc.2009.455; DAS S, 1994, AM J HUM GENET, V55, P883; FLEJTER WL, 1989, GENE CHROMOSOME CANC, V1, P148, DOI 10.1002/gcc.2870010207; Flores RM, 2008, J THORAC CARDIOV SUR, V135, P620, DOI 10.1016/j.jtcvs.2007.10.054; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldberg M, 2006, OCCUP ENVIRON MED, V63, P390, DOI 10.1136/oem.2005.023200; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Houlston RS, 1999, EYE, V13, P43, DOI 10.1038/eye.1999.9; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LU YY, 1994, GENE CHROMOSOME CANC, V9, P76, DOI 10.1002/gcc.2870090114; Makinen VP, 2005, EUR J HUM GENET, V13, P987, DOI 10.1038/sj.ejhg.5201430; Moolgavkar SH, 2009, CANCER CAUSE CONTROL, V20, P935, DOI 10.1007/s10552-009-9328-9; Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H; Pan XL, 2005, AM J RESP CRIT CARE, V172, P1019, DOI 10.1164/rccm.200412-1731OC; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tweedale G, 2002, NAT REV CANCER, V2, P311, DOI 10.1038/nrc774; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107	31	636	644	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					1022	U140		10.1038/ng.912			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	WOS:000295316200020	21874000	Green Accepted	Y	N	2022-01-24	
J	Filichkin, SA; Priest, HD; Givan, SA; Shen, RK; Bryant, DW; Fox, SE; Wong, WK; Mockler, TC				Filichkin, Sergei A.; Priest, Henry D.; Givan, Scott A.; Shen, Rongkun; Bryant, Douglas W.; Fox, Samuel E.; Wong, Weng-Keen; Mockler, Todd C.			Genome-wide mapping of alternative splicing in Arabidopsis thaliana	GENOME RESEARCH			English	Article							MESSENGER-RNA DECAY; PLANT SR PROTEINS; HUMAN TRANSCRIPTOME; GENE-EXPRESSION; SEQUENCE; ANNOTATION; COMPLEXITY; RICE; NMD; IDENTIFICATION	Alternative splicing can enhance transcriptome plasticity and proteome diversity. In plants, alternative splicing can be manifested at different developmental stages, and is frequently associated with specific tissue types or environmental conditions such as abiotic stress. We mapped the Arabidopsis transcriptome at single-base resolution using the Illumina platform for ultrahigh-throughput RNA sequencing (RNA-seq). Deep transcriptome sequencing confirmed a majority of annotated introns and identified thousands of novel alternatively spliced mRNA isoforms. Our analysis suggests that at least similar to 42% of intron-containing genes in Arabidopsis are alternatively spliced; this is significantly higher than previous estimates based on cDNA/expressed sequence tag sequencing. Random validation confirmed that novel splice isoforms empirically predicted by RNA-seq can be detected in vivo. Novel introns detected by RNA-seq were substantially enriched in non-consensus terminal dinucleotide splice signals. Alternative isoforms with premature termination codons (PTCs) comprised the majority of alternatively spliced transcripts. Using an example of an essential circadian clock gene, we show that intron retention can generate relatively abundant PTC+ isoforms and that this specific event is highly conserved among diverse plant species. Alternatively spliced PTC+ isoforms can be potentially targeted for degradation by the nonsense mediated mRNA decay (NMD) surveillance machinery or regulate the level of functional transcripts by the mechanism of regulated unproductive splicing and translation (RUST). We demonstrate that the relative ratios of the PTC+ and reference isoforms for several key regulatory genes can be considerably shifted under abiotic stress treatments. Taken together, our results suggest that like in animals, NMD and RUST may be widespread in plants and may play important roles in regulating gene expression.	[Filichkin, Sergei A.; Priest, Henry D.; Givan, Scott A.; Shen, Rongkun; Bryant, Douglas W.; Fox, Samuel E.; Mockler, Todd C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Filichkin, Sergei A.; Priest, Henry D.; Givan, Scott A.; Shen, Rongkun; Bryant, Douglas W.; Fox, Samuel E.; Mockler, Todd C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Bryant, Douglas W.; Wong, Weng-Keen] Oregon State Univ, Dept Elect Engn & Comp Sci, Corvallis, OR 97331 USA		Mockler, TC (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	tmockler@cgrb.oregonstate.edu	Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Givan, Scott/0000-0002-0630-8589	Oregon State University; NSFNational Science Foundation (NSF) [DBI 0605240]; USDA NRIUnited States Department of Agriculture (USDA) [2008-01077]	We thank Mark Dasenko for assistance with Illumina sequencing, Anne Marie Dougherty, Jennifer Long, and Kate Peremyslova for assistance with RNA preparation, and Chris Sullivan and Steve Drake for computational support. This work was funded by Oregon State University startup funds to T. C. M., and partially supported by NSF Plant Genome Grant DBI 0605240 to T. C. M. and USDA NRI Grant 2008-01077 to T. C. M. and S. A. F. H. D. P. was supported by a Computational and Genome Biology Initiative Fellowship from Oregon State University.	Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Ali GS, 2006, J CELL SCI, V119, P3527, DOI 10.1242/jcs.03144; Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barta A, 2008, CURR TOP MICROBIOL, V326, P83; Black DL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-317; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen FC, 2007, PLANT PHYSIOL, V143, P1086, DOI 10.1104/pp.106.092460; Chen WH, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-55; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Churbanov A, 2008, BIOL DIRECT, V3, P1, DOI 10.1186/1745-6150-3-30; Copenhaver GP, 2003, CHROMOSOME RES, V11, P255, DOI 10.1023/A:1022887926807; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Farrer T, 2002, NUCLEIC ACIDS RES, V30, P3360, DOI 10.1093/nar/gkf465; Filichkin SA, 2007, PLANT BIOTECHNOL J, V5, P615, DOI 10.1111/j.1467-7652.2007.00267.x; Fox S, 2009, METHODS MOL BIOL, V553, P79, DOI 10.1007/978-1-60327-563-7_5; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Isshiki M, 2006, PLANT CELL, V18, P146, DOI 10.1105/tpc.105.037069; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kalyna M, 2003, MOL BIOL CELL, V14, P3565, DOI 10.1091/mbc.E03-02-0109; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kotani H, 1999, DNA Res, V6, P381, DOI 10.1093/dnares/6.6.381; Kumekawa N, 2001, DNA RES, V8, P285, DOI 10.1093/dnares/8.6.285; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ner-Gaon H, 2007, PLANT PHYSIOL, V144, P1632, DOI 10.1104/pp.107.098640; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; R Development Core Team, 2008, R LANG ENV STAT COMP; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sambrook J., 1989, MOL CLONING LAB MANU; Schoning JC, 2007, PLANT J, V52, P1119, DOI 10.1111/j.1365-313X.2007.03302.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Soller M, 2006, CELL MOL LIFE SCI, V63, P796, DOI 10.1007/s00018-005-5391-x; Song HR, 2009, PLANT CELL, V21, P1195, DOI 10.1105/tpc.108.064774; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Tanabe N, 2007, PLANT CELL PHYSIOL, V48, P1036, DOI 10.1093/pcp/pcm069; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Zhu W, 2003, PLANT PHYSIOL, V132, P469, DOI 10.1104/pp.102.018101; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	75	636	675	7	141	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2010	20	1					45	58		10.1101/gr.093302.109			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	539JF	WOS:000273249500006	19858364	Bronze, Green Published			2022-01-24	
J	Morales, CP; Holt, SE; Ouellette, M; Kaur, KJ; Yan, Y; Wilson, KS; White, MA; Wright, WE; Shay, JW				Morales, CP; Holt, SE; Ouellette, M; Kaur, KJ; Yan, Y; Wilson, KS; White, MA; Wright, WE; Shay, JW			Absence of cancer-associated changes in human fibroblasts immortalized with telomerase	NATURE GENETICS			English	Article							CELL-CYCLE REGULATION; EPITHELIAL-CELLS; DNA-DAMAGE; GENE; P53; SENESCENCE; DISRUPTION; CULTURE; PROTEIN	The ectopic expression of telomerase(1-2) in normal human cells results in an extended lifespan(3-4), indicating that telomere shortening regulates the timing of cellular senescence, As telomerase expression is a hallmark of cancer, we investigated the long-term effects of forced expression of human telomerase catalytic component (hTERT) in normal human fibroblasts. In vitro growth requirements, cell-cycle checkpoints and karyotypic stability in telomerase-expressing cells are similar to those of untransfected controls. In addition, co-expression of telomerase, the viral oncoproteins HPV16 E6/E7 (which inactivate p53 and pRB) and oncogenic HRAS does not result in growth in soft agar, Thus, although ectopic expression of telomerase in human fibroblasts is sufficient for immortalization, it does not result in changes typically associated with malignant transformation.	Univ Texas, SW Med Ctr, Dept Cell Biol & Neurosci, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pathol, Richmond, VA 23298 USA		Shay, JW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol & Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	shay@utsw.swmed.edu	Gagneja, Kanwalinderjit K/K-3204-2017; Shay, Jerry W/F-7878-2011	Gagneja, Kanwalinderjit K/0000-0001-7844-8583; 	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA071443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG007992] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA71443] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG07992] Funding Source: Medline		ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; BENN PA, 1976, AM J HUM GENET, V28, P465; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gustashaw Karen M., 1997, P259; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Holt SE, 1996, INT J ONCOL, V8, P263; Honda T, 1996, MUTAT RES-FUND MOL M, V354, P15, DOI 10.1016/0027-5107(96)00003-6; KASTAN MB, 1991, CANCER RES, V51, P6304; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; NOWELL PC, 1987, DEV RECOGNITION TRAN, P1; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; SCHER CD, 1971, EXP CELL RES, V68, P479, DOI 10.1016/0014-4827(71)90181-9; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666	29	636	654	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					115	118		10.1038/5063			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	WOS:000077960700021	9916803				2022-01-24	
J	STUBER, CW; LINCOLN, SE; WOLFF, DW; HELENTJARIS, T; LANDER, ES				STUBER, CW; LINCOLN, SE; WOLFF, DW; HELENTJARIS, T; LANDER, ES			IDENTIFICATION OF GENETIC-FACTORS CONTRIBUTING TO HETEROSIS IN A HYBRID FROM 2 ELITE MAIZE INBRED LINES USING MOLECULAR MARKERS	GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; FRAGMENT LENGTH POLYMORPHISMS; MENDELIAN FACTORS; FACILITATED INVESTIGATIONS; LINKAGE MAPS; TOMATO; CROSSES; TOOLS; YIELD	The use of molecular markers to identify quantitative trait loci (QTLs) affecting agriculturally important traits has become a key approach in plant genetics-both for understanding the genetic basis of these traits and to help design novel plant improvement programs. In the study reported here, we mapped QTLs (and evaluated their phenotypic effects) associated with seven major traits (including grain yield) in a cross between two widely used elite maize inbred lines, B73 and Mo17, in order to explore two important phenomena in maize genetics-heterosis (hybrid vigor) and genotype-by-environment (G x E) interaction. We also compared two analytical approaches for identifying QTLs, the traditional single-marker method and the more recently described interval-mapping method. Phenotypic evaluations were made on 3168 plots (nearly 100,000 plants) grown in three states. Using 76 markers that represented 90-95% of the maize genome, both analytical methods showed virtually the same results in detecting QTLs affecting grain yield throughout the genome, except on chromosome 6. Fewer QTLs were detected for other quantitative traits measured. Whenever a QTL for grain yield was detected, the heterozygote had a higher phenotype than the respective homozygote (with only one exception) suggesting not only overdominance (or pseudo-overdominance) but also that these detected QTLs play a significant role in heterosis. This conclusion was reinforced by a high correlation between grain yield and proportion of heterozygous markers. Although plant materials were grown and measured in six diverse environments (North Carolina, Iowa and Illinois) there was little evidence for G x E interaction for most QTLs.	N CAROLINA STATE UNIV,DEPT GENET,RALEIGH,NC 27695; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,CAMBRIDGE,MA 02139; UNIV ARIZONA,DEPT BIOL,TUCSON,AZ 85721		STUBER, CW (corresponding author), USDA ARS,RALEIGH,NC 27695, USA.				NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00198] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM11546] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R37HG000198, R01HG000198] Funding Source: NIH RePORTER		ABLER BSB, 1991, CROP SCI, V31, P267, DOI 10.2135/cropsci1991.0011183X003100020006x; ALLARD R. W., 1964, CROP SCI, V4, P503; BUBECK DM, 1992, IN PRESS CROP SCI; BURR B, 1988, GENETICS, V118, P519; Crow J. F., 1952, Heterosis., P282; EDWARDS MD, 1987, GENETICS, V116, P113; EDWARDS MD, 1992, THEOR APPL GENET, V83, P765, DOI 10.1007/BF00226696; EVERSON E. H., 1955, Agronomy Journal, V47, P276; Hayes H. K., 1952, Heterosis., P49; HELENTJARIS T, 1988, GENETICS, V118, P353; HELENTJARIS T, 1985, PLANT MOL BIOL, V5, P109, DOI 10.1007/BF00020093; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; LINCOLN SE, 1989, MAPPING GENES CONTRO; MOLL RH, 1978, CROP SCI, V18, P641, DOI 10.2135/cropsci1978.0011183X001800040029x; PATERSON AH, 1991, GENETICS, V127, P181; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PATERSON AH, 1990, GENETICS, V124, P735; Rasmusson J, 1933, HEREDITAS, V18, P245; Sax K, 1923, GENETICS, V8, P552; SOLLER M, 1976, THEOR APPL GENET, V47, P35, DOI 10.1007/BF00277402; Stuber C.W., 1989, PLANT POPULATION GEN, P334; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; STUBER CW, 1988, NC AGR RES SERV NC S, V286; STUBER CW, 1992, PL BRED RE, V0009, P00037; TANKSLEY SD, 1982, HEREDITY, V49, P11, DOI 10.1038/hdy.1982.61; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; WEBER D, 1989, GENETICS, V121, P583	30	636	786	0	77	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	NOV	1992	132	3					823	839					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JV144	WOS:A1992JV14400017	1468633				2022-01-24	
J	BENNETT, ST; LUCASSEN, AM; GOUGH, SCL; POWELL, EE; UNDLIEN, DE; PRITCHARD, LE; MERRIMAN, ME; KAWAGUCHI, Y; DRONSFIELD, MJ; POCIOT, F; NERUP, J; BOUZEKRI, N; CAMBONTHOMSEN, A; RONNINGEN, KS; BARNETT, AH; BAIN, SC; TODD, JA				BENNETT, ST; LUCASSEN, AM; GOUGH, SCL; POWELL, EE; UNDLIEN, DE; PRITCHARD, LE; MERRIMAN, ME; KAWAGUCHI, Y; DRONSFIELD, MJ; POCIOT, F; NERUP, J; BOUZEKRI, N; CAMBONTHOMSEN, A; RONNINGEN, KS; BARNETT, AH; BAIN, SC; TODD, JA			SUSCEPTIBILITY TO HUMAN TYPE-1 DIABETES AT IDDM2 IS DETERMINED BY TANDEM REPEAT VARIATION AT THE INSULIN GENE MINISATELLITE LOCUS	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; 5'-FLANKING REGION; HRAS1 MINISATELLITE; NEGATIVE REGULATION; POLYMORPHIC REGION; MELLITUS; INDIVIDUALS; EXPRESSION; SEQUENCES; RISK	The IDDM2 locus encoding susceptibility to type 1 diabetes was mapped previously to a 4.1-kb region spanning the insulin gene and a minisatellite or variable number of tandem repeats (VNTR) locus on human chromosome 11p15.5. By 'cross-match' haplotype analysis and linkage disequilibrium mapping, we have mapped the mutation IDDM2 to within the VNTR itself. Other polymorphisms were systematically excluded as primary disease determinants. Transmission of IDDM2 may be influenced by parent-of-origin phenomena. Although we show that the insulin gene is expressed biallelically in the adult pancreas, we present preliminary evidence that the level of transcription in vivo is correlated with allelic variation within the VNTR. Allelic variation at VNTRs may play an important general role in human disease.	UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; NATL HOSP NORWAY,INST TRANSPLANTAT IMMUNOL,N-0027 OSLO,NORWAY; UNIV BIRMINGHAM,BIRMINGHAM HEARTLANDS HOSP,DEPT MED DIABET ENDOCRINOL,BIRMINGHAM B9 5SS,W MIDLANDS,ENGLAND; STENO DIABET CTR,DK-2820 GENTOFTE,DENMARK; HOP PURPAN,CTR IMMUNOPATHOL & GENET HUMAINE,CNRS,UPR 8291,F-31300 TOULOUSE,FRANCE		BENNETT, ST (corresponding author), UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT SURG,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		Todd, John A/A-3542-2010; Powell, Elizabeth/B-4455-2011; Lucassen, Anneke/D-7764-2017	Todd, John A/0000-0003-2740-8148; Powell, Elizabeth/0000-0001-5008-8061; Lucassen, Anneke/0000-0003-3324-4338; Pociot, Flemming/0000-0003-3274-5448	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; BUI MM, 1993, DIABETES, V42, pA63; COCCOZA S, 1988, EUR J CLIN INVEST, V18, P582; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1988, AM J HUM GENET, V43, P495; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GREEN M, 1993, GENOMICS, V17, P429, DOI 10.1006/geno.1993.1343; HAMMONDKOSACK MCU, 1992, NUCLEIC ACIDS RES, V20, P231, DOI 10.1093/nar/20.2.231; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; KELLER MA, 1993, PCR METH APPL, V3, P32; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; LUCASSEN AM, IN PRESS HUM MOL GEN; MARTINSON JJ, 1994, AM J HUM GENET, V55, P513; MCGINNIS RE, 1994, AM J HUM GENET, V55, P526; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; OUDET C, 1993, AM J HUM GENET, V52, P297; OUDET C, 1991, AM J HUM GENET, V49, P311; OWERBACH D, 1982, LANCET, V1, P880; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; PERMUTT MA, 1985, DIABETES, V34, P311, DOI 10.2337/diabetes.34.4.311; PRITCHARD LE, 1995, HUM MOL GENET, V4, P197, DOI 10.1093/hmg/4.2.197; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RENGES HH, 1992, ANN HUM GENET, V56, P11, DOI 10.1111/j.1469-1809.1992.tb01126.x; ROYCE NJ, 1988, GENOMICS, V3, P352; SHEEHY MJ, 1992, DIABETES, V41, P123, DOI 10.2337/diabetes.41.2.123; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TAKEDA J, 1989, FEBS LETT, V247, P41, DOI 10.1016/0014-5793(89)81236-0; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; TODD JA, 1994, DIABETIC MED, V11, P6, DOI 10.1111/j.1464-5491.1994.tb00222.x; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WEAVER JU, 1992, EUR J CLIN INVEST, V22, P265, DOI 10.1111/j.1365-2362.1992.tb01461.x; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	51	635	650	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					284	292		10.1038/ng0395-284			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	WOS:A1995QL23200019	7773291				2022-01-24	
J	Kraytsberg, Y; Kudryavtseva, E; Mckee, AC; Geula, C; Kowall, NW; Khrapko, K				Kraytsberg, Y; Kudryavtseva, E; Mckee, AC; Geula, C; Kowall, NW; Khrapko, K			Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons	NATURE GENETICS			English	Article							PARKINSONIAN SIGNS; HUMAN BRAIN; MUTATIONS	Using a novel single-molecule PCR approach to quantify the total burden of mitochondrial DNA (mtDNA) molecules with deletions, we show that a high proportion of individual pigmented neurons in the aged human substantia nigra contain very high levels of mtDNA deletions. Molecules with deletions are largely clonal within each neuron; that is, they originate from a single deleted mtDNA molecule that has expanded clonally. The fraction of mtDNA deletions is significantly higher in cytochrome c oxidase (COX)- deficient neurons than in COX-positive neurons, suggesting that mtDNA deletions may be directly responsible for impaired cellular respiration.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA		Khrapko, K (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	khrapko@hms.harvard.edu	Kowall, Neil/M-5378-2019; Khrapko, Konstantin/A-3244-2009	Kowall, Neil/0000-0002-6624-0213; 	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG13846, AG19787] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ES11343] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES011343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG019787, P30AG013846] Funding Source: NIH RePORTER		Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6; Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x; Khrapko K, 2005, REJUV RES, V8, P6, DOI 10.1089/rej.2005.8.6; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; KHRAPKO K, IN PRESS AGING CELL; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Nekhaeva E, 2002, MECH AGEING DEV, V123, P891, DOI 10.1016/S0047-6374(02)00026-X; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; SOONG NW, 1992, NAT GENET, V2, P318	15	634	653	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					518	520		10.1038/ng1778			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	WOS:000237147500010	16604072				2022-01-24	
J	daSilva, SM; Hacker, A; Harley, V; Goodfellow, P; Swain, A; LovellBadge, R				daSilva, SM; Hacker, A; Harley, V; Goodfellow, P; Swain, A; LovellBadge, R			Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds	NATURE GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; INHIBITING SUBSTANCE GENE; DETERMINING REGION; Y-CHROMOSOME; CAMPOMELIC DYSPLASIA; FEMALE MICE; NUCLEAR RECEPTOR; FETAL MOUSE; XY	Heterozygous mutations in SOX9 lead to a human dwarfism syndrome, Campomelic dysplasia. Consistent with a role in sex determination, we find that Sox9 expression closely follows differentiation of Sertoli cells in the mouse testis, in experimental sex reversal when fetal ovaries are grafted to adult kidneys and in the chick where there is no evidence for a Sry gene. Our results imply that Sox9 plays an essential role in sex determination, possibly immediately downstream of Sry in mammals, and that it functions as a critical Sertoli cell differentiation factor, perhaps in all vertebrates.	NATL INST MED RES, MRC, DIV DEV GENET, LONDON NW7 1AA, ENGLAND; UNIV CAMBRIDGE, DEPT GENET, CAMBRIDGE CB2 3EH, ENGLAND				Harley, Vincent/B-8092-2018	Harley, Vincent/0000-0002-2405-1262; Swain, Amanda/0000-0001-8666-1608; Morais da Silva, Sara/0000-0001-8337-9893; Lovell-Badge, Robin/0000-0001-9364-4179	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Behringer RR, 1995, PHILOS T ROY SOC B, V350, P285, DOI 10.1098/rstb.1995.0163; BERKOVITZ GD, 1992, HUM GENET, V88, P411, DOI 10.1007/BF00215675; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BUEHR M, 1993, DEVELOPMENT, V117, P273; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLINTON M, 1994, ANIM GENET, V25, P361, DOI 10.1111/j.1365-2052.1994.tb00374.x; Collignon J, 1996, DEVELOPMENT, V122, P509; CORIAT AM, 1994, J EXP ZOOL, V270, P112, DOI 10.1002/jez.1402700112; DRESSER WD, 1995, HUM MOL GENET, V4, P1513; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Eusebe DC, 1996, J BIOL CHEM, V271, P4798, DOI 10.1074/jbc.271.9.4798; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; Graves JAM, 1995, PHILOS T R SOC B, V350, P305, DOI 10.1098/rstb.1995.0166; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HACKER A, 1995, DEVELOPMENT, V121, P1603; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Harlow E, 1988, ANTIBODIES LAB MANUA; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; HUNT PA, 1991, CHROMOSOMA, V100, P293, DOI 10.1007/BF00360527; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Johnston CM, 1995, PHILOS T R SOC B, V350, P297, DOI 10.1098/rstb.1995.0165; JOST A, 1972, J REPROD FERTIL, V29, P349, DOI 10.1530/jrf.0.0290349; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Karl J, 1995, PHILOS T ROY SOC B, V350, P235, DOI 10.1098/rstb.1995.0157; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KRISHAN A, 1965, CHROMOSOMA, V17, P258; KWOK C, 1995, AM J HUM GENET, V57, P1028; LANOS HM, 1993, INT J DEV BIOL; LAVAL SH, 1995, P NATL ACAD SCI USA, V92, P10403, DOI 10.1073/pnas.92.22.10403; LovellBadge R, 1995, PHILOS T R SOC B, V350, P205, DOI 10.1098/rstb.1995.0153; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MAHADEVAIAH SK, 1993, J REPROD FERTIL, V97, P151, DOI 10.1530/jrf.0.0970151; MCELREAVEY K, 1993, EUR J BIOCHEM, V218, P769, DOI 10.1111/j.1432-1033.1993.tb18432.x; McLaren A, 1995, PHILOS T R SOC B, V350, P229, DOI 10.1098/rstb.1995.0156; MEYERSWALLEN VN, 1995, J HERED, V86, P369, DOI 10.1093/oxfordjournals.jhered.a111605; OHNO S, 1960, EXP CELL RES, V19, P180, DOI 10.1016/0014-4827(60)90048-3; PALMER SJ, 1991, DEVELOPMENT, V112, P265; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; TAKETO T, 1986, PROGR DEV BIOL A, P171; TAKETOHOSOTANI T, 1985, J EXP ZOOL, V236, P229, DOI 10.1002/jez.1402360213; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VIGIER B, 1987, DEVELOPMENT, V100, P43; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15	58	634	641	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1996	14	1					62	68		10.1038/ng0996-62			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	WOS:A1996VF61100022	8782821				2022-01-24	
J	Rao, E; Weiss, B; Fukami, M; Rump, A; Niesler, B; Mertz, A; Muroya, K; Binder, G; Kirsch, S; Winkelmann, M; Nordsiek, G; Heinrich, U; Breuning, MH; Ranke, MB; Rosenthal, A; Ogata, T; Rappold, GA				Rao, E; Weiss, B; Fukami, M; Rump, A; Niesler, B; Mertz, A; Muroya, K; Binder, G; Kirsch, S; Winkelmann, M; Nordsiek, G; Heinrich, U; Breuning, MH; Ranke, MB; Rosenthal, A; Ogata, T; Rappold, GA			Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome	NATURE GENETICS			English	Article							HUMAN X-CHROMOSOME; Y-CHROMOSOME; SHORT ARM; WAARDENBURG SYNDROME; SEX DETERMINATION; HORMONE RECEPTOR; CRITICAL REGION; CODING REGIONS; DNA-SEQUENCES; ALPHA-SUBUNIT	Growth retardation resulting in short stature is a major concern for parents and due to its great variety of causes, a complex diagnostic challenge for clinicians. A major locus involved in linear growth has been implicated within the pseudoautosomal region (PAR1) of the human sex chromosomes. We have determined an interval of 170 kb of DNA within PAR1 which was deleted in 36 individuals with short stature and different rearrangements on Xp22 or Yp11.3, This deletion was not detected in any of the relatives with normal stature or in a further 30 individuals with rearrangements on Xp22 or Yp11.3 with normal height, We have isolated a homeobox-containing gene (SHOX) from this region, which has at least two alternatively spliced forms, encoding proteins with different patterns of expression. We also identified one functionally significant SHOX mutation by screening 91 individuals with idiopathic short stature. Our data suggest an involvement of SHOX in idiopathic growth retardation and in the short stature phenotype of Turner syndrome patients.	UNIV HEIDELBERG,INST HUMAN GENET,D-69120 HEIDELBERG,GERMANY; KEIO UNIV,DEPT PAEDIAT,TOKYO 160,JAPAN; INST MOL BIOTECHNOL,DEPT GENOME ANAL,D-07745 JENA,GERMANY; UNIV TUBINGEN,CHILDRENS HOSP,SECT PAEDIAT ENDOCRINOL,D-72070 TUBINGEN,GERMANY; UNIV HEIDELBERG,CHILDRENS HOSP,DEPT PAEDIAT,D-69120 HEIDELBERG,GERMANY; LEIDEN UNIV,DEPT HUMAN GENET,SYLVIUS LAB,NL-2300 RA LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,HOSP DIJKZIGT,DEPT CLIN GENET,NL-3015 GD ROTTERDAM,NETHERLANDS				Breuning, Martijn H/E-3429-2010; Muroya, Koji/J-1304-2016	Muroya, Koji/0000-0002-1810-9894; Ogata, Tsutomu/0000-0001-7178-9991; Rump, Andreas/0000-0001-7116-6364			ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BARBAUX S, 1995, HUM MOL GENET, V4, P1565, DOI 10.1093/hmg/4.9.1565; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P381, DOI 10.1530/jrf.0.0680381; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; CHENG T, 1994, J BIOL CHEM, V269, P30848; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; FERRARI D, 1994, BIOCHEM BIOPH RES CO, V205, P429, DOI 10.1006/bbrc.1994.2683; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GODDARD AD, 1995, NEW ENGL J MED, V333, P1093, DOI 10.1056/NEJM199510263331701; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HALL JG, 1990, PEDIATR CLIN N AM, V37, P1421; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HENKE A, 1991, AM J HUM GENET, V49, P811; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; KULHARYA AS, 1995, AM J MED GENET, V56, P16, DOI 10.1002/ajmg.1320560106; LEHRACH H, 1990, GENOME ANAL, V1; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LICHTER P, 1992, HUMAN CYTOGENETICS P; MAGENIS RE, 1984, J PEDIATR-US, V105, P916, DOI 10.1016/S0022-3476(84)80077-3; Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965; MARTIAL JA, 1979, SCIENCE, V205, P602, DOI 10.1126/science.377496; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; OGATA T, 1993, HUM GENET, V91, P551; OGATA T, 1992, J MED GENET, V29, P455; OGATA T, 1995, J MED GENET, V32, P831, DOI 10.1136/jmg.32.10.831; OGATA T, 1993, J MED GENET, V30, P918, DOI 10.1136/jmg.30.11.918; OGATA T, 1997, IN PRESS Y SPECIFIC; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; Ranke MB, 1996, HORM RES, V45, P64, DOI 10.1159/000184851; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RIED K, 1995, GENOMICS, V29, P787, DOI 10.1006/geno.1995.9933; ROBINSON A, 1990, DEMOGRAPHY PREVALENC; ROSENFELD RG, 1994, ENDOCRINOLOGIST, V4, P351, DOI 10.1097/00019616-199409000-00006; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Rovescalli AC, 1996, P NATL ACAD SCI USA, V93, P10691, DOI 10.1073/pnas.93.20.10691; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHIEBEL K, 1993, NAT GENET, V3, P82, DOI 10.1038/ng0193-82; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THOMAS A, 1994, IMA J MATH APPL MED, V11, P149; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Ullrich O., 1930, Z KINDERHEILKD, V49, P271; VOGEL F, 1997, HUMAN GENETICS; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291; ZUFFARDI O, 1982, AM J MED GENET, V12, P175, DOI 10.1002/ajmg.1320120207; 1993, QIAGEN TGGE HDB	66	633	664	0	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					54	63		10.1038/ng0597-54			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	WOS:A1997WX02400022	9140395				2022-01-24	
J	GARDNER, EJ; RICHARDS, RC				GARDNER, EJ; RICHARDS, RC			MULTIPLE CUTANEOUS AND SUBCUTANEOUS LESIONS OCCURRING SIMULTANEOUSLY WITH HEREDITARY POLYPOSIS AND OSTEOMATOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																	GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GARDNER EJ, 1952, AM J HUM GENET, V4, P31	2	633	641	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					139	147					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	WOS:A1953XW63000003	13065261				2022-01-24	
J	Caporaso, JG; Lauber, CL; Costello, EK; Berg-Lyons, D; Gonzalez, A; Stombaugh, J; Knights, D; Gajer, P; Ravel, J; Fierer, N; Gordon, JI; Knight, R				Caporaso, J. Gregory; Lauber, Christian L.; Costello, Elizabeth K.; Berg-Lyons, Donna; Gonzalez, Antonio; Stombaugh, Jesse; Knights, Dan; Gajer, Pawel; Ravel, Jacques; Fierer, Noah; Gordon, Jeffrey I.; Knight, Rob			Moving pictures of the human microbiome	GENOME BIOLOGY			English	Article							GUT MICROBIOTA; DIVERSITY	Background: Understanding the normal temporal variation in the human microbiome is critical to developing treatments for putative microbiome-related afflictions such as obesity, Crohn's disease, inflammatory bowel disease and malnutrition. Sequencing and computational technologies, however, have been a limiting factor in performing dense time series analysis of the human microbiome. Here, we present the largest human microbiota time series analysis to date, covering two individuals at four body sites over 396 timepoints. Results: We find that despite stable differences between body sites and individuals, there is pronounced variability in an individual's microbiota across months, weeks and even days. Additionally, only a small fraction of the total taxa found within a single body site appear to be present across all time points, suggesting that no core temporal microbiome exists at high abundance (although some microbes may be present but drop below the detection threshold). Many more taxa appear to be persistent but non-permanent community members. Conclusions: DNA sequencing and computational advances described here provide the ability to go beyond infrequent snapshots of our human-associated microbial ecology to high-resolution assessments of temporal variations over protracted periods, within and between body habitats and individuals. This capacity will allow us to define normal variation and pathologic states, and assess responses to therapeutic interventions.	[Caporaso, J. Gregory; Stombaugh, Jesse; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Lauber, Christian L.; Berg-Lyons, Donna; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Costello, Elizabeth K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Gonzalez, Antonio; Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Gajer, Pawel; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA		Knight, R (corresponding author), Univ Colorado, Dept Chem & Biochem, 215 UCB, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Ravel, Jacques/D-2530-2009; Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018	Caporaso, Greg/0000-0002-8865-1670; Stombaugh, Jesse/0000-0001-9631-0748; Knight, Rob/0000-0002-0975-9019; Ravel, Jacques/0000-0002-0851-2233; FIERER, NOAH/0000-0002-6432-4261	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG004872, DK078669, AI070921, AI083264]; ARRA supplement [HG004872-02S1]; Crohn's and Colitis Foundation of America; Bill and Melinda Gates FoundationBill & Melinda Gates Foundation; Amazon Web Services (AWS); Howard Hughes Medical InstituteHoward Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U01AI070921, UH2AI083264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK078669] Funding Source: NIH RePORTER	We wish to acknowledge funding from NIH (HG004872, DK078669, AI070921 and AI083264), ARRA supplement (HG004872-02S1); Crohn's and Colitis Foundation of America; the Bill and Melinda Gates Foundation; Amazon Web Services (AWS) in Education Researchers Grant; and the Howard Hughes Medical Institute. We additionally wish to acknowledge Nigel Cook for assisting with deployment of QIIME on AWS, and Reece Gesumaria for performing DNA extraction.	[Anonymous], INVUE; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540	22	632	649	10	194	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2011	12	5							R50	10.1186/gb-2011-12-5-r50			8	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	831LR	WOS:000295732700014	21624126	Green Published, hybrid	Y	N	2022-01-24	
J	HENDRIKS, L; VANDUIJN, CM; CRAS, P; CRUTS, M; VANHUL, W; VANHARSKAMP, F; WARREN, A; MCINNIS, MG; ANTONARAKIS, SE; MARTIN, JJ; HOFMAN, A; VAN BROECKHOVEN, C				HENDRIKS, L; VANDUIJN, CM; CRAS, P; CRUTS, M; VANHUL, W; VANHARSKAMP, F; WARREN, A; MCINNIS, MG; ANTONARAKIS, SE; MARTIN, JJ; HOFMAN, A; VAN BROECKHOVEN, C			PRESENILE-DEMENTIA AND CEREBRAL-HEMORRHAGE LINKED TO A MUTATION AT CODON-692 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE	NATURE GENETICS			English	Article							SENILE PLAQUE NEURITES; ALZHEIMERS-DISEASE; DUTCH TYPE; NEUROFIBRILLARY TANGLES; HEMORRHAGE; DNA	Several families with an early-onset form of familial Alzheimer's disease have been found to harbour mutations at a specific codon (717) of the gene for the beta-amyloid precursor protein (APP) on chromosome 21. We now report, a novel base mutation in the same exon of the APP gene which co-segregates in one family with presenile dementia and cerebral haemorrhage due to cerebral amyloid angiopathy. The mutation results in the substitution of alanine into glycine at codon 692. These results suggest that the clinically distinct entities, presenile dementia and cerebral amyloid angiopathy, can be caused by the same mutation in the APP gene.	UNIV INSTELLING ANTWERP, BORN BUNGE FDN,DEPT BIOCHEM,NEUROGENET LAB, UNIV PLEIN 1, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, BORN BUNGE FDN, DEPT MED, NEUROBIOL LAB, B-2610 WILRIJK, BELGIUM; UNIV INSTELLING ANTWERP, BORN BUNGE FDN, DEPT MED, NEUROPATHOL LAB, B-2610 WILRIJK, BELGIUM; ERASMUS UNIV, SCH MED, DEPT EPIDEMIOL & BIOSTAT, 3000 DR ROTTERDAM, NETHERLANDS; JOHNS HOPKINS UNIV, SCH MED, DEPT PSYCHIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; ACAD HOSP ROTTERDAM DIJKZIGT, DEPT NEUROL, 3000 DR ROTTERDAM, NETHERLANDS				McInnis, Melvin G/F-6963-2012; Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/M-7853-2019; Antonarakis, Stylianos E/N-8866-2014	McInnis, Melvin G/0000-0002-0375-6247; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Antonarakis, Stylianos E/0000-0001-8907-5823; Van Hul, Wim/0000-0002-5065-7858			ARAI H, 1990, P NATL ACAD SCI USA, V87, P2249, DOI 10.1073/pnas.87.6.2249; BAKKER E, 1991, AM J HUM GENET, V49, P518; BARCIKOWSKA M, 1989, ACTA NEUROPATHOL, V78, P225, DOI 10.1007/BF00687751; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; CASTANO EM, 1988, LAB INVEST, V58, P122; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAAN J, 1990, ARCH NEUROL-CHICAGO, V47, P649, DOI 10.1001/archneur.1990.00530060059018; HAAN J, 1990, ARCH NEUROL-CHICAGO, V47, P965, DOI 10.1001/archneur.1990.00530090035010; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MERCKEN M, IN PRESS ACTA NEUROP; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1985, ANAL HUMAN GENETIC L, P141; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; PROBST A, 1989, ACTA NEUROPATHOL, V77, P430, DOI 10.1007/BF00687379; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P4630; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TIMMERS WF, 1990, NEUROSCI LETT, V118, P2232; UHLEN M, 1989, NATURE, V340, P733, DOI 10.1038/340733a0; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANDUYN CM, 1990, BRIT J PSYCHIAT, V158, P471; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N	34	632	640	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1992	1	3					218	221		10.1038/ng0692-218			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	WOS:A1992JC98200017	1303239				2022-01-24	
J	Rioux, JD; Daly, MJ; Silverberg, MS; Lindblad, K; Steinhart, H; Cohen, Z; Delmonte, T; Kocher, K; Miller, K; Guschwan, S; Kulbokas, EJ; O'Leary, S; Winchester, E; Dewar, K; Green, T; Stone, V; Chow, C; Cohen, A; Langelier, D; Lapointe, G; Gaudet, D; Faith, J; Branco, N; Bull, SB; McLeod, RS; Griffiths, AM; Bitton, A; Greenberg, GR; Lander, ES; Siminovitch, KA; Hudson, TJ				Rioux, JD; Daly, MJ; Silverberg, MS; Lindblad, K; Steinhart, H; Cohen, Z; Delmonte, T; Kocher, K; Miller, K; Guschwan, S; Kulbokas, EJ; O'Leary, S; Winchester, E; Dewar, K; Green, T; Stone, V; Chow, C; Cohen, A; Langelier, D; Lapointe, G; Gaudet, D; Faith, J; Branco, N; Bull, SB; McLeod, RS; Griffiths, AM; Bitton, A; Greenberg, GR; Lander, ES; Siminovitch, KA; Hudson, TJ			Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; ASSOCIATION; REGION	Linkage disequilibrium (LD) mapping provides a powerful method for fine-structure localization of rare disease genes, but has not yet been widely applied to common disease(1). We sought to design a systematic approach for LD mapping and apply it to the localization of a gene (IBD5) conferring susceptibility to Crohn disease. The key issues are: (i) to detect a significant LD signal (ii) to rigorously bound the critical region and (iii) to identify the causal genetic variant within this region. We previously mapped the IBD5 locus to a large region spanning 18 cM of chromosome 5q31 (P<10(-4)). Using dense genetic maps of microsatellite markers and single-nucleotide polymorphisms (SNPs) across the entire region, we found strong evidence of LD. We bound the region to a common haplotype spanning 250 kb that shows strong association with the disease (P<2x10(-7)) and contains the cytokine gene cluster, This finding provides overwhelming evidence that a specific common haplotype of the cytokine region in 5q31 confers susceptibility to Crohn disease. However, genetic evidence alone is not sufficient to identify the causal mutation within this region, as strong LD across the region results in multiple SNPs having equivalent genetic evidence-each consistent with the expected properties of the 1BD5 locus. These results have important implications for Crohn disease in particular and LID mapping in general.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Immunol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; McGill Univ, Ctr Hlth, Dept Gastroenterol, Montreal, PQ, Canada; McGill Univ, Montreal Genome Ctr, Montreal, PQ, Canada; Ctr Hosp Sherbrooke, Sherbrooke, PQ, Canada; Ctr Hosp Sagamie, Chicoutimi, PQ, Canada; MIT, Dept Biol, Cambridge, MA USA		Rioux, JD (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rioux@genome.wi.mit.edu; lander@wi.mit.edu; ksiminovitch@mtsinai.on.ca; tjhudson@med.mcgill.ca	Daly, Mark J/B-2453-2017; Siminovitch, Katherine/K-1475-2013; McLeod, Robin/K-1476-2013; Rioux, John D/A-9599-2015; Silverberg, Mark/B-4183-2008; Bull, Shelley B/A-1920-2013; Greenberg, Gordon/C-4620-2015	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; 			Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; Clavell M, 2000, J PEDIATR GASTR NUTR, V30, P43, DOI 10.1097/00005176-200001000-00016; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; FARTHING MJG, 1978, GUT, V19, P743, DOI 10.1136/gut.19.8.743; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Spielman RS, 1996, AM J HUM GENET, V59, P983; Zhu YW, 2000, P NATL ACAD SCI USA, V97, P1137, DOI 10.1073/pnas.97.3.1137	15	630	644	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					223	228		10.1038/ng1001-223			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	WOS:000171374100032	11586304				2022-01-24	
J	Harushima, Y; Yano, M; Shomura, P; Sato, M; Shimano, T; Kuboki, Y; Yamamoto, T; Lin, SY; Antonio, BA; Parco, A; Kajiya, H; Huang, N; Yamamoto, K; Nagamura, Y; Kurata, N; Khush, GS; Sasaki, T				Harushima, Y; Yano, M; Shomura, P; Sato, M; Shimano, T; Kuboki, Y; Yamamoto, T; Lin, SY; Antonio, BA; Parco, A; Kajiya, H; Huang, N; Yamamoto, K; Nagamura, Y; Kurata, N; Khush, GS; Sasaki, T			A high-density rice genetic linkage map with 2275 markers using a single F-2 population	GENETICS			English	Article							ORYZA-SATIVA L; MOLECULAR MAP; PHYSICAL MAP; LIBRARY; GENOME; WHEAT; PLANTS; DNA	A 2275-marker genetic map of rice (Oryza sativa L.) covering 1521.6 cM in the Kosambi function has been constructed using 186 F-2 plants from a single cross between the japonica variety Nipponbare and the indica variety Kasalath. The map provides the most detailed and informative genetic map of any plant. Centromere locations on 12 linkage groups were determined by dosage analysis of secondary and telotrisomics using >130 DNA markers located on respective chromosome arms. A limited influence on meiotic recombination inhibition by the centromere in the genetic map was discussed. The main sources of the markers in this map were expressed sequence tag (EST) clones from Nipponbare callus, root, and shoot libraries. We mapped 1455 loci using ESTs; 615 of these loci showed significant similarities to known, genes, including single-copy genes, family genes, and isozyme genes. The high-resolution genetic map permitted us to characterize meiotic recombinations in the whole genome. Positive interference of meiotic recombination was detected both by the distribution of recombination number per each chromosome and by the distribution of double crossover interval lengths.	Natl Inst Agrobiol Resources, Rice Genome Res Program, Inst Soc Technoinnovat Agr Forestry & Fisheries, Ibaraki, Osaka 305, Japan; Int Rice Res Inst, Manila 1099, Philippines		Yano, M (corresponding author), Natl Inst Agrobiol Resources, Rice Genome Res Program, Inst Soc Technoinnovat Agr Forestry & Fisheries, 2-1-2 Kannondai, Ibaraki, Osaka 305, Japan.		Khush, Gurdev Singh/C-5109-2009	Kajiya-Kanegae, Hiromi/0000-0002-5719-7559; Yamamoto, Toshio/0000-0002-5209-7735			AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Antonio B A, 1996, DNA Res, V3, P393, DOI 10.1093/dnares/3.6.393; Antonio BA, 1996, GENOME, V39, P946, DOI 10.1139/g96-119; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ashikawa I, 1994, DNA Res, V1, P67, DOI 10.1093/dnares/1.2.67; CAUSSE MA, 1994, GENETICS, V138, P1251; CURTIS CA, 1991, THEOR APPL GENET, V81, P245, DOI 10.1007/BF00215730; Dobzhansky T, 1930, GENETICS, V15, P347; Fukuoka S, 1994, DNA Res, V1, P271, DOI 10.1093/dnares/1.6.271; Gill KS, 1996, GENETICS, V143, P1001; HALDANE J. B. S., 1931, CYTOLOGIA, V3, P54; Harushima Y, 1996, THEOR APPL GENET, V92, P145, DOI 10.1007/BF00223368; Havukkala IJ, 1996, CURR OPIN GENET DEV, V6, P711, DOI 10.1016/S0959-437X(96)80025-6; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Izawa T, 1996, TRENDS PLANT SCI, V1, P95, DOI 10.1016/S1360-1385(96)80041-0; Kinoshita T., 1993, RICE GENET NEWSLETT, V10, P7; Koike K, 1997, DNA Res, V4, P27, DOI 10.1093/dnares/4.1.27; Kurata N, 1997, PLANT MOL BIOL, V35, P101, DOI 10.1023/A:1005760717474; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; LAMBIE EJ, 1986, GENETICS, V114, P769; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LIN SY, 1994, RICE GENET NEWSL, V11, P108; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; Miyao A, 1996, DNA Res, V3, P233, DOI 10.1093/dnares/3.4.233; Monna L, 1994, DNA Res, V1, P139, DOI 10.1093/dnares/1.3.139; Monna L, 1997, THEOR APPL GENET, V94, P170, DOI 10.1007/s001220050396; Monna L, 1995, DNA Res, V2, P101, DOI 10.1093/dnares/2.3.101; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; MORISHIMA H, 1990, RICE GENET NEWSLETT, V7, P50; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Muller HJ, 1916, AM NAT, V50, P350, DOI 10.1086/279547; Muller HJ, 1916, AM NAT, V50, P284, DOI 10.1086/279541; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; Nagamura Y, 1997, PLANT MOL BIOL, V35, P79, DOI 10.1023/A:1005712010033; NAGAMURA Y, 1995, BREEDING SCI, V45, P373; NILSSON NO, 1993, TRENDS GENET, V9, P344, DOI 10.1016/0168-9525(93)90038-J; Nozue F, 1996, DNA SEQUENCE, V6, P127, DOI 10.3109/10425179609010200; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SAITO A, 1991, JPN J BREED, V41, P665; Saji S, 1996, DNA Res, V3, P297, DOI 10.1093/dnares/3.5.297; SALL T, 1994, THEOR APPL GENET, V89, P211, DOI 10.1007/BF00225144; SASAKI T, 1994, PLANT J, V6, P615, DOI 10.1046/j.1365-313X.1994.6040615.x; SCHMIDT R, 1995, SCIENCE, V270, P480, DOI 10.1126/science.270.5235.480; SHIMAMOTO K, 1989, NATURE, V338, P274, DOI 10.1038/338274a0; Shimokawa T, 1996, DNA Res, V3, P401, DOI 10.1093/dnares/3.6.401; Singh K, 1996, P NATL ACAD SCI USA, V93, P6163, DOI 10.1073/pnas.93.12.6163; Song J, 1996, DNA Res, V3, P303, DOI 10.1093/dnares/3.5.303; SONG WY, 1995, SCIENCE, V270, P1772; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; TANKSLEY SD, 1992, GENETICS, V132, P1141; Tanoue H, 1997, DNA Res, V4, P133, DOI 10.1093/dnares/4.2.133; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; UMEHARA Y, 1995, MOL BREEDING, V1, P79, DOI 10.1007/BF01682091; Umehara Y, 1997, DNA Res, V4, P127, DOI 10.1093/dnares/4.2.127; Umehara Y, 1996, GENOME RES, V6, P935, DOI 10.1101/gr.6.10.935; Wang Z X, 1996, DNA Res, V3, P291, DOI 10.1093/dnares/3.5.291; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; Wu JZ, 1995, GENOME, V38, P1189, DOI 10.1139/g95-157; Yamamoto K, 1997, PLANT MOL BIOL, V35, P135, DOI 10.1023/A:1005735322577; YANO M, 1997, IN PRESS THEOR APPL; YOKOO M, 1978, Japanese Journal of Breeding, V28, P49	63	630	745	1	35	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JAN	1998	148	1					479	494					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YR425	WOS:000071494000044	9475757				2022-01-24	
J	Vaser, R; Sovic, I; Nagarajan, N; Sikic, M				Vaser, Robert; Sovic, Ivan; Nagarajan, Niranjan; Sikic, Mile			Fast and accurate de novo genome assembly from long uncorrected reads	GENOME RESEARCH			English	Article							SEQUENCING READS; ALGORITHM; ALIGNMENT; NONHYBRID	The assembly of long reads from Pacific Biosciences and Oxford Nanopore Technologies typically requires resource-intensive error-correction and consensus-generation steps to obtain high-quality assemblies. We show that the error-correction step can be omitted and that high-quality consensus sequences can be generated efficiently with a SIMD-accelerated, partial-order alignment-based, stand-alone consensus module called Racon. Based on tests with PacBio and Oxford Nanopore data sets, we show that Racon coupled with miniasm enables consensus genomes with similar or better quality than state-of-the-art methods while being an order of magnitude faster.	[Vaser, Robert; Sikic, Mile] Univ Zagreb, Fac Elect Engn & Comp, Dept Elect Syst & Informat Proc, Zagreb 10000, Croatia; [Sovic, Ivan] Rudjer Boskovic Inst, Ctr Informat & Comp, Zagreb 10000, Croatia; [Nagarajan, Niranjan] Genome Inst Singapore, Singapore 138672, Singapore; [Sikic, Mile] Bioinformat Inst, Singapore 138671, Singapore		Sikic, M (corresponding author), Univ Zagreb, Fac Elect Engn & Comp, Dept Elect Syst & Informat Proc, Zagreb 10000, Croatia.; Sikic, M (corresponding author), Bioinformat Inst, Singapore 138671, Singapore.	mile.sikic@fer.hr	Sikic, Mile/A-9325-2015	Sikic, Mile/0000-0002-8370-0891	Croatian Science Foundation [UIP-11-2013-7353]; Croatian Academy of Sciences and Arts; A*STAR, SingaporeAgency for Science Technology & Research (ASTAR)	This work has been supported in part by Croatian Science Foundation under the project UIP-11-2013-7353. I.S. is supported in part by the Croatian Academy of Sciences and Arts under the project "Methods for alignment and assembly of DNA sequences using nanopore sequencing data." N.N. is supported by funding from A*STAR, Singapore.	Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Istace B, 2016, BIORXIV, DOI [10.1101/066613, DOI 10.1101/066613]; Lee C, 2003, BIOINFORMATICS, V19, P999, DOI 10.1093/bioinformatics/btg109; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]; Myers G, 1999, J ACM, V46, P395, DOI 10.1145/316542.316550; Rognes T, 2000, BIOINFORMATICS, V16, P699, DOI 10.1093/bioinformatics/16.8.699; Sosic M, 2016, BIORXIV, DOI [10.1101/070649, DOI 10.1101/070649]; Sovic I, 2016, BIOINFORMATICS, V32, P2582, DOI 10.1093/bioinformatics/btw237; Sovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11307; Ye CX, 2016, PEERJ, V4, DOI 10.7717/peerj.2016	18	628	634	12	62	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2017	27	5					737	746		10.1101/gr.214270.116			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	ET6HP	WOS:000400392400008	28100585	hybrid, Green Published, Green Submitted	Y	N	2022-01-24	
J	Wang, K; Yuen, ST; Xu, JC; Lee, SP; Yan, HHN; Shi, ST; Siu, HC; Deng, SB; Chu, KM; Law, S; Chan, KH; Chan, ASY; Tsui, WY; Ho, SL; Chan, AKW; Man, JLK; Foglizzo, V; Ng, MK; Chan, AS; Ching, YP; Cheng, GHW; Xie, T; Fernandez, J; Li, VSW; Clevers, H; Rejto, PA; Mao, M; Leung, SY				Wang, Kai; Yuen, Siu Tsan; Xu, Jiangchun; Lee, Siu Po; Yan, Helen H. N.; Shi, Stephanie T.; Siu, Hoi Cheong; Deng, Shibing; Chu, Kent Man; Law, Simon; Chan, Kok Hoe; Chan, Annie S. Y.; Tsui, Wai Yin; Ho, Siu Lun; Chan, Anthony K. W.; Man, Jonathan L. K.; Foglizzo, Valentina; Ng, Man Kin; Chan, April S.; Ching, Yick Pang; Cheng, Grace H. W.; Xie, Tao; Fernandez, Julio; Li, Vivian S. W.; Clevers, Hans; Rejto, Paul A.; Mao, Mao; Leung, Suet Yi			Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer	NATURE GENETICS			English	Article							CPG ISLAND METHYLATION; STEM-CELLS; MICROSATELLITE INSTABILITY; INTESTINAL-METAPLASIA; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; BINDING PROTEIN; RHOA; GENE; ACTIVATION	Gastric cancer is a heterogeneous disease with diverse molecular and histological subtypes. We performed whole-genome sequencing in 100 tumor-normal pairs, along with DNA copy number, gene expression and methylation profiling, for integrative genomic analysis. We found subtype-specific genetic and epigenetic perturbations and unique mutational signatures. We identified previously known (TP53, ARID1A and CDH1) and new (MUC6, CTNNA2, GLI3, RNF43 and others) significantly mutated driver genes. Specifically, we found RHOA mutations in 14.3% of diffuse-type tumors but not in intestinal-type tumors (P < 0.001). The mutations clustered in recurrent hotspots affecting functional domains and caused defective RHOA signaling, promoting escape from anoikis in organoid cultures. The top perturbed pathways in gastric cancer included adherens junction and focal adhesion, in which RHOA and other mutated genes we identified participate as key players. These findings illustrate a multidimensional and comprehensive genomic landscape that highlights the molecular complexity of gastric cancer and provides a road map to facilitate genome-guided personalized therapy.	[Wang, Kai; Xu, Jiangchun; Deng, Shibing; Xie, Tao; Fernandez, Julio; Rejto, Paul A.; Mao, Mao] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA; [Yuen, Siu Tsan; Lee, Siu Po; Yan, Helen H. N.; Siu, Hoi Cheong; Chan, Kok Hoe; Chan, Annie S. Y.; Tsui, Wai Yin; Ho, Siu Lun; Chan, Anthony K. W.; Man, Jonathan L. K.; Ng, Man Kin; Chan, April S.; Cheng, Grace H. W.; Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Shi, Stephanie T.] Pfizer Worldwide Res & Dev, External Res Solut, San Diego, CA USA; [Chu, Kent Man; Law, Simon] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Foglizzo, Valentina; Li, Vivian S. W.] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Ching, Yick Pang] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands		Leung, SY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China.	mao_m@yahoo.com; suetyi@hku.hk	Chan, Kok Hoe/AAN-7838-2020; Rejto, Paul/M-4782-2019; Law, Simon/C-4324-2009; Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Leung, Suet Yi/T-9620-2019	Chan, Kok Hoe/0000-0002-2550-1122; Law, Simon/0000-0002-6518-5806; Leung, Suet Yi/0000-0001-8614-4619; CHING, Yick Pang/0000-0002-6461-8358; Wang, Kai/0000-0003-0567-3004; Li, Vivian/0000-0003-2041-0085; Yan, Hoi Ning Helen/0000-0001-5693-8231; Fernandez Banet, Julio/0000-0003-0901-1286; Foglizzo, Valentina/0000-0001-5059-3279; Chan, April/0000-0002-4797-7009	PfizerPfizer; Research Grants Council of the Hong Kong Special Administrative RegionHong Kong Research Grants Council [HKU7719/10M]; S.T. Pan; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UP_1202/7] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UP_1202/7] Funding Source: researchfish	We thank J. Shen for assistance with bioinformatics and clinicians at the Hong Kong Hospital Authority for clinical care. We thank Illumina for performing whole-genome sequencing, TruSeq and array experiments and the Centre for Genomics Sciences at the University of Hong Kong for other sequencing services. Funding for the whole-genome sequencing study and associated validation was provided by Pfizer. Funding for the methylation analysis was provided by the Research Grants Council of the Hong Kong Special Administrative Region (General Research Fund grant HKU7719/10M). Funding for the functional assays was provided by a donation from S.T. Pan.	Ahuja N, 1997, CANCER RES, V57, P3370; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Bogaerts S, 2005, EXP CELL RES, V311, P1, DOI 10.1016/j.yexcr.2005.06.018; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Fujii Y, 2012, P NATL ACAD SCI USA, V109, P20584, DOI 10.1073/pnas.1208651109; Garcia E, 1997, CANCER EPIDEM BIOMAR, V6, P1071; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kang GH, 2001, CANCER RES, V61, P2847; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kwon JA, 2010, HUM MUTAT, V31, P942, DOI 10.1002/humu.21289; Kwon OH, 2013, CANCER SCI, V104, P391, DOI 10.1111/cas.12076; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Majewski IJ, 2013, J PATHOL, V229, P621, DOI 10.1002/path.4152; Matsuoka T, 2011, CLIN EXP METASTAS, V28, P627, DOI 10.1007/s10585-011-9396-6; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Oue N, 2003, ONCOLOGY-BASEL, V64, P423, DOI 10.1159/000070302; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pang JCS, 2010, BRAIN PATHOL, V20, P1021, DOI 10.1111/j.1750-3639.2010.00405.x; Park SH, 2001, ONCOGENE, V20, P1235, DOI 10.1038/sj.onc.1204227; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rau TT, 2012, AM J PATHOL, V181, P487, DOI 10.1016/j.ajpath.2012.04.028; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Tuncel H, 2012, INT J ONCOL, V41, P2079, DOI 10.3892/ijo.2012.1652; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang J, 2013, CANCER BIOL THER, V14, P262, DOI 10.4161/cbt.23299; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Yoshioka K, 1999, CANCER RES, V59, P2004; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zheng HC, 2006, J CANCER RES CLIN, V132, P817, DOI 10.1007/s00432-006-0135-3; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	64	628	642	6	206	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					573	582		10.1038/ng.2983			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	WOS:000336870700013	24816253		Y	N	2022-01-24	
J	John, S; Sabo, PJ; Thurman, RE; Sung, MH; Biddie, SC; Johnson, TA; Hager, GL; Stamatoyannopoulos, JA				John, Sam; Sabo, Peter J.; Thurman, Robert E.; Sung, Myong-Hee; Biddie, Simon C.; Johnson, Thomas A.; Hager, Gordon L.; Stamatoyannopoulos, John A.			Chromatin accessibility pre-determines glucocorticoid receptor binding patterns	NATURE GENETICS			English	Article							IN-VIVO; HYPERSENSITIVE SITES; DNA; GENE; INTERPLAY; CELLS	Development, differentiation and response to environmental stimuli are characterized by sequential changes in cellular state initiated by the de novo binding of regulated transcriptional factors to their cognate genomic sites(1-3). The mechanism whereby a given regulatory factor selects a limited number of in vivo targets from a myriad of potential genomic binding sites is undetermined. Here we show that up to 95% of de novo genomic binding by the glucocorticoid receptor(4), a paradigmatic ligand-activated transcription factor, is targeted to preexisting foci of accessible chromatin. Factor binding invariably potentiates chromatin accessibility. Cell-selective glucocorticoid receptor occupancy patterns appear to be comprehensively predetermined by cell-specific differences in baseline chromatin accessibility patterns, with secondary contributions from local sequence features. The results define a framework for understanding regulatory factor-genome interactions and provide a molecular basis for the tissue selectivity of steroid pharmaceuticals and other agents that intersect the living genome.	[Sabo, Peter J.; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [John, Sam; Sung, Myong-Hee; Biddie, Simon C.; Johnson, Thomas A.; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA		Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	hagerg@exchange.nih.gov; jstam@uw.edu		Biddie, Simon/0000-0002-8253-0253; Mott, Richard/0000-0002-1022-9330; Sung, Myong-Hee/0000-0002-9739-8558	US NIH, National Cancer Institute, Center for Cancer ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RC2HG005654]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIABC005450] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [RC2HG005654] Funding Source: NIH RePORTER	We would like to thank T. Miranda, S. Morris, K. Nalley and L. Grontved for critical reading of the manuscript. We also thank M. Weaver, K. Lee, F. Neri, D. Bates and M. Diegel for technical assistance with the DNase I library preparation and sequencing. This research was supported in part by the Intramural Research Program of the US NIH, National Cancer Institute, Center for Cancer Research and funding from US NIH grant 1RC2HG005654 to J.A.S.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2000, BIOINFORMATICS, V16, P488, DOI 10.1093/bioinformatics/16.5.488; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; BECKER P, 1984, EMBO J, V3, P2015, DOI 10.1002/j.1460-2075.1984.tb02084.x; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; CORDINGLEY MG, 1988, NUCLEIC ACIDS RES, V16, P609, DOI 10.1093/nar/16.2.609; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAGER GL, 1993, COLD SPRING HARB SYM, V58, P63, DOI 10.1101/SQB.1993.058.01.010; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VONDERAHE D, 1985, NATURE, V313, P706, DOI 10.1038/313706a0; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	30	628	638	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					264	U116		10.1038/ng.759			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	WOS:000287693800019	21258342	Green Accepted	Y	N	2022-01-24	
J	Yu, JM; Holland, JB; McMullen, MD; Buckler, ES				Yu, Jianming; Holland, James B.; McMullen, Michael D.; Buckler, Edward S.			Genetic design and statistical power of nested association mapping in maize	GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; INBRED LINES; ARTIFICIAL SELECTION; MODEL SELECTION; COMPLEX TRAITS; JOINT LINKAGE; ARCHITECTURE; DISSECTION; GENOME	We investigated the genetic and statistical properties of the nested association mapping (NAM) design currently being implemented in maize (26 diverse founders and 5000 distinct immortal genotypes) to dissect the genetic basis of complex quantitative traits. The NAM design simultaneously exploits the advantages of both linkage analysis and association mapping. We demonstrated the power of NAM for high-power cost-effective genome scans through computer simulations based on empirical marker data and simulated traits with different complexities. With common-parent-specific (CPS) markers genotype for the founders and the progenies, the inheritance of chromosome segments nested within two adjacent CPS markers vas inferred through linkage. Genotyping the founders with additional high-density markers enabled the projection of genetic information, capturing linkage disequilibrium information, from founders to progenies. With 5000 genotypes, 30-79% of the simulated quantitative trait loci (QTL) were precisely identified. By integrating genetic design, natural diversity, and genomics technologies, this new complex trait dissection strategy should greatly facilitate endeavors to link molecular variation with phenotypic variation for various complex traits.	[Yu, Jianming; Buckler, Edward S.] Cornell Univ, Inst Gen Divers, USDA ARS, Ithaca, NY 14853 USA; [Holland, James B.] N Carolina State Univ, USDA ARS, Raleigh, NC 27695 USA; [Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [McMullen, Michael D.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA		Buckler, ES (corresponding author), Cornell Univ, Inst Gen Divers, USDA ARS, 159 Biotechnol Bldg, Ithaca, NY 14853 USA.	esb@cornell.edu	Yu, Jianming/Q-6722-2019; Buckler, Edward/L-7651-2019	Yu, Jianming/0000-0001-5326-3099; Buckler, Edward/0000-0002-3100-371X; Holland, James/0000-0002-4341-9675			Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo RN, 2002, BREEDING QUANTITATIV; Blott S, 2003, GENETICS, V163, P253; Bogdan M, 2005, HEREDITY, V95, P476, DOI 10.1038/sj.hdy.6800747; Broman KW, 2005, GENETICS, V169, P1133, DOI 10.1534/genetics.104.035212; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Coe E, 2002, PLANT PHYSIOL, V128, P9, DOI 10.1104/pp.010953; Cooper M, 2005, AUST J AGR RES, V56, P895, DOI 10.1071/AR05154; Darvasi A, 2005, NAT GENET, V37, P118, DOI 10.1038/ng0205-118; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Falush D, 2003, GENETICS, V164, P1567; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Gardiner J, 2004, PLANT PHYSIOL, V134, P1317, DOI 10.1104/pp.103.034538; Hallauer A. R., 1988, Corn and corn improvement. Third edition., P463; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Holland JB, 2002, PL BRED RE, V22, P9; Jansen RC, 2003, CROP SCI, V43, P829, DOI 10.2135/cropsci2003.0829; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; LANDE R, 1990, GENETICS, V124, P743; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li RH, 2005, GENETICS, V169, P1699, DOI 10.1534/genetics.104.033993; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu KJ, 2003, GENETICS, V165, P2117; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; Meuwissen THE, 2002, GENETICS, V161, P373; Miranda Filho, 1988, QUANTITATIVE GENETIC; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mott R, 2002, GENETICS, V160, P1609; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Qian HR, 2005, GENOMICS, V86, P495, DOI 10.1016/j.ygeno.2005.06.007; Rebai A, 2000, GENET RES, V75, P243, DOI 10.1017/S0016672399004358; REBAI A, 1993, THEOR APPL GENET, V86, P1014, DOI 10.1007/BF00211055; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shifman S, 2005, GENETICS, V169, P849, DOI 10.1534/genetics.104.032474; Sillanpaa MJ, 2005, GENETICS, V169, P427, DOI 10.1534/genetics.104.032680; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; Sprague G. F., 1988, CORN CORN IMPROVEMEN; STUBER CW, 1992, GENETICS, V132, P823; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; Wang H, 2005, GENETICS, V170, P465, DOI 10.1534/genetics.104.039354; Wang T, 2001, MOL PSYCHIATR, V6, P109, DOI 10.1038/sj.mp.4000803; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu RL, 2002, GENETICS, V160, P779; Wu RL, 2001, GENETICS, V157, P899; Xu SZ, 1998, GENETICS, V148, P517; Xu SZ, 2003, GENETICS, V163, P789; Yi NJ, 2005, GENETICS, V170, P1333, DOI 10.1534/genetics.104.040386; Yi NJ, 2002, GENETICA, V114, P217, DOI 10.1023/A:1016296225065; Yu J, 2005, THEOR APPL GENET, V110, P1061, DOI 10.1007/s00122-005-1926-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu JM, 2004, CROP SCI, V44, P405, DOI 10.2135/cropsci2004.4050; Zhang M, 2005, GENETICS, V169, P2305, DOI 10.1534/genetics.104.034181	75	628	656	2	132	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	2008	178	1					539	551		10.1534/genetics.107.074245			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256PN	WOS:000252742200042	18202393	Green Published, Bronze			2022-01-24	
J	Straub, RE; Jiang, YX; MacLean, CJ; Ma, YL; Webb, BT; Myakishev, MV; Harris-Kerr, C; Wormley, B; Sadek, H; Kadambi, B; Cesare, AJ; Gibberman, A; Wang, X; O'Neill, FA; Walsh, D; Kendler, KS				Straub, RE; Jiang, YX; MacLean, CJ; Ma, YL; Webb, BT; Myakishev, MV; Harris-Kerr, C; Wormley, B; Sadek, H; Kadambi, B; Cesare, AJ; Gibberman, A; Wang, X; O'Neill, FA; Walsh, D; Kendler, KS			Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SINGLE-NUCLEOTIDE POLYMORPHISMS; TYPE-2 DIABETES-MELLITUS; CHROMOSOME 6P; SUSCEPTIBILITY LOCUS; ROSCOMMON FAMILY; LINKAGE ANALYSIS; TRANSMISSION/DISEQUILIBRIUM TEST; COGNITIVE IMPAIRMENT; BRAIN DYSTROPHIN	Prior evidence has supported the existence of multiple susceptibility genes for schizophrenia. Multipoint linkage analysis of the 270 Irish high-density pedigrees that we have studied, as well as results from several other samples, suggest that at least one such gene is located in region 6p24-21. In the present study, family-based association analysis of 36 simple sequence-length-polymorphism markers and of 17 SNP markers implicated two regions, separated by (7similar to) Mb. The first region, and the focus of this report, is 6p22.3. In this region, single-nucleotide polymorphisms within the 140-kb gene DTNBP1 ((d) under bar ys (t) under bar robrevi (n) under bar -binding (p) under bar rotein (1) under bar, or dysbindin) are strongly associated with schizophrenia. Uncorrected, empirical P values produced by the program TRANSMIT were significant (P<.01) for a number of individual SNP markers, and most remained significant when the data were restricted to include only one affected offspring per nuclear family per extended pedigree; multiple three-marker haplotypes were highly significant (P=.008-.0001) under the restricted conditions. The pattern of linkage disequilibrium is consistent with the presence of more than one susceptibility allele, but this important issue is unresolved. The number of markers tested in the adjacent genes, all of which are negative, is not sufficient to rule out the possibility that the dysbindin gene is not the actual susceptibility gene, but this possibility appears to be very unlikely. We conclude that further investigation of dysbindin is warranted.	Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; Queens Univ Belfast, Dept Psychiat, Belfast, Antrim, North Ireland; Hlth Res Board, Dublin, Ireland		Straub, RE (corresponding author), NIMH, Clin Brain Disorders Branch, IRP, NIH, Bldg 10,Room 4N-311,MSC 1385, Bethesda, MD 20892 USA.	straubr@intra.nimh.nih.gov	Cesare, Anthony J/F-4691-2010; O'Neill, Francis A/C-5582-2008; Kendler, Kenneth/AAF-2876-2019; Webb, Bradley T/B-1459-2009; Cesare, Anthony/N-7415-2019	Cesare, Anthony J/0000-0002-0864-1254; O'Neill, Francis A/0000-0002-7531-7657; Webb, Bradley T/0000-0002-0576-5366; Cesare, Anthony/0000-0002-0864-1254	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH041953, MH 52537, MH 41953, MH 45390] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH041953, R01MH045390, R01MH052537] Funding Source: NIH RePORTER		Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; Arolt V, 1996, AM J MED GENET, V67, P564, DOI 10.1002/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; Benes FM, 2000, BRAIN RES REV, V31, P251, DOI 10.1016/S0165-0173(99)00041-7; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2000, TRENDS NEUROSCI, V23, P92, DOI 10.1016/S0166-2236(99)01510-6; Bray NJ, 2001, TRENDS MOL MED, V7, P169, DOI 10.1016/S1471-4914(01)01950-5; Bredt DS, 1999, NAT CELL BIOL, V1, pE89, DOI 10.1038/12085; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; Chen XN, 1999, GENET ANAL-BIOMOL E, V14, P157, DOI 10.1016/S1050-3862(98)00016-3; Chen XN, 1999, GENOME RES, V9, P492; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Daly MJ, 1998, JAMA-J AM MED ASSOC, V280, P652, DOI 10.1001/jama.280.7.652; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Glantz LA, 2001, ARCH GEN PSYCHIAT, V58, P203, DOI 10.1001/archpsyc.58.2.203; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; GOTTESMAN II, 1982, SCHIZOPHRENIA EPIGEN; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443; Hwu HG, 2000, AM J MED GENET, V96, P74, DOI 10.1002/(SICI)1096-8628(20000207)96:1<74::AID-AJMG15>3.3.CO;2-7; Imai K, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-1; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Joo EJ, 1999, PSYCHIATR GENET, V9, P7, DOI 10.1097/00041444-199903000-00002; Karayiorgou M, 1997, MOL PSYCHIATR, V2, P211, DOI 10.1038/sj.mp.4000271; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.3.CO;2-Y; KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Levinson DF, 1996, AM J MED GENET, V67, P580; LEWONTIN RC, 1988, GENETICS, V120, P849; Lindholm E, 1999, AM J MED GENET, V88, P369, DOI 10.1002/(SICI)1096-8628(19990820)88:4<369::AID-AJMG14>3.3.CO;2-0; LINDOR NM, 1994, AM J MED GENET, V54, P1, DOI 10.1002/ajmg.1320540102; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.0.CO;2-R; Maziade M, 2001, MOL PSYCHIATR, V6, P684, DOI 10.1038/sj.mp.4000915; McGinnis RE, 2001, NAT GENET, V28, P128, DOI 10.1038/88839; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; MELO M, 1993, BRIT J PSYCHIAT, V162, P711, DOI 10.1192/bjp.162.5.711b; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Moukhles H, 2001, J NEUROCHEM, V78, P824, DOI 10.1046/j.1471-4159.2001.00466.x; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Mukhopadhyay N, 1999, AM J HUM GENET, V65, pA436; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Pearlson GD, 2000, ANN NEUROL, V48, P556, DOI 10.1002/1531-8249(200010)48:4<556::AID-ANA2>3.3.CO;2-U; Pujana MA, 1997, HUM GENET, V99, P772, DOI 10.1007/s004390050446; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Riley BP, 2000, AM J MED GENET, V97, P23, DOI 10.1002/(SICI)1096-8628(200021)97:1<23::AID-AJMG5>3.0.CO;2-K; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roberts RG, 2001, GENOME BIOL, V2; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Sklar P, 2001, NAT GENET, V28, P126, DOI 10.1038/88836; Sobel E, 1996, AM J HUM GENET, V58, P1323; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Straub RE, 1996, MOL PSYCHIATR, V1, P89; Sullivan PF, 2001, AM J MED GENET, V105, P479, DOI 10.1002/ajmg.1433; Tsuang MT, 1999, HARVARD REV PSYCHIAT, V7, P185, DOI 10.1093/hrp/7.4.185; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Ujike H, 2001, NEUROSCI LETT, V301, P41, DOI 10.1016/S0304-3940(01)01602-0; Vieland VJ, 2001, NAT GENET, V29, P244, DOI 10.1038/ng1101-244; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Wang SB, 1996, AM J HUM GENET, V59, P731; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weinberger DR, 1999, BIOL PSYCHIAT, V45, P395, DOI 10.1016/S0006-3223(98)00331-X; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wright P, 2001, SCHIZOPHR RES, V47, P1, DOI 10.1016/S0920-9964(00)00022-0; ZATZ M, 1993, J MED GENET, V30, P131, DOI 10.1136/jmg.30.2.131; [No title captured]	92	628	658	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					337	348		10.1086/341750			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	WOS:000176977700012	12098102	Bronze, Green Published			2022-01-24	
J	Ye, BH; Cattoretti, G; Shen, QO; Zhang, JD; Hawe, N; deWaard, R; Leung, C; NouriShirazi, M; Orazi, A; Chaganti, RSK; Rothman, P; Stall, AM; Pandolfi, PP; DallaFavera, R				Ye, BH; Cattoretti, G; Shen, QO; Zhang, JD; Hawe, N; deWaard, R; Leung, C; NouriShirazi, M; Orazi, A; Chaganti, RSK; Rothman, P; Stall, AM; Pandolfi, PP; DallaFavera, R			The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation	NATURE GENETICS			English	Article							NON-HODGKINS-LYMPHOMA; FINGER ENCODING GENE; CENTER B-CELLS; INTERACTION MOTIF; IMMUNE-RESPONSES; BTB/POZ DOMAIN; DEFICIENT MICE; ZINC FINGERS; EXPRESSION; RECEPTOR	Structural alterations of the promoter region of the BCL-6 proto-oncogene represent the most frequent genetic alteration associated with non-Hodgkin lymphoma, a malignancy often deriving from germinal-centre B cells. The BCL-6 gene encodes a zinc-finger transcriptional repressor normally expressed in both B cells and CD4(+) T cells within germinal centres, but its precise function is unknown. We show that mice deficient in BCL-6 displayed normal B-cell, T-cell and lymphoid-organ development but have a selective defect in T-cell-dependent antibody responses. This defect included a complete lack of affinity maturation and was due to the inability of follicular B cells to proliferate and form germinal centres. In addition, BCL-6-deficient mice developed an inflammatory response in multiple organs characterized by infiltrations of eosinophils and IgE-bearing B lymphocytes typical of a Th2-mediated hyperimmune response. Thus, BCL-6 functions as a transcriptional switch that controls germinal centre formation and may also modulate specific T-cell-mediated responses. Altered expression of BCL-6 in lymphoma represents a deregulation of the pathway normally leading to B cell proliferation and germinal centre formation.	COLUMBIA UNIV,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT MICROBIOL,NEW YORK,NY 10032; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT BIOL MOL,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,CELL BIOL PROGRAM,NEW YORK,NY 10021; INDIANA UNIV,SCH MED,DEPT PATHOL & LAB MED,INDIANAPOLIS,IN 46202				Nouri-Shirazi, Mahyar/AAG-5663-2020; Cattoretti, Giorgio/H-2340-2011	O'Connor, Nicola/0000-0003-1981-3055; Cattoretti, Giorgio/0000-0003-3799-3221; orazi, attilio/0000-0002-1660-7013			Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; BASTARD C, 1994, BLOOD, V83, P2423; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; CRABBE PA, 1970, LAB INVEST, V22, P448; Dalla-Favera Riccardo, 1996, P139; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DEWEINDT C, 1993, GENE CHROMOSOME CANC, V8, P149, DOI 10.1002/gcc.2870080303; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Dhordain P, 1995, ONCOGENE, V11, P2689; DIBELLO PR, 1991, GENETICS, V129, P385; Flenghi L, 1996, AM J PATHOL, V148, P1543; GAIDANO G, IN PRESS BLOOD; Hardy RR, 1995, ANN NY ACAD SCI, V764, P19; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HONG R, 1987, NELSON TXB PEDIATRIC, P461; ISHIZAKA A, 1990, IMMUNOLOGY, V70, P414; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOIKE M, 1994, INT ARCH ALLERGY IMM, V104, P1, DOI 10.1159/000236702; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LAM KP, 1994, J EXP MED, V180, P507, DOI 10.1084/jem.180.2.507; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; LOCOCO F, 1994, BLOOD, V83, P1757, DOI 10.1182/blood.V83.7.1757.bloodjournal8371757; LUNA LG, 1960, MANUAL HISTOLOGIC ST; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; MIKI T, 1994, BLOOD, V83, P26; Mombaerts P, 1995, Int Rev Immunol, V13, P43, DOI 10.3109/08830189509061737; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; MURRAY AB, 1990, VET PATHOL, V27, P274, DOI 10.1177/030098589002700409; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Orazi A, 1996, LAB INVEST, V75, P33; OTSUKI T, 1995, BLOOD, V85, P2877, DOI 10.1182/blood.V85.10.2877.bloodjournal85102877; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; Seyfert VL, 1996, ONCOGENE, V12, P2331; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; STALL AM, 1997, HDB EXPT IMMUNOLOGY, V2, pCH63; STEIN H, 1992, NEOPLASTIC HEMATOPAT, P675; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WELLS SM, 1994, J IMMUNOL, V153, P5503; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; YE BHH, 1993, CANCER RES, V53, P2732	63	628	642	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					161	170		10.1038/ng0697-161			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	WOS:A1997XB54300016	9171827	Bronze			2022-01-24	
J	HANSSON, JH; NELSONWILLIAMS, C; SUZUKI, H; SCHILD, L; SHIMKETS, R; LU, Y; CANESSA, C; IWASAKI, T; ROSSIER, B; LIFTON, RP				HANSSON, JH; NELSONWILLIAMS, C; SUZUKI, H; SCHILD, L; SHIMKETS, R; LU, Y; CANESSA, C; IWASAKI, T; ROSSIER, B; LIFTON, RP			HYPERTENSION CAUSED BY A TRUNCATED EPITHELIAL SODIUM-CHANNEL GAMMA-SUBUNIT - GENETIC-HETEROGENEITY OF LIDDLE SYNDROME	NATURE GENETICS			English	Article							ALDOSTERONE SYNTHASE; MOLECULAR-GENETICS; DIABETES-MELLITUS; BLOOD-PRESSURE; DNA; COSEGREGATION; GLUCOKINASE; MUTATIONS; LINKAGE; HOMOLOG	Sensitivity of blood pressure to dietary salt is a common feature in subjects with hypertension. These features are exemplified by the mendelian disorder, Liddle's syndrome, previously shown to arise from constitutive activation of the renal epithelial sodium channel due to mutation in the beta subunit of this channel. We now demonstrate that this disease can also result from a mutation truncating the carboxy terminus of the gamma subunit of this channel; this truncated subunit also activates channel activity. These findings demonstrate genetic heterogeneity of Liddle's syndrome, indicate independent roles of beta and gamma subunits in the negative regulation of channel activity, and identify a new gene in which mutation causes a salt-sensitive form of human hypertension.	YALE UNIV, SCH MED, BOYER CTR MOLEC MED, HOWARD HUGHES MED INST, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, BOYER CTR MOLEC MED, DEPT MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, BOYER CTR MOLEC MED, DEPT GENET, NEW HAVEN, CT 06510 USA; HYOGO MED UNIV, DEPT INTERNAL MED 1, NISHINOMIYA, HYOGO 663, JAPAN; UNIV LAUSANNE, INST PHARMACOL & TOXICOL, CH-1005 LAUSANNE, SWITZERLAND; YALE UNIV, SCH MED, DEPT PHYSIOL, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, DEPT MED, NEW HAVEN, CT 06520 USA								BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; FUKUTAKE N, 1988, J JAP SOC INT MED, V77, P441; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRIS EL, 1993, AM J HYPERTENS, V6, P330, DOI 10.1093/ajh/6.4.330; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Lifton Richard P., 1995, P2163; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; LINDPAINTNER K, 1993, J HYPERTENS, V11, P19, DOI 10.1097/00004872-199301000-00004; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; NABLKA T, 1995, HYPERTENSION, V25, P6; NATHANS J, 1992, J GEN PHYSIOL, V47, P110; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; RENARD S, 1994, J BIOL CHEM, V269, P12981; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X	35	628	640	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1995	11	1					76	82		10.1038/ng0995-76			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	WOS:A1995RR72800019	7550319				2022-01-24	
J	Schultheis, PJ; Clarke, LL; Meneton, P; Miller, ML; Soleimani, M; Gawenis, LR; Riddle, TM; Duffy, JJ; Doetschman, T; Wang, T; Giebisch, G; Aronson, PS; Lorenz, JN; Shull, GE				Schultheis, PJ; Clarke, LL; Meneton, P; Miller, ML; Soleimani, M; Gawenis, LR; Riddle, TM; Duffy, JJ; Doetschman, T; Wang, T; Giebisch, G; Aronson, PS; Lorenz, JN; Shull, GE			Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger	NATURE GENETICS			English	Article							BLOOD-PRESSURE; BRUSH-BORDER; HYPOKALEMIC ALKALOSIS; BARTTERS-SYNDROME; EXPRESSION; MUTATIONS; ISOFORM; COTRANSPORTER; TRANSPORT; MEMBRANE	NHE3 is one of five plasma membrane Na+/H+ exchangers(1-3) and is encoded by the mouse gene Slc9a3. It is expressed on apical membranes of renal proximal tubule(4,5) and intestinal epithelial cells(6,7) and is thought to play a major role in NaCl and HCO3- absorption(4-10). As the distribution of NHE3 overlaps with that of the NHE2 isoform in kidney(7,11) and intestine(7,12,13), the function and relative importance of NHE3 in vivo is unclear. To analyse its physiological functions, we generated mice lacking NHE3 function. Homozygous mutant (Slc9a3(-/-)) mice survive, but they have slight diarrhoea and blood analysis revealed that they are mildly acidotic. HCO3- and fluid absorption are sharply reduced in proximal convoluted tubules, blood pressure is reduced and there is a severe absorptive defect in the intestine. Thus, compensatory mechanisms must limit gross perturbations of electrolyte and acid-base balance. Plasma aldosterone is increased in NHE3-deficient mice, and expression of both renin and the AE1 (Slc4a1) Cl-/HCO3- exchanger mRNAs are induced in kidney. In the colon, epithelial Na+ channel activity is increased and colonic H+.K+-ATPase mRNA is massively induced. These data show that NHE3 is the major absorptive Na+/H+ exchanger in kidney and intestine, and that lack of the exchanger impairs acid-base balance and Na+-fluid volume homeostasis.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Physiol, Cincinnati, OH 45267 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; Univ Missouri, Dept Vet Biomed Sci, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA		Shull, GE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.		Meneton, Pierre/T-1216-2019; Clarke, Lane L/AAK-2866-2020	Clarke, Lane L/0000-0002-4938-6261	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL041496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK050594, R56DK048816, R01DK048816, R29DK048816, R37DK050594] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL41496] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK48816, DK50594, R29 DK048816] Funding Source: Medline		AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Aronson PS, 1997, AM J PHYSIOL-RENAL, V273, pF179, DOI 10.1152/ajprenal.1997.273.2.F179; Azuma KK, 1996, AM J PHYSIOL-CELL PH, V270, pC585, DOI 10.1152/ajpcell.1996.270.2.C585; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Bookstein C, 1997, AM J PHYSIOL-CELL PH, V273, pC1496, DOI 10.1152/ajpcell.1997.273.5.C1496; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Clarke LL, 1996, AM J PHYSIOL-GASTR L, V270, pG259, DOI 10.1152/ajpgi.1996.270.2.G259; DASILVA JCT, 1991, AM J PHYSIOL, V260, pF204, DOI 10.1152/ajprenal.1991.260.2.F204; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; FELL JM, 1992, J PEDIATR GASTR NUTR, V15, P112, DOI 10.1097/00005176-199208000-00002; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; KAUNITZ JD, 1995, TXB GASTROENTEROLOGY, P326; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; Meneton P, 1998, J CLIN INVEST, V101, P536, DOI 10.1172/JCI1720; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; POWELL DW, 1995, TXB GASTROENTEROLOGY, P813; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; TSE CM, 1992, J BIOL CHEM, V267, P9340; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WANG T, 1990, J PHARMACOL EXP THER, V252, P689; Wu MS, 1996, J BIOL CHEM, V271, P32749, DOI 10.1074/jbc.271.51.32749; YUN CHC, 1993, J BIOL CHEM, V268, P206	30	627	635	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					282	285		10.1038/969			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	WOS:000074565900028	9662405				2022-01-24	
J	Wang, K; Li, MY; Bucan, M				Wang, Kai; Li, Mingyao; Bucan, Maja			Pathway-based approaches for analysis of genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSONS-DISEASE; STATISTICS; EXPRESSION; GLUTAMATE; FALSE; TESTS; SCANS; POWER	Published genomewide association (GWA) studies typically analyze and report single-nucleotide polymorphisms (SNPs) and their neighboring genes with the strongest evidence of association (the "most-significant SNPs/genes" approach), while paying little attention to the rest. Borrowing ideas from microarray data analysis, we demonstrate that pathway-based approaches, which jointly consider multiple contributing factors in the same pathway, might complement the most-significant SNPs/genes approach and provide additional insights into interpretation of GWA data on complex diseases.	Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA		Wang, K (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	kai@mail.med.upenn.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH604687] Funding Source: Medline		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Espinosa B, 2001, J NEUROPATH EXP NEUR, V60, P441, DOI 10.1093/jnen/60.5.441; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLLANDER M., 1999, NONPARAMETRIC STAT M; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lee G, 2004, PHARM RES-DORDR, V21, P1313, DOI 10.1023/B:PHAM.0000036905.82914.8e; Lefebvre T, 2005, EXPERT REV PROTEOMIC, V2, P265, DOI 10.1586/14789450.2.2.265; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Marino MJ, 2003, DRUG AGING, V20, P377, DOI 10.2165/00002512-200320050-00006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wille A, 2003, GENET EPIDEMIOL, V25, P350, DOI 10.1002/gepi.10263; Zaykin DV, 2005, GENETICS, V171, P813, DOI 10.1534/genetics.105.044206	29	625	653	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1278	1283		10.1086/522374			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	WOS:000251098800013	17966091	Green Published, Bronze			2022-01-24	
J	Buaas, FW; Kirsh, AL; Sharma, M; McLean, DJ; Morris, JL; Griswold, MD; de Rooij, DG; Braun, RE				Buaas, FW; Kirsh, AL; Sharma, M; McLean, DJ; Morris, JL; Griswold, MD; de Rooij, DG; Braun, RE			Plzf is required in adult male germ cells for stem cell self-renewal	NATURE GENETICS			English	Article							ZINC-FINGER PROTEIN; PROMYELOCYTIC LEUKEMIA; GENE-EXPRESSION; MOUSE; DIFFERENTIATION; PROLIFERATION; EMBRYO; BMI-1; MAP	Adult germline stem cells are capable of self-renewal, tissue regeneration and production of large numbers of differentiated progeny. We show here that the classical mouse mutant luxoid affects adult germline stem cell self-renewal. Young homozygous luxoid mutant mice produce limited numbers of normal spermatozoa and then progressively lose their germ line after birth. Transplantation studies showed that germ cells from mutant mice did not colonize recipient testes, suggesting that the defect is intrinsic to the stem cells. We determined that the luxoid mutant contains a nonsense mutation in the gene encoding Plzf, a transcriptional repressor that regulates the epigenetic state of undifferentiated cells, and showed that Plzf is coexpressed with Oct4 in undifferentiated spermatogonia. This is the first gene shown to be required in germ cells for stem cell self-renewal in mammals.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Fac Biol, Dept Endocrinol, NL-3584 CH Utrecht, Netherlands		Braun, RE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Box 357730,1705 NE Pacific St, Seattle, WA 98195 USA.	braun@u.washington.edu	de Rooij, D.G./AAW-1195-2021	McLean, Derek/0000-0001-6151-2796; de Rooij, Dirk/0000-0003-3932-4419			BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; FORSTHOEFEL PAULINUS FREDERICK, 1958, J MORPH, V102, P247, DOI 10.1002/jmor.1051020203; GREEN MARGARET C., 1955, JOUR HEREDITY, V46, P91; Hawe N, 1996, BLOOD, V88, P1151; JOHNSON DR, 1971, J EMBRYOL EXP MORPH, V25, P223; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OBRIEN DA, 1980, DEV BIOL, V75, P405, DOI 10.1016/0012-1606(80)90172-4; Ohmura M, 2003, BIOL REPROD, V68, P2304, DOI 10.1095/biolreprod.102.013276; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; REID A, 1995, BLOOD, V86, P4544, DOI 10.1182/blood.V86.12.4544.bloodjournal86124544; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	29	625	661	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					647	652		10.1038/ng1366			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	WOS:000221763700025	15156142	Bronze, Green Submitted			2022-01-24	
J	Thibault, ST; Singer, MA; Miyazaki, WY; Milash, B; Dompe, NA; Singh, CM; Buchholz, R; Demsky, M; Fawcett, R; Francis-Lang, HL; Ryner, L; Cheung, LM; Chong, A; Erickson, C; Fisher, WW; Greer, K; Hartouni, SR; Howie, E; Jakkula, L; Joo, D; Killpack, K; Laufer, A; Mazzotta, J; Smith, RD; Stevens, LM; Stuber, C; Tan, LR; Ventura, R; Woo, A; Zakrajsek, I; Zhao, L; Chen, F; Swimmer, C; Kopczynski, C; Duyk, G; Winberg, ML; Margolis, J				Thibault, ST; Singer, MA; Miyazaki, WY; Milash, B; Dompe, NA; Singh, CM; Buchholz, R; Demsky, M; Fawcett, R; Francis-Lang, HL; Ryner, L; Cheung, LM; Chong, A; Erickson, C; Fisher, WW; Greer, K; Hartouni, SR; Howie, E; Jakkula, L; Joo, D; Killpack, K; Laufer, A; Mazzotta, J; Smith, RD; Stevens, LM; Stuber, C; Tan, LR; Ventura, R; Woo, A; Zakrajsek, I; Zhao, L; Chen, F; Swimmer, C; Kopczynski, C; Duyk, G; Winberg, ML; Margolis, J			A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac	NATURE GENETICS			English	Article							INSERTIONAL MUTAGENESIS; FLP RECOMBINASE; GENOME PROJECT; ELEMENT; GENE; TRANSFORMATION; SEQUENCE; PROTEIN; RNA	With the availability of complete genome sequence for Drosophila melanogaster, one of the next strategic goals for fly researchers is a complete gene knockout collection. The P element transposon(1), the workhorse of D. melanogaster molecular genetics, has a pronounced nonrandom insertion spectrum(2). It has been estimated that 87% saturation of the 13,500-gene complement of D. melanogaster(3) might require generating and analyzing up to 150,000 insertions(2). We describe specific improvements to the lepidopteran transposon piggyBac(4) and the P element that enabled us to tag and disrupt genes in D. melanogaster more efficiently. We generated over 29,000 inserts resulting in 53% gene saturation and a more diverse collection of phenotypically stronger insertional alleles. We found that piggyBac has distinct global and local gene-tagging behavior from that of P elements. Notably, piggyBac excisions from the germ line are nearly always precise, piggyBac does not share chromosomal hotspots associated with P and piggyBac is more effective at gene disruption because it lacks the P bias for insertion in 5' regulatory sequences.	Exelixis, San Francisco, CA 94083 USA		Thibault, ST (corresponding author), Exelixis, 170 Harbor Way, San Francisco, CA 94083 USA.	thibault@exelixis.com	Wilson, Matthew H/K-3193-2013				Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M., 1989, DROSOPHILA LAB HDB; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Goodwin SF, 2000, GENETICS, V154, P725; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P111, DOI 10.1016/S0965-1748(00)00159-4; Horn C, 2003, GENETICS, V163, P647; HOROWITZ H, 1995, GENETICS, V139, P327; KIM YJ, 1992, GENE DEV, V6, P2569, DOI 10.1101/gad.6.12b.2569; PARKS AL, 2004, NAT GENET       0222; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROSEMAN RR, 1995, GENETICS, V141, P1061; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; SERANO T, 1995, DEVELOPMENT, V121, P3809; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; THEURKAUF WE, 1986, P NATL ACAD SCI USA, V83, P8477, DOI 10.1073/pnas.83.22.8477; ZHANG P, 1993, GENETICS, V133, P361	26	625	635	1	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2004	36	3					283	287		10.1038/ng1314			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	WOS:000189250400018	14981521	Bronze			2022-01-24	
J	Dabora, SL; Jozwiak, S; Franz, DN; Roberts, PS; Nieto, A; Chung, J; Choy, YS; Reeve, MP; Thiele, E; Egelhoff, JC; Kasprzyk-Obara, J; Domanska-Pakiela, D; Kwiatkowski, DJ				Dabora, SL; Jozwiak, S; Franz, DN; Roberts, PS; Nieto, A; Chung, J; Choy, YS; Reeve, MP; Thiele, E; Egelhoff, JC; Kasprzyk-Obara, J; Domanska-Pakiela, D; Kwiatkowski, DJ			Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRUNCATION TEST PTT; GERMLINE MUTATIONS; UNRELATED PATIENTS; GENE; COMPLEX; HAMARTOMAS; MOSAICISM; DIAGNOSIS; FREQUENCY; DELETIONS	Tuberous sclerosis (TSC) is a relatively common hamartoma syndrome caused by mutations in either of two genes, TSC1 and TSC2. Here we report comprehensive mutation analysis in 224 index patients with TSC and correlate mutation findings with clinical features, Denaturing high-performance liquid chromatography, long-range polymerase chain reaction (PCR), and quantitative PCR were used for mutation detection. Mutations were identified in 186 (83%) of 224 of cases, comprising 138 small TSC2 mutations, 20 large TSC2 mutations, and 28 small TSC1 mutations. A standardized clinical assessment instrument covering 16 TSC manifestations was used. Sporadic patients with TSC1 mutations had, on average, milder disease in comparison with patients with TSC2 mutations, despite being of similar age. They had a lower frequency of seizures and moderate-to-severe mental retardation, fewer subependymal nodules and cortical tubers, less-severe kidney involvement, no retinal hamartomas, and less-severe facial angiofibroma. Patients in whom no mutation was found also had disease that was milder, on average, than that in patients with TSC2 mutations and was somewhat distinct from patients with TSC1 mutations. Although there was overlap in the spectrum of many clinical features of patients with TSC1 versus TSC2 mutations, some features (grade 2-4 kidney cysts or angiomyolipomas, forehead plaques, retinal hamartomas, and liver angiomyolipomas) were very rare or not seen at all in TSC1 patients. Thus both germline and somatic mutations appear to be less common in TSC1 than in TSC2. The reduced severity of disease in patients without defined mutations suggests that many of these patients are mosaic for a TSC2 mutation and/or have TSC because of mutations in an as-yet-unidentified locus with a relatively mild clinical phenotype.	Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Neurol, Boston, MA 02115 USA; Childrens Hosp, Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; Childrens Mem Hosp, Dept Child Neurol, Warsaw, Poland		Dabora, SL (corresponding author), Brigham & Womens Hosp, Div Hematol, Genet Lab, 221 Longwood Ave,LMRC 301, Boston, MA 02115 USA.	sdabora@rics.bwh.harvard.edu; dk@zk.bwh.harvard.edu	/AAD-2267-2020	/0000-0003-4810-4434	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R33CA086248, K08CA071445, R21CA086248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031535, R37NS031535] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R33 CA086248, R21 CA086248, CA71445, CA86248] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS031535, R37 NS031535, NS31535] Funding Source: Medline		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Beauchamp RL, 1998, HUM MUTAT, V12, P408, DOI 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.3.CO;2-G; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Choy YS, 1999, ANN HUM GENET, V63, P383, DOI 10.1046/j.1469-1809.1999.6350383.x; Dabora SL, 1998, ANN HUM GENET, V62, P491, DOI 10.1046/j.1469-1809.1998.6260491.x; Dabora SL, 2000, J MED GENET, V37, P877, DOI 10.1136/jmg.37.11.877; Eussen BHJ, 2000, J MED GENET, V37, P287, DOI 10.1136/jmg.37.4.287; Ewalt DH, 1998, J UROLOGY, V160, P141, DOI 10.1016/S0022-5347(01)63072-6; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; Goodman M, 1997, J CHILD NEUROL, V12, P85, DOI 10.1177/088307389701200203; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Jones AC, 2000, HUM GENET, V106, P663, DOI 10.1007/s004390050040; JOZWIAK S, 1994, EUR J PEDIATR, V153, P155, DOI 10.1007/s004310050110; Jozwiak S, 1998, INT J DERMATOL, V37, P911; JOZWIAK S, 1992, ARCH DIS CHILD, V67, P1363, DOI 10.1136/adc.67.11.1363; Kim KK, 1995, CELL MOL BIOL RES, V41, P515; KOBAYASHI T, 1995, NUCLEIC ACIDS RES, V23, P2608, DOI 10.1093/nar/23.14.2608; Kwiatkowska J, 1998, ANN HUM GENET, V62, P277, DOI 10.1046/j.1469-1809.1998.6240277.x; Kwiatkowska J, 1999, NEW ENGL J MED, V340, P703, DOI 10.1056/NEJM199903043400905; KWIATKOWSKI DJ, 1994, ARCH DERMATOL, V130, P348, DOI 10.1001/archderm.130.3.348; Maheshwar MM, 1996, HUM MOL GENET, V5, P131, DOI 10.1093/hmg/5.1.131; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Mayer K, 1999, HUM MUTAT, V14, P401, DOI 10.1002/(SICI)1098-1004(199911)14:5<401::AID-HUMU6>3.0.CO;2-R; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; O'Callaghan FJK, 2000, J MED GENET, V37, P156, DOI 10.1136/jmg.37.2.156; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; van Slegtenhorst M, 1999, J MED GENET, V36, P285; vanBakel I, 1997, HUM MOL GENET, V6, P1409, DOI 10.1093/hmg/6.9.1409; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verhoef S, 1999, AM J HUM GENET, V64, P1632, DOI 10.1086/302412; Webb DW, 1996, BRIT J DERMATOL, V135, P1; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550; Young JM, 1998, ANN HUM GENET, V62, P203, DOI 10.1046/j.1469-1809.1998.6230203.x; [No title captured]	45	624	663	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					64	80		10.1086/316951			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	WOS:000166399900006	11112665	Green Published, Bronze			2022-01-24	
J	Lee, SH; Wray, NR; Goddard, ME; Visscher, PM				Lee, Sang Hong; Wray, Naomi R.; Goddard, Michael E.; Visscher, Peter M.			Estimating Missing Heritability for Disease from Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON SNPS EXPLAIN; LARGE PROPORTION; INFORMATION; LIABILITY; VARIANCE	Genome-wide association studies are designed to discover SNPs that are associated with a complex trait. Employing strict significance thresholds when testing individual SNPs avoids false positives at the expense of increasing false negatives. Recently, we developed a method for quantitative traits that estimates the variation accounted for when fitting all SNPs simultaneously. Here we develop this method further for case-control studies. We use a linear mixed model for analysis of binary traits and transform the estimates to a liability scale by adjusting both for scale and for ascertainment of the case samples. We show by theory and simulation that the method is unbiased. We apply the method to data from the Wellcome Trust Case Control Consortium and show that a substantial proportion of variation in liability for Crohn disease, bipolar disorder, and type I diabetes is tagged by common SNPs.	[Lee, Sang Hong; Wray, Naomi R.; Visscher, Peter M.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic 3086, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic 3010, Australia		Visscher, PM (corresponding author), Queensland Inst Med Res, 300 Herston Rd, Herston, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Visscher, Peter/ABB-6151-2020; Wray, Naomi/C-8639-2015; Lee, Sang Hong/A-2569-2011; Austin, Eric Douglas/A-6070-2013	Visscher, Peter/0000-0002-2143-8760; Wray, Naomi/0000-0001-7421-3357; Lee, Sang Hong/0000-0001-9701-2718; Austin, Eric Douglas/0000-0002-1709-9022; Goddard, Michael/0000-0001-9917-7946	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [389892, 442915, 496688, 613672, 613601]; Australian Research CouncilAustralian Research Council [DP0770096, DP1093900]; Wellcome TrustWellcome TrustEuropean Commission [076113]; Netherlands Scientific Organization [NWO 480-05-003]	We acknowledge funding from the Australian National Health and Medical Research Council (Grants 389892, 442915, 496688, 613672, and 613601) and the Australian Research Council (Grants DP0770096 and DP1093900 and Future Fellowship to N.R.W.). This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the WTCCC data is available from www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. We thank Stuart Macgregor for useful discussions and suggestions. S.H.L. acknowledges the use of the Genetic Cluster Computer for carrying out simulations. The cluster is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). We thank the referees for many helpful comments and suggestions.	Barr DR, 1999, AM STAT, V53, P357, DOI 10.2307/2686057; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; DEMPSTER ER, 1950, GENETICS, V35, P212; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Gilmour A. R., 2006, ASREML USER GUIDE RE; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; GILMOUR AR, 1985, BIOMETRIKA, V72, P593, DOI 10.1093/biomet/72.3.593; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Gottesman II, 2010, ARCH GEN PSYCHIAT, V67, P252, DOI 10.1001/archgenpsychiatry.2010.1; Henderson CR., 1984, APPL LINEAR MODELS A; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Lee SH, 2010, GENET EPIDEMIOL, V34, P854, DOI 10.1002/gepi.20541; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lynch M., 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; SCHALL R, 1991, BIOMETRIKA, V78, P719; VANVLECK LD, 1972, J DAIRY SCI, V55, P218, DOI 10.3168/jds.S0022-0302(72)85463-8; VENABLES WN, 2010, INTRO R VERSION 2 11; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	31	623	635	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					294	305		10.1016/j.ajhg.2011.02.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	WOS:000288589000007	21376301	Bronze, Green Published	Y	N	2022-01-24	
J	Kao, CH; Zeng, ZB; Teasdale, RD				Kao, CH; Zeng, ZB; Teasdale, RD			Multiple interval mapping for quantitative trait loci	GENETICS			English	Article							RESIDUAL MAXIMUM-LIKELIHOOD; SIMPLE REGRESSION METHOD; LINE CROSSES; OUTCROSS POPULATIONS; BAYESIAN-ANALYSIS; GENETIC-MARKERS; PRIOR KNOWLEDGE; EM ALGORITHM; LINKAGE; MODEL	A new statistical method for mapping quantitative trait loci (QTL), called multiple interval mapping (MIM), is presented. It uses multiple marker intervals simultaneously to fit multiple putative QTL directly in the model for mapping QTL. The MIM model is based on Cockerham's model for interpreting genetic parameters and the method of maximum likelihood for estimating genetic parameters. With the MIM approach, the precision and power of QTL mapping could be improved. Also, epistasis between QTL, genotypic values of individuals, and heritabilities of quantitative traits can be readily estimated and analyzed. Using the MIM model, a stepwise selection procedure with likelihood ratio test statistic as a criterion is proposed to identify QTL. This MIM method was applied to a mapping data set of radiata pine on three traits: brown cone number, tree diameter, and branch quality scores. Based on the MIM result, seven, six, and five QTL were detected for the three traits, respectively. The detected QTL individually contributed from similar to 1 to 27% of the total genetic variation. Significant epistasis between four pairs of QTL in two traits was detected, and the four pairs of QTL contributed similar to 10.38 and 14.14% of the total genetic variation. The asymptotic variances of QTL positions and effects were also provided to construct the confidence intervals. The estimated heritabilities were 0.5606, 0.5226, and 0.3630 for the three traits, respectively. With the estimated QTL effects and positions, the best strategy of marker-assisted selection for trait improvement for a specific purpose and requirement can be explored. The MIM FORTRAN program is available on the worldwide web (http://www,stat.sinica.edu.tw/similar to chkao/).	Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; N Carolina State Univ, Dept Stat, Program Stat Genet, Raleigh, NC 27695 USA; Forbio Res Pty Ltd, Toowong, Qld 4066, Australia		Kao, CH (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.		Kao, Chen-Hung/AAQ-5374-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-45344] Funding Source: Medline		AITKEN KS, 1997, FRI B, V203, P337; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ATKINSON AC, 1980, BIOMETRIKA, V67, P413, DOI 10.2307/2335484; CARBONELL EA, 1992, BIOMETRICS, V48, P305, DOI 10.2307/2532757; CHURCHILL GA, 1994, GENETICS, V138, P967; DARVASI A, 1993, GENETICS, V134, P943; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DOERGE RW, 1996, GENETICS, V142, P284; Draper N., 1981, APPL REGRESSION ANAL, V2nd; Dupuis J, 1999, GENETICS, V151, P373; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Grattapaglia D, 1996, GENETICS, V144, P1205; GRATTAPAGLIA D, 1994, GENETICS, V137, P121; Grignola FE, 1996, GENET SEL EVOL, V28, P491, DOI 10.1051/gse:19960603; Grignola FE, 1996, GENET SEL EVOL, V28, P479, DOI 10.1051/gse:19960602; Hackett CA, 1995, BIOMETRICS, V51, P1252, DOI 10.2307/2533257; Haldane JBS, 1919, J GENET, V8, P299; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HOESCHELE I, 1993, THEOR APPL GENET, V85, P946, DOI 10.1007/BF00215033; HOESCHELE I, 1993, THEOR APPL GENET, V85, P953, DOI 10.1007/BF00215034; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; JAYAKAR SD, 1970, BIOMETRICS, V26, P451, DOI 10.2307/2529101; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; KAO C, 1995, THESIS N CAROLINA ST; KAO CH, 1997, BIOMETRICS, V53, P359; Kleinbaum DG., 1988, APPL REGRESSION ANAL, Vvol 601; LANDER ES, 1989, GENETICS, V121, P185; Li ZK, 1997, GENETICS, V145, P453; Lincoln SE, 1993, CONSTRUCTING GENETIC; Little RJA., 1987, STAT ANAL MISSING DA; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; Miller A.J, 1990, SUBSET SELECTION REG; Satagopan JM, 1996, GENETICS, V144, P805; Sax K, 1923, GENETICS, V8, P552; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sillanpaa MJ, 1998, GENETICS, V148, P1373; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; TERASVIRTA T, 1986, SCAND J STAT, V13, P159; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; Visscher PM, 1996, THEOR APPL GENET, V93, P691, DOI 10.1007/BF00224064; Weir BS, 1996, GENETIC DATA ANAL; XU SH, 1995, GENETICS, V141, P1189; XU SH, 1995, GENETICS, V141, P1657; Xu SZ, 1996, GENETICS, V143, P1417; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	48	623	695	2	61	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JUL	1999	152	3					1203	1216					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214RT	WOS:000081341900031	10388834				2022-01-24	
J	Yang, J; Ferreira, T; Morris, AP; Medland, SE; Madden, PAF; Heath, AC; Martin, NG; Montgomery, GW; Weedon, MN; Loos, RJ; Frayling, TM; McCarthy, MI; Hirschhorn, JN; Goddard, ME; Visscher, PM				Yang, Jian; Ferreira, Teresa; Morris, Andrew P.; Medland, Sarah E.; Madden, Pamela A. F.; Heath, Andrew C.; Martin, Nicholas G.; Montgomery, Grant W.; Weedon, Michael N.; Loos, Ruth J.; Frayling, Timothy M.; McCarthy, Mark I.; Hirschhorn, Joel N.; Goddard, Michael E.; Visscher, Peter M.		Genetic Invest ANthropometric Trai; DIAbet Genetics Replication Meta-A	Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON SNPS; SUSCEPTIBILITY LOCI; GENETIC-VARIATION; HUMAN HEIGHT; HERITABILITY; DISEASE; RISK; MAP	We present an approximate conditional and joint association analysis that can use summary-level statistics from a meta-analysis of genome-wide association studies (GWAS) and estimated linkage disequilibrium (LD) from a reference sample with individual-level genotype data. Using this method, we analyzed meta-analysis summary data from the GIANT Consortium for height and body mass index (BMI), with the LD structure estimated from genotype data in two independent cohorts. We identified 36 loci with multiple associated variants for height (38 leading and 49 additional SNPs, 87 in total) via a genome-wide SNP selection procedure. The 49 new SNPs explain approximately 1.3% of variance, nearly doubling the heritability explained at the 36 loci. We did not find any locus showing multiple associated SNPs for BMI. The method we present is computationally fast and is also applicable to case-control data, which we demonstrate in an example from meta-analysis of type 2 diabetes by the DIAGRAM Consortium.	[Yang, Jian; Medland, Sarah E.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Ferreira, Teresa; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Madden, Pamela A. F.; Heath, Andrew C.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Loos, Ruth J.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [McCarthy, Mark I.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Broad Inst, Cambridge, MA USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia		Visscher, PM (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	peter.visscher@uq.edu.au	Loos, Ruth J F/Q-2862-2016; Meitinger, Thomas/O-1318-2015; Medland, Sarah E/C-7630-2013; Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020; Martin, Nicholas/R-9235-2019; Yang, Jian/A-5852-2010; Medland, Sarah/AAT-7595-2020; McCarthy, Mark/M-3763-2015	Loos, Ruth J F/0000-0002-8532-5087; Medland, Sarah E/0000-0003-1382-380X; Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760; Martin, Nicholas/0000-0003-4069-8020; Yang, Jian/0000-0003-2001-2474; Medland, Sarah/0000-0003-1382-380X; Weedon, Michael/0000-0002-6174-6135; Goddard, Michael/0000-0001-9917-7946; McCarthy, Mark/0000-0002-4393-0510	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672, 613601, 1011506]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854, HHSN268200625226C]; Australian Research Council (ARC)Australian Research Council [DP0770096, DP1093502]; Wellcome TrustWellcome TrustEuropean Commission [WT081682/Z/06/Z, WT083270]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; XXX [R01HL087641, R01HL59367, R01HL086694]; US National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004402]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1RR025005]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U106188470] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U106188470] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL059367, R01HL086694, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA013320, R01AA013321, R01AA014041, R01AA007535, R01AA013326, K05AA017688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R56DA012854, R01DA012854] Funding Source: NIH RePORTER	The authors thank the staff and participants of the ARIC study for their important contributions. We thank all referees for many constructive comments and suggestions. We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC; 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672, 613601 and 1011506), the US National Institutes of Health (AA07535, AA10248, AA014041, AA13320, AA13321, AA13326 and DA12854) and the Australian Research Council (ARC; DP0770096 and DP1093502). A.P.M. acknowledges financial support from the Wellcome Trust (WT081682/Z/06/Z). M.I.M. acknowledges financial support from the Wellcome Trust (WT083270). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by contracts with the National Heart, Lung, and Blood Institute (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C), the XXX (R01HL087641, R01HL59367 and R01HL086694), the US National Human Genome Research Institute (U01HG004402) and the US National Institutes of Health (HHSN268200625226C). Infrastructure was partly supported by a component of the US National Institutes of Health and NIH Roadmap for Medical Research (UL1RR025005).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Magnusson P. K. E., 2002, International Journal of Obesity, V26, P1225, DOI 10.1038/sj.ijo.0802041; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Pardo L, 2009, EUR J HUM GENET, V17, P802, DOI 10.1038/ejhg.2008.248; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sonesson AK, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-41; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weir BS, 1990, GENETIC DATA ANAL; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	33	622	628	9	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					369	U170		10.1038/ng.2213			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	WOS:000302130600008	22426310	Green Accepted	Y	N	2022-01-24	
J	Borrow, J; Stanton, VP; Andresen, JM; Becher, R; Behm, FG; Chaganti, RSK; Civin, CI; Disteche, C; Dube, I; Frischauf, AM; Horsman, D; Mitelman, F; Volinia, S; Watmore, AE; Housman, DE				Borrow, J; Stanton, VP; Andresen, JM; Becher, R; Behm, FG; Chaganti, RSK; Civin, CI; Disteche, C; Dube, I; Frischauf, AM; Horsman, D; Mitelman, F; Volinia, S; Watmore, AE; Housman, DE			The translocation t(8;l6)(p11, p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein	NATURE GENETICS			English	Article							TRANSCRIPTIONAL COACTIVATOR CBP; RUBINSTEIN-TAYBI SYNDROME; T(8 16)(P11 P13); SACCHAROMYCES-CEREVISIAE; SHORT ARM; GENE; LEUKEMIA; YEAST; FINGER; ACETYLATION	The recurrent translocation t(8;16)(p11;p13) is a cytogenetic hallmark for the M4/M5 subtype of acute myeloid leukaemia. Here we identify the breakpoint-associated genes. Positional cloning on chromosome 16 implicates the CREB-binding protein (CBP), a transcriptional adaptor/coactivator protein. At the chromosome 8 breakpoint we identify a novel gene, MOZ, which encodes a 2,004-amino-acid protein characterized by two C4HC3 zinc fingers and a single C2HC zinc finger in conjunction with a putative acetyltransferase signature. In-frame MOZ-CBP fusion transcripts combine the MOZ finger motifs and putative acetyltransferase domain with a largely intact CBP. We suggest that MOZ may represent a chromatin-associated acetyltransferase, and raise the possibility that a dominant MOZ-CBP fusion protein could mediate leukaemogenesis via aberrant chromatin acetylation.	W GERMAN CANC CTR, D-45122 ESSEN 1, GERMANY; ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA; MEM SLOAN KETTERING CANC CTR, NEW YORK, NY 10021 USA; JOHNS HOPKINS ONCOL CTR, BALTIMORE, MD 21287 USA; UNIV WASHINGTON, MED CTR, SEATTLE, WA 98195 USA; UNIV TORONTO, SUNNYBROOK HLTH SCI CTR, TORONTO, ON M4N 3M5, CANADA; IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND; BRITISH COLUMBIA CANC AGCY, VANCOUVER, BC V5Z 4E6, CANADA; UNIV LUND HOSP, DEPT CLIN GENET, S-22185 LUND, SWEDEN; UNIV FERRARA, I-44100 FERRARA, ITALY; CTR HUMAN GENET, SHEFFIELD S10 5DN, S YORKSHIRE, ENGLAND		Borrow, J (corresponding author), MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA.		Volinia, Stefano/AAA-9264-2019; Volinia, Stefano/A-3029-2010	Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Stanton, Vincent/0000-0002-2205-6000; Andresen, J. Michael/0000-0002-8791-1266	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA034775, U10CA028476, U10CA031566] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 34775, 5U01 CA31566, 5U01 CA28476] Funding Source: Medline		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; ALTABA AR, 1987, EMBO J, V6, P3065, DOI 10.1002/j.1460-2075.1987.tb02613.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1988, CANCER GENET CYTOGEN, V30, P1; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BALDARELLI RM, 1988, DEV BIOL, V125, P85, DOI 10.1016/0012-1606(88)90061-9; BELLOMO MJ, 1992, BRIT J HAEMATOL, V81, P307, DOI 10.1111/j.1365-2141.1992.tb08225.x; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BUCHMAN VL, 1992, NUCLEIC ACIDS RES, V20, P5579, DOI 10.1093/nar/20.21.5579; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DIB A, 1995, ONCOGENE, V10, P995; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; GABIG TG, 1994, J BIOL CHEM, V269, P29515; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; HANSLIP JJ, 1992, LEUKEMIA LYMPHOMA, V6, P479, DOI 10.3109/10428199209053586; HIMMELBAUER H, 1991, AM J HUM GENET, V48, P325; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; INHORN RC, 1995, BLOOD, V85, P1881, DOI 10.1182/blood.V85.7.1881.bloodjournal8571881; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; KOKEN MHM, 1995, CR ACAD SCI III-VIE, V318, P733; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAI JL, 1992, CANCER GENET CYTOGEN, V60, P180, DOI 10.1016/0165-4608(92)90013-X; LEE FJS, 1989, J BACTERIOL, V171, P5795, DOI 10.1128/jb.171.11.5795-5802.1989; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LIU J, 1995, GENOMICS, V26, P178, DOI 10.1016/0888-7543(95)80199-V; LOIDL P, 1994, CHROMOSOMA, V103, P441; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MITELMAN F, 1992, GENE CHROMOSOME CANC, V5, P57, DOI 10.1002/gcc.2870050109; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; QUESNEL B, 1993, J CLIN ONCOL, V11, P2370, DOI 10.1200/JCO.1993.11.12.2370; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; RINE J, 1987, GENETICS, V116, P9; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Sambrook J., 1989, MOL CLONING LAB MANU; SCHERENS B, 1993, YEAST, V9, P1355, DOI 10.1002/yea.320091210; STARK B, 1995, LEUKEMIA RES, V19, P367, DOI 10.1016/0145-2126(94)00150-9; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TANAKA S, 1989, MOL GEN GENET, V217, P289, DOI 10.1007/BF02464895; TANZER J, 1988, NOUV REV FR HEMATOL, V30, P63; TERCERO JC, 1992, J BIOL CHEM, V267, P20270; WESSELS JW, 1991, BLOOD, V77, P1555; WYDNER KL, 1995, GENOMICS, V30, P395	59	622	637	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1996	14	1					33	41		10.1038/ng0996-33			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	WOS:A1996VF61100018	8782817				2022-01-24	
J	WAPLES, RS				WAPLES, RS			A GENERALIZED-APPROACH FOR ESTIMATING EFFECTIVE POPULATION-SIZE FROM TEMPORAL CHANGES IN ALLELE FREQUENCY	GENETICS			English	Article											WAPLES, RS (corresponding author), NOAA,NATL MARINE FISHERIES SERV,NW & ALASKA FISHERIES CTR,SEATTLE,WA 98112, USA.		Waples, Robin S/K-1126-2016				Crow J.F., 1954, STAT MATH BIOL, P543; CROW JF, 1988, EVOLUTION, V42, P482, DOI 10.1111/j.1558-5646.1988.tb04154.x; GILLESPIE JH, 1978, THEOR POPUL BIOL, V14, P1, DOI 10.1016/0040-5809(78)90002-3; HILL WG, 1979, GENETICS, V92, P317; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Kimura M., 1971, THEORETICAL ASPECTS; KRIMBAS CB, 1971, EVOLUTION, V25, P454, DOI 10.1111/j.1558-5646.1971.tb01904.x; LAURIEAHLBERG CC, 1979, GENETICS, V92, P1295; LEWONTIN RC, 1973, GENETICS, V74, P175; MUELLER LD, 1985, GENETICS, V110, P495; NEI M, 1981, GENETICS, V98, P625; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; NEI M, 1978, GENETICS, V89, P583; NICHOLAS FW, 1976, THEOR APPL GENET, V48, P263, DOI 10.1007/BF00264957; PAMILO P, 1980, GENETICS, V95, P1055; POLLAK E, 1983, GENETICS, V104, P531; SCHAFFER HE, 1977, GENETICS, V87, P371; Sokal R.R., 1969, BIOMETRY; TAJIMA F, 1984, GENETICS, V106, P569; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WILSON SR, 1980, GENETICS, V95, P489; [No title captured]	22	622	629	0	60	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	FEB	1989	121	2					379	391					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T1015	WOS:A1989T101500017	2731727				2022-01-24	
J	HODGKIN, J; HORVITZ, HR; BRENNER, S				HODGKIN, J; HORVITZ, HR; BRENNER, S			NONDISJUNCTION MUTANTS OF THE NEMATODE CAENORHABDITIS-ELEGANS	GENETICS			English	Article											HODGKIN, J (corresponding author), MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND.						BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BAKER BS, 1976, P NATL ACAD SCI USA, V73, P4140, DOI 10.1073/pnas.73.11.4140; BAKER BS, 1976, GENETICS BIOL DROSOP, V1; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CARPENTER ATC, 1974, GENETICS, V76, P435; GETHMANN RC, 1974, GENETICS, V78, P1127; GREEN MM, 1976, GENETICS BIOL DROS B, V1; GRELL RF, 1976, GENETICS BIOL DROS A, V1; HALL JC, 1976, GENETICS BIOL DROS A, V1; HARTL DL, 1976, GENETICS BIOL DROS B, V1; HEDGECOCK EM, 1976, AM NAT, V110, P1007, DOI 10.1086/283123; HERMAN RK, 1978, GENETICS, V88, P49; HERMAN RK, 1976, GENETICS, V83, P91; HIRSH D, 1976, DEV BIOL, V49, P220, DOI 10.1016/0012-1606(76)90268-2; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Hodgkin JA., 1974, THESIS DARWIN COLLEG; KLASS M, 1976, DEV BIOL, V52, P1, DOI 10.1016/0012-1606(76)90002-6; LUCCHESI JC, 1976, GENETICS BIOL DROS A, V1; NIGON V, 1955, CHROMOSOMA, V7, P129, DOI 10.1007/BF00329722; NIGON V, 1965, TRAITE ZOOLOGIE, V4; PARKER JS, 1975, CHROMOSOMA, V49, P391; STAMBERG J, 1973, GENET RES, V22, P101, DOI 10.1017/S0016672300012878; Stern C., 1968, GENETIC MOSAICS OTHE; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; VALENTIN J, 1973, HEREDITAS, V75, P5	27	622	634	0	18	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1979	91	1					67	94					28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG639	WOS:A1979GG63900005	17248881				2022-01-24	
J	Servant, N; Varoquaux, N; Lajoie, BR; Viara, E; Chen, CJ; Vert, JP; Heard, E; Dekker, J; Barillot, E				Servant, Nicolas; Varoquaux, Nelle; Lajoie, Bryan R.; Viara, Eric; Chen, Chong-Jian; Vert, Jean-Philippe; Heard, Edith; Dekker, Job; Barillot, Emmanuel			HiC-Pro: an optimized and flexible pipeline for Hi-C data processing	GENOME BIOLOGY			English	Article						Chromosome conformation; Hi-C; Bioinformatics pipeline; Normalization	HUMAN GENOME; CHROMOSOME; ORGANIZATION; INTERACTOME; PRINCIPLES; BIASES; MAP	HiC-Pro is an optimized and flexible pipeline for processing Hi-C data from raw reads to normalized contact maps. HiC-Pro maps reads, detects valid ligation products, performs quality controls and generates intra-and inter-chromosomal contact maps. It includes a fast implementation of the iterative correction method and is based on a memory-efficient data format for Hi-C contact maps. In addition, HiC-Pro can use phased genotype data to build allele-specific contact maps. We applied HiC-Pro to different Hi-C datasets, demonstrating its ability to easily process large data in a reasonable time. Source code and documentation are available at http://github.com/nservant/HiC-Pro.	[Servant, Nicolas; Varoquaux, Nelle; Chen, Chong-Jian; Vert, Jean-Philippe; Heard, Edith; Barillot, Emmanuel] Inst Curie, Paris, France; [Servant, Nicolas; Varoquaux, Nelle; Chen, Chong-Jian; Vert, Jean-Philippe; Barillot, Emmanuel] INSERM, U900, Paris, France; [Servant, Nicolas; Varoquaux, Nelle; Chen, Chong-Jian; Vert, Jean-Philippe; Barillot, Emmanuel] PSL Res Univ, Mines ParisTech, CBIO Ctr Computat Biol, Fontainebleau, France; [Lajoie, Bryan R.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA USA; [Viara, Eric] Sysra, Yerres, France; [Chen, Chong-Jian; Heard, Edith] CNRS, UMR3215, Paris, France; [Chen, Chong-Jian; Heard, Edith] INSERM, U934, Paris, France; [Chen, Chong-Jian] Annoroad Gene Technol Co Ltd, Beijing, Peoples R China; [Dekker, Job] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol,Program Syst Biol, Worcester, MA 01605 USA		Servant, N (corresponding author), Inst Curie, Paris, France.	nicolas.servant@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; BARILLOT, Emmanuel/0000-0003-2724-2002; Vert, Jean-Philippe/0000-0001-9510-8441; varoquaux, Nelle/0000-0002-8748-6546; Servant, Nicolas/0000-0003-1678-7410	France Genomique National infrastructure [ANR-10-INBS-09]; Labex Deep; European Research Coucil [SMAC-ERC-280032]; ERC Advanced Investigator award [ERC-250367]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [HEALTH-F5-2012-305626]; ABS4NGS projectFrench National Research Agency (ANR) [ANR-11-BINF-0001]; National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG003143]; Paris Alliance of Cancer Research Institutes (PACRI-ANR)French National Research Agency (ANR); NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003143] Funding Source: NIH RePORTER	We would like to thank Felix Krueger for useful discussion about allele-specific analysis, and Jesse Dixon and Neva Cherniavsky for their advice in defining the best GM12878 phasing data. This work was supported by the France Genomique National infrastructure (ANR-10-INBS-09), the Labex Deep, the European Research Coucil (SMAC-ERC-280032), the ERC Advanced Investigator award (ERC-250367), the European Commission (HEALTH-F5-2012-305626), the ABS4NGS project (ANR-11-BINF-0001), the National Human Genome Research Institute (R01 HG003143), and the Paris Alliance of Cancer Research Institutes (PACRI-ANR). J.D. is an Investigator of the Howard Hughes Medical Institute.	Barutcu AR, 2016, J CELL PHYSIOL, V231, P31, DOI 10.1002/jcp.25062; Castellano G, 2015, COLD SPRING HARBOR L, DOI [10.1101/020636, DOI 10.1101/020636]; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Deng XX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0728-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WY, 2015, BIOINFORMATICS, V31, P960, DOI 10.1093/bioinformatics/btu747; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/nmeth.3205, 10.1038/NMETH.3205]; Minajigi A, 2015, SCIENCE, V349, DOI 10.1126/science.aab2276; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Schmid MW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0678-x; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	24	621	630	16	66	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.	DEC 1	2015	16								259	10.1186/s13059-015-0831-x			11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CX3BR	WOS:000365571000001	26619908	gold, Green Published	Y	N	2022-01-24	
J	Wang, KB; Wang, ZW; Li, FG; Ye, WW; Wang, JY; Song, GL; Yue, Z; Cong, L; Shang, HH; Zhu, SL; Zou, CS; Li, Q; Yuan, YL; Lu, CR; Wei, HL; Gou, CY; Zheng, ZQ; Yin, Y; Zhang, XY; Liu, K; Wang, B; Song, C; Shi, N; Kohel, RJ; Percy, RG; Yu, JZ; Zhu, YX; Wang, J; Yu, SX				Wang, Kunbo; Wang, Zhiwen; Li, Fuguang; Ye, Wuwei; Wang, Junyi; Song, Guoli; Yue, Zhen; Cong, Lin; Shang, Haihong; Zhu, Shilin; Zou, Changsong; Li, Qin; Yuan, Youlu; Lu, Cairui; Wei, Hengling; Gou, Caiyun; Zheng, Zequn; Yin, Ye; Zhang, Xueyan; Liu, Kun; Wang, Bo; Song, Chi; Shi, Nan; Kohel, Russell J.; Percy, Richard G.; Yu, John Z.; Zhu, Yu-Xian; Wang, Jun; Yu, Shuxun			The draft genome of a diploid cotton Gossypium raimondii	NATURE GENETICS			English	Article							(+)-DELTA-CADINENE SYNTHASE; FIBER; SEQUENCE; EXPRESSION; MAP; ORGANIZATION; POLYPLOIDY; ELONGATION; EVOLUTION; ETHYLENE	We have sequenced and assembled a draft genome of G. raimondii, whose progenitor is the putative contributor of the D subgenome to the economically important fiber-producing cotton species Gossypium hirsutum and Gossypium barbadense. Over 73% of the assembled sequences were anchored on 13 G. raimondii chromosomes. The genome contains 40,976 protein-coding genes, with 92.2% of these further confirmed by transcriptome data. Evidence of the hexaploidization event shared by the eudicots as well as of a cotton-specific whole-genome duplication approximately 13-20 million years ago was observed. We identified 2,355 syntenic blocks in the G. raimondii genome, and we found that approximately 40% of the paralogous genes were present in more than 1 block, which suggests that this genome has undergone substantial chromosome rearrangement during its evolution. Cotton, and probably Theobroma cacao, are the only sequenced plant species that possess an authentic CDN1 gene family for gossypol biosynthesis, as revealed by phylogenetic analysis.	[Wang, Kunbo; Li, Fuguang; Ye, Wuwei; Song, Guoli; Shang, Haihong; Zou, Changsong; Yuan, Youlu; Lu, Cairui; Wei, Hengling; Zhang, Xueyan; Liu, Kun; Yu, Shuxun] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Cotton Res Inst, Anyang, Peoples R China; [Wang, Zhiwen; Wang, Junyi; Yue, Zhen; Cong, Lin; Zhu, Shilin; Gou, Caiyun; Zheng, Zequn; Yin, Ye; Wang, Bo; Song, Chi; Shi, Nan; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Qin; Zhu, Yu-Xian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Kohel, Russell J.; Percy, Richard G.; Yu, John Z.] USDA ARS, Crop Germplasm Res Unit, So Plains Agr Res Ctr, College Stn, TX USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark		Yu, SX (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Cotton Res Inst, Anyang, Peoples R China.	zhuyx2@pku.edu.cn; wangj@genomics.org.cn; yu@cricaas.com.cn	Li, Qin/AAP-9448-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Li, Qin/0000-0002-8948-2717; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Zhu, Yuxian/0000-0003-2371-5933; yu, shuxun/0000-0002-9715-3462	China National Basic Research ProgramNational Basic Research Program of China [2010CB126000]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [90717009]	We thank X.-Y. Chen for his valuable criticisms and suggestions to the manuscript. This work was supported by a grant from the China National Basic Research Program (grant 2010CB126000) and by the National Natural Science Foundation of China (grant 90717009).	Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen XY, 1996, J NAT PROD, V59, P944, DOI 10.1021/np960344w; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Desai A, 2006, GENOME, V49, P336, DOI 10.1139/G05-116; ESSENBERG M, 1990, PHYTOCHEMISTRY, V29, P3107, DOI 10.1016/0031-9422(90)80166-E; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jia S., 2006, TRANSGENIC COTTON; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin LF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-395; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; REINISCH AJ, 1994, GENETICS, V138, P829; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu J.Z., 2004, PLANT BREEDING NEWS	44	621	743	20	216	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1098	+		10.1038/ng.2371			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	WOS:000309550200008	22922876		Y	N	2022-01-24	
J	Miska, EA; Alvarez-Saavedra, E; Townsend, M; Yoshii, A; Sestan, N; Rakic, P; Constantine-Paton, M; Horvitz, HR				Miska, EA; Alvarez-Saavedra, E; Townsend, M; Yoshii, A; Sestan, N; Rakic, P; Constantine-Paton, M; Horvitz, HR			Microarray analysis of microRNA expression in the developing mammalian brain	GENOME BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; NUCLEAR EXPORT; SMALL RNAS; IDENTIFICATION; ASYMMETRY; ENCODES; LIN-14; ROLES	Background: MicroRNAs are a large new class of tiny regulatory RNAs found in nematodes, plants, insects and mammals. MicroRNAs are thought to act as post-transcriptional modulators of gene expression. In invertebrates microRNAs have been implicated as regulators of developmental timing, neuronal differentiation, cell proliferation, programmed cell death and fat metabolism. Little is known about the roles of microRNAs in mammals. Results: We isolated 18-26 nucleotide RNAs from developing rat and monkey brains. From the sequences of these RNAs and the sequences of the rat and human genomes we determined which of these small RNAs are likely to have derived from stem-loop precursors typical of microRNAs. Next, we developed a microarray technology suitable for detecting microRNAs and printed a microRNA microarray representing 138 mammalian microRNAs corresponding to the sequences of the microRNAs we cloned as well as to other known microRNAs. We used this microarray to determine the profile of microRNAs expressed in the developing mouse brain. We observed a temporal wave of expression of microRNAs, suggesting that microRNAs play important roles in the development of the mammalian brain. Conclusion: We describe a microarray technology that can be used to analyze the expression of microRNAs and of other small RNAs. MicroRNA microarrays offer a new tool that should facilitate studies of the biological roles of microRNAs. We used this method to determine the microRNA expression profile during mouse brain development and observed a temporal wave of gene expression of sequential classes of microRNAs.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA		Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu		Miska, Eric/0000-0002-4450-576X	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY006039] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY06039, R01 EY006039] Funding Source: Medline		AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; [Anonymous], GENE EXPRESSION OMNI; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHENN A, 1997, MOL CELLULAR APPROAC, P440; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gupta V, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng013; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nimmakayalu M, 2000, BIOTECHNIQUES, V28, P518, DOI 10.2144/00283st11; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Taniguchi M, 2001, GENOMICS, V71, P34, DOI 10.1006/geno.2000.6427; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	621	759	2	40	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2004	5	9							R68	10.1186/gb-2004-5-9-r68			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	851AM	WOS:000223656100013	15345052	Green Published, hybrid			2022-01-24	
J	Jeffreys, AJ; Kauppi, L; Neumann, R				Jeffreys, AJ; Kauppi, L; Neumann, R			Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; DISEASE GENES; YEAST; HOTSPOTS; MEIOSIS; SITES; DNA; AMPLIFICATION	There is considerable interest in understanding patterns of linkage disequilibrium (LD) in the human genome, to aid investigations of human evolution and facilitate association studies in complex disease(1-5). The relative influences of meiotic crossover distribution and population history on LD remain unclear, however(5). In particular, it is uncertain to what extent crossovers are clustered into 'hot SpotS,(6-8) that might influence LID patterns. As a first step to investigating the relationship between LD and recombination, we have analyzed a 216-kb segment of the class II region of the major histocompatibility complex (MHC) already characterized for familial crossovers(9). High-resolution LD analysis shows the existence of extended domains of strong association interrupted by patchwork areas of LD breakdown. Sperm typing shows that these areas correspond precisely to meiotic crossover hot spots. All six hot spots defined share a remarkably similar symmetrical morphology but vary considerably in intensity, and are not obviously associated with any primary DNA sequence determinants of hot-spot activity. These hot spots occur in clusters and together account for almost all crossovers in this region of the MHC. These data show that, within the MHC at least, crossovers are far from randomly distributed at the molecular level and that recombination hot spots can profoundly affect LD patterns.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England		Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@1e.ac.uk	Peng, Bo/A-6920-2009; Kauppi, Liisa/H-5845-2012	Peng, Bo/0000-0001-8225-2284; Kauppi, Liisa/0000-0002-6759-8997			Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; CULLEN M, 1995, AM J HUM GENET, V56, P1350; Cullen M, 1997, AM J HUM GENET, V60, P397; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEDRICK PW, 1988, HEREDITY, V60, P435, DOI 10.1038/hdy.1988.61; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWONTIN RC, 1964, GENETICS, V49, P49; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Morton N. E., 1982, OUTLINE GENETIC EPID; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SHIROISHI T, 1995, ADV BIOPHYS, V31, P119, DOI 10.1016/0065-227X(95)99387-5; Snoek M, 1998, J IMMUNOL, V160, P266; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; SVED J A, 1971, Theoretical Population Biology, V2, P125; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959	34	620	640	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					217	222		10.1038/ng1001-217			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	WOS:000171374100031	11586303				2022-01-24	
J	Lee, JJ; Wedow, R; Okbay, A; Kong, E; Maghzian, O; Zacher, M; Nguyen-Viet, TA; Bowers, P; Sidorenko, J; Linner, RK; Fontana, MA; Kundu, T; Lee, C; Li, H; Li, RX; Royer, R; Timshel, PN; Walters, RK; Willoughby, EA; Yengo, L; Alver, M; Bao, YC; Clark, DW; Day, FR; Furlotte, NA; Joshi, PK; Kemper, KE; Kleinman, A; Langenberg, C; Magi, R; Trampush, JW; Verma, SS; Wu, Y; Lam, M; Zhao, JH; Zheng, ZL; Boardman, JD; Campbell, H; Freese, J; Harris, KM; Hayward, C; Herd, P; Kumari, M; Lencz, T; Luan, JA; Malhotra, AK; Metspalu, A; Milani, L; Ong, KK; Perry, JRB; Porteous, DJ; Ritchie, MD; Smart, MC; Smith, BH; Tung, JY; Wareham, NJ; Wilson, JF; Beauchamp, JP; Conley, DC; Esko, T; Lehrer, SF; Magnusson, PKE; Oskarsson, S; Pers, TH; Robinson, MR; Thom, K; Watson, C; Chabris, CF; Meyer, MN; Laibson, DI; Yang, J; Johannesson, M; Koellinger, PD; Turley, P; Visscher, PM; Benjamin, DJ; Cesarini, D				Lee, James J.; Wedow, Robbee; Okbay, Aysu; Kong, Edward; Maghzian, Omeed; Zacher, Meghan; Tuan Anh Nguyen-Viet; Bowers, Peter; Sidorenko, Julia; Linner, Richard Karlsson; Fontana, Mark Alan; Kundu, Tushar; Lee, Chanwook; Li, Hui; Li, Ruoxi; Royer, Rebecca; Timshel, Pascal N.; Walters, Raymond K.; Willoughby, Emily A.; Yengo, Loic; Alver, Maris; Bao, Yanchun; Clark, David W.; Day, Felix R.; Furlotte, Nicholas A.; Joshi, Peter K.; Kemper, Kathryn E.; Kleinman, Aaron; Langenberg, Claudia; Magi, Reedik; Trampush, Joey W.; Verma, Shefali Setia; Wu, Yang; Lam, Max; Zhao, Jing Hua; Zheng, Zhili; Boardman, Jason D.; Campbell, Harry; Freese, Jeremy; Harris, Kathleen Mullan; Hayward, Caroline; Herd, Pamela; Kumari, Meena; Lencz, Todd; Luan, Jian'an; Malhotra, Anil K.; Metspalu, Andres; Milani, Lili; Ong, Ken K.; Perry, John R. B.; Porteous, David J.; Ritchie, Marylyn D.; Smart, Melissa C.; Smith, Blair H.; Tung, Joyce Y.; Wareham, Nicholas J.; Wilson, James F.; Beauchamp, Jonathan P.; Conley, Dalton C.; Esko, Tonu; Lehrer, Steven F.; Magnusson, Patrik K. E.; Oskarsson, Sven; Pers, Tune H.; Robinson, Matthew R.; Thom, Kevin; Watson, Chelsea; Chabris, Christopher F.; Meyer, Michelle N.; Laibson, David I.; Yang, Jian; Johannesson, Magnus; Koellinger, Philipp D.; Turley, Patrick; Visscher, Peter M.; Benjamin, Daniel J.; Cesarini, David		23Me Res Team; COGENT Cognitive Genomics Consorti; Social Sci Genetic Assoc Consortiu	Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals	NATURE GENETICS			English	Article							MAPPING CAUSAL VARIANTS; HERITABILITY; METAANALYSIS; LOCI; GWAS; BRAIN	Here we conducted a large-scale genetic association analysis of educational attainment in a sample of approximately 1.1 million individuals and identify 1,271 independent genome-wide-significant SNPs. For the SNPs taken together, we found evidence of heterogeneous effects across environments. The SNPs implicate genes involved in brain-development processes and neuron-to-neuron communication. In a separate analysis of the X chromosome, we identify 10 independent genome-wide-significant SNPs and estimate a SNP heritability of around 0.3% in both men and women, consistent with partial dosage compensation. A joint (multi-phenotype) analysis of educational attainment and three related cognitive phenotypes generates polygenic scores that explain 11-13% of the variance in educational attainment and 7-10% of the variance in cognitive performance. This prediction accuracy substantially increases the utility of polygenic scores as tools in research.	[Lee, James J.; Willoughby, Emily A.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA; [Wedow, Robbee; Boardman, Jason D.] Univ Colorado, Dept Sociol, Boulder, CO 80309 USA; [Wedow, Robbee; Boardman, Jason D.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Wedow, Robbee; Boardman, Jason D.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Okbay, Aysu; Linner, Richard Karlsson; Koellinger, Philipp D.] Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Okbay, Aysu; Linner, Richard Karlsson; Koellinger, Philipp D.] Vrije Univ Amsterdam, Sch Business & Econ, Dept Econ, Amsterdam, Netherlands; [Kong, Edward; Maghzian, Omeed; Bowers, Peter; Lee, Chanwook; Li, Hui; Laibson, David I.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Zacher, Meghan] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Tuan Anh Nguyen-Viet; Kundu, Tushar; Li, Ruoxi; Royer, Rebecca; Watson, Chelsea; Benjamin, Daniel J.] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA USA; [Sidorenko, Julia; Yengo, Loic; Kemper, Kathryn E.; Wu, Yang; Zheng, Zhili; Yang, Jian; Visscher, Peter M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Sidorenko, Julia; Alver, Maris; Magi, Reedik; Metspalu, Andres; Milani, Lili; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Koellinger, Philipp D.] Erasmus Univ, Inst Behav & Biol, Rotterdam, Netherlands; [Fontana, Mark Alan] Hosp Special Surg, Ctr Adv Value Musculoskeletal Care, 535 E 70th St, New York, NY 10021 USA; [Timshel, Pascal N.; Pers, Tune H.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Timshel, Pascal N.; Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Walters, Raymond K.; Turley, Patrick] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Walters, Raymond K.; Turley, Patrick] MIT & Harvard, Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA USA; [Bao, Yanchun; Herd, Pamela; Kumari, Meena] Univ Essex, Inst Social & Econ Res, Colchester, Essex, England; [Clark, David W.; Joshi, Peter K.; Campbell, Harry; Smart, Melissa C.; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Day, Felix R.; Langenberg, Claudia; Zhao, Jing Hua; Luan, Jian'an; Ong, Ken K.; Perry, John R. B.; Wareham, Nicholas J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Furlotte, Nicholas A.; Kleinman, Aaron; Tung, Joyce Y.] 23&Me Inc, Mountain View, CA USA; [Joshi, Peter K.] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Trampush, Joey W.] BrainWorkup LLC, Santa Monica, CA USA; [Trampush, Joey W.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [Verma, Shefali Setia] Geisinger Hlth Syst, Dept Biomed & Translat Informat, Danville, PA USA; [Lam, Max] Inst Mental Hlth, Singapore, Singapore; [Lam, Max] Genome Inst, Singapore, Singapore; [Zheng, Zhili] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Eye Hosp, Wenzhou, Peoples R China; [Freese, Jeremy] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Harris, Kathleen Mullan] Univ North Carolina Chapel Hill, Dept Sociol, Chapel Hill, NC USA; [Harris, Kathleen Mullan] Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC USA; [Hayward, Caroline; Wilson, James F.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Herd, Pamela] Univ Wisconsin, La Follette Sch Publ Affairs, Madison, WI USA; [Lencz, Todd; Malhotra, Anil K.] Hofstra Northwell Sch Med, Dept Psychiat, Hempstead, NY USA; [Lencz, Todd; Malhotra, Anil K.] Hofstra Northwell Sch Med, Dept Mol Med, Hempstead, NY USA; [Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Lencz, Todd; Malhotra, Anil K.] Zucker Hillside Hosp, Psychiat Res, Glen Oaks, CA USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Smith, Blair H.] Univ Dundee, Div Populat Hlth Sci, Ninewells Hosp, Dundee, Scotland; [Smith, Blair H.] Univ Dundee, Med Sch, Dundee, Scotland; [Smith, Blair H.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Beauchamp, Jonathan P.] Univ Toronto, Dept Econ, Toronto, ON, Canada; [Conley, Dalton C.] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Lehrer, Steven F.] Queens Univ, Sch Policy Studies, Kingston, ON, Canada; [Lehrer, Steven F.] New York Univ Shanghai, Dept Econ, Shanghai, Peoples R China; [Lehrer, Steven F.; Benjamin, Daniel J.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Magnusson, Patrik K. E.] Karolinska Inst, Depnt Med Epidemiol & Biostat, Stockholm, Sweden; [Oskarsson, Sven] Uppsala Univ, Dept Govt, Uppsala, Sweden; [Robinson, Matthew R.] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Thom, Kevin] NYU, Dept Econ, New York, NY 10003 USA; [Chabris, Christopher F.] Geisinger Hlth Syst, Autism & Dev Med Inst, Lewisburg, PA USA; [Meyer, Michelle N.] Geisinger Hlth Syst, Ctr Translat Bioeth & Hlth Care Policy, Danville, PA USA; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, Stockholm, Sweden; [Benjamin, Daniel J.] Univ Southern Calif, Dept Econ, Los Angeles, CA USA; [Cesarini, David] NYU, Ctr Expt Social Sci, New York, NY USA		Okbay, A (corresponding author), Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands.; Okbay, A (corresponding author), Vrije Univ Amsterdam, Sch Business & Econ, Dept Econ, Amsterdam, Netherlands.	a.okbay@vu.nl; peter.visscher@uq.edu.au; daniel.benjamin@gmail.com	Porteous, David/AAA-3446-2021; Gupta, Richa/J-4774-2019; Zheng, Zhili/L-1632-2019; Laibson, David/AAA-7362-2022; Milani, Lili/N-1097-2019; Yang, Jian/A-5852-2010; Kaprio, Jaakko/A-1820-2008; Lam, Max/AAM-4946-2021; Campbell, Harry/E-2959-2010; Kanoni, Stavroula/AAN-7161-2021; Magnusson, Patrik KE/C-4458-2017; Bertram, Lars/K-3889-2015; Wilson, James F/A-5704-2009; Deary, Ian J/C-6297-2009; Kemper, Kathryn/ABF-1003-2020; Magi, Reedik/AAJ-9679-2021; Lind, Penelope A/B-2553-2009; Kiemeney, Lambertus A./D-3357-2009; Galesloot, Tessel/P-6667-2015; Lind, Penelope A/ABC-5341-2021; Attrill, Lauren/V-1688-2018; Johannesson, Magnus/E-9680-2011; Lencz, Todd/J-3418-2014; Colaus, PsyColaus/K-6607-2013; Verweij, Niek/ABC-6249-2021; Staessen, Jan A/A-1065-2011; Lahti, Jari/P-2283-2019; Timpson, Nicholas John/O-7548-2015; Salvi, Erika/AAA-1415-2019; Langenberg, Claudia/ABG-9067-2021; Linner, Richard Karlsson/AAA-9755-2021; Visscher, Peter/ABB-6151-2020; Girotto, Giorgia/I-9452-2018; Evans, David/H-6325-2013; Smith, Blair/G-2834-2012; Marques-Vidal, Pedro/C-9449-2009; Medland, Sarah/C-7630-2013; Gudnason, Vilmundur/K-6885-2015; Pendleton, Neil/F-2333-2015; Penninx, Brenda WJH/S-7627-2017; Smith, Albert Vernon/K-5150-2015; Feitosa, Mary/K-8044-2012; Gratten, Jacob/G-1485-2011; Yengo, Loic/D-2692-2017; Robino, Antonietta/K-9398-2016; Scott, Rodney/B-2827-2013; Nyholt, Dale/J-3174-2017; Hypponen, Elina/B-2596-2014	Porteous, David/0000-0003-1249-6106; Gupta, Richa/0000-0001-7700-5828; Zheng, Zhili/0000-0003-2102-221X; Milani, Lili/0000-0002-5323-3102; Yang, Jian/0000-0003-2001-2474; Kaprio, Jaakko/0000-0002-3716-2455; Campbell, Harry/0000-0002-6169-6262; Kanoni, Stavroula/0000-0002-1691-9615; Magnusson, Patrik KE/0000-0002-7315-7899; Bertram, Lars/0000-0002-0108-124X; Wilson, James F/0000-0001-5751-9178; Deary, Ian J/0000-0002-1733-263X; Kemper, Kathryn/0000-0002-9288-4522; Lind, Penelope A/0000-0002-3887-2598; Kiemeney, Lambertus A./0000-0002-2368-1326; Galesloot, Tessel/0000-0002-2717-3679; Lind, Penelope A/0000-0002-3887-2598; Johannesson, Magnus/0000-0001-8759-6393; Lencz, Todd/0000-0001-8586-338X; Verweij, Niek/0000-0002-4303-7685; Staessen, Jan A/0000-0002-3026-1637; Lahti, Jari/0000-0002-4310-5297; Timpson, Nicholas John/0000-0002-7141-9189; Salvi, Erika/0000-0002-2724-2291; Langenberg, Claudia/0000-0002-5017-7344; Linner, Richard Karlsson/0000-0001-7839-2858; Visscher, Peter/0000-0002-2143-8760; Girotto, Giorgia/0000-0003-4507-6589; Evans, David/0000-0003-0663-4621; Smith, Blair/0000-0002-5362-9430; Marques-Vidal, Pedro/0000-0002-4548-8500; Medland, Sarah/0000-0003-1382-380X; Gudnason, Vilmundur/0000-0001-5696-0084; Pendleton, Neil/0000-0003-0794-2386; CUCCA, Francesco/0000-0002-7414-1995; Tobin, Martin/0000-0002-3596-7874; Sidorenko, Julia/0000-0003-1494-6772; Derringer, Jaime/0000-0002-7352-9859; Kahonen, Mika/0000-0002-4510-7341; Timshel, Pascal/0000-0002-0352-4323; Van Duijn, Cornelia/0000-0002-2374-9204; Posthuma, Danielle/0000-0001-7582-2365; Pirastu, Nicola/0000-0002-5363-3886; Gasparini, Paolo/0000-0002-0859-0856; Emilsson, Valur/0000-0001-9982-0524; Robinson, Matthew/0000-0001-8982-8813; Penninx, Brenda WJH/0000-0001-7779-9672; Wedow, Robbee/0000-0002-3108-7087; Trampush, Joey/0000-0003-0830-508X; Joshi, Peter/0000-0002-6361-5059; Nelson, Christopher/0000-0001-8025-2897; Maki-Opas, Tomi/0000-0002-0472-719X; Smith, Albert Vernon/0000-0003-1942-5845; Feitosa, Mary/0000-0002-0933-2410; Deloukas, Panos/0000-0001-9251-070X; Lee, James J/0000-0001-6547-5128; van der Lee, Sven/0000-0003-1606-8643; Gratten, Jacob/0000-0003-1293-409X; concas, maria pina/0000-0003-3598-2537; Yengo, Loic/0000-0002-4272-9305; Li, Hui/0000-0003-3625-2851; Peyrot, Wouter/0000-0001-7954-8383; Robino, Antonietta/0000-0003-2152-2353; Pers, Tune/0000-0003-0207-4831; Scott, Rodney/0000-0001-7724-3404; Palotie, Aarno/0000-0002-2527-5874; Okbay, Aysu/0000-0002-5170-7781; Day, Felix/0000-0003-3789-7651; Nyholt, Dale/0000-0001-7159-3040; Hypponen, Elina/0000-0003-3670-9399; Volker, Uwe/0000-0002-5689-3448; Raikkonen, Katri/0000-0003-3124-3470; de Leeuw, Christiaan/0000-0003-1076-9828; Venturini, Cristina/0000-0002-4769-7912; Alipanahi, Babak/0000-0001-8216-7178; Latvala, Antti/0000-0001-5695-117X; Vuckovic, Dragana/0000-0001-9343-6142; Loukola, Anu-Maria/0000-0003-0542-5967; Willemsen, Gonneke/0000-0003-3755-0236; Bjornsdottir, Gyda/0000-0002-8100-0306; Groenen, Patrick/0000-0001-6683-8971; Bacelis, Jonas/0000-0002-2450-732X; Oldmeadow, Christopher/0000-0001-6104-1322; Koellinger, Philipp/0000-0001-7413-0412; GANDIN, ILARIA/0000-0003-3196-2491; Terracciano, Antonio/0000-0001-5799-8885	Social Science Genetic Association Consortium (SSGAC); Swedish Research CouncilSwedish Research CouncilEuropean Commission [2017-00641, 421-2013-1061]; Ragnar Soderberg Foundation [E9/11, E42/15]; Jan Wallander and Tom Hedelius Foundation; ERC Consolidator GrantEuropean Research Council (ERC) [647648 EdGe]; Pershing Square Fund of the Foundations of Human Behavior; Open Philanthropy Project [2016-152872]; NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23, R01-AG042568]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD050924, P2CHD047879, R01HD073342, P2CHD066613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG012810, R01AG055406, P30AG010161, R01AG042568, R01AG015819, T32AG000186, RF1AG015819, P01AG005842] Funding Source: NIH RePORTER; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F022441/1, BB/F019394/1] Funding Source: UKRI; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/K005774/1, ES/S008349/1, ES/M008592/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1811434, G1001799, G0901461, MR/N01104X/1, MC_UU_12015/2, G0100594, MC_UU_12015/1, MR/N01104X/2, G0600237] Funding Source: UKRI	This research was carried out under the auspices of the Social Science Genetic Association Consortium (SSGAC). The research has also been conducted using the UK Biobank Resource under application numbers 11425 and 12512. We acknowledge the Swedish Twin Registry for access to data. The Swedish Twin Registry is managed by the Karolinska Institutet and receives funding through the Swedish Research Council under the grant number 2017-00641. This study was supported by funding from the Ragnar Soderberg Foundation (E9/11, E42/15), the Swedish Research Council (421-2013-1061), The Jan Wallander and Tom Hedelius Foundation, an ERC Consolidator Grant (647648 EdGe), the Pershing Square Fund of the Foundations of Human Behavior, The Open Philanthropy Project (2016-152872), and the NIA/NIH through grants P01-AG005842, P01-AG005842-20S2, P30-AG012810 and T32-AG000186-23 to N.B.E.R. and R01-AG042568 to U.S.C. A full list of acknowledgments is provided in the Supplementary Note.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Belsky DW, 2016, PSYCHOL SCI, V27, P957, DOI 10.1177/0956797616643070; Branigan AR, 2013, SOC FORCES, V92, P109, DOI 10.1093/sf/sot076; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cameron A. C., 2015, ROBUST INFERENCE DYA; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen WA, 2016, GENETICS, V204, P933, DOI 10.1534/genetics.116.188953; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Conti G, 2010, AM ECON REV, V100, P234, DOI 10.1257/aer.100.2.234; Cutler DM, 2006, NATL POVERTY CTR WOR, DOI DOI 10.3386/W12352; Davies G., 2017, 99 INDEPENDENT GENET, DOI [10.1101/176511, DOI 10.1101/176511, 10. 1101/176511]; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; de Vlaming R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006495; Domingue BW, 2015, AERA OPEN, V1, DOI 10.1177/2332858415599972; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; HEATH AC, 1985, NATURE, V314, P734, DOI 10.1038/314734a0; Henmon V., 1946, HENMON NELSON TESTS; Johnson W, 2008, PERSPECT PSYCHOL SCI, V3, P518, DOI 10.1111/j.1745-6924.2008.00096.x; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kong A, 2018, SCIENCE, V359, P424, DOI 10.1126/science.aan6877; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Marioni RE, 2016, P NATL ACAD SCI USA, V113, P13366, DOI 10.1073/pnas.1605334113; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; REED TE, 1991, INTELLIGENCE, V15, P33, DOI 10.1016/0160-2896(91)90021-5; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Savage J. E., 2017, GWAS METAANALYSIS N2, DOI [10. 1101/184853, DOI 10.1101/184853, 10.1101/184853]; Schmitz LL, 2017, ECON EDUC REV, V61, P85, DOI 10.1016/j.econedurev.2017.10.001; Scutari M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006288; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Trampush JW, 2017, MOL PSYCHIATR, V22, P336, DOI 10.1038/mp.2016.244; Tropf FC, 2017, NAT HUM BEHAV, V1, P757, DOI 10.1038/s41562-017-0195-1; Turley P, 2018, NAT GENET, V50, P229, DOI 10.1038/s41588-017-0009-4; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wang GF, 2015, GENE DEV, V29, P1535, DOI 10.1101/gad.260869.115; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1216-0; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	49	619	621	6	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2018	50	8					1112	+		10.1038/s41588-018-0147-3			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GO9JP	WOS:000440423400010	30038396	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Lee, JT; Davidow, LS; Warshawsky, D				Lee, JT; Davidow, LS; Warshawsky, D			Tsix, a gene antisense to Xist at the X-inactivation centre	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; RNA; DNA; DIFFERENTIATION; STABILIZATION; INTERPHASE; EXPRESSION; NUCLEUS; INVITRO; REGION	In mammals, dosage compensation is achieved by X inactivation(1) and is regulated in cis by the X-inactivation centre(2) (Xic) and Xist (refs 3-5). The Xic controls X-chromosome counting, choice of X to inactivate and initiation of silencing. Xic action culminates in a change in Xist RNA property from a scarce, unstable RNA (refs 6,7) to highly expressed Xist RNA that coats the future inactive X (ref. 8). Deleting a 65-kb region downstream of Xist results in constitutive Xist expression and X inactivation, implying the presence of a cis-regulatory element(9). In this region, we now report the discovery of a gene antisense to Xist. Tsix is a 40-kb RNA originating 15 kb downstream of Xist and transcribed across the Xist locus. Tsix sequence is conserved at the human XIC. Tsix RNA has no conserved ORFs, is seen exclusively in the nucleus and is localized at Xic. Before the onset of X inactivation, Tsix is expressed from both X chromosomes. At the onset of X inactivation, Tsix expression becomes monoallelic, is associated with the future active X and persists until Xist is turned off. Tsix is not found on the inactive X once cells enter the X-inactivation pathway. Tsix has features suggesting a role in regulating the early steps of X inactivation, but not the silencing step.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA		Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA.						Ausubel FM., 1994, CURRENT PROTOCOLS MO; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LEE JA, IN PRESS P NATL ACAD; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MARTIN GR, 1978, NATURE, V271, P329, DOI 10.1038/271329a0; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Simmler MC, 1996, HUM MOL GENET, V5, P1713, DOI 10.1093/hmg/5.11.1713; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	26	619	640	1	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					400	404		10.1038/7734			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	WOS:000079439700022	10192391				2022-01-24	
J	Matsuura, T; Sutcliffe, JS; Fang, P; Galjaard, RJ; Jiang, YH; Benton, CS; Rommens, JM; Beaudet, AL				Matsuura, T; Sutcliffe, JS; Fang, P; Galjaard, RJ; Jiang, YH; Benton, CS; Rommens, JM; Beaudet, AL			De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome	NATURE GENETICS			English	Article							WILLI-SYNDROME REGION; FACTOR-II GENE; LINKAGE ANALYSIS; EXPRESSED GENE; E6 ONCOPROTEIN; SNRPN GENE; IDENTIFICATION; 15Q11-Q13; DEFINE; P53	Angelman syndrome (AS) is associated with maternal deletions of human chromosome 15q11-q13 and with paternal uniparental disomy for this region indicating that deficiency of an imprinted, maternally expressed gene within the critical interval is the likely cause of the syndrome, Although the gene for EG-AP ubiquitin-protein ligase (UBE3A) was mapped to the critical region for AS, evidence of expression from both parental alleles initially suggested that it was an unlikely candidate gene for this disorder, Because attempts to identify any novel maternally expressed transcripts were unsuccessful and because the UBE3A gene remained within a narrowed AS critical region, we searched for mutations in UBE3A in 11 AS patients without known molecular defects (large deletion, uniparental disomy, or imprinting mutation), This analysis tested the possibility that deficiency of an undefined, maternally expressed transcript or isoform of the UBE3A gene could cause AS, Four mutations were identified including a de novo frameshift mutation and a de novo nonsense mutation in exon 3 and two missense mutations of less certain significance, The de novo truncating mutations indicate that UBE3A is the AS gene and suggest the possibility of a maternally expressed gene product in addition to the biallelically expressed transcript, Intragenic mutation of UBE3A in AS is the first example of a genetic disorder of the ubiquitin-dependent proteolytic pathway in mammals, It may represent an example of a human genetic disorder associated with a locus producing functionally distinct imprinted and biallelically expressed gene products.	BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MED & MOL GENET,TORONTO,ON M5G 1X8,CANADA				Sutcliffe, James S/C-1348-2012	Sutcliffe, James S/0000-0001-5200-6007	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024064] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR 00188] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD24064] Funding Source: Medline		BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burke LW, 1996, AM J HUM GENET, V58, P777; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Clechanover A., 1994, CELL, V79, P13; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Matuschewski K, 1996, J BIOL CHEM, V271, P2789, DOI 10.1074/jbc.271.5.2789; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; OH CE, 1994, J NEUROSCI, V14, P3166; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; WOODAGE T, 1994, GENOMICS, V19, P170, DOI 10.1006/geno.1994.1031	29	619	634	3	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					74	77		10.1038/ng0197-74			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300024	8988172				2022-01-24	
J	BROWNE, DL; GANCHER, ST; NUTT, JG; BRUNT, ERP; SMITH, EA; KRAMER, P; LITT, M				BROWNE, DL; GANCHER, ST; NUTT, JG; BRUNT, ERP; SMITH, EA; KRAMER, P; LITT, M			EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1	NATURE GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; SODIUM-CHANNEL; ATAXIA; MYOKYMIA; FAMILY	Episodic ataxia (EA) is a rare, familial disorder producing attacks of generalized ataxia, with normal or near-normal neurological function between attacks. One type of EA is characterized by brief episodes of ataxia with myokymia (rippling of muscles) evident between attacks. Linkage studies in four such families suggested localization of an EA/myokymia gene near the voltage gated K+ channel gene, KCNA1 (Kv1.1), on chromosome 12p. Mutation analysis of the KCNA1 coding region in these families identified four different missense point mutations present in the heterozygous state, indicating that EA/myokymia can result from mutations in this gene.	OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED & MOLEC GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; UNIV GRONINGEN HOSP,DEPT NEUROL,9700 RB GRONINGEN,NETHERLANDS						NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00022] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS25370] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025370] Funding Source: NIH RePORTER		BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HANSON PA, 1977, ANN NEUROL, V1, P120, DOI 10.1002/ana.410010203; LITT M, IN PRESS AM J HUM GE; LIVINGSTONE IR, 1984, J NEUROL SCI, V64, P89, DOI 10.1016/0022-510X(84)90059-5; MCCLATCHEY AI, 1992, NAT GENET, V2, P148, DOI 10.1038/ng1092-148; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; PTACEK LJ, 1991, CELL, V67, P1021; RAMASWAMI M, 1990, Molecular and Cellular Neuroscience, V1, P214, DOI 10.1016/1044-7431(90)90004-N; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; SALAM M, 1975, HDB CLIN NEUROLOGY, V211, P573; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; VANDYKE DH, 1975, J NEUROL SCI, V25, P109, DOI 10.1016/0022-510X(75)90191-4	19	619	630	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					136	140		10.1038/ng1094-136			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	WOS:A1994PL12300014	7842011				2022-01-24	
J	Sebaihia, M; Wren, BW; Mullany, P; Fairweather, NF; Minton, N; Stabler, R; Thomson, NR; Roberts, AP; Cerdeno-Tarrraga, AM; Wang, HW; Holden, MTG; Wright, A; Churcher, C; Quail, MA; Baker, S; Bason, N; Brooks, K; Chillingworth, T; Cronin, A; Davis, P; Dowd, L; Fraser, A; Feltwell, T; Hance, Z; Holroyd, S; Jagels, K; Moule, S; Mungall, K; Price, C; Rabbinowitsch, E; Sharp, S; Simmonds, M; Stevens, K; Unwin, L; Whithead, S; Dupuy, B; Dougan, G; Barrell, B; Parkhill, J				Sebaihia, Mohammed; Wren, Brendan W.; Mullany, Peter; Fairweather, Neil F.; Minton, Nigel; Stabler, Richard; Thomson, Nicholas R.; Roberts, Adam P.; Cerdeno-Tarrraga, Ana M.; Wang, Hongmei; Holden, Matthew T. G.; Wright, Anne; Churcher, Carol; Quail, Michael A.; Baker, Stephen; Bason, Nathalie; Brooks, Karen; Chillingworth, Tracey; Cronin, Ann; Davis, Paul; Dowd, Linda; Fraser, Audrey; Feltwell, Theresa; Hance, Zahra; Holroyd, Simon; Jagels, Kay; Moule, Sharon; Mungall, Karen; Price, Claire; Rabbinowitsch, Ester; Sharp, Sarah; Simmonds, Mark; Stevens, Kim; Unwin, Louise; Whithead, Sally; Dupuy, Bruno; Dougan, Gordon; Barrell, Bart; Parkhill, Julian			The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome	NATURE GENETICS			English	Article							STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; CONJUGAL TRANSFER; SURFACE PROTEIN; VIRULENCE; SEQUENCE; GENE; ELEMENT; IDENTIFICATION; PERFRINGENS	We determined the complete genome sequence of Clostridium difficile strain 630, a virulent and multidrug-resistant strain. Our analysis indicates that a large proportion (11%) of the genome consists of mobile genetic elements, mainly in the form of conjugative transposons. These mobile elements are putatively responsible for the acquisition by C. difficile of an extensive array of genes involved in antimicrobial resistance, virulence, host interaction and the production of surface structures. The metabolic capabilities encoded in the genome show multiple adaptations for survival and growth within the gut environment. The extreme genome variability was confirmed by whole-genome microarray analysis; it may reflect the organism's niche in the gut and should provide information on the evolution of virulence in this organism.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; UCL, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England; Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Univ Nottingham, Inst Infect Immun & Inflammat, Ctr Biomol Sci, Nottingham NG7 2RD, England; Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris 15, France		Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Gen Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk	Holden, Matthew TG/K-6449-2014; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Sebaihia, Mohammed/AAF-6589-2019; Roberts, Adam/AAU-5493-2021; Roberts, Adam P/C-1787-2008; Thomson, Nicholas/P-5988-2014	Holden, Matthew TG/0000-0002-4958-2166; Parkhill, Julian/0000-0002-7069-5958; Sebaihia, Mohammed/0000-0002-3324-3346; Roberts, Adam/0000-0002-0760-3088; Roberts, Adam P/0000-0002-0760-3088; Stabler, Richard/0000-0002-2402-6630; Thomson, Nicholas/0000-0002-4432-8505; Baker, Stephen/0000-0003-1308-5755; Davis, Paul/0000-0001-5545-0824; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Minton, Nigel/0000-0002-9277-1261	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ARTHUR M, 1995, GENE, V154, P87, DOI 10.1016/0378-1119(94)00851-I; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; BORRIELLO SP, 1988, J MED MICROBIOL, V25, P191, DOI 10.1099/00222615-25-3-191; Braun V, 2000, MOL MICROBIOL, V36, P1447, DOI 10.1046/j.1365-2958.2000.01965.x; Broussolle V, 2002, ANAEROBE, V8, P89, DOI 10.1006/anae.2002.0424; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Carter GP, 2005, J MED MICROBIOL, V54, P119, DOI 10.1099/jmm.0.45817-0; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; DAVIES HA, 1990, MICROB PATHOGENESIS, V9, P141, DOI 10.1016/0882-4010(90)90088-8; de Vries YP, 2005, FEMS MICROBIOL LETT, V252, P169, DOI 10.1016/j.femsle.2005.08.042; Depardieu F, 2003, MOL MICROBIOL, V50, P931, DOI 10.1046/j.1365-2958.2003.03737.x; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Farrow KA, 2001, MICROBIOL-SGM, V147, P2717, DOI 10.1099/00221287-147-10-2717; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Garnier F, 2000, MICROBIOL-UK, V146, P1481, DOI 10.1099/00221287-146-6-1481; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moir A, 2002, CELL MOL LIFE SCI, V59, P403, DOI 10.1007/s00018-002-8432-8; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MULLANY P, 1990, J GEN MICROBIOL, V136, P1343, DOI 10.1099/00221287-136-7-1343; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Ohtani K, 2002, MOL MICROBIOL, V44, P171, DOI 10.1046/j.1365-2958.2002.02863.x; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Poilane I, 1998, CAN J MICROBIOL, V44, P157, DOI 10.1139/cjm-44-2-157; Roberts AP, 2001, MICROBIOL-SGM, V147, P1243, DOI 10.1099/00221287-147-5-1243; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Savariau-Lacomme MP, 2003, J BACTERIOL, V185, P4461, DOI 10.1128/JB.185.15.4461-4470.2003; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wang HM, 2000, J BACTERIOL, V182, P6577, DOI 10.1128/JB.182.23.6577-6583.2000; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1016/S0168-6445(01)00059-6; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; WUST J, 1982, J CLIN MICROBIOL, V16, P1096	50	618	933	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					779	786		10.1038/ng1830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	WOS:000238669300013	16804543				2022-01-24	
J	Hermisson, J; Pennings, PS				Hermisson, J; Pennings, PS			Soft sweeps: Molecular population genetics of adaptation from standing genetic variation	GENETICS			English	Article							ARTIFICIAL SELECTION; HITCHHIKING; EVOLVABILITY; SIGNATURE; INSERTION; FIXATION	A population can adapt to a rapid environmental change or habitat expansion in two ways. It may adapt either through new beneficial mutations that subsequently sweep through the population or by using alleles from the standing genetic variation. We rise diffusion theory to calculate the probabilities for selective adaptations and find a large increase in the fixation probability for weak substitutions, if alleles originate from the standing genetic variation. We then determine the parameter regions where each scenario-standing variation vs. new mutations-is more likely. Adaptations front the standing genetic variation are favored if either the selective advantage is weak or the selection coefficient and the mutation rate are both high. Finally, we analyze the probability of "soft sweeps," where multiple copies of the selected allele contribute to a substitution, and discuss the consequences for the footprint of selection on linked neutral variation. We find that soft sweeps with weaker selective footprints are likely tinder both scenarios if the mutation rate and/or the selection coefficient is high.	Univ Munich, Dept Biol 2, Sect Evolut Biol, D-82152 Plannegg Martinsried, Germany		Hermisson, J (corresponding author), Univ Munich, Dept Biol 2, Sect Evolut Biol, Grosshaderner Str 2, D-82152 Plannegg Martinsried, Germany.	joachim.hermisson@lmu.de					Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; BARTON NH, 1995, GENETICS, V140, P821; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Ewens  W., 2004, MATH POPULATION GENT, V1; FALCONER DS, 1996, INTRO QUALTITATIVE G; Fisher, 1930, GENETICAL THEORY NAT; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hansen TF, 2003, J EVOLUTION BIOL, V16, P754, DOI 10.1046/j.1420-9101.2003.00556.x; HOULE D, 1992, GENETICS, V130, P195; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; KACSER H, 1981, GENETICS, V97, P639; KAPLAN NL, 1989, GENETICS, V123, P887; Keightley PD, 1996, GENETICS, V143, P621; Kern AD, 2002, GENETICS, V162, P1753; Kim Y, 2000, GENETICS, V155, P1415; Kim Y, 2003, GENETICS, V164, P389; Kim Y, 2002, GENETICS, V160, P765; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; Kimura M., 1983, NEUTRAL THEORY MOL E; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; LYNCH M, 1998, GENTICS ANAL QUANTIT; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; ORR HA, 1991, P NATL ACAD SCI USA, V88, P11413, DOI 10.1073/pnas.88.24.11413; Orr HA, 2001, GENETICS, V157, P875; Otto SP, 1997, GENETICS, V146, P723; Przeworski M, 2002, GENETICS, V160, P1179; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3	29	618	627	1	145	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2005	169	4					2335	2352		10.1534/genetics.104.036947			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	928IA	WOS:000229263700045	15716498	Green Published, Bronze			2022-01-24	
J	SLATKIN, M; MADDISON, WP				SLATKIN, M; MADDISON, WP			A CLADISTIC MEASURE OF GENE FLOW INFERRED FROM THE PHYLOGENIES OF ALLELES	GENETICS			English	Article											SLATKIN, M (corresponding author), UNIV CALIF BERKELEY, DEPT ZOOL, BERKELEY, CA 94720 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM040282] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM40282] Funding Source: Medline		AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BERMINGHAM E, 1986, GENETICS, V113, P939; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; MADDISON WP, 1989, IN PRESS CLADISTICS; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; SLATKIN M, 1989, GENETICS, V121, P609; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; TAKAHATA N, 1988, GENET RES, V52, P213, DOI 10.1017/S0016672300027683; TAKAHATA N, 1989, UNPUB THEOR POPUL BI; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3	18	618	624	0	15	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	1989	123	3					603	613					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX267	WOS:A1989AX26700020	2599370				2022-01-24	
J	HARTWELL, LH; MORTIMER, RK; CULOTTI, J; CULOTTI, M				HARTWELL, LH; MORTIMER, RK; CULOTTI, J; CULOTTI, M			GENETIC-CONTROL OF CELL-DIVISION CYCLE IN YEAST .5. GENETIC ANALYSIS OF CDC MUTANTS	GENETICS			English	Article									UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195				Culotti, Joseph/G-6467-2013	Culotti, Joseph/0000-0001-6325-4612			CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; HARTWELL LH, 1970, J BACTERIOL, V104, P1280, DOI 10.1128/JB.104.3.1280-1285.1970; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HAWTHORNE DC, 1969, MUTAT RES, V7, P187, DOI 10.1016/0027-5107(69)90030-X; HAWTHORNE DC, 1968, GENETICS, V60, P735; MORTIMER RK, 1969, YEAST 1; PUCK TT, 1963, BIOPHYS J, V3, P379, DOI 10.1016/S0006-3495(63)86828-9; ROBINOW CF, 1966, J CELL BIOL, V29, P129, DOI 10.1083/jcb.29.1.129	11	618	626	2	23	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1973	74	2					267	286					20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q3153	WOS:A1973Q315300006	17248617				2022-01-24	
J	Gusev, A; Ko, A; Shi, H; Bhatia, G; Chung, W; Penninx, BWJH; Jansen, R; de Geus, EJC; Boomsma, DI; Wright, FA; Sullivan, PF; Nikkola, E; Alvarez, M; Civelek, M; Lusis, AJ; Lehtimaki, T; Raitoharju, E; Kahonen, M; Seppala, I; Raitakari, OT; Kuusisto, J; Laakso, M; Price, AL; Pajukanta, P; Pasaniuc, B				Gusev, Alexander; Ko, Arthur; Shi, Huwenbo; Bhatia, Gaurav; Chung, Wonil; Penninx, Brenda W. J. H.; Jansen, Rick; de Geus, Eco J. C.; Boomsma, Dorret I.; Wright, Fred A.; Sullivan, Patrick F.; Nikkola, Elina; Alvarez, Marcus; Civelek, Mete; Lusis, Aldons J.; Lehtimaki, Terho; Raitoharju, Emma; Kahonen, Mika; Seppala, Ilkka; Raitakari, Olli T.; Kuusisto, Johanna; Laakso, Markku; Price, Alkes L.; Pajukanta, Paivi; Pasaniuc, Bogdan			Integrative approaches for large-scale transcriptome-wide association studies	NATURE GENETICS			English	Article							GENE-EXPRESSION; PARTITIONING HERITABILITY; MENDELIAN RANDOMIZATION; REGULATORY VARIATION; CARDIOVASCULAR RISK; COMPLEX TRAITS; STATISTICS; VARIANTS; IDENTIFICATION; ARCHITECTURE	Many genetic variants influence complex traits by modulating gene expression, thus altering the abundance of one or multiple proteins. Here we introduce a powerful strategy that integrates gene expression measurements with summary association statistics from large-scale genome-wide association studies (GWAS) to identify genes whose cis-regulated expression is associated with complex traits. We leverage expression imputation from genetic data to perform a transcriptome-wide association study (TWAS) to identify significant expression-trait associations. We applied our approaches to expression data from blood and adipose tissue measured in similar to 3,000 individuals overall. We imputed gene expression into GWAS data from over 900,000 phenotype measurements to identify 69 new genes significantly associated with obesity-related traits (BMI, lipids and height). Many of these genes are associated with relevant phenotypes in the Hybrid Mouse Diversity Panel. Our results showcase the power of integrating genotype, gene expression and phenotype to gain insights into the genetic basis of complex traits.	[Gusev, Alexander; Bhatia, Gaurav; Chung, Wonil; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Gusev, Alexander; Bhatia, Gaurav; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Gusev, Alexander; Bhatia, Gaurav; Price, Alkes L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Ko, Arthur; Nikkola, Elina; Alvarez, Marcus; Lusis, Aldons J.; Pajukanta, Paivi; Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Ko, Arthur; Pajukanta, Paivi] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Shi, Huwenbo; Pasaniuc, Bogdan] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA; [Penninx, Brenda W. J. H.; Jansen, Rick] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Wright, Fred A.] N Carolina State Univ, Dept Biol Sci, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Civelek, Mete; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lehtimaki, Terho; Raitoharju, Emma; Seppala, Ilkka] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho; Seppala, Ilkka] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kahonen, Mika] Pirkanmaa Hosp Dist, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA		Gusev, A (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.; Gusev, A (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.; Gusev, A (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	agusev@hsph.harvard.edu; pasaniuc@ucla.edu	Penninx, Brenda WJH/S-7627-2017; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Raitakari, Olli/AAQ-7389-2021	Penninx, Brenda WJH/0000-0001-7779-9672; de Geus, Eco J.C./0000-0001-6022-2666; Civelek, Mete/0000-0002-8141-0284; Pasaniuc, Bogdan/0000-0002-0227-2056; Jansen, Rick/0000-0002-3333-6737; Raitoharju, Emma/0000-0002-7023-8706; Ko, Arthur/0000-0002-1523-7225; Chung, Wonil/0000-0002-5766-6247; Gusev, Alexander/0000-0002-7980-4620; Kahonen, Mika/0000-0002-4510-7341	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32 GM106584, RO1 GM053725, ROl GM105857, HL-28481, HL-095056]; US NIH training grant in Genomic Analysis and Interpretation [T32 HG002536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F31HL127921, P01HL028481, R01HL095056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM105857, F32GM106584, R25GM055052] Funding Source: NIH RePORTER	We thank the individuals who participated in the study. We also acknowledge L. Yang for helpful discussions that have improved the quality of this manuscript. We also thank K. Mohlke, M. Boehnke and F. Collins for help with the METSIM data. This work was funded in part by US National Institutes of Health (NIH) grants F32 GM106584 (A.G.), RO1 GM053725 (B.P.), ROl GM105857 (A.L.P., A.G. and G.B.), HL-28481 (P.P., A.J.L. and M.C.) and HL-095056 (P.P. and B.P.) and by the US NIH training grant in Genomic Analysis and Interpretation T32 HG002536 (A.K.).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee D, 2015, BIOINFORMATICS, V31, P1176, DOI 10.1093/bioinformatics/btu816; Lee D, 2013, BIOINFORMATICS, V29, P2925, DOI 10.1093/bioinformatics/btt500; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nuotio J, 2014, SCAND J PUBLIC HEALT, V42, P563, DOI 10.1177/1403494814541597; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell J.K., 2015, BIORXIV, DOI [10.1101/018150, DOI 10.1101/018150]; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Robinson, 1991, STAT SCI, V6, P15, DOI 10.1214/ss/1177011933.; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wen WQ, 2014, HUM MOL GENET, V23, P5492, DOI 10.1093/hmg/ddu248; Wen XQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005176; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	51	617	623	7	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					245	252		10.1038/ng.3506			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	WOS:000370902600008	26854917	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Camaschella, C; Roetto, A; Cali, A; De Gobbi, M; Garozzo, G; Carella, M; Majorano, N; Totaro, A; Gasparini, P				Camaschella, C; Roetto, A; Cali, A; De Gobbi, M; Garozzo, G; Carella, M; Majorano, N; Totaro, A; Gasparini, P			The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22	NATURE GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR; HLA-H; JUVENILE		IRCCS Osped CSS, Serv Genet Med, Foggia, Italy; Azienda Osped Civile M Paterno Arezzo, Serv Immunoematol & Med Trasfus, Ragusa, Italy; Univ Turin, Azienda Osped S Luigi, Dipartimento Sci Clin & Biol, Orbassano Torino, Italy		Gasparini, P (corresponding author), IRCCS Osped CSS, Serv Genet Med, Foggia, Italy.		Gasparini, Paolo/B-6173-2014; De Gobbi, Marco/E-8136-2013; Roetto, Antonella/K-4731-2016; Camaschella, Clara/A-3289-2015; Carella, Massimo/A-2804-2014	Carella, Massimo/0000-0002-6830-6829; De Gobbi, Marco/0000-0003-4261-7642; Gasparini, Paolo/0000-0002-0859-0856; ROETTO, Antonella/0000-0003-1188-7375	TelethonFondazione Telethon [E.0679] Funding Source: Medline		Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Camaschella C, 1997, EUR J HUM GENET, V5, P371, DOI 10.1159/000484794; Camaschella C, 1999, HEPATOLOGY, V29, P1563, DOI 10.1002/hep.510290509; Carella M, 1997, AM J HUM GENET, V60, P828; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Glockner G, 1998, GENOME RES, V8, P1060; GORDEUK V, 1992, NEW ENGL J MED, V326, P95, DOI 10.1056/NEJM199201093260204; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003; Piperno A, 1998, GASTROENTEROLOGY, V114, P996, DOI 10.1016/S0016-5085(98)70319-1; Robson KJH, 1997, GUT, V41, P841; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379	15	616	642	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					14	15		10.1038/75534			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	WOS:000086884000007	10802645				2022-01-24	
J	Sanpei, K; Takano, H; Igarashi, S; Sato, T; Oyake, M; Sasaki, H; Wakisaka, A; Tashiro, K; Ishida, Y; Ikeuchi, T; Koide, R; Saito, M; Sato, A; Tanaka, T; Hanyu, S; Takiyama, Y; Nishizawa, M; Shimizu, N; Nomura, Y; Segawa, M; Iwabuchi, K; Eguchi, I; Tanaka, H; Takahashi, H; Tsuji, S				Sanpei, K; Takano, H; Igarashi, S; Sato, T; Oyake, M; Sasaki, H; Wakisaka, A; Tashiro, K; Ishida, Y; Ikeuchi, T; Koide, R; Saito, M; Sato, A; Tanaka, T; Hanyu, S; Takiyama, Y; Nishizawa, M; Shimizu, N; Nomura, Y; Segawa, M; Iwabuchi, K; Eguchi, I; Tanaka, H; Takahashi, H; Tsuji, S			Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT	NATURE GENETICS			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DOMINANT CEREBELLAR-ATAXIA; CAG REPEAT; DISEASE; DNA; TRINUCLEOTIDE; ANTICIPATION; HYBRIDIZATION; AMPLIFICATION; HETEROGENEITY	Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant, neurodegenerative disorder that affects the cerebellum and other areas of the central nervous system. We have devised a novel strategy, the direct identification of repeat expansion and cloning technique (DIRECT), which allows selective detection of expanded CAG repeats and cloning of the genes involved. By applying DIRECT, we identified an expanded CAG repeat Of the gene for SCA2. CAG repeats of normal alleles range in size from 15 to 24 repeat units, while those of SCA2 chromosomes are expanded to 35 to 59 repeat units. The SCA2 cDNA is predicted to code for 1,313 amino acids - with the CAG repeats coding for a polyglutamine tract. DIRECT is a robust strategy for identification of pathologically expanded trinucleotide repeats and will dramatically accelerate the search for causative genes of neuropsychiatric diseases caused by trinucleotide repeat expansions.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT PATHOL,NIIGATA 951,JAPAN; HOKKAIDO UNIV,SCH MED,DEPT PATHOL 1,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN; NIIGATA UNIV,SCH MED,DEPT PSYCHIAT,NIIGATA 951,JAPAN; JICHI MED SCH,DEPT NEUROL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; TEIKYO UNIV,SCH MED,ICHIHARA HOSP,DEPT NEUROL,ICHIHARA 29901,JAPAN; SEGAWA NEUROL CLIN CHILDREN,CHIYODA KU,TOKYO 101,JAPAN; KANAGAWA REHABIL CTR,DEPT NEUROL & PSYCHIAT,ATSUGI,KANAGAWA 24301,JAPAN					Sato, Toshiya/0000-0001-7844-9930			BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BASSETT AS, 1994, AM J HUM GENET, V54, P864; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; IHARA T, 1994, JPN J HUM GENET, V39, P305, DOI 10.1007/BF01874049; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; ONODERA O, 1995, AM J HUM GENET, V57, P1050; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANPEI K, 1995, BIOCHEM BIOPH RES CO, V212, P341, DOI 10.1006/bbrc.1995.1975; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Takano H, 1996, AM J HUM GENET, V58, P1212; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	37	616	624	1	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					277	284		10.1038/ng1196-277			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	WOS:A1996VQ14600021	8896556				2022-01-24	
J	AMOS, CI				AMOS, CI			ROBUST VARIANCE-COMPONENTS APPROACH FOR ASSESSING GENETIC-LINKAGE IN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; LINEAR-MODELS; MARKER LOCUS; IDENTITY	To assess evidence for genetic linkage from pedigrees, I developed a limited variance-components approach. In this method, variability among trait observations from individuals within pedigrees is expressed in terms of fixed effects from covariates and effects due to an unobservable trait-affecting major locus, random polygenic effects, and residual nongenetic variance. The effect attributable to a locus linked to a marker is a function of the additive and dominance components of variance of the locus, the recombination fraction, and the proportion of genes identical by descent at the marker locus for each pair of sibs. For unlinked loci, the polygenic variance component depends only on the relationship between the relative pair. Parameters can be estimated by either maximum-likelihood methods or quasi-likelihood methods. The forms of quasi-likelihood estimators are provided. Hypothesis tests derived from the maximum-likelihood approach are constructed by appeal to asymptotic theory. A simulation study showed that the size of likelihood-ratio tests was appropriate but that the monogenic component of variance was generally underestimated by the likelihood approach.	NIAMS,GENET STUDIES SECT,BETHESDA,MD		AMOS, CI (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EPIDEMIOL,1515 HOLCOMBE BLVD,BOX 189,HOUSTON,TX 77030, USA.						AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; AMOS CI, 1990, AM J HUM GENET, V47, P842; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AMOS CI, IN PRESS GENET EPIDE; BRUES AM, 1950, AM J HUM GENET, V2, P215; CAREY G, 1991, AM J HUM GENET, V49, P786; CARROLL RJ, 1982, ANN STAT, V10, P429, DOI 10.1214/aos/1176345784; CHEVALET C, 1984, GENET SEL EVOL, V16, P431, DOI 10.1186/1297-9686-16-4-431; CORBEIL RR, 1976, BIOMETRICS, V32, P779, DOI 10.2307/2529264; DEMENAIS FM, 1989, PROG CLIN BIOL RES, V329, P201; ELSTON RC, 1986, 7TH INT C HUM GEN BE; FISHER RT, 1918, T R SOC EDINB, P399; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; JAYAKAR SD, 1970, BIOMETRICS, V26, P451, DOI 10.2307/2529101; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAMMERER CM, 1985, HUM HERED, V35, P319, DOI 10.1159/000153570; LANDER ES, 1989, GENETICS, V121, P185; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MACCLUER JW, 1989, MONOGR HUM GENET, V12, P50; MCCULLAGH P, 1989, GEN LINEAR MODELS; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; PENROSE LS, 1935, ANN EUGEN, V6, P133; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306	27	616	628	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					535	543					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	WOS:A1994MZ15800017	8116623				2022-01-24	
J	Kautz, L; Jung, G; Valore, EV; Rivella, S; Nemeth, E; Ganz, T				Kautz, Leon; Jung, Grace; Valore, Erika V.; Rivella, Stefano; Nemeth, Elizabeta; Ganz, Tomas			Identification of erythroferrone as an erythroid regulator of iron metabolism	NATURE GENETICS			English	Article							DIFFERENTIATION FACTOR 15; BETA-THALASSEMIA; HEPCIDIN EXPRESSION; ANEMIA; ERYTHROPOIETIN; OVERLOAD; HYPOXIA; MURINE; BMP6; HOMEOSTASIS	Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory hormone hepcidin allows increased iron absorption and mobilization from stores. We identified a new hormone, erythroferrone (ERFE), that mediates hepcidin suppression during stress erythropoiesis. ERFE is produced by erythroblasts in response to erythropoietin. ERFE-deficient mice fail to suppress hepcidin rapidly after hemorrhage and exhibit a delay in recovery from blood loss. ERFE expression is greatly increased in Hbb(th3/+) mice with thalassemia intermedia, where it contributes to the suppression of hepcidin and the systemic iron overload characteristic of this disease.	[Kautz, Leon; Jung, Grace; Valore, Erika V.; Nemeth, Elizabeta; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA		Ganz, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	tganz@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Kautz, Leon/0000-0002-2320-0457; Rivella, Stefano/0000-0002-0938-6558; Nemeth, Elizabeta/0000-0002-3477-2397; Ganz, Tomas/0000-0002-2830-5469	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; JCCC from US NIH [P30-CA-016042]; CURE: Digestive Disease Research Core Center from US NIH [P30-DK-041301]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-DK-065029]; American Society of Hematology scholar award;  [R01-DK-090554];  [5R01-DK-095112]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK041301, R01DK090554, R01DK095112, R01DK065029] Funding Source: NIH RePORTER	The authors thank V. Gabayan for her invaluable work with mouse breeding. Flow cytometry was performed in the University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center (JCCC) and the Center for AIDS Research Flow Cytometry Core Facility, which is supported by US National Institutes of Health (NIH) awards CA-16042 and AI-28697 and by the JCCC, the UCLA AIDS Institute and the David Geffen School of Medicine at UCLA. The UCLA Vector Core is supported by the JCCC from US NIH grant P30-CA-016042 and the CURE: Digestive Disease Research Core Center from US NIH grant P30-DK-041301. This research was supported by US NIH grant R01-DK-065029 to T.G. and grants R01-DK-090554 and 5R01-DK-095112 to S.R. and by the American Society of Hematology scholar award to L.K.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Ashby DR, 2010, HAEMATOL-HEMATOL J, V95, P505, DOI 10.3324/haematol.2009.013136; Casanovas G, 2013, HAEMATOLOGICA, V98, P444, DOI 10.3324/haematol.2012.069807; Centis F, 2000, BLOOD, V96, P3624; Diaz V, 2013, HEPATOLOGY, V58, P2122, DOI 10.1002/hep.26550; FINCH C, 1994, BLOOD, V84, P1697; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; PIPPARD MJ, 1979, LANCET, V2, P819; Porpiglia E, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001383; Ramos P, 2010, ANN NY ACAD SCI, V1202, P24, DOI 10.1111/j.1749-6632.2010.05596.x; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Theurl I, 2010, BRIT J HAEMATOL, V148, P449, DOI 10.1111/j.1365-2141.2009.07961.x; Vokurka M, 2006, PHYSIOL RES, V55, P667; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x	34	615	644	6	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					678	684		10.1038/ng.2996			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	WOS:000338093800007	24880340	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Tassone, F; Hagerman, RJ; Taylor, AK; Gane, LW; Godfrey, TE; Hagerman, PJ				Tassone, F; Hagerman, RJ; Taylor, AK; Gane, LW; Godfrey, TE; Hagerman, PJ			Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAPID ANTIBODY-TEST; FEMALE CARRIERS; CGG REPEAT; GENE-EXPRESSION; PREMUTATION; PHENOTYPE; MUTATION; PCR; EXPANSION; METHYLATION	Fragile-X syndrome is a trinucleotide-repeat-expansion disorder in which the clinical phenotype is believed to result from transcriptional silencing of the fragile-X mental retardation 1 (FMR1) gene as the number of CGG repeats exceeds similar to 200. For premutation alleles (similar to 55-200 repeats), no abnormalities in FMR1-gene expression have been described, despite growing evidence of clinical involvement in premutation carriers. To address this (apparent) paradox, we have determined, for 16 carrier males (55-192 repeats), the relative levels of leukocyte FMR1 mRNA, by use of automated fluorescence-detection reverse transcriptase-PCR, and the percent of lymphocytes that are immunoreactive for FMR1 protein (FMRP). For some alleles with >100 repeats, there was a reduction in the number of FMRP-positive cells. Unexpectedly, FMR1 mRNA levels were elevated at least fivefold within this same range. No significant increase in FMR1 mRNA stability was observed in a lymphoblastoid cell line (160 repeats) derived from one of the carrier males, suggesting that the increased message levels are due to an increased rate of transcription. Current results support a mechanism of involvement in premutation carriers, in which reduced translational efficiency is at least partially compensated through increased transcriptional activity. Thus, diminished translational efficiency may be important throughout much of the premutation range, with a mechanistic switch occurring in the full-mutation range as the FMR1 gene is silenced.	Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA; Childrens Hosp, Child Dev Unit, Denver, CO 80218 USA; Childrens Hosp, Fragile Treatment & Res Ctr X, Denver, CO 80218 USA; Univ Calif San Francisco, Ctr Canc, San Francisco, CA USA; Kimball Genet Inc, Denver, CO USA		Hagerman, PJ (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, B-121,4200 E 9th Ave, Denver, CO 80262 USA.	paul.hagerman@uchsc.edu	Godfrey, Tony/A-5572-2013	Godfrey, Tony/0000-0002-3283-6983	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM035305] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD036071, HD36071] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM35305] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-089413] Funding Source: Medline		Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; BAEYENS DA, 1993, J CELL PHYSIOL, V157, P70, DOI 10.1002/jcp.1041570109; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; deVries BBA, 1996, J MED GENET, V33, P1007, DOI 10.1136/jmg.33.12.1007; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DORN MB, 1994, J AM ACAD CHILD PSY, V33, P256, DOI 10.1097/00004583-199402000-00015; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FENG Y, 1995, AM J HUM GENET, V56, P106; Franke P, 1998, PSYCHIAT RES, V80, P113, DOI 10.1016/S0165-1781(98)00055-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Hagerman R., 1996, FRAGILE X SYNDROME D, P3; Hagerman R. J., 1999, NEURODEVELOPMENTAL D, P61; Hagerman RJ, 1996, PEDIATRICS, V97, P122; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hmadcha A, 1998, J LAB CLIN MED, V131, P170, DOI 10.1016/S0022-2143(98)90160-3; Kaufmann WE, 1999, AM J MED GENET, V83, P286, DOI 10.1002/(SICI)1096-8628(19990402)83:4<286::AID-AJMG10>3.3.CO;2-8; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LOESCH DZ, 1994, AM J MED GENET, V51, P392, DOI 10.1002/ajmg.1320510418; LOESCH DZ, 1987, AM J MED GENET, V27, P401, DOI 10.1002/ajmg.1320270219; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1993, AM J HUM GENET, V52, P884; Riddle JE, 1998, AM J MENT RETARD, V102, P590; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SMEETS HJM, 1995, HUM MOL GENET, V4, P2103, DOI 10.1093/hmg/4.11.2103; SMITS A, 1994, AM J MED GENET, V51, P497, DOI 10.1002/ajmg.1320510440; Steyaert J, 1996, AM J MED GENET, V64, P274, DOI 10.1002/(SICI)1096-8628(19960809)64:2<274::AID-AJMG8>3.0.CO;2-U; Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.3.CO;2-W; TASSONE F, IN PRESS AM J MED GE; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; TURNER G, 1994, LANCET, V344, P1500, DOI 10.1016/S0140-6736(94)90313-1; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Waring JD, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P131; WILLEMSEN R, 1995, LANCET, V345, P1147, DOI 10.1016/S0140-6736(95)90979-6; Willemsen R, 1997, HUM GENET, V99, P308, DOI 10.1007/s004390050363	40	615	622	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					6	15		10.1086/302720			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	279FK	WOS:000085033600003	10631132	Bronze, Green Published			2022-01-24	
J	CHELLY, J; TUMER, Z; TONNESEN, T; PETTERSON, A; ISHIKAWABRUSH, Y; TOMMERUP, N; HORN, N; MONACO, AP				CHELLY, J; TUMER, Z; TONNESEN, T; PETTERSON, A; ISHIKAWABRUSH, Y; TOMMERUP, N; HORN, N; MONACO, AP			ISOLATION OF A CANDIDATE GENE FOR MENKES DISEASE THAT ENCODES A POTENTIAL HEAVY-METAL BINDING-PROTEIN	NATURE GENETICS			English	Article							AUREUS PLASMID PI258; NUCLEOTIDE-SEQUENCE; CADMIUM RESISTANCE; X-CHROMOSOME; TRANSLOCATION; SEARCH; EFFLUX	Menkes disease is a lethal-X linked recessive disorder associated with copper metabolism disturbance. We have recently mapped two chromosome breakpoints related to this disease in a 1 megabase yeast artificial chromosome contig at Xq13.3. We now report the construction of a phage contig and the isolation of candidate partial cDNAs for the Menkes disease gene. The candidate gene expresses an 8 kb message in all investigated tissues, and deletions were detected in 16% of 100 unrelated Menkes patients. The deduced partial protein sequence shared the GMTCXXC motif with bacterial metal resistance operons, suggesting a potential heavy metal binding protein. These findings should lead to more accurate prenatal diagnosis of this severe disease and a better understanding of the cellular homeostasis of essential heavy metals.	JOHN RADCLIFFE HOSP,INST MOLEC MED,ICRF LABS,OXFORD OX3 9DU,ENGLAND; DANISH CTR HUMAN GENOME RES,DK-2600 GLOSTRUP,DENMARK; JOHN F KENNEDY INST,GLOSTRUP,DENMARK				Monaco, Anthony P/A-4495-2010; Tumer, Zeynep/C-4235-2014; Chelly, Jamel/J-7528-2015; Tommerup, Niels/T-8776-2017; Tumer, Zeynep/AAF-8501-2019	Monaco, Anthony P/0000-0001-7480-3197; Chelly, Jamel/0000-0002-0939-8719; Tommerup, Niels/0000-0003-2304-0112; Tumer, Zeynep/0000-0002-4777-5802			ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BROWN NL, 1983, BIOCHEMISTRY-US, V22, P4089, DOI 10.1021/bi00286a015; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DANKS DM, 1989, METABOLIC BASIS INHE, P1422; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DAVISSON M T, 1987, Genomics, V1, P213, DOI 10.1016/0888-7543(87)90047-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRAEBER MB, IN PRESS HUM GENET; HERD SM, 1987, BIOCHEM J, V247, P341, DOI 10.1042/bj2470341; HORN N, 1992, BRAIN PATHOL, V2, P351, DOI 10.1111/j.1750-3639.1992.tb00711.x; HORN N, 1984, ANN HUM GENET, V48, P161, DOI 10.1111/j.1469-1809.1984.tb01011.x; HORN N, 1984, METABOLISM TRACE MET, P25; INOUE C, 1991, MOL MICROBIOL, V5, P2707, DOI 10.1111/j.1365-2958.1991.tb01979.x; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LADDAGA RA, 1987, P NATL ACAD SCI USA, V84, P5106, DOI 10.1073/pnas.84.15.5106; MENKES JH, 1962, PEDIATRICS, V29, P764; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NOOJEN JL, 1981, PEDIATR RES, V15, P284; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SCHEINBERG IH, 1989, LANCET, V1, P619; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; TENNESEN T, 1992, AM J HUM GENET, V50, P1012; TONNESEN T, 1989, J INHERIT METAB DIS, V12, P207, DOI 10.1007/BF01799296; TURNER Z, 1992, HUM GENET, V88, P668; TURNER Z, 1992, HUM MOL GENET, V1, P483; VERGA V, 1991, AM J HUM GENET, V48, P1133; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WIEACKER P, 1983, HUM GENET, V64, P139, DOI 10.1007/BF00327110; WIENKER TF, 1983, HUM GENET, V65, P72, DOI 10.1007/BF00285032; YANG HM, 1990, CLIN GENET, V38, P94; YAZAKI M, 1981, Nagoya Medical Journal, V25, P169; YOON KP, 1991, J BACTERIOL, V173, P7636, DOI 10.1128/jb.173.23.7636-7642.1991	38	615	620	2	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					14	19		10.1038/ng0193-14			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	WOS:A1993KF37200006	8490646				2022-01-24	
J	Kajitani, R; Toshimoto, K; Noguchi, H; Toyoda, A; Ogura, Y; Okuno, M; Yabana, M; Harada, M; Nagayasu, E; Maruyama, H; Kohara, Y; Fujiyama, A; Hayashi, T; Itoh, T				Kajitani, Rei; Toshimoto, Kouta; Noguchi, Hideki; Toyoda, Atsushi; Ogura, Yoshitoshi; Okuno, Miki; Yabana, Mitsuru; Harada, Masayuki; Nagayasu, Eiji; Maruyama, Haruhiko; Kohara, Yuji; Fujiyama, Asao; Hayashi, Tetsuya; Itoh, Takehiko			Efficient de novo assembly of highly heterozygous genomes from whole-genome shotgun short reads	GENOME RESEARCH			English	Article							SEQUENCE; REVEALS; ALGORITHMS; ALIGNMENT; INSIGHTS	Although many de novo genome assembly projects have recently been conducted using high-throughput sequencers, assembling highly heterozygous diploid genomes is a substantial challenge due to the increased complexity of the de Bruijn graph structure predominantly used. To address the increasing demand for sequencing of nonmodel and/or wild-type samples, in most cases inbred lines or fosmid-based hierarchical sequencing methods are used to overcome such problems. However, these methods are costly and time consuming, forfeiting the advantages of massive parallel sequencing. Here, we describe a novel de novo assembler, Platanus, that can effectively manage high-throughput data from heterozygous samples. Platanus assembles DNA fragments (reads) into contigs by constructing de Bruijn graphs with automatically optimized k-mer sizes followed by the scaffolding of contigs based on paired-end information. The complicated graph structures that result from the heterozygosity are simplified during not only the contig assembly step but also the scaffolding step. We evaluated the assembly results on eukaryotic samples with various levels of heterozygosity. Compared with other assemblers, Platanus yields assembly results that have a larger scaffold NG50 length without any accompanying loss of accuracy in both simulated and real data. In addition, Platanus recorded the largest scaffold NG50 values for two of the three low-heterozygosity species used in the de novo assembly contest, Assemblathon 2. Platanus therefore provides a novel and efficient approach for the assembly of gigabase-sized highly heterozygous genomes and is an attractive alternative to the existing assemblers designed for genomes of lower heterozygosity.	[Kajitani, Rei; Toshimoto, Kouta; Okuno, Miki; Yabana, Mitsuru; Harada, Masayuki; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 1528550, Japan; [Toshimoto, Kouta] AXIOHELIX Co Ltd, Chuo Ku, Tokyo 1030075, Japan; [Noguchi, Hideki; Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Adv Genom Ctr, Mishima, Shizuoka 4718540, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Microbial Genom, Miyazaki 8897692, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Fac Med, Div Microbiol, Miyazaki 8891692, Japan; [Nagayasu, Eiji; Maruyama, Haruhiko] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki 8891692, Japan; [Kohara, Yuji] Natl Inst Genet, Genet Strains Res Ctr, Mishima, Shizuoka 4118540, Japan		Itoh, T (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 1528550, Japan.	takehiko@bio.titech.ac.jp	Itoh, Takehiko/E-8873-2014; Hayashi, Tetsuya/ABA-1074-2020	Itoh, Takehiko/0000-0002-6113-557X; Kajitani, Rei/0000-0002-5013-0052	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22125008, 24310142, 221S0002]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25250024] Funding Source: KAKEN	We thank all the members of the laboratories involved in this project for their helpful discussions. This work was supported by KAKENHI (Grant-in-Aid for Scientific Research on Innovative Areas, No. 22125008), KAKENHI (Grant-in-Aid for Scientific Research [B], No. 24310142), and KAKENHI for Innovative Areas "Genome Science" (No. 221S0002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	32	614	622	5	63	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2014	24	8					1384	1395		10.1101/gr.170720.113			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	AM4XT	WOS:000339860200013	24755901	Green Submitted, Green Published, hybrid	Y	N	2022-01-24	
J	Marchini, J; Cardon, LR; Phillips, MS; Donnelly, P				Marchini, J; Cardon, LR; Phillips, MS; Donnelly, P			The effects of human population structure on large genetic association studies	NATURE GENETICS			English	Article							STRATIFICATION; DIFFERENTIATION; INFERENCE	Large-scale association studies hold substantial promise for unraveling the genetic basis of common human diseases. A well-known problem with such studies is the presence of undetected population structure, which can lead to both false positive results and failures to detect genuine associations. Here we examine similar to15,000 genome-wide single-nucleotide polymorphisms typed in three population groups to assess the consequences of population structure on the coming generation of association studies. The consequences of population structure on association outcomes increase markedly with sample size. For the size of study needed to detect typical genetic effects in common diseases, even the modest levels of population structure within population groups cannot safely be ignored. We also examine one method for correcting for population structure ( Genomic Control). Although it often performs well, it may not correct for structure if too few loci are used and may overcorrect in other settings, leading to substantial loss of power. The results of our analysis can guide the design of large-scale association studies.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; McGill Univ, Genome Ctr, Montreal, PQ H3A 1A4, Canada; Genome Quebec, Montreal, PQ H3A 1A4, Canada		Donnelly, P (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	donnelly@stats.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020; Peng, Bo/A-6920-2009	Marchini, Jonathan/0000-0003-0610-8322; Peng, Bo/0000-0001-8225-2284; Donnelly, Peter/0000-0001-9495-3408			Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Balding DJ, 2002, J R STAT SOC B, V64, P737; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CLAYTON D, 2001, HDB STAT GENETICS, P519; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EXCOFFIER L, 2001, HDB STAT GENETICS, P00271, DOI DOI 10.1002/9780470061619CH29; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Moller T, 2003, ANN ONCOL, V14, P946, DOI 10.1093/annonc/mdg255; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Ripatti S, 2001, GENET EPIDEMIOL, V21, pS409, DOI 10.1002/gepi.2001.21.s1.s409; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Spence MA, 2003, AM J HUM GENET, V72, P1084, DOI 10.1086/374826; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	29	614	640	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					512	517		10.1038/ng1337			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	WOS:000221183000026	15052271	Bronze			2022-01-24	
J	Vafiadis, P; Bennett, ST; Todd, JA; Nadeau, J; Grabs, R; Goodyer, CG; Wickramasinghe, S; Colle, E; Polychronakos, C				Vafiadis, P; Bennett, ST; Todd, JA; Nadeau, J; Grabs, R; Goodyer, CG; Wickramasinghe, S; Colle, E; Polychronakos, C			Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus	NATURE GENETICS			English	Article							DIABETES SUSCEPTIBILITY LOCUS; GENE; PROINSULIN; TOLERANCE; SELECTION; REGION; RISK; AUTOANTIBODIES; MINISATELLITE; TRANSCRIPTION	Type 1 diabetes or insulin-dependent diabetes mellitus (IDDM) is due to autoimmune destruction of pancreatic beta-cells. Genetic susceptibility to IDDM is encoded by several loci, one of which (IDDM2) maps to a variable number of tandem repeats (VNTR) minisatellite, upstream of the insulin gene (INS)(1-5). The short class 1 VNTR alleles (26-63 repeats) predispose to IDDM, while class III alleles (140-210 repeats) have a dominant protective effect(1-6). We have reported that, in human adult(4,6) and fetal(7) pancreas in vivo, class III alleles are associated with marginally lower INS mRNA levels than class I, suggesting transcriptional effects of the VNTR. These may be related to type 1 diabetes pathogenesis, as insulin is the only known beta-cell specific IDDM autoantigen. In search of a more plausible mechanism for the dominant effect of class III alleles, we analysed expression of insulin in human fetal thymus, a critical site for tolerance induction to self proteins. Insulin was detected in all thymus tissues examined and class III VNTR alleles were associated with 2- to 3-fold higher INS mRNA levels than class I. We therefore propose higher levels of thymic INS expression, facilitating immune tolerance induction, as a mechanism for the dominant protective effect of class III alleles.	MCGILL UNIV, MONTREAL CHILDRENS HOSP, RES INST, MONTREAL, PQ H3H 1P3, CANADA; MCGILL UNIV, DEPT PEDIAT, DIV ENDOCRINOL, MONTREAL, PQ H3H 1P3, CANADA; UNIV OXFORD, NUFFIELD DEPT SURG, WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7BN, ENGLAND; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ H3G 1A4, CANADA; MONTREAL GEN HOSP, MONTREAL, PQ H3G 1A4, CANADA				Todd, John A/A-3542-2010; Polychronakos, Constantin/B-8151-2008	Todd, John A/0000-0003-2740-8148; Polychronakos, Constantin/0000-0002-7624-6635	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ANTONIA SJ, 1995, INT IMMUNOL, V7, P715, DOI 10.1093/intimm/7.5.715; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; BATANERO E, 1992, BRAIN BEHAV IMMUN, V6, P249, DOI 10.1016/0889-1591(92)90047-R; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BERG H, 1993, J IMMUNOL METHODS, V164, P221, DOI 10.1016/0022-1759(93)90315-X; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; DENNY P, IN PRESS DIABETES; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GRIFFIN AC, 1995, AM J PATHOL, V147, P845; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KEILACKER H, 1995, HORM METAB RES, V27, P90, DOI 10.1055/s-2007-979915; KELLER RJ, 1993, LANCET, V341, P927, DOI 10.1016/0140-6736(93)91215-8; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; MCGINNIS RE, 1995, DIABETES, V44, P1296, DOI 10.2337/diabetes.44.11.1296; MILLER JFAP, 1989, COLD SH Q B, V54, P807; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; Owerbach D, 1996, DIABETES, V45, P544, DOI 10.2337/diabetes.45.5.544; POLYCHRONAKOS C, 1995, DIABETOLOGIA, V38, P715, DOI 10.1007/BF00401845; POSSELT AM, 1992, SCIENCE, V256, P1321, DOI 10.1126/science.1598576; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; RUDY G, 1995, MOL MED, V1, P625, DOI 10.1007/BF03401603; Saoudi A, 1996, IMMUNOL REV, V149, P195, DOI 10.1111/j.1600-065X.1996.tb00905.x; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SMRZKA OW, 1995, HUM MOL GENET, V4, P1945, DOI 10.1093/hmg/4.10.1945; UNDLIEN DE, 1995, DIABETES, V44, P620, DOI 10.2337/diabetes.44.6.620; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; VONHERRATH MG, 1994, J EXP MED, V180, P1901, DOI 10.1084/jem.180.5.1901; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542	37	614	627	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					289	292		10.1038/ng0397-289			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	WOS:A1997WK38600021	9054944				2022-01-24	
J	Chun, S; Fay, JC				Chun, Sung; Fay, Justin C.			Identification of deleterious mutations within three human genomes	GENOME RESEARCH			English	Article							SEQUENCE; POLYMORPHISMS; SUBSTITUTIONS; PREDICTION; CONSTRAINT; ALLELES; DISEASE; FITNESS; SNPS	Each human carries a large number of deleterious mutations. Together, these mutations make a significant contribution to human disease. Identification of deleterious mutations within individual genome sequences could substantially impact an individual's health through personalized prevention and treatment of disease. Yet, distinguishing deleterious mutations from the massive number of nonfunctional variants that occur within a single genome is a considerable challenge. Using a comparative genomics data set of 32 vertebrate species we show that a likelihood ratio test (LRT) can accurately identify a subset of deleterious mutations that disrupt highly conserved amino acids within protein-coding sequences, which are likely to be unconditionally deleterious. The LRT is also able to identify known human disease alleles and performs as well as two commonly used heuristic methods, SIFT and PolyPhen. Application of the LRT to three human genomes reveals 796-837 deleterious mutations per individual, similar to 40% of which are estimated to be at <5% allele frequency. However, the overlap between predictions made by the LRT, SIFT, and PolyPhen, is low; 76% of predictions are unique to one of the three methods, and only 5% of predictions are shared across all three methods. Our results indicate that only a small subset of deleterious mutations can be reliably identified, but that this subset provides the raw material for personalized medicine.	[Chun, Sung; Fay, Justin C.] Washington Univ, Computat Biol Program, St Louis, MO 63108 USA; [Fay, Justin C.] Washington Univ, Dept Genet, St Louis, MO 63108 USA		Fay, JC (corresponding author), Washington Univ, Computat Biol Program, St Louis, MO 63108 USA.	jfay@genetics.wustl.edu	Chun, Sung/I-2212-2015	Chun, Sung/0000-0003-3440-1913; Fay, Justin/0000-0003-1893-877X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM-080669]; Alfred P. Sloan Research FellowshipAlfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM080669] Funding Source: NIH RePORTER	We thank members of the Fay laboratory and S. Sunyaev for helpful suggestions, S. Sunyaev for sending us the PolyPhen algorithm, and The International HapMap Consortium for making the Phase III genotyping data available. This work was supported by a National Institutes of Health grant (GM-080669) and an Alfred P. Sloan Research Fellowship to J. C. F.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Care MA, 2007, BIOINFORMATICS, V23, P664, DOI 10.1093/bioinformatics/btl649; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fay JC, 2001, GENETICS, V158, P1227; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaffney DJ, 2005, GENOME RES, V15, P1086, DOI 10.1101/gr.3895005; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; Lynch M, 2000, GENETICS, V154, P459; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Stone EA, 2005, ANNU REV GENOM HUM G, V6, P143, DOI 10.1146/annurev.genom.6.080604.162146; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	50	613	620	1	22	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2009	19	9					1553	1561		10.1101/gr.092619.109			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	490ET	WOS:000269482200005	19602639	Green Published, Bronze			2022-01-24	
J	Wallace, RH; Marini, C; Petrou, S; Harkin, LA; Bowser, DN; Panchal, RG; Williams, DA; Sutherland, GR; Mulley, JC; Scheffer, IE; Berkovic, SF				Wallace, RH; Marini, C; Petrou, S; Harkin, LA; Bowser, DN; Panchal, RG; Williams, DA; Sutherland, GR; Mulley, JC; Scheffer, IE; Berkovic, SF			Mutant GABA(A) receptor gamma 2-subunit in childhood absence epilepsy and febrile seizures	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSIES; POTASSIUM CHANNEL GENE; SUBUNIT; LINKAGE; MUTATION; ASSOCIATION; CLUSTER	Epilepsies affect at least 2% of the population at some time in life, and many forms have genetic determinants(1,2). We have found a mutation in a gene encoding a GABA, receptor subunit in a large family with epilepsy. The two main phenotypes were childhood absence epilepsy (CAE) and febrile seizures (FS), There is a recognized genetic: relationship between FS and CAE, yet the two syndromes have different ages of onset, and the physiology of absences and convulsions is distinct. This suggests the mutation has age-dependent effects on different neuronal networks that influence the expression of these clinically distinct, but genetically related, epilepsy phenotypes. We found that the mutation in GABRG2 (encoding the gamma2-subunit) abolished in vitro sensitivity to diazepam, raising the possibility that endozepines do in fact exist and have a physiological role in preventing seizures.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Epilepsy Res Inst, Heidelberg, Vic, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic, Australia; Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia		Wallace, RH (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia.	rwallace@wch.bionomics.com.au	Scheffer, Ingrid E/G-1668-2013; Marini, Carla/AAC-2413-2022; Sutherland, Grant Robert/D-2606-2012; Petrou, Steven/M-8332-2013; Panchal, Rekha/None	Scheffer, Ingrid E/0000-0002-2311-2174; Marini, Carla/0000-0002-9212-2691; Wallace, Robyn/0000-0001-6141-3317; Berkovic, Samuel/0000-0003-4580-841X; Bowser, David/0000-0002-8974-9442; Panchal, Rekha/0000-0001-8621-9078; Petrou, Steven/0000-0002-4960-6375			[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BIANCHI A, 1993, EPILEPSIA, V34, P819; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BROOKSKAYAL AR, 1993, ANN NEUROL, V34, P687, DOI 10.1002/ana.410340511; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Fusco M, 2000, NAT GENET, V26, P275; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Feucht M, 1999, BIOL PSYCHIAT, V46, P997, DOI 10.1016/S0006-3223(99)00039-6; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Knudsen FU, 2000, EPILEPSIA, V41, P2, DOI 10.1111/j.1528-1157.2000.tb01497.x; Kucken AM, 2000, MOL PHARMACOL, V57, P932; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Olsen RW, 1997, EPILEPSIA, V38, P399, DOI 10.1111/j.1528-1157.1997.tb01728.x; Sander T, 1999, AM J MED GENET, V88, P305, DOI 10.1002/(SICI)1096-8628(19990820)88:4<305::AID-AJMG5>3.0.CO;2-X; Sander T, 1997, ACTA NEUROL SCAND, V96, P1; Sander T, 1996, EPILEPSY RES, V23, P235, DOI 10.1016/0920-1211(95)00098-4; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Scheffer IE, 2000, CURR OPIN PEDIATR, V12, P536, DOI 10.1097/00008480-200012000-00004; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Snead O C 3rd, 1999, Adv Neurol, V79, P253; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	27	613	647	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					49	52		10.1038/88259			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	WOS:000168413300015	11326275				2022-01-24	
J	ICHINOSE, H; OHYE, T; TAKAHASHI, E; SEKI, N; HORI, T; SEGAWA, M; NOMURA, Y; ENDO, K; TANAKA, H; TSUJI, S; FUJITA, K; NAGATSU, T				ICHINOSE, H; OHYE, T; TAKAHASHI, E; SEKI, N; HORI, T; SEGAWA, M; NOMURA, Y; ENDO, K; TANAKA, H; TSUJI, S; FUJITA, K; NAGATSU, T			HEREDITARY PROGRESSIVE DYSTONIA WITH MARKED DIURNAL FLUCTUATION CAUSED BY MUTATIONS IN THE GTP CYCLOHYDROLASE-I GENE	NATURE GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; DOPA-RESPONSIVE DYSTONIA; TETRAHYDROBIOPTERIN; RAT; DEFICIENCY; ENZYME; BIOSYNTHESIS; BIOPTERIN; CLONING; HYPERPHENYLALANINEMIA	Hereditary progressive dystonia with marked diurnal fluctuation (HPD) (also known as dopa responsive dystonia) is a dystonia with onset in childhood that shows a marked response without any side effects to levodopa. Recently the gene for dopa responsive dystonia (DRD) was mapped to chromosome 14q. Here we report that GTP cyclohydrolase I is mapped to 14q22.1-q22.2. The identification of four independent mutations of the gene for GTP cyclohydrolase I in patients with HPD, as well as a marked decrease in the enzymes activity in mononuclear blood cells, confirms that the GTP cyclohydrolase I gene is a causative gene for HPD/DRD. This is the first report of a causative gene for the inherited dystonias.	FUJITA HLTH UNIV,SCH MED,INST COMPREHENS MED SCI,TOYOAKE,AICHI 47011,JAPAN; NATL INST RADIOL SCI,DIV GENET,CHIBA,JAPAN; KAZUSA DNA RES INST,GENE STRUCT LAB 1,CHIBA 292,JAPAN; SEGAWA NEUROL CLIN CHILDREN,TOKYO 101,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN				Ichinose, Hiroshi/D-8986-2015; Jansen, Heiko T./A-5770-2008	Ichinose, Hiroshi/0000-0001-6008-6860; Jansen, Heiko T./0000-0003-0178-396X			BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BLAU N, 1985, CLIN CHIM ACTA, V148, P47, DOI 10.1016/0009-8981(85)90299-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DHONDT JL, 1985, J PEDIATR-US, V106, P954, DOI 10.1016/S0022-3476(85)80251-1; ENDO K, 1995, IN PRESS AGE RELATED; FINK JK, 1988, NEUROLOGY, V38, P707, DOI 10.1212/WNL.38.5.707; FINK JK, 1989, NEUROLOGY, V39, P1393, DOI 10.1212/WNL.39.10.1393; FLETCHER NA, 1989, J NEUROL NEUROSUR PS, V52, P112, DOI 10.1136/jnnp.52.1.112; FURUKAWA Y, 1993, ADV NEUROL, V60, P562; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATAKEYAMA K, 1989, J BIOL CHEM, V264, P21660; HATAKEYAMA K, 1991, J BIOL CHEM, V266, P765; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHIGA M, 1993, J PHARMACOL EXP THER, V267, P971; ICHINOSE H, 1991, BIOCHEM BIOPH RES CO, V179, P183, DOI 10.1016/0006-291X(91)91352-D; KAPATOS G, 1990, J NEUROCHEM, V55, P129, DOI 10.1111/j.1471-4159.1990.tb08830.x; KAUFMAN S, 1959, J BIOL CHEM, V234, P2677; KETTLER R, 1974, NATURE, V249, P476, DOI 10.1038/249476a0; LEVINE RA, 1981, SCIENCE, V214, P919, DOI 10.1126/science.6117945; LEWITT PA, 1986, NEUROLOGY, V36, P760, DOI 10.1212/WNL.36.6.760; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; MIWA S, 1985, ARCH BIOCHEM BIOPHYS, V239, P234, DOI 10.1016/0003-9861(85)90831-8; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NAGATSU T, 1985, SELECTED TOPICS NEUR, P325; NAYLOR EW, 1987, PEDIATRICS, V79, P374; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.bi.54.070185.003501; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; NOMURA T, 1993, BIOCHEM BIOPH RES CO, V191, P523, DOI 10.1006/bbrc.1993.1249; Nomura Y, 1993, HEREDITARY PROGR DYS, P73; Nygaard T G, 1988, Adv Neurol, V50, P377; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; NYGAARD TG, 1991, NEUROLOGY, V41, P174, DOI 10.1212/WNL.41.2_Part_1.174; NYGAARD TG, 1993, HEREDITARY PROGR DYS, P21; RAJPUT AH, 1994, ANN NEUROL, V35, P396, DOI 10.1002/ana.410350405; REISERT I, 1989, CELL TISSUE RES, V255, P411; SAWADA M, 1986, ANAL BIOCHEM, V154, P361, DOI 10.1016/0003-2697(86)90537-3; Segawa M, 1976, Adv Neurol, V14, P215; SEGAWA M, 1988, HDB CLIN NEUROLOGY, P529; Segawa M, 1971, SHINRYO TOKYO, V24, P667; TAKAHASHI E, 1991, CYTOGENET CELL GENET, V57, P109, DOI 10.1159/000133124; TAKAHASHI E, 1990, HUM GENET, V86, P14; TAKAHASHI E, 1991, HUM GENET, V88, P119, DOI 10.1007/BF00204942; TAKAHASHI H, 1994, ANN NEUROL, V35, P354, DOI 10.1002/ana.410350317; TOGARI A, 1992, BIOCHEM BIOPH RES CO, V187, P359, DOI 10.1016/S0006-291X(05)81501-3; TSUJI S, 1993, HEREDITARY PROGR DYS, P107; VIEGASPEQUIGNOT E, 1989, HUM GENET, V83, P33, DOI 10.1007/BF00274143; WILLIAMS A, 1979, LANCET, V2, P410	48	613	644	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					236	242		10.1038/ng1194-236			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	WOS:A1994PP76500012	7874165				2022-01-24	
J	MERCER, JFB; LIVINGSTON, J; HALL, B; PAYNTER, JA; BEGY, C; CHANDRASEKHARAPPA, S; LOCKHART, P; GRIMES, A; BHAVE, M; SIEMIENIAK, D; GLOVER, TW				MERCER, JFB; LIVINGSTON, J; HALL, B; PAYNTER, JA; BEGY, C; CHANDRASEKHARAPPA, S; LOCKHART, P; GRIMES, A; BHAVE, M; SIEMIENIAK, D; GLOVER, TW			ISOLATION OF A PARTIAL CANDIDATE GENE FOR MENKES DISEASE BY POSITIONAL CLONING	NATURE GENETICS			English	Article							TRANSLOCATION; RESISTANCES; COPPER; CELLS	Menkes disease is an X-linked recessive disorder of copper metabolism resulting in death in early infancy. The gene has been mapped to band Xq13 based, in part, on a translocation breakpoint in a female with the disease, which was found to lie within 300 kilobases (kb) of the PGK-1 locus, allowing the isolation of a YAC clone spanning the breakpoint. Phage subclones from the breakpoint region were isolated and used to screen cDNA libraries. cDNA clones were found which detect an 8 kb transcript from normal individuals but show diminished or absent hybridization in Menkes disease patients. Partial sequence of the cDNA shows a unique open reading frame containing putative metal binding motifs which have been found in heavy metal resistance genes in bacteria. This gene is a strong candidate for the Menkes disease gene.	UNIV MICHIGAN,HOWARD HUGHES MED INST,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,CTR GENOME,ANN ARBOR,MI 48109; MURDOCH UNIV,SCOBIE & CLAIRE MACKINNON TRACE ELEMENT LAB,MURDOCH,WA 6150,AUSTRALIA				Lockhart, Paul J/E-7753-2011; Mercer, Julian/R-8583-2019	Lockhart, Paul J/0000-0003-2531-8413; 	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P30HGO-0209] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK 44130, R55 DK 44130] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P30HG000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R55DK044130, R01DK044130] Funding Source: NIH RePORTER		BROWN NL, 1991, J CELL BIOCHEM, V46, P106; CAMAKARIS J, 1980, BIOCHEM GENET, V18, P117, DOI 10.1007/BF00504364; Danks D.M., 1989, METABOLIC BASIS INHE, P1411; DANKS DM, 1972, LANCET, V1, P1100; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; GONSALES GG, 1992, GENOMICS, V14, P557; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KUWANO A, 1991, CYTOGENET CELL GENET, V56, P212, DOI 10.1159/000133091; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; MENKES JH, 1962, PEDIATRICS, V29, P764; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PIERETTI M, 1991, NUCLEIC ACIDS RES, V19, P2795, DOI 10.1093/nar/19.10.2795; SABURO S, 1988, J BIOL CHEM, V263, P16899; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SILVER S, 1988, ANNU REV MICROBIOL, V42, P717, DOI 10.1146/annurev.mi.42.100188.003441; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; TONNESEN T, 1992, AM J HUM GENET, V50, P1012; TURNER Z, 1992, HUM MOL GENET, P483; VERGA V, 1991, AM J HUM GENET, V48, P1133	23	613	616	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					20	25		10.1038/ng0193-20			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	WOS:A1993KF37200007	8490647				2022-01-24	
J	Kozlitina, J; Smagris, E; Stender, S; Nordestgaard, BG; Zhou, HH; Tybjaerg-Hansen, A; Vogt, TF; Hobbs, HH; Cohen, JC				Kozlitina, Julia; Smagris, Eriks; Stender, Stefan; Nordestgaard, Borge G.; Zhou, Heather H.; Tybjaerg-Hansen, Anne; Vogt, Thomas F.; Hobbs, Helen H.; Cohen, Jonathan C.			Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENETIC-VARIATION; LOCI; POPULATION; PLASMA; STEATOSIS; ENZYMES; PNPLA3; HEALTH	Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease. To elucidate the molecular basis of NAFLD, we performed an exome-wide association study of liver fat content. Three variants were associated with higher liver fat levels at the exome-wide significance level of 3.6 Chi 10(-7): two in PNPLA3, an established locus for NAFLD, and one (encoding p. Glu167Lys) in TM6SF2, a gene of unknown function. The TM6SF2 variant encoding p. Glu167Lys was also associated with higher circulating levels of alanine transaminase, a marker of liver injury, and with lower levels of low-density lipoprotein-cholesterol (LDL-C), triglycerides and alkaline phosphatase in 3 independent populations (n > 80,000). When recombinant protein was expressed in cultured hepatocytes, 50% less Glu167Lys TM6SF2 protein was produced relative to wild-type TM6SF2. Adeno-associated virus-mediated short hairpin RNA knockdown of Tm6sf2 in mice increased liver triglyceride content by threefold and decreased very-low-density lipoprotein (VLDL) secretion by 50%. Taken together, these data indicate that TM6SF2 activity is required for normal VLDL secretion and that impaired TM6SF2 function causally contributes to NAFLD.	[Kozlitina, Julia; Smagris, Eriks; Hobbs, Helen H.; Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, McDermott Ctr, Human Growth & Dev, Dallas, TX 75390 USA; [Stender, Stefan; Tybjaerg-Hansen, Anne] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Stender, Stefan; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Zhou, Heather H.; Vogt, Thomas F.] Merck Res Labs, Kenilworth, NJ USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA		Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, McDermott Ctr, Human Growth & Dev, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu; jonathan.cohen@utsouthwestern.edu	Stender, Stefan/AAC-8258-2019	Stender, Stefan/0000-0003-0281-5900; Kozlitina, Julia/0000-0001-7720-2290	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL20948, 1HL092550, DK090066]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL020948, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK090066] Funding Source: NIH RePORTER	We thank F. Xu for excellent technical assistance. This work was supported by grants from the US National Institutes of Health (HL20948, 1HL092550 and DK090066) and the National Center for Advancing Translational Sciences (UL1TR001105). T.F.V. acknowledges the contributions of G. Gao (University of Massachusetts) for advice and assistance with AAV vector production.	Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen Z, 2011, J CARDIOVASC TRANSL, V4, P801, DOI 10.1007/s12265-011-9309-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gorden A, 2013, HUM HERED, V75, P34, DOI 10.1159/000346195; Hernaez R, 2013, CLIN GASTROENTEROL H, V11, P1183, DOI 10.1016/j.cgh.2013.02.011; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	22	612	628	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					352	+		10.1038/ng.2901			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	WOS:000334510100010	24531328	Green Accepted	Y	N	2022-01-24	
J	Fujimoto, A; Totoki, Y; Abe, T; Boroevich, KA; Hosoda, F; Nguyen, HH; Aoki, M; Hosono, N; Kubo, M; Miya, F; Arai, Y; Takahashi, H; Shirakihara, T; Nagasaki, M; Shibuya, T; Nakano, K; Watanabe-Makino, K; Tanaka, H; Nakamura, H; Kusuda, J; Ojima, H; Shimada, K; Okusaka, T; Ueno, M; Shigekawa, Y; Kawakami, Y; Arihiro, K; Ohdan, H; Gotoh, K; Ishikawa, O; Ariizumi, S; Yamamoto, M; Yamada, T; Chayama, K; Kosuge, T; Yamaue, H; Kamatani, N; Miyano, S; Nakagama, H; Nakamura, Y; Tsunoda, T; Shibata, T; Nakagawa, H				Fujimoto, Akihiro; Totoki, Yasushi; Abe, Tetsuo; Boroevich, Keith A.; Hosoda, Fumie; Nguyen, Ha Hai; Aoki, Masayuki; Hosono, Naoya; Kubo, Michiaki; Miya, Fuyuki; Arai, Yasuhito; Takahashi, Hiroyuki; Shirakihara, Takuya; Nagasaki, Masao; Shibuya, Tetsuo; Nakano, Kaoru; Watanabe-Makino, Kumiko; Tanaka, Hiroko; Nakamura, Hiromi; Kusuda, Jun; Ojima, Hidenori; Shimada, Kazuaki; Okusaka, Takuji; Ueno, Masaki; Shigekawa, Yoshinobu; Kawakami, Yoshiiku; Arihiro, Koji; Ohdan, Hideki; Gotoh, Kunihito; Ishikawa, Osamu; Ariizumi, Shun-ichi; Yamamoto, Masakazu; Yamada, Terumasa; Chayama, Kazuaki; Kosuge, Tomoo; Yamaue, Hiroki; Kamatani, Naoyuki; Miyano, Satoru; Nakagama, Hitoshi; Nakamura, Yusuke; Tsunoda, Tatsuhiko; Shibata, Tatsuhiro; Nakagawa, Hidewaki			Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators	NATURE GENETICS			English	Article							B VIRUS-DNA; HEPATOCELLULAR-CARCINOMA; NEGATIVE REGULATOR; SOMATIC MUTATIONS; INTEGRATION; ALIGNMENT; COMPLEX; TARGETS	Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. We sequenced and analyzed the whole genomes of 27 HCCs, 25 of which were associated with hepatitis B or C virus infections, including two sets of multicentric tumors. Although no common somatic mutations were identified in the multicentric tumor pairs, their whole-genome substitution patterns were similar, suggesting that these tumors developed from independent mutations, although their shared etiological backgrounds may have strongly influenced their somatic mutation patterns. Statistical and functional analyses yielded a list of recurrently mutated genes. Multiple chromatin regulators, including ARID1A, ARID1B, ARID2, MLL and MLL3, were mutated in similar to 50% of the tumors. Hepatitis B virus genome integration in the TERT locus was frequently observed in a high clonal proportion. Our whole-genome sequencing analysis of HCCs identified the influence of etiological background on somatic mutation patterns and subsequent carcinogenesis, as well as recurrent mutations in chromatin regulators in HCCs.	[Fujimoto, Akihiro; Abe, Tetsuo; Boroevich, Keith A.; Nguyen, Ha Hai; Aoki, Masayuki; Hosono, Naoya; Kubo, Michiaki; Miya, Fuyuki; Nakano, Kaoru; Watanabe-Makino, Kumiko; Chayama, Kazuaki; Kamatani, Naoyuki; Nakamura, Yusuke; Tsunoda, Tatsuhiko; Nakagawa, Hidewaki] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Totoki, Yasushi; Hosoda, Fumie; Arai, Yasuhito; Takahashi, Hiroyuki; Shirakihara, Takuya; Nakamura, Hiromi] Natl Canc Ctr, Res Inst, Tokyo 104, Japan; [Nagasaki, Masao; Shibuya, Tetsuo; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Kusuda, Jun] Natl Inst Biomed Innovat, Ibaraki, Osaka, Japan; [Ojima, Hidenori; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Ueno, Masaki; Shigekawa, Yoshinobu; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg Gastroenterol, Wakayama, Japan; [Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Sch Med, Dept Med & Mol Sci, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ, Sch Med, Dept Surg Gastroenterol, Hiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Pathol Anat, Hiroshima, Japan; [Gotoh, Kunihito; Ishikawa, Osamu; Yamada, Terumasa] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ariizumi, Shun-ichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Dept Surg Gastroenterol, Tokyo, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan		Nakagawa, H (corresponding author), RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan.	tashibat@ncc.go.jp; hidewaki@ims.u-tokyo.ac.jp	Ohdan, Hideki/G-4719-2019; Tsunoda, Tatsuhiko/K-2061-2014; Shibata, Tatsuhiro/AAO-1278-2021; Kubo, Michiaki/N-7947-2015; Shibata, Tatsuhiro/ABA-8234-2020; nguyễn, Ha/V-6993-2019	Ohdan, Hideki/0000-0002-9066-1288; Tsunoda, Tatsuhiko/0000-0002-5439-7918; nguyễn, Ha/0000-0002-5431-5935; Boroevich, Keith/0000-0001-7095-7332; Nagasaki, Masao/0000-0002-4292-8785; Miya, Fuyuki/0000-0001-6758-2015; Arai, Yasuhito/0000-0001-6306-9409; Miyano, Satoru/0000-0002-1753-6616	National Institute of Biomedical Innovation (NIBIO)National Institute of Biomedical Innovation; National Cancer Center [23-A-8]; RIKEN; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24659368] Funding Source: KAKEN	The supercomputing resource SHIROKANE was provided by the Human Genome Center at The University of Tokyo. The authors thank T. Urushidate, S. Ohashi, N. Okada, A. Kokubu and H. Shimizu at the National Cancer Center Research Institute and C. Inai, R. Ooishi, and R. Kitada at the RIKEN Center for Genomic Medicine for their technical assistances. This work was supported partially by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the National Cancer Center Research and Development Fund (23-A-8) and the RIKEN Strategic Research Program for R&D of President's Fund 2011.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson R, 2008, BIOINFORMATICS, V24, P751, DOI 10.1093/bioinformatics/btn003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; ZHOU YZ, 1987, J NATL CANCER I, V79, P223	30	612	633	3	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					760	U182		10.1038/ng.2291			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	WOS:000305886900008	22634756		Y	N	2022-01-24	
J	Yang, X; Schadt, EE; Wang, S; Wang, H; Arnold, AP; Ingram-Drake, L; Drake, TA; Lusis, AJ				Yang, Xia; Schadt, Eric E.; Wang, Susanna; Wang, Hui; Arnold, Arthur P.; Ingram-Drake, Leslie; Drake, Thomas A.; Lusis, Aldons J.			Tissue-specific expression and regulation of sexually dimorphic genes in mice	GENOME RESEARCH			English	Article							X-LINKED GENE; SEX DETERMINATION; GROWTH-HORMONE; RAT-BRAIN; MOUSE; GENDER; METABOLISM; FEMALE; CELLS; CHROMOSOME	We report a comprehensive analysis of gene expression differences between sexes in multiple somatic tissues of 334 mice derived from an intercross between inbred mouse strains C57BL/6J and C3H/HeJ. The analysis of a large number of individuals provided the power to detect relatively small differences in expression between sexes, and the use of an intercross allowed analysis of the genetic control of sexually dimorphic gene expression. Microarray analysis of 23,574 transcripts revealed that the extent of sexual dimorphism in gene expression was much greater than previously recognized. Thus, thousands of genes showed sexual dimorphism in liver, adipose, and muscle, and hundreds of genes were sexually dimorphic in brain. These genes exhibited highly tissue-specific patterns of expression and were enriched for distinct pathways represented in the Gene Ontology database. They also showed evidence of chromosomal enrichment, not only on the sex chromosomes, but also on several autosomes. Genetic analyses provided evidence of the global regulation of subsets of the sexually dimorphic genes, as the transcript levels of a large number of these genes were controlled by several expression quantitative trait loci (eQTL) hotspots that exhibited tissue-specific control. Moreover, many tissue-specific transcription factor binding sites were found to be enriched in the sexually dimorphic genes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Wholly Owned Subsidiary Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Coll Letters & Sci, Dept Stat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Neuroendocrinol Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA		Lusis, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	jlusis@mednet.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL028481, P01HL030568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK071673] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01 HL030568, HL30568, P01 HL028481, HL28481] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK071673, R01 DK071673] Funding Source: Medline		Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063; Anderson Gail D, 2002, J Gend Specif Med, V5, P25; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Arnold AP, 2004, TRENDS ENDOCRIN MET, V15, P6, DOI 10.1016/j.tem.2003.11.001; ARNOLD AP, 2002, HORMONES BRAIN BEHAV, V4, P105; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; BEYER C, 1992, BRAIN RES, V593, P253, DOI 10.1016/0006-8993(92)91315-6; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Depner TA, 2003, ADV RENAL REPLACE TH, V10, P71, DOI 10.1053/jarr.2003.50007; DEVITO WJ, 1988, NEUROENDOCRINOLOGY, V47, P284, DOI 10.1159/000124926; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Farsetti A, 2001, ENDOCRINOLOGY, V142, P3380, DOI 10.1210/en.142.8.3380; HAYDEN JM, 1992, J ANIM SCI, V70, P2109, DOI 10.2527/1992.7072109x; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Hughes IA, 2001, ENDOCRINOLOGY, V142, P3281, DOI 10.1210/en.142.8.3281; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kahlert S, 1997, BIOCHEM BIOPH RES CO, V232, P373, DOI 10.1006/bbrc.1997.6223; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Krebs CJ, 2003, GENE DEV, V17, P2664, DOI 10.1101/gad.1135703; LAUBER AH, 1991, J STEROID BIOCHEM, V40, P53, DOI 10.1016/0960-0760(91)90167-4; Lee CE, 2001, CURR APPL PHYS, V1, P107, DOI 10.1016/S1567-1739(00)00020-1; LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461; LUSIS AJ, 1983, J BIOL CHEM, V258, P5071; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; Mann P E, 2001, Prog Brain Res, V133, P251; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; McElreavey K, 1995, HEREDITY, V75, P599, DOI 10.1038/hdy.1995.179; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Richards SM, 2006, EXP EYE RES, V82, P13, DOI 10.1016/j.exer.2005.04.014; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; SMITH MJ, 1994, CURR BIOL, V4, P1003, DOI 10.1016/S0960-9822(00)00226-8; Spitzer JA, 1999, LUPUS, V8, P380, DOI 10.1177/096120339900800510; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Tullis KM, 2003, ENDOCRINOLOGY, V144, P1854, DOI 10.1210/en.2002-0190; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Vilain E, 1998, MOL GENET METAB, V65, P74, DOI 10.1006/mgme.1998.2749; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Waxman DJ, 2003, GENE DEV, V17, P2607, DOI 10.1101/gad.1154603; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Wizemann T.M., 2001, EXPLORING BIOL CONTR; Xu J, 2006, GENE EXPR PATTERNS, V6, P146, DOI 10.1016/j.modgep.2005.06.011	55	612	619	2	56	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2006	16	8					995	1004		10.1101/gr.5217506			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	069JE	WOS:000239441400006	16825664	Green Published, Bronze			2022-01-24	
J	Pingault, V; Bondurand, N; Kuhlbrodt, K; Goerich, DE; Prehu, MO; Puliti, A; Herbarth, B; Hermans-Borgmeyer, I; Legius, E; Matthijs, G; Amiel, J; Lyonnet, S; Ceccherini, I; Romeo, G; Smith, JC; Read, AP; Wegner, M; Goossens, M				Pingault, V; Bondurand, N; Kuhlbrodt, K; Goerich, DE; Prehu, MO; Puliti, A; Herbarth, B; Hermans-Borgmeyer, I; Legius, E; Matthijs, G; Amiel, J; Lyonnet, S; Ceccherini, I; Romeo, G; Smith, JC; Read, AP; Wegner, M; Goossens, M			SOX10 mutations in patients with Waardenburg-Hirschsprung disease	NATURE GENETICS			English	Article							ENDOTHELIN-B RECEPTOR; PAIRED DOMAIN; HMG BOX; GENE; MEGACOLON; MICE; MELANOCYTES; ASSOCIATION; TYPE-2; MOUSE	Waardenburg syndrome (WS; deafness with pigmentary abnormalities) and Hirschsprung's disease (HSCR; aganglionic megacolon) are congenital disorders caused by defective function of the embryonic neural crest(1,2). WS and HSCR are associated in patients with Waardenburg-Shah syndrome (WS4), whose symptoms are reminiscent of the white coat-spotting and aganglionic megacolon displayed by the mouse mutants Dom (Dominant megacolon), piebald-lethal(s(l)) and lethal spotting (Is). The s(l) and Is phenotypes are caused by mutations in the genes encoding the Endothelin-B receptor (Ednrb) and Endothelin 3 (Edn3), respectively(3,4). The identification of Sox10 as the gene mutated in Dom mice (B.H. et al., manuscript submitted) prompted us to analyse the role of its human homologue SOx10 in neural crest defects. Here we show that patients from four families with WS4 have mutations in SOx10, whereas no mutation could be detected in patients with HSCR alone. These mutations are likely to result in haploinsufficiency of the SOx10 product. Our findings further define the locus heterogeneity of Waardenburg-Hirschsprung syndromes. and point to an essential role of SOx10 in the development of two neural crest-derived human cell lineages.	Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Hop Necker Enfants Malad, INSERM, U393, F-75743 Paris, France; Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England		Goossens, M (corresponding author), Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France.	goossens@im3.inserm.fr	Puliti, Aldamaria/K-7866-2016; Ceccherini, Isabella/P-8195-2014; Puliti, Aldamaria/AAF-5400-2021; amiel, jeanne/H-3501-2017; Legius, Eric/H-1735-2011; Bondurand, Nadege/H-4737-2017; Lyonnet, Stanislas/H-5483-2017	Puliti, Aldamaria/0000-0001-9310-6514; Ceccherini, Isabella/0000-0001-8732-1955; amiel, jeanne/0000-0001-5973-4728; Bondurand, Nadege/0000-0002-1531-1544; Lyonnet, Stanislas/0000-0001-5426-9417; Matthijs, Gert/0000-0001-6710-1912; Wegner, Michael/0000-0002-4586-3294; Pingault, Veronique/0000-0001-7064-0765			AMBANI LM, 1983, J PEDIATR-US, V102, P802, DOI 10.1016/S0022-3476(83)80267-4; BADNER JA, 1990, AM J HUM GENET, V46, P568; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Chakravarti A, 1996, HUM MOL GENET, V5, P303; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; FRIED K, 1980, CLIN GENET, V18, P91; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; HOTH CF, 1993, AM J HUM GENET, V52, P455; Kapur RP, 1996, DEV BIOL, V174, P360, DOI 10.1006/dbio.1996.0080; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; MEIRE F, 1987, AM J MED GENET, V27, P683, DOI 10.1002/ajmg.1320270322; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; PAVAN WJ, 1995, GENOME RES, V5, P29, DOI 10.1101/gr.5.1.29; Pringault V, 1997, GENOMICS, V39, P86, DOI 10.1006/geno.1996.4476; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Puliti A, 1996, NEUROREPORT, V7, P489, DOI 10.1097/00001756-199601310-00027; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STEEL KP, 1989, DEVELOPMENT, V107, P453; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; vanHoute LPA, 1995, J BIOL CHEM, V270, P30516, DOI 10.1074/jbc.270.51.30516; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4	31	612	628	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					171	173		10.1038/ng0298-171			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	WOS:000071779500028	9462749				2022-01-24	
J	Chang, SS; Grunder, S; Hanukoglu, A; Rosler, A; Mathew, PM; Hanukoglu, I; Schild, L; Lu, Y; Shimkets, RA; NelsonWilliams, C; Rossier, BC; Lifton, RP				Chang, SS; Grunder, S; Hanukoglu, A; Rosler, A; Mathew, PM; Hanukoglu, I; Schild, L; Lu, Y; Shimkets, RA; NelsonWilliams, C; Rossier, BC; Lifton, RP			Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1	NATURE GENETICS			English	Article							NEURODEGENERATION; INHERITANCE; DEFECTS; DNA	Autosomal recessive pseudohypoaldosteronism type I is a rave life-threatening disease characterized by severe neonatal salt wasting, hyperkalaemia, metabolic acidosis, and unresponsiveness to mineralocorticoid hormones. Investigation of affected offspring of consanguineous union reveals mutations in either the alpha or beta subunits of the amiloride-sensitive epithelial sodium channel in five kindreds. These mutations are homozygous in affected subjects, co-segregate with the disease, and introduce frameshift, premature termination or missense mutations that result in loss of channel activity. These findings demonstrate the molecular basis and explain the pathophysiology of this disease.	YALE UNIV, SCH MED,HOWARD HUGHES MED INST,DEPT GENET, BOYER CTR MOLEC MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT MED, NEPHROL SECT, NEW HAVEN, CT 06510 USA; UNIV LAUSANNE, INST PHARMACOL & TOXICOL, CH-1005 LAUSANNE, SWITZERLAND; E WOLFSON HOSP, DEPT PEDIAT, HOLON, ISRAEL; TEL AVIV UNIV, SACKLER SCH MED, IL-69978 TEL AVIV, ISRAEL; HEBREW UNIV JERUSALEM, HADASSAH MED CTR, DEPT ENDOCRINOL & METAB, JERUSALEM, ISRAEL; DHAHRAN HLTH CTR, DEPT PEDIAT, DHAHRAN, SAUDI ARABIA; COLL JUDEA & SAMARIA, RES INST, ARIEL, ISRAEL; SOURASKY MED CTR, INST ENDOCRINOL, TEL AVIV, ISRAEL				Grunder, Stefan/I-2495-2019; Hanukoglu, Israel/B-9694-2008; Hanukoglu, Aaron/L-4892-2016	Grunder, Stefan/0000-0002-7635-9883; Hanukoglu, Israel/0000-0003-3889-0320; Hanukoglu, Aaron/0000-0003-1486-6641			ARMANINI D, 1985, NEW ENGL J MED, V313, P1178, DOI 10.1056/NEJM198511073131902; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOSSON D, 1986, ACTA ENDOCRINOL-COP, V113, P376, DOI 10.1530/acta.0.112S376; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHEEK DB, 1958, ARCH DIS CHILD, V33, P252, DOI 10.1136/adc.33.169.252; DILLON MJ, 1980, ARCH DIS CHILD, V55, P427, DOI 10.1136/adc.55.6.427; DONNELL GN, 1959, AMA J DIS CHILD, V97, P813, DOI 10.1001/archpedi.1959.02070010815008; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HANUKOGLU A, 1994, J PEDIATR-US, V125, P752, DOI 10.1016/S0022-3476(94)70071-0; HANUKOGLU A, 1991, J CLIN ENDOCR METAB, V73, P936, DOI 10.1210/jcem-73-5-936; HANUKOGLU A, 1978, LANCET, V1, P1359; HOGG RJ, 1991, PEDIATR NEPHROL, V5, P205, DOI 10.1007/BF01095953; HORISBERGER JD, 1993, CELL PHYSIOL BIOCHEM, V3, P283, DOI 10.1159/000154694; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; KOMESAROFF PA, 1994, J CLIN ENDOCR METAB, V79, P27, DOI 10.1210/jc.79.1.27; KUHNLE U, 1990, J CLIN ENDOCR METAB, V70, P638, DOI 10.1210/jcem-70-3-638; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LI XJ, 1995, MOL PHARMACOL, V47, P1133; LIMAL JM, 1978, LANCET, V1, P51; MATHEW PM, 1993, CLIN PEDIATR, V32, P58, DOI 10.1177/000992289303200112; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; POPOW C, 1988, ACTA PAEDIATR SCAND, V77, P136, DOI 10.1111/j.1651-2227.1988.tb10612.x; PUOTI A, 1995, AM J PHYSIOL-CELL PH, V269, pC188, DOI 10.1152/ajpcell.1995.269.1.C188; ROSLER A, 1984, J CLIN ENDOCR METAB, V59, P689; ROSSIER BC, 1992, KIDNEY PHYSL PATHOPH, P1373; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SPEISER PW, 1986, MECHANISMS CLIN ASPE, P173; STRANG LB, 1991, PHYSIOL REV, V71, P991, DOI 10.1152/physrev.1991.71.4.991; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; ZENNARO MC, 1994, J CLIN ENDOCR METAB, V79, P32, DOI 10.1210/jc.79.1.32	40	612	620	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					248	253		10.1038/ng0396-248			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	WOS:A1996TY18300012	8589714				2022-01-24	
J	TEMPLETON, AR; BOERWINKLE, E; SING, CF				TEMPLETON, AR; BOERWINKLE, E; SING, CF			A CLADISTIC-ANALYSIS OF PHENOTYPIC ASSOCIATIONS WITH HAPLOTYPES INFERRED FROM RESTRICTION ENDONUCLEASE MAPPING .1. BASIC THEORY AND AN ANALYSIS OF ALCOHOL-DEHYDROGENASE ACTIVITY IN DROSOPHILA	GENETICS			English	Article									UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109				Templeton, Alan R./F-5963-2011	Sing, Charles/0000-0001-5872-7956; Templeton, Alan/0000-0002-0167-845X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL024489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG002246] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL24489] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG02246] Funding Source: Medline		ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; AQUADRO CF, 1986, GENETICS, V114, P1165; Bishop Y.M., 1975, DISCRETE MULTIVARIAT; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; CROSS SRH, 1986, BIOCHEM GENET, V24, P415, DOI 10.1007/BF00499097; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOLDING GB, 1986, P NATL ACAD SCI USA, V83, P427, DOI 10.1073/pnas.83.2.427; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; KAN YW, 1980, SCIENCE, V209, P388, DOI 10.1126/science.7384810; Kimura M., 1983, NEUTRAL THEORY MOL E; ORKIN SH, 1984, ANNU REV GENET, V18, P131; SING CF, 1985, AM J HUM GENET, V37, P268; Templeton A., 1986, P365; Templeton A.R., 1983, STAT ANAL DNA SEQUEN, P151; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; [No title captured]	16	611	625	0	11	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1987	117	2					343	351					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K3673	WOS:A1987K367300018	2822535				2022-01-24	
J	Aharoni, A; Gaidukov, L; Khersonsky, O; Gould, SM; Roodveldt, C; Tawfik, DS				Aharoni, A; Gaidukov, L; Khersonsky, O; Gould, SM; Roodveldt, C; Tawfik, DS			The 'evolvability' of promiscuous protein functions	NATURE GENETICS			English	Article							CONFORMATIONAL DIVERSITY; CATALYTIC PROMISCUITY; DIRECTED EVOLUTION; ENZYME; SPECIFICITY; SUBSTRATE; PARAOXONASES; MECHANISM; BINDING; FAMILY	How proteins with new functions (e. g., drug or antibiotic resistance or degradation of man-made chemicals) evolve in a matter of months or years is still unclear. This ability is dependent on the induction of new phenotypic traits by a small number of mutations (plasticity). But mutations often have deleterious effects on functions that are essential for survival. How are these seemingly conflicting demands met at the single-protein level? Results from directed laboratory evolution experiments indicate that the evolution of a new function is driven by mutations that have little effect on the native function but large effects on the promiscuous functions that serve as starting point. Thus, an evolving protein can initially acquire increased fitness for a new function without losing its original function. Gene duplication and the divergence of a completely new protein may then follow.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel		Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Roodveldt, Cintia/I-9118-2014	Roodveldt, Cintia/0000-0003-4124-8769; Aharoni, Amir/0000-0003-2701-6996			Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; BORNSCHEUER UT, 2004, ANGEW CHEM INT EDIT, V43, P2; Chong YH, 2004, FRONT BIOSCI-LANDMRK, V9, P164, DOI 10.2741/1220; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; James LC, 2001, PROTEIN SCI, V10, P2600, DOI 10.1110/ps.ps.14601; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; KREBS JF, 1993, J BIOL CHEM, V268, P27458; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Pata JD, 2004, P NATL ACAD SCI USA, V101, P10548, DOI 10.1073/pnas.0404151101; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; Raushel FM, 2000, ADV ENZYMOL RAMB, V74, P51; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Taverna DM, 2002, J MOL BIOL, V315, P479, DOI 10.1006/jmbi.2001.5226; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101	30	610	616	4	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					73	76		10.1038/ng1482			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	WOS:000225997500023	15568024				2022-01-24	
J	Mitelman, F; Mertens, F; Johansson, B				Mitelman, F; Mertens, F; Johansson, B			A breakpoint map of recurrent chromosomal rearrangements in human neoplasia	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENES; CANCER; TRANSLOCATIONS; ONCOGENES	Cytogenetic studies over the past few decades have revealed clonal chromosomal aberrations in almost 27,000 human neoplasms. Many of these neoplasia-associated chromosomal abnormalities have been characterised at the molecular level, revealing previously unknown genes that are closely associated with the tumorigenic process. Information on chromosome changes in neoplasia is growing rapidly, making it difficult to identify all recurrent chromosomal aberrations. We have developed a computer program to ascertain, for the first time, all recurrent structural abnormalities in all haematological malignancies and solid tumours published up to June 1996. Out of 26,523 cases, a total of 215 balanced and 1,588 unbalanced recurrent aberrations were identified among 75 different neoplastic disorders. Our compilation of all recurrent balanced and unbalanced neoplasia-associated rearrangements should help in directing future efforts aimed at identifying the molecular mechanisms involved in tumorigenesis.			Mitelman, F (corresponding author), UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN.			Mertens, Fredrik/0000-0002-6278-5232			BAYREUTHER K, 1960, NATURE, V186, P6, DOI 10.1038/186006a0; BERGER R, 1982, CYTOGENET CELL GENET, V32, P205, DOI 10.1159/000131700; Boveri T, 1914, FRAGE ENTSTEHUNG MAL; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; HEIM S, 1995, CANC CYTOGENETICS; HEUBNER K, 1989, CANCER RES, V49, P4071; KLEIN G, 1989, GENE CHROMOSOME CANC, V1, P3, DOI 10.1002/gcc.2870010103; KNUDSON AG, 1985, CANCER RES, V45, P1437; Knudson AG, 1995, ADV CANCER RES, V67, P1, DOI 10.1016/S0065-230X(08)60708-3; KOLLER PC, 1972, RECENT RESULTS CANC, V38; LEVAN A, 1967, HEREDITAS-GENETISK A, V57, P343; Mitelman F., 1996, P1332; MITELMAN F, 1994, CATALOG CHROMOSOME A; MITELMAN F, IN PRESS CANC GENEN; NOWELL PC, 1960, SCIENCE, V132, P1497; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; ROWLEY JD, 1993, JAMA-J AM MED ASSOC, V270, P2331, DOI 10.1001/jama.270.19.2331; ROWLEY JD, 1990, CANCER, V65, P2178, DOI 10.1002/1097-0142(19900515)65:10<2178::AID-CNCR2820651004>3.0.CO;2-#; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SCHROCK, 1996, SCIENCE, V273, P494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; STANBRIDGE EJ, 1992, CANCER SURV, V12, P5; VONHANSEMANN D, 1890, ARCH PATHOL ANAT PHY, V119, P299; WEINBERG RA, 1994, CA-CANCER J CLIN, V44, P160, DOI 10.3322/canjclin.44.3.160; WINGE O., 1930, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELL FORSCH U MIKROSK, V10, P683, DOI 10.1007/BF00372971	27	610	623	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15				SI		417	474		10.1038/ng0497supp-417			58	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX845	WOS:A1997WX84500003	9140409				2022-01-24	
J	Mayakonda, A; Lin, DC; Assenov, Y; Plass, C; Koeffler, HP				Mayakonda, Anand; Lin, De-Chen; Assenov, Yassen; Plass, Christoph; Koeffler, H. Phillip			Maftools: efficient and comprehensive analysis of somatic variants in cancer	GENOME RESEARCH			English	Article							SQUAMOUS-CELL CARCINOMA; ACUTE MYELOID-LEUKEMIA; MUTATIONAL PROCESSES; MOLECULAR CHARACTERIZATION; ION CHANNELS; GENOME; SIGNATURES; GENES; HETEROGENEITY; DISCOVERY	Numerous large-scale genomic studies of matched tumor-normal samples have established the somatic landscapes of most cancer types. However, the downstream analysis of data from somatic mutations entails a number of computational and statistical approaches, requiring usage of independent software and numerous tools. Here, we describe an R Bioconductor package, Maftools, which offers a multitude of analysis and visualization modules that are commonly used in cancer genomic studies, including driver gene identification, pathway, signature, enrichment, and association analyses. Maftools only requires somatic variants in Mutation Annotation Format (MAF) and is independent of larger alignment files. With the implementation of well-established statistical and computational methods, Maftools facilitates data-driven research and comparative analysis to discover novel results from publicly available data sets. In the present study, using three of the well-annotated cohorts from The Cancer Genome Atlas (TCGA), we describe the application of Maftools to reproduce known results. More importantly, we show that Maftools can also be used to uncover novel findings through integrative analysis.	[Mayakonda, Anand; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Mayakonda, Anand; Assenov, Yassen; Plass, Christoph] German Canc Res Ctr, Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Lin, De-Chen; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Assenov, Yassen; Plass, Christoph] German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, D-69120 Heidelberg, Germany; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Singapore 119074, Singapore		Mayakonda, A (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore.; Mayakonda, A (corresponding author), German Canc Res Ctr, Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany.; Lin, DC (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	a.mayakonda@dkfz-heidelberg.de; dchlin11@gmail.com		Mayakonda, Anand/0000-0003-1162-687X	National Research Foundation Singapore under its Singapore Translational Research (STaR) Investigator AwardNational Research Foundation, Singapore [NMRC/STaR/0021/2014]; NMRC Centre GrantNational Medical Research Council, Singapore; National University Cancer Institute of Singapore; National Research Foundation SingaporeNational Research Foundation, Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiativesMinistry of Education, Singapore; RNA Biology Center at the Cancer Science Institute of Singapore, NUS under the Singapore Ministry of Education's Tier 3 grantsMinistry of Education, SingaporeNational University of Singapore [MOE2014-T3-1-006]; DeGregorio Family Foundation; Price Family Foundation; Samuel Oschin Comprehensive Cancer Institute (SOCCI) at Cedars-Sinai Medical Center through the Translational Pipeline Discovery Fund	We thank the users who provided useful suggestions, bug reports, and feature requests during the development of the package. This research is supported by the National Research Foundation Singapore under its Singapore Translational Research (STaR) Investigator Award (NMRC/STaR/0021/2014) and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), the NMRC Centre Grant awarded to National University Cancer Institute of Singapore, the National Research Foundation Singapore, and the Singapore Ministry of Education under its Research Centers of Excellence initiatives. This research is also supported by the RNA Biology Center at the Cancer Science Institute of Singapore, NUS, as part of funding under the Singapore Ministry of Education's Tier 3 grants, grant number MOE2014-T3-1-006. D.-C.L. is supported by the DeGregorio Family Foundation, the Price Family Foundation, as well as Samuel Oschin Comprehensive Cancer Institute (SOCCI) at Cedars-Sinai Medical Center through the Translational Pipeline Discovery Fund.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Biswas S, 2008, GENE CHROMOSOME CANC, V47, P95, DOI 10.1002/gcc.20511; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; D'Antonio M, 2016, CELL REP, V16, P672, DOI 10.1016/j.celrep.2016.06.026; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2014, NAT REV GENET, V15, P556, DOI 10.1038/nrg3767; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Fichter CD, 2014, J MOL MED, V92, P1209, DOI 10.1007/s00109-014-1187-5; Fischer A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r39; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hao JJ, 2016, NAT GENET, V48, P1500, DOI 10.1038/ng.3683; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; House CD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11541; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Joshi AD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-17; Killick R, 2014, J STAT SOFTW, V58, P1; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lin DC, 2018, GUT, V67, P1769, DOI 10.1136/gutjnl-2017-314607; Lin DC, 2018, GASTROENTEROLOGY, V154, P374, DOI 10.1053/j.gastro.2017.06.066; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parsons BL, 2003, P NATL ACAD SCI USA, V100, P14601, DOI 10.1073/pnas.2637169100; Patel KP, 2011, AM J CLIN PATHOL, V135, P35, DOI 10.1309/AJCPD7NR2RMNQDVF; R Core Team, 2018, R LANG ENV STAT COMP; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taketani T, 2003, GENE CHROMOSOME CANC, V38, P1, DOI 10.1002/gcc.10246; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Wheeler DA, 2013, GENOME RES, V23, P1054, DOI 10.1101/gr.157602.113; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Zapata L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12888-1	61	609	612	10	28	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2018	28	11					1747	1756		10.1101/gr.239244.118			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	GY9GW	WOS:000448950400014	30341162	Green Published, hybrid	Y	N	2022-01-24	
J	Tsoi, LC; Spain, SL; Knight, J; Ellinghaus, E; Stuart, PE; Capon, F; Ding, J; Li, YM; Tejasvi, T; Gudjonsson, JE; Kang, HM; Allen, MH; McManus, R; Novelli, G; Samuelsson, L; Schalkwijk, J; Stahle, M; Burden, AD; Smith, CH; Cork, MJ; Estivill, X; Bowcock, AM; Krueger, GG; Weger, W; Worthington, J; Tazi-Ahnini, R; Nestle, FO; Hayday, A; Hoffmann, P; Winkelmann, J; Wijmenga, C; Langford, C; Edkins, S; Andrews, R; Blackburn, H; Strange, A; Band, G; Pearson, RD; Vukcevic, D; Spencer, CCA; Deloukas, P; Mrowietz, U; Schreiber, S; Weidinger, S; Koks, S; Kingo, K; Esko, T; Metspalu, A; Lim, HW; Voorhees, JJ; Weichenthal, M; Wichmann, HE; Chandran, V; Rosen, CF; Rahman, P; Gladman, DD; Griffiths, CEM; Reis, A; Kere, J; Nair, RP; Franke, A; Barker, JNWN; Abecasis, GR; Elder, JT; Trembath, RC; Duffin, KC; Helms, C; Goldgar, D; Li, Y; Paschall, J; Malloy, MJ; Pullinger, CR; Kane, JP; Gardner, J; Perlmutter, A; Miner, A; Feng, BJ; Hiremagalore, R; Ike, RW; Christophers, E; Henseler, T; Ruether, A; Schrodi, SJ; Prahalad, S; Guthery, SL; Fischer, J; Liao, W; Kwok, P; Menter, A; Lathrop, GM; Wise, C; Begovich, AB; Onoufriadis, A; Weale, ME; Hofer, A; Salmhofer, W; Wolf, P; Kainu, K; Saarialho-Kere, U; Suomela, S; Badorf, P; Huffmeier, U; Kurrat, W; Kuster, W; Lascorz, J; Mossner, R; Schurmeier-Horst, F; Stander, M; Traupe, H; Bergboer, JGM; den Heijer, M; van de Kerkhof, PCV; Zeeuwen, PLJM; Barnes, L; Campbell, LE; Cusack, C; Coleman, C; Conroy, J; Ennis, S; Fitzgerald, O; Gallagher, P; Irvine, AD; Kirby, B; Markham, T; McLean, WHI; McPartlin, J; Rogers, SF; Ryan, AW; Zawirska, A; Giardina, E; Lepre, T; Perricone, C; Martin-Ezquerra, G; Pujol, RM; Riveira-Munoz, E; Inerot, A; Naluai, AT; Mallbris, L; Wolk, K; Leman, J; Barton, A; Warren, RB; Young, HS; Ricano-Ponce, I; Trynka, G; Pellett, FJ; Henschel, A; Aurand, M; Bebo, B; Gieger, C; Illig, T; Moebus, S; Jockel, KH; Erbe, R; Donnelly, P; Peltonen, L; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Craddock, N; Duncanson, A; Jankowski, J; Markus, HS; Mathew, CG; McCarthy, MI; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Samani, N; Viswanathan, AC; Wood, NW; Bellenguez, C; Freeman, C; Hellenthal, G; Giannoulatou, E; Pirinen, M; Su, Z; Hunt, SE; Gwilliam, R; Bumpstead, SJ; Dronov, S; Gillman, M; Gray, E; Hammond, N; Jayakumar, A; McCann, OT; Liddle, J; Perez, ML; Potter, SC; Ravindrarajah, R; Ricketts, M; Waller, M; Weston, P; Widaa, S; Whittaker, P				Tsoi, Lam C.; Spain, Sarah L.; Knight, Jo; Ellinghaus, Eva; Stuart, Philip E.; Capon, Francesca; Ding, Jun; Li, Yanming; Tejasvi, Trilokraj; Gudjonsson, Johann E.; Kang, Hyun M.; Allen, Michael H.; McManus, Ross; Novelli, Giuseppe; Samuelsson, Lena; Schalkwijk, Joost; Stahle, Mona; Burden, A. David; Smith, Catherine H.; Cork, Michael J.; Estivill, Xavier; Bowcock, Anne M.; Krueger, Gerald G.; Weger, Wolfgang; Worthington, Jane; Tazi-Ahnini, Rachid; Nestle, Frank O.; Hayday, Adrian; Hoffmann, Per; Winkelmann, Juliane; Wijmenga, Cisca; Langford, Cordelia; Edkins, Sarah; Andrews, Robert; Blackburn, Hannah; Strange, Amy; Band, Gavin; Pearson, Richard D.; Vukcevic, Damjan; Spencer, Chris C. A.; Deloukas, Panos; Mrowietz, Ulrich; Schreiber, Stefan; Weidinger, Stephan; Koks, Sulev; Kingo, Kuelli; Esko, Tonu; Metspalu, Andres; Lim, Henry W.; Voorhees, John J.; Weichenthal, Michael; Wichmann, H. Erich; Chandran, Vinod; Rosen, Cheryl F.; Rahman, Proton; Gladman, Dafna D.; Griffiths, Christopher E. M.; Reis, Andre; Kere, Juha; Nair, Rajan P.; Franke, Andre; Barker, Jonathan N. W. N.; Abecasis, Goncalo R.; Elder, James T.; Trembath, Richard C.; Duffin, Kristina Callis; Helms, Cindy; Goldgar, David; Li, Yun; Paschall, Justin; Malloy, Mary J.; Pullinger, Clive R.; Kane, John P.; Gardner, Jennifer; Perlmutter, Amy; Miner, Andrew; Feng, Bing Jian; Hiremagalore, Ravi; Ike, Robert W.; Christophers, Enno; Henseler, Tilo; Ruether, Andreas; Schrodi, Steven J.; Prahalad, Sampath; Guthery, Stephen L.; Fischer, Judith; Liao, Wilson; Kwok, Pui; Menter, Alan; Lathrop, G. Mark; Wise, C.; Begovich, Ann B.; Onoufriadis, Alexandros; Weale, Michael E.; Hofer, Angelika; Salmhofer, Wolfgang; Wolf, Peter; Kainu, Kati; Saarialho-Kere, Ulpu; Suomela, Sari; Badorf, Petra; Hueffmeier, Ulrike; Kurrat, Werner; Kuester, Wolfgang; Lascorz, Jesus; Moessner, Rotraut; Schuermeier-Horst, Funda; Staender, Markward; Traupe, Heiko; Bergboer, Judith G. M.; den Heijer, Martin; van de Kerkhof, Peter C.; Zeeuwen, Patrick L. J. M.; Barnes, Louise; Campbell, Linda E.; Cusack, Caitriona; Coleman, Ciara; Conroy, Judith; Ennis, Sean; Fitzgerald, Oliver; Gallagher, Phil; Irvine, Alan D.; Kirby, Brian; Markham, Trevor; McLean, W. H. Irwin; McPartlin, Joe; Rogers, Sarah F.; Ryan, Anthony W.; Zawirska, Agnieszka; Giardina, Emiliano; Lepre, Tiziana; Perricone, Carlo; Martin-Ezquerra, Gemma; Pujol, Ramon M.; Riveira-Munoz, Eva; Inerot, Annica; Naluai, Asa T.; Mallbris, Lotus; Wolk, Katarina; Leman, Joyce; Barton, Anne; Warren, Richard B.; Young, Helen S.; Ricano-Ponce, Isis; Trynka, Gosia; Pellett, Fawnda J.; Henschel, Andrew; Aurand, Marin; Bebo, Bruce; Gieger, Christian; Illig, Thomas; Moebus, Susanne; Joeckel, Karl-Heinz; Erbe, Raimund; Donnelly, Peter; Peltonen, Leena; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S.; Mathew, Christopher G.; McCarthy, Mark I.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Samani, Nilesh; Viswanathan, Ananth C.; Wood, Nicholas W.; Bellenguez, Celine; Freeman, Colin; Hellenthal, Garrett; Giannoulatou, Eleni; Pirinen, Matti; Su, Zhan; Hunt, Sarah E.; Gwilliam, Rhian; Bumpstead, Suzannah J.; Dronov, Serge; Gillman, Matthew; Gray, Emma; Hammond, Naomi; Jayakumar, Alagurevathi; McCann, Owen T.; Liddle, Jennifer; Perez, Marc L.; Potter, Simon C.; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Widaa, Sara; Whittaker, Pamela		Collaborative Assoc Study Psoriasi; Genetic Anal Psoriasis Consortium; Psoriasis Assoc Genetics Extension; Wellcome Trust Case Control Consor	Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; T-CELL DEVELOPMENT; SIGNALING PATHWAYS; NEGATIVE REGULATOR; INTERFERON-GAMMA; COMMON VARIANTS; MULTIPLE COMMON; GENE-EXPRESSION; INDUCIBLE GENE; DISEASE	To gain further insight into the genetic architecture of psoriasis, we conducted a meta-analysis of 3 genome-wide association studies (GWAS) and 2 independent data sets genotyped on the Immunochip, including 10,588 cases and 22,806 controls. We identified 15 new susceptibility loci, increasing to 36 the number associated with psoriasis in European individuals. We also identified, using conditional analyses, five independent signals within previously known loci. The newly identified loci shared with other autoimmune diseases include candidate genes with roles in regulating T-cell function (such as RUNX3, TA GAP and STAT3). Notably, they included candidate genes whose products are involved in innate host defense, including interferon-mediated antiviral responses (DDX58), macrophage activation (ZC3H12C) and nuclear factor (NF)-kappa B signaling (CARD14 and CARM1). These results portend a better understanding of shared and distinctive genetic determinants of immune-mediated inflammatory disorders and emphasize the importance of the skin in innate and acquired host defense.	[Spain, Sarah L.; Capon, Francesca; Allen, Michael H.; Nestle, Frank O.; Barker, Jonathan N. W. N.; Trembath, Richard C.; Onoufriadis, Alexandros; Weale, Michael E.; Mathew, Christopher G.; Viswanathan, Ananth C.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Tsoi, Lam C.; Ding, Jun; Li, Yanming; Kang, Hyun M.; Abecasis, Goncalo R.; Li, Yun] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Knight, Jo] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Knight, Jo] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Ellinghaus, Eva; Schreiber, Stefan; Franke, Andre; Ruether, Andreas] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Stuart, Philip E.; Tejasvi, Trilokraj; Gudjonsson, Johann E.; Voorhees, John J.; Nair, Rajan P.; Elder, James T.; Hiremagalore, Ravi] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [McManus, Ross; Barnes, Louise; Coleman, Ciara; Conroy, Judith; Ennis, Sean; McPartlin, Joe; Ryan, Anthony W.] St James Hosp, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [McManus, Ross; Barnes, Louise; Coleman, Ciara; Conroy, Judith; Ennis, Sean; McPartlin, Joe; Ryan, Anthony W.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Novelli, Giuseppe; Giardina, Emiliano; Lepre, Tiziana; Perricone, Carlo] Natl Agcy Evaluat Univ & Res Inst ANVUR, Rome, Italy; [Novelli, Giuseppe] San Pietro Hosp, Res Ctr, Rome, Italy; [Samuelsson, Lena; Naluai, Asa T.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med & Clin Genet, Gothenburg, Sweden; [Schalkwijk, Joost; Bergboer, Judith G. M.; van de Kerkhof, Peter C.; Zeeuwen, Patrick L. J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Stahle, Mona; Mallbris, Lotus; Wolk, Katarina] Karolinska Inst, Dept Med, Dermatol Unit, Stockholm, Sweden; [Burden, A. David; Leman, Joyce] Univ Glasgow, Western Infirm, Dept Dermatol, Glasgow G11 6NT, Lanark, Scotland; [Smith, Catherine H.; Barker, Jonathan N. W. N.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Cork, Michael J.; Tazi-Ahnini, Rachid] Univ Sheffield, Dept Infect & Immun, Acad Unit Dermatol Res, Sheffield, S Yorkshire, England; [Estivill, Xavier; Riveira-Munoz, Eva] CRG, Genes & Dis Programme, Barcelona, Spain; [Estivill, Xavier; Riveira-Munoz, Eva] Pompeu Fabra Univ, Hosp Mar, Res Inst, Barcelona, Spain; [Estivill, Xavier; Riveira-Munoz, Eva] Publ Hlth & Epidemiol Network Biomed Res Ctr CIBE, Barcelona, Spain; [Bowcock, Anne M.; Helms, Cindy; Gardner, Jennifer] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Krueger, Gerald G.; Duffin, Kristina Callis; Goldgar, David; Feng, Bing Jian] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Weger, Wolfgang; Hofer, Angelika; Salmhofer, Wolfgang; Wolf, Peter] Med Univ Graz, Dept Dermatol, Graz, Austria; [Worthington, Jane; Barton, Anne] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Hayday, Adrian] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Hoffmann, Per] Univ Bonn, Inst Human Genet, Bonn, Germany; [Hoffmann, Per] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane; Duncanson, Audrey] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Human Genet, Munich, Germany; [Wijmenga, Cisca; Ricano-Ponce, Isis; Trynka, Gosia] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca; Ricano-Ponce, Isis; Trynka, Gosia] Univ Groningen, Groningen, Netherlands; [Langford, Cordelia; Edkins, Sarah; Andrews, Robert; Blackburn, Hannah; Deloukas, Panos; Peltonen, Leena; Hunt, Sarah E.; Gwilliam, Rhian; Bumpstead, Suzannah J.; Dronov, Serge; Gillman, Matthew; Gray, Emma; Hammond, Naomi; Jayakumar, Alagurevathi; McCann, Owen T.; Liddle, Jennifer; Perez, Marc L.; Potter, Simon C.; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Widaa, Sara; Whittaker, Pamela] Wellcome Trust Sanger Inst, Cambridge, England; [Strange, Amy; Band, Gavin; Pearson, Richard D.; Vukcevic, Damjan; Spencer, Chris C. A.; Donnelly, Peter; Rautanen, Anna; Bellenguez, Celine; Freeman, Colin; Hellenthal, Garrett; Giannoulatou, Eleni; Pirinen, Matti; Su, Zhan] Wellcome Trust Ctr Human Genet, Oxford, England; [Mrowietz, Ulrich; Weidinger, Stephan; Weichenthal, Michael; Christophers, Enno; Henseler, Tilo] Univ Kiel, Dept Dermatol, Univ Hosp, D-2300 Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Koks, Sulev] Univ Tartu, Ctr Translat Med, Dept Physiol, EE-50090 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Ctr Translat Genom, EE-50090 Tartu, Estonia; [Kingo, Kuelli] Univ Tartu, Dept Dermatol & Venerol, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Lim, Henry W.] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA; [Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Chandran, Vinod; Gladman, Dafna D.; Pellett, Fawnda J.] Univ Toronto, Toronto Western Hosp, Div Rheumatol, Dept Med, Toronto, ON M5T 2S8, Canada; [Rosen, Cheryl F.] Univ Toronto, Toronto Western Hosp, Div Dermatol, Dept Med, Toronto, ON M5T 2S8, Canada; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Griffiths, Christopher E. M.; Warren, Richard B.; Young, Helen S.] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Reis, Andre; Badorf, Petra; Hueffmeier, Ulrike] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Trembath, Richard C.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Paschall, Justin] US Natl Inst Hlth, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA; [Malloy, Mary J.; Pullinger, Clive R.; Kane, John P.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Malloy, Mary J.; Pullinger, Clive R.; Kane, John P.] Univ Calif San Francisco, Ctr Human Genet, San Francisco, CA 94143 USA; [Perlmutter, Amy; Miner, Andrew] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Ike, Robert W.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Schrodi, Steven J.; Begovich, Ann B.] Celera, Alameda, CA USA; [Prahalad, Sampath; Guthery, Stephen L.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Prahalad, Sampath; Guthery, Stephen L.] Univ Utah, Dept Rheumatol, Salt Lake City, UT USA; [Prahalad, Sampath; Guthery, Stephen L.] Univ Utah, Dept Gastroenterol, Salt Lake City, UT USA; [Fischer, Judith; Lathrop, G. Mark] Inst Genom Commissariat Energie Atom, Ctr Natl Genotypage, Evry, France; [Liao, Wilson; Kwok, Pui] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Menter, Alan] Baylor Univ, Med Ctr, Dept Dermatol, Dallas, TX USA; [Wise, C.] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Kainu, Kati; Saarialho-Kere, Ulpu; Suomela, Sari] Univ Helsinki, Dept Dermatol & Venerol, Helsinki, Finland; [Kurrat, Werner] Asklepios Nordseeklin, Westerland Sylt, Germany; [Kuester, Wolfgang] TOMESA Clin, Bad Salzschlirf, Germany; [Lascorz, Jesus] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Moessner, Rotraut] Univ Gottingen, Dept Dermatol, Gottingen, Germany; [Schuermeier-Horst, Funda; Traupe, Heiko] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Staender, Markward] Psoriasis Rehabil Hosp, Bad Bentheim, Germany; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6525 ED Nijmegen, Netherlands; [Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Dundee, Scotland; [Cusack, Caitriona; Markham, Trevor] Univ Coll Hosp Galway, Dept Dermatol, Galway, Ireland; [Fitzgerald, Oliver; Gallagher, Phil; Kirby, Brian; Rogers, Sarah F.; Zawirska, Agnieszka] St Vincents Univ Hosp, Dept Dermatol, Dublin 4, Ireland; [Irvine, Alan D.] Our Ladys Childrens Hosp Crumlin, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [Martin-Ezquerra, Gemma; Pujol, Ramon M.] Hosp Mar, IMAS, Dermatol Serv, Barcelona, Spain; [Inerot, Annica] Sahlgrens Univ Hosp, Dept Dermatol & Venerol, Gothenburg, Sweden; [Henschel, Andrew; Aurand, Marin; Bebo, Bruce] Natl Psoriasis Fdn, Portland, OR USA; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Genet Epidemiol, Neuherberg, Germany; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Moebus, Susanne; Joeckel, Karl-Heinz] Univ Duisburg Essen, IMIBE, Essen, Germany; [Erbe, Raimund] Univ Duisburg Essen, Univ Hosp Essen, W German Heart Ctr, Clin Cardiol, Essen, Germany; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Suciaco, WA, Australia; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Markus, Hugh S.] St Georges Univ London, London, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab ICDEM, Oxford OX3 7LJ, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Sawcer, Stephen J.; Samani, Nilesh] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, Dept Genet, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England		Trembath, RC (corresponding author), Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England.	goncalo@umich.edu; jelder@umich.edu; vp-health@qmul.ac.uk	Blackwell, Jenefer M/H-3015-2015; Wijmenga, Cisca/D-2173-2009; Irvine, Alan D/A-3982-2008; Young, Helen/H-5247-2015; Kingo, Kulli/H-3603-2012; Wichmann, Heinz Erich/AAA-5695-2022; Ike, Robert William/AAC-3582-2021; Martin-Ezquerra, Gemma/AAF-2276-2021; Worthington, Jane/M-9770-2014; Franke, Andre/B-2151-2010; Ryan, Anthony W/A-1336-2010; Naluai, Asa Torinsson/AAB-2166-2021; Kere, Juha/AAX-9117-2021; Estivill, Xavier/A-3125-2013; Weale, Michael E/F-2587-2010; Palmer, Colin NA/C-7053-2008; Abecasis, Goncalo R/B-7840-2010; Giardina, Emiliano/J-1965-2012; Ricano-Ponce, Isis/ABC-5454-2020; Reis, Andre/D-2309-2009; Belllenguez, Celine/Y-3183-2018; Voorhees, John/AAM-9966-2020; Schalkwijk, Joost/R-7509-2019; Ellinghaus, Eva/E-6490-2012; Mallbris, Lotus/L-8607-2019; Wood, Nicholas W/C-2505-2009; Smith, Catherine H./G-5268-2012; Zeeuwen, Patrick LJM/N-1779-2013; Naluai, Asa Torinsson/P-3269-2015; Deloukas, Panos/B-2922-2013; Warren, Richard B/G-4929-2015; Hoffmann, Per/A-5149-2010; Jankowski, Janusz/H-2706-2012; Koks, Sulev/H-3655-2015; Wijmenga, Cisca/AAE-7719-2019; Ding, Jun/G-3918-2011; Schrodi, Steven J./O-4288-2019; Bramon, Elvira/A-9463-2011; Novelli, Giuseppe/A-5195-2013; Barton, Anne/N-2053-2014; Capon, Francesca/F-4763-2011; Mathew, Christopher G/G-3434-2015; Bellenguez, Celine/X-4004-2019; Griffiths, Christopher E.M./P-5448-2014; McManus, Ross/AAE-9236-2020; Novelli, Giuseppe/T-8822-2019; Kere, Juha/A-9179-2008; Schalkwijk, Joost/N-1774-2013; Huffmeier, Ulrike/D-2806-2013; Fischer, Judith/E-6327-2016; Brown, Matthew A/E-5749-2010; Weidinger, Stephan/C-8461-2011; McCarthy, Mark/M-3763-2015; Spain, Sarah/G-1968-2010; den Heijer, Martin/J-8036-2015	Irvine, Alan D/0000-0002-9048-2044; Young, Helen/0000-0003-1538-445X; Martin-Ezquerra, Gemma/0000-0002-5106-7526; Worthington, Jane/0000-0003-0544-042X; Franke, Andre/0000-0003-1530-5811; Naluai, Asa Torinsson/0000-0002-0504-6492; Kere, Juha/0000-0003-1974-0271; Estivill, Xavier/0000-0002-0723-2256; Weale, Michael E/0000-0003-4593-1186; Palmer, Colin NA/0000-0002-6415-6560; Ricano-Ponce, Isis/0000-0002-7530-9526; Reis, Andre/0000-0002-6301-6363; Belllenguez, Celine/0000-0002-1240-7874; Voorhees, John/0000-0003-1856-785X; Schalkwijk, Joost/0000-0002-1308-1319; Ellinghaus, Eva/0000-0003-2914-3382; Wood, Nicholas W/0000-0002-9500-3348; Smith, Catherine H./0000-0001-9918-1144; Zeeuwen, Patrick LJM/0000-0002-6878-2438; Naluai, Asa Torinsson/0000-0002-0504-6492; Deloukas, Panos/0000-0001-9251-070X; Warren, Richard B/0000-0002-2918-6481; Hoffmann, Per/0000-0002-6573-983X; Jankowski, Janusz/0000-0003-2130-9181; Koks, Sulev/0000-0001-6087-6643; Wijmenga, Cisca/0000-0002-5635-1614; Schrodi, Steven J./0000-0003-2304-8528; Novelli, Giuseppe/0000-0002-7781-602X; Barton, Anne/0000-0003-3316-2527; Capon, Francesca/0000-0003-2432-5793; Mathew, Christopher G/0000-0003-4178-1838; Bellenguez, Celine/0000-0002-1240-7874; Griffiths, Christopher E.M./0000-0001-5371-4427; Novelli, Giuseppe/0000-0002-7781-602X; Kere, Juha/0000-0003-1974-0271; Huffmeier, Ulrike/0000-0001-6448-4671; Fischer, Judith/0000-0002-8580-8118; Brown, Matthew A/0000-0003-0538-8211; Weidinger, Stephan/0000-0003-3944-252X; Abecasis, Goncalo/0000-0003-1509-1825; Knight, Joanne/0000-0002-7148-1660; HAYDAY, ADRIAN/0000-0002-9495-5793; Trembath, Richard/0000-0003-0550-3400; Tsoi, Lam Cheung/0000-0003-1627-5722; FitzGerald, Oliver/0000-0002-6607-6070; Ryan, Anthony/0000-0001-5005-3344; Walters, James/0000-0002-6980-4053; Corvin, Aiden/0000-0001-6717-4089; Kingo, Kulli/0000-0001-6301-9612; Gieger, Christian/0000-0001-6986-9554; Bowcock, Anne/0000-0001-8691-9090; Trynka, Gosia/0000-0002-6955-9529; Vukcevic, Damjan/0000-0001-7780-9586; Ennis, Sean/0000-0002-4330-1386; Cork, Michael/0000-0003-4428-2428; Pirinen, Matti/0000-0002-1664-1350; McCarthy, Mark/0000-0002-4393-0510; Perricone, Carlo/0000-0003-4771-6981; Spain, Sarah/0000-0002-7591-8364; McManus, Ross/0000-0002-0529-9617; Wise, Carol/0000-0002-6790-2194; Plomin, Robert/0000-0002-0756-3629; McLean, William Henry Irwin/0000-0001-5539-5757; den Heijer, Martin/0000-0003-3620-5617; giardina, emiliano/0000-0002-2741-5009; Barker, Jonathan/0000-0002-9030-183X; Winkelmann, Juliane/0000-0003-2667-9691; Esko, Tonu/0000-0003-1982-6569; PUJOL, RAMON M/0000-0002-5622-6055; Gillman, Matthew S./0000-0002-2340-6930; Riveira Munoz, Eva/0000-0002-6396-1162	UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934]; Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02]; UK National Blood Service controls; Welcome TrustWellcome Trust; Barbara and Neal Henschel Charitable Foundation; Health Research Board; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601387, MR/J006742/1, G0000934, G0700314] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2008-06-002, NF-SI-0507-10379] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601387, G0700314, G0000934] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG006513, R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR050511, R01AR054966, R01AR042742, R01AR050266, K08AR060802, RC1AR058315, K08AR057763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000693] Funding Source: NIH RePORTER	Major support for this study was provided by the US National Institutes of Health, the Wellcome Trust and the German Research Foundation. We thank J.C. Barrett for contribution to the design of the Immunochip and helpful analytical discussion, as well as E. Gray, S. Bumpstead, D. Simpkin and the staff of the Wellcome Trust Sanger Institute Sample Management and Genotyping teams for their genotyping and analytical contributions. We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the UK Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02), and the UK National Blood Service controls, funded by the Welcome Trust. We acknowledge CASP for the contribution of GWAS data, as well as the provision of control DNA samples by the Cooperative Research in the Region of Augsburg (KORA) and Heinz-Nixdorf Recall (Risk Factors, Evaluation of Coronary Calcification and Lifestyle) study (HNR) and genotyping data generated by the Dietary, Lifestyle and Genetic determinants of Obesity and Metabolic syndrome (DILGOM) Consortium. We thank the Barbara and Neal Henschel Charitable Foundation for their support of the National Psoriasis Victor Henschel BioBank. We acknowledge the Genetic repository in Ireland for Psoriasis and Psoriatic Arthritis (GRIPPsA), the Irish blood transfusion service/Trinity College Dublin Biobank and the Dublin Centre for Clinical Research (funded by the Health Research Board and the Wellcome Trust). A detailed list of contributing consortia and relevant funding support is provided in the Supplementary Note.	Amler LC, 2000, GENOMICS, V64, P195, DOI 10.1006/geno.1999.6097; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Cal Santiago, 2006, BMC Biochem, V7, P9, DOI 10.1186/1471-2091-7-9; Capon F, 2012, J INVEST DERMATOL, V132, P915, DOI 10.1038/jid.2011.395; Chang Ing-Feng, 2005, Current Alzheimer Research, V2, P559, DOI 10.2174/156720505774932269; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cui XF, 2004, BIOCHEM CELL BIOL, V82, P401, DOI 10.1139/O04-041; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garber K, 2011, NAT BIOTECHNOL, V29, P563, DOI 10.1038/nbt.1906; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Grjibovski AM, 2007, J EUR ACAD DERMATOL, V21, P1337, DOI 10.1111/j.1468-3083.2007.02268.x; Gudjonsson JE, 2012, FITZPATRICKS DERMATO, V8th, P197; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kersh EN, 2006, J IMMUNOL, V177, P3821, DOI 10.4049/jimmunol.177.6.3821; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Ludvigsson JF, 2011, J INVEST DERMATOL, V131, P2010, DOI 10.1038/jid.2011.162; Mason CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-98; Modlin RL, 2012, J INVEST DERMATOL, V132, P882, DOI 10.1038/jid.2011.373; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Riveira-Munoz E, 2011, J INVEST DERMATOL, V131, P1105, DOI 10.1038/jid.2010.350; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Song MY, 2012, GENE, V493, P211, DOI 10.1016/j.gene.2011.11.058; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Togayachi A, 2010, METHOD ENZYMOL, V479, P185, DOI 10.1016/S0076-6879(10)79011-X; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Wei L, 2008, SEMIN CELL DEV BIOL, V19, P394, DOI 10.1016/j.semcdb.2008.07.011; Wolfle U, 2009, J DTSCH DERMATOL GES, V7, P862, DOI 10.1111/j.1610-0387.2009.07202.x; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zheng HF, 2011, J DERMATOL SCI, V61, P124, DOI 10.1016/j.jdermsci.2010.12.001; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	69	609	626	1	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1341	1348		10.1038/ng.2467			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	WOS:000311713200013	23143594	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Spelbrink, JN; Li, FY; Tiranti, V; Nikali, K; Yuan, QP; Tariq, M; Wanrooij, S; Garrido, N; Comi, G; Morandi, L; Santoro, L; Toscano, A; Fabrizi, GM; Somer, H; Croxen, R; Beeson, D; Poulton, L; Suomalainen, A; Jacobs, HT; Zeviani, M; Larsson, C				Spelbrink, JN; Li, FY; Tiranti, V; Nikali, K; Yuan, QP; Tariq, M; Wanrooij, S; Garrido, N; Comi, G; Morandi, L; Santoro, L; Toscano, A; Fabrizi, GM; Somer, H; Croxen, R; Beeson, D; Poulton, L; Suomalainen, A; Jacobs, HT; Zeviani, M; Larsson, C			Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene LF-like protein localized in mitochondria	NATURE GENETICS			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MULTIPLE DELETIONS; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; HELICASE DOMAIN; BACTERIOPHAGE-T7; MTDNA; POLYMERASE; PRIMASE; YEAST	The gene products involved in mammalian mitochondrial DNA (mtDNA) maintenance and organization remain largely unknown. We report here a novel mitochondrial protein. Twinkle, with structural similarity to phage T7 gene 4 primase/helicase and other hexameric ring helicases. Twinkle colocalizes with mtDNA in mitochondrial nucleoids. Screening of the gene encoding Twinkle in individuals with autosomal dominant progressive external ophthalmoplegia (adPEO). associated with multiple mtDNA deletions, identified 11 different coding-region mutations co-segregating with the disorder in 12 adPEO pedigrees of various ethnic origins. The mutations duster in a region of the protein proposed to be involved in subunit interactions. The function of Twinkle is inferred to be critical for lifetime maintenance of human mtDNA integrity.	Karolinska Hosp, Dept Mol Med, S-17176 Stockholm, Sweden; Tampere Univ Hosp, Tampere, Finland; Inst Med Technol, Tampere, Finland; Natl Neurol Inst C Besta, Div Biochem & Genet, Milan, Italy; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Pakistan Inst Med Sci, Dept Neurol, Islamabad, Pakistan; Univ Milan, Sch Med, Inst Clin Neurol, Dino Ferrari Ctr, Milan, Italy; Natl Neurol Inst C Besta, Dept Neuromuscular Disorders, Milan, Italy; Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; Univ Messina, Inst Clin Neurol, Messina, Italy; Univ Verona, Inst Clin Neurol, I-37100 Verona, Italy; Univ Helsinki, Dept Neurol, Helsinki, Finland; John Radcliffe Hosp, Neurosci Grp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DS, England; McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland		Spelbrink, JN (corresponding author), Inst Med Technol, Tampere, Finland.		Wanrooij, Sjoerd/J-1367-2019; Tiranti, Valeria/J-8233-2016; Zeviani, Massimo/K-2891-2014; Jacobs, Howard T/G-2434-2011; Spelbrink, Johannes N/L-4661-2015	Tiranti, Valeria/0000-0002-3584-7338; Spelbrink, Johannes N/0000-0002-9756-2602; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Zeviani, Massimo/0000-0002-9067-5508; Comi, Giacomo/0000-0002-1383-5248; Wanrooij, Sjoerd/0000-0001-6126-4382; Poulton, Joanna/0000-0002-2460-5587; Santoro, Lucio/0000-0001-9507-2303; Jacobs, Howard/0000-0003-1895-6003	TelethonFondazione Telethon [1180] Funding Source: Medline		Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Davis LG., 1986, BASIC METHODS MOL BI; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; FOURY F, 1989, J BIOL CHEM, V264, P20552; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; HEHMAN GL, 1992, P NATL ACAD SCI USA, V89, P8562, DOI 10.1073/pnas.89.18.8562; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Iyengar B, 1999, GENETICS, V153, P1809; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Kornberg A., 1992, DNA REPLICATION, V2nd ed.; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; Leipe DD, 2000, GENOME RES, V10, P5; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li FY, 2001, FEBS LETT, V494, P79, DOI 10.1016/S0014-5793(01)02319-5; Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Melberg A, 1996, MUSCLE NERVE, V19, P751; MIYAKAWA I, 1987, J CELL SCI, V88, P431; Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; PATEL SS, 1993, J BIOL CHEM, V268, P10668; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Santorelli FM, 2000, J INHERIT METAB DIS, V23, P155, DOI 10.1023/A:1005617916260; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; ZHANG PL, 1994, MOL CARCINOGEN, V9, P46, DOI 10.1002/mc.2940090109	49	608	622	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					223	231		10.1038/90058			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	WOS:000169656400014	11431692				2022-01-24	
J	Huang, XH; Zhao, Y; Wei, XH; Li, CY; Wang, A; Zhao, Q; Li, WJ; Guo, YL; Deng, LW; Zhu, CR; Fan, DL; Lu, YQ; Weng, QJ; Liu, KY; Zhou, TY; Jing, YF; Si, LZ; Dong, GJ; Huang, T; Lu, TT; Feng, Q; Qian, Q; Li, JY; Han, B				Huang, Xuehui; Zhao, Yan; Wei, Xinghua; Li, Canyang; Wang, Ahong; Zhao, Qiang; Li, Wenjun; Guo, Yunli; Deng, Liuwei; Zhu, Chuanrang; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Liu, Kunyan; Zhou, Taoying; Jing, Yufeng; Si, Lizhen; Dong, Guojun; Huang, Tao; Lu, Tingting; Feng, Qi; Qian, Qian; Li, Jiayang; Han, Bin			Genome-wide association study of flowering time and grain yield traits in a worldwide collection of rice germplasm	NATURE GENETICS			English	Article							SPATIAL GENE-EXPRESSION; ARABIDOPSIS-THALIANA; NATURAL VARIATION; MAPPING POPULATION; OPEN SOFTWARE; MAJOR QTL; ENCODES; PROTEIN; LOCUS; DOMESTICATION	A high-density haplotype map recently enabled a genome-wide association study (GWAS) in a population of indica subspecies of Chinese rice landraces. Here we extend this methodology to a larger and more diverse sample of 950 worldwide rice varieties, including the Oryza sativa indica and Oryza sativa japonica subspecies, to perform an additional GWAS. We identified a total of 32 new loci associated with flowering time and with ten grain-related traits, indicating that the larger sample increased the power to detect trait-associated variants using GWAS. To characterize various alleles and complex genetic variation, we developed an analytical framework for haplotype-based de novo assembly of the low-coverage sequencing data in rice. We identified candidate genes for 18 associated loci through detailed annotation. This study shows that the integrated approach of sequence-based GWAS and functional genome annotation has the potential to match complex traits to their causal polymorphisms in rice.	[Huang, Xuehui; Zhao, Yan; Li, Canyang; Wang, Ahong; Zhao, Qiang; Li, Wenjun; Guo, Yunli; Deng, Liuwei; Zhu, Chuanrang; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Liu, Kunyan; Zhou, Taoying; Jing, Yufeng; Si, Lizhen; Dong, Guojun; Huang, Tao; Lu, Tingting; Feng, Qi; Han, Bin] Chinese Acad Sci, Natl Ctr Gene Res, Natl Ctr Plant Gene Res Shanghai, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Huang, Xuehui; Zhao, Yan; Han, Bin] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Wei, Xinghua; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Peoples R China; [Li, Jiayang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China		Han, B (corresponding author), Chinese Acad Sci, Natl Ctr Gene Res, Natl Ctr Plant Gene Res Shanghai, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn	qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020	Han, Bin/0000-0001-8695-0274; Huang, Xuehui/0000-0003-0529-1532	Chinese Academy of SciencesChinese Academy of Sciences [KSCX2-YW-N-094]; Ministry of Agriculture of ChinaMinistry of Agriculture, China [2011ZX08001-004, 2011ZX08009-002]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30821004]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2011CB100205]	We thank the China National Rice Research Institute for providing the rice germplasm samples. We thank S. Griffiths and G. Moore for critical reading of the manuscript. We thank Z. Zhang and E.S. Buckler for helping us use the compressed MLM and Z. Ning for assistance with sequence alignment. This work was supported by the Chinese Academy of Sciences (KSCX2-YW-N-094), the Ministry of Agriculture of China (2011ZX08001-004 and 2011ZX08009-002), the National Natural Science Foundation of China (30821004) and the Ministry of Science and Technology of China (2011CB100205) to B.H.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clark RM, 2010, NAT GENET, V42, P926, DOI 10.1038/ng1110-926; Cui JJ, 2007, J INTEGR PLANT BIOL, V49, P678, DOI 10.1111/j.1744-7909.2007.00467.x; Dai LY, 2010, THEOR APPL GENET, V121, P295, DOI 10.1007/s00122-010-1310-0; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tan YF, 2001, THEOR APPL GENET, V103, P1037, DOI 10.1007/s001220100665; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	45	606	663	34	437	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2012	44	1					32	U53		10.1038/ng.1018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	WOS:000298664000010	22138690		Y	N	2022-01-24	
J	Young, LE; Fernandes, K; McEvoy, TG; Butterwith, SC; Gutierrez, CG; Carolan, C; Broadbent, PJ; Robinson, JJ; Wilmut, I; Sinclair, KD				Young, LE; Fernandes, K; McEvoy, TG; Butterwith, SC; Gutierrez, CG; Carolan, C; Broadbent, PJ; Robinson, JJ; Wilmut, I; Sinclair, KD			Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture	NATURE GENETICS			English	Article							BINDING-PROTEINS; PERINATAL LETHALITY; IN-VITRO; GROWTH; GENE; CATTLE; SERUM	Manipulation or non-physiological embryo culture environments can lead to defective fetal programming in livestock. Our demonstration of reduced fetal methylation and expression of ovine IGF2R suggests pre-implantation embryo procedures may be vulnerable to epigenetic alterations in imprinted genes. This highlights the potential benefits of epigenetic diagnostic screening in developing embryo procedures.	Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Scottish Agr Coll, Aberdeen, Scotland		Young, LE (corresponding author), Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.		Gutierrez, Carlos G/H-3192-2013; de Souza Castilho, Anthony Cesar/C-4420-2012	Gutierrez, Carlos G/0000-0002-6098-3913; Sinclair, Kevin/0000-0002-6375-215X			ARMSTRONG DG, 1989, J ENDOCRINOL, V120, P373, DOI 10.1677/joe.0.1200373; BUTLER JH, 1986, J ENDOCRINOL, V109, P333, DOI 10.1677/joe.0.1090333; Dean W, 1998, DEVELOPMENT, V125, P2273; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Gutierrez CG, 1997, J ENDOCRINOL, V153, P231, DOI 10.1677/joe.0.1530231; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Sinclair KD, 1998, THERIOGENOLOGY, V49, P218, DOI 10.1016/S0093-691X(98)90571-4; Vogt T, 1998, CLIN CANCER RES, V4, P791; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Young LE, 2000, THERIOGENOLOGY, V53, P627, DOI 10.1016/S0093-691X(99)00263-0; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	15	606	644	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					153	154		10.1038/84769			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	WOS:000166839200013	11175780				2022-01-24	
J	Aitman, TJ; Glazier, AM; Wallace, CA; Cooper, LD; Norsworthy, PJ; Wahid, FN; Al-Majali, KM; Trembling, PM; Mann, CJ; Shoulders, CC; Graf, D; St Lezin, E; Kurtz, TW; Kren, V; Pravenec, M; Ibrahimi, A; Abumrad, NA; Stanton, LW; Scott, J				Aitman, TJ; Glazier, AM; Wallace, CA; Cooper, LD; Norsworthy, PJ; Wahid, FN; Al-Majali, KM; Trembling, PM; Mann, CJ; Shoulders, CC; Graf, D; St Lezin, E; Kurtz, TW; Kren, V; Pravenec, M; Ibrahimi, A; Abumrad, NA; Stanton, LW; Scott, J			Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats	NATURE GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED STRAINS; BLOOD-PRESSURE; LIPOLYSIS; MAP; CHROMOSOMES; LIPOPROTEIN; EXPRESSION; OBESITY	The human insulin-resistance syndromes, type 2 diabetes, obesity, combined hyperlipidaemia and essential hypertension, are complex disorders whose genetic basis is unknown. The spontaneously hypertensive rat (SHR) is insulin resistant and a model of these human syndromes. Quantitative trait loci (QTLs) for SHR defects in glucose and fatty acid metabolism, hypertriglyceridaemia and hypertension map to a single locus on rat chromosome 4. Here we combine use of cDNA microarrays, congenic mapping and radiation hybrid (RH) mapping to identify a defective SHR gene, Cd36 (also known as Fat, as it encodes fatty acid translocase), at the peak of linkage to these QTLs. SHR Cd36 cDNA contains multiple sequence variants, caused by unequal genomic recombination of a duplicated ancestral gene. The encoded protein product is undetectable in SHR adipocyte plasma membrane. Transgenic mice overexpressing Cd36 have reduced blood lipids. We conclude that Cd36 deficiency underlies insulin resistance, defective fatty acid metabolism and hypertriglyceridaemia in SHR and may be important in the pathogenesis of human insulin-resistance syndromes.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Clin Sci Ctr,Mol Med Grp, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Natl Heart & Lung Inst, London W12 0NN, England; Charles Univ Prague, Fac Med 1, Dept Biol, Prague 12800 2, Czech Republic; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Czech Republic; SUNY Stony Brook, Stony Brook, NY 11733 USA; Scios Inc, Sunnyvale, CA 94086 USA		Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Clin Sci Ctr,Mol Med Grp, London W12 0NN, England.	taitman@ic.ac.uk	Pravenec, Michal/B-1666-2012; Graf, Daniel/H-1214-2011	Pravenec, Michal/0000-0001-9197-5871; Graf, Daniel/0000-0003-1163-8117; Trembling, Paul/0000-0002-5016-4607; Ibrahimi, Azeddine/0000-0003-3226-3836; Norsworthy, Penny/0000-0002-5572-8491	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL56028] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK33301] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL056028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK033301] Funding Source: NIH RePORTER		ABUMRAD NA, IN PRESS J LIPID RES; Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; ARMESILLA AL, 1994, J BIOL CHEM, V269, P18985; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Calvo D, 1998, J LIPID RES, V39, P777; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; Curtis BR, 1996, TRANSFUSION, V36, P331, DOI 10.1046/j.1537-2995.1996.36496226147.x; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; GOLDMUNTZ EA, 1995, MAMM GENOME, V6, P459, DOI 10.1007/BF00360654; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; Hwang EH, 1998, J NUCL MED, V39, P1681; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; IRITANI N, 1977, ATHEROSCLEROSIS, V28, P217, DOI 10.1016/0021-9150(77)90171-X; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; Kovacs P, 1998, ARCH BIOCHEM BIOPHYS, V354, P139, DOI 10.1006/abbi.1998.0686; KUNZ HW, 1978, J IMMUNOGENET, V5, P365; LANGE K, 1995, GENOME RES, V5, P136, DOI 10.1101/gr.5.2.136; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; LIFTON RP, 1995, J CLIN INVEST, V95, P1040; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NATHAN DM, 1997, LANCET S1, V350, P1; Pravenec M, 1996, MAMM GENOME, V7, P117, DOI 10.1007/s003359900031; Pravenec M, 1997, MAMM GENOME, V8, P387, DOI 10.1007/s003359900452; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Qu XQ, 1997, AM J HYPERTENS, V10, P1053, DOI 10.1016/S0895-7061(97)00273-2; RANDLE PJ, 1963, LANCET, V1, P785; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; REAVEN GM, 1989, DIABETES, V38, P1155, DOI 10.2337/diabetes.38.9.1155; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; REYNISDOTTIR S, 1994, J CLIN INVEST, V93, P2590, DOI 10.1172/JCI117271; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tanaka T, 1997, J MOL CELL CARDIOL, V29, P121, DOI 10.1006/jmcc.1996.0257; TAYLOR KT, 1993, GENE, V133, P205, DOI 10.1016/0378-1119(93)90639-K; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; URWIJITAROON Y, 1995, TRANSFUSION, V35, P868, DOI 10.1046/j.1537-2995.1995.351096026370.x; Watanabe Kenichi, 1997, Kaku Igaku, V34, P1125	49	606	619	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1999	21	1					76	83		10.1038/5013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	WOS:000077960700013	9916795				2022-01-24	
J	Cao, L; Jiao, XY; Zuzga, DS; Liu, YH; Fong, DM; Young, D; During, MJ				Cao, L; Jiao, XY; Zuzga, DS; Liu, YH; Fong, DM; Young, D; During, MJ			VEGF links hippocampal activity with neurogenesis, learning and memory	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ENVIRONMENTAL ENRICHMENT; CELL-PROLIFERATION; RESPONSE ELEMENT; RAT-BRAIN; EXPRESSION; ANGIOGENESIS; VIVO; DIFFERENTIATION	An enriched environment is associated with hippocampal plasticity, including improved cognitive performance and increased neurogenesis. Here, we show that hippocampal expression of vascular endothelial growth factor ( VEGF) is increased by both an enriched environment and performance in a spatial maze. Hippocampal gene transfer of VEGF in adult rats resulted in similar to2 times more neurogenesis associated with improved cognition. In contrast, overexpression of placental growth factor, which signals through Flt1 but not kinase insert domain protein receptors (KDRs), had negative effects on neurogenesis and inhibited learning, although it similarly increased endothelial cell proliferation. Expression of a dominant-negative mutant KDR inhibited basal neurogenesis and impaired learning. Coexpression of mutant KDR antagonized VEGF-enhanced neurogenesis and learning without inhibiting endothelial cell proliferation. Furthermore, inhibition of VEGF expression by RNA interference completely blocked the environmental induction of neurogenesis. These data support a model in which VEGF, acting through KDR, mediates the effect of the environment on neurogenesis and cognition.	Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; Univ Auckland, Dept Mol Med & Pathol, Lab Funct Genom & Translat Neurosci, Auckland, New Zealand		During, MJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA.	mjd2002@med.cornell.edu	During, Matthew/AAC-1388-2020; Cao, Lei/H-3185-2019; Cao, Lei/E-2841-2011	Young, Deborah/0000-0003-1085-2824			Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Cao L, 2000, J VIROL, V74, P11456, DOI 10.1128/JVI.74.24.11456-11463.2000; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee MY, 1999, NEUROSCI LETT, V265, P107, DOI 10.1016/S0304-3940(99)00219-0; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PARK JE, 1994, J BIOL CHEM, V269, P25646; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEATHERLY LS, 1996, BRAIN RES, V716, P29; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	43	605	645	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					827	835		10.1038/ng1395			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	WOS:000222974000014	15258583				2022-01-24	
J	Yoshikawa, H; Matsubara, K; Qian, GS; Jackson, P; Groopman, JD; Manning, JE; Harris, CC; Herman, JG				Yoshikawa, H; Matsubara, K; Qian, GS; Jackson, P; Groopman, JD; Manning, JE; Harris, CC; Herman, JG			SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity	NATURE GENETICS			English	Article							CONSTITUTIVE ACTIVATION; PROMOTER HYPERMETHYLATION; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; DNA METHYLATION; GENE; PROTEIN; CELLS; INACTIVATION; LEUKEMIA	Hepatocellular carcinoma (HCC) is a major cause of cancer death, but the molecular mechanism for its development beyond its initiation has not been well characterized. Suppressor of cytokine signaling (SOCS-1; also known as JAB and SSI-1) switches cytokine signaling 'off' by means of its direct interaction with Janus kinase (JAK). We identified aberrant methylation in the CpG island of SOCS-1 that correlated with its transcription silencing in HCC cell lines. The incidence of aberrant methylation was 65% in the 26 human primary HCC tumor samples analyzed. Moreover, the restoration of SOCS-1 suppressed both growth rate and anchorage-independent growth of cells in which SOCS-1 was methylation-silenced and JAK2 was constitutively activated. This growth suppression was caused by apoptosis and was reproduced by AG490. a specific, chemical JAK2 inhibitor that reversed constitutive phosphorylation of STAT3 in SOCS-1 inactivated cells. The high prevalence of the aberrant SOCS-1 methylation and its growth suppression activity demonstrated the importance of the constitutive activation of the JAK/STAT pathway in the development of HCC. Our results also indicate therapeutic strategies for the treatment of HCC including use of SOCS-1 in gene therapy and inhibition of JAK2 by small molecules, such as AG490.	Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Nara Inst Sci & Technol, Nara, Japan; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA; Shanghai Canc Inst, Shanghai, Peoples R China; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA		Herman, JG (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA.		/X-4205-2019	/0000-0003-4690-2133	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50 CA58184] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA058184] Funding Source: NIH RePORTER		Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Esteller M, 1999, CANCER RES, V59, P793; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; GRAFF JR, 1995, CANCER RES, V55, P5195; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kramer JA, 1997, BIOTECHNIQUES, V22, P826, DOI 10.2144/97225bm07; Kramer JA, 1998, J EXP ZOOL, V282, P245, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2<245::AID-JEZ26>3.3.CO;2-H; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Losman JA, 1999, J IMMUNOL, V162, P3770; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; NAGAI H, 1994, CANCER RES, V54, P1545; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; RAMPONI G, 1992, INT J CANCER, V51, P652, DOI 10.1002/ijc.2910510424; Rashid A, 1999, BRIT J CANCER, V80, P59, DOI 10.1038/sj.bjc.6690321; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; WeberNordt RM, 1996, BLOOD, V88, P809; Yoshikawa H, 1997, GENE, V197, P129, DOI 10.1016/S0378-1119(97)00251-5; Yoshikawa H, 1998, GENOMICS, V49, P237, DOI 10.1006/geno.1998.5246; ZLATANOVA J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P211	44	604	631	2	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					29	35		10.1038/ng0501-29			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	WOS:000168413300011	11326271				2022-01-24	
J	Gratz, SJ; Cummings, AM; Nguyen, JN; Hamm, DC; Donohue, LK; Harrison, MM; Wildonger, J; O'Connor-Giles, KM				Gratz, Scott J.; Cummings, Alexander M.; Nguyen, Jennifer N.; Hamm, Danielle C.; Donohue, Laura K.; Harrison, Melissa M.; Wildonger, Jill; O'Connor-Giles, Kate M.			Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease	GENETICS			English	Article							ZINC-FINGER NUCLEASES; INDUCED GAP REPAIR; HOMOLOGOUS RECOMBINATION; GENE; EFFICIENT; MELANOGASTER; MUTAGENESIS; ENDONUCLEASE; INTERFERENCE; REPLACEMENT	We have adapted a bacterial CRISPR RNA/Cas9 system to precisely engineer the Drosophila genome and report that Cas9-mediated genomic modifications are efficiently transmitted through the germline. This RNA-guided Cas9 system can be rapidly programmed to generate targeted alleles for probing gene function in Drosophila.	[Gratz, Scott J.; O'Connor-Giles, Kate M.] Univ Wisconsin, Genet Training Program, Madison, WI 53706 USA; [Cummings, Alexander M.; Donohue, Laura K.; O'Connor-Giles, Kate M.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Nguyen, Jennifer N.; Wildonger, Jill] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Hamm, Danielle C.; Harrison, Melissa M.] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [O'Connor-Giles, Kate M.] Univ Wisconsin, Lab Cell & Mol Biol, Madison, WI 53706 USA; [Harrison, Melissa M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA		Harrison, MM (corresponding author), 6204B Biochem Sci Bldg,440 Henry Mall, Madison, WI 53706 USA.	mharrison3@wisc.edu; wildonger@wisc.edu; oconnorgiles@wisc.edu		O'Connor-Giles, Kate/0000-0002-2259-8408	University of Wisconsin; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 NS072252, R00 NS060985]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078179, R00NS060985, R00NS072252] Funding Source: NIH RePORTER	We thank the Bloomington Drosophila Stock Center for fly stocks and Michael Cox, Carlos Flores, Judith Kimble, and Andrew Mehle for invaluable discussions and critical comments on the manuscript. We are grateful to Feng Zhang for sharing reagents and an unpublished manuscript with us, Kevin Eliceiri for sharing injection equipment, and Kathy Vaccaro for sharing her expertise on embryo injections. This work was funded by startup funds from the University of Wisconsin to M.M.H., J.W., and K.O.C.G. and grants from the National Institute of Neurological Disorders and Stroke, National Institutes of Health to J.W. (R00 NS072252) and K.O.C.G. (R00 NS060985). All plasmids used in this study will be made available to academic laboratories through the nonprofit distributor Addgene along with detailed guidance at http://FlyCRISPR.molbio.wisc.edu.	BANGA SS, 1992, P NATL ACAD SCI USA, V89, P1735, DOI 10.1073/pnas.89.5.1735; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2002, GENETICS, V161, P1169; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Gao G, 2008, P NATL ACAD SCI USA, V105, P13999, DOI 10.1073/pnas.0805843105; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Shen B., 2013, CELL RES; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Wakiyama M, 2005, BIOCHEM BIOPH RES CO, V331, P1163, DOI 10.1016/j.bbrc.2005.03.240; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773	31	603	657	17	236	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	AUG	2013	194	4					1029	+		10.1534/genetics.113.152710			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	193RB	WOS:000322578000017	23709638	Green Published, Bronze	Y	N	2022-01-24	
J	Xu, B; Roos, JL; Levy, S; Van Rensburg, EJ; Gogos, JA; Karayiorgou, M				Xu, Bin; Roos, J. Louw; Levy, Shawn; Van Rensburg, E. J.; Gogos, Joseph A.; Karayiorgou, Maria			Strong association of de novo copy number mutations with sporadic schizophrenia	NATURE GENETICS			English	Article							CARDIO-FACIAL SYNDROME; BIPOLAR DISORDER; GENES; CITRON; SUSCEPTIBILITY; REARRANGEMENTS; METAANALYSIS; BIOGENESIS; PATHWAYS; DELETION	Schizophrenia is an etiologically heterogeneous psychiatric disease, which exists in familial and nonfamilial (sporadic) forms(1). Here, we examine the possibility that rare de novo copy number (CN) mutations with relatively high penetrance contribute to the genetic component of schizophrenia. We carried out a whole-genome scan and implemented a number of steps for finding and confirming CN mutations. Confirmed de novo mutations were significantly associated with schizophrenia (P = 0.00078) and were collectively similar to 8 times more frequent in sporadic (but not familial) cases with schizophrenia than in unaffected controls. In comparison, rare inherited CN mutations were only modestly enriched in sporadic cases. Our results suggest that rare de novo germline mutations contribute to schizophrenia vulnerability in sporadic cases and that rare genetic lesions at many different loci can account, at least in part, for the genetic heterogeneity of this disease.	[Xu, Bin; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Roos, J. Louw] Weskoppies Hosp, ZA-0001 Pretoria, South Africa; [Levy, Shawn] Vanderbilt Univ, Nashville, TN 37232 USA; [Van Rensburg, E. J.] Univ Pretoria, Dept Genet, ZA-0001 Pretoria, South Africa; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA		Gogos, JA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu; mk2758@columbia.edu	van Rensburg, Elizabeth J./B-9104-2011	Levy, Shawn/0000-0002-1369-5740; van Rensburg, Elizabeth/0000-0003-2077-230X; Roos, Johannes/0000-0002-0572-1072	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH077235, R01MH061399] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA68485] Funding Source: Medline; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30 EY08126] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH077235, MH061399] Funding Source: Medline		Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Bennett RL, 1997, AM J HUM GENET, V61, P1450, DOI 10.1086/301634; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Karayiorgou M, 2006, EUR J HUM GENET, V14, P512, DOI 10.1038/sj.ejhg.5201587; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lyons-Warren A, 2005, MOL PSYCHIATR, V10, P807, DOI 10.1038/sj.mp.4001703; MacIntyre D, 2003, MOL PSYCHIATR, V8, P275, DOI 10.1038/sj.mp.4001232; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wiehahn GJ, 2004, AM J MED GENET B, V129B, P20, DOI 10.1002/ajmg.b.20168; Yue Y, 1999, J NEUROSCI, V19, P2090	30	603	626	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					880	885		10.1038/ng.162			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	WOS:000257166500023	18511947				2022-01-24	
J	Liu, J; Aoki, M; Illa, I; Wu, CY; Fardeau, M; Angelini, C; Serrano, C; Urtizberea, JA; Hentati, F; Ben Hamida, M; Bohlega, S; Culper, EJ; Amato, AA; Bossie, K; Oeltjen, T; Bejaoui, K; McKenna-Yasek, D; Hosler, BA; Schurr, E; Arahata, K; de Jong, PJ; Brown, RH				Liu, J; Aoki, M; Illa, I; Wu, CY; Fardeau, M; Angelini, C; Serrano, C; Urtizberea, JA; Hentati, F; Ben Hamida, M; Bohlega, S; Culper, EJ; Amato, AA; Bossie, K; Oeltjen, T; Bejaoui, K; McKenna-Yasek, D; Hosler, BA; Schurr, E; Arahata, K; de Jong, PJ; Brown, RH			Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy	NATURE GENETICS			English	Article							FERTILIZATION-DEFECTIVE MUTANTS; HUMAN GENOME; CAENORHABDITIS-ELEGANS; CHROMOSOME 2P; SPERM; LOCUS; CYTOSKELETON; PROTEINS; DOMAINS; DOC2	Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that we have mapped to human chromosome 2p13. We recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig spanning the MM candidate region. This clarified the order of genetic markers across the MM locus, provided five new polymorphic markers within it and narrowed the locus to approximately 2 Mb. Five skeletal muscle expressed sequence tags (ESTs) map in this region. We report that one of these is located in a novel, full-length 6.9-kb muscle cDNA, and we designate the corresponding protein 'dysferlin'. We describe nine mutations in the dysferlin gene in nine families; five are predicted to prevent dysferlin expression. Identical mutations in the dysferlin gene can produce more than one myopathy phenotype (MM, limb girdle dystrophy, distal myopathy with anterior tibial onset).	Day Neuromuscular Res Lab, Charlestown, MA 02129 USA; UAB, Hosp St Pau, Dept Neurol, Neuromuscular Dis Sect, Barcelona, Spain; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Hop La Pitie Salpetriere, Assoc Francaise Myopathies, Inst Myol, F-75651 Paris 13, France; Univ Padua, Dept Neurol, Neuromuscular Ctr, I-35128 Padua, Italy; Serv Neurol, Tunis, Tunisia; King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; Univ Texas, Hlth Sci Ctr, Dept Med Neurol, San Antonio, TX 78284 USA; Montreal Gen Hosp, Res Inst, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan		Brown, RH (corresponding author), Day Neuromuscular Res Lab, Room 6627,Bldg 149,13th St,Navy Yard, Charlestown, MA 02129 USA.	brown@helix.mgh.harvard.edu	Angelini, Corrado/J-3655-2019; ILLA, Isabel/AAD-1816-2019	Angelini, Corrado/0000-0002-9554-8794; Serrano Munuera, Carmen/0000-0003-3551-8240	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG012992] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5PO1AG12992] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5PO1NS31248] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [5RO1N834913A] Funding Source: Medline; TelethonFondazione Telethon [552] Funding Source: Medline		Achanzar WE, 1997, J CELL SCI, V110, P1073; Aoki M, 1998, ANN NEUROL, V43, P645, DOI 10.1002/ana.410430514; ARGON Y, 1980, GENETICS, V96, P413; Bashir R, 1996, GENOMICS, V33, P46, DOI 10.1006/geno.1996.0157; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bejaoui K, 1998, NEUROGENETICS, V1, P189, DOI 10.1007/s100480050028; Benes V, 1997, BIOTECHNIQUES, V23, P98, DOI 10.2144/97231bm21; Bonnemann Carsten G., 1996, Current Opinion in Pediatrics, V8, P569; Brown RH, 1997, ANNU REV MED, V48, P457, DOI 10.1146/annurev.med.48.1.457; GASTIER JM, 1995, HUM MOL GENET, V4, P1829, DOI 10.1093/hmg/4.10.1829; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Hoffman EP, 1996, BRAIN PATHOL, V6, P49, DOI 10.1111/j.1750-3639.1996.tb00782.x; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Illarioshkin SN, 1997, GENOMICS, V42, P345, DOI 10.1006/geno.1997.4725; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Liu J, 1998, GENOMICS, V49, P23, DOI 10.1006/geno.1998.5204; MIYOSHI K, 1986, BRAIN, V109, P31, DOI 10.1093/brain/109.1.31; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; SAMBROOK J, 1989, MOL CLONING LIB MANU; SCHON EA, J BIOENEG BIOMEMBR, V29, P131; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; Weiler T, 1996, AM J HUM GENET, V59, P872	35	603	619	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					31	36		10.1038/1682			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	WOS:000075671400014	9731526				2022-01-24	
J	SNELL, RG; MACMILLAN, JC; CHEADLE, JP; FENTON, I; LAZAROU, LP; DAVIES, P; MACDONALD, ME; GUSELLA, JF; HARPER, PS; SHAW, DJ				SNELL, RG; MACMILLAN, JC; CHEADLE, JP; FENTON, I; LAZAROU, LP; DAVIES, P; MACDONALD, ME; GUSELLA, JF; HARPER, PS; SHAW, DJ			RELATIONSHIP BETWEEN TRINUCLEOTIDE REPEAT EXPANSION AND PHENOTYPIC VARIATION IN HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; TRANSMISSION; PATTERNS; REGION; ONSET; GENE; AGE	The molecular analysis of a specific CAG repeat sequence in the Huntington's disease gene in 440 Huntington's disease patients and 360 normal controls reveals a range of 30-70 repeats in affected individuals and 9-34 in normals. We find significant negative correlations between the number of repeats on the HD chromosome and age at onset, regardless of sex of the transmitting parent, and between the number of repeats on the normal paternal allele and age at onset in individuals with maternally transmitted disease. This effect of the normal paternal allele may account for the weaker age at onset correlation between affected sib pairs with disease of maternal as opposed to paternal origin and suggests that normal gene function varies because of the size of the repeat in the normal range and a sex-specific modifying effect.	UNIV WALES COLL MED,INST MED GENET,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115				MacMillan, John C/C-9591-2011	Snell, Russell/0000-0002-8166-4014	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, IN PRESS AM J HUM GE; FENTON I, 1992, 2ND INT WORKSH PKD, P70; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARPER PS, 1992, AM J HUM GENET, V51, P10; Harper PS, 1991, HUNTINGTONS DISEASE; KRAWCZAK M, 1991, AM J HUM GENET, V49, P735; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1983, LANCET, V1, P208; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RIDLEY RM, 1991, J MED GENET, V28, P224, DOI 10.1136/jmg.28.4.224; SNELL RG, 1989, J MED GENET, V26, P273; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WENT LN, 1983, ANN HUM GENET, V47, P205, DOI 10.1111/j.1469-1809.1983.tb00989.x; WENT LN, 1984, LANCET, V1, P1100	22	603	609	0	28	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					393	397		10.1038/ng0893-393			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	WOS:A1993LQ17800018	8401588				2022-01-24	
J	Palles, C; Cazier, JB; Howarth, KM; Domingo, E; Jones, AM; Broderick, P; Kemp, Z; Spain, SL; Almeida, EG; Salguero, I; Sherborne, A; Chubb, D; Carvajal-Carmona, LG; Ma, Y; Kaur, K; Dobbins, S; Barclay, E; Gorman, M; Martin, L; Kovac, MB; Humphray, S; Lucassen, A; Holmes, CC; Bentley, D; Donnelly, P; Taylor, J; Petridis, C; Roylance, R; Sawyer, EJ; Kerr, DJ; Clark, S; Grimes, J; Kearsey, SE; Thomas, HJW; McVean, G; Houlston, RS; Tomlinson, I				Palles, Claire; Cazier, Jean-Baptiste; Howarth, Kimberley M.; Domingo, Enric; Jones, Angela M.; Broderick, Peter; Kemp, Zoe; Spain, Sarah L.; Almeida, Estrella Guarino; Salguero, Israel; Sherborne, Amy; Chubb, Daniel; Carvajal-Carmona, Luis G.; Ma, Yusanne; Kaur, Kulvinder; Dobbins, Sara; Barclay, Ella; Gorman, Maggie; Martin, Lynn; Kovac, Michal B.; Humphray, Sean; Lucassen, Anneke; Holmes, Christopher C.; Bentley, David; Donnelly, Peter; Taylor, Jenny; Petridis, Christos; Roylance, Rebecca; Sawyer, Elinor J.; Kerr, David J.; Clark, Susan; Grimes, Jonathan; Kearsey, Stephen E.; Thomas, Huw J. W.; McVean, Gilean; Houlston, Richard S.; Tomlinson, Ian		CORGI Consortium; WGS500 Consortium	Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas	NATURE GENETICS			English	Article							DNA-POLYMERASE-DELTA; CANCER SUSCEPTIBILITY; EXCISION-REPAIR; MUTATOR; YEAST; PHENOTYPES; EPSILON; GENE	Many individuals with multiple or large colorectal adenomas or early-onset colorectal cancer (CRC) have no detectable germline mutations in the known cancer predisposition genes. Using whole-genome sequencing, supplemented by linkage and association analysis, we identified specific heterozygous POLE or POLD1 germline variants in several multiple-adenoma and/or CRC cases but in no controls. The variants associated with susceptibility, POLE p.Leu424Val and POLD1 p.Ser478Asn, have high penetrance, and POLD1 mutation was also associated with endometrial cancer predisposition. The mutations map to equivalent sites in the proofreading (exonuclease) domain of DNA polymerases E and 8 and are predicted to cause a defect in the correction of mispaired bases inserted during DNA replication. In agreement with this prediction, the tumors from mutation carriers were microsatellite stable but tended to acquire base substitution mutations, as confirmed by yeast functional assays. Further analysis of published data showed that the recently described group of hypermutant, microsatellite-stable CRCs is likely to be caused by somatic POLE mutations affecting the exonuclease domain.	[Palles, Claire; Howarth, Kimberley M.; Domingo, Enric; Jones, Angela M.; Kemp, Zoe; Spain, Sarah L.; Carvajal-Carmona, Luis G.; Barclay, Ella; Gorman, Maggie; Martin, Lynn; Kovac, Michal B.; Tomlinson, Ian] Univ Oxford, Mol & Populat Genet Lab, Wellcome Trust Ctr Human Genet, Oxford, England; [Cazier, Jean-Baptiste; Donnelly, Peter; McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Broderick, Peter; Sherborne, Amy; Chubb, Daniel; Ma, Yusanne; Dobbins, Sara; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Almeida, Estrella Guarino; Salguero, Israel; Kearsey, Stephen E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Kaur, Kulvinder; Taylor, Jenny; Tomlinson, Ian] Univ Oxford, Oxford Natl Inst Hlth Res NIHR Comprehens Biomed, Wellcome Trust Ctr Human Genet, Oxford, England; [Kovac, Michal B.] Univ Basel, Res Grp Human Genet, Dept Biomed, Basel, Switzerland; [Humphray, Sean; Bentley, David] Illumina Cambridge Ltd, Saffron Walden, England; [Lucassen, Anneke] Princess Anne Hosp, Wessex Reg Genet Lab, Southampton, Hants, England; [Holmes, Christopher C.; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Petridis, Christos; Sawyer, Elinor J.] Kings Coll London, Div Canc Studies, NIHR Comprehens Biomed Res Ctr, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust Par, London WC2R 2LS, England; [Roylance, Rebecca] Univ London, Inst Canc, Barts & London Med Sch, Queen Mary Coll, London, England; [Kerr, David J.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Clark, Susan] Univ London Imperial Coll Sci Technol & Med, Polyposis Registry, Sch Med, St Marks Hosp, Harrow, Middx, England; [Grimes, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England; [Grimes, Jonathan] Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England; [Thomas, Huw J. W.] Univ London Imperial Coll Sci Technol & Med, Family Canc Clin, Sch Med, St Marks Hosp, Harrow, Middx, England		Tomlinson, I (corresponding author), Univ Oxford, Mol & Populat Genet Lab, Wellcome Trust Ctr Human Genet, Oxford, England.	iant@well.ox.ac.uk	Carvajal-Carmona, Luis G/B-3882-2010; Kovac, Michal/A-4027-2011; Domingo, Enric/A-9099-2018; Kovac, Michal/AAF-9605-2020; Knight, Julian Charles/W-2399-2019; Kanapin, Alexander A/Q-7590-2016; Humburg, Peter/A-4191-2009; Pinheiro, Maisa/E-7424-2012; Cazier, Jean-Baptiste/F-2369-2010; Wilkie, Andrew/AAC-3820-2020; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	Carvajal-Carmona, Luis G/0000-0001-7129-2918; Domingo, Enric/0000-0003-4390-8767; Kovac, Michal/0000-0003-4526-1071; Knight, Julian Charles/0000-0002-0377-5536; Kanapin, Alexander A/0000-0001-9802-5297; Humburg, Peter/0000-0002-3331-6496; Wilkie, Andrew/0000-0002-2972-5481; Spain, Sarah/0000-0002-7591-8364; Bishop, Tim/0000-0002-8752-8785; Palles, Claire/0000-0002-9670-2263; Lucassen, Anneke/0000-0003-3324-4338; Cazier, Jean-Baptiste/0000-0001-7581-9051; Evans, Gareth/0000-0002-8482-5784; Broderick, Peter/0000-0002-8348-5829; Lunter, Gerton/0000-0002-3798-2058; Houlston, Richard/0000-0002-5268-0242; McVean, Gil/0000-0002-5012-4162; Kerr, David/0000-0001-7811-6722; Taylor, Jenny/0000-0003-3602-5704; Green, Andrew/0000-0002-0488-5913	Cancer Research UKCancer Research UK [C6199/A10417, C1298/A8362]; Oxford NIHR Comprehensive Biomedical Research Centre; Wellcome TrustWellcome TrustEuropean Commission [090532/Z/09/Z]; John Fell Oxford University Press (OUP) Research Fund; Junta de Extremadura, Spain (Consejeria de Economia, Comercio e Innovacion); European Union Seventh Framework Programme under FP7 collaborative project SYSCOL [FP7/207-2013, 258236]; Bobby Moore Fund; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I02593X/1] Funding Source: researchfish; Cancer Research UKCancer Research UK [10589, 16459] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UP_A390_1107] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [03/DHCS/03/G121/51] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I02593X/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UP_A390_1107] Funding Source: UKRI	We are grateful to all the affected individuals and their relatives in the families studied and to those who have provided their medical care. We acknowledge the help of many colleagues who are part of the teams who work on the CORGI study. We acknowledge the use of DNA from the British 1958 Birth Cohort collection. This work was principally funded by Cancer Research UK (C6199/A10417) and the Oxford NIHR Comprehensive Biomedical Research Centre (to We also acknowledge core funding to the Wellcome Trust Centre for Human Genetics from the Wellcome Trust (090532/Z/09/Z). Work in the laboratory of R.S.H. is supported by funding from Cancer Research UK (C1298/A8362, supported by the Bobby Moore Fund). Work in the laboratory of S.E.K. was supported by project grants from Cancer Research UK and the John Fell Oxford University Press (OUP) Research Fund. We thank O. Fleck (University of Copenhagen) for fission yeast strains. I.S. is supported by a fellowship from the Junta de Extremadura, Spain (Consejeria de Economia, Comercio e Innovacion). R.S.H. and I.T. acknowledge funding from the European Union Seventh Framework Programme (FP7/207-2013) under grant 258236, FP7 collaborative project SYSCOL.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; DACOSTA LT, 1995, NAT GENET, V9, P10, DOI 10.1038/ng0195-10; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fleck O, 1999, NAT GENET, V21, P314, DOI 10.1038/6838; Flohr T, 1999, INT J CANCER, V80, P919, DOI 10.1002/(SICI)1097-0215(19990315)80:6<919::AID-IJC19>3.0.CO;2-U; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Hindges R, 1997, BIOL CHEM, V378, P345; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jones AM, 2007, J PATHOL, V213, P249, DOI 10.1002/path.2234; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; LANSPA SJ, 1990, GASTROENTEROLOGY, V98, P1117, DOI 10.1016/0016-5085(90)90323-S; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Murphy K, 2006, GENOME, V49, P403, DOI 10.1139/G05-106; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Papaemmanuil E, 2008, EUR J HUM GENET, V16, P1477, DOI 10.1038/ejhg.2008.129; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Yoshida R, 2011, EUR J HUM GENET, V19, P320, DOI 10.1038/ejhg.2010.216	29	602	614	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					136	144		10.1038/ng.2503			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	WOS:000314333000008	23263490	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Napirei, M; Karsunky, H; Zevnik, B; Stephan, H; Mannherz, HG; Moroy, T				Napirei, M; Karsunky, H; Zevnik, B; Stephan, H; Mannherz, HG; Moroy, T			Features of systemic lupus erythematosus in Dnase1-deficient mice	NATURE GENETICS			English	Article							DEOXYRIBONUCLEASE-I DNASE; AUTOANTIBODIES; TISSUES; SERUM; NEPHRITIS; APOPTOSIS	Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease that affects over one million people in the United States. SLE is characterized by the presence of anti-nuclear antibodies (ANA) directed against naked DNA and entire nucleosomes. It is thought that the resulting immune complexes accumulate in vessel walls, glomeruli and joints and cause a hypersensitivity reaction type ill, which manifests as glomerulonephritis, arthritis and general vasculitis, The aetiology of SLE is unknown, but several studies suggest that increased liberation or disturbed clearance of nuclear DNA-protein complexes after cell death may initiate and propagate the disease(1-6). Consequently, Dnase1, which is the major nuclease present in serum, urine and secreta, may be responsible for the removal of DNA from nuclear antigens at sites of high cell turnover and thus for the prevention of SLE (refs 7-11). To test this hypothesis, we have generated Dnase1-deficient mice by gene targeting. We report here that these animals show the classical symptoms of SLE. namely the presence of ANA, the deposition of immune complexes in glomeruli and full-blown glomerulonephritis in a Dnasel-dose-dependent manner. Moreover, in agreement with earlier reports(10), we found Dnase1 activities in serum to be lower in SLE patients than in normal subjects. Our findings suggest that lack or reduction of Dnase1 is a critical factor in the initiation of human SLE.	Ruhr Univ Bochum, Fak Med, Abt Anat & Embryol, D-4630 Bochum, Germany; Univ Essen Gesamthsch Klinikum, IFZ, Inst Zellbiol Tumorforsch, D-4300 Essen, Germany		Moroy, T (corresponding author), Ruhr Univ Bochum, Fak Med, Abt Anat & Embryol, Univ Str 150, D-4630 Bochum, Germany.	moeroey@uni-essen.de	Moroy, Tarik/D-9923-2011; Stephan, Harald/AAT-6802-2021; Zevnik, Branko/AAB-7853-2020	Zevnik, Branko/0000-0001-7845-9522; Mannherz, Hans Georg/0000-0001-8158-5722			Berden JHM, 1999, CURR OPIN NEPHROL HY, V8, P299, DOI 10.1097/00041552-199905000-00005; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Carroll MC, 1998, NAT GENET, V19, P3, DOI 10.1038/ng0598-3; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P55, DOI 10.1007/BF00541153; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Eilat D, 1999, IMMUNOL TODAY, V20, P339, DOI 10.1016/S0167-5699(99)01457-7; ELKON KB, 1985, J EXP MED, V162, P459, DOI 10.1084/jem.162.2.459; LACHMANN PJ, 1961, IMMUNOLOGY, V4, P153; LACKS SA, 1981, J BIOL CHEM, V256, P2644; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; MOORE TL, 1981, SEMIN ARTHRITIS RHEU, V10, P309, DOI 10.1016/0049-0172(81)90007-X; NADANO D, 1993, CLIN CHEM, V39, P448; Peitsch M C, 1994, Cell Death Differ, V1, P1; PEITSCH MC, 1995, BIOCHEM BIOPH RES CO, V207, P62, DOI 10.1006/bbrc.1995.1153; POLZAR B, 1990, NUCLEIC ACIDS RES, V18, P7151, DOI 10.1093/nar/18.23.7151; POLZAR B, 1994, EUR J CELL BIOL, V64, P200; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; Shimoda M, 1998, IMMUNOLOGY, V95, P200; Takeshita H, 1997, BIOCHEM MOL BIOL INT, V42, P65; Vanholder R, 1998, EUR J DERMATOL, V8, P4; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037	24	602	627	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					177	181		10.1038/76032			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200016	10835632				2022-01-24	
J	Draptchinskaia, N; Gustavsson, P; Andersson, B; Pettersson, M; Willig, TN; Dianzani, I; Ball, S; Tchernia, G; Klar, J; Matsson, H; Tentler, D; Mohandas, N; Carlsson, B; Dahl, N				Draptchinskaia, N; Gustavsson, P; Andersson, B; Pettersson, M; Willig, TN; Dianzani, I; Ball, S; Tchernia, G; Klar, J; Matsson, H; Tentler, D; Mohandas, N; Carlsson, B; Dahl, N			The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia	NATURE GENETICS			English	Article							MESSENGER-RNAS; SEQUENCE-ANALYSIS; TURNER SYNDROME; DNA-SEQUENCE; ANEMIA; CHROMOSOME; EXPRESSION; GROWTH	Diamond-Blackfan anaemia (DBA) is a constitutional erythroblastopenia characterized by absent or decreased erythroid precursors. The disease, previously mapped to human chromosome 19q13, is frequently associated with a variety of malformation. To identify the gene involved in DBA, we cloned the chromosome 19q13 breakpoint in a patient with a reciprocal X; 19 chromosome translocation. The breakpoint occurred in the gene encoding ribosomal protein S19. Furthermore, we identified mutations in RPS19 in 10 of 40 unrelated DMA patients, including nonsense, frameshift, splice site and missense mutations, as well as two intragenic deletions. These mutations are associated with clinical features that suggest a function for RPS19 in erythropoiesis and embryogenesis.	Uppsala Univ, Dept Genet & Pathol, Clin Genet Unit, S-75185 Uppsala, Sweden; Uppsala Univ, Dept Genet & Pathol, Unit Med Genet, S-75185 Uppsala, Sweden; Uppsala Univ, Dept Genet & Pathol, Unit Pathol, S-75185 Uppsala, Sweden; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Hop Bicetre, AP HP, Dept Hematol, Le Kremlin Bicetre, France; Fac Med Paris Sud, Le Kremlin Bicetre, France; Univ Turin, Dept Pediat, I-10126 Turin, Italy; Univ London St Georges Hosp, Sch Med, Dept Haematol, London SW17 0RE, England		Dahl, N (corresponding author), Uppsala Univ, Dept Genet & Pathol, Clin Genet Unit, S-75185 Uppsala, Sweden.	niklas.dahl@klingen.uu.se	Klar, Joakim/H-2900-2019; Andersson, Bjorn/G-9832-2013; Matsson, Hans/A-5787-2019; Tentler, Dmitri/AAE-4519-2019	Klar, Joakim/0000-0003-4185-7409; Andersson, Bjorn/0000-0002-4624-0259; Matsson, Hans/0000-0001-6161-1559; Tentler, Dmitri/0000-0003-3976-1205	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK 26263, DK 32094] Funding Source: Medline; TelethonFondazione Telethon [E.0619] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK026263, P01DK032094, R37DK026263] Funding Source: NIH RePORTER		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson B, 1996, BIOTECHNIQUES, V20, P1022; Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; BAGNARA GP, 1991, BLOOD, V78, P2203; Ball SE, 1996, BRIT J HAEMATOL, V94, P645, DOI 10.1046/j.1365-2141.1996.d01-1839.x; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAMTON SE, 1994, GENETICS, V137, P1039; Diamond L K, 1976, Adv Pediatr, V22, P349; Dianzani I, 1996, BLOOD, V87, P2568, DOI 10.1182/blood.V87.6.2568.bloodjournal8762568; ETTER A, SCIENCE, V265, P954; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRIGERIO JM, 1995, BBA-GENE STRUCT EXPR, V1262, P64, DOI 10.1016/0167-4781(95)00045-I; Gelbart WM, 1997, NUCLEIC ACIDS RES, V25, P63, DOI 10.1093/nar/25.1.63; Gustavsson P, 1997, NAT GENET, V16, P368, DOI 10.1038/ng0897-368; Gustavsson P, 1998, AM J HUM GENET, V63, P1388, DOI 10.1086/302100; Gustavsson P, 1997, J MED GENET, V34, P779, DOI 10.1136/jmg.34.9.779; HALPERIN DS, 1989, AM J PEDIAT HEMATOL, V11, P380; HART K, 1993, MECH DEVELOP, V43, P101, DOI 10.1016/0925-4773(93)90028-V; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; HASHIMOTO S, 1994, IMMUNOGENETICS, V40, P287; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; KONDOH N, 1992, CANCER RES, V52, P791; MCGUCKIN CP, 1995, BRIT J HAEMATOL, V89, P457, DOI 10.1111/j.1365-2141.1995.tb08349.x; Meyuhas Oded, 1996, V30, P363; MUGISHIMA H, 1995, BONE MARROW TRANSPL, V15, P55; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; PETTERSSON M, 1995, BLOOD, V86, P2747; Richards S., 1994, AUTOMATED DNA SEQUEN, P191; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; TSAI PH, 1989, BRIT J HAEMATOL, V73, P112, DOI 10.1111/j.1365-2141.1989.tb00229.x; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WATANABE M, 1993, NAT GENET, V4, P268, DOI 10.1038/ng0793-268; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302; Willig T N, 1998, Curr Opin Hematol, V5, P109; Wool I. G., 1996, TRANSLATIONAL CONTRO, P685; WOOL IG, 1996, RIBOSOMAL RNA GROUP, P153; Young NS, 1994, APLASTIC ANEMIA ACQU	43	602	618	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1999	21	2					169	175		10.1038/5951			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	WOS:000078399500017	9988267				2022-01-24	
J	David, G; Abbas, N; Stevanin, G; Durr, A; Yvert, G; Cancel, G; Weber, C; Imbert, G; Saudou, F; Antoniou, E; Drabkin, H; Gemmill, R; Giunti, P; Benomar, A; Wood, N; Ruberg, M; Agid, Y; Mandel, JL; Brice, A				David, G; Abbas, N; Stevanin, G; Durr, A; Yvert, G; Cancel, G; Weber, C; Imbert, G; Saudou, F; Antoniou, E; Drabkin, H; Gemmill, R; Giunti, P; Benomar, A; Wood, N; Ruberg, M; Agid, Y; Mandel, JL; Brice, A			Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; PALLIDOLUYSIAN ATROPHY DRPLA; MACHADO-JOSEPH DISEASE; PIGMENTARY MACULAR DYSTROPHY; RETINAL DEGENERATION; CHROMOSOME 3P12-P21.1; HUNTINGTONS-DISEASE; SEQUENCES; LOCUS; ANTICIPATION	The gene for spinocerebellar ataxia 7 (SCA7) has been mapped to chromosome 3q12-13. By positional cloning, we have identified a new gene of unknown function containing a CAG repeat that is expanded in SCA7 patients. On mutated alleles, CAG repeat size is highly variable, ranging from 38 to 130 repeats, whereas on normal alleles it ranges from 7 to 17 repeats. Gonadal instability in SCA7 is greater than that observed in any of the seven known neuro-degenerative diseases caused by translated CAG repeat expansions, and is markedly associated with paternal transmissions. SCA7 is the first such disorder in which the degenerative process also affects the retina.	HOP LA PITIE SALPETRIERE, INSERM U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, FEDERAT NEUROL, F-75651 PARIS 13, FRANCE; ULP, INSERM, IGBMC, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; UNIV COLORADO, HLTH SCI CTR, DENVER, CO 80262 USA; INST NEUROL, LONDON WC1N 3BG, ENGLAND; HOP SPECIAL, SERV NEUROL, RABAT, MOROCCO				Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; Wood, Nicholas W/C-2505-2009; brice, alexis/AAE-8275-2019; SAUDOU, Frederic/L-3454-2014; Giunti, Paola/E-5526-2012	Stevanin, Giovanni/0000-0001-9368-8657; Wood, Nicholas W/0000-0002-9500-3348; brice, alexis/0000-0002-0941-3990; SAUDOU, Frederic/0000-0001-6107-1046; Giunti, Paola/0000-0003-3508-4788; Yvert, Gael/0000-0003-1955-4786; Cancel-Tassin, Geraldine/0000-0002-9583-6382	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000358] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG000358] Funding Source: Medline		BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; BERCIANO J, 1982, J NEUROL SCI, V53, P253, DOI 10.1016/0022-510X(82)90011-9; CANCEL G, 1995, AM J HUM GENET, V57, P809; Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; David G, 1996, AM J HUM GENET, V59, P1328; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Durr A, 1996, CURR OPIN NEUROL, V9, P290; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IKEUCHI T, 1995, SEMIN CELL BIOL, V6, P37, DOI 10.1016/1043-4682(95)90013-6; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Jobsis GJ, 1997, J NEUROL NEUROSUR PS, V62, P367, DOI 10.1136/jnnp.62.4.367; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krols L, 1997, HUM GENET, V99, P225, DOI 10.1007/s004390050344; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandel JL, 1997, NATURE, V386, P767, DOI 10.1038/386767a0; Maniatis T., 1989, MOL CLONING; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ruberg M, 1997, J NEUROCHEM, V68, P2098; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Stevanin G, 1996, HUM MOL GENET, V5, P1887, DOI 10.1093/hmg/5.12.1887; Stevanin G, 1997, AM J HUM GENET, V60, P1548; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	44	602	620	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					65	70		10.1038/ng0997-65			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	WOS:A1997XU72400019	9288099				2022-01-24	
J	Gaugler, T; Klei, L; Sanders, SJ; Bodea, CA; Goldberg, AP; Lee, AB; Mahajan, ML; Manaa, D; Pawitan, YD; Reichert, J; Ripke, S; Sandin, S; Sklar, P; Svantesson, O; Reichenberg, A; Hultman, CM; Devlin, B; Roeder, K; Buxbaum, JD				Gaugler, Trent; Klei, Lambertus; Sanders, Stephan J.; Bodea, Corneliu A.; Goldberg, Arthur P.; Lee, Ann B.; Mahajan, Milind; Manaa, Dina; Pawitan, Yudi; Reichert, Jennifer; Ripke, Stephan; Sandin, Sven; Sklar, Pamela; Svantesson, Oscar; Reichenberg, Abraham; Hultman, Christina M.; Devlin, Bernie; Roeder, Kathryn; Buxbaum, Joseph D.			Most genetic risk for autism resides with common variation	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; SPECTRUM DISORDERS; HERITABILITY; VARIANTS; REVEALS; LOCI	A key component of genetic architecture is the allelic spectrum influencing trait variability. For autism spectrum disorder (herein termed autism), the nature of the allelic spectrum is uncertain. Individual risk-associated genes have been identified from rare variation, especially de novo mutations(1-8). From this evidence, one might conclude that rare variation dominates the allelic spectrum in autism, yet recent studies show that common variation, individually of small effect, has substantial impact en masse(9,10). At issue is how much of an impact relative to rare variation this common variation has. Using a unique epidemiological sample from Sweden, new methods that distinguish total narrow-sense heritability from that due to common variation and synthesis of results from other studies, we reach several conclusions about autism's genetic architecture: its narrow-sense heritability is similar to 52.4%, with most due to common variation, and rare de novo mutations contribute substantially to individual liability, yet their contribution to variance in liability, 2.6%, is modest compared to that for heritable variation.	[Gaugler, Trent; Bodea, Corneliu A.; Lee, Ann B.; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Sanders, Stephan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Goldberg, Arthur P.; Reichert, Jennifer; Reichenberg, Abraham; Buxbaum, Joseph D.] Seaver Autism Ctr Res & Treatment, Icahn Sch Med Mt Sinai, New York, NY USA; [Goldberg, Arthur P.; Reichert, Jennifer; Sklar, Pamela; Reichenberg, Abraham; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Goldberg, Arthur P.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY USA; [Mahajan, Milind; Manaa, Dina; Sklar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Pawitan, Yudi; Sandin, Sven; Svantesson, Oscar; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ripke, Stephan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA USA; [Sklar, Pamela; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Div Psychiat Gen, New York, NY USA; [Reichenberg, Abraham] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY USA; [Roeder, Kathryn] Carnegie Mellon Univ, Ray & Stephanie Lane Ctr Computat Biol, Pittsburgh, PA USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA		Roeder, K (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	roeder@stat.cmu.edu; joseph.buxbaum@mssm.edu	Sandin, Sven/ABE-2959-2021; Sanders, Stephan/S-8645-2019; Buxbaum, Joseph D/G-6001-2010; Ripke, Stephan/AAK-5486-2021; Sandin, Sven/L-5357-2015	Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884; ripke, stephan/0000-0003-3622-835X; Roeder, Kathryn/0000-0002-8869-6254; Gaugler, Trent/0000-0002-8006-9184; Sanders, Stephan/0000-0001-9112-5148; Buxbaum, Joseph/0000-0001-8898-8313	National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH057881, MH097849]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH095034, MH077139]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NSO42165, NSO49261]; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Assistance Publique-Hopitaux de Paris, France; Autism Speaks, UK; Canada Foundation for Innovation/Ontario Innovation TrustCanada Foundation for Innovation; Deutsche Forschungsgemeinschaft, GermanyGerman Research Foundation (DFG) [Po 255/17-4]; European Community's Sixth Framework Programme AUTISM MOLGEN; Fundacao Calouste Gulbenkian, Portugal; Fondation de FranceFondation de France; Fondation FondaMental, France; Fondation Orange, France; Fondation pour la Recherche Medicale, FranceFondation pour la Recherche Medicale; Fundacao pars a Ciencia e Tecnologia, Portugal; Hospital for Sick Children Foundation; University of Toronto, CanadaUniversity of Toronto; INSERM, FranceInstitut National de la Sante et de la Recherche Medicale (Inserm); Institut Pasteur, France; Italian Ministry of HealthMinistry of Health, Italy [181]; John P. Hussman Foundation, USA; McLaughlin Centre, Canada; Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [Rubicon 825.06.031]; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Ontario Ministry of Research and Innovation, CanadaMinistry of Research and Innovation, Ontario; Seaver Foundation, USA; Swedish Science Council; Centre for Applied Genomics, Canada; Utah Autism Foundation, USA; Wellcome Trust, UKWellcome Trust [075491/Z/04]; Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50HD055782, P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH095034, R01MH077139, U54MH066673, R10MH055284, U10MH066766, R37MH057881, R01MH097849, R56MH097849, R01MH080647, R01MH081754, R01MH061009, R01MH055284, R01MH057881, R01MH052708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS026630, R01NS049261, R01NS042165] Funding Source: NIH RePORTER	This study was supported by National Institute of Mental Health (NIMH) grants MH057881 and MH097849 and also in part through the computational resources and staff expertise provided by the Scientific Computing Facility at the Icahn School of Medicine at Mount Sinai. We thank the Mount Sinai Genomics Core Facility for carrying out Illumina bead array genotyping. We thank D. Cutler, M. Daly and S. Purcell for comments on the manuscript and M. Daly and P. Sullivan for facilitating access to control samples, collected and genotyped by M. Daly, C.M.H., P.S. and P. Sullivan with support from NIMH grants MH095034 and MH077139. We also thank the nurses, A.-K. Sundberg and A.-B. Holmgren, for their hard work in collecting the samples. AGP: We used data from the Autism Genome Project (AGP) Consortium Whole-Genome Association and Copy Number Variation Study of over 2,600 parent-offspring trios (database of Genotypes and Phenotypes (dbGaP) study phs000267.v4.p2). Funding for AGP was provided from the US NIH (HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NSO42165 and NSO49261); the Canadian Institutes for Health Research (CIHR); Assistance Publique-Hopitaux de Paris, France; Autism Speaks, UK; the Canada Foundation for Innovation/Ontario Innovation Trust; grant Po 255/17-4 from Deutsche Forschungsgemeinschaft, Germany; the European Community's Sixth Framework Programme AUTISM MOLGEN; Fundacao Calouste Gulbenkian, Portugal; Fondation de France; Fondation FondaMental, France; Fondation Orange, France; Fondation pour la Recherche Medicale, France; Fundacao pars a Ciencia e Tecnologia, Portugal; The Hospital for Sick Children Foundation and the University of Toronto, Canada; INSERM, France; Institut Pasteur, France; Convention 181 of 19.10.2001 from the Italian Ministry of Health; the John P. Hussman Foundation, USA; the McLaughlin Centre, Canada; Rubicon 825.06.031 from the Netherlands Organization for Scientific Research; TMF/DA/5801 from the Royal Netherlands Academy of Arts and Sciences; the Ontario Ministry of Research and Innovation, Canada; the Seaver Foundation, USA; the Swedish Science Council; the Centre for Applied Genomics, Canada; the Utah Autism Foundation, USA; and Core award 075491/Z/04 from the Wellcome Trust, UK. Genotype and phenotype data were obtained from dbGaP, as provided by AGP study investigators. HealthABC: These controls were obtained from dbGaP. Funding support for the CIDR Visceral Adiposity Study (dbGaP study phs000169.v1.p1) was provided through the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging. The CIDR Visceral Adiposity Study includes a GWAS funded as part of the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, National Institute on Aging. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by Health ABC study investigators. This manuscript reflects the views of the authors and does not necessarily reflect the opinions or views of the US NIH.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Crossett A, 2013, ANN APPL STAT, V7, P669, DOI 10.1214/12-AOAS598; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lundstrom S, 2012, ARCH GEN PSYCHIAT, V69, P46, DOI 10.1001/archgenpsychiatry.2011.144; Lynch M., 1998, GENETICS ANAL QUANTI; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Orozco G, 2010, HUM MOL GENET, V19, pR137, DOI 10.1093/hmg/ddq368; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sandin S., 2014, J AM MED AS IN PRESS; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	32	601	611	3	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					881	885		10.1038/ng.3039			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	WOS:000339704400018	25038753	Green Accepted	Y	N	2022-01-24	
J	Wakabayashi, N; Itoh, K; Wakabayashi, J; Motohashi, H; Noda, S; Takahashi, S; Imakado, S; Kotsuji, T; Otsuka, F; Roop, DR; Harada, T; Engel, JD; Yamamoto, M				Wakabayashi, N; Itoh, K; Wakabayashi, J; Motohashi, H; Noda, S; Takahashi, S; Imakado, S; Kotsuji, T; Otsuka, F; Roop, DR; Harada, T; Engel, JD; Yamamoto, M			Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; LAMELLAR ICHTHYOSIS; OXIDATIVE STRESS; DROSOPHILA KELCH; DEFICIENT MICE; KNOCKOUT MICE; IN-VITRO; PROTEIN; GENES; EXPRESSION	Transcription factor Nrf2 (encoded by Nfe2l2) regulates a battery of detoxifying and antioxidant genes, and Keap1 represses Nrf2 function. When we ablated Keap1, Keap1-deficient mice died postnatally, probably from malnutrition resulting from hyperkeratosis in the esophagus and forestomach. Nrf2 activity affects the expression levels of several squamous epithelial genes. Biochemical data show that, without Keap1, Nrf2 constitutively accumulates in the nucleus to stimulate transcription of cytoprotective genes. Breeding to Nrf2-deficient mice reversed the phenotypic Keap1 deficiencies. These experiments show that Keap1 acts upstream of Nrf2 in the cellular response to oxidative and xenobiotic stress.	Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, ERATO, JST, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Clin Med Sci, Tsukuba, Ibaraki 3058577, Japan; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Inst Environm Toxicol, Mitsukaido, Ibaraki 3030043, Japan; Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA		Yamamoto, M (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	masi@tara.tsukuba.ac.jp	Yamamoto, Masayuki/A-4873-2010; Itoh, Ken/B-9506-2013; Motohashi, Hozumi/AAZ-2628-2020	Itoh, Ken/0000-0002-5518-0729; 			Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; DiSepio D, 1999, DIFFERENTIATION, V64, P225, DOI 10.1046/j.1432-0436.1999.6440225.x; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Li NX, 2000, METHOD ENZYMOL, V319, P273; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Parmentier L, 1996, HUM MOL GENET, V5, P555, DOI 10.1093/hmg/5.4.555; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; RUSSELL LJ, 1994, AM J HUM GENET, V55, P1146; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; Thiele JJ, 1999, J INVEST DERMATOL, V113, P335, DOI 10.1046/j.1523-1747.1999.00693.x; TIEMANN F, 1994, ONCOGENE, V9, P1907; Virolainen E, 2000, AM J HUM GENET, V66, P1132, DOI 10.1086/302813; WILLIAMS ML, 1985, ARCH DERMATOL, V121, P477, DOI 10.1001/archderm.121.4.477; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yoshida C, 1999, GENES CELLS, V4, P643, DOI 10.1046/j.1365-2443.1999.00291.x; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	36	601	620	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					238	245		10.1038/ng1248			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	WOS:000186273300019	14517554				2022-01-24	
J	Parra, EJ; Marcini, A; Akey, L; Martinson, J; Batzer, MA; Cooper, R; Forrester, T; Allison, DB; Deka, R; Ferrell, RE; Shriver, MD				Parra, EJ; Marcini, A; Akey, L; Martinson, J; Batzer, MA; Cooper, R; Forrester, T; Allison, DB; Deka, R; Ferrell, RE; Shriver, MD			Estimating African American admixture proportions by use of population-specific alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ADMIXED POPULATIONS; GENE; REGION; MTDNA; DNA; IDENTIFICATION; MITOCHONDRIAL; HAPLOGROUPS; SEQUENCE	We analyzed the European genetic contribution to 10 populations of African descent in the United States (Maywood, Illinois; Detroit; New York; Philadelphia; Pittsburgh; Baltimore; Charleston, South Carolina; New Orleans; and Houston) and in Jamaica, using nine autosomal DNA markers. These markers either are population-specific or show frequency differences >45 % between the parental populations and are thus especially informative for admixture. European genetic ancestry ranged from 6.8% (Jamaica) to 22.5% (New Orleans). The unique utility of these markers is reflected in the low variance associated with these admixture estimates (SEM 1.3%-2.7%). We also estimated the male and female European contribution to African Americans, on the basis of informative mtDNA (haplogroups H and L) and Y Alu polymorphic markers. Results indicate a sex-biased gene flow from Europeans, the male contribution being substantially greater than the female contribution. mtDNA haplogroups analysis shows no evidence of a significant maternal Amerindian contribution to any of the 10 populations. We detected significant nonrandom association between two markers located 22 cM apart (FY-null and AT3), most likely due to admixture linkage disequilibrium created in the interbreeding off the two parental populations. The strength of this association and the substantial genetic distance between FY and AT3 emphasize the importance of admired populations as a useful resource for mapping traits with different prevalence in two parental populations.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Allegheny Univ Hlth Sci, Dept Human Genet, Philadelphia, PA USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; Louisiana State Univ, Med Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA; Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ W Indies, Trop Metab Res Unit, Mona, Jamaica; Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp, New York, NY USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA		Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, 409 Carpenter Bldg, University Pk, PA 16802 USA.	mds17@psu.edu	Parra, Esteban J/A-4957-2008	Shriver, Mark/0000-0003-0006-0479; Allison, David/0000-0003-3566-9399; parra, esteban J/0000-0002-2057-8577; Martinson, Jeremy/0000-0003-4673-7238	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM045861] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM45861] Funding Source: Medline		ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; Allison DB, 1997, AM J HUM GENET, V60, P676; Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4; Batzer MA, 1996, J MOL EVOL, V42, P22, DOI 10.1007/BF00163207; BOOKSTEIN R, 1990, NUCLEIC ACIDS RES, V18, P1666, DOI 10.1093/nar/18.6.1666; BRISCOE D, 1994, J HERED, V85, P59; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CHAKRABORTY R, 1975, AM J PHYS ANTHROPOL, V42, P507, DOI 10.1002/ajpa.1330420319; CHEN YS, 1995, AM J HUM GENET, V57, P133; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Curtin PD., 1969, ATLANTIC SLAVE TRADE; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; GOTODA T, 1992, J LIPID RES, V33, P1067; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Herskovits Melville Jean, 1930, ANTHROPOMETRY AM NEG; HSIEH CL, 1992, ANN HUM GENET, V56, P105, DOI 10.1111/j.1469-1809.1992.tb01137.x; Johnson D. M., 1981, BLACK MIGRATION AM S; Kaplan NL, 1997, AM J HUM GENET, V61, pA202; KATZ WL, 1986, BLACK INDIANS HIDDEN; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; LIU Y, 1995, HUM HERED, V45, P192, DOI 10.1159/000154288; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1995, AM J HUM GENET, V56, P799; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Meier A, 1949, AM J PHYS ANTHROP-NE, V7, P227, DOI 10.1002/ajpa.1330070206; PIERSEN WD, 1996, AFRICA AM; RAYMOND M, 1995, GENEPOP VERSION 2 0; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; Schneider S, 1997, ARLEQUIN SOFTWARE PO; Shriver MD, 1997, AM J HUM GENET, V60, P957; Soodyall H, 1996, AM J HUM GENET, V58, P595; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; WALLACE DC, 1992, HUM BIOL, V64, P403; WILKINSON Doris Y, 1975, BLACK MALE WHITE FEM; WILLIAMSON J, 1995, NEW PEOPLE MISCEGENA; WORKMAN PL, 1968, HUM BIOL, V40, P260; [No title captured]	50	601	618	0	28	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1839	1851		10.1086/302148			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	151EL	WOS:000077707700029	9837836	Green Published, Bronze			2022-01-24	
J	SLAGBOOM, PE; DROOG, S; BOOMSMA, DI				SLAGBOOM, PE; DROOG, S; BOOMSMA, DI			GENETIC DETERMINATION OF TELOMERE SIZE IN HUMANS - A TWIN STUDY OF 3 AGE-GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN FIBROBLASTS; PEDIGREE ANALYSIS; DNA; LYMPHOCYTES; CHROMOSOMES; ELONGATION; YEAST	Reduction of telomere length has been postulated to be a causal factor in cellular aging. Human telomeres terminate in tandemly arranged repeat arrays consisting of the (TTAGGG) motif. The length of these arrays in cells from human mitotic tissues is inversely related to the age of the donor, indicating telomere reduction with age. In addition to telomere length differences between different age cohorts, considerable variation is present among individuals of the same age. To investigate whether this variation can be ascribed to genetic influences, we have measured the size of terminal restriction fragments (TRFs) in HaeIII-digested genomic DNA from 123 human MZ and DZ twin pairs 2-95 years of age. The average rate of telomere shortening was 31 bp/year, which is similar to that observed by others. Statistical analysis in 115 pairs 2-63 years of age indicates a 78% heritability for mean TRF length in this age cohort. The individual differences in mean TRF length in blood, therefore, seem to a large extent to be genetically determined.	FREE UNIV AMSTERDAM,DEPT PSYCHOL,AMSTERDAM,NETHERLANDS		SLAGBOOM, PE (corresponding author), TNO PG,DEPT VASC & CONNECT TISSUE RES,ZERNIKEDREEF 9,POB 430,2300 AK LEIDEN,NETHERLANDS.		Slagboom, P. Eline/R-4790-2016; Boomsma, Dorret I/AAX-4470-2020	Slagboom, P. Eline/0000-0002-2875-4723; 			ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BENDER MA, 1989, MUTAT RES, V212, P149, DOI 10.1016/0027-5107(89)90065-1; BIESSMANN H, 1992, ADV GENET, V30, P185, DOI 10.1016/S0065-2660(08)60321-1; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOOMSMA DI, 1993, ATHEROSCLEROSIS, V99, P23, DOI 10.1016/0021-9150(93)90047-X; BOOMSMA DI, 1992, BEHAV GENET, V22, P247, DOI 10.1007/BF01067004; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SNIEDER H, IN PRESS BEHAVIOR GE; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; VANDEHOFSTEDE JW, 1993, 1993 MED INF C P, P149; VAZIRI H, 1993, AM J HUM GENET, V52, P661	24	601	623	0	38	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					876	882					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	WOS:A1994QB68200005	7977349				2022-01-24	
J	SORENSEN, PHB; LESSNICK, SL; LOPEZTERRADA, D; LIU, XF; TRICHE, TJ; DENNY, CT				SORENSEN, PHB; LESSNICK, SL; LOPEZTERRADA, D; LIU, XF; TRICHE, TJ; DENNY, CT			A 2ND EWINGS-SARCOMA TRANSLOCATION, T(2122), FUSES THE EWS GENE TO ANOTHER ETS-FAMILY TRANSCRIPTION FACTOR, ERG	NATURE GENETICS			English	Article							ACUTE LEUKEMIAS; CHROMOSOME-TRANSLOCATION; DROSOPHILA-TRITHORAX; FLI-1	The t(11;22)(q24;q12), present in 85% of Ewing's sarcoma and related tumours, fuses the EWS gene from chromosome 22q12 and the ETS family member, FLI-1 This results in the expression of a chimaeric protein containing the amino-terminal portion of EWS fused to the ETS DNA-binding domain of FLI-1. We have identified a second Ewing's sarcoma translocation, t(21;22)(q22;q12), that fuses EWS to a different ETS family member, the ERG gene located on band 21q22. Identical EWS nucleotide sequences found in the EWS/FLI-1 fusion transcripts are fused to portions of ERG encoding an ETS DNA-binding domain resulting in expression of a hybrid EWS/ERG protein. These findings suggest that fusion of EWS to different members of the ETS family of transcription factor genes may result in the expression of similar disease phenotypes.	UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90027; UNIV CALIF LOS ANGELES,DEPT PEDIAT,GWYNNE HAZEN CHERRY MEM LABS,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90024								BARCH MJ, 1991, ACT CYTOGENETICS LAB; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; DELATTRE O, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P604; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KLEMSZ MJ, 1993, J BIOL CHEM, V268, P5769; LAUTENBERGER JA, 1992, ONCOGENE, V7, P1713; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PRASAD DDK, 1992, CANCER RES, V52, P5833; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; SORENSEN PHB, 1993, DIAGN MOL PATHOL, V2, P147, DOI 10.1097/00019606-199309000-00002; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TURCCAREL C, 1983, NEW ENGL J MED, V309, P497; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	29	600	616	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					146	151		10.1038/ng0294-146			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	WOS:A1994MU76300008	8162068				2022-01-24	
J	Zhao, Z; Tavoosidana, G; Sjolinder, M; Gondor, A; Mariano, P; Wang, S; Kanduri, C; Lezcano, M; Sandhu, KS; Singh, U; Pant, V; Tiwari, V; Kurukuti, S; Ohlsson, R				Zhao, Zhihu; Tavoosidana, Gholamreza; Sjolinder, Mikael; Gondor, Anita; Mariano, Piero; Wang, Sha; Kanduri, Chandrasekhar; Lezcano, Magda; Sandhu, Kuljeet Singh; Singh, Umashankar; Pant, Vinod; Tiwari, Vijay; Kurukuti, Sreenivasulu; Ohlsson, Rolf			Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions	NATURE GENETICS			English	Article							GENES; IGF2; CTCF; H19; COLOCALIZATION; INACTIVATION; ASSOCIATION; METHYLATION; EXPRESSION; PARENT	Accumulating evidence converges on the possibility that chromosomes interact with each other to regulate transcription in trans. To systematically explore the epigenetic dimension of such interactions, we devised a strategy termed circular chromosome conformation capture (4C). This approach involves a circularization step that enables high-throughput screening of physical interactions between chromosomes without a preconceived idea of the interacting partners. Here we identify 114 unique sequences from all autosomes, several of which interact primarily with the maternally inherited H19 imprinting control region. Imprinted domains were strongly overrepresented in the library of 4C sequences, further highlighting the epigenetic nature of these interactions. Moreover, we found that the direct interaction between differentially methylated regions was linked to epigenetic regulation of transcription in trans. Finally, the patterns of interactions specific to the maternal H19 imprinting control region underwent reprogramming during in vitro maturation of embryonic stem cells. These observations shed new light on development, cancer epigenetics and the evolution of imprinting.	Uppsala Univ, Dept Genet & Dev, Evolut Biol Ctr, SE-75136 Uppsala, Sweden		Ohlsson, R (corresponding author), Uppsala Univ, Dept Genet & Dev, Evolut Biol Ctr, SE-75136 Uppsala, Sweden.	rolf.ohlsson@ebc.uu.se	kurukuti, sreenivasulu/AAI-5663-2020; Mariano, Pier Nilsson/AAP-5562-2021; Tavoosidana, Gholamreza/AAV-3893-2020; Singh, Umashankar/ABE-3830-2020	Tavoosidana, Gholamreza/0000-0002-1079-7434; Singh, Umashankar/0000-0001-8578-8201; Sandhu, Kuljeet/0000-0001-7632-6339; Gondor, Anita/0000-0002-1523-4411; Kanduri, Chandrasekhar/0000-0001-6271-9078; Pant, Vinod/0000-0002-3286-1804; Tiwari, Vijay/0000-0003-0292-6635			Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Dean W, 1998, DEVELOPMENT, V125, P2273; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ohlsson R, 2001, TRENDS GENET, V17, P136, DOI 10.1016/S0168-9525(00)02211-3; Okamura K, 2004, DNA RES, V11, P381, DOI 10.1093/dnares/11.6.381; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0	19	599	627	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1341	1347		10.1038/ng1891			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	WOS:000241592700025	17033624				2022-01-24	
J	Marsh, DG; Maestri, NE; Freidhoff, LR; Barnes, KC; Togias, A; Ehrlich, E; Beaty, T; Duffy, D; Rosenthal, R; Imani, F; Dunston, G; FurbertHarris, P; Malveaux, F; Ober, C; Cox, NJ; Lester, LA; Peterson, R; Gidley, H; Pluzhnikov, A; Anderson, J; Solway, J; Leff, A; Wolf, R; Wylam, M; Kurtz, B; Richardson, A; Parry, R; Blumenthal, MN; King, RA; Oetting, W; Drury, D; Rosenberg, A; Daniels, L; McEvoy, C; Lou, J; Hamra, M; Brott, M; Rich, SS; Spray, BJ; Weber, JL; Yuan, B; Wang, ZY; Bleecker, ER; Amelung, P; Rechstiner, B; Meyers, DA; Samet, J; Wiesch, D; Xu, JF; Murphy, S; BanksSchlegel, S				Marsh, DG; Maestri, NE; Freidhoff, LR; Barnes, KC; Togias, A; Ehrlich, E; Beaty, T; Duffy, D; Rosenthal, R; Imani, F; Dunston, G; FurbertHarris, P; Malveaux, F; Ober, C; Cox, NJ; Lester, LA; Peterson, R; Gidley, H; Pluzhnikov, A; Anderson, J; Solway, J; Leff, A; Wolf, R; Wylam, M; Kurtz, B; Richardson, A; Parry, R; Blumenthal, MN; King, RA; Oetting, W; Drury, D; Rosenberg, A; Daniels, L; McEvoy, C; Lou, J; Hamra, M; Brott, M; Rich, SS; Spray, BJ; Weber, JL; Yuan, B; Wang, ZY; Bleecker, ER; Amelung, P; Rechstiner, B; Meyers, DA; Samet, J; Wiesch, D; Xu, JF; Murphy, S; BanksSchlegel, S			A genome-wide search for asthma susceptibility loci in ethnically diverse populations	NATURE GENETICS			English	Article							RESPONSES UNDERLYING ASTHMA; IMMUNOGLOBULIN-E RESPONSES; INHALATION CHALLENGE; LINKAGE; RHINITIS; ATOPY; CHROMOSOME-11Q; REACTIVITY; ALLERGY	Asthma is an inflammatory airways disease associated with intermittent respiratory symptoms, bronchial hyperresponsiveness (BHR) and reversible airflow obstruction and is phenotypically heterogeneous(1,2). Patterns of clustering and segregation analyses in asthma families have suggested a genetic component to asthma(3-6). Previous studies reported linkage of BHR and atopy to chromosomes 5q (refs 7-9), 6p (refs 10-12), 11q (refs 13-15), 14q (ref. 16), and 12q (ref. 17) using candidate gene approaches. However, the relative roles of these genes in the pathogenesis of asthma or atopy are difficult to assess outside of the context of a genome-wide search. One genome-wide search in atopic sib pairs has been reported(18), however, only 12% of their subjects had asthma. We conducted a genome-wide search in 140 families with greater than or equal to 2 asthmatic sibs, from three racial groups and report evidence for linkage to six novel regions: 5p15 (P = 0.0008) and 17p11.1-q11.2 (P = 0.0015) in African Americans; 11p15 (P = 0.0089) and 19q13 (P = 0.0013) in Caucasians; 2q33 (P = 0.0005) and 21q21 (P = 0.0040) in Hispanics. Evidence for linkage was also detected in five regions previously reported to be linked to asthma-associated phenotypes: 5q23-31 (P = 0.0187), 6p21.3-23 (P = 0.0129), 12q14-24.2 (P = 0.0042), 13q21.3-qter (P = 0.0014), and 14q11.2-13 (P = 0.0062) in Caucasians and 12q14-24.2 (P = 0.0260) in Hispanics.	UNIV CHICAGO, CTR MED GENET, CHICAGO, IL 60637 USA; JOHNS HOPKINS UNIV, BALTIMORE, MD USA; HOWARD UNIV, WASHINGTON, DC 20059 USA; UNIV S DAKOTA, SIOUX FALLS, SD USA; UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA; WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC USA; MARSHFIELD CLIN FDN MED RES & EDUC, MARSHFIELD, WI 54449 USA; UNIV MARYLAND, BALTIMORE, MD 21201 USA; UNIV NEW MEXICO, ALBUQUERQUE, NM 87131 USA; NIH, BETHESDA, MD 20892 USA				Duffy, David L/B-7392-2013; Solway, Julian/B-1116-2008	Duffy, David L/0000-0001-7227-632X; Solway, Julian/0000-0002-0898-8530	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL049609, U01HL049609, U01HL049596, U01HL049612] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL/AI-49596, HL/AI-49609, HL/AI-49612] Funding Source: Medline		*ATS, 1987, AM J RESP CRIT CARE, V153, P1285; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; BLUMENTHAL M, 1992, J IMMUNOL, V148, P411; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHATHAM M, 1982, CHEST, V82, P15, DOI 10.1378/chest.82.1.15; COOKSON WOCM, 1989, LANCET, V1, P1292; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; EDFORSLUBS ML, 1971, ACTA ALLERGOL, V26, P249, DOI 10.1111/j.1398-9995.1971.tb01300.x; HOPP RJ, 1988, ANN ALLERGY, V61, P184; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LAPP NL, 1974, THORAX, V29, P185, DOI 10.1136/thx.29.2.185; MARSH D, 1990, GENETIC ENV FACTORS; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; *NHLBI, 1992, NAT HEART LUNG BLOOD; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; SHEFFER AL, 1991, J ALLERGY CLIN IMMUN, V87, P468, DOI 10.1016/0091-6749(91)90002-6; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; SHIRAKAWA T, 1991, CYTOGENET CELL GENET, V58, P1970; SIBBALD B, 1979, THORAX, V34, P332, DOI 10.1136/thx.34.3.332; Suarez BK, 1994, GENETIC APPROACHES M, P23; WEISS ST, 1984, AM REV RESPIR DIS, V129, P898; YOUNG RP, 1994, CLIN EXP ALLERGY, V24, P431, DOI 10.1111/j.1365-2222.1994.tb00931.x	26	599	605	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					389	392					4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	WOS:A1997WQ38900018	9090385				2022-01-24	
J	Evans, DM; Spencer, CCA; Pointon, JJ; Su, Z; Harvey, D; Kochan, G; Opperman, U; Dilthey, A; Pirinen, M; Stone, MA; Appleton, L; Moutsianis, L; Leslie, S; Wordsworth, T; Kenna, TJ; Karaderi, T; Thomas, GP; Ward, MM; Weisman, MH; Farrar, C; Bradbury, LA; Danoy, P; Inman, RD; Maksymowych, W; Gladman, D; Rahman, P; Morgan, A; Marzo-Ortega, H; Bowness, P; Gaffney, K; Gaston, JSH; Smith, M; Bruges-Armas, J; Couto, AR; Sorrentino, R; Paladini, F; Ferreira, MA; Xu, HJ; Liu, Y; Jiang, L; Lopez-Larrea, C; Diaz-Pena, R; Lopez-Vazquez, A; Zayats, T; Band, G; Bellenguez, C; Blackburn, H; Blackwell, JM; Bramon, E; Bumpstead, SJ; Casas, JP; Corvin, A; Craddock, N; Deloukas, P; Dronov, S; Duncanson, A; Edkins, S; Freeman, C; Gillman, M; Gray, E; Gwilliam, R; Hammond, N; Hunt, SE; Jankowski, J; Jayakumar, A; Langford, C; Liddle, J; Markus, HS; Mathew, CG; McCann, OT; McCarthy, MI; Palmer, CNA; Peltonen, L; Plomin, R; Potter, SC; Rautanen, A; Ravindrarajah, R; Ricketts, M; Samani, N; Sawcer, SJ; Strange, A; Trembath, RC; Viswanathan, AC; Waller, M; Weston, P; Whittaker, P; Widaa, S; Wood, NW; McVean, G; Reveille, JD; Wordsworth, BP; Brown, MA; Donnelly, P				Evans, David M.; Spencer, Chris C. A.; Pointon, Jennifer J.; Su, Zhan; Harvey, David; Kochan, Grazyna; Opperman, Udo; Dilthey, Alexander; Pirinen, Matti; Stone, Millicent A.; Appleton, Louise; Moutsianis, Loukas; Leslie, Stephen; Wordsworth, Tom; Kenna, Tony J.; Karaderi, Tugce; Thomas, Gethin P.; Ward, Michael M.; Weisman, Michael H.; Farrar, Claire; Bradbury, Linda A.; Danoy, Patrick; Inman, Robert D.; Maksymowych, Walter; Gladman, Dafna; Rahman, Proton; Morgan, Ann; Marzo-Ortega, Helena; Bowness, Paul; Gaffney, Karl; Gaston, J. S. Hill; Smith, Malcolm; Bruges-Armas, Jacome; Couto, Ana-Rita; Sorrentino, Rosa; Paladini, Fabiana; Ferreira, Manuel A.; Xu, Huji; Liu, Yu; Jiang, Lei; Lopez-Larrea, Carlos; Diaz-Pena, Roberto; Lopez-Vazquez, Antonio; Zayats, Tetyana; Band, Gavin; Bellenguez, Celine; Blackburn, Hannah; Blackwell, Jenefer M.; Bramon, Elvira; Bumpstead, Suzannah J.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Deloukas, Panos; Dronov, Serge; Duncanson, Audrey; Edkins, Sarah; Freeman, Colin; Gillman, Matthew; Gray, Emma; Gwilliam, Rhian; Hammond, Naomi; Hunt, Sarah E.; Jankowski, Janusz; Jayakumar, Alagurevathi; Langford, Cordelia; Liddle, Jennifer; Markus, Hugh S.; Mathew, Christopher G.; McCann, Owen T.; McCarthy, Mark I.; Palmer, Colin N. A.; Peltonen, Leena; Plomin, Robert; Potter, Simon C.; Rautanen, Anna; Ravindrarajah, Radhi; Ricketts, Michelle; Samani, Nilesh; Sawcer, Stephen J.; Strange, Amy; Trembath, Richard C.; Viswanathan, Ananth C.; Waller, Matthew; Weston, Paul; Whittaker, Pamela; Widaa, Sara; Wood, Nicholas W.; McVean, Gilean; Reveille, John D.; Wordsworth, B. Paul; Brown, Matthew A.; Donnelly, Peter		Australo-Anglo-Amer Spondyloarthri; Wellcome Trust Case Control Consor; Spondyloarthrit Res Consortium Can	Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; GENETIC ASSOCIATION; TRIMS PRECURSORS; AMINOPEPTIDASE; RISK; HLA; POPULATION; PROMOTES; CELLS	Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. Here we report the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 x 10(-8) in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all our datasets (P < 5 x 10(-6) overall, with support in each of the three datasets studied). We also show that polymorphisms of ERAP1, which encodes an endoplasmic reticulum aminopeptidase involved in peptide trimming before HLA class I presentation, only affect ankylosing spondylitis risk in HLA-B27-positive individuals. These findings provide strong evidence that HLA-B27 operates in ankylosing spondylitis through a mechanism involving aberrant processing of antigenic peptides.	[Spencer, Chris C. A.; Su, Zhan; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Strange, Amy; McVean, Gilean; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Evans, David M.; Dilthey, Alexander; Pirinen, Matti; Zayats, Tetyana] Univ Bristol, Sch Social & Community Med, Med Res Council MRC Ctr Causal Anal Translat Epid, Bristol, Avon, England; [Pointon, Jennifer J.; Harvey, David; Appleton, Louise; Wordsworth, Tom; Karaderi, Tugce; Farrar, Claire; Bowness, Paul; Wordsworth, B. Paul] Nuffield Orthopaed Ctr, Natl Inst Hlth Res Musculoskeletal Biomed Res Uni, Oxford OX3 7LD, England; [Kochan, Grazyna; Opperman, Udo] Univ Oxford, Struct Genom Consortium, Oxford, England; [Stone, Millicent A.] Univ Bath, Bath BA2 7AY, Avon, England; [Moutsianis, Loukas] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Leslie, Stephen] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Kenna, Tony J.; Thomas, Gethin P.; Bradbury, Linda A.; Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Ward, Michael M.] NIAMSD, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Weisman, Michael H.] Cedars Sinai Med Ctr, Dept Med Rheumatol, Los Angeles, CA 90048 USA; [Inman, Robert D.; Gladman, Dafna] Univ Toronto, Toronto, ON, Canada; [Maksymowych, Walter] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Rahman, Proton] Mem Univ Newfoundland, St John, NF, Canada; [Morgan, Ann; Marzo-Ortega, Helena] Univ Leeds, NIHR, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Gaffney, Karl] Norfolk & Norwich Univ Hosp, Dept Rheumatol, Norwich, Norfolk, England; [Gaston, J. S. Hill] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Smith, Malcolm] Repatriat Gen Hosp, Adelaide, SA, Australia; [Bruges-Armas, Jacome; Couto, Ana-Rita] Hosp Santo Espirito, Serv Especializado Epidemiol & Biol Mol, Terceira, The Azores, Portugal; [Bruges-Armas, Jacome] Univ Porto, Inst Mol & Cell Biol IBMC, Genet & Arthrit Res Grp, P-4100 Oporto, Portugal; [Sorrentino, Rosa; Paladini, Fabiana] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Ferreira, Manuel A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Xu, Huji; Liu, Yu; Jiang, Lei] Second Mil Med Univ Hosp, Shanghai Changzheng Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Lopez-Larrea, Carlos; Diaz-Pena, Roberto; Lopez-Vazquez, Antonio; Blackburn, Hannah] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Bramon, Elvira; Bumpstead, Suzannah J.; Deloukas, Panos; Dronov, Serge; Edkins, Sarah; Gillman, Matthew; Gray, Emma; Gwilliam, Rhian; Hammond, Naomi; Hunt, Sarah E.; Jayakumar, Alagurevathi; Langford, Cordelia; Liddle, Jennifer; McCann, Owen T.; Peltonen, Leena; Potter, Simon C.; Rautanen, Anna; Ravindrarajah, Radhi; Ricketts, Michelle; Waller, Matthew; Weston, Paul; Whittaker, Pamela; Widaa, Sara] Wellcome Trust Sanger Inst, Cambridge, England; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Markus, Hugh S.] St Georges Univ London, London, England; [Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Samani, Nilesh] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, Dept Genet, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA		Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	matt.brown@uq.edu.au; peter.donnelly@well.ox.ac.uk	Belllenguez, Celine/Y-3183-2018; Kochan, Grazyna/A-1094-2009; Blackwell, Jenefer M/H-3015-2015; Mathew, Christopher G/G-3434-2015; Palmer, Colin NA/C-7053-2008; Sorrentino, Rosa/G-5472-2012; Kenna, Tony/A-6035-2011; Bowness, Paul/AAH-2484-2019; Gaffney, Karl/S-4518-2019; Jankowski, Janusz/H-2706-2012; Diaz-Pena, Roberto/ABF-4396-2020; Wood, Nicholas W/C-2505-2009; Thomas, Gethin P/A-3624-2011; Evans, David M/H-6325-2013; Bellenguez, Celine/X-4004-2019; Diaz-Pena, Roberto/AAB-1205-2020; Plomin, Robert/B-8911-2008; Brown, Matthew A/E-5749-2010; Karaderi, Tugce/W-8729-2019; Bramon, Elvira/A-9463-2011; Ferreira, Manuel A R/D-3609-2013; Deloukas, Panos/B-2922-2013; Xu, Huji/AAB-2902-2021; McCarthy, Mark/M-3763-2015	Belllenguez, Celine/0000-0002-1240-7874; Mathew, Christopher G/0000-0003-4178-1838; Palmer, Colin NA/0000-0002-6415-6560; Sorrentino, Rosa/0000-0002-9632-2383; Jankowski, Janusz/0000-0003-2130-9181; Diaz-Pena, Roberto/0000-0002-0114-2292; Wood, Nicholas W/0000-0002-9500-3348; Evans, David M/0000-0003-0663-4621; Bellenguez, Celine/0000-0002-1240-7874; Brown, Matthew A/0000-0003-0538-8211; Karaderi, Tugce/0000-0001-9763-8139; Ferreira, Manuel A R/0000-0001-9059-1825; Deloukas, Panos/0000-0001-9251-070X; Xu, Huji/0000-0002-8588-118X; McCarthy, Mark/0000-0002-4393-0510; Gaffney, Karl/0000-0002-7863-9176; Potter, Simon/0000-0003-4208-4102; Gillman, Matthew S./0000-0002-2340-6930; Inman, Robert/0000-0002-4750-1422; Trembath, Richard/0000-0003-0550-3400; Couto Rendeiro, Ana Rita/0000-0002-3600-2812; Morgan, Ann/0000-0003-1109-624X; Paladini, Fabiana/0000-0003-1040-452X; Corvin, Aiden/0000-0001-6717-4089; Kochan, Grazyna/0000-0002-0534-9661; bowness, paul/0000-0003-4597-0484; Bramon, Elvira/0000-0003-1369-5983; Armas, Jacome/0000-0001-7671-6521; Walters, James/0000-0002-6980-4053; Pirinen, Matti/0000-0002-1664-1350; McVean, Gil/0000-0002-5012-4162; Hunt, Sarah/0000-0002-8350-1235; Plomin, Robert/0000-0002-0756-3629; Kenna, Tony/0000-0001-6844-3463; Thomas, Gethin/0000-0001-9081-3686	Wellcome TrustWellcome TrustEuropean Commission [083948/Z/07/Z, 076113, 068545/Z/02]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01-052915, R01-AR046208]; University of Texas at Houston Clinical and Translational Science [UL1RR024188]; Cedars-Sinai General Clinical Research Centre [MO1-RR00425]; Intramural Research Program; NIAMS/US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rebecca Cooper Foundation (Australia); Arthritis Research UKVersus Arthritis [19536, 18797]; Oxford Comprehensive Biomedical Research Centre [A91202]; Arthritis Society (Canada); Lions Medical Research Foundation fellowship; National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia; National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia [566938, 569829]; Australian Cancer Research Foundation; Rebecca Cooper Medical Research Foundation; Wolfson-Royal Society Merit AwardRoyal Society of London; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Oxford Musculoskeletal Biomedical Research Unit; NIHR Thames Valley Comprehensive Local Research Network; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Foundation for InnovationCanada Foundation for Innovation; Genome Canada through the Ontario Genomics InstituteGenome Canada; GlaxoSmithKlineGlaxoSmithKline; Karolinska InstitutetKarolinska Institutet; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and InnovationMinistry of Research and Innovation, Ontario; Merck Co., Inc.Merck & Company; Novartis Research Foundation; Swedish Agency for Innovation SystemsVinnova; Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR046208, ZIDAR041180, ZIAAR041153] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600705, G0000934, G0800582, G19/2, G0901310] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000800g, G9817803B, G0600705, G0901310, G0800582, G19/2] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10379, PDA/02/06/016] Funding Source: researchfish	We would like to thank all participating subjects with ankylosing spondylitis and healthy individuals who provided the DNA and clinical information necessary for this study. The Wellcome Trust Case Control Consortium 2 project is funded by the Wellcome Trust (083948/Z/07/Z). We also thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, A. Wilk, C. R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. The TASC study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants P01-052915 and R01-AR046208. Funding was also received from the University of Texas at Houston Clinical and Translational Science Awards grant UL1RR024188, Cedars-Sinai General Clinical Research Centre grant MO1-RR00425, Intramural Research Program, NIAMS/US National Institutes of Health and Rebecca Cooper Foundation (Australia). This study was funded, in part, by Arthritis Research UK (Grants 19536 and 18797), by the Wellcome Trust (grant number 076113) and by the Oxford Comprehensive Biomedical Research Centre ankylosing spondylitis chronic disease cohort (theme code: A91202). The Spondyloarthritis Research Consortium of Canada (SPARCC) was funded by a National Research Initiative Award from the Arthritis Society (Canada). G. P. T. was funded by a Lions Medical Research Foundation fellowship. M. A. B. is funded by a National Health and Medical Research Council (Australia) Principal Research Fellowship, and support for this study was received from a National Health and Medical Research Council (Australia) program grant (566938) and project grant (569829) and from the Australian Cancer Research Foundation and Rebecca Cooper Medical Research Foundation. P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. We are also very grateful for the invaluable support received from the National Ankylosing Spondylitis Society (UK) and Spondyloarthritis Association of America in case recruitment. Additional financial and technical support for subject recruitment was provided by the National Institute for Health Research (NIHR), Oxford Musculoskeletal Biomedical Research Unit and NIHR Thames Valley Comprehensive Local Research Network. We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and we thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust. We would like to thank A. Mathieu (Cagliari University) and S. Brown (Cedars-Sinai Hospital) for providing samples. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.	Amroun H, 2005, HUM IMMUNOL, V66, P1057, DOI 10.1016/j.humimm.2005.09.004; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; BROWN MA, 2009, ARTHRITIS RHEUM S, V60, pS437; CALIN A, 1983, ARTHRITIS RHEUM, V26, P1460, DOI 10.1002/art.1780261207; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Evnouchidou I, 2009, ANAL BIOCHEM, V395, P33, DOI 10.1016/j.ab.2009.07.032; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Gagliardi MC, 2010, J LEUKOCYTE BIOL, V88, P947, DOI 10.1189/jlb.0310139; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jaakkola E, 2006, ANN RHEUM DIS, V65, P775, DOI 10.1136/ard.2005.041103; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; LOPEZLARREA C, 1995, TISSUE ANTIGENS, V45, P169, DOI 10.1111/j.1399-0039.1995.tb02436.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pedersen OB, 2008, SCAND J RHEUMATOL, V37, P120, DOI 10.1080/03009740701824613; Pointon JJ, 2011, GENES IMMUN, V12, P319, DOI 10.1038/gene.2011.22; Pointon JJ, 2010, ANN RHEUM DIS, V69, P1243, DOI 10.1136/ard.2009.115147; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Development Team, 2009, R LANG ENV STAT COMP; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; Rudwaleit M, 2009, J RHEUMATOL, V36, P801, DOI 10.3899/jrheum.081048; Ruutu M, 2010, ARTHRITIS RHEUM S, VS1, P1446; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Simon R, 2007, CANCER INFORM, V3, P11; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yabuki K, 1999, HUM IMMUNOL, V60, P83, DOI 10.1016/S0198-8859(98)00092-5; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	51	598	614	7	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2011	43	8					761	U67		10.1038/ng.873			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	WOS:000293178300012	21743469	Green Accepted, Green Published	Y	N	2022-01-24	
J	JACKS, T; SHIH, TS; SCHMITT, EM; BRONSON, RT; BERNARDS, A; WEINBERG, RA				JACKS, T; SHIH, TS; SCHMITT, EM; BRONSON, RT; BERNARDS, A; WEINBERG, RA			TUMOR PREDISPOSITION IN MICE HETEROZYGOUS FOR A TARGETED MUTATION IN NF1	NATURE GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; TRANSGENIC MOUSE MODEL; NEURAL CREST; CELL-LINES; PROTEIN PRODUCT; CDNA SEQUENCE; MESSENGER-RNA; STEM-CELLS; IDENTIFICATION; GAP	Human neurofibromatosis type 1 is a dominant disease caused by the inheritance of a mutant allele of the NF1 gene. In order to study NF1 function, we have constructed a mouse strain carrying a germline mutation in the murine homologue. Heterozygous animals do not exhibit the classical symptoms of the human disease, but are highly predisposed to the formation of various tumour types, notably phaeochomocytoma, a tumour of the neural crest-derived adrenal medulla, and myeloid leukaemia, both of which occur with increased frequency in human NF1 patients. The wild-type Nf1 allele is lost in approximately half of the tumours from heterozygous animals. In addition, homozygosity for the Nf1 mutation leads to abnormal cardiac development and midgestational embryonic lethality.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; TUFTS UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02111 USA; TUFTS UNIV, SCH VET MED, DEPT PATHOL, BOSTON, MA 02111 USA; MASSACHUSETTS GEN HOSP E, MOLEC NEUROGENET UNIT, BOSTON, MA 02129 USA; MASSACHUSETTS GEN HOSP E, CTR CANC, BOSTON, MA 02129 USA; MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA		JACKS, T (corresponding author), MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA.						AINSWORTH PJ, 1993, HUM GENET, V91, P151; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Ausubel FM., 1994, CURRENT PROTOCOLS MO; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BERNARDS A, 1993, HUM MOL GENET, V2, P645, DOI 10.1093/hmg/2.6.645; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Bronson R.T., 1990, GENETICS AGING, P280; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHETTY R, 1993, AM J SURG PATHOL, V17, P837, DOI 10.1097/00000478-199308000-00009; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DASTON MM, 1992, NEURON, V8, P415, DOI 10.1016/0896-6273(92)90270-N; DASTON MM, 1992, DEV DYNAM, V195, P216, DOI 10.1002/aja.1001950307; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; EASTON DF, 1993, AM J HUM GENET, V53, P305; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESTIVILL X, 1991, HUM GENET, V88, P185; FRANZ T, 1989, ANAT EMBRYOL, V180, P457, DOI 10.1007/BF00305120; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; GREEN JE, 1992, AM J PATHOL, V140, P1401; GUTMANN DH, 1993, HUM MOL GENET, V2, P989; HINRICHS SH, 1987, SCIENCE, V237, P1340, DOI 10.1126/science.2888191; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hope D G, 1981, Adv Neurol, V29, P33; HUYNH DP, 1994, DEV BIOL, V161, P538, DOI 10.1006/dbio.1994.1052; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Le Douarin N, 1982, NEURAL CREST; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Riccardi VM., 1992, NEUROFIBROMATOSIS PH; Robertson E, 1987, TERATOCARCINOMAS EMB; SEIZINGER BR, 1993, NAT GENET, V3, P97, DOI 10.1038/ng0293-97; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; XIE WQ, 1991, BIOTECHNIQUES, V11, P324; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	56	598	606	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1994	7	3					353	361		10.1038/ng0794-353			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	WOS:A1994NU30600008	7920653				2022-01-24	
J	Shete, S; Hosking, FJ; Robertson, LB; Dobbins, SE; Sanson, M; Malmer, B; Simon, M; Marie, Y; Boisselier, B; Delattre, JY; Hoang-Xuan, K; El Hallani, S; Idbaih, A; Zelenika, D; Andersson, U; Henriksson, R; Bergenheim, AT; Feychting, M; Lonn, S; Ahlbom, A; Schramm, J; Linnebank, M; Hemminki, K; Kumar, R; Hepworth, SJ; Price, A; Armstrong, G; Liu, YH; Gu, XJ; Yu, R; Lau, C; Schoemaker, M; Muir, K; Swerdlow, A; Lathrop, M; Bondy, M; Houlston, RS				Shete, Sanjay; Hosking, Fay J.; Robertson, Lindsay B.; Dobbins, Sara E.; Sanson, Marc; Malmer, Beatrice; Simon, Matthias; Marie, Yannick; Boisselier, Blandine; Delattre, Jean-Yves; Hoang-Xuan, Khe; El Hallani, Soufiane; Idbaih, Ahmed; Zelenika, Diana; Andersson, Ulrika; Henriksson, Roger; Bergenheim, A. Tommy; Feychting, Maria; Lonn, Stefan; Ahlbom, Anders; Schramm, Johannes; Linnebank, Michael; Hemminki, Kari; Kumar, Rajiv; Hepworth, Sarah J.; Price, Amy; Armstrong, Georgina; Liu, Yanhong; Gu, Xiangjun; Yu, Robert; Lau, Ching; Schoemaker, Minouk; Muir, Kenneth; Swerdlow, Anthony; Lathrop, Mark; Bondy, Melissa; Houlston, Richard S.			Genome-wide association study identifies five susceptibility loci for glioma	NATURE GENETICS			English	Article							NERVOUS-SYSTEM TUMORS; BIRTH-WEIGHT; GENE-EXPRESSION; BREAST-CANCER; RETINOIC ACID; RISK; POPULATION; GLIOBLASTOMA; DELETION; 8Q24	To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association studies by genotyping 550K tagging SNPs in a total of 1,878 cases and 3,670 controls, with validation in three additional independent series totaling 2,545 cases and 2,953 controls. We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). These data show that common low-penetrance susceptibility alleles contribute to the risk of developing glioma and provide insight into disease causation of this primary brain tumor.	[Hosking, Fay J.; Robertson, Lindsay B.; Dobbins, Sara E.; Price, Amy; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Shete, Sanjay; Armstrong, Georgina; Liu, Yanhong; Gu, Xiangjun; Yu, Robert; Bondy, Melissa] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sanson, Marc; Marie, Yannick; Boisselier, Blandine; Delattre, Jean-Yves; Hoang-Xuan, Khe; El Hallani, Soufiane; Idbaih, Ahmed] UPMC, GH Pitie Salpetriere, AP HP, Serv Neurol Mazarin, Paris, France; [Sanson, Marc; Marie, Yannick; Boisselier, Blandine; Delattre, Jean-Yves; Hoang-Xuan, Khe; El Hallani, Soufiane; Idbaih, Ahmed] UPMC, GH Pitie Salpetriere, AP HP, INSERM,UMR 975, Paris, France; [Malmer, Beatrice; Andersson, Ulrika; Henriksson, Roger] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Sanson, Marc; Schramm, Johannes] Neurochirurg Univ Klin Bonn, Bonn, Germany; [Zelenika, Diana; Lathrop, Mark] IG CEA, Ctr Natl Genotypage, Evry, France; [Bergenheim, A. Tommy] Umea Univ, Dept Clin Neurosci, Umea, Sweden; [Feychting, Maria; Ahlbom, Anders] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Lonn, Stefan] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Linnebank, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Hepworth, Sarah J.] Univ Leeds, Fac Med & Hlth, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Lau, Ching] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Schoemaker, Minouk; Swerdlow, Anthony] Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; [Muir, Kenneth] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Queens Med Ctr, Nottingham, England; [Lathrop, Mark] Fdn Jean Dausett CEPH, Paris, France		Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	mbondy@mdanderson.org; Richard.houlston@icr.ac.uk	Hoang-Xuan, Khe/O-7527-2017; LIU, YANHONG/A-1495-2010; BOISSELIER, Blandine/K-4377-2015; Kumar, Rajiv/H-6431-2019; Henriksson, Roger/AAI-8608-2020; Simon, Matthias/F-3046-2014; Idbaih, Ahmed/N-8746-2017	Kumar, Rajiv/0000-0002-6093-0395; Idbaih, Ahmed/0000-0001-5290-1204; Fleming, Sarah/0000-0002-7655-4806; Houlston, Richard/0000-0002-5268-0242; Schoemaker, Minouk/0000-0001-8403-2234; Hosking, Fay/0000-0002-1101-039X; Swerdlow, Anthony/0000-0001-5550-4159	Cancer Research UKCancer Research UK [C1298/A8362] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934] Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5R01 CA119215, 5R01 CA070917, R01 CA119215, T32 CA096520, R01 CA070917] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA119215, R01CA070917, T32CA096520] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934] Funding Source: UKRI		Arakawa Y, 2005, ACTA NEUROPATHOL, V109, P294, DOI 10.1007/s00401-004-0956-6; Bahuau M, 1998, CANCER RES, V58, P2298; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bille C, 2005, AM J EPIDEMIOL, V161, P1047, DOI 10.1093/aje/kwi132; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Cardis E, 2007, EUR J EPIDEMIOL, V22, P647, DOI 10.1007/s10654-007-9152-z; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Das A, 2007, NEUROCHEM RES, V32, P2167, DOI 10.1007/s11064-007-9413-y; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferrie JE, 2006, INT J EPIDEMIOL, V35, P1532, DOI 10.1093/ije/dyl184; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Harder T, 2008, AM J EPIDEMIOL, V168, P366, DOI 10.1093/aje/kwn144; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P1137; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Simon M, 2006, ONCOL REP, V16, P127; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wager M, 2008, BRIT J CANCER, V98, P1830, DOI 10.1038/sj.bjc.6604378; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yin W, 2006, ONCOGENE, V25, P3735, DOI 10.1038/sj.onc.1209410	37	597	610	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					899	U54		10.1038/ng.407			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	WOS:000268432900013	19578367	Green Accepted			2022-01-24	
J	Viswanathan, SR; Powers, JT; Einhorn, W; Hoshida, Y; Ng, TL; Toffanin, S; O'Sullivan, M; Lu, J; Phillips, LA; Lockhart, VL; Shah, SP; Tanwar, PS; Mermel, CH; Beroukhim, R; Azam, M; Teixeira, J; Meyerson, M; Hughes, TP; Llovet, JM; Radich, J; Mullighan, CG; Golub, TR; Sorensen, PH; Daley, GQ				Viswanathan, Srinivas R.; Powers, John T.; Einhorn, William; Hoshida, Yujin; Ng, Tony L.; Toffanin, Sara; O'Sullivan, Maureen; Lu, Jun; Phillips, Letha A.; Lockhart, Victoria L.; Shah, Samar P.; Tanwar, Pradeep S.; Mermel, Craig H.; Beroukhim, Rameen; Azam, Mohammad; Teixeira, Jose; Meyerson, Matthew; Hughes, Timothy P.; Llovet, Josep M.; Radich, Jerald; Mullighan, Charles G.; Golub, Todd R.; Sorensen, Poul H.; Daley, George Q.			Lin28 promotes transformation and is associated with advanced human malignancies	NATURE GENETICS			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; LUNG-CANCER; LET-7; TUMOR; LIN-28; REGION; MYC; DIFFERENTIATION; T(5/6)(Q21,Q21)	Multiple members of the let-7 family of miRNAs are often repressed in human cancers(1,2), thereby promoting oncogenesis by derepressing targets such as HMGA2, K-Ras and c-Myc(3,4). However, the mechanism by which let-7 miRNAs are coordinately repressed is unclear. The RNA-binding proteins LIN28 and LIN28B block let-7 precursors from being processed to mature nmiRNAs(5-8), suggesting that their overexpression might promote malignancy through repression of let-7. Here we show that LIN28 and LIN28B are overexpressed in primary human tumors and human cancer cell lines (overall frequency B15%), and that overexpression is linked to repression of let-7 family miRNAs and derepression of let-7 targets. LIN28 and LIN28b facilitate cellular transformation in vitro, and overexpression is associated with advanced disease across multiple tumor types. Our work provides a mechanism for the coordinate repression of let-7 miRNAs observed in a subset of human cancers, and associates activation of LIN28 and LIN28B with poor clinical prognosis.	[Viswanathan, Srinivas R.; Powers, John T.; Einhorn, William; Shah, Samar P.; Azam, Mohammad; Daley, George Q.] Harvard Univ, Childrens Hosp, Dept Biol Chem & Mol Pharmacol, Med Sch,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Hoshida, Yujin; Golub, Todd R.; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Cambridge, MA USA; [Hoshida, Yujin; Golub, Todd R.; Daley, George Q.] Dana Farber Canc Inst, Cambridge, MA USA; [Hoshida, Yujin; Lu, Jun; Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew; Golub, Todd R.] MIT & Harvard, Broad Inst, Canc Program, Cambridge, MA USA; [Hoshida, Yujin; Lu, Jun; Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hoshida, Yujin; Lu, Jun; Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Ng, Tony L.; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Ng, Tony L.; Sorensen, Poul H.] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada; [Toffanin, Sara; Llovet, Josep M.] Mt Sinai Sch Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY USA; [Toffanin, Sara] IRCSS Fdn, Natl Canc Inst, Gastrointestinal Surg & Liver Transplantat Unit, Milan, Italy; [O'Sullivan, Maureen] Our Ladys Childrens Hosp, Dept Pathol, Dublin, Ireland; [O'Sullivan, Maureen] Trinity Coll Dublin, Dept Pathol, Dublin, Ireland; [Phillips, Letha A.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lockhart, Victoria L.; Radich, Jerald] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Tanwar, Pradeep S.; Teixeira, Jose] Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Hughes, Timothy P.] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia; [Llovet, Josep M.] Hosp Clin Barcelona, HCC Translat Res Lab, Barcelona Clin Liver Canc Grp,CIBERehd, Liver Unit,Inst Invest Biomed August Pi & Sunyer, Catalonia, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Catalonia, Spain; [Golub, Todd R.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA		Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp, Dept Biol Chem & Mol Pharmacol, Med Sch,Harvard Stem Cell Inst, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Mermel, Craig/AAZ-7322-2020; Powers, John/AAO-1018-2020; Meyerson, Matthew L/E-7123-2012; Llovet, Josep M/D-4340-2014; Mullighan, Charles/H-3253-2011; Tanwar, Pradeep/AAU-6831-2020; Llovet, Josep M/ABB-6264-2021; Viswanathan, Srinivas/ABA-6316-2021; Hoshida, Yujin/R-7513-2019; Teixeira, Jose/P-2542-2014	Mermel, Craig/0000-0002-0816-3395; Llovet, Josep M/0000-0003-0547-2667; Mullighan, Charles/0000-0002-1871-1850; Llovet, Josep M/0000-0003-0547-2667; Viswanathan, Srinivas/0000-0003-1856-3023; O'Sullivan, Maureen/0000-0001-5838-1609; Hughes, Timothy/0000-0002-0910-3730; Teixeira, Jose/0000-0002-6438-5064	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD052701] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK076986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP1OD000256] Funding Source: NIH RePORTER; ICREAICREA Funding Source: Custom; Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32-HL 66987] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD052701, R01 HD052701-02] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK076986, 1 R01 DK076986-01] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007753] Funding Source: Medline; NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP1 OD000256, DP1 OD000256-01] Funding Source: Medline		Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bruce CK, 2003, CANCER GENET CYTOGEN, V141, P106, DOI 10.1016/S0165-4608(02)00669-6; Bruecher-Encke B, 2001, LEUKEMIA, V15, P1424, DOI 10.1038/sj.leu.2402214; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; ENGELMAN A, 1990, MOL CELL BIOL, V10, P4365, DOI 10.1128/MCB.10.8.4365; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fernandez CV, 2001, CANCER GENET CYTOGEN, V129, P165, DOI 10.1016/S0165-4608(01)00445-9; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hoban PR, 1997, J MED GENET, V34, P343, DOI 10.1136/jmg.34.4.343; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; KEATH EJ, 1984, CELL, V39, P339, DOI 10.1016/0092-8674(84)90012-6; Korshunov A, 2007, AM J CLIN PATHOL, V127, P585, DOI 10.1309/DE4LNX3YMACCC1ER; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meyer B, 2007, LEUKEMIA LYMPHOMA, V48, P2008, DOI 10.1080/10428190701559116; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Summersgill B, 1998, BRIT J CANCER, V77, P305, DOI 10.1038/bjc.1998.47; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621	55	597	612	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					843	U109		10.1038/ng.392			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	WOS:000267786200018	19483683	Green Accepted			2022-01-24	
J	Baulac, S; Huberfeld, G; Gourfinkel-An, I; Mitropoulou, G; Beranger, A; Prud'homme, JF; Baulac, M; Brice, A; Bruzzone, R; LeGuern, E				Baulac, S; Huberfeld, G; Gourfinkel-An, I; Mitropoulou, G; Beranger, A; Prud'homme, JF; Baulac, M; Brice, A; Bruzzone, R; LeGuern, E			First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma 2-subunit gene	NATURE GENETICS			English	Article							FEBRILE SEIZURES PLUS; POTASSIUM CHANNEL GENE; GENERALIZED EPILEPSY; SUBUNIT; FAMILY; LOCUS; IDENTIFICATION; DISEASE; MAPS	Major advances in the identification of genes implicated in idiopathic epilepsy have been made. Generalized epilepsy with febrile seizures plus (GEFS+), benign familiar neonatal convulsions and nocturnal frontal lobe epilepsy, three autosomal dominant idiopathic epilepsies, result from mutations affecting voltage-gated sodium and potassium channels, and nicotinic acetylcholine receptors, respectively(1-6), Disruption of GABAergic neurotransmission mediated by gamma -aminobutyric acid (GABA) has been implicated in epilepsy for many decades(7). We now report a K289M mutation in the GABA(A) receptor gamma2-subunit gene (GABRG2) that segregates in a family with a phenotype closely related to GEFS+ (ref. 8), an autosomal dominant disorder associating febrile seizures and generalized epilepsy previously linked to mutations in sodium channel genes(1,2). The K289M mutation affects a highly conserved residue located in the extracellular loop between transmembrane segments M2 and M3. Analysis of the mutated and wild-type alleles in Xenopus laevis oocytes confirmed the predicted effect of the mutation, a decrease in the amplitude of GABA-activated currents. We thus provide the first genetic evidence that a GABA(A) receptor is directly involved in human idiopathic epilepsy.	Hop La Pitie Salpetriere, INSERM, U289, Paris, France; Hop La Pitie Salpetriere, Ctr Epileptol, Paris, France; Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, Paris, France; Genethon, Evry, France; Inst Pasteur, NRSN, Paris, France		LeGuern, E (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, Paris, France.		Brice, Alexis/A-2170-2009; Bruzzone, Roberto/C-4719-2009; Bruzzone, Roberto/G-9355-2017; brice, alexis/AAE-8275-2019; Baulac, Stephanie/O-2099-2016	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; brice, alexis/0000-0002-0941-3990; Baulac, Stephanie/0000-0001-6430-4693			Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Boileau AJ, 1999, J NEUROSCI, V19, P10213; CASTRO RAMIREZ L.C., 2010, NAT GENET, VXXXI, P33; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Elmslie FV, 1996, J MED GENET, V33, P435, DOI 10.1136/jmg.33.5.435; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Kostrzewa M, 1996, EUR J HUM GENET, V4, P199; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Olsen R W, 1999, Adv Neurol, V79, P499; Ressot C, 1998, J NEUROSCI, V18, P4063; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Sigel E, 1999, J NEUROCHEM, V73, P1758, DOI 10.1046/j.1471-4159.1999.731758.x; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WILCOX AS, 1992, P NATL ACAD SCI USA, V89, P5857, DOI 10.1073/pnas.89.13.5857	21	597	630	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					46	48		10.1038/ng0501-46			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	WOS:000168413300014	11326274				2022-01-24	
J	LINDSLEY, DL; SANDLER, L; JACOBS, PA; NOZAWA, H; PARRY, DM; CARPENTER, AT; BAKER, BS; DENELL, RE; HESSLER, A; DAVIS, BK; HARDY, RW; HALL, JC; GOULDSOM.M; GETHMANN, RC; MILLER, SM; MIKLOS, GLG				LINDSLEY, DL; SANDLER, L; JACOBS, PA; NOZAWA, H; PARRY, DM; CARPENTER, AT; BAKER, BS; DENELL, RE; HESSLER, A; DAVIS, BK; HARDY, RW; HALL, JC; GOULDSOM.M; GETHMANN, RC; MILLER, SM; MIKLOS, GLG			SEGMENTAL ANEUPLOIDY AND GENETIC GROSS STRUCTURE OF DROSOPHILA GENOME	GENETICS			English	Article																	BALDWIN MC, 1971, MUTAT RES, V11, P203; Bauer H, 1938, GENETICS, V23, P610; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Kel'shtein L. V., 1938, Biol J Moscow, V7, P1145; KING RC, 1970, OVARIAN DEVELOPMENT; LIFSCHYTZ E, 1969, GENETICS, V62, P353; LINDSLEY DL, 1968, 627 CARN I WASH PUBL; Patterson JT, 1935, GENETICS, V20, P0259; PATTERSON JT, 1940, 4032 U TEX PUBL, P167	9	597	601	0	9	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1972	71	1					157	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M7760	WOS:A1972M776000011	4624779				2022-01-24	
J	Acar, M; Mettetal, JT; van Oudenaarden, A				Acar, Murat; Mettetal, Jerome T.; van Oudenaarden, Alexander			Stochastic switching as a survival strategy in fluctuating environments	NATURE GENETICS			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; TOGGLE SWITCH; NOISE; HETEROGENEITY; CONSEQUENCES; PHENOTYPES; DIVERSITY; BACTERIA; NETWORKS	A classic problem in population and evolutionary biology is to understand how a population optimizes its fitness in fluctuating environments(1-4). A population might enhance its fitness by allowing individual cells to stochastically transition among multiple phenotypes, thus ensuring that some cells are always prepared for an unforeseen environmental fluctuation. Here we experimentally explore how switching affects population growth by using the galactose utilization network of Saccharomyces cerevisiae. We engineered a strain that randomly transitions between two phenotypes as a result of stochastic gene expression(5-9). Each phenotype was designed to confer a growth advantage over the other phenotype in a certain environment. When we compared the growth of two populations with different switching rates, we found that fast-switching populations outgrow slow switchers when the environment fluctuates rapidly, whereas slow-switching phenotypes outgrow fast switchers when the environment changes rarely. These results suggest that cells may tune inter-phenotype switching rates to the frequency of environmental changes.	[Acar, Murat; Mettetal, Jerome T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA		van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM077183] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM077183] Funding Source: Medline		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRYSON V, 1952, SCIENCE, V115, P45; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; LEVINS RICHARD, 1968; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Samoilov M., 2006, SCI STKE, V2006, DOI [10.1126/stke.3662006re17, DOI 10.1126/STKE.3662006RE17]; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	30	596	603	4	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					471	475		10.1038/ng.110			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	WOS:000254388100020	18362885				2022-01-24	
J	Giresi, PG; Kim, J; McDaniell, RM; Iyer, VR; Lieb, JD				Giresi, Paul G.; Kim, Jonghwan; McDaniell, Ryan M.; Iyer, Vishwanath R.; Lieb, Jason D.			FAIRE ((F)under-barormaldehyde-(A)under-barssisted (I)under-barsolation of (R)under-baregulatory (E)under-barlements) isolates active regulatory elements from human chromatin	GENOME RESEARCH			English	Article							HIGH-RESOLUTION MAP; MESSENGER-RNA; GENOME; IDENTIFICATION; PROMOTERS; TRANSCRIPTION; EXPRESSION; GENES; YEAST; PROBE	DNA segments that actively regulate transcription in vivo are typically characterized by eviction of nucleosomes from chromatin and are experimentally identified by their hypersensitivity to nucleases. Here we demonstrate a simple procedure for the isolation of nucleosome-depleted DNA from human chromatin, termed FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements). To perform FAIRE, chromatin is crosslinked with formaldehyde in vivo, sheared by sonication, and phenol-chloroform extracted. The DNA recovered in the aqueous phase is fluorescently labeled and hybridized to a DNA microarray. FAIRE performed in human cells strongly enriches DNA coincident with the location of DNaseI hypersensitive sites, transcriptional start sites, and active promoters. Evidence for cell-type-specific patterns of FAIRE enrichment is also presented. FAIRE has utility as a positive selection for genomic regions associated with regulatory activity, including regions traditionally detected by nuclease hypersensitivity assays.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Texas, Ctr Syst & Synthet Biol, Austin, TX 78712 USA		Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843; Lieb, Jason/0000-0001-7601-8061	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM072518] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG3532-2, R01 HG003532] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM072518, R01 GM072518-02, R01 GM072518-01A1] Funding Source: Medline		Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; BRUTLAG D, 1969, BIOCHEMISTRY-US, V8, P3214, DOI 10.1021/bi00836a013; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; GIMBLE JM, 1993, J IMMUNOL, V150, P115; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Hurowitz EH, 2004, GENOME BIOL, V5; KEENE MA, 1981, CELL, V27, P57, DOI 10.1016/0092-8674(81)90360-3; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEVY A, 1981, NATURE, V289, P198, DOI 10.1038/289198a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margulies EH, 2006, TRENDS GENET, V22, P187, DOI 10.1016/j.tig.2006.02.005; MISENER VL, 1994, J CELL SCI, V107, P3591; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Thompson AA, 1996, GENOMICS, V32, P352, DOI 10.1006/geno.1996.0129; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; Walter P., 2002, MOL BIOL CELL, V91, P401; Wong GKS, 2001, GENOME RES, V11, P1975, DOI 10.1101/gr.202401; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	43	596	614	2	28	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2007	17	6					877	885		10.1101/gr.5533506			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	178NH	WOS:000247226900019	17179217	Green Published, Bronze			2022-01-24	
J	Nielsen, R; Williamson, S; Kim, Y; Hubisz, MJ; Clark, AG; Bustamante, C				Nielsen, R; Williamson, S; Kim, Y; Hubisz, MJ; Clark, AG; Bustamante, C			Genomic scans for selective sweeps using SNP data	GENOME RESEARCH			English	Article							RECENT POSITIVE SELECTION; FREQUENCY-SPECTRUM; HITCHHIKING; POLYMORPHISM; SIGNATURE; PATTERNS; NEUTRALITY; MUTATIONS	Detecting selective sweeps from genomic SNP data is complicated by the intricate ascertainment schemes used to discover SNPs, and by the confounding influence of the underlying complex demographics and varying Mutation and recombination rates. Current methods for detecting selective sweeps have little or no robustness to the demographic assumptions and varying recombination rates, and provide no method for correcting for ascertainment biases. Here, we present several new tests aimed at detecting selective sweeps from genomic SNP data. Using extensive simulations, we show that a new parametric test, based on composite likelihood, has a high power to detect selective sweeps and is Surprisingly robust to assumptions regarding recombination rates and demography (i.e., has low Type I error). Our new test also provides estimates of the location of the selective sweep(s) and the magnitude of the selection coefficient. To illustrate the method, we apply our approach to data from the Seattle SNP project and to Chromosome 2 data from the HapMap project. In Chromosome 2, the most extreme signal is found in the lactase gene, which previously has been shown to be undergoing positive selection. Evidence for selective sweeps is also found in many other regions, including genes known to be associated with disease risk such as DPP10 and COL4A3.	Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Univ Copenhagen, Ctr Bioinformat, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark; Univ Rochester, Dept Biol, Rochester, NY 14627 USA		Nielsen, R (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	rasmus@binf.ku.dk	Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Hubisz, Melissa/0000-0002-9561-6830; Clark, Andrew/0000-0001-7159-8511; Bustamante, Carlos D./0000-0002-4187-7920	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG003229, R01 HG003229-01, HG003229] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [DMS/NIGMS-0201037] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003229] Funding Source: NIH RePORTER		Akashi H, 1999, GENETICS, V151, P221; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Barton NH, 2004, GENETICS, V166, P1115, DOI 10.1534/genetics.166.2.1115; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; CAVALLISFORZA LL, 1973, AM J HUM GENET, V25, P82; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Fay JC, 2000, GENETICS, V155, P1405; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; KAPLAN NL, 1989, GENETICS, V123, P887; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kim Y, 2002, GENETICS, V160, P765; LEWONTIN RC, 1973, GENETICS, V74, P175; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen Rasmus, 2004, Human Genomics, V1, P218; Parsch J, 2001, GENETICS, V159, P647; Przeworski M, 2003, GENETICS, V164, P1667; Przeworski M, 2002, GENETICS, V160, P1179; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SIMONSEN KL, 1995, GENETICS, V141, P413; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P597; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	35	596	612	9	154	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2005	15	11					1566	1575		10.1101/gr.4252305			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	978QZ	WOS:000232889400012	16251466	Green Published, Bronze			2022-01-24	
J	Splawski, I; TristaniFirouzi, M; Lehmann, MH; Sanguinetti, MC; Keating, MT				Splawski, I; TristaniFirouzi, M; Lehmann, MH; Sanguinetti, MC; Keating, MT			Mutations in the hminK gene cause long QT syndrome and suppress I-Ks function	NATURE GENETICS			English	Article							DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; K(V)LQT1; PROTEINS; SUBUNIT; FORM; KR	Ion-channel beta-subunits are ancillary proteins that co-assemble with alpha-subunits to modulate the gating kinetics and enhance stability of multimeric channel complexes(1,2). Despite their functional importance, dysfunction of potassium-channel beta-subunits has not been associated with disease. Recent physiological studies suggest that KCNE1 encodes beta-subunits (hminK) that co-assemble with KvLQT1 alpha-subunits to form the slowly activating delayed rectifier K+ (I-Ks) channel(3,4). Because KVLQT1 mutations cause arrhythmia susceptibility in the long QT syndrome (LQT)(5-7), we hypothesized that mutations in KCNE1 also cause this disorder. Here, we define KCNE1 missense mutations in affected members of two LQT families. Both mutations (S74L, D76N) reduced I-Ks by shifting the voltage dependence of activation and accelerating channel deactivation, D76N hminK also had a strong dominant-negative effect, The functional consequences of these mutations would be delayed cardiac repolarization and an increased risk of arrhythmia. This is the first description of KCNE1 as an LQT gene and confirms that hminK is an integral protein of the I-Ks channel.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; UNIV UTAH,ECCLES PROGRAM HUMAN MOL BIOL & GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112; UNIV UTAH,DIV CARDIOL,SALT LAKE CITY,UT 84112; UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; SINAI HOSP,ARRHYTHMIA CTR,DETROIT,MI 48235				Sanguinetti, Michael/AAN-2615-2020		NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50HL052338] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00064] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50-HL52338-02, R01 HL48074] Funding Source: Medline		Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; SWANSON R, 1993, SEMIN NEUROSCI, V5, P117; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017	17	596	613	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					338	340		10.1038/ng1197-338			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	WOS:A1997YD66700032	9354802				2022-01-24	
J	Layer, RM; Chiang, C; Quinlan, AR; Hall, IM				Layer, Ryan M.; Chiang, Colby; Quinlan, Aaron R.; Hall, Ira M.			LUMPY: a probabilistic framework for structural variant discovery	GENOME BIOLOGY			English	Article							BURROWS-WHEELER TRANSFORM; COPY NUMBER VARIATION; LONG-READ ALIGNMENT; PAIRED-END; POPULATION-SCALE; SEQUENCING DATA; GENOMES	Comprehensive discovery of structural variation (SV) from whole genome sequencing data requires multiple detection signals including read-pair, split-read, read-depth and prior knowledge. Owing to technical challenges, extant SV discovery algorithms either use one signal in isolation, or at best use two sequentially. We present LUMPY, a novel SV discovery framework that naturally integrates multiple SV signals jointly across multiple samples. We show that LUMPY yields improved sensitivity, especially when SV signal is reduced owing to either low coverage data or low intra-sample variant allele frequency. We also report a set of 4,564 validated breakpoints from the NA12878 human genome.	[Layer, Ryan M.; Chiang, Colby; Quinlan, Aaron R.; Hall, Ira M.] Univ Virginia, Ctr Publ Hlth Genom, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Quinlan, Aaron R.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Quinlan, Aaron R.; Hall, Ira M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA		Quinlan, AR (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	arq5x@virginia.edu; irahall@virginia.edu		Chiang, Colby/0000-0002-4113-6065; Quinlan, Aaron/0000-0003-1756-0859	NIH/NHGRI award [1R01HG006693-01]; NIH New Innovator AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD006493-01]; Burroughs Wellcome Fund Career AwardBurroughs Wellcome Fund; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009109] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG006693] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD006493] Funding Source: NIH RePORTER	We thank G Faust for sharing unpublished SV simulation algorithms and for advising on simulation experiments, M Lindberg for code development, A Ritz and S Sindi for help with GASVPro, T Rausch for help with DELLY, and K Ye for help with Pindel. This work was supported by an NIH/NHGRI award to AQ (1R01HG006693-01) and an NIH New Innovator Award (DP2OD006493-01) and a Burroughs Wellcome Fund Career Award to IH.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Faust GG, 2012, BIOINFORMATICS, V28, P2417, DOI 10.1093/bioinformatics/bts456; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hormozdiari F, 2011, GENOME RES, V21, P2203, DOI 10.1101/gr.120501.111; Li H, ALIGNING SEQUENCE RE; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	19	595	602	3	38	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.		2014	15	6							R84	10.1186/gb-2014-15-6-r84			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AO3WZ	WOS:000341269300009	24970577	Green Published, hybrid, Green Submitted	Y	N	2022-01-24	
J	Kluijtmans, LAJ; vandenHeuvel, LPWJ; Boers, GHJ; Frosst, P; Stevens, EMB; vanOost, BA; denHeijer, M; Trijbels, FJM; Rozen, R; Blom, HJ				Kluijtmans, LAJ; vandenHeuvel, LPWJ; Boers, GHJ; Frosst, P; Stevens, EMB; vanOost, BA; denHeijer, M; Trijbels, FJM; Rozen, R; Blom, HJ			Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; CULTURED FIBROBLASTS; VASCULAR-DISEASE; HOMOCYSTINURIA; HOMOCYSTEINEMIA; HETEROZYGOTES; DEFICIENCY; METABOLISM; CELLS	Mild hyperhomocysteinemia is an established risk factor for cardiovascular disease. Genetic aberrations in the cystathionine beta-synthase (CBS) and methylenetetrahydrofolate reductase (MTHFR) genes may account for reduced enzyme activities and elevated plasma homocysteine levels. In 15 unrelated Dutch patients with homozygous CBS deficiency, we observed the 833T-->C (I278T) mutation in 50% of the alleles. Very recently, we identified a common mutation (677C-->T; A-->V) in the MTHFR gene, which, in homozygous state, is responsible for the thermolabile phenotype and which is associated with decreased specific MTHFR activity and elevated homocysteine levels. We screened 60 cardiovascular patients and 111 controls for these two mutations, to determine whether these mutations are risk factors for premature cardiovascular disease. Heterozygosity for the 833T-->C mutation in the CBS gene was observed in one individual of the control group but was absent in patients with premature cardiovascular disease. Homozygosity for the 677C-->T mutation in the MTHFR gene was found in 9 (15%) of 60 cardiovascular patients and in only 6 (similar to 5%) of 111 control individuals (odds ratio 3.1 [95% confidence interval 1.0-9.2]). Because of both the high prevalence of the 833T-->C mutation among homozygotes for CBS deficiency and its absence in 60 cardiovascular patients, we may conclude that heterozygosity for CBS deficiency does not appear to be involved in premature cardiovascular disease. However, a frequent homozygous mutation in the MTHFR gene is associated with a threefold increase in risk for premature cardiovascular disease.	UNIV NIJMEGEN HOSP,DEPT PEDIAT,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT HUMAN GENET,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT PEDIAT,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT BIOL,MONTREAL,PQ H3H 1P3,CANADA; MUNICIPAL HOSP LEYENBURG,DEPT HEMATOL,THE HAGUE,NETHERLANDS				van den Heuvel, Lambertus/AAM-1772-2021; Rozen, Rima/AAE-9294-2020; van den Heuvel, L.P.W.J./H-8044-2014; Kluijtmans, Leo A/L-4437-2015	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Blom, Henk/0000-0001-5202-9241			BOERS GHJ, 1985, HUM GENET, V69, P164, DOI 10.1007/BF00293290; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BOERS GHJ, 1986, CLIN RES SERIES, V3; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DALY L, 1993, Q J MED, V86, P685, DOI 10.1093/qjmed/86.10.685; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FINKELSTEIN JD, 1964, SCIENCE, V146, P785, DOI 10.1126/science.146.3645.785; FOWLER B, 1978, J CLIN INVEST, V61, P645, DOI 10.1172/JCI108976; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GOYETTE P, 1995, AM J HUM GENET, V56, P1052; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; GUTTORMSEN AB, 1994, J NUTR, V124, P1934, DOI 10.1093/jn/124.10.1934; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1993, CIRCULATION, V88, P1463, DOI 10.1161/01.CIR.88.4.1463; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; KLUIJTMANS LAJ, 1995, HUM GENET, V96, P249, DOI 10.1007/BF00207394; KOZICH V, 1995, HUM MOL GENET, V4, P623, DOI 10.1093/hmg/4.4.623; KRAUS JP, 1993, HUM MOL GENET, V2, P1633, DOI 10.1093/hmg/2.10.1633; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALINOW MR, 1994, J INTERN MED, V236, P603, DOI 10.1111/j.1365-2796.1994.tb00854.x; MILLER JW, 1992, AM J CLIN NUTR, V55, P1154, DOI 10.1093/ajcn/55.6.1154; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORRIS JA, 1989, STATISTICS CONFIDENC, P50; MUDD SH, 1981, AM J HUM GENET, V33, P883; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Te Poele-Pothoff M. T. W. B., 1995, Annals of Clinical Biochemistry, V32, P218; WHITEHEAD AS, 1994, METHIONINE METABOLIS, P79; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350	35	595	614	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					35	41					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	WOS:A1996TL69700007	8554066				2022-01-24	
J	Gateva, V; Sandling, JK; Hom, G; Taylor, KE; Chung, SA; Sun, X; Ortmann, W; Kosoy, R; Ferreira, RC; Nordmark, G; Gunnarsson, I; Svenungsson, E; Padyukov, L; Sturfelt, G; Jonsen, A; Bengtsson, AA; Rantapaa-Dahlqvist, S; Baechler, EC; Brown, EE; Alarcon, GS; Edberg, JC; Ramsey-Goldman, R; McGwin, G; Reveille, JD; Vila, LM; Kimberly, RP; Manzi, S; Petri, MA; Lee, A; Gregersen, PK; Seldin, MF; Ronnblom, L; Criswell, LA; Syvanen, AC; Behrens, TW; Graham, RR				Gateva, Vesela; Sandling, Johanna K.; Hom, Geoff; Taylor, Kimberly E.; Chung, Sharon A.; Sun, Xin; Ortmann, Ward; Kosoy, Roman; Ferreira, Ricardo C.; Nordmark, Gunnel; Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid; Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.; Rantapaa-Dahlqvist, Solbritt; Baechler, Emily C.; Brown, Elizabeth E.; Alarcon, Graciela S.; Edberg, Jeffrey C.; Ramsey-Goldman, Rosalind; McGwin, Gerald, Jr.; Reveille, John D.; Vila, Luis M.; Kimberly, Robert P.; Manzi, Susan; Petri, Michelle A.; Lee, Annette; Gregersen, Peter K.; Seldin, Michael F.; Ronnblom, Lars; Criswell, Lindsey A.; Syvanen, Ann-Christine; Behrens, Timothy W.; Graham, Robert R.			A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; COMMON VARIANTS; POLYMORPHISMS; MULTIPLE; PATHOGENESIS; METAANALYSIS; CLEC16A; LINKAGE	Genome-wide association studies have recently identified at least 15 susceptibility loci for systemic lupus erythematosus (SLE). To confirm additional risk loci, we selected SNPs from 2,466 regions that showed nominal evidence of association to SLE (P < 0.05) in a genome-wide study and genotyped them in an independent sample of 1,963 cases and 4,329 controls. This replication effort identified five new SLE susceptibility loci (P < 5 x 10(-8)): TNIP1 (odds ratio (OR) = 1.27), PRDM1 (OR = 1.20), JAZF1 (OR = 1.20), UHRF1BP1 (OR = 1.17) and IL10 (OR = 1.19). We identified 21 additional candidate loci with P <= 1 x 10(-5). A candidate screen of alleles previously associated with other autoimmune diseases suggested five loci (P < 1 x 10(-3)) that may contribute to SLE: IFIH1, CFB, CLEC16A, IL12B and SH2B3. These results expand the number of confirmed and candidate SLE susceptibility loci and implicate several key immunologic pathways in SLE pathogenesis.	[Gateva, Vesela; Hom, Geoff; Sun, Xin; Ortmann, Ward; Ferreira, Ricardo C.; Behrens, Timothy W.; Graham, Robert R.] Genentech Inc, Immunol Biomarkers Grp, San Francisco, CA 94080 USA; [Nordmark, Gunnel; Ronnblom, Lars] Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden; [Taylor, Kimberly E.; Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Kosoy, Roman; Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Gunnarsson, Iva; Svenungsson, Elisabet; Padyukov, Leonid] Karolinska Univ Hosp, Dept Med, Karolinska Inst, Rheumatol Unit, Stockholm, Sweden; [Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.] Univ Lund Hosp, Dept Clin Sci, Rheumatol Sect, S-22185 Lund, Sweden; [Rantapaa-Dahlqvist, Solbritt] Umea Univ Hosp, Dept Rheumatol, S-90185 Umea, Sweden; [Baechler, Emily C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Brown, Elizabeth E.; Alarcon, Graciela S.; Edberg, Jeffrey C.; McGwin, Gerald, Jr.; Kimberly, Robert P.] Univ Alabama Birmingham, Birmingham, AL USA; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Reveille, John D.] Univ Texas Houston Hlth Sci Ctr, Houston, TX USA; [Vila, Luis M.] Univ Puerto Rico, San Juan, PR 00936 USA; [Manzi, Susan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lee, Annette; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA		Graham, RR (corresponding author), Genentech Inc, Immunol Biomarkers Grp, San Francisco, CA 94080 USA.	graham.robert@gene.com	Sandling, Johanna K/B-2973-2016; Sandling, Johanna/AAG-6376-2019; Gillespie, Emily/N-1265-2013; Padyukov, Leonid/A-4890-2009	Sandling, Johanna K/0000-0003-1382-2321; Sandling, Johanna/0000-0003-1382-2321; Gillespie, Emily/0000-0001-5261-3931; Padyukov, Leonid/0000-0003-2950-5670; Kimberly, Robert/0000-0002-5330-3086; Ferreira, Ricardo C./0000-0001-5733-3285; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Svenungsson, Elisabet/0000-0003-3396-3244	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025741, UL1RR025005, M01 RR000079, UL1 RR025005-01, 5 M01 RR-00079, UL1 RR025005] Funding Source: Medline; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K24 AR002175, R01 AR044804-01A1, R01 AR043727, K24 AR002175-01A1, R01 AR44804, K24 AR02175, R01 AR043727-03, R01 AR43727] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741, UL1RR025005, M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR044804, K24AR002175, R01AR043727] Funding Source: NIH RePORTER		Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Awata T, 2009, J CLIN ENDOCR METAB, V94, P231, DOI 10.1210/jc.2008-0718; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kozyrev SV, 2008, NAT GENET, V40, P484, DOI 10.1038/ng0408-484; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nath SK, 2005, HUM GENET, V118, P225, DOI 10.1007/s00439-005-0044-6; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Sutherland A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/jc.2007-0173; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84; [No title captured]	47	594	609	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1228	U93		10.1038/ng.468			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	WOS:000271247600016	19838195	Green Accepted			2022-01-24	
J	Boyden, ED; Dietrich, WF				Boyden, ED; Dietrich, WF			Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin	NATURE GENETICS			English	Article							STRAIN DISTRIBUTION PATTERN; SSLP MARKERS; PROTEIN; ACTIVATION; INFLAMMASOME; RESISTANCE; RELEASE; SET; MAP	The pathogenesis of Bacillus anthracis, the bacterium that causes anthrax, depends on secretion of three factors that combine to form two bipartite toxins. Edema toxin, consisting of protective antigen (PA) and edema factor (EF), causes the edema associated with cutaneous anthrax infections, whereas lethal toxin (LeTx), consisting of PA and lethal factor (LF), is believed to be responsible for causing death in systemic anthrax infections(1). EF and LF can be transported by PA into the cytosol of many cell types(2). In mouse macrophages, LF can cause rapid necrosis that may be related to the pathology of systemic infections(3-5). Inbred mouse strains display variable sensitivity to LeTx-induced macrophage necrosis(6,7). This trait difference has been mapped to a locus on chromosome 11 named Ltxs1 (refs. 7,8). Here we show that an extremely polymorphic gene in this locus, Nalp1b, is the primary mediator of mouse macrophage susceptibility to LeTx. We also show that LeTx-induced macrophage death requires caspase-1, which is activated in susceptible, but not resistant, macrophages after intoxication, suggesting that Nalp1b directly or indirectly activates caspase-1 in response to LeTx.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA		Dietrich, WF (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	dietrich@genetics.med.harvard.edu					Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; HANNA PC, 1992, MOL BIOL CELL, V3, P1269, DOI 10.1091/mbc.3.11.1269; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Menard A, 1996, BIOCHEM J, V320, P687, DOI 10.1042/bj3200687; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Reifsnyder PC, 1999, MAMM GENOME, V10, P161, DOI 10.1007/s003359900962; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Shultz KL, 1996, MAMM GENOME, V7, P526, DOI 10.1007/s003359900156; STEPHEN J, 1981, PHARMACOL THERAPEUT, V12, P501, DOI 10.1016/0163-7258(81)90095-4; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; SVENSON KL, 1995, MAMM GENOME, V6, P867, DOI 10.1007/BF00292437; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Watters JW, 2001, CURR BIOL, V11, P1503, DOI 10.1016/S0960-9822(01)00476-6; Watters JW, 2001, GENOMICS, V73, P223, DOI 10.1006/geno.2001.6453; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097	30	594	624	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					240	244		10.1038/ng1724			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	WOS:000234953200022	16429160				2022-01-24	
J	Mendell, JT; Sharifi, NA; Meyers, JL; Martinez-Murillo, FM; Dietz, HC				Mendell, JT; Sharifi, NA; Meyers, JL; Martinez-Murillo, FM; Dietz, HC			Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise	NATURE GENETICS			English	Article							MESSENGER-RNA DECAY; AMINO-ACID STARVATION; MEDIATED DECAY; TERMINATION-CODON; YEAST; GENE; PATHWAYS; CELLS; ABUNDANCE; MECHANISM	Premature termination codons induce rapid transcript degradation in eukaryotic cells through nonsense-mediated mRNA decay (NMD)(1,2). This pathway can modulate phenotypes arising from nonsense or frameshift mutations, but little is known about the physiologic role of NMD in higher eukaryotes. To address this issue, we examined expression profiles in mammalian cells depleted of Rent1 (also called hUpf1), a factor essential for NMD3,4. Upregulated transcripts included those with upstream open reading frames in the 5' untranslated region, alternative splicing that introduces nonsense codons or frameshifts, introns in the 3' untranslated region or selenocysteine codons. Transcripts derived from ancient transposons and endogenous retroviruses were also upregulated. These RNAs are unified by the presence of a spliced intron at least 50 nucleotides downstream of a termination codon, a context sufficient to initiate NMD5. Consistent with direct regulation by NMD, representative upregulated transcripts decayed more slowly in cells deficient in NMD. In addition, inhibition of NMD induced by amino acid starvation upregulated transcripts that promote amino acid homeostasis. These results document that nonsense surveillance is a crucial post-transcriptional regulatory event that influences the expression of broad classes of physiologic transcripts, has been functionally incorporated into essential homeostatic mechanisms and suppresses expression of evolutionary remnants.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA		Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 539 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	hdietz@jhmi.edu					Aubel C, 2003, INT J BIOCHEM CELL B, V35, P1388, DOI 10.1016/S1357-2725(03)00098-0; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; GOODCHILD NL, 1995, VIROLOGY, V206, P164, DOI 10.1016/S0042-6822(95)80031-X; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lindeskog M, 1997, J GEN VIROL, V78, P2575, DOI 10.1099/0022-1317-78-10-2575; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Robertson HM, 1997, GENE, V205, P219, DOI 10.1016/S0378-1119(97)00471-X; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wagner E, 2002, J CELL SCI, V115, P3033; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231	30	594	602	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1073	1078		10.1038/ng1429			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	WOS:000224156500015	15448691	Bronze			2022-01-24	
J	Courcelle, J; Khodursky, A; Peter, B; Brown, PO; Hanawalt, PC				Courcelle, J; Khodursky, A; Peter, B; Brown, PO; Hanawalt, PC			Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli	GENETICS			English	Article							DNA POLYMERASE-II; GENOME SEQUENCE; EXCISION-REPAIR; BINDING-SITES; LEXA; INDUCTION; PROTEIN; REPLICATION; MUTAGENESIS; DAMAGE	The SOS response in W-irradiated Escherichia coli includes the upregulation of several dozen genes that are negatively regulated by the LexA repressor. Using DNA microarrays containing amplified DNA fragments from 95.5% of all open reading frames identified on the E. coli chromosome, we have examined the changes in gene expression following UV exposure in both wild-type cells and lexA1 mutants, which are unable to induce genes under LexA control. We report here the rime courses of expression of che genes surrounding the 26 documented lexA-regulated regions on the E. coli chromosome. We observed 17 additional sites that responded in a lexA-dependent manner and a large number of genes that were upregulated in a lexA-independent manner although upregulation in this manner was generally not more than twofold. in addition, several transcripts were either downregulated or degraded following UV irradiation. These newly identified W-responsive genes are discussed with respect to their possible roles in cellular recovery following exposure to W irradiation.	Mississippi State Univ, Dept Sci Biol, Mississippi State, MS 39762 USA; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept MCB, Berkeley, CA 94720 USA		Courcelle, J (corresponding author), Mississippi State Univ, Dept Sci Biol, POB GY, Mississippi State, MS 39762 USA.	jcourcelle@biology.msstate.edu	Peter, Brian/AAZ-7323-2020		NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA44349] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00983] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM08295-11] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R35CA044349] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008295] Funding Source: NIH RePORTER		ARTHUR HM, 1983, GENE, V25, P309, DOI 10.1016/0378-1119(83)90235-4; BAGG A, 1981, P NATL ACAD SCI-BIOL, V78, P5749, DOI 10.1073/pnas.78.9.5749; BARONDESS JJ, 1995, J BACTERIOL, V177, P1247, DOI 10.1128/jb.177.5.1247-1253.1995; BARONDESS JJ, 1990, NATURE, V346, P871, DOI 10.1038/346871a0; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BRANDSMA JA, 1983, NATURE, V305, P243, DOI 10.1038/305243a0; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; CASAREGOLA S, 1982, MOL GEN GENET, V185, P430, DOI 10.1007/BF00334135; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; Crowley DJ, 1998, J BACTERIOL, V180, P3345, DOI 10.1128/JB.180.13.3345-3352.1998; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; FOGLIANO M, 1981, NATURE, V289, P196, DOI 10.1038/289196a0; Friedberg E. C., 1995, DNA REPAIR MUTAGENES; Georgiou T, 1998, P NATL ACAD SCI USA, V95, P2891, DOI 10.1073/pnas.95.6.2891; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; IWASAKI H, 1990, J BACTERIOL, V172, P6268, DOI 10.1128/jb.172.11.6268-6273.1990; Jin S, 1996, J MOL BIOL, V256, P264, DOI 10.1006/jmbi.1996.0084; KENYON CJ, 1981, NATURE, V289, P808, DOI 10.1038/289808a0; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Koch WH, 1998, CONT CANC RES, P107; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; LLOYD RG, 1983, MOL GEN GENET, V190, P162, DOI 10.1007/BF00330340; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; OHMORI H, 1995, MUTAT RES LETT, V347, P1, DOI 10.1016/0165-7992(95)90024-1; PERRINO FW, 1987, MOL GEN GENET, V209, P612, DOI 10.1007/BF00331171; PERRY KL, 1985, P NATL ACAD SCI USA, V82, P4331, DOI 10.1073/pnas.82.13.4331; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; Radman M., 1974, BASIC LIFE SCI, V5A, P355; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; SALLES B, 1983, P NATL ACAD SCI-BIOL, V80, P65, DOI 10.1073/pnas.80.1.65; SANDLER SJ, 1994, MOL GEN GENET, V245, P741, DOI 10.1007/BF00297281; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SHURVINTON CE, 1982, MOL GEN GENET, V185, P352, DOI 10.1007/BF00330811; SIEGEL EC, 1983, MOL GEN GENET, V191, P397, DOI 10.1007/BF00425753; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; TADDEI F, 1995, P NATL ACAD SCI USA, V92, P11736, DOI 10.1073/pnas.92.25.11736; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; Wood LF, 1997, J MOL BIOL, V274, P1, DOI 10.1006/jmbi.1997.1390; WOODGATE R, 1991, MOL GEN GENET, V229, P10, DOI 10.1007/BF00264207	48	594	609	1	42	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	2001	158	1					41	64					24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	431NG	WOS:000168637000005	11333217				2022-01-24	
J	SPITZE, K				SPITZE, K			POPULATION-STRUCTURE IN DAPHNIA-OBTUSA - QUANTITATIVE GENETIC AND ALLOZYMIC VARIATION	GENETICS			English	Article							LIFE-HISTORY EVOLUTION; PHENOTYPIC EVOLUTION; NATURAL-SELECTION; BODY-SIZE; ANTAGONISTIC PLEIOTROPY; CYCLICAL PARTHENOGEN; UNIFORM SELECTION; PULEX GROUP; CHARACTERS; FREQUENCIES	Quantitative genetic analyses for body size and for life history characters within and among populations of Daphnia obtusa reveal substantial genetic variance at both hierarchical levels for all traits measured. Simultaneous allozymic analysis on the same population samples indicate a moderate degree of differentiation: G(ST) = 0.28. No associations between electrophoretic genotype and phenotypic characters were found, providing support for the null hypothesis that the allozymic variants are effectively neutral. Therefore, G(ST) can be used as the null hypothesis that neutral phenotypic evolution within populations led to the observed differentiation for the quantitative traits, which I call Q(ST). The results of this study provide evidence that natural selection has promoted diversification for body size among populations, and has impeded diversification for relative fitness. Analyses of population differentiation for clutch size, age at reproduction, and growth rate indicate that neutral phenotypic evolution cannot be excluded as the cause.			SPITZE, K (corresponding author), UNIV MIAMI, DEPT BIOL, CORAL GABLES, FL 33124 USA.						ALLEGRUCCI G, 1987, BIOL J LINN SOC, V31, P151, DOI 10.1111/j.1095-8312.1987.tb01986.x; Bulmer MG, 1980, MATH THEORY QUANTITA; CHAKRABORTY R, 1982, GENET RES, V39, P303, DOI 10.1017/S0016672300020978; Charlesworth B, 1980, EVOLUTION AGE STRUCT; COHAN FM, 1984, EVOLUTION, V38, P495, DOI [10.2307/2408699, 10.1111/j.1558-5646.1984.tb00315.x]; CREASE TJ, 1990, MOL BIOL EVOL, V7, P444; Crow JF., 1986, BASIC CONCEPTS POPUL; DODSON SI, 1972, ECOLOGY, V53, P1011, DOI 10.2307/1935414; DODSON SI, 1970, LIMNOL OCEANOGR, V15, P131; Endler J.A., 1986, Monographs in Population Biology, pviii; EWING EP, 1979, AM NAT, V114, P197, DOI 10.1086/283468; Falconer DS, 1981, INTRO QUANTITATIVE G; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; FELSENSTEIN J, 1986, AM NAT, V127, P731, DOI 10.1086/284520; Fisher R. A., 1958, GENETICAL THEORY NAT; HEBERT PD, 1989, AM MIDL NAT, V122, P59, DOI 10.2307/2425683; HEBERT PDN, 1985, BIOL BULL, V169, P143, DOI 10.2307/1541394; INNES DJ, 1989, J HERED, V80, P6, DOI 10.1093/oxfordjournals.jhered.a110791; INNES DJ, 1986, HEREDITY, V57, P345, DOI 10.1038/hdy.1986.134; KARL SA, 1987, AUK, V104, P767, DOI 10.1093/auk/104.4.767; Koehn R.K., 1983, P115; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LANDE R, 1992, EVOLUTION, V46, P381, DOI [10.2307/2409859, 10.1111/j.1558-5646.1992.tb02046.x]; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lande R., 1982, P21; LANDE R, 1977, EVOLUTION, V31, P442, DOI 10.1111/j.1558-5646.1977.tb01025.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; LEIBOLD M, 1991, OECOLOGIA, V86, P342, DOI 10.1007/BF00317599; LEWONTIN RC, 1984, AM NAT, V123, P115, DOI 10.1086/284190; LYNCH M, 1985, EVOLUTION, V39, P804, DOI 10.1111/j.1558-5646.1985.tb00422.x; LYNCH M, 1984, EVOLUTION, V38, P465, DOI 10.1111/j.1558-5646.1984.tb00312.x; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; LYNCH M, 1989, EVOLUTION, V43, P1724, DOI 10.1111/j.1558-5646.1989.tb02622.x; LYNCH M, 1986, EVOLUTION, V40, P640, DOI 10.1111/j.1558-5646.1986.tb00515.x; Lynch M., 1979, Limnology and Oceanography, V24, P253; LYNCH M, 1983, EXP GERONTOL, V18, P147, DOI 10.1016/0531-5565(83)90008-6; LYNCH M, 1987, GENETICS, V115, P657; LYNCH M, 1984, EVOLUTION, V38, P186, DOI 10.1111/j.1558-5646.1984.tb00271.x; LYNCH M, 1983, EVOLUTION, V37, P358, DOI 10.1111/j.1558-5646.1983.tb05545.x; LYNCH M, 1988, GENET RES, V51, P137, DOI 10.1017/S0016672300024150; Lynch M., 1988, P29; LYNCH M, 1993, ECOLOGICAL GENETICS; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; PROUT T, 1993, GENETICS, V134, P369; RITLAND K, 1984, OECOLOGIA, V63, P243, DOI 10.1007/BF00379884; ROFF DA, 1987, HEREDITY, V58, P103, DOI 10.1038/hdy.1987.15; Roff Derek A., 1992; ROGERS AR, 1983, GENETICS, V105, P985; ROGERS AR, 1986, AM NAT, V127, P729, DOI 10.1086/284519; ROSE MR, 1982, HEREDITY, V48, P63, DOI 10.1038/hdy.1982.7; ROSE MR, 1983, AM ZOOL, V23, P15; ROSE MR, 1985, THEOR POPUL BIOL, V28, P342, DOI 10.1016/0040-5809(85)90034-6; SCHNELL GD, 1978, SYST ZOOL, V27, P34, DOI 10.2307/2412811; SCHWARTZ SS, 1985, LIMNOL OCEANOGR, V30, P189, DOI 10.4319/lo.1985.30.1.0189; SPITZE K, 1985, ECOLOGY, V66, P938, DOI 10.2307/1940556; SPITZE K, 1991, EVOLUTION, V45, P1081, DOI 10.1111/j.1558-5646.1991.tb04376.x; SPITZE K, 1991, EVOLUTION, V45, P82, DOI [10.1111/j.1558-5646.1991.tb05268.x, 10.2307/2409484]; TESSIER AJ, 1992, LIMNOL OCEANOGR, V37, P1; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; TURNER BJ, 1974, EVOLUTION, V28, P281, DOI 10.1111/j.1558-5646.1974.tb00748.x; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	67	594	604	0	92	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	1993	135	2					367	374					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ432	WOS:A1993LZ43200012	8244001				2022-01-24	
J	Li, W; Xu, H; Xiao, TF; Cong, L; Love, MI; Zhang, F; Irizarry, RA; Liu, JS; Brown, M; Liu, XS				Li, Wei; Xu, Han; Xiao, Tengfei; Cong, Le; Love, Michael I.; Zhang, Feng; Irizarry, Rafael A.; Liu, Jun S.; Brown, Myles; Liu, X. Shirley			MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens	GENOME BIOLOGY			English	Article							ZINC-FINGER PROTEIN; DIFFERENTIAL EXPRESSION; COLORECTAL CANCERS; INHIBITION; CADHERIN; BRAF	We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK demonstrates better performance compared with existing methods, identifies both positively- and negatively-selected genes simultaneously, and reports robust results across different experimental conditions. Using public datasets, MAGeCK identified novel essential genes and pathways, including EGFR in vemurafenib treated A375 cells harboring a BRAF mutation. MAGeCK also detected cell-type specific essential genes including BCR and ABL1 in the KBM7 cells bearing a BCR-ABL fusion, and IGF1R in the HL-60 cells, which depends on the insulin signaling pathway for proliferation.	[Li, Wei; Xu, Han; Love, Michael I.; Irizarry, Rafael A.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Li, Wei; Xu, Han; Xiao, Tengfei; Brown, Myles; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Xiao, Tengfei; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02215 USA; [Cong, Le; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Cong, Le; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol Engn, Cambridge, MA 02139 USA; [Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Brown, Myles] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02215 USA		Liu, XS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.	li.david.wei@gmail.com; hanxu@jimmy.harvard.edu; xtfmail@gmail.com; congle.thu@gmail.com; michaelisaiahlove@gmail.com; zhangf@mit.edu; rairizarry@gmail.com; jliu1600@gmail.com; myles_brown@dfci.harvard.edu; xsliu@jimmy.harvard.edu	Cong, Le/M-9981-2013; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008; Macrae, Rhiannon/AAX-1536-2020	Cong, Le/0000-0003-4725-8714; Brown, Myles/0000-0002-8213-1658; Love, Michael/0000-0001-8401-0545; Li, Wei/0000-0002-2163-7903; Liu, Xiaole/0000-0003-4736-7339	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM099409]; Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM099409] Funding Source: NIH RePORTER	The authors would like to thank Drs. Tim Wang, Eric Lander, David Sabatini, Ophir Shalem, Neville Sanjana, Graham McVicker and Clifford Meyer for providing the datasets and helpful discussions. This project was supported by the NIH R01 GM099409 (to X.S.L.), and the Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson BS, 1995, LEUKEMIA, V9, P2100; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Ellmann L, 2012, LAB INVEST, V92, P1788, DOI 10.1038/labinvest.2012.140; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hendrickson AEW, 2009, CANCER RES, V69, P7635, DOI 10.1158/0008-5472.CAN-09-0511; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Lam D, 2009, P NATL ACAD SCI USA, V106, P11978, DOI 10.1073/pnas.0900608106; Liu RH, 2008, MOL CELL BIOL, V28, P7236, DOI 10.1128/MCB.01334-08; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Toyooka S, 2002, CANCER RES, V62, P3382; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Zhang L, 1999, NUCLEIC ACIDS RES, V27, P2947, DOI 10.1093/nar/27.14.2947; Zhang XD, 2007, J BIOMOL SCREEN, V12, P497, DOI 10.1177/1087057107300646; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	36	593	604	16	67	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2014	15	12							554	10.1186/s13059-014-0554-4			24	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AW9XX	WOS:000346609500026	25476604	gold, Green Published	Y	N	2022-01-24	
J	Liu, JZ; Mcrae, AF; Nyholt, DR; Medland, SE; Wray, NR; Brown, KM; Hayward, NK; Montgomery, GW; Visscher, PM; Martin, NG; Macgregor, S				Liu, Jimmy Z.; Mcrae, Allan F.; Nyholt, Dale R.; Medland, Sarah E.; Wray, Naomi R.; Brown, Kevin M.; Hayward, Nicholas K.; Montgomery, Grant W.; Visscher, Peter M.; Martin, Nicholas G.; Macgregor, Stuart		AMFS Investigators	A Versatile Gene-Based Test for Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; SEQUENCE VARIANTS; LINKAGE; PATHWAY; HEIGHT; LOCI	We have derived a versatile gene-based test for genome-wide association studies (GWAS). Our approach, called VEGAS (versatile gene-based association study), is applicable to all GWAS designs, including family-based GWAS, meta-analyses of GWAS on the basis of summary data, and DNA-pooling-based GWAS, where existing approaches based on permutation are not possible, as well as singleton data, where they are. The test incorporates information from a full set of markers (or a defined subset) within a gene and accounts for linkage disequilibrium between markers by using simulations from the multivariate normal distribution. We show that for an association study using singletons, our approach produces results equivalent to those obtained via permutation in a fraction of the computation time. We demonstrate proof-of-principle by using the gene-based test to replicate several genes known to be associated on the basis of results from a family-based GWAS for height in 11,536 individuals and a DNA-pooling-based GWAS for melanoma in similar to 1300 cases and controls. Our method has the potential to identify novel associated genes; provide a basis for selecting SNPs for replication; and be directly used in network (pathway) approaches that require per-gene association test statistics. We have implemented the approach in both an easy-to-use web interface, which only requires the uploading of markers with their association p-values, and a separate downloadable application.	[Liu, Jimmy Z.; Mcrae, Allan F.; Nyholt, Dale R.; Medland, Sarah E.; Wray, Naomi R.; Hayward, Nicholas K.; Montgomery, Grant W.; Visscher, Peter M.; Martin, Nicholas G.; Macgregor, Stuart] Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia; [Brown, Kevin M.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85028 USA		Liu, JZ (corresponding author), Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia.	jimmy.liu@uqconnect.edu.au; stuart.macgregor@qimr.edu.au	Visscher, Peter/ABB-6151-2020; Macgregor, Stuart/C-6442-2009; Wray, Naomi/C-8639-2015; Medland, Sarah/AAT-7595-2020; McRae, Allan F/J-2644-2014; hayward, nicholas k/C-1367-2015; Nyholt, Dale R/J-3174-2017; Medland, Sarah E/C-7630-2013; hayward, nick/AAV-8802-2020; Mann, Graham J/G-4758-2014; Montgomery, Grant W/B-7148-2008	Visscher, Peter/0000-0002-2143-8760; Macgregor, Stuart/0000-0001-6731-8142; Wray, Naomi/0000-0001-7421-3357; Medland, Sarah/0000-0003-1382-380X; McRae, Allan F/0000-0001-5286-5485; hayward, nicholas k/0000-0003-4760-1033; Nyholt, Dale R/0000-0001-7159-3040; Medland, Sarah E/0000-0003-1382-380X; Mann, Graham J/0000-0003-1301-405X; Montgomery, Grant W/0000-0002-4140-8139; Kefford, Richard/0000-0001-9251-9229; Aitken, Joanne/0000-0001-6859-2186; Martin, Nicholas/0000-0003-4069-8020	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [496675]; Australian Research CouncilAustralian Research Council; Melanoma Research Foundation; National Cancer Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA109544, CA083115]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083115, R01CA109544] Funding Source: NIH RePORTER	Australian Melanoma Family Study Investigators: Graham J. Mann and Richard F. Kefford (Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, PO Box 412, Westmead, NSW 2145, Australia); John L. Hopper (Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, School of Population Health, Level 2, 723 Swanston Street, University of Melbourne, VIC 3052, Australia); Joanne E Aitken (Viertel Centre for Research in Cancer Control, The Queensland Cancer Council Queensland, PO Box 201, Spring Hill, QLD 4004, Australia); Graham G. Giles (Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, VIC 3053, Australia); and Bruce K. Armstrong (School of Public Health, A27, University of Sydney, NSW 2006, Australia). J.Z.L. is supported by National Health and Medical Research Council (NHMRC) project grant 496675. S.M., N.K.H., G.W.M., P.M.V., ARM., and S.E.M. are supported by the NHMRC Fellowships scheme. N.R.W. and D.R.N. are supported by Australian Research Council Fellowships. K.M.B. is a recipient of a Career Development Award from the Melanoma Research Foundation and is supported by the National Cancer Institute, National Institutes of Health (CA109544, CA083115). We thank Joseph Powell for suggesting the name VEGAS. Additional acknowledgements are provided in the Supplemental Data.	Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Benyamin B, 2008, EUR J HUM GENET, V16, P516, DOI 10.1038/sj.ejhg.5201992; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Cornes BK, 2005, TWIN RES HUM GENET, V8, P616; Cui YH, 2008, GENETICS, V179, P637, DOI 10.1534/genetics.107.082370; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; FARACO J, 1995, GENOMICS, V25, P630, DOI 10.1016/0888-7543(95)80004-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GENZ A, 2009, MVTNORM MULTIVARIATE; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; HIGHAM NJ, 1988, LINEAR ALGEBRA APPL, V103, P103, DOI 10.1016/0024-3795(88)90223-6; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; SCHAEFER J, 2009, EFFICIENT ESTIMATION; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	26	593	600	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					139	145		10.1016/j.ajhg.2010.06.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	WOS:000280029200015	20598278	Bronze, Green Published			2022-01-24	
J	Campbell, PJ; Stephens, PJ; Pleasance, ED; O'Meara, S; Li, H; Santarius, T; Stebbings, LA; Leroy, C; Edkins, S; Hardy, C; Teague, JW; Menzies, A; Goodhead, I; Turner, DJ; Clee, CM; Quail, MA; Cox, A; Brown, C; Durbin, R; Hurles, ME; Edwards, PAW; Bignell, GR; Stratton, MR; Futreal, PA				Campbell, Peter J.; Stephens, Philip J.; Pleasance, Erin D.; O'Meara, Sarah; Li, Heng; Santarius, Thomas; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Hardy, Claire; Teague, Jon W.; Menzies, Andrew; Goodhead, Ian; Turner, Daniel J.; Clee, Christopher M.; Quail, Michael A.; Cox, Antony; Brown, Clive; Durbin, Richard; Hurles, Matthew E.; Edwards, Paul A. W.; Bignell, Graham R.; Stratton, Michael R.; Futreal, P. Andrew			Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing	NATURE GENETICS			English	Article							PARTIAL TANDEM DUPLICATION; PROSTATE-CANCER; LUNG-CANCER; FUSION; GENES; TRANSLOCATIONS; TRANSCRIPTS; INVOLVE; LOCUS	Human cancers often carry many somatically acquired genomic rearrangements, some of which may be implicated in cancer development. However, conventional strategies for characterizing rearrangements are laborious and low-throughput and have low sensitivity or poor resolution. We used massively parallel sequencing to generate sequence reads from both ends of short DNA fragments derived from the genomes of two individuals with lung cancer. By investigating read pairs that did not align correctly with respect to each other on the reference human genome, we characterized 306 germline structural variants and 103 somatic rearrangements to the base-pair level of resolution. The patterns of germline and somatic rearrangement were markedly different. Many somatic rearrangements were from amplicons, although rearrangements outside these regions, notably including tandem duplications, were also observed. Some somatic rearrangements led to abnormal transcripts, including two from internal tandem duplications and two fusion transcripts created by interchromosomal rearrangements. Germline variants were predominantly mediated by retrotransposition, often involving AluY and LINE elements. The results demonstrate the feasibility of systematic, genome-wide characterization of rearrangements in complex human cancer genomes, raising the prospect of a new harvest of genes associated with cancer using this strategy.	[Campbell, Peter J.; Stephens, Philip J.; Pleasance, Erin D.; O'Meara, Sarah; Li, Heng; Santarius, Thomas; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Hardy, Claire; Teague, Jon W.; Menzies, Andrew; Goodhead, Ian; Turner, Daniel J.; Clee, Christopher M.; Quail, Michael A.; Cox, Antony; Brown, Clive; Durbin, Richard; Hurles, Matthew E.; Bignell, Graham R.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Edwards, Paul A. W.] Univ Cambridge, Hutchison Med Res Council, Res Ctr, Cambridge CB2 0XZ, England; [Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge CB2 0XZ, England; [Santarius, Thomas] Univ Cambridge, Dept Neurosurg, Cambridge CB2 2QQ, England		Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk; paf@sanger.ac.uk	Edwards, Paul A/M-8291-2014; Quail, michael/ABE-6131-2020; Durbin, Richard/AAE-7178-2019; Goodhead, Ian/ABC-9200-2020; Li, Heng/D-9344-2011	Edwards, Paul A/0000-0002-4789-3374; Durbin, Richard/0000-0002-9130-1006; Li, Heng/0000-0003-4874-2874; Goodhead, Ian/0000-0002-3110-9442; Santarius, Thomas/0000-0002-1416-9566	Wellcome TrustWellcome TrustEuropean Commission [077012, 088340] Funding Source: Medline		Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Cahill D, 2006, FRONT BIOSCI-LANDMRK, V11, P1958, DOI 10.2741/1938; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gazdar AF, 1996, J CELL BIOCHEM, P1; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grigorova M, 2005, CANCER GENET CYTOGEN, V162, P1, DOI 10.1016/j.cancergencyto.2005.03.007; HOWARTH KD, 2007, ONCOGENE ADV, DOI DOI 10.1038/SJ.ONC.1210993; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Robinson KO, 2005, MAMM GENOME, V16, P32, DOI 10.1007/s00335-004-2423-z; Rozier L, 2004, ONCOGENE, V23, P6872, DOI 10.1038/sj.onc.1207809; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wu GJ, 2000, CANCER RES, V60, P5371	24	593	608	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					722	729		10.1038/ng.128			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	WOS:000256212000014	18438408	Green Accepted			2022-01-24	
J	Karafet, TM; Mendez, FL; Meilerman, MB; Underhill, PA; Zegura, SL; Hammer, MF				Karafet, Tatiana M.; Mendez, Fernando L.; Meilerman, Monica B.; Underhill, Peter A.; Zegura, Stephen L.; Hammer, Michael F.			New binary polymorphisms reshape and increase resolution of the human Y chromosomal haplogroup tree	GENOME RESEARCH			English	Article							POPULATION-STRUCTURE; EAST-ASIA; CONTRASTING PATTERNS; SEQUENCE VARIATION; MITOCHONDRIAL-DNA; HUNTER-GATHERER; SOUTHEAST-ASIA; ORIGINS; MIGRATION; MTDNA	Markers on the non-recombining portion of the human Y chromosome continue to have applications in many fields including evolutionary biology, forensics, medical genetics, and genealogical reconstruction. In 2002, the Y Chromosome Consortium published a single parsimony tree showing the relationships among 153 haplogroups based on 243 binary markers and devised a standardized nomenclature system to name lineages nested within this tree. Here we present an extensively revised Y chromosome tree containing 311 distinct haplogroups, including two new major haplogroups (S and T), and incorporating approximately 600 binary markers. We describe major changes in the topology of the parsimony tree and provide names for new and rearranged lineages within the tree following the rules presented by the Y Chromosome Consortium in 2002. Several changes in the tree topology have important implications for studies of human ancestry. We also present demography-independent age estimates for 11 of the major clades in the new Y chromosome tree.	[Karafet, Tatiana M.; Mendez, Fernando L.; Meilerman, Monica B.; Hammer, Michael F.] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA; [Mendez, Fernando L.; Hammer, Michael F.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Underhill, Peter A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Zegura, Stephen L.; Hammer, Michael F.] Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA		Hammer, MF (corresponding author), Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA.	mfh@u.arizona.edu		Mendez, Fernando/0000-0002-0879-3813			Adams SM, 2006, FORENSIC SCI INT, V159, P14, DOI 10.1016/j.forsciint.2005.06.003; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Calafell F, 2002, GENOME RES, V12, P219, DOI 10.1101/gr.226502; Cann HM, 2002, SCIENCE, V296, P261; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cox MP, 2007, HUM BIOL, V79, P525; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Ellis N, 2002, GENOME RES, V12, P339; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 2003, GENETICS, V164, P1495; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Hurles ME, 2002, GENETICS, V160, P289; Jobling M.A, 2004, HUMAN EVOLUTIONARY G; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; King TE, 2007, AM J PHYS ANTHROPOL, V132, P584, DOI 10.1002/ajpa.20557; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Nasidze I, 2005, ANN HUM GENET, V69, P401, DOI 10.1046/j.1529-8817.2005.00174.x; Nonaka I, 2007, ANN HUM GENET, V71, P480, DOI 10.1111/j.1469-1809.2006.00343.x; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Scheinfeldt L, 2006, MOL BIOL EVOL, V23, P1628, DOI 10.1093/molbev/msl028; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Sims Lynn M, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9469; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Tang H, 2002, GENETICS, V161, P447; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zerjal T, 2007, HUM GENET, V121, P137, DOI 10.1007/s00439-006-0282-2	59	593	633	1	60	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2008	18	5					830	838		10.1101/gr.7172008			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	295WK	WOS:000255504600015	18385274	Green Published, Bronze			2022-01-24	
J	Weedon, MN; Lango, H; Lindgren, CM; Wallace, C; Evans, DM; Mangino, M; Freathy, RM; Perry, JRB; Stevens, S; Hall, AS; Samani, NJ; Shields, B; Prokopenko, I; Farrall, M; Dominiczak, A; Johnson, T; Bergmann, S; Beckmann, JS; Vollenweider, P; Waterworth, DM; Mooser, V; Palmer, CNA; Morris, AD; Ouwehand, WH; Caulfield, M; Munroe, PB; Hattersley, AT; McCarthy, MI; Frayling, TM				Weedon, Michael N.; Lango, Hana; Lindgren, Cecilia M.; Wallace, Chris; Evans, David M.; Mangino, Massimo; Freathy, Rachel M.; Perry, John R. B.; Stevens, Suzanne; Hall, Alistair S.; Samani, Nilesh J.; Shields, Beverly; Prokopenko, Inga; Farrall, Martin; Dominiczak, Anna; Johnson, Toby; Bergmann, Sven; Beckmann, Jacques S.; Vollenweider, Peter; Waterworth, Dawn M.; Mooser, Vincent; Palmer, Colin N. A.; Morris, Andrew D.; Ouwehand, Willem H.; Caulfield, Mark; Munroe, Patricia B.; Hattersley, Andrew T.; McCarthy, Mark I.; Frayling, Timothy M.		Diabet Genetics Initiat; Wellcome Trust Case Control Consor; Cambridge GEM Consortium	Genome-wide association analysis identifies 20 loci that influence adult height	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; BODY HEIGHT; SUSCEPTIBILITY; POPULATION; STRATIFICATION; OSTEOARTHRITIS; HERITABILITY; EXPRESSION; STATURE; COHORTS	Adult height is a model polygenic trait, but there has been limited success in identifying the genes underlying its normal variation. To identify genetic variants influencing adult human height, we used genome-wide association data from 13,665 individuals and genotyped 39 variants in an additional 16,482 samples. We identified 20 variants associated with adult height ( P < 5 x 10(-7), with 10 reaching P < 1 iota x 10(-10)). Combined, the 20 SNPs explain similar to 3% of height variation, with a similar to 5 cm difference between the 6.2% of people with iota 7 or fewer 'tall' alleles compared to the 5.5% with 27 or more 'tall' alleles. The loci we identified implicate genes in Hedgehog signaling ( IHH, HHIP, PTCH1), extracellular matrix ( EFEMP1, ADAMTSL3, ACAN) and cancer ( CDK6, HMGA2, DLEU7) pathways, and provide new insights into human growth and developmental processes. Finally, our results provide insights into the genetic architecture of a classic quantitative trait.	[Weedon, Michael N.; Lango, Hana; Freathy, Rachel M.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Penn Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Weedon, Michael N.; Lango, Hana; Freathy, Rachel M.; Perry, John R. B.; Shields, Beverly; Hattersley, Andrew T.; Frayling, Timothy M.] Penn Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Wallace, Chris; Munroe, Patricia B.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [Evans, David M.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2PR, Avon, England; [Mangino, Massimo; Stevens, Suzanne; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Alistair S.] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Dominiczak, Anna] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Johnson, Toby; Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Johnson, Toby] CHU Vaudois, Inst Univ Med Sociale & Prevent, CH-1011 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Vollenweider, Peter] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA 19406 USA; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut, Dundee DD1 9SY, Scotland; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 2BT, England; [Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 2BT, England		Frayling, TM (corresponding author), Penn Med Sch, Inst Biomed & Clin Sci, Genet Complex Traits,Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Palmer, Colin NA/C-7053-2008; Prokopenko, Inga/H-3241-2014; Dominiczak, Anna F/D-2262-2009; Prokopenko, Inga/AAU-9895-2020; Colaus, PsyColaus/K-6607-2013; Evans, David M/H-6325-2013; Dominiczak, Anna F/P-9390-2017; mangino, massimo/F-5134-2011; Study, GoDARTS/K-9448-2016; Cambridge, G/N-3776-2015; Beckmann, Jacques S/A-9772-2008; Hall, Alistair/K-1953-2019; Allen, Hana Lango/G-9026-2012; Morris, Andrew D/C-2837-2009; Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015; Loos, Ruth/Q-2862-2016	Palmer, Colin NA/0000-0002-6415-6560; Prokopenko, Inga/0000-0003-1624-7457; Evans, David M/0000-0003-0663-4621; Dominiczak, Anna F/0000-0003-4913-3608; mangino, massimo/0000-0002-2167-7470; Cambridge, G/0000-0002-6022-6322; Beckmann, Jacques S/0000-0002-9741-1900; Allen, Hana Lango/0000-0002-7803-8688; Deloukas, Panos/0000-0001-9251-070X; Wallace, Chris/0000-0001-9755-1703; Inouye, Michael/0000-0001-9413-6520; Hattersley, Andrew/0000-0001-5620-473X; Barroso, Ines/0000-0001-5800-4520; McCarthy, Mark/0000-0002-4393-0510; Lindgren, Cecilia/0000-0002-4903-9374; Munroe, Patricia/0000-0002-4176-2947; Wheeler, Eleanor/0000-0002-8616-6444; Frayling, Timothy/0000-0001-8362-2603; Bergmann, Sven/0000-0002-6785-9034; Johnson, Toby/0000-0002-5998-3270; Caulfield, Mark/0000-0001-9295-3594; Hall, Alistair/0000-0003-0306-7887; Soranzo, Nicole/0000-0003-1095-3852; Loos, Ruth/0000-0002-8532-5087; Weedon, Michael/0000-0002-6174-6135; Freathy, Rachel/0000-0003-4152-2238	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U106188470, G0701863, G0600705, G9521010] Funding Source: UKRI; British Heart FoundationBritish Heart Foundation [PG/02/128/14470, PG02/128, FS/05/061/19501] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9521010(63660), G9521010D, G0701863, G0600705, MC_U106188470, G9521010] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [076113, 090532, 077016, 077011] Funding Source: Medline		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fisher RA, 1918, PHILOS T ROYAL SOC E, V52, P399, DOI DOI 10.1017/S0080456800012163; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; LETTRE G, 2008, NAT GENET; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MARQUESVIDAL P, 2007, EUR J CLIN NUTR ADV; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; STIRLING WD, 1982, STATISTICIAN, V31, P211; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	27	593	611	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					575	583		10.1038/ng.121			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	WOS:000255366700025	18391952	Green Accepted, Green Published			2022-01-24	
J	Wang, PJ; McCarrey, JR; Yang, F; Page, DC				Wang, PJ; McCarrey, JR; Yang, F; Page, DC			An abundance of X-linked genes expressed in spermatogonia	NATURE GENETICS			English	Article							RADIATION HYBRID MAP; MOUSE Y-CHROMOSOME; GERM-CELLS; SEX-CHROMOSOMES; MEIOTIC DRIVE; DAZ GENE; STERILITY; EVOLUTION; HOMOLOG; EXPLANATION	Spermatogonia are the self-renewing, mitotic germ cells of the testis from which sperm arise by means of the differentiation pathway known as spermatogenesis'. By contrast with hematopoietic and other mammalian stem-cell populations. which have been subjects of intense molecular genetic investigation, spermatogonia have remained largely unexplored at the molecular level. Here we describe a systematic search for genes expressed in mouse spermatogonia, but not in somatic tissues. We identified 25 genes (19 of which are novel) that are expressed in only mate germ cells. Of the 25 genes, 3 are Y-linked and 10 are X-linked. If these genes had been distributed randomly in the genome, one would have expected zero to two of the genes to be X-linked. Our findings indicate that the X chromosome has a predominant role in pre-meiotic stages of mammalian spermatogenesis. We hypothesize that the X chromosome acquired this prominent role in male germ-cell development as it evolved from an ordinary, unspecialized autosome.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Whitehead Inst, Cambridge, MA USA; MIT, Dept Biol, Cambridge, MA USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA		Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.			Yang, Fengtang/0000-0002-3573-2354			BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bergstrom DE, 1998, GENOMICS, V48, P304, DOI 10.1006/geno.1997.5176; Brooks R, 2000, NATURE, V406, P67, DOI 10.1038/35017552; CHARLESWORTH B, 1993, GENETICS, V133, P421; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Elliott DJ, 1996, HUM MOL GENET, V5, P869, DOI 10.1093/hmg/5.7.869; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Graves JAM, 1998, CYTOGENET CELL GENET, V80, P94, DOI 10.1159/000014963; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; Hurst LD, 1999, TRENDS GENET, V15, P383, DOI 10.1016/S0168-9525(99)01809-0; HURST LD, 1991, GENETICS, V128, P841; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lavery DJ, 1997, P NATL ACAD SCI USA, V94, P6831, DOI 10.1073/pnas.94.13.6831; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; MORRISONGRAHAM K, 1993, BIOESSAYS, V15, P77, DOI 10.1002/bies.950150202; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI [10.2307/2408385, 10.1111/j.1558-5646.1984.tb00346.x]; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962	30	593	647	3	34	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					422	426		10.1038/86927			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	WOS:000167811200018	11279525				2022-01-24	
J	Calon, A; Lonardo, E; Berenguer-Llergo, A; Espinet, E; Hernando-Momblona, X; Iglesias, M; Sevillano, M; Palomo-Ponce, S; Tauriello, DVF; Byrom, D; Cortina, C; Morral, C; Barcelo, C; Tosi, S; Riera, A; Attolini, CSO; Rossell, D; Sancho, E; Batlle, E				Calon, Alexandre; Lonardo, Enza; Berenguer-Llergo, Antonio; Espinet, Elisa; Hernando-Momblona, Xavier; Iglesias, Mar; Sevillano, Marta; Palomo-Ponce, Sergio; Tauriello, Daniele V. F.; Byrom, Daniel; Cortina, Carme; Morral, Clara; Barcelo, Carles; Tosi, Sebastien; Riera, Antoni; Attolini, Camille Stephan-Otto; Rossell, David; Sancho, Elena; Batlle, Eduard			Stromal gene expression defines poor-prognosis subtypes in colorectal cancer	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; HUMAN-COLON; TGF-BETA; STEM-CELL; MOLECULAR SUBTYPES; TUMOR-GROWTH; GENOME; RECEPTOR; TUMORIGENESIS; METASTASIS	Recent molecular classifications of colorectal cancer (CRC) based on global gene expression profiles have defined subtypes displaying resistance to therapy and poor prognosis. Upon evaluation of these classification systems, we discovered that their predictive power arises from genes expressed by stromal cells rather than epithelial tumor cells. Bioinformatic and immunohistochemical analyses identify stromal markers that associate robustly with disease relapse across the various classifications. Functional studies indicate that cancer-associated fibroblasts (CAFs) increase the frequency of tumor-initiating cells, an effect that is dramatically enhanced by transforming growth factor (TGF)-beta signaling. Likewise, we find that all poor-prognosis CRC subtypes share a gene program induced by TGF-beta in tumor stromal cells. Using patient-derived tumor organoids and xenografts, we show that the use of TGF-beta signaling inhibitors to block the cross-talk between cancer cells and the microenvironment halts disease progression.	[Calon, Alexandre; Lonardo, Enza; Berenguer-Llergo, Antonio; Espinet, Elisa; Hernando-Momblona, Xavier; Sevillano, Marta; Palomo-Ponce, Sergio; Tauriello, Daniele V. F.; Byrom, Daniel; Cortina, Carme; Morral, Clara; Barcelo, Carles; Tosi, Sebastien; Riera, Antoni; Attolini, Camille Stephan-Otto; Rossell, David; Sancho, Elena; Batlle, Eduard] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Iglesias, Mar] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Iglesias, Mar] Hosp del Mar, Res Inst IMIM, Canc Res Program, Barcelona, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Batlle, Eduard] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain		Batlle, E (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.	eduard.batlle@irbbarcelona.org	Sancho, Elena/ABH-4867-2020; Riera, Antoni/C-4385-2008; Palomo-Ponce, Sergio/L-2749-2017; Rossell, David/AAM-4292-2021; Batlle, Eduard/K-8080-2014; lonardo, enza/AAI-5726-2020; Hernando-Momblona, Xavier/ABH-4881-2020; Cortina Duran, Carme/K-7203-2017; Espinet, Elisa/ABI-5385-2020; Tauriello, Daniele/H-4644-2018	Sancho, Elena/0000-0002-8182-513X; Riera, Antoni/0000-0001-7142-7675; Palomo-Ponce, Sergio/0000-0002-3371-6457; Rossell, David/0000-0002-7104-5789; Batlle, Eduard/0000-0003-2422-0326; Cortina Duran, Carme/0000-0003-3477-4322; Espinet, Elisa/0000-0002-0690-9878; Tauriello, Daniele/0000-0003-1522-3496; Stephan-Otto Attolini, Camille/0000-0001-8045-320X; Berenguer-LLergo, Antoni/0000-0002-3742-8161; SEVILLANO, MARTA/0000-0001-5761-0879; Tosi, Sebastien/0000-0001-8348-2778; Lonardo, Enza/0000-0001-6654-1043; Hernando-Momblona, Xavier/0000-0003-0755-333X	Spanish Ministry of Economy and CompetitivenessSpanish Government; Fundacion Olga Torres; Doctor Josef Steiner Foundation; AECC; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [RTICC:RD12/0036/0024]; Xarxa de Bancs de Tumors - Pla Director d'Oncologia de Catalunya (XBTC); Asociacion Espanola contra el Cancer (AECC);  [SAF2011-27068]; ICREAICREA Funding Source: Custom	We thank G. Stassi (University of Palermo) for providing PDO7 and PDO8, L. Wakefield (US National Cancer Institute) for providing the plasmid encoding DNR, I. Joval for assistance in mounting the figures, M. Virtudes Cespedes and R. Mangues (IIB Sant Pau) for logistic support with CRC samples, and all members of the Batlle laboratory for support and discussions We are grateful for the excellent assistance of the IRB Barcelona core facilities for Histology, Functional Genomics and Advanced Digital Micropscopy. D.V.F.T. holds a Juan de la Cierva postdoctoral fellowship, from the Spanish Ministry of Economy and Competitiveness, and E.L. holds a fellowship from Fundacion Olga Torres and Asociacion Espanola contra el Cancer (AECC). This work has been supported by grants from the Doctor Josef Steiner Foundation, AECC, Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III (RTICC:RD12/0036/0024) and grant SAF2011-27068, the latter two from the Spanish Ministry of Economy and Competitiveness, and by 'Xarxa de Bancs de Tumors' sponsored by Pla Director d'Oncologia de Catalunya (XBTC).	Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berdiel-Acer M, 2014, ONCOTARGET, V5, P6437, DOI 10.18632/oncotarget.2237; Bottinger EP, 1997, CANCER RES, V57, P5564; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; MORIKAWA K, 1988, CANCER RES, V48, P1943; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; O'Shannessy DJ, 2014, ONCOTARGET, V5, P3983, DOI 10.18632/oncotarget.2108; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pathmanathan S, 2011, BIOCHEM SOC T, V39, P694, DOI 10.1042/BST0390694; R Core Team, 2014, R LANGUAGE ENV STAT; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Witten I.H., 1999, ICONIP ANZIIS ANNES, V99, P192; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	54	592	599	4	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					320	U62		10.1038/ng.3225			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	WOS:000351922900006	25706628	Green Accepted	Y	N	2022-01-24	
J	Huang, XY; Yuan, TZ; Tschannen, M; Sun, ZF; Jacob, H; Du, MJ; Liang, MH; Dittmar, RL; Liu, Y; Liang, MY; Kohli, M; Thibodeau, SN; Boardman, L; Wang, L				Huang, Xiaoyi; Yuan, Tiezheng; Tschannen, Michael; Sun, Zhifu; Jacob, Howard; Du, Meijun; Liang, Meihua; Dittmar, Rachel L.; Liu, Yong; Liang, Mingyu; Kohli, Manish; Thibodeau, Stephen N.; Boardman, Lisa; Wang, Liang			Characterization of human plasma-derived exosomal RNAs by deep sequencing	BMC GENOMICS			English	Article						Exosome; microRNA; Next generation sequencing; Plasma; Biomarker	DIAGNOSTIC BIOMARKERS; CELL-DIFFERENTIATION; CEREBROSPINAL-FLUID; PROTEOMIC ANALYSIS; PROSTATE-CANCER; DENDRITIC CELLS; MESSENGER-RNAS; GASTRIC-CANCER; OVARIAN-CANCER; HUMAN SALIVA	Background: Exosomes, endosome-derived membrane microvesicles, contain specific RNA transcripts that are thought to be involved in cell-cell communication. These RNA transcripts have great potential as disease biomarkers. To characterize exosomal RNA profiles systemically, we performed RNA sequencing analysis using three human plasma samples and evaluated the efficacies of small RNA library preparation protocols from three manufacturers. In all we evaluated 14 libraries (7 replicates). Results: From the 14 size-selected sequencing libraries, we obtained a total of 101.8 million raw single-end reads, an average of about 7.27 million reads per library. Sequence analysis showed that there was a diverse collection of the exosomal RNA species among which microRNAs (miRNAs) were the most abundant, making up over 42.32% of all raw reads and 76.20% of all mappable reads. At the current read depth, 593 miRNAs were detectable. The five most common miRNAs (miR-99a-5p, miR-128, miR-124-3p, miR-22-3p, and miR-99b-5p) collectively accounted for 48.99% of all mappable miRNA sequences. MiRNA target gene enrichment analysis suggested that the highly abundant miRNAs may play an important role in biological functions such as protein phosphorylation, RNA splicing, chromosomal abnormality, and angiogenesis. From the unknown RNA sequences, we predicted 185 potential miRNA candidates. Furthermore, we detected significant fractions of other RNA species including ribosomal RNA (9.16% of all mappable counts), long non-coding RNA (3.36%), piwi-interacting RNA (1.31%), transfer RNA (1.24%), small nuclear RNA (0.18%), and small nucleolar RNA (0.01%); fragments of coding sequence (1.36%), 5' untranslated region (0.21%), and 3' untranslated region (0.54%) were also present. In addition to the RNA composition of the libraries, we found that the three tested commercial kits generated a sufficient number of DNA fragments for sequencing but each had significant bias toward capturing specific RNAs. Conclusions: This study demonstrated that a wide variety of RNA species are embedded in the circulating vesicles. To our knowledge, this is the first report that applied deep sequencing to discover and characterize profiles of plasma-derived exosomal RNAs. Further characterization of these extracellular RNAs in diverse human populations will provide reference profiles and open new doors for the development of blood-based biomarkers for human diseases.	[Huang, Xiaoyi; Yuan, Tiezheng; Du, Meijun; Dittmar, Rachel L.; Wang, Liang] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Huang, Xiaoyi; Yuan, Tiezheng; Du, Meijun; Dittmar, Rachel L.; Wang, Liang] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Tschannen, Michael; Jacob, Howard] Med Coll Wisconsin, Human Mol Genet Ctr, Milwaukee, WI 53226 USA; [Sun, Zhifu] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Liang, Meihua] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin 150086, Peoples R China; [Liu, Yong; Liang, Mingyu] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Kohli, Manish; Boardman, Lisa] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA		Wang, L (corresponding author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.	liwang@mcw.edu	Liang, Mingyu/A-2331-2008; Kohli, Manish/AAN-8862-2021	Sun, Zhifu/0000-0001-8461-7523; Huang, Xiaoyi/0000-0002-2355-5688; Dittmar, Rachel/0000-0002-0567-2450	Advancing a Healthier Wisconsin fund; National Institute of Health (NIH), USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL082798, HL111580]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R21HL111580, P01HL082798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK084567] Funding Source: NIH RePORTER	This study was supported by the Advancing a Healthier Wisconsin fund to LW and the National Institute of Health (NIH), USA (Grant Nos: HL082798 and HL111580 to ML). We thank Kimberly Cook and Ruth Johnson at the Mayo Clinic for preparing the samples. We also thank Sequencing Core at the Medical College of Wisconsin for sequencing consultation and support.	Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Alge JL, 2010, BLOOD, V116, P547; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Ben-Dov IZ, 2011, AM J KIDNEY DIS, V57, pA24; Biederbick Annette, 2004, BMC Biochemistry, V5, P8, DOI 10.1186/1471-2091-5-8; Blanc L, 2005, BLOOD CELL MOL DIS, V35, P21, DOI 10.1016/j.bcmd.2005.04.008; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Ciesla M, 2011, ANAL BIOANAL CHEM, V401, P2051, DOI 10.1007/s00216-011-5001-8; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Conde-Vancells J, 2010, PROTEOM CLIN APPL, V4, P416, DOI 10.1002/prca.200900103; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Harada H, 2012, AM J TRANSPLANT, V12, P369; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Johansson SM, 2006, J IMMUNOL, V176, pS184; Jones JC, 2011, INT J RADIAT ONCOL, V81, pS754, DOI 10.1016/j.ijrobp.2011.06.1254; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lance RS, 2011, EXPERT REV ANTICANC, V11, P1341, DOI [10.1586/ERA.11.134, 10.1586/era.11.134]; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu YL, 2010, AM J PATHOL, V176, P2490, DOI 10.2353/ajpath.2010.090777; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Lv Xiao-Bin, 2011, Chin J Cancer, V30, P821, DOI 10.5732/cjc.011.10289; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Paredes PT, 2012, ALLERGY, V67, P911, DOI 10.1111/j.1398-9995.2012.02835.x; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peng P, 2011, ONCOL REP, V25, P749, DOI 10.3892/or.2010.1119; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rupp AK, 2011, GYNECOL ONCOL, V122, P437, DOI 10.1016/j.ygyno.2011.04.035; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhong HJ, 2011, INT J HYPERTHER, V27, P604, DOI 10.3109/02656736.2011.564598	70	592	622	12	179	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 10	2013	14								319	10.1186/1471-2164-14-319			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	144MQ	WOS:000318944200001	23663360	Green Published, gold	Y	N	2022-01-24	
J	Shomura, A; Izawa, T; Ebana, K; Ebitani, T; Kanegae, H; Konishi, S; Yano, M				Shomura, Ayahiko; Izawa, Takeshi; Ebana, Kaworu; Ebitani, Takeshi; Kanegae, Hiromi; Konishi, Saeko; Yano, Masahiro			Deletion in a gene associated with grain size increased yields during rice domestication	NATURE GENETICS			English	Article							SELECTION; MUTATION; ORIGIN; WHEAT	The domestication of crops involves a complex process of selection in plant evolution and is associated with changes in the DNA regulating agronomically important traits. Here we report the cloning of a newly identified QTL, qSW5 (QTL for seed width on chromosome 5), involved in the determination of grain width in rice. Through fine mapping, complementation testing and association analysis, we found that a deletion in qSW5 resulted in a significant increase in sink size owing to an increase in cell number in the outer glume of the rice flower; this trait might have been selected by ancient humans to increase yield of rice grains. In addition, we mapped two other defective functional nucleotide polymorphisms of rice domestication-related genes with genome-wide RFLP polymorphisms of various rice landraces. These analyses show that the qSW5 deletion had an important historical role in artificial selection, propagation of cultivation and natural crossings in rice domestication, and shed light on how the rice genome was domesticated.	[Izawa, Takeshi; Konishi, Saeko] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Shomura, Ayahiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Ebana, Kaworu; Kanegae, Hiromi; Yano, Masahiro] Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Ebitani, Takeshi] Toyama Agr Res Ctr, Toyama 9398153, Japan		Izawa, T (corresponding author), Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	tizawa@nias.affrc.go.jp	Kajiya-Kanegae, Hiromi/AAA-2951-2020; Yano, Masahiro/AAC-5441-2019	Kajiya-Kanegae, Hiromi/0000-0002-5719-7559; 			Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; DARWIN C, 1857, VARIATIONS ANIMALS P; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Hong SK, 1996, DEVELOPMENT, V122, P2051; Isshiki M, 1998, PLANT J, V15, P133, DOI 10.1046/j.1365-313X.1998.00189.x; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Olsen KM, 2002, GENETICS, V162, P941; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1744-7909.2007.00510.x; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	23	592	724	11	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					1023	1028		10.1038/ng.169			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	WOS:000258026900021	18604208				2022-01-24	
J	Becht, E; Giraldo, NA; Lacroix, L; Buttard, B; Elarouci, N; Petitprez, F; Selves, J; Laurent-Puig, P; Sautes-Fridman, C; Fridman, WH; de Reynies, A				Becht, Etienne; Giraldo, Nicolas A.; Lacroix, Laetitia; Buttard, Benedicte; Elarouci, Nabila; Petitprez, Florent; Selves, Janick; Laurent-Puig, Pierre; Sautes-Fridman, Catherine; Fridman, Wolf H.; de Reynies, Aurelien			Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression	GENOME BIOLOGY			English	Article						Transcriptomic markers; Gene signatures; Deconvolution; Tumor microenvironment	TERTIARY LYMPHOID STRUCTURES; CONTEXTURE; DECONVOLUTION; LANDSCAPE	We introduce the Microenvironment Cell Populations-counter (MCP-counter) method, which allows the robust quantification of the absolute abundance of eight immune and two stromal cell populations in heterogeneous tissues from transcriptomic data. We present in vitro mRNA mixture and ex vivo immunohistochemical data that quantitatively support the validity of our method's estimates. Additionally, we demonstrate that MCP-counter overcomes several limitations or weaknesses of previously proposed computational approaches. MCP-counter is applied to draw a global picture of immune infiltrates across human healthy tissues and non-hematopoietic human tumors and recapitulates microenvironment-based patient stratifications associated with overall survival in lung adenocarcinoma and colorectal and breast cancer.	[Becht, Etienne; Giraldo, Nicolas A.; Lacroix, Laetitia; Buttard, Benedicte; Petitprez, Florent; Sautes-Fridman, Catherine; Fridman, Wolf H.] INSERM UMR S 1138, Canc Immune Control & Escape, Cordeliers Res Ctr, Paris, France; [Becht, Etienne; Giraldo, Nicolas A.; Lacroix, Laetitia; Buttard, Benedicte; Petitprez, Florent; Sautes-Fridman, Catherine; Fridman, Wolf H.] Univ Paris 05, Paris, France; [Becht, Etienne; Giraldo, Nicolas A.; Lacroix, Laetitia; Buttard, Benedicte; Petitprez, Florent; Sautes-Fridman, Catherine; Fridman, Wolf H.] Univ Paris 06, Paris, France; [Becht, Etienne; Elarouci, Nabila; Petitprez, Florent; de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs, Paris, France; [Selves, Janick] Univ Toulouse 3, Ctr Rech Cancerol Toulouse, UMR 1037, INSERM, Toulouse, France; [Selves, Janick] Ctr Hosp Univ Toulouse, Dept Pathol, Toulouse, France; [Laurent-Puig, Pierre] INSERM, UMR S1147, Paris, France		de Reynies, A (corresponding author), Ligue Natl Canc, Programme Cartes Identite Tumeurs, Paris, France.	aurelien.DeReynies@ligue-cancer.net	de Reynies, Aurelien/Q-8640-2017; Laurent-Puig, Pierre/K-3641-2019; Giraldo, Nicolas/U-6521-2017; Petitprez, Florent/AAD-5296-2020	de Reynies, Aurelien/0000-0002-1328-5290; Laurent-Puig, Pierre/0000-0001-8475-5459; Giraldo, Nicolas/0000-0002-7452-1103; Petitprez, Florent/0000-0002-5117-6466; sautes-fridman, catherine/0000-0003-1735-8722; fridman, wolf herman/0000-0002-1332-0973	Institut National de la Sante et de la Recherche MedicaleInstitut National de la Sante et de la Recherche Medicale (Inserm); University Paris-Descartes; University Pierre et Marie Curie; Institut National du CancerInstitut National du Cancer (INCA) France [2011-1-PLBIO-06-INSERM 6-1, PLBIO09-088-IDF-KROEMER]; CARPEM (CAncer Research for PErsonalized Medicine); Labex Immuno-Oncology [LAXE62_9UMS872 FRIDMAN]; Fondation ARC pour la recherche sur le cancerFondation ARC pour la Recherche sur le Cancer; Canceropole Ile-de-FranceRegion Ile-de-France; Universidad de los Andes School of Medicine; ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias; CARPEM post-doctorate fellowship; PPATH doctorate fellowship	This work was supported by the "Institut National de la Sante et de la Recherche Medicale", the University Paris-Descartes, the University Pierre et Marie Curie, the Institut National du Cancer (2011-1-PLBIO-06-INSERM 6-1), CARPEM (CAncer Research for PErsonalized Medicine), Labex Immuno-Oncology (LAXE62_9UMS872 FRIDMAN), the Fondation ARC pour la recherche sur le cancer, the Canceropole Ile-de-France, Institut National du Cancer (2011-1-PLBIO-06-INSERM 6-1, PLBIO09-088-IDF-KROEMER), the Universidad de los Andes School of Medicine (NAG), Colciencias (NAG). EB is supported by CARPEM post-doctorate fellowship and NAG by PPATH doctorate fellowship.	Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; Becht E, 2016, ADV IMMUNOL, V130, P95, DOI 10.1016/bs.ai.2015.12.002; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brown SD, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0248-x; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Fehrmann RSN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001656; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Giraldo NA, 2015, CLIN CANCER RES, V21, P3031, DOI 10.1158/1078-0432.CCR-14-2926; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Gong T, 2013, BIOINFORMATICS, V29, P1083, DOI 10.1093/bioinformatics/btt090; Iglesia MD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw144; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	27	591	591	3	27	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	OCT 20	2016	17								218	10.1186/s13059-016-1070-5			20	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	DZ3RL	WOS:000385766600001	27765066	Green Published, gold	Y	N	2022-01-24	
J	TRENT, C; TSUNG, N; HORVITZ, HR				TRENT, C; TSUNG, N; HORVITZ, HR			EGG-LAYING DEFECTIVE-MUTANTS OF THE NEMATODE CAENORHABDITIS-ELEGANS	GENETICS			English	Article											TRENT, C (corresponding author), MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM024943, R37GM024663, R01GM024663] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD00369] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM24663, GM24943, GM07287] Funding Source: Medline		ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BENTLEY D, 1975, SCIENCE, V187, P760, DOI 10.1126/science.1114323; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CULOTTI JG, 1978, GENETICS, V90, P243; DUSENBERY DB, 1975, GENETICS, V80, P297; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; EVANS PD, 1978, J EXP BIOL, V73, P235; Goodman L., 1975, PHARM BASIS THERAPEU; GREENWALD IS, 1980, GENETICS, V96, P147; HALL JC, 1979, GENETICS, V92, P437; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Herman R.K., 1980, P227; HERMAN RK, 1978, GENETICS, V88, P49; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; HODGKIN J, 1980, GENETICS, V96, P649; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1983, GENETICS, V103, P43; HODGKIN JA, 1977, GENETICS, V86, P275; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; HORVITZ HR, 1980, GENETICS, V96, P435; HORVITZ R, 1982, NEUROSCI COMMENT, V1, P56; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; MULLEN RJ, 1979, NEUROGENETICS GENETI, P173; Pak W.L., 1979, P67; RIDDLE D, 1982, GENETICS MAPS, P244; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON J, 1983, DEV BIOL; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; TRENT C, 1982, THESIS MASSACHUSETTS; von Ehrenstein G., 1980, P1; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WATERSTON RH, 1977, J MOL BIOL, V117, P679, DOI 10.1016/0022-2836(77)90064-X; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	52	591	657	0	41	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1983	104	4					619	647					29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RB320	WOS:A1983RB32000005	11813735				2022-01-24	
J	Wang, SK; Wu, K; Yuan, QB; Liu, XY; Liu, ZB; Lin, XY; Zeng, RZ; Zhu, HT; Dong, GJ; Qian, Q; Zhang, GQ; Fu, XD				Wang, Shaokui; Wu, Kun; Yuan, Qingbo; Liu, Xueying; Liu, Zhengbin; Lin, Xiaoyan; Zeng, Ruizhen; Zhu, Haitao; Dong, Guojun; Qian, Qian; Zhang, Guiquan; Fu, Xiangdong			Control of grain size, shape and quality by OsSPL16 in rice	NATURE GENETICS			English	Article							ORYZA-SATIVA L.; SBP-BOX GENE; ARABIDOPSIS-THALIANA; NATURAL VARIATION; TRANSCRIPTION FACTORS; YIELD; QTL; ARCHITECTURE; EXPRESSION; RESPONSES	Grain size and shape are important components of grain yield and quality and have been under selection since cereals were first domesticated. Here, we show that a quantitative trait locus GW8 is synonymous with OsSPL16, which encodes a protein that is a positive regulator of cell proliferation. Higher expression of this gene promotes cell division and grain filling, with positive consequences for grain width and yield in rice. Conversely, a loss-of-function mutation in Basmati rice is associated with the formation of a more slender grain and better quality of appearance. The correlation between grain size and allelic variation at the GW8 locus suggests that mutations within the promoter region were likely selected in rice breeding programs. We also show that a marker-assisted strategy targeted at elite alleles of GS3 and OsSPL16 underlying grain size and shape can be effectively used to simultaneously improve grain quality and yield.	[Wang, Shaokui; Wu, Kun; Yuan, Qingbo; Liu, Xueying; Liu, Zhengbin; Fu, Xiangdong] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Wang, Shaokui; Lin, Xiaoyan; Zeng, Ruizhen; Zhu, Haitao; Zhang, Guiquan] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Dong, Guojun; Qian, Qian] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China		Fu, XD (corresponding author), Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China.	gqzhang@scau.edu.cn; xdfu@genetics.ac.cn	qian, qian/AAH-8708-2021	Liu, Zhengbin/0000-0001-6638-2708	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2011CB915403, 2012AA10A301, 2009CB941501]; Chinese Academy of SciencesChinese Academy of Sciences [KSCX2EW-N-01, KSCX2-EW-J-4]; National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [31130070, U1031002, 30830074]	We thank X. Wei and the China National Rice Research Institute for providing rice germplasm samples. We also thank S. Ge for providing accessions of wild rice and W. Wang for help with nucleotide diversity analysis. This work was supported by grants from the Ministry of Science and Technology of China (2011CB915403, 2012AA10A301 and 2009CB941501), the Chinese Academy of Sciences (KSCX2EW-N-01 and KSCX2-EW-J-4) and the National Natural Science Foundation (31130070, U1031002 and 30830074).	Berckmans B, 2009, CURR OPIN PLANT BIOL, V12, P599, DOI 10.1016/j.pbi.2009.07.005; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fu XD, 2001, PLANT CELL, V13, P1791, DOI 10.1105/tpc.13.8.1791; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Khush G. S., 2000, P5; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xi ZY, 2006, GENOME, V49, P476, DOI 10.1139/G06-005; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Zhang G Q, 2004, RICE GENET NEWSL, V21, P85; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0	28	590	745	32	444	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					950	+		10.1038/ng.2327			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	WOS:000306854700024	22729225		Y	N	2022-01-24	
J	Rual, JF; Ceron, J; Koreth, J; Hao, T; Nicot, AS; Hirozane-Kishikawa, T; Vandenhaute, J; Orkin, SH; Hill, DE; van den Heuvel, S; Vidal, M				Rual, JF; Ceron, J; Koreth, J; Hao, T; Nicot, AS; Hirozane-Kishikawa, T; Vandenhaute, J; Orkin, SH; Hill, DE; van den Heuvel, S; Vidal, M			Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library	GENOME RESEARCH			English	Article							FUNCTIONAL GENOMIC ANALYSIS; DOUBLE-STRANDED-RNA; C-ELEGANS; GENETIC INTERFERENCE; CHROMOSOME-I; DNA; CONSTRUCTION; PHENOTYPES; RESOURCE; PROJECTS	The recently completed Caenorhabditis elegans genome sequence allows application of high-throughput (HT) approaches for phenotypic analyses using RNA interference (RNAi). As large phenotypic data sets become available, "phenoclustering" strategies can be used to begin understanding the complex molecular networks involved in development and other biological processes. The Current HT-RNAi resources represent a great asset for phenotypic profiling but are limited by lack of flexibility. For instance, existing resources do not take advantage of the latest improvements in RNAi technology, such as inducible hairpin RNAi. Here we show that a C. elegans ORFeome resource, generated with the Gateway cloning system, can be used as a starting point to generate alternative HT-RNAi resources with enhanced flexibility. The versatility inherent to the Gateway system suggests that additional HT-RNAi libraries can now be readily generated to perform gene knockdowns under various conditions, increasing the possibilities for phenome mapping in C, elegans.	Harvard Univ, Sch Med, Gen Hosp Canc Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Fac Univ Notre Dame Paix, B-5000 Namur, Belgium; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA		van den Heuvel, S (corresponding author), Harvard Univ, Sch Med, Gen Hosp Canc Ctr, Charlestown, MA 02129 USA.	heuvel@helix.mgh.harvard.edu; marc_vidal@dfci.harvard.edu	Hill, David E/B-6617-2011; van den Heuvel, Sander J.L./B-8892-2011; ceron, julian/AAA-8008-2019	van den Heuvel, Sander J.L./0000-0001-9015-7463; Ceron, Julian/0000-0003-4739-2243; Rual, Jean-Francois/0000-0003-4465-8819	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R33CA081658, P01CA095281] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [7 R33 CA81658-02, CA95281, P01 CA095281] Funding Source: Medline		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Cutter AD, 2003, GENOME RES, V13, P2651, DOI 10.1101/gr.1659203; DRICOT A, 2004, GENOME RES; DUPUY D, 2004, GENOME RES; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110; Hanazawa M, 2001, P NATL ACAD SCI USA, V98, P8686, DOI 10.1073/pnas.141004698; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; LAMESCH P, 2004, GENOMES RES; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Rual JF, 2004, CURR OPIN CHEM BIOL, V8, P20, DOI 10.1016/j.cbpa.2003.12.002; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tewari M, 2004, MOL CELL, V13, P469, DOI 10.1016/S1097-2765(04)00033-4; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vaglio P, 2003, NUCLEIC ACIDS RES, V31, P237, DOI 10.1093/nar/gkg092; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	41	590	595	1	23	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2004	14	10B					2162	2168		10.1101/gr.2505604			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	862TM	WOS:000224514000022	15489339	Green Published, Bronze			2022-01-24	
J	Pharoah, PDP; Antoniou, A; Bobrow, M; Zimmern, RL; Easton, DF; Ponder, BAJ				Pharoah, PDP; Antoniou, A; Bobrow, M; Zimmern, RL; Easton, DF; Ponder, BAJ			Polygenic susceptibility to breast cancer and implications for prevention	NATURE GENETICS			English	Article							RISK; FAMILY; BRCA1; WOMEN; TWINS	The knowledge of human genetic variation that will come from the human genome sequence makes feasible a polygenic approach to disease prevention, in which it will be possible to identify individuals as susceptible by their genotype profile and to prevent disease by targeting interventions to those at risk. There is doubt, however, regarding the magnitude of these genetic effects and thus the potential to apply them to either individuals or populations. We have therefore examined the potential for prediction of risk based on common genetic variation using data from a population-based series of individuals with breast cancer. The data are compatible with a log-normal distribution of genetic risk in the population that is sufficiently wide to provide useful discrimination of high- and low-risk groups. Assuming all of the susceptibility genes could be identified, the half of the population at highest risk would account for 88% of all affected individuals. By contrast, if currently identified risk factors for breast cancer were used to stratify the population, the half of the population at highest risk would account for only 62% of all cases. These results suggest that the construction and use of genetic-risk profiles may provide significant improvements in the efficacy of population-based programs of intervention for cancers and other diseases.	Strangeways Res Labs, Dept Oncol, Canc Res UK Human Canc Genet Grp, Cambridge CB1 8RN, England; Strangeways Res Labs, Publ Hlth Genet Unit, Cambridge CB1 8RN, England; Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Addenbrookes Hosp, Dept Clin Genet, Cambridge CB1 2QQ, England		Pharoah, PDP (corresponding author), Strangeways Res Labs, Dept Oncol, Canc Res UK Human Canc Genet Grp, Cambridge CB1 8RN, England.	paul.pharoah@srl.cam.ac.uk	Pharoah, Paul/V-6658-2019	Pharoah, Paul/0000-0001-8494-732X			Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; ANTONIOU AC, 2001, IN PRESS BR J CANC; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Friend SH, 1999, BRIT MED J, V319, P1306, DOI 10.1136/bmj.319.7220.1306; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Pharoah PDP, 1998, BREAST, V7, P255, DOI 10.1016/S0960-9776(98)90091-1; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Vaittinen P, 2000, INT J CANCER, V88, P998, DOI 10.1002/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2	20	590	600	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					33	36		10.1038/ng853			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	WOS:000175362500011	11984562	Green Submitted, Bronze			2022-01-24	
J	DIETRICH, WF; MILLER, JC; STEEN, RG; MERCHANT, M; DAMRON, D; NAHF, R; GROSS, A; JOYCE, DC; WESSEL, M; DREDGE, RD; MARQUIS, A; STEIN, LD; GOODMAN, N; PAGE, DC; LANDER, ES				DIETRICH, WF; MILLER, JC; STEEN, RG; MERCHANT, M; DAMRON, D; NAHF, R; GROSS, A; JOYCE, DC; WESSEL, M; DREDGE, RD; MARQUIS, A; STEIN, LD; GOODMAN, N; PAGE, DC; LANDER, ES			A GENETIC-MAP OF THE MOUSE WITH 4,006 SIMPLE SEQUENCE LENGTH POLYMORPHISMS	NATURE GENETICS			English	Article							LINKAGE MAP; HUMAN DNA; GENOME; CONSTRUCTION; MARKERS; SEX	We have constructed a genetic map of the mouse genome containing 4,006 simple sequence length polymorphims (SSLPs). The map provides an average spacing of 0.35 centiMorgans (cM) between markers, corresponding to about 750 kb. Approximately 90% of the genome lies within 1.1 cM of a marker and 99% lies within 2.2 cM. The markers have an average polymorphism rate of 50% in crosses between laboratory strains. The markers are distributed in a relatively uniform fashion across the genome, although some deviations from randomness can be detected. In particular, there is a significant underrepresentation of markers on the X chromosome. This map represents the two-thirds point toward our goal of developing a mouse genetic map containing 6,000 SSLPs.			DIETRICH, WF (corresponding author), MIT, WHITEHEAD INST BIOMED RES, CTR GENOME RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.			Merchant, Mark/0000-0003-0690-8581			Arratia R, 1990, STAT SCI, V5, P403, DOI 10.1214/ss/1177012015; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; BRYDA EC, 1992, MAMM GENOME, V2, P123, DOI 10.1007/BF00353860; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1992, GENETIC MAPS 1992; EICHER EM, 1993, MAMM GENOME, V4, P226, DOI 10.1007/BF00417568; EVANS EP, 1989, GENETIC VARIANTS STR, P576; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hawkins T., 1992, DNA Sequence, V3, P65, DOI 10.3109/10425179209033998; HOFKER MH, 1986, AM J HUM GENET, V39, P438; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MARDON G, 1990, MOL CELL BIOL, V10, P681, DOI 10.1128/MCB.10.2.681; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MILLER JC, IN PRESS GENETIC VAR; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; TANZI RE, 1992, AM J HUM GENET, V50, P551; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	25	590	593	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1994	7	2			SI		220	245		10.1038/ng0694supp-220			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ898	WOS:A1994NQ89800003	7920646				2022-01-24	
J	JANSEN, RC				JANSEN, RC			INTERVAL MAPPING OF MULTIPLE QUANTITATIVE TRAIT LOCI	GENETICS			English	Article							MARKERS	The interval mapping method is widely used for the mapping of quantitative trait loci (QTLs) in segregating generations derived from crosses between inbred lines. The efficiency of detecting and the accuracy of mapping multiple QTLs by using genetic markers are much increased by employing multiple QTL models instead of the single QTL models (and no QTL models) used in interval mapping. However, the computational work involved with multiple QTL models is considerable when the number of QTLs is large. In this paper it is proposed to combine multiple linear regression methods with conventional interval mapping. This is achieved by fitting one QTL at a time in a given interval and simultaneously using (part of) the markers as cofactors to eliminate the effects of additional QTLs. It is shown that the proposed method combines the easy computation of the single QTL interval mapping method with much of the efficiency and accuracy of multiple QTL models.			JANSEN, RC (corresponding author), DLO,CPRO,CTR PLANT BREEDING & REPROD RES,POB 1B,6700 AA WAGENINGEN,NETHERLANDS.		Jansen, Ritsert C/C-1160-2013	Jansen, Ritsert C/0000-0003-2977-9110			COWEN NM, 1989, DEV APPL MOL MARKERS, P113; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; JANSEN RC, 1992, THEOR APPL GENET, V85, P252, DOI 10.1007/BF00222867; KNAPP SJ, 1990, THEOR APPL GENET, V79, P583, DOI 10.1007/BF00226869; LANDER ES, 1989, GENETICS, V121, P185; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; SAKAMOTO Y, 1986, AKAIKE INFORM CRITER, V0081; STAM P, 1991, 8TH P M EUC SECT BIO	8	590	621	1	35	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	SEP	1993	135	1					205	211					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LW033	WOS:A1993LW03300019	8224820				2022-01-24	
J	DEVYS, D; LUTZ, Y; ROUYER, N; BELLOCQ, JP; MANDEL, JL				DEVYS, D; LUTZ, Y; ROUYER, N; BELLOCQ, JP; MANDEL, JL			THE FMR-1 PROTEIN IS CYTOPLASMIC, MOST ABUNDANT IN NEURONS AND APPEARS NORMAL IN CARRIERS OF A FRAGILE X PREMUTATION	NATURE GENETICS			English	Article							GENE; DNA; INSTABILITY; METHYLATION; TRANSCRIPTION; EXPRESSION; SEQUENCE; REPEAT; SITES	Fragile X mental retardation syndrome is caused by the unstable expansion of a CGG repeat in the FMR-1 gene. In patients with a full mutation, abnormal methylation results in suppression of FMR-1 transcription. FMR-1 is expressed in many tissues but its function is unknown. We have raised monoclonal antibodies specific for the FMR-1 protein. They detect 4-5 protein bands which appear identical in cells of normal males and of males carrying a premutation, but are absent in affected males with a full mutation. Immunohistochemistry shows a cytoplasmic localization of FMR-1. The highest levels were observed in neurons, while glial cells contain very low levels. In epithelial tissues, levels of FMR-1 were higher in dividing layers. In adult testis, FMR-1 was detected only in spermatogonia. FMR-1 was not detected in dermis and cardiac muscle except under pathological conditions.	FAC MED STRASBOURG,CNRS,INSERM,UNITE 184,GENET MOLEC EUCARYOTES LAB,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; CHRU,F-67085 STRASBOURG,FRANCE; CHU,HOSP HAUTEPIERRE,SERV ANAT PATHOL GEN,F-67089 STRASBOURG,FRANCE					Devys, Didier/0000-0001-9655-3512			ABITBOL M, 1993, NAT GENET, V4, P148; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BERRYKRAVIS E, 1992, ANN NEUROL, V31, P22, DOI 10.1002/ana.410310105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HAGERMANN, 1991, FRAGILE X SYNDROME D, P3; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HARLOW E, 1988, ANTIBODIES LABORATOR; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; JOHANNISSON R, 1988, HUM GENET, V79, P231, DOI 10.1007/BF00366242; JOHANNISSON R, 1987, HUM GENET, V76, P141, DOI 10.1007/BF00284911; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; MANTOVANI R, 1992, EMBO J, V11, P3315, DOI 10.1002/j.1460-2075.1992.tb05410.x; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; STGROTH FS, 1986, J IMMUNOL METHODS, V35, P1; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	36	590	598	2	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					335	340		10.1038/ng0893-335			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	WOS:A1993LQ17800008	8401578				2022-01-24	
J	Moles, CG; Mendes, P; Banga, JR				Moles, CG; Mendes, P; Banga, JR			Parameter estimation in biochemical pathways: A comparison of global optimization methods	GENOME RESEARCH			English	Article; Proceedings Paper	3rd International Conference on Systems Biology 2002	DEC 13-15, 2002	KAROLINSKA INST, STOCKHOLM, SWEDEN		KAROLINSKA INST		EVOLUTION STRATEGIES; ALGORITHMS; SEARCH	Here we address the problem of parameter estimation (inverse problem) of nonlinear dynamic biochemical pathways. This problem is stated as a nonlinear programming (NLP) problem subject to nonlinear differential-algebraic constraints. These problems are known to be frequently ill-conditioned and multimodal. Thus, traditional (gradient-based) local optimization methods fall to arrive at satisfactory solutions. To surmount this limitation, the use of several state-of-the-art deterministic and stochastic global optimization methods is explored. A case Study considering the estimation of 36 parameters of a nonlinear biochemical dynamic model is taken as a benchmark. Only a certain type of stochastic algorithm, evolution strategies (ES), is able to solve this problem successfully. Although these stochastic methods cannot guarantee global optimality with certainty, their robustness, plus the fact that in inverse problems they have a known lower bound for the cost function, make them the best available candidates.	CSIC, Inst Invest Marinas, Proc Engn Grp, Vigo 36208, Spain; Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA		Banga, JR (corresponding author), CSIC, Inst Invest Marinas, Proc Engn Grp, Vigo 36208, Spain.	julio@iim.csic.es	Banga, Julio R./A-8388-2008; Banga, Julio R./ABD-8629-2020	Banga, Julio R./0000-0002-4245-0320; Banga, Julio R./0000-0002-4245-0320; Mendes, Pedro/0000-0001-6507-9168			Ali MM, 1997, J OPTIMIZ THEORY APP, V95, P545, DOI 10.1023/A:1022617804737; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI 10.1109/4235.985690; Back T, 1996, LECT NOTES COMPUT SC, V1063, P3; BALSACANTO E, 1998, P ACOFOP 4 AUT CONTR, P2; Banga J.R., 1987, ICHEME S SER, V100, P183; Banga JR, 1997, BIOTECHNOL PROGR, V13, P326, DOI 10.1021/bp970015+; Banga JR, 1996, NONCON OPTIM ITS APP, V7, P563; BANGA JR, 2002, P MED C CONTR AUT ME; BOENDER CGE, 1995, HDB GLOBAL OPTIMIZAT, V2, P829, DOI DOI 10.1007/978-1-4615-2025-2_15; BROOKS SH, 1958, OPER RES, V6, P244, DOI 10.1287/opre.6.2.244; Cho KH, 2003, LECT NOTES COMPUT SC, V2602, P127; Corne D., 1999, NEW IDEAS OPTIMIZATI; Costa L, 2001, COMPUT CHEM ENG, V25, P257, DOI 10.1016/S0098-1354(00)00653-0; Darwin C, 1859, ORIGINS SPECIES MEAN; Esposito WR, 2000, IND ENG CHEM RES, V39, P1291, DOI 10.1021/ie990486w; FOGEL DB, 1966, ARTIFICIAL INTELLIGE; Goldberg D. E., 1989, GENETIC ALGORITHMS S; GOULCHER R, 1978, COMPUT CHEM ENG, V2, P33, DOI 10.1016/0098-1354(78)80004-0; GROSSMANN IE, 1996, GLOBAL OPTIMIZATION; Hansen N., 1997, 5 EUR C INT TECHN SO, P650; HINDMARSH AC, 1983, SCI COMPUTING, P55; Hoffmeister F., 1991, Parallel Problem Solving from Nature. 1st Workshop, PPSN 1 Proceedings, P455; Holland J. H., 1992, ADAPTATION NATURAL A; HOLMSTROM K, 2001, P 42 SIMS C, P00089; Horst R., 1990, GLOBAL OPTIMIZATION; Huyer W, 1999, J GLOBAL OPTIM, V14, P331, DOI 10.1023/A:1008382309369; JONES DR, 1993, J OPTIMIZ THEORY APP, V79, P157, DOI 10.1007/BF00941892; JONES DR, 2001, ENCY OPTIMIZATION, P431, DOI DOI 10.1007/0-306-48332-7; KAN AHGR, 1987, MATH PROGRAM, V39, P27; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; MATYAS J, 1965, AUTOMAT REM CONTR+, V26, P244; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Mendes Pedro, 2001, P163; Michalewicz Z., 2000, EVOLUTIONARY COMPUTA; MOLES CG, 2001, P EUR CONTR C ECC 20; Papamichail I, 2002, J GLOBAL OPTIM, V24, P1, DOI 10.1023/A:1016259507911; Pinter J., 1996, GLOBAL OPTIMIZATION; RASTRIGIN LA, 1969, AUTOMATIC CONTROL, V2, P23; Rechenberg I, 2000, COMPUT METHOD APPL M, V186, P125, DOI 10.1016/S0045-7825(99)00381-3; Runarsson TP, 2000, IEEE T EVOLUT COMPUT, V4, P284, DOI 10.1109/4235.873238; SARAVANAN N, 1995, BIOSYSTEMS, V36, P157, DOI 10.1016/0303-2647(95)01534-R; Schwefel HP, 1995, EVOLUTION OPTIMUM SE; SINGER AB, 2001, COMPUTER AIDED CHEM, V9, P767; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Torn A, 1999, J GLOBAL OPTIM, V14, P437, DOI 10.1023/A:1008395408187; TORN A, 1973, P COMP SIM VERS AN S, P191; van Laarhoven P. J. M., 1987, SIMULATED ANNEALING; ZABINSKY ZB, 1992, MATH PROGRAM, V53, P323, DOI 10.1007/BF01585710; 2000, OPTIMIZATION TOOLBOX; [No title captured]; [No title captured]	53	589	602	1	47	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2003	13	11					2467	2474		10.1101/gr.1262503			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	739QB	WOS:000186357000013	14559783	Bronze, Green Published			2022-01-24	
J	Puel, A; Ziegler, SF; Buckley, RH; Leonard, WJ				Puel, A; Ziegler, SF; Buckley, RH; Leonard, WJ			Defective IL7R expression in T-B+NK+ severe combined immunodeficiency	NATURE GENETICS			English	Article							RECEPTOR-GAMMA-CHAIN; NATURAL-KILLER-CELLS; IL-2 RECEPTOR; INTERLEUKIN-7 RECEPTOR; FUNCTIONAL COMPONENT; PROGENITOR CELLS; LIGAND-BINDING; DIFFERENTIATION; MUTATION; JAK3	Severe combined immunodeficiency (SCID) is caused by multiple genetic defects(1-3). The most common form of SCID, X-linked SCID (XSCID), results from mutations in IL2RG (ref. 4), which encodes the common cytokine receptor gamma chain (gamma(c)) that is shared by the IL-2, IL-4, IL-7, IL-9 and IL-15 receptors(1,5-10). In XSCID and SCID resulting from mutations in JAK3, which encodes a Janus family tyrosine kinase that couples to gamma(c) (refs 9,11,12) and is required for gamma(c)-dependent signalling, T- and natural killer (NK)-cells are decreased but B-cell numbers are normal(1-3,13,14) (T-B+NK- SCID). Some SCID patients lack T cells but retain NK cells. Given diminished T-cell development in IL7- or IL7r-deficient mice(15,16) and that Il7r-deficient mice have NK cells(17), we hypothesized that T-B+NK+ SCID might result from defective IL-7 signalling, although apparent differences in the role of the IL-7/IL-7R pathway in humans and mice in T-cell and B-cell development have been suggested(1,18). We now demonstrate medium control that defective IL7R expression causes T-B+NK+ SCID, indicating that the T-cell, but not the NK-cell, defect in XSCID results from inactivation of IL-7 alpha signalling.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Virginia Mason Med Ctr, Seattle, WA 98101 USA; Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA		Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.		Buckley, Rebecca/AAB-1578-2019; Puel, Anne/H-7305-2017; Leonard, Warren/AAA-1397-2022	Puel, Anne/0000-0003-2603-0323; 			BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; CavazzanaCalvo M, 1996, BLOOD, V88, P3901, DOI 10.1182/blood.V88.10.3901.bloodjournal88103901; DISANTO JP, 1994, EUR J IMMUNOL, V24, P475, DOI 10.1002/eji.1830240232; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; ISHII N, 1994, J IMMUNOL, V153, P1310; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Leclercq G, 1996, J EXP MED, V184, P325, DOI 10.1084/jem.184.2.325; Leonard WJ, 1996, ANNU REV MED, V47, P229; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; Puck JM, 1997, BLOOD, V89, P1968; Puzanov IJ, 1996, J IMMUNOL, V157, P4282; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Zhu MH, 1998, J BIOL CHEM, V273, P10719, DOI 10.1074/jbc.273.17.10719	29	589	598	2	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					394	397		10.1038/3877			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	WOS:000077199600031	9843216				2022-01-24	
J	Codd, V; Nelson, CP; Albrecht, E; Mangino, M; Deelen, J; Buxton, JL; Hottenga, JJ; Fischer, K; Esko, T; Surakka, I; Broer, L; Nyholt, DR; Leach, IM; Salo, P; Hagg, S; Matthews, MK; Palmen, J; Norata, GD; O'Reilly, PF; Saleheen, D; Amin, N; Balmforth, AJ; Beekman, M; de Boer, RA; Bohringer, S; Braund, PS; Burton, PR; de Craen, AJM; Denniff, M; Dong, YB; Douroudis, K; Dubinina, E; Eriksson, JG; Garlaschelli, K; Guo, DH; Hartikainen, AL; Henders, AK; Houwing-Duistermaat, JJ; Kananen, L; Karssen, LC; Kettunen, J; Klopp, N; Lagou, V; van Leeuwen, EM; Madden, PA; Magi, R; Magnusson, PKE; Mannisto, S; McCarthy, MI; Medland, SE; Mihailov, E; Montgomery, GW; Oostra, B; Palotie, A; Peters, A; Pollard, H; Pouta, A; Prokopenko, I; Ripatti, S; Salomaa, V; Suchiman, HED; Valdes, AM; Verweij, N; Vinuela, A; Wang, XL; Wichmann, HE; Widen, E; Willemsen, G; Wright, MJ; Xia, K; Xiao, XJ; van Veldhuisen, DJ; Catapano, AL; Tobin, MD; Hall, AS; Blakemore, AIF; van Gilst, WH; Zhu, HD; Erdmann, J; Reilly, MP; Kathiresan, S; Schunkert, H; Talmud, PJ; Pedersen, NL; Perola, M; Ouwehand, W; Kaprio, J; Martin, NG; van Duijn, CM; Hovatta, I; Gieger, C; Metspalu, A; Boomsma, DI; Jarvelin, MR; Slagboom, PE; Thompson, JR; Spector, TD; van der Harst, P; Samani, NJ				Codd, Veryan; Nelson, Christopher P.; Albrecht, Eva; Mangino, Massimo; Deelen, Joris; Buxton, Jessica L.; Hottenga, Jouke Jan; Fischer, Krista; Esko, Tonu; Surakka, Ida; Broer, Linda; Nyholt, Dale R.; Leach, Irene Mateo; Salo, Perttu; Hagg, Sara; Matthews, Mary K.; Palmen, Jutta; Norata, Giuseppe D.; O'Reilly, Paul F.; Saleheen, Danish; Amin, Najaf; Balmforth, Anthony J.; Beekman, Marian; de Boer, Rudolf A.; Bohringer, Stefan; Braund, Peter S.; Burton, Paul R.; de Craen, Anton J. M.; Denniff, Matthew; Dong, Yanbin; Douroudis, Konstantinos; Dubinina, Elena; Eriksson, Johan G.; Garlaschelli, Katia; Guo, Dehuang; Hartikainen, Anna-Liisa; Henders, Anjali K.; Houwing-Duistermaat, Jeanine J.; Kananen, Laura; Karssen, Lennart C.; Kettunen, Johannes; Klopp, Norman; Lagou, Vasiliki; van Leeuwen, Elisabeth M.; Madden, Pamela A.; Maegi, Reedik; Magnusson, Patrik K. E.; Mannisto, Satu; McCarthy, Mark I.; Medland, Sarah E.; Mihailov, Evelin; Montgomery, Grant W.; Oostra, Ben A.; Palotie, Aarno; Peters, Annette; Pollard, Helen; Pouta, Anneli; Prokopenko, Inga; Ripatti, Samuli; Salomaa, Veikko; Suchiman, H. Eka D.; Valdes, Ana M.; Verweij, Niek; Vinuela, Ana; Wang, Xiaoling; Wichmann, H-Erich; Widen, Elisabeth; Willemsen, Gonneke; Wright, Margaret J.; Xia, Kai; Xiao, Xiangjun; van Veldhuisen, Dirk J.; Catapano, Alberico L.; Tobin, Martin D.; Hall, Alistair S.; Blakemore, Alexandra I. F.; van Gilst, Wiek H.; Zhu, Haidong; Erdmann, Jeanette; Reilly, Muredach P.; Kathiresan, Sekar; Schunkert, Heribert; Talmud, Philippa J.; Pedersen, Nancy L.; Perola, Markus; Ouwehand, Willem; Kaprio, Jaakko; Martin, Nicholas G.; van Duijn, Cornelia M.; Hovatta, Iris; Gieger, Christian; Metspalu, Andres; Boomsma, Dorret I.; Jarvelin, Marjo-Riitta; Slagboom, P. Eline; Thompson, John R.; Spector, Tim D.; van der Harst, Pim; Samani, Nilesh J.		CARDIoGRAM Consortium	Identification of seven loci affecting mean telomere length and their association with disease	NATURE GENETICS			English	Article							CANCER; RISK; ATHEROSCLEROSIS; SUSCEPTIBILITY; HUMANS; TERC; DNA	Interindividual variation in mean leukocyte telomere length (LTL) is associated with cancer and several age-associated diseases. We report here a genome-wide meta-analysis of 37,684 individuals with replication of selected variants in an additional 10,739 individuals. We identified seven loci, including five new loci, associated with mean LTL (P < 5 x 10(-8)). Five of the loci contain candidate genes (TERC, TERT, NAF1, OBFC1 and RTEL1) that are known to be involved in telomere biology. Lead SNPs at two loci (TERC and TERT) associate with several cancers and other diseases, including idiopathic pulmonary fibrosis. Moreover, a genetic risk score analysis combining lead variants at all 7 loci in 22,233 coronary artery disease cases and 64,762 controls showed an association of the alleles associated with shorter LTL with increased risk of coronary artery disease (21% (95% confidence interval, 5-35%) per standard deviation in LTL, P = 0.014). Our findings support a causal role of telomere-length variation in some age-related diseases.	[Codd, Veryan; Nelson, Christopher P.; Matthews, Mary K.; Braund, Peter S.; Denniff, Matthew; Dubinina, Elena; Pollard, Helen; van der Harst, Pim; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Nelson, Christopher P.; Samani, Nilesh J.] Glenfield Gen Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Albrecht, Eva; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Mangino, Massimo; Valdes, Ana M.; Vinuela, Ana; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Deelen, Joris; Beekman, Marian; Suchiman, H. Eka D.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Sect Mol Epidemiol, Leiden, Netherlands; [Deelen, Joris; Broer, Linda; Beekman, Marian; Houwing-Duistermaat, Jeanine J.; van Duijn, Cornelia M.; Slagboom, P. Eline] Leiden Univ, Med Ctr, Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Buxton, Jessica L.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Sect Invest Med, London, England; [Hottenga, Jouke Jan; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Fischer, Krista; Esko, Tonu; Douroudis, Konstantinos; Maegi, Reedik; Mihailov, Evelin; Perola, Markus; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Surakka, Ida; Kettunen, Johannes; Ripatti, Samuli; Widen, Elisabeth; Perola, Markus; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Surakka, Ida; Salo, Perttu; Eriksson, Johan G.; Kettunen, Johannes; Mannisto, Satu; Ripatti, Samuli; Salomaa, Veikko; Perola, Markus] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Broer, Linda; Amin, Najaf; Karssen, Lennart C.; van Leeuwen, Elisabeth M.; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Broer, Linda; van Duijn, Cornelia M.] Ctr Med Syst Biol, Leiden, Netherlands; [Nyholt, Dale R.; Henders, Anjali K.; Medland, Sarah E.; Montgomery, Grant W.; Wright, Margaret J.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Leach, Irene Mateo; de Boer, Rudolf A.; Verweij, Niek; van Veldhuisen, Dirk J.; van Gilst, Wiek H.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Hagg, Sara; Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Palmen, Jutta; Talmud, Philippa J.] UCL, Inst Cardiovasc Sci, London, England; [Norata, Giuseppe D.; Catapano, Alberico L.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Norata, Giuseppe D.; Garlaschelli, Katia] Bassini Hosp, Ctr Soc Italiana Studio Aterosclerosi, Cinisello Balsamo, Italy; [Norata, Giuseppe D.] Queen Mary Univ, Barts & London Sch Med & Dent, Blizard Inst, London, England; [O'Reilly, Paul F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [O'Reilly, Paul F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Hlth Protect Agcy Ctr Environm & Hlth, London, England; [Saleheen, Danish] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Sch Med, Div Epidemiol, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Bohringer, Stefan; Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Sect Med Stat, Leiden, Netherlands; [Burton, Paul R.; Tobin, Martin D.; Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Dong, Yanbin; Guo, Dehuang; Wang, Xiaoling; Zhu, Haidong] Georgia Hlth Sci Univ, Georgia Prevent Inst, Augusta, GA USA; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; [Kananen, Laura; Hovatta, Iris] Univ Helsinki, Biomedicum Helsinki, Res Programs Unit, Helsinki, Finland; [Kananen, Laura; Hovatta, Iris] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Klopp, Norman; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Klopp, Norman] Hannover Med Sch, Hanover Unified Biobank, Hannover, NH, Germany; [Lagou, Vasiliki; McCarthy, Mark I.; Prokopenko, Inga] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Madden, Pamela A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7LJ, England; [Palotie, Aarno; Ripatti, Samuli; Ouwehand, Willem] Wellcome Trust Sanger Inst, Hinxton, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Helsinki Univ Hosp, Helsinki, Finland; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Peters, Annette] Munich Heart Alliance, Munich, Germany; [Pouta, Anneli] Natl Inst Hlth & Welf, Oulu, Finland; [Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-80539 Munich, Germany; [Xia, Kai] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Xiao, Xiangjun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Catapano, Alberico L.] Inst Ricovero & Cura Carattere Sci Multimed, Milan, Italy; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Reilly, Muredach P.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Broad Inst Massachusetts Inst Technol & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Ouwehand, Willem] Univ Cambridge, Dept Hematol, Cambridge, England; [Ouwehand, Willem] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Kaprio, Jaakko; Hovatta, Iris] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [van der Harst, Pim] Univ Groningen, Univ Med Ctr, Dept Genet, Groningen, Netherlands		Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	njs@le.ac.uk	Deelen, Joris/H-3201-2019; Hall, Alistair/K-1953-2019; van Veldhuisen, Dirk Jan/E-8967-2014; Houwing-Duistermaat, Jeanne/V-9048-2018; Buxton, Jessica L/I-4033-2014; Erdmann, Jeanette/P-7513-2014; mangino, massimo/F-5134-2011; Slagboom, P. Eline/R-4790-2016; Vinuela, Ana/L-5015-2019; Xia, Kai/B-7214-2014; van Leeuwen, Elisabeth/G-3382-2017; Nyholt, Dale R/J-3174-2017; Martin, Nicholas/R-9235-2019; Verweij, Niek/A-4499-2017; Catapano, alberico/AAC-2827-2019; Boehringer, Stefan/Y-2442-2018; Hovatta, Iiris/D-6871-2012; Burton, Paul R/H-7527-2016; Magnusson, Patrik KE/C-4458-2017; Erdmann, Jeanette/A-4417-2009; Medland, Sarah/AAT-7595-2020; Kaprio, Jaakko/A-1820-2008; Magi, Reedik/AAJ-9679-2021; Blakemore, Alexandra I F/D-2253-2009; Wright, Margaret Jane/A-4560-2016; Ripatti, Samuli/H-9446-2014; Peters, Annette/A-6117-2011; van Gilst, Wiek/R-1806-2019; Suchiman, H. Eka D./F-5024-2017; Beekman, Marian/L-3004-2019; Buxton, Jessica/L-9849-2019; de Boer, Rudolf/ABE-9879-2020; Meitinger, Thomas/O-1318-2015; Prokopenko, Inga/AAU-9895-2020; Prokopenko, Inga/H-3241-2014; Norata, Giuseppe Danilo/AAC-2863-2019; Medland, Sarah E/C-7630-2013; Montgomery, Grant W/B-7148-2008; Lagou, Vasiliki/N-8451-2013; Wichmann, Heinz Erich/AAA-5695-2022; Verweij, Niek/ABC-6249-2021; Wright, Margaret J/H-3308-2014; Henders, Anjali/E-3126-2017; McCarthy, Mark/M-3763-2015	Deelen, Joris/0000-0003-4483-3701; Buxton, Jessica L/0000-0002-0918-9335; Erdmann, Jeanette/0000-0002-4486-6231; mangino, massimo/0000-0002-2167-7470; Slagboom, P. Eline/0000-0002-2875-4723; Vinuela, Ana/0000-0003-3771-8537; Nyholt, Dale R/0000-0001-7159-3040; Martin, Nicholas/0000-0003-4069-8020; Catapano, alberico/0000-0002-7593-2094; Boehringer, Stefan/0000-0001-9108-9212; Hovatta, Iiris/0000-0002-5990-7892; Magnusson, Patrik KE/0000-0002-7315-7899; Medland, Sarah/0000-0003-1382-380X; Kaprio, Jaakko/0000-0002-3716-2455; Blakemore, Alexandra I F/0000-0003-0661-564X; Wright, Margaret Jane/0000-0001-7133-4970; Ripatti, Samuli/0000-0002-0504-1202; Peters, Annette/0000-0001-6645-0985; van Gilst, Wiek/0000-0003-2968-8585; Suchiman, H. Eka D./0000-0002-7168-5516; Beekman, Marian/0000-0003-0585-6206; Prokopenko, Inga/0000-0003-1624-7457; Medland, Sarah E/0000-0003-1382-380X; Montgomery, Grant W/0000-0002-4140-8139; Verweij, Niek/0000-0002-4303-7685; Valdes, Ana M./0000-0003-1141-4471; O'Reilly, Paul/0000-0001-7515-0845; Hagg, Sara/0000-0002-2452-1500; Van Duijn, Cornelia/0000-0002-2374-9204; Henders, Anjali/0000-0003-3672-1451; Magi, Reedik/0000-0002-2964-6011; Amin, Najaf/0000-0002-8944-1771; Esko, Tonu/0000-0003-1982-6569; Karssen, Lennart C./0000-0002-1959-342X; Kananen, Laura/0000-0003-3742-8927; Reilly, Muredach/0000-0002-3035-9386; Mannisto, Satu/0000-0002-8668-3046; Ouwehand, Willem/0000-0002-7744-1790; Talmud, Philippa/0000-0002-5560-1933; Eriksson, Johan/0000-0002-2516-2060; Nelson, Christopher/0000-0001-8025-2897; Douroudis, Konstantinos/0000-0002-6383-7145; Hall, Alistair/0000-0003-0306-7887; Palotie, Aarno/0000-0002-2527-5874; McCarthy, Mark/0000-0002-4393-0510; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Gieger, Christian/0000-0001-6986-9554; Codd, Veryan/0000-0002-9430-8254; Willemsen, Gonneke/0000-0003-3755-0236; Xia, Kai/0000-0003-1326-0891; Tobin, Martin/0000-0002-3596-7874; Norata, Giuseppe Danilo/0000-0002-6081-1257	European Union Framework 7 ENGAGE Project [HEALTH-F4-2007-201413]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0902313, G0801056B, MR/K014536/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10170] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R56DA012854] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0902313, MR/K014536/1] Funding Source: UKRI	This study was undertaken under the framework of European Union Framework 7 ENGAGE Project (HEALTH-F4-2007-201413).	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2008, HEART, V94, P422, DOI 10.1136/hrt.2007.139675; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Kim JW, 2007, DIFFERENTIATION, V75, P147, DOI 10.1111/j.1432-0436.2006.00118.x; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385	39	588	599	1	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					422	427		10.1038/ng.2528			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	WOS:000316840600013	23535734	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Kielbasa, SM; Wan, R; Sato, K; Horton, P; Frith, MC				Kielbasa, Szymon M.; Wan, Raymond; Sato, Kengo; Horton, Paul; Frith, Martin C.			Adaptive seeds tame genomic sequence comparison	GENOME RESEARCH			English	Article							GENERATION; REPEATS; BLAST	The main way of analyzing biological sequences is by comparing and aligning them to each other. It remains difficult, however, to compare modern multi-billionbase DNA data sets. The difficulty is caused by the nonuniform (oligo) nucleotide composition of these sequences, rather than their size per se. To solve this problem, we modified the standard seed-and-extend approach (e. g., BLAST) to use adaptive seeds. Adaptive seeds are matches that are chosen based on their rareness, instead of using fixed-length matches. This method guarantees that the number of matches, and thus the running time, increases linearly, instead of quadratically, with sequence length. LAST, our open source implementation of adaptive seeds, enables fast and sensitive comparison of large sequences with arbitrarily nonuniform composition.	[Wan, Raymond; Horton, Paul; Frith, Martin C.] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Kielbasa, Szymon M.] Max Planck Inst Mol Genet, Dept Computat Biol, D-14195 Berlin, Germany; [Sato, Kengo] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan		Frith, MC (corresponding author), Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan.	martin@cbrc.jp	Kielbasa, Szymon/G-1636-2018; Kielbasa, Szymon M./K-2792-2019; Sato, Kengo/D-6043-2012; Wan, Raymond/I-2885-2012	Kielbasa, Szymon/0000-0003-2805-6535; Sato, Kengo/0000-0001-6744-7390; Wan, Raymond/0000-0003-3202-7008; Frith, Martin/0000-0003-0998-2859	German National Genome Research Network (NGFN-Plus) [01GS0815]; INTEC Systems Institute, Inc.	We thank Kenichiro Imai for suggesting a protein reduced alphabet and Martin Vingron for helpful suggestions. We thank Tim Bailey, Zhiping Weng, Kiyoshi Asai, and Christine Sers for commenting on the manuscript. Sz.M.K. received support from the German National Genome Research Network (NGFN-Plus, grant no. 01GS0815). R. W. is supported by INTEC Systems Institute, Inc.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Carlton J, 2005, CURR ISSUES MOL BIOL, V7, P23; Csuros M, 2004, LECT NOTES COMPUT SC, V3109, P373; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Frith MC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq010; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Gusfield D., 1997, ACM SIGACT NEWS, V28, P41; Harris R., 2007, THESIS PENNSYLVANIA; Horton P., 2008, P WORKSH KNOWL LANG, P1; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Kucherov G., 2006, Journal of Bioinformatics and Computational Biology, V4, pXV, DOI 10.1142/S0219720006002107; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; McIlroy P. M., 1993, Computing Systems, V6, P5; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nguyen TV, 2001, J BIOL CHEM, V276, P26724, DOI 10.1074/jbc.M103375200; Ohlebusch E, 2008, J COMPUT BIOL, V15, P357, DOI 10.1089/cmb.2007.0105; Publisi SJ, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1242471.1242472; Romero LC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-83; Roytberg M, 2009, IEEE ACM T COMPUT BI, V6, P483, DOI 10.1109/TCBB.2009.4; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455	33	588	597	6	37	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2011	21	3					487	493		10.1101/gr.113985.110			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	727ZE	WOS:000287841100014	21209072	Green Published, Bronze	Y	N	2022-01-24	
J	Segre, JA; Bauer, C; Fuchs, E				Segre, JA; Bauer, C; Fuchs, E			Klf4 is a transcription factor required for establishing the barrier function of the skin	NATURE GENETICS			English	Article							ZINC-FINGER PROTEIN; KRUPPEL-LIKE FACTOR; EPIDERMAL-KERATINOCYTES; STRATUM-CORNEUM; ACID RECEPTOR; MICE LACKING; GENE; DIFFERENTIATION; EXPRESSION; ENVELOPES	Located at the interface between body and environment, the epidermis must protect the body against toxic agents and dehydration, and protect itself against physical and mechanical stresses(1-4). Acquired just before birth and at the last stage of epidermal differentiation, the skin's proteinaceous/lipid barrier creates a surface seal essential for protecting animals against microbial infections and dehydration. We show here that Kruppel-like factor 4 (Klf4, encoded by the gene Klf4), highly expressed in the differentiating layers of epidermis, is both vital to and selective for barrier acquisition. Klf4(-/-) mice die shortly after birth due to loss of skin barrier function, as measured by penetration of external dyes and rapid loss of body fluids. The defect was not corrected by grafting of Klf4(-/-) skin onto nude mice. Loss of the barrier occurs without morphological and biochemical alterations to the well-known structural features of epidermis that are essential for mechanical integrity. Instead, late-stage differentiation structures are selectively perturbed, including the cornified envelope, a likely scaffold for lipid organization. Using suppressive subtractive hybridization, we identified three transcripts encoding cornified envelope proteins with altered expression in the absence of Klf4. Sprr2a is one, and is the only epidermal gene whose promoter is known to possess a functional Klf4 binding site. Our studies provide new insights into transcriptional governance of barrier function, and pave the way for unravelling the molecular events that orchestrate this essential process.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA		Fuchs, E (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR031737] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [AR31737] Funding Source: Medline		ADAMS JC, 1993, DEVELOPMENT, V117, P1183; DOWNING DT, 1992, J LIPID RES, V33, P301; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cellbio.11.1.123; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HOHL D, 1991, J BIOL CHEM, V266, P6626; HOU SYE, 1991, J INVEST DERMATOL, V96, P215, DOI 10.1111/1523-1747.ep12461361; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; JENSEN PJ, 1995, EXP CELL RES, V217, P65, DOI 10.1006/excr.1995.1064; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; MICHEL S, 1988, J INVEST DERMATOL, V91, P11, DOI 10.1111/1523-1747.ep12463281; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Song HJ, 1999, GENOMICS, V55, P28, DOI 10.1006/geno.1998.5607; STEVEN AC, 1994, J CELL SCI, V107, P693; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; WICKETT RR, 1995, SKIN PHARMACOL, V8, P179; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026	30	588	607	0	51	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1999	22	4					356	360		10.1038/11926			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	WOS:000081772500017	10431239				2022-01-24	
J	Pilia, G; HughesBenzie, RM; MacKenzie, A; Baybayan, P; Chen, EY; Huber, R; Neri, G; Cao, A; Forabosco, A; Schlessinger, D				Pilia, G; HughesBenzie, RM; MacKenzie, A; Baybayan, P; Chen, EY; Huber, R; Neri, G; Cao, A; Forabosco, A; Schlessinger, D			Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome	NATURE GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ARTIFICIAL CHROMOSOME; MOLECULAR-CLONING; BINDING-PROTEINS; GROWTH; YEAST; RAT; SEQUENCES; SERUM; DNA	Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked condition characterized by pre- and postnatal overgrowth with visceral and skeletal anomalies, To identify the causative gene, breakpoints in two female patients with X;autosome translocations were identified. The breakpoints occur near the 5' and 3' ends of a gene, GPC3, that spans more than 500 kilobases in Xq26; in three families, different microdeletions encompassing exons cosegregate with SGBS. GPC3 encodes a putative extracellular proteoglycan, glypican 3, that is inferred to play an important role in growth control in embryonic mesodermal tissues in which it is selectively expressed. Initial western- and ligand-blotting experiments suggest that glypican 3 forms a complex with insulin-like growth factor 2 (IGF2), and might thereby modulate IGF2 action.	WASHINGTON UNIV, SCH MED, CTR GENET MED, ST LOUIS, MO 63110 USA; CHILDRENS HOSP EASTERN ONTARIO, DEPT PEDIAT, OTTAWA, ON K1H 8L1, CANADA; PERKIN ELMER CORP, ADV CTR GENET TECHNOL, APPL BIOSYST DIV, FOSTER CITY, CA 94404 USA; UNIV CATTOLICA SACRO CUORE, IST GENET UMANA, I-00168 ROME, ITALY; UNIV CAGLIARI, IST CLIN & BIOL ETA EVOLUT, I-09121 CAGLIARI, ITALY; IST RIC TALASSEMIE & ANEMIE MEDITERRANEE, I-09121 CAGLIARI, ITALY; UNIV MODENA, DIPARTIMENTO SCI MORFOL & MED LEGALI, I-41100 MODENA, ITALY					NOIRI, Eisei/0000-0002-9515-7582	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000247] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00247, HG00201] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BEHMEL A, 1984, HUM GENET, V67, P409, DOI 10.1007/BF00291401; Blanchard M M, 1993, PCR Methods Appl, V2, P234; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Cohen MM, 1989, ADV HUM GENET, V18, p[181, 373]; COHEN MM, 1989, ADV HUM GENET, V18, P181; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DESPOSITO M, 1994, NUCLEIC ACIDS RES, V22, P4806, DOI 10.1093/nar/22.22.4806; FILMUS J, 1988, MOL CELL BIOL, V8, P4243, DOI 10.1128/MCB.8.10.4243; GARGANTA CL, 1992, AM J MED GENET, V44, P129, DOI 10.1002/ajmg.1320440202; *GEN COMP GROUP, 1991, PROGR MAN GCG PACK V; GOLABI M, 1984, AM J MED GENET, V17, P345, DOI 10.1002/ajmg.1320170128; GREEN PJ, 1995, FEBS LETT, V360, P34, DOI 10.1016/0014-5793(95)00050-J; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; HUGHESBENZIE R, 1992, J MED GENET, V29, P928, DOI 10.1136/jmg.29.12.928-b; HUGHESBENZIE RM, 1992, AM J MED GENET, V43, P428, DOI 10.1002/ajmg.1320430165; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEDBETTER SA, 1991, AM J MED GENET, V38, P418, DOI 10.1002/ajmg.1320380254; LINDLOF M, 1989, AM J HUM GENET, V44, P496; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; LORIES V, 1987, J BIOL CHEM, V262, P854; Mannens M., 1994, European Journal of Human Genetics, V2, P3; NERI G, 1988, AM J MED GENET, V30, P287, DOI 10.1002/ajmg.1320300130; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; ORTH U, 1994, AM J MED GENET, V50, P388, DOI 10.1002/ajmg.1320500423; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; PUNNETT HH, 1994, AM J MED GENET, V50, P391, DOI 10.1002/ajmg.1320500424; Sambrook J, 1989, MOL CLONIG LAB MANUA; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SHIMASAKI S, 1991, J BIOL CHEM, V266, P10646; Simpson J L, 1975, Birth Defects Orig Artic Ser, V11, P18; STIPP CS, 1992, MOL BIOL CELL, V3, pA65; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VERLOES A, 1995, CLIN GENET, V47, P257; VERMEESCH JR, 1995, GENOMICS, V25, P327, DOI 10.1016/0888-7543(95)80152-C; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; XUAN JY, 1994, HUM MOL GENET, V3, P133, DOI 10.1093/hmg/3.1.133	45	588	630	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					241	247		10.1038/ng0396-241			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	WOS:A1996TY18300011	8589713				2022-01-24	
J	Skibinski, G; Parkinson, NJ; Brown, JM; Chakrabarti, L; Lloyd, SL; Hummerich, H; Nielsen, JE; Hodges, JR; Spillantini, MG; Thusgaard, T; Brandner, S; Brun, A; Rossor, MN; Gade, A; Johannsen, P; Sorensen, SA; Gydesen, S; Fisher, EMC; Collinge, J				Skibinski, G; Parkinson, NJ; Brown, JM; Chakrabarti, L; Lloyd, SL; Hummerich, H; Nielsen, JE; Hodges, JR; Spillantini, MG; Thusgaard, T; Brandner, S; Brun, A; Rossor, MN; Gade, A; Johannsen, P; Sorensen, SA; Gydesen, S; Fisher, EMC; Collinge, J			Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia	NATURE GENETICS			English	Article							PROTEIN; TRAFFICKING; DISEASE; FTD-3	We have previously reported a large Danish pedigree with autosomal dominant frontotemporal dementia (FTD) linked to chromosome 3 (FTD3). Here we identify a mutation in CHMP2B, encoding a component of the endosomal ESCRTIII complex, and show that it results in aberrant mRNA splicing in tissue samples from affected members of this family. We also describe an additional missense mutation in an unrelated individual with FTD. Aberration in the endosomal ESCRTIII complex may result in FTD and neurodegenerative disease.	UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England; UCL, Inst Neurol, MRC, Prion Unit, London, England; Addenbrookes Hosp, Dept Neurol, MRC, Cognit & Brain Sci Unit, Cambridge, England; Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, Neurogenet Sect, DK-1168 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Memory Disorders Res Unit, DK-2100 Copenhagen, Denmark; Univ Cambridge, Dept Clin Neurosci, Ctr Brain Repair, Cambridge, England; Parkvaenget Nursing Home, Holstebro, Denmark; Univ Lund Hosp, Dept Pathol, S-22185 Lund, Sweden; Univ Copenhagen, Rigshosp, Dept Psychol, DK-1168 Copenhagen, Denmark; Cent Hosp, Dept Psychiat, Holbaek, Denmark		Fisher, EMC (corresponding author), UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England.	e.fisher@prion.ucl.ac.uk	Chakrabarti, Lisa/G-4236-2011; Johannsen, Peter/G-1079-2011; Fisher, Elizabeth MC/C-2168-2008; Brandner, Sebastian/J-4562-2014; Rossor, Martin/C-1598-2008	Johannsen, Peter/0000-0002-0528-1070; Fisher, Elizabeth MC/0000-0003-2850-9936; Brandner, Sebastian/0000-0002-9821-0342; , lisa/0000-0001-7213-6837; Rossor, Martin/0000-0001-8215-3120; Nielsen, Jorgen Erik/0000-0003-0453-5582			Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; COLLINGE J, 1994, J NEUROL NEUROSUR PS, V57, P762, DOI 10.1136/jnnp.57.6.762; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Gydesen S, 2002, NEUROLOGY, V59, P1585, DOI 10.1212/01.WNL.0000034763.54161.1F; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KNOPMAN DS, 1990, NEUROLOGY, V40, P251, DOI 10.1212/WNL.40.2.251; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Yancopoulu D, 2003, J NEUROPATH EXP NEUR, V62, P878, DOI 10.1093/jnen/62.8.878	15	587	602	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					806	808		10.1038/ng1609			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	WOS:000230880400009	16041373	Green Published			2022-01-24	
J	Peltekova, VD; Wintle, RF; Rubin, LA; Amos, CI; Huang, QQ; Gu, XJ; Newman, B; Van Oene, M; Cescon, D; Greenberg, G; Griffiths, AM; St George-Hyslop, PH; Siminovitch, KA				Peltekova, VD; Wintle, RF; Rubin, LA; Amos, CI; Huang, QQ; Gu, XJ; Newman, B; Van Oene, M; Cescon, D; Greenberg, G; Griffiths, AM; St George-Hyslop, PH; Siminovitch, KA			Functional variants of OCTN cation transporter genes are associated with Crohn disease	NATURE GENETICS			English	Article							ORGANIC CATION/CARNITINE TRANSPORTER; TISSUE DISTRIBUTION PATTERN; INFLAMMATORY-BOWEL-DISEASE; CARNITINE TRANSPORT; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; TRANSCRIPTION; LOCALIZATION; EXPRESSION; ALLELES	Crohn disease is a chronic, inflammatory disease of the gastrointestinal tract. A locus of similar to250 kb at 5q31 (IBD5)(1,2) was previously associated with susceptibility to Crohn disease, as indicated by increased prevalence of a risk haplotype of 11 single-nucleotide polymorphisms(3) among individuals with Crohn disease, but the pathogenic lesion in the region has not yet been identified. We report here that two variants in the organic cation transporter cluster at 5q31 ( a missense substitution in SLC22A4 and a G-->C transversion in the SLC22A5 promoter) form a haplotype associated with susceptibility to Crohn disease. These variants alter transcription and transporter functions of the organic cation transporters and interact with variants in another gene associated with Crohn disease, CARD15, to increase risk of Crohn disease. These results suggest that SLC22A4, SLC22A5 and CARD15 act in a common pathogenic pathway to cause Crohn disease.	Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Immunol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Toronto Gen Res Inst, Toronto, ON, Canada; Ellipsis Biotherapeut Corp, Toronto, ON M5G 1Z6, Canada; St Michaels Hosp, Div Rheumatol, Toronto, ON M5B 1W8, Canada; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Hlth Network, Toronto, ON, Canada		Siminovitch, KA (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada.	ksimin@ellipsisbiotherapeutics.com	Siminovitch, Katherine/K-1475-2013; Greenberg, Gordon/C-4620-2015	Newman, William/0000-0002-6382-4678; St George-Hyslop, Peter/0000-0003-0796-7209; Wintle, Richard/0000-0003-1987-1095			BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; CONLON RA, 1992, DEVELOPMENT, V116, P357; Duran JM, 2002, J MEMBRANE BIOL, V185, P65, DOI 10.1007/s00232-001-0110-5; Elimrani I, 2003, AM J PHYSIOL-GASTR L, V284, pG863, DOI 10.1152/ajpgi.00220.2002; Giallourakis C, 2003, AM J HUM GENET, V73, P205, DOI 10.1086/376417; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamhonwah AM, 2003, BIOCHEM BIOPH RES CO, V301, P98, DOI 10.1016/S0006-291X(02)02946-7; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mirza MM, 2003, AM J HUM GENET, V72, P1018, DOI 10.1086/373880; Newman B, 2004, AM J GASTROENTEROL, V99, P306, DOI 10.1111/j.1572-0241.2004.04038.x; Newman B, 2003, J RHEUMATOL, V30, P305; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROEDIGER WEW, 1986, BRIT J EXP PATHOL, V67, P773; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Seth P, 1999, J BIOL CHEM, V274, P33388, DOI 10.1074/jbc.274.47.33388; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu X, 2000, BBA-BIOMEMBRANES, V1466, P315, DOI 10.1016/S0005-2736(00)00189-9; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482	27	587	610	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					471	475		10.1038/ng1339			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	WOS:000221183000018	15107849	Bronze			2022-01-24	
J	Esnault, C; Maestre, J; Heidmann, T				Esnault, C; Maestre, J; Heidmann, T			Human LINE retrotransposons generate processed pseudogenes	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSPOSABLE ELEMENTS; INDICATOR GENE; RNA; GENOME; CELLS; INFECTION; TRANSPOSITION; PARTICLES; SEQUENCE	Long interspersed elements (LINEs) are endogenous mobile genetic elements(1-4) that have dispersed and accumulated in the genomes of higher eukaryotes via germline transposition, with up to 100,000 copies in mammalian genomes. In humans, LINEs are the major source of insertional mutagenesis, being involved in both germinal and somatic mutant phenotypes(4). Here we show that the human LINE retrotransposons, which transpose through the reverse transcription of their own transcript(2), can also mobilize transcribed DNA not associated with a LIME sequence by a process involving the diversion of the LINE enzymatic machinery by the corresponding mRNA transcripts. This results in the 'retroposition' of the transcribed gene and the formation of new copies that disclose features characteristic of the widespread and naturally occurring processed pseudogenes: loss of intron and promoter, acquisition of a poly(A) 3' end and presence of target-site duplications of varying length(5,6). We further show-by introducing deletions within either coding sequence of the human LINE-that both ORFs are necessary for the formation of the processed pseudogenes, and that retroviral-like elements are not able to produce similar structures in the same assay. Our results strengthen the unique versatility of LINEs as genome modellers.	Inst Gustave Roussy, CNRS, UMR 1573, Unite Retrovirus Endogenes & Elements Retroides E, Villejuif, France		Heidmann, T (corresponding author), Inst Gustave Roussy, CNRS, UMR 1573, Unite Retrovirus Endogenes & Elements Retroides E, Rue Camille Desmoulins, Villejuif, France.						Boeke J. D., 1997, P343; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; CARLTON MBL, 1995, MAMM GENOME, V6, P90, DOI 10.1007/BF00303250; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; Dhellin O, 1997, EMBO J, V16, P6590, DOI 10.1093/emboj/16.21.6590; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DORNBURG R, 1990, MOL CELL BIOL, V10, P68, DOI 10.1128/MCB.10.1.68; Eickbush T, 1999, SCIENCE, V283, P1465, DOI 10.1126/science.283.5407.1465; FINNEGAN DJ, 1989, MOBILE DNA, P503; Gabriel A, 1998, TRENDS GENET, V14, P220, DOI 10.1016/S0168-9525(98)01474-7; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; JENSEN S, 1991, EMBO J, V10, P1927, DOI 10.1002/j.1460-2075.1991.tb07719.x; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; LEVINE KL, 1990, MOL CELL BIOL, V10, P1891, DOI 10.1128/MCB.10.5.1891; Maestre J, 1995, EMBO J, V14, P6333, DOI 10.1002/j.1460-2075.1995.tb00324.x; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Sandmeyer S, 1998, GENOME RES, V8, P416, DOI 10.1101/gr.8.5.416; TCHENIO T, 1993, EMBO J, V12, P1487, DOI 10.1002/j.1460-2075.1993.tb05792.x; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.biochem.55.1.631; Weiss RA, 1997, NATURE, V390, P235, DOI 10.1038/36740	30	587	604	0	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					363	367		10.1038/74184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	WOS:000086192800013	10742098				2022-01-24	
J	Hong, SE; Shugart, YY; Huang, DT; Shahwan, SA; Grant, PE; Hourihane, JOB; Martin, NDT; Walsh, CA				Hong, SE; Shugart, YY; Huang, DT; Shahwan, SA; Grant, PE; Hourihane, JOB; Martin, NDT; Walsh, CA			Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations	NATURE GENETICS			English	Article							NEURONAL MIGRATION; CORTICAL DEVELOPMENT; VLDL RECEPTOR; REELIN GENE; PROTEIN; EXPRESSION; SEQUENCE; ENCODES; CORTEX; MICE	Normal development of the cerebral cortex requires long-range migration of cortical neurons from proliferative regions deep in the brain. Lissencephaly ("smooth brain." from "lissos," meaning smooth, and "encephalos," meaning brain) is a severe developmental disorder in which neuronal migration is impaired, leading to a thickened cerebral cortex whose normally folded contour is simplified and smooth. Two identified lissencephaly genes(1-3) do not account for all known cases(4), and additional lissencephaly syndromes have been described(5). An autosomal recessive form of lissencephaly (LCH) associated with severe abnormalities of the cerebellum, hippocampus and brainstem maps to chromosome 7q22, and is associated with two independent mutations in the human gene encoding reelin (RELN). The mutations disrupt splicing of RELN cDNA, resulting in low or undetectable amounts of reelin protein. LCH parallels the reeler mouse mutant (Reln(rl)). in which Rein mutations cause cerebellar hypoplasia, abnormal cerebral cortical neuronal migration and abnormal axonal connectivity(6,7). RELN encodes a large (388 kD) secreted proteins that acts on migrating cortical neurons by binding to the very low density lipoprotein receptor (VLDLR), the apolipoprotein E receptor 2 (ApoER2; refs 9-11), alpha 3 beta 1 integrin(12) and protocadherins(13). Although reelin was previously thought to function exclusively in brain, some humans with RELN mutations show abnormal neuromuscular connectivity and congenital lymphoedema, suggesting previously unsuspected functions for reelin in and outside of the brain.	Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neurogenet, Boston, MA 02115 USA; Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; Riyadh Armed Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; Riyadh Armed Forces Hosp, Dept Neurosci, Riyadh, Saudi Arabia; Massachusetts Gen Hosp, Dept Radiol, Serv Neuroradiol, Boston, MA 02114 USA; Kent & Canterbury Hosp, Dept Pediat, Canterbury, Kent, England		Walsh, CA (corresponding author), Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neurogenet, Boston, MA 02115 USA.			Walsh, Christopher/0000-0002-0156-2238	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038097, P01NS039404, R01NS035129] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS35129, R01 NS38097, P01 NS39404] Funding Source: Medline		CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P229, DOI 10.1006/exnr.1999.7019; de Rouvroit CL, 1998, GENOMICS, V53, P246, DOI 10.1006/geno.1998.5523; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; des Portes V, 1998, CELL, V92, P51; DeSilva U, 1997, GENOME RES, V7, P157, DOI 10.1101/gr.7.2.157; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; GUYER M, 1992, SCIENCE, V258, P67; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOURIHANE JO, 1993, NEUROPEDIATRICS, V24, P43, DOI 10.1055/s-2008-1071511; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Royaux I, 1997, GENOMICS, V42, P479, DOI 10.1006/geno.1997.4772; Royaux I, 1997, GENOMICS, V46, P240, DOI 10.1006/geno.1997.4983; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7	28	586	611	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					93	96		10.1038/79246			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000026	10973257				2022-01-24	
J	KAMB, A; SHATTUCKEIDENS, D; EELES, R; LIU, Q; GRUIS, NA; DING, W; HUSSEY, C; TRAN, T; MIKI, Y; WEAVERFELDHAUS, J; MCCLURE, M; AITKEN, JF; ANDERSON, DE; BERGMAN, W; FRANTS, R; GOLDGAR, DE; GREEN, A; MACLENNAN, R; MARTIN, NG; MEYER, LJ; YOUL, P; ZONE, JJ; SKOLNICK, MH; CANNONALBRIGHT, LA				KAMB, A; SHATTUCKEIDENS, D; EELES, R; LIU, Q; GRUIS, NA; DING, W; HUSSEY, C; TRAN, T; MIKI, Y; WEAVERFELDHAUS, J; MCCLURE, M; AITKEN, JF; ANDERSON, DE; BERGMAN, W; FRANTS, R; GOLDGAR, DE; GREEN, A; MACLENNAN, R; MARTIN, NG; MEYER, LJ; YOUL, P; ZONE, JJ; SKOLNICK, MH; CANNONALBRIGHT, LA			ANALYSIS OF THE P16 GENE (CDKN2) AS A CANDIDATE FOR THE CHROMOSOME 9P MELANOMA SUSCEPTIBILITY LOCUS	NATURE GENETICS			English	Article							CUTANEOUS MALIGNANT-MELANOMA; DYSPLASTIC NEVUS SYNDROME; FAMILIAL MELANOMA; LINKAGE; CANCER; EXCLUSION; PEDIGREES; MUTATIONS; REGIONS; MLM	A locus for familial melanoma, MLM, has been mapped within the same interval on chromosome 9p21 as the gene for a putative cell cycle regulator, p16(INK4)(CDKN2) MTS1. This gene is homozygously deleted from many tumour cell lines including melanomas, suggesting that CDKN2 is a good candidate for MLM. We have analysed CDKN2 coding sequences in pedigrees segregating 9p melanoma susceptibility and 38 other melanoma-prone families. in only two families were potential predisposing mutations identified. No evidence was found for heterozygous deletions of CDKN2 in the germline of melanoma-prone individuals. The low frequency of potential predisposing mutations detected suggests that either the majority of mutations fall outside the CDKN2 coding sequence or that CDKN2 is not MLM.	UNIV UTAH,MED CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84108; INST CANC RES,SUTTON SM2 5PT,SURREY,ENGLAND; ROYAL MARSDEN HOSP,CRC,ACAD UNIT RADIOTHERAPY,SUTTON SM2 5PT,SURREY,ENGLAND; LEIDEN UNIV,MGC,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT DERMATOL,LEIDEN,NETHERLANDS; QUEENSLAND INST MED RES,BRISBANE,QLD 4029,AUSTRALIA; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030; UNIV UTAH,SCH MED,DEPT INTERNAL MED,SALT LAKE CITY,UT 84132; VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,SALT LAKE CITY,UT 84148		KAMB, A (corresponding author), MYRIAD GENET INC,421 WAKARA WAY,SALT LAKE CITY,UT 84108, USA.		Green, Adele C/P-2736-2014; Youl, Philippa H/C-4131-2009; Green, Adele C/B-5324-2011; Aitken, Joanne F/C-5289-2009	Green, Adele C/0000-0002-2753-4841; 			AITKEN JF, IN PRESS AM J EPIDEM; ANDERSON DE, 1991, ANTICANCER RES, V11, P433; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BERGMAN W, 1986, ANN HUM GENET, V50, P249, DOI 10.1111/j.1469-1809.1986.tb01046.x; CAI SP, 1992, BLOOD, V79, P1342; CAIRNS P, 1994, SCIENCE, V265, P415, DOI 10.1126/science.8023167; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CANNONALBRIGHT LA, IN PRESS GENOMICS; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; GOLDSTEIN AM, 1994, AM J HUM GENET, V54, P489; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; GRUIS NA, 1990, NEW ENGL J MED, V322, P853; GRUIS NA, 1993, MELANOMA RES, V3, P271; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; KAMB A, 1994, SCIENCE, V265, P416, DOI 10.1126/science.265.5170.416; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MIKI Y, 1992, CANCER RES, V52, P643; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; RANDALL T, 1993, JAMA-J AM MED ASSOC, V269, P558; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; TAKAHIRO M, 1994, CANCER RES, V54, P3396; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; WEAVERFELDHAUS J, 1994, P NATL ACAD SCI USA, V91, P7563, DOI 10.1073/pnas.91.16.7563	32	586	595	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					22	26		10.1038/ng0994-22			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	WOS:A1994PE15700011					2022-01-24	
J	TEMPLETON, AR; SING, CF				TEMPLETON, AR; SING, CF			A CLADISTIC-ANALYSIS OF PHENOTYPIC ASSOCIATIONS WITH HAPLOTYPES INFERRED FROM RESTRICTION ENDONUCLEASE MAPPING .4. NESTED ANALYSES WITH CLADOGRAM UNCERTAINTY AND RECOMBINATION	GENETICS			English	Article							DROSOPHILA-MELANOGASTER; NATURAL-POPULATIONS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM; CHI-2	We previously developed an analytical strategy based on cladistic theory to identify subsets of haplotypes that are associated with significant phenotypic deviations. Our initial approach was limited to segments of DNA in which little recombination occurs. In such cases, a cladogram can be constructed from the restriction site data to estimate the evolutionary steps that interrelate the observed haplotypes to one another. The cladogram is then used to define a nested statistical design for identifying mutational steps associated with significant phenotypic deviations. The central assumption behind this strategy is that a mutation responsible for a particular phenotypic effect is embedded within the evolutionary history that is represented by the cladogram. The power of this approach depends on the accuracy of the cladogram in portraying the evolutionary history of the DNA region. This accuracy can be diminished both by recombination and by uncertainty in the estimated cladogram topology. In a previous paper, we presented an algorithm for estimating the set of likely cladograms and recombination events. In this paper we present an algorithm for defining a nested statistical design under cladogram uncertainty and recombination. Given the nested design, phenotypic associations can be examined using either a nested analysis of variance (for haploids or homozygous strains) or permutation testing (for outcrossed, diploid gene regions). In this paper we also extend this analytical strategy to include categorical phenotypes in addition to quantitative phenotypes. Some worked examples are presented using Drosophila data sets. These examples illustrate that having some recombination may actually enhance the biological inferences that may derived from a cladistic analysis. In particular, recombination can be used to assign a physical localization to a given subregion for mutations responsible for significant phenotypic effects.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109		TEMPLETON, AR (corresponding author), WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130, USA.		Templeton, Alan R./F-5963-2011	Sing, Charles/0000-0001-5872-7956; Templeton, Alan/0000-0002-0167-845X	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 R01 HL39107] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL039107] Funding Source: NIH RePORTER		CLARK AG, 1992, MOL BIOL EVOL, V9, P744; Edgington E.S., 1987, RANDOMIZATION TESTS; GAME AY, 1990, GENETICS, V126, P1021; LANGLEY CH, 1977, GENETICS, V86, P447; LANGLEY CH, 1988, GENETICS, V119, P619; LLOYD DG, 1991, J EVOLUTION BIOL, V4, P9, DOI 10.1046/j.1420-9101.1991.4010009.x; PRUM B, 1990, ANN HUM GENET, V54, P315, DOI 10.1111/j.1469-1809.1990.tb00387.x; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; SWOFFORD DL, 1991, PAUP 3 0 USERS MANUA; Templeton A.R., 1983, STAT ANAL DNA SEQUEN, P151; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1988, GENETICS, V120, P1145; YAMAZAKI T, 1984, JPN J GENET, V59, P33, DOI 10.1266/jjg.59.33	14	586	607	0	19	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUN	1993	134	2					659	669					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LE038	WOS:A1993LE03800023	8100789				2022-01-24	
J	Ramagopalan, SV; Heger, A; Berlanga, AJ; Maugeri, NJ; Lincoln, MR; Burrell, A; Handunnetthi, L; Handel, AE; Disanto, G; Orton, SM; Watson, CT; Morahan, JM; Giovannoni, G; Ponting, CP; Ebers, GC; Knight, JC				Ramagopalan, Sreeram V.; Heger, Andreas; Berlanga, Antonio J.; Maugeri, Narelle J.; Lincoln, Matthew R.; Burrell, Amy; Handunnetthi, Lahiru; Handel, Adam E.; Disanto, Giulio; Orton, Sarah-Michelle; Watson, Corey T.; Morahan, Julia M.; Giovannoni, Gavin; Ponting, Chris P.; Ebers, George C.; Knight, Julian C.			A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution	GENOME RESEARCH			English	Article							SUSCEPTIBILITY LOCI; MULTIPLE-SCLEROSIS; DNA-SEQUENCES; TARGET GENES; IDENTIFICATION; METAANALYSIS; PATHWAYS; DATABASE; BROWSER; REGIONS	Initially thought to play a restricted role in calcium homeostasis, the pleiotropic actions of vitamin D in biology and their clinical significance are only now becoming apparent. However, the mode of action of vitamin D, through its cognate nuclear vitamin D receptor (VDR), and its contribution to diverse disorders, remain poorly understood. We determined VDR binding throughout the human genome using chromatin immunoprecipitation followed by massively parallel DNA sequencing (ChIP-seq). After calcitriol stimulation, we identified 2776 genomic positions occupied by the VDR and 229 genes with significant changes in expression in response to vitamin D. VDR binding sites were significantly enriched near autoimmune and cancer associated genes identified from genome-wide association (GWA) studies. Notable genes with VDR binding included IRF8, associated with MS, and PTPN2 associated with Crohn's disease and T1D. Furthermore, a number of single nucleotide polymorphism associations from GWA were located directly within VDR binding intervals, for example, rs13385731 associated with SLE and rs947474 associated with T1D. We also observed significant enrichment of VDR intervals within regions of positive selection among individuals of Asian and European descent. ChIP-seq determination of transcription factor binding, in combination with GWA data, provides a powerful approach to further understanding the molecular bases of complex diseases.	[Ramagopalan, Sreeram V.; Berlanga, Antonio J.; Maugeri, Narelle J.; Lincoln, Matthew R.; Burrell, Amy; Handunnetthi, Lahiru; Handel, Adam E.; Disanto, Giulio; Orton, Sarah-Michelle; Morahan, Julia M.; Ebers, George C.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Ramagopalan, Sreeram V.; Berlanga, Antonio J.; Lincoln, Matthew R.; Burrell, Amy; Handunnetthi, Lahiru; Handel, Adam E.; Disanto, Giulio; Orton, Sarah-Michelle; Morahan, Julia M.; Ebers, George C.] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Ramagopalan, Sreeram V.; Giovannoni, Gavin] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London E1 2AT, England; [Heger, Andreas; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Watson, Corey T.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada		Ramagopalan, SV (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	sreeramr@well.ox.ac.uk; george.ebers@clneuro.ox.ac.uk; julian@well.ox.ac.uk	Ponting, Chris/AAV-2621-2021; Knight, Julian Charles/W-2399-2019; Lincoln, Matthew R/ABD-1504-2020; Handel, Adam/F-2489-2011; Knight, Julian/C-7242-2009	Knight, Julian Charles/0000-0002-0377-5536; Lincoln, Matthew R/0000-0003-2962-6253; Knight, Julian/0000-0002-0377-5536; Orton, Sarah-Michelle/0000-0001-7502-7353; Handunnetthi, Lahiru/0000-0002-8242-3722; Ponting, Chris/0000-0003-0202-7816; Heger, Andreas/0000-0001-7720-0447; Handel, Adam/0000-0001-8385-6346; Watson, Corey/0000-0001-7248-8787; Ebers, George/0000-0003-4771-4177	Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of Great Britain and Northern Ireland; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Wellcome TrustWellcome TrustEuropean Commission [074318, 075491/Z/04]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U137761446] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U137761446] Funding Source: researchfish	This work was funded by the Multiple Sclerosis Society of Canada Scientific Research Foundation, the Multiple Sclerosis Society of Great Britain and Northern Ireland, the Medical Research Council, and the Wellcome Trust [074318; 075491/Z/04]. S.V.R. is a Goodger Scholar at the University of Oxford. J.C.K. is a Wellcome Trust Senior Research Fellow in Clinical Science.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Baranzini SE, 2009, CURR OPIN IMMUNOL, V21, P596, DOI 10.1016/j.coi.2009.09.014; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Carlberg C, 2006, ANTICANCER RES, V26, P2637; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Feldman D, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu X, 2001, Pac Symp Biocomput, P127; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHWENDER H, 2006, RNEWS, V6, P45; Seuter S, 2007, BBA-MOL CELL BIOL L, V1771, P864, DOI 10.1016/j.bbalip.2007.04.007; Sinkkonen L, 2005, NUCLEIC ACIDS RES, V33, P2440, DOI 10.1093/nar/gki502; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang TT, 2010, J BIOL CHEM, V285, P2237, DOI 10.1074/jbc.C109.071225; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; [No title captured]	47	585	601	1	63	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2010	20	10					1352	1360		10.1101/gr.107920.110			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	656XS	WOS:000282375000005	20736230	Bronze, Green Published			2022-01-24	
J	JIANG, CJ; ZENG, ZB				JIANG, CJ; ZENG, ZB			MULTIPLE-TRAIT ANALYSIS OF GENETIC-MAPPING FOR QUANTITATIVE TRAIT LOCI	GENETICS			English	Article							MOLECULAR MARKERS	We present in this paper models and statistical methods for performing multiple trait analysis on mapping quantitative trait loci (QTL) based on the composite interval mapping method. By taking into account the correlated structure of multiple traits, this joint analysis has several advantages, compared with separate analyses, for mapping QTL, including the expected improvement on the statistical power of the test for QTL and on the precision of parameter estimation. Also this joint analysis provides formal procedures to test a number of biologically interesting hypotheses concerning the nature of genetic correlations between different traits. Among the testing procedures considered are those for joint mapping, pleiotropy, QTL by environment interaction, and pleiotropy vs. close linkage. The test of pleiotropy (one pleiotropic QTL at a genome position) vs. close linkage (multiple nearby nonpleiotropic QTL) can have important implications for our understanding of the nature of genetic correlations between different traits in certain regions of a genome and also for practical applications in animal and plant breeding because one of the major goals in breeding is to break unfavorable linkage. Results of extensive simulation studies are presented to illustrate various properties of the analyses.	N CAROLINA STATE UNIV,DEPT STAT,PROGRAM STAT GENET,RALEIGH,NC 27695; JIANGSU AGR COLL,DEPT AGRON,JIANGSU,PEOPLES R CHINA						NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-45344] Funding Source: Medline		CHURCHILL GA, 1994, GENETICS, V138, P963; Dongarra JJ, 1979, LINPACK USERS GUIDE; FALCONER DS, 1952, AM NAT, V86, P293, DOI 10.1086/281736; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1992, THEOR APPL GENET, V85, P252, DOI 10.1007/BF00222867; LANDER ES, 1989, GENETICS, V121, P185; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.1093/biomet/80.2.267; PATERSON AH, 1991, GENETICS, V127, P181; PATTERSON AH, 1988, NATURE, V335, P721, DOI DOI 10.1038/335721A0; STUBER CW, 1992, GENETICS, V132, P823; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; ZENG ZB, 1992, GENETICS, V131, P987	14	585	623	0	36	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUL	1995	140	3					1111	1127					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE868	WOS:A1995RE86800023	7672582				2022-01-24	
J	REARDON, W; WINTER, RM; RUTLAND, P; PULLEYN, LJ; JONES, BM; MALCOLM, S				REARDON, W; WINTER, RM; RUTLAND, P; PULLEYN, LJ; JONES, BM; MALCOLM, S			MUTATIONS IN THE FIBROBLAST GROWTH-FACTOR RECEPTOR-2 GENE CAUSE CROUZON-SYNDROME	NATURE GENETICS			English	Article							SAETHRE-CHOTZEN SYNDROME; CRANIOSYNOSTOSIS; FAMILY; FORMS; RNA; LINKAGE; CLONING; CELLS; MAPS; DNA	Crouzon syndrome is an autosomal dominant condition causing premature fusion of the cranial sutures (craniosynostosis) and maps to chromosome 10q25-q26. We now present evidence that mutations in the fibroblast growth factor receptor 2 gene (FGFR2) cause Crouzon syndrome. We found SSCP variations in the B exon of FGFR2 in nine unrelated affected individuals as well as complete cosegregation between SSCP variation and disease in three unrelated multigenerational families. In four sporadic cases, the normal parents did not have SSCP variation. Finally, direct sequencing has revealed specific mutations in the B exon in all nine sporadic and familial cases, including replacement of a cysteine in an immunoglobulin-like domain in five patients.	INST CHILD HLTH, MOLEC GENET UNIT, LONDON WC1N 1EH, ENGLAND; HOSP CHILDREN, DEPT PLAST & RECONSTRUCT SURG, LONDON WC1N 3JN, ENGLAND		REARDON, W (corresponding author), INST CHILD HLTH, MOTHERCARE UNIT CLIN GENET & FETAL MED, 30 GUILFORD ST, LONDON WC1N 1EH, ENGLAND.						BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; COHEN MM, 1986, CRANIOSYNOSTOSISF DI; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DIONNE CA, 1992, CYTOGENET CELL GENET, V60, P34, DOI 10.1159/000133290; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; Langer L O Jr, 1987, Am J Med Genet Suppl, V3, P167; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; MATTEI MG, 1991, HUM GENET, V87, P84, DOI 10.1007/BF01213098; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLER U, 1993, HUM MOL GENET, V2, P119, DOI 10.1093/hmg/2.2.119; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1990, P NATL ACAD SCI USA, V87, P5812, DOI 10.1073/pnas.87.15.5812; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; RAZ V, 1991, ONCOGENE, V6, P753; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, J MED GENET, V31, P219, DOI 10.1136/jmg.31.3.219; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; WARMAN ML, 1993, AM J MED GENET, V46, P444, DOI 10.1002/ajmg.1320460420; WINTER RM, 1994, LONDON DYSMORPHOLOGY	37	585	607	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1994	8	1					98	103		10.1038/ng0994-98			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	WOS:A1994PE15700023	7987400				2022-01-24	
J	HUI, CC; JOYNER, AL				HUI, CC; JOYNER, AL			A MOUSE MODEL OF GREIG CEPHALOPOLYSYNDACTYLY SYNDROME - THE EXTRA-TOES(J) MUTATION CONTAINS AN INTRAGENIC DELETION OF THE GLI3 GENE	NATURE GENETICS			English	Article							CRANIOFACIAL ANOMALIES; KRUPPEL FAMILY; EXTRA-TOES; TRANSLOCATION; LOCALIZATION; DROSOPHILA; DOMINANT; 7P13; XT	Greig cephalopolysyndactyly syndrome (GCPS) is an autosomal dominant disorder affecting limb and craniofacial development. Recently, the human GLl3 gene has been proposed to be a candidate gene for GCPS. Here we describe the molecular characterization of extra-toes (Xt), which is a mouse model of GCPS. The Xt heterozygotes show craniofacial defects and a polydactyly phenotype similar to GCPS. We show that a deficiency of Gli3 expression in the Xt(J) mutant is due to a deletion within the 3' end of the gene. Furthermore, structures affected in the mouse mutant and human syndrome were found to correlate with expression domains of Gli3 in mouse. These results strongly suggest that the deficiency of GLl3 function leads to GCPS.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA		HUI, CC (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DIV MOLEC & DEV BIOL,TORONTO M5G 1X5,ONTARIO,CANADA.						BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARAITSER M, 1983, CLIN GENET, V24, P257; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DRABKIN H, 1989, GENOMICS, V4, P518, DOI 10.1016/0888-7543(89)90275-9; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FRYNS JP, 1977, EUR J PEDIATR, V126, P283, DOI 10.1007/BF00477055; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOLLOP TR, 1985, AM J MED GENET, V22, P59, DOI 10.1002/ajmg.1320220106; GREIG DAVID M., 1926, EDINBURGH MED JOUR, V33, P189; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HAYASAKA I, 1980, EXP ANIM, V29, P391; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hinchliffe J.R., 1980, DEV VERTEBRATE LIMB; HOOTNICK D, 1972, CLIN GENET, V3, P128; HUNTER CP, 1990, CELL, V63, P1193, DOI 10.1016/0092-8674(90)90415-B; JOHNSON DR, 1969, GENET RES, V13, P275, DOI 10.1017/S0016672300002962; JOHNSON DR, 1986, GENETICS SKELETON; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V3, P543; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KRUGER G, 1989, AM J MED GENET, V32, P411, DOI 10.1002/ajmg.1320320329; Lyon M. F., 1992, Mouse Genome, V90, P22; LYON MF, 1967, GENET RES, V9, P383, DOI 10.1017/S0016672300010673; McKusick VA, 1990, MENDELIAN INHERITANC; MERLOB P, 1981, ACTA PAEDIATR SCAND, V70, P275, DOI 10.1111/j.1651-2227.1981.tb05557.x; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; NARUSE I, 1989, Environmental Medicine (Nagoya), V33, P27; NARUSE I, 1984, ENV MED, V28, P89; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; PETTIGREW AL, 1991, HUM GENET, V87, P452; POHL TM, 1990, DEVELOPMENT, V110, P1153; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Smith F., 1987, CURRENT PROTOCOLS MO; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TOMMERUP N, 1983, AM J MED GENET, V16, P313, DOI 10.1002/ajmg.1320160304; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER K, 1990, GENOMICS, V8, P487, DOI 10.1016/0888-7543(90)90035-S; WINTER RM, 1988, AM J MED GENET, V31, P793, DOI 10.1002/ajmg.1320310411; ZARKOWER D, 1992, CELL, V70, P237, DOI 10.1016/0092-8674(92)90099-X	45	584	591	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					241	246		10.1038/ng0393-241			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	WOS:A1993KP79000014	8387379				2022-01-24	
J	BONIERBALE, MW; PLAISTED, RL; TANKSLEY, SD				BONIERBALE, MW; PLAISTED, RL; TANKSLEY, SD			RFLP MAPS BASED ON A COMMON SET OF CLONES REVEAL MODES OF CHROMOSOMAL EVOLUTION IN POTATO AND TOMATO	GENETICS			English	Article											BONIERBALE, MW (corresponding author), CORNELL UNIV,DEPT PLANT BREEDING & BIOMETRY,ITHACA,NY 14853, USA.						Arnheim N., 1983, P38; BERNATZKY R, 1986, GENETICS, V112, P887; BERNATZKY R, 1986, MOL GEN GENET, V203, P8, DOI 10.1007/BF00330377; BOCK IR, 1971, CHROMOSOMA, V34, P206; Brown W. V., 1972, TXB CYTOGENETICS; CARSON HL, 1970, SCIENCE, V168, P1414, DOI 10.1126/science.168.3938.1414; DARCY WG, 1976, BIOL TAXONOMY SOLANA, P3; DOBZHANSKY T, 1972, SCIENCE, V177, P664, DOI 10.1126/science.177.4050.664; DOUCHES DS, 1988, HEREDITY, V60, P183, DOI 10.1038/hdy.1988.30; DOUCHES DS, 1987, GENOME, V29, P519, DOI 10.1139/g87-089; EDWARDS MD, 1987, GENETICS, V116, P113; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GANAL MW, 1988, MOL GEN GENET, V213, P262, DOI 10.1007/BF00339590; GILL BS, 1980, CAN J GENET CYTOL, V22, P333, DOI 10.1139/g80-041; HANNEMAN RE, 1986, WISC AGR RES STN B, V533; HOOKER WJ, 1981, COMPENDIUM POTATO DI; HOWARD HW, 1970, GENETICS POTATO; HUAMAN Z, 1985, AM POTATO J, V62, P629, DOI 10.1007/BF02854438; JORGENSEN RA, 1982, CARNEGIE I WASH YB, V81, P98; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; MELCHERS G, 1978, CARLSBERG RES COMMUN, V43, P203, DOI 10.1007/BF02906548; MOK DWS, 1975, CAN J GENET CYTOL, V17, P217, DOI 10.1139/g75-029; OSBORN TC, 1987, THEOR APPL GENET, V73, P350, DOI 10.1007/BF00262500; PICHERSKY E, 1985, GENE, V40, P247, DOI 10.1016/0378-1119(85)90047-2; PICHERSKY E, 1986, P NATL ACAD SCI USA, V83, P3880, DOI 10.1073/pnas.83.11.3880; PICKERSGILL B, 1978, BIOL TAXONOMY SOLANA, P679; Richardson MM, 1936, J GENET, V32, P411; RICK CM, 1969, GENETICS, V62, P753; RIGBY P, 1977, NUCLEIC ACIDS RES, V7, P1263; SCHWEIZER G, 1988, THEOR APPL GENET, V75, P679, DOI 10.1007/BF00265587; STONE WS, 1955, COLD SPRING HARB SYM, V20, P256, DOI 10.1101/SQB.1955.020.01.024; STONE WS, 1960, P NATL ACAD SCI USA, V46, P350, DOI 10.1073/pnas.46.3.350; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Tanksley S. D., 1987, GENETIC MAPS 1987 CO, P655; TANKSLEY SD, 1984, CHROMOSOMA, V89, P352, DOI 10.1007/BF00331252; TANKSLEY SD, 1988, THEOR APPL GENET, V75, P811, DOI 10.1007/BF00265610; TANKSLEY SD, 1984, EUPHYTICA, V33, P769, DOI 10.1007/BF00021903; TANKSLEY SD, 1988, P NATL ACAD SCI USA, V85, P6419, DOI 10.1073/pnas.85.17.6419; TANKSLEY SD, 1985, BIOCHEM GENET, V23, P441, DOI 10.1007/BF00499085; TANKSLEY SD, 1987, CHROMOSOME STRUCTURE, P157; YEH BP, 1965, AM J BOT, V52, P1014, DOI 10.2307/2440131; YOUNG ND, 1988, IN PRESS RESTRICTION; ZAMIR D, 1988, MOL GEN GENET, V213, P254, DOI 10.1007/BF00339589	43	584	621	0	22	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	DEC	1988	120	4					1095	1103					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R2865	WOS:A1988R286500022	17246486				2022-01-24	
J	Pena-LlopiS, S; Vega-Rubin-De-Celis, S; Liao, A; Leng, N; Pavia-Jimenez, A; Wang, S; Yamasaki, T; Zhrebker, L; Sivanand, S; Spence, P; Kinch, L; Hambuch, T; Jain, S; Lotan, Y; Margulis, V; Sagalowsky, AI; Summerour, PB; Kabbani, W; Wong, SWW; Grishin, N; Laurent, M; Xie, XJ; Haudenschild, CD; Ross, MT; Bentley, DR; Kapur, P; Brugarolas, J				Pena-LlopiS, Samuel; Vega-Rubin-de-Celis, Silvia; Liao, Arnold; Leng, Nan; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Zhrebker, Leah; Sivanand, Sharanya; Spence, Patrick; Kinch, Lisa; Hambuch, Tina; Jain, Suneer; Lotan, Yair; Margulis, Vitaly; Sagalowsky, Arthur I.; Summerour, Pia Banerji; Kabbani, Wareef; Wong, S. W. Wendy; Grishin, Nick; Laurent, Marc; Xie, Xian-Jin; Haudenschild, Christian D.; Ross, Mark T.; Bentley, David R.; Kapur, Payal; Brugarolas, James			BAP1 loss defines a new class of renal cell carcinoma	NATURE GENETICS			English	Article							BRCA1-ASSOCIATED PROTEIN-1; OCULOCUTANEOUS ALBINISM; UBIQUITIN HYDROLASE; SOMATIC MUTATIONS; FREQUENT MUTATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; FACTOR-I; P-GENE; COMPLEX	The molecular pathogenesis of renal cell carcinoma (RCC) is poorly understood. Whole-genome and exome sequencing followed by innovative tumorgraft analyses (to accurately determine mutant allele ratios) identified several putative two-hit tumor suppressor genes, including BAP1. The BAP1 protein, a nuclear deubiquitinase, is inactivated in 15% of clear cell RCCs. BAP1 cofractionates with and binds to HCF-1 in tumorgrafts. Mutations disrupting the HCF-1 binding motif impair BAP1-mediated suppression of cell proliferation but not deubiquitination of monoubiquitinated histone 2A lysine 119 (H2AK119ub1). BAP1 loss sensitizes RCC cells in vitro to genotoxic stress. Notably, mutations in BAP1 and PBRM1 anticorrelate in tumors (P = 3 x 10(-5)), and combined loss of BAP1 and PBRM1 in a few RCCs was associated with rhabdoid features (q = 0.0007). BAP1 and PBRM1 regulate seemingly different gene expression programs, and BAP1 loss was associated with high tumor grade (q = 0.0005). Our results establish the foundation for an integrated pathological and molecular genetic classification of RCC, paving the way for subtype-specific treatments exploiting genetic vulnerabilities.	[Vega-Rubin-de-Celis, Silvia; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Sivanand, Sharanya; Spence, Patrick; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pena-LlopiS, Samuel; Vega-Rubin-de-Celis, Silvia; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Zhrebker, Leah; Sivanand, Sharanya; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Pena-LlopiS, Samuel; Vega-Rubin-de-Celis, Silvia; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Zhrebker, Leah; Sivanand, Sharanya; Spence, Patrick; Summerour, Pia Banerji; Xie, Xian-Jin; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Liao, Arnold; Leng, Nan; Hambuch, Tina; Jain, Suneer; Laurent, Marc; Haudenschild, Christian D.] Illumina Inc, San Diego, CA USA; [Kinch, Lisa; Grishin, Nick] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lotan, Yair; Margulis, Vitaly; Sagalowsky, Arthur I.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Summerour, Pia Banerji] Univ Texas SW Med Ctr Dallas, Dept Clin Genet, Dallas, TX 75390 USA; [Kabbani, Wareef; Kapur, Payal] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Wong, S. W. Wendy; Ross, Mark T.; Bentley, David R.] Illumina Cambridge Ltd, Saffron Walden, England		Brugarolas, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	james.brugarolas@utsouthwestern.edu	Pena-Llopis, Samuel/ABH-2358-2020	Sivanand, Sharanya/0000-0002-2559-9270; Kinch, Lisa/0000-0003-3041-2615; Brugarolas, James/0000-0002-8575-499X; Pena-Llopis, Samuel/0000-0003-3847-1353	Generalitat ValencianaGeneralitat ValencianaEuropean CommissionGeneral Electric [BPOSTDOC06/004]; Cancer Prevention and Research Institute of Texas [RP101075]; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); American Cancer SocietyAmerican Cancer Society [115739]; US. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 CA129387]; US National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1P30CA142543]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA129387, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM094575] Funding Source: NIH RePORTER	We recognize the individuals who participated in the study and who donated samples. We thank O. Sepulveda, A. Husain and A. Yadlapalli for technical support, S. Cohenour and D. Sheppard for assistance with contracts and regulatory considerations, Y. Machida (Mayo Clinic) for providing plasmids, B. Grossman (MD Anderson Cancer Center) for providing the UMRC cells, C. Camacho and N. Tomimatsu for irradiating cells, and the staff of the UT Southwestern Tissue Resource. This work was supported by a fellowship of excellence from Generalitat Valenciana (BPOSTDOC06/004 to S.P.-L.) and by the following awards to J.B.: a grant from the Cancer Prevention and Research Institute of Texas (RP101075), a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, an American Cancer Society Research Scholar grant (115739) and a grant from the US. National Institutes of Health (RO1 CA129387). The tissue management shared resource is supported in part by the US National Cancer Institute (NCI) (1P30CA142543). J.B. is a Virginia Murchison Linthicum Scholar in Medical Research at UT Southwestern. The content herein is solely the responsibility of the authors and does not represent the official views of any of the granting agencies.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; BRETHEAU D, 1995, CANCER, V76, P2543, DOI 10.1002/1097-0142(19951215)76:12<2543::AID-CNCR2820761221>3.0.CO;2-S; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Brugarolas J, 2012, RENAL CELL CARCINOMA: TRANSLATIONAL BIOLOGY, PERSONALIZED MEDICINE, AND NOVEL THERAPEUTIC TARGETS, P161, DOI 10.1007/978-1-4614-2400-0_8; Chapman-Fredricks JR, 2011, ANN DIAGN PATHOL, V15, P333, DOI 10.1016/j.anndiagpath.2011.03.002; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Ficarra V, 2010, EUR UROL, V58, P655, DOI 10.1016/j.eururo.2010.08.001; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gokden N, 2000, AM J SURG PATHOL, V24, P1329; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; HAHN SA, 1995, CANCER RES, V55, P4670; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kaelin WG, 2012, RENAL CELL CARCINOMA: TRANSLATIONAL BIOLOGY, PERSONALIZED MEDICINE, AND NOVEL THERAPEUTIC TARGETS, P27, DOI 10.1007/978-1-4614-2400-0_2; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pantuck AJ, 2007, CANCER-AM CANCER SOC, V109, P2257, DOI 10.1002/cncr.22677; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Suzuki T, 2003, J INVEST DERMATOL, V120, P781, DOI 10.1046/j.1523-1747.2003.12127.x; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	58	583	594	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					751	U174		10.1038/ng.2323			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	WOS:000305886900007	22683710	Green Accepted	Y	N	2022-01-24	
J	De Jager, PL; Jia, XM; Wang, J; de Bakker, PIW; Ottoboni, L; Aggarwal, NT; Piccio, L; Raychaudhuri, S; Tran, D; Aubin, C; Briskin, R; Romano, S; Baranzini, SE; McCauley, JL; Pericak-Vance, MA; Haines, JL; Gibson, RA; Naeglin, Y; Uitdehaag, B; Matthews, PM; Kappos, L; Polman, C; McArdle, WL; Strachan, DP; Evans, D; Cross, AH; Daly, MJ; Compston, A; Sawcer, SJ; Weiner, HL; Hauser, SL; Hafler, DA; Oksenberg, JR				De Jager, Philip L.; Jia, Xiaoming; Wang, Joanne; de Bakker, Paul I. W.; Ottoboni, Linda; Aggarwal, Neelum T.; Piccio, Laura; Raychaudhuri, Soumya; Tran, Dong; Aubin, Cristin; Briskin, Rebeccah; Romano, Susan; Baranzini, Sergio E.; McCauley, Jacob L.; Pericak-Vance, Margaret A.; Haines, Jonathan L.; Gibson, Rachel A.; Naeglin, Yvonne; Uitdehaag, Bernard; Matthews, Paul M.; Kappos, Ludwig; Polman, Chris; McArdle, Wendy L.; Strachan, David P.; Evans, Denis; Cross, Anne H.; Daly, Mark J.; Compston, Alastair; Sawcer, Stephen J.; Weiner, Howard L.; Hauser, Stephen L.; Hafler, David A.; Oksenberg, Jorge R.		Int MS Genetics Consortium	Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD CELLS; WIDE ASSOCIATION; PERIODIC-SYNDROME; R92Q MUTATION; RHEUMATOID-ARTHRITIS; HAPLOTYPE MAP; INTERFERON; DISEASE; RISK	We report the results of a meta-analysis of genome-wide association scans for multiple sclerosis (MS) susceptibility that includes 2,624 subjects with MS and 7,220 control subjects. Replication in an independent set of 2,215 subjects with MS and 2,116 control subjects validates new MS susceptibility loci at TNFRSF1A (combined P = 1.59 x 10(-11)), IRF8 (P = 3.73 x 10(-9)) and CD6 (P = 3.79 x 10(-9)). TNFRSF1A harbors two independent susceptibility alleles: rs1800693 is a common variant with modest effect (odds ratio 1.2), whereas rs4149584 is a nonsynonymous coding polymorphism of low frequency but with stronger effect (allele frequency 0.02; odds ratio 1.6). We also report that the susceptibility allele near IRF8, which encodes a transcription factor known to function in type I interferon signaling, is associated with higher mRNA expression of interferon-response pathway genes in subjects with MS.	[De Jager, Philip L.; Ottoboni, Linda; Romano, Susan; Weiner, Howard L.; Hafler, David A.] Brigham & Womens Hosp, Div Mol Immunol, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip L.; Ottoboni, Linda; Briskin, Rebeccah] Partners Ctr Personalized Genet Med, Boston, MA USA; [De Jager, Philip L.; de Bakker, Paul I. W.; Ottoboni, Linda; Raychaudhuri, Soumya; Tran, Dong; Aubin, Cristin; Daly, Mark J.; Hafler, David A.] Harvard Univ, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02138 USA; [De Jager, Philip L.; de Bakker, Paul I. W.; Ottoboni, Linda; Raychaudhuri, Soumya; Tran, Dong; Aubin, Cristin; Daly, Mark J.; Hafler, David A.] MIT, Cambridge, MA 02139 USA; [Jia, Xiaoming; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Wang, Joanne; Baranzini, Sergio E.; Hauser, Stephen L.; Oksenberg, Jorge R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Wang, Joanne; Hauser, Stephen L.; Oksenberg, Jorge R.] Univ Calif San Francisco, Inst Human Genet, Sch Med, San Francisco, CA 94143 USA; [Aggarwal, Neelum T.; Evans, Denis] Rush Univ, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Aggarwal, Neelum T.; Evans, Denis] Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA; [Piccio, Laura; Cross, Anne H.] Washington Univ, Dept Neurol, St Louis, MO USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Immunol Allergy & Rheumatol, Boston, MA 02115 USA; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Gibson, Rachel A.; Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London SW7 2AZ, England; [Gibson, Rachel A.; Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, GlaxoSmithKline Clin Imaging Ctr, London SW7 2AZ, England; [Naeglin, Yvonne; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Uitdehaag, Bernard; Polman, Chris] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Compston, Alastair; Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England		De Jager, PL (corresponding author), Brigham & Womens Hosp, Div Mol Immunol, Ctr Neurol Dis, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu	Haines, Jonathan/C-3374-2012; Hauser, Stephen L/J-2978-2016; Baranzini, Sergio/A-9422-2013; Ottoboni, Linda/AAC-4508-2022; Piccio, Laura/AAE-1706-2020; Daly, Mark J/B-2453-2017; de Bakker, Paul IW/B-8730-2009	Haines, Jonathan/0000-0002-4351-4728; Baranzini, Sergio/0000-0003-0067-194X; Ottoboni, Linda/0000-0001-5412-7785; Piccio, Laura/0000-0002-8760-109X; Daly, Mark J/0000-0002-0949-8752; de Bakker, Paul IW/0000-0001-7735-7858; Jia, Xiaoming/0000-0002-5104-5431; Gibson, Rachel/0000-0002-1338-1290; Cross, Anne/0000-0003-0829-7569; Raychaudhuri, Soumya/0000-0002-1901-8265; Matthews, Paul M/0000-0002-1619-8328	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934, MC_QA137934] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01 AI039671] Funding Source: Medline; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08 AR055688, K08 AR055688-01A1] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS046341, K08 NS46341, R01 NS046630, R01 NS049477] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934, MC_qA137934] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_qA137934] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10335] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01AI039671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS046341, R01NS049477, R01NS046630] Funding Source: NIH RePORTER		Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; Castro MAA, 2007, J IMMUNOL, V178, P4351, DOI 10.4049/jimmunol.178.7.4351; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; De Jager PL, 2008, NEUROLOGY, V70, P1113, DOI 10.1212/01.wnl.0000294325.63006.f8; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; DEGRE M, 1976, ACTA NEUROL SCAND, V53, P152, DOI 10.1111/j.1600-0404.1976.tb04333.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauthier SA, 2006, AUTOIMMUN REV, V5, P532, DOI 10.1016/j.autrev.2006.02.012; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; HAFLER DA, 1986, NEUROLOGY, V36, P777, DOI 10.1212/WNL.36.6.777; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hoffmann LA, 2008, NEUROLOGY, V70, P1155, DOI 10.1212/01.wnl.0000296279.98236.8a; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jenne DE, 2007, ANN RHEUM DIS, V66, P1266, DOI 10.1136/ard.2006.065987; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kumpfel T, 2007, ARTHRITIS RHEUM, V56, P2774, DOI 10.1002/art.22795; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pedchenko TV, 2005, AM J PHYSIOL-LUNG C, V289, pL429, DOI 10.1152/ajplung.00046.2005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Siddigui MAA, 2006, BIODRUGS, V20, P67, DOI 10.2165/00063030-200620010-00008; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Wildemann B, 2007, NEUROLOGY, V68, P1742, DOI 10.1212/01.wnl.0000260226.21010.2b; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	48	583	588	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2009	41	7					776	U26		10.1038/ng.401			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	WOS:000267786200006	19525953	Green Accepted			2022-01-24	
J	Taylor, MD; Liu, L; Raffel, C; Hui, CC; Mainprize, TG; Zhang, XY; Agatep, R; Chiappa, S; Gao, LZ; Lowrance, A; Hao, AH; Goldstein, AM; Stavrou, T; Scherer, SW; Dura, WT; Wainwright, B; Squire, JA; Rutka, JT; Hogg, D				Taylor, MD; Liu, L; Raffel, C; Hui, CC; Mainprize, TG; Zhang, XY; Agatep, R; Chiappa, S; Gao, LZ; Lowrance, A; Hao, AH; Goldstein, AM; Stavrou, T; Scherer, SW; Dura, WT; Wainwright, B; Squire, JA; Rutka, JT; Hogg, D			Mutations in SUFU predispose to medulloblastoma	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMAS; PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; HUMAN HOMOLOG; SONIC HEDGEHOG; GORLIN SYNDROME; PATCHED PTCH; GENE; SUPPRESSOR; SKIN	The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms and is disrupted in a variety of malignancies. Pathway activation is triggered by binding of hedgehog proteins to the multipass Patched-1 (PTCH) receptor, which in the absence of hedgehog suppresses the activity of the seven-pass membrane protein Smoothened (SMOH). De-repression of SMOH culminates in the activation of one or more of the GLI transcription factors that regulate the transcription of downstream targets. Individuals with germline mutations of the SHH receptor gene PTCH are at high risk of developmental anomalies and of basal-cell carcinomas, medulloblastomas and other cancers (a pattern consistent with nevoid basal-cell carcinoma syndrome, NBCCS). In keeping with the role of PTCH as a tumor-suppressor gene, somatic mutations of this gene occur in sporadic basal-cell carcinomas and medulloblastomas. We report here that a subset of children with medulloblastoma carry germline and somatic mutations in SUFU (encoding the human suppressor of fused) of the SHH pathway, accompanied by loss of heterozygosity of the wildtype allele. Several of these mutations encode truncated proteins that are unable to export the GLI transcription factor from nucleus to cytoplasm, resulting in the activation of SHH signaling. SUFU is a newly identified tumor-suppressor gene that predisposes individuals to medulloblastoma by modulating the SHH signaling pathway through a newly identified mechanism.	Univ Toronto, Div Clin Sci, Toronto, ON, Canada; Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Mayo Clin, Dept Neurosurg, Rochester, MN USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA; Univ Warsaw, Dept Pathol, Warsaw, Poland; Univ Queensland, Ritchie Res Labs, St Lucia, Qld, Australia; Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Dept Med Biophys, Toronto, ON, Canada		Rutka, JT (corresponding author), Univ Toronto, Div Clin Sci, Toronto, ON, Canada.		Scherer, Stephen W/B-3785-2013; Squire, Jeremy A/F-4437-2012; Squire, Jeremy A/A-9352-2012	Scherer, Stephen W/0000-0002-8326-1999; Squire, Jeremy A/0000-0002-9863-468X; Taylor, Michael/0000-0001-7009-3466; Wainwright, Brandon/0000-0003-0406-2092			Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Chidambaram A, 1996, CANCER RES, V56, P4599; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.3.CO;2-#; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; LOBO S, 1992, AM J MED GENET, V43, P701, DOI 10.1002/ajmg.1320430410; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raffel C, 1997, CANCER RES, V57, P842; Raffel C, 1999, CLIN CANCER RES, V5, P4085; Reifenberger J, 1998, CANCER RES, V58, P1798; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Taylor MD, 2000, NEUROSURGERY, V47, P888, DOI 10.1097/00006123-200010000-00020; Unden AB, 1996, CANCER RES, V56, P4562; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wicking C, 1997, AM J HUM GENET, V60, P21; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zurawel RH, 1998, CANCER RES, V58, P896; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	31	583	604	1	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					306	310		10.1038/ng916			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	WOS:000176494100021	12068298				2022-01-24	
J	ZEITLIN, S; LIU, JP; CHAPMAN, DL; PAPAIOANNOU, VE; EFSTRATIADIS, A				ZEITLIN, S; LIU, JP; CHAPMAN, DL; PAPAIOANNOU, VE; EFSTRATIADIS, A			INCREASED APOPTOSIS AND EARLY EMBRYONIC LETHALITY IN MICE NULLIZYGOUS FOR THE HUNTINGTONS-DISEASE GENE HOMOLOG	NATURE GENETICS			English	Article							PROGRAMMED CELL-DEATH; TRINUCLEOTIDE REPEAT; DYNAMIC MUTATIONS; MOUSE EMBRYOS; LENGTH; GROWTH; DISRUPTION; TISSUES; ONSET; IT-15	The expansion of CAG triplet repeats in the translated region of the human HD gene, encoding a protein (huntingtin) of unknown function, is a dominant mutation leading to manifestation of Huntington's disease. Targeted disruption of the homologous mouse gene (Hdh), to examine the normal role of huntingtin, shows that this protein is functionally indispensable, since nullizygous embryos become developmentally retarded and disorganized, and die between days 8.5 and 10.5 of gestation. Based on the observation that the level of the regionalized apoptotic cell death in the embryonic ectoderm, a layer expressing the Hdh gene, is much higher than normal in the null mutants, we propose that huntingtin is involved in processes counterbalancing the operation of an apoptotic pathway.	COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032		ZEITLIN, S (corresponding author), COLUMBIA UNIV,DEPT PATHOL,701 W 168TH ST,NEW YORK,NY 10032, USA.		Zeitlin, Scott/P-5787-2019	Chapman, Deborah/0000-0002-8695-6243; Papaioannou, Virginia/0000-0001-7558-8601			ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; AMBROSE MP, 1995, ANN NEUROL, V37, P218; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; BARRON LH, 1994, HUM MOL GENET, V3, P173, DOI 10.1093/hmg/3.1.173; BELLAMY COC, 1995, SEMIN CANCER BIOL, V6, P3, DOI 10.1006/scbi.1995.0002; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P131; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; GAO X, 1994, TERATOLOGY, V49, P1, DOI 10.1002/tera.1420490103; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GREER CE, 1994, PCR METH APPL, V3, pS113; GUSELLA JF, 1995, SEMIN CELL BIOL, V6, P21, DOI 10.1016/1043-4682(95)90011-X; HARLAND RM, 1991, METHOD CELL BIOL, V36, P675; HARPER PS, 1991, MAJOR PROBLEMS NEURO, V22; Hogan B., 1994, MANIPULATING MOUSE E; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; KADOKAWA Y, 1987, CELL DIFFER DEV, V21, P69, DOI 10.1016/0045-6039(87)90450-7; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LEWIS SE, 1976, J EMBRYOL EXP MORPH, V36, P363; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LIN B, 1994, HUM MOL GENET, V3, P1541; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN SJ, 1994, TRENDS BIOCHEM SCI, V19, P26, DOI 10.1016/0968-0004(94)90170-8; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NISWANDER L, 1988, DEVELOPMENT, V102, P45; POELMANN RE, 1980, J EMBRYOL EXP MORPH, V55, P33; POELMANN RE, 1977, J ANAT, V124, P238; POELMANN RE, 1976, PROGR DIFFERENTIATIO, P93; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RAFF MC, 1992, NATURE, V365, P397; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; Robertson E.J., 1987, TERATOCARCINOMAS EMB, P71; SCHUBERT EL, 1993, HUM MUTAT, V2, P123, DOI 10.1002/humu.1380020211; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SNOW MHL, 1981, BRIT MED BULL, V37, P221, DOI 10.1093/oxfordjournals.bmb.a071706; SNOW MHL, 1979, NATURE, V279, P555, DOI 10.1038/279555a0; SNOW MHL, 1986, HUMAN GROWTH COMPREH, V3, P67; SPYROPOULOS DD, 1994, GENE DEV, V8, P1949, DOI 10.1101/gad.8.16.1949; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; SUTHERLAND GR, 1993, J MED GENET, V30, P978, DOI 10.1136/jmg.30.12.978; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS LB, IN PRESS EXP NEUROL; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	60	583	592	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					155	163		10.1038/ng1095-155			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	WOS:A1995RX80600017	7550343				2022-01-24	
J	Miura, K; Ikeda, M; Matsubara, A; Song, XJ; Ito, M; Asano, K; Matsuoka, M; Kitano, H; Ashikari, M				Miura, Kotaro; Ikeda, Mayuko; Matsubara, Atsushi; Song, Xian-Jun; Ito, Midori; Asano, Kenji; Matsuoka, Makoto; Kitano, Hidemi; Ashikari, Motoyuki			OsSPL14 promotes panicle branching and higher grain productivity in rice	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; DNA METHYLATION; TRANSCRIPTION FACTORS; PROTEIN; PLANTS; GENES; ACCUMULATION; EXPRESSION; MERISTEM; ENCODES	Identification of alleles that improve crop production and lead to higher-yielding varieties are needed for food security. Here we show that the quantitative trait locus WFP (WEALTHY FARMER'S PANICLE) encodes OsSPL14 (SQUAMOSA PROMOTER BINDING PROTEIN-LIKE 14, also known as IPA1). Higher expression of OsSPL14 in the reproductive stage promotes panicle branching and higher grain yield in rice. OsSPL14 controls shoot branching in the vegetative stage and is affected by microRNA excision. We also demonstrate the feasibility of using the OsSLP14(WFP) allele to increase rice crop yield. Introduction of the high-yielding OsSPL14(WFP) allele into the standard rice variety Nipponbare resulted in increased rice production.	[Miura, Kotaro; Ikeda, Mayuko; Matsubara, Atsushi; Song, Xian-Jun; Ito, Midori; Asano, Kenji; Matsuoka, Makoto; Kitano, Hidemi; Ashikari, Motoyuki] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan		Ashikari, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	ashi@agr.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of JapanMinistry of Agriculture Forestry & Fisheries - Japan [QTL-1001]	We thank K. Imamura for providing the detailed protocol for in situ hybridization, S. Mizuno for maintenance of the paddy field and E. Kouketsu and K. Sakata for helping to produce transgenic plants. This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Integrated Research Project for Plants, Insects and Animals using Genome Technology, QTL-1001).	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Ikeda-Kawakatsu K, 2009, PLANT PHYSIOL, V150, P736, DOI 10.1104/pp.109.136739; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; KOUCHI H, 1993, MOL GEN GENET, V238, P106, DOI 10.1007/BF00279537; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Sasaki T, 2008, RICE, V1, P1, DOI 10.1007/s12284-008-9010-y; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	32	581	661	15	230	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					545	U102		10.1038/ng.592			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	WOS:000278081500023	20495564				2022-01-24	
J	O'Driscoll, M; Ruiz-Perez, VL; Woods, CG; Jeggo, PA; Goodship, JA				O'Driscoll, M; Ruiz-Perez, VL; Woods, CG; Jeggo, PA; Goodship, JA			A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome	NATURE GENETICS			English	Article							DNA-DAMAGE; CELLULAR RADIOSENSITIVITY; HISTONE H2AX; CHECKPOINT; GENE; FIBROBLASTS; SEQUENCE	Seckel syndrome (OMIM 210600) is an autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly and mental retardation. Clinically, Seckel syndrome shares features in common with disorders involving impaired DNA-damage responses, such as Nijmegen breakage syndrome (OMIM 251260) and LIG4 syndrome (OMIM 606593). We previously mapped a locus associated with Seckel syndrome to chromosome 3q22.1-q24 in two consanguineous Pakistani families(1). Further marker analysis in the families, including a recently born unaffected child with a recombination in the critical region, narrowed the region to an interval of 5 Mbp between markers D3S1316 and D3S1S57 (145.29 Mbp and 150.37 Mbp). The gene encoding ataxia-telangiectasia and Rad3-related protein (ATR) maps to this region(2,3). A fibroblast cell line derived from an affected individual displays a defective DNA damage response caused by impaired ATR function. We identified a synonymous mutation in affected individuals that alters ATR splicing. The mutation confers a phenotype including marked microcephaly (head circumference 12 s.d. below the mean) and dwarfism (5 s.d. below the mean). Our analysis shows that UV-induced ATR activation can occur in non-replicating cells following processing by nucleotide excision repair.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England		Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk	woods, christopher g/A-1361-2010; Ruiz-Perez, Victor L/K-6066-2014	Ruiz-Perez, Victor L/0000-0003-0635-3619; O'Driscoll, Mark/0000-0003-2765-316X			ARLETT CF, 1988, INT J RADIAT BIOL, V54, P911, DOI 10.1080/09553008814552321; ARLETT CF, 1992, MUTAT RES, V273, P127, DOI 10.1016/0921-8777(92)90074-D; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brown EJ, 2000, GENE DEV, V14, P397; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Marcou Y, 2001, RADIOTHER ONCOL, V60, P75, DOI 10.1016/S0167-8140(01)00370-X; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	20	581	587	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					497	501		10.1038/ng1129			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	WOS:000181928600021	12640452	Bronze			2022-01-24	
J	Chavanas, S; Bodemer, C; Rochat, A; Hamel-Teillac, D; Ali, M; Irvine, AD; Bonafe, JL; Wilkinson, J; Taieb, A; Barrandon, Y; Harper, JI; de Prost, Y; Hovnanian, A				Chavanas, S; Bodemer, C; Rochat, A; Hamel-Teillac, D; Ali, M; Irvine, AD; Bonafe, JL; Wilkinson, J; Taieb, A; Barrandon, Y; Harper, JI; de Prost, Y; Hovnanian, A			Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome	NATURE GENETICS			English	Article							ACTIVATION; CONSEQUENCES; RECEPTOR; ATOPY		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Necker Hosp, Dept Dermatol, Paris, France; Ecole Normale Super, Epithelial Differentiat Lab, F-75231 Paris, France; Amersham Hosp, Dept Dermatol, Amersham, England; Great Ormond St Hosp Children, Dept Paediat Dermatol, London WC1N 3JH, England; Rangueil Hosp, Dept Dermatol, Toulouse, France; St Andre Hosp, Dept Dermatol, Bordeaux, France		Hovnanian, A (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.		Hovnanian, Alain/I-4711-2017; Irvine, Alan D/A-3982-2008; Chavanas, stephane/K-1183-2014	Hovnanian, Alain/0000-0003-3412-7512; Irvine, Alan D/0000-0002-9048-2044; chavanas, stephane/0000-0003-4323-2656			Chavanas S, 2000, AM J HUM GENET, V66, P914, DOI 10.1086/302824; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Fartasch M, 1999, ARCH DERMATOL, V135, P823, DOI 10.1001/archderm.135.7.823; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Lentsch AB, 1999, AM J PATHOL, V154, P239, DOI 10.1016/S0002-9440(10)65270-4; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Oettgen HC, 1999, J CLIN INVEST, V104, P829, DOI 10.1172/JCI8205; Rossi A, 1998, J BIOL CHEM, V273, P16446, DOI 10.1074/jbc.273.26.16446; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; TRAUPE H, 1989, ICHTHYOSIS GUIDE CLI; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8	15	581	597	2	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					141	142		10.1038/75977			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200008	10835624				2022-01-24	
J	Bell, JT; Pai, AA; Pickrell, JK; Gaffney, DJ; Pique-Regi, R; Degner, JF; Gilad, Y; Pritchard, JK				Bell, Jordana T.; Pai, Athma A.; Pickrell, Joseph K.; Gaffney, Daniel J.; Pique-Regi, Roger; Degner, Jacob F.; Gilad, Yoav; Pritchard, Jonathan K.			DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines	GENOME BIOLOGY			English	Article							TRANSCRIPTION FACTOR-BINDING; HUMAN-LYMPHOCYTES; HUMAN GENOME; CPG ISLANDS; SEQUENCE; HYPERMETHYLATION; CANCER; HUMANS; POPULATION; SIGNATURES	Background: DNA methylation is an essential epigenetic mechanism involved in gene regulation and disease, but little is known about the mechanisms underlying inter-individual variation in methylation profiles. Here we measured methylation levels at 22,290 CpG dinucleotides in lymphoblastoid cell lines from 77 HapMap Yoruba individuals, for which genome-wide gene expression and genotype data were also available. Results: Association analyses of methylation levels with more than three million common single nucleotide polymorphisms (SNPs) identified 180 CpG-sites in 173 genes that were associated with nearby SNPs (putatively in cis, usually within 5 kb) at a false discovery rate of 10%. The most intriguing trans signal was obtained for SNP rs10876043 in the disco-interacting protein 2 homolog B gene (DIP2B, previously postulated to play a role in DNA methylation), that had a genome-wide significant association with the first principal component of patterns of methylation; however, we found only modest signal of trans-acting associations overall. As expected, we found significant negative correlations between promoter methylation and gene expression levels measured by RNA sequencing across genes. Finally, there was a significant overlap of SNPs that were associated with both methylation and gene expression levels. Conclusions: Our results demonstrate a strong genetic component to inter-individual variation in DNA methylation profiles. Furthermore, there was an enrichment of SNPs that affect both methylation and gene expression, providing evidence for shared mechanisms in a fraction of genes.	[Bell, Jordana T.; Pai, Athma A.; Pickrell, Joseph K.; Gaffney, Daniel J.; Pique-Regi, Roger; Degner, Jacob F.; Gilad, Yoav; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gaffney, Daniel J.; Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Bell, Jordana T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England		Bell, JT (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	jordana@well.ox.ac.uk; gilad@uchicago.edu; gilad@uchicago.edu	Bell, Jordana/AAH-7312-2019; Pique-Regi, Roger/A-4110-2009	Pique-Regi, Roger/0000-0002-1262-2275; Bell, Jordana/0000-0002-3858-5986; Pai, Athma/0000-0002-7995-9948; Gaffney, Daniel/0000-0002-1529-1862	Sir Henry Wellcome postdoctoral fellowship; Chicago Fellows Program; American Heart AssociationAmerican Heart Association; Howard Hughes Medical InstituteHoward Hughes Medical Institute; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T 532 GM007197-34, RO1 MH084703-01, GM077959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007197, R01GM077959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084703] Funding Source: NIH RePORTER	We thank Joseph deYoung (UCLA Southern California Genotyping Consortium) for performing the Illumina methylation assays. We thank the anonymous reviewers for helpful comments. We thank Matthew Stephens, Anna di Rienzo, Barbara Engelhardt, Jean-Baptiste Veyrieras, Yongtao Guan, Kevin Bullaughey, Gorka Alkorta-Aranburu, and members of the Pritchard, Przeworski, and Stephens labs for helpful discussions. We acknowledge the ENCODE Project for providing publicly-available histone modification and DNase data (collected by the Bernstein and Crawford labs). JTB is supported by a Sir Henry Wellcome postdoctoral fellowship. RPR is supported by the Chicago Fellows Program. AAP is supported by an American Heart Association predoctoral fellowship. This work was supported by the Howard Hughes Medical Institute, and by grants from the National Institutes of Health (Genetics and Regulation Training T 532 GM007197-34 support for JFD and AAP; RO1 MH084703-01 to JKPr; and GM077959 to YG).	[Anonymous], NCBI GEN EXPR OMN; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bhasin M, 2005, FEBS LETT, V579, P4302, DOI 10.1016/j.febslet.2005.07.002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; El-Maarri O, 2009, HUM MOL GENET, V18, P1755, DOI 10.1093/hmg/ddp088; Enard W, 2004, CURR BIOL, V14, pR148, DOI 10.1016/S0960-9822(04)00072-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friso S, 2005, CANCER EPIDEM BIOMAR, V14, P938, DOI 10.1158/1055-9965.EPI-04-0601; Fry RC, 2008, GENE DEV, V22, P2621, DOI 10.1101/gad.1688508; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Gomez E, 2009, J REPROD DEVELOP, V55, P607, DOI 10.1262/jrd.09-077M; Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kim M, 2008, RNA, V14, P1005, DOI 10.1261/rna.974608; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; PIQUEREGI R, 2011, GENOME RES IN PRESS; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Sandell LL, 2003, P NATL ACAD SCI USA, V100, P4622, DOI 10.1073/pnas.0230424100; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Sun YV, 2010, HUM GENET, V127, P651, DOI 10.1007/s00439-010-0810-y; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Zempleni J, 2009, J NUTR, V139, P2389, DOI 10.3945/jn.109.111856; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934; COMPLETE METHYLATION	64	580	587	3	55	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.		2011	12	1							R10	10.1186/gb-2011-12-1-r10			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	749BL	WOS:000289437000005	21251332	gold, Green Published	Y	N	2022-01-24	
J	Stacey, SN; Manolescu, A; Sulem, P; Rafnar, T; Gudmundsson, J; Gudjonsson, SA; Masson, G; Jakobsdottir, M; Thorlacius, S; Helgason, A; Aben, KK; Strobbe, LJ; Albers-Akkers, MT; Swinkels, DW; Henderson, BE; Kolonel, LN; Le Marchand, L; Millastre, E; Andres, R; Godino, J; Garcia-Prats, MD; Polo, E; Tres, A; Mouy, M; Saemundsdottir, J; Backman, VM; Gudmundsson, L; Kristjansson, K; Bergthorsson, JT; Kostic, J; Frigge, ML; Geller, F; Gudbjartsson, D; Sigurdsson, H; Jonsdottir, T; Hrafnkelsson, J; Johannsson, J; Sveinsson, T; Myrdal, G; Grimsson, HN; Jonsson, T; von Holst, S; Werelius, B; Margolin, S; Lindblom, A; Mayordomo, JI; Haiman, CA; Kiemeney, LA; Johannsson, OT; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Stacey, Simon N.; Manolescu, Andrei; Sulem, Patrick; Rafnar, Thorunn; Gudmundsson, Julius; Gudjonsson, Sigurjon A.; Masson, Gisli; Jakobsdottir, Margret; Thorlacius, Steinunn; Helgason, Agnar; Aben, Katja K.; Strobbe, Luc J.; Albers-Akkers, Marjo T.; Swinkels, Dorine W.; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loic; Millastre, Esther; Andres, Raquel; Godino, Javier; Garcia-Prats, Maria Dolores; Polo, Eduardo; Tres, Alejandro; Mouy, Magali; Saemundsdottir, Jona; Backman, Valgerdur M.; Gudmundsson, Larus; Kristjansson, Kristleifur; Bergthorsson, Jon T.; Kostic, Jelena; Frigge, Michael L.; Geller, Frank; Gudbjartsson, Daniel; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Jonsson, Thorvaldur; von Holst, Susanna; Werelius, Barbro; Margolin, Sara; Lindblom, Annika; Mayordomo, Jose I.; Haiman, Christopher A.; Kiemeney, Lambertus A.; Johannsson, Oskar Th; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK; FEATURES; GENES; BONE	Familial clustering studies indicate that breast cancer risk has a substantial genetic component(1-3). To identify new breast cancer risk variants, we genotyped approximately 300,000 SNPs in 1,600 Icelandic individuals with breast cancer and 11,563 controls using the Illumina Hap300 platform. We then tested selected SNPs in five replication sample sets. Overall, we studied 4,554 affected individuals and 17,577 controls. Two SNPs consistently associated with breast cancer: similar to 25% of individuals of European descent are homozygous for allele A of rs13387042 on chromosome 2q35 and have an estimated 1.44- fold greater risk than noncarriers, and for allele T of rs3803662 on 16q12, about 7% are homozygous and have a 1.64- fold greater risk. Risk from both alleles was confined to estrogen receptor - positive tumors. At present, no genes have been identified in the linkage disequilibrium block containing rs13387042. rs3803662 is near the 5' end of TNRC9, a high mobility group chromatin - associated protein whose expression is implicated in breast cancer metastasis to bone(4).	deCODE Genet, IS-101 Reykjavik, Iceland; Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; Canisius Wilhelmina Hosp, Dept Surg, NL-6500 GS Nijmegen, Netherlands; INR Thrombosis Serv, NL-6525 ED Nijmegen, Netherlands; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza, Spain; San Jorge Gen Hosp, Div Pathol, Huesca 22004, Spain; Ernest Lluch Hosp, Div Med Oncol, Calatayud 50300, Spain; Univ Hosp, Landspitali, Dept Oncol, Reykjavik, Iceland; Univ Hosp, Landspitali, Dept Surg, Reykjavik, Iceland; Univ Hosp, Landspitali, Dept Radiat Phys, Reykjavik, Iceland; Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; Karolinska Univ Hosp, Sodersjukhuset, S-11883 Stockholm, Sweden		Stacey, SN (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	simon.stacey@decode.is; kari.stefansson@decode.is	Kiemeney, Lambertus A./D-3357-2009; Strobbe, Luc JA/N-8760-2018; Margolin, Sara/AAX-9034-2020; Manolescu, Andrei/G-4565-2014; Helgason, Agnar/K-1522-2015; Aben, Katja KH/G-9686-2016; Stefansson, Kari/AAE-7187-2019; Mayordomo, Jose/K-3453-2013; Swinkels, Dorine W./H-8098-2014; Godino, Javier/M-3753-2018	Kiemeney, Lambertus A./0000-0002-2368-1326; Manolescu, Andrei/0000-0002-0713-4664; Aben, Katja KH/0000-0002-0214-2147; Swinkels, Dorine W./0000-0002-1040-9446; Godino, Javier/0000-0002-5653-2722; Bergthorsson, Jon Thor/0000-0002-0560-2639; Gudbjartsson, Daniel/0000-0002-5222-9857; Millastre Bocos, Maria Esther/0000-0002-4781-068X; Kong, Augustine/0000-0001-8193-5438; Geller, Frank/0000-0002-9238-3269; Gudjonsson, Sigurjon A./0000-0001-9314-7412			Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P2378; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; James JJ, 2003, BRIT J CANCER, V89, P660, DOI 10.1038/sj.bjc.6601198; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; KOENDERS PG, 1991, BREAST CANCER RES TR, V18, P27, DOI 10.1007/BF01975440; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	24	580	597	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					865	869		10.1038/ng2064			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	WOS:000247619800016	17529974				2022-01-24	
J	Li, N; Stephens, M				Li, N; Stephens, M			Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data	GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; HIDDEN MARKOV-MODELS; HAPLOTYPE STRUCTURE; POPULATION-DATA; DNA-SEQUENCES; INFERENCE; RATES; GENE; SAMPLES; DIVERSITY	We introduce a new statistical model for patterns of linkage disequilibriurn (LD) among multiple SNPs in a population sample. The model overcomes limitations of existing approaches to understanding, summarizing, and interpreting LD by (i) relating patterns of LD directly to the underlying recombination process; (ii) considering all loci simultaneously, rather than pairwise; (iii) avoiding the assumption that LD necessarily has a "block-like" structure; and (iv) being computationally tractable for huge genomic regions (up to complete chromosomes). We examine in detail one natural application of the model: estimation of underlying recombination rates from population data. Using simulation, we show that in the case where recombination is assumed constant across the region of interest, recombination rate estimates based on our model are competitive with the very best of current available methods. More importantly, we demonstrate, on real and simulated data, the potential of the model to help identify and quantify fine-scale variation in recombination rate from population data. We also outline how the model could be useful in other contexts, such as in the development of more efficient haplotype-based methods for LD mapping.	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Stephens, M (corresponding author), Univ Washington, Dept Stat, Padelford B-313, Seattle, WA 98195 USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002585] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [1R01HG/LM02585-01] Funding Source: Medline		BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fearnhead P, 2001, GENETICS, V159, P1299; Fearnhead P, 2002, J ROY STAT SOC B, V64, P657, DOI 10.1111/1467-9868.00355; Flannery, 1992, NUMERICAL RECIPES C; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Harding RM, 1997, AM J HUM GENET, V60, P772; Hey J, 1997, GENETICS, V145, P833; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuhner MK, 2000, GENETICS, V156, P1393; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; McVean G, 2002, GENETICS, V160, P1231; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Nielsen R, 2000, GENETICS, V154, P931; Olivier M, 2001, GENOMICS, V78, P64, DOI 10.1006/geno.2001.6646; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; UEBERHUBER CW, 1997, NUMERIC COMPUTATION, V1; Wakeley J, 1997, GENET RES, V69, P45, DOI 10.1017/S0016672396002571; Wall JD, 2000, MOL BIOL EVOL, V17, P156, DOI 10.1093/oxfordjournals.molbev.a026228; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398	42	580	587	2	35	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	DEC	2003	165	4					2213	2233					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	760HJ	WOS:000187805300045	14704198				2022-01-24	
J	Ellis, N; Hammer, M; Hurles, ME; Jobling, MA; Karafet, T; King, TE; de Knijff, P; Pandya, A; Redd, A; Santos, FR; Tyler-Smith, C; Underhill, P; Wood, E; Thomas, M; Cavalli-Sforza, L; Ellis, N; Jenkins, T; Kidd, J; Kidd, K; Forster, P; Zegura, S; Kaplan, M				Ellis, N; Hammer, M; Hurles, ME; Jobling, MA; Karafet, T; King, TE; de Knijff, P; Pandya, A; Redd, A; Santos, FR; Tyler-Smith, C; Underhill, P; Wood, E; Thomas, M; Cavalli-Sforza, L; Ellis, N; Jenkins, T; Kidd, J; Kidd, K; Forster, P; Zegura, S; Kaplan, M		Y Chromosome Consortium	A nomenclature system for the tree of human Y-chromosomal binary haplogroups	GENOME RESEARCH			English	Article							SEQUENCE VARIATION; MITOCHONDRIAL-DNA; FORENSIC ANALYSIS; HUMAN-POPULATIONS; HAPLOTYPES; POLYMORPHISMS; PATTERNS; HISTORY; ASIA; PHYLOGEOGRAPHY	The Y chromosome contains the largest nonrecombining block in the human genome. By virtue of its many polymorphisms, it is now the most informative haplotyping system, with applications in evolutionary studies, forensics, medical genetics, and genealogical reconstruction. However, the emergence of several unrelated and nonsystematic nomenclatures for Y-chromosomal binary haplogroups is an increasing source of confusion. To resolve this issue, 245 markers were genotyped in a globally representative set of samples, 74 of which were males from the Y Chromosome Consortium cell line repository. A single most parsimonious phylogeny was constructed for the 153 binary haplogroups observed. A simple set of rules was developed to unambiguously label the different clades nested within this tree. This hierarchical nomenclature system supersedes and unifies past nomenclatures and allows the inclusion of additional mutations and haplogroups yet to be discovered.	Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Leicester, Leicester LE1 7RH, Leics, England; Leiden Univ, NL-2300 RA Leiden, Netherlands; Univ Oxford, Oxford OX1 2JD, England; Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; Stanford Univ, Stanford, CA 94305 USA; UCL, London WC1E 6BT, England; Univ Witwatersrand, ZA-2050 Wits, South Africa; Yale Univ, New Haven, CT 06520 USA		Hammer, M (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	mhammer@u.arizona.edu	de Knijff, Peter/Y-2519-2018; dos Santos, Fabricio Rodrigues/H-2370-2011	de Knijff, Peter/0000-0002-0899-771X; dos Santos, Fabricio Rodrigues/0000-0001-9088-1750	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM28428, GM53566, GM55273] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM053566, R01GM055273, R29GM053566, P01GM028428] Funding Source: NIH RePORTER		Bao WD, 2000, GENE, V244, P29, DOI 10.1016/S0378-1119(00)00021-4; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Gill P, 2001, INT J LEGAL MED, V114, P305, DOI 10.1007/s004140100232; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 2001, TRENDS GENET, V17, P353, DOI 10.1016/S0168-9525(01)02284-3; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; JOBLING MA, 1994, HUM MOL GENET, V3, P107, DOI 10.1093/hmg/3.1.107; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; PANDYA A, 1998, IND J HUM GENET, V4, P52; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Shinka T, 1999, J HUM GENET, V44, P240, DOI 10.1007/s100380050151; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	33	580	610	1	27	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	FEB	2002	12	2					339	348					10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	518VY	WOS:000173689600015	11827954				2022-01-24	
J	Tsuji, K; Bandyopadhyay, A; Harfe, BD; Cox, K; Kakar, S; Gerstenfeld, L; Einhorn, T; Tabin, CJ; Rosen, V				Tsuji, Kunikazu; Bandyopadhyay, Amitabha; Harfe, Brian D.; Cox, Karen; Kakar, Sanjeev; Gerstenfeld, Louis; Einhorn, Thomas; Tabin, Clifford J.; Rosen, Vicki			BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing	NATURE GENETICS			English	Article							SKELETAL OVEREXPRESSION; BETA FAMILY; EXPRESSION; MICE; PROTEIN; OSTEOPENIA; CARTILAGE; COLLAGEN; DEFECTS; REVEALS	Adult bones have a notable regenerative capacity. Over 40 years ago, an intrinsic activity capable of initiating this reparative response was found to reside within bone itself, and the term bone morphogenetic protein(1) (BMP) was coined to describe the molecules responsible for it. A family of BMP proteins was subsequently identified(2-4), but no individual BMP has been shown to be the initiator of the endogenous bone repair response. Here we demonstrate that BMP2 is a necessary component of the signaling cascade that governs fracture repair. Mice lacking the ability to produce BMP2 in their limb bones have spontaneous fractures that do not resolve with time. In fact, in bones lacking BMP2, the earliest steps of fracture healing seem to be blocked. Although other osteogenic stimuli are still present in the limb skeleton of BMP2-deficient mice, they cannot compensate for the absence of BMP2. Collectively, our results identify BMP2 as an endogenous mediator necessary for fracture repair.	Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Boston Univ, Sch Med, Dept Orthoped, Boston, MA 02118 USA		Rosen, V (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	vicki_rosen@hsdm.harvard.edu	Bandyopadhyay, Amitabha/B-9735-2008	Einhorn, Thomas/0000-0002-5075-4885; Bandyopadhyay, Amitabha/0000-0002-0429-438X; /0000-0002-0477-1211			BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; Bertone AL, 2004, J ORTHOP RES, V22, P1261, DOI 10.1016/j.orthres.2004.03.014; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; COOK SD, 1994, CLIN ORTHOP RELAT R, P302; DESBOIS C, 1994, J BIOL CHEM, V269, P1183; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; KOHNO K, 1984, J BIOL CHEM, V259, P3668; Lanske B, 1998, ENDOCRINOLOGY, V139, P5194, DOI 10.1210/en.139.12.5194; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Murnaghan M, 2005, J ORTHOP RES, V23, P625, DOI 10.1016/j.orthres.2004.12.008; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sipe JB, 2004, BONE, V35, P1316, DOI 10.1016/j.bone.2004.08.020; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005; Zhang HB, 1996, DEVELOPMENT, V122, P2977	30	579	606	4	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1424	1429		10.1038/ng1916			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	WOS:000242404200020	17099713				2022-01-24	
J	CLARK, J; ROCQUES, PJ; CREW, AJ; GILL, S; SHIPLEY, J; CHAN, AML; GUSTERSON, BA; COOPER, CS				CLARK, J; ROCQUES, PJ; CREW, AJ; GILL, S; SHIPLEY, J; CHAN, AML; GUSTERSON, BA; COOPER, CS			IDENTIFICATION OF NOVEL GENES, SYT AND SSX, INVOLVED IN THE T(X18)(P11.2Q11.2) TRANSLOCATION FOUND IN HUMAN SYNOVIAL SARCOMA	NATURE GENETICS			English	Article							SOFT-TISSUE TUMORS; CHROMOSOME-TRANSLOCATION; CELL-LINE; PROTEIN; FUSION; CHOP; HYBRIDIZATION; LIPOSARCOMA; EXPRESSION; REGULATOR	Human synovial sarcomas contain a recurrent and specific chromosomal translocation t(X;18)(p11.2;q11.2). By screening a synovial sarcoma cDNA library with a yeast artificial chromosome spanning the X chromosome breakpoint, we have indentified a hybrid transcript that contains 5' sequences (designated SYT) mapping to chromosome 18 and 3' sequences (designated SSX) mapping to chromosome X. An SM probe detected genomic rearrangements in 10/13 synovial sarcomas. Sequencing of cDNA clones shows that the normal SM gene encodes a protein rich in glutamine, proline and glycine, and indicates that in synovial sarcoma rearrangement of the SYT gene results in the formation of an STT-SSX fusion protein. Both SYT and SSX failed to exhibit significant homology to known gene sequences.	INST CANC RES, HADDOW LABS, DEPT MOLEC CARCINOGENESIS, SUTTON SM2 5NG, SURREY, ENGLAND; ROCKEFELLER UNIV, MT SINAI SCH MED, RUTTENBERG CANC CTR, NEW YORK, NY 10021 USA				gusterson, barry a/D-3752-2009; Chan, Andrew Man-Lok/J-9497-2013; Chan, Andrew/AAC-1145-2020	Chan, Andrew Man-Lok/0000-0001-9923-5464; Chan, Andrew/0000-0001-9923-5464; Shipley, Janet/0000-0001-6748-8678			AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; BUETTNER R, 1991, MOL CELL BIOL, V11, P3573, DOI 10.1128/MCB.11.7.3573; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; COOPER CS, 1993, ADV CANCER RES, V60, P75; COOPER CS, 1991, CARCINOGENESIS, V12, P155, DOI 10.1093/carcin/12.2.155; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Enzinger FM, 1988, SOFT TISSUE TUMORS; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER C, 1994, CURR DIAGN PATHOL, V1, P13; FRY MJ, 1993, PROTEIN SCI, V2, P1785, DOI 10.1002/pro.5560021102; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GROSS SJ, 1975, NATURE, V255, P68; KNIGHT JC, 1992, HUM MOL GENET, V1, P633, DOI 10.1093/hmg/1.8.633; KNIGHT JC, 1992, INT J ONCOL, V1, P747; LAFRENIERE RG, 1991, GENOMICS, V10, P276, DOI 10.1016/0888-7543(91)90512-D; LIMON J, 1991, GENE CHROMOSOME CANC, V3, P338, DOI 10.1002/gcc.2870030504; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; MITCHELL PJ, 1992, ONCOGENE, V7, P383; MITCHELL PJ, 1992, ONCOGENE, V7, P2329; MYLIN LM, 1991, NUCLEIC ACIDS RES, V19, P5345, DOI 10.1093/nar/19.19.5345; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; REEVES BR, 1989, CANCER CEL, V7, P69; REEVES BR, 1989, ONCOGENE, V4, P373; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENG WW, 1987, CANCER GENET CYTOGEN, V29, P179, DOI 10.1016/0165-4608(87)90048-3; SHIPLEY JM, 1994, ONCOGENE, V9, P1447; SMITH S, 1987, CANCER GENET CYTOGEN, V26, P179, DOI 10.1016/0165-4608(87)90147-6; SNELL RG, 1993, HUM MOL GENET, V2, P305, DOI 10.1093/hmg/2.3.305; SONOBE H, 1992, LAB INVEST, V67, P498; STROEHER VL, 1986, MOL CELL BIOL, V6, P4667, DOI 10.1128/MCB.6.12.4667; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	34	579	601	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					502	508		10.1038/ng0894-502			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	WOS:A1994PA83200017	7951320				2022-01-24	
J	Ueda, HR; Hayashi, S; Chen, WB; Sano, M; Machida, M; Shigeyoshi, Y; Iino, M; Hashimoto, S				Ueda, HR; Hayashi, S; Chen, WB; Sano, M; Machida, M; Shigeyoshi, Y; Iino, M; Hashimoto, S			System-level identification of transcriptional circuits underlying mammalian circadian clocks	NATURE GENETICS			English	Article							PERIOD HOMOLOGS; EXPRESSION; PROTEIN; OSCILLATION; COMPONENT; CLONING; MOUSE; LIMB; PAR	Mammalian circadian clocks consist of complexly integrated regulatory loops(1-5), making it difficult to elucidate them without both the accurate measurement of system dynamics and the comprehensive identification of network circuits(6). Toward a system-level understanding of this transcriptional circuitry, we identified clock-controlled elements on 16 clock and clock-controlled genes in a comprehensive surveillance of evolutionarily conserved cis elements and measurement of their transcriptional dynamics. Here we report the roles of E/E' boxes, DBP/E4BP4 binding elements(7) and RevErbA/ROR binding elements(8) in nine, seven and six genes, respectively. Our results indicate that circadian transcriptional circuits are governed by two design principles: regulation of E/E boxes and RevErbA/ROR binding elements follows a repressor-precedes-activator pattern, resulting in delayed transcriptional activity, whereas regulation of DBP/E4BP4 binding elements follows a repressor-antiphasic-to-activator mechanism, which generates high-amplitude transcriptional activity. Our analysis further suggests that regulation of E/E boxes is a topological vulnerability in mammalian circadian clocks, a concept that has been functionally verified using in vitro phenotype assay systems.	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan; RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan; Natl Inst Adv Ind Sci & technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osakasayama, Osaka 5898511, Japan		Ueda, HR (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014	Ueda, Hiroki R/0000-0001-8342-9176			Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Falvey E, 1996, BIOL CHEM, V377, P797; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	30	578	591	0	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					187	192		10.1038/ng1504			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	WOS:000226690100027	15665827				2022-01-24	
J	Prokunina, L; Castillejo-Lopez, C; Oberg, F; Gunnarsson, I; Berg, L; Magnusson, V; Brookes, AJ; Tentler, D; Kristjansdottir, H; Grondal, G; Bolstad, AI; Svenungsson, E; Lundberg, I; Sturfelt, G; Jonssen, A; Truedsson, L; Lima, G; Alcocer-Varela, J; Jonsson, R; Gyllensten, UB; Harley, JB; Alarcon-Segovia, D; Steinsson, K; Alarcon-Riquelme, ME				Prokunina, L; Castillejo-Lopez, C; Oberg, F; Gunnarsson, I; Berg, L; Magnusson, V; Brookes, AJ; Tentler, D; Kristjansdottir, H; Grondal, G; Bolstad, AI; Svenungsson, E; Lundberg, I; Sturfelt, G; Jonssen, A; Truedsson, L; Lima, G; Alcocer-Varela, J; Jonsson, R; Gyllensten, UB; Harley, JB; Alarcon-Segovia, D; Steinsson, K; Alarcon-Riquelme, ME			A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans	NATURE GENETICS			English	Article							ALLELE-SPECIFIC HYBRIDIZATION; SIB-PAIR FAMILIES; HUMAN PD-1 GENE; AUTOIMMUNE-DISEASES; CROHNS-DISEASE; T-LYMPHOCYTES; EXPRESSION; IMMUNORECEPTOR; TOLERANCE; PEDIGREES	Systemic lupus erythematosus (SLE, OMIM 152700) is a complex autoimmune disease that affects 0.05% of the Western population, predominantly women(1-4). A number of susceptibility loci for SLE have been suggested in different populations, but the nature of the susceptibility genes and mutations is yet to be identified(5-9). We previously reported a susceptibility locus (SLEB2) for Nordic multi-case families(9,10). Within this locus, the programmed cell death 1 gene (PDCD1, also called PD-1) was considered the strongest candidate for association with the disease(11-14). Here, we analyzed 2,510 individuals, including members of five independent sets of families as well as unrelated individuals affected with SLE, for single-nucleotide polymorphisms (SNPs) that we identified in PDCD1. We show that one intronic SNP in PDCD1 is associated with development of SLE in Europeans (found in 12% of affected individuals versus 5% of controls; P=0.00001, r.r. (relative risk)=2.6) and Mexicans (found in 7% of affected individuals versus 2% of controls; P=0.0009, r.r.=3.5). The associated allele of this SNP alters a binding site for the runt-related transcription factor 1 (RUNX1, also called AML1) located in an intronic enhancer, suggesting a mechanism through which it can contribute to the development of SLE in humans.	Univ Uppsala, Rudbeck Labs, Inst Genet & Pathol, Med Genet Sect, S-75185 Uppsala, Sweden; Everygene AB, Uppsala, Sweden; Univ Uppsala, Rudbeck Labs, Inst Genet & Pathol, Sect Pathol, S-75185 Uppsala, Sweden; Univ Uppsala, Evolut Biol Ctr, Dept Comparat Physiol, S-75185 Uppsala, Sweden; Karolinska Inst, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, Stockholm, Sweden; Labdpitalinn, Dept Rheumatol, Reykjavik, Iceland; Labdpitalinn, Ctr Rheumatol Res, Reykjavik, Iceland; Univ Bergen, Broegelmann Res Lab, Bergen, Norway; Haukeland Univ Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; Univ Lund Hosp, Dept Clin Immunol, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden; Inst Nacl Ciencias Med & Nutr Salvador Zubirdan, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; Univ Oklahoma, Dept Med, Arthrit & Immunol Program, Oklahoma Med Res Fdn, Oklahoma City, OK USA; US Dept Vet Affairs, Oklahoma City, OK USA		Alarcon-Riquelme, ME (corresponding author), Univ Uppsala, Rudbeck Labs, Inst Genet & Pathol, Med Genet Sect, Dag Hammarsjolds Vag 20, S-75185 Uppsala, Sweden.		Hoiom, Veronica/F-4153-2012; Alarcon-Riquelme, Marta E./ABF-8163-2020; Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Tentler, Dmitri/AAE-4519-2019; lima, giuseppina GPPL/C-5995-2012	Alarcon-Riquelme, Marta E./0000-0002-7632-4154; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Tentler, Dmitri/0000-0003-3976-1205; lima, giuseppina GPPL/0000-0002-1792-2605; Svenungsson, Elisabet/0000-0003-3396-3244; Berg, Louise/0000-0001-6538-2837			ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARNETT FC, 1992, RHEUM DIS CLIN N AM, V18, P865; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Goodnow CC, 2001, LANCET, V357, P2115; GUDMUNDSSON S, 1990, J RHEUMATOL, V17, P1162; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; LATHROP GM, 1983, TISSUE ANTIGENS, V22, P160, DOI 10.1111/j.1399-0039.1983.tb01183.x; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; Magnusson V, 2000, GENOMICS, V70, P307, DOI 10.1006/geno.2000.6374; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Prince JA, 2001, GENOME RES, V11, P152, DOI 10.1101/gr.150201; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Stahl-Hallengren C, 2000, J RHEUMATOL, V27, P685; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THOMSON G, 1995, AM J HUM GENET, V57, P487; Vibhakar R, 1997, EXP CELL RES, V232, P25, DOI 10.1006/excr.1997.3493; Wong HK, 1999, J IMMUNOL, V163, P1682	29	578	607	1	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					666	669		10.1038/ng1020			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	WOS:000179593000022	12402038				2022-01-24	
J	Van Goethem, G; Dermaut, B; Lofgren, A; Martin, JJ; Van Broeckhoven, C				Van Goethem, G; Dermaut, B; Lofgren, A; Martin, JJ; Van Broeckhoven, C			Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMERASE; MULTIPLE DELETIONS; REPLICATION; DISORDER; GAMMA; GENE	Progressive external ophthalmoplegias (PEO) characterized by accumulation of large-scale mitochondrial DNA (mtDNA) deletions are rare human diseases. We mapped a new locus for dominant PEO at 15q22-q26 in a Belgian pedigree and identified a heterozygous mutation (Y955C) in the polymerase motif B of the mtDNA polymerase gamma (POLG). We identified three additional POLG missense mutations compatible with recessive PEO In two nuclear families. POLG is the only DNA polymerase responsible for mtDNA replication.	Univ Antwerp VIB, Born Bunge Fdn, Dept Mol Genet, B-2610 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Univ Antwerp, Born Bunge Fdn, Neuropathol Lab, Dept Med, B-2610 Antwerp, Belgium		Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Born Bunge Fdn, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	cvbroeck@uia.ua.ac.be	Dermaut, Bart/AAM-2483-2020; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665			Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Heringa Jaap, 1994, P87; Iyengar B, 1999, GENETICS, V153, P1809; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Liu HT, 2000, J VIROL, V74, P11681, DOI 10.1128/JVI.74.24.11681-11689.2000; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Pinz KG, 2000, J BIOL CHEM, V275, P12509, DOI 10.1074/jbc.275.17.12509; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Van Goethem G, 2000, J MED GENET, V37, P547, DOI 10.1136/jmg.37.7.547; VanGoethem G, 1997, EUR J NEUROL, V4, P476; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	18	578	583	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					211	212		10.1038/90034			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	WOS:000169656400008	11431686				2022-01-24	
J	Emms, DM; Kelly, S				Emms, David M.; Kelly, Steven			OrthoFinder: phylogenetic orthology inference for comparative genomics	GENOME BIOLOGY			English	Article						Ortholog inference; Gene tree inference; Gene duplication; Comparative genomics	GENE DUPLICATION; TREE; ALGORITHM	Here, we present a major advance of the OrthoFinder method. This extends OrthoFinder's high accuracy orthogroup inference to provide phylogenetic inference of orthologs, rooted gene trees, gene duplication events, the rooted species tree, and comparative genomics statistics. Each output is benchmarked on appropriate real or simulated datasets, and where comparable methods exist, OrthoFinder is equivalent to or outperforms these methods. Furthermore, OrthoFinder is the most accurate ortholog inference method on the Quest for Orthologs benchmark test. Finally, OrthoFinder's comprehensive phylogenetic analysis is achieved with equivalent speed and scalability to the fastest, score-based heuristic methods. OrthoFinder is available at https://github.com/davidemms/OrthoFinder.	[Emms, David M.; Kelly, Steven] Univ Oxford, Dept Plant Sci, South Parks Rd, Oxford OX1 3RB, England		Kelly, S (corresponding author), Univ Oxford, Dept Plant Sci, South Parks Rd, Oxford OX1 3RB, England.	steven.kelly@plants.ox.ac.uk	Kelly, Steven/F-7237-2011	Kelly, Steven/0000-0001-8583-5362	European UnionEuropean Commission [637765]	This work was supported by the European Union's Horizon 2020 research and innovation program under grant agreement number 637765. SK is a Royal Society University Research Fellow.	Altenhoff AM, 2016, NAT METHODS, V13, P425, DOI [10.1038/NMETH.3830, 10.1038/nmeth.3830]; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cosentino S, 2019, BIOINFORMATICS, V35, P149, DOI 10.1093/bioinformatics/bty631; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dalquen DA, 2013, GENOME BIOL EVOL, V5, P1800, DOI 10.1093/gbe/evt132; Emms D, 2019, SUPPLEMENTAL DATASET, DOI [10.5281/zenodo.1481147 2019, DOI 10.5281/ZENODO.1481147]; Emms D, 2019, ORTHOFINDER; Emms DM, 2017, MOL BIOL EVOL, V34, P3267, DOI 10.1093/molbev/msx259; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Herrero J, 2016, DATABASE-OXFORD, DOI [10.1093/database/baw053, 10.1093/database/bav096]; Huerta-Cepas J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r109; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelly S, 2018, STAG SPECIES TREE IN, DOI [10.1101/267914v1, DOI 10.1101/267914V1]; Kelly S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058537; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lafond M, 2018, BIOINFORMATICS, V34, P366, DOI 10.1093/bioinformatics/bty242; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Nichio BTL, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00165; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Schreiber F, 2013, J MOL BIOL, V425, P2072, DOI 10.1016/j.jmb.2013.02.018; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; Tange O., 2011, LOGIN USENIX MAGAZIN, V36, P42; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Wu YC, 2014, GENOME RES, V24, P475, DOI 10.1101/gr.161968.113; Yates A, 2015, BIOINFORMATICS, V31, P143, DOI 10.1093/bioinformatics/btu613; Zhou XF, 2018, MOL BIOL EVOL, V35, P486, DOI 10.1093/molbev/msx302; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	46	577	582	51	93	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	NOV 14	2019	20	1							238	10.1186/s13059-019-1832-y			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	JO6QY	WOS:000497703300004	31727128	Green Published, gold	Y	Y	2022-01-24	
J	Coffey, AJ; Brooksbank, RA; Brandau, O; Oohashi, T; Howell, GR; Bye, JM; Cahn, AP; Durham, J; Heath, P; Wray, P; Pavitt, R; Wilkinson, J; Leversha, M; Huckle, E; Shaw-Smith, CJ; Dunham, A; Rhodes, S; Schuster, V; Porta, G; Yin, L; Serafini, P; Sylla, B; Zollo, M; Franco, B; Bolino, A; Seri, M; Lanyi, A; Davis, JR; Webster, D; Harris, A; Lenoir, G; St Basile, GD; Jones, A; Behloradsky, BH; Achatz, H; Murken, J; Fassler, R; Sumegi, J; Romeo, G; Vaudin, M; Ross, MT; Meindl, A; Bentley, DR				Coffey, AJ; Brooksbank, RA; Brandau, O; Oohashi, T; Howell, GR; Bye, JM; Cahn, AP; Durham, J; Heath, P; Wray, P; Pavitt, R; Wilkinson, J; Leversha, M; Huckle, E; Shaw-Smith, CJ; Dunham, A; Rhodes, S; Schuster, V; Porta, G; Yin, L; Serafini, P; Sylla, B; Zollo, M; Franco, B; Bolino, A; Seri, M; Lanyi, A; Davis, JR; Webster, D; Harris, A; Lenoir, G; St Basile, GD; Jones, A; Behloradsky, BH; Achatz, H; Murken, J; Fassler, R; Sumegi, J; Romeo, G; Vaudin, M; Ross, MT; Meindl, A; Bentley, DR			Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; ARTIFICIAL CHROMOSOME LIBRARIES; BONE-MARROW TRANSPLANTATION; HUMAN DYSTROPHIN GENE; XLP LOCUS; LARGE INSERTS; SH3 DOMAINS; HUMAN DNA; PROTEIN; DELETION	X-linked lymphoproliferative syndrome (XLP or Duncan disease) is characterized by extreme sensitivity to Epstein-Barr virus (EBV), resulting in a complex phenotype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia and malignant lymphoma. We have identified a gene, SH2D1A, that is mutated in XLP patients and encodes a novel protein composed of a single SH2 domain. SH2D1A is expressed in many tissues involved in the immune system. The identification of SH2D1A will allow the determination of its mechanism of action as a possible regulator of the EBV-induced immune response.	Sanger Ctr, Hinxton CB10 1SA, Cambs, England; LMU, Abt Med Genet, D-80336 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Addenbrookes Hosp, Dept Resp Med, Cambridge CB2 2QQ, England; Univ Wurzburg, Kinderklin, D-97080 Wurzburg, Germany; Osped San Paolo, Ist Sci Biomed, Cattedra Gen Umana, Milan, Italy; Univ Pavia, Fac Med 2, Dip Patol Umana & Ereditaria, I-27100 Pavia, Italy; Int Agcy Res Canc, Genet Canc Susceptibil Unit, F-69372 Lyon, France; TIGEM, I-20132 Milan, Italy; Inst Gaslini, Mol Genet Lab, Genoa, Italy; Univ Nebraska, Dept Microbiol & Pathol, Omaha, NE 68182 USA; Royal Free Hosp, Sch Med, Dept Clin Immunol, London, England; Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Int Agcy Res Canc, Programme Viral & Hereditary Factors Carcinogenes, F-69372 Lyon, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; LMU, Haunersche Immundefektambulanz, D-80336 Munich, Germany		Coffey, AJ (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	ajc@sanger.ac.uk	Bolino, Alessandra/AAN-5442-2020; Oohashi, Toshitaka/B-1599-2011; Seri, Marco/A-4339-2014; FRANCO, Brunella/S-2882-2018	Bolino, Alessandra/0000-0002-8980-4878; porta, giovanni/0000-0001-5260-2415; Seri, Marco/0000-0003-2425-2176; Oohashi, Toshitaka/0000-0002-9302-1913; FRANCO, Brunella/0000-0001-5588-4569	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI033532] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [1 R01 AI33532-OIA3] Funding Source: Medline; TelethonFondazione Telethon [E.0440, TGM06S01] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; ARKWRIGHT PD, IN PRESS ARCH DIS CH; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BOLINO A, IN PRESS EUR J HUM G; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; FAINSTEIN E, 1989, ONCOGENE, V4, P1477; FILIPOVICH AH, 1986, TRANSPLANTATION, V42, P222; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gregory SG, 1997, GENOME RES, V7, P1162, DOI 10.1101/gr.7.12.1162; HARRINGTON DS, 1987, CANCER-AM CANCER SOC, V59, P1419, DOI 10.1002/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO;2-P; HUANG SH, 1993, METHODS MOL BIOL PCR, P357; IMAI S, 1994, P NATL ACAD SCI USA, V91, P9131, DOI 10.1073/pnas.91.19.9131; KLEIN G, 1975, NEW ENGL J MED, V293, P1353, DOI 10.1056/NEJM197512252932607; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KURIYAN J, 1993, CURR OPIN STRUC BIOL, V3, P828, DOI 10.1016/0959-440X(93)90145-B; Lamartine J, 1996, EUR J HUM GENET, V4, P342; Lanyi A, 1997, GENOMICS, V39, P55, DOI 10.1006/geno.1996.4466; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MCCLAIN KL, 1995, NEW ENGL J MED, V332, P12, DOI 10.1056/NEJM199501053320103; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; PURTILO D T, 1991, Pediatric Pathology, V11, P685; PURTILO DT, 1975, LANCET, V1, P936; Rickinson AB, 1996, CURR OPIN IMMUNOL, V8, P492, DOI 10.1016/S0952-7915(96)80036-7; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; SANGER WG, 1990, CANCER GENET CYTOGEN, V47, P163, DOI 10.1016/0165-4608(90)90026-7; SCHUSTER V, 1994, EUR J PEDIATR, V153, P432; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SKARE J, 1993, GENOMICS, V16, P254, DOI 10.1006/geno.1993.1169; SKARE JC, 1989, HUM GENET, V82, P354; Soderlund C, 1995, COMPUT APPL BIOSCI, V11, P645; SOLOVYEV VV, 1995, INTELLIGENT SYSTEMS, V3, P367; Thompson AD, 1996, ONCOGENE, V13, P2649; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VOWELS MR, 1993, NEW ENGL J MED, V329, P1623, DOI 10.1056/NEJM199311253292205; Ware JE, 1996, BEHAV HEALTHC TOM, V5, P88; WEISENBURGER DD, 1986, EPSTEINBARR VIRUS RE, P129; WILLIAMS LL, 1993, LANCET, V342, P587, DOI 10.1016/0140-6736(93)91413-G; WU BL, 1993, GENOMICS, V17, P163, DOI 10.1006/geno.1993.1298; WYANDT HE, 1989, AM J MED GENET, V33, P426, DOI 10.1002/ajmg.1320330331; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	53	577	595	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					129	135		10.1038/2424			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	WOS:000076231300013	9771704				2022-01-24	
J	Wu, G; Diaz, AK; Paugh, BS; Rankin, SL; Ju, BS; Li, YJ; Zhu, XY; Qui, CX; Chen, X; Zhang, JY; Easton, J; Edmonson, M; Ma, XT; Lu, C; Nagahawatte, P; Hedlund, E; Rusch, M; Pounds, S; Lin, T; Onar-Thomas, A; Huether, R; Kriwacki, R; Parker, M; Gupta, P; Becksfort, J; Wei, L; Mulder, HL; Boggs, K; Vadodaria, B; Yergeau, D; Russell, JC; Ochoa, KI; Fulton, RS; Fulton, LL; Jones, C; Boop, FA; Broniscer, A; Wetmore, C; Gajjar, A; Ding, L; Mardis, ER; Wilson, RK; Taylor, MR; Downing, JR; Ellison, DW; Zhang, JH; Baker, SJ				Wu, Gang; Diaz, Alexander K.; Paugh, Barbara S.; Rankin, Sherri L.; Ju, Bensheng; Li, Yongjin; Zhu, Xiaoyan; Qui, Chunxu; Chen, Xiang; Zhang, Junyuan; Easton, John; Edmonson, Michael; Ma, Xiaotu; Lu, Charles; Nagahawatte, Panduka; Hedlund, Erin; Rusch, Michael; Pounds, Stanley; Lin, Tong; Onar-Thomas, Arzu; Huether, Robert; Kriwacki, Richard; Parker, Matthew; Gupta, Pankaj; Becksfort, Jared; Wei, Lei; Mulder, Heather L.; Boggs, Kristy; Vadodaria, Bhavin; Yergeau, Donald; Russell, Jake C.; Ochoa, Kern I.; Fulton, Robert S.; Fulton, Lucinda L.; Jones, Chris; Boop, Frederick A.; Broniscer, Alberto; Wetmore, Cynthia; Gajjar, Amar; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.; Taylor, Michael R.; Downing, James R.; Ellison, David W.; Zhang, Jinghui; Baker, Suzanne J.		St Jude Childrens Res Hosp; Washington Univ Pediat Canc Genome	The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; BONE MORPHOGENETIC PROTEINS; DISTINCT SUBGROUPS; INITIATING CELLS; GENE-EXPRESSION; HISTONE H3.3; C-MYC; GLIOBLASTOMA; MUTATIONS; MEDULLOBLASTOMA	Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis(1). We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs(2-5). Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.	[Wu, Gang; Li, Yongjin; Qui, Chunxu; Chen, Xiang; Edmonson, Michael; Ma, Xiaotu; Nagahawatte, Panduka; Hedlund, Erin; Rusch, Michael; Huether, Robert; Parker, Matthew; Gupta, Pankaj; Becksfort, Jared; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Diaz, Alexander K.; Paugh, Barbara S.; Rankin, Sherri L.; Zhu, Xiaoyan; Zhang, Junyuan; Russell, Jake C.; Baker, Suzanne J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Baker, Suzanne J.] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Ju, Bensheng; Taylor, Michael R.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Easton, John; Mulder, Heather L.; Vadodaria, Bhavin; Yergeau, Donald] St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Ochoa, Kern I.; Fulton, Robert S.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Pounds, Stanley; Lin, Tong; Onar-Thomas, Arzu] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wei, Lei] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Jones, Chris] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Jones, Chris] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Boop, Frederick A.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Broniscer, Alberto; Wetmore, Cynthia; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Downing, James R.; Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA		Baker, SJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jinghui.zhang@stjude.org; suzanne.baker@stjude.org	LI, YONGJIN/E-1688-2011; Wu, Gang/M-8012-2014; Downing, James R./N-8102-2018; Huether, Robert/E-9638-2012; Onar-Thomas, Arzu/M-9356-2018; Rusch, Michael/AAG-1998-2019; Jones, Chris/ABE-6059-2021; Chen, Xiang/N-2524-2018; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Pounds, Stanley B/N-2480-2018; Kriwacki, Richard/N-8154-2018; Ellison, David/N-4806-2018; Gajjar, Amar/N-8059-2018; Baker, Suzanne J/N-8167-2018	Wu, Gang/0000-0002-1678-5864; Huether, Robert/0000-0001-7077-7470; Rusch, Michael/0000-0002-5363-1848; Jones, Chris/0000-0001-8118-2296; Chen, Xiang/0000-0002-2499-8261; Wilson, Richard K./0000-0002-1992-1358; Pounds, Stanley B/0000-0002-9167-2114; Kriwacki, Richard/0000-0002-9798-6018; Easton, John/0000-0003-4503-6608; Russell, Jake/0000-0001-5539-2716; Broniscer, Alberto/0000-0001-9646-0463; Parker, Matthew/0000-0003-2999-3870	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities (ALSAC) of St. Jude Children's Research HospitalAmerican Lebanese Syrian Associated Charities (ALSAC); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 CA096832, R01 CA135554]; Cure Starts Now Foundation; Smile for Sophie Forever Foundation; Tyler's Treehouse and Musicians Against Childhood Cancer; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA135554, P01CA096832, P30CA016056, P30CA021765] Funding Source: NIH RePORTER	We thank the St. Jude Children's Research Hospital Tissue Resource Facility and B. Gordon, M. Johnson, S. Brown and C. Calabrese in the St. Jude Small Animal Imaging Core for expert assistance with intracranial implantations. We thank E. Shore and A. Culbert (University of Pennsylvania) for helpful advice with antibody selection. This work was supported by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, by the American Lebanese and Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, by grants from the US National Institutes of Health (P01 CA096832 to S.J.B., Jinghui Zhang and D.W.E. and R01 CA135554 to S.J.B.), by the Cure Starts Now Foundation and the Smile for Sophie Forever Foundation, and by Tyler's Treehouse and Musicians Against Childhood Cancer.	Bagarova J, 2013, MOL CELL BIOL, V33, P2413, DOI 10.1128/MCB.01595-12; Barrow J, 2011, NEURO-ONCOLOGY, V13, P212, DOI 10.1093/neuonc/noq158; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bax DA, 2009, CLIN CANCER RES, V15, P5753, DOI 10.1158/1078-0432.CCR-08-3210; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; BUTTI MG, 1995, GENOMICS, V28, P15, DOI 10.1006/geno.1995.1100; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Gottardo NG, 2008, J CHILD NEUROL, V23, P1149, DOI 10.1177/0883073808321765; Harel L, 2010, DEV NEUROBIOL, V70, P298, DOI 10.1002/dneu.20769; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li G, 2012, J NEURO-ONCOL, V108, P395, DOI 10.1007/s11060-012-0842-3; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pollack IF, 2001, CANCER RES, V61, P7404; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore Eileen M, 2011, Curr Osteoporos Rep, V9, P83, DOI 10.1007/s11914-011-0046-3; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	55	576	581	3	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					444	450		10.1038/ng.2938			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	WOS:000335422900009	24705251	Green Accepted	Y	N	2022-01-24	
J	Rane, SG; Dubus, P; Mettus, RV; Galbreath, EJ; Boden, G; Reddy, EP; Barbacid, M				Rane, SG; Dubus, P; Mettus, RV; Galbreath, EJ; Boden, G; Reddy, EP; Barbacid, M			Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia	NATURE GENETICS			English	Article							DEPENDENT KINASE INHIBITORS; PANCREATIC B-CELL; MICE LACKING; LEYDIG-CELLS; CYCLIN D1; GROWTH; GENE; PROLIFERATION; DISRUPTION; RAT	To ascertain the role of cyclin-dependent kinase 4 (Cdk4) in vivo, we have targeted the mouse Cdk4 locus by homologous recombination to generate two strains of mice, one that lacks Cdk4 expression and one that expresses a Cdk4 molecule with an activating mutation. Embryonic fibroblasts proliferate normally in the absence of Cdk4 but have a delayed S phase on re-entry into the cell cycle. Moreover, mice devoid of Cdk4 are viable, but small in size and infertile. These mice also develop insulin-deficient diabetes due to a reduction in beta-islet pancreatic cells. In contrast, mice expressing a mutant Cdk4 that cannot bind the cell-cycle inhibitor p16(INK4a) display pancreatic hyperplasia due to abnormal proliferation of beta-islet cells. These results establish Cdk4 as an essential regulator of specific cell types.	Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; Univ Bordeaux 2, Lab Histol Embryol, F-33076 Bordeaux, France; Eli Lilly & Co, Indianapolis, IN 46285 USA; Temple Univ, Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Gen Clin Res Ctr, Philadelphia, PA 19140 USA; Ctr Nacl Invest Oncol Carlos III, Madrid 28220, Spain		Reddy, EP (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, 3307 N Broad St, Philadelphia, PA 19140 USA.		Reddy, E. Premkumar/F-6233-2011	Dubus, Pierre/0000-0003-1803-4711; Galbreath, Elizabeth/0000-0003-0162-8329	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-00349] Funding Source: Medline; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01-AA-10221] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG-07988] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA010221] Funding Source: NIH RePORTER		ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Ashcroft F., 1992, INSULIN MOL BIOL PAT; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Balvers M, 1998, ENDOCRINOLOGY, V139, P2960, DOI 10.1210/en.139.6.2960; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; CAMERON DF, 1985, ANAT REC, V213, P53, DOI 10.1002/ar.1092130108; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DELLA NG, 1995, CELL TISSUE RES, V279, P411, DOI 10.1007/BF00318499; Dunlop M, 1996, BIOCHEM BIOPH RES CO, V218, P132, DOI 10.1006/bbrc.1996.0023; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GRANA X, 1995, ONCOGENE, V11, P211; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; HIRAMA T, 1995, BLOOD, V86, P841; HOPPENER JWM, 1994, J CELL BIOCHEM, V55, P39, DOI 10.1002/jcb.240550006; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Lejeune H, 1998, J MOL ENDOCRINOL, V20, P1, DOI 10.1677/jme.0.0200001; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MARTINEZ AR, 1995, INT J FERTIL MENOP S, V40, P139; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; MURRAY FT, 1983, METABOLISM, V32, P141, DOI 10.1016/S0026-0495(83)80028-6; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; SWENNE I, 1983, DIABETES, V32, P14, DOI 10.2337/diabetes.32.1.14; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; UNGER R H, 1985, P1018; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	42	576	590	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					44	52		10.1038/8751			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	WOS:000080096300021	10319860				2022-01-24	
J	Brinkmann, B; Klintschar, M; Neuhuber, F; Huhne, J; Rolf, B				Brinkmann, B; Klintschar, M; Neuhuber, F; Huhne, J; Rolf, B			Mutation rate in human microsatellites: Influence of the structure and length of the tandem repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; LOCUS; POLYMORPHISM; DNA; SEQUENCES; EVOLUTION; ACTBP2; CELLS; STRS	In 10,844 parent/child allelic transfers at nine short-tandem-repeat (STR) loci, 23 isolated STR mismatches were observed. The parenthood in each of these cases was highly validated (probability >99.97%). The event was always repeal related, owing to either a single-step mutation (n = 22) or a double-step mutation (n = 1). The mutation rate was between 0 and 7 x 10(-3) per locus per gamete per generation. No mutations were observed in three of the nine Loci. Mutation events in the male germ line were five to six times more frequent than in the female germ line. A positive exponential correlation between the geometric mean of the number of uninterrupted repeats and the mutation rate was observed. Our data demonstrate that mutation rates of different loci can differ by several orders of magnitude and that different alleles at one locus exhibit different mutation rates.	Univ Munster, Inst Rechtsmed, D-48129 Munster, Germany; Gerichtlich Med Inst, Graz, Austria; Inst Gerichtliche Med, Salzburg, Austria		Brinkmann, B (corresponding author), Univ Munster, Inst Rechtsmed, von Esmarch Str 62, D-48129 Munster, Germany.		Schneider, Peter M./A-6661-2011				ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; ALPER B, 1995, INT J LEGAL MED, V108, P93, DOI 10.1007/BF01369912; Barber MD, 1996, INT J LEGAL MED, V108, P180, DOI 10.1007/BF01369788; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brinkmann B, 1996, EUR J HUM GENET, V4, P175; Brinkmann B, 1998, HUM MUTAT, V11, P135, DOI 10.1002/(SICI)1098-1004(1998)11:2<135::AID-HUMU6>3.0.CO;2-I; Brinkmann B, 1996, HUM GENET, V98, P60, DOI 10.1007/s004390050160; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; EDWARDS A, 1991, AM J HUM GENET, V49, P746; EDWARDS MC, 1991, NUCLEIC ACIDS RES, V19, P4791, DOI 10.1093/nar/19.17.4791-a; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; EVBETT IW, 1997, INT J LEGAL MED, V110, P5; Fimmers R, 1992, ADV FORENSIC HAEMOGE, V4, P285; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; Klintschar M, 1998, INT J LEGAL MED, V111, P107, DOI 10.1007/s004140050128; KODAIRA M, 1995, AM J HUM GENET, V57, P1275; Lareu MV, 1996, INT J LEGAL MED, V109, P134, DOI 10.1007/BF01369673; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MEYER E, 1995, INT J LEGAL MED, V107, P314, DOI 10.1007/BF01246881; MEYER E, 1995, J MOL EVOL, V41, P10; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLLER A, 1994, INT J LEGAL MED, V106, P319, DOI 10.1007/BF01224779; MOLLER A, 1994, INT J LEGAL MED, V106, P262, DOI 10.1007/BF01225417; NISHIMURA DY, 1992, NUCLEIC ACIDS RES, V20, P1167, DOI 10.1093/nar/20.5.1167; Petes TD, 1997, GENETICS, V146, P491; POLYMEROPOULOS MH, 1992, NUCLEIC ACIDS RES, V20, P1432, DOI 10.1093/nar/20.6.1432; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018; Richards RI, 1996, HUM MUTAT, V8, P1; Rolf B, 1997, INT J LEGAL MED, V110, P69, DOI 10.1007/s004140050033; Rolf B., 1997, RECHTSMEDIZIN, V7, P157; SHARMA V, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67-a; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Shriver MD, 1997, AM J HUM GENET, V60, P957; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; VALDES AM, 1993, GENETICS, V133, P737; Vogel F, 1997, HUMAN GENETICS PROBL; WAYE JS, 1989, BIOTECHNIQUES, V7, P852; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WIEGAND P, 1993, INT J LEGAL MED, V105, P315, DOI 10.1007/BF01222114; Wierdl M, 1997, GENETICS, V146, P769	46	576	627	0	26	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1408	1415		10.1086/301869			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	WOS:000074174700017	9585597	Bronze, Green Published			2022-01-24	
J	Southard-Smith, EM; Kos, L; Pavan, WJ				Southard-Smith, EM; Kos, L; Pavan, WJ			Sox10 mutation disrupts neural crest development in DOM Hirschsprung mouse model	NATURE GENETICS			English	Article							MICE LACKING GDNF; AUTOSOMAL SEX REVERSAL; ENDOTHELIN-B RECEPTOR; SRY-RELATED GENE; ENTERIC NEURONS; MESSENGER-RNA; CAMPOMELIC DYSPLASIA; MEGACOLON; MELANOCYTES; FAMILY	Hirschsprung disease (HSCR, MIM #142623) is a multigenic neurocristopathy (neural crest disorder) characterized by absence of enteric ganglia in a variable portion of the distal colon. Subsets of HSCR individuals also present with neural crest-derived melanocyte deficiencies (Hirschsprung-Waardenburg, HSCR-WS, MIM #277580). Murine models have been instrumental in the identification and analysis of HSCR disease genes. These include mice with deficiencies of endothelin B receptor (Ednrb(s-l); refs 1,2) endothelin 3 (Edn3(ls); refs 1,3) the tyrosine kinase receptor cRet(4) and glial-derived neurotrophic factor(5-7). Another mouse model of HSCR disease, Dom, arose spontaneously at the Jackson Laboratory(8). While Dom/+ heterozygous mice display regional deficiencies of neural crest-derived enteric ganglia in the distal colon, Dom/Dom homozygous animals are embryonic lethal(8). We have determined that premature termination of Sox10, a member of the SRY-like HMG box family of transcription factors, is responsible for absence of the neural crest derivatives in Dom mice. We demonstrate expression of Sox10 in normal neural crest cells, disrupted expression of both Sox10 and the HSCR disease gene Ednrb in Dom mutant embryos, and loss of neural crest derivatives due to apoptosis. Our studies suggest that Sox10 is essential for proper peripheral nervous system development. We propose SOX10 as a candidate disease gene for individuals with HSCR whose disease does not have an identified genetic origin.	Natl Human Genome Res Inst, Mouse Embryol Sect, Lab Genet Dis Res, NIH, Bethesda, MD 20892 USA		Pavan, WJ (corresponding author), Natl Human Genome Res Inst, Mouse Embryol Sect, Lab Genet Dis Res, NIH, Bldg 49,Room 4A82,49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	bpavan@nhgri.nih.gov	Southard-Smith, Michelle/C-3488-2012	Southard-Smith, E Michelle/0000-0003-4718-5869; Pavan, William/0000-0001-8281-5120			BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GERSHON MD, 1995, CURR BIOL, V5, P601, DOI 10.1016/S0960-9822(95)00120-5; Hashimoto Y, 1996, CANCER RES, V56, P5266; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; KAPUR RP, 1993, DEVELOPMENT, V117, P993; Kapur RP, 1996, DEV BIOL, V174, P360, DOI 10.1006/dbio.1996.0080; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; PAVAN WJ, 1995, GENOME RES, V5, P29, DOI 10.1101/gr.5.1.29; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pringault V, 1997, GENOMICS, V39, P86, DOI 10.1006/geno.1996.4476; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; PULITI A, 1995, MAMM GENOME, V6, P763, DOI 10.1007/BF00539000; Reid K, 1996, DEVELOPMENT, V122, P3911; ROTHMAN TP, 1993, DEV BIOL, V159, P559, DOI 10.1006/dbio.1993.1264; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Stock DW, 1996, GENOMICS, V37, P234, DOI 10.1006/geno.1996.0548; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; SWIFT GH, 1982, P NATL ACAD SCI-BIOL, V79, P7263, DOI 10.1073/pnas.79.23.7263; Tani M, 1997, GENOMICS, V39, P30, DOI 10.1006/geno.1996.4483; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT EM, 1993, NUCLEIC ACIDS RES, V21, P744, DOI 10.1093/nar/21.3.744	36	576	587	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1998	18	1					60	64		10.1038/ng0198-60			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600023	9425902	Green Published			2022-01-24	
J	Wu, LJC; Wang, ZW; Tsan, JT; Spillman, MA; Phung, A; Xu, XL; Yang, MCW; Hwang, LY; Bowcock, AM; Baer, R				Wu, LJC; Wang, ZW; Tsan, JT; Spillman, MA; Phung, A; Xu, XL; Yang, MCW; Hwang, LY; Bowcock, AM; Baer, R			Identification of a RING protein that can interact in vivo with the BRCA1 gene product	NATURE GENETICS			English	Article							GLUTATHIONE-S-TRANSFERASE; OVARIAN-CANCER; ESCHERICHIA-COLI; FAMILIAL BREAST; LEUCINE ZIPPER; DNA-BINDING; MUTATIONS; PURIFICATION; EXPRESSION; POLYPEPTIDES	The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine-rich RING motif, a zinc-binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N-terminal region of BRCA1. This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.	UNIV TEXAS,SW MED CTR,DEPT MICROBIOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PEDIAT,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,MCDERMOTT CTR HUMAN GROWTH & DEV,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,MOL IMMUNOL CTR,DALLAS,TX 75235					Bowcock, Anne/0000-0001-8691-9090	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA060650] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA60650] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BENNETT LM, 1995, GENOMICS, V29, P576, DOI 10.1006/geno.1995.9963; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EASTON DF, 1993, AM J HUM GENET, V52, P678; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HARPER JW, 1993, CELL, V75, P805; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HSU HL, 1994, P NATL ACAD SCI USA, V91, P3181, DOI 10.1073/pnas.91.8.3181; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sambrook J., 1989, MOL CLONING LAB MANU; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SHARAN SK, 1995, HUM MOL GENET, V4, P2275, DOI 10.1093/hmg/4.12.2275; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TSAN JT, IN PRESS YEAST 2 HYB	30	576	585	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					430	440		10.1038/ng1296-430			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	WOS:A1996VV73000019	8944023				2022-01-24	
J	Yang, J; Manolio, TA; Pasquale, LR; Boerwinkle, E; Caporaso, N; Cunningham, JM; de Andrade, M; Feenstra, B; Feingold, E; Hayes, MG; Hill, WG; Landi, MT; Alonso, A; Lettre, G; Lin, P; Ling, H; Lowe, W; Mathias, RA; Melbye, M; Pugh, E; Cornelis, MC; Weir, BS; Goddard, ME; Visscher, PM				Yang, Jian; Manolio, Teri A.; Pasquale, Louis R.; Boerwinkle, Eric; Caporaso, Neil; Cunningham, Julie M.; de Andrade, Mariza; Feenstra, Bjarke; Feingold, Eleanor; Hayes, M. Geoffrey; Hill, William G.; Landi, Maria Teresa; Alonso, Alvaro; Lettre, Guillaume; Lin, Peng; Ling, Hua; Lowe, William; Mathias, Rasika A.; Melbye, Mads; Pugh, Elizabeth; Cornelis, Marilyn C.; Weir, Bruce S.; Goddard, Michael E.; Visscher, Peter M.			Genome partitioning of genetic variation for complex traits using common SNPs	NATURE GENETICS			English	Article							VON-WILLEBRAND-FACTOR; BODY-MASS INDEX; WIDE ASSOCIATION; LARGE PROPORTION; AGING RESEARCH; FACTOR-VIII; HERITABILITY; LOCI; POPULATION; VARIANTS	We estimate and partition genetic variation for height, body mass index (BMI), von Willebrand factor and QT interval (QTi) using 586,898 SNPs genotyped on 11,586 unrelated individuals. We estimate that similar to 45%, similar to 17%, similar to 25% and similar to 21% of the variance in height, BMI, von Willebrand factor and QTi, respectively, can be explained by all autosomal SNPs and a further similar to 0.5-1% can be explained by X chromosome SNPs. We show that the variance explained by each chromosome is proportional to its length, and that SNPs in or near genes explain more variation than SNPs between genes. We propose a new approach to estimate variation due to cryptic relatedness and population stratification. Our results provide further evidence that a substantial proportion of heritability is captured by common SNPs, that height, BMI and QTi are highly polygenic traits, and that the additive variation explained by a part of the genome is approximately proportional to the total length of DNA contained within genes therein.	[Yang, Jian; Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [Manolio, Teri A.] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA; [Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Div Epidemiol, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Caporaso, Neil; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Cunningham, Julie M.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Feenstra, Bjarke; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Feingold, Eleanor] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Hayes, M. Geoffrey] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Hill, William G.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Lin, Peng] Washington Univ, Sch Med, Human & Stat Genet Program, St Louis, MO USA; [Ling, Hua; Pugh, Elizabeth] Johns Hopkins Univ, Sch Med, Ctr Inherited Dis Res, Baltimore, MD USA; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Gen Internal Med, Baltimore, MD USA; [Cornelis, Marilyn C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Melbourne, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia		Visscher, PM (corresponding author), Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Weir, Bruce S/A-2894-2013; Lin, P/G-7702-2014; Alonso, Alvaro/A-4917-2010; Yang, Jian/A-5852-2010; Visscher, Peter/ABB-6151-2020; Hill, William/B-3198-2012	Alonso, Alvaro/0000-0002-2225-8323; Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760; Feenstra, Bjarke/0000-0003-1478-649X; de Andrade, Mariza/0000-0003-2329-2686; melbye, mads/0000-0001-8264-6785; Goddard, Michael/0000-0001-9917-7946; Feingold, Eleanor/0000-0003-2898-6484; Hayes, M Geoffrey/0000-0002-4617-3981	US National Institutes of Health Genes, Environment and Health InitiativeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Research to Prevent Blindness in New York CityResearch to Prevent Blindness (RPB); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [389892, 613672]; Australian Research Council (ARC)Australian Research Council [DP0770096, DP1093900];  [U01 HG 004402];  [U01 HG 004399];  [U01 HG 004728];  [U01 HG04424];  [U01 HG 004446]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004402, U01HG004446, U01HG004399, U01HG004728, U01HG004424] Funding Source: NIH RePORTER	Funding support for the Gene, Environment Association Studies (GENEVA) project has been provided through the US National Institutes of Health Genes, Environment and Health Initiative. For the ARIC project, support was from U01 HG 004402 (PI: E. A. Boerwinkle). For the NHS and HPFS support is from U01 HG 004399 and U01 HG 004728 (PIs: F. B. Hu and L. R. Pasquale). The genotyping for the ARIC, NHS and HPFS studies was performed at the Broad Institute of MIT and Harvard with funding support from U01 HG04424 (PI: S. Gabriel). The GENEVA Coordinating Center receives support from U01 HG 004446 (PI: B. S. Weir). Assistance with GENEVA data cleaning was provided by the National Center for Biotechnology Information. D. Crosslin and C. Laurie of the GENEVA project assisted in making the data available for analysis. A Physician Scientist Award from Research to Prevent Blindness in New York City also supports L. R. P. M. C. C. is a recipient of a Canadian Institutes of Health Research Fellowship. We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC grants 389892 and 613672) and the Australian Research Council (ARC grants DP0770096 and DP1093900). We thank D. Posthuma for discussions and the referees for constructive comments.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bulmer MG, 1985, MATH THEORY QUANTITA; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; Dalageorgou C, 2008, J CARDIOVASC ELECTR, V19, P386, DOI 10.1111/j.1540-8167.2007.01030.x; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kent JW, 2005, GENET EPIDEMIOL, V29, P377, DOI 10.1002/gepi.20093; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; O'Donnell J, 2002, ARTERIOSCL THROM VAS, V22, P335, DOI 10.1161/hq0202.103997; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; PRESTON AE, 1964, BRIT J HAEMATOL, V10, P238, DOI 10.1111/j.1365-2141.1964.tb00698.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Shah SH, 2009, NAT GENET, V41, P388, DOI 10.1038/ng0409-388; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	43	575	581	0	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					519	U44		10.1038/ng.823			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	WOS:000291017000007	21552263	Green Accepted	Y	N	2022-01-24	
J	Crow, YJ; Hayward, BE; Parmar, R; Robins, P; Leitch, A; Ali, M; Black, DN; van Bokhoven, H; Brunner, HG; Hamel, BC; Corry, PC; Cowan, FM; Frints, SG; Klepper, J; Livingston, JH; Lynch, SA; Massey, RF; Meritet, JF; Michaud, JL; Ponsot, G; Voit, T; Lebon, P; Bonthron, DT; Jackson, AP; Barnes, DE; Lindahl, T				Crow, Yanick J.; Hayward, Bruce E.; Parmar, Rekha; Robins, Peter; Leitch, Andrea; Ali, Manir; Black, Deborah N.; van Bokhoven, Hans; Brunner, Han G.; Hamel, Ben C.; Corry, Peter C.; Cowan, Frances M.; Frints, Suzanne G.; Klepper, Joerg; Livingston, John H.; Lynch, Sally Ann; Massey, Roger F.; Meritet, Jean Francois; Michaud, Jacques L.; Ponsot, Gerard; Voit, Thomas; Lebon, Pierre; Bonthron, David T.; Jackson, Andrew P.; Barnes, Deborah E.; Lindahl, Tomas			Mutations in the gene encoding the 3 '-5 ' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROGRESSIVE FAMILIAL ENCEPHALOPATHY; INTERFERON-ALPHA; INTRATHECAL SYNTHESIS; MICE; ENCEPHALITIS; INDUCTION; INFECTION; SERUM	Aicardi-Goutieres syndrome (AGS) presents as a severe neurological brain disease and is a genetic mimic of the sequelae of transplacentally acquired viral infection(1,2). Evidence exists for a perturbation of innate immunity as a primary pathogenic event in the disease phenotype(3). Here, we show that TREX1, encoding the major mammalian 3'-> 5' DNA exonuclease(4), is the AGS1 gene, and AGS-causing mutations result in abrogation of TREX1 enzyme activity. Similar loss of function in the Trex1(-/-) mouse leads to an inflammatory phenotype(5). Our findings suggest an unanticipated role for TREX1 in processing or clearing anomalous DNA structures, failure of which results in the triggering of an abnormal innate immune response.	Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England; London Res Inst, Canc Res UK, S Mimms EN6 3LD, Herts, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; McGill Univ, Montreal Neurol Inst, Dept Neurogenet, Montreal, PQ, Canada; Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 417, NL-6525 GA Nijmegen, Netherlands; St Lukes Hosp, Bradford Child Dev Ctr, Bradford BD5 0NA, W Yorkshire, England; Hammersmith Hosp, Imperial Coll, Dept Paediat, London W12 0HS, England; Univ Hosp AzM Maastricht, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; Univ Hosp Essen, Dept Pediat & Pediat Neurol, D-45122 Essen, Germany; Gen Infirm, Dept Paediat Neurol, Leeds LS1 3EX, W Yorkshire, England; Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; Hull Royal Infirm, Dept Paediat, Kingston Upon Hull HU3 2JZ, N Humberside, England; Hop Cochin, Serv Virol, F-75674 Paris, France; Univ Paris 05, F-75674 Paris, France; Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; Hop Cochin, Serv Neuropediat, F-75674 Paris, France		Crow, YJ (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	yanickcrow@mac.com	van Bokhoven, Hans/D-8764-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013; Crow, Yanick J/N-6120-2014; Jackson, Andrew P/D-3442-2009; Ali, Manir/ABE-5251-2020	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Crow, Yanick J/0000-0001-7211-7564; Jackson, Andrew P/0000-0002-8739-2646; Ali, Manir/0000-0003-3204-3788; Bonthron, David/0000-0001-8132-8179; Frints, Suzanna G.M./0000-0002-5027-8364; Lynch, Sally Ann/0000-0003-3540-1333	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127580972] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U127580972] Funding Source: Medline		AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Akwa Y, 1998, J IMMUNOL, V161, P5016; Ali M, 2006, J MED GENET, V43, P444, DOI 10.1136/jmg.2005.031880; Batteux F, 1999, EUR CYTOKINE NETW, V10, P509; BLACK DN, 1988, ANN NEUROL, V24, P483, DOI 10.1002/ana.410240402; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2000, AM J HUM GENET, V67, P213, DOI 10.1086/302955; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; DUSSAIX E, 1985, ACTA NEUROL SCAND, V71, P504; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; LEBON P, 1983, BRIT MED J, V287, P1165, DOI 10.1136/bmj.287.6400.1165; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Prokunina L, 2004, HUM MOL GENET, V13, pR143, DOI 10.1093/hmg/ddh076; Raymond AA, 1996, LUPUS, V5, P123, DOI 10.1177/096120339600500207; RICH SA, 1986, ARTHRITIS RHEUM, V29, P501, DOI 10.1002/art.1780290407; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; STEPHENSON J, 2002, EUR J PEDIAT NEUR SA, V6, P67; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	30	575	593	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					917	920		10.1038/ng1845			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	WOS:000239325700021	16845398				2022-01-24	
J	Kondo, S; Schutte, BC; Richardson, RJ; Bjork, BC; Knight, AS; Watanabe, Y; Howard, E; de Lima, RLLF; Daack-Hirsch, S; Sander, A; McDonald-McGinn, DM; Zackai, EH; Lammer, EJ; Aylsworth, AS; Ardinger, HH; Lidral, AC; Pober, BR; Moreno, L; Arcos-Burgos, M; Valencia, C; Houdayer, C; Bahuau, M; Moretti-Ferreira, D; Richieri-Costa, A; Dixon, MJ; Murray, JC				Kondo, S; Schutte, BC; Richardson, RJ; Bjork, BC; Knight, AS; Watanabe, Y; Howard, E; de Lima, RLLF; Daack-Hirsch, S; Sander, A; McDonald-McGinn, DM; Zackai, EH; Lammer, EJ; Aylsworth, AS; Ardinger, HH; Lidral, AC; Pober, BR; Moreno, L; Arcos-Burgos, M; Valencia, C; Houdayer, C; Bahuau, M; Moretti-Ferreira, D; Richieri-Costa, A; Dixon, MJ; Murray, JC			Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes	NATURE GENETICS			English	Article							INTERFERON REGULATORY FACTORS; SEQUENCE; GENE; EXPRESSION; 1Q32-Q41; HOMOLOG; DEFECTS; LINKAGE; DOMAIN; PALATE	Interferon regulatory factor 6 (IRF6) belongs to a family of nine transcription factors that share a highly conserved helix-turn-helix DNA-binding domain and a less conserved protein-binding domain. Most IRFs regulate the expression of interferon-alpha and -beta after viral infection(1), but the function of IRF6 is unknown. The gene encoding IRF6 is located in the critical region for the Van der Woude syndrome (VWS; OMIM 119300) locus at chromosome 1q32-q41 (refs 2,3). The disorder is an autosomal dominant form of cleft lip and palate with lip pits(4), and is the most common syndromic form of cleft lip or palate. Popliteal pterygium syndrome (PPS; OMIM 119500) is a disorder with a similar orofacial phenotype that also includes skin and genital anomalies(5). Phenotypic overlap(6) and linkage data(7) suggest that these two disorders are allelic. We found a nonsense mutation in IRF6 in the affected twin of a pair of monozygotic twins who were discordant for VWS. Subsequently, we identified mutations in IRF6 in 45 additional unrelated families affected with VWS and distinct mutations in 13 families affected with PPS. Expression analyses showed high levels of Irf6 mRNA along the medial edge of the fusing palate, tooth buds, hair follicles, genitalia and skin. Our observations demonstrate that haploinsufficiency of IRF6 disrupts orofacial development and are consistent with dominant-negative mutations disturbing development of the skin and genitalia.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary PhD Program Genet, Iowa City, IA 52242 USA; Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; Univ Manchester, Dept Dent Med & Surg, Manchester, Lancs, England; Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Estadual Paulista, Serv Aconselhamento Genet, Botucatu, SP, Brazil; Univ Hamburg, Clin Oral Maxillofacial Surg, Hamburg, Germany; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Childrens Hosp, Oakland, CA 94609 USA; Univ N Carolina, Dept Pediat & Genet, Chapel Hill, NC USA; Univ Kansas, Childrens Med Ctr, Dept Pediat, Kansas City, KS USA; Univ Iowa, Dept Orthodont, Iowa City, IA USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Iowa, PhD Program Oral Sci, Iowa City, IA USA; Univ Antioquia, Medellin, Colombia; Hop Enfants Armand Trousseau, Serv Biochim & Biol Mol, Paris, France; Hop Enfants Armand Trousseau, Serv Chirurg Maxillofaciale & Plast Stomatol, Paris, France; Univ Sao Paulo, Serv Chirurg Maxillofaciale & Lesoes Labio Palati, Dept Clin Genet, Bauru, Brazil; Univ Iowa, Dept Biol, Iowa City, IA 52242 USA		Murray, JC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.		Richieri-Costa, Antonio/B-2514-2013; McDonald-McGinn, Donna/L-8643-2019; Moretti-Ferreira, Danilo/F-9565-2012; Moretti-Ferreira, Danilo/P-3456-2019; Richardson, Rebecca/L-5198-2019; Arcos-Burgos, Mauricio/H-1326-2017	Moretti-Ferreira, Danilo/0000-0002-9256-7623; Richardson, Rebecca/0000-0002-4701-8713; Daack-Hirsch, Sandra/0000-0003-1192-7154; Watanabe, Yoriko/0000-0003-4685-8021; Houdayer, Claude/0000-0002-5190-0389; Arcos-Burgos, Mauricio/0000-0002-8529-0574; /0000-0003-4077-250X; Britt, Allison/0000-0001-6601-0453	NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [P60 DE013076-03S10005, R01 DE014667-02, R01 DE014667-03, P60 DE013076-010005, P60 DE013076-020005, P60 DE013076-040005, R01 DE014667-04, P60 DE013076-050005, P60 DE013076, R01 DE014667-01, P60 DE013076-030005, R01 DE014667, P60 DE013076-01S10005] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [P60DE013076, R01DE014667] Funding Source: NIH RePORTER		Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; BIXLER D, 1973, CLIN GENET, V4, P220; BOCIAN M, 1987, AM J MED GENET, V26, P437, DOI 10.1002/ajmg.1320260223; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Dixon J, 1997, HUM MOL GENET, V6, P727, DOI 10.1093/hmg/6.5.727; Eroshkin A, 1999, J MOL MED, V77, P403, DOI 10.1007/s001090050369; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; FRASER F C, 1955, Acta Genet Stat Med, V5, P358; GORLIN RJ, 1968, PEDIATRICS, V41, P503; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Lees MM, 1999, J MED GENET, V36, P888; Lin RT, 1999, MOL CELL BIOL, V19, P959; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; MURRAY JC, 1990, AM J HUM GENET, V46, P486; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SANDER A, 1994, HUM MOL GENET, V3, P575, DOI 10.1093/hmg/3.4.575; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schutte BC, 1999, AM J MED GENET, V84, P145, DOI 10.1002/(SICI)1096-8628(19990521)84:2<145::AID-AJMG11>3.0.CO;2-L; Schutte BC, 2000, GENOME RES, V10, P81; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244	29	575	600	0	72	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					285	289		10.1038/ng985			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	WOS:000178311100018	12219090	Green Accepted, Green Published			2022-01-24	
J	Satokata, I; Ma, L; Ohshima, H; Bei, M; Woo, I; Nishizawa, K; Maeda, T; Takano, Y; Uchiyama, M; Heaney, S; Peters, H; Tang, ZQ; Maxson, R; Maas, R				Satokata, I; Ma, L; Ohshima, H; Bei, M; Woo, I; Nishizawa, K; Maeda, T; Takano, Y; Uchiyama, M; Heaney, S; Peters, H; Tang, ZQ; Maxson, R; Maas, R			Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation	NATURE GENETICS			English	Article							PARIETAL FORAMINA; TOOTH DEVELOPMENT; INDIAN HEDGEHOG; HOMEODOMAIN; GENE; CRANIOSYNOSTOSIS; EXPRESSION; MUTATION; FAMILY; FETAL	The composite structure of the mammalian skull, which forms predominantly via intramembranous ossification, requires precise pre- and post-natal growth regulation of individual calvarial elements. Disturbances of this process frequently cause severe clinical manifestations in humans. Enhanced DNA binding by a mutant MSX2 homeodomain results in a gain of function and produces craniosynostosis in humans(1,2). Here we show that Msx2-deficient mice have defects of skull ossification and persistent calvarial foramen, This phenotype results from defective proliferation of osteoprogenitors at the osteogenic front during calvarial morphogenesis, and closely resembles that associated with human MSX2 haploinsufficiency in parietal foramina(3) (PFM), Msx2(-/-) mice also have defects in endochondral bone formation. In the axial and appendicular skeleton, post-natal deficits in Pth/Pthrp receptor (Pthr) signalling and in expression of marker genes for bone differentiation indicate that Msx2 is required for both chondrogenesis and osteogenesis, Consistent with phenotypes associated with PFM, Msx2-mutant mice also display defective tooth, hair follicle and mammary gland development, and seizures, the latter accompanied by abnormal development of the cerebellum. Most Msx2-mutant phenotypes, including calvarial defects, are enhanced by genetic combination with Msx1 loss of function, indicating that Msx gene dosage can modify expression of the PFM phenotype. Our results provide a developmental basis for PFM and demonstrate that Msx2 is essential at multiple sites during organogenesis.	Univ So Calif, Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Norris Canc Ctr, Los Angeles, CA USA; Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Niigata Univ, Sch Med, Dept Pediat, Asahimachi, Japan; Niigata Univ, Fac Dent, Dept Oral Anat, Niigata, Japan; Tokyo Med & Dent Univ, Fac Dent, Dept Oral Anat, Tokyo, Japan		Maas, R (corresponding author), Univ So Calif, Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.		Ohshima, Hayato/AAW-5545-2020	Ohshima, Hayato/0000-0001-8571-9900	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE011697] Funding Source: NIH RePORTER; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE11697] Funding Source: Medline		Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; Bei M, 1998, DEVELOPMENT, V125, P4325; Chrzanowska K, 1998, AM J MED GENET, V78, P401, DOI 10.1002/(SICI)1096-8628(19980806)78:5<401::AID-AJMG1>3.0.CO;2-O; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KITE WC, 1961, NEUROLOGY, V11, P345, DOI 10.1097/00132985-196104000-00010; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LITTLE BB, 1990, AM J MED GENET, V35, P453, DOI 10.1002/ajmg.1320350402; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; McKusick V.A., 1998, MENDELIAN INHERITANC; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Phippard DJ, 1996, DEVELOPMENT, V122, P2729; PREIS S, 1995, ACTA PAEDIATR, V84, P701, DOI 10.1111/j.1651-2227.1995.tb13735.x; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Sakakura T., 1987, The mammary gland. Development, regulation, and function., P37; SAKAKURA Y, 1989, AM J ANAT, V184, P287, DOI 10.1002/aja.1001840404; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722	29	574	592	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					391	395		10.1038/74231			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	WOS:000086192800019	10742104				2022-01-24	
J	GOYETTE, P; SUMNER, JS; MILOS, R; DUNCAN, AMV; ROSENBLATT, DS; MATTHEWS, RG; ROZEN, R				GOYETTE, P; SUMNER, JS; MILOS, R; DUNCAN, AMV; ROSENBLATT, DS; MATTHEWS, RG; ROZEN, R			HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE - ISOLATION OF CDNA, MAPPING AND MUTATION IDENTIFICATION	NATURE GENETICS			English	Article							NUCLEOTIDE-SEQUENCE; INSITU HYBRIDIZATION; ESCHERICHIA-COLI; RISK FACTOR; GENE; DISEASE; HYPERHOMOCYSTEINEMIA; HETEROZYGOSITY; PURIFICATION; LOCALIZATION	Methylenetetrahydrofolate reductase (MTHFR) catalyses the reduction of methylenetetrahydrofolate to methyltetrahydrofolate, a cofactor for homocysteine methylation to methionine. MTHFR deficiency, an autosomal recessive disorder, results in homocysteinemia. Using degenerate oligonucleotides based on porcine peptide sequence data, we isolated a 90-bp cDNA by PCR from pig liver RNA. This cDNA was used to isolate a human cDNA, the predicted amino acid sequence of which shows strong homology to porcine MTHFR and to bacterial metF genes. The human gene has been localized to chromosome 1 p36.3. Two mutations were identified in MTHFR-deficient patients: a missense mutation (Arg to Gln), in a residue conserved in bacterial enzymes, and a nonsense mutation (Arg to Ter).	MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT PEDIAT,MONTREAL H3H 1P3,PQ,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT HUMAN GENET,MONTREAL H3H 1P3,PQ,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT BIOL,MONTREAL H3H 1P3,PQ,CANADA; UNIV MICHIGAN,DIV BIOPHYS RES,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; QUEENS UNIV,KINGSTON K7L 2V7,ON,CANADA; KINGSTON GEN HOSP,KINGSTON K7L 2V7,ON,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1A1,PQ,CANADA						NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM024908] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA46952] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1 RR00042] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37 GM24908] Funding Source: Medline		BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; Branden C., 1991, INTRO PROTEIN STRUCT; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DAUBNER SC, 1982, J BIOL CHEM, V257, P140; DOCKHORNDWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P2500, DOI 10.1093/nar/19.9.2500; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HAWORTH JC, 1993, AM J MED GENET, V45, P572, DOI 10.1002/ajmg.1320450510; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1991, AM J HUM GENET, V48, P546; KATZEN HM, 1965, J BIOL CHEM, V240, P825; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LIN CC, 1985, CYTOGENET CELL GENET, V39, P269, DOI 10.1159/000132156; MATTHEWS RG, 1984, J BIOL CHEM, V259, P1647; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; ORITA M, 1989, GENOMICS, V5, P8874; ROSENBLATT DS, 1992, BIOCHEM MED METAB B, V47, P221, DOI 10.1016/0885-4505(92)90029-X; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SAINTGIRONS I, 1983, NUCLEIC ACIDS RES, V11, P6723, DOI 10.1093/nar/11.19.6723; SOM S, 1990, J BIOL CHEM, V265, P4278; STAUFFER GV, 1988, MOL GEN GENET, V212, P246, DOI 10.1007/BF00334692; SUMNER J, 1986, J BIOL CHEM, V261, P7697; YANG E, 1984, MOL CELL BIOL, V4, P2161, DOI 10.1128/MCB.4.10.2161; ZHOU JM, 1990, BIOCHEM MED METAB B, V43, P234, DOI 10.1016/0885-4505(90)90029-Z	24	574	620	1	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					195	200		10.1038/ng0694-195			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	WOS:A1994NQ03700022	7920641				2022-01-24	
J	Bar-Even, A; Paulsson, J; Maheshri, N; Carmi, M; O'Shea, E; Pilpel, Y; Barkai, N				Bar-Even, Arren; Paulsson, Johan; Maheshri, Narendra; Carmi, Miri; O'Shea, Erin; Pilpel, Yitzhak; Barkai, Naama			Noise in protein expression scales with natural protein abundance	NATURE GENETICS			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; SINGLE-CELL; GLOBAL ANALYSIS; NETWORKS; YEAST; FLUCTUATIONS; POPULATION; MECHANISMS; MODEL	Noise in gene expression is generated at multiple levels, such as transcription and translation, chromatin remodeling and pathway-specific regulation. Studies of individual promoters have suggested different dominating noise sources, raising the question of whether a general trend exists across a large number of genes and conditions. We examined the variation in the expression levels of 43 Saccharomyces cerevisiae proteins, in cells grown under 11 experimental conditions. For all classes of genes and under all conditions, the expression variance was approximately proportional to the mean; the same scaling was observed at steady state and during the transient responses to the perturbations. Theoretical analysis suggests that this scaling behavior reflects variability in mRNA copy number, resulting from random 'birth and death' of mRNA molecules or from promoter fluctuations. Deviation of coexpressed genes from this general trend, including high noise in stress-related genes and low noise in proteasomal genes, may indicate fluctuations in pathway-specific regulators or a differential activation pattern of the underlying gene promoters.	Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Weizmann Inst Sci, Phys Complex Syst, IL-76100 Rehovot, Israel		Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il; naama.barkai@weizmann.ac.il		Bar-Even, Arren/0000-0002-1039-4328			Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; de Menezes MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068701; de Menezes MA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028701; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; NEWMAN JRS, IN PRESS NATURE; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RIGNEY DR, 1977, J THEOR BIOL, V69, P761, DOI 10.1016/0022-5193(77)90381-2; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; VOLFSON D, 2005, NATURE; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799	40	573	575	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					636	643		10.1038/ng1807			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	WOS:000237954800016	16715097				2022-01-24	
J	Reiser, J; Polu, KR; Moller, CC; Kenlan, P; Altintas, MM; Wei, CL; Faul, C; Herbert, S; Villegas, I; Avila-Casado, C; McGee, M; Sugimoto, H; Brown, D; Kalluri, R; Mundel, P; Smith, PL; Clapham, DE; Pollak, MR				Reiser, J; Polu, KR; Moller, CC; Kenlan, P; Altintas, MM; Wei, CL; Faul, C; Herbert, S; Villegas, I; Avila-Casado, C; McGee, M; Sugimoto, H; Brown, D; Kalluri, R; Mundel, P; Smith, PL; Clapham, DE; Pollak, MR			TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function	NATURE GENETICS			English	Article							PROTEIN; NEPHRIN; KIDNEY; RAT; PODOCYTES; GENE	Progressive kidney failure is a genetically and clinically heterogeneous group of disorders. Podocyte foot processes and the interposed glomerular slit diaphragm are essential components of the permeability barrier in the kidney. Mutations in genes encoding structural proteins of the podocyte lead to the development of proteinuria, resulting in progressive kidney failure and focal segmental glomerulosclerosis. Here, we show that the canonical transient receptor potential 6 ( TRPC6) ion channel is expressed in podocytes and is a component of the glomerular slit diaphragm. We identified five families with autosomal dominant focal segmental glomerulosclerosis in which disease segregated with mutations in the gene TRPC6 on chromosome 11q. Two of the TRPC6 mutants had increased current amplitudes. These data show that TRPC6 channel activity at the slit diaphragm is essential for proper regulation of podocyte structure and function.	Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Inst Nacl Cardiol Ignacio Chavez, Dept Pathol, Mexico City 14080, DF, Mexico; Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02129 USA; Beth Israel Deaconess Med Ctr, Ctr Matrix Biol, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA		Reiser, J (corresponding author), Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02129 USA.	jreiser@partners.org; mpollak@rics.bwh.harvard.edu	Clapham, David/S-1123-2019; Altintas, Mehmet Mete/ABI-5904-2020; Faul, Christian/D-1549-2011; Clapham, David/R-5974-2019; Altintas, Mehmet/T-5333-2018; Kalluri, Raghu/E-2677-2015	Clapham, David/0000-0002-4459-9428; Altintas, Mehmet/0000-0002-1871-6985; Kalluri, Raghu/0000-0002-2190-547X	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL007572] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK055001, R01 DK054931, R56 DK054931, R01 DK057683] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R56DK054931, R01DK055001, R01DK057683, R01DK054931] Funding Source: NIH RePORTER		Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pavenstadt H, 2002, MICROSC RES TECHNIQ, V57, P224, DOI 10.1002/jemt.10078; Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; WINN MP, 2005, SCIENCE         0505, DOI DOI 10.1126/SCIENCE.1106215; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x	26	573	622	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					739	744		10.1038/ng1592			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	WOS:000230196400021	15924139	Green Accepted			2022-01-24	
J	Parks, AL; Cook, KR; Belvin, M; Dompe, NA; Fawcett, R; Huppert, K; Tan, LR; Winter, CG; Bogart, KP; Deal, JE; Deal-Herr, ME; Grant, D; Marcinko, M; Miyazaki, WY; Robertson, S; Shaw, KJ; Tabios, M; Vysotskaia, V; Zhao, L; Andrade, RS; Edgar, KA; Howie, E; Killpack, K; Milash, B; Norton, A; Thao, D; Whittaker, K; Winner, MA; Friedman, L; Margolis, J; Singer, MA; Kopczynski, C; Curtis, D; Kaufman, TC; Plowman, GD; Duyk, G; Francis-Lang, HL				Parks, AL; Cook, KR; Belvin, M; Dompe, NA; Fawcett, R; Huppert, K; Tan, LR; Winter, CG; Bogart, KP; Deal, JE; Deal-Herr, ME; Grant, D; Marcinko, M; Miyazaki, WY; Robertson, S; Shaw, KJ; Tabios, M; Vysotskaia, V; Zhao, L; Andrade, RS; Edgar, KA; Howie, E; Killpack, K; Milash, B; Norton, A; Thao, D; Whittaker, K; Winner, MA; Friedman, L; Margolis, J; Singer, MA; Kopczynski, C; Curtis, D; Kaufman, TC; Plowman, GD; Duyk, G; Francis-Lang, HL			Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome	NATURE GENETICS			English	Article							CHROMOSOME REARRANGEMENTS; RECOMBINATION	In fruit fly research, chromosomal deletions are indispensable tools for mapping mutations, characterizing alleles and identifying interacting loci. Most widely used deletions were generated by irradiation or chemical mutagenesis. These methods are labor-intensive, generate random breakpoints and result in unwanted secondary mutations that can confound phenotypic analyses. Most of the existing deletions are large, have molecularly undefined endpoints and are maintained in genetically complex stocks. Furthermore, the existence of haplolethal or haplosterile loci makes the recovery of deletions of certain regions exceedingly difficult by traditional methods, resulting in gaps in coverage. Here we describe two methods that address these problems by providing for the systematic isolation of targeted deletions in the D. melanogaster genome. The first strategy used a P element based technique to generate deletions that closely flank haploinsufficient genes and minimize undeleted regions. This deletion set has increased overall genomic coverage by 5-7%. The second strategy used FLP recombinase and the large array of FRT-bearing insertions described in the accompanying paper(1) to generate 519 isogenic deletions with molecularly defined endpoints. This second deletion collection provides 56% genome coverage so far. The latter methodology enables the generation of small custom deletions with predictable endpoints throughout the genome and should make their isolation a simple and routine task.	Indiana Univ, Dept Biol, Bloomington Drosophila Stock Ctr, Bloomington, IN 47405 USA; Exelixis, San Francisco, CA 94083 USA		Cook, KR (corresponding author), Indiana Univ, Dept Biol, Bloomington Drosophila Stock Ctr, 1001 E 3rd St, Bloomington, IN 47405 USA.	kcook@bio.indiana.edu	PLOWMAN, Greg D/E-2012-2011	Cook, Kevin/0000-0001-9260-364X; Plowman, Gregory D/0000-0002-6465-309X; Parks, Annette/0000-0002-4619-2277	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R24RR014106] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R24 RR014106] Funding Source: Medline		Ashburner M., 1989, DROSOPHILA LAB HDB; BERG R, 1980, SCIENCE, V210, P427, DOI 10.1126/science.6776625; COOLEY L, 1990, P NATL ACAD SCI USA, V87, P3170, DOI 10.1073/pnas.87.8.3170; Golic KG, 1996, GENETICS, V144, P1693; Gray YHM, 1996, GENETICS, V144, P1601; Preston CR, 1996, GENETICS, V144, P1623; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; THIBAULT ST, 2004, NAT GENET       0222; TOWER J, 1993, GENETICS, V133, P347	9	573	584	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					288	292		10.1038/ng1312			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	WOS:000189250400019	14981519	Bronze			2022-01-24	
J	DEMPSTER, ER; LERNER, IM				DEMPSTER, ER; LERNER, IM			HERITABILITY OF THRESHOLD CHARACTERS	GENETICS			English	Article																	Bliss CI, 1935, ANN APPL BIOL, V22, P134, DOI 10.1111/j.1744-7348.1935.tb07713.x; Finney D.J., 1947, PROBIT ANAL; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher RA, 1932, GENETICS, V17, P0107; Hazel LN, 1943, GENETICS, V28, P476; Johannsen, 1903, ERBLICHKEIT POPULATI; LERNER IM, 1948, POULTRY SCI, V27, P67, DOI 10.3382/ps.0270067; Lush J. L., 1945, ANIMAL BREEDING PLAN; LUSH JL, 1947, AM NAT, V81, P362, DOI 10.1086/281532; LUSH JL, 1948, POULTRY SCI, V27, P375, DOI 10.3382/ps.0270375; LUSH JL, 1947, AM NAT, V81, P241, DOI 10.1086/281520; ROBERTSON A, 1949, GENETICS, V34, P395; Smith HF, 1936, ANN EUGENIC, V7, P240, DOI 10.1111/j.1469-1809.1936.tb02143.x; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; Weinberg W., 1908, Z INDUKTIVE ABSTAMMU, V1, P377, DOI [10.1007/BF01990605, DOI 10.1007/BF01990605]; Weinberg Wilhelm, 1910, Archiv Rassenbiol Leipzig, V7; Weinberg Wilhelm., 1910, Archiv Rassenbiol Leipzig, V7; Wright S, 1935, J GENET, V30, P243, DOI 10.1007/BF02982239; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Wright S, 1918, GENETICS, V3, P367; Wright S, 1934, GENETICS, V19, P0537; Wright S, 1934, GENETICS, V19, P0506; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; Wright S, 1926, J AM STAT ASSOC, V21, P162, DOI 10.2307/2277143; Wright S, 1943, GENETICS, V28, P139; Wright S., 1921, J AGR RES, V10, P557; Wright S., 1917, J WASHINGTON ACAD SC, V7, P532; [No title captured]	28	573	579	0	17	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1950	35	2					212	236					25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW839	WOS:A1950XW83900006	17247344				2022-01-24	
J	Jansen, IE; Savage, JE; Watanabe, K; Bryois, J; Williams, DM; Steinberg, S; Sealock, J; Karlsson, IK; Hagg, S; Athanasiu, L; Voyle, N; Proitsi, P; Witoelar, A; Stringer, S; Aarsland, D; Almdahl, IS; Andersen, F; Bergh, S; Bettella, F; Bjornsson, S; Braekhus, A; Brathen, G; de Leeuw, C; Desikan, RS; Djurovic, S; Dumitrescu, L; Fladby, T; Hohman, TJ; Jonsson, PV; Kiddle, SJ; Rongve, A; Saltvedt, I; Sando, SB; Selbaek, G; Shoai, M; Skene, NG; Snaedal, J; Stordal, E; Ulstein, ID; Wang, YP; White, LR; Hardy, J; Hjerling-Leffler, J; Sullivan, PF; van der Flier, WM; Dobson, R; Davis, LK; Stefansson, H; Stefansson, K; Pedersen, NL; Ripke, S; Andreassen, OA; Posthuma, D				Jansen, Iris E.; Savage, Jeanne E.; Watanabe, Kyoko; Bryois, Julien; Williams, Dylan M.; Steinberg, Stacy; Sealock, Julia; Karlsson, Ida K.; Hagg, Sara; Athanasiu, Lavinia; Voyle, Nicola; Proitsi, Petroula; Witoelar, Aree; Stringer, Sven; Aarsland, Dag; Almdahl, Ina S.; Andersen, Fred; Bergh, Sverre; Bettella, Francesco; Bjornsson, Sigurbjorn; Braekhus, Anne; Brathen, Geir; de Leeuw, Christiaan; Desikan, Rahul S.; Djurovic, Srdjan; Dumitrescu, Logan; Fladby, Tormod; Hohman, Timothy J.; Jonsson, Palmi, V; Kiddle, Steven J.; Rongve, Arvid; Saltvedt, Ingvild; Sando, Sigrid B.; Selbaek, Geir; Shoai, Maryam; Skene, Nathan G.; Snaedal, Jon; Stordal, Eystein; Ulstein, Ingun D.; Wang, Yunpeng; White, Linda R.; Hardy, John; Hjerling-Leffler, Jens; Sullivan, Patrick F.; van der Flier, Wiesje M.; Dobson, Richard; Davis, Lea K.; Stefansson, Hreinn; Stefansson, Kari; Pedersen, Nancy L.; Ripke, Stephan; Andreassen, Ole A.; Posthuma, Danielle			Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk	NATURE GENETICS			English	Article							POLYGENIC RISK; MISSENSE MUTATIONS; COGNITIVE RESERVE; GENE-EXPRESSION; VARIANTS; ASSOCIATION; RARE; ANNOTATION; DISCOVERY; DEMENTIA	Alzheimer's disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci. Yet these only explain a small proportion of the genetic variance, indicating that undiscovered loci remain. Here, we performed a large genome-wide association study of clinically diagnosed AD and AD-by-proxy (71,880 cases, 383,378 controls). AD-by-proxy, based on parental diagnoses, showed strong genetic correlation with AD (r(g) = 0.81). Meta-analysis identified 29 risk loci, implicating 215 potential causative genes. Associated genes are strongly expressed in immune-related tissues and cell types (spleen, liver, and microglia). Gene-set analyses indicate biological mechanisms involved in lipid-related processes and degradation of amyloid precursor proteins. We show strong genetic correlations with multiple health-related outcomes, and Mendelian randomization results suggest a protective effect of cognitive ability on AD risk. These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD.	[Jansen, Iris E.; Savage, Jeanne E.; Watanabe, Kyoko; Stringer, Sven; de Leeuw, Christiaan; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam Neurosci, Amsterdam, Netherlands; [Jansen, Iris E.; van der Flier, Wiesje M.] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands; [Bryois, Julien; Williams, Dylan M.; Karlsson, Ida K.; Hagg, Sara; Sullivan, Patrick F.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland; [Sealock, Julia] Vanderbilt Univ, Interdisciplinary Grad Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Karlsson, Ida K.] Jonkoping Univ, Sch Hlth & Welf, Inst Gerontol & Aging Res Network Jonkoping ARN J, Jonkoping, Sweden; [Athanasiu, Lavinia; Witoelar, Aree; Bettella, Francesco; Djurovic, Srdjan; Wang, Yunpeng; Andreassen, Ole A.] Univ Oslo, KG Jebsen Ctr Psychosis Res, Inst Clin Med, NORMENT, Oslo, Norway; [Athanasiu, Lavinia] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Voyle, Nicola; Proitsi, Petroula; Aarsland, Dag; Dobson, Richard] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Witoelar, Aree; Bettella, Francesco; Wang, Yunpeng; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Dis, Stavanger, Norway; [Almdahl, Ina S.; Fladby, Tormod] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Almdahl, Ina S.; Fladby, Tormod] Univ Oslo, AHUS Campus, Oslo, Norway; [Almdahl, Ina S.] Oslo Univ Hosp, Dept Psychiat Old Age, Oslo, Norway; [Andersen, Fred] Univ Tromso, Dept Community Med, Tromso, Norway; [Bergh, Sverre; Braekhus, Anne; Selbaek, Geir] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Bergh, Sverre] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway; [Bjornsson, Sigurbjorn; Jonsson, Palmi, V; Snaedal, Jon] Landspitali Univ Hosp, Dept Geriatr Med, Reykjavik, Iceland; [Braekhus, Anne] Oslo Univ Hosp, Geriatr Dept, Oslo, Norway; [Brathen, Geir; Saltvedt, Ingvild; Sando, Sigrid B.; White, Linda R.] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway; [Brathen, Geir; Sando, Sigrid B.; White, Linda R.] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Desikan, Rahul S.] Univ Calif San Francisco, Neuroradiol Sect, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Dumitrescu, Logan; Hohman, Timothy J.] Vanderbilt Univ, Med Ctr, Dept Neurol, Vanderbilt Memory & Alzheimers Ctr, Nashville, TN USA; [Dumitrescu, Logan; Hohman, Timothy J.; Davis, Lea K.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA; [Jonsson, Palmi, V] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kiddle, Steven J.] Univ Cambridge, Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Rongve, Arvid] Helse Fonna, Dept Res & Innovat, Haugesund, Norway; [Rongve, Arvid] Univ Bergen, Dept Clin Med, Bergen, Norway; [Saltvedt, Ingvild] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Geriatr, Trondheim, Norway; [Selbaek, Geir] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Shoai, Maryam; Hardy, John] UCL, Dept Neurodegenerat Disorders, Inst Neurol, London, England; [Skene, Nathan G.; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden; [Skene, Nathan G.] UCL, Inst Neurol, Dept Neuromuscular Dis, London, England; [Stordal, Eystein] Namsos Hosp, Dept Psychiat, Namsos, Norway; [Stordal, Eystein] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway; [Ulstein, Ingun D.] Oslo Univ Hosp, Geriatr Dept, Memory Clin, Oslo, Norway; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Dobson, Richard] South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Dobson, Richard] Kings Coll London, London, England; [Dobson, Richard] UCL, Inst Hlth Informat Res, London, England; [Dobson, Richard] UCL, Hlth Data Res UK London, London, England; [Davis, Lea K.] Vanderbilt Univ, Med Ctr, Dept Med, Div Genet Med, Nashville, TN USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Posthuma, Danielle] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands		Posthuma, D (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam Neurosci, Amsterdam, Netherlands.; Posthuma, D (corresponding author), Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands.	d.posthuma@vu.nl	Stefansson, Kari/AAE-7187-2019; Wang, Yunpeng/W-8871-2018; Hardy, John/C-2451-2009; Ripke, Stephan/AAK-5486-2021; Andreassen, Ole A./AAY-7531-2020; Karlsson, Ida K/S-6064-2019; dobson, richard/C-9269-2011	Wang, Yunpeng/0000-0001-9831-1090; Hardy, John/0000-0002-3122-0423; Karlsson, Ida K/0000-0003-3605-7829; Kiddle, Steven/0000-0003-4350-7437; dobson, richard/0000-0003-4224-9245; Williams, Dylan/0000-0002-3825-2487; Hagg, Sara/0000-0002-2452-1500; Fladby, Tormod/0000-0002-9984-9797; Shoai, Maryam/0000-0003-2499-8533; Proitsi, Petroula/0000-0002-2553-6974; Aarsland, Dag/0000-0001-6314-216X; Hohman, Timothy/0000-0002-3377-7014; ripke, stephan/0000-0003-3622-835X; Savage, Jeanne/0000-0002-2034-8341; Pedersen, Nancy/0000-0001-8057-3543; de Leeuw, Christiaan/0000-0003-1076-9828; Djurovic, Srdjan/0000-0002-8140-8061; Posthuma, Danielle/0000-0001-7582-2365; Skene, Nathan/0000-0002-6807-3180	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [NWO VICI 453-14-005]; Netherlands Scientific Organization [NWO: 480-05-003]; VU University, Amsterdam, the NetherlandsNetherlands Government; Dutch Brain Foundation; Research Council of NorwayResearch Council of Norway [251134, 248778, 223273, 213837, 225989]; KG Jebsen Stiftelsen; Norwegian Health Association; European Community's JPND Program; ApGeM RCN grant [237250]; European CommunityEuropean Commission [PIAPP-GA-2011-286213 PsychDPC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH109536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG049164, R01AG059716] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P021573/1, MC_PC_17214, UKDRI-1009] Funding Source: UKRI	This work was funded by the Netherlands Organization for Scientific Research (NWO VICI 453-14-005). The analyses were carried out on the Genetic Cluster Computer, which is financed by the Netherlands Scientific Organization (NWO: 480-05-003), by the VU University, Amsterdam, the Netherlands, and by the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services SurfSARA. The work was also funded by the Research Council of Norway (grant nos. 251134, 248778, 223273, 213837, and 225989), KG Jebsen Stiftelsen, the Norwegian Health Association, European Community's JPND Program, ApGeM RCN grant no. 237250, and the European Community's grant no. PIAPP-GA-2011-286213 PsychDPC. This research has been conducted using the UK Biobank resource under application number 16406 and the public ADSP data set, obtained through the Database of Genotypes and Phenotypes under accession number phs000572. Full acknowledgments for the studies that contributed data can be found in the Supplementary Note. We thank the numerous participants, researchers, and staff from many studies who collected and contributed to the data.	Abbott RD, 1998, PEDIATRICS, V102, P602, DOI 10.1542/peds.102.3.602; Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cacace R, 2016, ALZHEIMERS DEMENT, V12, P733, DOI 10.1016/j.jalz.2016.01.012; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Desikan RS, 2015, CIRCULATION, V131, P2061, DOI 10.1161/CIRCULATIONAHA.115.015489; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Dumitriu A, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0164-y; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Giuffrida ML, 2012, MOL NEUROBIOL, V46, P605, DOI 10.1007/s12035-012-8313-6; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Graves AB, 1996, BRIT J PSYCHIAT, V169, P86, DOI 10.1192/bjp.169.1.86; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gurses MS, 2016, AGING DIS, V7, P479, DOI 10.14336/AD.2016.0111; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; Loewendorf A., 2015, J IMMUNOL RES, V2, P1022; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; Marioni RE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0150-6; Ng B, 2017, NAT NEUROSCI, V20, P1418, DOI 10.1038/nn.4632; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Satizabal C, 2016, NEW ENGL J MED, V375, P93, DOI 10.1056/NEJMc1604823; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Skene NG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00016; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Valentina EP, 2017, ANN NEUROL, V82, P311, DOI 10.1002/ana.24999; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	65	572	575	22	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2019	51	3					404	+		10.1038/s41588-018-0311-9			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN1KZ	WOS:000459947200010	30617256	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Korn, JM; Kuruvilla, FG; McCarroll, SA; Wysoker, A; Nemesh, J; Cawley, S; Hubbell, E; Veitch, J; Collins, PJ; Darvishi, K; Lee, C; Nizzari, MM; Gabriel, SB; Purcell, S; Daly, MJ; Altshuler, D				Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Wysoker, Alec; Nemesh, James; Cawley, Simon; Hubbell, Earl; Veitch, Jim; Collins, Patrick J.; Darvishi, Katayoon; Lee, Charles; Nizzari, Marcia M.; Gabriel, Stacey B.; Purcell, Shaun; Daly, Mark J.; Altshuler, David			Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs	NATURE GENETICS			English	Article							HUMAN GENOME; ALGORITHM; LIKELIHOOD; ACCURATE; ARRAYS	Accurate and complete measurement of single nucleotide (SNP) and copy number (CNV) variants, both common and rare, will be required to understand the role of genetic variation in disease. We present Birdsuite, a four-stage analytical framework instantiated in software for deriving integrated and mutually consistent copy number and SNP genotypes. The method sequentially assigns copy number across regions of common copy number polymorphisms (CNPs), calls genotypes of SNPs, identifies rare CNVs via a hidden Markov model (HMM), and generates an integrated sequence and copy number genotype at every locus (for example, including genotypes such as A-null, AAB and BBB in addition to AA, AB and BB calls). Such genotypes more accurately depict the underlying sequence of each individual, reducing the rate of apparent mendelian inconsistencies. The Birdsuite software is applied here to data from the Affymetrix SNP 6.0 array. Additionally, we describe a method, implemented in PLINK, to utilize these combined SNP and CNV genotypes for association testing with a phenotype.	[Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Wysoker, Alec; Nemesh, James; Nizzari, Marcia M.; Gabriel, Stacey B.; Purcell, Shaun; Daly, Mark J.; Altshuler, David] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Wysoker, Alec; Nemesh, James; Nizzari, Marcia M.; Gabriel, Stacey B.; Purcell, Shaun; Daly, Mark J.; Altshuler, David] MIT, Cambridge, MA 02142 USA; [Korn, Joshua M.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Purcell, Shaun; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kuruvilla, Finny G.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Cawley, Simon; Hubbell, Earl; Veitch, Jim; Collins, Patrick J.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Darvishi, Katayoon; Lee, Charles] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA		Korn, JM (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	jkorn@broad.mit.edu; altshuler@molbio.mgh.harvard.edu	Daly, Mark J/B-2453-2017; McCarroll, Steven A/A-8433-2009; Altshuler, David M/A-4476-2009	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; McCarroll, Steven/0000-0002-6954-8184; Hubbell, Earl/0000-0001-7301-3759	Lilly Life Sciences Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008313] Funding Source: NIH RePORTER	We wish to thank G. Getz for discussions on algorithms and comments regarding the supplemental methods. We also thank E. Lander and J. Hirschhorn for their readings and feedback. Finally, we are indebted to the testing labs that provided us with many replicates of HapMap samples run on the Affymetrix SNP 6.0 array. S. A. M. was supported by a Lilly Life Sciences Research Fellowship.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; *INT SCHIZ CONS, 2008, NATURE          0830, DOI DOI 10.1038/NATURE07239; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; MacConaill LE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-211; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Nicolae DL, 2006, BIOINFORMATICS, V22, P1942, DOI 10.1093/bioinformatics/btl341; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	21	572	583	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1253	1260		10.1038/ng.237			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	WOS:000259651000028	18776909	Green Accepted, Green Published			2022-01-24	
J	Amundadottir, LT; Sulem, P; Gudmundsson, J; Helgason, A; Baker, A; Agnarsson, BA; Sigurdsson, A; Benediktsdottir, KR; Cazier, JB; Sainz, J; Jakobsdottir, M; Kostic, J; Magnusdottir, DN; Ghosh, S; Agnarsson, K; Birgisdottir, B; Le Roux, L; Olafsdottir, A; Blondal, T; Andresdottir, M; Gretarsdottir, OS; Bergthorsson, JT; Gudbjartsson, D; Gylfason, A; Thorleifsson, G; Manolescu, A; Kristjansson, K; Geirsson, G; Isaksson, H; Douglas, J; Johansson, JE; Balter, K; Wiklund, F; Montie, JE; Yu, XY; Suarez, BK; Ober, C; Cooney, KA; Gronberg, H; Catalona, WJ; Einarsson, GV; Barkardottir, RB; Gulcher, JR; Kong, A; Thorsteinsdottir, U; Stefansson, K				Amundadottir, Laufey T.; Sulem, Patrick; Gudmundsson, Julius; Helgason, Agnar; Baker, Adam; Agnarsson, Bjarni A.; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Cazier, Jean-Baptiste; Sainz, Jesus; Jakobsdottir, Margret; Kostic, Jelena; Magnusdottir, Droplaug N.; Ghosh, Shyamali; Agnarsson, Kari; Birgisdottir, Birgitta; Le Roux, Louise; Olafsdottir, Adalheidur; Blondal, Thorarinn; Andresdottir, Margret; Gretarsdottir, Olafia Svandis; Bergthorsson, Jon T.; Gudbjartsson, Daniel; Gylfason, Arnaldur; Thorleifsson, Gudmar; Manolescu, Andrei; Kristjansson, Kristleifur; Geirsson, Gudmundur; Isaksson, Helgi; Douglas, Julie; Johansson, Jan-Erik; Balter, Katarina; Wiklund, Fredrik; Montie, James E.; Yu, Xiaoying; Suarez, Brian K.; Ober, Carole; Cooney, Kathleen A.; Gronberg, Henrik; Catalona, William J.; Einarsson, Gudmundur V.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			A common variant associated with prostate cancer in European and African populations	NATURE GENETICS			English	Article							CONFERS RISK; GENE; INFERENCE; POLYMORPHISMS	With the increasing incidence of prostate cancer, identifying common genetic variants that confer risk of the disease is important. Here we report such a variant on chromosome 8q24, a region initially identified through a study of Icelandic families. Allele -8 of the microsatellite DG8S737 was associated with prostate cancer in three case-control series of European ancestry from Iceland, Sweden and the US. The estimated odds ratio ( OR) of the allele is 1.62 (P = 2.7 x 10(-11)). About 19% of affected men and 13% of the general population carry at least one copy, yielding a population attributable risk ( PAR) of similar to 8%. The association was also replicated in an African American case-control group with a similar OR, in which 41% of affected individuals and 30% of the population are carriers. This leads to a greater estimated PAR (16%) that may contribute to higher incidence of prostate cancer in African American men than in men of European ancestry.	DeCODE Genet, IS-101 Reykjavik, Iceland; Univ Iceland, Landspitali Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Univ Iceland, Landspitali Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Orebro Univ Hosp, Dept Urol & Clin Med, Orebro, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA		Thorsteinsdottir, U (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Cazier, Jean-Baptiste/F-2369-2010; Stefansson, Kari/AAE-7187-2019; Manolescu, Andrei/G-4565-2014; Amundadottir, Laufey T/L-7656-2016	Manolescu, Andrei/0000-0002-0713-4664; Amundadottir, Laufey T/0000-0003-1859-8971; Yu, Xiaoying/0000-0003-1659-2365; Ober, Carole/0000-0003-4626-9809; Bergthorsson, Jon Thor/0000-0002-0560-2639; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Cooney, Kathleen/0000-0003-3831-6943; Cazier, Jean-Baptiste/0000-0001-7581-9051	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA105055] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1R01CA105055-01A1] Funding Source: Medline		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Beebe-Dimmer JL, 2006, PROSTATE CANCER P D, V9, P50, DOI 10.1038/sj.pcan.4500840; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Douglas JA, 2005, CANCER EPIDEM BIOMAR, V14, P2035, DOI 10.1158/1055-9965.EPI-05-0170; El Gedaily A, 2001, PROSTATE, V46, P184; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 2001, CANCER J, V7, P61; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindmark F, 2004, JNCI-J NATL CANCER I, V96, P1248, DOI 10.1093/jnci/djh227; MANTEL N, 1959, J NATL CANCER I, V22, P719; *NIH, 1999, NIH PUB, V99; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072	28	572	590	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					652	658		10.1038/ng1808			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	WOS:000237954800018	16682969				2022-01-24	
J	Collins, FS; Brooks, LD; Chakravarti, A				Collins, FS; Brooks, LD; Chakravarti, A			A DNA polymorphism discovery resource for research on human genetic variation	GENOME RESEARCH			English	Article							CYSTIC-FIBROSIS GENE; IDENTIFICATION		Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA		Brooks, LD (corresponding author), Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA.						Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; *COMM HUM GEN DIV, 1997, EV HUM GEN DIV; Foster MW, 1998, GENOME RES, V8, P755, DOI 10.1101/gr.8.8.755; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weiss KM, 1998, GENOME RES, V8, P691, DOI 10.1101/gr.8.7.691	16	572	604	0	37	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	DEC	1998	8	12					1229	1231		10.1101/gr.8.12.1229			3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	153YG	WOS:000077860700001	9872978	Bronze			2022-01-24	
J	Comas, I; Coscolla, M; Luo, T; Borrell, S; Holt, KE; Kato-Maeda, M; Parkhill, J; Malla, B; Berg, S; Thwaites, G; Yeboah-Manu, D; Bothamley, G; Mei, J; Wei, LH; Bentley, S; Harris, SR; Niemann, S; Diel, R; Aseffa, A; Gao, Q; Young, D; Gagneux, S				Comas, Inaki; Coscolla, Mireia; Luo, Tao; Borrell, Sonia; Holt, Kathryn E.; Kato-Maeda, Midori; Parkhill, Julian; Malla, Bijaya; Berg, Stefan; Thwaites, Guy; Yeboah-Manu, Dorothy; Bothamley, Graham; Mei, Jian; Wei, Lanhai; Bentley, Stephen; Harris, Simon R.; Niemann, Stefan; Diel, Roland; Aseffa, Abraham; Gao, Qian; Young, Douglas; Gagneux, Sebastien			Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans	NATURE GENETICS			English	Article							YERSINIA-PESTIS; GENOME; TRANSMISSION; EVOLUTION; ORIGINS; ASSOCIATION; POPULATION; PHYLOGENY; MUTATION; REVEALS	Tuberculosis caused 20% of all human deaths in the Western world between the seventeenth and nineteenth centuries and remains a cause of high mortality in developing countries. In analogy to other crowd diseases, the origin of human tuberculosis has been associated with the Neolithic Demographic Transition, but recent studies point to a much earlier origin. We analyzed the whole genomes of 259 M. tuberculosis complex (MTBC) strains and used this data set to characterize global diversity and to reconstruct the evolutionary history of this pathogen. Coalescent analyses indicate that MTBC emerged about 70,000 years ago, accompanied migrations of anatomically modern humans out of Africa and expanded as a consequence of increases in human population density during the Neolithic period. This long coevolutionary history is consistent with MTBC displaying characteristics indicative of adaptation to both low and high host densities.	[Comas, Inaki] CSISP FISABIO, Ctr Publ Hlth Res, Genom & Hlth Unit, Valencia, Spain; [Comas, Inaki] CIBER Ctr Invest Biomed Red Epidemiol & Publ Hlth, Barcelona, Spain; [Coscolla, Mireia; Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Coscolla, Mireia; Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Luo, Tao; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai, Peoples R China; [Luo, Tao; Gao, Qian] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Shanghai, Peoples R China; [Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Holt, Kathryn E.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia; [Kato-Maeda, Midori] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Berg, Stefan] Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England; [Thwaites, Guy] Kings Coll London, Dept Infect Dis, London, England; [Thwaites, Guy] Kings Coll London, Ctr Clin Infect & Diagnost Res, London, England; [Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Bothamley, Graham] Homerton Univ Hosp, Dept Resp Med, London, England; [Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China; [Wei, Lanhai] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ, Shanghai 200433, Peoples R China; [Wei, Lanhai] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Niemann, Stefan] Mol Mycobacteriol Res Ctr Borstel, Borstel, Germany; [Diel, Roland] Schleswig Holstein Univ Hosp, Inst Epidemiol, Kiel, Germany; [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Young, Douglas] Natl Inst Med Res, MRC, London NW7 1AA, England; [Young, Douglas] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Young, Douglas] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, London, England		Comas, I (corresponding author), CSISP FISABIO, Ctr Publ Hlth Res, Genom & Hlth Unit, Valencia, Spain.	inaki.comas@uv.es; qgao99@yahoo.com; sebastien.gagneux@unibas.ch	Parkhill, Julian/G-4703-2011; Coscolla, Mireia/L-5893-2017; Thwaites, Guy E/R-4993-2019; Comas, Inaki/F-1185-2011; Berg, Stefan/AAU-6463-2020; Wei, Lan-Hai/R-6876-2018; Harris, Simon R/K-1318-2013; Berg, Stefan O/D-3847-2011; Niemann, Stefan/C-9327-2011; Holt, Kathryn E/A-8108-2012; Coscolla, Mireia/ABD-7942-2021; Gagneux, Sebastien/ABE-7909-2020; Aseffa, Abraham/J-3248-2016; Comas, Inaki/AAA-1155-2019; Yeboah-Manu, Dorothy/A-1933-2016	Parkhill, Julian/0000-0002-7069-5958; Coscolla, Mireia/0000-0003-0752-0538; Thwaites, Guy E/0000-0002-2858-2087; Comas, Inaki/0000-0001-5504-9408; Berg, Stefan/0000-0002-3470-7579; Wei, Lan-Hai/0000-0003-3119-7400; Harris, Simon R/0000-0003-1512-6194; Holt, Kathryn E/0000-0003-3949-2471; Coscolla, Mireia/0000-0003-0752-0538; Aseffa, Abraham/0000-0002-8028-1150; Comas, Inaki/0000-0001-5504-9408; Yeboah-Manu, Dorothy/0000-0002-1663-6287; Gagneux, Sebastien/0000-0001-7783-9048; Niemann, Stefan/0000-0002-6604-0684	MRC UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [U.1175.02.002.00015.01, U117581288]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PP0033-119205]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AI090928, HHSN266200700022C]; Leverhulme-Royal Society Africa Award [AA080019]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91231115]; Wellcome TrustWellcome TrustEuropean Commission [098051]; European Community (SysteMTb) [HEALTH-F4-2010-241587]; European UnionEuropean Commission [272086]; Ministerio de Economia y Competitividad (Spain) [BFU2011-24112]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI090928] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U117588500, MC_U117581288] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U117588500, MC_U117581288] Funding Source: UKRI	We thank D. Behar and S. Rosset for providing the mitochondrial genome sequences and C. Gignoux for advice on the mitochondrial Neolithic data set, N. Mistry (The Foundation for Medical Research) for providing bacterial strains and C. Dye, F. Balloux and L. Weinert for comments on the manuscript. This work was supported by the MRC UK (grants U.1175.02.002.00015.01 to S. G. and U117581288 to D.Y.), the Swiss National Science Foundation (PP0033-119205 to S. G.), the US National Institutes of Health (AI090928 and HHSN266200700022C to S. G.), the Leverhulme-Royal Society Africa Award (AA080019 to S. G.) and the Natural Science Foundation of China (grant 91231115 to Q. G.). DNA sequencing was partially supported by core funding of the Wellcome Trust (grant 098051) and by a Framework Programme 7 project of the European Community (SysteMTb HEALTH-F4-2010-241587 to D.Y.). I. C. is supported by European Union funding from the Marie Curie Framework Programme 7 actions (project 272086) and project BFU2011-24112 from the Ministerio de Economia y Competitividad (Spain).	Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Barnes I, 2011, EVOLUTION, V65, P842, DOI 10.1111/j.1558-5646.2010.01132.x; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bellwood P, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P13, DOI 10.1007/978-1-4020-8539-0_2; Berg G., 1940, JAMA-J AM MED ASSOC, V114, P1954; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Diamond J., 1999, GUNS GERMS STEEL FAT, P496; Djelouadji Z, 2011, LANCET INFECT DIS, V11, P641, DOI 10.1016/S1473-3099(11)70093-7; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hall TA, 1999, NUCL ACIDS S SER, P95; Hamilton MJ, 2007, P R SOC B, V274, P2195, DOI 10.1098/rspb.2007.0564; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; *WHO, 2011, GLOB PLAN STOP TB 20; Wilson LG, 2005, INT J EPIDEMIOL, V34, P521, DOI 10.1093/ije/dyh196; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	60	571	585	11	199	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1176	U311		10.1038/ng.2744			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	WOS:000324989600013	23995134	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Ji, WZ; Foo, JN; O'Roak, BJ; Zhao, H; Larson, MG; Simon, DB; Newton-Cheh, C; State, MW; Levy, D; Lifton, RP				Ji, Weizhen; Foo, Jia Nee; O'Roak, Brian J.; Zhao, Hongyu; Larson, Martin G.; Simon, David B.; Newton-Cheh, Christopher; State, Matthew W.; Levy, Daniel; Lifton, Richard P.			Rare independent mutations in renal salt handling genes contribute to blood pressure variation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NA-CL COTRANSPORTER; CORONARY-HEART-DISEASE; BARTTERS-SYNDROME; HYPOKALEMIC ALKALOSIS; RISK; HYPERCALCIURIA; SUSCEPTIBILITY; MECHANISMS; EXPRESSION	The effects of alleles in many genes are believed to contribute to common complex diseases such as hypertension. Whether risk alleles comprise a small number of common variants or many rare independent mutations at trait loci is largely unknown. We screened members of the Framingham Heart Study (FHS) for variation in three genes-SLC12A3 (NCCT), SLC12A1 (NKCC2) and KCNJ1 (ROMK)- causing rare recessive diseases featuring large reductions in blood pressure. Using comparative genomics, genetics and biochemistry, we identified subjects with mutations proven or inferred to be functional. These mutations, all heterozygous and rare, produce clinically significant blood pressure reduction and protect from development of hypertension. Our findings implicate many rare alleles that alter renal salt handling in blood pressure variation in the general population, and identify alleles with health benefit that are nonetheless under purifying selection. These findings have implications for the genetic architecture of hypertension and other common complex traits.	[Ji, Weizhen; Foo, Jia Nee; O'Roak, Brian J.; Zhao, Hongyu; Simon, David B.; State, Matthew W.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ji, Weizhen; Foo, Jia Nee; Simon, David B.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Larson, Martin G.; Newton-Cheh, Christopher; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, New Haven, CT 06520 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA		Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Levy, Daniel/ABB-2752-2021; Foo, Jia Nee/D-6069-2014; Levy, Daniel/ABF-6873-2021; State, Matthew/W-2256-2019	Foo, Jia Nee/0000-0001-9899-2308; Levy, Daniel/0000-0003-1843-8724; O'Roak, Brian/0000-0002-4141-0095; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [ZIAHL006001, P50HL055007] Funding Source: NIH RePORTER; Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50 HL055007, N01-HC-25195, N01HC25195] Funding Source: Medline		[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper DN, 1995, METABOLIC MOL BASES, P259; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Cruz DN, 2001, NEPHROL DIAL TRANSPL, V16, P691, DOI 10.1093/ndt/16.4.691-a; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; He J, 1999, AM HEART J, V138, pS211, DOI 10.1016/S0002-8703(99)70312-1; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; Lemmink HH, 1998, KIDNEY INT, V54, P720, DOI 10.1046/j.1523-1755.1998.00070.x; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Murphy KM, 2003, EXPERT REV MOL DIAGN, V3, P811, DOI 10.1586/14737159.3.6.811; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; RUDIN A, 1988, ACTA MED SCAND, V224, P165; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaer AJ, 2001, AM J MED SCI, V322, P316, DOI 10.1097/00000441-200112000-00004; SIECK UV, 1984, OBSTET GYNECOL, V63, pS22; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Syren Marie-Louise, 2002, Hum Mutat, V20, P78, DOI 10.1002/humu.9045; Takahashi N, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133604; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	46	571	595	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					592	599		10.1038/ng.118			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	WOS:000255366700027	18391953	Green Accepted			2022-01-24	
J	Mill, J; Tang, T; Kaminsky, Z; Khare, T; Yazdanpanah, S; Bouchard, L; Jia, P; Assadzadeh, A; Flanagan, J; Schumacher, A; Wang, SC; Petronis, A				Mill, Jonathan; Tang, Thomas; Kaminsky, Zachary; Khare, Tarang; Yazdanpanah, Simin; Bouchard, Luigi; Jia, Peixin; Assadzadeh, Abbas; Flanagan, James; Schumacher, Axel; Wang, Sun-Chong; Petronis, Arturas			Epigenomic profiling reveals DNA-Methylation changes associated with major psychosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR DISORDER; MESSENGER-RNA; INCREASED EXPRESSION; EPIGENETIC VARIATION; GENDER-DIFFERENCES; PREFRONTAL CORTEX; SCHIZOPHRENIA; PROMOTER; GENE; BRAIN	Epigenetic misregulation is consistent with various non-Mendelian features of schizophrenia and bipolar disorder. To date, however, few studies have investigated the role of DNA methylation in major psychosis, and none have taken a genome-wide epigenomic approach. In this study we used CpG-island microarrays to identify DNA-methylation changes in the frontal cortex and germline associated with schizophrenia and bipolar disorder. In the frontal cortex we find evidence for psychosis-associated DNA-methylation differences in numerous loci, including several involved in glutamatergic and GABAergic neurotransmission, brain development, and other processes functionally linked to disease etiology. DNA-methylation changes in a significant proportion of these loci correspond to reported changes of steady-state mRNA level associated with psychosis. Gene-ontology analysis highlighted epigenetic disruption to loci involved in mitochondrial function, brain development, and stress response. Methylome network analysis uncovered decreased epigenetic modularity in both the brain and the germline of affected individuals, suggesting that systemic epigenetic dysfunction may be associated with major psychosis. We also report evidence for a strong correlation between DNA methylation in the MEK1 gene promoter region and lifetime antipsychotic use in schizophrenia patients. Finally, we observe that frontal-cortex DNA methylation in the BDNF gene is correlated with genotype at a nearby nonsynonymous SNP that has been previously associated with major psychosis. Our data are consistent with the epigenetic theory of major psychosis and suggest that DNA-methylation changes are important to the etiology of schizophrenia and bipolar disorder.	[Mill, Jonathan; Tang, Thomas; Kaminsky, Zachary; Khare, Tarang; Yazdanpanah, Simin; Bouchard, Luigi; Jia, Peixin; Assadzadeh, Abbas; Flanagan, James; Schumacher, Axel; Wang, Sun-Chong; Petronis, Arturas] Ctr Addict & Mental Hlth, Krembil Family Epigenet lab, Toronto, ON M5T 1R8, Canada; [Mill, Jonathan] Kings Coll London, Inst Psychiat, SGDP Res Ctr, London SE5 8AF, England; [Bouchard, Luigi] Univ Laval, Lipid Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Bouchard, Luigi] Univ Laval, Laval Univ Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Flanagan, James] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Schumacher, Axel] Tech Univ Munich, D-80333 Munich, Germany; [Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli 32001, Taiwan		Petronis, A (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet lab, 250 Coll St, Toronto, ON M5T 1R8, Canada.	arturas_petronis@camh.net	Schumacher, Axel/C-6612-2008; Mill, Jonathan S/B-3276-2010; Petronis, Art/AAD-4491-2019; Mill, Jonathan/B-5678-2014	Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Flanagan, James/0000-0003-4955-1383	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH088413, R01MH074127] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9817803B] Funding Source: researchfish; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH074127-01, R01 MH088413, R01 MH074127] Funding Source: Medline		Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Arnold LM, 2003, PSYCHIAT CLIN N AM, V26, P595, DOI 10.1016/S0193-953X(03)00036-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning JL, 2005, BIOL PSYCHIAT, V57, P617, DOI 10.1016/j.biopsych.2004.12.002; Bruneau EG, 2005, SCHIZOPHR RES, V75, P27, DOI 10.1016/j.schres.2004.12.012; Couve A, 2004, J BIOL CHEM, V279, P13934, DOI 10.1074/jbc.M311737200; Cowled P, 2005, NEOPLASIA, V7, P1091, DOI 10.1593/neo.05364; Coyle JT, 2004, BIOCHEM PHARMACOL, V68, P1507, DOI 10.1016/j.bcp.2004.07.034; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; Dempster EL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-10; Eastwood SL, 2005, SCHIZOPHR RES, V73, P159, DOI 10.1016/j.schres.2004.05.010; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Gupta DS, 2005, SYNAPSE, V57, P123, DOI 10.1002/syn.20164; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; HORROBIN DF, 1994, SCHIZOPHR RES, V13, P195, DOI 10.1016/0920-9964(94)90043-4; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Jung HH, 2004, J CLIN PSYCHIAT, V65, P722; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; KLEMPNAUER KH, 1993, ONCOGENE, V8, P111; Kontkanen O, 2002, NEUROPSYCHOPHARMACOL, V27, P152, DOI 10.1016/S0893-133X(02)00289-0; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mann H, 2003, MOL CELL, V12, P925, DOI 10.1016/S1097-2765(03)00357-5; Marksteiner J, 2001, NEUROSCIENCE, V104, P325, DOI 10.1016/S0306-4522(01)00081-1; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; MCQUILLIN A, 2007, GENOMICS, V17, P605; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Petronis A, 2004, BIOL PSYCHIAT, V55, P965, DOI 10.1016/j.biopsych.2004.02.005; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; RIGGS AD, 1998, NOVART FDN SYMP, V214, P225; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; SALUZ HP, 1986, P NATL ACAD SCI USA, V83, P7167, DOI 10.1073/pnas.83.19.7167; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Smith RE, 2001, NEUROREPORT, V12, P2885, DOI 10.1097/00001756-200109170-00026; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Westhoff C M, 2004, Immunohematology, V20, P37; Xing GQ, 2006, SCHIZOPHR RES, V84, P36, DOI 10.1016/j.schres.2005.11.006; YOKOMORI N, 1995, P NATL ACAD SCI USA, V92, P1302, DOI 10.1073/pnas.92.5.1302	63	571	593	0	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					696	711		10.1016/j.ajhg.2008.01.008			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	WOS:000254067800014	18319075	Green Published, Bronze			2022-01-24	
